{"early receptor bind study": 0.01286, "induce acute respiratory distress syndrome": 0.01016, "il-5 receptor": 0.02571, "dna-recognition": 6e-05, "anti-cd28 costimulation": 0.00171, "erythroid development": 0.00633, "stone-forming condition": 0.0036, "variable": 0.0031, "il-10 inhibit induction": 0.0127, "camp regulatory element bind protein": 0.01811, "genistein fail": 0.00347, "t-cell trans-activator": 0.00962, "rhil-2": 6e-05, "exogenous tumor necrosis factor": 0.0143, "substantial": 0.00254, "small basic potential phosphoprotein": 0.00302, "integrin signal pathway": 0.0109, "transcription factor protein": 0.03019, "additional stimulation": 0.0112, "bja-b": 0.00019, "maintain nf-kappa": 0.01414, "c-jun n-terminal kinase": 0.00792, "mcp-1 show parallel variation": 0.013, "-95 nt relative": 0.00184, "cbf alpha": 0.01169, "major part": 0.00574, "hbx sequence": 0.01625, "intracellular transcriptional factor": 0.01907, "class ii mhc/superantigen": 0.00484, "stlv-i-bearing": 6e-05, "footprinted binding site": 0.01445, "multiple cytokine": 0.01123, "glucocorticoid receptor expression": 0.02775, "early productive cycle": 0.00552, "formamide free": 0.00127, "il-1beta transcription": 0.0281, "myeloid cell differentiation": 0.0512, "point mutagenesis": 0.00183, "glucocorticoid induce down-regulation": 0.01694, "low salt condition": 0.00471, "ets family member reacts": 0.0042, "cd28 ligation": 0.00323, "bcl-2 family protein": 0.03019, "polyacrylamide gel electrophoresis": 0.0011, "cell adhesion molecule": 0.0512, "tumour": 0.00366, "genetic predisposition": 0.00288, "calcineurin result": 0.0161, "acute myeloid leukemia": 0.00333, "lymphocyte function associated-antigen-1": 0.00988, ":29038": 0.00012, "cellular redox": 0.00893, "thymocytes affect": 0.00797, "cells-binding factor": 0.0286, "fibroblast growth factor": 0.01907, "typical aitl": 0.00118, "mimic thrombin": 0.00174, "hiv p24 antigen release": 0.00409, "sensitive measurement": 0.00273, "liquid nitrogen": 0.00028, "il-1beta treatment lead": 0.00676, "decrease il-12 production": 0.00695, "ivs1-10t": 6e-05, "pcna": 0.00019, "mice generate": 0.00453, "hmg-1": 0.00025, "lps-stimulated human monocytic cell line": 0.03072, "abrogate": 0.00509, "genomic anonymous probe": 0.0018, "adult beta-globin gene activator protein eklf": 0.0151, "transfection analysis": 0.01179, "rnf-il6 express": 0.01846, "critical downstream effector": 0.00285, "pmns chemotaxis": 0.00047, "backbone vector": 0.00319, "pseudoautosomal region": 0.01467, "distinguishable gr bind abnormality": 0.01013, "individual viable cell": 0.0512, "mouse lymph node": 0.00649, "model account": 0.00422, "additional residue abolish": 0.00236, "30-40 min": 0.00127, "detergent": 0.0005, "inositol phosphate response": 0.01294, "pu.1 mediate": 0.01231, "ifn-alpha responsiveness": 0.00323, "affect spi-b function": 0.00887, "primary human blood lymphocyte": 0.01881, "heterogeneous nuclear ribonucleoprotein": 0.01123, "trancriptional role": 0.01328, "dissection": 0.00012, "increase gene expression": 0.02903, "chain mrna induction": 0.01071, "physiological function": 0.01331, "major difference": 0.00574, "rna synthesis": 0.00583, "pkc-zeta cell provide": 0.0512, "ternary icsa-n-wasp-arp2/3 complex": 0.01123, "dramatic dose-dependent shift": 0.00122, "heterodimeric binding complex": 0.01237, "cell specific": 0.0768, "zinc finger transcription factor gata-1": 0.01144, "conditional tyrosine kinase oncogene": 0.00594, "janus kinase/signal transducer": 0.00077, "estrogen-dependent manner": 0.00282, "tcdd treatment decrease steady state level": 0.00607, "promyelomonocytic leukemic hl-60 cell": 0.0384, "5'-regulatory region": 0.01467, "distinct interference": 0.00698, "b-lymphoid tissue": 0.00664, "class i-restricted ctls": 0.00428, "classical": 0.00341, "immunoblotting experiment": 0.00397, "beta- versus alpha-globin chain": 0.00219, "respiratory manifestation": 0.00078, "important functional site": 0.01445, "term rfx-b": 0.00413, "il-2 induces tyrosine phosphorylation": 0.00558, "ets-1 proto-oncogene": 0.0013, "carboxy-terminus": 0.00019, "arthritic rat": 0.00285, "stat5a": 0.00143, "stat6 detect": 0.00726, "hiv1-infected monocyte": 0.01197, "suppress transcriptional activation": 0.02109, "promyelocytic": 0.00186, "451.4+/-45.4 cells/mm2": 0.00012, "flanking region": 0.01467, "nfat transcription factor play": 0.0143, "proliferation": 0.01607, "benign clinical": 0.00425, "test tyloxapol": 0.00487, "fk506-mediated inhibition": 0.01061, "nf-kappa b2 p100 gene product": 0.01742, "e2a protein": 0.04529, "synthesized compound show": 0.01733, "hil-5-responsive cell line": 0.0512, "external stimulus": 0.0027, "nf-kappa b-dependent element": 0.01115, "accelerate erythroid differentiation": 0.00786, "excellent model": 0.00422, "substspl234": 0.00012, "e47 product": 0.00533, "cell leukemia": 0.0768, "adnexal mass": 0.00084, "bcl-2 promoter inhibits transactivation": 0.01168, "e47 binding site": 0.01445, "tre": 0.00105, "mediate change": 0.01231, "p65 labeling": 0.00388, "human monocytic leukemia cell line thp-1 differentiates": 0.02194, "normal mesothelial cell": 0.0512, "recombinant ifn-gamma": 0.00481, "lymphocyte synthesize": 0.01483, "proviral transcription": 0.0281, "weak chi": 0.00174, "human neuroblastoma cell line": 0.0384, "von willebrand factor": 0.01907, "recent discovery": 0.0014, "cell bound": 0.0768, "cell activation occur": 0.0512, "chicken homolog": 0.00078, "cho-cd86": 0.00037, "demonstrate low calcemic effect": 0.01058, "carbimazole": 6e-05, "p-like element show": 0.01733, "yy-1 protein": 0.04529, "anti-cd28 moab": 0.00081, "ltr": 0.0062, "cell subpopulation": 0.0768, "oxidative specie release": 0.00323, "tropical spastic paraparesis/htlv-i-associated myelopathy": 0.00011, "neutrophil biology": 0.00496, "rearrangement lead": 0.00996, "differentiate erythroid cell": 0.0512, "tnfalpha treatment induce": 0.01694, "intracellular free ca2+ concentration": 0.00335, "cysteine-rich domain": 0.01207, "cell inhibitory activity present": 0.0384, "receptor initiate": 0.02571, "hemin treatment": 0.01014, "il-4 stat activation cycle": 0.01582, "phosphorylation-defective form": 0.01055, "tcf-1 constitute": 0.00189, "gos19": 0.00025, "pma exhibit": 0.00664, "il-13 utilizes il-4r": 0.00122, "il-7 act": 0.00496, "tumor cell block apoptosis induce": 0.03072, "lox-1": 0.00056, "t-cell-mediated autoimmune disease": 0.00449, "include cd14": 0.01439, "giant cell": 0.0768, "serine/threonine protein kinase inhibitor h-7": 0.01811, "synergistic induction": 0.01607, "nf-kappa b-independent mechanism": 0.00943, "late granulocytic maturation": 0.0017, "ru486 suggest": 0.02022, "nf-kappab target": 0.00999, "cytoplasmic subunit": 0.00484, "antioxidant treatment": 0.01014, "human t-lymphotrophic virus type": 0.01881, "inhibitory subunit": 0.00484, "negative regulatory element": 0.01115, "nf-kappa b-containing plasmid correlate": 0.00707, "reveal consensus ckii sit": 0.00549, "major mechanism": 0.01058, "unliganded c-erba/tr support growth": 0.00409, "transcription factor sp1": 0.01907, "ifn-gamma-dependent mechanism": 0.01058, "release estrogen predominance": 0.00323, "antiviral action": 0.00499, "dna-protein complex specific": 0.01123, "murine spleen": 0.00623, "tuberculous patient": 0.01666, "hematopoietic-specific transcription factor": 0.01907, "suppress": 0.01222, "acidic activator": 0.00552, "primary mouse": 0.00974, "activate viral gene expression": 0.02177, "nh2cl": 0.00037, "control proliferate": 0.01303, "crucial element": 0.01672, "nfkb family member rel-a": 0.0042, "secrete tnf-alpha mediate": 0.00821, "dual effect": 0.02115, "stimulate proliferation": 0.01101, "autocrine effect": 0.02115, "d-box": 0.0, "neutrophil development": 0.00633, "kappa-opioid receptor": 0.02571, "anthracycline-treated cell": 0.0768, "monocytic/myeloid leukemia-derived cell line": 0.0384, "persistent group": 0.00487, "receptor-coupled pld activation": 0.02109, "nucleolin cdna expression construct": 0.02081, "anti-tat sfv intrabodies": 0.00017, "kit225 cell culture": 0.0512, "somatic hypermutation mechanism active": 0.00529, "dna-binding characteristic": 0.00561, "amino acid alteration": 0.00571, "antisense oligonucleotide block": 0.00715, "viral expression": 0.04163, "antiestrogens h1285": 0.00012, "4e-bp1": 0.00043, "t-cell-specific factor": 0.0286, "hsv-specific clone isolate": 0.00492, "activate hiv-1": 0.01777, "vcam promoter": 0.02336, "fos/jun-containing nf-at complex": 0.01123, "probe homologous": 0.00261, "develop glucocorticoid resistance characterize": 0.00425, "liver function": 0.01331, "ccaat element present": 0.01115, "inducing loss": 0.00298, "l132 cell transfected": 0.0512, "camkiv/ gr signaling": 0.00372, "inducible oct-2 dna binding activity": 0.0117, "cd8 cell surface": 0.0512, "display differential binding": 0.01237, "copy dna": 0.01483, "similar analysis": 0.01179, "q21q26": 0.0, "switch": 0.0049, "hiv-1 ltr activity": 0.0195, "jund gene": 0.04355, "mutant tsap-binding site": 0.01445, "truncation mutant": 0.0081, "gamma ray": 0.0044, "central pathogenic mechanism": 0.00705, "cd40-dependent signal": 0.01635, "increase c-jun expression": 0.02775, "remain high": 0.00931, "aged group": 0.00487, "rel/nuclear factor kappab": 0.01907, "hiv-1 nre": 0.00878, "phorbol 12-myristate 13-acetate": 0.00362, "1h-imidazole": 0.00012, "proviral genome": 0.0014, "ad5e1a-specific ctl activity": 0.0195, "dna segment": 0.01483, "prevent rar activation": 0.02109, "tax function": 0.01331, "np-tcii": 6e-05, "aids-c": 0.00031, "compromised degradation": 0.00332, "show effective inhibition": 0.01733, "jy25 cell": 0.0768, "ppargamma activation": 0.03164, "neoplastic disease": 0.00673, "90-kda stat3alpha": 0.00056, "transcription activity": 0.02925, "up-regulate protein binding": 0.03019, "favor tumor growth": 0.00622, "distinct pattern": 0.00698, "il-2 regulatory region": 0.00978, "human naive cell": 0.0512, "il-2r alpha-": 0.00251, "cell express cd40l": 0.0512, "ii kappa b-1": 0.00498, "oxidative signalling provide": 0.0043, "akata cell": 0.0768, "s-phase p107 complex": 0.01123, "chem": 0.00025, "feature suggestive": 0.00217, "-0.791": 0.0, "cell redox status": 0.0512, "human u-937 leukemia cell": 0.0384, "finger transcription factor require": 0.0143, "normal expression": 0.04163, "lncap cell line": 0.0512, "gm3 form": 0.01055, "distal purine box": 0.00203, "nuclear translocation signal": 0.01123, "nt encode": 0.00853, "ba-induced differentiation": 0.01179, "differential activity": 0.02925, "leukemic atll cell": 0.0512, "human tcf-1": 0.03762, "multiple regulatory site": 0.01445, "position -72": 0.00236, "dna region": 0.01483, "occur sequence variant": 0.01084, "antigen processing": 0.00819, "autoantigen ssb": 0.00043, "endotoxin lethality": 0.00102, "consolidation chemotherapy": 0.00071, "tnf-treated huvecs": 0.00081, "hl-60/vinc line": 0.01653, "signal lead": 0.01635, "nk-cell lineage": 0.00366, "wave": 0.00025, "intravenous pretreatment": 0.00146, "traf6 adaptor": 0.00068, "human genomic dna sequence upstream": 0.01505, "receptor antagonist ru-38486": 0.01714, "il-1 exert": 0.00332, "hiv-1 genome expression": 0.02775, "ductal": 0.00074, "regular menses": 0.00019, "increase il-4 promoter activity": 0.01462, "long neurite process": 0.00296, "ionomycin/cyclosporin a-responsive element": 0.01115, "rar beta": 0.00673, "human monoblastic leukemia cell line u937": 0.0256, "factor function": 0.0286, "erythroid protein": 0.04529, "ifn-gamma potentiates": 0.00481, "nf-atp-/- mouse": 0.00974, "prolactin": 0.00112, "oca-b alters": 0.00099, "rheumatoid arthritis synovial tissue": 0.00332, "hiv tat": 0.00592, "erk-2 pathway": 0.01278, "thyroid hormone inhibit": 0.0127, "ig heavy chain promoter": 0.01168, "erythroblast render": 0.00152, "ra receptor": 0.02571, "lymphoid-related dc": 0.00202, "activate cell proliferation": 0.0512, "active protein-tyrosine kinase regulatory pathway": 0.00511, "nf90 protein": 0.04529, "normal profile": 0.0121, "s-x-y region": 0.01467, "e1a activity": 0.02925, "vivo substrate": 0.0053, "activate monocyte": 0.01777, "t-cell-activating signal": 0.01635, "profound effect": 0.02115, "non-ashkenazi jew": 0.00012, "aim activation pathway regulate": 0.01582, "activate nf-kappabp65": 0.01777, "sheep mammary gland tissue": 0.00332, "lcd motif": 0.00875, "exhibit fast growth rate": 0.00409, "specific 'pre-activation": 0.01238, "cell line bear human": 0.0384, "cell harvester": 0.0768, "ap-1-tre": 6e-05, "major orf2 consist": 0.00383, "mrna vary": 0.01526, "rapid production": 0.01042, "cpo gene": 0.04355, "share receptor": 0.02571, "factor-specific coactivator": 0.00149, "adenovirus e1b-19 kda": 0.00126, "gamma-ifn signaling": 0.00558, "virus reactivation": 0.00887, "transcription factor gene": 0.02903, "c/ebp family member": 0.0056, "immunodeficiency syndrome patient": 0.0111, "scl transcription": 0.0281, "fcgammari promoter": 0.02336, "tyloxapol inhibits activation": 0.02109, "class ii negative": 0.00484, "alpha-globin enhancer": 0.00909, "ptpases": 0.00012, "antagonistic activity": 0.02925, "increase gp91phox mrna expression": 0.02081, "cleavage site": 0.02168, "cell arrest": 0.0768, "eu -and hyperthyroid patient": 0.00833, "irf family transcription factor gene expression": 0.01452, "il-2-r alpha": 0.01169, "immunity": 0.00223, "104-522 ppt i-te": 0.00014, "steroid dose sparing": 0.00194, "mpe": 0.00012, "adaptive immunity": 0.00112, "acquired form": 0.01055, "active vitamin d3 metabolite 1,25-dihydroxycholecalciferol": 0.00237, "receptor decrease": 0.02571, "unidentified ligand pair": 0.00395, "bcl-2 prevents": 0.00295, "corticosteroid suppress inflammation": 0.00407, "cyclic amp": 0.00149, "viral ligand": 0.00732, "promoter proximal region upstream": 0.01168, "peripheral-blood mononuclear cell": 0.0512, "feb": 0.00012, "prolactin-inducible interferon regulatory factor-1 gene": 0.01742, "megakaryocytic gene expression": 0.02903, "potential effect": 0.02115, "j.y.h": 6e-05, "multiple regulatory element": 0.01115, "rapid phosphorylation": 0.00983, "show minimal constitutive virus expression": 0.01665, "immunocytochemical experiment": 0.00397, "ap-1 consensus site": 0.01445, "acute leukemia": 0.00499, "transcription factor nf-kappa b. transcriptional activation": 0.01055, "2.3-kb cdna clone": 0.00492, "-beta heterodimer express": 0.0123, "temporary": 0.00012, "probe encompass": 0.00261, "foreign cell": 0.0768, "stable adhesion": 0.0058, "constitutive interferon-gamma receptor": 0.01714, "serum withdrawal": 0.00378, "il-1r": 0.00068, "tur cell": 0.0768, "4-trifluoromethyl salicylate derivative": 0.00128, "isolate cdna clone": 0.00492, "genistein inhibit": 0.01904, "primary restriction element": 0.01115, "inhibit cell proliferation": 0.0512, "-atpase target": 0.00825, ".01": 6e-05, "gr chimeric receptor": 0.01714, "fas/fasl interaction initiate cell death": 0.03072, "cd23 mrna": 0.01526, "tnf-alpha mrna": 0.01526, "th2 pathway": 0.01278, "icam-i mrna": 0.01526, "pool": 0.00087, "pma induce": 0.0254, "human leukemic": 0.03762, "progressive infection": 0.0062, "stat5 site present": 0.01445, "stromal cell induce tcell survival": 0.03072, "remain elusive": 0.00521, "component tyrosine phosphorylated subsequent": 0.00355, "sequence 5'-ggaacctccccc-3": 0.01625, "nf-kappab site present": 0.01445, "physiologic setting": 0.00071, "stimulation-dependent signal transduction": 0.0109, "rna-packaging defect": 0.00279, "hla-dma": 0.00019, "potent immunosuppressive agent": 0.00281, "high affinity ige receptor": 0.01286, "collagenase induction": 0.01607, "professional apc": 0.00093, "promonocytic cell undergoing apoptosis": 0.0384, "transcriptional basis": 0.01151, "low shear flow-induced haec vcam-1 expression": 0.01388, "membrane potential": 0.00605, "c-myc transcriptional regulator": 0.00767, "rdna transcription": 0.0281, "human gammac promoter": 0.02508, "unknown pathway": 0.01278, "blast crisis phase": 0.00184, "coding gene": 0.04355, "regulatory promoter element": 0.01557, "immunoglobulin molecule": 0.00853, "anti-p-selectin antibody": 0.00893, "b-cell line test show nf-kappa": 0.0104, "dna similarly": 0.01483, "dephosphorylated": 0.00112, "human t-cell fk506-binding protein": 0.02264, "erythrocyte-specific carbonic anhydrase ii": 0.00363, "minimal beta-globin promoter": 0.01557, "initiating event": 0.00552, "solution structure": 0.00319, "ebv genome positive lymphoid cell line": 0.0256, "gre-dependent luciferase reporter gene": 0.02177, "intracellular mechanism": 0.01058, "impaired dna-protein interaction": 0.00658, "primary rodent cell": 0.0512, "young": 0.00149, "subtle down-regulatory effect": 0.0141, "normal human lymphocyte": 0.02508, "east african population": 0.00205, "specific complex formation": 0.01123, "pma/a23187-induced nf-at": 0.00397, "alloimmune thrombocytopenia": 6e-05, "hybrid gene": 0.04355, "mvec": 0.00025, "ylpa": 6e-05, "cd106": 0.00019, "recent sib-pair analysis reveal": 0.00589, "calpain inhibitor": 0.009, "human il-4 promoter exists": 0.01881, "transgenic mouse model": 0.00649, "monocytic ikappab kinase signalsome activation": 0.01266, "254-266": 6e-05, "proliferation/differentiation": 6e-05, "elisa screening": 0.00062, "general mechanism": 0.01058, "c. albicans enhance hiv expression": 0.01665, "anionic phospholipid": 0.0005, "human matrix metalloproteinase": 0.02508, "induce transcription": 0.0281, "enhance tyrosine phosphorylation": 0.00656, "polymerase chain reaction-based method": 0.00219, "regulate target effector": 0.00835, "alternative approach": 0.00205, "bare lymphocyte syndrome": 0.00988, "pma-inducible factor": 0.0286, "ca2+ load": 0.00304, "de novo alpha-galactosidase": 0.00105, "activate hiv-1 ltr-dependent gene expression": 0.01742, "mcp-1": 0.00248, "promoter deletion": 0.02336, "hiv-tf1-binding site": 0.02168, "induce kappab-dependent reporter activity": 0.01462, "tg -but": 0.00093, "twice/d": 0.0, "coincubation": 0.00056, "biogenesis": 6e-05, "large panel": 0.00205, "hypophosphorylated prb bind": 0.0135, "gm-csf gene essential": 0.02903, "immunoelectron microscopy reveal land": 0.00549, "jun/fos protein": 0.04529, "bob1/obf-1/oca-b": 0.00012, "gm3": 0.0005, "retinoid-dependent granulocytic marker expression": 0.02081, "hormone-binding domain": 0.01207, "ut-7/epo": 6e-05, "burkitt tumor cell": 0.0512, "ubiquitous polypeptide": 0.00136, "ap-1 dna-binding activity": 0.0195, "clear induction": 0.01607, "ito associate": 0.01092, "human homolog baf155": 0.02508, "overexpressed hsf3 measure": 0.00258, "purified factor": 0.0286, "active dna replication": 0.00988, "a.garzino-demo": 0.00012, "multiple administration": 0.00689, "adult mouse tissue reveal": 0.00549, "multipotent eml cell harbor substantial nuclear hormone receptor coactivator activity": 0.01536, "kda nf-kappa": 0.01414, "induce signal event result": 0.0127, "p. a.": 0.00081, "single transcription factor": 0.01907, "nucleus compartment": 0.00319, "functional assay": 0.01002, "breast cancer prior": 0.00172, "increase gata-1 level": 0.01464, "comparative analysis": 0.01179, "il-2 control il-2 receptor alpha": 0.01029, "enigmatic aspect": 0.00124, "mineralization": 0.00012, "pel": 0.00081, "primary source": 0.00738, "demonstrate membrane binding": 0.01237, "oxidative stress": 0.0031, "fusion promoter": 0.02336, "ap1/c-jun proto-oncogene": 0.0013, "important immunomodulatory role": 0.00885, "lef-1": 0.00155, "growth factor": 0.0286, "pfu": 6e-05, "ionomycin stimulation": 0.0112, "transcriptional repressor encode": 0.00767, "parental cell line": 0.0512, "5'-race": 0.00012, "steroid nucleus": 0.00319, "box bind protein": 0.03019, "target gene": 0.04355, "nucleolin": 0.00081, "limited side effect": 0.0141, "overlap sp1/egr-1 site": 0.01445, "signalsome activation": 0.03164, "l.chene": 0.00012, "lymphoma line result": 0.01102, "il-2 deprivation": 0.01117, "clinical spectrum": 0.00425, "partial proteolysis": 0.00143, "two-step model": 0.00422, "anatomic tumor size": 0.00622, "chronic renal failure patient": 0.00833, "cip1": 6e-05, "sequence proximal": 0.01625, "t-all base": 0.0031, "transcriptional down-regulation": 0.01151, "luciferase construct drive": 0.00484, "inducer": 0.00273, "mouse myeloid cell line": 0.0384, "t-cell antigen receptor-cd3": 0.00641, "cell-death pathway": 0.01278, "hungary": 6e-05, "hair follicle": 0.00031, "lymphoid specific": 0.01238, "transcription initiation complex assembly": 0.01405, "yeast two-hybrid": 0.00155, "render inactive": 0.00161, "affect ifn-gamma-induced tyrosine phosphorylation": 0.00492, "zymography": 6e-05, "significance": 0.00155, "c-fos mrna correlate": 0.01017, "maintain survival": 0.00239, "five-": 0.00012, "3-week": 0.0, "'nuclear factor": 0.0286, "programmed activation/repression": 0.00022, "tcr beta enhancer": 0.00606, "cl assay": 0.01002, "accessory gene": 0.04355, "leukaemic cell": 0.0768, "chimeric gp130": 0.00164, "predominant form": 0.01055, "-1280 element": 0.01672, "ca2+/calmodulin-regulated": 6e-05, "subgroup": 0.00031, "gel shift data": 0.0017, "super-shift analysis reveal": 0.00786, "factor form": 0.0286, "reporter activity": 0.02925, "term tab": 0.00413, "pdbu": 0.00043, "anti-jun ab": 0.00167, "puzzle": 6e-05, "viral clearance": 0.00732, "p65-p50 heterodimer": 0.00205, "functional domain responsible": 0.00804, "bcl6 rearrangement": 0.00199, "stimulate mononuclear phagocyte": 0.00734, "differentiation response": 0.01942, "potent monocyte/macrophage-specific stimulator": 0.00238, "blood vary": 0.00592, "dna-binding": 0.01123, "chromosome inactivation": 0.00295, "deletion mutation prevent": 0.00395, "mrna expression": 0.04163, "il-10 pretreatment prevent lps-induced decrease": 0.00388, "nuclear factor present": 0.01907, "g-csf receptor signal": 0.01714, "ospa": 0.00043, "terminal granulocyte differentiation": 0.00786, "nfil3 protein": 0.04529, "il-12 correlate": 0.00654, "rheumatoid arthritis": 0.00093, "transcription factor tfiia": 0.01907, "htlv-1 gene regulation": 0.02903, "develop safe live-attenuated hiv": 0.00296, "p40-kappab site": 0.02168, "glucocorticosteroid": 0.00081, "hypoxic endothelium show": 0.01733, "cd45 tyrosine phosphatase": 0.00474, "heterologous herpes thymidine kinase": 0.00594, "lps-lps binding protein complex": 0.02264, "m-tat/epo": 0.00025, "25-ohd": 6e-05, "fusion transcript": 0.00599, "steroid binding activity": 0.0195, "block erk activation": 0.02109, "human promonocytic u937 cell": 0.0384, "pyg": 0.00031, "bcl-2 phosphorylation": 0.00983, "unpublished observation": 0.00149, "expression cloning": 0.04163, "lps-stimulated cell": 0.0768, "bad": 0.00025, "soluble nuclear matrix preparation base": 0.00674, "prl stimulation": 0.0112, "mature myelomonocytic cell line": 0.0384, "ebf interacts": 0.00136, "cord blood lymphocyte": 0.00988, "her-2/neu overexpression correlate": 0.00436, "constitutively activated tumor necrosis factor receptor": 0.00953, "immunohistochemical evidence": 0.00422, "t-cell-directed tal-1 expression induces t-cell malignancy": 0.01388, "p-methoxyphenyl": 0.00012, "biotinylated dna-streptavidin matrix": 0.00087, "lymphoid-specific ets transcription factor": 0.0143, "full-length chimeric receptor": 0.01714, "stimulate pkc": 0.01101, "important human mediator": 0.02508, "fusion protein comprise": 0.03019, "sr": 0.00087, "gene transfer": 0.04355, "erk-dependent": 6e-05, "type ii bare lymphocyte syndrome-associated transactivators ciita": 0.00424, "cellular tyrosine hydroxylase gene": 0.02177, "constitutive transcriptional activation": 0.02109, "yield and/or": 0.0045, "normal tcrzeta level": 0.01214, "cell activation pathway": 0.0512, "ebv antigen": 0.00819, "tcr alpha/delta": 0.00478, "circular dna remain": 0.00988, "bipartite dna binding domain": 0.00927, "alter neutrophil adhesivity": 0.00331, "hiv-1 transcriptional activation": 0.02109, "tissue expression": 0.04163, "cbp35": 6e-05, "nf-kappab activation induce": 0.02109, "combined pituitary hormone deficiency": 0.00222, "cellular stimulus": 0.00893, "site alpha-": 0.02168, "cd28 adhesion molecule": 0.00569, "promoter specificity": 0.02336, "igm+ igd+ cd30+": 0.00012, "profound": 0.00099, "single oct": 0.0036, "pyrimidine-rich region": 0.01467, "rat macrophage cell line r2": 0.03072, "efficient competitor": 0.00189, "radiation dos": 0.00121, "unlabeled compound": 0.0022, "den": 0.00012, "gel-shift analysis demonstrate dose-dependent inhibition": 0.00639, "negative glucocorticoid response element": 0.00971, "b7-positive": 6e-05, "signaling pathways important": 0.00459, "igh-enhancer-luciferase construct": 0.00726, "fresh blood": 0.00592, "potent cd40 agonist": 0.00248, "lymphocyte differ": 0.01483, "molecular feature": 0.0045, "leukemia-associated fusion protein aml1/mds1/evi1": 0.02264, "cro-ap/5 express indeterminate": 0.0123, "l128g": 0.0, "unusual feature": 0.00217, "characteristic domain": 0.01207, "alternative rna splice": 0.00304, "tax transforms mouse fibroblast": 0.00487, "additional screening": 0.00341, "vitro immunization": 0.00785, "cd28-dependent elevation": 0.00093, "gradual decline": 0.00121, "fasl protein": 0.04529, "c-jun n-terminal transactivation domain": 0.00603, "prominent enzyme": 0.0031, "lymphoblastoid": 0.00217, "high density lipoprotein": 0.0062, "hiv disease": 0.00673, "functional rbp bind site": 0.01084, "early-onset type": 0.00949, "suppressive action": 0.00499, "report long-range cis-inactivating effect": 0.01058, "diverse": 0.0031, "raji human": 0.03762, "gamma- globin gene": 0.02903, "cross-linking": 0.00484, "t-helper-cell determinant": 0.00118, "required step": 0.00189, "mature human monocytic cell": 0.0384, "ebv-encoded latent membrane protein": 0.02264, "footprint assay": 0.01002, "early growth response gene": 0.02177, "fetal brain": 0.00214, "current finding suggest": 0.01348, "gr bind power": 0.0135, "protein co-migrating": 0.04529, "cell surface": 0.0768, "m-crf": 0.00012, "densitometry": 6e-05, "cd56+ cell": 0.0768, "il-7-treated": 0.00019, "monocytic cell line study": 0.0384, "hiv-1 ap-1 dna recognition sequence": 0.0065, "oncogene express sensitive target fibroblast": 0.00738, "human thymocytes": 0.03762, "include stem cell": 0.0512, "occupied": 0.00012, "vivo activity": 0.02925, "hepatoma cell line": 0.0512, "peripheral circulation": 0.00524, "hexon gene": 0.04355, "gata-3 gene expression": 0.02903, "cytokine-induced activation": 0.03164, "tumor er concentration": 0.00622, "subclones release": 0.00484, "il-2 responsive": 0.01117, "minimal promoter exhibit b-cell-specific activity": 0.0117, "gc exert": 0.0031, "dna-protein complex formation": 0.01123, "il-10 arrested cell": 0.0512, "nucleotide -137": 0.00202, "angiotensin at1 receptor antagonist losartan": 0.01029, "exert negative influence": 0.00343, "covalent modification": 0.00183, "-165/-148 nxs": 0.00012, "respective chromosome": 0.00295, "ut-7/gmt": 0.00025, "live-hiv-1": 0.00012, "putative p13mtcp1 protein": 0.03019, "hs": 0.00043, "glucocorticoid-mediated apoptosis": 0.0089, "sh2/sh3 adapter protein": 0.03019, "cd30 ligation": 0.0018, "herpes virus transactivator vp16": 0.00444, "induce nf-kb expression": 0.02775, "antagonistic anti-fas mab": 0.00178, "drive th1 development": 0.00422, "undifferentiated non-prl-secreting endometrial stromal cell": 0.03072, "transfected clone reveal": 0.00732, "immunoblotting": 0.00074, "monocyte lineage serve": 0.00798, "decidual gammadelta": 0.00022, "viral production": 0.01042, "thyroid antibody production": 0.00695, "lps-treated cell": 0.0768, "pml-rar mrna": 0.01526, "rxr alpha receptor": 0.01714, "erythroid-specific gata-1": 0.00413, "phytohemagglutinin-stimulated lymphocyte": 0.01483, "il-2 result": 0.0161, "p13mtcp1": 0.0005, "additional enhancer": 0.00909, "potent transcriptional activator": 0.00767, "04:00-08:00": 6e-05, "t3-subjects receive placebo": 0.00074, "intracellular protein regulate nf-kappa": 0.02264, "disulfide-linked dimer regulate human": 0.01881, "spliced isoform": 0.00171, "kappa b-binding activity constitutively express": 0.0117, "nf-kappab/rel family member": 0.0056, "neutral ph": 0.0004, "ringed sideroblast": 0.00022, "tyrosine-phosphorylated p80c-rel": 0.00074, "hek": 0.00012, "il-2-dependent line": 0.01653, "erythropoietin-dependent erythroid progenitor": 0.00414, "sp-a activate nf-kappa": 0.01185, "lysosomal protein": 0.04529, "ifn-gamma-inducible expression": 0.04163, "gig18 induction": 0.01607, "intact chimeric egf-gp130 receptor": 0.01286, "related oligonucleotides": 0.00236, "receptor change": 0.02571, "ra-treated cell": 0.0768, "lac-z reporter gene": 0.02903, "human group": 0.03762, "mutant human cd40": 0.02508, "induce cell lysis": 0.0512, "cell growth-related gene": 0.0512, "competitive inhibitor": 0.009, "differanisole": 0.00012, "sh2 domain activate syk-family kinase": 0.00711, "gradient gel electrophoresis": 0.0011, "bank": 0.0, "late secretory phase eutopic endometrium": 0.0011, "antibody due": 0.00893, "persistent eosinophilia associate": 0.00728, "fgf receptor": 0.02571, "injury-induced necrosis": 0.00239, "octamerlike sequence": 0.01625, "receptor cluster": 0.02571, "u89": 0.00012, "analogous region": 0.01467, "expression occurs": 0.04163, "dna fragmentation": 0.01483, "segment": 0.00378, "result report": 0.0161, "translocation case": 0.00515, "e2a gene encodes transcription factor": 0.01742, "ciita construct": 0.00726, "affect constitutive nf-kappa": 0.00943, "nf-kappab/rel member": 0.00413, "stimulation induces rapid tyrosine phosphorylation": 0.00448, "circadian rhythm": 0.00034, "cytokine imbalance": 0.01123, "macrophage csf": 0.00589, "proliferate erythroid cell": 0.0512, "related targeting mechanism": 0.00705, "core binding factor-alpha": 0.01237, "age-matched control subject show": 0.013, "myeloid precursor": 0.00462, "specific complex": 0.01684, "regulate fork head domain transcription factor family": 0.00817, "documented reversible airway obstruction": 0.00045, "dna-protein binding assay": 0.01237, "gm-csf expression": 0.04163, "p53 paradox": 0.00149, "monocyte provide evidence": 0.00798, "glucocorticosteroid receptor number": 0.01714, "erythroid colony": 0.0062, "glucocorticoid-resistant cem-c1 cell": 0.0512, "growth-factor dependent": 0.00388, "gene knock-out": 0.04355, "include human immunodeficiency virus": 0.01881, "comparable level": 0.01821, "pma+ionomycin": 0.00012, "tyrosine kinase-dependent pathway": 0.00852, "beta-casein gene": 0.04355, "co-transfected": 0.00062, "non-heat shock gene": 0.02903, "activate differentiation-linked gene expression": 0.02177, "cold exposure": 0.0035, "sarcoma": 0.00037, "standard": 0.00093, "type ii il-1 receptor": 0.01286, "activate ra": 0.01777, "inhibitor protein": 0.04529, "wild-type e. coli endotoxin": 0.00189, "a-t": 0.00037, "acute myeloblastic leukemia cell": 0.0384, "-150 bp": 0.00267, "spi-1 overexpression increase": 0.01464, "e-selectin gene": 0.04355, "thyrotropin receptor": 0.02571, "inhibited cd23 expression": 0.02775, "activate inflammatory pathway": 0.01185, "androgen receptor mrna": 0.01714, "differential utilization": 0.00323, "translocated c-myc allele": 0.00149, "neuropathogenic process associate": 0.00728, "serum total thyroxine": 0.00252, "induced 24-hydroxylase mrna expression": 0.02081, "er- cell test remain sensitive": 0.03072, "leukocyte-specific": 0.00025, "nf-mue3": 0.0, "lumen": 6e-05, "cytokine receptor dimerization": 0.01714, "inhibit mature": 0.01904, "p/i mediate induction": 0.01071, "hsp90 bound": 0.00292, "cyclin-like udg gene product": 0.02177, "induce nfatc": 0.0254, "additional expression": 0.04163, "dysregulated": 0.00019, "chromosomal copy": 0.00102, "human erythroid 5-aminolevulinate synthase": 0.01881, "persistent latency": 0.0014, "chloramphenicol acetyltransferase activity mediate": 0.01462, "hypoxic ec": 0.00254, "natural dominant negative hlh factor id3": 0.00953, "common intracellular pathway": 0.00852, "subsequent synthesis": 0.00583, "increase dna-binding activity": 0.0195, "gst-tax": 0.00025, "biphasic fashion": 0.00161, "physiologic significance": 0.00078, "recent investigation": 0.0014, "representative sample": 0.00208, "e2f-1/dp1 complex binding": 0.01237, "pcr-based humara method": 0.00157, "48-hr filarial antigen stimulate t-cells": 0.0044, "redox-regulated enzyme trigger signal cascade": 0.00654, "cd336": 0.00012, "tnf-mediated apoptosis": 0.0089, "helper subset": 0.00192, "proteasome activity": 0.02925, "apoptotic vascular smooth muscle cell": 0.03072, "p105/p50": 0.00031, "ethidium bromide": 6e-05, "link luciferase gene": 0.02903, "transcriptional activator precursor p105": 0.00575, "result implicate c/ebp beta": 0.00805, "progressive 5'-deletion construct": 0.00484, "deletional analysis": 0.01179, "gene reveal significant difference": 0.02177, "key molecular mechanism": 0.00705, "se occur": 0.00654, "gal4 site": 0.02168, "respective receptor": 0.02571, "subepithelium": 6e-05, "cd40 cross-linking": 0.00372, "g. vaginalis increase": 0.01464, "present study show": 0.01733, "stimulate ifn-gamma production": 0.00734, "erk1 kinase activity": 0.0195, "study alteration": 0.01355, "epicardin/capsulin/pod-1": 0.0, "stat6 activation lead": 0.02109, "heterodimeric binding partner": 0.01237, "human beta-globin gene cluster": 0.02177, "alphoid array": 0.00034, "ifn signaling": 0.00558, "protect human": 0.03762, "t-lineage cell lead": 0.0512, "increased autophosphorylation": 0.00363, "recombinant vascular-cell adhesion molecule-1": 0.0029, "human breast tumor": 0.02508, "increase viral transcription": 0.01873, "gr variant": 0.004, "transcription factor function": 0.01907, "nuclear matrix-associated site iv": 0.01084, "triptolide-induced apoptosis": 0.0089, "recent evidence suggest": 0.01348, "report provide": 0.00645, "cellular block": 0.01073, "assumption": 0.00019, "react": 0.00149, "ala precursor": 0.00323, "view": 0.00025, "principal cytoplasmic inhibitor": 0.006, "tal1 locus": 0.00288, "steroid binding domain": 0.01237, "peak content": 0.00158, "lmp-1 trigger": 0.00409, "cd3-epsilon enhancer": 0.00909, "aids-c group": 0.00487, "transcription regulatory function": 0.01873, "thp decrease": 0.00971, "c/ebpbeta": 0.00087, "cellular factor nf-kappa b. transfections": 0.01144, "mutant ikappabalpha": 0.0081, "cell line raji": 0.0512, "consequent modulation": 0.00257, "t-cell developmental pathway": 0.00852, "myeloperoxidase": 0.00081, "enhance transcription": 0.0281, "rel-a": 0.00062, "class ii-peptide complex": 0.01123, "cd11c/cd18": 6e-05, "immunoelectron microscopy demonstrate": 0.01065, "ifn-gamma involves": 0.00481, "poor induction": 0.01607, "pharmaceutical product": 0.00533, "palindromic nf-kappa": 0.01414, "interferon receptor": 0.02571, "alpha/mad-3 mrna": 0.01526, "sickle red blood cell": 0.0384, "transcription factor family ap-1": 0.0143, "synthetic steroid": 0.00292, "protein synthesis inhibitor differ": 0.02264, "43-47 kd": 0.00174, "augmented adherence": 0.00118, "classical hd case": 0.00242, "rfx5 fuse": 0.00149, "unicellular-unilineage erythropoietic culture": 0.00414, "abrupt downregulation": 0.0009, "cell constitutively express": 0.0512, "promote differentiation": 0.01179, "suggested role": 0.01328, "r.f.siliciano": 6e-05, "alternative splice/polyadenylation event": 0.00368, "peripheral mononuclear leukocyte": 0.00349, "oxidoreductive regulatory pathway": 0.00852, "tnf induced apoptosis": 0.00593, "efficient ebv activation": 0.02109, "herpesvirus saimiri": 0.00074, "gammac chain deficiency": 0.00292, "core enhancer": 0.00909, "delayed ros-dependent signal pathway": 0.00817, "-650": 0.00012, "proof": 0.00031, "vernal keratoconjunctivitis": 9e-05, "human t-cell receptor": 0.02508, "htlv-1-infected": 0.00031, "nf kappab family protein": 0.02264, "multiple protein interact": 0.03019, "dna synthesis": 0.01483, "west african": 0.00016, "measure plasma hormone": 0.00296, "regulate nf-at-binding activity": 0.0195, "o-linked monosaccharide glycans": 6e-05, "tgase": 0.00019, "t-cell stimulation defect associate": 0.0056, "cd18-mediated leukocyte adhesion": 0.00387, "visualization": 0.00019, "-228": 6e-05, "macrophage-restricted member": 0.00413, "cell receptor engagement activate transcription factor important": 0.02194, "active molecule": 0.00853, "selective role": 0.01328, "daudi cell": 0.0768, "potent immunoregulatory molecule": 0.00569, "thyroid antigen": 0.00819, "competent vector": 0.00319, "high-titer antibody response": 0.01294, "roi-dependent nf-kappab mediate transcription": 0.01405, "lps-induced tnfalpha": 0.00233, "nuclear translocate glucocorticoid receptor": 0.01286, "shortened life span": 0.00101, "human t-cells": 0.03762, "kilobase": 0.00012, "cd4+ t-cells": 0.00288, "pleural effusion": 0.00025, "lps-induced activation": 0.03164, "translocation breakpoint": 0.00515, "resemble pha/pma stimulation": 0.00746, "cell separation": 0.0768, "betaherpesvirus": 0.0, "induce ab secretion": 0.01694, "glucocorticoid fall": 0.0085, "operational characteristic": 0.00329, "jurkat-derived": 6e-05, "acid": 0.01712, "false positive prediction": 0.00312, "p130/rb2": 0.0, "test steroid": 0.00487, "erythrocyte nucleus": 0.00319, "sea urchin protein tsap": 0.02264, "efficient": 0.00378, "stephania cepharantha hayata": 6e-05, "abnormal eosinophil": 0.00295, "tgf-beta1 suggests": 0.00053, "embryo": 0.00068, "'altruistic suicide": 6e-05, "pma-treated fibroblast": 0.00338, "n-oct factor": 0.0286, "principal mediator": 0.00195, "s-allyl cysteine inhibits activation": 0.01582, "associate carcinoma": 0.01092, "ifna gene": 0.04355, "complement receptor-1 cell surface protein": 0.03072, "cultured monocyte": 0.01197, "rapid calcineurin-dependent translocation": 0.00343, "low failure rate": 0.00471, "janus kinase function": 0.00887, "steroid-mediated cell death occurs": 0.0384, "display extensive xanthomatosis": 0.00333, "vivo footprinting demonstrate": 0.01065, "cd8 lineage": 0.00366, "e2f bind": 0.02025, "immunoglobulin-like transcript-2/leukocyte ig-like receptor": 0.01286, "pparalpha expression": 0.04163, "distinct regulatory domain control": 0.00651, "platelet/endothelium interaction play": 0.00658, "putative gtp-binding motif": 0.00583, "persistent hiv infection": 0.00414, "50-kda protein nfkb1": 0.03019, "tp1 rna start site": 0.01084, "murine nfatp": 0.00623, "non-transformed murine th1": 0.00416, "msr expression": 0.04163, "coordinated function": 0.01331, "mature monocyte/macrophage-like cell": 0.0512, "nup475": 6e-05, "class ii mhc molecule": 0.00426, "induced expression": 0.04163, "gamma-activating sequence": 0.01625, "human immunoglobulin heavy-chain gene enhancer": 0.01742, "cytokine signaling": 0.01123, "menopausal woman": 0.00233, "characteristic dna-binding domain": 0.00804, "ggtagttccc": 6e-05, "-59/-54": 6e-05, "fraction": 0.00341, "target nfat-1-dependent gene expression": 0.02177, "related nf-kappa": 0.01414, "protein-tyrosine kinase activation": 0.02109, "simian immunodeficiency virus isolates": 0.00444, "albuminuria associate endothelial dysfunction": 0.00546, "cd4 coreceptor interacts": 0.00221, "antiandrogens result": 0.0161, "cell surface expression": 0.0512, "hiv-1 genome carry": 0.00585, "interleukin-7 receptor alpha chain": 0.01286, "foreign body giant cell associate": 0.03072, "cell uniformly lack alpha-": 0.0384, "colony-forming capacity": 0.00329, "il-2-preactivated nk cell result": 0.0384, "fas/apo-1": 0.00019, "pro639": 6e-05, "herpetic lesion": 0.00143, "inhibit activation mediate": 0.02109, "tolerization": 6e-05, "occupancy": 0.00143, "stimulate peripheral blood mononuclear cell": 0.03072, "alter nf-kappab": 0.00999, "tumor suppressor p16": 0.00622, "ul55": 6e-05, "pkc subfamily induce": 0.01694, "rangtp": 6e-05, "cell-specific enhancer element": 0.01115, "extravascular inflammation": 0.00316, "src kinase inhibitor": 0.00792, "cell-type-specific suppression": 0.00416, "pka inhibits": 0.0053, "receptor-mediated ap-1 induction": 0.01071, "transcription factor": 0.0286, "nlss": 6e-05, "impair host immunity": 0.00143, "specific dna binding protein": 0.02264, "time post-dosing": 0.00273, "h2o2-induced nf-kappab activation": 0.02109, "vivo anergized cd4+": 0.00354, "monocyte-like hl-60 cell": 0.0512, "incomplete androgen insensitivity": 0.00108, "memory response": 0.01942, "target non-ig gene": 0.02903, "specific bind power": 0.0135, "picornavirus mrna": 0.01526, "eed gene": 0.04355, "-dependent mouse pro-b lymphocyte": 0.00741, "a/r insult reduces pmn adhesion": 0.00232, "internalization": 0.00037, "growth arrest": 0.00819, "cytosolic component": 0.00456, "competence phase": 0.00276, "structure-activity relationship": 0.00158, "mononuclear cell reaction": 0.0512, "egr-1 promoter": 0.02336, "rj2.2.5 restored expression": 0.02775, "c-fos control": 0.01303, "ti": 0.00019, "c-jun promoter construct confirm": 0.01168, "crucial molecule": 0.00853, "rapid ca2+-mediated activation": 0.02109, "litaf": 0.0005, "develop cell-free system": 0.00445, "primary invasive breast cancer": 0.00369, "study interaction": 0.01355, "immunosuppressant ciclosporin": 0.00047, "pbmc proliferation": 0.00803, "augment 2-3 time": 0.00182, "artery wall": 0.00056, "tcr beta": 0.00673, "lt-4 react": 0.00074, "caat box-like motif": 0.00583, "cellular differentiation occur": 0.00786, "cmf": 0.00012, "tandem cre": 0.00121, "j774": 0.00012, "soluble lytic transglycosylase": 0.00149, "cell cytokine": 0.0768, "cd40-mediated event": 0.00552, "express immunostainable ppargamma": 0.0123, "phosphatidic acid": 0.00856, "glucocorticoid-induced apoptosis": 0.0089, "block tnf alpha production induce": 0.01016, "adult globin developmental program": 0.00211, "cellular protein tyrosine kinase": 0.02264, "activate nfat": 0.01777, "antigen b27": 0.00819, "assessment": 0.00031, "thymoma cell line": 0.0512, "stat3beta": 0.00019, "gcrbeta-immunoreactive cell": 0.0768, "nfat-dependent expression": 0.04163, "mononuclear cell culture": 0.0512, "mitogen-activated protein kinase": 0.03019, "control phosphorylation": 0.01303, "il-3": 0.00254, "anti-ro": 0.00012, "deficient activity": 0.02925, "homozygous stat6-deficient mouse": 0.00649, "single form": 0.01055, "cellular oxidant stress": 0.00596, "protein kinase a/protein kinase": 0.02264, "mediate inhibition": 0.01231, "induction requirement": 0.01607, "normal thyroid tissue": 0.00806, "transactivation sequence": 0.01625, "glucocorticoid receptor complex": 0.01714, "regulate cellular proliferation": 0.00835, "require rip": 0.01315, "pim-1": 0.00019, "tyrosine phosphorylation stat1": 0.00656, "monocytic u937 cell": 0.0512, "cell undergoing megakaryocytic differentiation require": 0.03072, "euthyroid patient": 0.01666, "nf-kappab activation": 0.03164, "photoaffinity labeling": 0.0005, "untransformed": 0.00037, "cell-specific transcription": 0.0281, "dual specificity": 0.00335, "nf-at/ap-1-binding site": 0.02168, "platelet stimulate": 0.01101, "nf-kappab induction": 0.01607, "vivo differentiation": 0.01179, "sp1 transcription factor bound": 0.0143, "cell cycle kinetics": 0.0512, "sivmac239 mutant": 0.0081, "isolation procedure": 0.00078, "effective biologic inhibitory concentration": 0.00335, "cell line ht93a": 0.0512, "cytoplasmic domain": 0.01207, "permit oca-b": 0.00099, "chronic myelogenous leukemia": 0.00333, "complete understanding": 0.00171, "low expression": 0.04163, "optimal concentration": 0.0067, "id family": 0.00841, "nf-e1": 0.00093, "primary cd8+ t-pll cell": 0.0384, "functional rar beta": 0.00544, "oleate": 0.00056, "heat shock": 0.00189, "homogeneous": 0.00019, "pre-formed hsp90 complex": 0.01123, "gata-1 -erythroid cell": 0.0512, "ligand-binding domain": 0.01207, "deltorphin enhance transcriptional activity": 0.01462, "nk cell cytolytic program": 0.0384, "diverse biochemical signal generate": 0.00817, "normal function": 0.01331, "efficient adenovirus-mediated inhibition": 0.00707, "tat-activated": 6e-05, "sevenfold": 6e-05, "increase inflammatory infiltrate": 0.01464, "immunoregulatory effect": 0.02115, "macrophage function": 0.01331, "mediate high-level nf-kappab activation": 0.01582, "differentiation remain": 0.01179, "faster-migrating": 0.00031, "powerful activator": 0.00552, "position -345": 0.00236, "lfa-i": 0.00031, "monocytic gene": 0.04355, "transcription protein": 0.04529, "mechanism regulate gene expression": 0.02177, "prostaglandin e2 induction": 0.01071, "immune remission": 0.00599, "basolateral surface": 0.00515, "induce icam-1 expression": 0.02775, "rch1/importin": 6e-05, "breast tumor associate lymphocyte": 0.00741, "ldb-1": 6e-05, "cd40 signal pathway": 0.0109, "il-7-induced activation": 0.03164, "hbxag-specific synthetic polypeptide": 0.00134, "heat shock response": 0.01294, "octamer site-mediated immunoglobulin gene promoter activity": 0.01452, "b.": 0.00323, "chromosome translocation": 0.00515, "mrna-type promoter": 0.02336, "healthy neonate": 0.00177, "nf-kb activation": 0.03164, "differentiate cell type": 0.0512, "apoptotic human": 0.03762, "primary hpp-cfc colony": 0.00492, "normal granulocyte": 0.0121, "duffy antigen": 0.00819, "c1-c3": 0.00025, "selective pathway": 0.01278, "separate pathway": 0.01278, "epithelial necrosis": 0.00239, "start population": 0.00307, "important transcriptional regulator": 0.00767, "pse": 0.00019, "erk2 activation": 0.03164, "normal pattern": 0.0121, "age": 0.00453, "interferon beta expression initiate": 0.02081, "type ii major histocompatibility complex combine immune deficiency": 0.00421, "mlr": 0.00025, "topoisomerase ii inhibitor": 0.006, "monocytic u937 cell line differs": 0.03072, "main cellular source": 0.00596, "human monoblastic leukemia u937 cell": 0.03072, "long-term expression": 0.04163, "normal human peripheral blood lymphocyte stimulate": 0.01254, "constitutively express nuclear factor": 0.0143, "bpi": 6e-05, "initial stage": 0.00248, "acute ethanol exposure": 0.00246, "yeast suggest": 0.02022, "activated t-cells": 0.00589, "30-90 ppt i-te": 0.00014, "reduced adhesion": 0.0058, "ligand bind domain": 0.0135, "12.2+/-1.6 versus": 0.00136, "glucocorticoid receptor present": 0.01714, "transmembrane activator": 0.00552, "ikappabalpha": 0.00397, "gingival fibroblast": 0.00338, "retinoid-resistant promyelocytic cell line": 0.0384, "wurzburg cell": 0.0768, "fak": 0.00012, "adrenal insufficiency": 0.00062, "antibody ablation/supershift assay reveal": 0.00549, "peripheral lung inflammation": 0.00349, "cyclosporin a-insensitive pathway": 0.00852, "immunoblot analysis show": 0.01733, "motif present": 0.00875, "promoter region": 0.02336, "transient activity": 0.02925, "cd40l-treated": 0.00012, "receive adjuvant chemotherapy consisting": 0.00056, "chimaeric oncoprotein": 0.00115, "ca2+-activated serine/threonine phosphatase": 0.00176, "rare phenotype": 0.00366, "rescue": 0.00267, "adult stage-specific interaction": 0.00658, "aml m2": 0.00087, "cell express cd34": 0.0512, "cell line bjab": 0.0512, "cell result": 0.0768, "northern analysis show similar level": 0.0104, "related retinoic acid receptor alpha": 0.01029, "ebv genome expression": 0.02775, "pkc activate phorbol ester 12-o-tetradecanoylphorbol-13-acetate": 0.00711, "elisa procedure": 0.00078, "viral infection": 0.00732, "exogenous il-2 growth factor": 0.0143, "respond cell": 0.0768, "cytoskeletal rearrangement": 0.00199, "hiv-1 require active nf-kappa": 0.00707, "cell-type specific expression": 0.02775, "ltr transactivation": 0.00515, "cd4+ cell correlate": 0.0512, "enhanced production": 0.01042, "cognate interaction": 0.00986, "kmt": 0.00012, "rna polymerase ii transcription system": 0.01124, "tumor vaccine": 0.00934, "active suppression": 0.00592, "major regulatory factor": 0.01907, "sp 1-binding site": 0.01445, "ca2+ co-stimulus require": 0.00877, "hematopoiesis": 0.00143, "gc box": 0.0031, "yeast isolated nf-atp": 0.00126, "centipoise": 6e-05, "creb detect": 0.00726, "mouse th2 clone d10": 0.00487, "transgene expression": 0.04163, "il-4 substrate include jak1": 0.0072, "il-2 -and pi 3-kinase-induced pathway": 0.00511, "monocyte chemoattractant protein-1": 0.00798, "heart disease": 0.00673, "detect activatable pld": 0.00484, "hyperkalemia": 0.00043, "cultured nk cell population": 0.0384, "ap-2 binding site": 0.01445, "fibroadenoma": 6e-05, "p21": 0.00087, "fli-1": 0.00099, "nf-y-responsive dqbeta promoter": 0.01557, "untranslated region": 0.01467, "mhc class ii-constitutive": 0.00428, "child affect": 0.00797, "co-transfecting": 0.00019, "om-10.1 culture": 0.0062, "protein tyrosine kinase activity p56lck": 0.01811, "ig": 0.00428, "near-basal level": 0.01821, "extent similar": 0.00673, "crosslinking": 0.00074, "class ii transactivator-independent endothelial cell mhc class ii gene activation induce": 0.01396, "tumor development": 0.00934, "testis-determining region": 0.01467, "plasma cell formation": 0.0512, "tyrosine phosphorylation": 0.00983, "cd14": 0.00341, "immunofluorescence colocalization": 0.00059, "pbx1 gene": 0.04355, "host immune-response gene": 0.02903, "ca2+ signal-dependent regulatory element obligatory": 0.00669, "upstream activator": 0.00552, "hinrichs": 0.00012, "vp16 433-442": 0.0009, "cytosolic": 0.00304, "differentiation-inducing activity": 0.02925, "nf-kappab correlate": 0.00999, "nf-at activation induce": 0.02109, "early study": 0.01355, "inducible complex bound": 0.01123, "icsbp": 0.00012, "purified monocytes/macrophages": 0.00261, "myeloid differentiation": 0.01179, "particulate fraction": 0.00171, "il-4ralpha": 0.00081, "mpro": 0.0005, "cat activity": 0.02925, "viral encode protein tax": 0.02264, "il-10 show": 0.02599, "powerful tool": 0.0005, "sequence reveal": 0.01625, "4e-bp2": 0.00019, "protein term bp1": 0.03019, "trans-cellular activation": 0.03164, "gene structure": 0.04355, "adjacent 20-base pair upstream sequence": 0.0065, "binding affinity": 0.01855, "myeloblast cell": 0.0768, "tissue-specific activity": 0.02925, "cr3": 0.00025, "luf syndrome": 0.00273, "promonocytic cell line u1": 0.0384, "determining role": 0.01328, "red cell": 0.0768, "pbx1": 0.00019, "sodium oleate": 0.00186, "promonocytic leukemia": 0.00499, "characterize mutant": 0.0081, "transforming cbl mutant": 0.0054, "glucocorticoid response element": 0.01294, "lineage leukemia": 0.00499, "radio-ligand binding analysis": 0.01237, "pcr analysis": 0.01179, "serum-free condition": 0.0036, "release hiv-inductive cytokine": 0.00749, "ikappab kinase complex activation": 0.01582, "distinct cell type": 0.0512, "good transactivator": 0.00161, "corticosteroid receptor characteristic": 0.01714, "c-jun complex": 0.01684, "clone cell line": 0.0512, "gel shift complex": 0.01123, "receptor intracellular domain": 0.01714, "rela.p50 nf-kappa": 0.01414, "cell differentiation": 0.0768, "surface il-4r": 0.00515, "tight linkage": 0.00037, "antigen complexed": 0.00819, "activation region": 0.03164, "okadaic acid induces ap1": 0.00428, "express e2a-pbx1": 0.01846, "mrna specie activate": 0.01185, "helper cell differentiation": 0.0512, "gene encode transcription factor": 0.02177, "1beta,25-dihydroxyvitamin d3": 0.00245, "ikb alpha phosphorylation": 0.0078, "agent block nf-kappa": 0.00943, "complex translocation": 0.01684, "woman undergo elective termination": 0.00116, "cbf1/rbp-jkappa": 0.00037, "acyclovir-treated cell": 0.0768, "unidentified estrogen receptor-related 29-kda protein selectively": 0.0151, "blood assay": 0.01002, "ag-490 inhibits": 0.0053, "normal breast parenchyma": 0.00806, "transcription factor spi-1/pu.1": 0.01907, "intracellular": 0.01166, "c-fos": 0.00943, "vaccinia vector": 0.00319, "lif effect": 0.02115, "subsites": 0.00019, "costimulatory molecule b7.1 provide": 0.00426, "affinity-binding assay show": 0.01733, "ebv trans-activator": 0.00565, "il-10 induced signal transduction": 0.00817, "bind characteristic": 0.02025, "subsequent mutagenesis": 0.00304, "fluoroquinolone antibiotic ciprofloxacin": 0.00025, "inhibit cd26 expression": 0.02775, "antisense oligodeoxynucleotides target": 0.0055, "rest human umbilical vein endothelial cell": 0.0256, "nur77 gamma": 0.0044, "aids-related epstein-barr virus": 0.00591, "potential overlap core recognition bind motif": 0.00675, "multiple biochemical pathway": 0.00852, "cd40 signal downregulates bcl-6 expression": 0.01665, "c. simon": 0.00143, "study il-6 production": 0.00904, "vdj recombination": 0.00093, "sequence-specific": 0.00211, "neuronal ceroid-lypofuscinosis": 0.00028, "secondary lymphoid organ": 0.00273, "efficient down-regulation": 0.00195, "truncated transcript": 0.00599, "gamma interferon activation site": 0.01582, "distal nf-kappa": 0.01414, "fetal calf serum": 0.00252, "pgn-induced activation": 0.03164, "strong constitutively active promoter": 0.01168, "induced level": 0.01821, "secretion level": 0.01821, "region document constitutive binding": 0.00927, "low pkc enzymatic activity": 0.01462, "tr beta": 0.00673, "blin-1 pre-b cell line express low level": 0.02194, "apoptosis sensitive cell line": 0.0384, "p65 complex": 0.01684, "eklf bind site": 0.01445, "ptks": 0.00019, "additional patient": 0.01666, "nf-kappa b. activation": 0.02109, "measure nf-kappa": 0.01414, "potent transactivator protein term tax": 0.01811, "genetic inactivation": 0.00288, "domain act": 0.01207, "hcleo": 0.00025, "th1 phenotype": 0.00366, "show preference": 0.02599, "inhibits proliferation": 0.00803, "suppress pai-1 overproduction": 0.00407, "pbm": 0.0005, "myeloid-specific zinc finger protein": 0.02264, "hypocomplementemia": 6e-05, "active mitogen-activated kinase": 0.00792, "dcoh regulate formation": 0.00835, "claim": 6e-05, "caev": 0.00031, "heterotetramer": 0.0, "cytokine gene regulation": 0.02903, "rapid tyrosine phosphorylation": 0.00656, "heterozygous": 0.0018, "u-937 leukemia cell": 0.0512, "nf-at concentration-dependent assembly": 0.00265, "lps stimulation": 0.0112, "leukocyte alkaline phosphatase": 0.00318, "normal polyclonal granulocyte": 0.00806, "pbsc collection": 0.00022, "common sh3-sh2-sh3 motif": 0.00583, "phosphatase": 0.00527, "co-culture": 0.00012, "adult level": 0.01821, "crucial regulatory event": 0.00455, "low threshold": 0.00707, "l-selectin gene": 0.04355, "major histocompatibility complex class ii invariant chain promoter": 0.00584, "hypercortisolemic patient": 0.01666, "nuclear rela stimulates p100 mrna": 0.00674, "enhance hiv transcription": 0.01873, "exogenous p27": 0.00214, "mouse pro-b cell line": 0.0384, "embryogenesis": 0.00043, "cd30 ligand": 0.00592, "link p35": 0.00347, "octamer-dependent promoter": 0.02336, "phorbol ester-induced production": 0.00695, "tnfrp55-deficient mouse strain": 0.00649, "human androgen receptor assay": 0.01881, "induce antiviral protection": 0.01694, "non-recurrent": 0.00012, "cdk4": 0.00037, "il4 enhancer": 0.00909, "hashimoto patient": 0.01666, "prriii": 6e-05, "anoxia/reoxygenation": 0.00012, "detect signal transducer": 0.0109, "s.m.schnittman": 6e-05, "signal-transducing": 0.00074, "nfat/ap-1 complex form": 0.01123, "flt-3 ligand": 0.00592, "ba-induced differentiation process": 0.00786, "intravenous administration": 0.00093, "potent cellular activator": 0.00596, "renal tubule": 0.00115, "breast cancer": 0.00257, "cell surface hla-dr antigen": 0.0384, "il-9-induced cell proliferation": 0.0512, "position -24": 0.00236, "endogenous ifn": 0.00459, "boston": 6e-05, "sp-deficient drosophila schneider": 0.00081, "protein tyrosine kinase activation": 0.02264, "consensus ap-1 site": 0.01445, "fas-mediated killing": 0.0005, "hiv-1 ltr result": 0.01073, "major interest": 0.00574, "high affinity cvz bind site": 0.00867, "nef phosphorylation": 0.00983, "low mobility ap-1 binding activity": 0.0117, "cell line lead": 0.0512, "transcription factor activation": 0.02109, "increase transcriptional elongation": 0.01464, "vpr suppresses expression": 0.02775, "vivo genomic dm footprinting reveal upstream": 0.00366, "similar construct": 0.00726, "hemoglobinization": 0.00037, "tow": 0.0, "cd27/cd70 interaction": 0.00986, "hesperidin": 0.0, "gst pull-down experiment demonstrate": 0.00799, "b-cll cell death": 0.0512, "progenitor proliferation": 0.00803, "granuloctyes": 0.0, "overexpression induce": 0.0254, "local modulation": 0.00257, "low amount": 0.00707, "myeloid-cell-specific gene expression": 0.02903, "il-10 inhibit tnf-alpha release": 0.00952, "cle0 binding protein": 0.03019, "nfkappab entry": 0.00189, "gata site separate": 0.01445, "mycobacterium tuberculosis include granuloma formation": 0.00576, "endogenous prl gene": 0.02903, "zymosan": 0.00012, "nuclear nf kappab": 0.01123, "functional anti-tumor immunity": 0.00544, "immune inflammation": 0.00599, "ed": 0.0, "selectively block mkk activity": 0.01462, "considerable evidence": 0.00422, "rar gamma-specific ligand": 0.00395, "mutant max": 0.0081, "103-amino-acid basic protein": 0.03019, "env gene": 0.04355, "blast cell express lineage-specific transcription factor": 0.0256, "study glucocorticosteroid receptor density": 0.01286, "complex undergo stimulus-responsive processing": 0.00842, "kennedy": 0.00012, "treated patient reveal": 0.0111, "nk cell occur": 0.0512, "transcription factor expression vector": 0.02081, "hgm-csf": 0.00025, "st patient": 0.01666, "ineffectiveness": 6e-05, "expression decline": 0.04163, "cytokine treatment": 0.01123, "activated lamina propria": 0.00393, "nerve cell provide": 0.0512, "multiple signaling defect": 0.00459, "cd3-epsilon": 0.0005, "target member": 0.00825, "gi protein": 0.04529, "regulate homotypic aggregation": 0.00835, "human endothelial cell activation": 0.0384, "shock": 0.00347, "pituitary cell system": 0.0512, "estrogen receptor beta": 0.01714, "hiv-1 infects rest peripheral blood mononuclear cell": 0.02194, "pathway result": 0.0161, "receptor-ligand interaction": 0.00986, "form protein/drug complex": 0.01123, "typical inducer": 0.00136, "cell demonstrate accelerate cell cycle progression": 0.0128, "adenylate cyclase inhibitor": 0.006, "quantitative sba": 0.00096, "nuclear factor-mu negative regulator": 0.00842, "type ii": 0.00949, "da": 0.0, "necessity": 0.00043, "lsp1": 0.0, "fetal/adult gene": 0.04355, "induce hiv-1 replication": 0.01694, "21-bp repeat": 0.00378, "long term therapy": 0.00275, "initial viral promoter": 0.01557, "pu.1 prime": 0.00285, "a6h mab upregulated cd80": 0.00133, "active pkb": 0.00592, "fosb mrna": 0.01526, "medium treatment": 0.01014, "maltose binding protein": 0.03019, "precisely lack exon": 0.00422, "human plasma": 0.03762, "leukemia cell inhibit interleukin-2": 0.0384, "potential interaction": 0.00986, "myeloperoxidase cytochemical reactivity": 0.00087, "c5a-stimulated pbmc": 0.00236, "pp56": 0.00031, "include cell growth": 0.0512, "specific chromosomal translocation": 0.00825, "sequence psptspt": 0.01625, "regulate distinct biologic function": 0.00665, "autocrine tnf-alpha secretion": 0.00364, "polarized epithelium": 0.00053, "inhibition occur": 0.01061, "rheumatoid arthritis synovium express receptor": 0.01029, "condition": 0.0072, "ciprofibrate-induced phorbol ester-dependent differentiation": 0.00589, "conservative treatment": 0.01014, "functional outcome": 0.00816, "colon": 0.00074, "vivo transactivation activity": 0.0195, "cytokine induce transcription": 0.01873, "atra-induced differentiation": 0.01179, "inducible activation": 0.03164, "express elk-1": 0.01846, "ikappabalpha gene": 0.04355, "pronounced down-regulation": 0.00195, "cyclic amp inhibits nf-kappab-mediated transcription": 0.01124, "oxidative stress enhances nuclear factor kappa": 0.00953, "promote human immunodeficiency virus replication": 0.01505, "co-immunoprecipitation analysis reveal": 0.00786, "tlrs": 0.00019, "cbl": 0.00149, "apl patient": 0.01666, "serum ig level": 0.01214, "receptor signal pathway": 0.01714, "key cytokine": 0.01123, "htlv-1-mediated transformation": 0.00288, "cystatin": 0.0, "pernis": 0.00012, "cell cycle exit trigger": 0.0384, "cd30": 0.00143, "hsv-1 strain f. immunoblot analysis": 0.00471, "exact cellular mechanism underlie": 0.00529, "normal comparison subject show": 0.013, "receptor alpha gene": 0.02903, "fenofibrate inhibits vcam-1 transcription": 0.01405, "antigen receptor costimulation": 0.01714, "ctl response": 0.01942, "cbl homologue cbl-b": 0.0005, "human leukemia u937 cell": 0.0384, "mrna stability": 0.01526, "present data demonstrate": 0.01065, "nuclear run-on assay": 0.01123, "gut inflammatory response": 0.01294, "reveal minimal immunoreactive ppargamma": 0.00549, "study show association": 0.01733, "specific instance": 0.01238, "vitro activate normal human lymphocyte": 0.01505, "nf-kappab translocation": 0.00999, "gpi-1": 0.00012, "gas": 0.00161, "host transcription factor nf-kappa": 0.0143, "hiv-1 dse": 0.00878, "protease -and oxidant-rich purulent airway secretion": 0.00143, "turnover": 0.00223, "bind all-trans-retinoic acid": 0.0135, "peripheral blood lymphocyte culture show": 0.0104, "increased incidence": 0.00363, "preclinical model suggest": 0.01348, "increase rna": 0.02196, "thyroidectomy": 0.00019, "reveal predominant expression": 0.02775, "cytokine signal": 0.01635, "ad-infected target": 0.00825, "cdna encode ptf beta": 0.00426, "cll case": 0.00363, "protein-tyrosine kinase inhibitor genistein": 0.00594, "b7.1 molecule": 0.00853, "vcam-1 mrna": 0.01526, "human interleukin-2": 0.03762, "alloreactive response": 0.01942, "long primary transcript": 0.00492, "porcine aortic endothelial cell": 0.0384, "exogenous e2f expression": 0.02775, "normal bone marrow myeloid": 0.00605, "scd": 0.00012, "nb protein": 0.04529, "olf-1": 0.00012, "cd3-stimulated human peripheral": 0.02508, "anti-stat ab": 0.00167, "germline transcript initiate": 0.00399, ".001": 0.00019, "pre-activation level": 0.01821, "mark contrast": 0.00546, "g0s2 expression": 0.04163, "receptor alpha chain gene": 0.02177, "block mabs": 0.01073, "jun/fos": 0.00068, "intracellular protein increase": 0.03019, "initial peak": 0.00189, "well-studied": 0.00012, "acetate": 0.00199, "granulocyte-macrophage colony-stimulating factor production": 0.0143, "transcription factor e2f bind": 0.0143, "deletion cd20 promoter-cat construct": 0.00363, "silencing effect": 0.02115, "hsn3 subunit": 0.00484, "ifn-alpha-treated cell": 0.0768, "lps-induced response": 0.01942, "inhalation": 6e-05, "sperm": 0.00043, "hbd mutant": 0.0081, "monocyte/macrophage activation": 0.03164, "granulocytic differentiation program": 0.00786, "endocrine change": 0.0063, "cytotoxic activity": 0.02925, "nuclear signal mechanism": 0.01123, "determine mr": 0.00779, "potent transcriptional repressor icer": 0.00575, "modification remain": 0.00521, "immune cell function": 0.0512, "murine b-cell cdna-library": 0.00416, "inhibits lipopolysaccharide": 0.0053, "human primary haemopoietic cell": 0.0384, "lowered content": 0.00158, "tgf-beta1": 0.00105, "peripheral blood mononuclear cell gcr bind affinity": 0.02194, "dexamethasone treatment": 0.01014, "virus activation": 0.03164, "cd4 thymocytes": 0.00332, "distinct stat3-like protein": 0.03019, "parallel experiment": 0.00397, "mouse intraspecies hybrid": 0.00649, "increased level": 0.01821, "c-erbb": 0.00037, "rxr-rxr homodimers": 0.00078, "ubiquitous cyclic amp-responsive element": 0.00836, "bed rest specific glucocorticoid bind": 0.0081, "cd40-activated human": 0.03762, "biallelic": 0.00025, "order": 0.00248, "active mapk": 0.00592, "faster-migrating nf kappa": 0.00498, "free radical-induced tissue damage": 0.00332, "hsfe": 0.00012, "nf-at transactivating pathway": 0.00852, "subdominant latent cycle reactivity": 0.00154, "inhibits monocyte tissue factor activation": 0.01266, "secondary increase": 0.02196, "non-insulin-dependent diabetes mellitus patient": 0.00833, "limited expression": 0.04163, "raralpha": 0.0005, "il3 promoter": 0.02336, ":2351": 6e-05, "single critical c-myb binding site": 0.00867, "-276": 0.00031, "non-rheumatoid arthritis": 0.00053, "d20s41": 0.00012, "dna-binding level": 0.01821, "immunopathology": 6e-05, "dor1": 0.00056, "co-opted": 6e-05, "post-translationally modified i-kappa": 0.00021, "similar dna control element": 0.00836, "include clear evidence": 0.00959, "ifngamma-": 0.00012, "sp1 transcription factor": 0.01907, "disease suggest": 0.02022, "cortisol receptor resistance": 0.01714, "cell bind": 0.0768, "bind endogenous intracellular receptor": 0.01286, "il13r": 0.0, "high metastatic potential": 0.0062, "kd allele": 0.0022, "tnf- alpha": 0.01169, "eosinophilic tissue infiltration": 0.00443, "branching morphogenesis": 6e-05, "magnetic bead separation": 0.00035, "78-nucleotide segment": 0.00189, "relevant dos": 0.00143, "cat enzyme activity": 0.0195, "hcd57-srei": 0.00031, "concomitant activation": 0.03164, "tradd": 0.00155, "autologous dendritic cell": 0.0512, "lymphocyte-specific enhancer": 0.00909, "mhc class ii deficient b-cell line": 0.00551, "intracellular signal molecule": 0.0109, "kappab-dependent manner": 0.00282, "growth factor receptor play": 0.0143, "abnormal binding": 0.01855, "additional difference": 0.00425, "cell immunopoiesis": 0.0768, "cell mature": 0.0768, "25-hydroxyvitamin d3 24-hydroxylase": 0.00163, "clone calm": 0.00738, "early human adult hematopoiesis": 0.01881, "beta-methyl analog": 0.00109, "bcl-2 protects cell": 0.0512, "donnelley": 0.00012, "oxidative stress-dependent activation": 0.02109, "beta isozymes": 0.00673, "traf3": 0.00043, "downstream gene regulate": 0.02903, "/cd3 complex": 0.01684, "pml-rar alpha expression": 0.02775, "er overexpression": 0.00382, "alpha expression increase event distal": 0.01665, "hematopoietic progenitor cell line": 0.0384, "demonstrate trilineage potential": 0.01065, "rhombotin gene family": 0.02903, "t-cell activation": 0.03164, "dec": 0.00012, "potential nf-kappa": 0.01414, "express cd38": 0.01846, "target specificity": 0.00825, "vascular-rich organ": 0.00118, "edman sequence": 0.01625, "anti-cd28": 0.00161, "show 9-cis retinoic acid": 0.013, "immunosuppressive compound": 0.0022, "n-tosylphenylalanine chloromethyl ketone": 0.00021, "nf-il6 enhanced expression": 0.02775, "mediate transcription": 0.0281, "zii domain": 0.01207, "anti-igm-induced apoptosis": 0.0089, "mouse gata3 transcription unit start": 0.01124, "prog increase survival": 0.01464, "transduce cell survival signal": 0.0384, "single agent": 0.00422, "dna sequence encode fkbp": 0.00813, "specific nuclear protein complex": 0.02264, "e1a render cell vulnerable": 0.0384, "il-2ralpha promoter": 0.02336, "refractory anemia": 0.00043, "gm-csf-stimulated pmn": 0.00078, "multiple hmg box": 0.00459, "conventional procedure": 0.00078, "isolates belong": 0.0005, "nucleotide -299": 0.00202, "repress postactivation death": 0.0017, "e-selectin surface expression": 0.02775, "estrogen affect vascular tone": 0.00399, "p90": 0.00012, "immunoglobulin gene": 0.04355, "endothelial cell stimulate": 0.0512, "inactive precursor": 0.00323, "unfractionated leukocyte": 0.00478, "-311ctcccttct-303": 0.00012, "recommended dos": 0.00121, "platelet glycoprotein ib alpha gene": 0.01742, "interacts": 0.00273, "genus": 6e-05, "control donor": 0.01303, "cd4-positive lymphocyte cell line": 0.0384, "y128": 0.00012, "rapid nongenomic": 0.00323, "initial concentration": 0.0067, "legionella pneumophila rpos gene": 0.02177, "human estrogen receptor": 0.02508, "proinflammatory cytokine tumor necrosis factor-alpha": 0.00449, ":3632": 6e-05, "ifn-beta synthesis": 0.00583, "amplified product show": 0.01733, "nfat-1 dependent": 0.00388, "enhance il-1beta promoter activity": 0.01462, "rel-deficient": 6e-05, "maintain nf-at transcription factor": 0.0143, "dra": 0.00199, "escherichia coli lipopolysaccharide": 0.00163, "mrna production": 0.01526, "oncogene expression": 0.04163, "prolymphocytic leukemia": 0.00499, "sixth month": 0.00068, "gp91phox gene": 0.04355, "oligoadenylate synthetase": 0.00037, "sequestered cytoplasmic form": 0.00703, "v-atpase subunit": 0.00484, "undifferentiated scc cell line remain unstained": 0.0256, "molecular function": 0.01331, "unphosphorylated protein": 0.04529, "mediate signaling": 0.01231, "human intestinal xenograft": 0.02508, "induce accumulation": 0.0254, "group show substantial decrease": 0.013, "specific antigen bind": 0.0135, "previous work implicate zebra": 0.00175, "include smooth muscle actin": 0.0072, "cell line nk3.3": 0.0512, "nf-at dna binding": 0.01237, "anti-il-1 beta antibody": 0.00596, "kinase upstream": 0.01188, "high estrogen": 0.00931, "regulate cellular growth": 0.00835, "pma/ionomycin inducible factor": 0.01907, "cpg island suggest expression": 0.02081, "induce cd5 expression": 0.02775, "cell specific-transcription": 0.0768, "lymphocyte gr receptor bind parameter": 0.01029, "cell proliferation response": 0.0512, "definite information": 0.00053, "half-maximal effect": 0.02115, "erythroid kruppel-like factor": 0.01907, "primary site": 0.02168, "lipid metabolism": 0.00124, "dna-binding lac repressor": 0.00374, "situ rt-pcr": 0.00087, "c-jun delta-domain inhibits neuroendocrine promoter activity": 0.00975, "homeobox gene essential": 0.02903, "human th2 line": 0.02508, "chimeric cd8alpha/il-4ralpha receptor": 0.01714, "belong": 0.00099, "alpha1 promoter": 0.02336, "pre-cultured": 0.00025, "platelet aggregation assay": 0.00668, "autoregulatory loop": 0.00109, "ca2+ ionophore": 0.00304, "ifn-alpha signaling": 0.00558, "epstein-barr virus nuclear protein": 0.02264, "study individual": 0.01355, "protein motif": 0.04529, "proliferative ebnas": 0.0018, "tata box suggest": 0.01348, "patient receive glucocorticoid therapy": 0.00833, "cr2/cd21": 6e-05, "balb/c mouse": 0.00974, "interphase": 0.00037, "skewed xci pattern": 0.00366, "-2010": 0.00012, "human th2 clone": 0.02508, "mobilization": 0.0018, "ubp": 6e-05, "alter relative": 0.00378, "b-lymphocyte transformation": 0.00288, "b1": 0.00205, "construct term pfp5a": 0.00484, "constitutively active ra": 0.00397, "uninduced thp-1 cell": 0.0512, "proximal functional promoter region": 0.01168, "rp-camp- sensitive pathway": 0.00852, "synergistic proinflammatory effect": 0.0141, "herpesvirus biology": 0.00074, "culture nasopharyngeal carcinoma": 0.00414, "u1a formation": 0.00484, "sp1 occurs": 0.0036, "tgf-alpha": 0.00043, "hit-t15 cell": 0.0768, "dominant negative inhibitor": 0.006, "nfkappab nuclear translocation": 0.01123, "clinical recovery": 0.00425, "exact site": 0.02168, "human b-lymphocyte precursor": 0.02508, "pparalpha activation": 0.03164, "function possess": 0.01331, "illegitimate": 6e-05, "activated eosinophil": 0.00589, "m10-expressing cell line remain infectable": 0.03072, "show": 0.05199, "at2.5": 0.00012, "induce c-fos mrna": 0.01694, "cam/cn-mediated pathway play": 0.00852, "grip-1": 6e-05, "provide functional evidence": 0.00544, "aml1/mds1/evi1": 0.0005, "factor oap": 0.0286, "degree similar": 0.00673, "il-2-dependent function": 0.01331, "efficiency": 0.00087, "human glial cell": 0.0512, "specific function": 0.01331, "cd4-cd8- murine": 0.00623, "nuclear kinase": 0.01684, "delta sp mutant": 0.0054, "murine t-all cell line": 0.0384, "slg+": 0.00019, "colostrum inhibitory factor": 0.01907, "drosophila toll protein": 0.03019, "knowledge": 0.0005, "up-regulate transcription": 0.0281, "endogenous shp1": 0.00459, "oestrogen-dependent tumour": 0.00183, "hierarchy": 0.00025, "gp120 enhances icam-1 gene expression": 0.01742, "chemoattractants fmlp": 0.00053, "resurgence": 0.0, "complex ii": 0.01684, "category iii cell": 0.0512, "glucocorticoid receptor function": 0.01714, "cell type specific gene": 0.0384, "respective transcription factor": 0.01907, "anti-class ii monoclonal antibody": 0.00447, "nf-kappab component c-rel": 0.00666, "rapid aldosterone effect": 0.0141, "testis": 0.00043, "stat4 expression": 0.04163, "candidate": 0.00118, "impair": 0.00329, "lymphocyte express socs-3": 0.0123, "proil-1beta gene transcription": 0.02903, "irf-1 promoter": 0.02336, "phenotype": 0.00732, "isoproterenol mimic": 0.00174, "nf-atc.alpha mrna": 0.01526, "sp1 activity": 0.02925, "sle": 0.00099, "spi-b transcription factor": 0.01907, "determination": 0.00112, "lymphoid-restricted": 0.00019, "purified viral material": 0.00488, "repress promoter": 0.02336, "signal require": 0.01635, "sex-binding globulin": 6e-05, "unique subunit association": 0.00323, "undifferentiated cell": 0.0768, "il-2 transcriptional inhibitor": 0.00767, "blast cell": 0.0768, "il-1beta gene transcription": 0.02903, "cytosolic phospholipase a2 suppress interleukin-1beta protein": 0.0151, "constitutive complex term complex": 0.00421, "time point": 0.00273, "vitro degradation experiment": 0.00523, "t-lymphocytic cell line": 0.0512, "disparate": 0.00062, "subset": 0.00385, "cl": 0.00037, "heat shock-treated om10.1": 0.00126, "partition selectively": 0.00292, "spi-b play": 0.0071, "trans-acting element": 0.01672, "regulate cell division": 0.0512, "normal control": 0.01303, "unactivated monocyte": 0.01197, "e.ramazzotti": 0.00012, "ige germline promoter": 0.01557, "transcriptional element": 0.01672, "basic leucine zipper": 0.00116, "clone binding": 0.01855, "cellular thiol level": 0.01214, "lymphocyte gr bind parameter": 0.01013, "trapoxin": 0.00019, "tax1-related antigen molecule detect": 0.00426, "foam cell formation": 0.0512, "detect clonal eosinophilia": 0.00484, "ceramide": 0.00043, "natural variant": 0.00276, "reduced number": 0.0053, "lmp-1-triggered signaling": 0.00558, "activation-induced apoptosis": 0.0089, ".2": 0.0, "blastic transformation": 0.00288, "stp-c488 p10": 0.00022, "short tandem repeat": 0.00252, "breast carcinoma cell": 0.0512, "stimulate expression": 0.04163, "luciferase": 0.00273, "human mononuclear": 0.03762, "hamartoma": 0.0, "thyroid status": 0.00217, "recombinant lef-1": 0.00391, "u937 cell express": 0.0512, "bind functional sequence": 0.0135, "term nfatp": 0.00413, "pathways inhibit": 0.01904, "pml/raralpha": 0.00155, "truncation result": 0.0161, "experimental strategy": 0.00121, "enhance il-1 receptor antagonist secretion": 0.01029, "hypercalcemia": 0.00019, "high activation level": 0.02109, "breast": 0.00515, "nre": 0.00068, "alpha chain promoter": 0.01557, "female mz twin pair": 0.00107, "s6 kinase": 0.01188, "single e2f-dna binding complex": 0.00927, "existence": 0.00087, "free plasma cortisol concentration": 0.00335, "cell surface activation marker": 0.0384, "non-erythroid cell line": 0.0512, "binding activity specific": 0.0195, "differential accumulation": 0.00323, "immature cd34+thy-1+ subset": 0.00128, "specific region": 0.01467, "tumor necrosis factor alpha-mediated activation": 0.01266, "long-lasting il-2 receptivity": 0.00744, "mast": 0.00074, "nre gamma site": 0.01445, "bind small lipophilic substance": 0.01013, "interleukin-1 alpha": 0.01169, "sporadic case show": 0.01733, "constitutively activate stat factor": 0.0143, "p63": 0.00012, "estrogen stimulate outgrowth": 0.00734, "include granulocyte-macrophage colony-stimulating factor": 0.0143, "chr": 0.00062, "bovine brain gangliosides": 0.0006, "bsap play": 0.0071, "show increase bind": 0.01733, "nac inhibit interleukin-1": 0.0127, "characteristic decline": 0.00329, "al.": 0.00068, "interleukin-4-induced transcription factor": 0.01907, "ligand-activated c-erba/tr accelerated differentiation": 0.00589, "t-cell specific": 0.01238, "derived protein sequence": 0.03019, "p24 ag assay": 0.00668, "c-maf cdna": 0.00456, "distinct nuclear factor": 0.01907, "pma inducibility": 0.00409, "model system": 0.00667, "high molecular weight complex": 0.00842, "activation signal hb24 mrna": 0.01582, "fas": 0.00199, "determine critical transcription factor": 0.0143, "offer": 0.00124, "icsat": 0.00062, "il-12 signal transduction": 0.0109, "human b-lymphocyte cdna library": 0.01881, "bind signal transducer": 0.0135, "component": 0.00912, "polymerase chain reaction amplification": 0.00219, "basic dbd adjacent": 0.00116, "macrophage determine": 0.00779, "mitogenic agent": 0.00422, "radioligand bind method": 0.0135, "ibr site": 0.02168, "monocytoid cell": 0.0768, "biochim biophys acta": 6e-05, "drosophila runt protein": 0.03019, "antioxidant inhibit agonist-induced monocyte adhesion": 0.00762, "human hematopoietic cell line": 0.0384, "renal cell carcinoma-derived gangliosides suppress nuclear factor-kappab activation": 0.0192, "early signal event": 0.0109, "degradation rate": 0.00332, "roi-forming mechanism": 0.01058, "individual stat protein": 0.03019, "b7.1 cdna": 0.00456, "gene promoter": 0.04355, "energy study": 0.01355, "bone morphogenetic protein-2-": 0.00143, "ucsd-aml1 cell line": 0.0512, "dqalpha": 6e-05, "tnf-alpha control dna repair": 0.00741, "tcr gamma locus": 0.00318, "upper spinous layer": 0.00027, "elf-1 site": 0.02168, "ald-treated cell": 0.0768, "tnf alpha treatment": 0.0078, "suspension": 0.00012, "stat-1 alpha": 0.01169, "transcription factor family": 0.01907, "inactive camkiv": 0.00161, "barrier function": 0.01331, "air-1 locus": 0.00288, "von willebrand receptor": 0.01714, "regulate transcriptional activity": 0.0195, "atopy": 0.00019, "normal mouse": 0.0121, "pulmonary heart disease": 0.00449, "nonpregnancy lymphocyte react": 0.00988, "e-selectin upregulation": 0.00192, "augment nf-at activation": 0.02109, "isolate dests": 0.00416, "inactive p50 homodimer": 0.00192, "il-13 induce expression": 0.02775, "mitogen-inducible transcription factor": 0.01907, "t-cell specificity": 0.00962, "icam-1 level correlate": 0.01214, "cp usage": 0.00081, "worker": 6e-05, "tax trans-activator induces nf-kappab activity": 0.0117, "linear ebv genome": 0.00376, "extensive immunocytochemical evaluation": 0.00079, "mrna": 0.03052, "vitro glucocorticoid receptor bind study": 0.01029, "proliferation assay": 0.01002, "related result": 0.0161, "linker protein slp-76": 0.03019, "extensive apoptosis": 0.0089, "stat factor": 0.0286, "cvz-resistant cell": 0.0768, "describe nuclear structure": 0.01123, "lipopolysaccharide induce": 0.0254, "receptor gene": 0.04355, "favor activation": 0.03164, "phagocytic stimulus": 0.0027, "tissue-specific promoter activity": 0.0195, "p53 molecule": 0.00853, "additional event": 0.00552, "germline promoter": 0.02336, "induction condition": 0.01607, "peculiar difference": 0.00425, "pkc-zeta overexpression stimulate": 0.00734, "human pro-interleukin-1beta gene": 0.02903, "internucleosomal dna fragmentation": 0.00988, "exert opposite effect": 0.0141, "large protein ligand": 0.03019, "bso-induced thiol/disulfide imbalance": 0.00014, "hdl-cholesterol": 0.00012, "tetraproline repeat": 0.00378, "rar alpha": 0.01169, "nucleosome-free region encompass": 0.00978, "enzymatic footprinting procedure": 0.00079, "melanoma": 0.00112, "id2 mrna": 0.01526, "exon encode": 0.00853, "nf-kappab-inducing kinase": 0.01188, "synthetic lipopeptides proceeds": 0.00134, "distinct stimulus": 0.00698, "b7 induce distinct effect": 0.0127, "patient cell": 0.0768, "epo-stimulated bfu-e colony growth": 0.00409, "intracellular signaling pathway couple": 0.00639, "lps-induced nf kappa": 0.00498, "parental granulocyte-macrophage colony-stimulating factor": 0.0143, "january": 6e-05, "c-fos form": 0.01055, "slap-130": 0.00043, "functioning": 6e-05, "change nuclear factor-kappa": 0.01123, "estrogen-mediated activation": 0.03164, "pkc-zeta cell express": 0.0512, "temporal change": 0.0063, "deletional switch recombination underlie": 0.00123, "exact etiology": 0.00031, "inhibit program cell death": 0.0384, "nadph-oxidase component cytochrome b558": 0.00228, "mm patient": 0.01666, "ap-1 consensus sequence": 0.01084, "diurnal rhythm": 0.00034, "antigen receptor-stimulated": 0.00819, "differentiation-inducing ability": 0.00431, "helix-loop-helix protein": 0.04529, "concurrence": 0.0, "rac-1": 0.00105, "c-terminal end": 0.00192, "ikappab kinase alpha": 0.00792, "influence antibody response": 0.01294, "cd8-positive lymphocyte": 0.01483, "core sequence aggc": 0.01084, "rap1 protein phosphorylation": 0.03019, "cytopathic property": 0.00397, "fibrogenesis": 0.00019, "abrogate growth-inhibition": 0.00254, "cell-type-dependent": 6e-05, "individual-specific modifier": 6e-05, "small molecule": 0.00853, "trep-containing dna fragment": 0.00988, "lipopolysaccharide-mediated nuclear translocation": 0.01123, "signal integration": 0.01635, "tpa maturation response": 0.01294, "cell-specific gene": 0.04355, "mumol/l": 6e-05, "v-erba oncoprotein": 0.00115, "lymphokine gene": 0.04355, "interassay variation": 0.00164, "required criterion": 0.00047, "micrograms/ml etoposide": 0.00037, "rel/nf-kappab transcription factor": 0.01907, "pre-i interacts": 0.00136, "concomitant loss": 0.00298, "fundamental": 0.00068, "glucocorticoid synthesis": 0.0085, "preferred spi-b binding site": 0.01084, "pha/pma": 0.00031, "morning plasma cortisol": 0.0025, "cmmol": 6e-05, "myeloid-specific promoter activity": 0.0195, "amino acid sequence comparison show": 0.0104, "p49": 0.00031, "differential gene regulation": 0.02903, "senescent cell": 0.0768, "septic patient": 0.01666, "constitutive nuclear localization": 0.01123, "fourfold high 12-lipoxygenase activity": 0.01462, "microgram/ml occur": 0.00654, "hydrocortisone injection": 0.00047, "mue3": 0.00019, "dose-dependent manner parallel": 0.00188, "debate": 6e-05, "render cell": 0.0768, "mumol cortisol": 0.00295, "dna virus": 0.01483, "secrete timp-1": 0.00208, "tar independent activation": 0.02109, "inhibit g-csf-stimulated myeloid": 0.0127, "t.folks": 0.00012, "ef1-like activity": 0.02925, "tandem array": 0.00121, "bmrf1": 0.00043, "screen single human tonsillar gc": 0.01505, "il-10 receptor site": 0.01714, "pma-induced ikb alpha phosphorylation/degradation irrespective": 0.00468, "heterozygous status": 0.00217, "describe bind site": 0.01445, "premature age": 0.00226, "regulate": 0.02506, "human il-2 activate nk cell": 0.03072, "constitutive dna-binding activity": 0.0195, "octamer-like factor bind": 0.01907, "aldh1": 0.0005, "actual proliferative activity": 0.0195, "vwf secretion": 0.00428, "rate correspond": 0.00279, "-150 ap-1 binding site": 0.01084, "glutamine-rich region": 0.01467, "myelomonoblastic cell": 0.0768, "gr bind characteristic": 0.0135, "open chromatin configuration": 0.00079, "lymphoid src kinase pp56": 0.00594, "ltr-directed gene expression": 0.02903, "tcr/cd28 costimulation": 0.00171, "dc differentiation": 0.01179, "granulocyte-macrophage colony-stimulating factor induce": 0.0143, "eed-mediated transcriptional effect": 0.0141, "hgrs": 6e-05, "gel shift analysis show": 0.013, "lipopolysaccharide-stimulated human monocyte": 0.02508, "dispersed localization": 0.00186, "pkc activity": 0.02925, "fos protein fail": 0.03019, "epithelial cell line": 0.0512, "regulate interleukin-1 production": 0.00835, "normoxic control": 0.01303, "intracytoplasmic tnfalpha level": 0.01214, "transformation process": 0.00444, "cytoplasmic cellular extract": 0.00596, "tsh": 0.00056, "carboxyl portion": 0.00074, "hormone delay terminal differentiation": 0.00589, "t47d mammary tumor cell": 0.0384, "gribben": 0.00012, "intracellular protein expression": 0.03019, "transcription factor regulate apoptosis": 0.0143, "chloramphenicol acetyl-transferase assay demonstrate": 0.00799, "antihuman tnf-alpha-neutralizing antibody": 0.00596, "12-0-tetradecanoyl phorbol-13-acetate": 0.00012, "critical cell cycle checkpoint": 0.0384, "augments association": 0.00282, "cell respond": 0.0768, "determine factor": 0.0286, "4,19-disubstituted derivative": 0.00192, "molecular size": 0.0045, "rabbit reticulocyte lysates": 0.00068, "-120 region": 0.01467, "tnf-alpha mrna level": 0.01214, "peptide antagonist": 0.00754, "pilot": 0.00037, "specific peptide residue identifies": 0.00619, "-1280": 6e-05, "c3 receptor-mediated nuclear translocation": 0.00842, "alpha tcr gene": 0.02903, "reticulocyte": 0.00112, "bind fos": 0.02025, "plasmacytoma cell extract": 0.0512, "specific dna-binding": 0.01238, "activate nf kappa": 0.01185, "recent data": 0.00254, "methylation interference study reveal": 0.00678, "pma-treated": 0.00037, "tk": 0.00062, "important functional alteration": 0.00544, "hml isolate": 0.00416, "rare cell": 0.0768, "lymphocyte display": 0.01483, "xy sex-reversed female": 0.00105, "long-term clinical effect": 0.0141, "nuclear trans-acting factor": 0.01907, "functional sp1 binding element": 0.00927, "fos early response gene": 0.02177, "common regulatory mechanism": 0.00705, "endogenous tg receptor": 0.01714, "creb/atf": 0.00099, "trace amount": 0.00285, "human hsf1": 0.03762, "transient transcriptional upregulation": 0.00767, "block paclitaxel-induced apoptosis": 0.00715, "p65-": 0.00019, "dynamic": 0.00037, "inverse effect": 0.02115, "pentazocine": 6e-05, "healthy virus carrier maintain": 0.00444, "lack detectable cd14 cell surface": 0.03072, "tyrosine phosphatase inhibitor": 0.006, "monospecific": 0.00012, "hormonal ovulatory situation": 0.00045, "oxldls": 0.0005, "protein differ": 0.04529, "h2o2-induced nuclear translocation": 0.01123, "activate receptor-1": 0.01777, "gm-csf promoter region": 0.01557, "q23": 0.00012, "p/caf": 6e-05, "kb id-3 transcript": 0.00399, "block jnk activity": 0.0195, "amylase increase": 0.02196, "cd16- nk precursor cell": 0.0384, "specific dna sequence": 0.01084, "characterize factor": 0.0286, "il-4-": 0.00037, "inefficient nf-kappab activation": 0.02109, "blps stimulate nuclear factor-kappab": 0.00842, "sham-exposed": 6e-05, "immunol": 0.00012, "ebv result": 0.0161, "bzlf1 expression precedes rampant virus replication": 0.01388, "molecular cloning": 0.0045, "e2f-dependent thymidine kinase regulation": 0.00594, "functional threshold": 0.00816, "cd44-cd25+": 6e-05, "late activation": 0.03164, "nf-kappab dna-binding complex": 0.01123, "pyrimidine-rich region upstream": 0.00978, "zearalenone": 0.00012, "nk activity variance": 0.0195, "mcr": 0.00012, "normal transendothelial migration response": 0.00971, "normal female": 0.0121, "ap-1/atf/creb family": 0.00841, "pma-activated promoter activity": 0.0195, "mgc formation induce": 0.01694, "compound alter": 0.00378, "richter": 0.00025, "pp52 mrna": 0.01526, "intracellular activity": 0.02925, "low extent": 0.00707, "activates jnk": 0.00164, "non-epithelial cell": 0.0768, "glucocorticoid receptor isoforms": 0.01714, "transcriptional factor ap-1": 0.01907, "reporter gene show": 0.02903, "c-jun mrna inducibility": 0.01017, "promoter-reporter gene behavior": 0.02903, "-250 bp": 0.00267, "human il4 transcription": 0.02508, "increase il-4 level": 0.01464, "hsn3 proteasome subunit": 0.00323, "promoter-proximal position": 0.00236, "hiv/siv genome": 0.0014, "tautomycin": 6e-05, "transduced": 0.00081, "complex family": 0.01684, "mononuclear phagocytic lineage": 0.00244, "endogenous nf-kappab activation": 0.02109, "immunoglobulin switch region": 0.00978, "alkaline phosphatase": 0.00264, "subsequent antigenic challenge": 0.00203, "pre-b cell induce": 0.0512, "xy": 0.00031, "stat3 binding site": 0.01445, "sigd": 0.00031, "s.r.": 0.00012, "lymphocyte exhibit lipid peroxidation": 0.00741, "platelet-activating factor bind": 0.01907, "mature p50": 0.00329, "signal event responsible": 0.0109, "human gamma-globin promoter": 0.02508, "regulate globin gene expression": 0.02177, "inducible nfkappab": 0.00484, "granulomonocytic colony formation": 0.00323, "nk cell activation early": 0.0384, "p65 mrna": 0.01526, "csa-sensitive regulation": 0.01008, "s. typhimurium survival": 0.00157, "-570": 6e-05, "t4": 0.00068, "nac inhibited il-1 beta-induced mrna": 0.0061, "estrogen receptor influence non-genomic event": 0.01029, "developmental stage-specific regulation": 0.00672, "large diffusion": 0.00205, "affect result suggest": 0.01348, "vaccine development": 0.00633, "la mrna": 0.01526, "alpha globin": 0.01169, "hhv-8": 0.00019, "tcl1 gene": 0.04355, "il-6 level": 0.01821, "high salt concentration": 0.0062, "ap1 motif": 0.00875, "induce maximal hiv-1 expression": 0.02081, "outpatient visit": 3e-05, "-59 region": 0.01467, "competitive antagonist": 0.00242, "megakaryocytic glycoprotein ix promoter": 0.01168, "ad group": 0.00487, "precise number": 0.0053, "mouse raw264.7": 0.00974, "protein express": 0.04529, "upstream kinase": 0.01188, "critical component": 0.00456, "human t-cell receptor beta-chain core promoter": 0.01254, "positive receptor status": 0.01714, "b-lineage-specific gene express": 0.02903, "bronchial cell": 0.0768, "erythroid/megakaryocytic bipotential progenitor cell": 0.0384, "inappropriate": 0.0005, "control cell": 0.0768, "il-2r alpha mrna": 0.01017, "ubiquitin-activating enzyme": 0.0031, "cre element": 0.01672, "lung": 0.00391, "promote neutrophil": 0.00496, "include stat1 alpha": 0.00959, "study confirm": 0.01355, "i.p": 0.00012, "zeta-globin promoter activity": 0.0195, "epstein-barr virus-immortalized b-cell line": 0.00827, "describe isoform nf-atc/a": 0.00265, "cleavage": 0.00186, "viral superantigen play": 0.00488, "synchronous": 6e-05, "ascorbate increase": 0.02196, "tnfalpha require": 0.01315, "intermediate activity": 0.02925, "vitd3 receptor network operate": 0.01286, "proliferation-specific transcription factor e2f1": 0.0143, "consensus nf kappa": 0.00498, "cd18 antigen": 0.00819, "b-cell-derived nf-kappa": 0.01414, "oct1 protein": 0.04529, "interferon alpha selectively affect expression": 0.01665, "preferential suppression": 0.00416, "rac-1 signaling pathway important": 0.00639, "il-2 activation": 0.03164, "sp1 cleavage": 0.0036, "-2 gene": 0.04355, "experimental basis": 0.00143, "bind ap-1": 0.02025, "block fas-mediated apoptosis": 0.00715, "medical relevance": 0.0005, "mucolytic agent": 0.00422, "cell recognition": 0.0768, "fourth g76": 0.00016, "ndp": 0.00062, "arrest development": 0.00633, "beta-estradiol suppress": 0.00611, "jak/stat inhibitory gene": 0.02903, "critical regulatory mechanism": 0.00705, "tcr gamma/delta+": 0.00478, "nfkb-like transcription factor": 0.01907, "event upstream": 0.00552, "pathological condition": 0.0036, "underlie ig gene extinction": 0.02177, "glycosylated member": 0.00413, "cell-specific protein": 0.04529, "putative silencer": 0.00372, "clonal ctl": 0.00167, "work report": 0.0049, "kappa light chain": 0.00498, "cd29": 0.00012, "activated stat5": 0.00589, "major coat protein": 0.03019, "jijoye": 6e-05, "thrombin response": 0.01942, "inhibited neutrophil influx": 0.00331, "promise": 0.00012, "cell growth exert": 0.0512, "x-chromosome methylation pattern": 0.00366, "egr-1 mrna expression": 0.02775, "important ramification": 0.00689, "sr asthma": 0.00161, "lt-producing c81-66-45 cell line": 0.0384, "mark difference": 0.00425, "hmg box transcription factor": 0.0143, "flank sequence control human b29 gene expression": 0.01244, "androgen receptor": 0.02571, "activate u2 snrna transcription": 0.01405, "alveolar lymphocyte": 0.01483, "bind consensus site": 0.01445, "laz3/bcl6 gene": 0.04355, "cif": 0.00074, "mek/erk pathway": 0.01278, "ebv-infected": 0.00081, "normal hematopoiesis mimic": 0.00806, "islet cell antibody": 0.0512, "epstein-barr virus-encoded transactivator protein bzlf1": 0.01811, "dna-": 6e-05, "-dependent k+ channel": 0.00091, "gm5 site": 0.02168, "creb/atf-1/crem family member": 0.0056, "tax-induced turnover": 0.00112, "monoblastoid cell": 0.0768, "profound pathogenesis": 0.00171, "nac inhibit": 0.01904, "elevated number": 0.0053, "glucocorticoid receptor regulation": 0.01714, "conserved lymphokine element": 0.01115, "il-9": 0.0005, "human t-cell leukemia virus-encoded tax protein": 0.0151, "c-sis/platelet-derived growth factor-b promoter": 0.01168, "homologues": 0.00056, "expression/repression": 6e-05, "differentiated feature": 0.00217, "ikappab-alpha inhibitor hydrolysis": 0.006, "secrete depressed amount": 0.0019, "cell bind site": 0.0512, "linker protein": 0.04529, "impaired nuclear translocation": 0.01123, "similarly": 0.00279, "rta": 0.00068, "m. seiki": 0.00115, "m44": 0.00012, "pml nb": 0.00167, "elevated": 0.00223, "ag amino acid sequence": 0.00813, "immediate-early major tegument protein": 0.02264, "drug-free patient": 0.01666, "myeloid cell lead": 0.0512, "study gata-1 expression": 0.02775, "distinct function": 0.01331, "mononuclear infiltrates": 0.00304, "human toll-like receptor-2": 0.02508, "mutational study": 0.01355, "all-trans": 0.0018, "nf-cle0 gamma binding": 0.01237, "egf treatment induce igm production": 0.01016, "time due": 0.00369, "lineage-restricted transcription factor display": 0.0143, "rap30": 0.00012, "enhancer-dependent transcription": 0.0281, "tlck inhibit lps induction": 0.00952, "vzv peptide": 0.00754, "bacterium surface": 0.00515, "significant effect": 0.02115, "cd4 gene activation": 0.02903, "diurnal rhythmicity": 0.00025, "dendritic cell function": 0.0512, "vzv ie62-hsv": 0.00065, "representative environmental estrogenic compound": 0.0011, "initial infection": 0.0062, "activated monocytes/macrophages": 0.00589, "purified nf-gm2 consists": 0.00174, "tcp acetate": 0.00099, "il-2 message": 0.01117, "ro5-3335": 6e-05, "immunoglobulin alpha-locus": 0.00276, "ie2 gene product": 0.02903, "oct-2 factor": 0.0286, "lack immunophilins": 0.00633, "ebv lmp-1 protein": 0.03019, "induce rapid": 0.0254, "high-affinity receptor express": 0.01714, "great ability": 0.00431, "express hgata-3-specific mrna": 0.0123, "30-fold induction": 0.01607, "nucleoplasm": 0.0, "nf-kappa b/rel activation induce": 0.01582, "tnfrp55-deficient mouse": 0.00974, "undefined role": 0.01328, "thy-tax transgenic mouse": 0.00649, "lean body mass": 0.00091, "essential nf-kappa": 0.01414, "natural retinoid": 0.00233, "cell pigmentation": 0.0768, "2594-3979": 0.00012, "chronic phase cml patient": 0.00833, "transcription factor c/ebpbeta": 0.01907, "inhibit interleukin-2 secretion": 0.0127, "puf site function": 0.01445, "hnp-1": 6e-05, "tf antigen": 0.00819, "large tsg101": 0.00205, "include src homology": 0.00959, "ad5wt": 6e-05, "inflammatory activator": 0.00552, "anti-z epstein-barr replicative activator": 0.00276, "2'-deoxy-3'-adenosine monophosphate": 0.00019, "representative mutant": 0.0081, "pro-inflammatory stimulus": 0.0027, "il-2 receptor alpha chain": 0.01286, "prolonged il-2": 0.01117, "direct evidence": 0.0054, "-il6": 6e-05, "complement receptor-1 cell-surface protein": 0.02264, "cellular immune": 0.00893, "nf-kappa b/c-rel protein": 0.03019, "transfected cell line express elevated level": 0.0256, "ig integrin ligand": 0.00395, "cd20+": 6e-05, "127-137": 6e-05, "complement atttgcat": 0.00099, "rar beta/rxr heterodimers": 0.00151, "thiobarbituric acid-reactive substance": 0.00031, "il-13 regulation": 0.01008, "distinct entity": 0.00698, "psa protein": 0.04529, "bpv": 0.00012, "inhibit hiv replication": 0.0127, "basal transcriptional machinery": 0.00767, "i.stefanescu": 0.00012, "/rel family member": 0.0056, "activate p21": 0.01777, "diverged octamer dna motif present": 0.00593, "stimulate transcription mediate": 0.01873, "11p14-15.1": 0.0, "enhances il-4 gene expression": 0.02177, "inv": 0.0, "cdna encode htafii105 reveals": 0.00426, "visual demonstration": 0.00065, "hiv-1 tat protein": 0.03019, "c/ebp epsilon mrna occur": 0.00763, "selective modulation": 0.00267, "transcription factor expression plasmid": 0.02081, "c5mj2 cell": 0.0768, "radiation-induced signaling cascade": 0.00372, "similar protein": 0.04529, "immunohistology": 0.00019, "rna transcript": 0.00599, "p65 dna binding activity": 0.01462, "dbf site exhibit": 0.01445, "promoter sequence": 0.02336, "rich": 0.00062, "immunoglobulin gene superfamily": 0.02903, "e214k-mediated ubiquitinylation": 0.00022, "p65 antisense oligomer": 0.00258, "x2": 0.0005, "human il-4 promoter": 0.02508, "metabolic state": 0.00267, "induce homo-": 0.0254, "costimulatory molecule": 0.00853, "carrier chronic virus replication remain": 0.00355, "cd8+cd18bright": 0.00012, "action remain": 0.00521, "pbsct": 0.00012, "control e2f transcriptional activity": 0.01462, "elastatinal": 6e-05, "activated erythropoietin receptor inhibit apoptosis": 0.01029, "adherence-dependent increase": 0.02196, "rest pbl": 0.00267, "mouse granulocyte/macrophage-colony stimulating factor": 0.0143, "specific anti-fc gamma": 0.00825, "b-cell-specific transcription factor bsap": 0.0143, "murine lck gene": 0.02903, "specific transcription factor bind site": 0.01144, "il-2 receptor expression occur": 0.02081, "monocyte/macrophage phenotype": 0.00366, "inhibition induce": 0.0254, "maternal immune system": 0.00445, "rhom-3": 0.0, "smu/sepsilon switch fragment": 0.00232, "ep": 0.00012, "pgd41": 0.00025, "rearrangement": 0.00397, "dex-resistant": 0.0005, "resistant variant": 0.00276, "erythroid": 0.01241, "doc": 6e-05, "stat3-independent bcl2 downregulation": 0.0006, "science": 0.00037, "single": 0.0072, "testosterone-bsa-induced ca2+ import": 0.00203, "er": 0.00527, "beta-gal": 0.00031, "patient receive il-2 immunotherapy": 0.00833, "aged rat": 0.00285, "-90/-79 sequence": 0.01625, "black people": 0.00025, "iu/ml": 0.00019, "tam-treated er+": 0.00019, "human tsp 1-chloramphenicol acetyltransferase construct": 0.01505, "cellular tip-associated protein": 0.03019, "murine fra-1 gene": 0.02903, "detect early invasive disease": 0.00414, "vdr mrna determine": 0.01017, "dna-binding site": 0.02168, "chromosome loss": 0.00298, "factor family remain unaltered": 0.0143, "spi-b function": 0.01331, "fo mrna": 0.01526, "retinoic acid-response element": 0.01115, "cellular mutant": 0.00893, "dex-induced apoptosis": 0.0089, "gt box": 0.00304, "enhance effect": 0.02115, "predictive clue": 0.00016, "9,11-dihydro derivative": 0.00192, "hiv-ltr": 0.00025, "article separate": 0.00155, "cytokine differential induction": 0.01071, "slight down-regulation": 0.00195, "human progesterone receptor": 0.02508, "augmented transcriptional activity": 0.0195, "stat protein bind site": 0.02264, "cell line occur": 0.0512, "element site": 0.02168, "fkhrl1": 0.00025, "hsp gene expression": 0.02903, "include immuno-modulatory effect": 0.0141, "chromosomal translocation result": 0.01073, "chi2=6.22": 6e-05, "subsequent squelching": 0.00304, "classic target tissue": 0.0055, "protein synthesis": 0.04529, "differentiate myeloid cell": 0.0512, "alpha-luciferase construct": 0.00726, "drosophila toll": 0.00121, "calcium-activated": 0.00031, "respective target sequence": 0.01084, "transcription factor important": 0.01907, "reverse effect": 0.02115, "cell receptor induce": 0.0512, "neutrophil adhesion": 0.0058, "zap-70-dependent signaling pathway": 0.00852, "virulent mutant": 0.0081, "rabbit beta-globin promoter": 0.01557, "iddm include insulin": 0.00959, "human epsilon-globin gene": 0.02903, "cell proliferation and/or differentiation": 0.0384, "soluble factor release": 0.01907, "lyn gene expression": 0.02903, "tcf-1/lef-1 play": 0.0071, "fibrinogen/mn2+": 0.0, "-induced hiv-1 replication": 0.00585, "probable regulatory point": 0.00455, "genetic system": 0.00667, "cox-2 protein expression": 0.03019, "pro-monocytic cell line u937": 0.0384, "hiv-1 transcriptional enhancer": 0.00767, "dominant negative mutant nfat delta418": 0.00324, "multiple pathway": 0.01278, "radiation damage": 0.0009, "iron": 0.00081, "crh regulation": 0.01008, "mrd-positive patient": 0.01666, "frequent expression": 0.04163, "sn50-induced apoptosis": 0.0089, "blood leukocyte": 0.00592, "stress kinase": 0.01188, "murine-specific ifn-gamma": 0.00481, "cytokine test": 0.01123, "target bhlh specificity": 0.0055, "impaired transcription factor ap-1 dna binding activity": 0.00836, "autosomal dominant mode": 0.00163, "tnf alpha concentration peak": 0.00585, "human t-cell leukemia line jurkat cell": 0.0256, "inhibit cd4 gene expression": 0.02177, "activation ag": 0.03164, "inexplicable": 6e-05, "domain characteristic": 0.01207, "actin gene": 0.04355, "e2f-mediated transcriptional activity": 0.0195, "active role": 0.01328, "macrophage remains unknown": 0.00393, "plasma renin activity": 0.0195, "inducible dna-binding protein": 0.03019, "transient expression data reveal": 0.02081, "irf-1 gene activation": 0.02903, "unstimulated u1 cell": 0.0512, "granulocyte-colony stimulating factor treatment": 0.0143, "interferon-gamma production": 0.01042, "characteristic th1-dominated chronic": 0.00265, "cell type-specific gene expression": 0.0384, "steroid receptor drug": 0.01714, "coactivator cbp": 0.00149, "u937 cell demonstrate": 0.0512, "potentiate nf-kappab-mediated transactivation": 0.00343, "coiled-coil region": 0.01467, "positional effect": 0.02115, "cell antigen receptor-induced mapk activation": 0.03072, "srf pathway": 0.01278, "fetal-calf serum": 0.00378, "double labeling": 0.00074, "human thyroid fragment": 0.02508, "estriol": 0.00012, "heterodimer complex formation": 0.01123, "delta gene segment": 0.02903, "wild-type gr gene": 0.02903, "cellular gene regulatory molecule induce": 0.01742, "inducible c1 protein": 0.03019, "transient cotransfection": 0.00344, "purified neonatal": 0.00261, "transduce signal": 0.01635, "map kinase cascade": 0.00792, "chtm show circadian rhythm": 0.013, "repress il-2 expression": 0.02775, "cell ige synthesis": 0.0512, "cytotoxic effector function": 0.00887, "serine protease express": 0.0123, "gr bind affinity": 0.0135, "inhibitory receptor": 0.02571, "il-10 receptor express": 0.01714, "inflammatory site": 0.02168, "altered balance": 0.00161, "fc gamma riia stimulation": 0.0056, "demonstrate redox regulation": 0.01065, "inhibit dc response induce": 0.0127, "progesterone receptor-specific monoclonal antibody": 0.00447, "amino acid carboxy-terminus generate": 0.00428, "creb alters": 0.00236, "flow cytometry reveal": 0.00732, "significant influence": 0.00471, "death gene": 0.04355, "detectable e1a sequence": 0.01084, "-c": 6e-05, "favor ige production": 0.00695, "oct-2a protein": 0.04529, "il-12": 0.00627, "human immunodeficiency virus": 0.02508, "oct-1 protein": 0.04529, "life-threatening disease progression": 0.00449, "anti-cd70 mab": 0.00267, "peroxide sensitive human wurzburg t-cells": 0.01505, "concurrent enhancement": 0.00233, "increase apoptosis sensitivity": 0.01464, "hormonal response": 0.01942, "primary target": 0.00825, "il-5 gene": 0.04355, "tissue fibroblast": 0.00664, "inactive form unable": 0.00703, "rxr alpha": 0.01169, "phosphorylated creb protein": 0.03019, "depressed patient": 0.01666, "il-4-induced stat5 activity": 0.0195, "concatameric linear dna": 0.00988, "resorption lacuna": 6e-05, "hl-60 cell differentiation": 0.0512, "integer number": 0.0053, "repeat cold-air exposure increase human triiodothyronine": 0.01254, "tfiie beta": 0.00673, "ebv chronic response": 0.01294, "pcr administration": 0.00115, "oligo sequence": 0.01625, "pha-induced proliferation": 0.00803, "nfat2": 0.00025, "mutant tax": 0.0081, "activate caspase": 0.01777, "tax-mediated transcription": 0.0281, "ciita-independent mechanism": 0.01058, "precursor activation": 0.03164, "select set": 0.00195, "cysteine protease": 0.00177, "decrease plasma bicarbonate level": 0.0091, "breast tumor sample": 0.00622, "human immunodeficiency virus vpr product": 0.01505, "mutated ciita construct": 0.00484, "tcrhigh thymocytes": 0.00257, "antitumor effect": 0.02115, "phorbol 12-myristate -13- acetate": 0.00271, "2.5-fold enhanced protein secretion": 0.02264, "cent": 0.0, "interferon receptor family": 0.01714, "overlap host range": 0.00143, "characterized": 0.00056, "mammary cancer patient": 0.0111, "cd2 antigen result": 0.01073, "hbsag-reactive cell": 0.0768, "two-site interaction": 0.00986, "tax include nf-kappa b/rel": 0.0072, "glucocorticoid test": 0.0085, "close examination": 0.00068, "aberrant": 0.0018, "hormonal dysregulation": 0.00068, "repressive effect": 0.02115, "il-9-induced activation": 0.03164, "altered activity": 0.02925, "hormone bind specificity": 0.0135, "beta-casein promoter": 0.02336, "anti-cd28 moab costimulation enhance": 0.00487, "significant": 0.00831, "ikappab level": 0.01821, "extrauterine site": 0.02168, "t-cell-specific promoter sequence": 0.01557, "vitro primary immune response": 0.00971, "9-cis retinoic acid stimulate differentiation": 0.00471, "il-4-induced up-regulation": 0.00276, "cysteine thiols play": 0.00474, "point mutant define": 0.0054, "ablation": 6e-05, "interferon-stimulated response element": 0.01294, "systemic disease": 0.00673, "intracellular biochemical event lead": 0.00498, "prolong": 0.00217, "1.2-3.3": 6e-05, "gene ul49": 0.04355, "similar degree": 0.00673, "interplay": 0.00056, "select gene": 0.04355, "lps response element": 0.01294, "gld": 0.00012, "cd2": 0.00292, "silent": 0.00087, "human gata3 zinc finger": 0.01881, "nm 12-o-tetradecanoylphorbol-13-acetate": 0.00093, "selection": 0.00242, "martin": 0.00012, "cytokine selectively": 0.01123, "render": 0.00304, "signal-transducing receptor": 0.02571, "nfil2": 6e-05, "anti cd20 monoclonal antibody": 0.00447, "waf1/cip1": 0.00012, "morphological change associate": 0.00728, "primary lymphocyte": 0.01483, "list": 0.00019, "base pair long region encode": 0.00587, "attractive target": 0.00825, "uf-1 cell": 0.0768, "induce mnp-1 expression": 0.02775, "mutant cell": 0.0768, "aggressive": 0.00012, "cdk": 0.00019, "regular interval": 0.00019, "serum-": 6e-05, "hiv-1 promoter-enhancer associate": 0.00728, "-108": 0.00019, "5869-bp region": 0.01467, "interest": 0.0005, "dna template": 0.01483, "transient co-transfection": 0.00344, "pu box-dependent transactivation": 0.00343, "nsaid lead": 0.00996, "vulvar mass": 0.00084, "familial androgen resistance": 0.00217, "transforming growth factor-beta promoter polymorphism": 0.00934, "mucinous sample show": 0.01733, "protects": 0.00056, "soluble tnf-alpha receptor type ii": 0.01029, "jak3 binding": 0.01855, "post-receptor defect": 0.00279, "result signal": 0.01635, "tsp gene family": 0.02903, "trep": 0.00056, "cell-type specific regulation": 0.00825, "antibody mib-1": 0.00893, "amino acid side chain": 0.00428, "interleukin-8 ap-1": 0.00695, "cell precursor acute lymphoblastic leukemia": 0.03072, "nkl human nk cell line": 0.03072, "differentiation induce": 0.0254, "undergo monocytic differentiation": 0.00786, "ebv-transformed human": 0.03762, "adequate approximation": 6e-05, "specie show": 0.02599, "low-level expression": 0.04163, "variant thereof": 0.00276, "increase basal level expression": 0.02081, "unique expression profile": 0.02775, "alter response": 0.01942, "synthetic peptide represent cytotoxic": 0.00377, "numerous gene require": 0.02903, "part due": 0.00369, "lps -and zymosan-treated cell show strong ap-1 activity": 0.0192, "emsa show": 0.02599, "c/ebp epsilon promoter/enhancer": 0.00149, "human tonsillar t-lymphocytes": 0.02508, "granulocyte-colony stimulate factor": 0.01907, "u1 monocytoid cell": 0.0512, "diffuse lymphoma": 0.00226, "pathophysiological background": 0.00115, "promoter transactivation": 0.02336, "il-2 gene expression": 0.02903, "peripheral lymphocyte isolate": 0.00988, "optimal expression": 0.04163, "hiv genomic rna": 0.00395, "cell-specific pathway lead": 0.00852, "breast tumor": 0.00934, "r-3-hydroxymyristate position": 0.00236, "primary ovarian carcinoma patient": 0.00833, "ly294002": 0.00037, "solution": 0.00112, "rat-1 fibroblast": 0.00338, "inhibit macrophage maturation": 0.0127, "human monocytic leukemia cell line thp-1 differentiate": 0.02194, "factor-dependent pkb/akt activity": 0.0195, "analog 433-442a bind": 0.0135, "immune system regulatory": 0.00455, "cd23-induced nf-kappab": 0.00999, "reagent": 0.00025, "fludarabine-induced immunosuppression": 0.00062, "time point prevent": 0.00349, "human il-4 receptor alpha-chain": 0.01881, "result contradict": 0.0161, "mcp-1 expression": 0.04163, "cross-competition assay": 0.01002, "duration": 0.00062, "rhombotin family": 0.00841, "mycotoxin": 6e-05, "subsequent step": 0.00304, "cognate receptor": 0.02571, "exclusive fashion": 0.00161, "distinct exon": 0.00698, "atf/cre bind site": 0.01445, "granulocyte differentiation": 0.01179, "rxr-rxr dimer": 0.00102, "lymphocyte signal": 0.01635, "rapid inducibility": 0.00323, "induce il-2 message": 0.01694, "ubiquitination": 0.00019, "il-12 induced phosphorylation": 0.00656, "ss oct-1 dna-binding abnormality correlate": 0.00262, "ifn-gamma affect": 0.00797, "mtcp1/a1 transcript": 0.00599, "site-directed mutagenesis demonstrate": 0.01065, "egr family protein": 0.03019, "cd40 cross-linking link": 0.00248, "gene fragment": 0.04355, "ap-1/tpa responsive element fuse": 0.00836, "promoter sequence polymorphism": 0.01557, "+265": 0.00012, "decreased transcription": 0.0281, "numerous inflammatory": 0.00471, "mature b-cell line": 0.01102, "detect bound": 0.00726, "estrogen receptor-related 27-kda heat shock protein": 0.0151, "cultivation": 0.00012, "encoded protein": 0.04529, "granulomatoses": 0.00012, "sch": 6e-05, "muscle": 0.0013, "e7 oncoprotein lack": 0.00422, "line differ": 0.01653, "p65/p50 subunit": 0.00484, "repress activity": 0.02925, "fcs- clonogenic culture": 0.00414, "alters gene expression": 0.02903, "human megakaryocyte": 0.03762, "activation correlate": 0.03164, "increase fos content": 0.01464, "c/ebpbeta activity": 0.02925, "kidney": 0.00118, "cellular defense system": 0.00596, "tax mutant suggest": 0.01348, "endogenous murine protein": 0.03019, "human granulocyte colony-stimulating factor receptor": 0.01505, "zinc-specific effect influence": 0.0141, "h-2d": 6e-05, "activated blood mononuclear cell": 0.0384, "v-erba oncogene": 0.00261, "vitro demonstrate": 0.01597, "ards": 0.00019, "require mapk activation": 0.02109, "determine activation status": 0.02109, "activation trigger": 0.03164, "n-hydroxy": 0.00012, "similar cleavage product": 0.00449, "kappab beta": 0.00673, "potent inductive signal": 0.0109, "-180 site": 0.02168, "anti-ehrlichia chaffeensis antibody complexed": 0.00447, "x-scid": 0.00056, "cytokine gene cluster": 0.02903, "surrogate receptor": 0.02571, "huh7 hepatoma cell": 0.0512, "wild-type": 0.00757, "localisation": 6e-05, "immunological study": 0.01355, "ara-c activate jnks": 0.01185, "incubation": 0.00416, "glucocorticoid correlate": 0.0085, "human toll": 0.03762, "cytokine receptor gene": 0.02903, "upstream segment": 0.00369, "major positive regulatory element": 0.00836, "dimerization domain": 0.01207, "common immunophilin": 0.0035, "calphostin": 0.00037, "commonly associate": 0.01092, "site link": 0.02168, "ifn beta promoter deletion": 0.01168, "sig-crosslinking-induced protein tyrosine phosphorylation": 0.02264, "schmidtmayerova": 0.00019, "eutopic endometrium": 0.00034, "induces maturation": 0.00803, "mediate growth inhibition": 0.00821, "gp130 receptor": 0.02571, "proteolytic activation": 0.03164, "isolate lung cell": 0.0512, "bind dna sequence": 0.0135, "il-10 enhance": 0.00974, "term infant cord blood mononuclear cell": 0.0256, "link binding site": 0.01445, "human nk": 0.03762, "transient transfection experiment show": 0.013, "gabp-mediated promoter-enhancer induction": 0.01071, "multiple stat protein": 0.03019, "antiretroviral compound": 0.0022, "weight gain": 0.00093, "probe reveal": 0.01098, "il-2rbeta": 0.00081, "nf-kappab complex": 0.01684, "igm-secreting plasma cell": 0.0512, "induce cd23 mrna transcription": 0.01405, "variable kinetics": 0.00167, "suppress transcription": 0.0281, "se induce dynamic change": 0.0127, "cell express cell surface glycophorin": 0.01536, "represent comparable event": 0.00368, "dhea modulation": 0.00257, "glucose transport": 0.00078, "gre binding": 0.01855, "benefit": 0.00074, "n-terminus": 6e-05, "observed e1a reiteration provide": 0.00323, "nfatp/ap-1 complex formation": 0.01123, "vitro activate lymphocyte": 0.01185, "negative effect": 0.02115, "lyn expression": 0.04163, "promonocytic u937 cell": 0.0512, "activation potential": 0.03164, "human cell include monocyte": 0.0384, "interleukin-6 production": 0.01042, "renal complication": 0.00115, "p.m.": 6e-05, "transient up-regulation": 0.00344, "reverse transcriptase polymerase chain reaction": 0.00175, "progesterone receptor complex": 0.01714, "activated platelet induce il-1 beta": 0.01016, "transduction mechanism": 0.01058, "t-cell anergy": 0.00962, "side effect": 0.02115, "hla-dq-specific immune response": 0.01294, "recombinant plasmid": 0.00391, "anti-c/ebpdelta": 6e-05, "preterms develop neonatal respiratory distress syndrome": 0.00134, "m.s.malnati": 0.00012, "htlv-i-transformed cell": 0.0768, "anti-cd3 stimulate": 0.01101, "anti-p-selectin mab": 0.00267, "generate e1": 0.00453, "signal-transducing pathway": 0.01278, "gene transfection": 0.04355, "minimal cd4 promoter": 0.01557, "dr11": 0.00012, "participate": 0.00261, "caat consensus site": 0.01445, "co-localization": 6e-05, "helical turn": 0.00093, "n-acetylcysteine": 0.00093, "e-box motif": 0.00875, "cortivazol mediate induction": 0.01071, "c-jun mrna expression": 0.02775, "il-10 cooperates": 0.00422, "deduced amino acid sequence similarity": 0.0065, "require costimulation": 0.01315, "nfatc mrna accumulation": 0.01017, "crisp-3": 6e-05, "hormone-induced tax activation induce": 0.01582, "systemic": 0.00205, "thyroid": 0.00304, "similar set": 0.00673, "normal induction": 0.01607, "erythroid ontogeny": 0.0062, "inducible proto-enhancer element": 0.01115, "targeted deletion": 0.00344, "mbob1": 0.00037, "cell line ach-2": 0.0512, "lack thereof": 0.00633, "wt/vol": 0.0, "bamhi-q promoter": 0.02336, "b-all case": 0.00363, "affect monocyte adhesion": 0.00798, "-182 bp": 0.00267, "tl-omi": 0.00012, "lps receptor": 0.02571, "bone marrow infiltration": 0.00143, "receptor alpha-chain": 0.02571, "cell-type-specific": 0.00105, "constitutive level": 0.01821, "monocytic cell line u937 require": 0.03072, "tcrg enhancer": 0.00909, "monocyte-type colony": 0.00171, "downregulates tnf production": 0.00695, "peptidyl-prolyl amide bond": 0.00012, "tumor tissue hormone sensitivity": 0.00467, "20-methyl-23-eneanalogues": 6e-05, "competent": 0.00074, "acidic": 0.00217, "molecule test": 0.00853, "full length sp1/dna complex": 0.00842, "early event detectable": 0.00552, "pzvh14": 0.00012, "estrogen binding activity": 0.0195, "aids-related neoplasm": 0.00034, "neuroectodermal origin": 0.00105, "precise mode": 0.00074, "t-cell regulatory cytokine": 0.00749, "genetic composition": 0.00288, "examination": 0.00093, "gm-csf": 0.00658, "qr activity": 0.02925, "engineered mutation": 0.00592, "protein translation start atg": 0.02264, "cmv transactivators enhance hiv-2 gene expression": 0.01452, "digoxigenin-labeled complementary dna probe": 0.00741, "p80c-rel tyrosine phosphorylation": 0.00656, "function independent": 0.01331, "resultant decrease": 0.00971, "nf-kappab complex induce": 0.01694, "sequential recruitment": 0.00164, "xenobiotics": 6e-05, "okadaic acid result": 0.01073, "response element": 0.01942, "dexamethasone inhibit leukocyte adhesion": 0.00952, "pou domain": 0.01207, "neutralizing anti-il-1beta antibody": 0.00596, "factor fail": 0.0286, "multifactor cis-dominant negative regulation": 0.00504, "kidney disease result": 0.01073, "orip depends": 0.00031, "wk induce": 0.0254, "ptpase": 0.0005, ":2430": 6e-05, "nf-kappab transcription factor": 0.01907, "cell membrane phospholipid": 0.0512, "ifn-gamma stimulation": 0.0112, "non-mcd14-mediated lp uptake stimulate": 0.00551, "wild-type zap-70 induce constitutive activation": 0.01266, "bal": 0.00056, "implicate jak kinase": 0.00792, "mdp": 0.00019, "luciferase reporter gene": 0.02903, "pgn": 0.00043, "germinal center cell": 0.0512, "undetectable glycoprotein iib": 0.00101, "rel-related transcription factor": 0.01907, "cancer chemotherapy": 0.00248, "er expression": 0.04163, "opposite effect": 0.02115, "ferritin heavy-chain gene": 0.02903, "growth modulator": 0.00819, "megakaryocytic differentiation induce": 0.01694, "drive il-5": 0.00233, "increase nuclearity": 0.02196, "rodent cell": 0.0768, "screen tsg101": 0.00099, "fatty acid metabolite": 0.00571, "cell line hl-60": 0.0512, "gam induce": 0.0254, "zvad-fmk": 0.00025, "zfh family": 0.00841, "consistency": 6e-05, "thyroid autoantigens": 0.00152, "propidium iodide staining": 0.00118, "influenza": 0.00074, "4-exon structure characteristic": 0.00219, "predominant e2f heterodimers": 0.00151, "enhance il-2 promoter-reporter": 0.00744, "h5sub304": 0.00012, "characteristic pattern": 0.00549, "prevent edelta": 0.00524, "skw": 0.00025, "vitro dna-binding study reveal": 0.00678, "p24rex production": 0.01042, "reinsertion": 0.0, "mitogen-stimulated": 0.00062, "murine haemopoietic cell": 0.0512, "cell inhibit il-2 secretion": 0.0384, "pka": 0.0005, "beta-sheet conformation": 0.00053, "p50-p65 nf-kappab heterodimers": 0.00666, "low base order-dependent stem-loop potential": 0.00283, "vdrnuc": 0.00012, "mutational inactivation": 0.00174, "neutrophil express": 0.01846, "pebp2/cbf factor": 0.0286, "antioxidant concentration high": 0.0062, "calcineurin catalytic domain": 0.00804, "rt-pcr": 0.00174, "basic helix-loop-helix": 0.00174, "chicken anemia virus": 0.00591, "trans-activating effect": 0.02115, "biochemical lesion": 0.0018, "trinucleotide repeat": 0.00378, "red cell survival": 0.0512, "stability": 0.00223, "selectively inhibits transcription factor nf-kappab": 0.01144, "effector function": 0.01331, "show essential": 0.02599, "ap-2 element": 0.01672, "25-140 ppt tcdd": 0.0005, "cooperative activity": 0.02925, "bb-94": 6e-05, "nondegradable mutant": 0.0081, "pathogenic factor": 0.0286, "good understand signal control proliferation": 0.00654, "bind ig heavy chain switch region sequence": 0.00579, "8-": 0.00012, "direct reporter gene expression": 0.02177, "distinct protein heterodimers encode": 0.02264, "epitope-tagged nucleolin expression construct": 0.02081, "marek": 6e-05, "transcriptional regulating protein fos": 0.02264, "high-affinity bsap-binding site": 0.01445, "ciprofloxacin show": 0.02599, "adjoining linker": 0.00043, "active extract": 0.00592, "alpha protein": 0.04529, "rap1 activation": 0.03164, "oct-2 gene expression": 0.02903, "il-2 teceptor": 0.01117, "apoptotic peer cell": 0.0512, "epitope specific": 0.01238, "ap-2 antibody": 0.00893, "constitutive tax expression": 0.02775, "low passage clinical strain": 0.00354, "neutrophil infiltration": 0.00496, "i-factor/nm23 protein": 0.04529, "germline ige promoter": 0.01557, "tnf-alpha synthesis": 0.00583, "gabpalpha": 0.00025, "chromosome 16p12-16p13.3": 0.00295, "neutrophil show": 0.02599, "antioxidant pyrrolidine dithiocarbarmate": 0.00167, "ets1 transactivates": 0.0005, "il-1 responsiveness": 0.00332, "gm-csf-responsive progenitor cell": 0.0512, "precise differentiation stage": 0.00786, "srg3 protein associate": 0.03019, "promote syncytia formation": 0.00323, "pan": 0.00105, "31-55 month": 0.00068, "so-called glucose toxicity": 0.00052, "select subordinate gene": 0.02903, "swi3": 0.00025, "phorbol ester responsiveness": 0.00362, "tat-enhanced expression": 0.04163, "signal cascade reveal": 0.0109, "reverse transcriptase polymerase chain reaction analysis": 0.00393, "il-10 induces c-fos expression": 0.02081, "pa domain": 0.01207, "dc-ck1 gene expression": 0.02903, "b-cell growth": 0.00819, "coordinate induction": 0.01607, "nonlymphoid": 0.00105, "bp-": 6e-05, "gm-csf promoter element responsible": 0.01168, "deoxyribonucleic acid": 0.00856, "eliminate sp1 interaction": 0.00658, "dna-bound oct-1 pou domain": 0.00603, "i-te": 0.00037, "cytotoxic concentration": 0.0067, "enhance interleukin-8 expression": 0.02775, "multiple cellular dna-binding transcription factor": 0.01144, "fivefold decrease": 0.00971, "expression pattern suggest": 0.02775, "low temperature": 0.00707, "tl-om1 consists": 0.0004, "expansion phase prior": 0.00184, "sl3": 0.00037, "reverse csa inhibition": 0.00707, "il-4 level detect": 0.01214, "cd16 ligand": 0.00592, "increased activity": 0.02925, "secreted-type placental alkaline phosphatase": 0.00132, "activate specific gene": 0.02903, "dopamine system": 0.00667, "induce tnf-alpha release": 0.01694, "scattered manner": 0.00282, "mature t-cell phenotype": 0.00641, "advance": 0.00062, "baf-3": 0.00012, "cellular collaboration": 0.00893, "cell adhesion molecule icam-1": 0.0384, "differentiation-dependent expression": 0.04163, "exclusive binding selectivity": 0.01237, "prepartal treatment": 0.01014, "luc": 0.00019, "activate htlv-i-ltr-cat": 0.01777, "lck promoter": 0.02336, "direct suppression": 0.0054, "rhombotin gene": 0.04355, "inhibit alpha/beta interferon": 0.0127, "proximal coding region": 0.00978, "c/ebp alpha regulate expression": 0.02081, "er -status": 0.00264, "gr expression": 0.04163, "luteal": 0.00012, "morphology": 0.00174, "fc gamma ri transcript level": 0.00728, "pdtc fail": 0.00347, "ad2/ad12 hybrid e1a gene product harbor": 0.01452, "outcome": 0.00074, "assay volume": 0.01002, "tef": 0.0, "targeted erythroleukemia cell": 0.0512, "pma/anti-cd28 mab": 0.00267, "cd4 signal mediates hiv-induced apoptosis": 0.00654, "cell line describe": 0.0512, "transcription factor recruitment": 0.01907, "plasmacytoma cell line": 0.0512, "pebp2 site-binding protein": 0.03019, "gene permit": 0.04355, "il-10 induced c-fos expression": 0.02081, "rel-a protein": 0.04529, "microh chain": 0.00437, "allergen": 0.00031, "elevated myb": 0.00112, "karyophilic protein": 0.04529, "spectroscopy": 6e-05, "fra-1": 0.00099, "activation antigen": 0.03164, "cd14 distal sp1-binding site": 0.01084, "tract-binding protein": 0.04529, "screening correspond": 0.00177, "alpha gene": 0.04355, "wild-type er": 0.00378, "soluble protein ag enter apc": 0.01811, "tissue oligonucleotide": 0.00664, "adrenal suppression": 0.00416, "air-1 locus defect": 0.00192, "cbf": 0.00292, "286-551": 0.00025, "irradiated culture": 0.0062, "microbicidal activity": 0.02925, "hl": 0.00031, "activated germinal center follicular": 0.00295, "rough mutant form": 0.00703, "dmso-treated cell": 0.0768, "nuclear factor-kappab induction": 0.01123, "monoclonal origin": 0.00279, "pi 3-kinase inhibited tcr-mediated nf-at response": 0.00647, "il-2-induced": 0.00261, "il-1beta mrna expression": 0.02775, "mycobacterial infection": 0.0062, "human b-cell development": 0.02508, "relative resistance": 0.00326, "bind trafs": 0.02025, "case show clonal rearrangement": 0.013, "endotoxin induces mn sod": 0.00402, "pu.1 promoter direct cell type-specific reporter gene expression": 0.0192, "dqb x-box": 0.00031, "vd3 treatment": 0.01014, "estrogen-induced hepatocytes": 0.00022, "c-terminal two-thirds": 0.00192, "subsequent loss": 0.00304, "v-fos": 6e-05, "common inflammatory condition": 0.00314, "induce lap": 0.0254, "stat6-responsive element": 0.01672, "-45": 0.00019, "antisense experiment": 0.00397, "bind experiment": 0.02025, "radioligand bind assay": 0.0135, "c-rel/p65": 0.00087, "blood serum": 0.00592, "future clinical gene therapy trial": 0.01742, "il-2-stimulated cell": 0.0768, "serine": 0.00279, "downstream signal": 0.01635, "immunocompetent cell": 0.0768, "c-myc oncogene": 0.00261, "9-mer peptide": 0.00754, "glucocorticoid receptor beta": 0.01714, "high affinity": 0.00931, "nf-kappab site": 0.02168, "cl-induced": 0.0, "cytokine activate factor": 0.01907, "downstream activation event": 0.02109, "induce cd38 expression": 0.02775, "adenovirus e1a": 0.00248, "in-situ detection": 0.00102, "rxr agonist activity": 0.0195, "important immunologic mediator implicate": 0.00344, "notch receptor protein": 0.03019, "enhance hiv-2": 0.00974, "cd3 ligation induce": 0.01694, "il-4 synthesis": 0.00667, "physiological test concentration": 0.00447, "composite kappa": 0.00748, "strong inducibility": 0.00347, "5'-flanking dna": 0.01483, "thyroid function": 0.01331, "cat construct transfected": 0.00484, "dexamethasone": 0.00788, "exist progenitor cell common": 0.0384, "acquisition": 0.00043, "nfat-sensitive gene": 0.04355, "simian immunodeficiency virus variant sivsmmpbj14": 0.00355, "nonthymocyte cell": 0.0768, "great sensitivity": 0.00236, "-mediated signaling": 0.00558, "gc resistance": 0.00326, "transcriptional regulatory protein": 0.03019, "-3757": 6e-05, "regulate cytokine gene expression": 0.02177, "stimulus result": 0.0161, "alveolar type ii-like cell": 0.0384, "activation-dependent event": 0.00552, "dominant-negative version": 0.00102, "peripheral lymph node": 0.00349, "primary tcr-mediated activation": 0.02109, "similarly inhibit": 0.01904, "cd62l": 6e-05, "mycobacterial protein": 0.04529, "nfatx1 dna binding activity": 0.01462, "cortisol production": 0.01042, "zp induction": 0.01607, "parental u937 cell": 0.0512, "repressive function": 0.01331, "murine leukemia virus enhancer core": 0.00364, "downregulated endotoxin-stimulated inflammatory": 0.00314, "regulate nfat activation": 0.02109, "hprl": 0.00012, "cytoplasmic and/or nuclear receptor": 0.01286, "putative hematopoietic transcription factor scl": 0.01144, "rcc-s": 0.00031, "lysopc inhibit": 0.01904, "hla-dr3 positive": 0.00468, "protect neutrophil": 0.00496, "ets sit": 0.00208, "dr3": 0.00031, "fragmentation": 0.00087, "47-bp sequence": 0.01625, "low density lipoprotein": 0.00471, "promoter-binding protein": 0.04529, "cos-1 cell": 0.0768, "hair": 0.00019, "response-specific pattern": 0.00549, "activate nuclear cam kinase ii": 0.00711, "clone receptor": 0.02571, "-and serum response factor-binding element activate": 0.00647, "pb-697": 6e-05, "tnf alpha mrna": 0.01017, "tmd case": 0.00363, "70z/3-mediated nfat activation": 0.02109, "tumor necrosis factor receptor-activated factor": 0.00572, "pwm induce egr-1 transcription": 0.01405, "nicoletti technique demonstrate": 0.01065, "promoter consist": 0.02336, "gc box bind protein bteb2": 0.01811, "memory cell": 0.0768, "val837": 6e-05, "class ii restriction element differ": 0.00669, "tfiiia zinc-finger consensus amino acid sequence": 0.00542, "developmental activity": 0.02925, "opsonized erythrocyte": 0.0013, "ifn-gamma receptor alpha-chain": 0.01714, "effector response": 0.01942, "differential inhibition": 0.01061, "leukemic dna": 0.01483, "gp120-stimulated human astrocyte": 0.02508, "nfatx1 nuclear translocation": 0.01123, "c-rel translocation": 0.00515, "hl cytosol": 0.00143, "cd69": 0.00112, "cell cycle regulator e2f": 0.0384, "pagc": 6e-05, "phosphotyrosine phosphatase": 0.00264, "1,25-": 0.00081, "position -67 bp": 0.00178, "encode": 0.01706, "major protein": 0.04529, "age-associated decline": 0.00121, "stress response system": 0.01294, "lytic ebv replication": 0.00376, "non-permissive chromatin structure": 0.00213, "toll-like receptor": 0.02571, "signal pathway regulate": 0.0109, "mouse cell line": 0.0512, "nip region": 0.01467, "growth factor act": 0.01907, "ikk-alpha": 0.00031, "specific bind": 0.02025, "control cellular proliferation": 0.00868, "synthetic double-stranded oligonucleotides show": 0.013, "small panel": 0.00313, "quantitative heterogeneity": 0.00096, "transcription factor usf1": 0.01907, "2.7+/-2.0": 6e-05, "drug therapy target ra express tumor": 0.00615, "kda stat5 isoform": 0.0017, "stage": 0.00496, "nf-kappab activation response": 0.02109, "csf-1": 0.00037, "vivo hiv-1 expression": 0.02775, "homogeneous cd4+": 0.00288, "cell require cd28 activation": 0.0384, "stat5 protein correlate": 0.03019, "t-cell line constitutively": 0.01102, "isg54": 6e-05, "disease include leukemia": 0.00959, "mitogen-stimulated cell": 0.0768, "transient expression system": 0.02775, "alpha protein level": 0.03019, "substantial clinical importance": 0.00283, "ngal mrna": 0.01526, "negative growth regulatory signal": 0.00817, "argument": 0.0, "interchangeable": 0.00012, "cell cytotoxicity": 0.0768, "tnf alpha induces cell differentiation": 0.03072, "rxr alpha expression increase": 0.02081, "type cys2-xaa12-his2": 0.00949, "avidity": 0.0005, "common target": 0.00825, "monocytic cell line mono mac": 0.03072, "vital importance": 0.0013, "hypercellularity": 0.00012, "immediate/early gene family": 0.02903, "strong enhancer element essential": 0.00836, "b10 mouse": 0.00974, "cellular system offer": 0.00596, "cd20": 0.00105, "erythroid mrna steady-state level": 0.0091, "de": 0.00316, "anti-cd15 cross-linked cell demonstrate enhanced level": 0.0256, "non-b cell line": 0.0512, "hybridization": 0.0031, "activation differ": 0.03164, "affect medium": 0.00797, "potent vp16": 0.00357, "polymerized nf-kappab binding sequence": 0.00927, "humara": 0.00068, "functional promoter": 0.02336, "specific receptor result": 0.01714, "ineffective dose": 0.00158, "human tonsil": 0.03762, "elucidation": 6e-05, "beta cell glucose toxicity": 0.0384, "enhancer position": 0.00909, "generate viable mature definitive erythroid cell": 0.0256, "subsequent coordinate reduction": 0.00203, "broad serine/threonine kinase inhibitor staurosporine": 0.00475, "human glucocorticoid receptor": 0.02508, "cytokine level": 0.01821, "synovium": 0.00031, "tax expression": 0.04163, "ebna 2-dependent enhancer": 0.00606, "differentiation-associated phenotype": 0.00366, "leukemia cell": 0.0768, "early killing effect": 0.0141, "e1a-expressing cell": 0.0768, "h. addition": 0.00673, "normal intergenic splicing": 0.00806, "immunoblotting extract": 0.00459, "symptom score": 0.00068, "kappa b-like site induce": 0.0127, "cell activation": 0.0768, "primary reservoir": 0.00738, "lps-induced nf-kappab dna binding": 0.00927, "chronic ebv infection": 0.00414, "dex-resistant cell": 0.0768, "ap-1 site": 0.02168, "murine pre-b cell line": 0.0384, "immune process": 0.00599, "nf-kappa b.": 0.01414, "rhythmic differentiation": 0.01179, "dihydrofolate reductase gene homolog": 0.02177, "chronic hiv infection result": 0.00805, "min/l": 0.00012, "sjogren": 0.00037, "host-cell transcription factor": 0.01907, "peripheral blood lymphocyte express progesterone receptor": 0.00857, "cf lung disease": 0.00449, "tandem zinc-finger sequence": 0.01084, "delta-ala": 0.00012, "aldh1 mrna": 0.01526, "lymphocyte death": 0.01483, "rar alpha gene": 0.02903, "recombinant thyroid hormone receptor": 0.01286, "hematopoietic progenitor cell": 0.0512, "polyomavirus transcription factor t-antigen": 0.0143, "consensus sit": 0.00288, "esb-l": 0.00012, "mouse thymus cdna expression library": 0.01665, "ls mutation": 0.00592, "lymphoid enhancer-binding factor": 0.01907, "cat reporter": 0.00552, "eosinophil biology": 0.00295, "atgcaaat": 0.00031, "constitutive stat5 activity": 0.0195, "serum androgen": 0.00378, "vary potential": 0.00605, "main factor responsible": 0.01907, "monocyte/b-cell-specific transcription factor pu.1": 0.0143, "lps-induced monocyte cytotoxicity": 0.00798, "promyelocytic stage": 0.00248, "thiazolidinediones": 6e-05, "pax-8": 6e-05, "region": 0.02934, "enhanced respiratory burst": 0.0019, "gamma interferon-induced tyrosine phosphorylation": 0.00492, "il-7 signaling pathway": 0.00852, "differentiation stage-specific dna-binding protein": 0.02264, "physiological regulator": 0.00304, "ligand-induced mpl homodimerization": 0.00048, "proto": 0.00012, "micrograms/kg": 0.0, "hsv": 0.00068, "c-erba/tr-specific ligand": 0.00592, "mcd14-expressing cell": 0.0768, "induced transcriptional activation": 0.02109, "normal peripheral blood": 0.00806, "bicoid": 0.0, "ec responsiveness": 0.00323, "result lead": 0.0161, "researcher": 0.0, "lymphocyte cytosolic glucocorticoid receptor": 0.01286, "lymphoid system": 0.00667, "430-444": 0.0005, "osteoblast": 0.00037, "calcium-dependent protease": 0.00177, "hs1 phosphorylation": 0.00983, "signal component": 0.01635, "vivo interaction": 0.00986, "block granulocytic differentiation": 0.00786, "human monocytic cell line bf24": 0.03072, "cell line rpmi": 0.0512, "non-voltage-gated": 0.00012, "spleen formation": 0.00484, "cell line el4": 0.0512, "class ii mutant cell line": 0.03072, "viral pathogenicity": 0.00732, "prototype octamer element": 0.01115, "c5a-induced il-8 production": 0.00695, "intact promoter": 0.02336, "receptor remain poorly define": 0.01286, "classical model": 0.00422, "pax-gene family": 0.00841, "gata-binding protein": 0.04529, "myelomonocytic lineage specific gene": 0.02177, "adherence-associated early gene": 0.02903, "mechanism lead": 0.01058, "e232k": 0.0, "tepoxalin inhibit lymphocyte proliferation": 0.00952, "receptor binding site": 0.01714, "freshly isolate normal": 0.00806, "combined treatment result": 0.01073, "vzv-susceptible donor": 0.0014, "kda factor": 0.0286, "epitope-encoded sequence": 0.01625, "neuroendocrine cell": 0.0768, "e2f-1 activates": 0.00164, "staurosporine-sensitive kinase": 0.01188, "general consequence": 0.00155, "spite": 0.00031, "activation domain present": 0.02109, "patient f.r": 0.01666, "anti cd28 release": 0.00323, "high titer anti-38,000-m": 0.0062, "hla-dr haplotype": 0.00124, "active proteasome inhibitor": 0.006, "sh2 domain-containing protein": 0.03019, "serine proteinase release": 0.00323, "major candidate": 0.00574, "cell reveal": 0.0768, "lipid kinase activity": 0.0195, "protein synthesis correlate": 0.03019, "wt": 0.00025, "signal molecule associate": 0.0109, "germline change": 0.0063, "prenatal immune challenge alter": 0.00299, "variant form": 0.01055, "pulse/chase-experiments": 6e-05, "woman": 0.00465, "lymphoma": 0.00453, "hippocampus": 6e-05, "severe preeclampsia": 0.00211, "il-2 lead": 0.01117, "transgenic mouse express pml/raralpha": 0.00923, "hla class ii gene": 0.02177, "nitrofurantoin": 6e-05, "receptor partner": 0.02571, "succinate": 0.0005, "g-csf receptor-/- mouse": 0.00649, "protein occur": 0.04529, "mapping": 0.00199, "e1a gene expression induces susceptibility": 0.01742, "complicated assay procedure": 0.00668, "gc-resistance": 6e-05, "rxr alpha level": 0.01214, "transgenic mouse show": 0.01733, "ebv-associated malignancy": 0.00115, "cd30 cytoplasmic domain": 0.00804, "pro-coagulant protein tissue factor": 0.02264, "207.9+/-31.5 cells/mm2": 0.00012, "primer specific": 0.01238, "diminished j393/cd43-mediated apoptosis": 0.00593, "enhance il-2 transcription correlate": 0.01405, "+12": 0.00025, "fasl induction": 0.01607, "monocyte-derived macrophage": 0.00589, "cd3/cd28 coligation": 0.00016, "charybdotoxin inhibit": 0.01904, "induce maturation": 0.0254, "key participant": 0.00152, "3'-flanking sequence": 0.01625, "lymphocyte-conditioned medium": 0.0014, "stat6 protein present": 0.03019, "transcription start site lead": 0.01405, "cohort": 0.00025, "microtitre assay system": 0.00668, "nf-kappa b-like family": 0.00943, "nef protein inhibit nf-kappa": 0.02264, "differential responsiveness": 0.00323, "london": 6e-05, "exophthalmos": 6e-05, "map kinase phosphatase-1": 0.00792, "major cellular component": 0.00596, "cell-specific transcriptional promoter activity mediate": 0.0117, "high molecular weight form": 0.00527, "mitogen": 0.00298, "elderly individual activate": 0.01185, "block p50": 0.01073, "ets bind site": 0.01445, "hs1": 0.00031, "c-fos and/or c-jun mrna": 0.00763, "fc gamma rii": 0.00294, "lymph-node involvement": 0.00254, "leukemogenesis": 0.00062, "express lineage specific marker": 0.00923, "lack pili": 0.00633, "p50/p50 homodimers": 0.00078, "guamerin-derived peptide": 0.00754, "il-6 protein": 0.04529, "delivery and/or": 0.0045, "proline-": 6e-05, "cd40 ligand+ hyper igm syndrome": 0.00149, "peripheral blood mononuclear leukocyte": 0.00296, "nuclear vitamin": 0.01684, "purified elastase": 0.00261, "ru": 0.00068, "rar-rxr heterodimers": 0.00226, "peroxisome proliferator-activated receptor activator target human endothelial cell": 0.0192, "n-acetyl-l-cysteine inhibits primary human": 0.01881, "methylation interference": 0.0009, "intragenic deletion": 0.00344, "histogenesis": 0.00031, "deacetylated metabolite 2-hydroxy-4-trifluoromethylbenzoic acid": 0.00428, "viral antigen recognition": 0.00546, "er peptide": 0.00754, "stat5-": 6e-05, "a6h transduce ap-1 activation pathway": 0.01266, "individual yield": 0.00409, "suppresses": 0.00167, "alpha-estradiol": 0.0, "c-jun expression prior": 0.02775, "incomplete": 0.00037, "nf kappa b/rel family": 0.0042, "tpa-": 0.00012, "parasite induces constitutive activation": 0.01582, "proximal pebp2/cbf site": 0.01445, "finding consistent": 0.00226, "43-50": 0.00012, "ltr-mediated synergy induce": 0.01694, "hydrocortisone-induced apoptosis": 0.0089, "activated memory": 0.00589, "early th2 development": 0.00552, "soluble fas ligand": 0.00395, "il-15 activate": 0.01777, "functional il-12 require": 0.00877, "vivo evidence": 0.0053, "myb-transformed hematopoietic cell": 0.0512, "k+ channel blockade": 0.00045, "essential factor": 0.0286, "lampf": 0.00025, "pbl": 0.00192, "htlv-i-infected peripheral blood": 0.00395, "interfollicular bcl-6+/cd3+ cell": 0.0512, "arachidonic acid oxygenation": 0.00571, "co-ordinate important signaling pathway": 0.00639, "cytochemistry": 0.00012, "fragment span nucleotide": 0.00232, "patient/histopathology data": 0.00254, "regulatory function": 0.01331, "amino acid 317-1130": 0.00571, "stat6 independent": 0.00363, "active tuberculosis": 0.00592, "10,000-fold selectivity": 0.00028, "hela extract": 0.00459, "limit chronic inflammation mediate": 0.00616, "subcloning": 6e-05, "vitro kinase activity": 0.0195, "caml-interacting member": 0.00413, "optimal dna sequence": 0.01084, "ibmx mimic": 0.00174, "chemoattractants stimulate": 0.01101, "apoptotic": 0.00378, "early growth response-1 gene": 0.02177, "pi3-k": 0.00087, "steroid-treated cell": 0.0768, "tax induces transformation": 0.00536, "accelerate virus replication": 0.00591, "immunodominant native peptide": 0.00502, "data present provide": 0.0049, "trans-acting dominant negative regulator": 0.00257, "alpha,25-dihydroxyvitamin d3 receptor": 0.01714, "110-130-kda nfatp protein": 0.03019, "wild type peptide": 0.00633, "significant anti inflammatory activity": 0.01462, "influence host defence": 0.00314, "excess beta-catenin": 0.0005, "recombinant herpes simplex virus-1": 0.00195, "stimulator": 0.00031, "-gamma production": 0.01042, "present review": 0.00735, "human beta-globin locus control region": 0.01505, "ap-1/octamer": 0.00025, "cem human leukemic cell clone": 0.03072, "tissue-specific splicing": 0.00217, "feasible manipulation": 0.00019, "critical mechanism underlie": 0.00705, "cross-linking induce nf-kappa": 0.01694, "human placenta": 0.03762, "alternative promoter site": 0.01557, "kappab-sp1 composite site": 0.01445, "lavage cell": 0.0768, "differentiation step": 0.01179, "amino acid residue": 0.00571, "hiv-1 vpr suppresses immune activation": 0.01266, "cushing": 0.00087, "cem": 0.00217, "combined pharmacologic": 0.00099, "increase hil-5 promoter activity": 0.01462, "anti-hla-dr monoclonal antibody": 0.00596, "fkbp12": 0.00012, "ligand-dependent activation": 0.03164, "-80": 6e-05, "lipopolysaccharide-stimulated rel-/- macrophage": 0.00393, "intracellular calcium increase": 0.01464, "hla-dq3.2 molecule regulate binding": 0.00927, "gene therapy strategy": 0.02903, "1-3 ppt tcdd": 0.0005, "differs": 0.00155, "stat4 binding": 0.01855, "t-cell immortalization mechanism": 0.00705, "e2f1 gene involves": 0.02903, "-deficient mouse": 0.00974, "neomycin resistance gene": 0.02903, "influence subcellular localization": 0.00314, "unique region": 0.01467, "enhanced binding activity": 0.0195, "block ab": 0.01073, "potential therapeutic application": 0.00403, "ctl active hplc peptide fraction": 0.00301, "show good correlation": 0.01733, "promoter chromatin structure result": 0.01168, "c-terminal hsp70 peptide": 0.00502, "platelet-derived growth factor": 0.01907, "ig-secreting cell": 0.0768, "smoker": 6e-05, "tumor necrosis factor receptor expression": 0.01665, "double-immunogold labeling": 0.0005, "tgf-beta": 0.00236, "isolate": 0.00831, "tropical spastic paraparesis": 0.00014, "plasmid pnf-kappa bluc": 0.00182, "gb": 0.00012, "tnf-alpha release": 0.00546, "untreated ht-2 cell": 0.0512, "putative ets bind site": 0.01084, "peripheral venous blood": 0.00395, "p38 kinase activity play": 0.01462, "cd14-mediated signal pathway": 0.0109, "multimerized recognition motif": 0.00583, "mouse srg3": 0.00974, "immune receptor risk rearrangement": 0.01286, "affinity chromatography": 0.00391, "endogenous il-6-responsive gene": 0.02903, "control inappropriate apoptosis": 0.00868, "eosinophil granule protein": 0.03019, "apoptotic cell death program": 0.0384, "control ig gene class switch recombination": 0.01452, "cooh-terminal portion": 0.00074, "microdeletions": 6e-05, "method render": 0.00236, "human cd34+ hpc": 0.02508, "sivmac251": 0.00012, "cd40 cytoplasmic domain truncation": 0.00603, "main transcription factor": 0.01907, "surface ganglioside": 0.00515, "-96": 0.00019, "min exposure time elisa": 0.00175, "patient study": 0.01666, "myeloid-related dc": 0.00202, "5-lox-dependent nf-kappab activation": 0.02109, "immunostained": 0.00012, "study show": 0.02599, "du-145 cell line": 0.0512, "adjacent brlf-1 locus": 0.00192, "limbic brain structure critical": 0.00214, "vd-responsive gene": 0.04355, "fas/apo-1 receptor result": 0.01714, "bp lp response element": 0.00971, "spl binding element": 0.01237, "major histocompatibility": 0.00574, "protein-protein interaction": 0.00986, "b29 atg start codon": 0.00059, "aly mediates context-dependent transcriptional activation": 0.01266, "human monocytic cell require activation": 0.03072, "b-cell stimulatory factor": 0.01907, "cooperative interaction": 0.00986, "naringenin": 0.0, "c/ebpepsilon": 0.00043, "18-20 residue-long peptide fragment": 0.00377, "sustained effect": 0.02115, "nuclear translocation independent": 0.01123, "malignant melanoma": 0.00158, "jak/stat protein": 0.04529, "immunophilin fkbp": 0.00047, "granule enzyme": 0.0031, "human squamous cell carcinoma": 0.0384, "normal control subject": 0.00868, "po": 0.00019, "p/i": 0.0005, "bat box 10-fold": 0.00203, "agonist-induced monocytic cell adhesion": 0.0384, "glycoconjugates": 6e-05, "heat-shock protein hsp90": 0.03019, "zdevd-fmk": 6e-05, "murine il-2 mrna inducibility": 0.00763, "cd69 promoter-based reporter gene construct": 0.01742, "mkk": 0.00025, "promonocytic thp-1 cell": 0.0512, "activate human natural killer cell": 0.03072, "cytokine il-2": 0.01123, "share homology": 0.00288, "hla-a3/peptide complex": 0.01684, "host immune factor": 0.01907, "human erythrocyte": 0.03762, "nmol": 0.00012, "c-jun amino-terminal kinase": 0.00792, "cd28 costimulation pathway": 0.00852, "altered property": 0.00397, "perception": 6e-05, "intraarterial measurement demonstrate": 0.01065, "k46": 0.00019, "initiate rac-1 regulated signal pathway": 0.00654, "stimulate bcl-xl gene expression": 0.02177, "human neutrophil express gh-n gene transcript": 0.01452, "regulate inducible gene expression": 0.02177, "plastic surface": 0.00515, "hl60 promyelocytic leukemia cell": 0.0384, "constitutive pi3-kinase/pkb/akt pathway": 0.00852, "cr group": 0.00487, "increase plasma": 0.02196, "cu2+": 0.00037, "histopathological analysis reveal lymphoma": 0.00589, "inhibit nf-kappab": 0.01904, "nfatc mrna": 0.01526, "cultured human keratinocytes": 0.02508, "carborane": 0.00012, "neuron": 0.00025, "gene expression result": 0.02903, "rev ltrs correlate": 0.00436, "ltr mutation": 0.00592, "chimeric receptor kit/il-4r alpha": 0.01286, "overnight 1-mg dexamethasone test": 0.00243, "nl": 0.00012, "tf activity promote": 0.0195, "significant elevation": 0.00416, "tpa increase": 0.02196, "obf-1 mrna": 0.01526, "epstein-barr virus-encoded dutpase": 0.0019, "potent anti-inflammatory": 0.00357, "basic region": 0.01467, "hs-72 cell": 0.0768, "lai ltr": 0.0031, "somatic gene therapy": 0.02903, "translational level": 0.01821, "heme biosynthetic pathway": 0.00852, "viral growth": 0.00819, "endogenous 5-lipoxygenase activity": 0.0195, "c81-66-45": 0.00037, "stat3 transcriptional activity": 0.0195, "synteny": 0.00012, "low micromolar range": 0.00471, "type ii eb": 0.00633, "pax-5e": 0.00019, "j.virol.67:6768-6777": 6e-05, "synergistic": 0.00223, "cd95l expression": 0.04163, "oncoproteins c-myc": 0.00223, "transcription factor nuclear factor-kappa": 0.0143, "additional regulatory factor": 0.01907, "proinflammatory cytokine release": 0.00749, "nonresponsive hematopoietic progenitor": 0.00244, "central role": 0.01328, "childhood acute": 0.00369, "human nkl cell line correlate": 0.03072, "np-5": 6e-05, "e3 mediate polyubiquitinylation": 0.00821, "acne": 0.00019, "human cdna encode subunit": 0.01881, "mcm family": 0.00841, "ald-induced calcium mobilization": 0.00157, "culture lack fresh antigen-presenting cell": 0.03072, "zinc-finger dna-binding transcription activator": 0.01405, "tcr alpha beta": 0.0078, "nf-kappab-dependent mechanism": 0.01058, "hcmv initiate": 0.00363, "human ige germline promoter": 0.01881, "bfrf3 promoter": 0.02336, "hsf2": 0.00062, "vdr level": 0.01821, "protein ag": 0.04529, "ubiquitin-carrier protein": 0.04529, "basic amino acid": 0.00571, "potential tata element": 0.01115, "oct2 transactivation": 0.00515, "peripheral mononuclear cell": 0.0512, "human t-cell lymphotrophic virus-1 tax transactivator-induced luciferase activity": 0.00941, "hsf2 isoforms play": 0.00474, "monocyte recruitment": 0.01197, "steroid hormone-resistant state": 0.00194, "tolerance": 0.00161, "western analysis": 0.01179, "c-jun-": 6e-05, "cd1a- cell": 0.0768, "early hematopoietic progenitor": 0.00552, "embryonal carcinoma cell demonstrate": 0.0384, "cell cycle perturbation": 0.0512, "tal1": 0.00261, "protein activity": 0.04529, "slp-76 linker protein interact": 0.02264, "-negative t-cell line": 0.01102, "cif inhibited induction": 0.01071, "adult erythroid mel cell": 0.0384, "pathological platelet": 0.00372, "alpha synthesis": 0.01169, "specific interferon isotypes": 0.00825, "segment correspond": 0.00189, "upregulation": 0.00385, "fos inhibits nf-at dna binding": 0.00742, "receptor concentration": 0.02571, "a6h ligation": 0.0018, "alternate mechanism": 0.01058, "p-selectin": 0.00093, "uncoupling": 0.00025, "box1 consensus sequence": 0.01084, "heat shock gene": 0.02903, "collagenase": 0.00081, "nuclear protein-dna complex": 0.01123, "dexamethasone suppression": 0.00416, "tds": 0.00019, "regulate il-2 gene transcription": 0.02177, "inducible footprint": 0.00484, "validity": 6e-05, "induce lytic viral replication": 0.0127, "vd analogue": 0.00062, "twin": 0.00068, "altered peptide associate": 0.00728, "read": 0.00019, "cd43/leukosialin": 6e-05, "molecule exist": 0.00853, "abdominal subject": 0.00354, "il-9-mediated cell growth": 0.0512, "motifs": 0.00025, "detectable il-2": 0.01117, "ctla-4 engagement": 0.00133, "pro-b cell": 0.0768, "essential usa fraction": 0.00325, "follicular expression pattern": 0.02775, "stat1 alpha protein bound": 0.02264, "il-2-inducible enhancer": 0.00909, "th1 cell development": 0.0512, "tax1": 0.00161, "three-layer percoll density gradient": 0.00057, "contrast il-12 -and ifn-alpha-inducible gene": 0.01742, "plastic multidishes": 0.00028, "dr alpha proximal promoter": 0.01168, "receptor alpha-chain gene": 0.02903, "functional protein binding sequence": 0.02264, "c-jun inhibitory response map": 0.00971, "transcription factor pax-5": 0.01907, "thymus section": 0.00112, "cellular-mediated immune response": 0.01294, "th2-specific cytokine gene": 0.02903, "cd5 structural gene": 0.02903, "akt/pkb": 0.00056, "coding region": 0.01467, "monoclonal antibody-mediated cross-linking induced tyrosine phosphorylation": 0.00328, "fabricius": 6e-05, "competition": 0.00199, "transcriptional activator nf-kappa b. activation": 0.01266, "human recombinant tumor necrosis factor": 0.01505, "environmental mycobacteria": 0.00068, "antagonize gralpha-mediated transactivation": 0.00343, "pax-5a": 0.00025, "nonpermissive temperature": 0.00022, "aurothioglucose": 0.00031, "platelet factor iv": 0.01907, "duffy-negative black carry": 0.00184, "differential splicing": 0.00323, "mammalian homolog": 0.00174, "cellular nf-kappa": 0.01414, "b-lymphocyte activation": 0.03164, "inhibit nf-kappab activation": 0.02109, "western-blot analysis": 0.01179, "il-6 transcription rate prompt": 0.01405, "progesterone receptor-specific monoclonal antibody mpri": 0.00357, "disappointing result": 0.0161, "cho/cd14": 0.00037, "p2 promoter": 0.02336, "10-15 min": 0.00127, "key cellular protein": 0.03019, "nonpeptidyl mimic": 0.00174, "ap-1-binding motif": 0.00875, "mm aminoguanidine": 0.00118, "interphase cell": 0.0768, "decrease surface expression": 0.02775, "transgenic mouse describe": 0.00649, "surrogate": 0.00093, "surface marker analysis show": 0.013, "consequent formation": 0.00484, "brca1 allele": 0.0022, "interleukin-6 expression": 0.04163, "strong inducible activity": 0.0195, "il-13 inhibits anti-cd3 mab/il-2-": 0.00265, "ltrs": 0.00149, "paf": 0.00149, "replicative capacity": 0.00329, "redistribution": 0.00031, "specific ab": 0.01238, "ebv early gene bzlf1": 0.02177, "fas expression": 0.04163, "differential signal": 0.01635, "human tnf-alpha promoter": 0.02508, "artifact": 0.0, "describe synergistic activation": 0.02109, "ebv-negative cell": 0.0768, "block antigen receptor agonism": 0.01286, "25-mer pml/rar-alpha": 0.00012, "prominent member": 0.00413, "s.henderson": 0.00012, "periductal angiogenesis": 9e-05, "giant": 0.00043, "hiv-1 provirus": 0.00878, "ds": 6e-05, "transformation system": 0.00667, "mechanism regulate human immunodeficiency virus": 0.01505, "early growth response gene-1": 0.00971, "express receptor mutant": 0.01714, "significant activation": 0.03164, "resolution": 0.00056, "nonlymphoid component": 0.00456, "xpd gene impairs ner": 0.02177, "continental europe": 6e-05, "early transient activation": 0.02109, "atl-1k": 0.00025, "tf activity": 0.02925, "biopsy-derived human tissue": 0.02508, "maximal enhancer activity": 0.0195, "serine/threonine protein phosphatase": 0.03019, "increase turnover": 0.02196, "transient and/or stage-specific expression": 0.02081, "optimal il-4 promoter activity": 0.01462, "express lmp1": 0.01846, "pcd41 trans-activation": 0.00078, "dd allele": 0.0022, "regulated host factor": 0.01907, "bacterial lipopolysaccharide activates nuclear factor-kappab": 0.00674, "contrary": 0.00012, "resistant segment": 0.00211, "alpha1 gene": 0.04355, "ap-1 detect": 0.00726, "inhibit nk cytotoxicity": 0.0127, "synergizing transcription factor": 0.01907, "consensus kappa": 0.00748, "interleukin-1 beta mrna level": 0.0091, "virus genome": 0.00887, "bilateral total adrenalectomy": 0.00108, "embryonic skeletal muscle lineage": 0.00183, "bcl-x protect": 0.0014, "readily break": 0.00074, "ubiquitous environmental contaminant": 0.00079, "fusion gene": 0.04355, "atherosclerosis-promoting effect": 0.02115, "proliferative disorder": 0.00223, "platelet aggregation": 0.00372, "cns disease state": 0.00449, "high transactivating ability": 0.0062, "n-terminal myristylation": 0.00202, "adhesion molecule-mediated interaction": 0.00658, "ap-1-mediated transcriptional activation": 0.02109, "promote 5-day": 0.00465, "il-2 gene activation": 0.02903, "nuclear body": 0.01684, "transcription-3": 0.00012, "conventional": 0.0013, "dendritic-like cell": 0.0768, "ki-67 cell cycle antigen": 0.0384, "tissue insult": 0.00664, "related gene constitute": 0.02903, "main goal": 0.00087, "nuclear factor kappab bind": 0.0143, "spi-1 transfectants": 0.00099, "recombinant protein": 0.04529, "globin gene activation": 0.02903, "ifn-gamma-induced icam-1 expression": 0.02775, "essential hypertension": 0.00487, "bhrf1 resemble": 0.0013, "cell type specificity influence": 0.0384, "ph": 0.00043, "clone voltage-gated na+ channel": 0.00369, "poor separation": 0.00053, "cell clone": 0.0768, "unique function": 0.01331, "tyr-493": 0.00019, "pentadecamer peptide cover": 0.00502, "oca-b bind": 0.02025, "human fa promoter require nf-kappab p50-p65 recruitment": 0.01075, "dna-protein binding complex formation": 0.00927, "interactive protein": 0.04529, "combine": 0.00323, "cd40 signal pathway exert": 0.00817, "cytoplasmic free calcium": 0.00267, "hematopoietic cell": 0.0768, "degree c.": 0.00146, "lethal": 0.00031, "region homologous": 0.01467, "d-": 6e-05, "reliable indicator": 0.00034, "quantitative dnase footprinting": 0.00079, "area bound": 0.00292, "limited stimulation": 0.0112, "p/i-inducible fa promoter activation": 0.01582, "human monocytic cell line thp-1 mimic pam": 0.02194, "membrane proximal": 0.0045, "organizational analysis": 0.01179, "ptf gamma/ptf delta": 0.00141, "common stat protein": 0.03019, "dramatic stimulation": 0.0112, "open read frame": 0.00048, "important signaling": 0.00689, "bha treatment prevent": 0.00676, "p45 megakaryocytic lineage cell": 0.0384, "a-myb": 0.00174, "abnormal blast cell": 0.0512, "comprehensive analysis": 0.01179, "hybridoma cell line": 0.0512, "cell-specific regulation": 0.01008, "nuclear": 0.03368, "transcription factor gata-3": 0.01907, "htlv-i trans-activator p40tax": 0.00184, "well-known immunological consequence": 0.00077, "cd3-tcr complex": 0.01684, "nf-kappab consensus oligonucleotides": 0.00666, "lfa-1": 0.00019, "high relative level": 0.01214, "pooled irish/german population": 0.00205, "statistical analysis": 0.01179, "show significant homology": 0.01733, "abrogate ick-1 binding": 0.01237, "19-bp element": 0.01672, "u937 cell line": 0.0512, "cytokine tnf-alpha": 0.01123, "hic1": 0.00012, "-160": 0.00012, "murine g-csf receptor": 0.01714, "activate endothelial cell": 0.0512, "rat fibroblast": 0.00338, "cyclic-amp-responsive element bind protein/activation transcription factor family": 0.00817, "cell preparation": 0.0768, "ltr-cat assay": 0.01002, "c-jun mrna level decrease": 0.0091, "specie specific": 0.01238, "addition": 0.01346, "variable region beta-chain family": 0.00734, "head": 0.00056, "peripheral tissue resistance": 0.00443, "dual colour fish analysis": 0.00589, "pou homeodomain": 0.0005, "ifngamma-driven enhanceosome formation": 0.00323, "data lead": 0.00996, "microtubule participate": 0.0013, ".0009": 0.0, "efficient gene activation require": 0.02177, "cu2+ inhibit": 0.01904, "sustained activity": 0.02925, "cdna fragment associate": 0.00728, "c3h-gld/gld cd4": 0.00332, "g75": 0.00031, "direct ebna-2-pu.1 interaction": 0.00658, "select": 0.00391, "single exon": 0.0036, "murine system": 0.00667, "-thymidine incorporation": 0.00068, "cell hiv-1 multiplication": 0.0512, "powerful skewer": 0.0005, "characteristic marker": 0.00382, "camp interact": 0.00372, "latent cycle regulatory gene": 0.02177, "molecular mimicry": 0.0045, "nac increase": 0.02196, "high affinity aldosterone bind site": 0.00867, "il 6-induced differentiation": 0.00786, "signal pathway": 0.01635, "ltr promoter": 0.02336, "-4 play": 0.0071, "il-2 regulation": 0.01117, "basic transcription machinery": 0.01873, "functional component": 0.00816, "disappearance": 0.00037, "interspecies hybrid": 0.00171, "transcription inhibit": 0.0281, "sequence upstream": 0.01625, "-negative lymphoid cell": 0.0512, "slp-76": 0.00254, "bzip transcription factor": 0.01907, "k562 erythroblast": 0.0018, "human lymphoma cell": 0.0512, "scid": 0.00043, "select sequence": 0.01625, "plasma ifn alpha": 0.0078, "resulting necessity": 0.00022, "erythrocyte receptor": 0.02571, "myeloid lineage-associated cytokine receptor": 0.01286, "human donor": 0.03762, "functional activation antigen": 0.02109, "sla-dq antigen induction": 0.01071, "downstream signal pathways require slp-76": 0.00654, "uracil-dna glycosylase": 0.00012, "deltanfkappab": 0.00025, "effective agent": 0.00422, "cd2 cross-linking": 0.00242, "include gre-specific dna binding": 0.00927, "recurrent theme": 0.00084, "tyrosine kinase p56": 0.00792, "sterol": 0.00074, "antigen-specific tolerance": 0.00081, "neutrophilic": 0.00112, "-73 bp": 0.00267, "adult hb synthesis": 0.00389, "cd40 signal component upstream": 0.00817, "nb2": 0.00037, "important initial step": 0.00459, "differentiating agent retinoic acid": 0.00428, "s194 cell": 0.0768, "induce naive": 0.0254, "molecular interaction": 0.00986, "3-fold reduction": 0.00295, "transcription factor associate": 0.01907, "report synergism": 0.0049, "longer latency": 0.0014, "feedback mechanism": 0.01058, "normal amount": 0.0121, "-1 beta": 0.00673, "induce phosphorylation": 0.0254, "transmigration": 0.00037, "threshold concentration": 0.0067, "dra promoter construct": 0.01557, "related condition occur": 0.00436, "unfractionated nuclear extract": 0.01123, "ige concentratios": 0.00189, "block gene transcription": 0.02903, "adjacent kappa": 0.00748, "chronic hiv-1 infection": 0.00585, "associate clinical feature": 0.00728, "cytokine il-6": 0.01123, "accelerate cytopathic effect": 0.0141, "il-1 -and lps-specific induction": 0.00803, "lipoxygenase activity": 0.02925, "aspirin inhibit": 0.01904, "similar mutation": 0.00673, "permissive temperature": 0.00043, "oct-2 regulate": 0.01253, "m10": 0.00019, "ifn-gamma inhibited up-regulation": 0.00321, "olfactory neuron": 0.00012, "cd4- cd8+ cell population": 0.0384, "nf-kappa b1 gene encode": 0.02177, "classic hd": 0.00047, "human cytomegalovirus ie2 protein": 0.02264, "exhibit constitutive": 0.00664, "ets family member elf-1": 0.0042, "initial interaction": 0.00986, "sp-1-like element": 0.01672, "zap-70 associate": 0.01092, "nf-kappa b-mediated signal transduction": 0.00817, "t-tropic primary isolate hiv-1": 0.00439, "combination chemotherapy": 0.00288, "tf activation": 0.03164, "signal cascade transduce": 0.0109, "tcr repertoire": 0.00478, "putative gas element": 0.01115, "irak2": 6e-05, "human monocytic cell line thp-1": 0.03072, "tpa-activated cell reveal abundant expression": 0.03072, "freshly isolated monocyte": 0.00798, "receptor allele": 0.02571, "chemr1 gene scya3r2": 0.02903, "fluctuation": 0.00019, "iddm subject": 0.00354, "wild-type littermates remain unresponsive": 0.00261, "viral dna polymerase": 0.00988, "myeloid cell induces ifn production": 0.03072, "20-epi-22-oxa-24a,26a,27a": 0.00012, "immunostained tumor cell": 0.0512, "utilized": 0.00012, "antiandrogens show agonistic property": 0.013, "protein fraction": 0.04529, "bone marrow graft": 0.00143, "ebv-immortalized": 0.00031, "low-serum apoptosis": 0.0089, "pd-135,158": 0.00019, "transduce signal lead": 0.0109, "tax1 protein": 0.04529, "t/nk": 0.00043, "immunity impairment": 0.00112, "lt-alpha1beta2": 0.0005, "separate gene": 0.04355, "link beta-promoter": 0.00347, "role monocyte": 0.01328, "construct suppress reporter gene activity drive": 0.01452, "yy1 bind site": 0.01445, "il-2 promoter correlate": 0.01557, "beta- bound complex": 0.01123, "mann-whitney u-test": 3e-05, "-mediated differentiation": 0.01179, "canonical": 0.00081, "r-responsive element": 0.01672, "interleukin-2 synthesis": 0.00583, "glucocorticoid bind site": 0.01445, "ad protein": 0.04529, "immunosuppressive potential": 0.00605, "mabs": 0.00118, "antigen-presenting cell type": 0.0512, "overexpression": 0.00763, "deduced amino acid sequence": 0.00813, "pml/rar-alpha protein": 0.04529, "rna processing": 0.00456, "differentiate effect": 0.02115, "dna-binding specificity similar": 0.00449, "turn phosphorylates": 0.00093, "up-regulates irf-1": 0.0013, "sample": 0.00416, "mineralocorticoid action": 0.00499, "high-affinity ifp53 gas site": 0.01084, "precursor cell common": 0.0512, "vasculitic syndrome": 0.00273, "double nf-kappab site": 0.01445, "glutamine-rich activation domain present": 0.01582, "human dr alpha": 0.02508, "oap40": 0.00025, "adenoidal tissue": 0.00664, "nf-at sequence": 0.01625, "early g1": 0.00828, "chimeric gal4-hsf3 protein": 0.03019, "detect il-2 mrna": 0.01017, "nuclear transcription factor c/ebp beta": 0.01144, "sox9 allele": 0.0022, "gamma inhibit p50-": 0.0127, "discontinuous percoll gradient": 0.00033, "lymphocyte development": 0.01483, "duffy protein": 0.04529, "dna motif": 0.01483, "specific peptide": 0.01238, "ikappab-alphas32/36a offer proof-of-principle": 0.00041, "active human tata binding factor": 0.01505, "cpg island": 0.00031, "pma-induced activation": 0.03164, "pfge": 0.00012, "human umbilical venous": 0.02508, "notch receptor signal": 0.01714, "hour decrease": 0.00971, "adult cd34+ bone marrow cell": 0.03072, "cd15 cross-linking induce tnf-alpha release": 0.01016, "vitro expansion": 0.00785, "protein reveal": 0.04529, "precisely": 0.00037, "microbial broth": 0.00037, "brlf1/bzlf1": 6e-05, "exhibit early arrest": 0.00552, "gudmundsson": 0.00012, "cyclin d3": 0.00245, "key signal": 0.01635, "receptor promoter": 0.02571, "cytokine-producing effector cell": 0.0512, "animal experiment": 0.00397, "endogenous tnf alpha/beta": 0.00321, "pd98059": 0.00062, "stromal cell-mediated tcell rescue": 0.00067, "mononuclear leucocyte recruitment": 0.00203, "e1a-": 0.0005, "vanadate prevent": 0.00524, "alas-e": 0.00012, "manlam": 0.00043, "tnfr": 0.0005, "lacz reporter gene": 0.02903, "helper cell": 0.0768, "internal homology": 0.00183, "helper differentiation proceeds": 0.00786, "isolate polyclonal": 0.00416, "steroid-treated patient": 0.01666, "cd40-stimulated human": 0.03762, "mac-2": 0.00012, "stat1-stat2 signaling complex": 0.01123, "t-cell": 0.01923, "imprinted gene": 0.04355, "aldh1 gene expression": 0.02903, "ns-meg cell": 0.0768, "pregnancy lymphocyte": 0.01483, "peripheral mononuclear leukocyte differ": 0.00262, "human erythroid ala isozyme": 0.01881, "5-10-fold high": 0.00931, "intracellular parasite theileria parva": 0.00292, "p53 tumor suppressor gene": 0.02177, "lef/tcf binding": 0.01855, "class ii-restricted antigen processing": 0.00409, "activate mononuclear cell": 0.0512, "mnda expression": 0.04163, "proximal 0.2-kb region": 0.00978, "protein-dna binding": 0.01855, "tnf translation efficiency": 0.00321, "distinct ligand-induced": 0.00698, "o2": 6e-05, "creb/atf protein": 0.04529, "lytic gene cascade": 0.02903, "dehydratase": 0.0, "prevent nuclear factor-kappa": 0.01123, "major histocompatibility complex class ii promoter": 0.00779, "lipoxygenase isoforms exhibit": 0.00443, "1.955-kb viral segment include": 0.0072, "primary rest": 0.00738, "b2 site abolish": 0.01445, "a-crf": 0.00025, "natural cytotoxicity": 0.00233, "pancreas": 0.0005, "proto-oncogene activation": 0.03164, "mapping reveal": 0.01098, "high-affinity il-2rs": 0.00081, "irak": 0.00056, "cdk4 gene": 0.04355, "mcp-1 induction": 0.01607, "tal1/scl gene": 0.04355, "il-2r alpha gene contribute": 0.02177, "diphenylhexatriene": 0.00012, "ngal": 0.00087, "include human immunodeficiency virus tat": 0.01505, "major objective": 0.00574, "infectious molecular clone": 0.00492, "leukemia cell line jurkat": 0.0384, "alter weak": 0.00378, "partial amino acid sequence": 0.00813, "p21ras activation": 0.03164, "potential alpha-helical domain separate": 0.00603, "analogue effect": 0.02115, "leucocytic estrogen receptor level": 0.01286, "kappa b-driven gene": 0.02903, "nih-3t3 fibroblast": 0.00338, "drosophila": 0.00242, "fungal c8-c7 sterol isomerase": 0.0002, "progesterone-mediated immunosuppression": 0.00062, "small mitochondrial protein": 0.03019, "wild-type protein": 0.04529, "aspirin": 0.0013, "phosphorothioate antisense oligodeoxynucleotide": 0.00108, "cross-linking cd30": 0.00242, "d1/cdr2-loop": 0.00019, "ptdins 3-kinase": 0.00109, "add-back experiment": 0.00397, "human papillomaviruses": 0.03762, "eic": 0.00012, "early hematopoietic differentiation": 0.00786, "enhance stat1": 0.00974, "increase hiv-1 replication": 0.01464, "imbalance exists": 0.00031, "il3": 0.00074, "complementation group": 0.00487, "p67srf": 6e-05, "tissue-specific gata-binding site": 0.01445, "-76 base pair": 0.00207, "coassociated protein": 0.04529, "vitro dna mobility shift assay": 0.00593, "synergism require": 0.01315, "rapid testing": 0.00323, "t- acute and- chronic leukemia": 0.002, "human il-4 receptor": 0.02508, "229-bp region": 0.01467, "sustained response": 0.01942, "cd28 surface expression": 0.02775, "c-myb": 0.00378, "lymphokine": 0.00217, "semiquantitative rt-pcr analysis": 0.00786, "stain lymphocyte": 0.01483, "venous": 0.00068, "similar inverse change": 0.00449, "fabry disease": 0.00673, "salt bridge structure": 0.00213, "hiv-1 ltr responsive": 0.00585, "amino acid encode": 0.00571, "transfected human": 0.03762, "p2": 0.00037, "early untreated ra manifest": 0.00414, "neuroblastoma cell differentiation": 0.0512, "rapid": 0.00645, "bind ets family protein": 0.02264, "inhibit monocytic cell adhesion": 0.0384, "dominant-acting repressor molecule": 0.00569, "electrophoretic mobility shift assay analysis suggest": 0.00674, "partial depletion": 0.00143, "tat-mediated ltr superactivation": 0.00207, "abolish": 0.00707, "general marker": 0.00382, "monocyte chemotactic protein-1": 0.00798, "cd40l expression vector": 0.02775, "structure important": 0.00689, "macrophage differentiation result": 0.01073, "anti-cd28 moab costimulation increase nf kappa": 0.00732, "allo drug": 0.00338, "single case": 0.00363, "migrate b2 complex": 0.01123, "rheumatoid synovium": 0.00093, "tissue-specific gene": 0.04355, "monocyte-endothelial interaction": 0.00986, "t-cell functional region": 0.00978, "human organ": 0.03762, "e47 synergize": 0.00084, "endogenous ikk enzymatic activity": 0.01462, "r-activating signal": 0.01635, "independent method": 0.00363, "creb/atf family": 0.00841, "high viral load": 0.0062, "low affinity receptor": 0.01714, "polymorphonuclear cell": 0.0768, "mm-derived cell line": 0.0512, "enhance lipopolysaccharide": 0.00974, "acute ethanol affect nf-kappa": 0.00707, "african": 0.00031, "yeast sterol isomerase": 0.00103, "human t-cell line jurkat": 0.01881, "nfat family": 0.00841, "consequent activation": 0.03164, "activate pkc": 0.01777, "e1a- ad vector": 0.00213, "unlabeled il-13 compete": 0.00122, "memory b-cell pathway": 0.00852, "nuclear factor-kappab": 0.01684, "functional study": 0.01355, "peroxisome proliferator-activated receptor alpha": 0.01286, "express a-myb": 0.01846, "rat thymocytes": 0.00285, "il-1beta stimulation": 0.0112, "full th2 level": 0.01214, "primary effect": 0.02115, "physical": 0.00192, "histone deacetylase": 0.00133, "decrease intracellular glutathione level": 0.0091, "cyclophilin b-binding protein": 0.03019, "19-bp nuclear factor bind site": 0.01144, "so-called high mobility group": 0.00465, "strong c-myc mrna expression": 0.02081, "t-cell growth factor interleukin": 0.0143, "albuminemia": 0.00012, "efficient class ii processing": 0.00363, "immunofluorescence assay": 0.01002, "flow cytometry reveal binding": 0.00927, "pb-induced activation": 0.03164, "cytokine secretion profile": 0.00749, "primary tumor": 0.00934, "potential site": 0.02168, "human monocytic differentiation": 0.02508, "ankyrin repeat domain": 0.00804, "clonal analysis": 0.01179, "time-dependent decrease": 0.00971, "immunohistochemistry": 0.00105, "therapeutic benefit": 0.00167, "quinone reductase": 0.00019, "n-ethyl": 6e-05, "lps-inducible response": 0.01942, "tap-independent fashion": 0.00161, "icam-1 promoter": 0.02336, "human c-fes gene": 0.02903, "low shear-induced activation": 0.02109, "hmnl": 0.00025, "oap40 complex": 0.01684, "beta peptide": 0.00754, "eukaryotic transcription factor": 0.01907, "human myeloid cell nuclear differentiation antigen promoter": 0.02194, "vasculopathy": 0.00025, "mapk response require": 0.01294, "-induced t-cell proliferation": 0.00641, "normal murine": 0.0121, "carcinoma": 0.0036, "thyroxine concentration": 0.0067, "htlv-1 provirus": 0.00112, "treatment regimen": 0.01014, "mouse inos promoter region": 0.01168, "partial nucleotide sequence": 0.01084, "cytolytic resistance": 0.00326, "chemiluminescent": 6e-05, "bronchial hyperresponsiveness": 0.00093, "b-cell maturation": 0.00459, "cag repeat stop": 0.00252, "alphacd3": 0.00025, "phosphorylation-dependent signal": 0.01635, "bccs": 6e-05, "anergic": 0.00099, "aged human": 0.03762, "immunoglobulin heavy chain expression": 0.02081, "gold ion": 0.00062, "4-phorbol 12-myristate 13-acetate": 0.00045, "down-regulates lck-mediated activation": 0.02109, "chemotherapeutic potential": 0.00605, "il-4 induced phosphorylation": 0.00656, "report human nrf-1/alpha-pal factor": 0.01881, "1-beta-d-arabinofuranosylcytosine": 0.00025, "specific site": 0.02168, "tumor necrosis factor-alpha-responsive element": 0.00836, "cytoplasmic complex": 0.01684, "high mobility complex term complex ii": 0.0031, "anti-e-selectin mab": 0.00267, "general factor": 0.0286, "myeloid gene": 0.04355, "c-myb expression decrease": 0.02775, "large family": 0.00841, "tcr signal": 0.01635, "unstimulated jurkat cell": 0.0512, "x-linked severe combine immunodeficiency": 0.00109, "affected heterozygous woman": 0.00155, "traf1": 0.00081, "carboxyl-terminal peptide": 0.00754, "nf-kappab factor-binding element": 0.01115, "activator and/or": 0.00552, "protease mapping": 0.00177, "distinct multi-protein complex": 0.01123, "nucleotide sequence": 0.01625, "biochemical criterion": 0.0018, "acidic sphingomyelinase": 0.00109, "il-7r signal transduction": 0.0109, "normal mature human": 0.02508, "m. tuberculosis-infected cell": 0.0512, "hbf": 0.00025, "c-myc protooncogene": 0.00223, "regulate dna binding": 0.01237, "promonocytic cell": 0.0768, "efficient recovery": 0.00189, "unprimed cell possess": 0.0512, "weak aggregation induce": 0.01694, "nuclear form": 0.01684, "rag-1": 0.00019, "human ebv oncogene": 0.02508, "suggest cd2 receptor modulation": 0.01286, "superantigens activate hiv-1 gene expression": 0.01742, "cd4+ t-cell line": 0.01102, "heat-activated unliganded receptor": 0.01714, "lps-stimulated monocyte show": 0.01733, "repress basal promoter activity": 0.01462, "rest cd4+ memory": 0.00192, "cro-ap/3": 0.00025, "s1t": 6e-05, "du-145": 0.00019, "coinducer": 6e-05, "remain cell": 0.0768, "antisense myb rna expression": 0.02081, "cho-cd86 stimulation": 0.0112, "term": 0.00825, "bryostatin": 6e-05, "ra-inducible": 0.00043, "similar susceptibility": 0.00673, "cell type-specific enhancer region": 0.0384, "csa-resistant synthesis": 0.00583, "microm inhibitor": 0.009, "control thymocyte differentiation": 0.00868, "72-kilodalton major immediate-early protein": 0.02264, "dominant promoter element consist": 0.01168, "hyperimmunoglobulin e. background": 0.00077, "tal-1 rearrangement": 0.00199, "antiviral function": 0.01331, "turn trigger": 0.00409, "alter": 0.00757, "myelomonocytic specific tyrosine kinase hck gene": 0.01452, "il-6 downregulated expression": 0.02775, "signal process": 0.01635, "granulocytic differentiation pathway": 0.00852, "cipro inhibit ifn-gamma synthesis": 0.00952, "ikappabs": 6e-05, "nuclear receptor protein result": 0.02264, "intestinal epithelial cell initiate": 0.0384, "signal transduction mechanism induce": 0.0127, "trigger alphaiibbeta3 activation": 0.02109, "mouse mammary tumor virus": 0.00487, "ibr cdna": 0.00456, "alter mobility": 0.00378, "alanine substitution": 0.00112, "enhance il-2 mrna stability": 0.00763, "define efficacy": 0.00323, "cd20/b1 antigen correlate": 0.00546, "traffic": 0.00025, "human interleukin-4 gene": 0.02903, "plasma adrenocorticotropin": 0.00375, "single major transcriptional start site": 0.00867, "chromatin-dependent manner": 0.00282, "class": 0.01284, "dominant-negative mutant tumor necrosis factor receptor": 0.00953, "distinct sequence-specific dna-binding protein": 0.02264, "virus-induced cellular transformation": 0.00596, "human motor activity": 0.02508, "endogenous 1,25-dihydroxyvitamin": 0.00459, "natural environmental photic cycle": 0.00154, "oxidant challenge": 0.00105, "estradiol act": 0.00496, "hypermutation": 0.00087, "molecular characterization": 0.0045, "triptolide induces apoptotic death": 0.00402, "erp protein": 0.04529, "zinc-finger region": 0.01467, "predicted sequence": 0.01625, "intracellular vitamin": 0.00583, "critical regulatory element": 0.01115, "cd34 expression": 0.04163, "epstein-barr virus latent protein": 0.02264, "cd19 cross-linking": 0.00242, "down-regulate adhesion molecule expression": 0.02081, "cd40-inducible gene": 0.04355, "eth2": 0.00031, "tiny ring": 0.00022, "unsuppressed": 0.00012, "successful antituberculous immune response": 0.00971, "effective apc": 0.00164, "vcam-1 induction": 0.01607, "cytolytic phenotype": 0.00366, "homozygote": 0.0, "vitamin d3": 0.00245, "pld": 0.00087, "secretable cytokine": 0.01123, "specific protein-dna complex": 0.01123, "mutated form": 0.01055, "il-6-induced b-cell differentiation": 0.00786, "early stage cell": 0.0512, "2-4 hr": 0.00059, "cyclic amp-responsive member": 0.00275, "tcl1 oncogene": 0.00261, "immune regulation": 0.01008, "megakaryocytic pathway": 0.01278, "ras mutation frequency varies": 0.00296, "stimuli include anti-cd3": 0.00959, "increase tumor necrosis factor-alphaand interleukin-1betaproduction": 0.00878, "similar box": 0.00673, "crh promoter": 0.02336, "common mechanism": 0.01058, "200-bp enhancer domain": 0.00804, "studied phenomenon": 0.00093, "monoclonal antibody ki-67 represent": 0.00447, "variability": 0.00025, "perspective": 0.00025, "ngal gene expression": 0.02903, "efficient transcription initiation": 0.01873, "late": 0.00509, "secondary stimulation": 0.0112, "biphasic increase": 0.02196, "nih": 0.00043, "cytotoxic": 0.00347, "c-terminal domain": 0.01207, "ifn-alpha induced great stat5 activation": 0.01266, "study suggest": 0.02022, "precondition": 6e-05, "rfx activity": 0.02925, "nf-kappa b. lp": 0.00943, "valid technique": 0.00109, "g-csf activate": 0.01777, "important costimulatory role": 0.00885, "oct2-isoform expression": 0.04163, "stimulate kappa b-directed transcription": 0.01405, "downstream nf-kappa": 0.01414, "oligonucleotide": 0.00329, "-137": 0.00012, "calm": 0.0005, "gr count": 0.004, "follicular center": 0.00112, "thrombin inducibility": 0.0014, "il-10 induces activation": 0.02109, "hlp-1 binding activity": 0.0195, "ubiquitous octamer-binding protein": 0.03019, "pituitary peptide hormone": 0.00502, "adduct": 6e-05, "release intracellular calcium": 0.00389, "ppars": 0.00012, "stat1 increase": 0.02196, "immature dn thymocytes": 0.00172, "p24 antigen production": 0.00695, "nk3.3 cell": 0.0768, "include il-6": 0.01439, "emigration": 0.00012, "h-7": 0.00056, "increase intracellular accumulation": 0.01464, "marked stimulation": 0.0112, "u-937 cell line": 0.0512, "dominant negative phenotype": 0.00343, "gel mobility shift analysis": 0.00589, "structure-function mutagenesis approach": 0.0011, "impair uv response": 0.01294, "dna-binding site specificity": 0.01445, "mature cell underwent premature cell death": 0.0128, "mouse thymocyte cell line": 0.0384, "cell growth": 0.0768, "include human fibroblast": 0.02508, "taxreb protein": 0.04529, "human tonsillar": 0.03762, "mac-1 cell surface antigen expression": 0.03072, "receptor c-erba": 0.02571, "proliferative advantage provide": 0.0043, "il-4-inducible gene expression": 0.02903, "rag-2 rna": 0.00456, "dual function": 0.01331, "activator protein-1": 0.00552, "nf kappa b2 effect": 0.01058, "rapamycin bound": 0.00292, "antiapoptotic property": 0.00397, "calcineurin inhibitor cyclosporin": 0.006, "unique gata site": 0.01445, "human gm-csf promoter": 0.02508, "transcription factor oct-2a": 0.01907, "tat release": 0.00484, "nfat-1 transcriptional complex": 0.01123, "resist": 0.00025, "mechanism include": 0.01439, "thalassemia": 0.00025, "il-2r expression": 0.04163, "complement-dependent lysis": 0.00136, "silent fy*b allele": 0.00147, "fusion point": 0.00326, "hiv-gene expression": 0.04163, "renin": 0.00043, "p65-dependent transcriptional activation mediate": 0.01582, "-kappab bind site": 0.01445, "diminished type": 0.00949, "ra-stimulated": 0.00019, "motor activity": 0.02925, "-141": 0.00019, "g0s2": 0.00056, "hiv-1 accessory gene product vpr": 0.01742, "phospholipase c.": 0.00143, "q12": 6e-05, "pu.1 mrna": 0.01526, "unrecognized composite binding site": 0.01084, "p50-p65 complex": 0.01684, "scid phenotype": 0.00366, "recent definition": 0.0014, "bcl2+": 0.00012, "lyf-1": 0.00012, "speculation": 0.0, "transcription start": 0.0281, "wt19 cell": 0.0768, "fork head cdna": 0.00304, "polymyxin": 0.00012, "human neutrophil": 0.03762, "rheumatic disease": 0.00673, "lp group": 0.00487, "early induction": 0.01607, "ra pathway activation": 0.02109, "gas-binding protein": 0.04529, "provide information": 0.00645, "lt-beta": 0.00019, "ad5 e1a dna": 0.00988, "fmol/micrograms": 0.00025, "regulate inducible expression": 0.02775, "wild-type counterpart": 0.00378, "cell type test": 0.0512, "promoter central": 0.02336, "alpha/mad-3": 0.00031, "hypoxic ec occur": 0.00436, "mouse embryo": 0.00974, "c-fos-two component": 0.00456, "ifngamma": 0.00105, "age distribution": 0.00226, "wnt signal pathway": 0.0109, "t-cell receptor/cd3 complex": 0.01123, "2.3-kb coding region": 0.00978, "monoallelic paternal expression": 0.02775, "uninfected": 0.0013, "dnasel hypersensitive site": 0.01445, "post-germinal centre": 9e-05, "viral peptide residue contact tcr": 0.00301, "cell line bear dqa1*0501/dqb1*0201 heterodimers present antigen": 0.02194, "hiv-1 plasmid": 0.00878, "determine granulocyte clonality": 0.00519, "genome positional homologues": 0.00093, "bat": 0.00062, "human immunodeficiency virus entry": 0.01881, "hepatic cirrhosis": 0.00074, "il-4 promoter associate": 0.01557, "paracrine action": 0.00499, "multiple sclerosis patient": 0.0111, "human nm23-h2 gene product": 0.02177, "yeast one-hybrid screening": 0.00103, "ilt-mat": 0.00012, "protein play": 0.04529, "yellow pigment": 9e-05, "stimulus induce il-10 production": 0.0127, "dominant-negative form": 0.01055, "lipopolysaccharide-induced nf-kappa": 0.01414, "cell system": 0.0768, "result diminished phosphorylation": 0.01073, "e-protein gene": 0.04355, "mutated enhancer": 0.00909, "lowering": 0.0, "global mechanism": 0.01058, "gangliosides": 0.00124, "nontuberculous pulmonary condition": 0.0024, "individual experiment": 0.00409, "1alpha,25-dihydroxyvitamin d3": 0.00245, "differential activation property": 0.02109, "enhanced nuclear translocation": 0.01123, "extracellular receptor": 0.02571, "mediate clinical syndrome include infectious": 0.00576, "obesity": 0.00012, "high c-myc mrna expression": 0.02081, "monocyte-derived il-1beta inhibits": 0.00354, "haemopoietic": 0.00043, "induce il-2 cytokine production": 0.0127, "molecular level": 0.01821, "c-myc rna": 0.00456, "tcr-stimulated cd95 ligand expression": 0.02081, "b-lymphoid": 0.00074, "ncl lymphocyte": 0.01483, "ikappabalpha turnover demonstrate": 0.01065, "42-": 0.00012, "gene generates": 0.04355, "expression": 0.08325, "il-4-specific gene expression": 0.02903, "ifn-gamma receptor beta-chain control responsiveness": 0.01029, "transgene dose-dependent reduction": 0.00196, "transcription factor egr1": 0.01907, "rapid decrease": 0.00971, "multiple enhanson domain": 0.00804, "integrins": 0.00068, "sl3 core": 0.0022, "epsilon-globin gene": 0.04355, "adrenocortical function": 0.01331, "cd11a": 0.00031, "active regulatory event": 0.00455, "migration-promoting property": 0.00397, "jak kinase": 0.01188, "repressor specific": 0.01238, "takayasu arteritis activate endothelial cell": 0.03072, "squamous differentiation": 0.01179, "host defense": 0.00214, "human ikappab alpha": 0.02508, "cdna expression library": 0.02775, "anti-la": 6e-05, "high cell turnover": 0.0512, "interferon-beta mediates stromal cell rescue": 0.03072, "entire mds1/evi1": 0.00078, "assay condition": 0.01002, "ap1 transcription factor": 0.01907, "tsh-r expression level": 0.02775, "isogenic mutant": 0.0081, "sh2 domain-containing leukocyte protein": 0.02264, "constitutive serine phosphorylation": 0.00656, "small change": 0.0063, "pre": 6e-05, "gamma-ifn inducible dna bind activity": 0.0117, "c-raf kinase": 0.01188, "increased mrna encode profibrotic growth factor": 0.00953, "gm-csf gene expression": 0.02903, "carboxy-terminal negative regulatory domain": 0.00603, "cdk2": 0.00031, "human thymus lobule": 0.02508, "eleven": 0.00012, "cbf alpha 2-451": 0.0078, "mitogen stimulation": 0.0112, "option": 0.00037, "dq2 binding": 0.01855, "mdhm": 0.00043, "unable": 0.00236, "h-89": 0.00043, "sp ii promoter": 0.01557, "pre-b lymphocyte": 0.01483, "adaptor protein function": 0.03019, "leukocyte subset": 0.00478, "wild type ikk2": 0.00633, "p.and karsenty": 6e-05, "search ag": 0.00158, "fy*b allele": 0.0022, "ireland": 0.00012, "sex-related influence": 0.00471, "cells-1": 6e-05, "secondary response pathway": 0.01294, "actual hla binding": 0.01237, "th2": 0.00378, "critical illness": 0.00428, "endothelial cell surface": 0.0512, "exhibit anti-tumour activity": 0.0195, "wp activity": 0.02925, "perforin gene expression": 0.02903, "alphabeta tcr phenotype": 0.00318, "close proximity": 0.00068, "section": 0.00062, "chimeric mouse": 0.00974, "apparent genomic alteration": 0.0018, "irf-1 gene": 0.04355, "fl monocytic progenitor": 0.00269, "electrophoretic dna mobility shift assay show": 0.00866, "provide increase evidence": 0.01464, "mpl receptor": 0.02571, "cellular response require intracellular signalling pathway": 0.00647, "severe acute disease": 0.00449, "rakfkqllq-specific ctl": 0.00115, "anti-cd8-fitc": 0.00012, "asp838": 6e-05, "double-stranded dna": 0.01483, "cell receptor-cd3 complex": 0.0512, "ltr transcriptional activity": 0.0195, "nf-at show": 0.02599, "follow-up study": 0.01355, "untranslated sequence": 0.01625, "phop-phoq two-component regulatory system": 0.00341, "low t3 syndrome": 0.00471, "protein kinase calpha": 0.03019, "embryonic-fetal liver": 0.00118, "diffuse large": 0.00205, "p70": 0.0013, "anti-il-6 monoclonal antibody": 0.00596, "anti-icam-1 antibody": 0.00893, "transcription factor nuclear factor kappa": 0.01124, "nervous": 0.00074, "synthetic ligand": 0.00592, "ectopic expression": 0.04163, "nf-at-regulated gene suggest": 0.02903, "tata sequence": 0.01625, "reduced level": 0.01821, "angiotensin": 0.0005, "age-related decline": 0.00121, "viral protein direct progenitor": 0.02264, "er transcript": 0.00599, "biochemical study demonstrate": 0.01065, "amino acid 1-450": 0.00571, "p0": 0.00056, "cd1+relb+ dendritic cell": 0.0512, "endogenous wild-type itk": 0.00306, "gene associate": 0.04355, "l389-l397": 0.0, "induce cepsilon germline transcript": 0.0127, "interleukin-1 receptor synthesis": 0.01714, "enhanced proliferation": 0.00803, "sequence-specific complex exhibit": 0.01123, "t-cell proliferative activity": 0.0195, "rare event": 0.00552, "consecutive series": 0.00161, "adp-activated platelet induce mcp-1": 0.0127, "aml/pebp2/cbf family": 0.00841, "-210": 0.00012, "lung injury": 0.00195, "deletion analysis show": 0.01733, "ap-1/nf-at": 6e-05, "il-6 transcription": 0.0281, "high histologic grade": 0.0062, "serotonin reuptake inhibitor": 0.006, "intercellular adhesion molecule": 0.00569, "radioreceptor assay": 0.01002, "human gata-4": 0.03762, "cell product il-2": 0.0512, "flow condition": 0.0036, "increased il-6": 0.00391, "ikaros gene": 0.04355, "phosphatidyl inositol 3-kinase": 0.00072, "pgf2 alpha": 0.01169, "hypersensitive site hs2 enhancer": 0.01084, "eosinophil-specific granule protein gene": 0.02264, "control cell differentiation": 0.0512, "constitutive pkr activity": 0.0195, "ebv carry cell line": 0.0384, "cytokine-stimulated human umbilical vein endothelial cell": 0.0256, "medium range": 0.00202, "polarized th1 cell": 0.0512, "phyto- hemagglutinin": 6e-05, "il-2rs": 0.00025, "pkc activation": 0.03164, "core promoter": 0.02336, "electrophoretic mobility shift analysis demonstrate": 0.00639, "antigen molecule": 0.00853, "complete elimination": 0.00171, "c.": 0.00285, "similar activation": 0.03164, "transcription factor aiolos interacts": 0.0143, "lung disease associate": 0.00728, "pharmacological effect include antitumor": 0.01058, "nf-kappab resides": 0.00999, "cross-priming": 0.00012, "gene control apoptosis": 0.02903, "functional vdr": 0.00816, "atopic dermatitis": 0.00068, "atherogenesis": 0.00074, "proto-oncogene belonging": 0.0013, "myeloid": 0.00924, "uncontrolled cell proliferation": 0.0512, "unidentified factor": 0.0286, "tat-responsive element": 0.01672, "immature cell differentiate": 0.0512, "epo-induced cellular proliferation": 0.00596, "differential cdna hybridization": 0.00304, "non-erythroid cell type": 0.0512, "large variety": 0.00205, "im-9 nuclear extract": 0.01123, "phk": 0.00012, "ras upstream": 0.00369, "gata-1 negative jurkat t-cell line": 0.00661, "x-y regulatory element": 0.01115, "e2f-1": 0.0013, "oxygen therapy": 0.00372, "sh2-deleted grf40 mutant lead": 0.00498, "minor protein": 0.04529, "cell surface enzyme immunoassay": 0.0384, "cytokine-stimulated activation": 0.03164, "cyclin-dependent kinase inhibitor p27kip1": 0.00594, "bp fragment": 0.00347, "cytokine tnf mediate": 0.00821, "vaccination": 0.00043, "ligase": 0.00037, "non-octamer motif": 0.00875, "normal person": 0.0121, "creb inhibit gal4-p65": 0.0127, "mobility shift assay": 0.00668, "92-kda dna bind protein": 0.02264, "induced protooncogenes": 0.0054, "n-acetylcysteine dose": 0.00158, "balance": 0.0013, "alloreactive": 0.00019, "immunoprecipitated": 0.00056, "immunogenic": 0.00087, "sml cytosol": 0.00143, "cytochalasin d.": 0.00062, "u86": 0.00019, "exhibit significant inhibition": 0.00707, "rickets": 0.00062, "vitro differentiation": 0.01179, "high frequency": 0.00931, "paper describe": 0.00397, "cd40 induces tyrosine phosphorylation": 0.00492, "cobalt chloride-induced signaling": 0.00372, "t. pallidum lipoproteins-lipopeptides induce": 0.0127, "il-5": 0.00465, "manogue": 0.00012, "lymphoblastoid cell line induce": 0.0384, "adaptor protein cbl": 0.03019, "chemical-induced erythroleukemia cell line": 0.0384, "experimental evidence suggest": 0.01348, "promyelocytic hl60 cell": 0.0512, "cellular process": 0.00893, "underphosphorylated traf2": 0.00074, "gamma response region": 0.01294, "tcr/cd3 trigger": 0.00409, "-ethane-n": 6e-05, "dprl promoter/reporter gene construct carry": 0.01742, "ets-like binding motif": 0.01237, "steroid-treated": 0.00031, "basal serum cortisol concentration": 0.00335, "vdr 3'-utr": 0.00233, "factor bind motif": 0.01907, "signal-transducing receptor subunit": 0.01714, "smooth muscle cell": 0.0512, "hypothalamic-hypophyseal-adrenocortical system": 0.00667, "octamer transcription factor": 0.01907, "autocrine regulatory mechanism": 0.00705, "fixative-sensitive": 0.0, "cell type include lymphocyte": 0.0384, "lmp1+": 0.00019, "timp-1 suppresses apoptosis": 0.00593, "tsc2 gene support": 0.02903, "adenovirus antigen": 0.00819, "position-": 6e-05, "ltb4 fail": 0.00347, "trans-rotamers": 6e-05, "marker": 0.00763, "transfected human erythroleukemia cell": 0.0384, "astrocytic glial cell support tar-independent transactivation": 0.0256, "regulate activation": 0.03164, "mnp family": 0.00841, "annular structure characteristic": 0.00219, "ap-1 transcriptional activity": 0.0195, "rat embryonal fibroblast ref52 cell": 0.03072, "express mnda include hairy cell leukemia": 0.0256, "cyclic undecapeptide": 0.00149, "lyl-1": 0.00025, "detect nf-atp": 0.00726, "nuclear extract bind": 0.0135, "early gene activation": 0.02903, "interleukin-1alpha": 0.00019, "regulate inducible t-cell gene expression remain unknown": 0.01244, "fusion reporter gene irrespective": 0.02177, "enter rest tissue": 0.00443, "mhc class ii extinction": 0.00363, "nuclear 3,5,3'-triiodothyronine receptor": 0.01714, "lysopc increase monocytic camp level": 0.00878, "plasma cell-specific repressor function": 0.00665, "antiandrogen-bound": 0.00031, "marked rise": 0.00102, "rctla4ig": 6e-05, "industrial compound 4-octylphenol": 0.00147, "nuclear matrix preparation": 0.01123, "-dependent pathways accelerate": 0.00091, "erythroid progenitor cell": 0.0512, "mitogenic lectin": 0.00105, "i. deltorphin": 0.00022, "human leukemic cell clone cem c7": 0.0256, "tnf-induced signaling": 0.00558, "exogenous ets1": 0.00214, "dna band-shift assay reveal": 0.00741, "high molecular weight dextran sulfate": 0.00372, "hiv-2 transcription": 0.0281, "cd40 cytoplasmic domain interact": 0.00603, "gp160": 0.00074, "complementary dna encode": 0.00988, "nonsense mutation": 0.00592, "single nucleotide mutation": 0.00395, "n19rhoa inhibited receptor clustering": 0.01286, "lmp1 dna": 0.01483, "human elk-1 promoter": 0.02508, "pu.1 dna binding activity": 0.01462, "genomic fragment transactivated": 0.00232, "pma/bt2camp-treated cell": 0.0768, "metabolite htb": 0.00109, "transient cat assay": 0.00668, "transplanted organ": 0.00118, "cellular proliferation": 0.00893, "s194 plasma cell": 0.0512, "d3-induced monocyte differentiation": 0.00798, "hsv-1 replication": 0.00471, "non-specific immunoreaction": 0.00012, "initiate": 0.00726, "potential ets transcription factor binding site": 0.00953, "hiv-1 activation": 0.03164, "p53-/- mouse": 0.00974, "oct2 transcription factor": 0.01907, "p50 nf-kappa": 0.01414, "ikappab-alpha protein level": 0.03019, "cultured cell lead": 0.0512, "past": 0.00012, "elf-2b lack": 0.00633, "benzene-induced apoptosis": 0.0089, "translation rate": 0.00279, "immunoblot": 0.00074, "bind assay show": 0.01733, "nonpituitary human prolactin gene transcription": 0.01742, "box region factor": 0.01907, "glutathione s-transferase": 0.00105, "gh3 extract": 0.00459, "0.25-2.0 gy": 0.00012, "ap-2 expression construct": 0.02775, "ctla4ig": 0.00012, "il-2 gene display": 0.02903, "5'-regulatory sequence": 0.01625, "nfat element": 0.01672, "interleukin-4 receptor alpha chain": 0.01286, "cholecystokinin": 0.00012, "u937 monocytic cell": 0.0512, "steroid-mr complex": 0.01684, "allergen-specific cd4+ t-cell clone": 0.00481, "mammalian pax-2": 0.00174, "differentiation-dependent peroxisomal proliferator-activated receptor gamma": 0.01029, "quantitative": 0.00192, "proliferative": 0.0036, "ready": 6e-05, "il-7 induces": 0.00803, "avian erythroblastosis virus": 0.00591, "antifungal effect": 0.02115, "bacterial endotoxin lipopolysaccharide": 0.00163, "17-bp sequence": 0.01625, "viral transcription factor": 0.01907, "bind oct1": 0.02025, "pwm-generated b-cell mitogenesis": 0.00306, "mrna encode c-fos": 0.01017, "chronic immune response": 0.01294, "regulate il-5 gene transcription": 0.02177, "dqa1*0201/dqb1*0201": 0.00025, "regulatory molecule": 0.00853, "increased chemotactic activity": 0.0195, "human atheroma": 0.03762, "commitment period": 0.00127, "cortisol-dependent ba patient": 0.0111, "time-dependent increase": 0.02196, "inhibit normal vdr-rxr heterodimer binding": 0.00762, "oxygen": 0.00199, "cell leukemia virus": 0.0512, "increase amount": 0.02196, "rheumatoid synovial cell": 0.0512, "pure recombinant p21ras demonstrate": 0.00799, "sensitive monitoring": 0.00273, "human b-cell line im-9": 0.01881, "phosphorylation analysis demonstrate": 0.01065, "affect": 0.01594, "resonance assignment": 0.00022, "liposomal formulation": 0.00019, "selectively inhibit nf kappa": 0.00952, "healthy volunteer": 0.00177, "homology term": 0.00413, "tnf-alpha signalling": 0.00546, "pcd41 clone demonstrate": 0.01065, "human rest": 0.03762, "regulate normal hematopoietic differentiation": 0.00627, "lfa-i beta chain": 0.00449, "support high level": 0.01214, "cd62e": 0.00031, "alpha-chain": 0.00124, "isolate cdna clone encode tcf-1 alpha": 0.0039, "il-8 gene function": 0.02903, "human primary b-lymphocytes": 0.02508, "mitogen-activated protein p38 kinase": 0.02264, "monocytic lineage": 0.00403, "anti-e. chaffeensis antibody": 0.00596, "human transcription factor": 0.02508, "bipotential myelomonoblastic cell population capable": 0.03072, "antiphosphotyrosine immunoblotting": 0.00037, "trigger": 0.00819, "globin synthesis": 0.00583, "promote": 0.00931, "induction show": 0.02599, "tissue-specific transcription factor bind": 0.0143, "cyp-40": 6e-05, "escherichia coli tester strain carry": 0.0011, "alpha induce": 0.0254, "e2f-binding site": 0.02168, "carry mutation": 0.00592, "hsv-infected cell": 0.0768, "varicella vaccination": 0.00025, "hiv promoter require": 0.01557, "caution": 6e-05, "couple ligand bind": 0.0135, "tcr-inducible gene expression": 0.02903, "term nuclear inhibitory protein": 0.02264, "incorporation": 0.00136, "protein kinase inhibitor h-7 block accumulation": 0.0151, "protodrug": 6e-05, "antisense myb rna": 0.00304, "high grbeta expression": 0.02775, "metastatic suppressor gene": 0.02903, "hematopoietic cell-specific pattern": 0.00366, "plasma membrane ca-atpase": 0.003, "minus": 0.00037, "differential phosphorylation": 0.00983, "lineage commitment": 0.00366, "cell-type specific induction": 0.01071, "gene target study": 0.02903, "uv cross-linking study reveal": 0.00678, "proximal binding element p0": 0.00927, "ap-1 consensus tre motif": 0.00437, "functional data show": 0.01733, "messenger": 0.00292, "vitro dnase": 0.00785, "il-1 beta": 0.00673, "induce anti-dna antibody": 0.01694, "hypothyroidism": 0.00043, "important molecular site": 0.01445, "ec1 antibody": 0.00893, "activation-inducible protein": 0.04529, "inhibit il 6-induced igm production": 0.00762, "bzlf": 0.00056, "author reveal alteration": 0.00732, "rodent fibroblast": 0.00338, "fas ligand expression": 0.02775, "cell replication": 0.0768, "hematopoietic gene": 0.04355, "distinct site": 0.02168, "tissue macrophage": 0.00664, "control kd": 0.01303, "donor": 0.00279, "immunoglobulin production": 0.01042, "calcitriol/vdr": 0.0, "common cis-acting element": 0.01115, "c-terminal acidic domain": 0.00804, "lysosomal degradation": 0.00332, "dna binding activity indistinguishable": 0.01462, "human nf-at": 0.03762, "induced ap-1 translocation": 0.00463, "dose-response curve": 0.00028, "il-2r alpha protein": 0.03019, "serum generate": 0.00453, "complex capable": 0.01684, "3.8-7.0": 0.00012, "parasite": 0.00074, "inactive sle": 0.00161, "a6h molecule": 0.00853, "-alpha": 0.00068, "lineage cell induce": 0.0512, "intronic enhancer": 0.00909, "ap3-like motif": 0.00875, "multiple minor susceptibility gene": 0.02177, "cytolytic lymphocyte": 0.01483, "recurrent spontaneous abortion": 0.00062, "galectin-3 expression": 0.04163, "urinary free cortisol": 0.00196, "flow": 0.00304, "reporter gene activity": 0.02903, "mel": 0.00062, "myeloid commitment": 0.00462, "nmi enhance": 0.00974, "immunogenic primary tumor": 0.00622, "stat protein pair": 0.03019, "aml-m0": 0.0, "isolate rna": 0.00456, "abrogate signalling": 0.00254, "chemical cross-linking": 0.00242, "arrest differentiation": 0.01179, "glucocorticoid effect": 0.02115, "phenomenon term extinction": 0.00275, "expression level increase": 0.02775, "limit": 0.00323, "t-pll tumour": 0.00183, "musculin protein": 0.04529, "nail": 0.00012, "envelope glycoprotein": 0.00152, "control beta-actin gene promoter": 0.02177, "jak/stat pathway": 0.01278, "normal myeloid development": 0.00806, "raloxifene": 6e-05, "malignant lymphocyte": 0.01483, "ppargamma activator": 0.00552, "trans-activation": 0.00155, "reciprocal product": 0.00533, "low-affinity il-12r beta1 subunit": 0.00242, "multisubunit adhesion receptor": 0.01714, "important role": 0.01328, "monocytic lineage mature": 0.00269, "nf-kappab require dual signal": 0.00817, "spatial": 0.00025, "start codon": 0.00118, "cellular event induce": 0.01694, "require rac-1 function": 0.00887, "potential regulator": 0.00605, "run-on analysis demonstrate detectable level": 0.00728, "nonreceptor tyrosine": 0.0071, "high proliferation": 0.00931, "ucsd-aml1": 0.00012, "measure protein tyrosine kinase activity": 0.01811, "measure postcapillary venule": 0.00258, "vi": 6e-05, "similar kinetics": 0.00673, "kd factor": 0.0286, "oka stimulation induce intense phosphorylation": 0.01016, "monoclonal antibody specific": 0.00825, "direct dna sequencing show": 0.013, "molecule": 0.01706, "dual enzyme inhibitor": 0.006, "result implicate": 0.0161, "map experiment": 0.00397, "cell-specific fashion": 0.00292, "manner opposite": 0.00282, "property similar": 0.00673, "footprinting": 0.00236, "ingested gliadins": 0.00012, "stat tyrosine phosphorylation": 0.00656, "cell surface paf receptor": 0.0384, "p-selectin-specific monoclonal antibody": 0.00596, "prednisolone therapy": 0.00372, "l2 domain": 0.01207, "receptor alpha chain/cd25 promoter": 0.01286, "structural motif share": 0.00583, "series cell": 0.0768, "dephosphorylated prb due": 0.00246, "zinc finger transcription factor require": 0.01144, "noncontiguous region": 0.01467, "wuchereria banerofti infection": 0.00414, "switch occur": 0.00654, "nuclear t3 receptor": 0.01714, "unoccupied receptor sit capable": 0.01286, "result demonstrate enhanced efficacy": 0.00805, "human peripheral monocyte": 0.02508, "nuclear protein hmg-i": 0.03019, "human umbilical vein endothelial cell": 0.03072, "v14rho": 0.00031, "lps toler ant human mono mac": 0.01254, "cd34": 0.00174, "lps-induced nf-kappa": 0.01414, "specific antiserum reveal decrease": 0.00619, "infected resting": 0.00167, "l-cystine": 6e-05, "healthy elderly subject increase": 0.01098, "atl-16t cell": 0.0768, "common component": 0.00456, "non-clonal progenitor cell remain": 0.0384, "chloramphenicol acetyltransferase reporter vector": 0.00276, "nef+ jurkat cell": 0.0512, "alpha2 integrin gene require signal": 0.01742, "d3 result": 0.0161, "kidney-tonifying": 0.00012, "sh3 domain": 0.01207, "critical step": 0.00428, "h. cd38+ cell": 0.0512, "inducible transcription factor": 0.01907, "activate binding": 0.01855, "major role": 0.01328, "h2o2-induced": 0.00043, "antiestrogenic activity": 0.02925, "il-4 responsive element": 0.01115, "basic mechanism": 0.01058, "short sequence motif": 0.01084, "cis-elements": 0.00056, "pdtc prevent nf-kappa": 0.00943, "antigen recognition": 0.00819, "in-situ labelling": 0.00019, "loss": 0.00596, "ap-2 bound": 0.00292, "disease patient": 0.01666, "base order": 0.0031, "murine ba/f3 cell transfected": 0.0384, "jak-1-deficient hela cell": 0.0512, "noncanonical egr": 0.00022, "p50.c-rel heterodimers": 0.00226, "gene rearrangement inhibit development": 0.02177, "adenoviral transfer": 0.0009, "serial sectioning": 9e-05, "lack lactoferrin": 0.00633, "ige-binding protein": 0.04529, "nf-atn": 0.00012, "base-substitution mutation": 0.00592, "danazol decrease transcription": 0.01873, "inhibit ligand-inducible degradation": 0.0127, "ifn-gamma pre-treatment affect": 0.00531, "erk1": 0.0005, "anergic murine": 0.00623, "cortisone-resistant bronchial asthma": 0.00108, "transplanted htlv-i tax-transformed tumor": 0.00467, "g0": 0.0005, "mhc class i-restricted peptide": 0.00377, "study include dnase": 0.00959, "southern blot hybridization": 0.00103, "human lymphoblastoid cell line": 0.0384, "rfx-b": 0.00019, "hcv-positive case": 0.00363, "normal human peripheral blood lymphocyte": 0.01505, "euthyroid subject": 0.00354, "pronounced deficiency": 0.00112, "tal-1 promoter": 0.02336, "malarial parasite": 0.00037, "artificial light regime": 0.00052, "haematopoietic cell": 0.0768, "tcr signal cascade": 0.0109, "latent infection": 0.0062, "homologous mechanism": 0.01058, "cd5 expression": 0.04163, "hl-60 differentiation": 0.01179, "progesterone suppression": 0.00416, "-92": 0.00025, "sucrose gradient analysis": 0.00786, "sf2 strain": 0.00186, "cdk2 inhibitor": 0.009, "risk": 0.00217, "alpha target": 0.01169, "diesel organic extract": 0.00306, "decreased il-2 production": 0.00744, "initiator": 0.00043, "normal level": 0.01821, "persistent infection ad5 underwent spontaneous mutation": 0.00207, "human interleukin-3 promoter": 0.02508, "prog": 0.00025, "class ii molecule": 0.00569, "cell receptor gamma enhancer": 0.0384, "pbmc preparation test": 0.00325, "unstimulated sp-b21 cell": 0.0512, "nfat family play": 0.0056, "hbd fragment eliminate": 0.00232, "analysis suggest": 0.02022, "jnk activity": 0.02925, "parasitic infection": 0.0062, "basal state": 0.0035, "nfatp immunoprecipitated": 0.00164, "ifn-stimulated gene factor": 0.02903, "blood platelet": 0.00592, "ras-regulated activation": 0.03164, "signal transduction generate": 0.0109, "nucleolar staining result": 0.01073, "pulmonary disease": 0.00673, "promoter analysis reveal": 0.01557, "transfection result": 0.0161, "cell follicle": 0.0768, "adenosine receptor agonist neca": 0.01286, "cre interact": 0.00372, "parp": 0.00037, "karyopherin": 0.00025, "tnf-alpha secrete": 0.00546, "pma -or ra-differentiated u937 cell": 0.03072, "caii transcription": 0.0281, "il-2r beta remain low": 0.00354, "primary hiv-1 isolate": 0.00585, "adp-ribose": 0.00012, "anetholdithiolthione": 0.00012, "m-tat/scf cell": 0.0768, "mechanical": 0.00068, "tetrahexamer binding protein": 0.03019, "-219 bp upstream": 0.00246, "ing-1": 6e-05, "mouse erythroleukemia": 0.00974, "mutant line": 0.01653, "stimulated jurkat cell": 0.0512, "suppress basal": 0.00611, "rapid change": 0.0063, "lithium": 0.00037, "activated jurkat cell line": 0.0384, "pma/ionomycin treatment": 0.01014, "induce mcp-1 secretion": 0.01694, "cd18 expression": 0.04163, "adrenal function": 0.01331, "control patient": 0.01666, "block il-4-induced germline cepsilon transcription": 0.01124, "cdna": 0.00912, "t-antigen-expressing plasmid": 0.00273, "regulate fas/apo-1/cd95-mediated death": 0.00835, "mouse osteocalcin gene": 0.02903, "quiescent progenitor": 0.00276, "rela function require": 0.00887, "negative-acting sequence repress enhancer activity": 0.0117, "octamer factor oct-1": 0.01907, "high potency": 0.00931, "proteasome inhibitor n-acetyl-leu-leu-norleucinal": 0.006, "-150 bp represent": 0.00267, "il-13 promoter": 0.02336, "peroxisome proliferator-activated receptor gamma": 0.01286, "ad2/ad12 hybrid e1a gene product": 0.01742, "il-13 induces phosphorylation": 0.00656, "cell line express vitamin": 0.0384, "integrin-ligand interaction trigger signal pathway": 0.00654, "sigd-crosslinking": 0.00025, "uncertain function": 0.01331, "neoplasm": 0.0005, "ets": 0.00416, "5'-end terminus": 0.00071, "resting g0/g1 state": 0.00178, "steady-state level": 0.01821, "high basal expression": 0.02775, "sequence-specific binding": 0.01855, "lymphocyte gcii": 0.01483, "early b-cell progenitor": 0.00552, "bladder carcinoma": 0.0018, "nitroblue tetrazolium": 0.00025, "positive regulatory domain": 0.00804, "augment il-2-": 0.00236, "-8 promoter": 0.02336, "gp ib alpha promoter activity": 0.0117, "nonimmunocompromised patient": 0.01666, "survanta": 0.00031, "m. m.": 0.00057, "clinical remission": 0.00425, "kg1": 0.00043, "quercetin": 0.00031, "subsequent isolation": 0.00304, "distinct signal transmission pathway": 0.00817, "transcription protein stat3": 0.03019, "distinct sequence motif": 0.01084, "80-kd stat5a molecule": 0.00569, "t. parva-infected cell": 0.0512, "ews/fli-1 peptide": 0.00754, "inhibit c/ebpalpha-dependent transcription": 0.01873, "ikappabalpha mediate": 0.01231, "induce anergy": 0.0254, "assay transcriptional activity": 0.0195, "fat/lean body mass ratio": 0.00068, "dramatic effect": 0.02115, "limit endothelial activation": 0.02109, "hematologic neoplasm": 0.00025, "prominent role": 0.01328, "unprimed eosinophil phenotype": 0.00244, "antiparallel mode": 0.00074, "erythropoietic development": 0.00633, "apoptosis mediate": 0.01231, "constitutive mhc class ii expression": 0.01665, "tax selectively stimulate nf-kappab-directed transcription": 0.01124, "potent costimulatory factor": 0.01907, "j.corbeil": 0.00012, "direct role": 0.01328, "transfected recombinant chloramphenicol acetyltransferase": 0.00195, "micrometer": 0.0, "o.j.": 0.00012, "helix-turn-helix transcription factor oct-1": 0.0143, "asp": 0.00025, "cell library": 0.0768, "protein complex act": 0.03019, "interferon-gamma-treated u937 cell": 0.0512, "prostatic spermine bind protein mrna": 0.01811, "viral inhibition": 0.01061, "c-rel-mediated transactivation and/or dna binding": 0.00742, "yae": 6e-05, "nf-kappab occurs": 0.00999, "well-standardized": 6e-05, "tumor necrosis factor-responsive gene": 0.02177, "perforin-expressing cell line": 0.0512, "human osteoclast develop": 0.02508, "chronic glomerulonephritis": 0.00397, "sp6 kappa promoter kappay element": 0.00934, "dc lineage commitment": 0.00244, "stat6 activation play": 0.02109, "similar molecular mechanism underlie transcription": 0.01124, "attenuation": 0.00025, "tf promoter require": 0.01557, "convergence point": 0.00183, "cis-acting dna element": 0.01115, "distinct component": 0.00698, "molecular remission": 0.0045, "ikappabalpha constitutive expression": 0.02775, "mouse thioglycollate-activated": 0.00974, "essential upstream il-2 response element": 0.00777, "r-responsive enhancer region": 0.00978, "il-2r alpha expression": 0.02775, "vitro cleavage": 0.00785, "aberrant pml gene product": 0.02177, "treatment": 0.02029, "genistein glucuronides": 0.00068, "relevant mechanism": 0.01058, "direct vesicle trafficking": 0.0036, "antagonize": 0.00161, "jurkat cell stimulate": 0.0512, "small human tissue sample": 0.01881, "rna complex": 0.01684, "play important role": 0.00885, "include domain": 0.01439, "b-cell mutant": 0.0081, "unrearranged tcr delta gene": 0.02177, "light chain gene": 0.02903, "cytotoxic effect": 0.02115, "surface immunoglobulin": 0.00515, "continuous administration": 0.00093, "multiple interact element": 0.01115, "serine/threonine kinase": 0.01188, "anti-cd28 stimulated rel-/-": 0.0007, "3h-triamcinolone acetonide": 9e-05, "transient": 0.00689, "individual enhancer sequence": 0.01084, "ptdins 3-kinase signal": 0.0109, "cell cycle variation": 0.0512, "pp1/pp2a": 0.00012, "monoclonal antibody pmi-1": 0.00596, "cd2 antigen-derived signal": 0.0109, "synthesize nuclear subunit": 0.01123, "primary human t-lymphocytes": 0.02508, "include repression": 0.01439, "beta-promoter activity": 0.02925, "-70": 0.0005, "htlv-i-infected cell line": 0.0512, "tcr alpha enhancer activity": 0.01462, "subfragment": 6e-05, "latent gene": 0.04355, "eb1-binding site": 0.02168, "gene demonstrate extensive": 0.02903, "induce ca2+ influx": 0.01694, "calcineurin associate": 0.01092, "tumor-associated phenomenon": 0.00093, "elusive oct2 target gene": 0.02177, "chymotryptic activity": 0.02925, "significant intracellular thiol decrease": 0.00485, "rgd exhibit": 0.00664, "aids-related cancer": 0.00248, "tumor sample": 0.00934, "concept": 0.00031, "human tumor necrosis factor alpha": 0.01505, "ubiquination": 0.00012, "decrease parasitemia": 0.00971, "malignant clone": 0.00738, "switch region": 0.01467, "pha-activated pbl": 0.00096, "nfkb1": 0.00031, "2-day incubation": 0.00208, "follow-up": 0.0005, "diabetes mellitus": 0.00031, "enhancer include": 0.01439, "cytokine signalling": 0.01123, "ap-2 site mutation": 0.01445, "mandatory": 0.00025, "brain": 0.00167, "peroxisome proliferators": 0.00031, "chotsh1-1": 0.00012, "parenteral corticosteroid": 0.00143, "apoptotic process induce": 0.01694, "desarg": 0.00012, "normal counterpart": 0.0121, "receptor chain": 0.02571, "acetylated transcription factor": 0.01907, "0.1-10 micromol/l enhance nk cell-mediated k562 cancer cell": 0.0192, "hela heterokaryons": 0.00233, "reactive thrombocytosis": 0.00211, "dfr": 6e-05, "e. coli": 0.00102, "early b-lymphoid progenitor": 0.00552, "block voltage-gated": 0.01073, "human homolog": 0.03762, "-h2": 0.00012, "ap1": 0.00279, "nuclear factor e1-binding site": 0.0143, "cotransfected jurkat-tag": 0.00047, "great potency": 0.00205, "x50-7": 6e-05, "intense staining": 0.00177, "show high level": 0.01733, "complementary dna result": 0.01073, "relative expression": 0.04163, "symbiotic": 0.00012, "intracellular event": 0.00583, "hyperreactive pituitary adrenocorticotropic hormone": 0.00222, "relevant clinical implication": 0.00283, "potential therapeutic target": 0.0055, "enhance normal erythroid proliferation": 0.00605, "calcium metabolism": 0.00236, "peripheral-blood lymphocyte": 0.01483, "transcriptional trans-activator tax": 0.00767, "zeta-chain": 0.00031, "htlv-i infected": 0.00276, "cell effector function": 0.0512, "triflusal inhibit pge2 production": 0.00952, "activated il-2 expression": 0.02775, "delta-chains": 0.00012, "mie": 0.00037, "interleukin-10 inhibits interferon-gamma-induced intercellular adhesion molecule-1 gene transcription": 0.01089, "clone oct2 cdna": 0.00492, "complete activation programme": 0.02109, "hla-dr-restricted": 0.00025, "integrin ligation": 0.0018, "peptide bcr1/25": 0.00754, "significant partial correlation": 0.00277, "dna-binding nuclear factor": 0.01907, "beta globin promoter yield": 0.01168, "human chronic lymphocytic leukemia": 0.01881, "mhc class ii expression play": 0.01665, "x-linked hypophosphatemic rickets": 0.00045, "interferon-inducible regulatory element": 0.01115, "ankyrin-rich inhibitory protein": 0.03019, "-dexamethasone": 0.00012, "good correlation": 0.00248, "csf-1 receptor": 0.02571, "escherichia coli yield": 0.00108, "block il-12-dependent up-regulation": 0.00715, "hematopoietic cell specific molecule": 0.0384, "r- inducible enhancer": 0.00606, "suggest monocyte mcp-1 expression induce": 0.01665, "nitric oxide selectively": 0.00194, "cells/ml": 0.0, "cell antigen receptor/cd3 complex": 0.0384, "stable integration": 0.00171, "internal standard consisting": 0.00058, "pkc-epsilon": 0.00012, "bone marrow-derived stromal cell line": 0.03072, "animal model": 0.00422, "human interferon regulatory factor": 0.01881, "clinical symptom": 0.00425, "human leukemia hl60 cell respond": 0.03072, "sequence divergence": 0.01625, "dutp": 6e-05, "vitro protein truncation test": 0.02264, "mediate il-12-induced gene expression": 0.02177, "select human": 0.03762, "ifn mrna": 0.01526, "guamerin-derived synthetic peptide": 0.00502, "ig-silenced": 0.00012, "mediate diverse immune response": 0.00971, "triptolide": 0.00043, "leukotriene b4 induce adhesion": 0.0127, "antagonistic": 0.0005, "suggest positive cooperativity": 0.01348, "foreign antigen": 0.00819, "ic50s": 0.00025, "interferon gamma activate": 0.01185, "intact nucleus": 0.00319, "fas ligand transcription": 0.01873, "remain obscure": 0.00521, "position -206": 0.00236, "cell receptor coengagement and/or exposure": 0.03072, "hzf": 0.00037, "residues": 0.00031, "inactive heterodimers": 0.00226, "pathophysiological condition": 0.0036, "quantitative assay": 0.01002, "share receptor motif": 0.01714, "g28-5 sfv": 0.00025, "increase ap-1 binding": 0.01464, "tnf-alpha mrna detectable": 0.01017, "form complex": 0.01684, "ciita mrna": 0.01526, "serum ast/alt": 0.00378, "vanadate": 0.00056, "recombinant il-2 increase nf-kappab binding activity": 0.00975, "activate tcf reporter gene": 0.02177, "a.s.fauci": 6e-05, "cognate octamer motif atgcaaat": 0.00437, "significant antimicrovascular ec activity": 0.01462, "bob1 increase": 0.02196, "statistical significance": 0.00078, "lymphoid origin": 0.00409, "-64": 0.00019, "bone density": 0.00214, "u937 cell increase": 0.0512, "tcf-responsive gene": 0.04355, "ca2+ chelator": 0.00304, "activate lymphocyte exert": 0.01185, "localized gain": 0.00037, "dna replication occur": 0.00988, "regulate nf-kappa": 0.01414, "multimer": 0.0, "vitro apoptosis induction": 0.01071, "cell express mrna": 0.0512, "induced proliferation": 0.00803, "inhibit inflammatory mediator expression": 0.02081, "25-dihydroxy vitamin d3": 0.00163, "mature human lymphocyte": 0.02508, "beta level": 0.01821, "high grade malignant astrocytomas": 0.00465, "monoclonal model": 0.00422, "essential component": 0.00487, "stimulate human immunodeficiency virus type 1-long terminal repeat": 0.00941, "human pcd/dcoh": 0.03762, "intrinsic transcriptional activation domain": 0.01582, "cn": 0.00099, "human myeloid nuclear differentiation antigen": 0.01505, "inducible transcriptional enhancement mediate": 0.00616, "pma-induced stimulation": 0.0112, "suppress myeloid cell differentiation": 0.0384, "spi-b protein": 0.04529, "spleen cell": 0.0768, "phorbol ester treatment": 0.00676, "nephropathy": 0.00037, "facs-isolated": 6e-05, "bacterial peptide": 0.00754, "pcr": 0.0023, "heterogeneous transcription start site": 0.01405, "cytosol fraction": 0.00171, "hiv enhancer activity": 0.0195, "optimum binding": 0.01855, "demonstrate induction": 0.01607, "u/ml": 0.00043, "zinc-finger domain": 0.01207, "glucocorticoid receptor capacity": 0.01714, "testosterone responsiveness": 0.00323, "herpesvirus": 0.00149, "csa-resistant nfat complex": 0.01123, "differentiated embryonic stem cell": 0.0384, "hit cell": 0.0768, "alpha,25-": 0.00012, "35s-tr alpha": 0.01169, "anti-fas killing": 0.00025, "mrna accumulation": 0.01526, "case express cd4": 0.0123, "interleukin-2 expression": 0.04163, "homologue mtcp1/c6.1b": 0.00047, "demonstrable effect": 0.02115, "ut-7 epo": 0.00171, "cell signal": 0.0768, "ra autoimmune inflammation": 0.00397, "complete dependence": 0.00171, "host protein": 0.04529, "pafr gene expression": 0.02903, "cll patient test": 0.0111, "cd4+ cell result": 0.0512, "sedimentation": 0.00037, "human peripheral blood nk cell": 0.03072, "notch signal pathway": 0.0109, "tumour necrosis factor-alpha": 0.00159, "eur.j.immunol.1994.24": 6e-05, "granulocyte-macrophage colony-stimulating factor stimulate jak2 signal pathway": 0.00817, "activate c-jun n-terminal kinase": 0.00889, "h. oct-2 mrna induction": 0.00803, "cb50": 6e-05, "tumor progression": 0.00934, "pro-glutathione antioxidant": 0.00251, "cadmium treatment": 0.01014, "pif dna bind activity": 0.01462, "18-": 0.00012, "special program": 0.00171, "good understand": 0.00155, "allele-specific expression profile": 0.02775, "h1-agonists": 6e-05, "unaffected family member": 0.0056, "cell express": 0.0768, "review analyze": 0.00456, "proline -and acidic amino acid-rich": 0.00109, "propagation": 0.00025, "dxm": 0.00012, "modification": 0.00366, "constitutively express transcription factor sp1": 0.01144, "inflammatory synovitis": 0.00471, "cbf beta require binding": 0.00927, "provide": 0.0129, "ht86": 0.00012, "cell-free synthesized hgr": 0.00054, "non-dividing": 6e-05, "immunoprecipitation study": 0.01355, "b-lymphoid cell line": 0.0512, "oct-1/oaf": 6e-05, "2-hydroxy-4-trifluoromethylbenzoic acid": 0.00856, "activity decrease": 0.02925, "hematopoietic protein-tyrosine phosphatase": 0.00244, "single signal transduction pathway": 0.00817, "nf-at-1": 0.00025, "repress transcription": 0.0281, "bcl-3": 0.00062, "uninduced cell": 0.0768, "reduced ap-1 binding activity": 0.01462, "t-helper cell activation": 0.0512, "competitive reverse transcription-pcr": 0.00157, "full complement": 0.0013, "key element": 0.01672, "specific dexamethasone binding": 0.01237, "select antibody": 0.00893, "destructive mechanism": 0.01058, "activated ln cell": 0.0512, "hyperthyroid": 0.00031, "nk-chi": 6e-05, "bcr": 0.00043, "rap74": 6e-05, "b.pertussis": 0.00012, "porphyromonas gingivalis lipopolysaccharide-stimulated human monocytic cell": 0.0256, "22-bp sequence duplication": 0.01084, "heat shock transcription factor": 0.0143, "prevent target cell uptake": 0.0384, "gene expression require integration": 0.02177, "lethality": 0.00025, "release cytokine": 0.01123, "notch1 transmembrane receptor": 0.01714, "5-day anti-cd3/il-2 activation": 0.02109, "membrane tyrosine phosphatase": 0.00474, "gata-1 require intact dna-binding domain": 0.00526, "selective dna bind": 0.0135, "ataxia telangiectasia": 0.00019, "key transcription factor": 0.01907, "bcd gene expression": 0.02903, "il-1-induced activation": 0.03164, "interferon gamma- induce gene": 0.02177, "immunoreactivity": 0.00056, "hematopoietic-specific dnase": 0.00096, "distal enhancer element": 0.01115, "a-myb responsible": 0.00279, "rheumatoid": 0.00186, "il-4-driven germline": 0.00136, "critical serine phosphorylation site": 0.01084, "demonstrate increased elaboration": 0.01065, "lmo": 0.00043, "proximal cd19 promoter reveal important role": 0.00779, "cis-acting region require": 0.00978, "cell specific expression": 0.0512, "purine-rich cd3r element": 0.01115, "t1/2": 0.00043, "extensive alternative splicing": 0.00136, "initial reduction": 0.00295, "mononuclear": 0.00608, "preclinical": 0.00056, "22-kda c-terminal sp1 protein fragment": 0.01811, "human c/ebp-epsilon protein exhibit strong": 0.01811, "increase c-myb expression": 0.02775, "simian virus": 0.00887, "june": 0.0, "poz-mediated protein interaction": 0.03019, "comedo": 0.0005, "airway inflammation associate": 0.00728, "ets transcription factor regulate": 0.0143, "resection margin": 0.00028, "proteasome activation": 0.03164, "v/v": 0.0, "colony assay": 0.01002, "important immunoregulatory hormone": 0.00459, "whole-cell competitive binding radioassay": 0.00927, "transduction pathway lead": 0.00852, "rvlp": 6e-05, "peculiarity": 6e-05, "form stable complex": 0.01123, "provide initial evidence link abnormal behavior": 0.00215, "cre-cat plasmide show": 0.01733, "okadaic acid increase": 0.01464, "leiomyoma": 0.00019, "retinoic acid-responsive element-containing promoter": 0.01168, "block development": 0.01073, "rigid": 0.0, "heterologous activation domain": 0.02109, "and/or specific compound test": 0.00619, "hypotension": 0.00012, "transactivators encode": 0.00853, "clinic population suggest": 0.01348, "fluorescence hplc show": 0.01733, "phosphatidylinositol": 0.00118, "kim": 0.0, "cd40 ligation lead": 0.00664, "severe": 0.00422, "lps-inducible factor nf-kappa": 0.01907, "basal transcription complex": 0.01873, "consecutive sample": 0.00208, "notch1": 0.00056, "initiator-like sequence present": 0.01084, "potent oncogene": 0.00357, "reactive oxygen specie": 0.00141, "inhibit tcr-induced fasl": 0.0127, "ags patient associate": 0.0111, "heat activation step promote dna binding": 0.01055, "affinity property": 0.00397, "major functional importance": 0.00544, "hiv-hd phenotype": 0.00366, "tumor necrosis factor alpha activation": 0.01266, "cd44 induction": 0.01607, "adult respiratory distress syndrome": 0.00211, "-206": 0.00012, "element regulate il-4 gene expression": 0.01742, "express octamer-binding factor": 0.01907, "tcr alpha enhancer complex": 0.00842, "hel cell": 0.0768, "subsequent interferon alpha treatment": 0.00585, "block nf-kappab-dna binding": 0.01237, "primary human bone marrow culture": 0.01505, "thalassaemia major patient": 0.0111, "c3/5 clone": 0.00738, "human allergen-specific th2 cell": 0.0384, "ifna-producing cell": 0.0768, "modified ltrs": 0.00074, "bcl-6": 0.00354, "gamma-1": 6e-05, "cell commitment": 0.0768, "proto-oncogene response": 0.01942, "stat3-independent signal": 0.01635, "il-4 treatment": 0.01014, "far-upstream alpha-globin enhancer": 0.00606, "stimuli-specific pathway": 0.01278, "flurbiprofen": 0.00012, "similar elevation": 0.00673, "immunophilin fkbp51": 0.0004, "il-6 gene expression": 0.02903, "sedentary subject": 0.00354, "il-13r": 0.00112, "induce tumor": 0.0254, "350/microliters": 6e-05, "receptor gene scya3r": 0.02903, "plasma testosterone": 0.00375, "tgf-beta 1-mediated modulation": 0.00172, "immunomodulatory": 0.00112, "clonal development": 0.00633, "mouse gm-csf promoter": 0.01557, "stat5b": 0.00118, "human allergen-specific": 0.03762, "cathepsin g-initiated platelet aggregation": 0.00186, "t-lymphocyte cell": 0.0768, "broad mantle zone": 0.00023, "promote basal htlv-i transcription": 0.01405, "nfkappab translocate": 0.00189, "increased tyrosine phosphorylation": 0.00656, "cancer include chronic myeloid leukaemia": 0.00576, "mutant ciita construct show": 0.013, "azelastine hydrochloride": 0.00025, "immunoaffinity": 6e-05, "inactive metabolite tetrahydrocortisol": 0.00108, "consensus binding sequence": 0.01237, "female steroid hormone estrogen": 0.00222, "tumour suppressor gene": 0.02903, "pml-rar": 0.00143, "specific": 0.02475, "b104 cell death": 0.0512, "tgf": 0.00043, "expression level induce": 0.02775, "proline/serine/threonine-rich domain": 0.01207, "p21rex": 6e-05, "murine cdna probe": 0.00416, "tal-1 transgenic animal": 0.00132, "il-4 activated signal transducer": 0.00817, "pancreatic endocrine beta-cells share identical pan/e2a complex": 0.00481, "anti-inflammatory drug sodium salicylate": 0.00169, "human primary t-lymphocytes": 0.02508, "myd": 0.00012, "primary breast cancer sample": 0.00369, "tai": 0.00012, "regulate tyrosine phosphorylation event": 0.00627, "co-immunoprecipitation analysis": 0.01179, "ifn-beta mrna": 0.01526, "nongenomic response": 0.01942, "k562 cell line": 0.0512, "human platelet lysates": 0.02508, "tyrosine kinase tyk2": 0.00792, "stat nuclear factor": 0.01907, "peptide mapping": 0.00754, "dn": 0.00056, "transcriptional activity": 0.02925, "non-b-cell line show nf-kappa": 0.013, "e1a gene product": 0.02903, "important cross-talk mechanism": 0.00705, "sre/carg motif": 0.00875, "m-csf activates": 0.0018, "cytochrome b558": 0.00037, "tnfalpha decrease": 0.00971, "gut-associated lymphoid organ": 0.00273, "preincubated": 0.00056, "icam-1 surface protein": 0.03019, "radiolabeled chemical probe": 0.00174, "significant implication": 0.00416, "pertussis toxin": 0.00053, "purified human colony form unit-erythroid cell": 0.0256, "immunosuppressive property": 0.00397, "hhv-8+/ebv- pel": 0.0004, "physiologic concentration": 0.0067, "transactivation capacity": 0.00515, "conalbumin promoter": 0.02336, "rapid mutational analysis": 0.00786, "retinoblastoma prb": 0.00136, "position nfat": 0.00431, "oncogenic ra": 0.00596, "branchial myoblasts": 6e-05, "mutated virus": 0.00887, "suffices": 6e-05, "two-dimensional electrophoretic analysis": 0.00786, "endotoxin-mediated induction": 0.01607, "caii-specific erba-binding site": 0.01445, "38,000-m": 0.0, "nonactivated": 0.00012, "subsequent cell activation": 0.0512, "patient experience long-term disease-free survival": 0.00666, "nonspecific protein kinase inhibition inhibit nf-kappab activation": 0.01294, "suppress nf-kappab expression": 0.02775, "mrnas encode gata-1": 0.00569, "extrarenal": 0.00031, "l. pneumophila rpos increase": 0.01098, "sp bind motif": 0.0135, "125i-labeled c-c chemokines": 0.00037, "ifn-gamma synthesized": 0.00481, "essential site": 0.02168, "dna sequence analysis": 0.01084, "radiolabeled immunoglobulin heavy chain germline epsilon promotor sequence": 0.00406, "b-cell-specific transcription factor pu.1/spi-1": 0.0143, "g28-5": 0.00043, "xist gene": 0.04355, "pi3-kinase": 0.00031, "nt -1609": 0.00034, "cv-1 cell": 0.0768, "dr alpha gene": 0.02903, "inhibitory action": 0.00499, "corticosteroid receptor function": 0.01714, "polyanionic glycosaminoglycan": 9e-05, "caspase-3 substrate poly": 0.00132, "gata-1 gene": 0.04355, "ra-dependent differentiation": 0.01179, "gene express 'late": 0.02903, "body mass": 0.00136, "-dependent program": 0.00171, "il-2rgamma": 6e-05, "anti-vcam antibody": 0.00893, "neoplastic follicle": 0.0009, "cell act": 0.0768, "gata-1 autoregulatory enhancer": 0.00606, "bind elf-1": 0.02025, "inducible transcriptional activator": 0.00767, "current work describe": 0.00265, "fos/jun protein": 0.04529, "gene display": 0.04355, "antisense expression construct": 0.02775, "rflp": 0.00031, "s. kenney": 0.00065, "linear correlation": 0.00248, "lymphocyte glucocorticoid receptor": 0.01714, "dominant negative atra receptor": 0.01286, "vitd3 response element": 0.01294, "nucleotide -46": 0.00202, "nf-kappab bound": 0.00999, "ifn-u937 cell": 0.0768, "hla dqb1*0201": 0.00192, "endogenous ap-1 regulate gene": 0.02177, "nuclear t3r alteration": 0.01123, "potential immunogenicity": 0.00605, "bind site-specific transcriptional property": 0.01013, "class ii non-inducible rb-defective tumor line": 0.00551, "single-chain protein": 0.04529, "untreated euthymic": 0.00115, "nh2-terminal": 0.00099, "92-bp cd11b promoter": 0.01557, "cell membrane fraction": 0.0512, "fk506 prevents dephosphorylation": 0.00099, "reporter transgenic mouse": 0.00649, "baf3 cell": 0.0768, "progesterone induction": 0.01607, "jagged1 transcript": 0.00599, "hypercortisolaemia": 0.00037, "agonist induces terminal granulocytic differentiation": 0.00471, "immature cell": 0.0768, "marked decrease": 0.00971, "environmental factor": 0.0286, "zebra domain": 0.01207, "maximal thymidine incorporation": 0.00122, "usa-derived component": 0.00456, "transient cotransfection show": 0.01733, "acute lymphoblastic leukemia": 0.00333, "htb": 0.00037, "phenotype induce": 0.0254, "code": 0.00019, "equipotent": 0.00012, "cell costimulatory molecule": 0.0512, "nuclear oncogene c-fos": 0.01123, "cyclic amp response element-binding protein nuclear complex": 0.01294, "il-6-type cytokine receptor": 0.01714, "tpo-treated ut-7/gmt cell": 0.0512, "b-1 lymphocyte constitutively express nuclear activate stat3": 0.00527, "vitamin d-mediated gene regulation": 0.02177, "immunomodulatory activity": 0.02925, "asymptomatic family member": 0.0056, "pebp2 alpha/aml-1 family": 0.0056, "kilobase pair": 0.00214, "common growth factor": 0.01907, "coproporphyrinogen oxidase gene": 0.02903, "increase": 0.04392, "e2f-1 binding protein": 0.03019, "b-cell-specific eb1-responsive element": 0.01115, "cell development": 0.0768, "negative regulatory region responsive": 0.00734, "nf-kappa b/rel complex": 0.01123, "cell suicide": 0.0768, "autocrine activation": 0.03164, "acute myeloid leukemic": 0.00308, "c-fos-positive lymphocyte": 0.01483, "system describe": 0.00667, "structural": 0.0036, "constitutively express nuclear protein": 0.02264, "-193": 0.00012, "1753-bp fragment": 0.00347, "extensive footprint": 0.00118, "anthracycline-induced differentiation": 0.01179, "phorbol ester-inducible transcription factor ap1": 0.01144, "human interleukin-1beta gene": 0.02903, "nonhematopoietic cell type": 0.0512, "mbc": 0.0005, "regulate monocyte-specific transcription": 0.01873, "tsg101": 0.00056, "low-ionic-strength condition": 0.0036, "inhibit lps-induced tf": 0.0127, "induce interleukin-1 beta": 0.01694, "ifn-gammaralpha chain": 0.00437, "transgenic mouse spleen": 0.00649, "neutralizing anti-il-6 ab": 0.00112, "serca activity": 0.02925, "cd45r0 cd4+": 0.00288, "lif increase steady-state level": 0.01098, "tshr": 0.00068, "activate function": 0.01777, "wildtype aes sequence": 0.01084, "tissue-specific mechanism": 0.01058, "obese patient": 0.01666, "induce transient increase": 0.01694, "stable benzoic derivative": 0.00128, "suggest up-regulation": 0.02022, "hiv-1 enhancer": 0.00909, "continuous nuclear expression": 0.02775, "fosb gene suggest": 0.02903, "healthy pregnant woman": 0.00155, "antioxidant": 0.00502, "oxldl activate p50/p65": 0.01185, "low level expression": 0.02775, "phenotypic effect": 0.02115, "detect gangliosides": 0.00726, "lymphocyte infiltration": 0.01483, "bh3": 6e-05, "inducible protein/dna interaction": 0.00658, "peroxyl radical scavenging": 0.00039, "t-cell antigen receptor function": 0.01286, "ifns induce": 0.0254, "interleukin-4-induced tyrosine phosphorylation": 0.00656, "p95vav activity": 0.02925, "pp70s6k activation": 0.03164, "memory": 0.00267, "reporter gene expression": 0.02903, "icam-1": 0.00533, "messenger response generate": 0.01294, "nf-kappa b-activating cytokine tumor necrosis factor alpha": 0.00817, "guanine nucleotide exchange factor": 0.0143, "keratinocytes": 0.0005, "inhibitor": 0.01799, "putative pu.1 binding site": 0.01084, "813-bp open reading frame": 0.00036, "possess distinct intrinsic dna bind affinity": 0.00675, "fitc-lps": 6e-05, "nf-kappab transcription factor family": 0.0143, "kappab-dependent transcriptional activity": 0.0195, "dominant cytotoxic": 0.00245, "viral lytic cycle promoter": 0.01168, "hypermethylation-associated silencing": 0.00037, "block formation": 0.01073, "vla-5 receptor": 0.02571, "dna damage agent": 0.00988, "gp91phox gene expression": 0.02903, "supershift experiment": 0.00397, "camp-response-element-binding protein": 0.04529, "fivefold increase formation": 0.01464, "basal transcription factor tfiih": 0.0143, "immature cem": 0.00161, "induced dra expression": 0.02775, "autologous peripheral blood stem cell transplantation": 0.0256, "cytoplasmic level": 0.01821, "post-dexamethasone": 0.00012, "facilitate antigen process": 0.00546, "human c/ebp epsilon": 0.02508, "hla-dra": 0.00143, "corticosteroid suppression": 0.00416, "cell-specific factor": 0.0286, "unidentified fc gamma ri gas dna-binding protein": 0.01294, "bone marrow-derived erythroid progenitor cell": 0.03072, "irf-1-dependent": 6e-05, "vitro fibroblast binding": 0.01237, "chronic inflammatory-type condition": 0.00265, "n-terminal portion": 0.00202, "men": 0.00062, "il-16": 0.00062, "cellular activation associate": 0.02109, "study cohort": 0.01355, "mad3/i kappa": 0.00748, "tap": 0.00025, "-317/-288": 6e-05, "widespread expression": 0.04163, "cd40-cd40l interaction": 0.00986, "enhance activation": 0.03164, "tyrosine": 0.01421, "preformed nf-at complex": 0.01123, "mitogen-activated rel-/-": 0.00112, "ebna-2-positive cell extract": 0.0512, "ehrlichiosis": 0.00019, "cfu-gemm/ bfu-e/cfu-m shift": 0.00122, "genistein": 0.00136, "rar-selective antagonist": 0.00242, "p75 tnf receptor": 0.01714, "-230": 0.00025, "study regulatory region": 0.00978, "arterial intima beneath stress ec": 0.00124, "pma+pha-inducible ifn-gamma transcription": 0.01873, "xq28 region": 0.01467, "human thromboxane receptor gene": 0.02177, "selectively regulate tyk2": 0.00835, "clonal": 0.00335, "h2.0": 6e-05, "bind site demonstrate": 0.01445, "leukemia inhibitory factor": 0.01907, "th2 effector function": 0.00887, "exogenous gene": 0.04355, "heterologous lp": 0.00354, "scm-1 gene": 0.04355, "acute t-cell malignancy term adult t-cell leukemia": 0.00143, "dna replication": 0.01483, "mhc class ii expression": 0.02081, "pre-i binding factor pos-1": 0.0143, "hb9 homeodomain": 0.00043, "cd38": 0.00099, "human interleukin-6": 0.03762, "cd3-epsilon expression": 0.04163, "tcr zeta chain": 0.00318, "cell surface igm": 0.0512, "il-2-mediated": 0.00056, "super-induced": 0.00012, "complementation": 0.00062, "b-": 0.00099, "divided regimen": 0.00031, "cooperate": 0.00236, "pkc-dependent pathway": 0.01278, "demonstrate sp1": 0.01597, "3,4-dichloroisocoumarin": 6e-05, "altered cell cycle regulation": 0.0384, "important pathway lead": 0.00852, "numerous inflammatory gene": 0.02903, "activate nuclear factor-kappa": 0.01185, "kappab-sp1 concatamers": 0.00016, "host defense mechanism trigger": 0.00529, "model effective versus ineffective cd3-mediated stimulation": 0.00373, "regulate nf-kappa b-mediated gene transcription": 0.01742, "il4r alpha": 0.01169, "naive cd4+": 0.00288, "distinct complex": 0.01684, "hdac-containing repressor complex": 0.01123, "comedo versus noncomedo status": 0.00109, "88.6+/-11.5 pg/ml": 0.00012, "mitogen-activated kinase": 0.01188, "cooperative effect": 0.02115, "leukemic cell": 0.0768, "synthetic thrombin receptor agonist peptide": 0.01029, "nongenomic activity": 0.02925, "cyclic adenosine monophosphate": 0.00099, "biochemical event induce": 0.01694, "irf-2 gene": 0.04355, "gch": 0.00037, "labial minor salivary gland biopsy": 0.00035, "complex network": 0.01684, "non-b cell": 0.0768, "exception": 0.00081, "low-potency agonist": 0.0022, "primary cd4+": 0.00738, "-294": 0.0, "mrna splice": 0.01526, "post-pma": 6e-05, "nf-atc enters": 0.00099, "hormone receptor status": 0.01714, "decrease lps-mediated tf expression": 0.02081, "chemical structure": 0.00319, "tpa-induced activation": 0.03164, "nf-kappa b. calcineurin act": 0.00707, "bzlf1-reactive component": 0.00456, "drive luciferase expression": 0.02775, "mediator": 0.00391, "-5-": 0.00012, "upstream decidual/lymphoid": 0.00369, "differential interaction": 0.00986, "rfx1 act": 0.00496, "erythroid-specific property": 0.00397, "p65s": 0.0, "human cdna fuse": 0.02508, "gata box": 0.00304, "cell ig production": 0.0512, "intracellular deletion variant": 0.00389, "lck-deficient cell line": 0.0512, "cytokine therapy": 0.01123, "represent difference": 0.00425, "latency ii": 0.00726, "mouse carry genetic defect": 0.00487, "bind complex": 0.02025, "enzymatic activity": 0.02925, "met": 6e-05, "sla-dq induction": 0.01607, "tcrg": 0.00031, "heterodimer p50/p65": 0.00205, "wgatar consensus motif": 0.00583, "current protocol": 0.00084, "exposed individual": 0.00409, "mediate murine thymocyte apoptosis": 0.00616, "bacterial vaginosis": 0.00223, "multiple transcription factor": 0.01907, "osteocalcine": 0.00012, "intact element": 0.01672, "space nearby sit": 0.00095, "adrenergic disease": 0.00673, "tgf-beta decrease": 0.00971, "study detect": 0.01355, "ileostomized patient": 0.01666, "50-kda hlp-1 protein": 0.03019, "dramatic inhibition": 0.01061, "bruton": 0.00012, "v-": 0.00012, "24-58 month": 0.00068, "late expression pattern": 0.02775, "acute phase response": 0.01294, "mature normal human myeloid cell": 0.03072, "pfp5a": 0.00025, "surface domain": 0.01207, "mhc class ii transcription": 0.01405, "bacterial protein icsa bind n-wasp": 0.01811, "role upstream": 0.01328, "steroid-receptor complex": 0.01684, "trinucleotide repeat expansion": 0.00252, "natural immunoglobulin promoter": 0.01557, "nuclear protein capable": 0.03019, "onset": 0.00143, "direct correlation": 0.0054, "pathogen shigella flexneri": 0.00027, "and/or sp1 bind site": 0.01084, "il-4 receptor alpha-chain cytoplasmic domain": 0.01029, "sustained increase": 0.02196, "kb telomeric": 0.0014, "residue": 0.00453, "time dependent": 0.00388, "aa fail": 0.00347, "cytoplasmic ikappabalpha level": 0.01214, "il-1 beta mrna appearance": 0.00763, "cd28 activation": 0.03164, "vaccine design": 0.0009, "nf-at cdna": 0.00456, "cytokine pathway result": 0.01073, "human activation antigen cd69": 0.01881, "topical fluticasone propionate": 0.00023, "relevant epitope": 0.00161, "dfc": 0.00012, "thymus stromal cell": 0.0512, "primary defect": 0.00738, "lymphocyte glucocorticoid receptor bind parameter": 0.01029, "mast cell lineage": 0.0512, "immature b-cell line": 0.01102, "hlf": 0.00112, "selective regulation": 0.01008, "quiescent peripheral blood mononuclear cell": 0.03072, "encode tumour necrosis factor": 0.0143, "beta-globin promoter interact": 0.01557, "breast cancer population": 0.00205, "azt affect nf-kappa": 0.00943, "kappa b-4": 0.00748, "upstream": 0.00738, "frequent infection": 0.0062, "tumour load": 0.00183, "palindromic thyroid hormone responsive element aggtcatgacct": 0.00557, "chronic bronchitis subject": 0.00265, "inducible nf-at complex": 0.01123, "protein kinase a-independent": 0.03019, "induce c-rel": 0.0254, "natural killer gene complex": 0.02177, "gene induction": 0.04355, "adhesion assay": 0.01002, "affect apoptosis": 0.0089, "des-arg form": 0.01055, "manner similar": 0.00673, "inhibit il-2r alpha": 0.0127, "il-10 activate stat1": 0.01185, "effect similar": 0.02115, "il-10 pre-treatment": 0.00422, "membrane-related rapid response": 0.01294, "e3330": 0.00074, "mechanical ventilation": 0.00034, "garfein": 0.00012, "cell activation event": 0.0512, "nk-": 0.00025, "mtcp1": 0.00056, "endothelial production": 0.01042, "putative peptide contact site": 0.01084, "p38 mapk activation remain": 0.01582, "cell form large 14-day colony": 0.03072, "syk/zap-70-family kinase": 0.01188, "genetic lesion": 0.00288, "mediate program cell death": 0.0384, "unrearranged ch gene": 0.02903, "mutant tnfri suggest": 0.01348, "restricted fashion": 0.00161, "ifn-gamma enhance": 0.00974, "hela nuclear extract": 0.01123, "severe secondary hyperaldosteronism": 0.00141, "oca-b": 0.00199, "inherited hla-dq haplotype": 0.00052, "cd40 receptor": 0.02571, "tobacco smoke": 0.00019, "infant brother": 0.00022, "unavailable": 6e-05, "tracking": 6e-05, "charge phospholipid surface enhance": 0.00487, "sarcoidosis patient": 0.01666, "leukocyte infiltration": 0.00478, "develop skin lesion": 0.00269, "ebv-transformed": 0.00099, "prime importance": 0.0013, "m1": 0.00037, "probe include sequence": 0.01084, "cell-mediated immunity play": 0.00474, "cell-specific interaction": 0.00986, "cadmium": 0.00056, "zebra activation region": 0.02109, "e2f4": 0.00019, "neuronal differentiation": 0.01179, "total mrna": 0.01526, "element bound": 0.01672, "rantes gene expression": 0.02903, "htlv-i infection": 0.0062, "wild-type plasmid": 0.00378, "g1/g0 cell": 0.0768, "develop th1 cell require il-12 signal": 0.0256, "hla-a2-restricted": 6e-05, "science ireland": 0.00019, "x1 box-specific activity": 0.0195, "functional change": 0.00816, "concentration report": 0.0067, "raralpha translocates": 0.00025, "multiple vzv peptide": 0.00502, "tumor ag": 0.00934, "vcam-1 promoter": 0.02336, "intravascular coagulation": 0.00031, "core promoter region": 0.01557, "sp-1 consensus sequence": 0.01084, "serum level": 0.01821, "gamma activation site": 0.02109, "unlabeled": 0.00093, "mtetra-induced il-1 beta": 0.00449, "heterodimeric form": 0.01055, "determine clonality": 0.00779, "scavenger": 0.00087, "causal relationship exist": 0.00105, "viral trans-activators": 0.00732, "major immediate-early protein ie1": 0.02264, "195-kd protein": 0.04529, "dna homology": 0.01483, "additional dna segment": 0.00988, "estrogenic response": 0.01942, "regulate adhesion": 0.01253, "intact nf-kappab binding sequence": 0.00927, "consistent cytogenetic": 0.00205, "disuse": 6e-05, "cross-linking result": 0.0161, "vivo therapy": 0.0053, "hoci": 0.0, "short isoform": 0.00171, "de novo retinoid resistance": 0.00163, "hla-dra mrna synthesis": 0.01017, "high titre antibody": 0.0062, "confers responsiveness": 0.00323, "phenotypic change": 0.0063, "increase nf-kappab binding activity": 0.01462, "tax co-transfected": 0.00478, "block induction": 0.01607, "pbl constitutively express c-jun transcript": 0.00738, "phorbol myristate acetate-mediated activation": 0.01582, "multiple lymphokine deficiency": 0.00459, "sodium diclofenac": 0.00186, "viral inducer": 0.00732, "sre motif": 0.00875, "systematic approach": 0.00164, "trans-acting activator function regulate": 0.00665, "mutant defective": 0.0081, "non-smokers": 0.0, "stable complex": 0.01684, "monocyte/macrophages": 0.00012, "peripheral mixed leucocyte": 0.00349, "optimal viral transcription": 0.01873, "nontranslated region": 0.01467, "cellular glucocorticoid receptor": 0.01714, "dna affinity precipitation assay": 0.00741, "steroid hormone receptor": 0.01714, "prognostic marker": 0.00382, "support human immunodeficiency virus": 0.01881, "large region": 0.01467, "splice alternative": 0.00205, "superantigens occur": 0.00654, "leukemia": 0.00999, "transcriptional trans-activator": 0.01151, "promoter activity": 0.02925, "support cellular proliferation": 0.00596, "m.m.": 0.00012, "potential nuclear factor": 0.01907, "atf-2 protein": 0.04529, "ebv immediate-early gene transcript": 0.02177, "active ingredient mediate": 0.00821, "repress erythroid differentiation": 0.00786, "peptide binding interaction": 0.01237, "p65": 0.00775, "tumor size": 0.00934, "transcriptional stimulatory activity": 0.0195, "structure/function analysis": 0.01179, "x-scid patient": 0.01666, "signal transduction pathway activate": 0.00889, "recombinant adeno-associated virus": 0.00591, "tsh-r transcript level": 0.01214, "endogenous nf-kappa b1 gene expression": 0.01742, "monocyte-binding receptor": 0.02571, "nf-kappab binding activity": 0.0195, "hnf-3alpha": 0.00025, "culture h-rs cell": 0.0512, "accurate model": 0.00422, "pp65 phosphoprotein": 0.00053, "differentiation induction system": 0.01071, "quantitation": 0.00025, "affected promoter activity": 0.0195, "involution": 0.00025, "protease": 0.00354, "ltr size variant": 0.00207, "primary nk cell": 0.0512, "putative nuclear target sequence": 0.00842, "human gamma-herpesvirus": 0.03762, "sensitive structure": 0.00319, "lipid moiety": 0.00124, "cem-3r43": 6e-05, "plasma sialyltransferase level": 0.01214, "lymphoid-specific oct-2a protein": 0.03019, "-induced change": 0.0063, "glucocorticoid receptor abnormality": 0.01714, "coactivator creb bind protein/p300": 0.01013, "repress th1 development distinct": 0.00349, "receptor level": 0.02571, "syk-family tyrosine kinase": 0.00792, "fmol t3/100 microgram dna": 0.00741, "specific promoter motif": 0.01557, "il-6 response element": 0.01294, "virus expression": 0.04163, "affect nf-kappa": 0.01414, "nuclear oncoproteins": 0.01684, "tyrosine kinase": 0.01188, "melana/mart-1-specific ctl clone": 0.00492, "dhea receptor": 0.02571, "epidemic": 0.0, "mzf protein": 0.04529, "block nfat activation": 0.02109, "il-6-induced cell resemble plasma cell": 0.01536, "immunocytochemical analysis": 0.01179, "major transcriptional initiation site": 0.01084, "dfx treatment limit": 0.00676, "bha block il-2-induced pbmc proliferation": 0.00429, "fos-b expression vector": 0.02775, "cd3 antigen-": 0.00161, "megakaryocytic-specific gene": 0.04355, "anti-ig response element": 0.01294, "faster mobility form": 0.00703, "hla-dr typing": 0.00124, "erythroid-specific gata-1 transcription factor gene": 0.01742, "cd28 require reactive oxygen production": 0.00526, "nf-kappab2 p52": 0.00047, "amino acid 1-421": 0.00571, "binding complex": 0.01855, "thp1": 0.00012, "primary human cd4+": 0.02508, "agataa": 6e-05, "lymphoma model": 0.00422, "human t-cell line": 0.02508, "targeted agent suggest": 0.01348, "redox imbalance": 0.00121, "megakaryocytic phenotype": 0.00366, "native": 0.00298, "human fibronectin receptor": 0.02508, "metamorphosis": 6e-05, "c-fms gene": 0.04355, "human eosinophil": 0.03762, "cd3 delta epsilon gamma": 0.0022, "ebna-5": 0.00031, "increase accessibility": 0.02196, "g.klein": 6e-05, "positive regulatory domain i-binding factor-1": 0.00483, "apoptotic vsmcs posse": 0.00126, "facilitate tumor growth": 0.00622, "block il-10 mediated c-fos expression": 0.01665, "pedigree": 0.0, "monocytic thp-1 cell line increase": 0.03072, "remixing": 6e-05, "tissue-specific primary transcriptional response": 0.00971, "self-antigens": 0.00012, "acidic ph": 0.00109, "cysteamine": 0.00056, "p60 protein express": 0.03019, "granulocyte suggests": 0.00254, "hs-40": 0.00105, "complex transcriptional regulation": 0.01123, "primary tumour": 0.00738, "akv mlv transcription": 0.01873, "micromol/": 6e-05, "6-24": 6e-05, "free radical scavenger": 0.00085, "healthy human volunteer": 0.02508, "anti-cd28-treated rel-/-": 0.00028, "dramatic reduction": 0.00295, "stat5 mrna": 0.01526, "cytokine-induced periodontal tissue damage": 0.00332, "il-12/10": 6e-05, "autologous de lcl": 0.00105, "negative transcriptional regulation": 0.00767, "negative regulatory event": 0.00455, "mononuclear leukocyte glucocorticoid receptor bind characteristic": 0.00857, "basal-level activity": 0.02925, "signal defect": 0.01635, "erythroid-specific repression": 0.00211, "suppress cellular infiltration": 0.00596, "cd3-negative variant": 0.00276, "molecular mechanism underlie selective expression": 0.01665, "proteolysis-resistant nuclear factor-kappab inhibitor": 0.00842, "infected u937 cell": 0.0512, "normal program": 0.0121, "mixed lymphocyte reaction": 0.00988, "1-1.5 mg/day": 6e-05, "l227 induce": 0.0254, "situ hybridization technique": 0.00103, "critical signaling pathway": 0.00852, "human thymus": 0.03762, "high cat activity": 0.0195, "e1a gene": 0.04355, "phosphoinositide 3-kinase": 0.00109, "human cell": 0.0768, "orf1 consist": 0.00183, "mm-ldl": 0.00043, "understood apoptotic pathway occur": 0.00639, "hgata-4": 0.00037, "active negative regulatory process occurs": 0.00273, "endosomal/lysosomal system": 0.00667, "k562 human erythroleukemia cell": 0.0384, "mopc": 0.00012, "high-density lipoprotein": 0.00118, "ebna promoter": 0.02336, "data suggest ap-1 regulated cytokine mrna expression": 0.01189, "great number": 0.0053, "mutated ikappabalpha molecule": 0.00569, "glucocorticoid inhibit signal downstream": 0.00952, "selectively abrogate": 0.00292, "acute myelogenous leukaemia": 0.00246, "regulatory system": 0.00682, "intracellular biochemical event": 0.00389, "intact beta interferon promoter": 0.01168, "kb fasl promoter respond": 0.01168, "underlined": 6e-05, "acute hepatitis": 0.00369, "ckii site": 0.02168, "mimic p21ras": 0.00174, "tar-deleted mutant": 0.0081, "cd3 receptor cross-linking": 0.01714, "messenger rna production": 0.00695, "signal resulting": 0.01635, "immunoregulatory property": 0.00397, "-96 sequence": 0.01625, "full length c-jun promoter": 0.01168, "original al1 virus stock": 0.00444, "receptor-dependent mechanism": 0.01058, "proteasome activity result": 0.0195, "zb-4": 0.00012, "icam-1 gene": 0.04355, "opening": 0.00012, "gas element eliminate responsiveness": 0.00836, "rapid expansion": 0.00323, "deficiency syndrome": 0.00273, "crucial g1 checkpoint": 0.00081, "protein antigen": 0.04529, "high mobility group protein": 0.02264, "nf-kappa b/rel site": 0.01445, "suboptimal concentration": 0.0067, "leukaemic change": 0.0063, "allergic disease": 0.00673, "vitro binding": 0.01855, "stimulate 3h-tdr incorporation": 0.00734, "monocyte stimulus lipopolysaccharide": 0.00798, "single cytokine receptor": 0.01714, "activate nuclear factor": 0.01907, "multiple event": 0.00689, "defensin": 0.00043, "zn sod": 0.00025, "facs": 0.00019, "adjacent cyclic amp response element": 0.00777, "cam kinase family": 0.00792, "nf-kappa b-controlled cytokine promoter": 0.01168, "jun play": 0.0071, "clonogenesis": 6e-05, "allogeneic mixed lymphocyte culture": 0.00741, "inhibit anti-cd3-induced shift": 0.0127, "viral protease": 0.00732, "reconcile": 0.00025, "human pro-interleukin": 0.03762, "hemin-induced dna binding activity": 0.01462, "immunoreceptor tyrosine-based inhibition motif": 0.0053, "phorbol ester-": 0.00543, "aldosteronism": 6e-05, "resemble mutant form": 0.00703, "protein kinase c-activating phorbol ester": 0.01811, "activation remain unknown": 0.02109, "sodium dodecyl sulfate-polyacrylamide gel electrophoresis show significant aldosterone binding": 0.00578, "rejection": 0.00093, "isoforms": 0.00614, "alter cell phenotype": 0.0512, "t-cell antigen receptor element": 0.01286, "powerful inducer": 0.00136, "concomitant decrease": 0.00971, "raldh2 gene": 0.04355, "complex change": 0.01684, "important part": 0.00689, "zre-b": 0.00012, "normal pregnant woman": 0.00806, "regulate nuclear processing": 0.01123, "dephosphorylated nf-at1": 0.00056, "concanavalin-a": 0.00012, "dendritic cell-t-cell syncytium": 0.00058, "tumor necrosis factor alpha release": 0.01144, "sterol-vdr complex": 0.01684, "pp": 0.00025, "deduced": 0.00025, "pebp2betamyh11 fusion": 0.00326, "hiv-2 transactivator gene": 0.02903, "cytoplasm": 0.00124, "constitutive tnf mrna expression": 0.02081, "human p75tnf-r": 0.03762, "dna stain": 0.01483, "-associated death domain protein tradd": 0.01811, "phosphorylation-dependent": 0.00031, "azeptin result": 0.0161, "human t-cell clone stimulate": 0.01881, "striking concordance": 0.00031, "clone tcf-1": 0.00738, "mitogen activation": 0.03164, "ebv latency reside": 0.00376, "character": 0.00012, "e1a": 0.00496, "cis-acting negative regulatory element": 0.00836, "chinese medicine": 0.00047, "measure glucocorticoid receptor": 0.01714, "pathway complement": 0.01278, "mhc/peptide density requirement": 0.00176, "nf-y driven promoter": 0.01557, "c-raf-1": 0.00019, "p38-catalysed phosphorylation": 0.00983, "adenoviral group": 0.00487, "spirochetal lipoprotein": 0.00118, "underlie immune hyporesponsiveness": 0.00399, "cm": 0.00019, "transformed human lymphocyte line": 0.01881, "ctl-specific expression": 0.04163, "inter-relationship": 6e-05, "deg5": 6e-05, "unique domain": 0.01207, "compartment": 0.00174, "sigma ligand": 0.00592, "activated p21ras": 0.00589, "constitutively phosphorylated": 0.00406, "anti-igm lead": 0.00996, "mammography": 0.00012, "calcineurin carry": 0.00316, "express factor": 0.0286, "mnda-expressing cell": 0.0768, "down-modulate": 0.00025, "nf-kappa b/rel protein": 0.03019, "il-2 mrna induction": 0.01071, "kappab epsilon": 0.00164, "t-cell clonal expansion show": 0.013, "anti-cd28 ab result": 0.01073, "class iii gene transcription factor tfiiib": 0.01452, "comparative study show": 0.01733, "aldosterone level": 0.01821, "elisa test": 0.00487, "inhibitory concentration": 0.0067, "nuclear relb translocation": 0.01123, "infiltrates": 0.00056, "platelet low-affinity igg receptor": 0.01286, "facilitate entry": 0.00199, "ad5 e1a gene": 0.02903, "proximal signal transduction event": 0.00817, "subsequent monocytic cell adhesion": 0.0384, "prevent gc-induced cell death": 0.0384, "direct repeat separate": 0.0036, "sry protein": 0.04529, "common t-cell mitogen": 0.00641, "butyric acid increase": 0.01464, "asa lead": 0.00996, "terminus": 0.00143, "ester derivative": 0.00202, "combined vaccine": 0.00099, "delta-globin gene": 0.04355, "glial cell line": 0.0512, "il-2/ifn alpha-based treatment": 0.00676, "insulin": 0.00217, "concentration readily": 0.0067, "stimulate transcription": 0.0281, "chromosome inactivation pattern": 0.00366, "bcl-6 5'-noncoding region": 0.00978, "neonatal lymphocyte": 0.01483, "liver-enriched transcription factor result": 0.0143, "52-year-old male present": 0.0049, "potential amphipatic alpha-helical protein segment": 0.01811, "morphological analysis demonstrate": 0.01065, "resistant mechanism": 0.01058, "human gamma-globin chain": 0.02508, "nef protein": 0.04529, "induce nfat": 0.0254, "chromosome study": 0.01355, "cell leukemia virus type": 0.0384, "potent repressor": 0.00357, "interleukin-2 promoter": 0.02336, "inhibitor-kappab alpha": 0.01169, "hsf2-alpha": 0.0005, "-ggaa-": 6e-05, "beta degradation": 0.00673, "immunophenotypic correlate": 0.00654, "irf-1 reporter construct": 0.00484, "er upstream regulatory region": 0.00734, "inhibit tat-": 0.01904, "divergent expression": 0.04163, "anti-jun": 0.00019, "t-cell acute leukemia": 0.00641, "interleukin-12 expression": 0.04163, "ikappab": 0.00273, "cd4-": 0.00025, "ctg-motif": 0.00012, "two-hybrid system": 0.00667, "abundant production": 0.01042, "memory th2 cell": 0.0512, "phase": 0.00552, "dominant inhibitory ra mutant": 0.00405, "cell area": 0.0768, "c-jun activation": 0.03164, "vitro mutagenized derivative": 0.00523, "normal tnf-alpha activation": 0.02109, "box1 motif abrogate il-9-induced cell proliferation": 0.0256, "b-cell development": 0.00633, "mo result": 0.0161, "fkbp": 0.00093, "fmol/mg protein": 0.04529, "biological model": 0.00422, "environmental estrogen": 0.00323, "pcos": 0.00012, "antisense oligonucleotides": 0.00183, "match control": 0.01303, "co-transfections": 0.00019, "sequence-specific collinear triplex": 0.0007, "disease pathogenesis": 0.00673, "c- terminal sh2 domain": 0.00603, "tyrosine-phosphorylated": 0.00149, "human red blood cell": 0.0384, "spontaneous lymphocyte proliferation": 0.00988, "c/ebp": 0.00447, "express nfat": 0.01846, "co-ordinate fashion": 0.00161, "observed": 0.00124, "binding medium": 0.01855, "main nf-kappab-binding site": 0.01445, "atra inducible": 0.00484, "human cdna encode kruppel-type zinc finger domain": 0.01075, "asn240-leu335": 6e-05, "yt-n17": 6e-05, "oxidant production": 0.01042, "human hl60 leukemia cell": 0.0384, "platelet activate factor": 0.01907, "reporter construct": 0.00726, "continuum": 0.00012, "per-arnt-sim": 6e-05, "low level activity": 0.0195, "er gene": 0.04355, "hypothalamic-pituitary-adrenal": 0.00056, "gene encode gamma-globin": 0.02903, "purified protein fraction reveal": 0.02264, "disease-derived": 6e-05, "pre-b cell stage": 0.0512, "bone-resorbing activity": 0.02925, "hemostasis": 6e-05, "b-cell-specific expression": 0.04163, "human umbilical cord": 0.02508, "antiserum direct": 0.0054, "glioblastoma cell line": 0.0512, "cd3-tcr-mediated signal transduction": 0.0109, "result show unequivocal evidence": 0.013, "distinct signal complex": 0.01123, "sequence variation": 0.01625, "pip2": 0.0, "anti-cd2 pathway": 0.01278, "carboxyl-terminal": 0.00105, "nuclear basis": 0.01684, "present study describe": 0.00904, "inclusion": 0.00019, "granulocyte-macrophage colony-stimulating factor mrna level": 0.01144, "cell wall derivative": 0.0512, "glycation-dependent": 6e-05, "oct-2 play": 0.0071, "hemopoietic cell": 0.0768, "flexibility": 6e-05, "tcr-stimulated activation": 0.03164, "splenic": 0.00174, "cultured endothelial cell": 0.0512, "cysteine inhibit": 0.01904, "heterozygous loss-of-function mutation": 0.00395, "trance": 6e-05, "flap": 0.00019, "cellular background": 0.00893, "laz3/bcl6 transcript": 0.00599, "ctll-2/tax": 0.0, "cytosolic compartment": 0.00152, "cd4+ cell": 0.0768, "virus dutpase isolate": 0.00591, "tip function": 0.01331, "total cellular pkc enzymatic activity": 0.0117, "detectable level": 0.01821, "hypokalemia": 0.00012, "inhibit il-4 receptor alpha-chain": 0.01286, "purified quiescent human blood": 0.01881, "distinct mitogen-inducible dna-binding complex": 0.00842, "ea-d promoter activity": 0.0195, "y701": 6e-05, "activate phosphatidylinositol 3-kinase": 0.01185, "kd molecule": 0.00853, "jun-d": 0.00031, "cell express osteoclast marker differentiate": 0.03072, "combat": 0.00025, "protect ag-activated": 0.0014, "oligonucleotide primer flank": 0.0011, "ifn-stimulated response element": 0.01294, "platelet activation": 0.03164, "extracellular cysteine supply": 0.00112, "tcr lead": 0.00996, "cd16 ligand bind involves": 0.01013, "pu.1 activate": 0.01777, "peroxisome proliferator-activated receptor-alpha": 0.00021, "lytic viral dna replication": 0.00741, "rpos gene": 0.04355, "e2a-hlf lead": 0.00996, "antitumor immune response": 0.01294, "unilineage erythroid": 0.0062, "neca": 0.00031, "cytokine activate signal transducer": 0.00889, "iono induce": 0.0254, "q35": 0.0, "induce minimal level": 0.01694, "gluco-": 0.00012, "peptidylprolyl cis-trans isomerase": 0.00027, "phorbol ester result": 0.01073, "cell-matrix interaction": 0.00986, "immunoregulatory hormone": 0.00444, "demarcation membrane": 0.0045, "diminished biological effect": 0.0141, "inhibit edema formation": 0.0127, "phosphate supplementation show": 0.01733, "nuclear translocation protect cell": 0.0384, "1-kb fragment promote high reporter gene activity": 0.01244, "immune complex result": 0.01123, "minimal residual disease": 0.00449, "il-4/il-13-inducible transcription factor": 0.01907, "calcium-signal transduction pathway": 0.00852, "ap-1-dependent transcription": 0.0281, "mouse mammary tumor virus-long terminal repeat": 0.00325, "lymphocyte stem cell": 0.0512, "m.rothe": 0.00012, "mouse reveal": 0.01098, "dephosphorylated form": 0.01055, "cytokine stimulate granulopoiesis": 0.00749, "gel-shift analysis reveal": 0.00786, "human b-cell-specific ciita": 0.02508, "intracellular signal-transducing protein stat6": 0.02264, "p65 homodimers": 0.00388, "erythropoietin stimulate transcription": 0.01873, "carry": 0.00552, "red cell progenitor": 0.0512, "tr55": 0.00025, "5-lox-independent pathway": 0.01278, "induce aim/cd69 cell-surface expression": 0.02081, "regulate transcription factor function": 0.0143, "cell specific fashion": 0.0512, "cytokine-driven": 6e-05, "sox-4": 0.00043, "granulocytic maturation": 0.00251, "early transcriptional response": 0.01294, "r.leonard": 6e-05, "intracellular parasite theileria parva protects": 0.00233, "anergized cell": 0.0768, "logarithmic": 0.00012, "cortisol response": 0.01942, "induces sapk": 0.00803, "gc-box defines": 0.00022, "colon cancer cell line": 0.0384, "cross-over dna": 0.01483, "lysophospholipids": 0.0, "promoter analysis": 0.02336, "short term culture desulfate t3 sulfate": 0.00207, "sb203580": 0.00025, "il-2 promoter stimulation": 0.01557, "adult globin express cell display": 0.03072, "similar upregulation": 0.00673, "tcf-1 alpha bind motif": 0.01013, "bz1 react": 0.00074, "clinical perspective": 0.00425, "significant proportion": 0.00416, "epstein-barr virus-immortalized lymphoblastoid cell line": 0.03072, "b7-2": 0.00012, "e2f-4": 0.00068, "acute asthma": 0.00369, "oxidant injury induce": 0.01694, "cd80": 0.00087, "binding domain": 0.01855, "native long terminal repeat": 0.00189, "defective onset": 0.00205, "mapk": 0.00304, "trans-activating protein": 0.04529, "e2f family": 0.00841, "foregoing data": 0.00254, "80-90": 0.00019, "tsc2-linked mother": 0.00019, "replicative cycle": 0.00307, "lmp1 activates transcription": 0.01873, "dbd": 0.00025, "nf-at core sequence tttcc": 0.00813, "il-6 receptor subunit gp130 fuse": 0.01029, "viral transcriptional transactivator": 0.00767, "retinoic acid downmodulates erythroid differentiation": 0.00471, "eklf mediate": 0.01231, "severe systemic anaphylaxis": 0.00141, "ap-1 bound": 0.00695, "il-4 naf": 0.00667, "fifteen patient": 0.01666, "normal bone marrow": 0.00806, "chronic immune-mediated inflammation": 0.00265, "viral persistence": 0.00732, "transcription specific difference": 0.01873, "laboratory data suggest": 0.01348, "606-611": 0.0, "severe combine immunodeficiency disease": 0.00337, "two-": 0.0005, "cd40 pathway": 0.01278, "suboptimal activation": 0.03164, "b-cell-specific activator protein": 0.03019, "alpha b5a": 0.01169, "p300/cbp": 0.00019, "induce tcf-controlled transcription": 0.01873, "tyrosine phosphorylation result": 0.01073, "express cd36": 0.01846, "r-pk": 0.00031, "pou family": 0.00841, "dna aneuploidy": 0.01483, "ikk-beta": 0.00031, "cell line express antisense egr-1 rna": 0.0256, "impact": 0.00143, "differential rna display": 0.00333, "ppargamma mrna expression": 0.02775, "myeloid cell undergo terminal neutrophilic maturation": 0.0256, "factor responsible": 0.0286, "recombinant oct-1": 0.00391, "thymocyte ontogeny": 0.00096, "cd44 cross-linking": 0.00242, "coactivator": 0.00298, "marked increase": 0.02196, "bcl2-responsive checkpoint": 0.00022, "construct recombinant plasmid": 0.00484, "lps-stimulated raw": 0.00118, "activate ca2+/calmodulin-dependent kinase include": 0.00889, "microb dna motif decrease transcriptional activity": 0.00975, "vitro cell culture system": 0.0384, "continuous treatment": 0.01014, "serum immunoglobulin": 0.00378, "block terminal differentiation": 0.00786, "po site": 0.02168, "interleukin-10 inhibits expression": 0.02775, "bp capable": 0.00267, "cytokine message induction": 0.01071, "cl response": 0.01942, "extracellular-regulated kinase": 0.01188, "dna- binding": 0.01855, "fk506 bind protein fkbp": 0.02264, "pi 3-kinase activation": 0.02109, "2-bp mutation": 0.00592, "exhibit inducible expression": 0.02775, "mcp-1 production": 0.01042, "wild-type pp56": 0.00378, "dexamethasone induce eosinophil apoptosis": 0.0127, "specific human inflammatory pathology": 0.01881, "85-kda protein": 0.04529, "macrophage-csf": 0.00025, "human myeloid cell line": 0.0384, "ser5": 6e-05, "tpa-induced increase": 0.02196, "electromobility shift assay reveal": 0.00549, "constitutive mhc class ii mrna expression": 0.01388, "thr729": 6e-05, "ka": 0.00037, "alpha-subunit": 0.00031, "pituitary-specific transcription factor": 0.01907, "autologous": 0.00155, "naive huvecs": 0.00133, "additional agent": 0.00422, "increased binding": 0.01855, "diverse specie": 0.00183, "1-3 min": 0.00127, "fast-green/neutral-red": 6e-05, "minimal discrepancy": 0.00214, "e1 oligonucleotide": 0.00164, "steroid-induced monokine gene expression": 0.02177, "hyperplastic gc": 0.0031, "pkc responsiveness": 0.00332, "increase intracellular glutathione disulfide level": 0.00878, "tar-independent transactivation": 0.00515, "octamer family": 0.00841, "selective pressure": 0.00267, "mrp14 promoter": 0.02336, "measure ifn alpha": 0.0078, "pyrilamine": 0.00019, "lps-stimulated whole-blood cell culture": 0.0384, "wild-type ifngr1 allele": 0.00252, "thymus-specific member": 0.00413, "untreated thp-1 cell": 0.0512, "bind mutant": 0.02025, "stat3 bind motif ylpq": 0.01013, "protein kinase raf-1": 0.03019, "aiolos induces bcl-2 expression": 0.02081, "nonactive dna-binding fragment": 0.00374, "develop cns": 0.00403, "vcam-1 gene promoter": 0.02903, "-like factor": 0.0286, "il-2 promoter-driven transcription stimulate": 0.01405, "human erythroleukemic cell": 0.0512, "combined inducer": 0.00136, "cell leukemia virus-i": 0.0512, "malignant tissue": 0.00664, "recombinant thioredoxin": 0.00391, "ala-x-ala fail": 0.00347, "wp activity lead": 0.0195, "human cancer": 0.03762, "putative systemic disorder": 0.00248, "cd28 auxiliary receptor": 0.01714, "e2a/heb protein": 0.04529, "decrease number": 0.00971, "phase-specific dna binding activity": 0.01462, "tat carry": 0.00276, "v.m": 0.0, "inhibit nf-kappa b-dependent transcription": 0.01405, "anticancer treatment": 0.01014, "q34": 0.00012, "trigger hiv-1 upregulation": 0.00585, "lymphotoxin-alpha": 0.00019, "differentiation therapy": 0.01179, "nucleotides upstream": 0.00369, "fl5.12": 0.00019, "14-18 torr": 9e-05, "1-2 microm as2o3": 0.00087, "piec clone": 0.00738, "logarithmic phase": 0.00276, "high efficacy": 0.00931, "vitellogenin gene b1 promoter show": 0.01742, "bronchial epithelium": 0.00093, "tal-1 locus": 0.00288, "variant allele": 0.00276, "pax-5 encode": 0.00853, "transcription factor result": 0.01907, "recent data suggest": 0.01348, "mutant escherichia coli endotoxin lack myristoyl fatty acid": 0.00214, "bcl-x gene": 0.04355, "cell lymphoma line": 0.0512, "conclusive": 0.00012, "tumor necrosis factor": 0.01907, "hyperimmunoglobulin": 0.00025, "pma -and pma/ionomycin-inducible": 0.00273, "il-4/il-13-induced gene expression": 0.02903, "t-cell enhancer": 0.00962, "inositol phosphate release": 0.00323, "target gene show": 0.02903, "tk inhibitor herbimycin": 0.006, "pit-1b": 0.00012, "thick": 0.00012, "simple binding": 0.01855, "disturb": 0.00037, "cre-mediated transcription": 0.0281, "downstream intronic sequence": 0.01084, "cd40-mediated nf-kappa": 0.01414, "hth recognition helix": 0.00172, "th1/th2": 0.00056, "transgenic mouse express": 0.0123, "freshly isolate monocyte constitutively express high level": 0.00527, "mycobacterium tuberculosis mannose-capped lipoarabinomannan": 0.00053, "method demonstrate": 0.01597, "phorbol myristic acetate": 0.00362, "reporter gene analysis reveal": 0.02177, "interleukin-1beta-converting enzyme family protease inhibitor": 0.0036, "characterize gene up-regulated": 0.02903, "dr unit bind": 0.0135, "lymphocyte induces gene": 0.02903, "requirement": 0.00527, "inducible transcription unit": 0.01873, "proteolytic degradation": 0.00332, "lymphoblastoid cell stimulate": 0.0512, "encode transcription factor": 0.01907, "chromosomal assignment": 0.00102, "increase neutrophil adhesion": 0.01464, "hitherto unrecognized property": 0.00265, "flavonoid test": 0.00487, "cd11b promoter show sp3-dependent expression": 0.01665, "describe oap40 element": 0.01115, "id2": 0.00056, "transactivation mediate": 0.01231, "protein tyrosine kinase activity": 0.02264, "thp-1 cell occur": 0.0512, "confocal laser": 0.00031, "stable transfectants": 0.00171, "ring sideroblast": 0.00022, "carboxyl-terminal domain": 0.01207, "endogenous nfkappab": 0.00459, "receptor-mediated response": 0.01942, "1,25d3-priming stage": 0.00248, "lbp-1": 0.00012, "multiple effect": 0.02115, "il-4 promoter": 0.02336, "syk": 0.00155, "antiandrogen-bound receptor complex": 0.01714, "steel factor": 0.0286, "residue c-235": 0.00226, "tumor cell trigger": 0.0512, "stat5 complex": 0.01684, "thyromimetic effect": 0.02115, "silencer": 0.00112, "vascular reactivity": 0.00174, "lymphoid malignancy show": 0.01733, "hypertensive patient": 0.01666, "nf-at transcriptional activity": 0.0195, "tandem gata bind site": 0.01084, "ubiquitous transcription factor nf-y": 0.0143, "16-hour incubation": 0.00208, "pha-activated lymphocyte": 0.01483, "heterogeneous population": 0.00307, "pol gene": 0.04355, "demonstrate potent inhibition": 0.01065, "elderly woman": 0.00233, "proinflammatory function": 0.01331, "anti-timp-1 antibody": 0.00893, "post-gc b-cells": 0.00093, "show increase acth": 0.01733, "altered gene expression": 0.02903, "hiv-infected myelomonocytic cell line om-10.1": 0.03072, "rakfkqllq": 0.00012, "apparent tal1 gene alteration": 0.02177, "c-rel/p50": 0.00019, "octamer element": 0.01672, "regulate eotaxin gene expression and/or mediate": 0.01452, "il-6 promoter activity": 0.0195, "regulatory mechanism control p27kip1 gene expression": 0.01452, "pu-sf complex": 0.01684, "multipotential progenitor": 0.00276, "numerous growth factor": 0.01907, "g.": 0.00124, "c-to-t base exchange": 0.00207, "important regulatory role": 0.00885, "969-bp promoter fragment": 0.01557, "hl60 cell variant": 0.0512, "adult murine tissue demonstrate spi-b mrna": 0.00532, "repressor protein": 0.04529, "granulocyte subset": 0.00254, "5-lox": 0.00081, "kb upstream": 0.00369, "phorbol dibutyrate/calcium ionophore a23187": 0.00271, "over-express neu-related lipocalin": 0.00017, "termed uas1": 0.00028, "situ hybridization reveal": 0.00732, "human intestinal receptor": 0.02508, "cell-specific element": 0.01672, "phenotypic expression": 0.04163, "cell-cycle analysis show": 0.01733, "tnfalpha production": 0.01042, "lr1-dna binding activity": 0.0195, "receptor characteristic": 0.02571, "tcrgamma delta": 0.00211, "mediate cell type-specific gene expression": 0.03072, "cdna represent mrna": 0.01017, "l-selectin promoter": 0.02336, "fundamental cellular process": 0.00596, "cag repeat region": 0.00978, "induces nuclear factor": 0.01907, "-m2 protein": 0.04529, "vivo protein-dna interaction": 0.00658, "human c-c chemokine receptor": 0.01881, "activation mediate": 0.03164, "tpa-induced hl-60 differentiation": 0.00786, "erythropoietin receptor mutant defective": 0.01286, "elderly subject": 0.00354, "patient population": 0.01666, "supine": 6e-05, "alternative reading frame": 0.00136, "regulate signaling": 0.01253, "spleen development show": 0.01733, "g0s gene": 0.04355, "strain": 0.00372, "nucleotide number 368-389": 0.00354, "conditional gata-2/estrogen receptor chimera arrest erythroid differentiation": 0.00735, "block hiv replication": 0.00715, "a-t patient": 0.01666, "flank region": 0.01467, "s-g2/m boundary": 0.00012, "il-4 activity": 0.02925, "cotransfected construct express cat": 0.00923, "term neonatal cord blood": 0.00296, "murine bcl6 gene": 0.02903, "ebv-specific memory response": 0.01294, "hla-dr chain share": 0.00292, "distinct region": 0.01467, "oestrogen-receptive organ": 0.00118, "normal cell": 0.0768, "bind nuclear protein": 0.03019, "normal variant": 0.0121, "nf-m": 0.0005, "triple autoregulatory loop": 0.00072, "basic": 0.00347, "tryptophan photoproduct 6-formylindolo": 0.00021, "il-6 kappa b-related kappa": 0.00195, "show myh11 genomic rearrangement": 0.013, "targeting": 0.00043, "degradation machinery": 0.00332, "h-2k": 6e-05, "gcr": 0.00267, "transcription factor mef2c": 0.01907, "trp stimulation": 0.0112, "peripheral human mononuclear leukocyte": 0.01881, "soluble cd4": 0.00332, "hiv-infected patient": 0.01666, "peripheral blood mononuclear cell culture": 0.03072, "human lymphoblastoid cell line im-9": 0.03072, "mucosal biopsy": 0.0005, "jurkat t-leukemia cell": 0.0512, "site exert": 0.02168, "phorbol ester pma": 0.00362, "drug reaction show": 0.01733, "11-base-pair dna sequence motif": 0.00813, "c/ebp epsilon": 0.00223, "alpha thf/thf ratio": 0.0078, "induce rapid apoptotic cell death": 0.03072, "uncommitted precursor": 0.00323, "cd28 surface molecule": 0.00569, "avian cell express": 0.0512, "undescribed": 0.00019, "gr mrna": 0.01526, "chloramphenicol acetyltransferase reporter plasmid": 0.00276, "cytokine gene lack respective binding site": 0.01452, "alter gene expression": 0.02903, "induced transcription": 0.0281, "bind antigenic peptide": 0.0135, "mouse t-cell line": 0.01102, "phorbol inducibility exhibit": 0.00443, "antigenic determinant": 0.00118, "epstein-barr virus infection": 0.00591, "constitutively express p50/p65": 0.0123, "increased natural killer cell activity correlate": 0.0256, "wash": 0.00043, "male infant bear": 0.00068, "functional interplay potentiate t-cell-specific transcription": 0.01124, "proliferative capacity": 0.00329, "nf-at-deficient mouse support": 0.00649, "domain result": 0.0161, "present work demonstrate": 0.01065, "enhance promoter activity": 0.0195, "cvz": 0.00068, "human naive neonatal": 0.02508, "nf-at-like response element present": 0.00971, "immunization": 0.00093, "provide good therapeutic option": 0.00323, "infectious proviral construct": 0.00484, "zap-70/syk-deficient jurkat cell": 0.0512, "zinc finger domain": 0.00804, "cell tropic strain": 0.0512, "adp aggregation": 0.00096, "mechanism underlie endothelial cell activation": 0.03072, "stem cell factor": 0.0512, "lps-stimulated tf mrna accumulation": 0.00763, "loss-of-function signaling defect": 0.00372, "cell-to-cell activation": 0.03164, "gc-r": 0.00037, "endogenous nfat": 0.00459, "platelet activator": 0.00552, "pre-messenger rna generate": 0.00304, "trigger nfkappab-mediated gene expression": 0.02177, "augments cd28-induced il-2 promoter activity": 0.0117, "transduction pathway regulate": 0.00852, "24,25-dihydroxyvitamin d3": 0.00245, "stat-1 phosphorylation": 0.00983, "curcumin": 0.00068, "ebv-positive case": 0.00363, "aids-gr": 0.00043, "signal nf-kappa": 0.01635, "ym268 increase": 0.02196, "suppress trans-activation": 0.00611, "activate nuclear factor-kappa b. cross-linking cd40": 0.00592, "monocytic cell type-specific transcriptional induction": 0.03072, "jurkat cell induce": 0.0512, "crude nuclear extract": 0.01123, "phop virulence regulon": 0.00021, "hematopoietic cytokine interleukin-2": 0.00749, "selectively fail": 0.00347, "leukocyte population": 0.00478, "early stimulation": 0.0112, "biological significance": 0.00217, "function-related gene": 0.04355, "bcl6 mutation": 0.00592, "sbe": 0.00012, "mol.cell": 6e-05, "immunodeficiency syndrome": 0.00273, "host transcription factor": 0.01907, "immunostaining": 0.00056, "normal brca1 allele": 0.00806, "molecular pathway": 0.01278, "transcription factor aml1 fuse in-frame": 0.01144, "sequestration": 0.00037, "viral activation process": 0.02109, "band migration differ": 0.00128, "translation analysis show": 0.01733, "ach-2 cell": 0.0768, "human monoblastic cell line": 0.0384, "real-time blood pressure monitor": 0.00296, "oap/octamer motif": 0.00875, "host cell type": 0.0512, "widespread inactivation": 0.00174, "predominant bls complementation group": 0.00243, "protein bcl-3": 0.04529, "cell harbor": 0.0768, "nonhematopoietic cell line nih": 0.0384, "cd40-mediated differentiation": 0.01179, "gsh depletion": 0.00121, "hl60 cell differentiation": 0.0512, "gardnerella vaginalis": 0.00022, "transcriptional regulatory protein bind distinct c-fos/c-jun promoter element": 0.01132, "acute episode": 0.00369, "human myelomonocytic lineage": 0.02508, "cd69 molecule": 0.00853, "-4 stimulation": 0.0112, "library screening": 0.00093, "-65 region": 0.01467, "zii domain upstream": 0.00804, "cytokine redundancy": 0.01123, "human hl-60 myeloid leukemia cell differentiate": 0.0256, "increased binding activity": 0.0195, "vitro inhibition": 0.01061, "upstream nf-kappa": 0.01414, "rxr mutant devoid": 0.0054, "life cycle": 0.00307, "elderly adult": 0.00422, "weakly inducible": 0.00484, "review suggest role": 0.01348, "alpha gene transcription": 0.02903, "induce distinct signal transduction pathway include": 0.00847, "adenovirus e1b": 0.00189, "anti-stat-1 ab": 0.00167, "moiety": 0.00099, "er variant": 0.00276, "specific family": 0.01238, "primary regulator": 0.00738, "classic gcr": 0.00133, "pkc-independent stimulus": 0.0027, "inhibit translocation": 0.01904, "vd3": 0.00081, "inducible enhancer": 0.00909, "stat-6": 0.00019, "blood lymphocyte": 0.01483, "conventional cytogenetics": 0.00065, "cjun": 0.00012, "htlv-i tax activation": 0.02109, "long-term inositol phosphate release": 0.00242, "primary il-13 receptor complex": 0.01286, "cd28-derived signal": 0.01635, "inhibition effect versus time": 0.01058, "alpha-helices": 0.00025, "colony": 0.00341, "ap-1 enhancer": 0.00909, "impaired glucocorticoid-mediated induction": 0.01071, "invariant": 0.00043, "nfkappab correlate": 0.00654, "hiv-1 transcription": 0.0281, "kda form": 0.01055, "complex phenomenon": 0.01684, "metastatic": 0.00136, "5-isoquinolinyl-sulfonyl": 0.00012, "unspliced viral gag-pol mrna": 0.00763, "-3090": 6e-05, "beta protein": 0.04529, "human class ii transplantation gene": 0.01742, "pebp2": 0.00149, "adenovirus infection": 0.0062, "reporter gene analysis reveals": 0.02177, "antigen receptor": 0.02571, "synchronized differentiation selectively": 0.00786, "northern analysis demonstrate increase il-2ralpha gene expression": 0.01244, "interleukin-4 signaling": 0.00558, "oxidant": 0.00211, "putative nuclear localization sequence decrease nuclear localization": 0.00464, "rar alpha agonist": 0.0078, "mediate transcription initiation": 0.01873, "developmental specificity": 0.00335, "posttranscriptional level": 0.01821, "gastroenterology": 0.00012, "mzf-1 protein": 0.04529, "fm patient remain": 0.0111, "hgm-csf-mediated cell growth": 0.0512, "g-protein coupling": 0.00025, "tced motif": 0.00875, "extrinsic asthma": 0.00161, "immunocytochemical staining": 0.00177, "purified rest human": 0.02508, "comedo carcinoma": 0.0018, "tpa-treated hl-60/vinc cell": 0.0512, "composition": 0.00081, "p100 inhibitor": 0.009, "anti-stat antibody": 0.00893, "sequence mediate": 0.01625, "il-2 ligation": 0.01117, "decreased sensitivity": 0.00236, "human immuno-deficiency virus": 0.02508, "fk-506": 0.00043, "jurkat cell demonstrate": 0.0512, "stat6 response element": 0.01294, "primary blood mononuclear cell": 0.0384, "effect": 0.04231, "specific protease": 0.01238, "antiinflammatory therapy": 0.00372, "rela/nf-kappab1 binding complex": 0.01237, "10-60 mm nac": 0.00079, "il-4-induced complex react": 0.01123, "gggggctttccc": 6e-05, "ranq69l preincubation": 0.00053, "il-3-": 6e-05, "2d3-mediated repression": 0.00211, "alpha-associated protein kinase": 0.03019, "airway cell": 0.0768, "primary myelodysplastic syndrome": 0.00492, "heterozygous mutation": 0.00592, "upstream promoter": 0.02336, "tax-mediated transcriptional activation": 0.02109, "nb4": 0.00149, "-183": 0.00025, "memory cd4": 0.00332, "nuclear protooncogenes c-fos": 0.01123, "icam-1 kappa": 0.00748, "stimulation experiment": 0.0112, "jun/ap-1": 0.0, "monocyte-specific response": 0.01942, "suppress nf-at binding impair": 0.00927, "sapks": 6e-05, "augment gr-dependent transcription": 0.01873, "tax mutant iexc29s": 0.0054, "increase monocyte adhesion": 0.01464, "modification and/or translocation": 0.00343, "erythropoietin": 0.00186, "active wild-type": 0.00592, "suggest local proliferation": 0.01348, "analog activity": 0.02925, "tcl1 locus": 0.00288, "cell maturation": 0.0768, "mediate pathophysiologic event": 0.00821, "atypical pkc isoenzymes": 0.00221, "cellular uptake": 0.00893, "activated t-cell": 0.00962, "tfiiib": 0.00031, "pocket protein-e2f complex": 0.01123, "cellular function": 0.01331, "phytohemagglutinin-stimulated peripheral blood lymphocyte culture": 0.00593, ":633": 6e-05, "p56lck-independent pathway": 0.01278, "augment interleukin-2 promoter activity": 0.01462, "antioxidant defence mechanism": 0.00705, "pma induction increase": 0.01464, "surface mhc class ii": 0.00363, "additional pathway": 0.01278, "norepinephrine": 0.00019, "zinc-finger transcription factor": 0.01907, "21-50 yr": 0.00022, "p. aeruginosa pak lack pili": 0.00253, "homologous": 0.00273, "naive": 0.00267, "mbp promoter": 0.02336, "essential feature": 0.00487, "p-lps-induced expression": 0.04163, "infiltrate": 0.00149, "ap-1-dna binding activity": 0.0195, "raw264.7 macrophage-like cell": 0.0512, "increase beta-globin gene expression": 0.02177, "helper-induced lymphocyte": 0.01483, "dose rate": 0.00279, "amino acid homology": 0.00571, "cytosins": 6e-05, "mammalian mcm5": 0.00174, "general population": 0.00307, "il-8 secretion": 0.00428, "ideal situation": 0.00019, "field": 0.00037, "egr-1 expression vector result": 0.02081, "induce calcium flux": 0.01694, "antigen-stimulated b-cell-mediated immune response": 0.00971, "murine gm-csf promoter": 0.01557, "support atf1-": 0.00409, "bind site determine": 0.01445, "dna-binding activity lef1/bcf1": 0.0195, "nude mouse": 0.00974, "bp repeat eliminate": 0.00252, "lupus": 0.00074, "xpb helicase activity": 0.0195, "reporter assay": 0.01002, "vitro treatment": 0.01014, "anti-human aortic ec activity": 0.01462, "untransformed steroid receptor": 0.01714, "th1 development mediate": 0.00821, "zeb block": 0.01073, "nm23.h1 gene": 0.04355, "northern blot experiment demonstrate": 0.00799, "vitro translation": 0.00785, "dr beta": 0.00673, "class ii major histocompatibility complex-negative cell line": 0.02194, "e1a region": 0.01467, "human monocyte isolate": 0.02508, "adjacent sequence": 0.01625, "amino-terminal domain": 0.01207, "il-6 expression": 0.04163, "icam-1 upregulation": 0.00267, "major pathway": 0.01278, "anti-cd45 antibody inhibit": 0.0127, "viral latent gene": 0.02903, "rar-mediated signaling pathway": 0.00852, "uas1 sequence combine": 0.01084, "yy1 class transcription factor": 0.0143, "powerful inhibitor": 0.009, "virol": 0.00012, "l753f": 6e-05, "il-13 level": 0.01821, "coamplification": 6e-05, "uncommitted": 0.00025, "oxidative signalling process operate": 0.00222, "-h": 0.0, "vpreb": 6e-05, "stat": 0.00565, "turner syndrome": 0.00273, "il-2 receptor stimulation": 0.01714, "transfected nih-3t3 cell": 0.0512, "8.5-fold induction": 0.01607, "vitro binding activity": 0.0195, "complete": 0.00341, "high percentage": 0.00931, "il-10 induce": 0.0254, "aminothiol compound": 0.0022, "tumour associate cell surface antigen a6h": 0.0256, "transcription factor nf-kb": 0.01907, "ci-i": 0.00012, "il-2r beta mrna level": 0.0091, "twofold": 0.00037, "mouse plasmacytoma cell line": 0.0384, "monitor residual disease": 0.00449, "p95vav": 0.00087, "hl-60 cell differentiation induce": 0.0384, "activate reporter gene expression": 0.02177, "include cd4-mediated enhancement": 0.00959, "promyelocytic leukemia line": 0.01102, "frequent maternal expression": 0.02775, "proliferation reduction mechanism": 0.00705, "psa": 0.00031, "alter proliferation": 0.00803, "concentration compatible": 0.0067, "weakly associate": 0.01092, "32p-labeled probe": 0.00261, "kappa b-like activity": 0.0195, "additional region": 0.01467, "clinical benefit": 0.00425, "chromosome mapping": 0.00295, "ifn-gamma-independent component": 0.00456, "cytoplasmic hela extract": 0.00306, "er-negative": 0.00037, "u937 histiocytic lymphoma cell": 0.0384, "recent-onset iddm subject": 0.00236, "lack functional glucocorticoid receptor": 0.01286, "il-13r alpha1 expression": 0.02775, "tumor cell line": 0.0512, "sp-a play": 0.0071, "jak/stat": 0.00087, "thermal activation": 0.03164, "t. pallidum lipoprotein": 0.00079, "fkbp51": 0.00081, "enlarged gc": 0.0031, "cell express macrophage cell surface ag": 0.0128, "cd5 gene": 0.04355, "erythrocyte membrane": 0.0045, "32p-probe": 0.0, "sig-crosslinking-induced egr-1 mrna expression": 0.02081, "fivefold transactivation": 0.00515, "coregulators": 6e-05, "uv": 0.00192, "bone marrow cell express nf-kappab": 0.03072, "decrease blood histamine response": 0.00971, "nk-kappa": 0.00031, "similar result": 0.0161, "m2 leukemic blast cell": 0.0384, "u1a/u1b": 6e-05, "degenerate oligonucleotide probe specific": 0.00619, "monocyte cytotoxicity": 0.01197, "adherent cell": 0.0768, "hyperimmunoglobulin e. analysis": 0.00786, "study test": 0.01355, "common gamma chain gene": 0.02177, "intracellular ro": 0.00583, "defective binding": 0.01855, "specific modification": 0.01238, "chignard": 6e-05, "hepatic leukaemia factor": 0.01907, "growth response": 0.01942, "milligram": 6e-05, "subnuclear structure": 0.00319, "nuclear run-on analysis": 0.01123, "human cd36 mediate signal transduction event": 0.01254, "regulatory network": 0.00682, "intracellular adhesion molecule-1 induction": 0.00803, "central nervous system-derived cell express": 0.03072, "32p-labeled oligonucleotide": 0.00164, "molecule induce cyclin e-associated kinase activity": 0.00975, "nuclear matrix": 0.01684, "-dependent gene": 0.04355, "h287a": 6e-05, "poorly virulent mycobacteria": 0.00056, "glucocorticosteroid bind assay": 0.0135, "functional data": 0.00816, "constitutively active shp1-deltash2": 0.00395, "xenoreactive natural antibody": 0.00596, "differential gene expression regulate": 0.02177, "crp1": 0.00012, "helper clone": 0.00738, "characteristic immunophenotype": 0.00329, "tax-mediated transformation": 0.00288, "apparent chromosome": 0.00295, "proposed strategy": 0.00121, "mechanism independent": 0.01058, "cellular signal pathway": 0.0109, "e-box-dependent bhlh homo-": 0.00045, "important negative regulator": 0.00459, "embryonic development": 0.00633, "friend leukemia require specific signal": 0.00654, "functional activation": 0.03164, "characterize raz": 0.00425, "nf-y binding activity": 0.0195, "p50/p65 heterodimer bound": 0.00194, "surfactant protein": 0.04529, "octamer-binding transcription factor": 0.01907, "functional analog": 0.00816, "undergo smu": 0.0023, "regulate cell cycle progression": 0.0384, "truncated peptide": 0.00754, "northern experiment": 0.00397, "rbp": 0.00043, "representative form": 0.01055, "lysine": 0.00025, "oncogene bind": 0.02025, "addisonian picture": 0.00031, "specific antigen recognition induce hiv ltr transactivation": 0.00726, "strong ca2+": 0.00347, "vitamin d-resistant cell nuclear extract": 0.03072, "cell cycle regulate histone h4 gene": 0.0256, "aitl": 0.00031, "hypothesis": 0.00267, "src homology domain 2-mediated association": 0.00483, "messenger generation": 0.00242, "catalase": 0.00074, "composite cis-element": 0.00068, "lymphokine interleukin-1": 0.00186, "gamma interferon-induced class ii transactivator expression": 0.01388, "active nf-kappa": 0.01414, "-insensitive asthma": 0.00161, "important b-cell growth": 0.00546, "cd48 gene": 0.04355, "topoisomerase inhibitor": 0.009, "short term priming": 0.00275, "centromere specific probe": 0.00825, "gd patient": 0.01666, "cellular content": 0.00893, "extracellular factor": 0.0286, "zap-70 kinase activity": 0.0195, "cdc2 mrna": 0.01526, "inhibit rantes mrna expression dose": 0.01665, "rar gamma": 0.0044, "il-2r alpha transcription": 0.01873, "cell remain": 0.0768, "duffy antigen/chemokine receptor gene": 0.02177, "testosterone low": 0.00707, "steroid receptor superfamily": 0.01714, "lymphocyte proliferation": 0.01483, "human ifna2 gene direct high level": 0.01452, "position -90": 0.00236, "mononuclear cell isolate": 0.0512, "phorbol ester response": 0.01294, "embryonic stem cell": 0.0512, "promyelocytes": 0.0005, "jurkat line": 0.01653, "sickle cell anemia patient": 0.0384, "jurkat t-cell clone": 0.00641, "nf-at bound": 0.00397, "endogenous mcm gene": 0.02903, "cis-acting dna site": 0.01445, "sp family member interact": 0.0042, "139-144": 0.0, "family regulate": 0.01253, "patient sample": 0.01666, "nf-kappab protein": 0.04529, "nonactivated memory": 0.00133, "hypothalamic-pituitary-adrenal system": 0.00667, "p16": 0.00093, "multiple host defense gene": 0.02177, "k562 nuclear extract": 0.01123, "eosinophil": 0.00589, "homologous recombination": 0.00136, "induce tal-1 protein expression": 0.02264, "local adjacent augmentative ci element": 0.00669, "intracellular signal": 0.01635, "provocative mechanism": 0.01058, "subtotal thyroidectomy": 0.00012, "pge2-dependent activating effect": 0.0141, "retroviral counterpart": 0.00047, "hla-dra promoter": 0.02336, "genomic pathway": 0.01278, "major signal cascade": 0.0109, "downstream sequence": 0.01625, "cd11c gene promoter": 0.02903, "tc2": 0.00012, "daudi cell line": 0.0512, "crystal structure": 0.00319, "clearance": 0.00124, "context-dependent activation domain": 0.02109, "20-30 yr": 0.00022, "cell repertoire development": 0.0512, "prognostic significance": 0.00078, "p70s6k": 0.00012, "fourteen percent": 0.00037, "thymocytes express four-": 0.0123, "anergic cd4+": 0.00288, "creb bound dna": 0.00988, "synthetic peptide substrate": 0.00502, "balf2": 0.0, "tsh level": 0.01821, "immune property": 0.00599, "bind member": 0.02025, "mhc class ii density": 0.00363, "young brother": 0.00074, "cell line lack p56": 0.0384, "analyze change": 0.0063, "moab": 0.00037, "vcam-1 expression": 0.04163, "enhancer interacts": 0.00909, "early nf-kappa b-mediated transcriptional regulation": 0.00566, "tax1-nf-y interaction": 0.00986, "bone marrow cell clonogenic function": 0.03072, "free": 0.00254, "predicted periplasmic domain": 0.00804, "ptdins 3-kinase activity": 0.0195, "kappa light chain gene": 0.02177, "long terminal repeat-directed transcription": 0.01405, "-mediated b-cell activation": 0.02109, "ltr-directed transcription": 0.0281, "immunosuppressive activity": 0.02925, "strong nuclear positivity": 0.01123, "patient experience severe toxicity secondary": 0.00666, "replication defect": 0.00471, "nuclear factor sp1": 0.01907, "localized suppression": 0.00416, "chronic state": 0.00397, "ubiquitous band": 0.00118, "transcription factor control": 0.01907, "cell blast up-regulates fa": 0.0384, "-independent signaling pathway": 0.00852, "tnf alpha expression": 0.02775, "hla-dr alpha promoter construct transfected": 0.00934, "spliced transcript": 0.00599, "collagen": 0.0005, "mutation machinery": 0.00592, "high metastatic capacity": 0.0062, "increase ap-1 complex": 0.01464, "compound exert": 0.00292, "nineteen ltrs clone": 0.00492, "p4 nfat element": 0.01115, "human alveolar macrophage": 0.02508, "single strand conformation polymorphism": 0.0018, "secondary lymphoid tissue development": 0.00332, "cell growth inhibitor": 0.0512, "tg epsilon26 thymocytes express gata-3": 0.00738, "nonactivating dna-binding domain": 0.00804, "factor promise": 0.0286, "toxic": 0.00056, "apolipoprotein a1": 0.0004, "hyperthyroid patient": 0.01666, "lymphoid jurkat cell": 0.0512, "gr n-terminal transactivation domain": 0.00603, "camp-dependent second-messenger pathway": 0.00852, "normal myeloid differentiation": 0.00806, "pdtc-insensitive pathway": 0.01278, "smoke contribute": 0.00378, "purified hematopoietic progenitor cell": 0.0384, "cell cycle-related protein": 0.0512, "dominant mutant": 0.0081, "nf-kappab component p50": 0.00666, "gene transcriptional activity": 0.02903, "indication": 0.00012, "important transcription factor": 0.01907, "beta-interferon gene": 0.04355, "pro24leu": 0.00012, "characterize antioxidant": 0.00425, "avidin-biotin complex": 0.01684, "trap+ cell": 0.0768, "competition analysis show": 0.01733, "alagille syndrome isolate": 0.00277, "epstein-barr virus latency": 0.00591, "neutrophil function": 0.01331, "thp-1-derived macrophage": 0.00589, "cd8+ cd28+ population show": 0.013, "functional myc-max heterodimer": 0.00544, "monocyte/macrophage-": 6e-05, "activate cellular immunity result": 0.00889, "cell nucleus": 0.0768, "identifies": 0.00099, "provide substantial evidence": 0.0043, "ray-gallet": 0.00012, "antibody induce elevation": 0.01694, "isg expression": 0.04163, "cellular context": 0.00893, "finding highlight": 0.00226, "ar-5 cell transfected": 0.0512, "metalloproteinases-1": 6e-05, "p48 protein": 0.04529, "redox-dependent gene transcription": 0.02903, "rar alpha-lbd play": 0.00474, "stat3 p92": 0.00354, "goldberg": 0.00012, "inhibit c-myc": 0.01904, "c-jun/c-fos heterodimers": 0.00226, "mnp-1 transcription factor": 0.01907, "basic helix-loop-helix domain": 0.00804, "identical zinc-finger domain": 0.00804, "regulate e2f function": 0.00887, "hil-5 receptor alpha-subunit": 0.01714, "distal part": 0.00152, "elevated gr concentration": 0.00447, "gm5": 0.00012, "enhancer inactivity": 0.00909, "vitro transcription study show reduced level": 0.00937, "human osteocalcin": 0.03762, "recurrent hsv infection": 0.00414, "search protein ag": 0.03019, "myosin light chain kinase": 0.00594, "signal transduction pathway relevant": 0.00817, "hela cell require": 0.0512, "human peripheral blood monocyte": 0.01881, "high affinity receptor": 0.01714, "specific nf-kappab complex": 0.01123, "functional nf-kappab": 0.00999, "tpl-2": 0.00056, "status": 0.00434, "lcr hs": 0.00056, "hiv-1 ltr transcription": 0.01873, "detect transcript": 0.00726, "human raji": 0.03762, "numerous feature": 0.00217, "adult t-cell leukemia cell": 0.0384, "gamma-specific antibody": 0.00893, "nuclear nf-kappab activity": 0.0195, "glioblastoma line": 0.01653, "endothelial monolayers": 0.00434, "catabolism": 0.00012, "mrna induction": 0.01607, "phorbol 12-myristate": 0.00543, "molecular link": 0.0045, "il-5 expression": 0.04163, "elk-1 protein mediate": 0.03019, "virion-associated regulatory protein": 0.03019, "transcription factor gabp alpha": 0.0143, "human cd14": 0.03762, "clone sigma": 0.00738, "underlie nef": 0.00217, "glutathione-s-transferase": 0.00012, "human type ii interleukin-1 fuse": 0.01505, "ser184": 0.00012, "nuclear transcription factor kappa beta": 0.01144, "adult t-cell lymphoma/leukemia": 0.00641, "bcl-2 family member": 0.0056, "null cell": 0.0768, "flow cytometry study": 0.00904, "tnfalpha block": 0.01073, "low affinity": 0.00707, "wbfos": 0.00012, "saa gene": 0.04355, "kox zinc finger gene": 0.02177, "reactive oxygen intermediate-dependent nf-kappab activation": 0.01266, "indistinct mantle zone": 0.00023, "potent ah-receptor agonist": 0.00238, "serotypes belong": 0.0005, "maintain erythroid cell viability": 0.0384, "expression control": 0.04163, "enhanced dnase": 0.00285, "promoter deletion study reveal": 0.01168, "type-specific t-cell clone reactive": 0.00481, "de novo hiv type": 0.00475, "frozen tissue section": 0.00443, "500-bp human il-5 gene segment": 0.01742, "qp activity": 0.02925, "morning glucocorticoid receptor": 0.01714, "cessation": 0.00025, "dexamethasone-treated rat thymocytes": 0.0019, "activation requirement": 0.03164, "chain expression": 0.04163, "genomic sequence": 0.01625, "ifn-gamma fail": 0.00481, "ikaros bind site": 0.01445, "double-stranded oligonucleotides": 0.00183, "v3 loop": 0.00109, "src gene family": 0.02903, "pma-induced cell adhesion": 0.0512, "toremifene exert multiple": 0.00459, "otf-1 activation": 0.03164, "il-4 production induce": 0.01694, "inhibitory protein term": 0.03019, "transactivation experiment": 0.00515, "mnl": 0.00081, "emission": 0.00012, "disease site": 0.02168, "selectively control il-5 synthesis": 0.00651, "c-terminal pou-specific homeodomain": 0.00128, "receive dopamine": 0.00112, "suppress e-selectin": 0.00611, "transduction pathway": 0.01278, "vpr": 0.00149, "biol chem": 0.00019, "control subject": 0.01303, "transactivator target": 0.00825, "nf-kappa b/rel factor": 0.01907, "c5a": 0.0005, "detergent-insoluble cytoskeleton": 0.00019, "single versus": 0.0036, "pseudogenes": 0.0, "persistent type": 0.00949, "high csa blood concentration": 0.00465, "human homologue": 0.03762, "hiv-1 tat downregulates mip-1 alpha expression": 0.01388, "chromatin-assembled dna": 0.01483, "female twin discordant": 0.00105, "lim-only protein gene": 0.03019, "transformed cell": 0.0768, "human ciita": 0.03762, "human immunodeficiency virus infection": 0.01881, "homologous group": 0.00487, "ppargamma": 0.00186, "activated stat-3 protein associate": 0.02264, "nk cell-induced hla-dr alpha mrna expression": 0.01388, "transcriptional activator protein": 0.03019, "chemical induction": 0.01607, "ets protein spi-b": 0.03019, "jun nh2-terminal kinase": 0.00792, "tbp": 0.00093, "il-2 promoter cd28 response element": 0.00934, "zip": 0.00031, "human hs": 0.03762, "t-cell hybridoma": 0.00962, "multiple start site": 0.01445, "fas-mediated cytotoxicity": 0.00143, "bone marrow sample": 0.00143, "pao interferes": 0.00034, "high level cd19 promoter expression": 0.01665, "retrovirus-like particle": 0.00074, "low receptor affinity": 0.01714, "induce nfat-": 0.0254, "fungal stimulus": 0.0027, "problem": 0.00074, "initiate class ii process": 0.00363, "immunoglobulin heavy": 0.00276, "gc induce apoptosis": 0.01694, "autocrine and/or paracrine factor": 0.0143, "ut-7": 0.00105, "m. baseler": 0.00115, "related receptor": 0.02571, "il-2-independent t-cell transformation induce": 0.0127, "adult globin program": 0.00281, "monocyte-macrophage cell": 0.0768, "glucocorticoid mediated apoptosis": 0.00593, "rai": 0.00056, "mc903 induce expression": 0.02775, "lac+to lac-": 6e-05, "neuroblastoma differentiation": 0.01179, "130tl-as": 6e-05, "terminus encode": 0.00853, "dendritic cell level": 0.0512, "microm kn-62": 0.0013, "graft rejection": 0.00047, "world primate cell": 0.0512, "433-442a": 0.00025, "lymphocyte associate transcription factor": 0.0143, "homeobox gene": 0.04355, "nfkappab responsive": 0.00223, "traditional chinese medicine": 0.00031, "critical role": 0.01328, "stat3 signaling": 0.00558, "dominant-negative mutant approach": 0.0054, "nf-kappab-like transcription factor": 0.01907, "hormone inhibit proliferation": 0.0127, "th2 cytokine gene": 0.02903, "rb mutant": 0.0081, "activated normal": 0.0121, "rnase treatment": 0.01014, "nacl": 0.00012, "sre": 0.00074, "enhanced ability": 0.00431, "v-myb": 0.00037, "inhibit concanavalin": 0.01904, "analyze": 0.00912, "nf-il-6 motif": 0.00875, "h. result similar": 0.01073, "p40 gene": 0.04355, "great magnitude": 0.00205, "lineage offer": 0.00366, "tcc-inducible mitotic signaling": 0.00372, "display difference": 0.00499, "maeca stimulate": 0.01101, "interleukin-4-dependent transcription factor nf-il4 share": 0.01144, "transcription factor rbp-jkappa": 0.01907, "glucocorticoid receptor affinity": 0.01714, "activate specific stat protein": 0.02264, "dehydroepiandrosterone modulation": 0.00257, "high stringency northern blotting": 0.00465, "ca2+-dependent signal cascade": 0.0109, "/rel protein": 0.04529, "important positive regulatory element": 0.00836, "aiolos transcription factor control cell death": 0.0256, "15b-7": 0.00019, "major protein-binding site": 0.01445, "ki-67 staining": 0.00177, "reed-sternberg": 0.00019, "web": 0.00025, "potential transcriptional activation element": 0.01582, "egr1 regulation": 0.01008, "factor synergize": 0.0286, "form definitive erythroid colony": 0.00527, "dp-i": 0.0, "virus replication": 0.00887, "lymphoid-specific transcription factor oct2": 0.0143, "mucosal hgr level": 0.01214, "sjo extract show": 0.01733, "r+": 0.00019, "cytotoxicity": 0.00285, "mmol/l buthionine sulfoximine": 6e-05, "program cell death": 0.0512, "plasma membrane-proximal element": 0.01115, "responsive cis-acting element": 0.01115, "block ifn-stimulated gene expression": 0.02177, "drosophila embryo": 0.00121, "cytoplasmic tail lack": 0.00422, "signal pathway activate": 0.01185, "interaction": 0.01973, "positive signal": 0.01635, "hypothalamus": 0.00012, "genetic screen": 0.00288, "cat construct": 0.00726, "hiv-ltr activation": 0.03164, "neuronal": 0.00056, "southern blot hybridisation": 0.00072, "intracellular signal transduction": 0.0109, "core ggaas": 0.0022, "ctll-2 cell": 0.0768, "affect viral replication": 0.00531, "hiv1-infected macrophage": 0.00589, "nf-kappab family": 0.00999, "myelomocytic cell line": 0.0512, "site mediate il-6 induction": 0.01084, "p26rex/p24rex": 0.00012, "noncoding control region": 0.00978, "baby rat kidney": 0.0019, "murine hematopoietic-specific gata-1": 0.00416, "telomeric": 0.00019, "identified natural dna response element": 0.00777, "increased mrna": 0.01526, "d20z1": 6e-05, "auxiliary nuclear protein": 0.03019, "nf-kappab-like nuclear transcription factor": 0.0143, "erythropoietin-mediated signal": 0.01635, "promyelocyte stage cell": 0.0512, "normal activation": 0.03164, "affect synthesis": 0.00797, "breast cancer exhibit abnormal protein expression": 0.0151, "transcriptional analysis": 0.01179, "previous transfection study": 0.00904, "strong induction": 0.01607, "productive replicative form": 0.00703, "ad5e1a-expressing tumor": 0.00934, "dna sequence select": 0.01084, "proteasome-mediated processing": 0.00133, "positive antidsdna antibody": 0.00596, "il-13 induce": 0.0254, "eosinophil play": 0.0071, "cellular transcription factor e2f": 0.0143, "mutation frequency data": 0.00395, "tpa induction inhibit": 0.0127, "mcp-1 inhibit": 0.01904, "epithelial hela": 0.00233, "antioxidant pyrrolidine dithiocarbamate": 0.00167, "involved step-wise increase physical exercise": 0.00878, "efficient promoter": 0.02336, "pha-stimulation": 6e-05, "derepression": 0.00012, "c/ebpepsilon mrna": 0.01526, "bcl-2-deficient": 6e-05, "up-modulation": 6e-05, "clone display": 0.00738, "fails": 0.00031, "box": 0.00608, "differentiate": 0.00533, "ifn-gamma result": 0.0161, "hybridization pattern": 0.00549, "lymphocyte ig secretion": 0.00988, "preeminent antiinflammatory agent": 0.00281, "induce catalase activity": 0.0195, "lal-mrna": 0.00012, "lysophosphatidylcholine": 0.00019, "sites/cell": 0.00087, "theoretical possibility": 0.00099, "proinflammatory gene": 0.04355, "transient transfection study": 0.00904, "sequence analysis": 0.01625, "hiv-1-infected patient": 0.01666, "class ii antigen express t-cell line maintain contact identical": 0.0041, "proinflammatory cytokine gamma-ifn": 0.00749, "vp16": 0.0018, "primary erythroblast transformation": 0.00492, "cd11/cd18 adhesion receptor": 0.01714, "mouse swi2": 0.00974, "nuclear membrane": 0.01684, "main feature": 0.00217, "cytokine similar": 0.01123, "dna damage-induced apoptosis": 0.00988, "vcam-1 mrna expression": 0.02775, "require low dos": 0.00877, "increase nuclear factor": 0.01907, "bcl-2 mrna induction": 0.01071, "accurate initiation": 0.00211, "transgenic versus control mouse": 0.00651, "clone icr-27 tk-3": 0.00492, "etoposide -and dexamethasone-induced apoptosis": 0.00445, "ubiquitin": 0.0005, "drug concentration": 0.0067, "early replication": 0.00828, "secrete interferon-gamma": 0.00208, "diagnosis": 0.00112, "ten control subject": 0.00868, "northern analysis demonstrate coordinate downregulation": 0.00639, "slow migrating form": 0.00703, "transcription factor activator protein": 0.02264, "-positive cell": 0.0768, "adjunctive substance aim": 0.00043, "morphologic risk factor": 0.01907, "inducible nuclear import": 0.01123, "influenza virus": 0.00887, "cell nuclear extract demonstrate": 0.0384, "proximal tsp": 0.00301, "processing rate": 0.00279, "antigen stimulation": 0.0112, "identical": 0.00453, "rapid expression": 0.04163, "2-gy exposure": 0.0035, "5'-tgcgtca-3": 6e-05, "inhibit il-2-mediated ifn-gamma production": 0.00952, "superantigen": 0.00087, "purified human peripheral-blood granulocyte express constitutively significant level": 0.00941, "m-csf signal transduction": 0.0109, "glutaminyl-ttg substrate": 0.00199, "mechanism regulate": 0.01253, "early immune response": 0.01294, "platelet function": 0.01331, "include pervanadate": 0.01439, "interleukin-2 il-2 receptor beta-chain": 0.01286, "icam-1-dependent endothelial adhesivity": 0.00289, "il-5 induce": 0.0254, "detectable calm": 0.00276, "subsequent treatment": 0.01014, "trans-disulfide": 6e-05, "therapeutical level": 0.01821, "cytoplasmic receptor": 0.02571, "-54 bp": 0.00267, "rar-specific antagonist": 0.00242, "human t-lymphocytes": 0.03762, "stem secondary structure result": 0.00805, "control virus spread": 0.00868, "dna electrophoresis mobility gel shift assay": 0.00494, "p120": 0.00019, "exhibit full agonist activity": 0.01462, "develop stable transfectant variant": 0.00202, "anti-onco-genic transcription factor": 0.01907, "numerous intracellular substrate": 0.00389, "encode t-cell-specific membrane protein": 0.02264, "dissociated glucocorticoid": 0.0085, "hsf3 dna-binding activity": 0.0195, "adherence offer": 0.00118, "principal epo-responsive cell type": 0.0384, "delta-aminolaevulinic acid": 0.00856, "tap1-/- cell": 0.0768, "induce significant production": 0.01694, "recent information": 0.0014, "deficient il-2 production": 0.00744, "impairment": 0.00068, "cell factor": 0.0768, "suppress viral replication": 0.00488, "x1-specific factor": 0.0286, "5'-cggagtttcc-3": 6e-05, "endometrial cell": 0.0768, "patient free": 0.01666, "immunofluorescence microscopy": 0.00059, "platelet monoamine oxidase": 0.00248, "cell exhibit enhance il-2 secretion": 0.03072, "e-selectin induction": 0.01607, "primary erythroblast": 0.00738, "ifn-gamma induce": 0.0254, "a/r-tolerant huvecs": 0.00081, "l-pk": 0.00012, "df": 6e-05, "direct free-radical scavenging property": 0.0027, "category remain unidentified": 0.00347, "lytic expression program": 0.02775, "tax1-inducible transcriptional pathway": 0.00852, "ambient": 6e-05, "mapk kinase-1": 0.00152, "method": 0.00471, "cd4+cd45r0+ cell remain significant": 0.0384, "sequence thr729-lys984": 0.01625, "oncogenic transformation": 0.00288, "rest t-cell nuclear extract": 0.00842, "site specific mutation": 0.01445, "mhc class ii promoter": 0.01168, "tumor": 0.01867, "nf-kappab-binding site": 0.02168, "stepwise deletion": 0.00344, "molecular factor responsible": 0.01907, "communication": 0.00043, "il-2 responsiveness": 0.01117, "activate cell": 0.0768, "decreased histone acetylation": 0.00147, "fc gamma rii-mediated antigen presentation": 0.00328, "high binding affinity": 0.01237, "g1 cell cycle progression": 0.0384, "stat transcription factor family": 0.0143, "lymphocyte-specific negative regulation": 0.00672, "mitochondrial respiration": 0.00034, "tetrahydrobiopterin": 0.00031, "retroviral mediate transfer": 0.00821, "rna sample": 0.00456, "il-4 gene share high homology": 0.01742, "extent interleukin-1": 0.00186, "transfected gene": 0.04355, "y113": 0.00012, "emsas": 0.00037, "hie correlate": 0.00654, "regression model": 0.00422, "accurate evaluation": 0.0005, "soluble interleukin-2 receptor release": 0.01286, "humara locus": 0.00288, "erba target gene caii": 0.02177, "mcf-7": 0.00037, "active transcription": 0.0281, "diminished response": 0.01942, "phosphatidylinositol turnover": 0.00112, "downstream activation": 0.03164, "pax-5 transcription": 0.0281, "tax stimulates rna polymerase iii-dependent gene expression": 0.01244, "differential sensitivity": 0.00323, "complex regulatory function": 0.01123, "microa": 0.00012, "gssg action": 0.00499, "identical karyotype": 0.00226, "augment leukotriene b4": 0.00157, "ba/f3": 0.00056, "doxorubicin": 0.00037, "putative aml1-binding site": 0.01445, "glucose transporter isoforms": 0.00205, "sb": 0.00037, "oral tolerance": 0.00081, "carg motif": 0.00875, "fresh bl case": 0.00242, "calcium-dependent pma": 0.00409, "helicase": 0.00031, "effective antigen-presenting cell function": 0.0384, "transcriptional suppressor protein": 0.03019, "ru38486": 0.00031, "fourfold increase": 0.02196, "beas-2b cell": 0.0768, "15-lipoxygenase": 0.00068, "correspond laboratory mutant": 0.0054, "pmn activate": 0.01777, "epo-dependent cell line": 0.0512, "variant form encompass er": 0.00527, "24-hydroxylase": 0.00062, "neutral smase activity": 0.0195, "evaluation": 0.00099, "mechanism responsible": 0.01058, "potent apc": 0.00357, "rapid turnover": 0.00323, "pkc independent": 0.00363, "mm nac": 0.00118, "carboxy terminus": 0.00071, "il-2 induce stat3 activation": 0.01582, "bcl-2 regulates nfat-mediated activation": 0.01582, "htr beta": 0.00673, "nuclear run-on experiment show": 0.013, "pou-specific domain": 0.01207, "pharmacological": 0.00136, "bovine homologue": 0.0009, "transcription factor ap-1": 0.01907, "activate calcineurin": 0.01777, "tumor estrogen/progesterone receptor status": 0.01286, "apoaldosterone": 0.0, "karyotypic detection": 0.00102, "growth factor beta suppress activation": 0.01266, "grbeta": 0.00056, "vivo passaging": 0.0053, "emcv mrna": 0.01526, "pioglitazone": 0.00025, "rat-1 fibroblast transformation": 0.00225, "acid phosphatase": 0.00856, "cmv infection increase": 0.01464, "il-10 production": 0.01042, "cck-8 exerts": 0.00037, "bona fide p50/p65 heterodimers": 0.00113, "region encode": 0.01467, "block cd28 bind": 0.0135, "mitogen binding": 0.01855, "12-fold": 0.00025, "ebna2 responsive cis-element": 0.00149, "inflammatory focus": 0.00471, "dual pattern": 0.00549, "human immunodeficiency virus type-1": 0.01881, "priming occur": 0.00654, "plasma cortisol concentration": 0.00447, "affect basal ltr function": 0.00665, "constitutively express functional human immune deficiency virus type": 0.00941, "lipopolysaccharide-stimulated human monocytic cell": 0.0384, "anti-fas-induced activation": 0.03164, "selective pkc inhibitor ro": 0.0045, "strong transcriptional activation": 0.02109, "late-myeloblast-like cell line": 0.0512, "high turnover rate": 0.0062, "tuberous sclerosis complex": 0.01123, "cd40-mediated upregulation": 0.00192, "proto-enhancer activity": 0.02925, "jun protein": 0.04529, "cooperative function": 0.01331, "oxidative signalling process": 0.00296, "transcription factor c/ebp beta": 0.0143, "enhanced prooxidant state": 0.0019, "retrovirus-mediated gene transfer": 0.02903, "great amount": 0.00285, "tax protein": 0.04529, "show dna damage-induced apoptosis": 0.013, "recurrent cytogenetic abnormality highlight putative": 0.00149, "cell line daudi": 0.0512, "calcineurin catalytic": 0.00316, "apoptotic effect": 0.02115, "pld pathway": 0.01278, "hydrophobicity": 6e-05, "cytoplasmic ikappab-alpha": 0.004, "gata": 0.00292, "g. vaginalis suggest": 0.01348, "tortolani": 0.00012, "h2 receptor": 0.02571, "type": 0.01898, "nfat4 oppose": 0.00062, "induces apoptosis": 0.0089, "bcl-2 proto-oncogene": 0.00295, "eklf-/- erythrocyte": 0.0013, "pwm stimulation": 0.0112, "potential therapeutic": 0.00605, "anti-apoptotic protein eib19k": 0.03019, "post-inductive": 0.00012, "half-maximal binding occur": 0.01237, "cell-dependent disease": 0.00673, "physiological role": 0.01328, "cell type-specific regulation": 0.0512, "culture corneal endothelial cell increase": 0.03072, "ar protein decrease": 0.03019, "cascade": 0.00428, "ifn-gamma induces change": 0.00536, "cocultivation": 0.00031, "therapeutic potency": 0.00167, "q27": 0.00012, "pu.1 play": 0.0071, "ctcf expression": 0.04163, "intracellular glutathione level": 0.01214, "cooperative": 0.00136, "fasl reporter": 0.00552, "lr1": 0.00025, "il-2-inducible dna binding activity": 0.01462, "measure blood plasma cortisol concentration": 0.00268, "significant reduction": 0.00416, "pp90rsk activity": 0.02925, "vzv immune human donor": 0.01881, "deletion study reveal": 0.00904, "cd3-induced hsi phosphorylation": 0.00656, "aml1/eto": 0.00093, "il-2-induced signal": 0.01635, "delta-": 0.00012, "sodium dodecyl sulfate-polyacrylamide gel": 0.00093, "isolated hilar adenopathy": 0.00126, "level increase": 0.02196, "freshly isolate normal human thymocytes": 0.01505, "hypothalamic-pituitary-adrenocortical axis": 0.0005, "gliadin peptide": 0.00754, "socs protein": 0.04529, "tax1 activated expression": 0.02775, "frameshift mutation": 0.00592, "cd34+ progenitor": 0.00276, "hla-do": 0.00043, "k.chadwick": 0.00012, "transcription factor rfx1": 0.01907, "block 1,25-": 0.01073, "haec": 0.0005, "poly": 0.00043, "extracellular matrix gene": 0.02903, "ap-2 response element": 0.01294, "young adult patient": 0.0111, "chromatin organization": 0.00118, "molecular alteration": 0.0045, "culture supernatant increase": 0.01464, "flap inhibitor": 0.009, "slap-130 diminishes": 0.00022, "similarity": 0.00199, "immunodominant": 0.00087, "upstream promoter sequence": 0.01557, "cd19 mrna": 0.01526, "developmental stage": 0.00248, "kappa b-alpha proteolysis": 0.00498, "il-1-ra": 6e-05, "bak gene expression": 0.02903, "plasmacytoma cell": 0.0768, "limit dilution clone": 0.00492, "nur77 dominant negative transgenic mouse suggest": 0.00674, "alpha isoform": 0.01169, "specific dna binding": 0.01237, "megakaryocytic feature": 0.00217, "cognate peptide": 0.00754, "atherosclerotic plaque formation": 0.00323, "decrease": 0.01942, "large-cell component": 0.00456, "superantigen staphylococcal enterotoxin": 0.00029, "zebra activation": 0.03164, "adulthood": 0.00025, "cytoskeleton-binding pp52": 0.00028, "cell-specific control region": 0.00978, "cell neoplasm": 0.0768, "protein kinase a-dependent fashion": 0.02264, "nfat-1 decreased activation": 0.02109, "iron-responsive element": 0.01672, "lps tolerant cell": 0.0512, "multiple nuclear factor": 0.01907, "taq": 0.00012, "rrna": 0.00012, "cd8+ t-pll express il-2ralpha": 0.00923, "lmp-1 activates nf-kappa": 0.00943, "sp1 phosphorylation induce": 0.01694, "parent confirm": 0.00335, "human promyelocytic leukemia cell line": 0.03072, "infection": 0.01241, "wild-type mouse": 0.00974, "dose-response manner": 0.00282, "porphyromonas gingivalis lipopolysaccharide": 0.00163, "single-cell rt-pcr analysis": 0.00786, "50-500 microm pdtc": 0.00087, "tal1 transcription": 0.0281, "stat3 mrna": 0.01526, "v-erba-mediated differentiation arrest": 0.00786, "tnf-alpha promoter element kappa": 0.01168, "acute myelogenous leukemia": 0.00333, "wild-type il-2r alpha kappa": 0.00585, "document cellular response": 0.01294, "lymphocyte tropism": 0.01483, "neutrophils express": 0.01846, "bioactivation": 6e-05, "early tissue damage": 0.00552, "monocytic cell adhesion": 0.0512, "unnecessary": 0.00012, "a-f": 6e-05, "8-bromo-camp": 0.00025, "fatal malignancy": 0.00115, "human il-5 gene promoter": 0.02177, "b-cell lymphoma/leukemia-2 gene product": 0.02177, "tcf-1 expression": 0.04163, "globin gene switching": 0.02903, "responsive cell type": 0.0512, "camp-response element cre": 0.01115, "timp-2": 0.0, "epitope-labeled bko demonstrate": 0.01065, "phosphotyrosine residue": 0.00226, "tcr-contact site heterogeneity": 0.01445, "b-cell population induce": 0.01694, "murine cdna encode transcription factor nfatc": 0.00953, "hsie": 0.00037, "prompt": 0.00093, "semiquantitative reverse transcriptase-linked polymerase chain reaction": 0.00146, "roi formation": 0.00484, "cell-specific translational regulation": 0.00672, "b-cell line bl41-p3hr1": 0.01102, "er -tumors": 0.00264, "lymphoid cell correlate": 0.0512, "direct temporal correlation exists": 0.0027, "pp90rsk": 0.0005, "preference": 0.00025, "bind fibrinogen": 0.02025, "mild asthma": 0.00161, "ctcf activity": 0.02925, "potential inhibition": 0.01061, "pu-box": 6e-05, "young rat": 0.00285, "tnfalpha gene": 0.04355, "differentiation-inducing therapy": 0.00372, "short region": 0.01467, "activation block cytokine gene transcription": 0.01742, "early increase": 0.02196, "inhibit growth": 0.01904, "transactivator protein tax": 0.03019, "region term cleo": 0.00978, "monocyte-conditioned medium": 0.0014, "mhc antigen expression": 0.02775, "vitro bound": 0.00785, "src family": 0.00841, "situ immunolabelling reveal": 0.00732, "differential nuclear localization": 0.01123, "r24 treatment result": 0.01073, "co-ligation": 0.0, "grf40 bind": 0.02025, "cellular activation and/or differentiation": 0.01582, "hypoxia constitute": 0.00118, "specific tyrosine residue": 0.00825, "minimal thy-1 promoter": 0.01557, "recruit": 0.00199, "restriction endonuclease": 0.00105, "individual gene represent": 0.02903, "truncated pecam-1 promoter segment clone": 0.00934, "epstein-barr virus latency bamhi-q promoter": 0.00934, "high amount": 0.00931, "additive": 0.00019, "early hematopoietic progenitor cell": 0.0384, "cd19": 0.00261, "cyclin-dependent-kinase-4": 6e-05, "metabolic": 0.0013, "human il-5 synthesis": 0.02508, "nonproductive interaction": 0.00986, "mip-2": 6e-05, "inflammatory gene": 0.04355, "pai-1": 0.00031, "ib-ix-v": 0.00012, "pmn": 0.00155, "mature peripheral": 0.00524, "pcr product": 0.00533, "bp insertion": 0.00267, "rhizome": 6e-05, "kshv": 0.00019, "distinct protein": 0.04529, "recombinant vp16 fusion protein": 0.02264, "dysfunctional": 6e-05, "mutated human ciita construct": 0.01881, "heterologous cell type": 0.0512, "mediate interleukin responsiveness": 0.00821, "plausible": 6e-05, "vimentin transcript": 0.00599, "preexisting": 0.00012, "human atherosclerosis": 0.03762, "molecular abnormality": 0.0045, "fish": 0.00056, "il-13": 0.00366, "183-bp region": 0.01467, "h5 promoter": 0.02336, "difficulty": 0.00012, "egls": 0.00043, "inflammatory mediator require tyrosine kinase activity": 0.00975, "nuclear transcription factor ap-1": 0.0143, "cd27 cross-linking result": 0.01073, "nuclear receptor superfamily responsible": 0.01286, "culture blood mononuclear cell": 0.0384, "simian cell line bear stlv-i": 0.03072, "chemotactic migration": 0.00155, "v.wendel-hansen": 6e-05, "megakaryocytic enhancer": 0.00909, "untreated jurkat cell": 0.0512, "pwm": 0.0005, "serum testosterone concentration": 0.00447, "enhance lps stimulation": 0.00746, "fluorescent probe react": 0.00174, "5'-most ets site": 0.01445, "functional consequence": 0.00816, "fli-1 transcript": 0.00599, "20-base pair sequence": 0.01084, "rho activity": 0.02925, "cell receptor signal pathway": 0.0384, "inhibited release": 0.00484, "two-layer percoll gradient": 0.00033, "dominant negative c/ebp protein lip inhibit hiv-1 mrna": 0.01132, "switch region bind protein": 0.02264, "tcr delta locus": 0.00318, "nf-kappab-controlled beta-globin reporter gene": 0.02177, "pp52 leukocyte protein": 0.03019, "cd11b": 0.0023, "genomic sequence reveals": 0.01084, "alpha b2 show": 0.01733, "stress gene": 0.04355, "potent gene regulatory": 0.02903, "indirect response": 0.01942, "stat1 homodimers": 0.00285, "enhanced asm activity": 0.0195, "adult beta globin gene contribute": 0.01742, "modified target": 0.00825, "signal transmission": 0.01635, "co-treatment": 0.00025, "pregerminal center": 0.00112, "hela cell selectively stimulate": 0.0384, "weakly estrogenic": 0.00081, "human hematopoietic progenitor cell": 0.0384, "patient decrease": 0.01666, "isoleucine": 0.00012, "cell differentiation contribute": 0.0512, "hemoglobin switch": 0.00245, "cdna prevent apoptosis": 0.00593, "htlv-1 transformed human": 0.02508, "ah receptor gene": 0.02903, "cross-react": 0.0, "hsv dna": 0.01483, "activated nfat": 0.00589, "common pathway": 0.01278, "lymphoid specific gene": 0.02903, "ligand binding": 0.01855, "nf-kappab1 p105/p50 level": 0.01214, "surface mhc class ii expression": 0.01665, "enzyme": 0.0062, "lytic replication": 0.00471, "cyclosporin a-resistant transactivation": 0.00343, "c-myb proto-oncogene product": 0.00356, "ra peptide": 0.00754, "depressed subject down-regulated bmax": 0.00177, "hypoxia enhance induction": 0.01071, "significant level": 0.01821, "affect sv40 promoter specific protein-1": 0.00934, "quantitative experiment": 0.00397, "air-1 gene": 0.04355, "fos-related gene": 0.04355, "il-4 down-regulates il-2-": 0.00445, "anti-tnf alpha antibody decrease": 0.00585, "reduced development": 0.00633, "inhibitor pd98059": 0.009, "elevated level": 0.01821, "paf activate map kinase kinase-3": 0.00711, "20-methyl derivative": 0.00192, "impair neutrophil development": 0.00422, "tcr-induced tyrosine phosphorylation": 0.00656, "mutagenesis analysis": 0.01179, "cd28 ligation lead": 0.00664, "nuclear transcription factor-kappab activation": 0.01582, "acanthamoeba castellanii": 9e-05, "unsynchronized": 6e-05, "liposome": 6e-05, "history": 0.00062, "inflammatory cytokine gene": 0.02903, "tumor necrosis factor-alpha induction": 0.00803, "tnf/neuron growth factor receptor family": 0.01144, "molecular event lead": 0.00664, "mast cell": 0.0768, "block translocation": 0.01073, "cd68-": 0.00012, "rat cerulein pancreatitis": 0.0019, "transcription complex": 0.0281, "autoimmune/inflammatory disease": 0.00673, "antithyroid drug": 0.00338, "bcl-2 inhibits apoptosis induce": 0.0127, "initial receptor binding": 0.01714, "c/ebp subfamily": 0.00223, "interleukin-10 production": 0.01042, "o'-bismyristoyl thiamine disulfide": 0.00029, "potential aml1-binding site": 0.01445, "vitamin d-dependent rickets": 0.00157, "mu enhancer": 0.00909, "2-7": 0.0, "htlv-1 infection": 0.0062, "nerve growth factor": 0.01907, "unknown locus": 0.00288, "erk and/or p38": 0.003, "increase nf-kappa": 0.02196, "tissular pattern": 0.00549, "nf-kappab/rel factor": 0.0286, "c-jun protein level": 0.03019, "high-mobility group": 0.00487, "interleukin-7": 0.00068, "nmi": 0.00068, "staphylococcal enterotoxin": 0.00028, "activator protein 1-mediated transcription": 0.02264, "immobilization": 0.00025, "latent": 0.00453, "eosinophil lineage": 0.00366, "h-7-sensitive pathway regulate stat3 dna bind": 0.00675, "ald": 0.00056, "analysis prompt sequencing": 0.00786, "regulated interaction": 0.00986, "ap-1 factor family": 0.01907, "committed": 0.00043, "mek-dependent": 6e-05, "amenorrhoeic": 0.0, "b-cell malignancy": 0.00459, "pkb/pi3-kinase activity": 0.02925, "increase unresponsiveness": 0.02196, "er positive monocyte": 0.00798, "-dependent membrane potential change": 0.00315, "subfamily": 0.00074, "specific aldosterone binding": 0.01237, "vary time": 0.00273, "maximal il-2rbeta promoter activity": 0.01462, "hepatic pcd/dcoh protein level": 0.02264, "differential treatment": 0.01014, "transcription factor nf-atc": 0.01907, "atmospheric urban pollution": 4e-05, "htlv-1-transformed cell": 0.0768, "-associated": 0.00099, "receptor isoforms": 0.02571, "p50": 0.00577, "aid case": 0.00363, "vivo antigen challenge": 0.00546, "cytoplasmic component": 0.00456, "macrolide fk506": 0.00149, "p105 nf-kappa": 0.01414, "studied regulatory element": 0.01115, "normal receptor": 0.02571, "4-month interval": 0.00019, "octamer-binding transcription factor oct-1": 0.0143, "immunosuppressant inhibit": 0.01904, "intracellular calcium concentration": 0.00447, "il-4-mediated signaling": 0.00558, "tcc express equal level": 0.00923, "ap1 activation suggest": 0.02109, "proliferation induce": 0.0254, "fibrosarcoma cell line": 0.0512, "mrna suggest": 0.02022, "immortalised": 0.00025, "n-oct-3 factor": 0.0286, "spatial alignment": 0.00012, "constitutive": 0.00955, "suppress inflammation": 0.00611, "pou family primer": 0.0056, "bp repeat": 0.00378, "activated form": 0.01055, "viral protein vp16": 0.03019, "facilitate tar-independent transactivation": 0.00343, "ml-9": 0.00081, "ifnalpha-induced gene expression": 0.02903, "phagocytosis": 0.00093, "dmso solvent/media control": 0.00868, "malignant breast tumor": 0.00622, "hematologic malignancy": 0.00115, "anti-capsular antibody": 0.00893, "messenger pathway": 0.01278, "store": 0.00056, "hs-40 region": 0.01467, "blr2 mrna": 0.01526, "endotoxin-induced inflammation": 0.00316, "weakness": 0.00012, "short-lived signal deliver": 0.0109, "regulate il-12": 0.01253, "basic-helix-loop-helix protein": 0.04529, "cell population": 0.0768, "measure dexamethasone suppressibility": 0.00263, "t3r": 0.00031, "hnf-1 alpha": 0.01169, "pbmc receptor": 0.02571, "human il-16 gene consist": 0.02177, "delivery": 0.00118, "independent mechanism": 0.01058, "546-nucleotide": 6e-05, "patient group": 0.01666, "initial ebv transcriptional program": 0.00575, "-4gamma": 6e-05, "genetic evidence suggest": 0.01348, "clone analyze": 0.00738, "vsmcs": 0.0005, "peptide correspond": 0.00754, "labeled nf-kappa": 0.01414, "redundant receptor intracellular domain sequence": 0.01029, "product": 0.01067, "a. chamissonis ssp": 0.00054, "immediate-early trans-activator protein": 0.03019, "isolated human mcm gene promoter": 0.01742, "nucleoprotein complex form": 0.01123, "ctcf protein": 0.04529, "display growth-stimulating property": 0.00333, "j.virol.72:5852-5861": 0.0, "molecular abnormality lie distal": 0.00225, "critical": 0.00856, "cd30+ cell": 0.0768, "phosphorylation induction": 0.01607, "include ap-1": 0.01439, "nef affect": 0.00797, "htlv-i tax production induce": 0.0127, "low epithelial layer": 0.00471, "gc insensitivity": 0.0031, "irreversible": 0.00037, "primitive progenitor proliferation": 0.00536, "id-bhlh function": 0.01331, "ovarian": 0.00093, "-236/-145 minimal e2re": 0.00143, "multiple signal protein": 0.03019, "activation-induced lymphocyte proliferation": 0.00988, "inactivation status": 0.00217, "165-fold": 0.0, "nucleosome-assembly system": 0.00667, "apai": 0.00012, "genomic response": 0.01942, "chronic airway inflammation": 0.00265, "mononuclear leucocyte": 0.00304, "antisense c/ebp-epsilon": 0.00161, "scmv sne sit": 0.00095, "cell surface molecule": 0.0512, "constitutive pkb/akt": 0.00478, "data support": 0.00409, "immunodominant kd-restricted epitope": 0.00108, "reverse orientation": 0.00236, "p65 mutant": 0.0081, "reiteration mutant": 0.0081, "neoplastic progression": 0.00164, "nih3t3 cell": 0.0768, "tar-independent pathway": 0.01278, "indicative": 0.00037, "structure-function analysis": 0.01179, "blast crisis transition": 0.00085, "utilization": 0.0005, "molecular chaperone": 0.0045, "anti cd28": 0.00323, "affect member": 0.00797, "chromium-release assay": 0.01002, "t-cell-receptor-mediated trans activation": 0.02109, "trans-acting factor common": 0.01907, "readily demonstrable": 0.00074, "cd14 mrna": 0.01526, "apoptotic vsmc-myc cell": 0.0512, "antiatherogenic effect": 0.02115, "variable proportion": 0.00155, "heterogeneity suggest": 0.02022, "tgf-beta2": 0.0, "adult": 0.00844, "ferritin": 0.00056, "ubiquitin protein ligase e3": 0.02264, "face": 6e-05, "overlap": 0.00354, "transcript level peak": 0.01214, "dutpase": 0.00062, "viral anti-apoptotic protein": 0.03019, "mkk4": 6e-05, "commetns": 0.0, "nmol/l": 0.00087, "putative human il-2re": 0.02508, "tgf-beta gene promoter": 0.02903, "sp1 binding site mutant": 0.01084, "sustained translocation": 0.00515, "quiescent monocyte": 0.01197, "endogenous host transcription factor": 0.0143, "gm-csf induced tyrosine phosphorylation": 0.00492, "beta-gal activity": 0.02925, "bronchial epithelial cell": 0.0512, "gradual": 0.00037, "beta isoforms": 0.00673, "immune function provide": 0.00887, "feature implicate enhance calcitriol action": 0.0039, "nuclear factor nf-il6": 0.01907, "purpose": 0.00056, "require protein synthesis": 0.03019, "nadir": 6e-05, "normal regulation": 0.0121, "specific constitutive binding": 0.01237, "janus kinase jak1": 0.00792, "august": 0.0, "cell leukemia/lymphoma": 0.0768, "dn construct": 0.00726, "functional contribution": 0.00816, "autocrine action": 0.00499, "pertussis toxin-insensitive pathway": 0.00852, "candidate oncogene bcl-3": 0.00174, "hiv-cat plasmid": 0.00273, "promoter segment": 0.02336, "hemin-induced accumulation": 0.00323, "gln": 6e-05, "hil-5 promoter": 0.02336, "upregulate nuclear factor-kappab": 0.01123, "mmtv ltr": 0.0031, "cytolytic effect": 0.02115, "nf-kb dependent": 0.00388, "signaling pathway": 0.01278, "human lymphocyte proliferation": 0.02508, "vdr interact protein": 0.03019, "hiv-2 function": 0.01331, "agent mediate il-8 induction": 0.00803, "increase cortisol clearance": 0.01464, "trough": 0.0, "mitogenic pair": 0.00214, "-130 ap-1-like site": 0.01445, "platelet-induced activation": 0.03164, "adult beta-globin": 0.00422, "mm precursor lesion": 0.00215, "potent mediator": 0.00357, "stat heterodimers": 0.00282, "physical interaction": 0.00986, "casein kinase ii": 0.00792, "pbls": 0.00019, "t-cell signaling molecule": 0.00641, "nf-kappa b/rel inhibition": 0.00943, "activate nf-at": 0.01777, "lbf4": 6e-05, "rodent gene encode": 0.02903, "normal cell stimulate": 0.0512, "dre": 0.00025, "n-terminal deletion": 0.00344, "nonresponsive": 0.00056, "elastase": 0.00062, "allergic inflammation": 0.00316, "gene activation identical": 0.02903, "cd4 promoter play": 0.01557, "mrl-lpr/lpr": 0.00019, "multi-functional domain protein": 0.03019, "increase interleukin": 0.02196, "main reservoir": 0.00087, "nonidentical pattern": 0.00549, "tcl1 occurs": 0.0009, "reverse transcriptase": 0.00236, "native mr form": 0.00703, "protein tyrosine phosphatase inhibitor": 0.02264, "ox-ox40 ligand": 0.00592, "gene encode ebna": 0.02903, "single vector encode": 0.00569, "regulate im-9 cell growth": 0.0384, "drug inhibit": 0.01904, "suppress tnf production": 0.00695, "specific binding site": 0.01445, "tcf-1 alpha bind element": 0.01013, "immediate-early gene": 0.04355, "jurkat cell lysates": 0.0512, "th2-type lymphokine": 0.00109, "nf-kappab dna binding": 0.01237, "erbb": 0.00012, "preterms": 0.00019, "adenovirus-transformed cell": 0.0768, "subtle alteration": 0.0023, "il-4 receptor": 0.02571, "smad7 exhibit differential inhibitory effect": 0.00846, "prenatal immune challenge increase": 0.01098, "human cd34+ cord blood cell": 0.03072, "bfl-1": 6e-05, "coinfected human": 0.03762, "thiol modulation inhibit": 0.0127, "cd3 pathway": 0.01278, "-1.7": 0.00012, "strong increase": 0.02196, "rela/p65": 0.00019, "il-2 gene promoter activity": 0.02177, "major isoflavone metabolite": 0.00383, "activate blk promoter transcription": 0.01405, "autologous antigen-presenting cell": 0.0512, "differentiate agent": 0.00422, "human peripheral blood lymphocyte": 0.01881, "3183-4450": 6e-05, "high-grade vulvar leiomyosarcoma": 0.0001, "t-cell differentiation": 0.01179, "differential manner": 0.00323, "block reaction": 0.01073, "transfected jurkat t-leukemia cell": 0.0384, "retrospective study base": 0.00904, "prevent inappropriate activation": 0.02109, "final gene rearrangement event": 0.02177, "heparin-binding epidermal growth factor-like growth factor": 0.00953, "p.k": 0.0, "dr+4": 6e-05, "nfat-mediated transactivation": 0.00515, "pyrilamine binding": 0.01855, "hybrid bcr/abl": 0.00171, "ssb": 0.00087, "chemotactic factor": 0.0286, "cell deficit": 0.0768, "class ii major histocompatibility complex gene hla-dra": 0.01244, "tuberculosis patient correlate": 0.0111, "obscure": 0.00025, "nitrogen": 0.00056, "43-mer oligonucleotide": 0.00164, "metastatic human malignant melanoma": 0.01881, "serum cortisol concentration": 0.00447, "shaping": 0.0, "wild-type virus": 0.00887, "trigger monocytic differentiation": 0.00786, "p27": 0.00043, "include jak2": 0.01439, "control mouse": 0.01303, "small intron": 0.00313, "alpha b2 protein bound": 0.02264, "stimulus-dependent cd44 transcription": 0.01873, "lef-1-interacting protein": 0.04529, "programme": 0.00037, "increase oestrogen receptor": 0.01714, "adenovirus encode protein": 0.03019, "t-cell gene": 0.04355, "vitro transcription assay": 0.01873, "describe lymphoid-specific oct2b protein": 0.02264, "-2a": 0.00012, "nf-kappa b/rel nuclear activity": 0.01462, "adult erythroid-specific genomic footprint": 0.00211, "t-cell tumorigenesis": 0.00962, "pathologic": 0.0005, "steroid-sensitive asthmatic patient": 0.0111, "lim-only protein": 0.04529, "monovalent gold ion": 0.00041, "selective activation": 0.03164, "gene characteristic": 0.04355, "inducible dyad symmetry element show": 0.0104, "calmodulin antagonist": 0.00242, "kappa b-beta": 0.00748, "nuclear factor nf-kb": 0.01907, "scanty": 6e-05, "normal concentration": 0.0121, "myeloid leukemogenesis": 0.00462, "note": 0.00093, "putative transmembrane segment": 0.00248, "x2 box protein-dna interaction": 0.00493, "gal4 dna bind site": 0.01084, "hpa system": 0.00667, "taci": 6e-05, "rest pbmcs": 0.00267, "activate arre-1 site": 0.01445, "-66": 0.00019, "cytokine activate transcription": 0.01873, "5'-utr comprise": 0.00105, "protease inhibitor": 0.009, "leukemic cell contamination": 0.0512, "joint": 0.00068, "subnuclear domain": 0.01207, "csa-sensitive translocation": 0.00515, "leukocyte signal transduction": 0.0109, "bhrf1": 0.00087, "stress condition": 0.0036, "antisense myb expression": 0.02775, "mcp-1 gene": 0.04355, "activating signal lead": 0.0109, "previous demonstration": 0.00133, "antiapoptotic function": 0.01331, "deletion/substitution mutant": 0.0081, "kd-values": 6e-05, "timp-1": 0.00074, "e2f-like sequence": 0.01625, "cyclosporin a-treated human": 0.02508, "b7 costimulation": 0.00171, "vascular pathology": 0.00174, "availability": 0.00068, "high level": 0.01821, "induces": 0.01607, "delta-opioid receptor express": 0.01714, "specific mapk/extracellular signal-regulated kinase kinase": 0.00495, "b2 site": 0.02168, "weakly": 0.00161, "cd4": 0.00664, "pma-induced superoxide release": 0.00323, "myeloid cell marker": 0.0512, "related protein": 0.04529, "sry": 0.00068, "gc-sensitive asthmatic": 0.00081, "protein inhibit dna binding": 0.02264, "alpha-hydroxyprogesterone response": 0.01942, "immunosuppressive agent": 0.00422, "receptor site": 0.02571, "critical concentration": 0.0067, "require processing": 0.01315, "steroid treatment": 0.01014, "differential lymphokine expression": 0.02775, "transcription efficiency": 0.0281, "develop transfection technique": 0.00269, "responsible": 0.00558, "monocytic cell differentiation": 0.0512, "lower-affinity site": 0.02168, "tnf-alpha-treated": 0.00012, "extensive nucleotide sequence": 0.01084, "57-": 0.00012, "mycoplasma fermentans-derived high-molecular-weight material": 0.00037, "htlv-i rex gene": 0.02903, "synthetic retinoid": 0.00202, "incomplete degradation": 0.00332, "permeabilized cell": 0.0768, "tnf-alpha production": 0.01042, "characteristic result": 0.0161, "k-562": 0.00012, "ifn-responsive reporter construct": 0.00484, "cd3-epsilon gene expression": 0.02903, "high bcl-xl expression": 0.02775, "d.m.powell": 0.00012, "primary function": 0.01331, "-mediated transcription": 0.0281, "nuclear tcf-1 expression": 0.02775, "functional testosterone receptor": 0.01714, "ppar": 0.00056, "glucocorticoid effector mechanism": 0.00705, "cellular stimulation": 0.0112, "live": 0.00025, "viral oncoproteins": 0.00732, "p-lps-treated cell": 0.0768, "industrial source": 0.00047, "-148": 6e-05, "p46": 6e-05, "serine residue position": 0.00157, "recurrent genital herpes simplex virus": 0.00355, "functional complementarity": 0.00816, "render cell sensitive": 0.0512, "signal mechanism": 0.01635, "cytoplasmic periphery": 0.004, "il-1 activated human umbilical vein endothelial cell": 0.02194, "nb4 apl cell line": 0.0384, "12-day fetal liver": 0.00143, "-5": 0.00025, "thioctic acid": 0.00856, "hiv-infected u937 cell": 0.0512, "distinct regulatory element": 0.01115, "63-kda isoform": 0.00171, "nonmutational mechanism": 0.01058, "persistent loss": 0.00298, "prodrugs": 6e-05, "time-": 0.00025, "nuclear c/ebp beta": 0.01123, "predominant stat transcription factor": 0.0143, "jnk protein": 0.04529, "rat splenocyte proliferation": 0.00536, "cell surface mu heavy chain associate": 0.0256, "inhibit proliferation": 0.01904, "p45 mrna": 0.01526, "mark basophilia": 0.00074, "mouse genome": 0.00974, "cultured mouse astrocyte": 0.00649, "m2-type leukemic cell": 0.0512, "cellular metabolism": 0.00893, "phosphatidylinositol 3-kinase": 0.00109, "structural analog": 0.0018, "val augment stat6 activation": 0.01582, "lps binding": 0.01855, "gr binding affinity": 0.01237, "macrophage induce": 0.0254, "j. biol": 0.00056, "primary cell": 0.0768, "propose clinical therapy": 0.00283, "ndp kinase expression": 0.02775, "tnf-mediated activation": 0.03164, "concert": 0.00074, "n-terminal acidic domain": 0.00804, "fhit gene occur": 0.02903, "6-k-pgf1 alpha": 0.01169, "pp1-sensitive tyrosine": 0.0071, "cell growth transformation": 0.0512, "adipogenesis": 6e-05, "hemin induction": 0.01607, "il-4ralpha induces janus kinase": 0.00594, "optimal il-4-signaling": 0.00152, "hypoxia enhance": 0.00974, "stat5a-stat5a homodimers": 0.00078, "decline": 0.00242, "ebv lytic cascade": 0.00376, "b-cell specificity": 0.00459, "host-derived mcd14 ligand": 0.00395, "intermediate cd4": 0.00332, "g.peters": 6e-05, "physiologic repressor": 0.00223, "hf": 0.00031, "antigen recognition stimulates limit proliferation": 0.00328, "induce endothelial cell activation": 0.0384, "atra-induced growth inhibition": 0.00707, "human antiviral": 0.03762, "prototype stress hormones-dexamethasone": 0.00207, "protein inhibit tumor cell proliferation": 0.03072, "-512": 0.0, "demonstrate gata-3 bind": 0.0135, "squelching": 0.00019, "hxbp-1 dna target sequence decrease dr alpha promoter activity": 0.0065, "tonsillar cell": 0.0768, "normal lymphoid cell": 0.0512, "5'-upstream sequence": 0.01625, "impairs": 0.00124, "viia": 0.00043, "nf-kappab inhibitor ikappab-alpha": 0.00666, "ciita overexpression": 0.00382, "p92": 0.00019, "anti-cd3-induced c-rel expression": 0.02775, "computer-assisted imaging": 6e-05, "redundant role": 0.01328, "icsa unmasks": 0.00025, "active tfiiib molecule": 0.00569, "cotransfected": 0.00093, "lend support": 0.00409, "stimulate significant level": 0.01214, "fibric acid derivative": 0.00571, "t.": 0.00112, "mitogen-stimulated human t-cells": 0.02508, "enzyme active site": 0.01445, "mnfatc transcript": 0.00599, "heme-treated friend leukemia cell": 0.0384, "enhance viral persistence": 0.00649, "transcriptional repressor activity": 0.0195, "express transgenic evil": 0.0123, "stat5 isoforms": 0.00307, "400-fold excess": 0.0005, "lif": 0.00056, "hypersensitivity": 0.00074, "hl60 cell": 0.0768, "macrophage-like lineage": 0.00366, "cell hybridoma hs-72 cell": 0.0192, "truncated raralpha exhibit dominant-negative activity": 0.0117, "il-1 beta mrna increase": 0.01098, "putative e2f bind site": 0.01084, "adult testis": 0.00422, "hemodynamic compensatory phase": 0.00184, "b-cell maturation arrest": 0.00306, "palombella": 0.00012, "mcm6 promoter": 0.02336, "nuclear runoff experiment": 0.01123, "arnica montana": 0.00012, "bl cell": 0.0768, "monoclonal antibody": 0.00893, "human corticotropin-releasing hormone gene promoter": 0.01742, "interleukin-1-beta": 6e-05, "tax increase": 0.02196, "laboratory data": 0.00254, "hl60": 0.00254, "epo-independent cell": 0.0768, "urapidil": 0.00025, "c-type chemokine": 0.00105, "group": 0.00974, "mineralocorticoid receptor mrna": 0.01714, "immunoglobulin kappa light chain gene link": 0.01452, "p23": 0.00031, "heme-responsive factor": 0.0286, "actinomycin": 0.00099, "important nf-kappab/nfat": 0.00689, "tnf polymorphism": 0.00481, "12-bp insert": 0.00043, "key": 0.00304, "substantial activation": 0.03164, "c-rel/p50 heterodimers": 0.00226, "ft4": 6e-05, "intrafollicular cd3+": 0.00028, "rap bind domain": 0.0135, "ngal gene include": 0.02903, "e. chaffeensis": 0.00102, "inhibit g-csf-induced growth": 0.0127, "prestimulated thp-1 monocytic cell": 0.0384, "macrophage precursor": 0.00589, "sickle cell disease": 0.0512, "adenomyotic lesion show identical steroid hormone receptor expression": 0.01041, "m-csf treatment": 0.01014, "final determinant": 0.00118, "c/ebp bind site": 0.01445, "il-2 promoter region": 0.01557, "activate normal human": 0.02508, "rex protein": 0.04529, "subst": 6e-05, "pkc stimulator": 0.00332, "-256": 0.00019, "experiment": 0.00794, "express hla class ii antigen": 0.00738, "'stressful": 6e-05, "similar mass": 0.00673, "granulocytic pathway": 0.01278, "backbone": 6e-05, "synthesize hemoglobin": 0.00158, "rex shuttle": 0.00059, "human cd37": 0.03762, "lipid-mediated dna transfer": 0.00988, "aids-c patient show low il-2": 0.0104, "enhance il-2 production": 0.00744, "d20s56": 0.00012, "nf-kappa b/rel family require dissociation": 0.00566, "present data suggest": 0.01348, "prototypic probe": 0.00261, "nonpermissive cell": 0.0768, "jak2 tyrosine kinase": 0.00792, "protein parallel": 0.04529, "promoter function": 0.02336, "fev1": 0.00025, "central position": 0.00236, "hr": 0.00118, "therapeutic intervention": 0.00167, "gamma/delta tcr+ pregnancy lymphocyte express progesterone receptor": 0.00735, "tcr beta analysis show": 0.013, "significant il-2 production": 0.00744, "tax-expressing cell": 0.0768, "purified human neutrophil": 0.02508, "recombinant polypeptide form sequence-specific complex": 0.00674, "transcription factor bind site downstream": 0.01144, "down-regulated": 0.0023, "specific genotoxic stimulus": 0.00825, "lineage choice": 0.00366, "lymphoid-specific transcription complex": 0.01873, "ciita-expressing cell": 0.0768, "t-cell lymphoma": 0.00962, "aid activation": 0.03164, "describe mutant jurkat cell": 0.0384, "acute promyelocytic cell": 0.0512, "single point estimation": 0.0024, "mammalian pax gene": 0.02903, "require il-2-induced": 0.01315, "pharmacological target": 0.00825, "pp2b": 6e-05, "pharmacodynamics": 6e-05, "monocytic differentiation": 0.01179, "co-receptor molecule": 0.00853, "atf/creb": 0.0005, "lipid peroxidation": 0.00124, "human acute myeloid leukemia": 0.01881, "upstream region": 0.01467, "c-raf-induced phosphorylation": 0.00983, "pg-b6p": 0.00012, "cd8+cd56+/cd57+": 6e-05, "siv": 0.00062, "chronic inflammatory disease": 0.00449, "divergent region": 0.01467, "phagocyte stimulation": 0.0112, "viral particle": 0.00732, "agonist": 0.0044, "nf-kappab/rel transcription factor family": 0.0143, "signal phosphorylation": 0.01635, "e. coli rpos mutation": 0.00296, "32p-labeled ht-2 cell migrate": 0.0384, "relative abundance": 0.00276, "posttranscriptional mechanism": 0.01058, "cd45 play": 0.0071, "site-directed mutational study demonstrate": 0.00799, "signal transduction cascade": 0.0109, "classical hd": 0.00171, "gst-pi-positive plasma cell": 0.0512, "antigenic peptide": 0.00754, "heterotrans-activation": 0.00012, "mouse csf-1": 0.00974, "human toll-like receptor": 0.02508, "cxc chemokine": 0.00105, "alpha result": 0.0161, "13-kilobase-pair": 6e-05, "m1 cell": 0.0768, "bq toxicity": 0.00056, "ino inhibit": 0.01904, "erythroid cell culture": 0.0512, "hu regulate c-jun mrna expression": 0.01665, "anemia-inducing strain": 0.00186, "dna sequence motif": 0.01084, "surface ligand associate": 0.00728, "hla-dm gene": 0.04355, "mark elevation": 0.00093, "high-affinity surface receptor": 0.01714, "human herpesvirus": 0.03762, "cotransfected hgata-3": 0.00047, "individual gata factor": 0.01907, "de novo mutation": 0.00395, "kappab dna binding activity": 0.01462, "lps-mediated induction": 0.01607, "inositol 1,4,5-trisphosphate/calcium pathway": 0.00852, "potential regulatory role": 0.00885, "syk tyrosine kinase": 0.00792, "xp-d lymphoblastoid cell exhibit similar transcription activity": 0.02194, "preliminary study": 0.01355, "abrogate kappab-driven gene expression": 0.02177, "approach": 0.00329, "corticosteroid resistance": 0.00326, "activate stat5a": 0.01777, "receptor-positive murine monocytic line": 0.00827, "precursor level": 0.01821, "prevent vcam-1 transcription": 0.01873, "molecular event": 0.00552, "radiation therapy": 0.00372, "nk cell development": 0.0512, "vacuolar h+-atpase": 0.00012, "induce nf-kappab": 0.0254, "important signaling molecule capable": 0.00426, "strong transactivation": 0.00515, "quantitative immunohistochemical analysis": 0.00786, "rev m10": 0.00047, "histidine-rich putative zinc finger domain": 0.00483, "m2 leukemic cell context": 0.0384, "atherosclerosis lesion": 0.00143, "pxqxt/s-containing sequence": 0.01625, "chemokine pathway": 0.01278, "essential positive regulatory element": 0.00836, "short": 0.00261, "nf-kappa b1 gene expression": 0.02177, "c-erba function": 0.01331, "myeloblastic leukemic ml-1 cell": 0.0384, "monocyte maturation/differentiation": 0.01197, "induce modest nuclear translocation": 0.0127, "il-4 suppress": 0.00667, "agent fail": 0.00422, "show sequence homology": 0.01733, "t-cell clone": 0.00962, "combine treatment": 0.01014, "activation-inducible enhancer element responsible": 0.00836, "ap-1 regulation": 0.01008, "activation phenotype": 0.03164, "50-fold induction": 0.01607, "t-cell factor-1": 0.00962, "cbf alpha2": 0.00146, "ifn-gamma-responsive promoter": 0.02336, "c-fos gene expression": 0.02903, "cell-tropic hiv-1 entry": 0.00585, "early regulatory protein": 0.03019, "cr asthmatic individual": 0.00273, "granulocytic differentiation": 0.01179, "variable proliferative response": 0.01294, "c3/5": 0.00037, "il-5-nonproducing clone": 0.00738, "master controller": 0.00012, "interact receptor-ligand pair require": 0.00658, "cross-reacted": 6e-05, "pebp2/cbf transcription factor": 0.01907, "pou": 0.00099, "tcl-5": 6e-05, "zr-75-1": 0.00012, "a-myb rna": 0.00456, "pp70s6k": 0.00031, "deletion mutant": 0.0081, "eosinophil-specific gene encode primary": 0.02177, "moloney murine leukemia virus promoter result": 0.00779, "cpp32": 0.0, "downregulation": 0.0018, "nac exert": 0.00292, "grr": 0.00019, "gel retardation": 0.00164, "intrinsic survival factor": 0.01907, "gt": 0.00037, "immunoglobulin rearrangement": 0.00276, "prooxidants": 6e-05, "chromatin structure": 0.00319, "offspring": 0.00012, "confirm mutation": 0.00592, "mhc-i": 0.00031, "spontaneous m2 blast cell": 0.0384, "herpes thymidine kinase": 0.00792, "hiv-1 iiib replication": 0.00585, "cd36 promoter": 0.02336, "cd14 ag": 0.00171, "diffuse large cell lymphoma": 0.0384, "exit": 0.00031, "survey": 0.00037, "family": 0.01681, "sp1 virus": 0.00887, "immune status": 0.00599, "parathyroid gland": 0.00087, "antigen receptor-induced signal": 0.0109, "transcriptional inhibition": 0.01151, "humoral immune response": 0.01294, "alter intercellular signal system": 0.00817, "consensus response element present": 0.00971, "autoregulation": 0.00062, "marker induce": 0.0254, "paucity": 6e-05, "tcr/cd3 induced activation": 0.02109, "increase protein kinase": 0.03019, "bind tpa responsive element": 0.01013, "clear-cut defect": 0.00279, "utr result": 0.0161, "heterodimeric cytokine": 0.01123, "blast differentiation": 0.01179, "two-color immunohistochemistry demonstrate": 0.01065, "induce hsp60": 0.0254, "cleavage stimulation factor cstf-64": 0.0143, "gsh": 0.00087, "cd28 signal": 0.01635, "cell-specific pattern": 0.00549, "anti-cd3/il-2-activated ln cell": 0.0512, "raz": 0.00019, "trace": 0.0005, "ccacc/sp1": 0.00019, "protein vital": 0.04529, "interleukin-10 receptor intracellular domain": 0.01286, "170-kd protein": 0.04529, "il-2 receptor alpha subunit": 0.01286, "augment antitumor immunity": 0.00157, "cytokine mediate biological effect": 0.01058, "e2f complex": 0.01684, "rat brain": 0.00285, "lps bind protein": 0.03019, "mature cytokine": 0.01123, "fo": 0.00143, "lipopolysaccharide-stimulated interleukin-1 beta messenger rna level": 0.00607, "huaecs": 0.00037, "alternative potential nf-kappab": 0.00666, "define": 0.00645, "prevent terminal differentiation": 0.00786, "b-cell immortalization": 0.00459, "unstable untreated asthmatic patient": 0.00833, "eicosanoids bind": 0.02025, "region center": 0.01467, "sds-polyacrylamide gel": 0.00164, "dc lineage": 0.00366, "line lead": 0.01653, "coronary": 0.00062, "primed": 0.00056, "hml share important feature": 0.00344, "heterogeneity": 0.00124, "lipoarabinomannan": 0.0005, "physical association": 0.00282, "eosinophlic inflammation": 0.00316, "nf-kappab component": 0.00999, "signal transduction pathway lead": 0.00817, "short-lived": 0.00025, "wild-type hgr": 0.00378, "index subject": 0.00354, "activate jurkat cell": 0.0512, "class ii mhc x1 box dna-binding protein": 0.01294, "3'-region": 6e-05, "c-to-a exchange": 0.00074, "creb trans-activate": 0.00236, "clonal analysis reveal individual response": 0.00777, "spontaneous abortion": 0.00093, "cd25 surface expression parallel activation": 0.01665, "detect er codon": 0.00484, "computer-assisted analysis": 0.01179, "long-lasting": 0.00087, "multivalent guanylhydrazone": 6e-05, "affinity": 0.00782, "+/- s.d": 0.00158, "constitutive nf-kappab dna-binding activity": 0.01462, "generate mature hela cell mrna": 0.03072, "gct": 0.00031, "depletion generate": 0.00453, "potential therapeutic measure": 0.00403, "ebv-infected cell line": 0.0512, "dp-1 mrna": 0.01526, "msr promoter activity": 0.0195, "rb status": 0.00217, "il-13 gene": 0.04355, "regulate stat3 tyrosine phosphorylation": 0.00627, "cell-expressed transcription factor": 0.01907, "site respond": 0.02168, "transient assay show": 0.01733, "p105 promoter upregulation": 0.01557, "topographical distribution": 0.00115, "electrophoretic mobility supershift assay": 0.00501, "stat-1alpha": 0.00037, "drosophila toll protein signal activation": 0.01811, "stat6 tyrosine phosphorylation": 0.00656, "influence inflammatory disease": 0.00449, "small increase": 0.02196, "cell lack gamma": 0.0512, "compatible protein interaction": 0.03019, "rel/nf-kappab-responsive gene": 0.04355, "rat thymocytes stimulate": 0.00734, "normal": 0.02419, "il-13 activation": 0.03164, "impaired glucose-stimulated insulin secretion": 0.00214, "rb rescue": 0.00167, "point mutant": 0.0081, "biochemical analysis": 0.01179, "fc gamma ri gene": 0.02177, "b4-2 dna": 0.01483, "macrophage-like morphology": 0.00087, "lbf2": 0.00012, "murine cdna clone": 0.00492, "epidermal growth factor receptor": 0.0143, "myb": 0.00081, "cyproterone": 6e-05, "base pair il-5 gene segment upstream": 0.01452, "ubiquitous bioinactivation mechanism": 0.00705, "receptor": 0.05143, "mutated ap-1 element": 0.01115, "local thrombin activation": 0.02109, "stoichiometry": 0.00025, "mrna encode receptor": 0.01714, "ire transcript": 0.00599, "vav function": 0.01331, "cd2-mediated interleukin-2 promoter activation": 0.01582, "mediate g1/s phase control and/or enhancement": 0.00434, "secrete tgf-alpha": 0.00208, "transcribed allele": 0.0022, "gm-csf receptor": 0.02571, "anti-dnp antibody": 0.00893, "nucleoprotein extract show decreased dna-binding activity": 0.00975, "strong potentiation": 0.00347, "control tnf-alpha gene expression": 0.02177, "hil-4r alpha": 0.01169, "nkl cell": 0.0768, "strong affinity": 0.00391, "mouse inducible": 0.00974, "-dependent growth": 0.00819, "absolute 'master gene": 0.02903, "minimal mu enhancer": 0.00606, "account": 0.00149, "polarized differentiation": 0.01179, "transcriptional interference": 0.01151, "epstein-barr virus cp latency-associated promoter": 0.00934, "ki-67 antigen": 0.00819, "x1 box dna-binding protein rfx": 0.01811, "c.h.fox": 0.00012, "zebra stain": 0.0013, "mediate lps induction": 0.01071, "death effector": 0.00276, "myh11": 0.00037, "g1 arrest": 0.00171, "hypothetical model": 0.00422, "phosphatidylinositol 3-kinase inhibitor": 0.006, "share structural feature": 0.00192, "hla-dr+ cell": 0.0768, "rap1 protein": 0.04529, "gf109203x": 0.00019, "latent growth-transforming infection": 0.00414, "tcr-ligand": 0.0, "ultimate outcome": 0.00037, "acute transfection": 0.00369, "igh enhancer": 0.00909, "a/r tolerance": 0.00081, "pkc suggest": 0.02022, "previous cotransfection experiment": 0.00265, "single bipartite retinoic acid response element": 0.00647, "induce": 0.05081, "pre-treatment": 0.0005, "c-fos gene 7-fold": 0.02903, "potential binding site": 0.01445, "persistent cytokine": 0.01123, "dna-protein crosslinking study": 0.00904, "study epstein-barr virus": 0.00904, "bioflavonoids": 6e-05, "express endothelial tethering factor": 0.0143, "recombinant jun": 0.00391, "elam-1": 0.0005, "stat6 bind site": 0.01445, "hormone binding domain": 0.01237, "stat1alpha-responsive gene": 0.04355, "insensitivity": 0.00099, "catalytic cleft": 0.00059, "ets-binding site include": 0.01445, "activate human csf-1r": 0.02508, "subunit vaccine": 0.00484, "brain ischemia": 0.00084, "fcr cross-linking": 0.00242, "alternative polyadenylylation site": 0.01445, "il-1ri": 0.00031, "natural killer cell activate endothelial cell": 0.0128, "human cmv": 0.03762, "putative nfat-1 site": 0.01445, "turn affect neutrophil-to-tumor cell binding": 0.03072, "conjugation": 0.00043, "enhancer-binding protein": 0.04529, "nk cell granule": 0.0512, "constitutive nf-kappab-binding activity": 0.0195, "independent sample": 0.00363, "major component": 0.00574, "herpes simplex virus type": 0.00475, "tnf": 0.00962, "tnfalpha": 0.00273, "sox-4 hmg box": 0.00203, "human leukemic cell line cem": 0.03072, "indolocarbazoles": 0.0, "nf-kappab": 0.01998, "prostate epithelium": 0.00053, "method describe": 0.00397, "h1-antagonists": 6e-05, "mediate cytoplasmic retention": 0.00821, "x-chromosome inactivation pattern": 0.00366, "hybrid dra/dqb reporter construct": 0.00363, "neuroendocrine-immune regulatory interaction": 0.00658, "intense physical exercise lead": 0.00498, "rel/kappab": 0.00031, "maniatis": 6e-05, "recent study reveal": 0.00904, "genetic element link": 0.01115, "ralgds": 0.00012, "select myeloid leukemic cell line": 0.03072, "distinct level": 0.01821, "receptor/stat interaction": 0.00986, "frame": 0.00081, "beta gene": 0.04355, "antigen-presenting cell": 0.0768, "-induced fas ligand transcription": 0.01405, "recognition site": 0.02168, "dna-binding phosphoprotein induce": 0.01694, "igh enhancer prevents nuclear matrix attachment": 0.00561, "cd45-deficient variant": 0.00276, "enhancer-like characteristic": 0.00329, "posttranslational level": 0.01821, "form functional nf-e2 complex": 0.00842, "finding correlate": 0.00654, "alpha/mad-3 gene transcription remain constant": 0.01742, "il-12-induced activation": 0.03164, "induce high level expression": 0.02081, "include dhea sulfate": 0.00959, "induce production": 0.0254, "mutation screening": 0.00592, "1,25-dihydroxy vitamin d3": 0.00163, "form heinz body": 0.00703, "vcam-1 mrna level": 0.01214, "u937 cell activate": 0.0512, "sodium butyrate": 0.00186, "single bcs": 0.0036, "fk506 suppress": 0.00611, "stat-6-binding site": 0.02168, "human neutrophil granulocyte": 0.02508, "multiple cell culture": 0.0512, "single binding site": 0.01445, "affect protein kinase c-mediated gene transcription": 0.0151, "result implicate nfil3/e4bp4": 0.01073, "patient sodium": 0.01666, "il-9 gene": 0.04355, "cd28-mediated stabilization": 0.00062, "raf-1 activity promote il-2 production": 0.0117, "chloramphenicol acetyltransferase gene drive": 0.02177, "min post-alphacd3 stimulation": 0.00746, "proximal promoter region abolish": 0.01168, "r59z activator cell": 0.0512, "h9 t-cell line": 0.01102, "slvmac239": 6e-05, "upstream enhancer": 0.00909, "acylation": 6e-05, "activation status": 0.03164, "human bone marrow ec": 0.01881, "well-characterized chick intestinal": 0.00052, "enhancer sequence": 0.01625, "om10.1 cell": 0.0768, "rwleu-4 cell": 0.0768, "fc3 plasmid": 0.00273, "-kinase activation": 0.03164, "cd28 response element": 0.01294, "causal relationship": 0.00158, "factor require": 0.0286, "tradd associate": 0.01092, "cytotoxic property": 0.00397, "gh3": 0.00031, "cd35": 6e-05, "transcriptional up-regulation": 0.01151, "adenovirus type": 0.00949, "se induce": 0.0254, "iv drug abuser": 0.00225, "eventual loss": 0.00298, "dp1": 0.00062, "macrophage scavenger receptor": 0.01714, "myeloid promoter": 0.02336, "msr promoter ap-1/ets element": 0.01168, "intracellular signal pathway": 0.0109, "unactivated": 0.0005, "poorly detect": 0.00726, "exposure": 0.00701, "transcript express": 0.01846, "ebv replication": 0.00565, "bcl2 gene": 0.04355, "periodontal disease": 0.00673, "siv-infected rhesus macaque": 0.00019, "d3 transport": 0.00245, "human interleukin-9 receptor alpha chain": 0.01505, "optimal binding": 0.01855, "hiv long terminal repeat activation": 0.01266, "tnf alpha effect": 0.0141, "consensus motif a/t a/t": 0.00437, "macrophage response": 0.01942, "habitual aborters": 9e-05, "mg2+": 6e-05, "site-dependent transcription": 0.0281, "membrane-associated lymphotoxin": 0.00025, "international working formulation": 8e-05, "gross rearrangement": 0.00199, "corticosteroid varies": 0.00143, "altered transcription": 0.0281, "costimulatory signal": 0.01635, "age-related lymphocyte dysfunction": 0.00988, "glut4 expression": 0.04163, "open reading frame brlf1": 0.00036, "dox-treated cell": 0.0768, "gata-1 motif": 0.00875, "phosphorylation process require t-cell costimulation": 0.00526, "dlcl suggest": 0.02022, "murine p105 nf-kappa": 0.00943, "anti-inflammatory remedy": 0.0013, "ltr activation": 0.03164, "hel": 0.00043, "lymphocyte gene activation": 0.02903, "ifn-gamma-independent manner": 0.00282, "ang ii": 0.00726, "atf -or nf-kappab-dependent promoter": 0.01168, "control discrete gene": 0.02903, "bt2": 0.00012, "fkbp bind": 0.02025, "normal mande": 0.0121, "constitutive redox status": 0.00318, "ciita-induced promoter occupancy": 0.01557, "cell-specific transacting factor": 0.01907, "anti-il-8": 0.00012, "result advance": 0.0161, "impair rna transcription activity": 0.01462, "splenocyte blastogenic response": 0.01294, "polyoma enhancer a-binding protein-3 site": 0.00867, "molt-4 cell": 0.0768, "serum-free grown hl60 cell": 0.0384, "erythropoietin receptor": 0.02571, "alpha inhibitory protein": 0.03019, "ltb4 mediate transactivation": 0.00821, "rb expression": 0.04163, "traf6 fail": 0.00347, "rapamycin-sensitive pathway": 0.01278, "inverse relation": 0.00062, "guanine nucleotide": 0.00202, "inhibit tpa-induced erk2 activity": 0.01462, "post-transcriptional mechanism": 0.01058, "viral protein induce": 0.03019, "repertoire": 0.00093, "translocation": 0.0103, "epstein-barr virus bzlf1 transactivator": 0.00444, "evolutionary benefit": 0.00037, "serine-rich region": 0.01467, "ficoll gradient": 0.0005, "activate rare-dependent transcription": 0.01873, "vcam-1 mediate": 0.01231, "human burkitt": 0.03762, "scl suggest": 0.02022, "nf-kappab-like factor": 0.0286, "c-jun tre": 0.00493, "il-7 delay": 0.00118, "glu-asp-gly-lys-lys-phe-asp": 0.00012, "primate lentiviruses": 0.00056, "promoter activity induce": 0.0195, "aml1 lead": 0.00996, "abrogate e-box-dependent bhlh homo -or heterodimer complex formation": 0.00421, "ap1 formation": 0.00484, "mitochondrion": 0.00012, "postinduction repression": 0.00211, "manner indistinguishable": 0.00282, "whilst nf-kappa": 0.01414, "dex treatment": 0.01014, "termination": 0.0005, "ec co-cultures": 0.00254, "eighteen": 0.00031, "35-amino acid": 0.00856, "microm stimulate": 0.01101, "critical regulatory interaction": 0.00658, "2-yr period": 0.00127, "electron-transport system": 0.00667, "cd14 antigen": 0.00819, "powerful suppressor": 0.00105, "agonistic monoclonal antibody": 0.00596, "e1a activate": 0.01777, "homozygotic": 6e-05, "monocyte specificity": 0.01197, "yeast transcriptional activator": 0.00767, "nuclear target": 0.01684, "hbmp-2": 0.00012, "apical surface": 0.00515, "promoter link": 0.02336, "phosphorylated polypeptide": 0.00202, "tata motif": 0.00875, "bacterial cell wall component play": 0.03072, "synovial fluid monocyte": 0.00798, "acute megakaryoblastic leukemia": 0.00333, "mild-moderate renal insufficiency": 0.00077, "cell responsiveness": 0.0768, "early protein": 0.04529, "lt-alpha1beta2 play": 0.0071, "hematopoietic control mechanism": 0.00868, "activate nf-kappab": 0.01777, "demonstrate crucial role": 0.01065, "nm23 function": 0.01331, "cold air": 0.00031, "cell type-specific": 0.0768, "estrogenic compound": 0.0022, "e2a-hlf chimera": 0.00112, "promote cell cycle": 0.0512, "il-4 induces cepsilon germline transcript": 0.00321, "interleukin-11": 0.00025, "stabilization": 0.00124, "cd40-mediated enhancement": 0.00233, "human inos promoter": 0.02508, "human thp-1 macrophage cell": 0.0384, "virus core promoter": 0.01557, "nuclear inhibition": 0.01684, "myeloid-cell-specific gene": 0.04355, "lymphocyte-specific gene": 0.04355, "il-2r alpha kappa": 0.0078, "possibility": 0.00199, "specie range": 0.00202, "prestimulated thp-1 cell": 0.0512, "pyruvate kinase erythroid-specific promoter": 0.01168, "mediate biological response induce": 0.0127, "reduces gr concentration": 0.00447, "e1": 0.00112, "camp accumulation": 0.00323, "initial pathway": 0.01278, "damage blood vessel": 0.00395, "gc cell": 0.0768, "myeloid differentiation protein": 0.03019, "bound kinase": 0.01188, "tre-dna": 0.00037, "1858-1869": 6e-05, "ras-dependent manner": 0.00282, "dominant negative pi3-k construct comprise individual": 0.00242, "base -186": 0.0031, "il-2r alpha regulation": 0.0078, "seb": 0.00025, "transgenic mouse display erythroid-specific expression": 0.01665, "l-34": 0.0, "inactive nuclear factor-kappab": 0.01123, "and/or pma": 0.0045, "discontinuation": 6e-05, "additional protein factor": 0.03019, "hocl-mediated lung injury": 0.0013, "infiltrating": 0.0005, "bcr-mediated signal transduction": 0.0109, "chromosome band": 0.00295, "suppress blastogenesis": 0.00611, "ospb": 6e-05, "u937 differentiation": 0.01179, "abnormal response": 0.01942, "multistep disorder associate": 0.00728, "nf-kappa b-dependent": 0.01414, "costimulus": 0.00031, "gm-csf receptor alpha promoter activity": 0.0117, "activation-dependent cell surface marker cd25": 0.03072, "implicate": 0.00701, "apoptosis-mediating receptor": 0.02571, "steroid-binding region": 0.01467, "il-2 action": 0.01117, "yj cell": 0.0768, "24-hydroxylated metabolite": 0.00109, "hiv-1 isolate": 0.00878, "il-5 induced rapid": 0.0036, "ifn-gamma-activated sequence": 0.01625, "inhibit histone deacetylation": 0.0127, "apparent requirement": 0.00264, "ureteral obstruction": 9e-05, "class iii snrna gene": 0.02177, "apoptotic process": 0.00444, "stimulate octamer-dependent enhancer activity": 0.01462, "complex fashion": 0.01684, "immunoglobulin heavy chain enhancer": 0.00454, "tcp": 0.00056, "serine-32": 6e-05, "alpha degradation exhibit similar": 0.00585, "rescue fas-induced cell death": 0.0384, "excised tumor": 0.00934, "tyrosine kinase activity": 0.0195, "g-protein-coupled chemoattractant receptor": 0.01714, "animal lectin play important role": 0.00531, "induce cytolytic susceptibility": 0.01694, "-dependent mechanism": 0.01058, "dissociation rate": 0.00279, "allele ratio": 0.0022, "adeno-associated virus p5 promoter": 0.01168, "accumulation": 0.00645, "c/ebp epsilon mrna accumulation": 0.00763, "human ciita gene": 0.02903, "cellular factor implicate": 0.01907, "restoration": 0.00031, "nonresponsive state": 0.00267, "gralpha": 0.00056, "functional consequence downstream": 0.00544, "synergizes": 0.00068, "carboxylic acid moiety": 0.00571, "prerequisite step": 0.00189, "il-10-induced modulation": 0.00257, "late activate": 0.01777, "lipid": 0.00248, "human immunodeficiency virus type-2 gene expression": 0.01452, "leishmania donovani": 0.00016, "atp hydrolyses": 0.0004, "odns show rapid regression": 0.013, "il-4-positive": 0.00012, "nf-kappa b-like factor": 0.01907, "tissue-specific alternative splicing": 0.00145, "diethyl dithiocarbamate": 0.00034, "reporter gene strategy": 0.02903, "abundant nucleolar protein": 0.03019, "elf-2b": 0.00012, "raf kinase": 0.01188, "nonexpression": 6e-05, "monocyte tf induction": 0.01071, "transcriptional regulatory factor": 0.01907, "sh-vdr": 6e-05, "impair gamma interferon-mediated tyrosine phosphorylation": 0.00393, "erythropoietin-dependent induction": 0.01607, "serum-equilibrated ptdins": 0.0004, "cat reporter gene construct": 0.02177, "valuable model": 0.00422, "trapped ldl": 0.00084, "histological feature": 0.00217, "p53-independent pathway": 0.01278, "transient-transfection assay": 0.01002, "pge2 activate": 0.01777, "c3h mouse": 0.00974, "direct correlation exist": 0.0036, "dhl-9": 6e-05, "cd4+ t-lymphocytes": 0.00288, "cytoplasmic signal molecule": 0.0109, "myeloid cell line express": 0.0384, "antitumor function": 0.01331, "angiogenesis": 0.00019, "beta-globin-expressing murine erythroid leukemia cell": 0.03072, "delta-domain motif": 0.00875, "excretion": 0.00062, "gtgggaa": 6e-05, "translation": 0.00217, "tal-1 gene encode": 0.02903, "cytotoxic response": 0.01942, "heat syndrome": 0.00273, "zymosan-mediated transcriptional induction": 0.01071, "-induced hl-60 cell differentiation": 0.0384, "facilitate rapid dominance": 0.00215, "retinoblastoma": 0.0013, "significant rise": 0.00416, "il-7r": 0.00124, "single promoter region": 0.01557, "retarded band": 0.00102, "cooh-terminal polypeptide": 0.00136, "odns": 0.00031, "express ifn-gamma": 0.01846, "intracellular redox status": 0.00389, "qualitative aspect": 0.00124, "increase recruitment": 0.02196, "immune function data": 0.00887, "advanced renal carcinoma": 0.0012, "cell adhesion assay": 0.0512, "cytochrome p-450": 0.00037, "mek/erk signal pathway": 0.0109, "primary sequence": 0.01625, "determine nf-kappab activation": 0.02109, "okadaic acid-sensitive ser/thr phosphatase": 0.00132, "circadian pacemaker": 0.00034, "data imply": 0.00254, "sarcoidosis": 0.00025, "vd3 induce 24r-hydroxylase activity": 0.01462, "sp1 bind site": 0.01445, "interleukin-3 expression": 0.04163, "biomarkers include dna ploidy": 0.00741, "ng/ml sodium selenite +/-": 0.00093, "cag": 0.00037, "diffusible activity": 0.02925, "il-4-triggered transcriptional control": 0.00868, "glucocorticoid hormone suppression": 0.00567, "ptca": 0.00019, "induce monocyte": 0.0254, "human delta-globin-encoding gene": 0.02903, "implication": 0.00316, "human leukemia cell line ut-7/gm": 0.03072, "sodium phenylacetate treatment": 0.00676, "ill-defined border": 0.00025, "ca2+ transient": 0.00344, "cell lymphotropic virus": 0.0512, "low 24-hour urinary cortisol excretion": 0.00283, "develop unicellular culture system": 0.00333, "clinical immunosuppressive drug": 0.00283, "human t-cell leukemia virus type 1-transformed mt-2 cell": 0.0192, "ebv-transformed b-cells": 0.00093, "sci": 0.00012, "il-8 messenger rna": 0.00304, "g-csf receptor mrna": 0.01714, "somatic deletion": 0.00344, "nm": 0.00186, "105-kda precursor polypeptide": 0.00215, "t-helper cell dysfunction": 0.0512, "monick": 0.00012, "low molecular nuclear protein": 0.02264, "fundamental role": 0.01328, "post-gc": 0.00043, "severe atopic dermatitis patient": 0.00833, "construct express": 0.01846, "signal pathway mediate": 0.0109, "gata-1 binding transcription factor": 0.0143, "alzheimer": 0.00025, "phosphatidylinositol-3,4,5-trisphosphate": 0.00012, "coregulation": 0.00031, "surface antigen expression": 0.02775, "mononuclear blood cell": 0.0512, "atl-1k cell line": 0.0512, "stimulus affect mitogen activate protein": 0.01811, "bone marrow-derived macrophage bind activity": 0.0117, "cell hybrid": 0.0768, "t-cell inhibitory effect": 0.0141, "am580": 0.00043, "minimal effect": 0.02115, "basal transcription factor": 0.01907, "deoxyribonuclease": 0.00019, "jurkat cell model": 0.0512, "occasional gc": 0.0031, "dependent": 0.00775, "abnormality of/or influence nf-at": 0.00236, "hrar alpha exhibit promyelocytic morphology": 0.00468, "induce transcriptional activation": 0.02109, "transduction pathways": 0.00425, "molecular base": 0.0045, "figure": 6e-05, "cell progress": 0.0768, "transient myeloproliferative disorder": 0.0023, "putative human oncogene bcl-3": 0.01881, "heterologous enhancer element": 0.01115, "mnp": 0.00037, "kappa intron enhancer": 0.00606, "erythroid-specific protein": 0.04529, "cellular gene play": 0.02903, "ligand bind data": 0.0135, "describe mutation": 0.00592, "transcriptional assay": 0.01151, "hbv": 0.00068, "response suggest": 0.02022, "tissue origin": 0.00664, "htlv-i gene include tax": 0.02177, "interconnected lck/fyn-": 6e-05, "count": 0.0013, "helper cell cytokine gene expression": 0.03072, "caprine arthritis-encephalitis virus": 0.00591, "bcl-6 protein level": 0.03019, "ap-1-like domain": 0.01207, "d+": 0.00025, "aids-associated disorder": 0.00223, "anti-vcam-1 monoclonal antibody": 0.00596, "live k562 cell": 0.0512, "murine mast cell": 0.0512, "bcl-6 coding domain": 0.00804, "drosophila esc": 0.00121, "5'-truncations show": 0.02599, "adaptive immune system": 0.00445, "adult beta-globin expression": 0.02775, "staging": 0.00012, "m4": 0.0005, "undifferentiated dc": 0.00202, "ms-2beta": 6e-05, "hormone treatment": 0.01014, "nk cell cytotoxicity": 0.0512, "asthma": 0.00323, "cytokine stimulate growth": 0.00749, "hydrocortisone": 0.00093, "mrna isoforms": 0.01526, "vanadate peroxide": 0.00034, "hiv-1 enhancer region": 0.00978, "dna-binding trimer": 0.00561, "j.virol.65:2436-2444": 6e-05, "c-fos messenger rna": 0.00314, "pp2a play": 0.0071, "membrane glycoprotein express": 0.0123, "p40tax": 0.00056, "pml/raralpha role": 0.01328, "base level": 0.01821, "tgf-beta promoter": 0.02336, "develop xanthomatosis": 0.00403, "raji cell induce": 0.0512, "elk-1 gene expression": 0.02903, "determine dna sequence": 0.01084, "lbp": 0.0005, "autosomal dominant inheritance": 0.00163, "proteolytic regulation": 0.01008, "sp1/ap-2": 0.00019, "2-hydroxyethyl": 0.00012, "cell subset isolate": 0.0512, "oct-4": 6e-05, "tcr rearrangement": 0.00478, "regulate viral": 0.01253, "72-hour incubation": 0.00208, "t-cell acute lymphoblastic leukemia": 0.00481, "cell cycle-associated gene": 0.0512, "murine macrophage-like cell line raw": 0.03072, "autoimmune response": 0.01942, "cotransfected human cell": 0.0512, "down-regulates cd95l transcription": 0.01873, "cathepsin g-stimulated platelet": 0.00248, "-1h-hexahydro-1,4-diazepine hydrochloride": 0.00025, "tcr-mediated signaling process": 0.00372, "tar-independent mechanism": 0.01058, "mouse thymus": 0.00974, "lps-lps binding protein": 0.03019, "monocytic production": 0.01042, "monocyte-specific function": 0.01331, "key protein": 0.04529, "inflamed joint": 0.00034, "sh2 domain-containing tyrosine phosphatase shp2": 0.00284, "snrna": 0.00043, "activate nf-at-dependent transcription": 0.01873, "human age": 0.03762, "bob-1": 0.00012, "alpha-tocopherol inhibits agonist-induced monocytic cell adhesion": 0.0256, "xscid provide": 0.00645, "hhv-6 infection": 0.0062, "hematopoietin/cytokine receptor superfamily": 0.01714, "important limitation": 0.00689, "hela cell extract": 0.0512, "hyponatremia": 0.00037, "cell type-specific increase": 0.0512, "nc2.10 induction": 0.01607, "phosphorylated prb": 0.00202, "dihydropyrimidine dehydrogenase deficiency": 0.00074, "15-30 min": 0.00127, "reproducible": 6e-05, "ltr posse functional redundancy": 0.00408, "block myogenesis": 0.01073, "tat upregulates interleukin-2 secretion": 0.00214, "calcium-dependent immediate-early gene induction": 0.02177, "cell lack marker": 0.0512, "estrogen receptor binding": 0.01714, "u1 monocytic cell": 0.0512, "bind contribute": 0.02025, "interassay coefficient": 0.00012, "gammac chain gene promoter": 0.02177, "autofluoresence": 6e-05, "nf-gm2 complex": 0.01684, "calcium/calmodulin-dependent serine/threonine phosphatase": 0.00176, "generate transgenic mouse express e2a-hlf": 0.00738, "ubiquitous otf-1 factor": 0.01907, "mitogenic signalling response": 0.01294, "tal-1 gene product": 0.02903, "undergone": 0.00062, "atf": 0.00056, "histone h1 suggest": 0.01348, "genetic mechanism": 0.01058, "pma enhance": 0.00974, "pan/e2a protein expression": 0.03019, "cd3 depletion": 0.00161, "nuclease s1 protection analysis reveal": 0.00471, "inhibit lps-stimulated accumulation": 0.0127, "prevents apoptosis": 0.0089, "basophil cell distribution": 0.0512, "small region": 0.01467, "okt3/pma": 0.00012, "re/ap reporter": 0.00552, "diabetic nephropathy show increase activation": 0.01266, "redox sensitivity": 0.00236, "5'-nt": 6e-05, "sox4": 0.0, "retroviral vector": 0.00319, "b-chronic lymphocytic leukemia": 0.00333, "-kappab activation": 0.03164, "mabs inhibits": 0.0053, "finding remain unclear": 0.00347, "missense mutation": 0.00592, "squirrel monkey f774l receptor": 0.01286, "5'-cgaaaatttcc-3": 6e-05, "rb protein": 0.04529, "cdna-transfected tf-1": 6e-05, "rho potentiate ap-1 transcription": 0.01405, "wiley-liss": 6e-05, "detectable tal1 rearrangement": 0.00184, "extracellular matrix glycoprotein": 0.00112, "ala substitution": 0.00112, "classic androgen receptor": 0.01714, "gamma-radiation": 6e-05, "erk": 0.00167, "soluble cytokine": 0.01123, "nuclear extract show decreased": 0.013, "corticosteroid": 0.00285, "transcriptional regulatory element require": 0.00836, "albeit": 0.0005, "suppress tyrosine phosphorylation": 0.00656, "gssg/gsh-induced adhesion response": 0.01294, "erythroid pathway contrast": 0.00852, "diverse physiologic role": 0.00885, "activate hsf": 0.01777, "reveal dysregulation": 0.01098, "tcr-cd8 complex condition long-term clonotype persistence": 0.00561, "intact nf-kappa": 0.01414, "fibrillar collagen": 0.00025, "ifn-alpha treatment": 0.01014, "32pi-labeled stat5 bind site": 0.01084, "hematopoietic cell line k562": 0.0384, "physiological process": 0.00444, "-152": 6e-05, "report represent": 0.0049, "ii": 0.01452, "pll": 6e-05, "nr2 hybrid": 0.00171, "lowered affinity": 0.00391, "genomic": 0.0054, "cdc42-like fashion": 0.00161, "kip1": 0.00031, "key functional role": 0.00885, "phosphorylation site": 0.02168, "lps tolerance": 0.0035, "venous blood lactate concentration": 0.00335, "ra-independent differentiation": 0.01179, "steady-state mrna level increase": 0.01098, "anti-lps mabs": 0.00059, "mzf-1 transcriptional regulation": 0.00767, "adherence result": 0.0161, "hormonal interaction": 0.00986, "apparent seasonal variation": 0.00128, "molecular mechanism regulate": 0.00835, "organizational pattern": 0.00549, "mycoplasma product": 0.00533, "oxidant hypochlorous acid": 0.00571, "human granulocyte apoptosis": 0.02508, "cell shape change": 0.0512, "permissivity factor": 0.0286, "signal transduction mediate": 0.0109, "zinc sulfate": 0.00177, "trap": 0.0005, "mouse il-10r construct": 0.00649, "total population": 0.00307, "itf-1": 6e-05, "glucocorticoid induces down-regulation": 0.00567, "cytoplasmic protein": 0.04529, "h2o2 treatment suppress dna-binding activity": 0.0117, "xlh": 0.00025, "antiproliferative response": 0.01942, "normal retinoid signaling": 0.00806, "repeat number equal": 0.00354, "peripheral blood-derived human monocyte": 0.01881, "acute leukemia patient": 0.0111, "subcellular compartmentalization": 0.0004, "-130": 0.00037, "phorbol ester 12-o-tetradecanoylphorbol-13-acetate": 0.00362, "human granzyme": 0.03762, "5'-flanking sequence": 0.01625, "site abolish lps induction": 0.01084, "copy upstream": 0.00369, "variant fusion partner": 0.00217, "previous result show": 0.01733, "gal4 dbd": 0.00047, "dnase i-hypersensitive chromatin site": 0.01084, "30-36 day": 0.00146, "site-directed mutagenesis reveal": 0.00732, "s2": 0.00012, "activated il-2 receptor complex increase": 0.01029, "study il-2": 0.01355, "human atherosclerotic lesion": 0.02508, "kappa b/mad-3": 0.00748, "protein show weak dna bind": 0.01811, "interact protein": 0.04529, "components/pathways": 6e-05, "lmp1 ct correspond": 0.0018, "proteasome inhibitor n-acetyl-l-leucinyl-l-leucinyl-l-norleucinal": 0.006, "therapeutic target": 0.00825, "inhibit lif-induced hiv replication": 0.00952, "functional study demonstrate": 0.01065, "cd3/tcr pathway enhance": 0.00852, "peptide cover": 0.00754, "hiv-1-": 0.00012, "pathogenic signal": 0.01635, "il-2 promoter-chloramphenicol acetyltransferase construct": 0.00558, "potent presenter": 0.00357, "functional density": 0.00816, "antiestrogens": 0.00025, "id3 level increase": 0.01464, "aged population": 0.00307, "ig expression": 0.04163, "sporadic case": 0.00363, "tnf-": 0.00043, "constitutive nf-kappa": 0.01414, "non-expressing cell": 0.0768, "-inducible protein": 0.04529, "spleen focus form virus": 0.00527, "cis-acting element gm-kappa b/gc-box": 0.00836, "share extensive homology": 0.00192, "phytohemagglutinin-mediated activation": 0.03164, "hu induce": 0.0254, "plant": 0.00031, "tumor necrosis factor receptor signal pathway": 0.00953, "clone-13": 0.00012, "promoter region lack": 0.01557, "putative factor": 0.0286, "tfiid": 0.00118, "can/nup214": 6e-05, "egr-1": 0.00515, "naov": 0.00019, "apc express": 0.01846, "kappab-dependent gene expression": 0.02903, "suggest platelet production": 0.01348, "promoter-proximal site": 0.02168, "substitute": 0.00149, "dna-binding form": 0.01055, "radiation dose": 0.00158, "male breast cancer patient": 0.00833, "consensus ah receptor dna bind site": 0.00857, "tumor respond": 0.00934, "isoforms pax-5d": 0.00307, "short-term systemic effect": 0.0141, "hormonal regulator": 0.00304, "arterial endothelial cell": 0.0512, "lytic cycle gene": 0.02903, "proximal jun1 tumor promoter-responsive element": 0.00669, "mkp-1 inactivates map kinase": 0.00594, "celiac disease due": 0.00449, "ebf-deficient mouse suggest": 0.01348, "lipoprotein": 0.00236, "cell source": 0.0768, "responsive element regulate expression": 0.02081, "bone marrow transplantation": 0.00143, "u-937 cell differentiation": 0.0512, "thymidine proliferation assay": 0.00668, "null": 0.00031, "aml1 runt dna-binding domain": 0.00603, "prepared monochloramine": 0.00037, "chromosome": 0.00589, "rxr alpha protein": 0.03019, "pet site": 0.02168, "subsequent dissociation": 0.00304, "interferon-gamma promoter": 0.02336, "htlv-1 transformed human lymphoid line": 0.01505, "conserved motif": 0.00875, "tyrosine phosphorylation status increase": 0.01098, "gel shift": 0.00183, "blr2 gene": 0.04355, "granulocyte macrophage colony-stimulating factor": 0.0143, "cell exhibit defect": 0.0512, "cho-cd80": 0.00031, "hypothyroid patient": 0.01666, "cis element": 0.01672, "cooperative inhibition": 0.01061, "altered ikappab-alpha phosphorylation": 0.00656, "common polymorphism": 0.0035, "predominant e2f complex": 0.01123, "tcf-1 belong": 0.00189, "il-4 similarly affect il-6 expression": 0.01665, "chemoattractant": 0.00112, "luciferase reporter gene link": 0.02177, "primary human monocyte change": 0.01881, "lysp100": 0.00068, "synaptic transmission": 0.00053, "nf-at oligonucleotide": 0.00397, "nfat gene family member characterize": 0.01742, "lupus express estrogen receptor transcript similar": 0.00857, "stimulated": 0.00211, "-4": 0.00068, "cem c7 cell show": 0.0384, "proximal purine box site": 0.01084, "cycle remain ovulatory": 0.00347, "phosphatase inhibition": 0.01061, "influence nfat-1": 0.00471, "hiv-1 isolates": 0.00878, "setting": 0.00012, "unidentified superantigen": 0.00078, "unprimed cell": 0.0768, "affect cell proliferation": 0.0512, "parameter determine": 0.00779, "constitutively active pkcs": 0.00395, "important tissue-specific regulatory dna element present": 0.00557, "elk-1 protein": 0.04529, "regulate glucocorticoid sensitivity": 0.00835, "autoregulatory control": 0.01303, "type ii gene expression": 0.02177, "cd28-mediated signal transduction": 0.0109, "gene-proximal regulatory element": 0.01115, "kappa b-binding": 0.00748, "biosynthesis": 0.00025, "receptor-containing cell": 0.0768, "distal enhancer": 0.00909, "divergent effect": 0.02115, "suppress arachidonate release": 0.00407, "trans-activating phenotype": 0.00366, "periodontal research": 0.00028, "autosome/xi translocation": 0.00515, "heterozygote carrier": 0.00053, "atll patient": 0.01666, "medical treatment": 0.01014, "apoptosis-resistant subclone": 0.0004, "il-4-independent mechanism": 0.01058, "subsequent deletion": 0.00344, "dapi banding pattern": 0.00366, "hypersensitive site": 0.02168, "hl-60 promyelocytic leukemia cell line": 0.03072, "immunoperoxidase staining": 0.00177, "aberrant activation": 0.03164, "huvec nucleus": 0.00319, "atg": 0.00031, "additional translocation": 0.00515, "ltr-cat reporter construct": 0.00484, "proximal membrane signaling": 0.00372, "malignant lymphoproliferative disorder": 0.00149, "apoptosis inducer": 0.0089, "apparent dissociation constant": 0.00128, "transfected reporter gene construct": 0.02177, "gal4": 0.00093, "octamer-binding protein oct-1": 0.03019, "non-lymphoid": 0.00031, "chimeric e2a-hlf protein isolate": 0.02264, "pathogenicity": 0.00025, "thiazolidinedione derivative": 0.00192, "high throughput screening": 0.0062, "stat3 activation occur early": 0.01582, "nf-il6 mrna": 0.01526, "constitutive c-fos transcript level": 0.0091, "vcam-1 gene transcription": 0.02903, "estrogen bind assay": 0.0135, "differentiation-inducing capacity": 0.00329, "immunophilin bound": 0.00292, "dexamethasone stimulation": 0.0112, "noticeable exception": 0.0004, "normal human subject": 0.02508, "human irf-2 gene": 0.02903, "salt": 0.00118, "regulate upstream kinase": 0.00835, "oct factor gene": 0.02903, "added lipopolysaccharide": 0.00245, "nadph oxidase": 0.00062, "induce erythroid-specific gene expression": 0.02177, "autoreactive thymocytes": 0.00257, "antisense cell line": 0.0512, "constitutive active version": 0.00395, "negative regulatory pathway": 0.00852, "non-classic target tissue": 0.0055, "vitro stimulation": 0.0112, "p-lps": 0.00012, "calcium signalling pathway": 0.00852, "promoter deletion construct demonstrate": 0.01168, "interleukin-8 gene expression": 0.02903, "drug hypersensitivity": 0.00338, "cytotoxic t-lymphocytes": 0.00174, "tcf-1 alpha bind site": 0.01084, "immunohistochemical technique": 0.00109, "precise molecular abnormality": 0.003, "c-fos mrna level": 0.01214, "nf kappa b-dependent gene expression": 0.01742, "cellular gene expression": 0.02903, "major pb1 nuclear protein-binding complex": 0.00674, "suggest alternative approach": 0.01348, "enhanced nf-kappa": 0.01414, "dna transfer": 0.01483, "human monoblast cell line u-937": 0.03072, "5'-untranslated leader": 0.00019, "d5g6": 0.0, "pathogenic retrovirus human t-cell leukemia virus type": 0.01075, "critical mechanism": 0.01058, "express early": 0.01846, "active treatment period": 0.00676, "atra-induced cd38+ cell": 0.0512, "concentration 100-fold low": 0.00471, "transformed lymphocyte": 0.01483, "abrogate gc-induced apoptosis": 0.00593, "increased degradation": 0.00363, "control viral infection": 0.00868, "tpck": 0.00081, "murine leukemia virus family": 0.00444, "beta 2-microglobulin": 0.00673, "vivo anti-inflammatory effect": 0.0141, "tumor-draining": 0.00056, "bind pebp2/cbf": 0.02025, "potent": 0.00713, "strong inducer": 0.00347, "high replicative capacity": 0.0062, "r129c": 0.00012, "elk-1 fusion protein": 0.03019, "prolong incubation": 0.00208, "nf-kappab-like element": 0.01672, "cytoplasmic": 0.008, "vitro expression assay": 0.02775, "enzymatic assay": 0.01002, "clone jak3 kinase": 0.00792, "require engagement": 0.01315, "caccc": 0.0005, "mycoplasma fermentans lipid-associated membrane protein": 0.01811, "dense lymphocyte infiltration": 0.00988, "physiologic mechanism": 0.01058, "pleural macrophage": 0.00589, "gene vary": 0.04355, "expression cdna cloning": 0.02775, "d.g.tenen": 6e-05, "signal event mediate": 0.0109, "enzyme participate": 0.0031, "excessive expression": 0.04163, "bmax": 0.00087, "distinct cell type-specific complex": 0.0384, "cell-specific component": 0.00456, "calcium-mobilizing receptor": 0.02571, "b-cell receptor complex": 0.01714, "fk506.fkbp12 drug-immunophilin complex inhibit": 0.00952, "inflammatory pathogenesis": 0.00471, "readily measure": 0.00388, "extent fra-1": 0.00115, "patient lack": 0.01666, "taqi": 0.0005, "genomic sterol regulatory sequence": 0.00813, "cytopathic virus inhibits ifn induction": 0.00643, "id3": 0.0018, "southern blotting": 0.00056, "antiviral drug acyclovir": 0.00225, "vulva": 6e-05, "7-day exposure": 0.0035, "bat box binding protein": 0.02264, "early erythroid precursor stimulate": 0.00551, "binding sit": 0.01855, "il-6 chloramphenicol acetyl transferase": 0.00195, "5-isoquinolinylsulphonyl": 0.00012, "-pentazocine": 0.00012, "chimeric oncoprotein": 0.00164, "rpos": 0.00087, "jnk/sapk activation upstream": 0.02109, "nf-kappab essential modulator": 0.00666, "h. diffusible endothelial protein": 0.02264, "aml-m1": 0.0, "binding activity": 0.02925, "9-cis ra-mediated granulocytic differentiation": 0.00589, "inhibit nf-kappab-mediated transcription": 0.01873, "language": 0.0, "stat-5 induction": 0.01607, "homozygous codeletion": 0.00028, "negative cis-acting dna element cluster": 0.00669, "tcr alpha gene": 0.02903, "normal menses": 0.0121, "nf-at-1 element": 0.01672, "eicosanoid metabolite": 0.00109, "lymphocyte activate": 0.01777, "cell express p45": 0.0512, "proinflammatory mediator": 0.00195, "antigen present cell interacts": 0.0384, "eosinophil-associated granule protein": 0.03019, "ig-mediated b-cell activation": 0.02109, "varicella": 0.0005, "ets family member": 0.0056, "ebv fail": 0.00565, "hydrolysis": 0.0005, "4-h nk cytolysis assay": 0.00501, "tcr engagement result": 0.01073, "leukocyte-platelet conjugate": 0.00028, "versus": 0.00273, "control hla-dq expression": 0.02775, "ly294002 study show": 0.01733, "lymphocytic receptor concentration": 0.01714, "sse-like element": 0.01672, "macrophage": 0.01179, "select case": 0.00363, "pleiotropic transcription factor": 0.01907, "element demonstrate": 0.01672, "il1-ra": 0.00012, "rat irf-1 gene": 0.02903, "coexpressed p50": 0.00288, "dq2": 0.00056, "aldosterone": 0.00372, "induce nf-kappab binding": 0.01694, "acute phase": 0.00369, "nuclear abundance": 0.01684, "clinical relevance": 0.00425, "limited proteolytic digestion": 0.00072, "caccc-binding protein": 0.04529, "b7.1 expression": 0.04163, "tamoxifen": 0.00087, "act downstream": 0.00496, "dq molecule": 0.00853, "3-5 day": 0.00146, "cd40 signaling": 0.00558, "developmental regulation": 0.01008, "lipopolysaccharide signal transduction": 0.0109, "murine b29 promoter": 0.01557, "cd15lo": 0.00012, "main activity": 0.02925, "host cell differentiation": 0.0512, "hsf2-beta inhibits hemin-induced heat shock gene expression": 0.01244, "glycosidase activity": 0.02925, "abolish acute hepatic injury": 0.00185, "c2 protein": 0.04529, "xy female": 0.00158, "partial sensitivity": 0.00236, "simultaneous": 0.00149, "glycoprotein iib": 0.00152, "hvs stp-c488 p10": 0.00014, "obvious sequence homology": 0.01084, "promoter sequence responsive": 0.01557, "pkc-independent pathway": 0.01278, "subsequent monocyte adhesion": 0.00798, "signaling role": 0.01328, "treatment increase ap-1": 0.01464, "thr alpha-ppar heterodimer": 0.00136, "caspase-6-like": 0.0, "activate jak kinase": 0.01185, "drive activity": 0.02925, "undergo": 0.00459, "cell receptor stimulation": 0.0512, "antigen activates phospholipase": 0.00546, "major histocompatibility complex class ii dra promoter occupancy mediate": 0.00519, "group iii burkitt": 0.00325, "ifn-gamma-induced reporter gene activity": 0.02177, "oncoprotein spi-1/pu.1": 0.00115, "serum-independent hl60 cell line": 0.0384, "heteromeric complex formation": 0.01123, "terminal protein": 0.04529, "lymphocyte-specific transcription factor oct2": 0.0143, "e2f-1 level": 0.01821, "infectious virus stock": 0.00591, "compound inhibit il-2 mrna": 0.00952, "hemoglobin-positive cell": 0.0768, "egr-1 transgene": 0.00257, "induce nf-kb binding activity": 0.01462, "helenalin": 0.00025, "hematopoietic transcription factor gata-1": 0.0143, "provide direct evidence": 0.0043, "n-myc gene": 0.04355, "inhibit il-2 response": 0.01294, "tetrahydrocortisol inhibited expression": 0.02775, "stat5-related protein": 0.04529, "shp2-interacting transmembrane adaptor protein": 0.02264, "amino acid function": 0.00887, "firm structural basis": 0.0012, "stimulate b29 transcription": 0.01873, "distal il-2 enhancer differs": 0.00558, "immunological implication": 0.00158, "abnormal hematopoiesis": 0.00195, "report describe significant systemic effect": 0.00846, "ctla-4 signal inhibits event early": 0.00654, "regulator": 0.00608, "hiv-infected cell": 0.0768, "oct-2 expression vector": 0.02775, "rat primary microglia": 0.00492, "pharmacologic blockade": 0.00068, "anti-immunoglobulin": 6e-05, "growth factor-induced gene": 0.02903, "mc1288": 0.00012, "jalaguier": 0.0, "cytokine pattern": 0.01123, "e2f-1 activity": 0.02925, "prolong infection": 0.0062, "microbial superantigens": 0.0004, "bacterial peptide express": 0.0123, "chronic activation": 0.03164, "target unrearranged igh gene": 0.02177, "include cholera toxin": 0.00959, "kb id-3l transcript": 0.00399, "protein expression increase 2-3-fold": 0.02264, "epo signal mechanism": 0.0109, "cell receptor signal transduction cascade csa resistant": 0.02194, "bind competition": 0.02025, "predominant synthesis": 0.00583, "lipopolysaccharide-induced e-selectin expression require continuous presence": 0.01388, "inactive shp1-d421a": 0.00161, "rbp-jkappa binding site": 0.01445, "murine il-16 gene share": 0.02177, "nfat-1 activity": 0.02925, "il-10 inhibits ifn-gamma-induced transcription": 0.01405, "nos inhibitor enhance basal nf kappab activation": 0.00904, "arsenic trioxide": 0.00022, "prostate-specific antigen": 0.00819, "characterize nf-kappa b-independent transcriptional activation": 0.01266, "beginning": 0.0, "specificity-conferring mechanism": 0.01058, "dna bind capacity": 0.0135, "aml-1": 0.00025, "jak1": 0.00248, "endemic burkitt": 0.00065, "facilitate accumulation": 0.00323, "permit functional diversification": 0.00544, "hs-40 enhancer region": 0.00978, "cre oligonucleotide probe": 0.00174, "adult type": 0.00949, "couple activated zap-70/syk": 0.00393, "cholera toxin": 0.00053, "select develop tissue": 0.00443, "adenoviral persistence base": 0.00207, "include bind site": 0.01445, "zebra/ebv biological system": 0.00445, "t-cell-specific transcription factor": 0.01907, "j. bernard": 0.00056, "transplant": 0.00081, "apc pulse": 0.00093, "cd2019": 0.00012, "rela-mediated transcription": 0.0281, "inducible binding": 0.01855, "p100 function": 0.01331, "sp1-binding site": 0.02168, "stat5a/stat5b heterodimerization": 0.00059, "oxidant-induced nf-kappab activation": 0.02109, "develop successful immunotherapy": 0.00269, "rares": 0.00019, "ptk substrate": 0.00199, "major inducible protein complex": 0.02264, "epithelial tumor ag": 0.00622, "murine fosb gene": 0.02903, "cytokine mrna level": 0.01214, "phorbol ester coincides": 0.00362, "presence correlate": 0.00654, "regulate cell-type-specific": 0.01253, "primary peripheral blood mononuclear cell": 0.03072, "2.6-kilobase messenger rna present": 0.00368, "r. h.": 0.00118, "tcl1 oncogene expression": 0.02775, "transcriptional property": 0.01151, "p1-79 probe": 0.00261, "burst-forming units-erythroid": 0.00025, "cd30 limit": 0.00161, "tissue-specific transcription factor": 0.01907, "functional receptor protein remain": 0.02264, "cp": 0.00161, "cd4 gene transcription start site": 0.01742, "stimulation": 0.02239, "recombinant timp-1": 0.00391, "type ii ifns": 0.00633, "epidermal cell": 0.0768, "neonatal": 0.00205, "charybdotoxin-sensitive": 0.0, "ikb alpha": 0.01169, "kinase inhibitor h-89": 0.00792, "ig gene silencing": 0.02903, "human hematopoietic cell": 0.0512, "125i-labeled tgf-beta": 0.00118, "flow cytometric analysis": 0.00786, "flre": 0.00012, "cord blood-derived cd34": 0.00068, "phorbol ester 12,13-phorbol dibutyric acid": 0.00342, "sequence-specific breakage": 0.00105, "core-specific mab inhibit mcd14-mediated uptake": 0.00762, "coordinated manner": 0.00282, "lt-alpha1beta2 act": 0.00496, "cellular redox status influence": 0.00447, "adult mouse thymus": 0.00649, "immune donor": 0.00599, "tuberculin": 0.0, "ifn-gamma response element": 0.01294, "express tgfs": 0.01846, "chronic rheumatoid arthritis": 0.00265, "tcc assembly": 0.00164, "subline": 0.00025, "nonasthmatic individual": 0.00409, "stain": 0.00192, "include cell distribution study": 0.0384, "cd95l promoter": 0.02336, "toll": 0.00043, "interferon alpha": 0.01169, "mmol/l diamide": 0.00022, "monocytic cell line u1": 0.0384, "phosphorylation status correlate": 0.00656, "-ii": 6e-05, "viral dna replication": 0.00988, "transcriptional regulation": 0.01151, "spi-b activity": 0.02925, "ap1-dependent reporter construct": 0.00484, "activin": 0.00068, "tnf resistance": 0.00481, "dq2-anchor residue": 0.00226, "isoforms show": 0.02599, "intracellular concentration": 0.0067, "stat4": 0.00174, "large cell": 0.0768, "signaling pathway implicate": 0.00852, "bind hsp90": 0.02025, "l-shaped": 6e-05, "il-6-": 0.00019, "minor transcription start site": 0.01405, "noncomedo carcinoma": 0.0018, "inducible metallothionein promoter": 0.01557, "fivefold increase": 0.02196, "c-fos mrna": 0.01526, "high risk breast cancer": 0.00465, "kappa b-like protein": 0.03019, "spliced isoforms": 0.00307, "isoelectric point": 0.00183, "-2 expression": 0.04163, "chimeric hlf protein": 0.03019, "inducer-mediated stimulation": 0.0112, "variable weak phosphorylation": 0.00656, "epstein-barr virus-immortalized human": 0.02508, "plasma cortisol": 0.00375, "aunt": 6e-05, "consensus ckii site": 0.01445, "elution property": 0.00397, "human coronary atherosclerotic plaque": 0.01881, "activate ap-1 complex": 0.01185, "anionic glycerophospholipid": 0.00022, "peptide-mhc avidity": 0.00025, "junb-control": 6e-05, "generate transgenic mouse": 0.00649, "human t-cell lymphoma cell line": 0.03072, "culture m-tat cell long term": 0.03072, "adhesion molecule include integrin alpha": 0.00576, "c-11-substituted": 6e-05, "atra-treated kasumi-1 cell": 0.0512, "low nm23.h1 gene expression": 0.02177, "g0 phase": 0.00276, "tcr/cd3 signal transduction pathway": 0.00817, "a-myb play": 0.0071, "identical deletion": 0.00344, "p50/relb": 0.00012, "pebp2 site": 0.02168, "ltr sequence": 0.01625, "conventional equi-effective dos": 0.00081, "il-2r beta membrane expression": 0.02081, "tax-by cyclosporin": 0.0022, "g1 phase transition": 0.00184, "report germ-line sequence": 0.01084, "protein structure": 0.04529, "transcriptional silencer": 0.01151, "proviral latency": 0.0014, "jak3 expression": 0.04163, "tsap": 0.00019, "capable": 0.00521, "-terminal kinase": 0.01188, "glial tumor": 0.00934, "tsh receptor": 0.02571, "complete haematological remission": 0.00114, "dd product reveal": 0.00732, "4-hour advancement": 3e-05, "ym-268": 6e-05, "antiatherogenic": 0.00031, "ligand-binding activity correlate": 0.0195, "glucocorticosteroids remain": 0.00521, "shp2": 0.0005, "allele mrna": 0.01526, "ccaat bind factor nf-y": 0.0143, "upstream regulatory sequence": 0.01084, "constitutively represses transcription": 0.01873, "late feedback": 0.00254, "alternative splice": 0.00205, "tpp47": 0.00012, "inducible ubiquitous nuclear component": 0.00842, "called costimulatory signal": 0.0109, "secretory vesicle": 0.00022, "signal pathway contributes": 0.0109, "strong cyto-differentiating potential": 0.00403, "gamma-positive cell": 0.0768, "tissue-specific regulators/adapters": 0.00217, "characterize mechanism responsible": 0.00705, "433-442 peptide stimulate": 0.00734, "alter camp-induced gr expression": 0.02081, "misfunction": 6e-05, "flow cytometric cell": 0.0512, "jun protein bind": 0.03019, "ad2 virus infection": 0.00591, "mapk activation": 0.03164, "culture corneal endothelial cell": 0.0384, "human umbilical vein ec": 0.01881, "nk/lgl cell": 0.0768, "tramp lead": 0.00996, "fragment confers cell-specific expression": 0.02081, "stimulate camp accumulation": 0.00734, "chimeric receptor ar/tr2/ar": 0.01714, "stimulate 18-fold": 0.01101, "stat enhancer": 0.00909, "dexamethasone inhibit il-2-induced": 0.0127, "gp160-induced ap-1 complex": 0.01123, "generality": 6e-05, "transcript initiate": 0.00599, "control group": 0.01303, "deficiency": 0.00223, "timp-1-positive bl line show resistance": 0.0104, "il-2 control": 0.01303, "hypercalciuria": 0.00019, "gel-mobility shift assay": 0.00668, "mediate cd4 accessory function": 0.00665, "wild-type hlf protein": 0.03019, "substrate specificity": 0.00335, "interstitial deletion constitute": 0.0023, "morphological differentiation": 0.01179, "substantial number": 0.0053, "glucocorticoid hormone compound": 0.00567, "pcr approach": 0.00164, "immunoelectron microscopy": 0.0005, "technique": 0.00217, "hybrid": 0.00341, "site overlap": 0.02168, "exhibit interaction": 0.00986, "60-kda precursor": 0.00323, "suppress tnfalpha": 0.00611, "nls peptide deliver": 0.00502, "bw5147": 6e-05, "il-10 prevents human monocyte nf-kappab activation": 0.01254, "ad vector": 0.00319, "transferrin receptor mrna": 0.01714, "oncogenic e2a-hlf fusion protein reverse": 0.01811, "mononuclear phagocyte play": 0.00474, "atherosclerotic event": 0.00552, "sufficient number": 0.0053, "lps-induced ap-1": 0.00695, "reactivity": 0.00261, "thymopoiesis": 0.00012, "intracellular calcium": 0.00583, "total level": 0.01821, "immune competence": 0.00599, "hot aqueous phenol extraction": 0.00011, "mrna synthesis": 0.01526, "immunomagnetic bead": 0.00016, "restricted subset": 0.00192, "palmitate": 0.00012, "immunophenotypic difference": 0.00425, "normal base": 0.0121, "hydrogen peroxide serve": 0.00103, "conventional mechanical ventilation": 0.00043, "nuclear export signal": 0.01123, "il-6 gene": 0.04355, "amino": 0.00546, "de novo infection": 0.00414, "ifn-induced gene": 0.04355, "clearance mechanism": 0.01058, "pkcs": 0.00012, "epstein-barr virus early antigen diffuse component": 0.00296, "primary b-lymphocyte growth transformation implicate traf aggregation": 0.00234, "cd4 promoter": 0.02336, "proximal cd25 promoter": 0.01557, "otf-2 protein enhance dra gene transcription": 0.0151, "gm-csf promoter play": 0.01557, "il-2r alpha gene transcription": 0.02177, "fetal thymocytes": 0.00257, "plasma membrane phospholipid": 0.003, "natural gata element": 0.01115, "bound nk cell": 0.0512, "tnf-alpha transcript": 0.00599, "g. vaginalis lysates activate hiv long-terminal repeat transcription": 0.00703, "-40/-32": 6e-05, "adenylate cyclase activator": 0.00368, "viral reactivation": 0.00732, "immunocompetent animal": 0.00118, "dopamine treatment": 0.01014, "octa": 0.00031, "pas region": 0.01467, "inducible cytoplasmic form associate": 0.00546, "autosomal recessive form": 0.00703, "isolated fdc cluster": 0.00126, "demonstrate activation": 0.03164, "additional vdr 3'-utr polymorphism": 0.00171, "soluble mediator": 0.00223, "convergence": 0.00019, "cell il-10 stimulates tyrosine phosphorylation": 0.03072, "carboxyl-terminal cytoplasmic tail": 0.00267, "ifn-gamma varies": 0.00481, "g0s24": 0.00012, "responsiveness": 0.00645, "gt ii": 0.00726, "sri responder show gcii sites/cell upregulated": 0.00866, "zinc-finger gene": 0.04355, "constitutive p21ras activity": 0.0195, "autoimmune disorder": 0.00223, "hla dqa1*0201": 0.00192, "cellular electrolyte transport": 0.00596, "gata factor expression": 0.02775, "core": 0.0044, "cyclic amp-responsive element-like sequence": 0.00813, "naive donor": 0.0014, "relevant protein": 0.04529, "confirm nodal involvement": 0.00223, "myc-associated zinc finger protein": 0.02264, "pd": 0.00031, "human lymphocyte base": 0.02508, "major identifiable risk factor": 0.0143, "decreased activation": 0.03164, "cis element bind": 0.0135, "natural host cell": 0.0512, "confluency": 6e-05, "mammary gland factor-stat5": 0.00066, "tat cdna": 0.00456, "level low": 0.01821, "provide transcriptional activation": 0.02109, "nf-kappa bp65": 0.01414, "intact cooh-terminal domain": 0.00804, "gene disruption": 0.04355, "activated t-lymphocytes": 0.00589, "immunoreactive": 0.00093, "detectable effect": 0.02115, "transient expression assay": 0.02775, "epithelial cancer": 0.00248, "analyze gata-1 expression": 0.02775, "include exogenous cytokine": 0.00959, "bhlh family": 0.00841, "protein kinase c-mediated pathway": 0.02264, "dermis": 0.0, "nls": 0.00093, "as2o3 treatment": 0.01014, "mediate nf-at induction": 0.01071, "tumor-draining lymph node": 0.00052, "src-family kinase": 0.01188, "radio-ligand binding method": 0.01237, "intact il-2 promoter drive": 0.01168, "e. coli rpos": 0.00068, "multiple biologic activity": 0.0195, "ap-1 transcription factor complex": 0.0143, "catecholamine norepinephrine": 0.00022, "hbcl6": 0.00012, "rel/nf-kappab protein": 0.04529, "carboxy-terminal sequence": 0.01625, "peripheral resistance": 0.00524, "antigen": 0.01638, "include sp-1": 0.01439, "optimal cd95 ligand reporter activity": 0.0117, "mononuclear phagocyte activation": 0.02109, "p. s.": 0.00065, "express selectively": 0.01846, "'latency ii": 0.00726, "developmental stage specificity": 0.00223, "dfx decrease": 0.00971, "-2987": 6e-05, "activate gst-pi promoter": 0.01557, "thymidine kinase promoter": 0.01557, "beta-interferon": 0.00012, "renal deterioration": 0.00115, "transcriptional regulatory element associate": 0.00836, "m.tremblay": 6e-05, "person": 0.00074, "activated leukocyte": 0.00589, "transcription factor ap-2": 0.01907, "ranbp1 restores nuclear export": 0.00842, "include cd3-epsilon knockout mouse": 0.0072, "lymphocyte growth factor": 0.01907, "octamer consensus": 0.00288, "n-terminal hydrophilic domain": 0.00804, "kb-like sequence gggatttcacc": 0.01084, "cd8+ lymphocyte": 0.01483, "transcription factor reveal": 0.01907, "induce growth inhibition": 0.01694, "phytohemagglutinin/anti-cd28 activated": 0.00589, "ebv early product encode": 0.00426, "distinct dna bind specificity regulate differential gene expression": 0.01089, "cle0 sequence": 0.01625, "ca2+-dependent pkc isoforms": 0.00221, "il-10-pretreated u937 cell": 0.0512, "human cd3epsilon transgenic mouse": 0.01881, "mt-i": 0.00037, "stimulated level": 0.01821, "fcs- liquid-suspension culture": 0.00414, "human interleukin": 0.03762, "stimulate neutrophil": 0.01101, "tes1 fail": 0.00347, "cellular change": 0.00893, "hiv transmission": 0.00592, "specific inducer": 0.01238, "dna-protein complex": 0.01684, "hiv-1 tat inhibitor": 0.006, "cytokine-induced hiv-1 expression": 0.02775, "glucocorticoid promote nonphlogistic phagocytosis": 0.00425, "platelet cytoadhesin gpiib-iiia": 0.00248, "murine myeloid cell": 0.0512, "sp-1": 0.00062, "low the/thf": 0.00707, "nf-yb": 0.00031, "hiv-1 infection result": 0.01073, "lymphocyte culture": 0.01483, "require antigenic peptide": 0.00877, "lymphoid jurkat cell line": 0.0384, "-47": 0.00012, "ga-binding protein factor": 0.03019, "cut/cdp protein": 0.04529, "csa serum concentration": 0.00447, "remain tcrhigh population": 0.00347, "microsequence analysis": 0.01179, "persisting genome": 0.0014, "cell culture stimulate": 0.0512, "large part": 0.00205, "epstein-barr virus bclf1": 0.00591, "important trans-acting factor": 0.01907, "biologic response": 0.01942, "freshly isolate b-cll cell": 0.0384, "transcriptional efficiency": 0.01151, "block 12-o-tetradecanoylphorbol 13-acetate induction": 0.00803, "lipid transfer protein": 0.03019, "cell receptor alpha enhancer": 0.0384, "differential hybridization analysis": 0.00786, "hmg1b": 0.0, "serine protease inhibitor": 0.006, "multiple activate agent": 0.01185, "-64 element": 0.01672, "study initiate": 0.01355, "erythroid ala precursor protein": 0.02264, "pkr activity": 0.02925, "trypsin": 0.00019, "rapid nuclear depletion": 0.01123, "delay expression": 0.04163, "c-rel protooncogene product repress nf-kappa": 0.00566, "heterodimeric nfkb2": 0.00081, "ra-mediated repression": 0.00211, "gene represent": 0.04355, "propose model": 0.00422, "chicken il2 correspond": 0.00118, "activation-specific expression": 0.04163, "differentiation inducer": 0.01179, ".3": 6e-05, "vitamin d3 receptor": 0.01714, "g-protein couple chemokine receptor": 0.01286, "migration protein cd44": 0.03019, "ig gene transcription": 0.02903, "pre-b cell-specific": 0.00292, "d3 concentration require": 0.00877, "t1": 0.00019, "cell costimulation": 0.0768, "monocyte mitochondrial": 0.01197, "acquired deletion": 0.00344, "pm": 0.0, "erp": 0.00062, "repressive state": 0.00267, "cultured blood mononuclear cell": 0.0384, "additional enhancement": 0.00341, "interleukin-2 receptor": 0.02571, "northern blotting": 0.00096, "direct t-cell recognition": 0.00641, "isolated eosinophil": 0.00295, "exogenous nf-kappab": 0.00999, "observed failure": 0.00136, "phenotype cd38+": 0.00366, "nef inhibits nf-kappa": 0.00943, "tissue-infiltrating macrophage": 0.00589, "five-fold": 6e-05, "protein component": 0.04529, "differential affinity": 0.00391, "ikappab cytoplasmic inhibitor": 0.006, "serum-supplemented culture": 0.0062, "microm sodium orthovanadate": 0.00124, "monoblast lineage": 0.00366, "protein-tre-dna complex": 0.01684, "variant receptor transcript lack exon": 0.01029, "tuberculosis present": 0.00735, "infiltrating ductal carcinoma": 0.0012, "thyrotropin receptor gene": 0.02903, "stable transformant": 0.00171, "pmol/mg": 0.0, "ea-d": 0.0005, "cdna clone reveal": 0.00732, "low molecular weight variant": 0.00354, "rel oncogene family capable": 0.0042, "proline-rich": 0.00087, "electrolyte concentration": 0.0067, "proto-oncogene c-erba": 0.0013, "paired dna-binding domain": 0.00804, "activate pag expression": 0.02775, "cll cell": 0.0768, "ltb4 induces synthesis": 0.00536, "position effect": 0.02115, "proximal domain": 0.01207, "caml form": 0.01055, "prevented induction": 0.01607, "covalent homodimer": 0.00081, "sp1 result": 0.0161, "bind result": 0.02025, "ptf gamma": 0.0044, "nfat oligonucleotide carry mutation": 0.00296, "cytospin preparation": 0.00074, "mouse th1 development": 0.00649, "myeloid-associated gene": 0.04355, "related": 0.00471, "bucala": 0.00012, "c-myc mrna expression": 0.02775, "increased sensitivity": 0.00363, "alternative polyadenylation event": 0.00368, "dna-protein binding analysis": 0.01237, "open reading frame encode": 0.00426, "actin assembly": 0.00164, "dfs": 0.00012, "ubiquitous protein neg-2 binding": 0.02264, "tg epsilon26 mouse": 0.00649, "substoichiometric taf": 9e-05, "bind nf-at": 0.02025, "soluble factor": 0.0286, "lymphocyte infiltrates": 0.01483, "laminin": 0.00025, "bind site lead": 0.01445, "basic method": 0.00236, "western blot analysis": 0.00786, "non-t-lymphocytes": 0.00012, "exert": 0.00583, "gene induce": 0.04355, "pharmacophore": 0.0, "bp1": 0.00037, "itk": 0.00056, "anti-cd3 stimulation demonstrate": 0.01065, "sensitive target k562": 0.0055, "dna change": 0.01483, "ah receptor": 0.02571, "inducible lmp-1 mutant": 0.0054, "il-4 exhibit": 0.00667, "cmv activate": 0.01777, "play": 0.01421, "fetal hematopoietic liver": 0.00244, "detectable": 0.00552, "atp": 0.00081, "sp1 factor": 0.0286, "mhc class ii transactivator": 0.00363, "constitutive nuclear form": 0.01123, "il-12 expression": 0.04163, "gamma interferon": 0.0044, "ifn-u937 cell respond": 0.0512, "blood leukocyte content": 0.00395, "o-phenanthroline": 6e-05, "il-12 heterodimer": 0.00313, "tumor tissue": 0.00934, "hsv-2 intertypic recombinant virus": 0.00444, "lncap human prostate cancer cell": 0.03072, "anemia": 0.00087, "virus-induced erythroleukemia": 0.00059, "flanking region augments alpha-globin promoter activity": 0.00975, "proximal region": 0.01467, "e1a-region": 0.00012, "marginal amount": 0.00285, "plb-985 cell represent": 0.0512, "alpha-/- mouse exhibit severe runting": 0.0039, "increase plasma cortisol concentration": 0.01098, "clonal relationship": 0.00167, "29-kda proteolysis-resisting fragment": 0.00232, "adult nucleated erythroblast": 0.00281, "cyclin/cdks activation": 0.03164, "coincident rise": 0.00068, "heterologous enhancer/promoters": 0.00127, "human jurkat lymphoblastoid cell": 0.0384, "hil-5": 0.00068, "specific progeny": 0.01238, "2d3-dependent modulation": 0.00257, "low molecular weight specie": 0.00354, ":1091": 6e-05, "low-level activation": 0.03164, "relative difference": 0.00425, "class ii-deficient congenital immunodeficiency": 0.00321, "proinflammatory cytokine signal cascade lead": 0.00654, "gamma-chains": 0.00012, "murine nf-at complex": 0.01123, "recombinant il-12": 0.00391, "p40 promoter": 0.02336, "alter responsiveness": 0.00378, "constitutively express icam-1": 0.0123, "electrophoretic mobility shift": 0.00122, "t-cell oncogenic protein hox11 activate aldh1 expression": 0.01294, "specific protein-dna complex form": 0.00842, "simultaneous immunocytogenetic study": 0.00904, "bp -267": 0.00267, "nf-at element": 0.01672, "nuclear factor nf-kappa": 0.01907, "bind sites/nucleus": 0.02025, "ifn-gamma treatment": 0.01014, "pbgd": 0.00031, "subclones": 0.00099, "mar-bp1": 0.00025, "il-6-stimulated 1a9-m cell": 0.0512, "cell antigen-receptor": 0.0768, "ige production show": 0.01733, "express bcl2": 0.01846, "cell line fail": 0.0512, "binding protein exhibit rapid change": 0.01811, "anti-ar antibody": 0.00893, "inflammatory": 0.00943, "relb knockout mouse": 0.00649, "csa inhibit": 0.01904, "au-motif-directed display": 0.00499, "important source": 0.00689, "normal lymphocyte": 0.01483, "include defect": 0.01439, "retinoic acid receptor alpha block myeloid cell differentiation": 0.0192, "activate pth cell": 0.0512, "class ii": 0.00726, "xpd gene encode protein": 0.02264, "tnf mrna accumulation": 0.01017, "elderly individual": 0.00409, "lps-treated neutrophil": 0.00496, "soluble cd4-igg abrogate": 0.0017, "nf-ya protein": 0.04529, "cell selectivity": 0.0768, "difficult-to-control asthma": 0.00161, "7-base-pair mutation": 0.00592, "cd11b/cd18": 0.00081, "swi3 protein": 0.04529, "motif-specific dna-binding activity": 0.0195, "export complex": 0.01684, "p38 cascade play": 0.00474, "-118": 0.00012, "t-cell protein": 0.04529, "placebo-treated subject": 0.00354, "prevent vwf-mediated adhesion": 0.00387, "atherosclerotic lesion": 0.00143, "untreated euthymic patient": 0.0111, "chloramphenicol acetyltransferase reporter gene system": 0.01742, "adsorption": 0.0, "aml1/eto transcript": 0.00599, "stimulators": 0.00019, "cis-activation": 0.00012, "term nf-cle0 gamma": 0.00294, "negative cross-talk": 0.00515, "ras/raf/erk pathway": 0.01278, "mol/l 9-cis ra": 0.00397, "ifn-beta transcription": 0.0281, "mhc-peptide ligand interaction": 0.00658, "il-4-producing th0-like human jurkat": 0.01881, "parameter": 0.00254, "mad3 mrna": 0.01526, "transgenic mouse": 0.00974, "hl-60r subclone": 0.0004, "expression vector": 0.04163, "vascular-specific gene expression": 0.02903, "event trigger": 0.00552, "proviral construct": 0.00726, "il-1beta promoter construct fuse": 0.01168, "putative c-rel homodimer": 0.00248, "il-10-treated cell": 0.0768, "acute myeloid leukemia m2-type cell line": 0.0256, "c-11 analog": 0.00109, "il-2 deprivation-induced apoptosis": 0.00744, "transient outgrowth": 0.00344, "sedimentation peak show": 0.01733, "chromosomal translocation": 0.00515, "close relatedness": 0.00068, "rhesus monkey": 0.00071, "express erythroid-specific mrna": 0.0123, "mediate antiproliferative effect": 0.0141, "pge2 inhibit cell proliferation": 0.0384, "signal activity": 0.02925, "additional gene": 0.04355, "bl-2": 0.00025, "human carboxylesterase analyze": 0.02508, "myelodysplasia": 0.00012, "inhibitory kappab-alpha": 0.00357, "nf-at-binding site": 0.02168, "significant decrease": 0.00971, "human ifngr1 small deletion hotspot associate": 0.01254, "scid mouse": 0.00974, "embryonic expression": 0.04163, "antigenic response": 0.01942, "5-fold low affinity": 0.00471, "dna nuclear localization": 0.01123, "gene responsible": 0.04355, "hormone receptor": 0.02571, "tf gene expression": 0.02903, "data present": 0.00735, "ifn gamma": 0.0044, "ectopic pregnancy": 0.0009, "nf-kappa b-like transcription factor": 0.0143, "hxbp-1 protein act": 0.03019, "cell tyrosine kinase zap-70": 0.0384, "tfiid isolate": 0.00416, "moderate level": 0.01821, "drug undecylprodigiosin": 0.00338, "cell-specific coactivator": 0.00292, "rat subject": 0.00354, "triflusal-treated animal show": 0.01733, "il-2-induced growth": 0.00819, "intrathymic maturation": 0.00251, "downregulated": 0.00161, "tnf alpha gene suggest": 0.02177, "tnf-alpha-mediated activation": 0.03164, "hla-dp": 6e-05, "inhibit expression": 0.04163, "slp-76 augmentation": 0.00127, "unique immunophenotype": 0.00261, "id1 protein": 0.04529, "viral trans-activator tax protein": 0.02264, "ets-nf-kappab/nfat interaction require": 0.00877, "analyze large genomic il-4 region": 0.00587, "ifn-gamma response": 0.01942, "-187": 0.00012, "cell-specific requirement": 0.00292, "monocyte chemotaxis": 0.01197, "latent membrane protein lmp2": 0.02264, "hsf2 activity": 0.02925, "biochemical modification responsible": 0.00186, "immature neutrophilic cell": 0.0512, "cd48": 0.00025, "ra induces": 0.00803, "long version": 0.00276, "il-4 signaling": 0.00667, "erythropoietic differentiation": 0.01179, "increase body burden": 0.01464, "nuclear dna binding": 0.01237, "constitutively active form": 0.00703, "target sit": 0.00825, "t-cell dysfunction remain": 0.00641, "putative metastatic suppressor gene": 0.02177, "calcium mediate": 0.01231, "post-nuclear extract": 0.00459, "ghost membrane": 0.0045, "hiv-1-encoded nef protein suggest": 0.02264, "10-fold reduction": 0.00295, "increase thromboxane receptor gene transcription": 0.01742, "b-cell activation": 0.03164, "parental mpc11 cell carry": 0.0384, "hormone level": 0.01821, "ligand-induced homodimerization": 0.00071, "tl-om1": 0.00025, "intracellular ca2+ concentration": 0.00447, "academic press": 6e-05, "additional complex": 0.01684, "air-1 gene product": 0.02903, "genotype group": 0.00487, "pak activation": 0.03164, "prolongation": 0.00019, "differentiation induction": 0.01607, "ebv status": 0.00565, "gamma-gene": 0.00025, "tonsil": 0.00087, "jun-b gene": 0.04355, "dna sequence bind affinity profile": 0.0081, "e2f-1 promoter": 0.02336, "dq0302 molecule": 0.00853, "multiple intracellular substrate": 0.00459, "intermediate complex": 0.01684, "hyperadhesivity": 0.00012, "normal adult erythroid differentiation": 0.00605, "potential c/ebp-binding site": 0.01445, "activation response": 0.03164, "phenotype resemble": 0.00366, "mrna expression pattern": 0.02775, "jak2/stat5 activation": 0.03164, "higher-order protein complex form": 0.02264, "-3110": 0.00012, "tgf expression": 0.04163, "-ifna2": 6e-05, "high intracellular level": 0.01214, "cd8+ t-lymphocytes": 0.00146, "n-wasp": 0.0005, "signal response domain": 0.01294, "il-10 inhibits nuclear stimulation": 0.00842, "insulin-gene regulation": 0.01008, "c-fms protooncogene": 0.00056, "hladq": 6e-05, "sex steroid hormone": 0.00296, "exogenous il-2": 0.01117, "po-b dna-binding": 0.00561, "ca2+/calmodulin-dependent protein phosphatase": 0.03019, "ebv-associated nasopharyngeal carcinoma": 0.0012, "alternative mechanism include": 0.00959, "dissociation constant": 0.00102, "stimulus-induced ikappabalpha degradation": 0.00221, "event result": 0.0161, "promote cell survival": 0.0512, "distinct nuclear protein complex": 0.02264, "alter protein": 0.04529, "er associate": 0.01092, "tnf-alpha-inducible": 0.00012, "pu.1-binding site": 0.02168, "tumor prevent local tumor control": 0.00521, "paf-receptor antagonist": 0.00242, "severe combine immunodeficiency": 0.00145, "retrievable alveolar macrophage": 0.00393, "important implication": 0.00689, "cultured human": 0.03762, "uas2": 0.00019, "retinoic-acid receptor type alpha": 0.01286, "basophil express gata-2": 0.0123, "-ionophore": 0.0, "nfil-2a site": 0.02168, "develop th2 cell": 0.0512, "vivo down-regulation": 0.0053, "dq3.3": 0.00019, "class ii promoter-specific dna bind factor": 0.00953, "tcf-1-mediated transcription": 0.0281, "hiv-2 tat": 0.00257, "genomic mechanism": 0.01058, "htlv-i-transformed": 0.00074, "egf treatment induce stat3 phosphorylation": 0.01016, "c-rel protooncogene": 0.00245, "gamma-globin promoter": 0.02336, "cbf beta-myh11 fusion transcript": 0.00299, "monocytic precursor": 0.00403, "l929 cell": 0.0768, "il-15 induced stat5 binding": 0.00927, "-83": 0.00019, "require specific signal": 0.0109, "c-jun expression require protein tyrosine kinase activity": 0.01294, "dapsone": 6e-05, "fold decrease": 0.00971, "inhibit nf-kappa": 0.01904, "oca-b stimulate": 0.01101, "leukocyte-type": 6e-05, "risk group": 0.00487, "atf/creb class": 0.00642, "relevant inhibitor": 0.009, "dyad symmetry element": 0.01115, "low dose dexamethasone therapy": 0.00354, "mark": 0.00149, "rna protection assay": 0.00668, "monocytes-macrophages": 0.00019, "tata-less blr1 core promoter": 0.01168, "endemic": 0.00031, "multiple positive": 0.00689, "sr-bp 50-fold high": 0.0062, "endotoxin-stimulated cell": 0.0768, "finger region": 0.01467, "readily": 0.00149, "isotype-matched control antibody": 0.00868, "genomic footprinting": 0.0027, "il-8 release increase": 0.01464, "significant amount": 0.00416, "caenorhabditis elegans ces-2": 0.00017, "gene term class ii transactivator": 0.01742, "bulbar conjunctival biopsy": 0.00033, "tegument-specific cd4 t-cell clone exhibit cytotoxic activity": 0.00836, "sp1 site mediate basal expression": 0.01665, "funcion": 6e-05, "synergy induce": 0.0254, "affected child": 0.00099, "related retrovirus": 0.00236, "jurkat expression library": 0.02775, "malignant fibrous histiocytoma": 0.00105, "surface cd4": 0.00515, "interferon-gamma activation sequence mediate": 0.01582, "multimerized wild-type": 0.00378, "cell proliferation rate": 0.0512, "112+/-28 iu/ml": 9e-05, "pma activation": 0.03164, "nf-kappa b1 gene": 0.02903, "murine peritoneal macrophage": 0.00416, "event lead": 0.00996, "tax transactivator": 0.00478, "peptide delivery": 0.00754, "cell deliver": 0.0768, "ctl recognition": 0.00257, "increase-ratios": 6e-05, "nef reconcile diverse phenotype": 0.00183, "aacaaag motif": 0.00875, "distinct stage": 0.00698, "dichotomy": 6e-05, "human gingival fibroblast": 0.02508, "potential functional motif": 0.00583, "il-7/il-7r system transcription factor": 0.0143, "ouabain resistant": 0.00211, "ii-expressing t-cell line": 0.01102, "aml protein": 0.04529, "uninfected thymocytes": 0.00257, "tnf abolish": 0.00481, "immortal cell line": 0.0512, "lymphoid nuclear extract": 0.01123, "leukaemia": 0.00174, "cellular redox status": 0.00596, "dnase i-hypersensitive site": 0.01445, "lymphoid development": 0.00633, "pure differentiate hematopoietic progenitor": 0.00183, "zeta isoform": 0.00171, "usf/c-myc up-regulates": 0.00056, "definitive erythroid cell": 0.0512, "fail": 0.00695, "chronic mpd": 0.00397, "lymphoblastoid cell line": 0.0512, "expression library": 0.04163, "inhibit immune activation pathway": 0.01582, "human herpesvirus associate": 0.02508, "stimulate il-2 gene transcription": 0.02177, "relevant form": 0.01055, "stage selector activity": 0.0195, "dexamethasone induce": 0.0254, "upstream regulatory region": 0.00978, "normal tonsil-": 0.0121, "cell autonomous coregulation": 0.0512, "activated th1 cell": 0.0512, "pos-1": 0.00031, "activate peripheral": 0.01777, "calculated molecular mass": 0.003, "monocytic": 0.00806, "ligand-inducible phosphorylation": 0.00983, "rel/nf-kb family": 0.00841, "kds": 6e-05, "functional receptor-effector system": 0.00544, "tnf-alpha mrna induction": 0.01071, "hiv long terminal repeat transactivation": 0.00237, "heat shock protein react": 0.02264, "nfat binding": 0.01855, "microgram fluticasone propionate aqueous nasal spray": 0.00011, "optimal nk function": 0.00887, "tyrosine phosphorylated stat5b bound": 0.00355, "jurkat-t cell induce dramatic cell aggregation": 0.0128, "c/ebp family": 0.00841, "regulates fas": 0.00099, "human nk cell": 0.0512, "nature": 0.00105, "nonspecific increase": 0.02196, "beta-gene": 0.0, "maeca induce ec expression": 0.02081, "immunology": 0.00025, "transient transfectants": 0.00344, "interleukin-2 receptor alpha-chain": 0.01714, "normal exon": 0.0121, "inducible nf-kappa": 0.01414, "du528": 6e-05, "nonproductive": 0.00043, "previous assumption": 0.00133, "dna bind characteristic": 0.0135, "possess": 0.00273, "affected mutant mouse": 0.00649, "transactivator ciita": 0.00295, "il-1alpha promoter": 0.02336, "physiologic status": 0.00217, "microbial lipoprotein": 0.00118, "octamer-binding protein play": 0.03019, "potassium occur": 0.00654, "positive activator region": 0.00978, "htlv-ii": 0.00087, "specific context": 0.01238, "alveolar macrophage play": 0.00474, "cd11a+": 0.00012, "non-mcd14-mediated lp uptake": 0.00236, "recent year": 0.0014, "ap-1 protein": 0.04529, "il-2mrna synthesis": 0.00583, "result describe": 0.0161, "thromboxane receptor gene promoter/chloramphenicol acetyltransferase": 0.01742, "nwp cell": 0.0768, "parallels morphological differentiation": 0.00786, "cell-to-cell contact activation": 0.02109, "ets consensus sequence": 0.01084, "cd40-specific single-chain fv construct": 0.00363, "human hepatitis": 0.03762, "rest tonsillar": 0.00267, "anti-cd30-specific monoclonal antibody": 0.00596, "cotransfected jak-1": 0.00047, "t-cell-specific transcriptional activator tcf-1": 0.00575, "describe protein": 0.04529, "alpha promoter region": 0.01557, "elderly subject exhibit decreased level": 0.00728, "low proliferative activity": 0.0195, "megakaryocyte reveal abnormal development characterize": 0.00439, "additive increase": 0.02196, "27-30": 0.0, "c-jun transactivate pthrp": 0.00329, "cell cycle progression initiate": 0.0384, "mouse hematopoietic tissue": 0.00649, "nuclear localization sequence": 0.01123, "id3-transduced": 6e-05, "dmso-induced differentiation": 0.01179, "large palindromic sequence": 0.01084, "htlv-i tax": 0.00478, "integration site": 0.02168, "phorbol myristate-induced production": 0.00695, "pd195599": 6e-05, "lung transplantation": 0.00195, "additional role": 0.01328, "antagonize dexamethasone-induced transcription": 0.01873, "benign mammary tissue": 0.00443, "il-9ralpha": 0.00012, "palmitate conjugate": 0.00022, "phosphatidylinositides bind": 0.02025, "c/ebp activator": 0.00552, "nf-atc/b": 0.00025, "require de novo protein synthesis": 0.01811, "potent inhibitor": 0.009, "wild-type id3": 0.00378, "core element": 0.01672, "morning-to-afternoon decline": 0.00121, "gata-1 mrna increase": 0.01464, "il-4 production": 0.01042, "25-dihydroxyvitamin d3": 0.00245, "common element": 0.01672, "potassium concentration": 0.0067, "pkc block": 0.01073, "cytokine result": 0.0161, "increased cd38 protein level": 0.02264, "40-fold stimulation": 0.0112, "recognition sequence": 0.01625, "oft-1": 0.0, "develop immune response": 0.01294, "units/ml human recombinant m-csf": 0.01881, "resistant icr27tk.3 human leukemic": 0.01881, "ebv reactivation": 0.00565, "tpa-induced mononuclear cell differentiation": 0.0384, "promoter element control collagenase transcription": 0.01124, "pulmonary infiltrates and/or cavity": 0.00225, "vertebrate homolog": 0.00047, "oct2ab": 0.00012, "detection": 0.00205, "homogeneous manner": 0.00282, "nf-at-oct construct": 0.00726, "respective secrete form": 0.00703, "platelet-activating factor": 0.0286, "decreased gag protein synthesis": 0.02264, "regulates": 0.00199, "alpha,25-oh": 0.0, "il-1 signal transduction": 0.0109, "induce maximal monocyte differentiation": 0.0127, "carboxy- terminal": 0.00332, "ad2 early gene": 0.02903, "proinflammatory cytokine gene": 0.02903, "weight loss": 0.00298, "lklf": 6e-05, "distinct receptor": 0.02571, "selective defect": 0.00279, "surface": 0.0103, "calyculin a-induced stat3 phosphorylation": 0.00492, "induce hl-60 cell": 0.0512, "cs individual": 0.00409, "megakaryocytic differentiation pathway": 0.00852, "deamidated peptide": 0.00754, "residual gr": 0.004, "potent antiinflammatory": 0.00357, "/gabp beta": 0.00673, "erythropoiesis": 0.00112, "distal nf-kappab transcription factor bind site": 0.00953, "mutual regulation": 0.01008, "proapoptotic factor": 0.0286, "rapid degradation": 0.00332, "arg91": 6e-05, "ngfi-b/nur77 family consist": 0.0056, "primary type": 0.00949, "individual nuclear factor": 0.01907, "heterodimeric p49/p65": 0.00081, "e2f-dna binding activity": 0.0195, "transcriptional difference": 0.01151, "danazol decrease": 0.00971, "sporadic report": 0.0049, "ifn-alpha-induced protection": 0.00081, "c-jun delta-domain": 0.00493, "drug-immunophilin complex": 0.01684, "t-cell receptor alpha-": 0.01714, "describe binding site": 0.01445, "e1a sequence present": 0.01084, "enhance cytolytic potential": 0.00649, "blood substrate": 0.00592, "gel shift assay demonstrate": 0.00799, "p3hr-1": 0.00025, "affected tissue": 0.00664, "c-raf-mediated increase": 0.02196, "functional gata-binding site": 0.01445, "select outcome": 0.00195, "suggest activation": 0.03164, "chromatographic step yield": 0.00126, "activated cord": 0.00589, "transactivate gene expression": 0.02903, "cyclin d1": 0.00093, "cdna library": 0.00456, "nearby polymorphism": 0.00177, "fasl/cd95 ligand": 0.00592, "phorbol ester induce jurkat t-cells": 0.01016, "unstimulated thp-1": 0.00239, "mediate cell": 0.0768, "neutrophil differentiation": 0.01179, "biologic function": 0.01331, "pkc-": 0.00037, "high dos": 0.00931, "link": 0.00695, "e2a protein concentration": 0.03019, "rangtp-dependent association": 0.00282, "enhance activity": 0.02925, "constitutive presence": 0.00524, "free solution": 0.00127, "csa-insensitive stage": 0.00248, "asm": 0.0005, "pld-derived lipid": 0.00124, "transformed erythroblast": 0.00105, "complex represent nip activity": 0.01462, "simian cmv": 0.00118, "monitor": 0.00217, "point mutation result": 0.01073, "immediate-early activation gene": 0.02903, "restricted pattern": 0.00549, "prevent tcr": 0.00524, "light zone": 0.00078, "obvious merit": 0.00025, "af-1 and/or af-2 support": 0.00225, "primary cultured human erythroid precursor": 0.01505, "il-1beta receptor type": 0.01714, "immune response develop": 0.01294, "human cd3epsilon gene": 0.02903, "virus-uninfected human": 0.03762, "pc12": 0.00012, "proviral dna present": 0.00988, "smad7 inhibit": 0.01904, "pi3k": 0.00043, "strong repressor element": 0.01115, "monoclonal integration": 0.00279, "cognate sequence": 0.01625, "creatininemia": 0.0, "signal cascade contribute": 0.0109, "sp": 0.00112, "putative g0s gene": 0.02903, "characteristic feature": 0.00329, "protein secretion": 0.04529, "region critical": 0.01467, "cell inhibit human immunodeficiency virus replication": 0.0256, "jak/stat activation lead": 0.02109, "human tcf-1 protein": 0.03019, "healthy control individual": 0.00868, "induce transcription factor activation": 0.01582, "rad": 0.00012, "general cellular transcription factor": 0.0143, "kd transcriptional activator nf-kappab subunit": 0.0046, "concentration dependent": 0.0067, "oligoclonal": 0.00019, "cytokine-based therapy": 0.00372, "reduced clonogenic cell growth": 0.0384, "cell antigen receptor-induced protein tyrosine kinase": 0.0256, "beta globin promoter": 0.01557, "induce erythroid progenitor": 0.01694, "pkc-independent mechanism": 0.01058, "position -51": 0.00236, "hypothalamic-pituitary-adrenal axis activation": 0.02109, "lfa-i alpha chain": 0.0078, "immunoglobulin isotype class switching": 0.00321, "leukocyte migrate": 0.00478, "display erythroid-specific activity": 0.0195, "ltb4 induce adhesion": 0.01694, "beta interferon kappa": 0.00498, "lymphocytic leukemia": 0.00499, "good clinical predictor": 0.00283, "signal control": 0.01635, "anti-cd3 monoclonal antibody result": 0.00805, "strong myeloid-cell-specific promoter": 0.01557, "octamer-bound oct-1": 0.00146, "mouse display elevated level": 0.0091, "vitro binding study demonstrate": 0.00927, "transcription factor mibp1": 0.01907, "two-dimensional gel analysis": 0.00786, "transformed": 0.00167, "hmg-i result": 0.0161, "beta2 integrins": 0.00034, "glucocorticoid hormone action": 0.00567, "development": 0.01266, "hla-dqb1 codon": 0.00071, "prevent apoptosis": 0.0089, "mapk kinase": 0.01188, "nuclear translocation": 0.01684, "ra-induced apoptosis": 0.0089, "human monocyte pdgf": 0.02508, "potency": 0.00136, "material preserving": 0.00074, "normal tissue": 0.0121, "e2a protein require intact": 0.02264, "antioxidant exert": 0.00292, "il-8 production": 0.01042, "vitd3 induction": 0.01607, "bacterial fraction": 0.00223, "cyc1 promoter associate": 0.01557, "pih": 0.0005, "dna fragmentation study": 0.00988, "neighboring element": 0.01672, "human serum express ppargamma mrna": 0.01505, "gata3 potentiate": 0.0018, "pp2a inhibitor": 0.009, "cbf beta-myh11 transcript": 0.00399, "poorly understood": 0.00084, "notch-1 expression provide significant protection": 0.01665, "2-methylhistamine": 6e-05, "enhanced signal transduction": 0.0109, "ikappab alpha phosphorylation": 0.0078, "m-csf addition": 0.00673, "hematopoietic cell-specific": 0.00366, "consensus dna bind sequence": 0.01013, "tetracycline": 0.0005, "multiple cellular factor": 0.01907, "retrovirus vector": 0.00319, "tissue destruction": 0.00664, "transactivated reporter construct": 0.00484, "aid nhl": 0.00161, "biological characteristic": 0.00329, "identical sequence ccgaaactgaaaagg": 0.01084, "reason": 0.00019, "cxcr4": 0.00019, "gamma-": 0.00037, "cell-specific expression": 0.04163, "ras-aiolos interaction": 0.00986, "brainstem nucleus": 0.00319, "autologous lymphoblastoid cell line stimulation": 0.03072, "postmenopausal woman": 0.00233, "single copy": 0.0036, "epo act": 0.00496, "gh4c1 pituitary cell": 0.0512, "drip205": 0.0, "human immunodeficiency virus enhancer": 0.01881, "morning fev1 increase": 0.01464, "suppression": 0.00831, "glucocorticoid-mediated transrepression": 0.00047, "epo signal": 0.01635, "sp3": 0.00093, "promising tool": 0.00047, "cell activator": 0.0768, "unusual case": 0.00363, "proportional": 0.00019, "pro-inflammatory protein tumor necrosis factor-alpha": 0.01811, "preeclamptic mother": 0.00019, "intestinal inflammation": 0.00316, "-45 site": 0.02168, "inhibited jak1 phosphorylation": 0.00656, "ebna-2-responsive element": 0.01672, "af-2": 0.00019, "multicatalytic protease": 0.00177, "progesterone receptor-negative status": 0.00145, "minimum region": 0.01467, "ikk complex": 0.01684, "limited proteolysis": 0.00081, "ppar activator influence": 0.00368, "undertaken": 0.0, "calcium concentration": 0.0067, "interested": 6e-05, "low affinity fc receptor": 0.01286, "m.baseler": 0.00012, "icr-27": 0.00012, "oca-b/oct-1-dependent transcription": 0.0281, "avidin-coupled agarose": 6e-05, "low proliferative capacity": 0.00471, "common structural element": 0.01115, "hvs": 0.00031, "monocyte adhesion": 0.01197, "steroid-binding property": 0.00397, "adult-t-cell-leukemia cell line": 0.0512, "lining layer": 0.0004, "1.87+/-0.36": 0.0, "combine data lend additional support": 0.00164, "side-chain": 6e-05, "helper cell level": 0.0512, "inhibited superoxide formation": 0.00323, "mdd": 0.00056, "beta-phorbol 12-myristate 13-acetate": 0.00045, "sil": 0.00012, "cytokine-binding": 6e-05, "specific trans-activating factor": 0.01907, "maeca activate ec": 0.01185, "signal event initiate": 0.0109, "cytoplasmic acidification facilitate nf-kappa": 0.00707, "camp/pka activation pathway": 0.02109, "primary pathogenic role": 0.00885, "dna-binding domain relative": 0.00804, "cellular binding protein": 0.03019, "renal transplantation": 0.00115, "t-helper cell cytokine": 0.0512, "dils": 0.00019, "tyrosine kinase abrogate gp120-mediated icam-1 expression": 0.01388, "relevant compound": 0.0022, "chloramphenicol acetyl-transferase vector": 0.00213, "irf-1 result": 0.0161, "mmp-9 activity": 0.02925, "d.baltimore": 0.00012, "facilitate binding": 0.01855, "human keratinocyte pcd/dcoh reveal": 0.01881, "analog": 0.00217, "dna isolate": 0.01483, "proc": 0.00019, "transcription factor iia": 0.01907, "normal platelet function": 0.00887, "atopic patient": 0.01666, "activate lt-293": 0.01777, "halflife": 6e-05, "-88": 0.00012, "potential implication": 0.00605, "cytokine repertoire": 0.01123, "hox11 null mouse": 0.00649, "cell prolymphocytic leukaemia": 0.0512, "underlie mechanism": 0.01058, "icam-1 mrna expression": 0.02775, "tandem ap1 site abolish": 0.01084, "muscle gene": 0.04355, "increase monokine secretion": 0.01464, "anti-cd28 ab stimulation study": 0.00678, "c-terminal portion": 0.00192, "rar-beta": 0.00012, "gross level": 0.01821, "inhibit monocyte adhesion": 0.0127, "adult beta-globin/alpha-globin mrna": 0.01017, "ra superfamily": 0.00596, "activation signal": 0.03164, "cell clone sp-b21": 0.0512, "myeloid surface marker cd11b": 0.00257, "anti-ig induction": 0.01607, "plasma clearance rate": 0.0025, "ciita-transfected cell hybrid": 0.0512, "atl leukemic cell": 0.0512, "copeland": 0.00012, "essential mediator": 0.00487, "il-4 gene transcription": 0.02903, "continuous proliferation": 0.00803, "secondary neutrophilia": 0.00189, "antiglucocorticoid ru": 0.00034, "3-methylcholanthrene": 6e-05, "helas3 cell": 0.0768, "progenitor": 0.00552, "wild-type endotoxin": 0.00378, "c5b-9-induced dna synthesis": 0.00988, "orthophosphate show": 0.02599, "nefs": 6e-05, "-130 region": 0.01467, "inducible": 0.00968, "-dependent phosphatase calcineurin": 0.00211, "electrolyte balance": 0.00065, "altered interaction": 0.00986, "major signal event": 0.0109, "indeterminate margin": 0.00016, "p65 -and p50-selected motif": 0.00437, "breast cancer sample": 0.00172, "aid iblp-associated cdna fragment generate": 0.00182, "shift complex": 0.01684, "p105 processing": 0.00155, "promoter activity stimulate": 0.0195, "il-4 gene regulation": 0.02903, "nfat inhibitor": 0.009, "extracellular matrix protein tenascin": 0.02264, "genomic footprinting data": 0.0018, "polyomavirus reactivation occur": 0.00436, "insect cell": 0.0768, "gamma b*cam-k inhibit": 0.0127, "endogenous mechanism": 0.01058, "bp il-2 promoter-luciferase reporter construct": 0.00447, "minimal b29 promoter": 0.01557, "il-6 promoter": 0.02336, "plasma level": 0.01821, "diabetic nephropathy": 0.00022, "molecular basis": 0.0045, "recent finding": 0.00226, "il-6 increase junb mrna": 0.01098, "tat-i": 0.00031, "bronchial asthma": 0.00161, "autostimulatory loop": 0.00109, "american society": 6e-05, "15-lo": 0.0005, "sexual dimorphism": 0.00031, "consistent footprint": 0.00205, "hiv1 gene product": 0.02903, "tumor necrosis factor-alpha-dependent": 0.00622, "high correlation": 0.00931, "vigorous replication": 0.00471, "murine homologue": 0.00623, "repression domain": 0.01207, "plap": 0.00031, "e1a-conserved region": 0.01467, "part control": 0.01303, "human monocytic m-csf receptor promoter direct reporter gene activity": 0.00968, "potential regulatory sequence similar": 0.00813, "inhibit cellular immunoreactions": 0.0127, "anti-ig": 0.00093, "activation event": 0.03164, "il-1beta gene": 0.04355, "low ki-67": 0.00707, "sesquiterpene lactones exert": 0.00194, "recovered protein": 0.04529, "human putative lymphocyte g0/g1 switch gene": 0.01452, "usefulness": 0.00025, "inert monomer": 0.00022, "cd11b antigen": 0.00819, "helper 2-type cytokine": 0.00749, "purified cam kinase ii": 0.00594, "il-1ri complex": 0.01684, "myeloid-cell-specific c-fes promoter": 0.01557, "asa inhibit nf-kappab activation": 0.01582, "multiple tcr delta transcript": 0.00344, "sp3 mediate transcriptional activation": 0.01582, "differentiate plasma cell": 0.0512, "myelomonocytic lineage": 0.00366, "nitric oxide-stimulated guanine nucleotide exchange": 0.00081, "40-kda protein": 0.04529, "-e2 bind": 0.02025, "vcam-1 antibody": 0.00893, "activator protein-2": 0.00552, "single gata-binding site": 0.01445, "cell type dependent": 0.0512, "n-terminal domain": 0.01207, "lipid homeostasis": 0.00124, "cell separation experiment suggest": 0.0384, "cytoplasmic inhibitor": 0.009, "c-fos sre binding complex": 0.00927, "faber": 6e-05, "co-stimulatory molecule": 0.00853, "ap3-l motif bind": 0.0135, "pma-induced respiratory burst": 0.00091, "abundant protein": 0.04529, "lps dose-dependent fashion": 0.00234, "electrophoretic mobility shift analysis show": 0.0104, "cellular promoter": 0.02336, "tnf- and/or anti-fas- induce cell death": 0.0256, "regulation": 0.02016, "ifn-alpha": 0.00292, "molecular process": 0.0045, "human inflammatory disease": 0.02508, "proliferation adjustment": 0.00803, "enhance atherosclerotic lesion formation": 0.00487, "multiple alteration": 0.00689, "erythroleukemias": 0.00025, "cytotoxic function": 0.01331, "detectable ad": 0.00276, "cell-to-cell contact activate": 0.01185, "bzlf1 expression": 0.04163, "pma/iono": 0.00012, "knowledge regard": 0.00109, "runt domain": 0.01207, "delta": 0.00422, "xpb mutation": 0.00592, "irish": 0.00012, "allergic reaction": 0.0022, "nm d3": 0.00245, "protein partner": 0.04529, "insulin gene transcription factor": 0.02177, "traf": 0.00124, "bind factor ii function": 0.0143, "viral gene": 0.04355, "-579 relative": 0.00276, "p8": 0.00012, "oligonucleotides show distinct effect": 0.013, "substsp23": 0.00012, "element specific": 0.01672, "control early event": 0.00868, "dyad symmetrical sequence": 0.01084, "infected lung": 0.00195, "atf-2/jun": 6e-05, "gsh level": 0.01821, "exhibit increase adherence": 0.01464, "scm-1": 0.00037, "bamhi": 0.00037, "avp": 0.00012, "display agonist activity": 0.0195, "multipotential cell line": 0.0512, "cyto-differentiating treatment": 0.01014, "lcrs": 6e-05, "tax transgenic mouse model reveal": 0.00439, "nf- kappab site": 0.01445, "distinct expression pattern demonstrate": 0.02081, "rest peripheral blood": 0.00395, "23:00-24:00": 0.0, "histone h5 gene": 0.02903, "ikb alpha induce": 0.01694, "jnk": 0.0023, "signal-dependent phosphorylation": 0.00983, "cho-dr": 0.00012, "30-fold high": 0.00931, "placement relative": 0.00276, "macrophage-like characteristic": 0.00329, "delay relative": 0.00276, "promoter-proximal": 0.00062, "immunoglobulin mu heavy chain gene": 0.01742, "plasminogen activator inhibitor type": 0.00475, "footprint analysis": 0.01179, "ras function require": 0.00887, "cultured human monocyte": 0.02508, "intracellular signal molecule bridge": 0.00817, "normal heterozygous lymphocyte": 0.00988, "cognate ligand": 0.00592, "immunotherapy": 0.00068, "vitro model system": 0.00523, "cell site": 0.0768, "sequence-specific transcriptional repressor": 0.00767, "phosphotyrosine immunoprecipitation": 0.00074, "alternative splicing mechanism": 0.00705, "myelopoiesis": 0.00112, "chronic hiv infection": 0.00414, "75-kda hematopoietic cell-specific intracellular signal protein": 0.0151, "loci relevant": 0.00143, "nucleoside diphosphate kinase": 0.00792, "immune induction": 0.01607, "sex determine region": 0.00978, "inflammatory stimulus": 0.00471, "high affinity ligand-binding": 0.0062, "thyroglobulin": 0.00037, "inhibit generation": 0.01904, "epo induced mature erythroblast": 0.0027, "response element form": 0.01294, "deltaspi-b": 0.00019, "region ii": 0.01467, "interferon inhibits growth": 0.00546, "physiological marker": 0.00382, "inhibit calcineurin": 0.01904, "hiv-associated abnormality": 0.00239, "gene expression require": 0.02903, "opposite": 0.00081, "pao-sensitive phosphatase": 0.00264, "trans-activation region": 0.01467, "icp36 family": 0.00841, "p96": 0.00012, "report describe study": 0.00904, "hominid evolution": 0.00022, "scrambled sequence": 0.01625, "bhlh domain": 0.01207, "er mrna": 0.01526, "ca2+/calmodulin-dependent protein kinase": 0.03019, "influence glucocorticoid receptor": 0.01714, "blast tcells": 0.00127, "lam": 0.0005, "radiation-induced apoptosis": 0.0089, "fc gamma riiia": 0.00294, "lps": 0.00701, "allele-specific regulatory system": 0.00455, "include pcr": 0.01439, "definitive erythropoiesis": 0.00056, "21-base-pair": 6e-05, "tumor necrosis factor-alpha": 0.00622, "differentiation/activation stimuli": 0.00028, "ach2 cell": 0.0768, "lymphopoiesis": 6e-05, "pou domain transcription factor oct-2": 0.01144, "nkl": 0.00043, "aids-gr monocyte": 0.01197, "myelodysplastic syndrome": 0.00273, "human tcf-1 display": 0.02508, "leu-7+ natural killer cell": 0.0384, "induces proliferation": 0.00803, "amino acid capable": 0.00571, "patient carry b27 antigen": 0.00833, "phenotypic difference": 0.00425, "myristate 13-acetate treatment": 0.00676, "p47phox-deficient patient": 0.01666, "otfs express wild-type level": 0.00923, "antipaternal antibody": 0.00893, "socs-1": 0.00019, "cell surface t-cell receptor": 0.0384, "cytosolic inhibitor ikappabalpha": 0.006, "mitogenic anti-cd2 antibody": 0.00596, "yt cell line": 0.0512, "aml1b": 0.0005, "increase hiv-1 ltr transcription": 0.01405, "chromatin-dependent process": 0.00444, "cd8-mediated inhibition": 0.01061, "staurosporine prevent secretion": 0.00349, "diisopropyl fluorophosphate-thrombin fail": 0.00232, "low content": 0.00707, "central tumor suppressor gene": 0.02177, "cd34+/-": 0.00012, "il-1rii gene": 0.04355, "dispensable": 0.00056, "16-18": 6e-05, "stage selector element": 0.01115, "exogenous bcl-2": 0.00295, "18-hydroxycorticosterone level": 0.01821, "tnf-alpha gene transcription": 0.02903, "human thp-1 monocytic cell": 0.0384, "pit-oct-unc": 0.00012, "cellular proliferation control": 0.00868, "il13": 0.00037, "thyromimetic": 6e-05, "transcription initiation sequence": 0.01873, "mzf1 transcription factor": 0.01907, "endogenous gm-csf mrna induce": 0.0127, "gad-creb fusion protein": 0.03019, "p45 expression": 0.04163, "resultant tnf-alpha production": 0.00695, "il-2-r alpha gene": 0.02903, "disorder": 0.00447, "15b-7 cdna": 0.00456, "manifest agonist": 0.0022, "subregions": 0.00025, "helper": 0.00211, "pml gene product": 0.02903, "mutated strain": 0.00186, "cis inactivation": 0.00174, "human er": 0.03762, "diverse function": 0.01331, "partial loss": 0.00298, "cell suggest": 0.0768, "cml cell": 0.0768, "specific antibody direct": 0.00825, "ap-1 enhancer activity": 0.0195, "efficient phosphorylation": 0.00983, "regard": 0.00217, "subsequent monocyte arrest": 0.00798, "drug-induced toxicity": 0.00056, "potentiate phagocytosis": 0.0018, "alcoholic": 0.00031, "high chromosome": 0.00931, "pml/raralpha expression": 0.04163, "high level il-2 production": 0.0091, "crc": 6e-05, "single transcript": 0.00599, "ikaros gene family": 0.02903, "signal-induced event": 0.00552, "distinct histopathological entity": 0.00465, "critical immunoregulatory cytokine": 0.00749, "linkage": 0.00074, "c-fos sense mrna expression": 0.02081, "m-csf involves": 0.0018, "infectious disease": 0.00673, "hiv-1 tat potentiate tnf-induced nf-kappa": 0.00566, "concomitant inhibitory effect": 0.0141, "ets protein elf-1": 0.03019, "mutated rar alpha gene": 0.02177, "inhibitor prevent tetanus toxoid antigen-specific": 0.0036, "hla-dq sequence": 0.01625, "p50/relb heterodimers": 0.00226, "regulatory hierarchy": 0.00682, "dendritic cell": 0.0768, "vitro activate helper": 0.01185, "lyt-10": 6e-05, "gtp-bound p21ras": 0.00152, "il-6-treated cell": 0.0768, "jun-b": 0.00099, "dpa promoter": 0.02336, "respective factor": 0.0286, "differentiation pathway": 0.01278, "muscle cdna library": 0.00304, "cell gene": 0.0768, "interaction require": 0.01315, "cytokines/lps reveal difference": 0.00732, "fc portion": 0.00164, "transcriptional activator nf-kappa": 0.00943, "peri-kappa": 0.00019, "select dna sequence reveal sequence specificity": 0.00494, "transcription factor test": 0.01907, "current drug": 0.00338, "major problem": 0.00574, "unactivated platelet": 0.00372, "under-representation": 0.00012, "intracellular messenger": 0.00583, "situ hybridization histochemistry": 0.00103, "calcineurin mutant render": 0.0054, "exogenous il-6": 0.00391, "ccaat motif present": 0.00583, "jurkat leukemic t-cell line": 0.00827, "dnd-41": 6e-05, "c-fes 5'-flanking sequence link": 0.00813, "autocrine and/or paracrine role": 0.00664, "low affinity bsap site": 0.01084, "vitro result provide": 0.01073, "transcription factor nf-kappab": 0.01907, "trifluoromethylketone inhibitor": 0.009, "direct immunoprecipitation": 0.0054, "air-1 locus function": 0.00887, "mi-2-hdac": 6e-05, "human peripheral mononuclear cell": 0.0384, "apoptotic change": 0.0063, "steroid resistance": 0.00326, "tgf-beta inhibits ig chain synthesis": 0.00233, "proximity": 0.00019, "hs-40 enhancer-zeta": 0.00053, "infected cell undergo apoptosis": 0.0384, "monocytic differentiation marker": 0.00786, "complete 491-amino-acid sequence": 0.01084, "alter expression": 0.04163, "il-4-induced effect": 0.02115, "jak-stat1 pathway": 0.01278, "traf/rank interaction reveal multiple traf bind site cluster": 0.00542, "aa2 cell": 0.0768, "native ability": 0.00431, "so-called 'lysis gene": 0.02903, "include phorbol 12-myristate 13-acetate": 0.0072, "individual site": 0.02168, "secrete heat stable placental alkaline phosphatase": 0.00088, "identical rbtn-2 binding region": 0.00927, "diferuoylmethane": 6e-05, "human autosome": 0.03762, "show decreased sensitivity": 0.01733, "nuclear t3r": 0.01684, "nfatd element": 0.01672, "receptor bind specificity": 0.01714, "min": 0.00254, "polyaromatic hydrocarbon": 6e-05, "dq": 0.00081, "decreased c-myc transcription": 0.01873, "tyr-492": 0.00031, "p130 phosphorylation": 0.00983, "trail": 0.00025, "e220k-ubiquitinylated c-jun": 0.00493, "high affinity site": 0.01445, "cyclooxygenase-2": 0.00031, "tumor metastasis regulation": 0.00672, "phorbol ester/il-2": 0.00543, "additional protein": 0.04529, "essential transcription factor": 0.01907, "diffuse large b-cell lymphoma": 0.0023, "thrombospondin": 0.00025, "cyclic amp-dependent protein kinase": 0.02264, "g1-": 6e-05, "immunoblot assay": 0.01002, "polyclonal activator phytohemagglutinin": 0.00368, "initial signal event": 0.0109, "data constitute": 0.00254, "long-term phorbol": 0.00543, "exocrine": 0.00037, "allergic response": 0.01942, "affect basal": 0.00797, "differentiated dc": 0.00202, "pharmacology": 0.00012, "pancreatic islet expression study": 0.02081, "primary infection": 0.00738, "bcl-x": 0.00081, "c-rel protein": 0.04529, "fludarabine lead": 0.00996, "lef-1-beta-catenin complex": 0.01684, "similarly stimulate normal": 0.00806, "tumor suppressor protein": 0.03019, "m/l calcitriol": 0.00078, "synthetic nonselective rar ligand": 0.00296, "mbp stimulate 2-fold increase": 0.01098, "nfat4 promote": 0.00465, "sp1-box": 6e-05, "vzv ge protein": 0.03019, "molecular analysis": 0.01179, "select genetic aberration": 0.00192, "e1a-induced cytolytic susceptibility": 0.00097, "1.3-7.6": 6e-05, "microglial cell stimulation": 0.0512, "potential ets bind site": 0.01084, "lytic cycle infectious progeny virus expression": 0.01388, "il-2 octamer motif": 0.00744, "immunogenic stimulus": 0.0027, "mouse fibroblastic cell line": 0.0384, "important target": 0.00825, "tat protein enhance": 0.03019, "dna bind ets domain": 0.01013, "matrix-adherent cell": 0.0768, "selective inhibition": 0.01061, "splenic lymphocyte": 0.01483, "multifunctional domain protein": 0.03019, "-kappa b/rel nuclear activity induce": 0.0117, "promote limited proliferation": 0.00536, "high population": 0.00931, "hla-drbeta": 6e-05, "lmp-1-expressing": 6e-05, "gene defective": 0.04355, "pafr transcript": 0.00599, "gupta": 0.00012, "il-2 independent cell line": 0.0384, "hla-restricting determinant": 0.00118, "blot": 0.00217, "t-cell activation response element": 0.01582, "promote ige synthesis": 0.00389, "-176 relative": 0.00276, "analysis": 0.02357, "macrophage migration inhibitory": 0.00393, "messenger up-regulation": 0.00276, "full transcriptional activation": 0.02109, "resemble": 0.00261, "ligand-activated transcription factor": 0.01907, "mouse hepa-1 cell": 0.0512, "potent proinflammatory mediator leukotriene b4": 0.00143, "high abundance": 0.00931, "transversion": 6e-05, "mad-3 protein": 0.04529, "single polypeptide chain": 0.00292, "vitro activation": 0.03164, "current data": 0.00254, "trans- dominant negative inhibitor": 0.0045, "gata motif": 0.00875, "common endodermal origin": 0.00234, "il-5-stimulated eosinophil": 0.00295, "bzip domain": 0.01207, "bcl2 abrogate": 0.00254, "hematopoietic cell test": 0.0512, "gnrh-stimulated gonadotropin": 9e-05, "ala ire": 0.00047, "cell receptor trigger activation": 0.0384, "3-4 hr": 0.00059, "regulate eosinophil response": 0.01294, "gene inactivation study": 0.02903, "ref-1": 0.00043, "similar complex": 0.01684, "adenoviral infection": 0.0062, "rate-limiting": 0.00031, "unknown mechanism": 0.01058, "c3 fragment": 0.00347, "ebv producer cell line b95.8": 0.03072, "high affinity tnfrp75 molecule": 0.00465, "tf site": 0.02168, "histone acetylation": 0.00133, "ttcttctaattaa": 6e-05, "alpha,25-dihydroxyvitamin d3": 0.00245, "transcriptional regulatory sequence": 0.01084, "express chemokine receptor": 0.01714, "syncytia-forming activity": 0.02925, "rhombotin-2": 0.00019, "cells/tube": 0.0, "tyrosine protein kinase": 0.03019, "therapeutic activity": 0.02925, "bp upstream": 0.00369, "proil-1 beta enhancer": 0.00606, "soluble peptide inhibitor": 0.006, "hiv-1 infection": 0.00878, "radiolabeled hormone": 0.00444, "proil-1 beta cap site-proximal region": 0.00587, "5-lipoxygenase": 0.00074, "present paper review": 0.0049, "ap-1 transcriptional activation": 0.02109, "bacterial lipopolysaccharides": 0.00223, "thymic lymphocyte": 0.01483, "tal-1 oncogenic potential": 0.00403, "include vav": 0.01439, "evidence": 0.00844, "tre structure": 0.00319, "previous hypothesis": 0.00133, "ikappab-alpha mrna transcript": 0.01017, "human nk/t cell": 0.0512, "ttca sequence": 0.01625, "wild-type mouse epor show": 0.013, "eosinophilic inflammatory disease": 0.00449, "csa treatment inhibit": 0.0127, "eukaryotic transcription": 0.0281, "human gamma delta": 0.02508, "nf-kappab/rel": 0.00118, "specific p38 mapk inhibitor": 0.00619, "potential nf-kappab-binding sequence": 0.01084, "early crucial step": 0.00552, "acetaminophen-": 0.00012, "affect nf-kappab binding activity": 0.01462, "vpr suppression": 0.00416, "abundant pybf activity": 0.0195, "tax prevent": 0.00524, "12-o-tetradecanoylphorbol-13-acetate": 0.00112, "tnf-alpha increase": 0.02196, "prdii element increase transcription": 0.01405, "nf-kappa b1 precursor p105": 0.00707, "triplex formation": 0.00484, "lps stimulation induce": 0.01694, "rel domain": 0.01207, "kda subunit": 0.00484, "cd71": 0.00037, "consanguinous parent": 0.00037, "immune/inflammatory effector cell": 0.0512, "bronchoalveolar lavage level": 0.01214, "metastasis": 0.00043, "high dose": 0.00931, "elf1": 6e-05, "induces secretion": 0.00803, "ikappabalpha transfected cell": 0.0512, "cellular cysteine supply": 0.00596, "single point assay": 0.00668, "interquartile range": 0.00202, "il-13-induced response": 0.01942, "cd40 survival signal": 0.0109, "air-1 trans-activator": 0.00093, "antigen-specific human": 0.03762, "ifn-regulated gene": 0.04355, "myb consensus site": 0.01445, "monocytoid u937": 0.00326, "late event": 0.00552, "lmp transcriptional start site": 0.01084, "total cell gelatinase": 0.0512, "herpes simplex virus": 0.00591, "pyrimidine catabolism": 0.00012, "shigella flexneri icsa protein promote actin nucleation": 0.01294, "synergistic increase": 0.02196, "hd": 0.00093, "polyclonal activation": 0.03164, "nf-kappab activity": 0.02925, "ser-32": 0.00012, "experimental system combine adenovirus-mediated gene transfer": 0.01452, "lmo2": 0.00012, "thrombin": 0.00279, "shutdown": 6e-05, "kda glial labile repressor protein": 0.01811, "membrane cd14": 0.0045, "glucocorticoid receptor-gre binding show": 0.013, "activation-inducer molecule/cd69 enhance": 0.00649, "promoter/5'-flank": 6e-05, "endogenous il-1 beta": 0.00449, "metallothionein promoter induction": 0.01557, "cu": 0.00012, "tfe3": 0.00019, "stat3 monoclonal antibody": 0.00596, "stimulate ikappab production": 0.00734, "leukemic cell line": 0.0512, "genistein suppress induction": 0.01071, "restriction fragment length polymorphism analysis": 0.00471, "functional gene": 0.04355, "regulatory tat protein": 0.03019, "lesion-derived cd4+ t-cell clone": 0.00481, "express functional retinoblastoma protein": 0.02264, "induced structural locus": 0.0036, "il-3-mediated stat5b tyrosine phosphorylation": 0.00492, "multipotent /erythroid/monocytic hpc growth couple": 0.00328, "element sit": 0.01672, "class ii promoter": 0.01557, "combined transcription/repair deficiency": 0.00074, "ad2 transactivation domain": 0.00804, "synchronized state": 0.00267, "litaf mrna expression": 0.02775, "pyrrolidinedithiocarbamate": 0.00031, "e47": 0.00074, "hormone-dependent activation": 0.03164, "receive combination cytokine therapy": 0.00561, "proinflammatory stimulus selectively initiate intracellular signal transduction": 0.00467, "mediate interleukin-1 induction": 0.01071, "nonproductive hiv-1 infection": 0.00585, "vivo study": 0.01355, "phosphorylation reaction": 0.00983, "mab j393 induce tyrosine phosphorylation": 0.01016, "increase mcp-1": 0.02196, "crkl": 0.0, "constitutive factor a1": 0.01907, "1,24-dihydroxy-22-ene-24-cyclopropyl-vitamin d3": 0.00245, "thyroiditis": 6e-05, "mmp9": 0.00025, "nm d3 show": 0.01733, "grbeta expression vector": 0.02775, "rex act": 0.00496, "hmg-coa synthase": 0.00081, "increase recognition": 0.02196, "erythroid lineage-": 0.0062, "stat3 act": 0.00496, "proteolytic assay": 0.01002, "cd13-": 0.00012, "microbial agonist": 0.0022, "n.engl.j": 6e-05, "cord blood": 0.00592, "ar protein": 0.04529, "transduce membrane-associated signal": 0.0109, "mutant viral stock present": 0.00405, "interferon-treated cell": 0.0768, "affect stat tyrosine phosphorylation": 0.00492, "ankyrin repeat region": 0.00978, "promote erythroid cell survival": 0.0384, "adhesion molecule express": 0.0123, "blood-brain barrier": 0.00025, "potential ap-1 binding site play": 0.00867, "tax-independent binding": 0.01855, "hpa": 0.00074, "degenerate oligonucleotides encode conserved sequence": 0.0065, "delayed stat3 bind": 0.0135, "cyp1a1": 0.0005, "opposite situation": 0.0004, "vivo hiv-1 replication": 0.00585, "intracellular il": 0.00583, "17beta-hsd iv mrna expression": 0.02081, "peak inhibitory activity": 0.0195, "pigeon cytochrome": 0.00037, "sm protein sequence show": 0.02264, "unresponsiveness": 0.0005, "increased resistance": 0.00363, "clone kv channel express": 0.00923, "involves": 0.00161, "regulatory pair": 0.00682, "homozygous type": 0.00949, "r24 mab stimulate gd3+": 0.00551, "mouse embryogenesis": 0.00974, "ptk activation": 0.03164, "spatial separation": 0.00053, "rat t-cell line": 0.01102, "regulate gene require": 0.02903, "ebv lytic origin": 0.00376, "tumor necrosis factor induce": 0.0143, "avidin-biotin peroxidase detection system": 0.00333, "mnda mrna level": 0.01214, "full-length cd14": 0.00171, "nuclear run-off assay": 0.01123, "p130": 0.00081, "il-2 stimulation": 0.0112, "clinical response": 0.01942, "latent antigen": 0.00819, "mhc class ii molecule": 0.00426, "transient activation": 0.03164, "prolactin-induced transcription factor": 0.01907, "cell-specific synergistic": 0.00292, "inducible regulator": 0.00484, "bis": 0.00012, "hiv-infected human monocytic cell": 0.0384, "cell cycle-controlling gene": 0.0512, "subtraction potential difference": 0.00403, "nfat-1-mediated gene expression": 0.02903, "immunologic parameter represent tumor defense": 0.00373, "induce mapk activity": 0.0195, "ebna-2": 0.00211, "human cd4": 0.03762, "hypertensive": 0.00062, "ligand expression": 0.04163, "constitutive hepor expression": 0.02775, "jun family member": 0.0056, "aberrant er form": 0.00703, "putative binding sequence": 0.01237, "aortic endothelial": 0.00434, "single cdna": 0.00456, "mnc homogenate increase": 0.01464, "hla-a2 molecule": 0.00853, "htlv-i enhancer": 0.00909, "70-base-pair fragment": 0.00347, "lytic cycle antigen": 0.00546, "activate stimulus invokes signal mechanism distinct": 0.00592, "x-thr-pro repeat": 0.00378, "dn variant": 0.00276, "gata-1 dna bind amplifies": 0.01013, "p210bcr-abl oncogene product": 0.00356, "ebv oncogenicity": 0.00565, "stringent activation requirement": 0.02109, "transcription initiation occur": 0.01873, "b2 subunit": 0.00484, "lef/tcf": 0.00031, "aneusomy": 6e-05, "immunologic activation": 0.03164, "cd4+ macrophage": 0.00589, "deactivation": 0.00012, "oppose macrophage differentiation": 0.00786, "fusion protein": 0.04529, "genesis": 0.00012, "gamma-herpesvirus": 0.00012, "b29 gene expression": 0.02903, "cell include hematopoietic cell": 0.0192, "point": 0.00366, "tl-mor": 6e-05, "c-fos correlate": 0.00654, "kinase/pkb": 0.00012, "transgenic mouse develop acute leukemia": 0.0039, "k562 cell": 0.0768, "cysteine protease inhibitor": 0.006, "low number": 0.00707, "ebv-negative b-cell line": 0.01102, "lineage-specific determinant": 0.00118, "stable e1a expression": 0.02775, "metabolic labeling": 0.00065, "rank cytoplasmic tail": 0.00267, "mechanism": 0.02115, "monomer": 0.00043, "orientation-independent manner": 0.00282, "negative regulatory effect": 0.0141, "nuclear regulatory factor-kappa beta": 0.00842, "prdi": 0.00019, "nf- kappa": 0.00748, "inflammatory activity": 0.02925, "proximal site": 0.02168, "site increase": 0.02196, "possess dna-binding property": 0.00374, "transcriptional regulator": 0.01151, "transcription factor jun-b": 0.01907, "include nf-kb": 0.01439, "normal developmental pattern": 0.00806, "tandem copy": 0.00121, "human carboxylesterase": 0.03762, "similar region": 0.01467, "chloramphenicol acetyl-transferase": 0.00093, "chronic steroid therapy": 0.00265, "single tissue-specific element": 0.01115, "mouse model": 0.00974, "cellular activity": 0.02925, "intrinsic asthmatic": 0.00121, "htlv-i ltr gene expression": 0.02177, "transfection study": 0.01355, "human jurkat lymphoblastic": 0.02508, "hormonal form": 0.01055, "staurosporine": 0.00093, "tnfrp55-/-mutant mouse lack expression": 0.02081, "id3 alters": 0.0009, "erk activation": 0.03164, "effectiveness": 0.00037, "uninfected cell extract": 0.0512, "elf-1 interacts": 0.00136, "adult erythroid progenitor": 0.00414, "estrogen initiate vascular response": 0.00971, "isoform nf-atc/b exerts": 0.00114, "gel electrophoretic mobility shift assay": 0.00401, "rex protein production": 0.03019, "nuclear corepressor": 0.01684, "nitroblue tetrazolium staining": 0.00118, "alpha2 integrin gene require": 0.02177, "enhance il-1beta mrna expression": 0.02081, "amino-terminal sequence": 0.01625, "cem cell display growth similar": 0.03072, "nf-kappa b/rel bind site": 0.01084, "inhibit interleukin": 0.01904, "a. rosen": 0.00081, "huvec adhesiveness": 0.00084, "relative affinity": 0.00391, "phenylarsine oxide inhibit": 0.0127, "cell proliferative response": 0.0512, "similar chromosomal rearrangement occur": 0.00337, "anti-atherosclerotic molecule": 0.00853, "downstream enhancer domain": 0.00804, "strong activation": 0.03164, "ligand-activatable": 6e-05, "cytosolic activation": 0.03164, "nf-kappab inhibition": 0.01061, "turn phosphorylates tyr-492 and/or tyr-493": 0.0018, "jejunostomy": 6e-05, "chi2 test": 0.00487, "-octyl-3,4,5-trimethoxybenzoate hydrochloride": 0.00025, "antioxidant dimethyl sulfoxide": 0.00167, "dtcs inhibit": 0.01904, "tcr/cd3 complex": 0.01684, "hyperthermia": 0.00031, "gc withdrawal": 0.0031, "steroid-resistant asthma": 0.00161, "non-applicable": 0.00012, "intracellular cyclic amp inhibit nf-kappab-mediated transcription": 0.00937, "activation and/or expression": 0.02775, "nh2 regulatory domain": 0.00804, "t-cell activation determine": 0.02109, "positive lymph node": 0.00312, "mn sod mrna": 0.01017, "mek1/mek2 inhibitor pd098059": 0.006, "frequent molecular lesion": 0.003, "co-immunoprecipitation experiment demonstrate": 0.01065, "non-globin promoter": 0.02336, "hematopoietic stem": 0.00366, "outside-in signal": 0.01635, "cell activation signal": 0.0512, "increase wet-to-dry ratio": 0.01464, "reporter gene": 0.04355, "dexamethasone inhibit": 0.01904, "prl regulate": 0.01253, "hb24 confers": 0.00146, "elevated turnover": 0.00112, "chronic myeloproliferative disorder": 0.00265, "pro-/antiinflammatory cytokine secretion": 0.00749, "show low activity": 0.0195, "h2o2 induces vcam-1": 0.00536, "gata site result": 0.01445, "white": 0.00062, "delayed": 0.00112, "monomeric polypeptide flexi-12": 0.00091, "lymphadenopathy": 0.0, "transient tyrosine phosphorylation": 0.00656, "blood mononuclear cell separate": 0.0384, "simian ebv lmp1": 0.00376, "full transactivation function": 0.00887, "adult t-cell leukemia cell line": 0.03072, "purification": 0.00087, "selective removal": 0.00267, "tax induction": 0.01607, "polymorphic dna marker": 0.00988, "experimental support": 0.00409, "nuclease protection assay carry": 0.00501, "ick-1a": 6e-05, "pma-induced il-2r alpha": 0.0078, "dna binding activity mediate": 0.01462, "human cd86": 0.03762, "cell cycle behavior": 0.0512, "term rar alpha": 0.0078, "high-affinity dehydroepiandrosterone binding activity": 0.01462, "potent antiinflammatory agent": 0.00281, "putative cd peptide bind": 0.01013, "motion": 0.00012, "weak interaction": 0.00986, "case map": 0.00363, "e1a viral transactivation domain": 0.00603, "pkc inhibitor": 0.009, "adult hpc undergo unilineage erythropoietic differentiation": 0.00393, "stat serine phosphorylation": 0.00656, "cd40 engagement": 0.00372, "phosphorylation status": 0.00983, "previous observation demonstrate": 0.01065, "functional disomy": 0.00816, "myeloid-related lineage": 0.00366, "steroid-sensitive": 0.00043, "elf-1 expression": 0.04163, "rt-pcr product": 0.00533, "predominate": 0.00019, "link grb2 sh3-binding protein sos1": 0.01811, "full-length cdna": 0.00456, "microb bind protein": 0.03019, "hu induces": 0.00803, "induce chemotaxis": 0.0254, "il-12 signal transduction pathway": 0.00817, "palindromic target sequence": 0.01084, "influence cellular proliferation": 0.00596, "conserved traf3 bind site": 0.01084, "scavenger macrophage": 0.00589, "sp1 binding site": 0.01445, "cellular defect lead": 0.00664, "monoclonal international workshop": 0.00186, "lck electrophoretic mobility": 0.00097, "present evidence": 0.00735, "fura": 0.00043, "oct-2-dependent transactivation": 0.00515, "isolates": 0.00093, "tnf alpha induced activation": 0.01582, "effector pathway": 0.01278, "increased tumor necrosis factor-alphaproduction": 0.00467, "lupus patient": 0.01666, "clinical application": 0.00425, "p38": 0.00248, "anti-cd3/anti-cd28 mab": 0.00267, "gc diffuse": 0.0031, "nonstructural": 0.00012, "nf kappa b2 nucleoprotein complex": 0.00674, "coactivators": 0.00043, "activate jnk mapks": 0.01185, "atra treatment": 0.01014, "hematopoietic lineage commitment": 0.00244, "relative contribution": 0.00276, "pivotal event": 0.00552, "secondary immune response": 0.01294, "microenvironment-directed": 0.00012, "pbmc response": 0.01942, "erythroid-specific transcription factor nf-e1": 0.0143, "lymphoblast cell line msb": 0.0384, "up-regulated vcam-1": 0.00233, "ap-1-dependent reporter construct": 0.00484, "namalwa": 0.00037, "mrna transcript": 0.01526, "lps bind": 0.02025, "gpiib": 0.00025, "data reveal": 0.01098, "induce complex": 0.0254, "sr patient": 0.01666, "human b7.1 gene regulate": 0.02177, "growth condition": 0.00819, "tf expression data suggest": 0.02081, "rest secretion": 0.00428, "dqb reporter construct": 0.00484, "michael": 0.00012, "sensitive rt-pcr assay": 0.00668, "cruciform dna": 0.01483, "cd patient": 0.01666, "induce terminal granulocytic differentiation": 0.0127, "ctl repertoire": 0.00115, "differentiated human mononuclear phagocyte": 0.01881, "stat1-dependent gene transcription": 0.02903, "alpha b-encoded isomer": 0.0078, "major subpopulation express": 0.0123, "band": 0.00205, "lps-stimulated control cell": 0.0512, "activation scheme present": 0.02109, "alter stat-1alpha binding": 0.01237, "cdna probe": 0.00456, "migrating isoform": 0.00171, "gata-3 represses gp91phox gene expression": 0.01742, "nuclear distribution": 0.01684, "l. pneumophila possess": 0.00091, "progeny": 0.00099, "exclusive paternal expression": 0.02775, "prototypical nf-kappa": 0.01414, "kappa b-mediated inhibition": 0.00707, "short-lived induction": 0.01607, "oxidative burst response": 0.01294, "hormone-dependent manner": 0.00282, "decidual prl gene": 0.02903, "tar region": 0.01467, "partitioning": 6e-05, "mononuclear leukocyte receptor kinetics": 0.01286, "mhc class ii promoter require bind": 0.00779, "optimal activity": 0.02925, "interferon signal transduction pathway": 0.00817, "hcd57-srei cell": 0.0768, "stat5 protein": 0.04529, "e1a induce cellular sensitivity": 0.0127, "recombinant il-1beta": 0.00391, "il-4ralpha carry": 0.00276, "endothelial activation": 0.03164, "ca2+ redistribution": 0.00304, "y519": 6e-05, "corepressor": 0.00012, "inhibit dna-binding": 0.01904, "conditional epstein-barr virus nuclear antigen": 0.00674, "surface receptor": 0.02571, "fcgamma receptor": 0.02571, "round nucleus": 0.00319, "multimerized response element": 0.01294, "intact pu.1 site adjacent": 0.01084, "normal cell counterpart microdissected": 0.0384, "subtle gene movement": 0.02903, "aspirin due": 0.00369, "transgenic pig donor": 0.00132, "cd95 expression": 0.04163, "oct-2 responsivity": 0.00226, "rodent": 0.00087, "alphaiibbeta3 integrin": 0.00112, "similar activity": 0.02925, "crucial determinant": 0.00121, "nucleotide -404/-220": 0.00202, "lymphokine interferon-gamma": 0.00158, "require conserved leucine charge domain": 0.00526, "tcr-initiated signaling": 0.00558, "hematopoietic transcription factor pu.1": 0.0143, "flow cytometric": 0.00152, "anti-igm stimulation": 0.0112, "intrafollicular": 0.00056, "inhibit pi3-k": 0.01904, "activated peripheral blood": 0.00395, "transient nf-kappa": 0.01414, "lymphocyte activate nf-kappa": 0.01185, "clinical consideration": 0.00425, "tcr constant region": 0.00978, "full activity": 0.02925, "multiple myeloma": 0.00689, "glucocorticoid target tissue": 0.00567, "cell-type specific": 0.01238, "heptp correlate": 0.00654, "transactivation domain": 0.01207, "initial attack": 0.00189, "p21-activated protein kinase": 0.03019, "enhanced biological effect": 0.0141, "targeted overexpression": 0.00382, "calcineurin-mediated signal transduction pathway": 0.00817, "negative reaction": 0.00515, "gata1 mrna induction": 0.01071, "gonadotropin-releasing hormone": 0.00444, "state": 0.00533, "previous report": 0.0049, "interleukin-1 gene": 0.04355, "hematopoietic supporting property": 0.00265, "cytokine-receptor family target": 0.0056, "cys": 0.00019, "gc-rich region behaves": 0.00978, "fkbp52": 0.00025, "repress late gene expression": 0.02177, "activated il-2 receptor complex": 0.01286, "peptide length": 0.00754, "impaired ability": 0.00431, "cre": 0.00192, "ras-raf-erk signal cascade exert": 0.00817, "long-term regulation": 0.01008, "early gene": 0.04355, "cytolytic effector cell function": 0.0384, "lytic replication cycle": 0.00314, "pkcalpha block": 0.01073, "adrenocortical activity": 0.02925, "carboxy-terminal dimerization region": 0.00978, "xpb helicase defect": 0.00186, "cd16-": 0.00087, "endocrine": 0.0018, "recombinant fragment": 0.00391, "jrfl": 6e-05, "therapeutic regimen": 0.00167, "vice versa": 6e-05, "src-family tyrosine kinase gene": 0.02177, "class ii promoter occupancy alteration": 0.00934, "human monoclonal antibody specific": 0.01881, "gp160 treatment": 0.01014, "psti repeat": 0.00378, "induce protective t-cell-mediated immunity": 0.0127, "7-fold increase": 0.02196, "infected adult": 0.00422, "specific receptor consist": 0.01714, "major hcmv glycoprotein": 0.00383, "ifn-gamma receptor chain": 0.01714, "putative steroid bind domain": 0.01013, "rbtn2": 6e-05, "il-1 receptor antagonist result": 0.01286, "nf-at-binding sequence": 0.01625, "specific down-regulation": 0.01238, "induction mechanism": 0.01607, "ikaros/lyf-1 transcription factor motif": 0.0143, "blood leucocyte": 0.00592, "triptolide induces": 0.00803, "messenger rna level": 0.01214, "class ii major histocompatibility complex gene dpa": 0.01244, "cd28 cosignaling": 0.00323, "overnight dst": 9e-05, "fkbp mrna": 0.01526, "ectopic endometrium": 0.00081, "renal cell carcinoma": 0.0512, "nuclear protein-binding activity": 0.0195, "clinical variable include response": 0.00971, "integral protein": 0.04529, "experimental model": 0.00422, "il-5 promoter activation": 0.02109, "cell nf-kappa": 0.0768, "term baby": 0.00413, "bl30": 0.0, "inactive cytoplasmic form": 0.00703, "salahuddin": 0.00012, "mutagenesis": 0.00161, "cold": 0.00062, "mice bearing tumor": 0.00622, "humoral homeostasis": 0.00065, "related il-6-mediated autocrine tumor cell growth": 0.0256, "untreated": 0.0023, "human lcr hs": 0.02508, "mdd result": 0.0161, "synergistic transactivation": 0.00515, "receptor-cdna": 0.0, "primitive erythroid tissue": 0.00443, "nf-kappab deprivation": 0.00999, "productive hiv-1 infection": 0.00585, "stressful condition": 0.0036, "bacterial lipoprotein": 0.00223, "small subunit describe": 0.00323, "t-cell receptor complex": 0.01714, "icr27": 0.0, "untreated ra": 0.00596, "intracellular adhesion molecule": 0.00569, "slight decrease": 0.00971, "erk2": 0.00105, "congestive heart failure": 0.00091, "cbf alpha 2-451 twofold": 0.00585, "nfat-1-mediated beta-galactosidase activity": 0.0195, "aldh1 protein": 0.04529, "antiglucocorticoid property": 0.00397, "experience": 0.00068, "ciita-deficient cell line": 0.0512, "tyrphostin": 0.00012, "truncated raralpha": 0.00074, "bob.1/obf.1": 0.00099, "peroxisome-proliferator activate receptor gamma": 0.01286, "stable": 0.00341, "amino acid residues c-terminal": 0.00428, "dna-binding/dimerization domain": 0.01207, "ngf": 6e-05, "ad vector lack": 0.00422, "protein bound": 0.04529, "ras-raf-1-map kinase": 0.01188, "pafr": 0.00043, "complete extinction": 0.00171, "cell mutant": 0.0768, "test data": 0.00487, "5'-most distal carg sequence": 0.00813, "ad-infected": 0.00025, "partial dna-binding domain": 0.00804, "tnfalpha-mediated nfkappab activity": 0.0195, "bsap correlate": 0.00654, "oct1.2": 6e-05, "c-sis/pdgf-b promoter": 0.02336, "spermatogonia": 0.00012, "gamma-globin mrna": 0.01526, "normal human eosinophil": 0.02508, "human leukocyte antigen status": 0.01881, "double mutation ap-1": 0.00463, "nonspecific stimulation": 0.0112, "transcription factor stat1alpha": 0.01907, "inhibit secretion": 0.01904, "110-kda member": 0.00413, "organism induce transcription": 0.01873, "modification regulate": 0.01253, "human epsilon-globin-encoding gene": 0.02903, "positive correlation": 0.00468, "capacitance": 0.00012, "reporter gene construct drive": 0.02177, "allergic": 0.00192, "crucial proximal human il-4 promoter": 0.01505, "wp": 0.00093, "intrinsic cellular apoptosis": 0.00596, "deletion mutant lack": 0.0054, "terminal neutrophil maturation": 0.00331, "seventeen": 0.00043, "tyrosine kinase syk": 0.00792, "primary human breast tumor": 0.01881, "ac cascade": 0.00214, "pfu/animal": 0.0, "cbf require": 0.01315, "stanley korsmeyer provide": 0.0043, "manifest": 0.00124, "higher-affinity site": 0.02168, "increased growth rate": 0.00546, "androgen-dependent lncap cell line": 0.0384, "low risk group": 0.00471, "bcl-6+": 0.00012, "anti-ig inducibility": 0.00127, "impaired recycling": 0.0018, "show variable degree": 0.01733, "gel mobility shift assay show": 0.0104, "potential clinical usefulness": 0.00403, "alpha-pml": 0.00019, "incubation post-uv irradiation": 0.00139, "deletion mutation analysis": 0.00786, "ra nuclear receptor": 0.01714, "normal human epidermal keratinocytes": 0.01881, "plasma": 0.00751, "germinal center cell origin": 0.0384, "p50/p65-nf-kappab": 6e-05, "lps-stimulated tnf-alpha production": 0.00695, "c-jun gene": 0.04355, "nf-atc": 0.00199, "-245 base pairs upstream": 0.00185, "translocation associate": 0.01092, "mammary tissue": 0.00664, "decreased plasma cysteine": 0.0025, "functional il-12": 0.00816, "puf site": 0.02168, "beta-hydroxysteroid dehydrogenase": 0.00053, "antisense phosphorothioate oligonucleotides": 0.00122, "vdr overexpression vector": 0.00254, "monocytic nuclear factor-kappa": 0.01123, "ctgtg": 0.0, "potent antioxidant drug": 0.00238, "oral administration": 0.00093, "supershift experiment reveal": 0.00732, "mnp site": 0.02168, "cellular mcp-1 content": 0.00596, "overlap ifngr1 frameshift small deletion": 0.00138, "c-fos promoter activity": 0.0195, "human gene encode lbr": 0.02177, "thyroid hormone-response element": 0.01115, "bcl-6 gene encode": 0.02903, "direct activation": 0.03164, "extended substrate recognition": 0.00172, "-223 base": 0.0031, "il-1beta production": 0.01042, "cell lineage cell arrest": 0.0192, "helix": 0.00124, "biochemical finding correlate": 0.00436, "human th1 clone": 0.02508, "human gata-3 protein play": 0.02264, "suppress cortisol secretion": 0.00407, "fli-1 binding": 0.01855, "oxidized low density lipoprotein": 0.00354, "'circadian pacemaker": 6e-05, "cotransfection assay": 0.01002, "cytoplasmic retention": 0.004, "mcm6 gene mediate": 0.02903, "include y292": 0.01439, "oct-1": 0.00292, "human lox-1 gene": 0.02903, "control plasmid": 0.01303, "mouse carry transgene": 0.00649, "strong similarity": 0.00347, "mediate cd16-induced activation": 0.02109, "quiescent cell": 0.0768, "mutant mouse lack mature": 0.00487, "megakaryoblastic phenotype": 0.00366, "owl monkey": 0.00071, "nuclear protein extract": 0.03019, "cytoplasmic ar": 0.004, "turn inhibits translocation": 0.00354, "high expression level": 0.02775, "activate macrophage contribute": 0.01185, "erythroblast": 0.00211, "apoptosis suppressor protein bcl-2": 0.02264, "positive cis-acting element": 0.01115, "show partial resistance": 0.01733, "kinase responsible": 0.01188, "active nuclear nf-kappa": 0.01123, "quiescent": 0.0023, "human peripheral leucocyte": 0.02508, "variant octamer motif bind oct-1": 0.0081, "cytokine facilitating progression": 0.00749, "endothelial cell increase expression": 0.0384, "detection rate": 0.00279, "normal population": 0.0121, "5-fold increase": 0.02196, "genomic dna": 0.01483, "differential signaling": 0.00558, "apparent th2 differentiation defect": 0.00589, "erythropoietic wave": 0.00028, "autoimmune disease subject": 0.00449, "glucocorticosteroid receptor": 0.02571, "up-regulate vcam-1 expression": 0.02775, "kit ligand cotreatment": 0.00395, "oxidative stress inhibited activity": 0.01462, "ataxia telangiectasia clonal proliferation": 0.00402, "undesirable overexpression": 0.00382, "stimulating antigen": 0.00819, "enhancer/promoter combination": 0.00288, "nf-kappab/ikappab complex": 0.01684, "regulate aspect": 0.01253, "acute onset": 0.00369, "increase class ii expression": 0.02081, "htlv-iiib": 0.00012, "p50 associate": 0.01092, "monocyte maturation": 0.01197, "devd-p-nitroanilide": 0.00012, "siv long terminal repeat possess": 0.00151, "enhanced initiation": 0.00285, "lymphoid-specific expression": 0.04163, "chemokine receptor blr2/ebi1": 0.01714, "ngfi-b/nur77-related transcription factor": 0.01907, "nfat-like element encompass overlap oct-": 0.00669, "ccl4 lead": 0.00996, "ghf-1": 0.00012, "stratified squamous epithelium": 0.00035, "ligand-independent mechanism": 0.01058, "nf-matp35 induction": 0.01607, "sl3 core remain": 0.00347, "xiste- ring chromosome": 0.00196, "tnf increase vcam-1 protein": 0.02264, "mg": 0.00081, "low prevalence": 0.00707, "activate hiv expression": 0.02775, "phosphatase treatment": 0.01014, "endogenous level": 0.01821, "dxm inhibit": 0.01904, "normal thymus environment": 0.00806, "cell line test": 0.0512, "regulate bcl-xl expression": 0.02775, "5269-5275": 0.0, "jun phosphorylation": 0.00983, "cellular differentiation": 0.01179, "fibroblastic cell line": 0.0512, "human tonsillar mononuclear cell": 0.0384, "transcriptional template": 0.01151, "abnormal pattern": 0.00549, "ccaat/enhancer bind protein": 0.03019, "y.": 6e-05, "develop asthma": 0.00403, "ap": 0.00012, "interleukin-1": 0.00372, ".001 versus lps": 0.00234, "nuclear run-on": 0.01684, "ovulation marker": 0.00382, "chan'su": 6e-05, "thymocyte": 0.00192, "physical proximity": 0.00096, "ongoing transcription": 0.0281, "transcriptional induction": 0.01607, "non-human primate": 0.00056, "unusual structure": 0.00319, "distinct intracellular pathway": 0.00852, "proinflammatory transcription factor nuclear factor-kappab": 0.01144, "human tnf-alpha gene": 0.02903, "receptor family": 0.02571, "gal4 activation domain": 0.02109, "drosophila cell show": 0.0512, "radioligand-binding assay": 0.01002, "icam-1 induction": 0.01607, "beta fragment fuse": 0.00449, "polymorphonuclear leukocyte": 0.00478, "concomitant cell proliferation": 0.0512, "tetanus toxoid specific": 0.00825, "intermediate thymocyte culture induce nf-kappab activity": 0.00975, "0-lymphocytes": 6e-05, "multiple complex": 0.01684, "cd16 ligand binding": 0.01237, "recombinant human il-10": 0.02508, "il-4 inducibility": 0.00667, "hb": 0.00037, "vitro stimulate human tonsil": 0.01881, "chronic myelomonocytic leukemia": 0.00333, "mood alteration": 0.0023, "lps-stimulated cmv transfected cell": 0.0384, "cell octamer-binding protein 1/octamer-binding factor": 0.03072, "monocyte infiltration": 0.01197, "multiplex messenger assay": 0.00668, "minimal dna sequence require": 0.00813, "prevent nuclear translocation": 0.01123, "il-1 receptor antagonist": 0.01714, "intragenic promoter drive": 0.01557, "gtp-bound form": 0.01055, "gamma-2": 0.00019, "bcl-6 coding region": 0.00978, "induce fra-1 expression": 0.02775, "lysates": 0.00205, "il-13 activate": 0.01777, "immunomodulating property": 0.00397, "q13-21": 6e-05, "multiple time": 0.00689, "day prior": 0.00155, "recombinant truncated glycoprotein": 0.00261, "hiv-1 tat": 0.00878, "proil-1beta": 0.00019, "benzene toxicity": 0.00056, "extracellular signal-related kinase": 0.00792, "thrombocytopenia": 0.00012, "oct site": 0.02168, "direct-repeat palindrome tgcgcatgcgca": 8e-05, "vascular cell": 0.0768, "recent report suggest": 0.01348, "adenovirus e2 promoter": 0.01557, "granule resemble": 0.0013, "demonstrate circadian variation": 0.01065, "junb": 0.00248, "integrin costimulation": 0.00171, "h/c link sequence": 0.01084, "supplemented cytokine": 0.01123, "leucine zipper protein family suggest c-myb": 0.0151, "differentiation program foreign": 0.00786, "specific cellular activation signal": 0.01582, "5-hydroxyeicosatetraenoic acid production": 0.00695, "cytokine-dependent cell line m-tat": 0.0384, "important role cbp/p300 play": 0.00664, "fc gamma": 0.0044, "western": 0.00167, "scl protein size": 0.03019, "nitric oxide synthase": 0.00054, "differentiation-related antigen": 0.00819, "ikappab-alpha overexpression": 0.00382, "latent nf-kappa": 0.01414, "raralpha-mediated signal": 0.01635, "octamer/oct-dependent transcription": 0.0281, "efficient tg presentation": 0.00126, "inorganic lead activate nf-kappa": 0.00889, "oncogene amplification": 0.00261, "gene domain": 0.04355, "canventol": 0.00019, "signal transducing protein": 0.03019, "p100 lead": 0.00996, "human apl": 0.03762, "proximal regulatory element": 0.01115, "antiphosphotyrosine immunoblots": 0.00016, "affected animal display marked splenomegaly": 0.002, "fk506 inhibit t-": 0.0127, "t-lymphocytic ach-2 cell": 0.0512, "m. tuberculosis manlam result": 0.00805, "antibody-mr complex": 0.01684, "signal transduce": 0.01635, "adherent monocyte": 0.01197, "ikappabalpha protein": 0.04529, "hormone concentration": 0.0067, "hemizygotic nephew": 3e-05, "initiate signaling": 0.00558, "main anti-inflammatory mediator": 0.0013, "il-1rs": 0.00012, "sodium": 0.00372, "lymphycryptoviruses provide": 0.00645, "lymphoid lineage-determining factor ikaros": 0.0143, "inefficient": 0.00043, "down-regulated c-myc expression": 0.02775, "granulocyte macrophage-colony stimulating factor": 0.0143, "il-1alpha gene transcription": 0.02903, "ifn-gamma induced": 0.0054, "undefined 84-kda protein": 0.03019, "inducible nuclear factor-kappab": 0.01123, "hematopoietic lineage": 0.00366, "-201": 0.00031, "purified polypeptide": 0.00261, "immunological marker": 0.00382, "multiple usa component": 0.00459, "cd4+ cell capable": 0.0512, "immunoglobulin heavy chain constant region": 0.00587, "cell apoptosis": 0.0768, "il-1 signal lead": 0.0109, "lipopolysaccharide-free cell culture system lead": 0.03072, "oxldls inhibit": 0.01904, "vitro correlate": 0.00785, "65-kda": 6e-05, "calcium signaling": 0.00558, "monkey exhibit quantitative": 0.00443, "lps-inducible nuclear factor-kappa b/rel complex": 0.00674, "atf family member bind": 0.01013, "augmented endothelial cell-monocyte": 0.00289, "immunoregulatory activity": 0.02925, "pkc-dependent pathway synergize": 0.00852, "cellular response": 0.01942, "selective eosinophil-activating factor": 0.01907, "suppresses interleukin 2-induced": 0.00184, "purified mbp-": 0.00261, "n-oct protein": 0.04529, "dna motif homologous": 0.00988, "megakaryocytic terminal maturation": 0.00221, "hiv-1 replication induce": 0.01694, "epstein-barr nuclear antigen": 0.01123, "irf-1 gene expression": 0.02903, "support proliferation": 0.00803, "zebra activation domain swap construct": 0.01266, "cysteine-rich antigen segment resistant": 0.00409, "protein kinase c.": 0.03019, "protein bind site": 0.03019, "superoxide dismutase": 0.00053, "increased lmp1 expression": 0.02775, "initial regulatory point": 0.00455, "acidic activator protein": 0.03019, "cell-derived cdna encode oct-binding factor": 0.01144, "immature erythroid cell": 0.0512, "dlcl development": 0.00633, "full length cdna": 0.00304, "daily excretion accounting": 0.00029, "form bind": 0.02025, "-351": 6e-05, "preleukaemic clone cell": 0.0512, "gata-1 fluorescence": 0.00413, "correct folding": 0.00034, "protein extract": 0.04529, "related cation": 0.00236, "nf-kappab protein change": 0.03019, "strong signal": 0.01635, "paraffin-embedded": 0.00012, "bronchial epithelial": 0.00189, "reinfusion": 0.00019, "phase gene inducible": 0.02903, "pulse experiment": 0.00397, "il-7 induce assembly": 0.01694, "potent cytokine": 0.01123, "inhaled corticosteroid fp": 0.00095, "aspirin-like drug": 0.00338, "cleavage product": 0.00533, "high il-2 level": 0.01214, "represent": 0.008, "native hgr": 0.00149, "intact nf-kappa b-binding site": 0.01084, "protease activation": 0.03164, "intracellular domain": 0.01207, "breast cytotoxic": 0.00257, "multiple sclerosis": 0.00689, "m22 mutant": 0.0081, "okadaic acid-induced cell": 0.0512, "up-regulate intercellular adhesion molecule-1": 0.0029, "quinone derivative": 0.00192, "activate signal transduction": 0.01185, "high-affinity cell surface receptor": 0.0384, "mabs exhibit": 0.00664, "cd8 variable contribution": 0.00103, "multiple x1 box-specific dna-binding activity exist": 0.00975, "differentiation block": 0.01179, "express nf-kappa b-inducible early gene": 0.01742, "rapl": 0.0, "52-year-old female present": 0.0049, "wild-type ciita activity": 0.0195, "human gata-3": 0.03762, "-250": 0.00031, "specific protein-tre-dna interaction": 0.00825, "purified human t-cells": 0.02508, "cobalt": 0.00025, "ig cross-linking": 0.00242, "nf-at factor": 0.0286, "catgtggc": 6e-05, "human k562 cell": 0.0512, "inhibit hiv production": 0.0127, "surfactant affect transcriptional mechanism": 0.00575, "low responder": 0.00707, "wild-type strain": 0.00378, "immature bone marrow cell": 0.0384, "untreated hl-60 cell": 0.0512, ".001 versus control": 0.00868, "ets protein family": 0.03019, "cell specification": 0.0768, "jeg-3 human choriocarcinoma-induced immunosuppression": 0.01881, "calcium/calmodulin-dependent protein kinase ii downregulates": 0.01811, "receptor heterodimer block nfatp/ap-1 complex formation": 0.00857, "purine-box/arre/nf-at": 6e-05, "tumor necrosis factor alpha-induced degradation": 0.01144, "p55": 0.0005, "somatic cell fusion": 0.0512, "significant rapid": 0.00416, "epo-inducible tal1 dna bind activity": 0.0117, "anti-hiv-1 therapy": 0.00372, "characteristic competitive binding profile": 0.00927, "epstein-barr virus transformation": 0.00591, "cell adaptor": 0.0768, "kinetics similar": 0.00673, "chtm": 0.00043, "site alpha": 0.02168, "signal transduction cascade link": 0.00817, "c-erba/t3 receptor": 0.02571, "provirus": 0.00124, "clinical study demonstrate": 0.01065, "kappab inactivation remain poorly understood": 0.00208, "non-b": 0.00056, "bare promoter": 0.02336, "ifn-alpha activated stat1 alpha": 0.00585, "il-2 share": 0.01117, "cat activity induce": 0.0195, "essential cis-acting enhancer motif": 0.00454, "br": 6e-05, "diminished il-13-induced expression": 0.02775, "lymphoma rael cell": 0.0512, "human glioblastoma": 0.03762, "allelic nucleotide": 0.00202, "bipartite dna-binding structure": 0.00374, "cd34+cd71+ cell stimulate": 0.0512, "cfu-gm": 0.00012, "camp response element site": 0.01084, "tcr repertoire selection": 0.00318, "similar concentration": 0.00673, "viral nuclear antigen": 0.01123, "unique transcriptional activator": 0.00767, "differential mrna display analysis": 0.00763, "gastric epithelial cell": 0.0512, "deficiency-cold syndrome": 0.00273, "mammalian protein bsap": 0.03019, "response require": 0.01942, "cell leukemia virus-1": 0.0512, "vitro-translated protein": 0.04529, "serum response": 0.01942, "p130 phosphorylated form": 0.00703, "tpa result": 0.0161, "anti-cd3 induced nf-at": 0.0036, "wingless/wnt signal transduction pathway": 0.00817, "inducible system": 0.00667, "hie": 0.00031, "early t-cell activation": 0.02109, "jun-b transfection": 0.00276, "autosome translocation": 0.00515, "phorbol myristate acetate-inducible creb -or ap1-dependent transcriptional activity": 0.00731, "secondary pathogenic infection": 0.00414, "ifn alpha production due": 0.00585, "gp41 envelope protein": 0.03019, "mouse il-4 promoter": 0.01557, "individual component": 0.00456, "gata factor": 0.0286, "ifn-regulated signal transduction pathway": 0.00817, "activate igkappa expression": 0.02775, "ptpases play": 0.0071, "heat shock induce virus activation": 0.01266, "liquid culture": 0.0062, "reciprocal translocation": 0.00515, "hormone-activated receptor binding": 0.01714, "recent observation": 0.00149, "pha-stimulated pbl": 0.00096, "pmnl": 6e-05, "long-term cultured nk clone": 0.00369, "multiple immunization": 0.00689, "fresh pbmc": 0.00236, "human immunodeficiency virus-infected monocyte": 0.01881, "lung vascular adhesion molecule": 0.00426, "glial-derived cell line": 0.0512, "c2h2-type": 0.0, "pdbu induce": 0.0254, "trx": 0.00043, "d20s58": 0.00012, "-0.568": 0.0, "2.5-fold increase": 0.02196, "epithelial signal transducer": 0.0109, "quantitative southern blotting demonstrate hemizygosity": 0.00639, "cd36-producing cho cell": 0.0512, "proteolytic stability": 0.00112, "general approach": 0.00164, "carboxy-terminal amino acid": 0.00571, "rii substrate peptide": 0.00502, "il-10 secretion": 0.00428, "endothelium-derived vasoactive factor": 0.01907, "ifn-alpha-mediated signaling pathway": 0.00852, "cell-specific mechanism": 0.01058, "ig kappa enhancer": 0.00606, "p105": 0.0031, "ikk-alpha/beta heterodimer": 0.00205, "il-5 induce signal": 0.01694, "lat-containing signaling complex": 0.01123, "min post-pha stimulation": 0.00746, "significant loss": 0.00416, "unknown inducible factor": 0.01907, "fas ligand induction": 0.01071, "immunoglobulin heavy-": 0.00276, "gro-alpha": 0.00019, "c/ebp beta": 0.00673, "cell line exhibit property": 0.0384, "fresh atl sample": 0.00139, "negative regulatory factor": 0.01907, "inducible nitric oxide synthase": 0.00242, "human vdr cdna": 0.02508, "fourfold": 0.00062, "p65 dna binding": 0.01237, "dyad symmetry": 0.00025, "target remodeling": 0.00825, "il-4 signal": 0.01635, "cerulein": 0.00019, "general transcriptional activator": 0.00767, "m-csf expression": 0.04163, "jurkat t-cell line zap-70": 0.00827, "mek1-interfering mutant inhibit": 0.0127, "5-lipoxygenase inhibitor zileuton": 0.006, "bacterial lipopolysaccharide-activated human blood": 0.01881, "il-12 nonresponsiveness": 0.00313, "upstream delta-globin region reveal protected sequence correspond": 0.00464, "molecular mechanism regulate human immunodeficiency virus": 0.01254, "internal deletion": 0.00344, "host apc": 0.00214, "intracellular stain": 0.00583, "reporter gene mediate": 0.02903, "transactivating ability": 0.00431, "distribution": 0.0023, "antitumor agent": 0.00422, "hormone bind domain variant": 0.01013, "cd8+": 0.00279, "sh2-deleted grb2 mutant": 0.0054, "intracellular camp inhibit": 0.0127, "unchanged level": 0.01821, "cell cycle entry": 0.0512, "light": 0.00155, "myeloid zinc finger gene": 0.02177, "peptide microsequencing": 0.00754, "gata-1 factor bind motif": 0.0143, "-induced differentiation": 0.01179, "so-called": 0.00136, "related factor spi-b bound": 0.0143, "fibronectin": 0.00155, "altered functioning": 0.00161, "doxepin": 0.00012, "cis -regulatory element": 0.01115, "infectious": 0.00192, "fkbp51 represent": 0.004, "restimulation": 0.00012, "between-subject variability": 0.00012, "specific hormone receptor": 0.01714, "pterin carbinolamine dehydratase/dimerization cofactor": 0.00039, "hacat cell line": 0.0512, "nuclear dna-binding protein": 0.03019, "early lymphoid cell": 0.0512, "significant association": 0.00416, "exogenous recombinant tat protein": 0.02264, "fos-like kinetics": 0.00167, "important morphogen": 0.00689, "jurkat cell activation": 0.0512, "rest pbl constitutively express prominent level": 0.00615, "nuclear rel-a": 0.01684, "dna-binding specificity": 0.00561, "full er function": 0.00887, "photoproducts": 6e-05, "decrease cell proliferation": 0.0512, "ciita mutant": 0.0081, "ebv mrna transcript encode immediate-early transcriptional transactivators": 0.00436, "lymphocytic level": 0.01821, "cd4+ human helper": 0.02508, "hmg-88": 6e-05, "protein require": 0.04529, "nodular lymphocyte predominance hd": 0.00741, "nonmitogenic": 6e-05, "human adenovirus": 0.03762, "monospecific antibody": 0.00893, "ebna": 0.00087, "ebna2 transactivates": 0.0014, "human nk cell activity": 0.0384, "nk- kappa": 0.00748, "il-2e": 0.0, "single inoculation": 0.0036, "ets-1 binding site": 0.01445, "germany": 6e-05, "idcs associate": 0.01092, "selective ifn responsiveness": 0.00215, "downstream target": 0.00825, "bind enhancer element": 0.0135, "carboxy terminal": 0.00332, "-independent pathway": 0.01278, "ikk-gamma": 6e-05, "c3 transferase": 0.0004, "ea/s-directed mlv transcription": 0.01873, "show mcp-1 expression": 0.02775, "cell fusion": 0.0768, "impairs successive gc therapy": 0.00186, "u-937 monocyte-like cell": 0.0512, "partial suppression": 0.00416, "hydrophobic region": 0.01467, "fmlp": 0.00105, "caspase-1": 0.00012, "tunel stain show": 0.01733, "joint disease": 0.00673, "intracellular trafficking": 0.00583, "human monocyte stimulate": 0.02508, "prognostic criterion": 0.00047, "nuclear protein complex": 0.03019, "v-abl protein tyrosine kinase trigger high-frequency rearrangement": 0.01294, "myeloid-cell-specific expression": 0.04163, "em": 0.00025, "interleukin-2-dependent transcription": 0.0281, "low dissociation constant": 0.00471, "-9": 0.00025, "gm-kappa": 0.00043, "attendant symptom": 0.00068, "b2 subunit promoter region": 0.01168, "block anti-cd3 induced peripheral blood": 0.00429, "cell permeable inhibitory peptide": 0.0384, "il-2 promoter repression": 0.01557, "lysopc": 0.00068, "autologous pbsct": 0.00078, "icrf-193": 0.00025, "il-13 occurs": 0.00183, "de novo synthesis": 0.00389, "peripheral blood monocyte isolate": 0.00599, "monovalent gold compound autg": 0.0011, "1-kb region": 0.01467, "ikappabalpha level correlate": 0.01214, "concomitant stimulation": 0.0112, "lectin pha": 0.00127, "c-terminal splice variant": 0.00184, "peripheral blood sample": 0.00395, "benign tumor": 0.00934, "biological stimulus": 0.0027, "reverse transcription-pcr": 0.00236, "epstein-barr virus zebra protein": 0.02264, "human immunodeficiency virus transcription": 0.01881, "hiv-1 ltr reporter construct": 0.00439, "human dc mediate": 0.02508, "anti-ig antibody": 0.00893, "specific nuclear translocation": 0.01123, "hla binding": 0.01855, "clinical side effect": 0.0141, "insulin gene transcription": 0.02903, "consensus bind motif": 0.0135, "el-4": 0.00068, "murine erythroid leukemia cell": 0.0384, "il-4 signal transduction": 0.0109, "specific depletion": 0.01238, "concentration-dependent fashion": 0.00161, "ebv-positive": 0.00124, "downstream sequence element": 0.01115, "level equivalent": 0.01821, "n-terminal antibody show normal level": 0.0104, "biochemical analysis show": 0.01733, "helpful": 0.00012, "rhu tnfr": 0.00025, "captopril": 0.0005, "ig beta": 0.00673, "no-induced downstream signal": 0.0109, "oligonucleotides inhibit cell adhesion": 0.0384, "solid tumor": 0.00934, "gata-3 transcriptional initiation site": 0.01084, "undergo surgery": 0.0023, "cell cytosol": 0.0768, "dna-probe": 6e-05, "bcd mrna transcript": 0.01017, "combined signaling": 0.00558, "short arm": 0.0013, "cellular haptenation": 0.00893, "transmembrane electrolyte movement": 0.00064, "mediate tax responsiveness": 0.00821, "pseudo-hypoaldosteronism": 0.00019, "hiv-induced apoptosis": 0.0089, "significant 2-4 fold increase": 0.01098, "caii reporter construct": 0.00484, "isg15-ltr-ifn hybrid gene insert": 0.02177, "cupric ion block nf kappa": 0.00429, "family study": 0.01355, "regulate transition": 0.01253, "identical condition": 0.0036, "conserved function": 0.01331, "stat6-expressing jurkat cell": 0.0512, "p49/p52": 0.00012, "v.j.": 0.00012, "constitutively activated receptor": 0.01714, "cyclophilin/calcineurin": 6e-05, "paternal": 0.00037, "direct analysis": 0.01179, "macrophage cell line": 0.0512, "prolonged poor glycemic control": 0.00651, "redox-sensitive transcription factor": 0.01907, "preliminary observation": 0.00149, "immunological variable": 0.00155, "inducible expression": 0.04163, "sit": 0.00285, "activate pbmc": 0.01777, "receptor activation": 0.03164, "ng/ml/h": 0.0, "normal nf-kappa": 0.01414, "lps-mcd14 binding": 0.01855, "electrophoresis mobility shift assay": 0.00501, "initiation site": 0.02168, "subtypes": 0.00081, "porcine serum": 0.00378, "control cell line": 0.0512, "fluorescein-labeled amplicon": 0.00012, "biological impact": 0.00217, "subtractive hybridisation method base": 0.00155, "briefly": 0.0, "specific dna binding capacity": 0.00927, "nuclear subunit": 0.01684, "specific receptor c-mpl": 0.01714, "alters dna conformation": 0.00988, "nuclear protein bind site": 0.02264, "p.g.": 0.0, "important inflammatory mediator": 0.00459, "anti-c5b-9 immunoprecipitates": 9e-05, "calcineurin-stimulated cell": 0.0768, "hiv-infected monocytic cell": 0.0512, "unique property": 0.00397, "thiol antioxidant regulate ige isotype switching": 0.00418, "peak expiratory flow": 0.00101, "uas1 bind site": 0.01445, "asymptomatic infection": 0.0062, "human prostatic epithelial cell": 0.0384, "suppress promoter activity": 0.0195, "p8mtcp1": 6e-05, "tumor proliferative activity": 0.0195, "double-positive": 0.00031, "nmr analysis demonstrate": 0.01065, "cell transcription factor gata-3 stimulates hiv-1 expression": 0.02194, "transactivating capacity": 0.00329, "pk": 0.00012, "inhibit cytokine-induced endothelial cell activation": 0.03072, "intermediate affinity yield intermediate": 0.00195, "purine box": 0.00304, "synthesis": 0.01166, "oxidized low-density lipoprotein": 0.00079, "cgata-3": 6e-05, "lymphoid-specific nuclear factor": 0.01907, "cyclosporin a-sensitive mechanism": 0.00705, "mutation/deletion": 6e-05, "liver": 0.00236, "lox": 0.00031, "vivo isolate peripheral blood mononuclear cell": 0.0256, "trans relationship": 0.00158, "quiescent hpcs": 0.00115, "g2/m-phase": 0.00012, "repress homeotic gene expression": 0.02177, "ebv-transformed lymphoblastoid cell line": 0.0384, "paget": 0.00012, "fk506 interferes": 0.00149, "interleukin-2-independent growth": 0.00819, "ifn-alpha enhance tyrosine phosphorylation": 0.00492, "yeast activated serum": 0.00393, "nonmatrix compartment": 0.00087, "signal deliver": 0.01635, "ra signal": 0.01635, "gpa": 0.00012, "release tnf-alpha": 0.00546, "region include": 0.01467, "epstein-barr virus immediate-early antigen": 0.00444, "prevent activation": 0.03164, "-like promoter element": 0.01557, "oxidative stimulus trigger nf-kappa": 0.00707, "consequent function": 0.01331, "thp inhibit transcription": 0.01873, "janus protein tyrosine kinase": 0.02264, "monocytic phenotype": 0.00403, "negative cofactor": 0.00515, "programmed cell death associate gene": 0.03072, "3-fold increase": 0.02196, "megakaryocyte/platelet-specific enhancer": 0.00909, "phenylarsine oxide": 0.00065, "regulate multiple stage": 0.00835, "acetylsalicylic acid": 0.00856, "therapeutic effect": 0.02115, "unidentified ets family protein bind": 0.01811, "suprachiasmatic nucleus": 0.00319, "cem c7 cell": 0.0512, "non-hodgkin": 0.00056, "synthesize nuclear component": 0.01123, "wild-type hlf": 0.00378, "hybrid reporter construct": 0.00484, "mechanism-based toxicity associate": 0.00728, "estrogen receptor-positive": 0.00323, "integrin-dependent adhesive function": 0.00887, "target plasmid": 0.00825, "atopic disorder": 0.00223, "endothelial cell": 0.0768, "inducible virus expression": 0.02775, "bp -245": 0.00267, "il-2-induced expression": 0.04163, "devd-cho": 6e-05, "balb/c3t3 cell": 0.0768, "uv cross-linking experiment suggest": 0.01011, "scf induces activation": 0.02109, "day": 0.00292, "compound induce g1 arrest": 0.0127, "nk cell-associated": 0.00366, "nfat peptide span": 0.00502, "human il-5 promoter/enhancer-luciferase gene construct transfected": 0.01452, "dihydrolipoic acid": 0.00856, "x-linked androgen receptor": 0.01714, "subset-restricted expression": 0.04163, "single isolate": 0.00416, "human gm-csf receptor alpha promoter direct reporter gene activity": 0.00968, "nf-kappab-p105/p50": 6e-05, "gata-factor": 0.0, "oct-2 transcription factor": 0.01907, "gcs up-regulate cytokine receptor expression": 0.01665, "acute inflammatory injury": 0.00314, "c-fos/c-jun family": 0.00841, "eklf": 0.00174, "tnf effect": 0.02115, "transcription factor consensus sequence oligonucleotides": 0.01144, "recombinant porcine interferon-gamma": 0.00261, "long-lasting activation": 0.03164, "zeta": 0.00087, "multiple cellular promoter": 0.01557, "encode product require": 0.00877, "ifngamma treatment": 0.01014, "il-15 upregulated il-2ralpha": 0.00072, "shp1": 0.00099, "release arachidonate": 0.00484, "lymphocyte express human t-cell leukemia virus type": 0.01075, "pathway": 0.02556, "body mass index": 0.00091, "homodimeric": 0.00062, "restriction enzyme-generated restriction fragment length polymorphism": 0.00116, "prominent substrate": 0.00199, "consistent site": 0.02168, "subendothelium": 6e-05, "breast-cancer sample": 0.00208, "s6 protein demonstrate stimulation": 0.02264, "induce overexpression": 0.0254, "nf-kappab p65": 0.00999, "nf-kappa b-binding complex": 0.01123, "intracellular oxidant stress induce": 0.0127, "influence production": 0.01042, "bcs": 0.00025, "il-4 activates gene expression": 0.02177, "soluble cd40 ligand stimulate fibroblast activation": 0.01055, "tsp": 0.00068, "nonopsonic phagocytosis": 0.00047, "cd4+ cd8+": 0.00288, "nuclear protein suggest": 0.03019, "striking heterogeneity": 0.00062, "clustering algorithm": 0.00028, "eliminate increase nf-kappa": 0.01464, "ige/allergen immune complex bind": 0.01013, "cyclin d2": 0.00093, "heat shock protein association": 0.02264, "histone deacetylase activity": 0.0195, "characterized pathway": 0.01278, "lp receptor": 0.02571, "hmg box": 0.00304, "433-442": 0.00037, "transient nf-kappa b-dna interaction": 0.00707, "expression require": 0.04163, "transactivating activity": 0.02925, "hydrophobic": 0.00037, "cbf1/rbp-jkappa binding site": 0.01445, "gal4 dna bind domain fuse": 0.0081, "latent membrane protein": 0.03019, "myeloid leukemia cell": 0.0512, "cd40l+": 0.00012, "stimulate cell": 0.0768, "cd13/apn": 0.00012, "dimethyl sulfate": 0.00062, "similar molecular weight suggest": 0.01011, "domain capable": 0.01207, "hsp60": 0.00037, "methylated de novo": 0.00105, "study htlv-i transcription": 0.01873, "cdna fusion protein": 0.03019, "beta-catenin localizes": 0.00047, "pre-b cell": 0.0768, "viral regulatory protein express": 0.02264, "cimetidine": 6e-05, "induce il-12 production": 0.01694, "cerami": 0.00019, "luciferase demonstrated": 0.00136, "b-cell-specific": 0.00242, "dq3.2": 0.00012, "lymphoma cell express b-cell": 0.0384, "degree": 0.00292, "individual cell line": 0.0512, "core-binding factor": 0.0286, "ner defect": 0.00279, "induced inhibition": 0.01061, "amino terminal domain": 0.00804, "paradigm": 0.00019, "abnormal activation": 0.03164, "il-1ra": 0.00112, "minimal promoter": 0.02336, "poor expression": 0.04163, "heterodimer dna-binding complex": 0.01123, "stat5 activation": 0.03164, "fcs+": 0.00019, "share structural similarity": 0.00192, "t-cell antigen receptor engagement": 0.01286, "immunoreactive gr": 0.004, "ap-1 binding site eliminate": 0.01084, "primary sjogrens": 0.00738, "fasl mrna": 0.01526, "induce sialoadhesin expression": 0.02775, "accepted part": 0.00152, "enhancer replacement": 0.00909, "il-10 induces": 0.00803, "hypothalamic level": 0.01821, "proenkephalin mrna": 0.01526, "agammaglobulinemia tyrosine kinase gene": 0.02177, "il-2 transcription": 0.0281, "e1c3 cell": 0.0768, "group ii cid cell": 0.0384, "dprl promoter": 0.02336, "interaction provide additional pathway": 0.00639, "u5 region": 0.01467, "cell surface immunoglobulin": 0.0512, "signal transduction abnormality": 0.0109, "glucocorticoid-repressible gene": 0.04355, "nuclear grade": 0.01684, "functional effect": 0.02115, "leukemia-specific": 0.00031, "decreased level": 0.01821, "active form": 0.01055, "clone tsc2": 0.00738, "herpesviruses": 0.00012, "rectal minus oral": 0.0005, "sole basis": 0.00143, "bun": 6e-05, "ap1-binding site": 0.02168, "105-kda sp1 specie": 0.0024, "transcription-4": 6e-05, "mbp": 0.00112, "osteoclast differentiation": 0.01179, "matched pair": 0.00214, "krab-containing zinc finger gene": 0.02177, "epo treatment": 0.01014, "immunophilin": 0.00037, "basal factor interact": 0.01907, "molecular data": 0.0045, "kd similar": 0.00673, "tax term m22": 0.00318, "nfat1 posse": 0.00068, "lmp promoter fragment": 0.01557, "human retinoic acid receptor alpha": 0.01505, "chronic inflammatory reaction result": 0.00805, "natural calcineurin": 0.00316, "regulate cell-cycle progression": 0.00835, "mutant virus": 0.00887, "mhc class ii inducibility": 0.00363, "cooh-terminal sh3-deleted grf40 mutant lack": 0.00324, "entire native mr": 0.00099, "oncogenic effect": 0.02115, "2-lumisterol3 prime nb4 leukemia cell": 0.03072, "human delta-globin gene promoter": 0.02177, "1-kb fragment": 0.00347, "situ dna bind assay determine stat3 activation": 0.00904, "enhance inactivation": 0.00974, "neoplastic lymphoid cell": 0.0512, "augments pma-dependent il-5 production": 0.00521, "cell line thp-1": 0.0512, "agent propidium iodide": 0.00281, "detectable nf-kappab dna binding activity": 0.0117, "multiple malignancy": 0.00689, "important transcription factor nf kappa": 0.01144, "element repeat": 0.01672, "alter mnda expression": 0.02775, "il-6 control junb transcription": 0.01405, "twhf": 0.00012, "trisubstituted xanthine derivative": 0.00128, "include": 0.02878, "mol": 0.00031, "cellular glucocorticoid receptor level": 0.01286, "footprint reside": 0.00084, "unique cd33+": 0.00261, "gamma gene transcription": 0.02903, "design": 0.0018, "ht-29": 0.00012, "affect lps-induced kappab-dependent transcription": 0.01405, "nuclear nf kappa": 0.01123, "endothelial adhesion molecule induction": 0.00803, "p97": 6e-05, "western blot analysis show": 0.013, "measure platelet-activating factor induce arachidonic acid release": 0.00817, "gene segment": 0.04355, "biochemistry": 6e-05, "one-tenth": 0.00012, "unrelated protein": 0.04529, "essential nature": 0.00487, "decrease plasma cyst": 0.00647, "cell infiltrate affected joint": 0.0384, "stress fiber formation": 0.00323, "mkk3": 0.00019, "suppress il-2-driven proliferation": 0.00536, "affect acute inflammation mediate": 0.00616, "arginine residue": 0.00226, "gamma-globin": 0.0018, "stimulate nf-kappab binding activity": 0.01462, "element cross-competed": 0.01672, "occur": 0.01309, "human t-lymphocyte gata-3 factor mediate transcription": 0.01254, "gm-csf-responsive bone marrow cell": 0.0384, "resistant patient show": 0.01733, "interferon exert": 0.00298, "125i-il-13": 0.0, "rutin exert": 0.00292, "distinct mechanism": 0.01058, "ap-2-like transcription factor": 0.01907, "phenotypic characteristic": 0.00329, "indistinguishable sequence specificity": 0.01084, "isoflavone glucuronides": 0.00019, "double repeat-kb enhancer sequence": 0.00813, "mnda mrna": 0.01526, "prevent triptolide-induced parp degradation": 0.00262, "acla-treated": 0.00019, "co-infection": 0.0, "isogenic": 0.00025, "retarded": 0.00031, "week": 0.00068, "receptor beta chain": 0.01714, "cyclosporin-sensitive": 0.00037, "proinflammatory cytokine cascade": 0.00749, "ptsd": 0.00056, "cell transformation assay": 0.0512, "long terminal repeat-luciferase construct show": 0.0104, "uninfected parental hl-60 subclones": 0.00098, "normal binding": 0.01855, "block factor": 0.0286, "differential pattern": 0.00549, "ttcc": 6e-05, "plap activity": 0.02925, "soluble tumor necrosis factor receptor inhibit phorbol myristate acetate": 0.00636, "-induced adhesion molecule expression": 0.02081, "irf-1-/- mouse": 0.00974, "myelomonocytic lineage-specific expression": 0.02775, "mouse cpo gene span": 0.02177, "specific dna protein complex formation": 0.01811, "survey oncogene associate": 0.00728, "latent transcription factor": 0.01907, "seventeen microsatellite marker": 0.00254, "cd43": 6e-05, "lineage-specific": 0.00124, "important hiv transcription factor": 0.0143, "mite allergen": 0.00016, "komatsu": 0.00019, "ag receptor cross-linking induces transient expression": 0.01388, "endometriotic lesion": 0.00143, "activate tcf transcription": 0.01873, "woman show": 0.02599, "tax-expressing jurkat cell": 0.0512, "actual transcription": 0.0281, "intact": 0.00478, "naive t-helper": 0.00133, "rachitic chick": 9e-05, "adrenocorticotropin": 0.00025, "inadequate": 0.00031, "reveal": 0.02196, "message": 0.00143, "high phorbol ester concentration": 0.00465, "viral mrna": 0.01526, "rxr-raralpha403 heterodimers": 0.00226, "locus activation": 0.03164, "htlv-1-associated myelopathy/tropical spastic paraparesis": 0.00011, "strong inhibition": 0.01061, "pha-activated mononuclear cell": 0.0512, "t-cell antigen receptor signal transduction": 0.01029, "tumor-derived cell line correlate": 0.0384, "traf2": 0.00149, "ig/ebp-1": 0.00019, "data provide direct evidence": 0.00323, "biochemical abnormality": 0.00239, "patient show loss": 0.01733, "t-cell accumulation": 0.00962, "cst3": 0.0, "nuclear transcription factor nf-kappa": 0.0143, "vitro effect": 0.02115, "sublining region": 0.01467, "full-length": 0.00248, "determine induction": 0.01607, "gel-shift assay reveal": 0.00732, "vascular cell adhesion molecule-1 gene": 0.03072, "exist hormonal regulation": 0.00672, "-95 bp": 0.00267, "ligation-mediated pcr": 0.00115, "presumed regulatory domain": 0.00804, "potentiating activity": 0.02925, "identical dna-binding specificity": 0.00374, "calcium ionophore": 0.00236, "hil-5-mediated signal": 0.01635, "genital skin fibroblast": 0.00225, "provide important insight": 0.00459, "increase alpha-globin promoter activity": 0.01462, "thp-1 monocytic cell line": 0.0384, "activated level": 0.01821, "shed light": 0.00078, ".03": 0.0, "dex": 0.00149, "bipotential t/natural killer": 0.00062, "observed nfkappab": 0.00189, "cell activation determine": 0.0512, "reduced receptor binding": 0.01714, "alternative mechanism": 0.01058, "design degenerate probe": 0.00174, "pathway essential": 0.01278, "express pkc isoenzymes": 0.0123, "lbr": 0.00019, "ltrs differ": 0.00192, "dual role": 0.01328, "prostate cancer": 0.00248, "activate irf-1 gene expression": 0.02177, "human burkitt lymphoma": 0.02508, "/mn2+": 6e-05, "specific progesterone receptor": 0.01714, "increased stability": 0.00363, "csa interferes": 0.00174, "natural killer cell development": 0.0384, "modest": 0.0005, "nucleotide -271": 0.00202, "pp70": 0.00012, "t-prolymphocytic": 6e-05, "tumor metastasis": 0.00934, "etoposide": 0.00074, "hm": 0.00037, "cd28 adhesion molecule induces": 0.00426, "cell lysis": 0.0768, "id2 mrna decrease": 0.01017, "interleukin-2": 0.00664, "bone metastasis": 0.00214, "reactive follicular hyperplasia": 0.00141, "membrane protein": 0.04529, "detect loss": 0.00726, "ets domain": 0.01207, "lytic infection render": 0.00414, "affect tnf-alpha-mediated nf-kappab activation": 0.01582, "inos": 0.00081, "hemoglobin concentration": 0.0067, "jnk pathway": 0.01278, "strict dependence": 0.00053, "beta-estradiol": 0.00043, "differentiative activity": 0.02925, "native ptf beta": 0.00449, "cyclosporin a-binding protein cyclophilin": 0.02264, "remain c-terminal residue": 0.00347, "atopy gene": 0.04355, "targeted cell": 0.0768, "dr-nm23": 0.00031, "vitro administration": 0.00785, "cbf beta": 0.00673, "major evidence show": 0.01733, "widespread applicability": 0.00016, "sarcoma-associated herpesvirus infection": 0.00414, "membrane level": 0.01821, "ciita inducibility": 0.00295, "tr2re-sv40": 0.00025, "potent regulator": 0.00357, "activate peripheral blood lymphocyte": 0.00889, "ionomycin pathway": 0.01278, "nfil3/e4bp4": 0.00062, "phytohemagglutinin-activated peripheral blood mononuclear cell": 0.03072, "hpv-transformed cell": 0.0768, "cat plasmid reporter construct": 0.00363, "hemizygous": 0.0, "myeloid-committed cd34+thy-l-cd45ra+ subset": 0.00128, "distal element": 0.01672, "amino enhancer": 0.00909, "vpr modulates t-cell receptor": 0.01286, "n-terminal c-jun kinase": 0.00792, "sodium molybdate": 0.00186, "allograft rejection": 0.00047, "sense cell line": 0.0512, "il-2r alpha remain": 0.0078, "cyclooxygenase": 0.00025, "myogenic factor remain unaltered": 0.0143, "rpos control": 0.01303, "conjugate": 0.00043, "compound act": 0.00496, "control virus": 0.01303, "b-cell lineage-specific transcription factor present": 0.01144, "lps-induced synthesis": 0.00583, "tced dna": 0.01483, "regulatory module": 0.00682, "human normal": 0.03762, "disease association": 0.00673, "project probability": 0.00022, "nfil3/e4bp4 transcription factor": 0.01907, "glucocorticoid receptor": 0.02571, "-induced maturation mediate": 0.00821, "tissue culture": 0.00664, "corticosensitivity": 0.00012, "degradation target": 0.00825, "long form": 0.01055, "haematopoietic cytokine": 0.01123, "leukemic cell transformation": 0.0512, "mip-1 alpha": 0.01169, "stat induction pattern": 0.01071, "b95-8 lymphoid cell": 0.0512, "activate platelet tether": 0.01185, "growth factor-beta suppresses human": 0.01881, "heterologous thymidine kinase promoter fail": 0.00934, "ccaat enhancer bind protein alpha": 0.01811, "functional nf-at1 transcription factor complex": 0.01144, "camp-dependent protein kinase activity": 0.02264, "separable domain": 0.01207, "interleukin-1 beta production": 0.00695, "cd16 stimulation require cellular": 0.00658, "selective activity": 0.02925, "brazilian black": 0.00025, "induce ap-1": 0.0254, "previous characterization": 0.0018, "cytokine expression": 0.04163, "zap-70 lacking interdomain": 0.00103, "stat1-dependent gene activation": 0.02903, "phase-2 neutrophil adhesion": 0.00387, "nab": 0.00019, "ed50": 6e-05, "reversed inhibition": 0.01061, "c-myc transcript": 0.00599, "histamine fail": 0.00347, "receive differentiative signal": 0.0109, "acad": 0.00019, "mediate negative selection": 0.00821, "c2h2 zinc finger gene encode": 0.01742, "major sialoglycoprotein": 0.00574, "ets-1 function": 0.01331, "granulocyte colony": 0.00254, "beta zero-thalassemia patient": 0.0111, "c-fos gene": 0.04355, "p38 mitogen-activated protein kinase": 0.02264, "hypo-": 0.00012, "inflammatory cell infiltration score": 0.0384, "inhibit gsk-3beta activity": 0.0195, "thymic epithelial cell": 0.0512, "cd4 receptor": 0.02571, "trace element preparation": 0.01115, "induce stat6 dna bind activity": 0.0117, "inhibited cytostasis": 0.00261, "rat lymphocyte": 0.01483, "broad range": 0.00202, "leukocyte-platelet adhesion": 0.0058, "virus host range": 0.00591, "human leukocyte": 0.03762, "lp enhance proteasome-dependent cytoplasmic-to-nuclear localization": 0.0039, "pre-existing complex": 0.01684, "immunized rat": 0.00285, "ciita-independent": 6e-05, "secondary lymphoid tissue": 0.00443, "transcription factor occur": 0.01907, "1-4": 0.00019, "functional role": 0.01328, "ligand-inducible transactivation function": 0.00887, "cortisol determination": 0.00295, "common binding site": 0.01445, "mouse peritoneal macrophage": 0.00649, "distinct tissue-specific constraint contribute": 0.00349, "activation-dependent scm-1 promoter activity": 0.01462, "physical activity": 0.02925, "conditioned medium": 0.0014, "lps-treated endothelial cell": 0.0512, "early-phase infection": 0.0062, "blk": 0.00043, "multiple transcription start site region": 0.01124, "sexual event": 0.00552, "-aldosterone derivative": 0.00192, "fusion plasmid": 0.00326, "dna affinity-purified protein": 0.03019, "amino acid 2-99": 0.00571, "h292": 0.00012, "domain": 0.02413, "myeloid pu.1 bind site": 0.01084, "forkhead protein family": 0.03019, "continuous myeloid cell line present": 0.03072, "cardiac transplant medicine": 0.00027, "distinct mhc class ii-negative cell": 0.03072, "block ifn-gamma-dependent up-regulation": 0.00715, "tcr-mediated binding": 0.01855, "c-ring modification": 0.00183, "yj cell line": 0.0512, "l. pneumophila rpos": 0.00031, "nf-kappa b/rel protein family": 0.02264, "maximal gene activation": 0.02903, "german control population": 0.00868, "cyclic amp response element-binding protein": 0.01811, "encounter": 0.00025, "transient pattern": 0.00549, "hla-dra gene promoter": 0.02903, "presentation": 0.00149, "immunosupershift": 6e-05, "hiv-1 rna": 0.00878, "essential 40-kda protein term tax": 0.01811, "cyclin d-associated kinase activity": 0.01462, "tyk2": 0.00068, "adjacent site": 0.02168, "increase phosphorylation": 0.02196, "protein kinase c-depleted endothelial cell": 0.03072, "anti-inflammatory cytokine": 0.01123, "12-o-tetradecanoylphorbol-13-acetate induced hemopoietic differentiation": 0.00589, "recognized peptide increase": 0.01464, "abundant tcl1 expression": 0.02775, "c-fes promoter": 0.02336, "active nuclear form": 0.01123, "early gene expression": 0.02903, "hiv-2 tat gene": 0.02903, "rapamycin-controlled process": 0.00444, "prdii nf-kappa b-binding domain": 0.00707, "structural similarity": 0.0018, "ectopic tissue": 0.00664, "rars case": 0.00363, "cat gene expression direct": 0.02177, "electrophoretic mobility-shift assay reveal": 0.00549, "intracellular formation": 0.00583, "nfat binding site": 0.01445, "kinase pathway": 0.01278, "latent provirus": 0.00226, "tcp succinate": 0.00028, "regulatory network operate": 0.00455, "endobronchial biopsy": 0.0005, "immunosuppressive reagent": 0.00102, "mutant tax protein deficient": 0.02264, "genetic element": 0.01672, "hela phenotype": 0.00366, "small intestinal epithelium": 0.00209, "usf/c-myc enhances": 0.00127, "cellular membrane": 0.00893, "relevant spectrum": 0.00143, "activated protein-1": 0.00589, "lymphocyte present": 0.01483, "nre gamma": 0.0044, "nef downmodulates ltr activation": 0.01582, "develop mental illness": 0.00269, "c26 element": 0.01672, "viral gene regulation": 0.02903, "viral": 0.01464, "il-1 receptor-associated kinase": 0.00792, "il-7-signaling pathway": 0.01278, "human glomerular mesangial cell": 0.0384, "fetal-to-adult globin gene switching": 0.02177, "c5b6 level": 0.01821, "lactose analogue": 0.0005, "isgf3gamma": 0.00019, "aid kappa": 0.00748, "myeloid-specific gene": 0.04355, "endogenous kinase": 0.01188, "s107 plasmacytoma cell": 0.0512, "granule exocytosis pathway": 0.00852, "serum deprivation": 0.00378, "pwm-induced b-cell mitogenesis": 0.00306, "aml-m2": 0.0, "gal4-binding dna element": 0.01115, "-20 gata binding site": 0.01084, "full promoter activity": 0.0195, "clinical medicine": 0.00425, "sustained nuclear translocation": 0.01123, "janus kinase-stat pathway": 0.00852, "zap70": 0.00012, "identical sequence": 0.01625, "mouse tissue": 0.00974, "receptor induce": 0.02571, "human tnf promoter": 0.02508, "signal-transducing smad protein": 0.03019, "mrd": 0.00012, "ebv-infected cell": 0.0768, "thp-1 myeloid leukemia cell line": 0.03072, "cd40-ig": 6e-05, "present antigen": 0.00819, "gct express": 0.01846, "pan gene encodes": 0.02903, "early time point": 0.00552, "glycosylation": 6e-05, "pp36-38": 6e-05, "calcineurin autoinhibitory domain": 0.00804, "promoter-proximal region": 0.01467, "d.-e.zhang": 0.00012, "dna-binding activity": 0.02925, "inhibit tyrosine phosphorylation": 0.0127, "vivo function": 0.01331, "morphologic": 0.00074, "ion flux": 0.00062, "transformation activity": 0.02925, "hepatic leukemic factor": 0.01907, "nf-kappa b/rel homodimer": 0.00943, "itk mutant lack": 0.0054, "previous level": 0.01821, "microm icrf-193": 0.0013, "jun liu": 0.00167, "polymorphonuclear leucocyte": 0.00093, "genomic configuration": 0.0027, "tcf-1 alpha bind site diminished enhancer activity": 0.00836, "amplified product": 0.00533, "active phorbol ester": 0.00395, "cell type suggest": 0.0512, "4-carboranyl-substituted compound": 0.0022, "myelo-monocytic cell": 0.0768, "ebv-replicative lesion": 0.00143, "primary monocyte": 0.01197, "fc gammar1 stat site": 0.01084, "scf": 0.00062, "total rna isolate": 0.00304, "fy*b": 0.00043, "phe50-tyr65": 6e-05, "aim": 0.0013, "homozygous": 0.00056, "regression analysis": 0.01179, "dra gene expression": 0.02903, "pkc isoforms alpha": 0.0078, "map kinase p38": 0.00792, "srf constitutively express": 0.0123, "mutated": 0.00186, "chronic inflammatory autoimmune disease": 0.00337, "protein specie": 0.04529, "run": 0.00019, "anti-ig stimulation": 0.0112, "supershift assay": 0.01002, "study 1,25-dihydroxyvitamin d3": 0.00904, "a-ring": 0.0, "ra-resistant hematopoietic cell": 0.0512, "104-bp minimal promoter region": 0.01168, "principal ligand": 0.00592, "germinal center reaction provide unique activation signal": 0.00904, "2-6": 0.00025, "lone c/ebp motif": 0.00583, "progesterone receptor-bearing cell": 0.0512, "dihydro derivative": 0.00192, "express vdr mrna": 0.0123, "il-13 play": 0.0071, "bcr1 type-pml/rar alpha fusion protein": 0.01811, "bind site": 0.02168, "interleukin-6 promotes multiple myeloma cell growth": 0.0256, "mol/l ra": 0.00596, "promoter-distal site": 0.02168, "lmp1 expression vector": 0.02775, "anti-cd2-fitc": 0.00012, "5.66-10": 6e-05, "significant inverse correlation": 0.00277, "cd14 sp1 site oligonucleotides bind": 0.00867, "c-terminal segment": 0.00192, "obstructive renal disease": 0.00449, "adenylyl cyclase": 0.00037, "cd16 cross-linking": 0.00242, "a/r insult result": 0.01073, "culture skin fibroblast": 0.00414, "fhit occur": 0.00654, "atp-dependent": 0.0, "729-6": 6e-05, "additional protein crossreactive": 0.03019, "tyr-113": 0.00012, "negative correlation": 0.00515, "mitogenic-activated": 0.00012, "type ii corticosteroid receptor": 0.01286, "philadelphia chromosome-positive chronic myeloid leukemia": 0.002, "tumor additional immunohistochemical study": 0.00678, "lp individual": 0.00409, "-dependent t-cell line ctll-2": 0.00827, "phorbol ester": 0.00543, "dna response element correspond": 0.00971, "consisting": 0.00112, "t-cell transcription factor block": 0.0143, "type-ii estrogen-binding site": 0.01445, "p38 map kinase": 0.00792, "bcd proto-oncogene": 0.0013, "bone marrow": 0.00214, "lytic cycle": 0.00307, "recent study show": 0.01733, "graft-versus-host disease": 0.00673, "bipotential precursor": 0.00323, "fibroblast-like synoviocytes": 6e-05, "hgmw-approved symbol olr1": 6e-05, "human intestinal epithelial cell inflammatory response": 0.0256, "situ immunolabelling": 0.00084, "preferred substrate": 0.00199, "calcium ionophore a23187 increase zp activity": 0.00975, "steroid-induced rebound": 0.00016, "tax-induced transactivation": 0.00515, "gata-3 expression": 0.04163, "tcr alpha": 0.01169, "herpes simplex vaccine": 0.0005, "contrast mrna represent pat": 0.00763, "increase hiv enhancer activity": 0.01462, "calcium/calcineurin signal": 0.01635, "-atpase": 0.00037, "constitutive nuclear translocation": 0.01123, "expression clone": 0.04163, "cell type-specific difference": 0.0512, "vcam-1 gene": 0.04355, "il-6r": 0.00019, "hsp70 expression": 0.04163, "homologous serum": 0.00378, "clinical xenotransplantation": 0.00425, "differentiate perivascular dc": 0.00178, "abovesaid": 0.0, "mapk-dependent": 0.00012, "proliferative parameter maintain": 0.00159, "mineralocorticoid binding site": 0.01445, "block transcriptional activity": 0.0195, "chromatin": 0.00236, "cd4 gene expression": 0.02903, "delayed induction": 0.01607, "physiological": 0.00366, "antiinfectious activity": 0.02925, "c-jun mrna level": 0.01214, "fos-b gene": 0.04355, "cell-specific coactivator bob.1/obf.1": 0.00194, "antidepressant medication": 0.00016, "active transcriptional activation domain": 0.01582, "daily dose": 0.00158, "non-genomic": 0.0005, "phorbol ester induce expression": 0.02081, "lbf4-binding site": 0.02168, "son": 0.0, "variable tcr affinity": 0.00318, "anti-cd95 ab treatment": 0.00676, "apparent non-cell-type-specific expression suggest": 0.02081, "functional vitamin": 0.00816, "primary normal b-cells": 0.00806, "induce resistance": 0.0254, "cell-specific transcriptional activity": 0.0195, "radiation-induced signal": 0.01635, "stimulate interleukin-8": 0.01101, "nuclear bind protein": 0.03019, "il2 mrna": 0.01526, "paper present study": 0.00904, "tnf-alpha-induced apoptosis": 0.0089, "ppar activator 15d-pgj": 0.00368, "p95": 0.00019, "base pair change abolish": 0.00315, "scl protein synthesis": 0.03019, "full length wild-type form": 0.00527, "ap-2 activation": 0.03164, "transfected scl gene yield": 0.02177, "e2a-hlf block": 0.01073, "cd4 oligomerization": 0.00332, "cell cycle arrest": 0.0512, "crucial signal": 0.01635, "tcr-mediated apoptosis": 0.0089, "heptamer motif aacaaag": 0.00583, "control day": 0.01303, "cbp decrease": 0.00971, "mouse interleukin": 0.00974, "tnf-alpha release peak": 0.00364, "tax-responsive element-1": 0.00019, "polymorphic nucleotide": 0.00202, "decisive role": 0.01328, "fm": 0.00068, "induce phenotypical differentiation": 0.01694, "endothelial cell glutathione": 0.0512, "7.5-fold": 6e-05, "stat5 target sequence": 0.01084, "secretory response": 0.01942, "reexpression": 6e-05, "anti-cd3 mab-stimulated": 0.00208, "promoter function analysis": 0.01557, "5.5-kilobase genomic clone": 0.00492, "induce program cell death": 0.0384, "central rel similarity region": 0.00734, "dna-cellulose": 0.00025, "glia cell line": 0.0512, "conceivable": 6e-05, "challenge": 0.00205, "human b29 gene": 0.02903, "intrinsic dna affinity": 0.00988, "ups": 6e-05, "cd43/leukosialin-mediated pathway": 0.01278, "selective increase": 0.02196, "long-term cell line": 0.0512, "androgen receptor blockade": 0.01714, "serum concentration": 0.0067, "cell cycle time": 0.0512, "epithelial specific manner": 0.00825, "canonical tata box": 0.00203, "vdr-rxr": 0.00031, "human promyelocytic leukemia cell": 0.0384, "include estrogen": 0.01439, "transcription factor atf-1": 0.01907, "germ line": 0.01653, "heptamer element 5'-ctcagga-3": 0.01115, "tetanus toxoid": 0.00028, "control oligonucleotides": 0.01303, "raralpha403": 6e-05, "cell require dual stimulation": 0.0384, "flow cytometry": 0.00152, "macrophage inflammatory protein": 0.03019, "tubal epithelium": 0.00053, "remarkable correlation": 0.00248, "e2f consists": 0.00192, "ut-7/gmt cell": 0.0768, "gal4 fusion": 0.00326, "commonly deleted region": 0.00978, "phenylarsine oxide inhibits": 0.00354, "high nk activity associate": 0.01462, "stat1 activity": 0.02925, "transactivate p53": 0.00149, "guanine nucleotide bind factor": 0.0143, "eukaryote": 0.00019, "50-kda nf-kappa": 0.01414, "dendritic antigen-presenting cell point": 0.0384, "signal molecule": 0.01635, "mimic tcr ligation": 0.00318, "cell-derived pathology": 0.00071, "concanavalin": 0.00037, "320-kda specie": 0.00183, "a1-vdr cell": 0.0768, "il-4 inhibits lps-induced expression": 0.02081, "wild-type cell": 0.0768, "12-o-tetradecanoyl-phorbol-13 acetate": 0.00099, "ionomycin treatment": 0.01014, "prolong mp plasma concentration": 0.00335, "study multiple nf-kappa": 0.00943, "rb expression vector re-establishes": 0.02081, "3-o-methyl-d-glucose uptake": 0.00167, "nfat family member": 0.0056, "wild type cell": 0.0512, "single-chain fv": 0.0004, "restriction point": 0.00183, "hydroxytoluene": 0.0, "jpx9 cell result": 0.0512, "hormone constitutively": 0.00444, "mnp site constitute": 0.01445, "s. h.": 0.00118, "specific protein kinase": 0.03019, "ficz": 0.00019, "chimeric promoter construction": 0.01557, "potent antiproliferative": 0.00357, "cd4+cd28null": 0.00012, "maximal stimulation": 0.0112, "erythrocyte sample": 0.00208, "alcohol-induced regulation": 0.01008, "carboxy-terminal half": 0.0004, "tbp7 sequence": 0.01625, "lineage-restricted transactivators": 0.00071, "express hla-dq": 0.01846, "traf2 inhibits bind": 0.0135, "mhc-peptide complex form": 0.01123, "protective mechanism": 0.01058, "erythroleukemia cell line k562": 0.0384, "human il-2 receptor alpha chain promoter": 0.01254, "rutin compete": 0.00078, "gh-v gene": 0.04355, "gamma-interferon expression": 0.04163, "affected lymphokine gene": 0.02903, "express bcl-2": 0.01846, "histological diagnosis": 0.00056, "chloramphenicol acetyltransferase": 0.00099, "crel": 6e-05, "nf-at3": 6e-05, "pmlrar alpha cdna": 0.0078, "a.i.": 6e-05, "lck-defective cell line": 0.0512, "oxidized ldl": 0.00084, "lt-293": 0.00043, "initiation region": 0.01467, "hcmv dna replication": 0.00988, "integrins cd18": 0.00034, "-91": 0.00012, "c/ebp protein": 0.04529, "tester strain repress": 0.00147, "-beta1 responsiveness": 0.00323, "enzyme link immunosorbent assay": 0.00501, "transactivation assay": 0.01002, "construct influence": 0.00726, "leucocytic er level": 0.01214, "leukemogenicity": 0.00012, "traf2 dominant-negative mutant": 0.0054, "human class ii transactivator": 0.01881, "class ii-specific transcription factor rfx": 0.01144, "hla dra promoter": 0.01557, "hla class ii molecule present antigen": 0.00284, "antigen encode": 0.00853, "blood concentration": 0.0067, "additional hemoglobinopathy": 0.00341, "cytoskeletal structure": 0.00319, "express human cd14": 0.02508, "vzv ge": 0.00065, "yy-1 site": 0.02168, "antagonistic anti-tr55 antibody": 0.00596, "beta-bound complex": 0.01684, "small dos": 0.00313, "cd28 signal cascade": 0.0109, "microtubular assembly prevents nuclear access": 0.00674, "skip": 6e-05, "aes peptide": 0.00754, "t-lymphocyte cell type": 0.0512, "protein-affinity chromatography": 0.0004, "untreated subject": 0.00354, "ebv-mediated immortalization": 0.00062, "colostrum": 0.0005, "recurrent feature": 0.00217, "genetic end target": 0.0055, "inactive allele": 0.0022, "cepsilon gene transcription": 0.02903, "id-3": 0.00043, "propose role": 0.01328, "rapid induction": 0.01607, "cell play": 0.0768, "p40 induction": 0.01607, "ifn-alpha-induced binding": 0.01855, "zinc-finger transcription factor encode": 0.0143, "signal transduction event": 0.0109, "high molecular weight dextran sulfate increase": 0.00732, "future research": 0.00028, "nonselfness": 0.0, "parp inactivation": 0.00174, "inhibit gpc91-phox gene expression": 0.02177, "ms-2 mediates induction": 0.01071, "minute exposure": 0.0035, "girl": 6e-05, "nasal lymphoma": 0.00226, "underwent differentiation": 0.01179, "distinct nf-kappab activation mechanism": 0.01582, "small cytokine": 0.01123, "oncogenic form": 0.01055, "stem/progenitor cell": 0.0768, "human monocyte": 0.03762, "detect constitutively": 0.00726, "sp-a treatment": 0.01014, "central": 0.00217, "adult male progeny": 0.00281, "comparative sequence analysis": 0.01084, "cd2 signal involves jun kinase": 0.00654, "il-10 inhibits ifn-gamma-induced icam-1 expression": 0.01665, "cem-c7": 0.0005, "eicosanoid generation": 0.00242, "connective tissue disease": 0.00449, "proc.natl.acad.sci.usa": 6e-05, "prodigiosin family": 0.00841, "inhibition": 0.02122, "receptor overexpression": 0.02571, "z-29": 0.00012, "ibd patient": 0.01666, "hla-dmb gene expression function": 0.02177, "congruous": 0.0, "random x-inactivation": 0.00043, "nuclease-hypersensitive site": 0.02168, "au-motif-directed differential display": 0.00333, "nf-at represent inhibition": 0.00707, "compound show": 0.02599, "molecule bound cd40": 0.00569, "cell unresponsiveness": 0.0768, "early lytic cycle protein": 0.02264, "over-lapping set": 0.0014, "-independent mechanism": 0.01058, "mc903": 0.00043, "gcr-beta": 0.00031, "pcvs": 0.00012, "camp": 0.00515, "cell line activate": 0.0512, "hb-egf expression": 0.04163, "epstein-barr": 0.00571, "oncogenic protein fli-1": 0.03019, "trans-activation domain": 0.01207, "select oligonucleotides": 0.00195, "ductal epithelium": 0.00053, "tnf promoter region": 0.01557, "lymphocyte-mediated lysis": 0.00136, "childrens": 0.0, "selective cck": 0.00267, "reporter gata-1/lacz gene": 0.02903, "identical kinetics": 0.00226, "exact mechanism": 0.01058, "cellular lysates": 0.00893, "rna polymerase iii-dependent gene": 0.02177, "dna binding domain": 0.01237, "pax gene": 0.04355, "complex response": 0.01942, "hla-dr antigen": 0.00819, "condition medium fail": 0.0024, "v-atpase": 0.0005, "p62c-fos": 0.0005, "hematopoietic stem cell": 0.0512, "ht-2 cell": 0.0768, "allergen-specific human helper": 0.02508, "minimal": 0.00428, "oligonucleotide competition experiment": 0.00265, "separate transduction pathway": 0.00852, "lectin-type oxidized ldl receptor": 0.01286, "xenopus laevis vitellogenin gene b1 promoter": 0.01452, "t-cells treatment": 0.01014, "reversible transformation": 0.00288, "schizosaccharomyces pombe": 0.00016, "transcription-1alpha": 6e-05, "comprise": 0.00211, "fk506 associate": 0.01092, "ag-pulsed accessory cell": 0.0512, "stat1alpha": 0.00105, "adjuvant treatment": 0.01014, "ccaat box": 0.00304, "primary translocation": 0.00738, "suppress growth": 0.00819, "inhibited stimulation": 0.0112, "multiple biological activity": 0.0195, "transactivator e2f-i": 0.00161, "immune-mediated lysis": 0.00136, "nfat regulate transcription": 0.01873, "undergo long-term proliferation": 0.00536, "repression": 0.00422, "data provide evidence": 0.0043, "weak affinity": 0.00391, "parental line": 0.01653, "positive/negative regulation": 0.01008, "intracellular signal transduction molecule": 0.00817, "cyclic nucleotide-dependent kinase": 0.00792, "chemokine production": 0.01042, "weak induction": 0.01607, "nfat1": 0.00136, "pre-b-cell stage": 0.00248, "type ii mhc cid": 0.00475, "enzyme level": 0.01821, "microm concentration": 0.0067, "dlcl": 0.00068, "e3330 decrease activate nf-kappa": 0.00889, "replicative/cytopathic capacity": 0.00329, "protect lymphocyte": 0.01483, "oct": 0.00143, "clinical picture": 0.00425, "transcriptional trans-activator require": 0.00877, "hl60r": 0.00012, "late onset menarche": 0.0017, "relb rna": 0.00456, "repression activity": 0.02925, "ionomycine": 0.00012, "extracellular stimulation": 0.0112, "phop locus": 0.00288, "immune dysfunction": 0.00599, "specific bind interaction": 0.0135, "share extensive n-terminal sequence homology": 0.0065, "x1-": 6e-05, "microg/g tissue": 0.00664, "high order nucleoprotein complex": 0.00842, "p50b": 0.00025, "il-1 signaling pathway": 0.00852, "traf signaling": 0.00558, "efficient binding": 0.01855, "52-kda form": 0.01055, "docking site": 0.02168, "human hla-dq class ii subset": 0.01505, "chromatin reorganization": 0.00118, "transcriptional 'silencer": 0.01151, "functional association": 0.00816, "flexible": 0.00031, "1,9-dideoxy forskolin": 0.0005, "chemotherapy maintain complete remission": 0.00119, "anti-fos antibody": 0.00893, "parallel induction": 0.01607, "responsive region": 0.01467, "y319 site": 0.02168, "b-cell fc gamma rii": 0.0023, "clonal level": 0.01821, "immune responsiveness": 0.00599, "stp oncoproteins": 0.00022, "regulate transcriptional activation mediate": 0.01582, "ubiquitous factor oct-1": 0.01907, "ec result": 0.0161, "baby unaffected": 0.00149, "calcineurin distinct": 0.00698, "cytokine stimulation lead": 0.00749, "intact octamer element": 0.01115, "element term e1": 0.01115, "abnormal fast feedback": 0.0013, "inducible il-2r alpha gene expression": 0.01742, "report nuclear factor": 0.01907, "predicted hb9 protein": 0.03019, "weak bind peptide": 0.0135, "nm23-h2": 0.00031, "cell-enriched transcription factor oct-2": 0.0143, "e220k": 0.00031, "consensus ap-1/cre site": 0.01445, "sample display": 0.00499, "tf complex": 0.01684, "ntps": 6e-05, "loss-of-function": 0.0005, "immunodominant antigen": 0.00819, "dexamethasone repression": 0.00394, "clinical test": 0.00487, "5'-most carg element": 0.01115, "retrodifferentiation": 0.00019, "lymphoblastoid phenotype": 0.00366, "specific manner": 0.01238, "gm-kappa b/gc-box region": 0.00978, "ifn-gamma-induced mrna": 0.01526, "dpm mg-1 cytosol protein": 0.02264, "human antigen-specific cd4": 0.02508, "verprolin-homology region": 0.01467, "trans-activating factor": 0.0286, "risk factor": 0.0286, "intracellular reactive oxygen specie generation": 0.00233, "ciita activation domain": 0.02109, "nuclear association": 0.01684, "hiv-1 viral burden": 0.00585, "hgr": 0.00161, "c-jun/c-fos": 0.00025, "structural motif require": 0.00877, "growth suppression": 0.00819, "-140": 0.00031, "overlap biological effect": 0.0141, "5-10": 0.00012, "polyomavirus t-antigen": 0.0004, "nuclear nf-kappab level": 0.01214, "low ifn-gamma level": 0.01214, "ra treatment": 0.01014, "unstimulated patient": 0.01666, "non-steroidal anti-inflammatory drug": 0.00225, "agent require nongenomic signal pathway": 0.00654, "endothelial and/or leukocyte adhesion molecule": 0.00341, "c-myb/ets provide": 0.00645, "affect cellular proliferation": 0.00596, "rp1 mrna": 0.01526, "carboxylesterase gene transcription": 0.02903, "administration": 0.00186, "acquired immunodeficiency syndrome": 0.00182, "mouse mammary tumor virus env gene": 0.01452, "ethylenediamine": 6e-05, "lps increase": 0.02196, "rheumatoid arthritis patient": 0.0111, "death-promoting member": 0.00413, "recent clinical therapeutic initiative": 0.00212, "nucleosome remodeling": 0.00025, "inhibit beta-galactosidase mrna level": 0.00952, "activate e2f-mediated transcription": 0.01873, "epstein-barr virus latent membrane protein": 0.01811, "intracytoplasmic content": 0.00158, "cd11b abrogate fibrinogen-induced nf-kappa": 0.00707, "hepor gene expression": 0.02903, "hcmv resides": 0.00071, "nonhomologous end-end joining recombination event": 0.00221, "oct-2 dna binding activity": 0.01462, "gamma-globin-expressing k562 cell": 0.0512, "alpha-lipoate": 0.00012, "confocal microscopy": 0.0005, "inhibit c-fos phosphorylation": 0.0127, "rhombotin": 0.00037, "il-2 induced release": 0.00744, "serum-supplemented": 0.00043, "high hbf production show": 0.013, "-reporter gene": 0.04355, "ca2+ signaling": 0.00558, "multiple creb isoforms": 0.00459, "carboxyl-terminal region": 0.01467, "epidermal growth factor receptor display increase tyrosine phosphorylation": 0.00715, "widr": 6e-05, "regulate t-cell-specific expression": 0.02775, "situ hybridization show": 0.01733, "growth-regulated expression": 0.04163, "current model": 0.00422, "synthesize corticosteroid": 0.00158, "microm": 0.00261, "abelson virus": 0.00887, "maintain v-abl-mediated differentiation arrest": 0.00589, "cell type-specific oct factor": 0.0384, "monocyte-to-macrophage differentiation": 0.01179, "subsequent determination": 0.00304, "reliability": 6e-05, "etiology": 0.00062, "indicator": 0.00068, "activated ra": 0.00596, "relb gene": 0.04355, "study characterize molecular event": 0.00678, "octamer binding sit": 0.01237, "abnormal biomarkers": 0.00195, "splenic precursor cell": 0.0512, "impair translation and/or": 0.003, "potential sp1 bind site": 0.01084, "hiv-2 infection": 0.0062, "complex induce": 0.0254, "atra-dependent growth inhibition": 0.00707, "n'-tetraacetic acid": 0.00856, "rb-e2f complex": 0.01684, "diminished nuclear nf-kappab": 0.01123, "mediate overexpression": 0.01231, "membrane form": 0.01055, "cortisol level": 0.01821, "ovarian tumor associate lymphocyte": 0.00741, "zii": 0.0005, "proil-1 beta promoter-proximal requirement": 0.00337, "th2-type cytokine": 0.01123, "demonstrate increased htlv-1 transcription": 0.01405, "critical serine residue": 0.00285, "fy*a": 6e-05, "tre complex": 0.01684, "provide indirect evidence": 0.0043, "conserved 20-bp sequence": 0.01084, "fact": 0.00099, "rap1gtp": 0.00012, "c-erbb2 gene sequence": 0.02903, "active p65": 0.00592, "nuclear dot": 0.01684, "peripheral blood leukocyte": 0.00395, "fasl gene": 0.04355, "ie62 peptide": 0.00754, "accumulation induce": 0.0254, "aml1/eto mrna": 0.01526, "cd45 ptpase": 0.00068, "tx": 0.00019, "leukemic relapse": 0.00251, "determine reactivity": 0.00779, "growth": 0.01638, "untransformed glucocorticoid receptor complex": 0.01286, "environmental bacterial antigen": 0.00546, "fresh monocyte fail": 0.00798, "bmax decrease": 0.00971, "5-60 mg": 0.0004, "metabolite": 0.00217, "cbf beta-187": 0.00146, "differential repression": 0.00323, "luteal phase": 0.00276, "tcr delta gene segment": 0.02177, "il-7-induced enhancement": 0.00233, "fms": 0.00025, "immunoglobulin heavy chain gene cluster": 0.01742, "72-kda protein": 0.04529, "kda heat shock protein": 0.02264, "c12 cell": 0.0768, "reactive eosinophilia": 0.00211, "antiinflammatory property": 0.00397, "block all-trans ra-induced differentiation": 0.00589, "il-2 level": 0.01821, "ccrf-cem": 0.00019, "granulocyte dna": 0.01483, "constitutively express human c-mpl": 0.01881, "squirrel monkey": 0.00071, "cd3/tcr complex": 0.01684, "cd45r0+": 0.0, "nf-at-directed transcription responsive": 0.01873, "cyclic amp response element bind": 0.0081, "cell hypoactivity": 0.0768, "stem-loop stability": 0.00112, "il-4 bind": 0.02025, "anti-estrogen tamoxifen": 0.00043, "heat activation": 0.03164, "micron/ml tumor necrosis factor alpha": 0.01144, "primary anaplastic astrocytomas/glioblastomas": 0.00492, "15-": 6e-05, "rai therapy": 0.00372, "ebv latency": 0.00565, "bound dexamethasone measure": 0.00263, "photoactivatable crosslinker": 3e-05, "egf": 0.00025, "simple derivation": 0.0004, "aid dementia complex": 0.01123, "calcineurin mutation": 0.00592, "intrinsic differentiating stimulus": 0.0018, "kinase trigger proteolytic degradation": 0.00594, "inducible nuclear form": 0.01123, "pp65": 0.00031, "coexpressed tal1": 0.0013, "yeast two-hybrid screen": 0.00103, "non-proliferative state": 0.00267, "fc gamma receptor": 0.01714, "major susceptibility gene": 0.02903, "-511": 0.00012, "activator act": 0.00552, "mouse mhc class ii gene": 0.01742, "tal1 transcription occur": 0.01873, "h-rs cell line": 0.0512, "endogenous protein": 0.04529, "bound nfatp/ap-1-dna complex": 0.01123, "physiologic plausibility": 0.00071, "ebv nuclear antigen": 0.01123, "allele-specific expression": 0.04163, "enhance mrp14 expression": 0.02775, "receptor alpha subunit": 0.01714, "calcitriol number": 0.0053, "'master regulator": 0.00304, "downstream tre-like camp response element": 0.00777, "cd34 mrna": 0.01526, "undefined": 0.00062, "weak inducible complex resemble nuclear factor": 0.00953, "reporter gene direct": 0.02903, "mll/af10 fusion": 0.00326, "multicomponent cytokine receptor": 0.01714, "pge2 modulation": 0.00257, "estrogen-dependent": 0.00031, "pertussis-toxin-sensitive gi/go protein": 0.03019, "require tyrosine kinase activity": 0.01462, "health state": 0.00267, "globin chain": 0.00437, "abundance": 0.00099, "continuous blood pressure measurement": 0.00296, "osteocalcin": 0.00074, "successful production": 0.01042, "increased nf-kappa": 0.01414, "autocrine": 0.00161, "effective therapy": 0.00372, "stat3-activation": 6e-05, "il-2r beta chain expression": 0.02081, "lectin-activated": 6e-05, "prostaglandin i2": 0.0005, "human ifngr1 small deletion": 0.01881, "cyclin/cdks": 0.00019, "megakaryocytic cell": 0.0768, "major 29-kda protein phosphorylated": 0.02264, "il-2 synthesis": 0.01117, "normal golgi processing": 0.00806, "codeletion": 0.00012, "human myeloid cell differentiation": 0.0384, "large isoform": 0.00205, "transduce remain unclear": 0.00347, "lps/zymosan inducibility": 0.00127, "genetic correlation": 0.00288, "vitro surrogate": 0.00785, "viral plaque assay": 0.00668, "kappab regulatory element": 0.01115, "over-expression": 0.00043, "3d-nmr": 0.00025, "il-12-induced signaling": 0.00558, "nf-at4": 0.00019, "lineage switching": 0.00366, "upstream regulatory element": 0.01115, "hormone therapy": 0.00444, "acinar cell damage": 0.0512, "strong activating element": 0.01115, "proviral clone": 0.00738, "adaptor": 0.00136, "bms2.4": 6e-05, "influence inflammation": 0.00471, "serine/threonine phosphatase calcineurin": 0.00211, "bob.1/obf.1 expression": 0.04163, "selective effect": 0.02115, "consensus element": 0.01672, "activated stat5a": 0.00589, "key regulator": 0.00304, "t-cells": 0.00422, "heparin-like": 0.00025, "form inhibitory complex": 0.01123, "early-lytic-cycle protein": 0.04529, "gene regulatory element": 0.02903, "lymphocyte transformation": 0.01483, "plasmodium falciparum": 0.00012, "aneuploidy": 0.00031, "csa": 0.00347, "il-2 promoter factor": 0.01907, "pu.1 mrna expression": 0.02775, "host cell gene encode": 0.0384, "p16-negative human acute lymphoblastic leukemia cell line": 0.02194, "human cell line": 0.0512, "induced tyrosine phosphorylation": 0.00656, "vitamin c.": 0.00236, "increase cortisol feedback resistance": 0.01098, "f.m": 6e-05, "peptide/glycoprotein": 6e-05, "common complex": 0.01684, "human alpha-globin gene": 0.02903, "anti-erk": 0.00012, "hyperthyroidism nuclear t3 maximal bind capacity": 0.00675, "nf kappab activation": 0.02109, "nf kappa b/rel transcription factor family": 0.00953, "show potential agonistic activity": 0.01462, "recognition structure": 0.00319, "deleted human chr": 0.02508, "axillary node involvement": 0.0017, "ifn-gamma responsive element": 0.01115, "e3330 inhibits nf-kappa": 0.00943, "pharmacogenetics": 0.00012, "npc": 0.00037, "semi-purified ap1 protein mixed": 0.02264, "hs-40 enhancer function": 0.00887, "il-12 signaling pathway": 0.00852, "therapeutic strategy": 0.00167, "myeloblast": 0.00031, "cpg-rich island encode": 0.00569, "er- cell": 0.0768, "suppress activation": 0.03164, "anti-cd4 mab": 0.00267, "block antigen-induced il-2 secretion": 0.00558, "key control determinant": 0.00868, "kb": 0.00279, "target antigen define": 0.0055, "ingested protein set": 0.03019, "metabolic activity": 0.02925, "late transcription": 0.0281, "mouse cytotoxic t-lymphocyte": 0.00649, "endogenous il-1ra production": 0.00695, "anti-inflammatory drug": 0.00338, "-36": 0.0005, "bead-1": 0.00025, "cytogenetic examination": 0.0005, "dna-binding study": 0.01355, "alternative promoter": 0.02336, "ebna gene promoter activity": 0.02177, "mouse tis11 gene": 0.02903, "ubiquitous oct-1": 0.00146, "bls": 0.00043, "hematology": 6e-05, "blood maintain": 0.00592, "specific inhibitor": 0.01238, "rprl promoter": 0.02336, "calcineurin inhibitor": 0.009, "include monocyte/macrophages": 0.01439, "hormone-binding activity": 0.02925, "bash result": 0.0161, "double stain reveal": 0.00732, "progenitor/precursor cell": 0.0768, "purified gangliosides": 0.00261, "arre/nf-at site": 0.02168, "rel/nf-kappab family": 0.00841, "maximum": 0.00124, "immunologic tolerance": 0.00081, "mediate transmission": 0.01231, "alpha2beta1 integrin": 0.00112, "growth factor beta1": 0.01907, "gm-csfralpha": 0.00037, "cd40-induced": 0.00056, "e2re": 0.00025, "death signal transduce": 0.0109, "il-12 receptor": 0.02571, "affect brca1 splicing": 0.00531, "abl": 0.00025, "tad-a": 0.00043, "gas motif": 0.00875, "study mutation": 0.01355, "specific nuclear marker": 0.01123, "24-h prl induction time": 0.00803, "antibody ki-67": 0.00893, "sv40 gene expression": 0.02903, "undetectable": 0.00143, "induced nuclear import": 0.01123, "pancreatic beta-cells": 0.00068, "native peptide vp16 430-444": 0.00377, "selective lysis": 0.00267, "antigen proceeds": 0.00819, "suppress vcam-1 induction": 0.01071, "polar": 0.00031, "immune dysregulation": 0.00599, "human monoamine oxidase": 0.02508, "tf": 0.00347, "eralpha": 0.00012, "myeloid leukemic cell": 0.0512, "fk506-sensitive pathway": 0.01278, "jurkat human leukaemic t-cells": 0.01881, "include cd28 signaling": 0.00959, "staphylococcal superantigens": 0.0004, "hiv-2 ltr": 0.0031, "surface ig": 0.00515, "hiv-2 enhancer": 0.00909, "relevance": 0.00099, "late differentiation stage": 0.00786, "cell-type dependent": 0.00388, "early diagnosis": 0.00828, "ebna-2 transactivation": 0.00515, "il-2 require": 0.01315, "signal transducing component": 0.0109, "normal erythroid development": 0.00806, "hsf3": 0.00081, "hirak": 0.00025, "c-rel-p65 heterodimer": 0.00205, "functional jun": 0.00816, "cytokine induce stat6": 0.01694, "tissue specific": 0.01238, "oap confers": 0.00146, "position -131": 0.00236, "organism": 0.0005, "high mobility group protein i/y": 0.01811, "cell proliferation correlate": 0.0512, "molecular subclassification": 0.0045, "sedentary control person": 0.00868, "early response gene": 0.02903, "ikkbeta activation": 0.03164, "severe leukopenia": 0.00211, "isolate adenovirus": 0.00416, "vast majority": 0.0005, "decrease tax-induced transactivation": 0.00647, "mediate lysis": 0.01231, "late kinetics": 0.00254, "monocyte-macrophage ag": 0.00158, "+/- sem body mass index": 0.00063, "cytotoxic cytokine": 0.01123, "major obstacle": 0.00574, "mutant erythropoietin receptor signaling": 0.01286, "double-stimulation": 0.0, "similar repeat motif": 0.00583, "placental trophoblast": 0.00037, "manuscript": 6e-05, "e2a-hlf fusion gene": 0.02903, "hiv-1-infected promonocytic u1 cell": 0.0384, "staining pattern": 0.00549, "good prototype": 0.00102, "low-grade clonal disorder": 0.00149, "tnf-alpha-activity neutralizing antibody": 0.00596, "cni-1493 inhibits monocyte/macrophage tumor necrosis factor": 0.00953, "structural homology": 0.00183, "mucosal inflammation gene transcription": 0.02177, "nuclear run-on analysis reveal": 0.00842, "b-2": 0.00056, "persistent infection": 0.0062, "nuclear protein complex bind": 0.02264, "human peripheral blood leukocyte": 0.01881, "egr1": 0.00087, "histone deacetylases": 0.00133, "class ii major histocompatibility": 0.00363, "gata1 induction": 0.01607, "regulate differentiation": 0.01253, "growth signal pathway": 0.0109, "uv-irradiated jurkat cell": 0.0512, "enhanced mrna stability": 0.01017, "cd40l": 0.00112, "unidentified proximal position": 0.00201, "indexing term": 0.00413, "nf-kappa b-": 0.01414, "cd18 promoter": 0.02336, "subsequent active maintenance": 0.00395, "life": 0.00081, "repeat injection": 0.00378, "inhibit hsc proliferation": 0.0127, "strong rbp-jkappa-binding site": 0.01445, "glutamine-rich activation domain": 0.02109, "hematopoietic cell type": 0.0512, "cellular inhibitor kappab alpha": 0.00585, "transcription factor elk-1": 0.01907, "major transcriptional start site": 0.01084, "glucocorticoid hormone inhibition": 0.00707, "functional reporter-gene assay": 0.00668, "lining cell depth": 0.0512, "suppress t-cell proliferation": 0.00641, "mimic tcr-cd3/cd28-mediated signaling": 0.00372, "infectious mononucleosis": 0.00096, "cbf beta subunit": 0.00449, "significant gap": 0.00416, "periovulatory period": 0.00127, "early adulthood": 0.00828, "bind leukocyte": 0.02025, "5'-rapid amplification": 0.00074, "high titer": 0.00931, "reaffirm": 0.0, "superantigen present": 0.00735, "hpr gene": 0.04355, "leukemic myeloid cell influence": 0.0384, "ferric chloride": 0.00016, "disease-resistant background transactivation": 0.00343, "lps-induced monocyte il-1ra secretion": 0.00599, "c-erb": 0.00019, "vcam-1": 0.00465, "increased risk": 0.00363, "cell transmembrane signal": 0.0512, "nf-kappa b-dependent reporter gene selectively inhibit": 0.01452, "cortisol concentration": 0.0067, "context-restricted manner": 0.00282, "underlie aberrancy": 0.00217, "antidepressant": 0.00019, "genetic transmission": 0.00288, "maintain ebv-positive npc cell line": 0.03072, "family member stat1 p91": 0.0042, "perceived quality": 0.00022, "caev ltr bind": 0.0135, "fourth cell line": 0.0512, "transcription factor ap2": 0.01907, "increase rate": 0.02196, "anti-cd3-": 6e-05, "membrane proximal proline-rich domain": 0.00603, "ns-meg cell undergo terminal differentiation": 0.03072, "dna sequence information": 0.01084, "subsequent coactivator function": 0.00887, "apoptotic signaling": 0.00558, "mutant strain": 0.0081, "pleiotropic cytokine": 0.01123, "elf-1 binding site": 0.01445, "il-2-independent cell line test": 0.0384, "glutathione": 0.00211, "germ-line mutation": 0.00592, "functional block": 0.01073, "human cell partner": 0.0512, "date": 0.00025, "discrete cell basis": 0.0512, "extensive similarity": 0.00118, "human nk cell line": 0.0384, "critical element": 0.01672, "weakly active region": 0.00978, "competent transcription initiation": 0.01873, "genomic transcription": 0.0281, "pam respond": 0.00251, "calcium-dependent": 0.00105, "suitable position": 0.00236, "hiv ltr activation": 0.02109, "rb-defective tumor line": 0.01102, "soluble interleukin-2 receptor": 0.01714, "gastric carcinoma": 0.0018, "cell element": 0.0768, "cross-link": 0.00025, "tumor cell differentiation": 0.0512, "form heterocomplexes": 0.01055, "affected patient": 0.01666, "adult chronic bronchitis": 0.00281, "erythroid heterokaryons": 0.0062, "anionic domain": 0.01207, "undergone pre-terminal differentiation": 0.00786, "female monozygotic twin pair": 0.00107, "tnf stimulation": 0.0112, "c-myc gene": 0.04355, "daudi b-cells": 0.00093, "primary immune response": 0.01294, "selective nk cell-mediated clearance": 0.00183, "alter platelet aggregation": 0.00252, "sequence-specific manner": 0.00282, "intracellular oxidant generation": 0.00389, "mutant ap-1 element": 0.01115, "transcriptional regulatory element": 0.01115, "recurrent chromosomal translocation": 0.00343, "human uterine thromboxane receptor cdna": 0.01505, "great proportion": 0.00205, "direct evidence regard": 0.0036, "juxtaposed stage": 0.00248, "normal human pulmonary alveolar macrophage": 0.01505, "mutagenized strain": 0.00186, "vitro immortalization": 0.00785, "megakaryocyte blocked differentiation": 0.00786, "gos19.1 promoter": 0.02336, "caax site": 0.02168, "er antagonist ici": 0.00176, "lmo act": 0.00496, "transcription factor e2f-1 play": 0.0143, "significant class": 0.00642, "co-activation": 0.00012, "mediate dopamine responsiveness": 0.00821, "selective ligand": 0.00592, "high stability": 0.00931, "sle patient": 0.01666, "cd": 0.0005, "tsh response": 0.01942, "cd19-mediated signal transduction activate": 0.00889, "nf- kappab activation": 0.02109, "diurnal fluctuation": 0.00025, "perennial allergic rhinitis": 0.00064, "control il-2 production": 0.00868, "prolonged period": 0.00127, "permanent suppression": 0.00416, "human fibroblast": 0.03762, "discussion": 6e-05, "full-length sp1 transcription factor": 0.0143, "nuclear transcriptional factor ap-1": 0.0143, "socs-3 associate": 0.01092, "amplified expression": 0.04163, "binding sites/cell": 0.01855, "plasmic reticulum": 0.00012, "implicate component": 0.00456, "heterozygous mutant mouse": 0.00649, "dna bind basic domain": 0.01013, "usf": 0.00031, "self-limiting": 6e-05, "immunochemical": 6e-05, "apl": 0.00248, "peptide ligand": 0.00754, "non-parametric test": 0.00487, "intranuclear environment capable": 0.00174, "rest memory": 0.00267, "haemopoietic differentiation": 0.01179, "viral fragment permit stable plasmid replication": 0.00244, "stp-c488-mediated transformation": 0.00288, "natural position": 0.00236, "alternative stage": 0.00248, "receptor complex binding": 0.01714, "permit active hiv-1 replication": 0.00439, "informed consent": 6e-05, "min/exposure": 0.0, "transcription factor generation reveal": 0.0143, "proposal": 6e-05, "minor importance": 0.0013, "g2715t": 0.0, "express anti-tat single-chain intracellular antibody": 0.00738, "10-d-pregnant rat receive": 0.0019, "severe inflammatory syndrome": 0.00314, "hydrophobic group": 0.00487, "thrombin receptor agonist peptide induce early event": 0.00735, "heterodimeric p50-p65 nf-kappa": 0.00943, "gc-receptor": 0.00012, "dendritic cell development": 0.0512, "understood": 0.00025, "5'-ggcaccctttga-3": 6e-05, "pu.1-/- mouse": 0.00974, "negative regulatory signal influence": 0.00817, "anti-estrogen": 0.00056, "tissue-specific gene expression": 0.02903, "observation imply": 0.00149, "v-myb oncogene": 0.00261, "promyelocytic/retinoic acid receptor alpha": 0.01286, "cortisol level suppress cell-mediated immunity": 0.00728, "anae": 0.00012, "hcleo element": 0.01672, "positive function": 0.01331, "freshly isolate monocyte": 0.00798, "related kinase": 0.01188, "sccs": 6e-05, "high extent": 0.00931, "cellular growth": 0.00893, "mapk/erk-specific inhibitor pd": 0.006, "inhibit nf-kappab activity": 0.0195, "increase oestrogen receptor expression": 0.02081, "transient transfection assay result": 0.00805, "distinct cytokine": 0.01123, "receptor affinity": 0.02571, "decidual prl gene expression": 0.02177, "relb expression": 0.04163, "virus-negative": 0.00031, "fetal erythroid cell line": 0.0384, "rapamycin-resistant": 0.00025, "lymphocyte population": 0.01483, "acquired clonal cytogenetic change present": 0.00294, "heparin-binding protein crucial": 0.03019, "gollob": 0.00012, "eutopic pregnancy": 0.0009, "26-kda membrane form": 0.00703, "previous investigation": 0.00133, "il-10-induced up-regulation": 0.00276, "cytokine activate": 0.01777, "signal critical": 0.01635, "bsap/pax5": 6e-05, "otf-2 expression vector result": 0.02081, "rna analysis": 0.01179, "flank": 0.00161, "early-late-class phosphoprotein": 0.00053, "clinical evaluation": 0.00425, "mammary epithelial cell": 0.0512, "oct-2-harboring tester strain": 0.00124, "hiv-1 disease": 0.00878, "human mhc class ii gene": 0.01742, "influence susceptibility": 0.00471, "normal receptor status": 0.01714, "cell surface receptor": 0.0512, "nip-mediated repression": 0.00211, "ku812f": 0.00012, "nf-kappa b-inducing agent": 0.00943, "intracellular response": 0.01942, "cysteine residue": 0.00226, "sre motif induce": 0.01694, "cd3-activated": 0.00031, "induce tumor necrosis factor-alpha production": 0.01016, "lymphocyte immunoglobulin production": 0.00988, "tcr-mediated signaling": 0.00558, "l-selectin": 0.00124, "enhances intercellular adhesion molecule-1 gene expression": 0.01452, "epstein-barr virus rta protein activate lytic cycle gene": 0.01132, "aggregated cell": 0.0768, "observation period": 0.00149, "nuclear regulatory protein": 0.03019, "therapeutic strategy include": 0.00959, "multipotent/erythroid/monocytic": 0.00012, "human cd80": 0.03762, "examined vitamin d3-mediated repression": 0.00118, "non-sequence-specific": 0.00012, "multifocal cancer": 0.00248, "extent": 0.0023, "mediate interleukin-4-induced tyrosine phosphorylation": 0.00616, "il-2 promoter response element": 0.01168, "g-csf stimulation": 0.0112, "p50 subunit gene promoter underlies self-perpetuation": 0.01452, "isolated effector domain": 0.00804, "hsf2-alpha isoform": 0.00171, "disease marker": 0.00673, "ultrastructural analysis": 0.01179, "distinct lt-betar": 0.00698, "cysteine-rich region": 0.01467, "ra-responsive gene": 0.04355, "constitutive generation": 0.00478, "high order transcriptional complex": 0.00842, "thyrotropin": 0.00025, "myb-transformed hemopoi-etic cell": 0.0512, "biopsy": 0.00099, "soluble": 0.00447, "gig10": 0.00012, "exp.cell": 6e-05, "stat factor mammary gland factor-stat5": 0.01144, "immunological activation": 0.03164, "saa promoter sequence": 0.01557, "hygromycin resistance gene": 0.02903, "autoradiography": 6e-05, "functional inhibition": 0.01061, "share feature": 0.00288, "emphasis place": 0.00062, "active prolactin": 0.00592, "igh enhancer pi site": 0.01084, "low shear stress flow pattern": 0.00283, "specific cytotoxicity": 0.01238, "factor affect": 0.0286, "eventual recovery": 0.0005, "cd14 promoter": 0.02336, "sea present": 0.00735, "activation-induced fas upregulation": 0.00128, "proline rich sequence": 0.01084, "hybridoma remain unaltered": 0.00347, "m-csf receptor": 0.02571, "-13": 0.00031, "cat activity reveal": 0.0195, "defect induce": 0.0254, "bandshift experiment show": 0.01733, "transcription factor express": 0.01907, "single cell assay": 0.0512, "protein tyrosine kinase dependent": 0.02264, "naive mono mac": 0.00089, "two-handed": 6e-05, "peptide hormone": 0.00754, "hnf-6": 0.00012, "lymphocytic cell line ach-2": 0.0384, "receptor expression": 0.04163, "edelta": 0.00025, "hormone responsiveness": 0.00444, "signal agent": 0.01635, "viable anergic": 0.0005, "overlap antisense rna probe": 0.00228, "aml1a exhibit": 0.00664, "creb fuse": 0.00236, "gr cdna": 0.00456, "express dq0302": 0.01846, "lipid-laden foam cell": 0.0512, "inhibitor p21": 0.009, "dna-binding property": 0.00561, "pkc-zeta mut": 0.00074, "develop": 0.00806, "anti-thrombin iii inhibit": 0.0127, "activate agent": 0.01777, "recombinant p50": 0.00391, "hiv-1": 0.01756, "virus reservoir": 0.00887, "accessory molecule play": 0.00569, "heterodimer comprise": 0.00205, "activate huvec": 0.01777, "anti-cd29": 0.00012, "zebra protein": 0.04529, "baseline level": 0.01821, "constitutively active calcineurin": 0.00395, "transcription factor hiv-tf1": 0.01907, "human t-lymphocyte transformation": 0.02508, "type ii mhc combine immune deficiency": 0.00316, "u1b": 6e-05, "decreased reactive oxygen intermediate formation": 0.00194, "mediate high-level transcription": 0.01873, "cd28-costimulated": 0.00012, "neutrophil apoptosis": 0.0089, "cd14 mrna expression": 0.02775, "dysregulated expression": 0.04163, "prevents": 0.00217, "e2f play": 0.0071, "pkc-mediated signal event": 0.0109, "normal human hematopoietic cell": 0.0384, "transcriptional factor stat-1alpha": 0.01907, "decrease tf mrna expression": 0.02081, "nordihydroguiauretic acid": 0.00856, "alpha,25": 0.00012, "acute promyelocytic leukemia": 0.00333, "transcription factor egr-1 activity down-regulates fa": 0.00975, "radiotherapy": 0.0005, "a.l.": 6e-05, "janus protein-tyrosine kinase": 0.00792, "subclinical marker": 0.00382, "lymphoid cell include peripheral blood mononuclear cell": 0.01097, "ra-induced down-modulation": 0.00037, "crux": 6e-05, "compound inhibit": 0.01904, "physicochemical property": 0.00397, "laboratory define optimal condition": 0.0018, "lobular": 6e-05, "nf-kappab/rel family member test": 0.0042, "cro-ap/5": 0.00037, "tbp-associated factor tafii32": 0.01907, "ciita transcript": 0.00599, "t- cell mitogen": 0.0512, "plb-985 cell": 0.0768, "defective htlv-i": 0.00276, "pathophysiological relevance": 0.0005, "cognate dna element": 0.01115, "phosphoserine mimetic": 9e-05, "ikks": 6e-05, "abnormal nfkappab activation": 0.02109, "transcription mechanism": 0.0281, "cd30 coengagement": 0.00071, "g3 tumor": 0.00934, "ebna2 lead": 0.00996, "multimerized nf-kappa": 0.01414, "inhibitor exert multiple effect": 0.01058, "cytosine": 6e-05, "fibroblast cell": 0.0768, "gpx activity": 0.02925, "pma-treated thp-1 cell": 0.0512, "maintain cellular": 0.00893, "intracellular signalling molecule": 0.00569, "structural constraint": 0.0018, "human interleukin-12": 0.03762, "alpha-/- embryonic fibroblast show minimal constitutive nf-kappa": 0.00743, "cosmid probe": 0.00261, "dna break": 0.01483, "induces c-jun transcription": 0.01873, "ifn-alpha/beta-induced transcription complex isgf3": 0.01405, "phosphatidylethanolamine": 6e-05, "regulatory region include cbf": 0.00734, "electrophoretic mobility shift assay analysis show": 0.00866, "cocl2-induced nf-kappab activation": 0.02109, "original igg": 0.00084, "transwell system": 0.00667, "j393/cd43 signal apoptosis": 0.0109, "b-cell-specific displacement": 0.00121, "cd4+ cd8-": 0.00288, "factor cooperate": 0.0286, "region translocate": 0.01467, "signal event trigger": 0.0109, "occurrence": 0.00056, "specific promoter site": 0.01557, "increased cd23 expression": 0.02775, "carotid artery": 0.0004, "sound basis": 0.00143, "p50/p65": 0.00211, "mub": 0.00025, "immunological defect": 0.00279, "methyl xanthine derivative": 0.00128, "regulate lymphocyte homeostasis": 0.00988, "function aid": 0.01331, "hepa-1 wild-type": 0.00378, "express sp1": 0.01846, "erythroid cell differentiation": 0.0512, "rel/nf-kappab-dependent induction": 0.01607, "mhc class ii-silenced cell hybrid": 0.03072, "pro-b lymphocyte": 0.01483, "sequence polymorphism": 0.01625, "sr-bp represent": 0.004, "tumor characteristic": 0.00934, "dst": 0.00012, "complex demonstrate predominant expression": 0.02081, "anti-cd3-induced tyrosine phosphorylation": 0.00656, "monocyte cell line induce": 0.0384, "targeted": 0.0013, "vr+": 0.00012, "c26": 0.00012, "cell mitogenesis": 0.0768, "nf-kappab transcription": 0.0281, "bp -253": 0.00267, "c.j.": 0.00012, "mub element": 0.01672, "vii": 0.00012, "vaso-occlusion": 0.00012, "plethora": 6e-05, "synergistic action": 0.00499, "bp -256": 0.00267, "effector cell generate": 0.0512, "related member": 0.00413, "signal-mediated induction": 0.01607, "young subject result": 0.01073, "psychiatric disorder": 0.00223, "hormone effect": 0.02115, "serum responsive element": 0.01115, "e2f-dependent activation": 0.03164, "massive amplification": 0.00074, "single genetic locus": 0.0024, "c-erba/thyroid hormone": 0.00444, "-resistant clone": 0.00738, "stat-specific antiserum": 0.00074, "hiv-2 transcriptional enhancer": 0.00767, "related antigen": 0.00819, "hd6 cell": 0.0768, "retinoid-dependent granulocytic marker": 0.00254, "total": 0.00323, "liganded mr": 0.00068, "cell surface recognition event": 0.0384, "e3330 inhibit degradation": 0.0127, "surrogate light chain": 0.00292, "endogenous vitamin d3 receptor": 0.01286, "cardiac transplantation": 0.00056, "erythroid progenitor correlate": 0.00436, "btk": 0.00031, "dissociation profile": 0.00152, "leukocyte-specific pp52 promoter": 0.01557, "dox induce": 0.0254, "long enhancer transcript": 0.00606, "p65 protein expression": 0.03019, "signal apoptosis": 0.01635, "skf525a decrease adhesion": 0.00647, "early precursor": 0.00828, "selective dna-binding activity": 0.0195, "serine kinase activity": 0.0195, "inflammatory airway disease": 0.00449, "phosphate absorption": 0.00065, "inflammatory lesion": 0.00471, "direct transcriptional control": 0.00868, "characterize primary hemopoietic cell": 0.0384, "apparent": 0.00385, "active inhibitory process": 0.00395, "kappab sequence": 0.01625, "defective hiv virus": 0.00591, "mmtv": 0.00043, "lymphoid development missense mutation": 0.00316, "receptors/cell": 0.00025, "hcmv version": 0.00071, "understand th1/th2 development": 0.00422, "include inhibition": 0.01439, "histologic examination show": 0.01733, "require functional syk kinase": 0.00658, "transactivate model": 0.00422, "globin locus control region": 0.00734, "src": 0.00105, "membrane-proximal determinant distinct": 0.00465, "mouse gata3 gene": 0.02903, "tes2": 0.0005, "normal signal-dependent nf-kappa": 0.00943, "cao": 0.00012, "cockayne": 6e-05, "increase intracellular store": 0.01464, "apl phenotype": 0.00366, "nf-kappab activation pathway": 0.02109, "-417 zeta-luciferase construct": 0.00484, "gel-retardation assay": 0.01002, "tissue-": 0.00037, "active principle": 0.00592, "departure": 6e-05, "dph": 6e-05, "3.4+/-0.3 versus 3.1+/-0.2 nmol/l": 0.00068, "antiandrogen bind": 0.02025, "leucine zipper class": 0.00428, "cytokine-modulating activity": 0.02925, "bslf2": 0.00012, "infected monocyte": 0.01197, "early gene transcription": 0.02903, "prominent protein kinase cascade": 0.02264, "membrane-proximal traf6 interaction domain": 0.00603, "hematopoietic-specific gene": 0.04355, "intracellular signal transduction component": 0.00817, "high-grade": 0.00031, "box bind protein enhance": 0.02264, "restriction enzyme suggest": 0.01348, "anti-fos antibody abolish bind": 0.01013, "stimulated lymphocyte": 0.01483, "beta stability": 0.00673, "promonocytic u1 cell line show": 0.03072, "nfat kinase": 0.01188, "mouse spleen development": 0.00649, "p288s": 6e-05, "bfu-e": 0.00043, "render ebv transformation incompetent": 0.00282, "tamoxifen result": 0.0161, "p5": 0.00025, "improved glucocorticoid-based drug": 0.00225, "mouse embryonic stem": 0.00649, "pertussis-toxin-sensitive": 0.00025, "dominant negative rhoa mutant": 0.00405, "hla-dm-do complex": 0.01684, "nf-kappab pathway contributes": 0.00852, "antineoplastic agent": 0.00422, "resist apoptosis": 0.0089, "hdac": 0.00012, "improvement": 0.00043, "young subject": 0.00354, "glycosaminoglycan synthesis": 0.00583, "express megakaryocytic marker": 0.0123, "rhesus macaque": 0.00028, "multiple response region": 0.01294, "enhance protein degradation": 0.03019, "copyright": 0.00012, "gal4-substituted hiv-1 enhancer": 0.00606, "peak response occur": 0.01294, "monocyte counter-receptor": 0.01197, "scatchard plot analysis reveal kd": 0.00471, "similarly affect": 0.00797, "result imply": 0.0161, "immunized knock-out mouse": 0.00649, "stress-activated protein kinase/c-jun nh2-terminal kinase": 0.01811, "-dependent pathway": 0.01278, "human tcr alpha enhancer": 0.01881, "shp-1": 0.00019, "increased phosphorylation": 0.00983, "interleukin-10 receptor expression": 0.02775, "erk-independent pathway target stat3": 0.00639, "classical action": 0.00499, "transfected human cell suggest": 0.0384, "1.2-kb cdna encode full-length human c/ebp-epsilon": 0.01254, "specific phase": 0.01238, "g-csf result": 0.0161, "n-formyl-methionine-leucine-phenyl-alanine": 0.00012, "cell stage-specific distribution": 0.0512, "idea": 0.00025, "e1a- adenovirus vector": 0.00213, "differential binding": 0.01855, "conserved zinc-finger domain": 0.00804, "methylation interference analysis demonstrate": 0.00799, "accelerate": 0.00149, "stimulate nuclear export": 0.01123, "progesterone-mbp-hbd": 0.0, "3h-thymidine": 0.00019, "kv1.3": 6e-05, "nf-kb binding site lead": 0.01084, "striking increase": 0.02196, "major histocompatibility complex class ii transactivator construct lack": 0.00421, "monocytoid u937 cell line": 0.0384, "tf-specific kappab site": 0.01445, "th2 lineage relative": 0.00244, "human erythroid ala mrna": 0.01881, "ecto-5'-nucleotidase promoter": 0.02336, "utr": 0.00025, "neck": 0.00012, "metabolic substrate": 0.00199, "normal human alveolar macrophage": 0.01881, "heterologous beta-globin reporter gene": 0.02177, "egr-1 site": 0.02168, "non-erythroid cell": 0.0768, "3-deazaadenosine": 0.00012, "dza promote": 0.00465, "cell show g1 phase arrest": 0.03072, "activity-stimulating growth": 0.00819, "a/r challenge": 0.00102, "pre-i form multiple dna-protein complex": 0.00674, "lymphoid neoplasm": 0.00409, "signal event": 0.01635, "tnfr1 signal": 0.01635, "chronic inflammatory condition": 0.00314, "evi1 gene": 0.04355, "gq/g11": 6e-05, "accordance": 0.00019, "oestrogen receptor gene polymorphism": 0.02177, "ebv protein": 0.04529, "unidentified c-c chemokine": 0.0007, "unique profilin-like functional fashion": 0.00408, "granulopoiesis": 0.00043, "accurate picture": 0.00031, "cushingoid feature": 0.00217, "dominant-negative cdk4": 0.00102, "goiter": 0.00025, "oct-2 express": 0.01846, "multiple ci element": 0.01115, "adenovirus major late promoter": 0.01168, "central nervous system": 0.00445, "mapping purpose": 0.00099, "preincubated cell": 0.0768, "critical signal response domain": 0.00971, "-73": 0.00037, "social factor": 0.0286, "augment inflammation": 0.00316, "inducer-mediated degradation": 0.00332, "estrogen receptor negativity": 0.01714, "optimal augmentation": 0.00152, "regulates gamma interferon": 0.00294, "malignancy": 0.0023, "crh": 0.00081, "b95-8 cytosol": 0.00143, "combine autoradiographic": 0.00161, "ag-490": 0.00037, "release": 0.00968, "hot": 0.00031, "snp": 6e-05, "oct2b": 0.00037, "stimulation il-2 gene transcription": 0.02177, "distinct cytokine profile": 0.00749, "dimethyl sulfoxide-differentiated hl-60 leukemia cell stimulate": 0.0256, "plasma sample": 0.00375, "fibric acid": 0.00856, "rho": 0.00124, "key inducer": 0.00152, "ifn-gamma priming": 0.00481, "platform": 0.0, "binding pattern": 0.01855, "4-fold increase": 0.02196, "human t-cell acute lymphoblastic leukemia": 0.01505, "early transcription factor": 0.01907, "allele-specific mrna stability": 0.01017, "il-2 promoter": 0.02336, "forced": 0.0005, "induce class ii mhc antigen expression": 0.01388, "camp-response element": 0.01672, "polyclonal anti-tf antibody show": 0.013, "prominent isoforms": 0.00307, "mitogen-activated mature": 0.00329, "ig alpha": 0.01169, "tt-selected": 0.00012, "cord lymphocyte maximum c-fos": 0.00741, "nf-at activity": 0.02925, "jm": 6e-05, "c-jun transcript remain elevated": 0.00299, "act-1": 0.00025, "jcam": 0.00019, "vdr 3'-utr haplotype": 0.00155, "kg1 dendritic-like cell include morphology": 0.03072, "map kinase extracellular signal-regulated kinase": 0.00238, "mol.cell.biol.15": 6e-05, "s9a inhibit tnf-alpha promoter-driven reporter gene activity": 0.01244, "limited number": 0.0053, "immune system origin": 0.00445, "encode gene clone": 0.02903, "bh1": 6e-05, "n-terminal thr729-leu765 region": 0.00978, "enigma": 6e-05, "promotion": 0.0005, "real effect": 0.02115, "synthesize p105 protein": 0.03019, "biological active form": 0.00703, "distinct nuclear focus": 0.01123, "cultured human dermal fibroblast": 0.01881, "immune cell infiltrate": 0.0512, "equivalent phosphorylation": 0.00983, "noninduction": 6e-05, "multiple regulatory region include": 0.00734, "b2 gene": 0.04355, "rheumatoid arthritis pathogenesis": 0.00114, "inhibit il-2-dependent": 0.01904, "intragenic tsg101 deletion": 0.0023, "major histocompatibility complex-restricted fashion": 0.00287, "major histocompatibility complex class": 0.00842, "discrete block": 0.01073, "enhancer property": 0.00909, "cd56+ cd16+ natural killer cell": 0.03072, "cocl2 -or hypoxia-induced increase": 0.01098, "gamma-ifn inhibits 1,25-": 0.00354, "cell differ": 0.0768, "hyper-": 0.00019, "tumor-suppressor gene": 0.04355, "extensive rearrangement": 0.00199, "block antibody": 0.01073, "oct-1p": 0.00012, "constitutive nuclear appearance": 0.01123, "fas promoter activity": 0.0195, "distinct regulation": 0.01008, "glucose uptake": 0.00167, "graft-vs-host reaction": 0.0022, "g-actin": 6e-05, "untreated cell": 0.0768, "activate phosphorylation": 0.01777, "adult cd4+cd45ro-": 0.00422, "aids-gr group": 0.00487, "human class ii isotypes": 0.01881, "underlie lymphocyte": 0.01483, "anti-cd3-activated peripheral human": 0.02508, "nuclear receptor peroxisome proliferator-activated receptor gamma": 0.00561, "histone deacetylase inhibitor": 0.006, "antiinflammatory": 0.00124, "pharmacodynamic model": 0.00422, "yeast transactivator gal4": 0.00108, "degenerate primer": 0.00081, "c-terminal region": 0.01467, "mutual repression": 0.00211, "control tal1 transcription": 0.01873, "cell require exposure": 0.0512, "proto-oncoprotein c-rel": 0.00245, "pma-induced il-2 production": 0.00744, "negative role": 0.01328, "cell responsive": 0.0768, "human remain obscure": 0.02508, "develop u937 transfectants express antisense vdr mrna": 0.00527, "prdi domain": 0.01207, "hematopoietic precursor cell line": 0.0384, "inflammatory synovial fluid": 0.00314, "overexpressed egr-2": 0.00087, "ecotropic viral insertion site": 0.01084, "maintain euthyroid": 0.00239, "-dependent activation": 0.03164, "rxr-alpha mrna": 0.01526, "three-dimensional nuclear magnetic resonance": 0.00842, "inhibit anti-cd3-induced interleukin-2 secretion": 0.00952, "htlv-1 transformation": 0.00288, "mvec occur": 0.00654, "cdna clone": 0.00738, "plasma cell-like": 0.00375, "bp repeat element react": 0.00836, "trypsin digestion": 0.00025, "upstream promoter element": 0.01557, "advanced chronic renal failure": 0.00199, "cooh terminus": 0.00071, "5'nf-e2/ap1": 0.00012, "similar alteration": 0.00673, "hormone-inducible trans-activating protein": 0.03019, "strong negative regulator": 0.00343, "intensified culturing procedure": 0.00052, "synthetic peptide": 0.00754, "hematopoietic cell lineage commitment": 0.0384, "mbp prolong": 0.00109, "well-characterized role": 0.01328, "enhanced sensitivity": 0.00285, "trans activate": 0.01777, "alpha interferon": 0.01169, "lck gene product": 0.02903, "similar cd30-mediated effect": 0.0141, "hybrid clone": 0.00738, "vitro peptide sensitization": 0.00523, "reaction mixture": 0.0022, "p50/rela": 0.00037, "transcriptional activator capable": 0.00767, "proteasome inhibitor n-ac-leu-leu-norleucinal inhibits": 0.0045, "important activity": 0.02925, "rapamycin-resistant mutant": 0.0081, "mel cell": 0.0768, "efficient mar-bp1 binding": 0.01237, "pu.1 autoregulatory site": 0.01445, "fly embryogenesis": 0.00022, "pseudohyperaldosteronism": 6e-05, "gpibalpha": 6e-05, "tnf alpha gene induction": 0.02177, "limited processing": 0.00133, "control flcs": 0.01303, "low malignancy yield": 0.00471, "t-cell receptor locus": 0.01714, "early": 0.01656, "consensus site": 0.02168, "inhibit ifn-mcp": 0.01904, "p50 component": 0.00456, "il-1-induced il-2 production": 0.00744, "low basal activity": 0.0195, "tuberculosis": 0.00211, "e2a-pbx1": 0.00081, "gene expression level": 0.02903, "k562 cell transfected": 0.0512, "potent agonist": 0.00357, "confocal immunocytochemistry": 0.00031, "overexpressed aml1a": 0.00087, "mobility": 0.00267, "interleukin-4 gene": 0.04355, "specific staining": 0.01238, "jak 2-stat": 0.00068, "human primary cd34": 0.02508, "alpha": 0.02339, "normal tgf-beta receptor profile": 0.01286, "microm etoposide": 0.0013, "stimulation process": 0.0112, "important secretory/transport function": 0.00887, "harbor": 0.0018, "relevant": 0.00285, "androgen-": 6e-05, "2d3-responsive cell": 0.0768, "induce nf-kb activity": 0.0195, "murine erythroleukemia": 0.00623, "lipopolysaccharide-induced tyrosine kinase activation": 0.01582, "29-kda phosphoprotein specie": 0.00122, "potent lipid proinflammatory mediator": 0.00178, "bq cytotoxicity": 0.00143, "nitric oxide": 0.00065, "situ hybridisation reveal musculin expression": 0.01665, "caenorhabditis elegans suggest": 0.01348, "complete inhibition": 0.01061, "isotype-specific activator": 0.00552, "blood mononuclear cell": 0.0512, "cle0": 0.00062, "flow cytometry analysis reveal": 0.00589, "specie specificity": 0.00335, "cytomegalovirus": 0.00124, "promoter dna": 0.02336, "il-5 gene transcription": 0.02903, "leukemia cell line": 0.0512, "large clonal t-cell population exhibit": 0.00385, "th1": 0.0031, "rhythmicity": 6e-05, "criterion": 0.00093, "tat": 0.00515, "unique set": 0.00261, "nonpituitary prl gene expression": 0.02177, "kinase substrate": 0.01188, "ap-1-like complex": 0.01684, "unique transcription factor": 0.01907, "nonhuman primate": 0.00056, "phagocyte nadph oxidase": 0.00058, "human monocytes/macrophages": 0.03762, "epithelial cell malignancy": 0.0512, "rna polymerase ii promoter": 0.01168, "describe truncated form": 0.00703, "decreased glucocorticoid receptor number": 0.01286, "non-malignant cell": 0.0768, "luciferase reporter": 0.00552, "extracellular matrix component": 0.00304, "implicate h2o2": 0.0035, "dna probe": 0.01483, "il-10 treatment prevent": 0.00676, "block tax induction": 0.01071, "lymphocytic aldosterone receptor": 0.01714, "malignant transformation": 0.00288, "90-kda heat shock protein": 0.02264, "pebp2betamyh11 inhibit neutrophilic differentiation": 0.00952, "nuclear factor-il-6beta": 0.01684, "variant id-3l protein": 0.03019, "decrease il-9-mediated tyrosine phosphorylation": 0.00492, "natural killer cell": 0.0512, "virus-encoded transactivator": 0.00161, "order low": 0.00707, "target ifn synthesis": 0.0055, "authentic e2f site": 0.01445, "itk play": 0.0071, "classical p50-p65 complex": 0.01123, "tuberculosis infection": 0.0062, "provide high level": 0.01214, "nonimmunoglobulin gene hypermutation": 0.02903, "abundant chromosomal protein hmg-1 belongs": 0.01811, "steroid mediate lysis": 0.00821, "differentiation potential": 0.01179, "receptor-bearing subset": 0.00192, "-associated factor": 0.0286, "primary involvement": 0.00738, "carrier": 0.00105, "element tced": 0.01672, "pkc down-regulation": 0.00332, "androgen-binding domain": 0.01207, "granulocyte colony-stimulating factor receptor": 0.0143, "southern blot analysis show rearrangement": 0.0104, "25-": 6e-05, "t-helper-cell epitope": 0.00161, "e2f bind site result": 0.01084, "anti-hgh mab": 0.00267, "cytosol support nfat export": 0.00216, "western blot detect change": 0.00363, "term complex": 0.01684, "synchronization": 6e-05, "spirochetal lipopeptides": 0.00012, "pma-induced cd4 down-modulation occur": 0.00327, "outward migration": 0.00155, "il-10 affect monocyte": 0.00798, "increase nf-kappa b/i kappa": 0.01098, "putative hematopoietic stem cell": 0.0384, "alpha-tocopherol": 0.00068, "dmso result": 0.0161, "inhibit lps induction": 0.0127, "smx": 0.00031, "striking downregulation": 0.0009, "coordinated production": 0.01042, "/rel": 0.00037, "tax-response element dna": 0.01115, "hiv-1 long terminal repeat promoter region": 0.00779, "anti-hla class": 0.00642, "pre-incubation": 0.00012, "nf-m-dependent promoter construct": 0.01557, "characterize camp-": 0.00425, "soluble factor secrete": 0.01907, "interleukin-1 beta gene": 0.02903, "human chr": 0.03762, "antibody study demonstrate": 0.01065, "bound tripartite complex": 0.01123, "il-2 transcriptional regulator c-fos": 0.00575, "sea stimulation": 0.0112, "human peripheral blood monocyte result": 0.01505, "homeobox": 0.0005, "reduced cellular content": 0.00596, "hiv-1 ltr": 0.00878, "intracellular generation": 0.00583, "iarc": 0.0005, "bufalin treatment activate activator protein-1 transcriptional activity": 0.00836, "ivs1-10tc": 0.0, "nucleotide excision repair": 0.00134, "apl patient express hla dr11": 0.00738, "prognostic character": 0.00047, "lipopolysaccharides": 0.00025, "jnk activation correlate": 0.02109, "monocyte/macrophage lineage represent": 0.00267, "transcription activation function": 0.02109, "cell-type specific transcription factor gata-1": 0.01144, "consecutive healthy control": 0.00868, "tfiid protein": 0.04529, "dna-binding complex": 0.01684, "smad7 prevent ligand-induced activation": 0.01582, "finding remain": 0.00521, "zymogen": 0.00025, "early fetal development": 0.00552, "stringent system": 0.00667, "cell response detect": 0.0512, "-resistant": 0.00019, "ikkbeta cellular kinase": 0.00792, "high initial level": 0.01214, "calcium ionophores": 0.00236, "phorbol myristate acetate": 0.00362, "positivity": 0.00037, "nuclear factor activate": 0.01907, "g0-g1 phase": 0.00276, "borrelia burgdorferi lipoprotein": 0.00079, "methylation-free island": 0.00031, "k46 transfectants": 0.00099, "related hemopoietic helix-loop-helix transcription factor": 0.01144, "scl/tal1": 6e-05, "fas stimulation result": 0.01073, "obstacle": 0.00031, "cyclosporin-sensitive dna-binding protein require": 0.02264, "heat-labile serum factor": 0.01907, "tcr-derived signal induce": 0.01694, "ap-5": 6e-05, "sp1 binding site present": 0.01084, "-76 site bind": 0.01445, "pdtc promote": 0.00465, "proteasome-dependent inhibitory kappa": 0.00498, "induce differentiation": 0.0254, "putative hormone bind domain": 0.01013, "precursor frequency": 0.00323, "her-2/neu oncogene": 0.00261, "scmv": 0.00037, "er-negative mda-mb-231 breast cancer cell line": 0.0256, "mhc-i mediate tyrosine phosphorylation": 0.00616, "il-6 kappa": 0.00748, "multifactorial": 0.00025, "ectopic implantation site": 0.01445, "low risk control": 0.00868, "activation-induced change": 0.0063, "ml-1a": 6e-05, "hiv-1 gp41-induced il-10 up-regulation": 0.00439, "intronic sequence": 0.01625, "mutant cdna clone": 0.0054, "element work": 0.01672, "significant factor": 0.0286, "cd4+ cell count": 0.0512, "monocyte tf activation occur": 0.01582, "retinoic acid-induced modulation": 0.00172, "provide preliminary evidence": 0.0043, "inflammatory cascade": 0.00471, "co-operative interaction": 0.00986, "detectable involvement": 0.00276, "transactivating property": 0.00397, "include epithelium": 0.01439, "human eotaxin gene": 0.02903, "activation-related gene": 0.04355, "maturation process": 0.00444, "prostate cell": 0.0768, "normal adult hematopoiesis": 0.00806, "ten healthy male volunteer": 0.00088, "hormone-dependent trans-activator": 0.00093, "p65-i kappa": 0.00748, "significant weight gain": 0.00277, "gc action": 0.00499, "steroid-responsive gene": 0.04355, "permanent growth": 0.00819, "daudi cell stimulate": 0.0512, "haloperidol": 6e-05, "devoid": 0.00087, "brk": 0.00012, "tat protein constitutively express": 0.02264, "result demonstrate distinct pattern": 0.00805, "western blot": 0.00109, "inhibitor block sp-a-dependent increase": 0.01098, "germline taqi restriction fragment length polymorphism": 0.00116, "okadaic acid-sensitive phosphatase": 0.00176, "additional isoforms": 0.00341, "human il-1beta promoter": 0.02508, "rapid activator": 0.00552, "e-selectin": 0.00273, "form dna-protein complex common": 0.00842, "quiescent human b-lymphocytes": 0.02508, "aberrant cd4": 0.00332, "hepatoprotective activity": 0.02925, "kappa b/mad-3 bind": 0.0135, "im-9 cell": 0.0768, "gm-csfralpha cytoplasmic domain": 0.00804, "specific antigenic stimulus": 0.00825, "phosphorylated substrate": 0.00202, "vitro globin gene switch model base": 0.01452, "schneider": 0.00031, "14-fold great": 0.00205, "lytic superinfection": 0.00161, "chromatin structure level": 0.01214, "dominant ikappab molecule": 0.00569, "consecutive cardiac transplant recipient": 0.0002, "gene encode cytokine": 0.02903, "normal peripheral blood lymphocyte": 0.00741, "sustained loss": 0.00298, "effector phenotype": 0.00366, "erythroid cell survival": 0.0512, "abolish lps induction": 0.01071, "ire correlate": 0.00654, "hla-dr11 restricting molecule": 0.00569, "cd4 expression": 0.04163, "pu.1 form": 0.01055, "regulatory mechanism": 0.01058, "placebo administration": 0.00093, "individual cd4+": 0.00409, "kd complex": 0.01684, "hypothalamic-pituitary-adrenal axis": 0.0005, "ifngamma-dependent transcription": 0.0281, "autocrine production": 0.01042, "basal cell carcinoma": 0.0512, "metalloproteinase activity": 0.02925, "il-2 expression": 0.04163, "hla-a3": 0.00012, "tacrolimus": 0.00012, "antiandrogen action": 0.00499, "ciita-transfected hybrid": 0.00171, "hl-60 cell line": 0.0512, "tnfrp55": 0.00037, "inactive state": 0.00267, "transrepression": 0.0005, "master switch": 0.00245, "spi-b bind dna sequence": 0.01013, "complete failure": 0.00171, "hydroxyurea": 0.00025, "activation-deficient": 0.00012, "endogenous ecto-5'-nt mrna": 0.01017, "7-bp response element": 0.01294, "peroxisomal proliferator-activated receptor gamma": 0.01286, "increase hiv-1 production": 0.01464, "i-ek": 0.00012, "molecular mechanism associate": 0.00728, "encounter self-antigens": 0.00012, "inert quality": 0.00022, "block kv": 0.01073, "inhibited interleukin": 0.00276, "tnf receptor family member": 0.01286, "stress treatment": 0.01014, "protein-dna interaction": 0.00986, "1549-1560": 6e-05, "human blood mononuclear cell culture": 0.03072, "attached dna": 0.01483, "multiple oct2 isoforms": 0.00459, "blood eosinophilia": 0.00592, "metal gold": 0.00025, "adenosine deaminase": 0.00037, "drive induction": 0.01607, "immunosuppressive": 0.00205, "increased number": 0.0053, "dexamethasone down-regulates tpa-induced transcription": 0.01405, "isolated fragment belong": 0.00232, "beta chain": 0.00673, "il-6 stimulation": 0.0112, "aberrant result": 0.0161, "activation-induced phosphorylation": 0.00983, "aged long-distance runner": 0.00033, "il-4-induced cd23 mrna": 0.01017, "distinct immunophilin-drug complex bind": 0.01013, "regulate intercellular adhesion molecule-1": 0.00627, "critical cytokine": 0.01123, "beta2 integrin": 0.00112, "tumor suppressor gene brca1": 0.02177, "c-mpl": 0.00031, "determine receptor function": 0.01714, "long-term activation": 0.03164, "gtp-binding protein": 0.04529, "hsv-1": 0.00093, "e1a transfection": 0.00276, "auc": 0.0005, "u937-derived clone render": 0.00492, "phorbol-myristate-acetate": 0.00019, "cellular distribution": 0.00893, "regulate activity": 0.02925, "lipopolysaccharide signaling": 0.00558, "circadian modification": 0.00183, "primary role": 0.01328, "concomitant overexpression": 0.00382, "protein display": 0.04529, "double-stranded kappab phosphorothioate oligonucleotide": 0.00082, "fine tuning": 0.00031, "choice": 0.00043, "resolve": 0.0005, "hematopoietic/lymphoid tissue": 0.00664, "m2-type leukemic blast cell": 0.0384, "6-fold high": 0.00931, "stat3ee": 6e-05, "anaerobic threshold": 0.00062, "include lipopolysaccharide": 0.01439, "survival": 0.00471, "viral dna synthesis": 0.00988, "mature monocytic phenotype": 0.00269, "speculate": 0.00037, "basal adhesion": 0.0058, "leukemic": 0.00502, "phytohemagglutinin-stimulated normal human lymphocyte": 0.01881, "antiglucocorticoid ru486": 0.00022, "regulatory protein": 0.04529, "serum ige level": 0.01214, "collagenase-1 transcription": 0.0281, "cis-encoded dq molecule encode": 0.00426, "human t-cell leukemia virus": 0.01881, "base occur": 0.00654, "cd3-cd16+ cell": 0.0768, "nfil-2b": 0.00019, "80-kda tyrosine-phosphorylated protein": 0.03019, "t-cell leukemia-specific translocation occur": 0.00481, "induce nf-kappab-dependent activation": 0.02109, "c-maf": 0.00105, "tosylphenylalanyl chloromethyl ketone": 0.00021, "bso": 0.00031, "similar construct control": 0.00868, "relative amount": 0.00285, "ibd": 0.00037, "chemokine gene expression": 0.02903, "transcription factor ifn regulatory factor-1": 0.01144, "ap-1 transrepression exhibit antiinflammatory activity": 0.0117, "result implicate cbl": 0.01073, "stationary-phase-dependent resistance": 0.00326, "pou dna-binding motif define": 0.00437, "murine pro-b cell": 0.0512, "sialyltransferase isozyme": 0.00022, "c-erba/tr": 0.00056, "exact cellular defect": 0.00596, "nf-at activation": 0.03164, "major mrna transcript": 0.01017, "zi repeat": 0.00378, "hirsutism": 0.00031, "cell-associated gene": 0.04355, "gpib-v-ix": 6e-05, "nf-kappab2 p100": 0.00065, "enhanced tumor growth": 0.00622, "diverse receptor": 0.02571, "aids-related non-hodgkin": 0.00034, "study il-5 signaling": 0.00904, "classic map-erk cascade": 0.00143, "nf-kappab protein activity": 0.03019, "lsf": 0.00031, "interesting model": 0.00422, "lps-stimulated translocation": 0.00515, "thymic dendritic cell": 0.0512, "nonpregnancy": 0.00012, "unilineage erythroid culture": 0.00414, "target predetermined dna sequence": 0.00813, "calcium influx": 0.00236, "lcl suggest": 0.02022, "tcr beta chain sequence": 0.00813, "acute promyelocytic": 0.00369, "pre-": 0.00031, "hbxag": 0.00043, "tcr result": 0.0161, "electrophoretic mobility shift assay show": 0.0104, "native human erythrocyte ndp kinase protein inhibit": 0.01294, "t3so4": 0.00056, "redox sensitive cytosolic transcription factor": 0.01144, "il-4 promoter activity": 0.0195, "show pleiotropic activity": 0.0195, "hl-60 promyelocytic leukemia cell correlate": 0.03072, "nfatp-": 0.00012, "significant difference": 0.00425, "analyze xci pattern": 0.00366, "stimulate replication": 0.01101, "anti-thrombotic": 6e-05, "pc60": 6e-05, "cotreatment": 0.00037, "marked enzymatic activation": 0.02109, "receptor cross-linking induced stress fiber assembly": 0.00857, "important factor": 0.0286, "hla-dr": 0.00248, "high gcr bind affinity": 0.01013, "beta-chain": 0.0013, "concanavalin a-activated cycling": 0.00012, "direct percutaneous transluminal coronary angioplasty": 0.00216, "suggest overlap mechanism": 0.01348, "cytokine gene": 0.04355, "cellular transduction mutant exhibit": 0.00447, "tax": 0.00955, "smoke menopausal patient": 0.0111, "intracellular reactive oxygen specie": 0.00292, "acute": 0.00738, "il-2 gene expression trigger": 0.02177, "intact human platelet": 0.02508, "dimethylsulfoxide": 0.00012, "repeat structure": 0.00378, "vascular endothelial": 0.00434, "infiltrating tumour": 0.00183, "il-2 promoter-enhancer induction": 0.01071, "irf-1 gas element": 0.01115, "pituitary-specific manner": 0.00282, "human immunodeficiency virus-induced apoptosis": 0.01881, "leukocyte integrins": 0.00478, "component include transcription": 0.01873, "-binding domain": 0.01207, "antioxidant inhibit monocyte adhesion": 0.00952, "ca2+-chelating agent": 0.00422, "immunosuppressive cytokine tgf-beta": 0.00749, "total lack": 0.00633, "fasl regulation": 0.01008, "putative nf-kappa b-binding site": 0.01084, "normal prickle cell": 0.0512, "dna-binding regulatory protein": 0.03019, "aml1": 0.00242, "pokeweed mitogen": 0.00149, "increase monocyte tf expression": 0.02081, "cyclosporin a-sensitive nuclear factor-at response element": 0.00647, "basal level": 0.01821, "implicate specific cis-active sequence": 0.00813, "irf-1 promoter region act": 0.01168, "inducible gene expression": 0.02903, "raw264": 6e-05, "p50 dimer": 0.00288, "stat3 activity": 0.02925, "cadmium chloride increase": 0.01464, "b7 stimulation induce": 0.01694, "constitute": 0.00236, "immune complex": 0.01684, "theory": 6e-05, "positive-negative regulation": 0.01008, "cell-specific cell surface molecule cd19": 0.03072, "rcc supernatant": 0.00093, "clinical responsiveness": 0.00425, "c/ebp activator nf-il-6": 0.00368, "dq8 specificity": 0.00335, "cell response include il-2": 0.0384, "major growth factor": 0.01907, "pi": 0.00149, "operational definition": 0.00028, "125i-labeled aldosterone": 0.00186, "murine cell": 0.0768, "ino": 0.00081, "tax expression promote n-terminal phosphorylation": 0.01665, "and/or": 0.009, "enhancer term cd28 responsive element": 0.00669, "downstream regulatory element": 0.01115, "uv cross-linking study confirm": 0.00678, "orfs": 0.00031, "callithrix jacchus": 6e-05, "relevant concentration exert specific action": 0.00495, "radical-generating system": 0.00667, "fc gamma rii-mediated endocytosis": 0.0022, "bacterial": 0.00447, "kappa immunoglobulin germline promoter": 0.01168, "ra/vd treatment": 0.01014, "5'-gggcgg": 6e-05, "il-2 promoter/reporter construct": 0.00744, "diverse regulatory protein": 0.03019, "phorbol ester reduces constitutive nuclear nf kappa": 0.00481, "commonly detect": 0.00726, "c-myc promoter construct": 0.01557, "mm d-ribose": 0.00118, "erythroid-specific chromatin structure reorganization": 0.0016, "calcineurin-dependent": 0.00056, "enhance tcr-controlled nf-at induction": 0.00803, "acetyl salicylic acid": 0.00571, "transcription": 0.0562, "stimulus": 0.0054, "metal-ion chelator": 0.00016, "deposition": 0.00031, "demonstrate differential binding": 0.01237, "l243": 6e-05, "tata box promoter element": 0.01168, "fos family": 0.00841, "growth factor beta": 0.01907, "varied effect": 0.02115, "anti-apoptosis protein": 0.04529, "rat mammary carcinoma": 0.0019, "normal lung parenchyma": 0.00806, "e-selectin expression": 0.04163, "cytotoxic nk cell granule": 0.0384, "dense": 0.00062, "pma result": 0.0161, "dr3-type vitamin d-responsive element": 0.00836, "predominant subunit": 0.00484, "normal liver": 0.0121, "intense self-perpetuated viral transcription": 0.01405, "tcf-1-specific hybridoma": 0.00065, "alternative procedure": 0.00205, "zeta 2-globin promoter activity": 0.01462, "human breast cancer": 0.02508, "ul21": 6e-05, "12-25 repeat": 0.00378, "molecular mechanism control": 0.00868, "principal cis-acting element": 0.01115, "simultaneous presence": 0.00524, "clinical stage": 0.00425, "hiv infected individual": 0.00395, "amino acid polymorphism": 0.00571, "early embryonic development": 0.00552, "pdbu-treated cell": 0.0768, "ifn-gamma responsiveness": 0.00481, "vitd3-treated cell": 0.0768, "gata1 erythroid transcription factor": 0.0143, "coping strategy": 0.00121, "cd4 transcription": 0.0281, "adenovirus early region": 0.00978, "fosb suggest": 0.02022, "xenogeneic human serum promotes leukocyte adhesion": 0.01254, "non-irradiated transfected cell line": 0.0384, "hypotonic buffer": 0.00016, "thiol-reducing compound reverse": 0.00157, "nf-il6 enhancer": 0.00909, "homologous disruption": 0.00136, "tyrosine-phosphorylated stat1 protein": 0.03019, "m-tat/gm-csf": 0.00025, "cytokine express": 0.01846, "clone pip/lsirf": 0.00738, "fresh leukemic cell": 0.0512, "benign polymorphism": 0.00177, "vaginal physiology": 0.00034, "irf": 0.00037, "imply": 0.00199, "renal dysplasia": 0.00115, "mature human monocyte": 0.02508, "inducible promoter": 0.02336, "increase intracellular free calcium": 0.01098, "host nk cell response": 0.0384, "oxygen radical scavenger n-acetyl-l-cysteine": 0.0005, "hla class ii expression": 0.02081, "fa signaling": 0.00558, "cd40 ligation": 0.00372, "disparate fate": 0.00043, "metastatic capacity": 0.00329, "cell-line dexamethasone": 0.00394, "mut-i kappa": 0.00748, "kappa b/mad-3 mask": 0.00498, "fa ligand": 0.00592, "bp long": 0.00276, "map kinase-specific phosphatase": 0.00176, "translocate hormone/receptor complex compete": 0.00842, "tcr-regulated nuclear factor": 0.01907, "cyclosporin a-resistant pathway": 0.00852, "covariant analysis": 0.01179, "similar glucocorticoid-mediated potentiation": 0.00449, "peripheral human": 0.03762, "sbma sperm type result": 0.00805, "nonreceptor protein tyrosine kinase": 0.02264, "15-deoxy-delta12,14-prostaglandin j2": 9e-05, "eosinophil specific beta-chemokine": 0.00825, "human umbilical vein segment": 0.01881, "oestrogen": 0.00118, "important subunit": 0.00689, "codon-10-variant type": 0.00949, "ap2": 0.00062, "factor bind": 0.0286, "transforming ability": 0.00431, "individual cytokine receptor": 0.01714, "resides": 0.00019, "asymptomatic phase": 0.00276, "small peptidyl substrate": 0.00209, "complex detect": 0.01684, "reverse transcription polymerase chain reaction": 0.01124, "mutation impair": 0.00592, "fyn": 0.00012, "classical prognostic feature": 0.00145, "study activation": 0.03164, "key enzyme": 0.0031, "aromatic residue": 0.00226, "u/ml interleukin-2": 0.00332, "h4 promoter": 0.02336, "helper cell differentiation system": 0.0384, "ick-1 binding site": 0.01445, "cellular permissivity": 0.00893, ":399": 6e-05, "gata-2 binding element require": 0.00927, "stimulate tumor progression": 0.00734, "osteoblast-specific cis-acting element": 0.01115, "vdr mrna": 0.01526, "stats1": 0.00012, "uninduced": 0.00105, "primary leukemia cell": 0.0512, "metal response element": 0.01294, "beta-subunit": 0.00019, "cell response": 0.0768, "base pair region demonstrate": 0.00799, "aggregation": 0.00192, "cell dysregulation": 0.0768, "kda protein": 0.04529, "preactivation": 0.0, "intracellular signaling complex": 0.01123, "phytohemagglutinin-stimulated t-lymphocytes": 0.00146, "epitope enhancement": 0.00233, "level similar": 0.01821, "immunoglobulin kappa": 0.00748, "rest lymphocyte": 0.01483, "humoral hbx immune response": 0.00971, "dna content": 0.01483, "ro-vdr cell show typical nuclear localization": 0.0256, "strong promoter activity": 0.0195, "decreased affinity": 0.00391, "src-related proto-oncogene": 0.0013, "present report": 0.00735, "longer form": 0.01055, "p38 jun-b": 0.00124, "gm-csf promoter sequence": 0.01557, "interleukin-12 p40 transcript": 0.00399, "include creb phosphorylation": 0.00959, "tnf-induced nf-kappa": 0.01414, "soluble il-6 receptor": 0.01714, "cyclin-like specie": 0.00183, "interact": 0.00744, "micrograms/ml display": 0.00499, "isozymes": 0.00043, "e15 embryonic liver": 0.00085, "ut-7 cell express detectable level": 0.03072, "-57": 6e-05, "tandem cre motif": 0.00583, "mm": 0.00236, "jun n-terminal kinase": 0.00792, "nf-kappa b-dependent luciferase construct": 0.00707, "srg3 encode": 0.00853, "cell express cd40": 0.0512, "p.s.sarin": 6e-05, "ctx combine": 0.00161, "minimal lox promoter fragment": 0.01168, "reversible differentiation": 0.01179, "hla dqa1 locus": 0.00192, "murine gata-3 factor show": 0.0143, "major basic protein": 0.03019, "transient transfection assay reveal": 0.00549, "lung vascular icam-1": 0.00178, "cell transcription factor pu.1 bind": 0.03072, "hla-dr/-dq positive parental cell line": 0.03072, "luciferase reporter construct": 0.00484, "anti-early antigen": 0.00819, "mcr/eic determine risk independent": 0.00389, "multiple e2f site": 0.01445, "active proliferation": 0.00803, "prevalent complex": 0.01684, "rel-related human cdna": 0.02508, "human immune system": 0.02508, "rare hereditary disorder presenting": 0.00112, "characterized human genomic dna clone": 0.01505, "long-term virus exposure": 0.00591, "augmented ability": 0.00431, "pxqxt/s sequence": 0.01625, "leucine zipper-like": 0.00053, "cd3-dependent phosphorylation": 0.00983, "gm-csf gene": 0.04355, "nearby": 0.00031, "sp-1 site": 0.02168, "hand": 0.00062, "lethal endotoxemia": 0.00016, "ym268": 0.00031, "monocyte-mediated": 6e-05, "level approach": 0.01821, "thrombin activate endothelial icam-1 expression": 0.01665, "fo play": 0.0071, "cell line bear dqa1*0201": 0.0384, "dna bind capability": 0.0135, "form tight complex": 0.01123, "gzero/g1 cell cycle phase": 0.0384, "profound impact": 0.00071, "signal transduction pathway trigger": 0.00817, "jak3": 0.00434, "transactivate gene": 0.04355, "tnf translational regulation": 0.00672, "early marker": 0.00828, "ngal expression": 0.04163, "gp120": 0.00056, "cpkc-alpha": 0.00019, "protein sequence": 0.04529, "ut-7 express similar level": 0.00923, "nf-kappa b1 dimer": 0.00943, "promoter deletion analysis suggest": 0.01168, "subcellular mechanism": 0.01058, "tre-dna binding protein": 0.03019, "colimycin": 6e-05, "bp repeat element": 0.01115, "tnf-alpha-mrna": 6e-05, "egr-1 include": 0.01439, "productive replication cycle": 0.00314, "protein binding": 0.04529, "alphaiib subunit heavy chain": 0.00242, "lineage-specific effector function": 0.00887, "mitogenic combination": 0.00288, "cytokine-induced nf-kappab activation": 0.02109, "octamer sequence": 0.01625, "lps-induced activity": 0.02925, "hrbc group": 0.00487, "nf-atc bind": 0.02025, "potent impact": 0.00357, "nf-activated": 6e-05, "synergistic function": 0.01331, "regulatory effect": 0.02115, "resulting occupancy display strong similarity": 0.002, "central function": 0.01331, "include suppression": 0.01439, "ifn-gamma-induced": 0.0023, "isotonic nacl solution": 0.00037, "consistent genetic alteration": 0.00192, "mucosa": 0.00031, "clustering": 0.00056, "human rhabdomyosarcoma cell": 0.0512, "rb inhibit elf-1-dependent transcription": 0.01405, "ba": 0.00037, "plot": 0.00031, "autonomous transrepressor domain": 0.00804, "ribosomal protein gene promoter": 0.02264, "interleukin-4-mediated ige production": 0.00695, "ach functional molecular clone": 0.00408, "lung instillation": 0.00195, "method develop": 0.00403, "nf-y": 0.00161, "potent pkc activator": 0.00368, "analyze cbf beta-myh11 fusion transcript": 0.00239, "ionomycin result": 0.0161, "m-tat": 0.00031, "major dnase-i hypersensitive site": 0.01084, "wd-40 repeat": 0.00378, "gene relates": 0.04355, "swi6/ankyrin repeat": 0.00378, "brca1 mrna": 0.01526, "polymorphonuclear neutrophil transendothelial migration": 0.00248, "nf-kappa": 0.02829, "helix-loop-helix": 0.00136, "induce critical rac-1 signaling pathway": 0.01016, "instructive fashion": 0.00161, "th1 cell-mediated immune response": 0.00971, "pge2 bind": 0.02025, "cell reveals": 0.0768, "cell lack active nf-kappa": 0.0384, "-44": 0.00025, "glucocorticoid-induced cell lysis": 0.0512, "il-8 promoter region": 0.01557, "enzyme-linked immunosorbent assay procedure": 0.00501, "cd86 lead": 0.00996, "ebna-2 mediates trans-activation": 0.0007, "ebv genome negative": 0.00376, "vehicle": 0.00025, "xp-d.": 6e-05, "inhibit terminal cell differentiation": 0.0384, "model monocytic cell line": 0.0384, "isolated hepatocytes": 0.00189, "progression": 0.00329, "enhance long terminal repeat-directed transcription": 0.01124, "human il-9ralpha": 0.03762, "ebv-positive gastric carcinoma tissue": 0.00332, "interleukin-3-dependent": 0.00012, "immediate-early brlf1 protein": 0.03019, "early regulator": 0.00828, "show consistent pattern": 0.01733, "apparent dissociation rate": 0.00186, "cellular sensitization": 0.00893, "differential stimulation": 0.0112, "modified natural surfactant": 0.00155, "dead cell": 0.0768, "matter": 0.00012, "serum-starved cell": 0.0768, "enhance stat1 activation": 0.02109, "suppress il-1 alpha": 0.0078, "cd28-responsive element present": 0.01115, "basal lesion": 0.0035, "receptor preparation": 0.02571, "pediatric sample": 0.00208, "proximal step": 0.00301, "70-bp element": 0.01672, "d.": 0.00124, "mef2c activation": 0.03164, "eighteen hirsute patient": 0.0111, "cd11b gene": 0.04355, "monocyte result": 0.0161, "hepatic": 0.00149, "kappab site": 0.02168, "tgf-alpha production": 0.01042, "dominant negative mapkk-1 prevents nfat induction": 0.00536, "inhibitor staurosporine": 0.009, "b3 factor": 0.0286, "il-4 promoter-reporter construct carry": 0.00363, "motifs present": 0.00735, "formation require": 0.01315, "susceptible segment": 0.00189, "sie gas motif": 0.00583, "ige isotype switching": 0.00126, "activate transcription initiation": 0.01873, "progenitor-specific surface marker": 0.00343, "nf-at-binding factor": 0.0286, "nonfunctional sequence motif": 0.01084, "nanomolar concentration": 0.0067, "share receptor subunit gamma c.": 0.01029, "b29 transcript": 0.00599, "thrombin receptor activation peptide": 0.01582, "ss patient": 0.01666, "control entry": 0.01303, "process generate": 0.00453, "ad5e1a234-243": 6e-05, "gc formation": 0.00484, "mononuclear cell activation": 0.0512, "eukaryotic gene": 0.04355, "dominant negative effector": 0.00343, "il-10": 0.00844, "fas ligand": 0.00592, "intermediate thymocyte compartment": 0.00079, "important contributor": 0.00689, "localization": 0.00372, "trans-activation activity": 0.02925, "aged subject": 0.00354, "include fdc": 0.01439, "blood fat": 0.00592, "mip": 0.00012, "apoplexic patient": 0.01666, "endogenous immunoglobulin surrogate light chain gene": 0.01452, "natural killer cell receptor cluster": 0.03072, "ggaaaa": 6e-05, "study demonstrate": 0.01597, "nuclear nf-at complex": 0.01123, "result define distinct role": 0.00805, "systemic glucocorticoid resistance": 0.00567, "evening exposure": 0.0035, "stat bind factor": 0.01907, "report comparable level": 0.01214, "hela cell-derived extract complement": 0.0023, "plasma acth": 0.00375, "ckii": 0.00037, "tyrosine kinase inhibitor genistein": 0.00594, "non-polymorphic region": 0.01467, "ra addition": 0.00673, "gel retardation assay": 0.00668, "ion": 0.00124, "steroid-treated control group": 0.00868, "lmp1 c-terminus": 0.0027, "segment function": 0.01331, "cytokine-dependent cell line": 0.0512, "active cushing": 0.00592, "induce stat6 activation": 0.02109, "maeca": 0.00068, "erythropoietic potential": 0.00605, "htlv-i +195": 0.00276, "body axis": 0.00136, "experimental expression": 0.04163, "opportunity": 0.00012, "g2 stage": 0.00248, "base exchange": 0.0031, "lcr": 0.00112, "immunoadsorption": 6e-05, "pml/raralpha transgenic": 0.00199, "box1 motif": 0.00875, "peripheral blood mononuclear cell": 0.0384, "transcription unit": 0.0281, "octamer site-dependent manner": 0.00188, "ra receptor alpha": 0.01714, "condition result": 0.0161, "ptf-oct-1-dna complex": 0.01684, "lps signal": 0.01635, "bq": 0.00037, "interleukin-8 gene": 0.04355, "rho family": 0.00841, "secrete interleukin-2": 0.00332, "igg fc receptor": 0.01714, "fractionated": 0.00012, "formyl-met-leu-phe": 6e-05, "immunohistochemical finding": 0.00226, "constitutive sla-dr": 0.00478, "319ll-rs": 6e-05, "a. hoffmeyer": 0.00081, "manner analogous": 0.00282, "rank-mediated nf-kappab signaling": 0.00666, "increase skin tumor formation": 0.01098, "kb transcript": 0.00599, "distal": 0.00273, "olfactory neuronal cell reveal virtual complete amino acid sequence identity": 0.01536, "retinoic acid": 0.00856, "tissue-type": 0.0, "gamma globin gene": 0.02903, "l2 mutation": 0.00592, "multiple lytic antigen-specific reactivity": 0.00344, "hiv-1 envelope": 0.00878, "large clone": 0.00738, "mrna production control": 0.01017, "ets-1": 0.00205, "tcf-1 gene encode": 0.02903, "all-trans retinoic acid treatment": 0.00507, "fetal/adult alpha globin gene": 0.02177, "virulence defect": 0.00279, "aml-1b": 0.00025, "partial inhibition": 0.01061, "ikkalpha": 0.00062, "glutathione peroxidase": 0.00105, "series": 0.00323, "primary hypothyroidism": 0.00738, "u-937 promonocytic cell": 0.0512, "de novo cox-2 expression": 0.02081, "21-acetoxy-11 beta,19-epoxypregn-5-ene-4,20-dione": 9e-05, "clinical cr": 0.00425, "endogenous lt": 0.00459, "generate radical": 0.00453, "signal pathways upstream": 0.0109, "ebv drive rest": 0.00376, "erythroid-specific mrna encode gamma-globin": 0.00763, "pkc-zeta cell constitutively express mrna transcript": 0.0256, "reduced pge2 production": 0.00695, "erythroid maturation": 0.0062, "single-stranded conformational polymorphism": 0.00118, "raldh2 transcript": 0.00599, "natural killer cell line": 0.0384, "ags patient": 0.01666, "double-stranded rna": 0.00456, "aiolos": 0.00093, "physiological concentration": 0.0067, "trans": 0.00105, "gamma-interferon inducible protein": 0.03019, "hiv ltr construct link": 0.00363, "suggest extensive cross-talk": 0.01348, "succinimide": 0.00025, "direct exposure": 0.0054, "hlh-2 expression": 0.04163, "extensive inflammatory cell infiltration": 0.0384, "stat1 c-terminal residue": 0.0019, "vivo genomic footprinting": 0.00354, "pancreatitis": 0.0005, "phosphate": 0.0013, "parallel zap-70 activation": 0.02109, "nucleotide -180": 0.00202, "cd28 stimulation contribute": 0.00746, "jurkat t-cell line": 0.01102, "tcr zeta-chain": 0.00478, "haplotype": 0.00093, "dominant-negative mek": 0.00102, "stat4-dependent": 0.00012, "ap-1-": 0.00056, "transient-cotransfection assay demonstrate": 0.01065, "spi-c-negative": 0.00012, "lysosomal-associated membrane protein-1+ endosomal compartment": 0.0018, "pattern similar": 0.00673, "ip-10": 0.00087, "cooperative model": 0.00422, "receptor bind defect": 0.01714, "simple procedure": 0.00078, "calm region": 0.01467, "e.hara": 0.00012, "nuclear import": 0.01684, "luciferase gene place": 0.02903, "hiv-1 inhibited hiv-1 replication": 0.00236, "j393 induces apoptosis": 0.00593, "precancerous mastopathy": 3e-05, "hiv-1-infected individual": 0.00409, "fashion": 0.00323, "proximal element": 0.01672, "tnf-induced vcam-1": 0.00233, "ss rbc-induced oxidant stress result": 0.00644, "augmented asm promoter activity": 0.01462, "expense": 6e-05, "sp1 bind motif": 0.0135, "autopsy tissue": 0.00664, "chemokine receptor": 0.02571, "chimaeric product": 0.00533, "alter dna-binding specificity mutant": 0.00405, "il-9 promoter activity": 0.0195, "viral pathogenesis": 0.00732, "full-length cdna encode murine": 0.00426, "suboptimal": 0.00037, "tax-expressing": 0.00105, "feca2+": 0.00012, "phenotypic marker": 0.00382, "pre-existing component": 0.00456, "il-2-independent": 0.00074, "specific cd8+ ctl line": 0.00827, "principal objective": 0.00043, "c-rel nf-kappab subunit": 0.00666, "chloramphenicol acetyltransferase reporter construct": 0.00363, "murine tcf-1": 0.00623, "agammaglobulinemia tyrosine kinase": 0.00792, "anti-tnf-alpha antibody": 0.00893, "syncytia lack activated cell": 0.0384, "potent modulator": 0.00357, "trx-expressing plasmid": 0.00273, "long-term outgrowth": 0.00171, "chicken erythrocyte factor": 0.01907, "block hla-dm function": 0.00887, "large 67-kda precursor protein": 0.02264, "epo induce embryonic": 0.01694, "vivo protein-dna contact": 0.00354, "sufficient th2 cell differentiation": 0.0384, "immune response": 0.01942, "share similar domain": 0.00804, "major histocompatibility complex molecule": 0.00842, "pd-c": 0.00012, "soot particle": 0.00074, "v-erba oncoprotein represent": 0.00267, "resumption": 6e-05, "pp125fak": 6e-05, "tool": 0.00093, "common pharmacogenetic syndrome": 0.00234, "bhrf1 protect": 0.0014, "world": 0.00037, "es cell-derived reticulocyte": 0.00048, "adult human tissue": 0.02508, "tandem e-box domain": 0.00804, "marked activation": 0.03164, "facilitate antigen processing": 0.00546, "pp52 promoter": 0.02336, "direct demonstration": 0.0054, "yb-1 expression plasmid increase htlv-i basal transcription": 0.01189, "notch1 ankyrin repeat region": 0.00734, "growth retardation": 0.00819, "1.5-1.6 time": 0.00273, "brtal": 6e-05, "carboxyl-terminus": 0.0, "p65 antisense phosphorothioate oligodeoxynucleotide": 0.00194, "t1/2 increase 6-8-fold": 0.01464, "amino acid 286-551": 0.00571, "human erythropoietin receptor gene": 0.02177, "superantigens": 0.00081, "human vaginal fluid specimen": 0.01881, "display impaired nfkappab activity prior": 0.0117, "eed-restricted homeotic gene expression": 0.02177, "short enhancer element": 0.01115, "promote apoptosis": 0.0089, "patient develop progressive cytokine-mediated inflammatory lung disease": 0.00476, "sl3 enhancer": 0.00909, "notch1 oncogenesis": 0.00028, "nf-microb-binding site play": 0.01445, "escape immune recognition": 0.00399, "epsilon-globin-encoding gene": 0.04355, "sequence ggggactttcc": 0.01625, "cd14 receptor system": 0.01714, "show genomic rearrangement correspond": 0.013, "antagonist activity": 0.02925, "methylprednisolone": 0.00093, "proapoptotic nip-2 protein": 0.03019, ":409": 0.00012, "infected human monocytic cell line u1": 0.0256, "neonatal lethality": 0.00102, "gal4 dna bind domain activated transcription": 0.00937, "cnbr": 0.0, "spi-1 and/or fli-1 gene": 0.02177, "undifferentiated human monocytic cell": 0.0384, "cell isolate": 0.0768, "induce gr mrna": 0.01694, "traf5 association": 0.00282, "il-4 down-regulatory effect": 0.0141, "m4 cell": 0.0768, "include all-trans-retinoic acid": 0.00959, "receptor clone": 0.02571, "significant sequence homology": 0.01084, "nuclear localization signal": 0.01123, "oncogenic gene": 0.04355, "antiprogestagens": 6e-05, "mcf13 murine leukemia virus long terminal repeat": 0.00253, "hemoglobin": 0.00136, "moderate body mass": 0.00091, "cytoplasmic reservoir": 0.004, "genetic level": 0.01821, "anoxia": 6e-05, "q26": 0.00025, "cam kinase": 0.01188, "triiodothyronine sulfate": 0.00062, "intestinal vitamin": 0.00236, "qp responsiveness": 0.00323, "female monozygotic": 0.00158, "unlabeled hormone": 0.00444, "entire x-box": 0.00078, "ebv-negative burkitt lymphoma": 0.00151, "macrophage inflammatory protein-2": 0.00393, "octamer-dna binding protein distinct": 0.02264, "myc": 0.0005, "transcription factor activation protein": 0.02264, "tyloxapol inhibit nf-kappa": 0.0127, "costimulation": 0.00341, "sudden increase": 0.02196, "bp": 0.00533, "c-jun gene expression": 0.02903, "methotrexate": 0.00012, "polymorphic": 0.00118, "irf-1 cotransfection": 0.0013, "globin gene expression": 0.02903, "erythroid precursor": 0.0062, "sequence show high responsiveness": 0.013, "ebna2 specific monoclonal antibody reveal": 0.00495, "ebv latent gene": 0.02903, "ebv genome carrying status": 0.00282, "viral interference": 0.00732, "macrophage differentiation": 0.01179, "codon": 0.00143, "oncogene c-myc": 0.00261, "p65 rela": 0.00388, "ebna2 mrna": 0.01526, "-559": 6e-05, "amino acid sequence information": 0.00813, "ose2": 0.00019, "intracellular tail": 0.00583, "nf-kappab-regulated promoter": 0.02336, "-2 increase": 0.02196, "mammalian gene": 0.04355, "hsf1": 0.00093, "clinical trial": 0.00425, "interferon-gamma-induced nuclear binding factor": 0.0143, "30-fold": 0.0005, "allelic variation": 0.00164, "include surface ag receptor-initiated signal event": 0.00545, "patient positive": 0.01666, "hgh": 6e-05, "nef inhibit": 0.01904, "weakly stimulate": 0.01101, "granulocyte-monocyte colony stimulate activity": 0.01462, "cell clone ar-5": 0.0512, "enhancer work": 0.00909, "complex adaptor function": 0.01123, "intranasal fluticasone propionate": 0.00023, "3-o-mg transport": 0.00068, "fc gamma riia stimulate cell": 0.03072, "inhibited agonist-induced": 0.00261, "yeast reporter strain": 0.00368, "human tcf-1 gene encode": 0.02177, "macrophage result": 0.0161, "autocrine secretion": 0.00428, "constitutive gh production": 0.00695, "gc-mediated cell process": 0.0512, "endemic goiter": 0.00016, "cf airway": 0.0009, "cd25 promoter induction": 0.01557, "g1": 0.00217, "cell surface glycoprotein": 0.0512, "vivo dimethyl sulfate footprinting erythroid cell express": 0.02194, "polymerase chain reaction analysis": 0.00589, "signal molecule t-cell receptor": 0.01286, "tolerance operate": 0.00081, "cell representative": 0.0768, "rhtnf-alpha": 6e-05, "putative ikappabalpha kinase": 0.00792, "saturable": 0.00031, "pro-b-cell acute lymphoblastic leukemia": 0.0025, "u2 formation": 0.00484, "cbp/p300": 0.00074, "hpc differentiation program": 0.00786, "lymphoblastoid t-cell line a2.01": 0.00827, "cycloheximide anytime": 0.0009, "viral enhancer": 0.00909, "alternative polyadenylation event contribute": 0.00276, "cellular protein": 0.04529, "bacterial superantigen induces stat3 activation": 0.01266, "select infected cell": 0.0512, "hiv-1 viral particle": 0.00585, "ml-1 human myeloblastic leukemia cell": 0.03072, "phosphatase activity": 0.02925, "interferon gamma function": 0.00887, "ubiquitous protein": 0.04529, "gch compound": 0.0022, "inhibit tumor necrosis factor-alpha-induced nf kappab activation": 0.00904, "promote hiv replication": 0.00395, "normal cd56+": 0.0121, "alpha cd3 ab co-immobilized": 0.00585, "anti-itk immunoprecipitate": 3e-05, "cell sorter analysis": 0.0512, "fk506 affect signal transducer": 0.00817, "-183/-166 nxs": 0.00012, "tax-dependent correlation": 0.00248, "safety phenotype": 0.00366, "gcr-beta gene result": 0.02903, "traf6 inhibit rankl-mediated nf-kappab activation": 0.01266, "antioxidant agent": 0.00422, "hiv enhancer-binding protein nf-kappa": 0.02264, "female": 0.00316, "cell surface antigen": 0.0512, "phorbol ester/ionomycin-induced nf-at activation": 0.01582, "b-lymphocyte differentiation control": 0.00868, "receptor-positive lymphocyte": 0.01483, "epstein-barr virus-mediated oncogenesis": 0.0019, "promyelocyte": 0.0005, "nmi lack": 0.00633, "ubiquitous oligopeptides": 0.00118, "induce increased expression": 0.02775, "il-8 gene induction": 0.02903, "e74 site independent": 0.01445, "epitope peptide-loaded dendritic cell": 0.0384, "focus attention": 0.00071, "genetic program mediating": 0.00192, "nasal nk-": 0.00031, "enhanced estradiol inactivation": 0.0019, "report il-2 nf-at": 0.00744, "chloramphenicol acetyltransferase expression construct": 0.02081, "htlv-i taxi": 0.00276, "case-oriented evidence": 0.00422, "nfkappab induction": 0.01607, "eosinophilic granule": 0.00112, "anti-cd3 mab activate": 0.01185, "early activation": 0.03164, "nf-e1 expression": 0.04163, "cd8 response": 0.01942, "om10.1": 0.00043, "cellular transcription factor nuclear factor-kappa": 0.01144, "alpha-dihydroxycholecalciferol": 6e-05, "maximum level": 0.01821, "crucial step": 0.00189, "transcriptional targeting": 0.01151, "immunotherapeutic protocol": 0.0005, "free e2f": 0.00192, "ets-domain protein": 0.04529, "3696-bp coding region encompass": 0.00734, "intracellular signaling pathway": 0.00852, "ring chromosome": 0.00295, "impdh": 0.00031, "disruption": 0.00174, "10-fold great amount": 0.0019, "polyclonal antibody": 0.00893, "spontaneous occurrence": 0.00093, "c-jun": 0.00986, "skewing": 0.00012, "morphological change consistent": 0.0042, "differential role": 0.01328, "tegument protein associate": 0.03019, "297+/-54": 6e-05, "grb2-binding protein": 0.04529, "human promyeloid leukemia cell": 0.0384, "tumour necrosis factor alpha expression": 0.01665, "template lack": 0.00633, "activation-driven fas upregulation": 0.00128, "dendritic cell differentiation": 0.0512, "phe774": 0.0, "nf-kappa b/i kappa": 0.00943, "devd-pna": 0.00012, "transcription factor c/ebpalpha": 0.01907, "functional caev ltr": 0.00544, "ca2+ influx": 0.00304, "nm epidermal growth factor": 0.0143, "diversity": 0.00081, "cytokine ifn-beta": 0.01123, "10-60": 0.00012, "e1 associate": 0.01092, "thp-1 macrophage cell line": 0.0384, "place": 0.00124, "size discrepancy": 0.00102, "activated human peripheral blood lymphocyte": 0.01505, "adult human bone marrow exhibit": 0.01505, "high c-erb b-2 expression": 0.02081, "immune response gene": 0.02903, "enhance stat3 tyrosine phosphorylation": 0.00492, "functionality": 0.00037, "age-related": 0.0013, "induces distinct stat6-dna binding complex": 0.00742, "t-cell mediate response": 0.01294, "bcp-all cell": 0.0768, "optimal transcriptional activity": 0.0195, "il-7 receptor alpha chain": 0.01286, "target genome": 0.00825, "epstein-barr virus-encoded nuclear antigen ebna-5 accumulates": 0.00561, "similar vitamin": 0.00673, "cyclophilin a/csa": 0.00062, "rb interacts": 0.00167, "ebv disease pathogenesis": 0.00449, "tlc": 6e-05, "non-depressed control subject": 0.00868, "jun/fos heterodimer": 0.00205, "information": 0.00105, "entirety": 6e-05, "csa-sensitive stage": 0.00248, "otf factor": 0.0286, "pha stimulation": 0.0112, "unknown protein": 0.04529, "observation provide additional evidence": 0.00323, "specific dor1 agonist": 0.00825, "gata-1 motif remain": 0.00583, "hiv-2 gene expression": 0.02903, "optimal function": 0.01331, "b7-1": 0.00037, "dominant negative mutant form": 0.00527, "fuse lymphoblastoid cell": 0.0512, "consistent feature": 0.00217, "monocyte differ": 0.01197, "inhibitor block": 0.01073, "related immunoglobulin": 0.00276, "ppar activator": 0.00552, "early serum responsive gene": 0.02177, "hmg box protein": 0.03019, "lyso-phospholipids": 0.00012, "4484-5643": 6e-05, "cag repeat": 0.00378, "inhibit apoptosis induce": 0.01694, "nuclear factor-il-6beta-ig/ebp-1 heterodimer": 0.01123, "pre-existing nf-at complex": 0.01123, "waf1": 0.00012, "tcr alpha enhancer": 0.0078, "nuclear proto-oncogenes c-fos": 0.01123, "azeptin-treated pbl": 0.00096, "inflammatory state": 0.00471, "alpha phosphorylation": 0.01169, "pyrrole-imidazole polyamide": 0.00012, "phorbol ester-induced mononuclear cell differentiation": 0.03072, "context": 0.0013, "fold": 0.00068, "cho cell": 0.0768, "vdr dna-binding mutant": 0.0054, "transmembrane": 0.00192, "elderly donor reveal": 0.00732, "study report": 0.01355, "inflammatory mediator": 0.00471, "transcriptional activation property": 0.02109, "galectin-3 promoter induction": 0.01557, "bcl-2 inhibited triptolide-induced degradation": 0.00166, "human mzf-2 protein consist": 0.02264, "jnk signal transduction pathway": 0.00817, "erythroid precursor fail": 0.00414, "ifn-gamma-inducible gene": 0.04355, "monocyte/macrophage lineage": 0.00366, "fluticasone propionate": 0.00034, "camp -and protein kinase": 0.02264, "nfat3": 0.00012, "ao": 0.00025, "epstein-barr virus protein ebna2 act": 0.01811, "ebv induce": 0.0254, "mediate cytokine up-regulation": 0.00821, "analyze x-inactivation pattern": 0.00366, "human cd5 antigen": 0.02508, "sequential deletion mutant": 0.0054, "mononuclear cell": 0.0768, "activate ra expression": 0.02775, "testosterone": 0.00143, "t-cell-specific ets protein elf-1": 0.02264, "isolated": 0.00378, "regulate il-4 transcription": 0.01873, "estrogen exert": 0.00323, "uncultured cell": 0.0768, "apo-1/cd95": 6e-05, "group carry": 0.00487, "cd28 engagement": 0.00323, "fibrinous provisional matrix": 0.00087, "dermatomyositis/polymyositis": 6e-05, "alternative transcript encode": 0.00569, "single-point mutation": 0.00592, "enhance growth inhibition": 0.00707, "increase sensitivity": 0.02196, "nk cell induce mhc class ii molecule": 0.02194, "provide specificity": 0.00645, "tat occur": 0.00654, "fli-1 gene": 0.04355, "beta-adrenergic receptor kinase": 0.01714, "oral prednisolone": 0.00074, "stimulate humoral immunity": 0.00734, "p50/c-rel": 0.00043, "virus production occur": 0.00695, "pkc-induced activation": 0.03164, "long-term maintenance": 0.00171, "intracellular calcium signaling": 0.00389, "well-studied costimulatory molecule b7-1": 0.00426, "il-1 receptor": 0.02571, "wild type domain": 0.00804, "cysteine-rich lim-domain oncogene": 0.00174, "nonstimulated cell": 0.0768, "biological effect": 0.02115, "positive-pressure mechanical ventilation support gas exchange": 0.00136, "source": 0.00093, "transduced interferon gene": 0.02903, "amino-terminal cysteine-rich dna-binding domain lack obvious sequence similarity": 0.00406, "egr-1 bound": 0.00292, "deficiency-heat": 0.00025, "regulatory gene expression": 0.02903, "tumor aggressivity": 0.00934, "trans-activate cd19 promoter construct": 0.01168, "ebna-2 transactivated lmp1": 0.0018, "cluster analysis": 0.01179, "gata transcription factor": 0.01907, "bcr1 type": 0.00949, "alter chromatin structure": 0.00252, "mild": 0.00081, "okadaic acid-induced monocytic differentiation": 0.00589, "fn induction": 0.01607, "gain": 0.00074, "t-cell malignancy": 0.00962, "prolonged protein kinase": 0.03019, "antiinflammatory drug": 0.00338, "resident tissue fibroblast": 0.00443, "phagocyte system": 0.00667, "lp mononuclear cell": 0.0512, "chemokine important": 0.00689, "time-dependent binding": 0.01855, "significant gr mrna induction": 0.00803, "b-lymphoid cell show": 0.0512, "-13 induce upregulation": 0.01694, "dna transfections": 0.01483, "del": 0.0, "cell system provide": 0.0512, "prototypic": 0.00043, "pma activate nf-kappa": 0.01185, "downstream binding factor": 0.01907, "enzyme play": 0.0071, "protein kinase c-zeta stimulates leukemic cell differentiation": 0.02194, "shear flow": 0.00152, "cell cycle regulate protein": 0.0384, "cell hybridoma lead": 0.0512, "unique subclone": 0.00261, "toll-like receptor-2": 0.00019, "transcriptional factor": 0.0286, "3'nf-e2/ap1 motif": 0.00875, "overproduction": 0.0005, "traf6 inhibit": 0.01904, "diethylamino": 0.00012, "gm-csf element": 0.01672, "a6h": 0.00105, "u937 cell transfected": 0.0512, "glucocorticoid treatment": 0.01014, "physiopathologic role": 0.01328, "leukocyte adherence": 0.00478, "cd28 costimulation": 0.00323, "nontransformed human": 0.03762, "adult globin gene program": 0.02177, "recent literature describe": 0.00265, "mixed endothelial-raw264.7 coculture system": 0.00333, "tissue specificity": 0.00664, "main piece": 0.00087, "region between-3134": 0.01467, "single gene": 0.04355, "overlap palindrome": 0.00177, "cd40 ligand": 0.00592, "persistent transcription": 0.0281, "jak-stat pathway correlate": 0.00852, "immunodominant peptide": 0.00754, "shp2 interact transmembrane adaptor protein": 0.01811, "human tnf transgene accelerate pathology": 0.01505, "zap-70 mutant study": 0.00904, "fall": 0.00031, "methylprednisolone treatment result": 0.01073, "1311-base pair human tumor necrosis factor": 0.01254, "glutathione disulfide": 0.00105, "vivo inhibition": 0.01061, "cover": 0.00056, "nuclear factor": 0.0286, "granulomatous reaction": 0.0022, "trs": 0.0005, "e. chaffeensis induces potent proinflammatory cytokine mrna expression": 0.01041, "clonal growth": 0.00819, "cd68- apc": 0.00093, "macromolecular synthesis": 0.00583, "patient young": 0.01666, "mature granulocyte": 0.00329, "antagonization": 0.00012, "prominent factor": 0.0286, "th1/th2 differentiation": 0.01179, "ebv serology": 0.00565, "cap": 0.00062, "gamma-interferon-induced resistance": 0.00326, "intrinsic high potential": 0.0062, "rela overexpression": 0.00382, "cortisol-resistant patient": 0.01666, "sh2 domain associate": 0.00804, "endothelial-leukocyte adhesion molecule-1": 0.00387, "x-rays-induced secretion": 0.00428, "eosinophil peroxidase": 0.00295, "ifn-mediated regulation": 0.01008, "multiple cytokine gene": 0.02903, "isotype-matched antibody": 0.00893, "ie-2": 0.00012, "dominant form": 0.01055, "hl-60": 0.00391, "hydrocortisone induces ikappab": 0.00536, "lifelong": 0.0, "genetic counseling": 0.00288, "nuclear factor-kappa b/rel induction": 0.00842, "sixty-six paper": 0.00037, "basophil cell return": 0.0512, "share functional kappa": 0.00544, "camp elevation": 0.00257, "potential nfat target gene": 0.02177, "anti-cd40 mab induced activation": 0.01582, "astrocyte-derived kappa b-binding activity": 0.01462, "study": 0.02711, "purified cd4+": 0.00288, "regulate signal pathway": 0.0109, "delta-globin contribute": 0.00378, "transduce il-1beta signal": 0.0109, "leukaemias/lymphomas test": 0.00487, "gc-induced monocyte apoptosis": 0.00798, "c-terminal zinc-finger motif": 0.00583, "cellular protein bind": 0.03019, "interleukin-10-stimulated stat molecule": 0.00569, "il-4 p0 element": 0.01115, "suppress nfkappab binding activity": 0.01462, "collapse": 0.00012, "hiv inhibition": 0.01061, "characterize glucocorticoid receptor": 0.01714, "depressed group": 0.00487, "activated receptor": 0.02571, "bending/flexure": 6e-05, "upstream sequence": 0.01625, "erythroid and/or megakaryocytic lineage": 0.0031, "negative regulation": 0.01008, "human lh-2": 0.03762, "brl": 0.0, "nm23/ndp kinase protein": 0.03019, "il-6-treated thp-1 macrophage": 0.00393, "additional open reading frame": 0.00171, "human gm-csf gene": 0.02903, "antioxidant-based therapy aim": 0.00248, "300-bp core promoter include": 0.01168, "p37": 0.00012, "as2o3-induced apoptosis": 0.0089, "il-4ralpha chain": 0.00437, "long-term lymphoblastoid cell proliferation": 0.0384, "eklf-/- adult erythrocyte": 0.00281, "clone c3/5 show specific proliferation": 0.0104, "unusual persistent expression": 0.02775, "pge2 action": 0.00499, "epo-independent": 0.00025, "upstream enhancer element": 0.01115, "b-lymphoid-specific gene": 0.04355, "abolish pma-induced ap-1 transcriptional activation": 0.01266, "include adhesive molecule": 0.00959, "glucocorticoid receptor cooperates": 0.01714, "a.m.": 6e-05, "r24 signal pathway": 0.0109, "polyamide inhibit virus replication": 0.00952, "clinic": 0.00031, "mutagenesis experiment demonstrate": 0.01065, "-224": 6e-05, "influence tcr-induced protein tyrosine phosphorylation": 0.01811, "expression study reveal": 0.02775, "cmat binding complex": 0.01237, "lymphocyte homing": 0.01483, "tf protein": 0.04529, "binding capacity": 0.01855, "heat-shock": 0.00031, "prolactin-inducible target gene": 0.02903, "inducible degradation": 0.00484, "helenalin inhibit nf-kappab activation": 0.01582, "basic protein": 0.04529, "composite element capable": 0.01115, "activation-deficient glucocorticoid receptor mutant": 0.01286, "homology region": 0.01467, "myod confers c-myc-like functional characteristic": 0.00326, "receptor initiate phosphatidic acid dependent signal": 0.00857, "subcellular localization": 0.00186, "bind nfatp": 0.02025, "benign uterus tumour": 0.00122, "tn": 0.00056, "hormonal metabolic status": 0.00145, "naive cell": 0.0768, "calm yacs": 0.00025, "pu.1": 0.00571, "lipopolysaccharide-mediated activation": 0.03164, "age change": 0.0063, "eosinophil-specific gene": 0.04355, "ad early region": 0.00978, "allergic inflammatory response": 0.01294, "normal skin": 0.0121, "human tissue reveal": 0.02508, "cd40-mediated nf-kappab-dependent transcriptional activation": 0.01582, "leucocytic estrogen receptor": 0.01714, "target cell lead": 0.0512, "cre-binding": 0.00025, "cd28-specific mab bw": 0.00178, "gp120-mediated icam-1 expression": 0.02775, "tnfr family": 0.00841, "mouse granulocyte/macrophage colony-stimulating factor gene": 0.01742, "induced p53": 0.0054, "nuclear factor-il6 motif": 0.01123, "ttp": 6e-05, "preosteoclast phenotype": 0.00366, "camp inducibility": 0.00257, "tcr/cd3 stimulation induces activation": 0.01582, "short amino-": 0.0013, "cytokine gene transcription": 0.02903, "electron microscopy": 0.0005, "mediate maximum transrepressive activity": 0.01462, "supershift analysis": 0.01179, "specific protease inhibitor": 0.00825, "exert immunmodulatory effect": 0.0141, "defined morphological stage": 0.00165, "tat transactivation mediate": 0.00821, "low level occur": 0.01214, "coordinated transcriptional activation": 0.02109, "size": 0.00205, "pge2-dependent up-regulating effect": 0.0141, "ifn-gamma induced mhc class ii expression": 0.01388, "cd11b integrin expression": 0.02775, "atf1 protein present": 0.03019, "intestinal epithelium": 0.00078, "differentiate monocyte": 0.01197, "benign tissue": 0.00664, "leukocyte chemoattractants": 0.00478, "egr-1 induction": 0.01607, "inhibit il-2 induced signal transduction": 0.00762, "tcr alpha/delta locus": 0.00318, "sp1 protein": 0.04529, "stat-3": 0.00099, "hiv -but": 0.00592, "heterodimeric cytokine important": 0.00749, "impeded ligand testosterone-bsa-fitc": 0.00395, "tnf-stimulated nuclear factor-kappab activation": 0.01582, "relative decrease": 0.00971, "sequence iii": 0.01625, "material": 0.00149, "study group": 0.01355, "gene include": 0.04355, "camp response": 0.01942, "target organ responsiveness": 0.0055, "exogenous provision": 0.00214, "secrete tumor necrosis factor alpha": 0.01144, "internal ribosomal entry site": 0.01084, "il-13ralpha1 chain": 0.00437, "up-regulated rb expression": 0.02775, "microb-dependent enhancer activity": 0.0195, "cxcr4 promoter activity": 0.0195, "inactive cytoplasmic state": 0.00267, "membrane-mediated signal event": 0.0109, "distinct change": 0.00698, "cd79b": 6e-05, "ra-induced monocytic differentiation": 0.00786, "previous analysis": 0.01179, "chen": 0.00012, "cell study": 0.0768, "tcr-stimulated protein tyrosine": 0.03019, "histologic type": 0.00949, "threonine": 0.00025, "hormonal": 0.00136, "ea/s motif": 0.00875, "comparative analysis identifies": 0.00786, "raw264.7 cell": 0.0768, "decrease dephosphorylated prb-e2f complex": 0.00842, "specific gene expression": 0.02903, "increase intracellular ca2+ concentration apoptosis mediate": 0.00732, "calcitriol": 0.00155, "bzlf-1 locus": 0.00288, "erp-related transcript": 0.00599, "mixture": 0.00068, "hydrochlorothiazide therapy result": 0.01073, "feasibility": 0.00019, "dna binding component": 0.01237, "rbp binding": 0.01855, "e2a-hlf mutant": 0.0081, "anti-inflammatory glucocorticoid": 0.0085, "nf-atc/p": 0.0, "pma-activated human pbl": 0.02508, "increase number": 0.02196, "hypolipidaemic peroxisome proliferator": 0.00021, "parental haplotype": 0.00074, "prognostic": 0.00093, "presence": 0.01048, "enhancer element": 0.01672, "exert direct physiological effect": 0.01058, "metamyelocytes": 0.00012, "d5 tumor": 0.00934, "pml/rar alpha fusion gene result": 0.01742, "important mechanism": 0.01058, "red blood cell": 0.0512, "polymorphism": 0.00354, "induce akt/pkb activity": 0.0195, "alter dna organization": 0.00988, "include activation": 0.03164, "class ii major histocompatibility gene": 0.01742, "immune system remain obscure": 0.00333, "subsequent accumulation": 0.00323, "superoxide anion radical play": 0.00355, "mgc": 0.00031, "ctll-2": 0.00056, "simplified 'representational difference analysis": 0.00589, "macroscopic multiplicity": 6e-05, "thyroid peroxidase": 0.00152, "improved method": 0.00236, "translational": 0.00081, "phorbol ester-treated hela": 0.00362, "human mammary epithelial cell": 0.0384, "regimen": 0.00062, "receptor study": 0.02571, "tpa activates protein kinase": 0.02264, "molecular mechanism underlie il-2 transcriptional blockade": 0.00384, "truncated tat protein": 0.03019, "nfat transcriptional activity": 0.0195, "cell activation-induced fasl expression": 0.0384, "squirrel monkey receptor": 0.01714, "e1a oncoprotein": 0.00248, "optimal site": 0.02168, "extracellular hiv-1 tat protein": 0.02264, "ra protein activity": 0.03019, "smx-nhoh": 0.00037, "-beta": 0.00112, "proline-rich sequence": 0.01625, "latent form": 0.01055, "sequential phosphorylation": 0.00983, "secrete granulocyte/macrophage-colony-stimulating factor": 0.01907, "promote monocytic differentiation": 0.00786, "-131/+15": 6e-05, "transient pseudohypoaldosteronism": 0.00344, "c-rel-specific antiserum": 0.00074, "alpha-globin expression": 0.04163, "aml1a expression": 0.04163, "precursor p100": 0.00323, "class ii trans-activator ciita interact": 0.0029, "result show": 0.02599, "methylation interference assay": 0.00668, "gene describe": 0.04355, "tata-less promoter": 0.02336, "cell express p85 mutant": 0.0384, "-receptor": 0.00025, "dna mobility shift assay reveal specific binding": 0.0053, "aly stimulate": 0.01101, "pou-specific homeodomain": 0.00043, "upregulation require expression": 0.02775, "moderate": 0.00118, "eightfold low amount": 0.00471, "cell show increased expression": 0.0384, "fine azurophilic granularity": 0.00021, "alternative splice generates type": 0.00475, "lymphoid-specific otf-2 factor": 0.01907, "7-day mdms": 0.00016, "serine-to-alanine substitution": 0.00112, "beta2 integrin cd11b": 0.00077, "mediate cell-type-specific transcription": 0.01873, "mnda": 0.00205, "ciita-mediated transactivation": 0.00515, "double point mutation": 0.00395, "transformed t-lymphocyte cell line": 0.0384, "block erythroid colony development": 0.00537, "electrophoretic mobility supershift assay determine": 0.00401, "promoter specific": 0.02336, "normal progenitor cell undergo": 0.0384, "drosophila schneider cell": 0.0512, "dtt antagonize": 0.00081, "twenty subject match": 0.00236, "myc-associated zinc finger protein bind site": 0.0151, "albumin": 0.00019, "include annexin-v staining": 0.00959, "pax-5 code": 0.00053, "key determinant": 0.00152, "show weak expression": 0.02775, "developmental control gene": 0.02903, "socs3": 0.0, "nf-kappa b-dna interaction": 0.00943, "mammalian cell": 0.0768, "hmg": 0.00136, "cell line yield": 0.0512, "h2o2 exhibit substantial increase": 0.01098, "cd69 gene reveal": 0.02903, "receptor molecule": 0.02571, "intrinsic kinase domain": 0.00804, "a/r challenge prevent": 0.00349, "familial hypercholesterolemic": 0.00037, "cmat protein": 0.04529, "mediate responsiveness": 0.01231, "nfat-1 element": 0.01672, "erythropoietin-stimulated erythroid cell": 0.0512, "bone metabolism": 0.00214, "w.c.greene": 0.00012, "downstream component": 0.00456, "increased expression": 0.04163, "tcr engagement": 0.00478, "protective effect": 0.02115, "chronic hbv infection show": 0.013, "decrease 4e-bp1 amount": 0.00647, "resident peritoneal macrophage": 0.00393, "inducible ap-1 family member c-fos": 0.00336, "prerequisite": 0.00037, "lysosomal enzyme activity": 0.0195, "il-2 promoter require t-cell costimulation deliver": 0.00779, "c-jun nh2-terminal kinase": 0.00792, "proil-1beta gene": 0.04355, "molecular mechanism regulate human granulocyte apoptosis": 0.01254, "involved prolong": 0.00109, "hiv-2 expression": 0.04163, "induces prominent tyrosine phosphorylation": 0.00492, "cancer cell": 0.0768, "permit stable replication": 0.00314, "248-263": 0.00012, "proteolysis": 0.0013, "amino-terminal fragment": 0.00347, "di-butyryl": 0.00012, "remarkable": 0.00062, "major positive regulatory region": 0.00734, "predominant nf-kappa": 0.01414, "ebv-bhrf1": 0.00012, "tumor specimen": 0.00934, "dmso induces granulocytic/neutrophillic differentiation": 0.00589, "male sibling": 0.00081, "b7.1-positive": 6e-05, "finding implicate hmg-i": 0.00234, "transcription factor downstream": 0.01907, "autoimmune disease primary biliary cirrhosis": 0.00295, "specific radiometric assay": 0.00825, "pulmonary granulomatous disease": 0.00449, "potential target": 0.00825, "result confirm": 0.0161, "plasma arsenic": 0.00375, "antigen-driven t-cell activation": 0.02109, "stable expression maintain": 0.02775, "gp41 fail": 0.00347, "-175 t-c": 6e-05, "induce stat/dna binding": 0.01694, "adult mouse": 0.00974, "cyclin-like dna repair enzyme": 0.00741, "express cd4 receptor": 0.01714, "hiv-1-ltr": 0.00012, "intron act": 0.00496, "ebv dna": 0.01483, "transgenic animal": 0.00199, "apoptosis-resistant t-cell transfectants": 0.00641, "stat5 expression": 0.04163, "il-4stat": 6e-05, "l.flamand": 0.00012, "delta psi": 0.00211, "interleukin-1 beta": 0.00673, "four-fold": 0.00012, "mitogen induction": 0.01607, "hepatic microsome": 0.00074, "vitd3 induces cd14": 0.00536, "gata-1 heterozygous mutant mouse show": 0.0104, "proliferation activity": 0.02925, "high-affinity lps bind protein membrane cd14": 0.0151, "central core": 0.0022, "activates gene transcription": 0.02903, "camp signal": 0.01635, "adult lymphocyte": 0.01483, "hlf ancillary dna-binding domain": 0.00603, "72-hr period": 0.00127, "proliferative deficiency": 0.0018, "differentiation factor": 0.0286, "perihepatic lymph node": 0.00052, "p98 precursor protein play": 0.02264, "ebna2 response element": 0.01294, "endotoxic challenge": 0.00102, "permanent th2 phenotype": 0.00244, "htlv-1-infected human": 0.03762, "specific property": 0.01238, "viral long terminal repeat": 0.00366, "undissociable": 6e-05, "ald stimulus": 0.0027, "gata-3 binding site": 0.01445, "twenty": 0.00019, "np-2": 6e-05, "pcr fragment": 0.00347, "activated rho-family gtpases": 0.00393, "structure function analysis": 0.00887, "sophisticated strategy": 0.00121, "calcitonin receptor": 0.02571, "cell lack dna-binding alf1": 0.0384, "net effect": 0.02115, "x-ray irradiation up-regulates hiv-1 ltr transcription": 0.00937, "suppress ifn-induced assembly": 0.00407, "bind switch region sequence suggest": 0.0081, "eventual activation": 0.03164, "mercury": 0.0, "vdr/rxr dna-binding complex": 0.01123, "high specificity": 0.00931, "principal initiator": 0.00043, "study blast": 0.01355, "hiv1 tat gene": 0.02903, "dl343": 0.00012, "nuclear tal1 protein": 0.03019, "roi-mediated signal": 0.01635, "abdominal obesity": 0.00019, "negative transcription regulation": 0.01873, "median dissociation constant": 0.00068, "hyperadhesion response induce": 0.01694, "develop tissue": 0.00664, "positive role": 0.01328, "low growth fraction": 0.00546, "aid iblp tumor": 0.00622, "pha-activated peripheral mononuclear cell": 0.0384, "-epsilon": 0.00025, "human equivalent": 0.03762, "gm-csf promoter-driven reporter plasmid": 0.00276, "pharmacokinetic study": 0.01355, "retinoids": 0.00136, "isomorphs": 6e-05, "interval": 0.00037, "important effector": 0.00689, "abl sh3-interacting protein": 0.03019, "binding protein": 0.04529, "phosphatase calcineurin": 0.00316, "lncap cell": 0.0768, "sjo": 0.00043, "term gcrbeta": 0.00413, "kinetic": 0.0005, "dna sequence homology": 0.01084, "d20s18": 6e-05, "histologic category": 0.00025, "nucleotide change": 0.0063, "cytoplasmic tyrosine kinase tec family": 0.00475, "dna fragment": 0.01483, "induced cat activity": 0.0195, "tcr transcript expression": 0.02775, "hpfh phenotype": 0.00366, "inactivity": 0.00012, "human thrombospondin": 0.03762, "microsomal membrane": 0.0045, "diffuse nucleoplasmic localization": 0.00124, "c/ebp gene family": 0.02903, "b-cell line wehi-231": 0.01102, "disease-free survival": 0.00236, "activation-dependent induction": 0.01607, "forced expression": 0.04163, "-diene-4,20-dione": 0.0, "receptor induce conformational change": 0.01286, "peripheral blood eosinophil": 0.00395, "enhance expression": 0.04163, "term il-6 kappa": 0.00498, "ebv reactivation process": 0.00376, "ciprofloxacin increase cat activity": 0.01462, "intact mzf-1 binding site": 0.01084, "gc-resistant group": 0.00487, "il-2 induced tyrosine": 0.00744, "vpr protein": 0.04529, "protect adenovirus gene therapy vector": 0.01742, "gel electrophoretic mobility shift assay detect": 0.00334, "cell thymic progenitor": 0.0512, "chronic hyperglycemia": 0.00397, "cell volume decrease": 0.0512, "striking insensitivity": 0.0005, "ad-transformed human cell": 0.0512, "lipopolysaccharide-stimulated monocyte cytotoxicity": 0.00798, "untreated sample": 0.00208, "japanese woman": 0.00233, "tumour differentiation": 0.01179, "lymphocyte progesterone act": 0.00988, "tumorigenic transformation": 0.00288, "-196": 6e-05, "interferon augments pml": 0.00199, "tcf-1": 0.00378, "interleukin-1 beta precursor": 0.00449, "hiv-long terminal repeat": 0.00252, "21-base pair sequence": 0.01084, "ctg-dimer virus": 0.00887, "reported role": 0.01328, "profound depression": 0.0005, "positive response": 0.01942, "normal pbl sample test": 0.00605, "tandem gata-like site": 0.01445, "nucleosomal dna": 0.01483, "rna extract": 0.00459, "kappa b-site": 0.00748, "hsf/hsp70-mediated inhibition": 0.01061, "migration": 0.0031, "c-fos protein mediate anti-cd19 induced ap-1-binding activity": 0.01294, "stlv-i": 0.00012, "ly+": 6e-05, "-54": 0.00043, "enhanced c-fos induction": 0.01071, "chromatin degradation": 0.00332, "cortisol incubation induce": 0.01694, "ec-mn adhesion": 0.0058, "c-site": 6e-05, "myeloid-cell-specific c-mim": 0.0004, "significant diminished proliferation capacity": 0.00402, "stat bind": 0.02025, "inverted duplication": 0.00022, "phorbol ester-responsive protein kinase": 0.02264, "small basic protein": 0.03019, "slight enhancement": 0.00233, "angioimmunoblastic t-cell lymphoma": 0.00641, "chain remain": 0.00521, "successful": 0.00062, "effector cd4+": 0.00288, "hmg-i bind": 0.02025, "catalyst thioredoxin": 0.00016, "rare variant translocation": 0.00343, "ets-domain protein pu.1": 0.03019, "transactivator": 0.00323, "fetal calf serum-supplemented": 0.00143, "crf patient": 0.01666, "huvecs": 0.00161, "ap-3": 0.00012, "subsequent transformation": 0.00304, "ifn-gamma antagonize": 0.00481, "important immunoregulatory effect": 0.0141, "mass-spectrometric analysis": 0.01179, "physiological condition": 0.0036, "dfx": 0.00043, "insulin-induced hypoglycemia": 6e-05, "herpesviral protein": 0.04529, "wild type cem": 0.00633, "plasma growth hormone concentration": 0.00409, "dose-dependent increase": 0.02196, "peroxidase-negative granule": 0.00112, "gata-1 expression": 0.04163, "show difference": 0.02599, "pcr product show ptt shift": 0.0104, "thymocytes": 0.00515, "functional criterion": 0.00816, "infected cell": 0.0768, "mip-1 alpha nuclear protein": 0.02264, "similar mrna level": 0.01214, "x-inactivation center": 0.00112, "nf-at site": 0.02168, "pro-": 0.00012, "prolactin gene": 0.04355, "mammalian stress response": 0.01294, "granulocytic clone": 0.00738, "fourth": 0.00031, "treated cll patient": 0.0111, "fetal haematopoiesis": 0.00214, "block tlr2-mediated signal transduction": 0.00817, "tissue-specific core promoter structure": 0.01168, "cell type-specific pattern": 0.0512, "rela": 0.00279, "reduced fecal loss": 0.00199, "constitutively bound protein": 0.03019, "bind transcription factor": 0.01907, "extracellular": 0.00335, "similar comparison": 0.00673, "latent epstein-barr virus": 0.00591, "tcr vbeta": 0.00478, "actual target": 0.00825, "human b-cell activation": 0.02508, "competition experiment": 0.00397, "common": 0.00701, "activated ht-2 cell": 0.0512, "il-4-induced gene expression": 0.02903, "stauro": 6e-05, "hrar alpha": 0.01169, "-aldosterone-derivative": 0.0, "regulate nuclear factor": 0.01907, "endothelial selectins": 0.00434, "high-affinity serum-inducible element": 0.01115, "non-erythroid nuclear protein": 0.03019, "hiv-1-induced cell fusion": 0.0512, "hyperparathyroidism secondary": 0.00189, "-mediated inhibition": 0.01061, "protein lack": 0.04529, "uv light": 0.00096, "adult red blood cell": 0.0384, "antisense cdna": 0.00456, "increase expression": 0.04163, "m. tuberculosis manlam lead": 0.00498, "mek": 0.00025, "biochemical basis": 0.0018, "unique viral latency": 0.00488, "chemotactic migration rate": 0.00186, "vitamin d. stable transfection": 0.00138, "rare-mediated signal": 0.01635, "immunoglobulin": 0.00552, "cis-": 0.00025, "nontoxic concentration": 0.0067, "prevents cell death": 0.0512, "functional relationship": 0.00816, "s-lb1": 0.00031, "deficiency-heat syndrome": 0.00273, "lps effect": 0.02115, "il-4 promoter activation": 0.02109, "lysope": 6e-05, "ap-1/oap-binding site": 0.02168, "-139": 0.00019, "humoral-": 0.00012, "bind steroid ligand": 0.0135, "tgf-beta-inducible promoter activity": 0.0195, "cd40 association": 0.00372, "ebv particle": 0.00565, "ets transcription factor family": 0.0143, "ranq69l": 0.00025, "clonal line": 0.01653, "exogenous cytokine": 0.01123, "unknown arthrogenic autoantigen": 0.00116, "estrogen decrease tnf gene expression": 0.01742, "dc-mediated response": 0.01942, "monocyte differentiation": 0.01197, "gc receptor affinity": 0.01714, "pentoxifylline": 0.00043, "histopathological analysis reveal": 0.00786, "cn action": 0.00499, "unilineage differentiation": 0.01179, "protein activate": 0.04529, "human anti-porcine t-cell immune response": 0.01505, "rag-1 gene": 0.04355, "collagenase promoter": 0.02336, "human epsilon-": 0.03762, "induce neutrophil maturation": 0.01694, "segregation": 6e-05, "cd49f": 0.00012, "activate ifn-beta transcription": 0.01873, "non-t-cells": 0.00019, "defective nuclear translocation": 0.01123, "low apparent dissociation constant": 0.00354, "atherosclerotic fatty streak": 0.00037, "contribute": 0.00757, "gm-kappa b/gc-box": 0.00022, "activate protein-1 activation": 0.02109, "channel": 0.00124, "tax cdna": 0.00478, "base pair repeat": 0.00252, "phorbol ester-induced differentiation": 0.00786, "ifn-gamma promoter": 0.02336, "receptor-effector mechanism": 0.01058, "literature suggest": 0.02022, "tnf-alpha transcription start site": 0.01405, "induce event": 0.0254, "nf-kappab subunit c-rel": 0.00666, "high affinity il-2r": 0.0062, "ad5 e1a deletion mutant": 0.00405, "gene consist": 0.04355, "protein tyrosine kinase zap-70 play": 0.01811, "human il-2rbeta promoter": 0.02508, "gel shift assay study": 0.00678, "il-4-inducible gene": 0.04355, "conserved transcriptional element": 0.01115, "th2 type cytokine": 0.00749, "consensus element consistent": 0.01115, "exist isoform": 0.00171, "nf-at dna binding activity": 0.01462, "vitro sensitization": 0.00785, "interleukin-3": 0.00068, "nf-atc isoforms": 0.00307, "fasl expression induce": 0.02775, "monocyte play": 0.01197, "specie": 0.00366, "regulate cell growth": 0.0512, "epicardium": 6e-05, "hd1": 6e-05, "ulcerative colitis": 9e-05, "apoptotic leukocyte": 0.00478, "dose-dependent manner comparable": 0.00188, "cortisol-resistant aid": 0.00161, "paper provide": 0.00645, "unique": 0.00521, "rkgsssnepssd": 0.0, "estrogen target organ": 0.0055, "lymphotoxin-alpha gene": 0.04355, "isgf3 activity": 0.02925, "decrease nf-kappa": 0.01414, "chemical inducer": 0.00136, "endogenous virus": 0.00887, "il-7r function": 0.01331, "gabp factor enhance": 0.01907, "class ii-like molecule": 0.00569, "cytokine cooperativity": 0.01123, "suggest autoregulatory control": 0.01348, "jurkat t-cells express hiv-1 tat": 0.00738, "bind lipopolysaccharide": 0.02025, "receptor gamma chain": 0.01714, "pkc-mediated cellular response": 0.01294, "immunoprecipitated nfatp": 0.00164, "ebv-mediated b-cell immortalization": 0.00306, "severe infection": 0.0062, "gal4-ebna3c fusion protein": 0.03019, "nf-at activity mediate": 0.0195, "htlv-1 long terminal repeat-chloramphenicol acetyltransferase reporter construct": 0.00207, "microm cold aldosterone": 0.00124, "carboxy-terminal region": 0.01467, "vr": 6e-05, "unaffected twin sister": 0.00099, "breast tissue abnormality": 0.00443, "tumor necrosis factor receptor-associated factor": 0.00572, "protein tyrosine kinase inhibitor": 0.02264, "calmodulin": 0.0005, "plasmodium vivax erythrocyte-binding protein": 0.02264, "cd11c promoter": 0.02336, "tal1 gene rearrangement": 0.02903, "base -214": 0.0031, "human lysosomal acid lipase": 0.01881, "peripheral adaptation": 0.00524, "pkc mutant suggest": 0.01348, "oligonucleotide probe": 0.00261, "catalytic activity": 0.02925, "blood hormone concentration": 0.00447, "drug-free control": 0.01303, "insulin-like growth factor": 0.01907, "human t-lymphoblastoid cell": 0.0512, "influence viral pathogenesis": 0.00488, "induces dna-binding activity": 0.0195, "exogenous fibrinogen": 0.00214, "cd4 cell activation": 0.0512, "cem t-cells": 0.00211, "pip": 0.00031, "cd30 hodgkin": 0.00071, "similar density": 0.00673, "fivefold reduction": 0.00295, "previous report suggest": 0.01348, "signal pathway operate downstream": 0.00817, "anti-tnf antibody": 0.00893, "protein degradation": 0.04529, "normal receptor affinity": 0.01714, "p40 promoter region": 0.01557, "adherence dependent": 0.00388, "pu-sf complex bind": 0.0135, "il2 enhancer": 0.00909, "protein remain unaltered": 0.03019, "genomic organisation": 0.0027, "ligated hgr": 0.00081, "tyr374": 0.00012, "human reticulocyte-type 15-lipoxygenase": 0.02508, "suppressed": 0.00056, "g0s24 product": 0.00533, "hl-60r cell": 0.0768, "-6": 0.00037, "constitutive dna": 0.01483, "ikkbeta": 0.00031, "44-kda protein": 0.04529, "cell line potentiate": 0.0512, "cytokine-induced abnormality": 0.00239, "accelerate pace": 0.00074, "nuclear p50": 0.01684, "chimeric protein": 0.04529, "transcription factor bind": 0.01907, "cpg-rich island suggest expression": 0.02081, "protein remain": 0.04529, "preterm": 0.00012, "inactive phorbol ester": 0.00362, "evolutionary event": 0.00552, "oct2a": 0.00025, "heterologous tec": 0.00127, "cell transcription factor": 0.0512, "pthrp": 0.00043, "interrelation": 0.0, "enhance chemotactic activity": 0.0195, "ca2+ signal similar": 0.0109, "m7 blast": 0.00127, "gata-1.05 mutant female": 0.0054, "skf525a": 0.00025, "/bp": 6e-05, "finapres": 6e-05, "ifn-gamma induced re-expression": 0.0036, "liquid culture show": 0.01733, "lymphoblast require": 0.01315, "interferon-gamma": 0.00316, "tar-deleted mutant hiv-1": 0.00585, "major source": 0.00574, "affinity purification": 0.00391, "mediate tnf-alpha induction": 0.01071, "lack hnf1": 0.00633, "800-base pair proximal promoter": 0.01168, "sex-determining gene sry": 0.02903, "so-called ankyrin repeat": 0.00252, "pma exert": 0.00409, "alpha-tubulin": 0.0, "macaque cell lysates": 0.0512, "structural requirement": 0.00264, "pituitary-dependent cushing": 0.00043, "b-cell-specific cofactor": 0.00121, "substsp34": 0.00025, "intracellular free calcium": 0.00389, "predominant producer": 0.00096, "fusion gene alter": 0.02903, "constitutive binding": 0.01855, "rfx5": 0.0005, "mediate activation signal": 0.02109, "recombinant adenovirus prevent tumor necrosis factor-alpha": 0.00311, "p85 phosphoinositide 3-kinase": 0.00072, "exogenous il-6 downregulated dephosphorylated prb": 0.00156, "duffy chemokine receptor gene": 0.02177, "mouse rhom-2": 0.00974, "entire period": 0.00127, "dna bind motif": 0.0135, "gy/min": 0.0, "respective virus": 0.00887, "activate lymphocyte": 0.01777, "polyclonal level": 0.01821, "il-10 stimulates human b-cells": 0.01881, "glucocorticoid responsiveness": 0.0085, "il1b": 0.00025, "h9 great": 0.00205, "gm": 0.00031, "ring": 0.00043, "lps-induced nuclear factor-kappab": 0.01123, "anti-cd2 antibody result": 0.01073, "integrin-dependent fashion": 0.00161, "microb site": 0.02168, "c-jun immunoreactivity": 0.00493, "ser551": 0.00012, "mr": 0.00136, "i-c": 0.0, "premature onset": 0.00071, "tfiia facilitates tax transactivation": 0.00257, "amino-": 0.00031, "herpes simplex virus t-cell antigen": 0.00385, "restriction fragment length polymorphism": 0.00174, "family receptor level": 0.01714, "t-cell activation human 15-lipoxygenase gene promoter": 0.01452, "composite element": 0.01672, "il-4 secrete": 0.00667, "cell-permeable sn50 peptide": 0.00502, "endogenous ikappab kinase": 0.00792, "contribution": 0.00149, "18-oh-b": 0.00012, "mature myelomonocytic cell": 0.0512, "distinct cis-acting element": 0.01115, "amlcg86/92 protocol": 0.0005, "decreased recruitment": 0.0022, "functional 1,25-": 0.00816, "non-cytotoxic dos": 0.00121, "test": 0.00974, "distinct nucleoprotein complex": 0.01123, "c-jun nh2-terminal kinase activity": 0.01462, "relevant creb kinase": 0.00792, "effective signal": 0.01635, "peroxisomal enzyme 17beta-hydroxysteroid dehydrogenase type iv": 0.00316, "ppt tcdd": 0.00074, "phenylalanine": 6e-05, "cd15 cross-linking": 0.00242, "reconstituted ubiquitinylating enzyme": 0.00207, "separate heterocomplexes": 0.00155, "affect hiv-1 replication": 0.00585, "human beta-globin locus": 0.02508, "deleted c-jun promoter fragment link": 0.00934, "freshly isolate apl blast": 0.00208, "herpesvirus saimiri stp": 0.0005, "myeloid cell type": 0.0512, "differential assembly": 0.00323, "fmol/10": 0.00031, "lymphocytes-1": 6e-05, "readily import": 0.00074, "oral calcitriol": 0.00078, "active enzyme": 0.00592, "nf-kappab essential modulator enhance": 0.00499, "cytoplasmic nls receptor complex comprise": 0.01029, "selectively influence": 0.00471, "gata- binding site": 0.01445, "ptf": 0.00099, "-40": 0.00037, "lymphoma cell": 0.0768, "position-dependent manner": 0.00282, "immortalizing": 0.0, "mediate early inflammatory response": 0.00971, "candidiasis": 6e-05, "sds-page": 0.00068, "infected area": 0.00167, "mediate protein-protein interaction": 0.00821, "nf-kappa b-dependent transcriptional stimulation": 0.00707, "total plasma sialyltransferase": 0.0025, "limited": 0.00161, "tnf-alpha treatment": 0.01014, "beta 2-m": 0.00673, "plasma lipoprotein": 0.00375, "high increase": 0.02196, "primed monocyte": 0.01197, "-positive": 0.00093, "stat5 mediate": 0.01231, "putative nf-kappa": 0.01414, "htlv-1 tax activate": 0.01185, "potent trigger substance": 0.00273, "human primary b-cells": 0.02508, "surface marker analysis": 0.00786, "x2-box": 0.00031, "phenol/chloroform": 0.00012, "trans-acting factor": 0.0286, "inducible factor": 0.0286, "continuous process": 0.00444, "demonstrate complete correlation": 0.01065, "short-": 6e-05, "tetra-": 0.00012, "current understanding": 0.00084, "bronchial": 0.00186, "gain-of-function": 0.00031, "tissue inhibitor": 0.009, "stat1-containing dna-binding complex": 0.01123, "increase c-jun": 0.02196, "nf-kappab nuclear translocation": 0.01123, "newborn": 0.0005, "common sequence variant": 0.01084, "endocrine event": 0.00552, "cd28 surface receptor provide": 0.01286, "bacterial chloramphenicol acetyltransferase": 0.00149, "undergoing apoptosis": 0.0089, "human intestinal epithelial cell": 0.0384, "potent immunosuppressive compound": 0.00238, "functional significance": 0.00816, "increase occur": 0.02196, "mrna occur": 0.01526, "inflammation": 0.00633, "temperature-sensitive v-abl mutant": 0.0054, "constitutively express tax": 0.0123, "immunophenotype": 0.00043, "do- human": 0.03762, "model propose": 0.00422, "diminished proliferative activity": 0.0195, "sivmacmer": 0.00012, "entire surface": 0.00515, "synthetic glucocorticoid hormone": 0.00567, "u1 cell": 0.0768, "noncytoxic concentration": 0.0067, "gr heterocomplex": 0.004, "p50 homodimer": 0.00288, "late erythroblast stage": 0.0017, "map kinase pathway": 0.00852, "slipped": 0.00012, "mcm gene product": 0.02903, "sole": 6e-05, "infection consists": 0.0062, "cell-specific gene expression": 0.02903, "zxda": 6e-05, "induce il-2 production": 0.01694, "neuronal cell": 0.0768, "non-lineage-specific silencer": 0.00056, "nuclear volume": 0.01684, "t-cell expression": 0.04163, "leucine-zipper motif": 0.00875, "cell-permeable camp analogue": 0.00172, "nucleotide -120": 0.00202, "nf-il2a": 6e-05, "il-2-dependent transformation step": 0.00192, "cytokine rescue": 0.01123, "bzlf1 trans-activator protein": 0.03019, "engagement": 0.00267, "re/ap": 0.00043, "nonresponsiveness occur": 0.00654, "bzlf1 promoter": 0.02336, "major e2f complex": 0.01123, "lmp-1 modifies signal transduction pathway": 0.00654, "fos protein": 0.04529, "flavonoid quercetin": 0.00031, "result fusion gene encode": 0.02177, "beneficial effect": 0.02115, "thymidine incorporation": 0.00068, "prevent transcriptional induction": 0.01071, "microg/ml lp": 0.00354, "pax-2": 0.00012, "significative change": 0.0063, "cd28 act": 0.00496, "e7 block": 0.01073, "aberrant expression": 0.04163, "ldp": 6e-05, "creb complex imply": 0.01123, "cognate": 0.00155, "vitronectin receptor": 0.02571, "105-kda precursor": 0.00323, "additional mutation": 0.00592, "mixed small": 0.00313, "coagulation": 0.00062, "integral role": 0.01328, "mg/kg p.o.": 0.00012, "ox ldl enhance dna binding activity": 0.00975, "abnormal myelopoiesis due": 0.00246, "region downstream": 0.01467, "gata-1 mrna": 0.01526, "whole-cell binding assay": 0.01237, "mtetra induction": 0.01607, "stat1 factor": 0.0286, "cellular transcriptional nuclear factor-kb": 0.00842, "hormone-receptor interaction": 0.00986, "mab g28-5": 0.00267, "gammac chain": 0.00437, "specific modulation": 0.01238, "deps": 6e-05, "s49.1": 6e-05, "transcriptional event": 0.01151, "decreased production": 0.01042, "ptk play": 0.0071, "upregulate": 0.00186, "reporter gene experiment": 0.02903, "alpha/mad-3 gene transcription": 0.02903, "erythroid ocim1": 0.0062, "signal generate": 0.01635, "cell population generate significant amount": 0.03072, "neutralizing antibody render": 0.00596, "homodimer": 0.00161, "camp-dependent reporter gene": 0.02903, "benzene induction": 0.01607, "two-phase neutrophil-endothelial cell adhesion response": 0.03072, "octamer element 5'-atgcaaag-3": 0.01115, "conformation": 0.00105, "tcr-mediated response": 0.01942, "close homologue": 0.00068, "dense tubule": 0.00031, "pancreatic development": 0.00633, "pertinent": 0.00025, "immunomodulatory property": 0.00397, "sequence show high homology": 0.013, "ebv-positive tumour tissue constitutively express ebv nuclear antigen": 0.00461, "type ii ifn receptor": 0.01286, "endothelial icam-1": 0.00434, "prior": 0.0031, "translation lysates": 0.00109, "include cytotoxicity": 0.01439, "influential": 0.0, "cyclic adenosine monophosphate signal": 0.00817, "vascular smooth muscle cell": 0.0384, "rt-pcr positive": 0.00468, "large number": 0.0053, "mgus": 0.00012, "rescue rapamycin inhibition": 0.00707, "h-7-sensitive kinase pathway": 0.00852, "present result demonstrate": 0.01073, "induce pha blast": 0.01694, "unlabeled amplicon": 0.00047, "host cellular factor": 0.01907, "entire il2 regulatory region": 0.00734, "combination test": 0.00487, "tcr expression": 0.04163, "cell-specific complex": 0.01684, "nf-atc operates": 0.00099, "rip": 0.0005, "th1/th2-like cytokine": 0.01123, "aberrant double-negative lpr": 0.0006, "-culture condition": 0.0036, "utilizing transient transfection assay": 0.00501, "well-defined signal transduction pathway": 0.00817, "receptor-negative s49 murine thymoma cell": 0.03072, "ball1": 0.0, "sne": 0.00025, "cross talk": 0.00034, "cell direct": 0.0768, "pocket region": 0.01467, "hmba-induced cell express reduced level": 0.03072, "transition": 0.00118, "mini-ebv plasmid carry": 0.00184, "human monocytic line mono mac": 0.01505, "cd8+ t-cell activation": 0.02109, "lysozyme release": 0.00484, "alpha-ifn": 0.00037, "dependence": 0.00105, "survival factor": 0.0286, "microb dna motif": 0.00988, "nf-kappab/rel pathway": 0.01278, "long terminal repeat-cat construct show": 0.0104, "glucocorticoid receptor return": 0.01714, "distinct apoptotic pathway": 0.00852, "nm23 gene family": 0.02903, "pertussis toxin treatment": 0.00676, "enhance nf-kappa": 0.01414, "specific effect": 0.02115, "aids-related lymphoma": 0.00226, "lymphocyte-specific transcription factor": 0.01907, "il-6 mrna": 0.01526, "leukocyte undergoing apoptosis promote": 0.00445, "alpha,25-dihydroxyvitamin d3-mediated gene regulation": 0.02177, "cytokine receptor signaling": 0.01714, "differential nf-kappa b-mediated gene expression": 0.01742, "varies": 0.00043, "ba92": 6e-05, "gamma-gene 5'-untranslated region": 0.00978, "gata-1 synthesis": 0.00583, "nf-at/ap-1 transcription factor": 0.01907, "stimulate t-cell nuclear extract consist": 0.00674, "include nf-kappa": 0.01439, ".003": 6e-05, "circumstance": 0.00025, "disulfide-linked homodimeric glycoprotein": 0.00101, "e3 enhancer motif": 0.00606, "hypoxic exposure": 0.0035, "14-amino-acid peptide represent": 0.00502, "consensus bind site": 0.01445, "costimulatory receptor cd2": 0.01714, "specific elastase inhibitor": 0.00825, "p-toluenesulfonic acid": 0.00856, "downstream effector protein": 0.03019, "cell due": 0.0768, "nitric oxide synthase regulate nuclear factor kappab activity": 0.00731, "rev protein": 0.04529, "median": 0.0005, "leukemic hematopoiesis": 0.00251, "promoter mediate endothelial icam-1 expression": 0.01665, "10-fold stimulation": 0.0112, "thrombotic": 0.00025, "nf": 0.00577, "gst-tax m32 activation mutant": 0.01582, "distinct expression": 0.04163, "mdhm-stimulated induction": 0.01607, "mediate autocrine": 0.01231, "sp1 display normal binding activity": 0.0117, "hnf3": 0.00012, "-associated protein tyrosine kinase": 0.02264, "ifn-u937": 0.00031, "deleted part": 0.00152, "synergistic activation": 0.03164, "human myeloid cell nuclear differentiation antigen gene promoter": 0.0192, "pdtc": 0.00223, "oligomerization": 0.00043, "rap1gdp": 6e-05, "sequence include": 0.01625, "relb knockout mouse implicate": 0.00487, "effector domain": 0.01207, "cell precursor acute lymphoblastic leukemia cell": 0.0128, "social support variable": 0.00273, "c-fos induction": 0.01607, "cd40-mediated function": 0.01331, "ecto-5'-nucleotidase": 0.00012, "bind tfiid": 0.02025, "superinduction": 0.00025, "h-8": 0.0, "chromatin condensation": 0.00118, "13-kb human c-fes locus": 0.01881, "transient rise": 0.00344, "adult t-cell leukemia": 0.00641, "clonogenic culture": 0.0062, "increment": 6e-05, "il-5-stimulated cell underwent autophosphorylation": 0.0384, "-zeta": 0.00012, "differentiation dependent increase": 0.01464, "clinical sign": 0.00425, "phenomenon": 0.00186, "induce g1 cell cycle arrest": 0.03072, "autocrine loop": 0.00109, "+/- 0.4-fold": 0.00158, "elf-2a": 0.00012, "bipotent human myeloid progenitor cell": 0.03072, "include cytokine synthesis": 0.00959, "il-5 gene expression": 0.02903, "transfection experiment show": 0.01733, "pre-b-cell variant line": 0.01102, "-104": 6e-05, "nf-at1": 0.00087, "transcription initiate": 0.0281, "domain similar": 0.01207, "stat family member": 0.0056, "rankl": 0.00019, "viscosity": 0.00025, "rgd domain": 0.01207, "gata-1 mrna level": 0.01214, "load": 0.00068, "undergo radiotherapy": 0.0023, "cysteine": 0.00248, "show enhance p40 mrna expression": 0.01665, "autopresentation": 6e-05, "elucidate": 0.00136, "leukocyte lineage": 0.00478, "vd treatment": 0.01014, "individual responsiveness": 0.00409, "multiple kinase pathway": 0.00852, "multiple myeloma cell line": 0.0384, "stimulate ec": 0.01101, "defective sexual differentiation": 0.00786, "host immunity": 0.00214, "tissue-specific regulation": 0.01008, "transdominant negative mutant": 0.0054, "concerted expression": 0.04163, "combined treatment": 0.01014, "60-kda protein bind": 0.03019, "92-kda protein": 0.04529, "membrane-proximal region": 0.01467, "special precaution": 0.00031, "infused pbsc harvest": 0.00014, "blps": 0.00031, "vascular cell adhesion molecule": 0.0384, "marked shift": 0.00183, "c. pneumoniae-infected endothelial cell": 0.0384, "cell specific activity": 0.0512, "cytokine interleukin-8": 0.01123, "rssb": 0.00012, "p50.p65 heterodimers": 0.00226, "tumor necrosis factor receptor": 0.0143, "anti-mhc class ii ab": 0.00363, "purified eosinophil": 0.00295, "-60": 0.00031, "d.v.ablashi": 6e-05, "cardiomyocytes": 6e-05, "il-6 cat": 0.00391, "il-1beta protein": 0.04529, "extracellular egta": 0.00167, "interleukin-1beta-converting enzyme family protease inhibitor ac-devd-cho": 0.003, "influence leukocyte phenotype": 0.00318, "monocyte-macrophage lineage": 0.00366, "bt2camp": 0.00019, "il-13r alpha1-positive thp-1 cell": 0.0384, "jurkat cd4+ cell line": 0.0384, "cross-linked anti-cd3 ab": 0.00139, "dr alpha promoter": 0.01557, "pkc inhibitor staurosporin": 0.006, "mouse hybridoma": 0.00974, "endothelial cell-derived condition medium": 0.00217, "viral reactivation occur": 0.00488, "full capacity": 0.00329, "ap-1 transcription factor family": 0.0143, "underlying degree": 0.00146, "o-side chain-specific mabs inhibit mcd14-mediated lp uptake": 0.00544, "cell receptor beta gene": 0.0384, "bcl-6/cd57": 0.0, "undifferentiated spindle-shaped basal cell epithelioma": 0.03072, "gr heterocomplexes": 0.004, "mediate il-2 repression": 0.00821, "dominant negative c-fos": 0.00343, "ec50": 0.00012, "molecular clone": 0.00738, "infiltration degree": 0.00146, "hiv activation": 0.03164, "prb posttranslational modification": 0.00122, "hla-cw*0702 system": 0.00667, "up-regulates x1": 0.00056, "leukaemic": 0.00074, "kappab-dependent reporter assay": 0.00668, "cooperates": 0.00056, "isgf3 component": 0.00456, "1.3-1.5 kb": 0.0014, "induced differential expression": 0.02775, "epithelial cell line transfected": 0.0384, "il-1beta": 0.00447, "htlv-i tax expression lead": 0.02081, "site similar": 0.02168, "suppress lai replication": 0.00407, "gene therapeutic agent": 0.02903, "sequence lack classical enhancer activity": 0.0117, "flowerheads": 6e-05, "thp-1 monocytic leukemia cell": 0.0384, "herpesvirus saimiri cis-acting dna fragment": 0.00593, "acidic terminal segment": 0.00221, "self-renewing b-1 cell": 0.0512, "monocyte migration": 0.01197, "kd tax1 antigen": 0.00546, "human erythroleukemia cell": 0.0512, "benzene-contaminated water concentration": 0.00447, "ihes": 0.00019, "eicosanoid profile": 0.00152, "bcl-6 staining": 0.00177, "cord blood culture show": 0.013, "p-selectin glycoprotein ligand-1": 0.00101, "sp1 cleavage product": 0.00356, "beta 2-integrin gene": 0.02903, "isoform lack exon": 0.00422, "author provide": 0.00645, "gala": 0.0, "affect thrombotic event": 0.00531, "clear l. monocytogenes": 0.00031, "augment transcription": 0.0281, "minimal maturation effect": 0.0141, "ag": 0.00316, "activate stat protein form homo-": 0.01811, "study il-6 promoter activity": 0.01462, "surface protein expression": 0.03019, "t-cell-specific expression": 0.04163, "dq cis-dimer availability": 0.00027, "glycation": 0.0005, "regulate gene drive": 0.02903, "il-2 promoter level": 0.01557, "slg+ b-acute lymphoblastic leukaemia": 0.00043, "p53-null cell": 0.0768, "neutrophils separate": 0.00155, "protein-dna interaction mediate ifn-beta induction": 0.00643, "concentration-dependent": 0.00056, "gene remain": 0.04355, "-18": 6e-05, "hetherington": 0.00012, "human myeloblastic leukemia ml-1 cell": 0.03072, "tpa-induced expression": 0.04163, "cd28 stimulation": 0.0112, "similar inhibition": 0.01061, "infected t-cells": 0.00211, "inhibitory n17-mutated dominant-negative ra construct": 0.0029, "sexual hormone": 0.00444, "possess discrete dna-binding": 0.00374, "high-resolution mapping": 0.00099, "mask": 0.00019, "recent development": 0.00633, "life-threatening hypokalemia": 0.00016, "maz": 0.00019, "rate 3.3-fold": 0.00279, "nef expression": 0.04163, "gr mrna turnover": 0.01017, "stat-mediated gene transcription": 0.02903, "ang": 0.00056, "atherosclerotic process": 0.00444, "phka1 locus": 0.00288, "therapeutic agent": 0.00422, "absolute time": 0.00273, "immunoprecipitation analysis demonstrate": 0.01065, "cagatg": 6e-05, "primary glucocorticoid resistance due": 0.00425, "anergy induction": 0.01607, "active v-abl kinase": 0.00792, "induce nf-at region transactivation": 0.0127, "durable inhibition": 0.01061, "tf gene transcription": 0.02903, "cofilin-homology sequence": 0.01625, "cell hybridoma": 0.0768, "transcription factor nf-kappa b. hiv-1-infected individual": 0.00953, "specific cytokine-producing effector cell": 0.0384, "distant enhancer": 0.00909, "major histocompatibility complex class ii gene expression": 0.01244, "homologous member": 0.00413, "steady-state tnf-alpha mrna": 0.01017, "ltr include": 0.01439, "ada": 0.00037, "cell-type-specific regulation": 0.01008, "quantitative thin-layer chromatography": 0.00064, "k.j": 6e-05, "c/ebp transcriptional activator": 0.00767, "clear-cut synergy": 0.00093, "encoded transactivator protein tax": 0.02264, "nonradioactive assay base": 0.00668, "normal cell cycle": 0.0512, "externalization": 6e-05, "linker substitution mutation": 0.00395, "concentration-dependent manner": 0.00282, "activate rac-1": 0.01777, "b-cell specific gene expression": 0.02177, "aberrant form": 0.01055, "cycloheximide prevent": 0.00524, "dna binding": 0.01855, "mature dc": 0.00329, "functional cooperativity": 0.00816, "glucocorticoid-sensitive human leukemic t-cell line": 0.01505, "microbicidal effect": 0.02115, "oncogenic property": 0.00397, "proximal region account": 0.00978, "ori lyt": 0.00012, "-2 molecule": 0.00853, "cell mediate immune response": 0.0384, "monocyte arrest": 0.01197, "modulatory switch": 0.00245, "z29 strain increase hiv promoter activity": 0.00975, "cell hybrid carry": 0.0512, "contact": 0.00186, "gelatinase granule": 0.00112, "nf kappa b2 site": 0.01084, "significant upregulation": 0.00416, "cell leukemia-derived factor": 0.0512, "general impairment": 0.00155, "protein dependent": 0.04529, "chloramphenicol acetyltransferase gene reveal": 0.02177, "cytoplasmic factor ikappabalpha": 0.01907, "influence bind affinity": 0.0135, "activate nra induce": 0.01694, "adenovirus vector": 0.00319, "reduced": 0.00416, "control": 0.02605, "virus gene expression": 0.02903, "activation-dependent": 0.00136, "augment effect": 0.02115, "detect adenovirus dna": 0.00988, "pancreatic weight": 0.00093, "tendency": 0.0, "pin*point assay": 0.01002, "vitro kinase assay": 0.00792, "il-2r enhancer": 0.00909, "force expression": 0.04163, "lak cell": 0.0768, "kda precursor": 0.00323, "lymphoid development agonistic activity": 0.01462, "single base pair mutation": 0.00296, "consensus nf-kappa": 0.01414, "h. similar effect": 0.0141, "cell-cycle regulation": 0.01008, "cell enhance il-2 secretion": 0.0384, "vivo hla-dr promoter occupancy": 0.01168, "p21ha-ras": 6e-05, "apoptotic pathway": 0.01278, "kd tumor necrosis factor receptor": 0.01144, "tnf receptor surface expression": 0.02081, "genetic response": 0.01942, "b-lymphocyte precursor": 0.00323, "squirrel monkey glucocorticoid receptor": 0.01286, "human kg-1 myeloid leukemia cell": 0.03072, "low-dose il-3/gm-csf": 0.00025, "simultaneous activation": 0.03164, "c-rel involvement": 0.00254, "tnf alpha": 0.01169, "pcdd/pcdf": 6e-05, "myeloid progenitor": 0.00462, "trimer": 6e-05, "primary cd45r0": 0.00738, "lamin": 6e-05, "distinct form": 0.01055, "e2f-4/p130 complex": 0.01684, "retroviral induction": 0.01607, "promoter lack": 0.02336, "ap-1 consists": 0.00695, "corticosteroid-treated ibd patient": 0.0111, "zxdb locus": 0.00288, "single conserved serine residue": 0.0018, "hsp70": 0.00167, "nt": 0.00068, "upstream exonic cryptic splice site": 0.00867, "sensitizing tumor": 0.00934, "hiv-1 nef expression": 0.02775, "eukaryotic gene expression": 0.02903, "grpl-slp-76 complex": 0.01684, "purine-box regulator operating": 0.00203, "progesterone": 0.00329, "thymidine uptake": 0.00167, "jak family": 0.00841, "receptor mediate interaction": 0.01714, "major risk factor": 0.01907, "multiple cellular": 0.00893, "purine-box/antigen receptor response element": 0.01286, "vitd3 -and": 0.00273, "constitutively present": 0.00735, "change vdr concentration": 0.00447, "tnf-alpha-stimulated jurkat cell": 0.0512, "readily activate": 0.01777, "conserved core": 0.0022, "receptor stimulation": 0.02571, "gm-csf receptor share": 0.01714, "short-term cellular response": 0.01294, "monocytic differentiation induce": 0.01694, "fl": 0.00074, "mid-age hypertensive patient": 0.0111, "large subunit": 0.00484, "meaning": 0.0, "fatigue": 6e-05, "patient underwent fiberoptic bronchoscopy": 0.00833, "observation demonstrate": 0.01597, "rel-b": 0.00019, "carboxy-terminal domain": 0.01207, "family play important role": 0.00664, "hemoglobin-producing cell": 0.0768, "host cell gene expression": 0.0384, "tnf-alpha secretion": 0.00546, "avian sarcoma/leukemia virus ltrs": 0.00444, "epstein-barr virus negative bl": 0.00444, "ciita dependent": 0.00388, "induced mip-1alpha expression": 0.02775, "calcineurin-": 6e-05, "hydroxyl radical": 0.00059, "pi-3,4,5-p3 production": 0.01042, "vivo regulation": 0.01008, "lps inducibility": 0.0035, "signal transduction pathway": 0.0109, "t-cell line": 0.01653, "transcription initiation site": 0.01873, "enzyme independent": 0.00363, "dc-specific cdna": 0.00456, "decrease fasl expression": 0.02775, "concomitant engagement": 0.00133, "link hla allele": 0.00232, "fractional inhibition": 0.01061, "cell type specific": 0.0512, "induced differentiation": 0.01179, "suppress nfat-p0 complex formation": 0.00842, "long isoforms": 0.00307, "antigen receptor signal prolong nf-kappa b-dna interaction": 0.00735, "unchanged": 0.00081, "src family kinase function": 0.00665, "dna bind subunit": 0.0135, "nuclear nfat": 0.01684, "destroys": 6e-05, "promoter-": 6e-05, "ym268 increase glucose uptake": 0.01098, "tp1 gene": 0.04355, "rprl footprint ii repressor site": 0.00867, "patient remain euthyroid": 0.0111, "centroblasts": 0.00012, "cll sample test": 0.00325, "cell hybridoma model a1.1": 0.0384, "neutrophilic lineage": 0.00366, "t-cell receptor-cd3 complex activate": 0.00889, "correspondent protein": 0.04529, "phosphorylated": 0.00403, "gcrbeta": 0.00043, "defined major depressive disorder patient": 0.00666, "factor play": 0.0286, "bfu-e-derived cell": 0.0768, "immunodominant epitope": 0.00161, "human u-937": 0.03762, "competitive reverse transcriptase polymerase chain reaction": 0.00146, "islet": 0.00068, "ifn-gamma-induced up-regulation": 0.00276, "series physical exercise": 0.00108, "fibrinogen-derived protein": 0.04529, "basic cocktail": 0.00174, "delay apoptosis": 0.0089, "precipitin": 6e-05, "result provide evidence": 0.01073, "cell hemoglobinization": 0.0768, "ca2+-atpase": 0.00019, "human il2 upstream enhancer region": 0.01505, "lps-binding protein": 0.04529, "human progenitor": 0.03762, "actin polymerization": 0.00074, "drug exhibit distinct normalizing effect": 0.00846, "kca current": 0.00084, "acute attack": 0.00369, "early generation": 0.00828, "expected induction": 0.01607, "mice lead": 0.00996, "epstein-barr virus transactivators": 0.00591, "diameter": 0.00012, "c57mg fibroblast cell": 0.0512, "caml": 0.00062, "il-2-secreting cell consist": 0.0512, "pathway responsible": 0.01278, "proteolytic activity": 0.02925, "classic model": 0.00422, "non-consensus gas motif": 0.00583, "lp increase nf-kappab dna binding": 0.00878, "p38alpha mapk result": 0.01073, "e3 mrna level": 0.01214, "protein tyrosine kinase-": 0.03019, "human cd95l promoter": 0.02508, "induce severe": 0.0254, "serum-activated jurkat": 0.00555, "genome": 0.00279, "harbor hiv": 0.00592, "singh": 0.00012, "p13mtcp1 protein": 0.04529, "fgf-1 stimulation": 0.0112, "-inducible antagonist": 0.00242, "occur frameshift mutation": 0.00436, "clinical serum concentration": 0.00447, "irs-2": 6e-05, "increased interfollicular bcl-6+/cd3+ cell": 0.0384, "nonlymphoid cell": 0.0768, "atra/9-cis ra": 0.00596, "receive increased attention": 0.00242, "c-myc gene amplification": 0.02903, "pag": 0.00031, "drug discovery": 0.00338, "immortalized": 0.00037, "drosophila morphogen dorsal": 0.00081, "jun tre-like motif": 0.00583, "mrna reveal": 0.01526, "block cd11b expression": 0.02775, "interleukin-4 inhibit": 0.01904, "complex system": 0.01684, "ubiquitous molecule": 0.00853, "structural organization": 0.0018, "stimuli": 0.00056, "ebna2 activity": 0.02925, "dprl": 0.00043, "hematopoietic precursor cell": 0.0512, "tal-1 transgenic mouse": 0.00649, "lipid kinase": 0.01188, "messenger system": 0.00667, "protein kinase c-dependent signal": 0.02264, "mutant rxrs": 0.0081, "phenotypic abnormality": 0.00239, "human cd19 gene": 0.02903, "5-hydroxyeicosatetraenoic acid": 0.00856, "her-2/neu expression": 0.04163, "challenge clinical problem": 0.00283, "proliferative response": 0.01942, "disadvantageous": 0.0, "atopic": 0.00136, "fab fragment": 0.00347, "region act": 0.01467, "gene h-2kb": 0.04355, "fast": 0.00074, "radiation injury": 0.00071, "delimitation": 6e-05, "growth-related activity-alpha": 0.00012, "pebp2 isoforms": 0.00307, "l. monocytogenes infection": 0.00414, "unit": 0.00211, "allelic form": 0.01055, "969-base pair": 0.00214, "rhom-2 gene": 0.04355, "increase leukocyte microbicidal activity": 0.01462, "map kinase": 0.01188, "mad-3": 0.00056, "g.furlini": 6e-05, "spontaneous cytotoxicity mediate": 0.00821, "central nervous system-enriched kappa": 0.00374, "ii interferon": 0.00726, "general observation": 0.00155, "6-8 week": 0.00034, "multipotent progenitor": 0.00276, "specific glucocorticoid binding": 0.01237, "dpd": 0.00025, "promoter/enhancer region": 0.01467, "hybrid protein pml/rar alpha present": 0.01811, "causative agent": 0.00422, "nf-kappab binding": 0.01855, "fya": 0.00012, "enhance beta-globin reporter gene expression": 0.01742, "p=.01": 6e-05, "abundant dna-binding activity": 0.0195, "androgen-bound receptor protein result": 0.02264, "provide biochemical evidence": 0.0043, "cyp1a1 mrna level induce": 0.0127, "estrogen receptor antagonist": 0.01714, "permanent control": 0.01303, "wild type ikk1": 0.00633, "inhibit ras-induced ap1 activation": 0.01582, "-8 production": 0.01042, "ppar behaves": 0.00028, "local control": 0.01303, "ductal sample": 0.00208, "vivo exposure": 0.0053, "primary cd45ra": 0.00738, "cell-specific activation": 0.03164, "il-12-": 6e-05, "mouse t-cell line ctll-2": 0.00827, "vitro suppression": 0.00785, "hiv rna": 0.00592, "raldh2": 0.00043, "latent state": 0.00267, "upstream stimulatory factor": 0.01907, "ebna-2 responsiveness": 0.00323, "dna strand break": 0.00988, "inhibit endothelial expression": 0.02775, "kcat": 6e-05, "tnf-alpha-mediated induction": 0.01607, "gel supershift assay demonstrate": 0.00799, "bind p56": 0.02025, "remain unresolved": 0.00521, "anti-aim mab": 0.00267, "lambda5": 0.00025, "sequence-specific dna binding": 0.01237, "sra1": 6e-05, "colony-stimulating factor": 0.0286, "glycation-induced cell": 0.0768, "ler": 6e-05, "inducibility": 0.00254, "cell cycle progression": 0.0512, "peripheral cd8": 0.00524, "water soluble phorbol ester reveal": 0.00439, "hl-60 cell transduce": 0.0512, "il-4 gene expression level": 0.02177, "phosphatidylinositol 3-kinase couple": 0.00087, "human sle": 0.03762, "zip site serf": 0.01445, "transcription factor ctf/nf-1": 0.01907, "diminished gr apparent binding affinity": 0.00742, "glut1": 0.00012, "important trigger": 0.00689, "include fcepsilonriib": 0.01439, "il-10 concentration": 0.0067, "epo-independent hcd57-srei cell": 0.0512, "gata site abolishes hs": 0.01084, "xanthine oxidase": 0.00062, "strict lineage-": 0.00016, "lymphotoxin": 0.00043, "immunosuppressant cyclosporine": 0.00047, "t-cell tumor": 0.00962, "late g1-to-s phase": 0.00184, "peptide loading": 0.00754, "bk virus plasmid expression vector": 0.01665, "aav": 0.00012, "specific action": 0.01238, "cd28 molecule": 0.00853, "cycle ergometer": 0.00307, "specific nuclear binding site": 0.01084, "human fetal": 0.03762, "augmented basal": 0.0035, "hla-dr expression": 0.04163, "red cell development": 0.0512, "characterisation": 0.00019, "steroid-regulated apoptosis": 0.0089, "human gm-csf": 0.03762, "similar inhibitory effect": 0.0141, "discrete nuclear structure": 0.01123, "nf kappa b/rel": 0.00498, "round": 0.00019, "jurkat-tat cell line": 0.0512, "untreated ibd patient": 0.0111, "human prointerleukin": 0.03762, "direct temporal relationship": 0.0036, "half-maximal activation": 0.03164, "pld action": 0.00499, "region direct": 0.01467, "respiratory distress syndrome": 0.00182, "term yt": 0.00413, "small amount": 0.00313, "3,21-diacetoxy-5 beta,19-cyclopregna-2,9": 9e-05, "cd3/cd4+ intrafollicular": 0.00028, "dibutyryl camp": 0.00257, "lps-stimulated transcriptional activity": 0.0195, "defective survival": 0.00236, "generation compound canventol": 0.00161, "world primate cell extract": 0.0384, "pouhd": 0.00037, "il-5 stimulation": 0.0112, "monocytic cell line mm6": 0.0384, "mediate gene activation": 0.02903, "present report demonstrate": 0.01065, "cell leukemia virus-i tax lead": 0.03072, "go-6976 result": 0.0161, "sp1 motif": 0.00875, "eosinophil granule": 0.00295, "reduces laboratory work": 0.00054, "axis": 0.00099, "conditional ngf-r": 0.00053, "chicken nf-m transcription factor": 0.0143, "sig": 0.00031, "normal bone marrow cell": 0.0384, "crem": 6e-05, "propranolol": 6e-05, "early treatment": 0.01014, "gtp": 0.00037, "il1b promoter fragment": 0.01557, "aldosterone level return": 0.01214, "pg490 inhibit": 0.01904, "renal fibrosis": 0.00115, "potent enzyme inhibitor": 0.006, "shed": 0.00037, "ap-1/nf-kappa": 6e-05, "transfectants": 0.00199, "hla stabilization experiment": 0.00265, "supershift assay reveal": 0.00732, "block erythroid differentiation": 0.00786, "precise regulation": 0.01008, "hiv-1 virus": 0.00887, "il-10 up-regulation": 0.00422, "jak2": 0.00211, "jak": 0.00136, "il-13 receptor complex": 0.01714, "cytosolic enzyme": 0.0031, "inhibit il-6 production": 0.0127, "cell type include cd8+": 0.0384, "virus induce": 0.0254, "primary granulocyte": 0.00738, "specific binding activity": 0.0195, "replacement": 0.00074, "pbmcs show": 0.02599, "transactivator protein": 0.04529, "yy1 down-regulates": 0.00074, "nb4 cell": 0.0768, "f.wang": 0.00012, "megakaryocytic transcription factor": 0.01907, "cell line lack stat3": 0.0384, "bicycle ergometer": 9e-05, "stress-activated protein": 0.04529, "antiproliferative": 0.00118, "negative transcriptional regulatory element": 0.00836, "responder patient": 0.01666, "-2": 0.00161, "ebv-positive b-cell": 0.00459, "fcepsilonri": 0.0, "cd3/t cell receptor": 0.0512, "human inflammatory": 0.03762, "normal bind affinity": 0.0135, "peripheral blood mononuclear cell associate": 0.03072, "wide range": 0.00202, "monoblastoid cell undergo tnf-alpha-induced apoptosis": 0.03072, "human beta-globin gene locus require": 0.01742, "large cytogenetic clone": 0.00492, "thrombin-generation curve": 0.00022, "dominant negative mutant ikk1": 0.00405, "peptide g75": 0.00754, "selective force": 0.00267, "lr1-dna binding activity increase": 0.01462, "p52": 0.00093, "tcr-alpha": 0.00019, "e1 element": 0.01672, "alpha'-dipyridyl": 0.00012, "hpa axis": 0.0005, "human macrophage": 0.03762, "hla-dq evolution": 0.00078, "mol/l pma": 0.00409, "early rheumatoid arthritis": 0.00552, "susceptible target cell": 0.0512, "c2h2 zinc finger": 0.00118, "mouse developmental mutant": 0.00649, "id3 impedes expression": 0.02775, "fk506 exerts": 0.00149, "enhanced p50": 0.00288, "maturity-onset diabetes": 0.00031, "sba": 0.00019, "il-16 expression": 0.04163, "common vdr genotype": 0.00234, "mhc class ii induction": 0.00803, "tyrosine phosphatase inhibitor phenylarsine oxide": 0.0036, "csa-sensitive manner": 0.00282, "cipro enhance il-2 gene induction": 0.01742, "thp-1 cell transfected": 0.0512, "th2 lymphocyte": 0.01483, "target cell sensitization": 0.0512, "distal sp1-binding site": 0.01445, "enhancer motif": 0.00909, "induce cd14 expression": 0.02775, "phorbol-di-butyrate": 6e-05, "cox-2": 0.00074, "activation-dependent engagement": 0.00133, "mn sod": 0.00028, "murine igh enhancer": 0.00606, "monomorphic": 6e-05, "hiv1": 0.00056, "regulated protein": 0.04529, "cytoplasmic protein extract": 0.03019, "signal transduction cascade downstream": 0.00817, "fusion cdna result": 0.01073, "tradd constitutively associate": 0.00728, "tax sequence": 0.01625, "proliferate thymocytes": 0.00257, "nucleoplasmic domain": 0.01207, "incubation time": 0.00273, "erg2 gene product": 0.02903, "study cytokine regulation": 0.00904, "local failure": 0.00136, "spd increase": 0.02196, "human il-5 gene transcription": 0.02177, "3,21-diacetoxy-5 beta,19-cyclopregn-5-ene-4,20-dione": 9e-05, "resynthesis": 6e-05, "130-kd protein": 0.04529, "c-myc protooncogene mrna expression": 0.02081, "pma respond": 0.00409, "activated nuclear factor": 0.01907, "cdc42-controlled machinery responsible": 0.00186, "separate cox analysis": 0.00786, "strong n-terminal trans-activation domain": 0.00603, "cell proliferation require signal": 0.0384, "285+/-100 iu/ml": 9e-05, "lymphoid cem line display resistance": 0.00661, "g1/s boundary": 0.00016, "parallel plate flow chamber": 0.00102, "primer extension method": 0.00157, "ras-transformed lymphocyte display": 0.00988, "stimulated tyrosine phosphorylation": 0.00656, "separate": 0.0031, "single methionine codon-initiated open reading frame": 0.0012, "nuclear extract show": 0.01733, "receptor rna increase": 0.01714, "malignant effusion": 0.00158, "steroidal effect": 0.02115, "modulating agent": 0.00422, "factor protein": 0.04529, "cat expression": 0.04163, "gamma-rays lead": 0.00996, "human il4 promoter-mediated transcription": 0.01881, "disproportionate occurrence": 0.00028, "pre-bound transcription factor": 0.01907, "type ii eb level": 0.0091, "regulate qp activity": 0.0195, "differentiate dc": 0.00267, "tnfri": 0.00074, "jak3 lead": 0.00996, "additional structural role": 0.00885, "immunohistochemistry reveal": 0.01098, "p38 mitogen-activated protein": 0.03019, "initial activation": 0.03164, "cellular activation": 0.03164, "increased dna binding": 0.01237, "bcl-xl expression": 0.04163, "tata-box binding protein": 0.03019, "anion exchange chromatography": 0.0005, "-240": 6e-05, "il-2 immunotherapy": 0.01117, "experimental anemia suggest": 0.01348, "ca2+ requirement": 0.00304, "cellular glucocorticoid receptor level increase": 0.01029, "-173": 0.00012, "phoq gene product": 0.02903, "cytoplasmic p62c-fos": 0.004, "kd tnfr play": 0.00474, "render nef nonfunctional": 0.00101, "normal cytoplasmic level": 0.01214, "block tnf": 0.01073, "neo": 6e-05, "chronic treatment": 0.01014, "complex effect": 0.02115, "repress hiv-1 transcription": 0.01873, "htlv-ii tax protein": 0.03019, "remarkable grade": 0.0004, "gst-hbd": 0.00012, "th2 proliferation": 0.00803, "active viral infection": 0.00488, "nfat-dependent transcriptional activation": 0.02109, "group sequence search": 0.01084, "distinct dna bind subunit": 0.01013, "p21ras effector pathway": 0.00852, "include member": 0.01439, "octamer-binding element": 0.01672, "decreased mmp-9 secretion": 0.00285, "x-linked combined immunodeficiency": 0.00145, "amino acid c-terminal": 0.00571, "aml m4": 0.00087, "interferon beta": 0.00673, "normal allele support": 0.00806, "menstrual cycle": 0.00307, "wild-type nfat1": 0.00378, "rest fibroblast": 0.00338, "cyclosporine": 0.00074, "-dexamethasone binding": 0.01855, "integrin beta": 0.00673, "tax1 interacts": 0.00136, "tr bound": 0.00292, "hematopoietic tumor": 0.00934, "mammary reduction test material": 0.00243, "drug therapy": 0.00372, "glucocorticoid insensitivity": 0.0085, "ser386-val525": 6e-05, "calcium-mediated activation": 0.03164, "il-13r alpha1-negative daudi cell": 0.0384, "pax protein": 0.04529, "prognostic parameter": 0.00127, "germ-line brca1 mutation": 0.00395, "xenobiotic response element-binding activity": 0.01462, "leishmania-infected cell": 0.0768, "latent cytoplasmic precursor": 0.00267, "aged person": 0.0005, "aid iblp": 0.00161, "4-6 fold increase": 0.01464, "receptor alpha": 0.02571, "affect mitogen-activated protein kinase": 0.02264, "cell-derived cytokine": 0.01123, "protein trans-factors": 0.04529, "thapsigargin induces il-2 receptor alpha-chain": 0.01029, "special focus": 0.00071, "adenovirus e1a sequence relevant": 0.00813, "e3 construct link": 0.00484, "purified tax": 0.00478, "-14": 6e-05, "complement-opsonized particle": 0.00074, "peptide-binding cleft": 9e-05, "kappa immunoglobulin intron enhancer bind inducible factor": 0.00817, "nonfinger region": 0.01467, "il-10 downregulates expression": 0.02775, "study vis-a-vis hormone metabolic status": 0.00542, "constitutive elk-1 expression": 0.02775, "current study": 0.01355, "competitor": 0.00043, "tinur belongs": 0.00022, "cell line ctll2": 0.0512, "individual gene": 0.04355, "steroid-resistant patient": 0.01666, "anergic condition": 0.0036, "protect cell": 0.0768, "subsequent event": 0.00552, "jan": 0.0, "cell-restricted activity": 0.02925, "il-4-triggered transcriptional activation": 0.02109, "word": 0.00012, "intermediate event": 0.00552, "direct coupling": 0.0054, "ps -and ptdins-mcd14 binding": 0.00927, "humara analysis": 0.01179, "increase infectivity": 0.02196, "nfatp": 0.00329, "ets protein": 0.04529, "initial fate": 0.00189, "scavenger receptor over-expressing monocyte": 0.01286, "pam": 0.00031, "double-positive cell": 0.0768, "tpa induction": 0.01607, "pml nuclear body": 0.01123, "excess": 0.00099, "pa6-neo": 6e-05, "immature t-cell line": 0.01102, "2-deoxyguanosine-treated thymus lobe show": 0.013, "cryptic splice site sequence": 0.01084, "unlabeled ap1 bind site": 0.01084, "human il-10r": 0.03762, "interferon-gamma activation site-like sequence upstream": 0.01266, "gene- specific function": 0.00887, "serum-free medium": 0.0014, "lps-induced tumor necrosis factor": 0.0143, "gr-dependent transcriptional activation": 0.02109, "high activity": 0.02925, "increased rar beta/rxr dna binding": 0.00742, "differentiate cell": 0.0768, "identity": 0.00074, "nuclear activity": 0.02925, "potential utility": 0.00605, "polya site": 0.02168, "potent inhibitory effect": 0.0141, "phorbol myristate acetate effect": 0.01058, "cathepsin g-induced platelet aggregation": 0.00186, "cd28 cell surface molecule delivers costimulatory signal essential": 0.0192, "rel-related factor": 0.0286, "cd30 engagement": 0.00133, "synthetic oligonucleotides": 0.00202, "alter mr-status": 0.00378, "pathway control segment polarity": 0.00651, "protect bovine pulmonary artery endothelial cell": 0.0256, "cytopathic virus infection": 0.00591, "ii kappa b-2": 0.00498, "cellular hemoglobin concentration": 0.00596, "lox-1 resembles": 0.00028, "human skin cancer": 0.02508, "cold shock": 0.00174, "preliminary report": 0.0049, "majority": 0.00099, "mds1-evi1": 6e-05, "case express cd2": 0.0123, "thf": 0.00019, "il-1 induces": 0.00803, "interstitial collagenase": 0.0004, "altered b-cell maturation pattern": 0.00275, "terminal differentiation": 0.01179, "full-length hiv transcript": 0.00399, "human cd14 gene": 0.02903, "nfs": 6e-05, "enhancer region link": 0.00978, "specific cd4": 0.01238, "minor": 0.00105, "focus": 0.00143, "enzyme activity mediate": 0.0195, "il-2 induce": 0.0254, "ra patient": 0.01666, "intron enhancer": 0.00909, "ifn-dependent increase": 0.02196, "m.": 0.0023, "infiltrate cd4-bearing": 0.00074, "tandem enhancer repeat": 0.00606, "nitric oxide synthase expression": 0.02081, "inositol-1,4,5-trisphosphate/calcium pathway": 0.01278, "cathepsin g.": 0.00062, "nuclear receptor": 0.02571, "mechanism control": 0.01303, "pu.1 result": 0.0161, "delayed kinetics relative": 0.00184, "cell antigen receptor-induced erk2 kinase activation": 0.0256, "platelet glycoprotein": 0.00372, "pcd41 sequence": 0.01625, "inhibitor hiv-1 transcription": 0.01873, "advanced infection": 0.0062, "paf activate c-jun nh2-terminal mapk": 0.00711, "6-cis-locked conformer": 6e-05, "il-2 transcriptional regulation differs": 0.00575, "progesterone-induced immunosuppression": 0.00062, "succinimide residue": 0.00226, "cognate motif": 0.00875, "significant variable": 0.00416, "peptide-binding groove": 0.00012, "anti-e. chaffeensis serum": 0.00252, "antisense oligodeoxynucleotides": 0.00161, "cb": 0.00043, "excessive fecal sodium loss": 0.00149, "obf-1/bob1/oca-b": 0.00019, "p21ras oncoprotein": 0.00152, "molecular consequence": 0.0045, "redox regulation": 0.01008, "vivo transient transfection study": 0.00678, "abnormal adherence": 0.00195, "inhibitor inhibit monocyte chemotactic activity": 0.0117, "display t-cell specificity": 0.00641, "h2-antagonist": 6e-05, "oligonucleotide-directed triple helix formation": 0.00242, "include cyclophilin": 0.01439, "ltb4 increase": 0.02196, "signal-transmitting receptor": 0.02571, "pro-apoptotic effect": 0.02115, "maf complex": 0.01684, "cell functional response": 0.0512, "family history": 0.00841, "ck-1": 0.00019, "culture plate": 0.0062, "myeloid transcription factor pu.1": 0.0143, "infects normal human": 0.02508, "mcf-fas cell": 0.0768, "mouse ccr-4": 0.00974, "cd28 coligation fails": 0.00215, "glutathione depletion": 0.00121, "uv light deliver": 0.00064, "permeabilized": 0.00019, "primary human peripheral blood mononuclear cell": 0.0256, "line layer depth": 0.01102, "serum-free medium return": 0.00093, "membrane il-2r alpha": 0.0078, "coactivator oca-b": 0.00149, "staphylococcus aureus": 0.00025, "lymphocyte protein": 0.04529, "gen": 0.00012, "affect constitutive signaling induce": 0.0127, "protein dimerization": 0.04529, "pg490 inhibits pma/iono-stimulated il-2 transcription": 0.01124, "gene targeting": 0.04355, "quinone reductase-dependent mechanism": 0.00705, "binding property": 0.01855, "cd34+ progenitor cell": 0.0512, "hiv-1-encoded nef protein inhibit": 0.02264, "autokinase activity": 0.02925, "tshr peptide": 0.00754, "lysp100 nuclear dot": 0.01123, "jun activation domain": 0.02109, "functional complex encompass": 0.01123, "exogenous c-fos": 0.00471, "a.de maria": 6e-05, "finding support": 0.00409, "major pkc substrate": 0.00383, "subsequent analysis": 0.01179, "efficient long-term lymphoblastoid cell outgrowth": 0.03072, "receptor-dependent": 0.00037, "peptide 158-176": 0.00754, "release growth arrest": 0.00546, "access": 0.00025, "breakpoints": 0.00019, "related lymphoma": 0.00236, "insufficient action": 0.00499, "hiv ltr cat": 0.00395, "form distinct heteromeric complex": 0.00842, "fc gammar1 gene lead": 0.02177, "high-affinity bind site": 0.01445, "nonspecific esterase activity": 0.0195, "cell-associated": 0.0005, "thyroid cell": 0.0768, "major envelope glycoprotein": 0.00383, "defined culture medium": 0.00414, "hypercalcemic effect": 0.02115, "bcl-2 expression require participation": 0.02081, "2.5-": 6e-05, "phoq protein": 0.04529, "ig heavy chain locus": 0.00219, "center": 0.00223, "atopic asthma patient": 0.0111, "coronary heart disease": 0.00449, "late time": 0.00273, "mixed combination suggest": 0.01348, "cell-free synthesize hgr": 0.00105, "class il transactivator ciita": 0.00321, "mhc class ii transcription factor rfx": 0.00953, "d1": 0.00019, "potent immunosuppressive": 0.00357, "leucine": 0.00105, "e1a-positive sample": 0.00208, "impair tnf-alpha-induced apoptosis": 0.00593, "thrombopoietin induces tyrosine phosphorylation": 0.00492, "sp-a dos": 0.00121, "rs cell": 0.0768, "jun/fos heterodimers": 0.00226, "cellular": 0.01787, "intracellular ca2+ mobilization suggest": 0.01011, "examination reveals": 0.00099, "enhance complement-dependent lp uptake": 0.00487, "s107 cell": 0.0768, "core histone": 0.0022, "g. w.": 0.00062, "human neutrophil stimulate": 0.02508, "duplicated ctg-motif": 0.00028, "vascular invasion": 0.00174, "nervous system": 0.00667, "hiv kappa": 0.00748, "binding mutant": 0.01855, "stimulus-induced degradation": 0.00332, "diverse agent": 0.00422, "unclear": 0.00105, "replication": 0.00943, "secondary hypothyroidism": 0.00189, "gene transfection assay": 0.02903, "functional defect": 0.00816, "i. proteolytic activity": 0.0195, "microgranular variant": 0.00276, "anti-diabetic action": 0.00499, "transgenic mouse exhibit abnormal development": 0.0039, "cellular response gene inducibility": 0.02177, "mo": 0.00087, "n-terminal sequencing": 0.00202, "require binding": 0.01855, "cbl-b-mediated activation": 0.03164, "e2a basic helix-loop-helix protein": 0.02264, "plasma volume": 0.00375, "wild-type promoter": 0.02336, "reappears": 6e-05, "accessory cell": 0.0768, "dexamethasone group": 0.00487, "phosphorylated residue kinetic analysis": 0.00589, "block nfat nuclear translocation": 0.00842, "ikaros family member": 0.0056, "bp fragment encompass nucleotide": 0.00174, "noncatalytic": 6e-05, "c-erba-dependent activation": 0.03164, "general agreement": 0.00155, "npc cell line hk666 lead": 0.03072, "gc-induced inhibition": 0.01061, "tax-activated transcription": 0.0281, "tcrzeta increase": 0.02196, "transcription factor effect": 0.01907, "tpa responsiveness": 0.00323, "mbp-induced release": 0.00484, "schizophrenic group": 0.00487, "forced exogenous expression": 0.02775, "il-2 production exhibit normal activation": 0.01266, "delta sp": 0.00211, "encompass": 0.00236, "lymphocyte adhesion": 0.01483, "2.8-fold": 6e-05, "provirus show": 0.02599, "adhesion molecule": 0.00853, "-3 dna bind ability": 0.01013, "cd3 complex induce expression": 0.02081, "co-transfection assay": 0.01002, "pma-": 0.00074, "c-fos protooncogene": 0.00471, "cck-8 effect": 0.02115, "major transcription initiation site": 0.01405, "pge2 synthesis": 0.00583, "subsequent apoptosis": 0.0089, "linear": 0.00074, "rest level": 0.01821, "stat serine kinase": 0.00792, "distinct intracellular signal pathway": 0.00817, "messenger molecule": 0.00853, "noncanonical octamer motif": 0.00583, "nonconsensus site": 0.02168, "human interleukin-2 receptor beta-chain promoter": 0.01505, "abnormal nf-kappa": 0.01414, "megakaryopoiesis": 0.00012, "oral salt supplementation": 0.0005, "delta19 beta-catenin mutant": 0.0054, "st": 0.00025, "cytosolic tyrosine motif include y440": 0.00576, "impaired induction": 0.01607, "ed-40515": 6e-05, "cell cycle arrest induce": 0.0384, "stable transfection": 0.00276, "metalloproteinases": 0.00025, "differential staining": 0.00323, "ciita interacts": 0.00295, "retinoic acid induces apoptosis": 0.00445, "enhanced binding": 0.01855, "tight control": 0.01303, "report difference": 0.0049, "human myeloid u-937 cell": 0.0384, "present investigation": 0.00735, "erythroid-specific hypersensitive site hs2 enhancer regulate": 0.00723, "h. radiolabeled vdr": 0.00155, "hashimoto": 0.00031, "suppresses stat5 phosphorylation": 0.00656, "oxldl-induced nf-kappa": 0.01414, "cd40 induce nf-kappa": 0.01694, "ca2+- signaling pathway downstream": 0.00639, "nf-kappab-mediated transcription": 0.0281, "complex protein-dna interaction": 0.01123, "appreciable level": 0.01821, "standard treatment": 0.01014, "vdr dna-binding domain": 0.00804, "protein phosphatase type": 0.03019, "proteasome inhibitor mg132 abolish dopamine-induced transcriptional activation": 0.00904, "l. donovani": 0.00047, "megakaryoblastic disorder": 0.00223, "vivo suggest": 0.02022, "anti-inflammatory sesquiterpene lactone": 0.00087, "aldosterone-mbp-hbd complex": 0.01684, "theoretical potential": 0.00605, "tissue injury": 0.00664, "normal peripheral blood monocyte": 0.00605, "type ii interferon": 0.00633, "p300/cbp-type transcriptional coactivators": 0.00767, "human motor activity result": 0.01881, "protein-protein": 0.00093, "reduced pma/ca2+ activation": 0.02109, "primer extension": 0.00081, "substitution result": 0.0161, "cd40-stimulated": 0.00037, "poz motif": 0.00875, "u.smola": 0.00012, "polymorphic determinant": 0.00118, "fos/jun": 0.00031, "near-perfect direct repeat": 0.0036, "class ii determinant": 0.00484, "wakim": 6e-05, "stat1-stat3 heterocomplexes": 0.00031, "glucocorticoid-mediated repression": 0.00211, "measure cellular incorporation": 0.00596, "dioxin": 0.0005, "normal development": 0.0121, "deltanfkappabdeltaspl": 0.00012, "kb act": 0.00496, "mhc concentration": 0.0067, "control culture trigger": 0.00868, "tyrosine kinase inhibitor herbimycin": 0.00594, "type iv collagen": 0.00633, "transduced hematopoietic stem cell": 0.0384, "early blood island": 0.00552, "resistant icr27tk.3 cell": 0.0512, "il-10 receptor activation": 0.02109, "immunoglobulin promoter": 0.02336, "herpes simplex virus oct-1 coregulator vp16": 0.00296, "cd2-activated lpmc": 0.00012, "hlh": 0.00062, "kind": 0.00037, "escape": 0.00037, "data elucidate difference": 0.00283, "clonal cell growth": 0.0512, "rb-related protein p107": 0.03019, "double-labeling immunogold electron microscopy": 0.00025, "pulse-treatment": 6e-05, "enhancer site": 0.02168, "ifna synthesis": 0.00583, "c-rel protooncogene encode": 0.00569, "ast/alt level": 0.01821, "epstein": 0.00012, "nk3.3 cell line": 0.0512, "sla-dra mrna induction": 0.01071, "early erythroid progenitor": 0.00552, "72-kda major immediate-early protein": 0.02264, "cytosolic ca2+": 0.00304, "fm group": 0.00487, "p38 mapk": 0.00152, "holo drug": 0.00338, "pub1": 0.00012, "distinct portion": 0.00698, "inducible interleukin-2 enhancer function require": 0.00532, "bls genetic complementation group": 0.00243, "optimal transcriptional activation": 0.02109, "active lipid generate": 0.00395, "exp": 6e-05, "human leukemic cell include hl-60": 0.03072, "false": 0.00019, "gata-1 protein level": 0.03019, "hpv-18 e7 oncoprotein": 0.00077, "olr1": 0.00019, "anti-cd2-activated purified": 0.00261, "human promonocytic cell line u937": 0.03072, "mhc class ii compartment": 0.00363, "retinoic acid receptor alpha": 0.01286, "cell-cycle gene activation": 0.02903, "sv40 promoter": 0.02336, "eleven patient": 0.01666, "il-4 signaling molecule": 0.00569, "lymphocyte immortalization": 0.01483, "caggtg e-boxes": 9e-05, "creb gene transcript": 0.02903, "lymphocyte jurkat cell": 0.0512, "uninfected peripheral blood monocyte": 0.00599, "direct sequencing": 0.0054, "downstream tata element": 0.01115, "lp signaling": 0.00558, "consensus o-tetradecanoylphorbol 13-acetate": 0.00192, "bacterial content": 0.00223, "ras mutation": 0.00592, "p50-p65 heterodimers": 0.00226, "igg fc receptor type": 0.01286, "ifn- gamma": 0.0044, "0-125 microm": 0.0013, "phosphorylates c-fos": 0.00471, "initial diagnosis": 0.00189, "enhance anti-ig induction": 0.01071, "tat-mediated increase": 0.02196, "small molecule s9a": 0.00569, "unique phosphopeptides": 0.00261, "bovine papilloma virus": 0.00591, "interfollicular zone": 0.00034, "transcription direct": 0.0281, "cdc2 gene": 0.04355, "inducible factor nk-kappa": 0.01907, "rbc adhesion": 0.0058, "mangabey cell lysates": 0.0512, "nfil-2b nuclear protein complex": 0.02264, "cytotoxicity marker": 0.00382, "ras oncogene": 0.00261, "signal pathway lead": 0.0109, "ets-related transcription factor elf-1": 0.0143, "tag": 0.00056, "elf-1 bound": 0.00292, "inactivation": 0.00347, "big": 0.00012, "nuclear translocalization": 0.01684, "cbf site": 0.02168, "-76": 0.00068, "crucial element important": 0.01115, "human tumor necrosis factor alpha gene regulation": 0.01244, "multiple microbiological antigen": 0.00546, "induced cell demonstrate": 0.0512, "human promyelocytic leukemia hl-60 cell": 0.03072, "stimulate purified human cd4+": 0.01881, "normal cem-c7": 0.0121, "ctl": 0.0023, "alters immune cell function": 0.0384, "antipeptide antibody generate": 0.00596, "unknown etiology": 0.00174, "gel-shift assay": 0.01002, "cell receptor-": 0.0768, "index": 0.00124, "analyze difference": 0.00456, "mediate cd40-dependent signal": 0.0109, "leukocyte chemotaxis": 0.00478, "early divergence": 0.00828, "tre1 probe": 0.00261, "rapid proteolytic degradation": 0.00221, "endocrine gland": 0.0009, "il-1beta expression": 0.04163, "increase labeling": 0.02196, "helper-inducer": 6e-05, "pombe system support effect": 0.01058, "agonist-induced activation": 0.03164, "undergo switch recombination": 0.00163, "jun oncogene family member": 0.0042, "disposition": 0.00025, "proviral insertion": 0.00078, "menadione": 0.00012, "organ inflammation independent": 0.00242, "prevent significant repression": 0.00349, "induce hiv-1 production": 0.01694, "activation state": 0.03164, "il-2-gene transcription rate": 0.01873, "mutual contact": 0.00093, "hiv-1-ltr-driven transcription": 0.0281, "p27rex/p21rex": 0.00012, "regulatory region": 0.01467, "s-nitrosylation": 6e-05, "exon 1-4": 0.00127, "id3 overexpression": 0.00382, "slight difference": 0.00425, "change": 0.01259, "normal cellular equivalent c-myb": 0.00605, "phosphatidylserine exposure": 0.0035, "ko": 0.00019, "lineage-specific expression": 0.04163, "sickle erythrocyte": 0.0013, "genetic approach": 0.00288, "nh2-terminal truncation mutant": 0.0054, "calcium-dependent phosphatase calcineurin": 0.00211, "induced processing": 0.0054, "truncated protein": 0.04529, "reversed transcribed rna": 0.00304, "alagille syndrome": 0.00273, "gcr regulation": 0.01008, "culture": 0.01241, "individual dr unit": 0.00273, "chronic myelogenous leukaemia": 0.00265, "distinctive expression pattern": 0.02775, "ecv304 cell": 0.0768, "vitro monocyte-derived macrophage": 0.00523, "inhibit viral replication": 0.0127, "agonistic activity": 0.02925, "electrophoretic mobility shift assay base semiquantitative detection system": 0.0025, "p7": 6e-05, "zinc-finger primer": 0.00081, "dep-pah-activated cell": 0.0768, "multiple organ dysfunction due": 0.00344, "owl monkey liver": 0.00079, "-dependent signal transduction pathway": 0.00817, "southern analysis": 0.01179, "final step": 0.00189, "concomitant 40-50": 0.00112, "delta promoter lead": 0.01557, "hemopoietins": 0.00025, "airway tissue": 0.00664, "alpha subunit": 0.01169, "muscle-specific gene": 0.04355, "cd40-cd40 ligand": 0.00592, "pgg-glucan enhances neutrophil anti-microbial function": 0.00532, "tandem ap1 bind site": 0.01084, "knock-out mouse": 0.00974, "congenital defect": 0.00279, "similar": 0.01346, "putative stat3 serine kinase": 0.00594, "receptor-positive": 0.00037, "t-cells increase c-fos": 0.01464, "avenue": 0.00012, "eukaryotic transcription regulatory factor": 0.0143, "dtc": 0.00019, "analog include 20-epi-22-oxa-24a,26a,27a-trihomo-1alpha,2 5-dihydroxyvitamin d3": 0.00576, "exclusion": 0.00043, "high quality emotional support": 0.00465, "rgd": 0.00025, "site suitable": 0.02168, "35s-methionine labelled protein": 0.03019, "investigator": 0.00012, "lymphocytic mineralocorticoid receptor": 0.01714, "ets1": 0.00099, "human pmn": 0.03762, "monocytoid u937 cell": 0.0512, "asymptomatic carrier": 0.00053, "ctl cross-priming": 0.00115, "actinomycin d. increase stat1": 0.01098, "er form": 0.01055, "dominant negative ikappabalpha": 0.00343, "chromatographic step": 0.00189, "egr-1/rela synergy": 0.00093, "mature t-cell proliferation": 0.00641, "express low level": 0.0123, "il-2 gene transcription": 0.02903, "properly position ccaat box": 0.00152, "regeneration": 6e-05, "kappab alpha": 0.01169, "blood vessel": 0.00592, "truncated version": 0.00074, "kappa b-responsive gene": 0.02903, "structural class": 0.00642, "cro-ap/5 cell line": 0.0512, "position -233": 0.00236, "fc gamma ric promoter sequence": 0.00934, "induce calcium mobilization": 0.01694, "nuclear affinity": 0.01684, "constitutional": 0.00025, "avian defective retrovirus": 0.00136, "differential display rt-pcr": 0.00333, "epo-binding site": 0.02168, "mimic mitogenic stimulation": 0.00746, "well-known immunosuppressive and/or anti-inflammatory cytokine": 0.00449, "steroid dos": 0.00292, "mediate signal pathway": 0.0109, "differentiation-inducing effect": 0.02115, "p38 mapk correlate": 0.00436, "e-selectin-nf-kappa": 0.00012, "sulfhydryl agent dithiothreitol": 0.00281, "stimulate scm-1-producer": 0.01101, "hmba": 0.00037, "enhance nuclear factor": 0.01907, "unrearranged kappa locus": 0.00498, "k562 cell increase gamma-globin mrna": 0.03072, "mrna encode": 0.01526, "maturation pathway": 0.01278, "kappa": 0.01495, "characterize prb-null clone": 0.00492, "primary dna breakage": 0.00988, "dysfunction": 0.00099, "trep binding": 0.01855, "major recent development": 0.00422, "thp": 0.00056, "confers strong transcriptional activity": 0.01462, "34-fold high": 0.00931, "il-6 inducibility": 0.00391, ".0048": 0.0, "reverse lps-mediated endothelial activation": 0.01582, "age-": 0.00012, "cis-acting site": 0.02168, "biological relevance": 0.00217, "synthetic gre oligonucleotides drive chloramphenicol acetyl-transferase expression": 0.01189, "serine kinase target": 0.00792, "primary ebv infection": 0.00492, "nf-at/dna binding defect": 0.01237, "th2 cytokine pattern": 0.00749, "chimeric tcr": 0.00478, "reverse transcription polymerase chain reaction amplification technique": 0.00803, "arg551": 6e-05, "mzf-2 mrna": 0.01526, "cell blast": 0.0768, "understanding belies": 0.00062, "-induced signal pathway": 0.0109, "dose": 0.00316, "differentiating thymocyte": 0.00096, "critical egr family bind element": 0.0081, "mip-1alpha gene": 0.04355, "human proximal sequence element-binding transcription factor": 0.01254, "wide array": 0.00034, "ras-related protein": 0.04529, "augment tcr-mediated il-2 production": 0.00558, "micrograms/d": 0.0, "rare cd3+/cd4+": 0.00068, "selective antagonist": 0.00267, "identical protein": 0.04529, "recipient joint": 0.00034, "tax-expressing t-cell line consist": 0.00827, "serine phosphorylation": 0.00983, "cell-type distribution": 0.00115, "d.zagury": 6e-05, "inducible early growth response protein egr-1": 0.0151, "interleukin-1 signal mediator": 0.0109, "anergized": 0.00031, "alanine": 0.00056, "myeloid leukemia cell line": 0.0384, "kasumi-1 cell": 0.0768, "human embryonic zeta": 0.02508, "patient present": 0.01666, "cell activator oct-2 function": 0.0384, "small deletion": 0.00344, "taxi induction": 0.01607, "camp activator": 0.00552, "base": 0.0062, "non-toxic concentration": 0.0067, "recent study suggest": 0.01348, "dm promoter": 0.02336, "isopropylidine group": 0.00487, "methylation pattern": 0.00549, "cyclized asparagine": 0.00025, "constitutively activate p21ras": 0.01185, "plasmacytoma": 0.00093, "c-jun mrna remain elevated": 0.00763, "recent identification": 0.0014, "similar cellular response": 0.01294, "frequency": 0.00192, "transcript deletion": 0.00599, "v.cholera": 6e-05, "hiv-infected individual experience episode": 0.00205, "structural analysis demonstrate": 0.01065, "truncated form": 0.01055, "cervical carcinoma": 0.0018, "etiologic agent": 0.00422, "optimized rna transcription assay": 0.01405, "lps cellular signaling": 0.00596, "type ii tgase": 0.00633, "human cd34+ hematopoietic stem cell": 0.03072, "tax activity": 0.02925, "methylprednisolone-mediated enhancement": 0.00233, "profile": 0.00304, "synthesize protein": 0.04529, "c/ebpalpha": 0.00087, "627-637": 0.0, "gr deficiency": 0.004, "er+": 0.00037, "transcription-6": 6e-05, "wild- type cd4": 0.00633, "neoplastic group": 0.00487, "cardiac transplant recipient": 0.00027, "ciita require": 0.01315, "alpha,25 dihydroxyvitamin d3": 0.00163, "tg epsilon26 mouse provide": 0.00487, "time maintain ifn-gamma receptor alpha-chain expression": 0.01388, "nm dexamethasone": 0.00394, "diabetic nephropathy oxidative stress": 0.00155, "antiserum": 0.00149, "gcrbeta-specific antibody": 0.00893, "major myeloid lineage": 0.00383, "human ramos": 0.03762, "transcriptional activation mediate": 0.02109, "primer extension analysis": 0.00786, "apoptotic cascade": 0.00214, "consensus gre": 0.00288, "differentiation require simultaneous treatment": 0.00658, "dose dependence": 0.00158, "exhibit strong tcl1 protein expression": 0.01811, "distinct cell surface receptor": 0.0384, "dominant negative activity": 0.0195, "c-fos regulatory region participates": 0.00734, "erythropoietin-induced erythroid differentiation": 0.00786, "genetic variation": 0.00288, "wild-type id3 protein": 0.03019, "small nuclear rna gene": 0.02177, "insulin tolerance test": 0.00325, "committed progenitor cell": 0.0512, "dose-dependent": 0.00161, "transient induction": 0.01607, "hela cdna library": 0.00304, "bind oct-1": 0.02025, "surfactant suppress nf-kappa": 0.00943, "500-bp fragment encompass": 0.00232, "pluripotent islet culture": 0.00414, "truncation": 0.00087, "abolished": 0.00019, "antisense oligonucleotides inhibits cell adhesion": 0.03072, "potential relevance": 0.00605, "tnf alpha mrna level": 0.0091, "endothelial-leukocyte adhesion molecule": 0.00569, "mature mitochondrial form": 0.00703, "early-induced peak": 0.00143, "hiv-1 long terminal repeat": 0.00439, "lymphokine-activated killer cell": 0.0512, "stat3 phosphorylation": 0.00983, "cell neoplasia": 0.0768, "cho-cd14 cell": 0.0768, "chronic inflammatory disorder": 0.00314, "gene product increase expression": 0.02177, "nuclear c-rel": 0.01684, "signal target": 0.01635, "studied": 0.00037, "advanced malignancy": 0.00115, "activate protein-1": 0.01777, "ebv-associated": 0.00062, "monocyte/macrophage function": 0.01331, "hiv-1 increase": 0.02196, "nonalcoholics": 6e-05, "calcium-ionophore activate platelet": 0.01185, "oncogenic human herpesvirus": 0.02508, "intrapulmonary activation": 0.03164, "rar alpha protein": 0.03019, "human monocytic cell line mono mac": 0.0256, "phosphatidylinositol-4-phosphate": 0.0, "epo-r": 0.00037, "vivo dnase": 0.0053, "slow initial decline": 0.00126, "protein present": 0.04529, "mutant subclone": 0.0081, "gammadelta-type": 0.00012, "express c-mpl": 0.01846, "present paper study": 0.00904, "representative adenoviral serotypes": 0.00039, "reduction parallel": 0.00295, "untransformed steroid receptor complex": 0.01286, "intracellular electrolyte": 0.00583, "individual member": 0.00413, "discrimination": 0.00012, "general feature": 0.00217, "tcf/lef function": 0.01331, "dioxyvit action": 0.00499, "clarification": 6e-05, "effective concentration": 0.0067, "thymic population": 0.00307, "autosome": 0.00037, "ala-substituted peptide 430-444,442a": 0.00502, "human promonocytic u937 cell line": 0.03072, "autoreactive": 0.00043, "p300": 0.00012, "jak1 expression": 0.04163, "oct-2a": 0.00223, "identical sensitivity": 0.00236, "il-2-independent activation": 0.03164, "ms-2gamma": 0.00012, "lambda light-chain gene": 0.02903, "twenty-two difference": 0.00425, "elf-1": 0.0018, "signalling": 0.00273, "t3-values": 6e-05, "generate thrombin": 0.00453, "family contribute": 0.00841, "vascular injury": 0.00174, "esc": 0.00031, "il-12r beta": 0.00673, "gc-r number": 0.0053, "favor": 0.0013, "enhance remodeling": 0.00974, "abrogate induction": 0.01607, "influence message stability": 0.00314, "heterodimeric nf-kappa": 0.01414, "main target": 0.00825, "mature b-cell stage": 0.00306, "mab j393": 0.00267, "early fetal thymus": 0.00552, "mutant cell line": 0.0512, "blood vessel increase": 0.01464, "htlv-i replication": 0.00471, "10,11-dihydroxyaporphine": 6e-05, "stromal cell": 0.0768, "staining": 0.00354, "hgata-3 expression plasmid": 0.02775, "active material partition": 0.00395, "sharp bend": 0.00022, "beta,19-epoxy-4,21-dihydroxypregn-4-ene-3,20-dione": 0.0, "hela cell": 0.0768, "human prostatic cancer lncap cell": 0.03072, "effective strategy": 0.00164, "ii bind protein": 0.03019, "serum cortisol": 0.00378, "concerted participation": 0.00031, "exhibit abnormal characteristic": 0.00443, "cytoplasmic nucleoporin ranbp2 promote": 0.00233, "kinetic similar": 0.00673, "c-reactive protein": 0.04529, "haematopoietic": 0.00074, "th1-type response": 0.01942, "hd histogenesis": 0.00047, "oct-1-binding genotype": 0.0004, "phosphatidic acid accumulation": 0.00571, "ap1 bind site upstream": 0.01084, "transcription factor nf kappa b. macrophage-colony-stimulating factor": 0.00803, "additional hhv-6 orfs": 0.00227, "nuclear transcription study": 0.01873, "proil-1 beta": 0.00673, "azt": 0.0005, "human papillomavirus-": 0.03762, "mice deficient": 0.00136, "glucocorticoid receptor site": 0.01714, "interleukin 6-induced differentiation": 0.00786, "base pair substitution": 0.00207, "cytoplasmic carboxyl terminus": 0.00267, "10-fold low activity": 0.0195, "pml/raralpha fusion protein": 0.03019, "intracellular receptor": 0.02571, "molecular mechanism control cd19 gene expression": 0.01452, "ba-induced overexpression": 0.00382, "macrophage-differentiation": 0.00043, "glucocorticoid represent": 0.0085, "clinical presentation": 0.00425, "transcription factor nf-at": 0.01907, "hyperphosphorylated form": 0.01055, "tcr/cd3 cross-linking": 0.00242, "autocrine mechanism": 0.01058, "uncultured leukemic": 0.00251, "regulatory role": 0.01328, "intracellular substrate": 0.00583, "proximal beta": 0.00673, "ab-vdr": 6e-05, "megakaryocyte growth": 0.00819, "human lcr/gamma-globin gene": 0.02903, "cell surface marker include": 0.0384, "acute process": 0.00444, "traf1/traf2 heteroaggregates": 6e-05, "ltr reporter construct": 0.00484, "ifn-activated nk cell": 0.0512, "proteasome-dependent stimulus": 0.0027, "factor control vascular-specific expression": 0.02081, "non-a-t individual": 0.00409, "bipolar disorder": 0.00223, "gcs": 0.00025, "tissue specific regulation": 0.00825, "zap-70 tyrosine kinase": 0.00792, "great negative feedback sensitivity": 0.00257, "mitogen-activated protein kinase pathway": 0.02264, "ap-1 binding site": 0.01445, "gm-csf-induced peripheral blood polymorphonuclear": 0.00296, "hla-dr-": 0.00025, "important transcriptional factor": 0.01907, "block stat3 activation": 0.02109, "mar-bp1 migrates": 0.00012, "anti-allergy agent azelastine hydrochloride": 0.00211, "amino acid distinguish": 0.00571, "hla-dm": 0.00031, "immunosuppressive drug rapamycin": 0.00225, "msr promoter": 0.02336, "negative expression": 0.04163, "sephadex lh-20 column": 0.0001, "aid patient": 0.01666, "critical hormone": 0.00444, "icp27 protein": 0.04529, "irreversible terminal differentiation induce": 0.0127, "lung transplant patient": 0.0111, "reservoir": 0.00093, "report demonstrate": 0.01597, "mutant nm23-h2his protein": 0.03019, "cell line": 0.0768, "average angle": 0.00028, "lncap cell variant": 0.0512, "apparent correlation": 0.00248, "stat transcription factor": 0.01907, "induce ifn-gamma production": 0.01694, "tcrzeta-associated signaling element": 0.01115, "calcineurin/nfat pathway": 0.01278, "activated cd4+": 0.00589, "lps core-": 0.0035, "nonstimulated platelet": 0.00372, "rabbit beta globin gene": 0.02177, "gm-csf locus": 0.00329, "s-x-y regulatory region": 0.00978, "mode": 0.00149, "blk promoter activity": 0.0195, "lps-induced event": 0.00552, "tnf-alpha-mediated degradation": 0.00332, "dna-bound multi-protein complex": 0.01123, "beta-lipoprotein": 0.00012, "immunological feature indistinguishable": 0.00145, "monocytic/macrophage pathway": 0.01278, "vitamin d3-responsive element": 0.01115, "u937 monocytic cell result": 0.0384, "pituitary-specific": 0.00043, "potent thiol antioxidant": 0.00238, "cd4 gene": 0.04355, "transactivation study show": 0.01733, "upstream prl response element": 0.00971, "il-3 deprivation": 0.00127, "rare": 0.00136, "alpha-tcp-induced decrease": 0.00971, "nf-kappab target dna sequence trigger": 0.0065, "ile50val variant": 0.00276, "ltr region link": 0.00978, "erythropoietin cooperate": 0.00118, "monocyte gene expression": 0.02903, "lal expression": 0.04163, "selectively bind": 0.02025, "proline-rich region": 0.01467, "mub site": 0.02168, "e47 induce efficient expression": 0.02081, "induce detectable cd28 tyrosyl phosphorylation": 0.01016, "regulate b7.1 expression": 0.02775, "marked reduction": 0.00295, "cooperation": 0.0018, "mutant p85": 0.0081, "heart": 0.00105, "important transcriptional element": 0.01115, "gata element": 0.01672, "nre gamma prevent rfx1": 0.00262, "and/or c-rel": 0.0045, "preformed p-selectin": 0.00047, "il-7-treated cell": 0.0768, "apoptotic mechanism": 0.01058, "block hiv infection": 0.00715, "csa alters nfatp migration": 0.00087, "t-cell factor": 0.0286, "fasl transcription": 0.0281, "15.5+/-1.8 versus 8.9+/-1.2 nmol/l": 0.00068, "inhibit p24 antigen production": 0.00952, "signaling pathway recruit": 0.00852, "mbp gene transcription": 0.02903, "posttranscriptional regulation": 0.01008, "3-o-mg": 0.00031, "signal branch": 0.01635, "gp ib alpha": 0.0078, "pdbu/iono": 0.00012, "ldl lipid and/or": 0.003, "pre-b cell-specific gene remain silent": 0.01742, "estrogen responsive unit": 0.00215, "plasma aldosterone": 0.00375, "altered phenotype suggestive": 0.00244, "12-o-tetradecanoyl-phorbol-13-acetate": 0.00012, "correct": 0.00068, "pattern recognition receptor": 0.01714, "cellular event": 0.00893, "il-2-induced beta-casein": 0.0013, "affect subcellular distribution": 0.00531, "lectin-induced switch": 0.00245, "-beta mediate anti-apoptotic effect": 0.01058, "vary condition": 0.0036, "lineage specificity": 0.00366, "protein render defective due": 0.02264, "t-helper cell": 0.0768, "icam-1 steady-state mrna": 0.01017, "suppressing central nervous system": 0.00333, "retinoid differentiation therapy": 0.00786, "endogenous thyroid hormone receptor alpha": 0.01029, ":3775": 6e-05, "il-10 suppression": 0.00422, "assay cat enzyme activity": 0.01462, "monocyte show": 0.02599, "gy": 0.00025, "cd44 mrna expression": 0.02775, "provirus induction": 0.01607, "interleukin 2-induced lymphocyte proliferation": 0.00741, "bacterial surface": 0.00515, "steroid addition": 0.00673, "upstream promoter sequence regulate": 0.01168, "jurkat cell co-expressed": 0.0512, "microbial product": 0.00533, "mpo": 6e-05, "thy-1 gene promoter resemble": 0.02177, "human ets-1 protein": 0.03019, "mycoestrogens": 0.0, "removal": 0.00074, "atherogenesis human ldl induce": 0.01881, "proximal polya site": 0.01445, "active suppression result": 0.01073, "ebv-immortalised b-cells": 0.00093, "dqa1*0501/dqb1*0201": 0.0005, "yj cell line exhibit eosinophilic characteristic": 0.0256, "plate-bound anti-cd3 monoclonal antibody": 0.00447, "peripheral blood mononuclear leucocyte": 0.00296, "cell homeostasis": 0.0768, "lmp1- tumour cell": 0.0512, "unrecognized mutation": 0.00592, "not-self antigen": 0.00819, "rxr-rar reporter construct": 0.00484, "respiratory epithelium": 0.00078, "commitment event": 0.00552, "5.5-fold": 0.00012, "cellular redox state": 0.00596, "detrimental effect": 0.02115, "nf kappa b/rel bind site": 0.00867, "asthmatic": 0.00161, "require agent": 0.01315, "il3 gene": 0.04355, "unprecedented fashion": 0.00161, "supramaximal dose": 0.00158, "feature associate": 0.01092, "dna-protein binding study": 0.01237, "ebv bind": 0.02025, "shp1 protein tyrosine phosphatase": 0.02264, "regulate cd40-mediated immunoglobulin class switch": 0.00501, "human population": 0.03762, "result constitute": 0.0161, "hgata-2": 0.00012, "nm vd3": 0.00093, "multi-organ failure": 0.00136, "lam -and lps-inducible il-6 promoter activity": 0.00975, "tyrosine-based signal motif": 0.0109, "amino acid sequence identity": 0.00813, "nf-kappab-dependent gene expression": 0.02903, "gr expression level": 0.02775, "nfat site": 0.02168, "nb4 cell pulse-exposed": 0.0512, "o-side chain-specific mab": 0.00178, "microgram/ml": 0.00031, "cytoskeletal": 0.0005, "drive colony-forming unit granulocyte-macrophage": 0.00082, "granulocytic colony formation": 0.00323, "optimal slp-76 function": 0.00887, "anti-ifn-alpha/beta antibody": 0.00893, "receptor alpha chain induces cepsilon germline transcript": 0.00735, "murine cell line": 0.0512, "monocyte decrease proteasome-mediated degradation": 0.00599, "antigen receptor engagement": 0.01714, "common regulatory element": 0.01115, "kbf1": 0.0005, "nf-il4": 0.00031, "vitro granulocytic differentiation": 0.00786, "target cell": 0.0768, "translated p50/p65 dimer": 0.0007, "full proliferative response": 0.01294, "present result show": 0.01733, "stearic": 0.00012, "apoptosis occur": 0.0089, "cd3+": 0.00037, "il3 colony": 0.00171, "related 16-bp": 0.00236, "mantel-cox": 6e-05, "lymphocyte initiate signal transduction cascade": 0.00654, "independent cloning": 0.00363, "selective transcriptional repressor": 0.00767, "adenomatous polyposis coli-binding eb1-like gene family": 0.01452, "spi-c rna": 0.00456, "enhanced cytolytic activity": 0.0195, "chimera inhibit": 0.01904, "id3 asp5 mutant": 0.0054, "uf-1": 0.00031, "human anti-e. chaffeensis serum": 0.01881, "important cofactor": 0.00689, "major depressive disorder remain unexplained": 0.0023, "prdii domain link": 0.00804, "activated macrophage": 0.00589, "sequence bound": 0.01625, "down-modulation": 0.00043, "anti-rantes": 0.00012, "phorbol myristate": 0.00543, "apo-1/fas": 0.00012, "c.h.r": 0.0, "yeast two-hybrid system": 0.00445, "additional effect": 0.02115, "193-bp region": 0.01467, "retroviral vector encode": 0.00569, "ck-1/cd28re region": 0.01467, "severe skewing": 0.00211, "ifn-gamma mrna": 0.01526, "viral dna fragment": 0.00988, "mineralocorticoid receptor": 0.02571, "iga": 0.00037, "plasma ria": 0.00375, "transient transfection analysis": 0.00786, "ptt shift": 0.00183, "vivo differentiation therapy": 0.00786, "cd4+ t-cell clonal line": 0.00827, "lymphokine-activated killer": 0.00093, "sharp contrast": 0.00546, "optimal kappa b/rel dna-binding motif": 0.0035, "prompt rapid apoptosis": 0.00593, "cytolysis": 0.00074, "antiinflammatory effect": 0.02115, "twhf extract stimulation": 0.00746, "monocyte tf expression": 0.02775, "lps concentration": 0.0067, "tlr2 associate": 0.01092, "study proliferate": 0.01355, "level decline": 0.01821, "computational approach": 0.00164, "overexpressed egr-1": 0.00257, "terminal peptide": 0.00754, "il-4 expression": 0.04163, "abnormal camp": 0.00257, "oxygen radical scavenger enzyme": 0.00155, "nf-kappab/nfat family": 0.00841, "anti-choleretic agent": 0.00422, "alternative possibility": 0.00205, "downmodulation": 0.00031, "inhibit tcr-mediated apoptosis": 0.0127, "contrasting effect": 0.02115, "early adult hpc": 0.00552, "long-range de novo inactivation": 0.00087, "cell-cycle position": 0.00236, "gata-4 show": 0.02599, "sex-": 6e-05, "ten atopic asthmatic subject": 0.00177, "borrelia burgdorferi": 0.00019, "mono mac": 0.0005, "suggest gamma-ifn inhibition": 0.01348, "non-tumor material": 0.00074, "cell transfectants express wild-type": 0.0384, "related protein c/ebp alpha": 0.02264, "ie2 transactivation": 0.00515, "decreased class ii expression": 0.02081, "nov2": 6e-05, "multiple tumor necrosis factor receptor": 0.01144, "mature myeloid cell suggest": 0.0384, "tissue-specific metabolism": 0.00217, "fosb/g0s3": 0.00012, "troublesome": 0.0, "epstein-barr virus sm protein": 0.02264, "myd88 gene result": 0.02903, "beta ii": 0.00726, "cell immunoglobulin": 0.0768, "specific positive regulation": 0.00825, "essential hypertensive": 0.00487, "twenty-seven patient": 0.01666, "glutathione synthesis": 0.00583, "myeloid leukemia": 0.00499, "mhc class ii antigen": 0.00409, "cell line el-4": 0.0512, "il-2r": 0.00502, "multiple signal": 0.01635, "octamer probe": 0.00261, "cloned cd8+": 0.0014, "distinct type": 0.00949, "tnf-alpha induced nuclear localization": 0.00842, "mzf-1 expression vector": 0.02775, "c-rel": 0.0049, "nf-kappa b-like activity": 0.0195, "4-methylsulphinylphenyl": 0.00012, "ectopic decidua": 0.00081, "partial responsiveness": 0.00323, "bipartite human interleukin-4": 0.02508, "additional size heterogeneity": 0.00227, "selective reduction": 0.00295, "strong nf-atp-mediated transactivation": 0.00343, "prognostic indicator": 0.00047, "il-18": 0.00019, "operate": 0.00112, "data regard": 0.00254, "hexon": 0.00031, "de novo ebv infection": 0.0031, "t-cell il-5 synthesis": 0.00641, "additional immunohistochemical staining": 0.00227, "vitd3 receptor": 0.02571, "alpha-zearalenol": 0.00019, "position -69": 0.00236, "pml/rar alpha fusion transcript": 0.00585, "additional c/ebpalpha target gene": 0.02177, "extreme c-terminus": 0.00028, "hematopoietic origin include": 0.00959, "kilobases": 0.00043, "mouse inos gene": 0.02903, "monomeric": 0.00031, "glucuronides": 0.00037, "monocyte-specific promoter activity": 0.0195, "il-2r alpha enhancer bind nf-kappa": 0.0081, "cell cycle control kinase cdc2": 0.03072, "constitutively active mapkk-1": 0.00395, "viability": 0.00099, "marked enhancement": 0.00233, "inflammatory mediator lipopolysaccharide": 0.00314, "stat-1 signal pathway provide": 0.00817, "pml/rar-alpha peptide": 0.00754, "herpes simplex": 0.00074, "oncogenic event": 0.00552, "partial explanation": 0.00143, "element upstream": 0.01672, "p65 protein": 0.04529, "octamer-binding site reduces transcription": 0.01405, "control underwent apoptosis": 0.00868, "ca2+ dependent": 0.00388, "ubiquitous transcription factor": 0.01907, "functional phosphoserine residue": 0.00544, "culture double time": 0.00414, "-dependent cell-free activation system": 0.01582, "stp-c488": 0.00043, "prednisolone": 0.00081, "il-2-induced factor": 0.0286, "beta-like globin cluster": 0.00134, "virus-exposed": 0.00019, "severity": 0.0005, "rar-specific": 0.00043, "nf-e2 binding site": 0.01445, "viral immediate-early transactivator": 0.00488, "genital tract infection": 0.00414, "rat vascular smooth muscle cell": 0.03072, "advanced tuberculosis": 0.00105, "vmax": 0.00031, "heterodimerization partner": 0.00081, "transfected cl-01 cell": 0.0512, "e-box consensus motif": 0.00583, "serine/threonine phosphatases-1": 0.00065, "immature hematopoietic ba/f3 cell": 0.0384, "g0/g1": 0.00093, "sensitized": 0.00012, "peak response": 0.01942, "gata-binding protein family member": 0.02264, "lncap": 0.00081, "aitl stain": 0.00096, "induce th1 development": 0.01694, "receptor alpha chain": 0.01714, "identical concentration": 0.0067, "hepatic htc cell": 0.0512, "bcr-induced increase": 0.02196, "unexpected observation": 0.00149, "female embryonic development": 0.00422, "u937 cell undergoing apoptosis": 0.0384, "cytoplasmic domain common": 0.00804, "receptor sequence": 0.02571, "hl-60/vinc": 0.0005, "patient affect": 0.01666, "6.5-": 6e-05, "32-kda nuclear phosphoprotein": 0.01123, "primary lymphocyte culture show partial independence": 0.00866, "multiple molecular partner": 0.00459, "il-2 responsiveness require": 0.00877, "fhit intragenic transcript deletion": 0.00299, "coincident": 0.00043, "specific monoclonal antibody": 0.00825, "molecular alteration responsible": 0.003, "secrete prl": 0.00208, "ca2+ bind": 0.02025, "ankyrin motif-rich protein include": 0.02264, "xist-specific fish": 0.00028, "hyperdemarcation": 0.00012, "stat1": 0.00571, "transient assay": 0.01002, "ebna-1 gene": 0.04355, "b-cell antigen receptor complex": 0.01286, "human ebv": 0.03762, "remain detectable": 0.00521, "basic helix-loop-helix protein-mediated regulation": 0.00504, "modulator": 0.00087, "positive transcriptional activator": 0.00767, "nfat transcriptional activation": 0.02109, "great": 0.00409, "calcium-mediated": 0.00012, "megakaryocytic": 0.00211, "safety reason": 0.00012, "inducible egr-1 protein": 0.03019, "activate human nk cell": 0.0384, "csfs": 0.00012, "potent suppressive property": 0.00265, "bcl-6 mutation represent": 0.00395, "significant number": 0.0053, "155+/-31": 6e-05, "gggaactacc": 6e-05, "-induced apoptosis": 0.0089, ":16983": 0.0, "encode related protein": 0.03019, "beta-binding profile": 0.00152, "cell type-specific activation": 0.0512, "ie-1": 0.00056, "ribonuclease protection": 0.00081, "p65 subunit": 0.00484, "effective activation": 0.03164, "distinct activity": 0.02925, "steady state mrna level": 0.0091, "tal1 gene occur": 0.02903, "anti-cd45 antibody": 0.00893, "brl49653": 0.00012, "selective cyto-differentiating effect": 0.0141, "adjacent inverted ets bind motif": 0.0081, "hematopoietic growth factor release": 0.0143, "il-2r gamma": 0.0044, "similar rise": 0.00673, "define therapeutic target": 0.0055, "n-terminal regulatory serine": 0.00455, "human nf-kappa": 0.03762, "detect surrogate tg receptor": 0.01286, "characterize estrogen receptor": 0.01714, "strong predisposition": 0.00347, "x-linked severe combine immunodeficiency characterize": 0.0017, "negative regulatory dna sequence": 0.00813, "sequence analysis reveal": 0.01084, "anti-lambda antibody reveal": 0.00732, "er content": 0.00264, "irradiation": 0.00093, "well-characterized morphology": 0.00087, "hcd57 erythroid cell": 0.0512, "receptor mutant show low level": 0.0104, "abundant cell generate": 0.0512, "plasmid carry multiple copy": 0.00344, "bovine fkbp": 0.0009, "rfx complex": 0.01684, "considerable change": 0.0063, "biphasic kinetics": 0.00167, "hiv-1 kappab oligonucleotide": 0.00585, "cox-2 activity": 0.02925, "ba-induced erythroid differentiation": 0.00786, "direct transcriptional target gene regulate": 0.01742, "cognate ag": 0.00158, "cytoskeleton": 0.00037, "human ada lcr-directed transgene expression": 0.01665, "ca2+-free medium": 0.0014, "cd40 negative": 0.00515, "glucocorticoid-receptors": 0.00012, "56-59-kilodalton protein": 0.04529, "allergic disease associate": 0.00728, "leucocyte-activating": 0.00012, "ebna-2a": 6e-05, "hsv-1 background": 0.00115, "cd11/cd18": 0.00037, "-beta promote": 0.00465, "term latency iii": 0.00275, "langerhans cell": 0.0768, "class ii expression": 0.02775, "kaposi": 0.00019, "pbyf": 6e-05, "triggering role": 0.01328, "lps-stimulated il-1ra secretion": 0.00285, "zap-70 responsiveness": 0.00323, "humara allele": 0.0022, "subsequent expression": 0.04163, "pleiotropic cellular transcription factor": 0.0143, "patient show residual positivity": 0.013, "base substitution": 0.0031, "interactive mechanism regulate monocytic": 0.00627, "ifn-beta": 0.00186, "hiv-infected human": 0.03762, "e3 site": 0.02168, "retroviral particle transduce tat": 0.00129, "inverted ccaat box": 0.00203, "up-regulate cd14": 0.00171, "interferon-gamma-stimulated piec clone transfected": 0.00369, "tentative leucine-zipper structure": 0.00213, "three-dimensional positioning": 0.00012, "methylation-sensitive hpaii site": 0.01445, "related interaction": 0.00986, "human monocyte lead": 0.02508, "b3": 0.00012, "maximal increase": 0.02196, "corneal endothelium": 0.00062, "generate rabbit antiserum": 0.00302, "withdrawal": 0.00056, "alveolar epithelial cell": 0.0512, "calcium show": 0.02599, "renal salt loss lead": 0.00498, "lin- murine bone marrow progenitor cell": 0.0256, "abnormal": 0.00391, "post-translationally": 0.00031, "plasma cell": 0.0768, "consensus binding site": 0.01445, "androgen receptor behavior": 0.01714, "intralymphocytic sodium": 0.00186, "healthy control": 0.01303, "host inflammatory response": 0.01294, "glucocorticoid-responsive element": 0.01672, "stimulate human immunodeficiency virus type": 0.01505, "proximal lck promoter": 0.01557, "pleiotropic cytokine affect growth": 0.00561, "degradative action": 0.00499, "signal transducer": 0.01635, "supt": 6e-05, "b-myb": 0.00019, "standard culture condition": 0.00414, "pebp2/cbf site": 0.02168, "dra reporter plasmid rescue expression": 0.01665, "factor act": 0.0286, "otf2": 0.00031, "tumor-specific immune response": 0.01294, "burkitt lymphoma": 0.00226, "putative cis-acting control": 0.00868, "kruppel-like zinc-finger motif": 0.00583, "promyelocytic feature": 0.00217, "fate": 0.00087, "bcl6 gene": 0.04355, "idbp": 0.00019, "ineffective": 0.00068, "protein-tyrosine phosphatase": 0.00264, "hsp27": 0.00025, "proteasome": 0.00174, "ltr-mediated transcription": 0.0281, "repress interleukin": 0.00276, "viral growth rate": 0.00546, "cd2 pathway": 0.01278, "d.a.": 0.00012, "myelogenous leukemia": 0.00499, "respective response element": 0.01294, "single nucleotide polymorphism": 0.0024, "mrl-ipr/ipr": 0.00012, "gel mobility shift assay confirm": 0.00401, "dna-relaxing activity": 0.02925, "distinguish heterozygous carrier": 0.00074, "single stimulus": 0.0036, "dm increase": 0.02196, "cotton-top tamarin b95-8 cell": 0.0384, "active compound": 0.00592, "rar-specific ligand am80": 0.00395, "cell monolayers demonstrate vector expression": 0.03072, "151-bp region": 0.01467, "human dr alpha gene": 0.02177, "ribophorin": 0.00019, "cytokine-stimulated transcription factor": 0.01907, "nuclear p50p50": 0.01684, "pkc- dependent signal system": 0.00817, "p105 gene": 0.04355, "present study reveal": 0.00904, "early infancy": 0.00828, "post-gc phenotype": 0.00366, "endogenous sp3 expression": 0.02775, "ptk": 0.00105, "ptk genistein": 0.00068, "rapid mode": 0.00323, "intravenous pcr injection lead": 0.00498, "protein latency expression": 0.03019, "single-strand conformation polymorphism": 0.00118, "syk-deficient dt-40": 6e-05, "isg15": 0.00025, "x1 box activity represent distinct dna bind protein": 0.01132, "human cd44 promoter": 0.02508, "localized pain condition": 0.0024, "cdc42 effector n-wasp": 0.00184, "malignant disease": 0.00673, "epstein-barr virus-induced cytotoxic": 0.0019, "transcription factor term signal transducer": 0.01144, "hmg protein family regulate": 0.02264, "m. tuberculosis infection": 0.00414, "80-kd stat5a protein": 0.03019, "generate growth factor": 0.01907, "ebv-induced immortalization": 0.00062, "d20s42": 0.00012, "okadaic acid provide": 0.00571, "tsc2 mutation": 0.00592, "ald-treated": 0.00019, "specific component": 0.01238, "viral antigen": 0.00819, "induce monocytic differentiation": 0.01694, "p. aeruginosa": 0.00065, "functional hiv tat protein": 0.02264, "alternative rna splicing": 0.00304, "optimal agent": 0.00422, "g/g": 0.00019, "transcription stat5": 0.0281, "promyelocyte stage": 0.00248, "2-50 gy result": 0.01073, "murine macrophage-like cell": 0.0512, "p85 construct reveal cooperative binding": 0.00742, "radiation trigger": 0.00409, "human thp-1 monocytic leukemia cell culture": 0.0256, "25-hydroxyvitamin d3": 0.00245, "platelet factor": 0.0286, "xiste-": 0.00019, "genome offer": 0.0014, "hhv-6 transactivation": 0.00515, "quieiescent patient": 0.01666, "120-kda protein": 0.04529, "diverse tcr profile": 0.00318, "a2": 0.00068, "combine mutation": 0.00592, "differentiate major depressive disorder": 0.00287, "weak": 0.00347, "skin sample": 0.00208, "induce 5.7-fold": 0.0254, "itf-2": 6e-05, "octamer-binding site": 0.02168, "x-ray-treated human colonic carcinoma cell line": 0.0256, "high-affinity receptor": 0.02571, "adenovirus dna": 0.01483, "disparate function": 0.01331, "human endothelial": 0.03762, "suppressed granulocytic differentiation": 0.00786, "1.955-kb viral segment": 0.00488, "forskolin": 0.00099, "dynes/cm2": 0.0, "membrane expression": 0.04163, "human proenkephalin gene": 0.02903, "promoter reveal": 0.02336, "inductive stimulation": 0.0112, "activate receptor-1 activation": 0.02109, "early ra addition": 0.00552, "phosphorylation pattern": 0.00983, "hla b8+ homozygous lcl": 0.00096, "c/ebpalpha mrna expression decrease": 0.02081, "cam-k ii remain unknown": 0.00363, "adt": 0.00037, "oxygen radical": 0.00099, "cortisol depletion": 0.00295, "cl-01": 0.00031, "phospholipid surface": 0.00515, "transformation-related activity": 0.02925, "tnfr1": 0.0005, "endogenous tyrosine amino transferase gene": 0.01742, "similar selective effect": 0.0141, "proline": 0.00056, "caml-interactor": 6e-05, "thrombin-induced p65 homodimer binding": 0.00927, "culture human umbilical vein endothelial cell": 0.0256, "pkc-induced nuclear nf-kb activity": 0.01462, "bone marrow-derived stromal cell line reveal": 0.0256, "human il-4": 0.03762, "decreased nf kappa": 0.00498, "inhibited induction": 0.01607, "/rela": 0.00012, "minute": 0.00087, "stimulate factor activity": 0.0195, "pathway suggest": 0.02022, "pou-dependent conformational change": 0.0042, "peripheral blood mononuclear cell glucocorticoid receptor": 0.0256, "powerful microbicidal pathway": 0.00852, "therapeutic chemical": 0.00167, "transcriptional factor include": 0.01907, "-dependent transcriptional event": 0.00767, "normal cell population exhibit intrinsic proliferative behavior": 0.02194, "typical seminoma": 0.00118, "e. verdin": 0.00102, "complete resistance": 0.00326, "attenuated enhancer activity": 0.0195, "sensitive identification": 0.00273, "relative binding affinity": 0.01237, "normal expansion": 0.0121, "vivo footprint analysis show": 0.013, "numerous gene fall": 0.02903, "mutant leukemic cell resistant": 0.0384, "proc natl acad sci": 5e-05, "p-bromophenacyl-bromide": 0.00012, "basal total white blood cell": 0.03072, "nucleic acid sequence": 0.01084, "heat-shock fail": 0.00347, "t-cell transcription factor nfat": 0.0143, "inducible transcription factor bind site": 0.01144, "hil-5 promoter activity": 0.0195, "man": 0.00043, "nonstimulating cd28 mab": 0.00215, "zta up-regulation": 0.00276, "il-2r beta support": 0.00449, "block nf-kappab inhibits": 0.00715, "spl": 0.00025, "eklf-/- cell": 0.0768, "cam kinase ii": 0.00792, "kda/65 kda": 0.00109, "abdominal obese subject": 0.00236, "ebna2": 0.00279, "ciita gene": 0.04355, "pilot protein": 0.04529, "pac-1": 0.00019, "bp -34": 0.00267, "steel factor affect scl expression": 0.01665, "human mononuclear cell": 0.0512, "viral dna polymerase inhibitor phosphonoformic acid": 0.00494, "pu.1 bind": 0.02025, "adverse environmental condition": 0.0024, "lps-induced il-6": 0.00391, "urinary protein excretion": 0.03019, "bcs stimulate transcription": 0.01873, "disease progression induce": 0.01694, "latent phase": 0.00276, "intact gata element": 0.01115, "e1 region": 0.01467, "gradual downmodulation": 0.00019, "p95vav play": 0.0071, "functional ebna2": 0.00816, "bimodal increase": 0.02196, "suppress adhesion": 0.00611, "glioblastoma cell express": 0.0512, "good understanding": 0.00102, "self-reactive": 0.00012, "catalytic": 0.00118, "normal adult": 0.0121, "framework": 0.00031, "antiandrogens": 0.00031, "generate": 0.00906, "chi2": 6e-05, "il-5-nonproducing": 0.00019, "octamer bind transcription factor": 0.0143, "mtcp1 locus configuration": 0.00192, "cocl2-induced cellular signal direct increased expression": 0.01388, "class ii major histocompatibility complex mutant cell line clone-13": 0.01707, "nb4 cell line": 0.0512, "unstimulated cell": 0.0768, "wild-type shp2": 0.00378, "interleukin-2 receptor alpha-chain enhancer": 0.01286, "activation-induced expression": 0.04163, "eliminate": 0.00248, "b-cell epitope": 0.00459, "healthy": 0.00354, "irreversible reduction": 0.00295, "ul50": 6e-05, "stat5 bind": 0.02025, "phorbol myristate acetate induce egr-1 mrna expression": 0.01189, "id3 mrna": 0.01526, "e2f-mediated transcription": 0.0281, "camkiv": 0.00031, "mlvs": 6e-05, "janus protein kinase": 0.03019, "c-jun early response gene": 0.02177, "ribonucleoproteins ro": 0.0009, "53-kd protein": 0.04529, "potential health impact": 0.00403, "diversified": 6e-05, "tracer": 6e-05, "cd18 express": 0.01846, "nitro blue tetrazolium reduction assay": 0.00401, "12-day period": 0.00127, "b-lymphocyte cell cycle activation": 0.0384, "synthesis 30-fold": 0.00583, "cd36 transfected chinese hampster ovary": 0.00148, "opioid effect": 0.02115, "myb site": 0.02168, "serum-grown hl60 cell": 0.0512, "rsk": 6e-05, "severe pathological condition": 0.0024, "active renin": 0.00592, "stem secondary structure": 0.00213, "poz domain": 0.01207, "p38 mapk isoforms": 0.00205, "human retrovirus": 0.03762, "vdr protein": 0.04529, "enhance basal activity": 0.0195, "process p105": 0.00444, "constituent": 0.00043, "il-2r alpha cell surface expression": 0.03072, "stat1 p91": 0.00285, "fragmentary": 0.0, "gerald": 0.00012, "blast sensitivity": 0.00236, "hematopoietin receptor": 0.02571, "cell nhl": 0.0768, "bind specificity": 0.02025, "tg induce increase": 0.01694, "vivo rela homodimers": 0.00354, "bcl6 play": 0.0071, "b-laip": 6e-05, "lymphoma cell line": 0.0512, "regulate ar gene transcription": 0.02177, "g/kg/h": 0.0, "leucocytic er": 0.00264, "alpha globin regulatory element": 0.00836, "platelet peroxidase activity": 0.0195, "pronounced inhibitory effect": 0.0141, "endothelial vcam-1 expression": 0.02775, "express adhesive molecule": 0.0123, "correspond tam-treated": 0.00177, "secosterol": 0.0, "proximal ap-1 site": 0.01445, "enhance tnf-alpha induced neutrophil apoptosis": 0.0039, "prostatic cell": 0.0768, "lps response": 0.01942, "rar alpha play": 0.0078, "liver belong": 0.00118, "32-36 day result": 0.01073, "hypomelanosis": 0.00012, "lps dose dependent": 0.00258, "retinoic acid-induced expression": 0.02775, "consistent": 0.00409, "viral peptide display": 0.00502, "mutated nef gene express": 0.02177, "entire il-2 promoter-enhancer": 0.00744, "disease phenotype": 0.00673, "janus": 0.0023, "signalsome": 0.00043, "chronic phase": 0.00397, "mediate adhesion": 0.01231, "retinaldehyde dehydrogenase": 0.00053, "c-fos production": 0.01042, "il-2 deprivation apoptosis": 0.00744, "cd40 expression": 0.04163, "sodium salicylate": 0.00186, "bait": 6e-05, "tyrosine phosphorylation status": 0.00656, "physiotherapy": 0.0, "intestinal hyperabsorption": 0.00078, "core sp1 consensus element": 0.00836, "performance status": 0.00217, "haemin": 0.00031, "specific nuclear ra receptor": 0.01286, "5'-deletion fragment": 0.00347, "form multiple complex suggest": 0.01011, "chromosome lack xist dna": 0.00741, "metabolic step": 0.00189, "aminoacid cys22-gly22": 6e-05, "aids-gr patient": 0.01666, "nuclear t3r mbc": 0.01123, "membrane-proximal box": 0.00304, "bp crh promoter fragment": 0.01168, "kmo": 6e-05, "human u-937 monoblast": 0.02508, "ndp kinase activity": 0.0195, "mab g10-2": 0.00267, "oscillatory ca2+ signal": 0.0109, "p49/p65": 0.00025, "enhanced ap-1 transcriptional activity": 0.01462, "jnk inhibit il-2 promoter activation": 0.01266, "monocyte number": 0.01197, "monocyte": 0.02395, "plasma free cortisol concentration": 0.00335, "perennial rhinitis": 0.00022, "mimic human apl": 0.02508, "specialized process": 0.00444, "gr number": 0.0053, "cd40-specific mab g28-5": 0.00178, "stimulatory effect": 0.02115, "regulate zinc finger protein": 0.02264, "chronic hiv-1 replication": 0.00585, "glial cell origin": 0.0512, "antisense rxr-alpha sequence": 0.01084, "c-terminal ankyrin motif domain": 0.00603, "c-fms": 0.00037, "il-5 synthesis": 0.00583, "lps-induced phosphotyrosine residue": 0.00155, "ki-67": 0.00118, "downstream target gene regulate": 0.02177, "steroid bind domain": 0.0135, "estrogen receptor alpha": 0.01714, "atl cell overexpressed": 0.0512, "enhance il-2": 0.01117, "-20": 0.00031, "coordinate manner": 0.00282, "calcium-dependent manner": 0.00282, "lipopolysaccharide-induced transcription factor regulate tumor necrosis factor alpha gene expression": 0.00871, "hbob1": 6e-05, "selenium-mediated inhibition": 0.01061, "transcriptional mechanism": 0.01151, "vdr messenger rna": 0.00304, "hyperkalemia suggest pha": 0.01348, "small percentage": 0.00313, "interferon-gamma-induced factor bind": 0.01907, "spouse": 6e-05, "nm 2,3,7,8-tcdd": 0.00093, "c/ebp epsilon protein": 0.03019, "mononuclear leukocyte isolate": 0.00318, "il-2rbeta dna bind motif differ": 0.0081, "differential monocyte adhesion": 0.00798, "tnfalpha synthesis": 0.00583, "primate": 0.00112, "virus stock": 0.00887, "heptp": 0.00056, "cytokine tumor necrosis factor alpha": 0.01144, "il-13 induced dose-": 0.0036, "unmanipulated conventional": 0.00065, "11:1321-1326": 0.0, "jnk activation": 0.03164, "induce stat3 tyrosine phosphorylation": 0.0127, "prothrombinase complex": 0.01684, "plaque formation": 0.00484, "p41": 6e-05, "gene activation pathway": 0.02903, "icam-1 remain overexpressed": 0.00347, "t/nk subset": 0.00192, "present hla molecule": 0.00569, "human il-1beta gene expression": 0.02177, "human t-cell lymphotropic virus": 0.01881, "guinea pig provide": 0.0043, "jnk1": 0.00043, "gp55-modified epor generate": 0.00302, "fc gamma riia cross-linking": 0.0022, "htlv-i transcriptional activator tax": 0.00575, "sds-polyacrylamide gel electrophoresis gel": 0.00041, "stat5a predominates": 0.00071, "ifn-gamma-producing": 0.00025, "cd45r0": 0.00037, "hdmec": 0.00025, "extracellular matrix protein fibronectin": 0.02264, "kappa b-alpha inhibits transcription factor nf-kappa": 0.00953, "induce cd8 antigen expression": 0.02081, "cpkc-betaii": 6e-05, "trident": 0.0005, "h. immunofluorescent staining": 0.00118, "class ii transcriptional mutant cell line": 0.0256, "extension": 0.00037, "dq8-binding hsv vp16 peptide": 0.00377, "non-specific manner": 0.00282, "b-cell chronic lymphocytic leukemia cell": 0.03072, "female provide": 0.00645, "gamma motif": 0.00875, "transcriptional control element": 0.01115, "hiv mrna": 0.01526, "cam-k ii": 0.00726, "rh-vdr": 0.00012, "low-density lipoprotein": 0.00118, "sequence-driven reporter plasmid": 0.00368, "glucocorticoid receptor/progesterone receptor": 0.01714, "baby": 0.00056, "cycle": 0.00614, "glucocorticoid-induced cytotoxicity": 0.00143, "virus infection": 0.00887, "nuclear p52": 0.01684, "physiological context": 0.00183, "phosphorothioate oligonucleotides": 0.00183, "provide therapeutic option": 0.0043, "csa inhibit il-2 gene transcription": 0.01742, "m67": 6e-05, "systemic effect": 0.02115, "gene specific": 0.04355, "pg/ml": 0.00025, "-gamma": 0.00037, "nongenomic effect": 0.02115, "rat splenocytes": 0.00285, "cd40 stimulation": 0.0112, "vcam": 0.00031, "cd19 gene": 0.04355, "catalytic event": 0.00552, "thrombomodulin plasma concentration": 0.00447, "nf kappa b-mediated gene expression": 0.01742, "ccaat/enhancer-binding protein": 0.04529, "dna sequence specificity": 0.01084, "il-2 induction": 0.01607, "interpretation": 0.00019, "comparable": 0.00192, "tcr": 0.00955, "overwhelming evidence": 0.00422, "single-stranded region": 0.01467, "fkbp12/fk506 complex": 0.01684, "2.6-fold": 6e-05, "coordinated increase": 0.02196, "include tumor necrosis factor alpha-induced": 0.01144, "heterologous activation region": 0.02109, "steroid hormone receptor expression": 0.02081, "present paper": 0.00735, "gp39-cd8 fusion protein": 0.03019, "il-13 gene expression": 0.02903, "ahr mrna level": 0.01214, "excisional biopsy": 0.0005, "dna damage agent induce expression": 0.01665, "aberrant consequence": 0.00115, "show constitutive activation": 0.02109, "response gene": 0.04355, "central pathogenic role": 0.00885, "gain good insight": 0.00068, "activin a-induced smad2 phosphorylation": 0.00492, "regulate host defence response": 0.00971, "tfiia": 0.00062, "donor age": 0.00226, "transcriptional activity determine": 0.0195, "leukocyte-platelet adhesion contributes": 0.00387, "mutational analysis": 0.01179, "-specific human": 0.03762, "simple": 0.00081, "biologic": 0.00155, "characterized absorptive hypercalciuric patient": 0.00833, "box abolish usf/c-myc -mediated up-regulation": 0.00141, "unknown gene": 0.04355, "full il-4 enhancement": 0.00445, "hiv-tf1 suggest": 0.02022, "tnf alpha activation": 0.02109, "transduction": 0.0085, "nk cell-mediated ec activation": 0.01582, "essential regulatory protein": 0.03019, "murine il-10 receptor": 0.01714, "-60 upstream": 0.00369, "monitor dpd activity": 0.0195, "assay reproducibility": 0.01002, "chronic hepatitis c. oligoclonal expansion": 0.00159, "characterize c. pneumoniae-mediated activation": 0.01582, "ifn synthesis": 0.00583, "sensitive tool": 0.00273, "costar": 6e-05, "ifn-gamma gene expression": 0.02903, "murine il-2 promoter": 0.01557, "dimethyldithiocarbamate": 0.00019, "restricted expression": 0.04163, "leukocyte adhesion molecule": 0.00569, "fgf-1-responsive": 0.00012, "defined deletion": 0.00344, "time kinetics": 0.00273, "hyperplastic lymph node": 0.00052, "adenomatous polyposis coli": 0.00045, "double-negative thymocytes": 0.00257, "s1": 0.00043, "kappa b-alpha": 0.00748, "nf-kappab element present": 0.01115, "hemin-mediated erythroid differentiation": 0.00786, "large case-control study": 0.00904, "nontransformed t-lineage cell population": 0.0384, "primary murine erythroblast": 0.00492, "zap": 0.00019, "adaptor molecule": 0.00853, "related cytokine": 0.01123, "evi1": 0.00031, "monocyte-macrophage lineage-associated surface antigen": 0.00409, "pkc-dependent fa expression": 0.02775, "key transcriptional regulator": 0.00767, "constitutive dephosphorylation": 0.00478, "express mnda": 0.01846, "cell antigen receptor complex induction": 0.03072, "stat3 induce": 0.0254, "endobronchial biopsy specimen": 0.00035, "cd36 transfected cell": 0.0512, "reductase": 0.00037, "advance age lead": 0.00664, "nf-il6beta expression": 0.04163, "fluticasone": 0.0005, "differentiate thymocytes": 0.00267, "tfiids": 0.0, ":910": 0.00012, "mammal": 0.00031, "ep level": 0.01821, "g-csf": 0.0023, "nucleoprotein": 0.00081, "ifn-gamma-responsive gene require tyrosine phosphorylation": 0.01742, "vitro undergo constitutive cell death": 0.03072, "human udg promoter sequence": 0.01881, "c-fos protein": 0.04529, "combined mutation": 0.00592, "human cdna": 0.03762, "phenotype phopc": 0.00366, "arg": 0.00019, "normal child-bearing-age woman": 0.00806, "afr behaves": 0.00016, "human plasma cell": 0.0512, "tlck": 0.00031, "chain-breaking antioxidant": 0.00251, "complex regulatory protein network": 0.02264, "control tal-1 expression": 0.02775, "e3 transcript": 0.00599, "integrin": 0.00223, "p.lusso": 0.00019, "hht": 0.00012, "adaptive immune response": 0.01294, "putative functional role": 0.00885, "degradation": 0.00664, "fcs": 0.00019, "tax-transfected human": 0.03762, "s9a": 0.00043, "mesenchyme": 0.0, "t/nk cell": 0.0768, "link stat1": 0.00347, "strong expression occur": 0.02775, "murine tnf gene": 0.02903, "exclusive interaction": 0.00986, "stimulate purified": 0.01101, "electrophoretic shift assay": 0.00668, "t-cell-specific enhancer": 0.00909, "hemopoietic lineage": 0.00366, "cellular senescence": 0.00893, "uninduced u937 cell": 0.0512, "mediate ebna2 dependent transactivation": 0.00616, "sequence alteration": 0.01625, "describe mutant": 0.0081, "regulate t-cell function": 0.00887, "northern hybridization": 0.00155, "e2a": 0.00205, "central mediator": 0.00195, "il-2 mrna": 0.01526, "1.7-kb irf-cat construct": 0.00484, "innate": 0.00056, "rapid depletion": 0.00323, "ebv-receptor interaction": 0.00986, "thymocytes control": 0.01303, "staphylococcus aureus replication initiation protein": 0.01811, "-negative b-cell line": 0.01102, "low body mass": 0.00471, "nf- kappab/rel family member": 0.0042, "protein store": 0.04529, "diverged drosophila homeobox gene": 0.02177, "polyclonal etiology": 0.00115, "mobility-shift analysis": 0.01179, "steroid hormone cooperate": 0.00296, "tissue culture cell express ebv": 0.03072, "cd28 co-receptor molecule": 0.00569, "urogenital mesoderm": 6e-05, "-128": 0.00012, "thyroid gland": 0.00152, "ap-1 family member": 0.0056, "multipotential progenitor cell": 0.0512, "relation": 0.00124, "electrochemistry": 6e-05, "inhibit nf-kappab-dependent reporter gene expression induce": 0.01452, "rheumatoid synovial fluid monocytes/macrophages": 0.00047, "ldl particle": 0.00084, "transcription factor stimulate gene expression": 0.01742, "ccatatatgg": 6e-05, "vitamin d-resistant cell line": 0.0384, "th0": 0.00012, "ltr expression": 0.04163, "related retinoic acid receptor": 0.01286, "anti-estrogen concentration": 0.0067, "mitogen-activated protein kinase activation": 0.02264, "associate protein traf1": 0.03019, "purine-rich region": 0.01467, "heterodimeric p50/p65 complex": 0.01123, "vascular adhesion molecule-1": 0.00387, "g-csf receptor": 0.02571, "pim-1 gene": 0.04355, "defined oral glucocorticoid treatment": 0.00507, "express surface igm": 0.0123, "uv cross-linking": 0.00242, "tr2 orphan receptor flank": 0.01286, "unrecognized mechanism": 0.01058, "microdeletion": 6e-05, "dp alpha": 0.01169, "normal healthy subject": 0.00806, "rat spleen": 0.00285, "magnetic bead": 0.00022, "ikappabepsilon": 0.0, "class ii major histocompatibility complex promoter": 0.00779, "wild-type tlr2": 0.00378, "type ii tax protein": 0.02264, "th2-specific cytokine": 0.01123, "ut-7 cell": 0.0768, "chemical synthesis": 0.00583, "normal rat result": 0.01073, "activation pathway": 0.03164, "oct2 protein": 0.04529, "luciferase expression": 0.04163, "independent transcriptional activation domain": 0.01582, "increase form": 0.02196, "cd28 enhances": 0.00323, "sds-stable class ii alphabeta dimer": 0.0029, "dose dependent": 0.00388, "primary adult erythroid cell": 0.0384, "culture medium": 0.0062, "single hmg motif": 0.00583, "inducible promoter activity": 0.0195, "tandem gata site": 0.01445, "growth-affecting gene": 0.04355, "apparent association": 0.00282, "pcos patient": 0.01666, "terminal step": 0.00332, "pu.1 repress gata-1-mediated transcriptional activation": 0.01266, "viral replicative pathway": 0.00852, "-49/-41": 0.0, "okt3": 0.00099, "multifunctional ca2+/calmodulin-dependent protein kinase ii": 0.01811, "tg epsilon26 thymus": 0.00074, "neuroglial": 0.00012, "ap-1-binding proto-oncogene product": 0.00356, "microgram/day": 0.0, "antioxidant therapy": 0.00372, "tax1-inducible transcription factor": 0.01907, "jak1 activity": 0.02925, "major histocompatibility complex class ii combine immunodeficiency": 0.00481, "nm23h2": 0.00025, "nf-ya mrna": 0.01526, "tcc": 0.00081, "peripheral blood t-lymphocytes": 0.00395, "endocrine system": 0.00667, "lytic cycle-induced cell": 0.0512, "anti-cd3-induced proliferation": 0.00803, "lineage-specific activation": 0.03164, "situ": 0.00167, "apoptosis effector bax": 0.00593, "carboxyterminal region": 0.01467, "upregulated ap-1 concentration": 0.00463, "fasl-dependent reporter construct": 0.00484, "3-day pha treatment": 0.00676, "cd34+thy-1-cd45ra- subset": 0.00192, "wash lead": 0.00996, "fourfold high": 0.00931, "female case": 0.00363, "stimulate interleukin": 0.01101, "il-2-independent growth": 0.00819, "deficient response": 0.01942, "inhibitory domain function": 0.00887, "level consistent": 0.01821, "contrast": 0.01092, "nf-il6beta": 0.00031, "c-rel subunit": 0.00484, "sequestration process": 0.00444, "blr1": 0.00056, "diesel exhaust emission": 0.00017, "active transcription factor": 0.01907, "tissue": 0.01328, "c/ebp site": 0.02168, "cd3-epsilon enhancer imply": 0.00606, "control remains": 0.01303, "epstein-barr virus positive": 0.00591, "upregulated nf-kappa": 0.01414, "br3": 0.00019, "ige": 0.00378, "early disease onset": 0.00552, "leu122": 0.00012, "aml1b inhibits erythroid differentiation induce": 0.01016, "lyso-platelet-activating factor": 0.0286, "b-cell neoplasia": 0.00459, "abrogate tax1-mediated activation": 0.02109, "freshly isolated clone": 0.00492, "free cortisol excretion": 0.00196, "raji": 0.00118, "mtcp1 gene": 0.04355, "exon-intron structure": 0.00319, "ef1": 0.00037, "primary human lymphocyte": 0.02508, "bleeding disorder associate": 0.00728, "recent isolation": 0.0014, "important marker": 0.00689, "computer program": 0.00171, "function thyroid gland": 0.00887, "lineage specification": 0.00366, "gene encode hepatocyte nuclear factor-3alpha": 0.01742, "screen bacteriophage lambda cdna expression library": 0.01388, "cell type-specific subunit": 0.0512, "tissue factor gene expression": 0.02177, "increase time": 0.02196, "vcam-1 promoter construct demonstrate": 0.01168, "ascorbate": 0.00118, "parent ut-7/gm cell": 0.0512, "threshold set": 0.0014, "fhit": 0.00043, "aa": 0.00043, "rnase treatment prior": 0.00676, "exchangeable ca2+": 0.00304, "affect development": 0.00797, "similar function": 0.01331, "metabolite act": 0.00496, "anemic stress": 0.0031, "control developmental event": 0.00868, "molt": 6e-05, "adapter molecule myd88": 0.00569, "human protein": 0.04529, "mutant-activated ra": 0.00596, "generalized gc resistance": 0.00217, "develop mark basophilia": 0.00269, "ig heavy chain class switching": 0.00257, "deficient": 0.00273, "mouse mammary tumor virus-long terminal repeat dna binding": 0.00464, "hiv-1 proviral latency": 0.00585, "suppressed gp41-induced il-10 production": 0.00521, "are-containing gene": 0.04355, "slight increase": 0.02196, "regulatory mechanism responsible": 0.00705, "property suggest": 0.02022, "protein tyrosine phosphorylation": 0.03019, "cd5": 0.00081, "thigh lesion": 0.00143, "ca2+-dependent induction": 0.01607, "unrearranged tcr delta transcript": 0.00299, "tissue-specific fashion": 0.00217, "atf/creb factor": 0.0286, "incompatible": 0.00019, "wild-type ebv": 0.00565, "genuine": 0.00043, "human nk-like cell line": 0.0384, "wp-34": 0.00012, "ige immune complex": 0.01123, "ccaat-box binding factor nf-y": 0.0143, "om-10.1 cell": 0.0768, "selective pkc inhibitor gf": 0.0045, "messenger rna": 0.00456, "abundant": 0.00124, "hbxag protein": 0.04529, "egr1-expressing subclone": 0.0004, "intra-cytoplasmic domain": 0.01207, "molecular mechanism underlie suppression": 0.00529, "clonal derivative alpha g2s": 0.00585, "enhance lps-induced mrna level": 0.0091, "nb4 promyelocytes": 0.00074, "putative ar-cre form specific": 0.00619, "il2 expression require": 0.02775, "distinct cytokine-production pattern": 0.00465, "efficient hiv replication": 0.00395, "signal-regulated kinase kinase": 0.00396, "promote clearance": 0.00465, "assessed mnda expression": 0.02775, "filament": 0.00043, "ctf": 0.00012, "transfection analysis offer": 0.00786, "prevent p-selectin": 0.00524, "spleen exhibit": 0.00664, "previous observation": 0.00149, "45-50 min": 0.00127, "nf-kappab generation": 0.00999, "hiv-1 pathogenesis": 0.00878, "electrophoretic mobility shift assay demonstrate": 0.00639, "tnfalpha-": 0.00012, "positive regulatory element nuclear factor-kappab induction": 0.00561, "nuclear fraction": 0.01684, "sequence abolish": 0.01625, "recognition": 0.00515, "steroid action": 0.00499, "epor fail": 0.00347, "production": 0.02084, "induces caspase-dependent apoptosis": 0.00593, "murine macrophage cell line raw": 0.03072, "gc act": 0.00496, "human t-cell lineage": 0.02508, "strong transcriptional activity": 0.0195, "urinary free cortisol level": 0.0091, "favor glucocorticoid action": 0.00567, "potent antioxidant": 0.00357, "mediate il-4-induced tyrosine phosphorylation event": 0.00493, "ih reveal": 0.01098, "human b-": 0.03762, "operational": 0.00025, "95-kda protein": 0.04529, "ig mrna": 0.01526, "activate kinase": 0.01777, "clone test": 0.00738, "calcineurin-nuclear factor": 0.0286, "zap-70 signal function": 0.0109, "nf-kappab action": 0.00999, "parent cell line u937": 0.0384, "multiple ets family member": 0.0042, "include atherosclerosis": 0.01439, "strong homology": 0.00347, "amebiasis": 6e-05, "late induction": 0.01607, "dominant fashion": 0.00245, "beta": 0.01346, "retinoblastoma control element present": 0.00836, "downregulated nf-kappab activation": 0.02109, "positive transcriptional element": 0.01115, "extensive purification": 0.00118, "immediate-early manner": 0.00282, "xscid-like phenotype": 0.00366, "repeat maximal response": 0.01294, "csa sensitivity": 0.00236, "mts1 tumor suppressor gene": 0.02177, "gr number fail": 0.00354, "canonical homeodomains": 0.0004, "multiple member": 0.00689, "inactive x-chromosome material": 0.00108, "cd70": 0.00037, "antigen stimulation signal": 0.0109, "40-kda transcriptional activator": 0.00767, "native envelope glycoprotein": 0.00101, "induced c-fos expression": 0.02775, "intracellular staining": 0.00583, "stat protein": 0.04529, "p62 complex": 0.01684, "human myeloproliferative disorder": 0.02508, "transcription factor complex form": 0.0143, "cd4 trigger delivers signal capable": 0.00654, "lineage limited transcription factor nf-e2": 0.01144, "site play": 0.02168, "ifn-gamma signaling": 0.00558, "vp22": 0.00031, "eosinophilic differentiation": 0.01179, "part mediate": 0.01231, "fetal liver": 0.00214, "granuloma": 0.00031, "dra x2-box": 0.00099, "nonproductive fashion": 0.00161, "mmhg": 6e-05, "charcoal bind assay": 0.0135, "plasma membrane cd14": 0.003, "glycosphingolipid lactosylceramide present": 0.0049, "leukocyte subpopulation": 0.00478, "biochemical approach demonstrate": 0.01065, "adenovirus-transformed cell correlate": 0.0512, "exert beneficial effect": 0.0141, "reveal cell-specific binding": 0.01237, "enhanced activity": 0.02925, "inflamed intestine": 0.00031, "mtetra": 0.00025, "early atherogenesis": 0.00828, "low serum condition": 0.00471, "nucleolin component": 0.00456, "cell-free processing system": 0.00445, "macrophage-like cell": 0.0768, "induce isg expression": 0.02775, "il-2-gene regulation": 0.01008, "human c-jun protein": 0.03019, "tyr477": 6e-05, "th2 response": 0.01942, "blood dna": 0.01483, "activated stat-3": 0.00589, "transdominant rev protein": 0.03019, "significant modification": 0.00416, "promote intimal plaque formation": 0.00242, "initial induction": 0.01607, "neutrophil undergo": 0.00496, "putative human homolog": 0.02508, "selective inhibitor": 0.009, "n-terminal": 0.00403, "il-1beta-cat+": 0.0, "immunocytochemistry": 0.0005, "replication competence": 0.00471, "molecular background": 0.0045, "cell develop": 0.0768, "human mineralocorticoid receptor hormone-binding domain": 0.01505, "cd4+cd45r0+cd45ra-cd29highcd11a+": 6e-05, "ikk": 0.00087, "inverse regulation": 0.01008, "v14rho construct incapable": 0.00484, "tumor matrix": 0.00934, "cell nfat complex": 0.0512, "lipase": 0.00043, "multimeric form": 0.01055, "receptor activate lyn tyrosine kinase": 0.01029, "high retinoidal activity": 0.0195, "elk-1 transcription": 0.0281, "ebv zebra protein": 0.03019, "kca": 0.00019, "tumor necrosis factor-a": 0.00622, "e2f binding": 0.01855, "water-soluble emulsion": 6e-05, "suppress plasma cortisol": 0.00407, "correct electrolyte abnormality": 0.00159, "caspase-3 inhibitor": 0.009, "calcitriol lead": 0.00996, "onward": 6e-05, "cellular activation signal": 0.02109, "immediate-early cytokine gene": 0.02903, "cd8+cd28null": 0.00012, "ra result": 0.0161, "primer detect": 0.00726, "rap": 0.00019, "dna element present include": 0.00836, "steroid receptor agonist cortisol": 0.01286, "homeodomain-containing protein": 0.04529, "malignant mammary tumor show important difference": 0.00866, "tbp mutant defective": 0.0054, "self-sustained": 0.00012, "peripheral blood stem cell": 0.0384, "platelet bound": 0.00372, "proinflammatory agonist": 0.0022, "anti-cd3-induced increase": 0.02196, "viral rna": 0.00732, "gre": 0.00124, "increase il-6": 0.02196, "post-transcription regulation": 0.01008, "icam-i promoter": 0.02336, "p91": 0.00031, "normal age process": 0.00806, "carboxy terminal insert": 0.00221, "immunosuppression induce": 0.0254, "recombinant retrovirus": 0.00391, "positive regulator": 0.00468, "csa-sensitive transcription factor": 0.01907, "tissue homogenate": 0.00664, "gm-csf-mediated growth": 0.00819, "ro-vdr": 0.00025, "sla-dq antigen": 0.00819, "strong positive-acting element": 0.01115, "stat3alpha": 0.00112, "d-ribose": 0.00019, "cis-linked cat gene": 0.02903, "corticosteroid derivative": 0.00192, "aml1 gene product": 0.02903, "high level gene expression": 0.02177, "illness": 0.00043, "intact gpix ets site": 0.01084, "mhc class ii gene-specific transcription activator": 0.00937, "signal molecule include syk": 0.00817, "interrelationship": 6e-05, "previous work": 0.00133, "rearranged tal1 allele": 0.00147, "anchored tf molecule": 0.00569, "ebv-transformed cell line": 0.0512, "heat-": 0.00012, "diverse cell type": 0.0512, "monocyte colony-stimulating factor": 0.01907, "her-2/neu overexpression": 0.00382, "vitd3 response element-driven reporter construct": 0.00777, "chloramphenicol acetyl transferase reporter gene link": 0.01452, "il-4-mediated phosphorylation": 0.00983, "human leukemic cell": 0.0512, "cell type specificity": 0.0512, "endothelial adhesion molecule-1": 0.00387, "include gata-1": 0.01439, "epstein-barr virus oncoprotein latent infection membrane protein": 0.01294, "unaltered": 0.00112, "transcription assay": 0.0281, "x2-boxes": 0.00012, "p50/65": 6e-05, "amino acid long human tramp": 0.01505, "trap-positive mgc": 0.00016, "kappa b-2": 0.00748, "reverse transcription-pcr-based approach": 0.00157, "ppar-alpha": 6e-05, "negligible dna-binding activity": 0.0195, "chicken il2": 0.00078, "phase expression": 0.04163, "rcc": 0.00068, "cd13": 0.00043, "undifferentiated": 0.00112, "inducible transcriptional activation": 0.02109, "erythroid delta-aminolevulinate synthase mrna level": 0.00728, "kb site": 0.02168, "core binding factor": 0.01907, "pervanadate": 0.00087, "normotensive volunteer": 0.00047, "fc gamma rii-negative b-cell line": 0.00661, "inappropriate activation": 0.03164, "gabp": 0.00093, "eur": 6e-05, "creb/atf-1": 0.00019, "dqbeta trans heterodimeric hla-dq molecule form": 0.00352, "unknown nuclear protein bound": 0.02264, "molecular understanding": 0.0045, "continued dna synthesis": 0.00988, "sublethal irradiation": 0.00047, "low blood lactate concentration": 0.00354, "serum thyroxine": 0.00378, "parallel differentiation": 0.01179, "cell transfected": 0.0768, "basic research": 0.00174, "-58": 6e-05, "thrombin play": 0.0071, "relevant stimulation": 0.0112, "nuclear protein": 0.04529, "recombinant otf-2 protein": 0.03019, "plasma membrane rich fraction": 0.00225, "activate jak1": 0.01777, "carboxy-terminal leucin-zipper region": 0.00978, "lining": 0.00037, "significant variation": 0.00416, "cd20 mrna": 0.01526, "encompass band": 0.00118, "immunomodulatory cytokine secrete": 0.00749, "membrane extract": 0.00459, "immediate-early g1 phase gene": 0.02177, "typical morphology": 0.00118, "cytopathic effect": 0.02115, "rheumatoid synovial cell up-regulates vcam-1": 0.03072, "kappab epsilon degradation": 0.00221, "cd56+ endometrial": 0.00047, "hitherto unknown mineralocorticoid": 0.00116, "nfat gene family member nfatc": 0.01742, "p38 mitogen-activated protein kinase mediate signal integration": 0.01294, "ik": 0.00062, "gamma b*cam-k": 0.0044, "clinical glucocorticoid resistance": 0.00567, "nf-atc expression switch": 0.02775, "chemical mismatch cleavage analysis": 0.00589, "climacteric syndrome": 0.00273, "carboxylesterases play": 0.0071, "indirect interaction occur": 0.00658, "tgf-beta 1-mediated growth inhibition": 0.0053, "normal human monocyte stimulate": 0.01881, "defective replicative phenotype": 0.00244, "peripheral leucocyte genomic dna": 0.00741, "-dependent pathway synergize": 0.00852, "il-4 receptor engagement": 0.01714, "agent commonly": 0.00422, "+448": 6e-05, "absolute htr beta": 0.00449, "culture human endothelial cell": 0.0384, "gene pml": 0.04355, "uterine decidua": 0.0004, "mycobacteria": 0.00031, "sf-2 strain": 0.00186, "gata-3/er": 6e-05, "hiv gene expression": 0.02903, "ap-2 cdna": 0.00456, "enzyme release arachidonic acid": 0.00428, "contransfection": 6e-05, "h-7 block": 0.01073, "biodisposal": 6e-05, "pkr": 0.00043, "casein kinase ii site": 0.01084, "il-4 signaling occurs": 0.00445, "hsf2-alpha result": 0.0161, "positive staining": 0.00468, "multiple effector pathway include": 0.0072, "similar signal mechanism": 0.0109, "thrombin receptor mrna": 0.01714, "cell-expressed gene": 0.04355, "important target cell": 0.0512, "lbf6": 6e-05, "decreased transactivation activity": 0.0195, "cardiac": 0.00081, "mediate hiv-2 enhancer activation": 0.01582, "gene-suppressive activity": 0.02925, "erk1/2": 0.00019, "leukemic hl60 cell": 0.0512, "fas mrna": 0.01526, "individual e-boxes": 0.00409, "induced transcript": 0.00599, "eotaxin": 0.00025, "interior": 0.0, "intermediate size range": 0.00134, "molecular marker associate": 0.00728, "turn translocates": 0.00093, "express constitutively": 0.01846, "possess repressive function": 0.00887, "-203": 0.00012, "vitro transcription assay show": 0.01405, "gene regulatory protein": 0.03019, "cycloheximide/polyinosinic-polycytidylic acid": 0.00856, "porcine b-cell line l23": 0.00827, "cell-encoded gene": 0.04355, "intracellular camp": 0.00583, "region promoter differ": 0.01557, "y292": 0.00025, "tcr alpha/beta locus": 0.00318, "ubiquitin-proteasome pathway": 0.01278, "dna bind study demonstrate": 0.01013, "quantitative assessment": 0.00096, "e1a n-terminal": 0.00248, "preferential presentation": 0.00074, "posttranscriptional trans-activator rex": 0.00062, "vpr product": 0.00533, "equilibrium fashion": 0.00161, "cdna express": 0.01846, "il-4 target gene": 0.02903, "include autoimmunity": 0.01439, "ciita mutant construction": 0.0054, "basic region/leucine zipper": 0.00116, "albuminuria": 0.00025, "cell reverse defect": 0.0512, "orf": 0.00037, "cell constitutively": 0.0768, "cd95l": 0.0005, "induced irf-1": 0.0054, "principle target": 0.00825, "cell-specific manner": 0.00292, "constitutive dna binding activity": 0.01462, "specific functional program": 0.00825, "hpv type": 0.00949, "eb1": 0.00031, "cd40 induce": 0.0254, "hiv-1 reactivation": 0.00878, "rheumatoid joint": 0.00093, "region ii interacts": 0.00978, "interferon consensus sequence bind protein": 0.01811, "unexplored": 6e-05, "exert immune activity": 0.0195, "implication regard": 0.00158, "retinoidal activity": 0.02925, "common stem cell": 0.0512, "phagocyte": 0.00174, "numerous study": 0.01355, "enhanced degradation": 0.00332, "mnfatc": 0.00031, "induce raldh2 expression": 0.02775, "link disorder result": 0.01073, "murine bone marrow": 0.00416, "6-h increase": 0.02196, "acute lymphoblastic leukemia chimera e2a-hlf": 0.002, "stimulate nf-at activity": 0.0195, "agonistic anti-cd28 antibody": 0.00596, "preactivated primary nk cell": 0.0384, "kit ligand-dependent proliferation": 0.00536, "serum osteocalcin": 0.00378, "ap-1 specificity": 0.00695, "normal pml": 0.0121, "dominant negative form": 0.00703, "signal transduction activate": 0.01185, "agent include interferon gamma": 0.0072, "type iia hyperlipidemia": 0.00633, "cell receptor alpha": 0.0512, "exhibit heterogeneous expression": 0.02775, "human gm-csf tata box": 0.01881, "a.rajadhyaksha": 0.00012, "human haematopoietic line": 0.02508, "human rar alpha expression": 0.02081, "activate raw": 0.01777, "aml1 bind": 0.02025, "clinician": 0.0, "multiple site": 0.02168, "reporter construct drive": 0.00484, "high 4-year probability": 0.0062, "transfected promoter-luciferase reporter plasmid": 0.00276, "yj": 0.00025, "ang ii effect": 0.0141, "il3 5'-flanking sequence": 0.01084, "activate transcription": 0.0281, "develop metastatic disease": 0.00449, "origin": 0.00211, "nh2-terminal transactivation domain": 0.00804, "stat4-independent phase": 0.00276, "gene require": 0.04355, "block infection": 0.01073, "tpo": 0.00093, "primary event lead": 0.00664, "asthmatic patient show": 0.01733, "gene selective": 0.04355, "fuse": 0.00298, "hemo-lymphoid progenitor": 0.00276, "enhancer function": 0.01331, "allele ratio great": 0.00147, "bound": 0.00583, "class ii non-inducible": 0.00484, "ut-7/gm": 0.00043, "atf2": 0.00012, "pml-rar alpha blast": 0.0078, "cell-restricted cofactor": 0.00078, "cocktail": 0.00025, "dos": 0.00242, "one-site kinetics": 0.00167, "-875": 6e-05, "hmg domain": 0.01207, "decrease nf-kappab activity": 0.0195, "band-shift": 0.00043, "data implicate trafs": 0.00234, "iron salt": 0.00059, "distinct transcript": 0.00698, "rar-rxr response pathway": 0.01294, "sf suppression": 0.00416, "pulse treatment": 0.01014, "acute myocardial infarction": 0.00246, "amino-terminal acidic region": 0.00978, "monocytic cell line u937": 0.0384, "c/ebp beta block tnf alpha promoter activation": 0.00904, "study determine": 0.01355, "cell line stimulate": 0.0512, "growth hormone receptor": 0.01714, "position -78": 0.00236, "single tal1 allele": 0.0024, "erythroid cell-specific histone h5": 0.0031, "interferon induce normal": 0.01694, "l-selectin show increased organ infiltration": 0.0104, "mouse chr": 0.00974, "danazol": 0.00056, "regulate il-2": 0.01253, "combined dexamethasone": 0.00394, "epstein-barr virus bamhi": 0.00591, "long lasting proliferation": 0.00536, "assay cd34 mrna transcript": 0.00763, "saf": 0.00019, "estradiol induce extrathymic t-cell differentiation": 0.01016, "heptp play": 0.0071, "stable homodimers": 0.00171, "delay": 0.00192, "ligand-dependent": 0.0005, "adult animal": 0.00422, "mutant displayed differential activity": 0.01462, "mouse myeloid leukemia m1 cell": 0.03072, "block nk-kappa": 0.01073, "deleted form": 0.01055, "french-american-british acute myeloid leukemia-m3": 0.00231, "cytosolic inhibitor protein ikappab-alpha": 0.02264, "cell stimulate": 0.0768, "peptide abolish": 0.00754, "htlv-1-transfected": 0.00012, "high-level replication": 0.00471, "ligand": 0.01185, "fkbp exhibit": 0.00664, "nf-kappa b-dependent induction": 0.01071, "transcribed sequence": 0.01625, "apc": 0.00186, "gene play": 0.04355, "cd28 mabs": 0.00323, "microb": 0.00056, "correlated consequence": 0.00115, "lipid soluble antioxidant": 0.00167, "immunoblastic lymphoma plasmacytoid": 0.00151, "purine-box/nuclear factor": 0.0286, "nonconsensus binding site": 0.01445, "tsc2 gene expression": 0.02903, "manlam-mediated activation": 0.03164, "tcr coengagement": 0.00478, "microtubule damage": 0.0009, "c/ebp-": 0.00012, "immunohistochemical procedure": 0.00078, "ire": 0.0005, "thrombin induce binding": 0.01694, "calcineurin act": 0.00496, "dex inhibit": 0.01904, "biphasic": 0.00105, "secrete il-2 serf": 0.00744, "irradiated pml/raralpha mouse enhance granulocyte recovery": 0.00325, "beta globin gene upstream element": 0.01742, "kinase participate": 0.01188, "normal b-cell-specific transcription": 0.01873, "extensive granulopoiesis": 0.00118, "mature cell type": 0.0512, "calcineurin responsiveness": 0.00323, "signaling pathway molecule jak1": 0.00639, "icr27tk.3 cell": 0.0768, "absorption": 0.00025, "-responsive cell block il-1-induced gene transcription": 0.0256, "ebv protein expression": 0.03019, "cytolytic machinery": 0.00109, "igh enhancer regulation": 0.00672, "il-1 beta gene expression": 0.02177, "hbsag stimulation": 0.0112, "er-": 0.00037, "icam-1 molecule": 0.00853, "zinc finger motif": 0.00583, "alveolar macrophage-depleted rat": 0.0019, "monocytic thp-1 cell": 0.0512, "retroviral infection": 0.0062, "mycobacterium tuberculosis -induced interleukin-2 receptor expression": 0.01388, "nf kappa b. cyclosporin": 0.00374, "granulocyte-macrophage colony-stimulating factor promoter": 0.0143, "thp-1 macrophage": 0.00589, "microg/100 ml": 0.00016, "sp1 regulate tf gene expression": 0.01742, "cmv": 0.00236, "cni-1493 inhibits macrophage tnf synthesis": 0.00236, "15-amino acid sequence": 0.01084, "activate mitogen-activated protein kinase": 0.02264, "dra promoter occupancy": 0.01557, "garcia-cozar": 0.00012, "alpha enhancer": 0.01169, "repressor activity": 0.02925, "ambiguous": 0.0, "related family": 0.00841, "topoisomerases": 0.00012, "tcf-1 alpha mrna": 0.01017, "p12-14": 6e-05, "il-10-": 0.00012, "inducible transcriptional activity mediate": 0.01462, "specific antagonist": 0.01238, "retinoid receptor": 0.02571, "c-rel protein expression": 0.03019, "differentiative fate": 0.00043, "egr-1 protein": 0.04529, "extra-renal": 0.00012, "erk activity": 0.02925, "affect cd19 reporter construct activity": 0.0117, "t-cell prolymphocytic leukemia": 0.00641, "human mononuclear leukocyte": 0.02508, "single viral gene": 0.02903, "glu30-leu41": 0.00012, "inducible mhc class ii gene activation": 0.01452, "viral structural protein": 0.03019, "circular dichroism analysis reveals": 0.00589, "versatile cellular homeostatic switch": 0.00447, "transfected ifn-stimulated gene": 0.02903, "kd change": 0.0063, "mrna transcription": 0.0281, "overexpression contributes": 0.00382, "kappa b. stimulation": 0.00746, "nfat4": 0.00037, "ifn-stimulated gene": 0.04355, "critical cytoplasmic domain": 0.00804, "daunomycin": 6e-05, "c-terminus": 0.00056, "cem great": 0.00205, "evidence suggest": 0.02022, "ibr/f harbor": 0.0009, "primitive": 0.0013, "erythroid lineage": 0.0062, "hyperaldosteronism": 0.00019, "vcam-1 promoter reporter gene construct": 0.01742, "mmtv induction": 0.01607, "rate and/or extent": 0.003, "syndecan-1 identifies distinct histogenetic subtypes": 0.00279, "decreased expression": 0.04163, "chronic virus infection develop antibody": 0.00357, "biomarkers": 0.00037, "rbp-jkappa": 0.00081, "e.kieff": 6e-05, "anh": 0.00031, "junb level": 0.01821, "b95-8": 0.00074, "lmp-1": 0.00236, "erythroid-lineage cell": 0.0768, "west africa": 9e-05, "iga1": 0.00012, "oleate inhibit": 0.01904, "adult t-cell leukemia involvement": 0.00481, "anaphylatoxins c5a": 0.00025, "monoamine oxidase": 0.00062, "ngfi-b/nur77 family": 0.00841, "endogenous ra": 0.00596, "leukemia-specific retinoic acid receptor pml-rar": 0.01029, "cd16": 0.00155, "factor present": 0.0286, "la": 0.00068, "electrophoretic mobility shift assay": 0.00501, "erg2 gene": 0.04355, "maximal activity": 0.02925, "viral dutpase": 0.00732, "liposomal mpl": 0.00043, "transient transfection assay": 0.00668, "anorexia nervosa": 0.00025, "tnf transcript": 0.00599, "human promyeloid leukemia cell line hl60": 0.0256, "basic helix loop helix zipper transcription factor interact": 0.00715, "potent stimulators": 0.00357, "year period": 0.00127, "follow-up period": 0.00127, "random sequence": 0.01625, "sre dna": 0.01483, "increased binding efficiency": 0.01237, "normal differentiation": 0.0121, "life-table analysis": 0.01179, "relapse": 0.00081, "-280": 0.00031, "alcoholic extract prepared form arnicae flos": 0.00352, "dna-pk": 0.00012, "tri-molecular complex permit": 0.01123, "situ uv cross-linking study": 0.00678, "prostaglandin pge2": 0.00136, "nfkappab translocation": 0.00515, "support platelet attachment": 0.00273, "late promoter": 0.02336, "ebna2 responsive element": 0.01115, "chimeric fusion protein": 0.03019, "sl3-3 murine leukemia retrovirus": 0.00312, "human t-cell clone": 0.02508, "sp140": 0.0005, "cd28 costimulatory pathway": 0.00852, "ratio": 0.00192, "elicited rat peritoneal neutrophil": 0.00248, "rapid pma-mediated induction": 0.01071, "mapk pathway": 0.01278, "severe combine immunodeficient": 0.00141, "hiv-1-infected asymptomatic subject": 0.00236, "autosomal material": 0.00074, "pml-containing body": 0.00136, "spi-1 transfected cell show reduced growth rate": 0.02194, "-72 abolish basal promoter activity": 0.0117, "partial reversion": 0.00143, "stimulated lymphocyte transfected": 0.00988, "thromboxane receptor gene": 0.02903, "present clinical": 0.00735, "chicken immature erythrocyte nuclear extract protein": 0.0151, "cdc-2": 0.00012, "cellular cholesterol homeostasis": 0.00596, "flutamide affect androgen receptor behavior": 0.01029, "b-cell chronic lymphocytic leukaemia": 0.0023, "iron result": 0.0161, "age young": 0.00226, "uncontrolled replication": 0.00471, "structural characteristic": 0.00329, "reversion": 0.00037, "molecular heterogeneity": 0.0045, "common requirement": 0.0035, "mature human": 0.03762, "response predictor": 0.01942, "site participate": 0.02168, "partial characterization": 0.0018, "anti-cd3-activated human": 0.03762, "failure": 0.00273, "inducible interleukin-2 enhancer function bind": 0.0081, "activate erk-2": 0.01777, "cd40 signal cascade": 0.0109, "ebna-2 transcript": 0.00599, "case": 0.00726, "progesterone receptor level": 0.01714, "amino terminal insert": 0.00221, "lysosomal serine protease": 0.00118, "synthesize fo": 0.00158, "redox status": 0.00217, "t-cell activation signal": 0.02109, "log-fold": 6e-05, "maltose bind protein": 0.03019, "gelatinase": 0.0005, "p65 activation domain": 0.02109, "block c-fos induction": 0.01071, "mitogen-inducible gene encode": 0.02903, "transcriptional repressor icer": 0.00767, "inhibitory nls peptide interacts": 0.00377, "progenitor cell": 0.0768, "pharmacokinetic mechanism": 0.01058, "p105 precursor": 0.00323, "lytic viral life cycle": 0.00366, "elongation": 0.00062, "nf-kappab and/or sp1 bind element": 0.0081, "assay ligand bind affinity": 0.01013, "elevated total serum ige": 0.00189, "il-18 receptor": 0.02571, "b-cll cell": 0.0768, "eosinophilic": 0.00161, "2,3-dimethoxy-6-methyl-1,4-benzoquinoyl": 6e-05, "conserved octanucleotide promoter element": 0.01168, "alloimmune": 6e-05, "site mediates human immunodeficiency virus type": 0.01254, "pc4": 0.00019, "low potential": 0.00707, "asa": 0.00043, "upstream beta globin sequence": 0.00813, "10-fold": 0.00155, "mouse mpc11 plasmacytoma cell": 0.0384, "alpha prevent": 0.01169, "prriii/cat reporter construct": 0.00484, "blood-thyroid hormone concentration": 0.00447, "a20": 0.00031, "mac-1": 0.00056, "individual protein factor bind": 0.02264, "x-y element": 0.01672, "pkc-depleted": 6e-05, "human multiple myeloma cell line represent": 0.0256, "tmd blast correspond": 0.00118, "bacteria reveal": 0.01098, "finding provide significant": 0.0043, "cystic fibrosis sputum": 0.00019, "tissue-specific rna polymerase ii transcription factor": 0.00953, "intrinsic biological activity": 0.0195, "histologic grade": 0.0004, "il-4-dependent regulation": 0.01008, "interleukin-4 stat": 0.00282, "mixed cellularity": 0.00081, "tumorigenic": 0.00025, "glucose phosphate isomerase-1": 0.00052, "mid-late g1": 0.00109, "inositol phosphate": 0.00065, "progressive expression": 0.04163, "cultured human ec": 0.02508, "protein heterodimers": 0.04529, "human t-cell-leukemia virus type": 0.01881, "lavage t-lymphocytes": 0.00146, "phorbol 12-myristate 13-acetate increase": 0.01098, "hiv-1 ltrs lack c/ebp site": 0.00867, "htlv-i-induced adult t-cell leukemia/lymphoma": 0.00481, "-3": 0.00093, "p19": 0.00025, "elevated ige": 0.00189, "kb promoter describe": 0.01557, "putative cell-specific transcription factor": 0.0143, "jak3/stat activation": 0.03164, "influence cell fate decision": 0.0384, "ip-10 mrna inducibility": 0.01017, "lymphocyte clonotypes": 0.01483, "calcitriol binding": 0.01855, "lymphocyte ability": 0.01483, "tcf-1 protein": 0.04529, "hiv-seronegative donor": 0.0014, "ebv-encoded nuclear antigen": 0.01123, "significant lung injury": 0.00277, "fn": 0.00025, "il-6 neutralizing antibody": 0.00596, "dna binding assay": 0.01237, "conditional allele": 0.0022, "interleukin-10 inhibition": 0.01061, "bp -301": 0.00267, "measurable il-2 production": 0.00744, "jay": 6e-05, "vascular inflammation": 0.00316, "skw6.4": 0.00025, "initiate intracellular signal pathway": 0.00817, "distinct n-terminal half": 0.00465, "repeat karyotypic study": 0.00904, "mdms": 0.00025, "control u937 cell": 0.0512, "nf-at": 0.00794, "tissue-specific deoxyribonuclease": 0.00217, "fas-mediated apoptosis": 0.0089, "cellular factor heb-1": 0.01907, "abc method": 0.00236, "pax5": 0.00031, "zebra abolish": 0.00354, "akv mlv": 0.00025, "inability": 0.00099, "arnica": 0.00025, "matrix metalloproteinase-9": 0.0013, "inactivation result": 0.0161, "ebs2": 0.00019, "specialized subset": 0.00192, "canonical tfiid bind site suppress": 0.00867, "nf-kappab-dependent": 0.00186, "increase serum il-4 level": 0.01098, "melana/mart1+ mm cell line enhance": 0.03072, "study protein-protein interaction": 0.00904, "r-h-tbp-1": 0.00012, "hiv-1 tat gene": 0.02903, "rrna processing": 0.00133, "tyrosine residue": 0.0071, "tcf-1/lef-1": 0.00012, "mhc class ii-restricted antigen processing": 0.00328, "represent glucocorticoid": 0.0085, "hemorrhagic shock": 0.00174, "lymphoblastoid cell": 0.0768, "p13": 0.00037, "constitutively active raf-1": 0.00395, "quiescence": 0.00019, "trypan blue exclusion cell counting": 0.03072, "rara": 0.00031, "step": 0.00378, "nb": 0.00025, "tcr triggering": 0.00478, "cbl-b": 0.00074, "activate proenkephalin transcription": 0.01873, "decreased human cell lysates": 0.0384, "mature": 0.00658, "clinical latency": 0.00425, "primary cell reveal substantial constitutive nf-kappa b-binding activity": 0.0192, "v-src expression correlate": 0.02775, "sp1 phosphorylation": 0.00983, "control immune surveillance": 0.00868, "bcl-6 rearrangement": 0.00199, "differentiation-associated gene": 0.04355, "hgata-3 bind site": 0.01445, "limiting-dilution analysis": 0.01179, "bromodomain": 6e-05, "cd28 pathway": 0.01278, "chloramphenicol acetyltransferase reporter gene": 0.02177, "sr patient demonstrate": 0.0111, "human genome": 0.03762, "subsequent proliferation activity": 0.0195, "e2a-hlf": 0.00223, "proteolytic cleavage": 0.00109, "volunteer": 0.00093, "putative nfat-1 region": 0.00978, "pma activate erk2 kinase": 0.00889, "lac operator sequence": 0.01084, "cell line lack capability": 0.0384, "camp inhibit": 0.01904, "similar half-life": 0.00673, "transfected ec enhance e-selectin": 0.00487, "toronto": 6e-05, "leukemic cell line jurkat induce": 0.03072, "tgacgtca": 0.00019, "nuclear receptor family": 0.01714, "12-o-tetradecanoyl phorbol-13-acetate": 0.00028, "cmv element": 0.01672, "deregulated expression": 0.04163, "nf-kappa b1/p50": 0.01414, "hox11 null mouse embryo": 0.00487, "monofactorial analysis": 0.01179, "increase body": 0.02196, "immunohistochemical": 0.00099, "exogenous gata-2/er promote proliferation": 0.00402, "lmp-1 upregulates": 0.00118, "substitution promoter": 0.02336, "preformed interleukin-1 beta mrna": 0.00763, "qualitative difference": 0.00425, "nur77": 0.00093, "acid sphingomyelinase": 0.00856, "gamma isoforms": 0.0044, "uvb range": 0.00202, "human jurkat-t cell": 0.0512, "germ-line igh gene": 0.02903, "antibiotic": 0.00031, "cellular localization": 0.00893, "rbpi21 result": 0.0161, "tepoxalin selectively inhibit intercellular adhesion molecule-1": 0.00635, "electrophoretic mobility shift analysis": 0.00589, "protein synthesis inhibitor": 0.03019, "h.m.": 0.00012, "coimmunoprecipitation assay show": 0.01733, "oct factor": 0.0286, "core promoter activity": 0.0195, "hiv-hd histogenesis": 0.00028, "p50/nf-kappa b-mediated inhibition": 0.00707, "healthy smoker": 0.00177, "3-5 min": 0.00127, "gralpha expression": 0.04163, "c-jun n-terminal kinase cascade": 0.00594, "globin gene switch": 0.02903, "ap3-l": 0.00031, "consist": 0.00366, "icam-1/beta": 6e-05, "growth-factor-dependent myeloid cell line": 0.0384, "dq2.1": 6e-05, "nf-kappa b. stimulation": 0.00943, "identified ligand": 0.00592, "ifn-gamma-primed lung fibroblast": 0.00225, "solid tumour influence growth": 0.00409, "plasma activity": 0.02925, "simian ebv": 0.00565, "ebna-2-positive": 0.00043, "confers long-lasting csf-1-dependent proliferation": 0.00402, "nf-x2": 0.00037, "express receptor": 0.02571, "sequence-specific dna-binding protein": 0.03019, "high-level nf-kappab activation": 0.02109, "co-stimulatory agent phorbol myristate acetate": 0.00217, "mineralocorticoid antagonist spironolactone": 0.00161, "enzymatic activation": 0.03164, "fatty streak": 0.00047, "soluble tnf receptor": 0.01714, "monocyte lineage": 0.01197, "concentration": 0.0134, "mutant signal molecule": 0.0109, "major importance": 0.00574, "fixation": 6e-05, "cd40 ag": 0.00372, "intracellular regulatory event": 0.00455, "hydrophobic domain": 0.01207, "post-transcriptional regulator": 0.00304, "issue": 0.00037, "clc": 0.00012, "major depression": 0.00574, "correlate": 0.01309, "lmp-1 promoter": 0.02336, "jurkat cell line": 0.0512, "main approach": 0.00164, "intervening dna": 0.01483, "ctg-monomer virus": 0.00887, "40-fold high activity": 0.0195, "pilot study": 0.01355, "neoplastic": 0.0018, "gata-2": 0.0013, "bsap": 0.00292, "serum-free culture system": 0.00445, "human il-5 promoter/enhancer-luciferase gene construct": 0.01742, "extracellular generation": 0.00242, "3.2-fold": 0.00012, "tcdd": 0.00149, "gp": 0.00062, "establishment": 0.00068, "moiety demonstrate": 0.01597, "glucocorticoid-receptor antagonist": 0.00242, "nuclear factor nf-at": 0.01907, "evaluable case": 0.00363, "b-cell population": 0.00459, "infected individual": 0.00409, "1.3-fold": 0.0, "inflammatory tissue": 0.00664, "similar level": 0.01821, "maturation defect occur": 0.00436, "control transcription": 0.0281, "tcrzeta expression": 0.04163, "cytokine-secreting effector": 0.00276, "gata-1 expression vector": 0.02775, "transcription factor include sp1": 0.0143, "hirudin": 6e-05, "serum amylase": 0.00378, "striking reduction": 0.00295, "interaction represent": 0.00986, "decrease cellular proliferation": 0.00647, "molecular mechanism underlie immunosenescence": 0.00529, "cd36 promoter couple": 0.01557, "fibroblast": 0.00676, "vzv protein": 0.04529, "treatment period symptom": 0.00676, "dna-swap experiment": 0.00397, "p27kip1": 0.00074, "thrombin-activated platelet": 0.00372, "scf-mediated ligation": 0.0018, "entire hgr cdna": 0.00304, "include phytohemagglutinin": 0.01439, "cooperate nuclear transcription factor": 0.0143, "nucleocytoplasmic translocation": 0.00515, "kinetic study": 0.01355, "freshly-isolated": 6e-05, "-40 upstream": 0.00369, "4-pyridyl": 0.00012, "control show": 0.02599, "previous mrna study": 0.01017, "finding define": 0.00323, "myod": 0.00031, "eklf allele": 0.0022, "feasible": 0.00019, "thymocyte subpopulation": 0.00096, "monomeric form": 0.01055, "united state": 0.00267, "el-4 cell": 0.0768, "constitutively active ra mutant": 0.00405, "warren strober describe": 0.00265, "cd13lo": 0.00012, "human host": 0.03762, "endogenous antioxidant glutathione": 0.00306, "hiv transcription mediate": 0.01873, "t-lymphocyte-depleted spleen cell": 0.0512, "genetic strategy": 0.00288, "y-box element": 0.01672, "c/ebp protein activate transcription": 0.02264, "transfected nonlymphoid cell": 0.0512, "heterologous dna-binding domain": 0.00804, "persistent bronchiolitis": 0.00124, "interleukin-2 promoter activity": 0.0195, "distinct cellular transcription factor": 0.0143, "bcg": 0.00012, "hiv plasmid construct": 0.00484, "enhance epo-induced beta-globin expression": 0.02081, "ap-1 component": 0.00695, "cmml": 0.0, "synovial": 0.00167, "progressive narrowing": 0.0004, "increase link gamma-globin promoter/luciferase gene expression": 0.01452, "c-rel-selected sequence": 0.01625, "decreased protection": 0.0022, "phagocytosis represent": 0.004, "tat-i gene product": 0.02903, "core region show": 0.01733, "activated monocyte": 0.01197, "placenta": 0.00031, "good prognosis": 0.00102, "repress functional il-12 signal": 0.00817, "hgr synthesize": 0.00158, "humoral": 0.0013, "vitro result": 0.0161, "occur sequence variation impact transcription factor bind": 0.00817, "socs-3 protein": 0.04529, "alter hypothalamic-pituitary-adrenocortical": 0.00378, "primary human blood mononuclear cell": 0.03072, "human c-type lectin leukocyte receptor aim/cd69": 0.01254, "mitogen-activated protein kinase family": 0.02264, "pebp2 alpha factor": 0.01907, "squamous cell carcinoma": 0.0512, "bmt inhibits nuclear translocation": 0.00842, "dibutyryl camp induce": 0.01694, "transcription factor complex occur": 0.0143, "high affinity fc gammari receptor": 0.01029, "precise spacing": 0.00065, "increase pdgf": 0.02196, "il-6 luciferase construct": 0.00484, "competitive progesterone antagonist": 0.00161, "nf-ya subunit play": 0.00474, "dna-mobility-shift assay": 0.01002, "caspase inhibitor z-vad-fmk": 0.006, "complex array": 0.01684, "lymphocyte function": 0.01483, "huvecs correlate": 0.00654, "anti-inflammatory potency": 0.0013, "significant negative correlation": 0.00343, "sepsis syndrome": 0.00273, "chimpanzee cmv mie enhancer": 0.00454, "continued cycling": 0.00034, "oncostatin": 0.0, "thiols": 0.00043, "lymphoid-derived disease": 0.00673, "association": 0.00565, "ifn-alpha/beta activate stat4": 0.01185, "salt daily": 0.00059, "genomic diversity": 0.0027, "induce hiv enhancer-dependent transcription": 0.01405, "immune costimulatory molecule b7.1": 0.00426, "gm-csf template": 0.00329, "molecule contribute": 0.00853, "vzv glycoprotein": 0.00152, "il13 induce": 0.0254, "tnf alpha-induced nf-kappa": 0.00943, "inhibitor pyrrolidinedithiocarbamate": 0.009, "c-fos protein expression": 0.03019, "class ii gene encode cell surface": 0.0256, "growth factor receptor engagement lead": 0.01144, "quk splice pattern": 0.00366, "important role transduce distal signal": 0.00654, "human myeloblastic leukemia hl-60 cell": 0.03072, "common dna sequence": 0.01084, "chimera pmlrar alpha play": 0.00585, "membrane": 0.009, "interleukin-4": 0.00174, "monocyte associate": 0.01197, "egr1 expression vector": 0.02775, "specific interaction": 0.01238, "estrogen receptor positive": 0.01714, "display cushingoid feature": 0.00333, "retarded complex": 0.01684, "viable u937 cell": 0.0512, "motif function": 0.01331, "individual cell cycle phase": 0.0384, "monkey": 0.00143, "ad2 infection induce transient increase": 0.01016, "potential antirheumatic": 0.00605, "sp1 bind": 0.02025, "quantitative analysis": 0.01179, "bhlh target": 0.00825, "transcription factor e2f": 0.01907, "mental retardation": 0.00034, "transcriptional": 0.02301, "hepo withdrawal": 0.00028, "csa-sensitive": 0.00093, "t3/t4": 0.00012, "pcr analysis demonstrate": 0.01065, "soluble tat protein": 0.03019, "corticotropin release hormone": 0.00323, "exchangeable": 6e-05, "interleukin-12": 0.00074, "major target": 0.00825, "regulate cd95 ligand expression": 0.02081, "subsequent cloning": 0.00304, "chronic inflammation induces hydrolysis": 0.00402, "cooh-terminal domain": 0.01207, "major glial cell": 0.0512, "ta-rich sequence present": 0.01084, "considerable sequence identity": 0.01084, "isolated human membrane system": 0.01881, "cytosolic phospholipase a2": 0.00101, "activate stat1 alpha": 0.01185, "mitogenic signaling": 0.00558, "growth inhibitory response": 0.01294, "primary human nk": 0.02508, "cystic fibrosis": 0.00028, "ace inhibitor captopril lead": 0.00498, "mouse macrophage raw": 0.00649, "facilitates actin polymerization": 0.0005, "complex role": 0.01684, "cd4- cd8-": 0.00012, "transfusion incompatibility": 0.00019, "second-degree relative": 0.00276, "immunosuppressant pg490": 0.00047, "human il-5 promoter/enhancer luciferase gene construct transfected": 0.01244, "pediatric patient reveal": 0.0111, "cytokine interleukin-2": 0.01123, "immunogenicity": 0.00031, "hiv-2 long terminal repeat": 0.00189, "induce vdr/drip interaction": 0.01694, "nucleoside diphosphate": 0.00016, "transcriptional factor activator protein-1": 0.0143, "peripheral mononuclear leucocyte": 0.00349, "dp2 remains": 0.00037, "undergo apoptotic cell death": 0.0384, "inhibitory version": 0.00357, "-146": 0.00012, "lymphocyte-tropic strain": 0.00186, "drug action": 0.00499, "il-10 gene": 0.04355, "aberrant fasl up-regulation": 0.00184, "competition analysis": 0.01179, "affect ap-1": 0.00797, "granulocytic-neutrophilic differentiation program": 0.00786, "dose-dependence study": 0.01355, "ra bind": 0.02025, "il-6 gene promoter stimulate": 0.02177, "non-il-2-secreting cell": 0.0768, "normal occupation": 0.0121, "cortisol ratio": 0.00295, "blood sample": 0.00592, "g2/m interphase": 0.00019, "cd14-mediated translocation": 0.00515, "resistant parental": 0.00211, "kit225 cell": 0.0768, "recent evidence": 0.00422, "cooperativity": 0.0005, "shock lung exhibit": 0.00443, "n-formyl-methionyl-leucyl-phenylalanine": 0.00025, "lps-stimulated il-6 secretion": 0.00285, "sequence element": 0.01672, "il-1alpha promoter-cat construct": 0.00484, "biochemical intervention": 0.0018, "em supershift analysis": 0.00786, "drug manifest": 0.00338, "f.massari": 0.00012, "-induced transactivation": 0.00515, "sr-bp gene expression reveal": 0.02177, "distinct inhibitory receptor lead": 0.01286, "posttraumatic stress disorder": 0.00207, "endocrine aspect": 0.00124, "il-4 regulatory element": 0.01115, "distinct effect": 0.02115, "gene enhancer": 0.04355, "gene expression associate": 0.02903, "t2": 0.00019, "endogenous ifn-beta": 0.00459, "nf-kappab p50": 0.00999, "ap-2 binding sequence": 0.01237, "express tax protein": 0.03019, "kappa 1-kappa": 0.00748, "exogenous promoter": 0.02336, "altered conformation": 0.00161, "distinct set": 0.00698, "proliferate cell": 0.0768, "mammalian genome": 0.00174, "complex development pathway": 0.01123, "crf": 0.00031, "enhancer repressor overlap nuclear matrix attachment region": 0.00481, "bovine serum albumin": 0.00252, "antioxidative capacity": 0.00329, "paf-induced change": 0.0063, "ahr": 0.00074, "cd95": 0.0013, "spontaneous production": 0.01042, "inactive form": 0.01055, "distal ccaat box apparent": 0.00152, "early passage cell": 0.0512, "leukaemogenesis": 0.00012, "janus tyrosine kinase-3": 0.00474, "parent": 0.00074, "mechanistic explanation": 0.00016, "lymphocyte": 0.02965, "antigen carriage": 0.00819, "co-cultivated": 0.00012, "105,000-": 6e-05, "a549": 6e-05, "unrearranged tcr delta gene expression": 0.01742, "mechanical ventilation induce low level": 0.01016, "constitutional loss": 0.00298, "proto-oncoprotein ets-1 defines": 0.00068, "hla-a2+": 6e-05, "saos": 0.00012, "respiratory burst": 0.00078, "dqb promoter": 0.02336, "minimum": 0.00025, "cav": 0.00019, "anti-cd3+ anti-cd28-mediated stimulation": 0.00746, "v-abl": 0.00118, "prolonged stimulation": 0.0112, "hypereosinophilic disease": 0.00673, "ccr-1 bind mip-1alpha": 0.0135, "rat nb2": 0.00285, "structure-based enhancement": 0.00233, "female family member": 0.0056, "report set": 0.0049, "weakly activate": 0.01777, "trigger il-6 secretion": 0.00285, "competitive reverse transcription polymerase chain reaction": 0.00937, "isolate nfatx isoforms": 0.00277, "malignant soft tissue tumor": 0.00467, "hnf-1 alpha dimer": 0.0078, "mammalian homologue": 0.00174, "milliliter concentration": 0.0067, "airflow limitation": 0.00019, "cellular factor induce": 0.01907, "gh3 ne": 0.00062, "dqa1 allele": 0.0022, "p50 dna bind subunit": 0.01013, "monoclonal anti-hsp antibody": 0.00596, "decrease ino production": 0.00695, "activated pkc isotypes test": 0.00295, "factor consist": 0.0286, "cf utilizing": 0.00037, "gene rearrangement": 0.04355, "p50/p50": 0.00074, "human dermal microvessel endothelial cell": 0.03072, "require simultaneous activation": 0.02109, "reciprocal chromosomal translocation": 0.00343, "il-4-mediated tyrosine phosphorylation": 0.00656, "b-cell nature": 0.00459, "9-cis-retinoic acid": 0.00856, "cell type-": 0.0768, "organ infitration": 0.00118, "heme-treated flcs": 0.00019, "thrombopoietin induces rapid tyrosine phosphorylation": 0.00393, "th2 pattern": 0.00549, "rest neutrophil": 0.00496, "20-fold high": 0.00931, "il-7r alpha determines specific signal event": 0.00545, "effective immunologic barrier": 0.0011, "parafollicular": 0.00012, "10-amino acid cd40 cytoplasmic signal determinant require": 0.00467, "protein kinase c-alpha": 0.03019, "airway epithelial cell": 0.0512, "sucrose density gradient analysis": 0.00589, "relative efficiency": 0.00276, "hla b8+ lcl target": 0.00413, "murine homolog": 0.00623, "genetic analysis": 0.01179, "anti-ebv antibody titre": 0.00596, "ebv lytic cycle": 0.00376, "exogenous il-12": 0.00313, "il-1ra mrna expression": 0.02775, "chimeric hlf protein display transcriptional activator property": 0.01294, "corticotropin-releasing hormone": 0.00444, "hiv production": 0.01042, "bp truncation": 0.00267, "cell-b cell interaction": 0.0512, "prevent translocation": 0.00524, "pkc act": 0.00496, "potential recognition site": 0.01445, "receptor ligation": 0.02571, "pu.1-family member": 0.00413, "h582": 0.00012, "tnfr-associated factor traf1": 0.01907, "androgen receptor status": 0.01714, "persistent hepatitis": 0.00124, "-kappab": 0.0005, "adenovirus-specific pcr": 0.00115, "u937 promonocytic cell line": 0.0384, "cd30 result": 0.0161, "secrete": 0.00416, "express beta-": 0.01846, "nuclear content": 0.01684, "blood cell development": 0.0512, "ciita-induced occupation": 0.00025, "low-molecular-weight chemokines": 0.00056, "concordant": 0.00012, "exon spread": 0.00127, "lz": 6e-05, "augment uptake": 0.00236, "cell type-specific gene": 0.0512, "chemokines interleukin": 0.00276, "neutrophils result": 0.0161, "il2r alpha": 0.01169, "propose": 0.00329, "n-terminal coactivator domain": 0.00804, "donor splice site": 0.01445, "vital": 0.00031, "breast-cancer pathology": 0.00034, "electrophoretic mobility shift assay suggest": 0.00809, "degranulation": 6e-05, "sex-and age-matched healthy subject": 0.00177, "heterodimeric receptor": 0.02571, "document expression": 0.04163, "1255-1266": 0.0, "vaccine": 0.00105, "lymphoid-enhancer binding factor": 0.01907, "cell activate expression": 0.0512, "localized alveolar collapse": 0.00064, "33-39 repeat": 0.00378, "exogeneous il-2": 0.01117, "augment alpha-globin promoter activity": 0.01462, "cd3h12": 0.00012, "bsap differs": 0.00146, "inhibit synthesis": 0.01904, "action mechanism": 0.01058, "idc": 0.00031, "homologous porcine serum": 0.00252, "nonmobilized peripheral blood mononuclear cell": 0.03072, "clonal population": 0.00307, "pml/rar alpha expression": 0.02775, "caat/enhancer bind protein": 0.03019, "target mutagenesis": 0.00825, "anti-cd3/pma-stimulated": 0.00012, "fy*b promoter": 0.02336, "cross-linked": 0.00081, "philadelphia chromosome positive chronic myelogenous leukemia": 0.00166, "definitive hematopoiesis": 0.00071, "erythroleukemic cell line": 0.0512, "saimiri boliviensis boliviensis": 0.00021, "tissue factor": 0.0286, "gcrs": 0.00012, "cell zone": 0.0768, "lymphotropic herpesvirus capable": 0.00174, "fibroblast environment": 0.00338, "cd27": 0.00031, "binding activity induce": 0.0195, "stimulus lam": 0.0027, "-like molecule": 0.00853, "il-4-driven germline cepsilon transcription": 0.01405, "autosomal recessive pattern": 0.00366, "embryonic": 0.00254, "plasma avp": 0.00375, "post-germinal center": 0.00112, "alpha binding": 0.01855, "modulators": 0.00012, "human mip-1 alpha gene": 0.02177, "mechanism dependent": 0.01058, "viral gene product": 0.02903, "normal erythroid differentiation": 0.00806, "kit225": 0.00031, "anti-tr55 antibody cross-linking": 0.00596, "clinical deterioration": 0.00425, "activate hiv gene expression": 0.02177, "oct-2 induction suggest": 0.01348, "untransfected cell": 0.0768, "mrna stability study show": 0.013, "slp-76-associated substrate": 0.00199, "consensus": 0.00577, "foundation": 0.00012, "share group": 0.00487, "pma/pha-mediated induction": 0.01607, "pre-i": 0.00074, "limit dilution analysis": 0.00786, "rapid mitotic rate": 0.00215, "cell test express tafii105 mrna": 0.03072, "il-1 stimulation": 0.0112, "ap-1 protein c-jun": 0.03019, "gel mobility shift assay": 0.00501, "follicular dendritic cell": 0.0512, "serum-free": 0.00093, "express": 0.03691, "laminin-coated flask exhibit": 0.00443, "prognosis": 0.00056, "rex": 0.00118, "induce dephosphorylation": 0.0254, "early region e1a": 0.00978, "a23187": 0.00062, "viral immediate-early protein": 0.03019, "mouse mutation": 0.00974, "map kinases/extracellular signal regulate kinase": 0.00654, "intact c3a": 0.00239, "reactive cd3+/cd4+": 0.00211, "somatic hypermutation act": 0.00331, "oct-2 protein": 0.04529, "co-stimulatory signal provide": 0.0109, "tg epsilon26": 0.00093, "age group": 0.00487, "human b29 gene lack": 0.02177, "3'-caggtg e-box": 0.00025, "cd56+": 0.00093, "3-bp mutation": 0.00592, "essays": 6e-05, "caspase inhibitor zvad-fmk": 0.006, "microm ra differentiate": 0.00397, "eml": 0.00031, "gamma delta lineage": 0.00294, "induces serine/threonine phosphorylation": 0.00656, "lcls assayed": 0.00016, "inducible nitric oxide synthase-mrna level": 0.00728, "ndp kinase": 0.01188, "analyze responsiveness": 0.00456, "epsilon germline promoter": 0.01557, "crucial": 0.00242, "bb genotype": 0.0004, "bzlf 1-expressing r59z activator cell": 0.03072, "fli-1 protein": 0.04529, "anti-intercellular adhesion molecule-1": 0.00387, "rprl": 0.00031, "human monocytic thp-1 cell": 0.0384, "gel shift analysis show synergistic complex formation": 0.00743, "steroid sensitivity": 0.00292, "excellent paradigm": 0.00016, "cf individual": 0.00409, "promoter domain": 0.02336, "hiv-1-infected cell line": 0.0512, "icenko-cushing": 0.00012, "medullary thymocytes": 0.00257, "hsv-2 vp16 protein": 0.03019, "cytoplasmic domain homologous": 0.00804, "leukemic transformation": 0.00288, "silencing": 0.00074, "il-8 mrna": 0.01526, "agamma-": 0.0, "messenger cascade": 0.00214, "tal-1 chromatin structure": 0.00213, "erythroid transcription factor erythroid factor-1": 0.01144, "apoptosis induce": 0.0254, "tnfalpha-inducible reactive oxygen specie": 0.00105, "transfected skw6.4 cell": 0.0512, "b2": 0.00186, "define dnase": 0.00323, "v-src": 0.00031, "data show": 0.02599, "proximal gc box": 0.00207, "pathway occur": 0.01278, "low gssg level": 0.01214, "multiple hematopoietic lineage": 0.00459, "il-2-deprived cell": 0.0768, "equimolar ratio": 0.00096, "immunorecessive epitope": 0.00161, "hormone bind domain": 0.0135, "il-6/interferon-gamma response element": 0.01294, "base substitution polymorphism": 0.00207, "associate disease": 0.01092, "subdominant lytic cycle epitope": 0.00154, "ng/ml endogenous tbp-1": 0.00306, "lymphoid cell express e2a-hlf": 0.0384, "0.1-0.5 microm dmdtc inhibits intracellular il-2 production": 0.00319, "irf-2": 0.00056, "vcam-nf-kappa": 0.00012, "start site": 0.02168, "human 15-lo promoter region": 0.01881, "clonal anergy": 0.00167, "up-regulated monocyte gene expression": 0.02177, "substantial growth inhibition": 0.00707, "il-6-induced macrophage-differentiation": 0.00047, "subsequent nuclear translocation": 0.01123, "cyclosporin a-sensitive induction": 0.01071, "ms-2gamma interact": 0.00372, "c-fps/fes protooncogene": 0.00056, "synthetic peptide represent amino acid sequence": 0.00542, "ifn inducible expression": 0.02775, "nonhepatic cell": 0.0768, "survival rate": 0.00279, "peptide sequence": 0.01625, "activate protein-1 binding activity": 0.01462, "protein show significant sequence similarity": 0.01811, "reduced sensitivity": 0.00236, "dopamine stimulate transcription": 0.01873, "term htlv-i-associated myelopathy": 0.00275, "nuclear receptor occupancy correlate": 0.01286, "htlv-i infected t-cells": 0.00184, "regulate il-2 gene expression": 0.02177, "erythroid transcription factor": 0.01907, "haploinsufficiency": 6e-05, "spreading": 0.00031, "pu.1 ggaa core sequence": 0.00813, "steroid hormone": 0.00444, "pleckstrin-homology domain": 0.01207, "bud": 0.00037, "cell-type-specific fashion": 0.00161, "adrenal cortex function": 0.00887, "recurrent inflammatory arthritis": 0.00314, "hela cell activate": 0.0512, "interleukin-5 synthesis": 0.00583, "transmembrane mechanism": 0.01058, "previous study": 0.01355, "2d3-vdr binding": 0.01855, "healthy male volunteer": 0.00118, "inducible form": 0.01055, "nfat nuclear translocation": 0.01123, "nfat family protein": 0.03019, "isolate cdna": 0.00456, "carter": 6e-05, "t-cell-expressed cytokine": 0.01123, "cell-specific activity": 0.02925, "specific chromosome translocation": 0.00825, "lucigenin-enhanced cl": 0.00019, "tyrosine kinase p59fyn": 0.00792, "transcription factor require": 0.01907, "qp": 0.00087, "tcr activation": 0.03164, "slow turnover": 0.00112, "rag gene transcription": 0.02903, "ascorbate free radical": 0.00085, "case share unique morphologic feature": 0.00145, "stat3 expression": 0.04163, "bcp-all case": 0.00363, "regulatory cascade": 0.00682, "infection include interleukin-1": 0.00959, "immune-mediated disease": 0.00673, "nf-atp": 0.00149, "t3-unresponsive jeg-3 cell": 0.0512, "gst": 0.00043, "il-10 treatment": 0.01014, "kappab element": 0.01672, "stats promote": 0.00465, "immune cell generate": 0.0512, "reactive": 0.00422, "provide fresh insight": 0.0043, "human adult blood": 0.02508, "dominant interference activity": 0.0195, "messenger ca2+": 0.00304, "human lymphoblastoid cell": 0.0512, "lymph node involvement": 0.0017, "suggest pretranslational control mechanism": 0.01011, "hiv tat expression": 0.02775, "kappa-binding site": 0.02168, "cytosol": 0.00285, "transcription factor ets-1": 0.01907, "interleukin-5/receptor interaction activate lyn": 0.00889, "bone resorption": 0.00214, "primary biliary cirrhosis": 0.00492, "calcineurin-dependent activation": 0.03164, "slp-76 recruit": 0.00127, "ap-1 transcription factor": 0.01907, "pma act": 0.00496, "cytokine induction": 0.01607, "elevated camp": 0.00257, "temporal consequence": 0.00115, "estrogenic pathway": 0.01278, "human tsh receptor": 0.02508, "dominant interfering deltadna-binding domain rxr": 0.00483, "obese": 0.00031, "rxr-beta mrna": 0.01526, "gel electrophoresis mobility shift assay": 0.00401, "symptom due": 0.00369, "understanding": 0.00124, "cd40": 0.00744, "interferon-gamma receptor": 0.02571, "nf-kappa b-related moiety differs": 0.00707, "healthy adult": 0.00422, "dlcl represent": 0.004, "include pkc-zeta": 0.01439, "fos kinase": 0.01188, "ikaros work": 0.00105, "l-29": 6e-05, "nf-kb-related factor": 0.0286, "low ratio": 0.00707, "intriguing possibility": 0.00099, "vimentin expression": 0.04163, "extracellular domain consisting": 0.00804, "bsap gene": 0.04355, "parental k562 cell": 0.0512, "bipolar patient": 0.01666, "pu.1/spi-1 proto-oncogene": 0.0013, "irradiated mouse": 0.00974, "dna-bound stat6": 0.00233, "variant present": 0.00735, "cd4 coreceptor": 0.00332, "protein factor": 0.04529, "x-chromosome-specific element": 0.01672, "calcium-independent": 0.00025, "gc-sensitive group": 0.00487, "bed rest": 0.00267, "cd2-mediated interleukin-2 production occur": 0.00521, "nh2cl inhibits pkc-mediated cellular response": 0.00777, "important stage": 0.00689, "efficacious inhibitor": 0.009, "thr beta": 0.00673, "ec": 0.00509, "pituitary transcription factor pit-1": 0.0143, "aml case": 0.00363, "molecular change": 0.0063, "nonpregnancy lymphocyte": 0.01483, "gel shift experiment": 0.00265, "amenable": 6e-05, "receptor result": 0.02571, "preclinical study": 0.01355, "early protein bzlf1": 0.03019, "pih group": 0.00487, "cyclophilin": 0.00124, "pma+pha": 6e-05, "murine b-cell lymphoma cell line a20": 0.0256, "wild-type fy*b gata": 0.00252, "sp1-": 0.00056, "cd28 expression": 0.04163, "cd40 ligand-positive": 0.00372, "chemr1": 0.0005, "regulatory high mobility group": 0.00465, "ambiguity intrinsic": 0.00121, "maximal basophilia": 0.00183, "signal-induced phosphorylation": 0.00983, "human peripheral granurocytes": 0.02508, "thp-1 monocytic cell show": 0.0384, "nk clone": 0.00738, "growth-inhibitory effect": 0.02115, "transactivating rela": 0.0014, "terminal b-cell differentiation": 0.00786, "intact il-4 promoter construct": 0.01168, "wild type phenotype": 0.00633, "inhibitory peptide": 0.00754, "tissue structural cell": 0.0512, "standard immunofluorescence method": 0.00157, "affect transcription": 0.0281, "clinical variable": 0.00425, "tetracycline-regulated promoter": 0.02336, "human prl": 0.03762, "activated calcineurin": 0.00589, "tissue-specific gc resistance": 0.00217, "restriction enzyme polymorphism": 0.00207, "cd23b promoter": 0.02336, "sea-activated cd4+ spleen": 0.00192, "exogenous tat protein": 0.03019, "peripheral blood": 0.00592, "bound glucocorticoid receptor": 0.01714, "recipient": 0.00043, "receptor mutant": 0.02571, "proto-oncogene c-fos": 0.00471, "arm": 0.0005, "distal promoter": 0.02336, "myeloid-associated growth factor receptor transcript": 0.01144, "similar kd": 0.00673, "stimuli activate nf-kappa": 0.01185, "ubiquitous": 0.00236, "complex": 0.03368, "mature human monocyte-derived": 0.02508, "primary cd8+ ctl response": 0.00971, "mrna stabilization event": 0.01017, "activate transcription factor/camp response element binding": 0.00937, "transcription factor change": 0.01907, "exert inhibitory": 0.00357, "ro47-5944": 6e-05, "distinct dnase-i hypersensitive site": 0.01084, "symptomatic vkc": 9e-05, "inhibit protein synthesis": 0.03019, "consensus gas motif": 0.00583, "sixth step": 0.00189, "upregulate cd21": 0.00093, "distinct silencer mechanism": 0.00705, "ebv-negative burkitt": 0.00065, "classification": 0.00037, "phorbol-12-myristate acetate": 0.00099, "measure steroid mediate lysis": 0.00616, "ap-2-like nuclear factor bind": 0.0143, "pkc": 0.00664, "798+/-67 pg/ml": 0.00012, "extracellular signal-regulated kinase": 0.00792, "receptor protein": 0.04529, "isre clone upstream": 0.00492, "pma/pha-stimulated": 6e-05, "normal allele": 0.0121, "conserved tissue-specific structure": 0.00213, "replication-competent hiv-1 construct carry wild-type": 0.00351, "-75": 0.00025, "cd2 marker": 0.00382, "current scheme": 0.00084, "gire": 0.00043, "s-allyl cysteine": 0.00124, "biologist": 6e-05, "etiological agent": 0.00422, "chromosome carry": 0.00295, "malignancy-associated defect": 0.00279, "6.7+/-0.5 versus 5.7+/-0.3 nmol/l": 0.00068, "base pair -55": 0.00207, "jagged1": 0.00068, "disease-free": 0.00037, "beta-amyloid peptide": 0.00754, "proliferative advantage": 0.0018, "peripheral lymphocyte": 0.01483, "disease specificity": 0.00673, "induced hrf": 0.0054, "cell proliferative signal": 0.0512, "beta-globin gene drive": 0.02903, "htlv-i contributes": 0.00276, "remain active": 0.00592, "separate specific function": 0.00887, "retinobenzoic acid": 0.00856, "reactive tonsil": 0.00211, "3-5": 0.00031, "contraction generate": 0.00453, "il-10 inhibitory activity": 0.0195, "65-kilodalton transactivating subunit": 0.00323, "cd28re/ap-1-specific complex": 0.01684, "reduces ar": 0.00081, "include anti-zebra activity": 0.0195, "il-10 increase": 0.02196, "receptor transcript": 0.02571, "readily detect": 0.00726, "pos-1b": 0.0, "preovulatory period": 0.00127, "gal4-elf-1 fusion protein reveal": 0.02264, "prolonged immunosuppression": 0.00074, "monocytic hl60 cell": 0.0512, "promoter carry": 0.02336, "substance interact": 0.00372, "thr-15": 0.00012, "ebf-binding site": 0.02168, "eo": 6e-05, "ikb": 0.00062, "enhance turnover": 0.00974, "abnormal regulation": 0.01008, "antibody super-shift reaction show": 0.013, "ikappab-alphas32/36a": 0.00062, "initial signal": 0.01635, "key negative regulator": 0.00343, "androgen-regulated gene": 0.04355, "hocl": 0.0005, "signal downstream": 0.01635, "24-hydroxylase message": 0.00071, "specific hla-dq allele": 0.00825, "glomerulonephritis": 0.00031, "acute ccl4-induced hepatic injury": 0.00185, "cd14+ adherent human monocyte": 0.01881, "cell-free system": 0.00667, "phorbol myristate-induced signal": 0.0109, "inhibitory agent": 0.00422, "informative": 0.00037, "class ii transcription": 0.01873, "lbr gene": 0.04355, "b29 promoter-controlled reporter construct 13-fold": 0.0029, "potentiation": 0.00074, "pcdds/pcdfs": 0.00037, "run-on assay": 0.01002, "tandem ap1 site": 0.01445, "cp activity": 0.02925, "intracellular signaling": 0.00583, "exogenous virus": 0.00887, "relevant promoter": 0.02336, "adherent leukocyte": 0.00478, "maximal effect": 0.02115, "dna bind study": 0.0135, "blast": 0.00254, "stress-activated protein kinase": 0.03019, "2m-1 cell": 0.0768, "cytochrome p-4501a1": 0.00037, "develop eukaryotic vector suitable": 0.00202, "mapkk-1/erk-2": 0.00012, "control expression": 0.04163, "particle": 0.00149, "68.5-kb genomic segment": 0.0018, "stat1 phosphorylated": 0.00285, "ligand promoter": 0.02336, "adult drosophila": 0.00422, "lef-1 complex": 0.01684, "regression": 0.00037, "antisense oligomers": 0.00161, "activate heat shock promoter": 0.01168, "n-terminal residue": 0.00226, "il-2 independent": 0.01117, "icam-1luc": 0.00012, "d.d.richman": 6e-05, "posttranslational activation": 0.03164, "regulate cellular gene expression implicate": 0.01742, "stat1 beta": 0.00673, "human erythroid precursor": 0.02508, "ikappabbeta protein expression": 0.03019, "disproportionate severity": 0.00025, "bcl6": 0.00112, "id3 mrna increase": 0.01464, "infectable cell": 0.0768, "e3 regulation": 0.01008, "strong": 0.00695, "human malignant melanoma study nm23 expression": 0.01388, "mek2": 6e-05, "dehydroascorbate": 0.00012, "prl-induced biphasic expression": 0.02775, "immunoprecipitation assay": 0.01002, "single site": 0.02168, "prior activation": 0.03164, "mmps": 6e-05, "low potency": 0.00707, "3h-r1881": 0.00012, "fibronectin enhances ifn-gamma-induced early signaling event": 0.00276, "insulin mrna": 0.01526, "metalloproteinase inhibition": 0.01061, "mutant jak1-deficient hela cell line": 0.03072, "cd21 promoter": 0.02336, "apparent discrepancy": 0.00192, "granulocytic differentiate": 0.00267, "induces cell maturation": 0.0512, "tnf receptor-associated factor": 0.01907, "mibp1": 0.00043, "strategic site": 0.02168, "serum creatinine": 0.00378, "major putative downstream site": 0.01084, "redox": 0.00242, "-1 transcription factor gene": 0.02177, "phi uptake": 0.00167, "structural gene": 0.04355, "thp-1 monocytic cell": 0.0512, "hypergammaglobulinemia": 0.00019, "wild-type ebna2": 0.00378, "normal thymus": 0.0121, "tumor-infiltrating lymphocyte induce": 0.01694, "adrenal androgen level": 0.01214, "pc4-depleted usa fraction": 0.00114, "neuron-specific enolase": 9e-05, "interfollicular cell": 0.0768, "jak-1": 0.00043, "ngfi-a": 0.00012, "ligand-binding domain match mutation": 0.00603, "scl mrna document": 0.01017, "cd2 activate": 0.01777, "transformation confirm early finding": 0.00414, "mediate high level gene expression": 0.01742, "inhibit antigen": 0.01904, "limitation": 0.00037, "enhance hbb transcription": 0.01873, "stimulated murine": 0.00623, "cleavage domain": 0.01207, "ebv activate": 0.01777, "possess sufficient endogenous trs": 0.0023, "macrophage activate": 0.01777, "common dna bind site": 0.01084, "beta-binding activity": 0.02925, "progesterone antagonist ru": 0.00161, "reactive oxygen species-mediated suppression": 0.00208, "include t-cell mitogen": 0.00959, "signalsome protein ikk-alpha": 0.03019, "electrophoretic mobility shift assay reveal": 0.00439, "delta383": 0.00012, "12/15-lipoxygenase mrna": 0.01526, "nfat-1 deletion": 0.00344, "reynolds": 0.00012, "p53 level": 0.01821, "zinc finger region": 0.00978, "varicella-zoster virus": 0.00887, "oestrogen receptor codon": 0.01714, "oct2 isoforms": 0.00307, "il-13 signaling": 0.00558, "c-fms expression": 0.04163, "stat5 rna": 0.00456, "hot acetic": 0.00016, "regulated expression": 0.04163, "motif": 0.01749, "tsc2 occur": 0.00654, "unstimulated": 0.00273, "wild-type lmp1": 0.00378, "c/ebpalpha-deficient mouse": 0.00974, "interferon beta gene transcription": 0.02177, "well-documented biological phenomenon": 0.00145, "th1 development": 0.00633, "otf-2": 0.00099, "idiopathic inflammatory bowel disease": 0.00337, "transcription activator protein-2 binding site": 0.01124, "normal race-": 0.0121, "surprising": 0.0, "similar regulatory response": 0.01294, "major histocompatibility class ii gene dra": 0.01452, "data suggest": 0.02022, "genital hsv-2 lesion": 0.00095, "atl16t": 0.00012, "dna sequence element term": 0.00836, "immature testis": 0.00161, "episome": 0.00025, "avian erythroblast express": 0.0123, "hgr glucocorticoid-binding domain": 0.00804, "hiv-": 6e-05, "stretch": 0.00037, "rat": 0.00571, "general transcription apparatus": 0.01873, "tnf-treated human umbilical vein endothelial cell": 0.0256, "maximal il-2 promoter activity": 0.01462, "meta parallel": 0.00205, "70-kda protein correspond": 0.03019, "nf-gm2 polypeptide": 0.00136, "tumour test": 0.00487, "super-induction": 0.00012, "e2f-i binding protein": 0.03019, "activated th2": 0.00589, "chloramphenicol acetyltransferase gene": 0.02903, "nk cell induce cytolysis": 0.0384, "gata binding site": 0.01445, "thrombin stimulation": 0.0112, "nuclear retention": 0.01684, "proboscipedia": 0.00019, "il-4 act": 0.00667, "vcam regulation": 0.01008, "hgata-1 transactivation": 0.00515, "hmg-coa": 0.00012, "early t-cell gene activation": 0.02177, "regulate gene expression": 0.02903, "benzene": 0.00062, "56-kda protein": 0.04529, "oca-b parallel": 0.00205, "mrna expression level": 0.02775, "pecam-1 promoter": 0.02336, "anthracyclines": 0.0, "triangle uplngfr": 6e-05, "report show": 0.02599, "heparin-like gag": 0.00043, "immunoregulatory gene": 0.04355, "promoter factor": 0.0286, "stimulate": 0.02202, "dual action": 0.00499, "dna sequencing reveal dna reiteration": 0.00439, "enhance gc-mediated induction": 0.01071, "transcriptional activation domain": 0.02109, "constitutive tyrosine phosphorylation": 0.00656, "kappay element reporter gene": 0.02177, "a.j.": 0.00012, "possess anti-inflammatory activity": 0.0195, "-and pha-induced t-cell mitogenesis": 0.00481, "fcgammari": 0.00019, "cell activation gene": 0.0512, "monocyte activate signal": 0.01185, "dd-restricted ctls": 0.00031, "106-kda component": 0.00456, "ba-induced differentiation remain": 0.00786, "m-csf receptor promoter": 0.01714, "efficient dra expression": 0.02775, "nonspecific esterase": 0.00043, "hiv-infected pbmc": 0.00236, "mediate virus": 0.01231, "bovine colostrum": 0.0009, "competitive single-cell rt-pcr": 0.0006, "dc manifest": 0.00202, "cell preincubated": 0.0768, "human putative lymphocyte g0/g1 switch gene homologous": 0.01244, "viable white blood cell": 0.0384, "alpha b5a cell show increased expression": 0.0256, "il-2 -and il-3": 0.00744, "el-4 cell confirm": 0.0512, "apoptotic cell death": 0.0512, "gr precursor mrna": 0.01017, "long survival": 0.00276, "nuclear factor x2": 0.01907, "affect bal fluid content": 0.00399, "sequence element upstream": 0.01115, "gamma-globin transcript": 0.00599, "dra promoter": 0.02336, "nf-kappa b-regulated inflammatory cytokine gene": 0.01742, "n-terminal amino acid": 0.00571, "oct-6": 6e-05, "transcription factor creb": 0.01907, "hh514-16 cell": 0.0768, "platelet membrane": 0.0045, "nucleotide -170": 0.00202, "b-cell commitment": 0.00459, "buffer": 0.00025, "5'-untranslated region": 0.01467, "decrease activated level": 0.01214, "biscoclaurine alkaloid isolate": 0.00277, "freshly isolate rat macrophage": 0.00295, "cd40 signal activates downstream effector": 0.00654, "drosophila sequence": 0.01625, "fva cell nuclear extract": 0.0384, "possess immunomodulatory activity": 0.0195, "apoptotic vsmcs express c-myc": 0.00923, "plasma membrane redox system exert": 0.00267, "fetal liver culture": 0.00414, "construct capable": 0.00726, "128-135": 0.00025, "basic helix-loop-helix protein e2a": 0.02264, "initiate apoptosis": 0.0089, "t-cell surface molecule": 0.00641, "human arteritis-scid chimera": 0.02508, "il-12 respond": 0.00313, "pathway lead": 0.01278, "great selectivity": 0.00205, "pathway inhibits nf-kappab transcription": 0.01405, "c-myb mrna decline": 0.01017, "lgl": 0.00012, "malaria": 0.00062, "dq2 homo -and heterozygous b-lcls": 0.00109, "affect calcineurin phosphatase activity": 0.01462, "erythroid specific enhancer upstream": 0.00619, "plzf-rar alpha fusion protein": 0.02264, "important trace element": 0.01115, "domain possess strong homology": 0.00603, "early index": 0.00828, "wild-type rxr": 0.00378, "atrophy": 0.00056, "rb-defective cell": 0.0768, "p53 tumor-suppressor gene": 0.02903, "beta-adrenoreceptor antagonist": 0.00242, "mutant inhibited tcr-induced activation": 0.01582, "nf-kappab signal pathway": 0.0109, "constitutively active type": 0.00633, "ifn-responsive gene": 0.04355, "traf bind domain": 0.0135, "pathological event": 0.00552, "adrenal androgen": 0.00161, "ratio-dependent increase": 0.02196, "apoptosis-resistant": 0.00037, "variant profile": 0.00276, "proliferate fresh human epstein-barr virus-negative": 0.01505, "sr-bp": 0.00093, "thrombin lead": 0.00996, "interferon-inducible gene": 0.04355, "site": 0.04336, "thp-1 cell extract": 0.0512, "abnormal nf-at binding activity": 0.01462, "antisense oligonucleotides implicate": 0.00234, "zebra-binding site": 0.02168, "inadequate response": 0.01942, "substitute peptide present": 0.00502, "remain unclear": 0.00521, "camp production": 0.01042, "hla-dra gene": 0.04355, "exposure time": 0.0035, "lupus nephritis": 0.00037, "friend virus-induced erythroblast": 0.0007, "opposite glucocorticoid receptor change": 0.01286, "long-lasting accumulation": 0.00323, "-35": 0.00019, "reduced availability": 0.00208, "p53-independent mechanism": 0.01058, "creb binding": 0.01855, "antibody supershift experiment": 0.00596, "polymorphic dinucleotide": 0.00059, "membrane fraction": 0.0045, "th1 function": 0.01331, "small complex due": 0.01123, "hsv-2-specific": 6e-05, "human cd5 gene": 0.02903, "smad7": 0.00062, "litaf map": 0.00205, "clone upstream": 0.00738, "enhance monocyte differentiation": 0.00798, "selenium lead": 0.00996, "upstream kinase zap-70": 0.00792, "dense peroxidase-negative granule": 0.00074, "discontinuous": 0.00025, "early event": 0.00828, "individual latent protein": 0.03019, "inducible cyclosporin a-sensitive dnase i-hypersensitive site": 0.00723, "mobility shift": 0.00183, "frame shift": 0.00183, "-alpha gene": 0.04355, "cell prolymphocytic leukemia cell mediate": 0.01536, "erythroid progenitor cell differentiation": 0.0384, "camp-dependent signal pathway exert": 0.00817, "microm pyrrolidine dithiocarbamate": 0.00087, "u1 line": 0.01653, "cho-cd80 stimulation": 0.0112, "fc gamma ri expression": 0.02081, "classical protein kinase": 0.03019, "therapeutic efficiency": 0.00167, "epstein-barr virus bind": 0.0135, "integral membrane glycoprotein cd36": 0.00225, "gram-positive bacteria": 0.00037, "collagen receptor": 0.02571, "blk gene": 0.04355, "p19 cell": 0.0768, "plasma factor vii/viia": 0.01907, "gal4-k protein": 0.04529, "non-irradiated cell": 0.0768, "tetraploid": 0.00012, "cat reporter construct": 0.00484, "thromboxane receptor promoter activity": 0.01462, "decrease tissue-specific promoter activity": 0.01462, ".poly": 0.0, "type ii estrogen bind site": 0.00867, "healthy child": 0.00177, "human cd4 gene": 0.02903, "rank-dependent induction": 0.01607, "suppress malignant cell growth": 0.0384, "normotensives": 6e-05, "monocyte interaction": 0.01197, "macrophage tissue factor expression": 0.02081, "embryonic gene": 0.04355, "circumvention": 6e-05, "maximum stimulation": 0.0112, "dominant negative allele": 0.00343, "translocate pax-5 gene": 0.02903, "tpa augment dexamethasone-induced transcriptional activation": 0.01266, "t-cell stimulation increase": 0.01464, "mycoplasma fermentans membrane lipoprotein": 0.00225, "ac unit": 0.00105, "nuclear factor-kappab/rel": 0.01684, "egr-1 transcription factor": 0.01907, "human interleukin-13 activate": 0.02508, "loop peptide": 0.00754, "transcribed 5'-untranslated leader region": 0.00734, "ras activation combine": 0.02109, "-kappab consensus sequence": 0.01084, "forty-one hd sample": 0.00139, "dna-binding subunit": 0.00561, "unusual repeat": 0.00378, "healthy female": 0.00177, "-207": 0.00025, "increase evidence": 0.02196, "site require": 0.02168, "luciferase gene": 0.04355, "increase synthesis": 0.02196, "alveolar macrophage nuclear protein result": 0.01811, "bik": 0.00037, "expression pattern describe": 0.02775, "dna repair": 0.01483, "tax transforms normal t-cells": 0.00605, "mcm modulatory action": 0.00333, "express cd44": 0.01846, "transplanted fibrosarcomas": 0.00031, "antigen response": 0.01942, "ipr": 0.00062, "promote monocyte differentiation": 0.00798, "elimination": 0.00031, "ser23-ala49": 0.00012, "chloramphenicol acetyltransferase-expressing plasmid": 0.00182, "individual ptk substrate": 0.00273, "mature organ develop": 0.00269, "p95vav involvement": 0.00254, "hla dqa1*0501": 0.00192, "rest eosinophil": 0.00295, "nf-kappa b-binding element": 0.01115, "candidate oxygen reactive specie": 0.00105, "mature monocyte": 0.01197, "signal cascade trigger": 0.0109, "chinese hamster ovary": 0.00031, "cell cycling": 0.0768, "positive transcription factor": 0.01907, "ah receptor ligand form": 0.01286, "vitro-cultured": 6e-05, "bacterial lp": 0.00354, "cl-01 cell": 0.0768, "beta-catenin undergoes": 0.00047, "inserting sequence": 0.01625, "ec redox environment": 0.0017, "id2 expression decrease": 0.02775, "unknown": 0.00347, "dnasei footprinting": 0.00118, "multiple consensus binding site": 0.01084, "camkiv/gr induce": 0.0254, "combined inhibitory effect": 0.0141, "ifn-gammar": 0.00043, "nuclear signal": 0.01684, "powerful assembly": 0.00164, "endothelium": 0.00124, "include corticosteroid": 0.01439, "strong immunohistological staining": 0.00232, "monoblastic differentiation induce": 0.01694, "ebv infection": 0.0062, "amino-acid motif": 0.00875, "hydrophobic c-terminal tail": 0.00128, "cytoplasmic serine kinase": 0.00792, "gamma-globin expression identifies eklf": 0.02081, "paclitaxel": 0.00012, "intracellular level": 0.01821, "lymphoproliferative disease": 0.00673, "e-box-binding repressor": 0.00223, "non-phlogistic manner": 0.00282, "site-directed mutagenesis study define essential gata": 0.00452, "replication-incompetent molecular clone": 0.00492, "adaptor protein cbl-b": 0.03019, "t-cell-specific transcription factor nf-at": 0.0143, "helper cell mrna": 0.0512, "infiltrating leukemic cell": 0.0512, "dna-binding regulatory factor": 0.01907, "q21": 0.00019, "erythroleukaemia cell": 0.0768, "southern blot hybridization show": 0.013, "ine": 6e-05, "estrogen replacement therapy": 0.00248, "tumor cell type": 0.0512, "cd44": 0.00155, "oppose effect": 0.02115, "interleukin-5 gene": 0.04355, "bfu-e-derived colony culture": 0.00414, "activated nf-kappa": 0.01414, "cyclosporin-sensitive promoter element": 0.01557, "alpha beta lineage": 0.0078, "ebv persistence": 0.00565, "tcf-mediated transcription": 0.0281, "gata3 zinc-finger protein": 0.03019, "co-transfection experiment confirm": 0.00265, "relapsed patient": 0.01666, "lactobacillus": 0.00012, "protein phosphorylation": 0.04529, "activated ec": 0.00589, "tggaaattcc": 6e-05, "il-2-induced ifn-gamma production": 0.00695, "activate human platelet": 0.02508, "comparable property": 0.00397, "hiv-1 regulation": 0.01008, "cotransfection": 0.00192, "cell-type-specific differential response": 0.01294, "primary breast cancer": 0.00492, "10-fold strong": 0.00347, "gene pax-5": 0.04355, "percent proliferative life span complete": 0.00072, "rel-related 65-kd protein": 0.03019, "receptor gene construct": 0.02903, "optimal": 0.00304, "microm 1-beta-d-arabinofuranosylcytosine induced nf-kappa": 0.00707, "adhesion-dependent": 0.00019, "sigma": 0.0005, "retrovirus": 0.00143, "primary cellular initiator": 0.00596, "chromosomal aberration result": 0.01073, "action remain unknown": 0.00347, "anti-cd3 monoclonal antibody": 0.00596, "stress-induced vimentin increase": 0.01464, "fas-fas ligand interaction": 0.00658, "harbor promoter element": 0.01557, "il-6": 0.00782, "activity require region": 0.0195, "press": 6e-05, "downstream target gene": 0.02903, "csa inhibits lymphocyte gene activation": 0.01742, "primary physiological regulator": 0.00492, "chemical": 0.00112, "il-2 receptor alpha chain gene": 0.01742, "chronic exposure": 0.00397, "polyunsaturated fatty acid": 0.00571, "pma/ionomycin-induced nuclear factor": 0.01907, "oestrogen receptor variant": 0.01714, "rapid proliferation": 0.00803, "gamma/delta tcr inhibit pibf": 0.00952, "adhesion molecule expression": 0.02775, "metalloproteinase": 0.00043, "alpha gene expression": 0.02903, "purified homodimer": 0.00261, "cell surface event": 0.0512, "human burkitt lymphoma cell line bl60": 0.0256, "direct dna sequencing": 0.00988, "anti-ptf beta antibody": 0.00596, "rest normal human": 0.02508, "complex bind": 0.02025, "causal linkage": 0.00037, "thymus-derived t-cell homeostasis": 0.00641, "bind soluble gp120": 0.0135, "pef": 6e-05, "p3hr1 virus genome": 0.00591, "permit productive interaction": 0.00658, "wortmannin": 0.00012, "human embryonal carcinoma cell line n-tera2": 0.0256, "clonal human": 0.03762, "il-2-induced il-2r alpha promoter activity require": 0.00975, "-1053/+34 construct": 0.00726, "partial homology": 0.00183, "noncleavable alteration": 0.0023, "pregnant woman show": 0.01733, "syk-mediated": 6e-05, "il-2 alpha gene": 0.02903, "female patient present": 0.0111, "hu": 0.00081, "suppress cell differentiation": 0.0512, "lesion result": 0.0161, "continuous nf-kappa": 0.01414, "ad5": 0.00099, "vitamin d3 responsiveness": 0.00215, "undergo form": 0.01055, "bzip domain defective": 0.00804, "er alpha": 0.01169, "chemotactic cytokine": 0.01123, "classical oct2a": 0.00171, "iron staining": 0.00177, "hunninghake": 6e-05, "receptor and/or transduction pathway": 0.01286, "subsequent inhibition": 0.01061, "cryptococcus neoformans": 0.00012, "hs-40 consists": 0.00053, "interleukin-6-induced igm production": 0.00695, "daughter cell analysis": 0.0512, "transcription start site": 0.01873, "mhc class ii signal": 0.00817, "increase hiv replication": 0.01464, "lamina propria": 0.00012, "chimeric promoter": 0.02336, "dominant-negative ets-binding factor": 0.01907, "myeloid cell-derived cytokine": 0.00749, "transcription factor belong": 0.01907, "powerful ptpase inhibitor": 0.006, "antisense inhibition": 0.01061, "c-terminal residue": 0.00226, "sp1 binding motif": 0.01237, "biologic effect": 0.02115, "retinoid-induced u-937 cell differentiation": 0.0384, "myeloid precursor cell line hl60": 0.03072, "n-terminal kinase": 0.01188, "detection suggest": 0.02022, "mip1 alpha nuclear protein": 0.02264, "early agonist-induced signalling": 0.00552, "stat3alpha protein phosphorylated": 0.03019, "cysteine derivative": 0.00192, "reticulocyte lysates": 0.00102, "parental hl-60 cell": 0.0512, "enhance mitogenesis": 0.00974, "surfactant downregulated inflammatory cytokine production similarly": 0.00374, "nuclear exclusion": 0.01684, "regulate erythroid differentiation": 0.00835, "mitogen-activated protein": 0.04529, "cell function": 0.0768, "marrow progenitor cell": 0.0512, "density centrifugation method": 0.00157, "n-terminal acidic transcriptional activation domain": 0.01266, "gene encode eosinophil granule protein": 0.01811, "cak": 6e-05, "developmental control": 0.01303, "ductal cancer": 0.00248, "bhlh heterodimer-dependent gene expression": 0.02177, "element": 0.03344, "immunomodulating activity": 0.02925, "action remain elusive": 0.00347, "il-2 nf-chi": 0.01117, "sequester rel/kappab": 0.00043, "anti-tag antibody": 0.00893, "thiol insufficiency": 0.00059, "downstream parathyroid hormone-related protein": 0.02264, "apoptotic cell death induce": 0.0384, "eight-fold enhancement": 0.00233, "human dendritic cell-based assay": 0.01881, "cytokine activation": 0.03164, "involvement": 0.00509, "roi-induced effect": 0.02115, "beta-globin gene promoter": 0.02903, "encephalomyocarditis virus": 0.00887, "human erythrocyte membrane": 0.02508, "nf-kappab signaling": 0.00999, "csa-sensitive component limit signal": 0.00817, "/lymphotactin": 6e-05, "anti-igm": 0.0013, "understanding v-abl": 0.00062, "kda": 0.00217, "tolerance induction": 0.01607, "heterodimers": 0.00453, "t-helper": 0.00062, "and/or sn-1,2 dioctanoyl glycerol": 0.00225, "ifnalpha-": 0.00019, "nf-kappa b/cd28-responsive complex": 0.01123, "reporter cell": 0.0768, "induce stress-activated protein": 0.03019, "5-lox activating protein": 0.03019, "rex function": 0.01331, "p3": 0.00019, "bipotent myeloid progenitor": 0.00308, "human lymphoid tumor": 0.02508, "lps-induced nf-kappab activation": 0.02109, "specific factor": 0.0286, "-dependent ht-2 line": 0.01102, "mn-sod rna protein level": 0.02264, "toxic metabolite": 0.00109, "increased nf-kappab nuclear translocation": 0.00842, "transient tyrosine": 0.0071, "inhibit t-cell interleukin-2 expression": 0.02081, "author": 0.0005, "mzf-2 carry": 0.00276, "ftoc": 0.00019, "nitrogen play": 0.0071, "express adaptor protein": 0.03019, "corticosteroid type": 0.00949, "murine microglia": 0.00623, "ba treatment": 0.01014, "contention": 6e-05, "cd2 signal induces phosphorylation": 0.00817, "dprl promoter construct": 0.01557, "altered expression level": 0.02775, "include tnf-alpha": 0.01439, "dephosphorylation event": 0.00552, "hiv-1 ltr-driven reporter gene activity": 0.01742, "unnoticed": 0.0, "lyonization": 0.00025, "spi-1 family member": 0.0056, "include change": 0.01439, "nf-kappab pathway": 0.01278, "house dust mite": 8e-05, "il-6-induced signal": 0.01635, "secreted form": 0.01055, "bind basic helix-loop-helix-zipper protein": 0.02264, "acth stimulation test": 0.00746, "hiv replication": 0.00592, "pathways mediate low shear-": 0.00616, "transient dna transfections": 0.00988, "metyrapone": 0.0, "darc gene": 0.04355, "important immunoregulatory cytokine": 0.00749, "retinoic acid receptor alpha gene": 0.01742, "pma/pha": 0.00025, "physiologic relevance": 0.00071, "cyclotetrapeptide": 6e-05, "major promoter": 0.02336, "translocate nfeb p65": 0.00258, "pharmacological concentration": 0.0067, "lyn": 0.00093, "estrogen exhibit": 0.00664, "pea3": 6e-05, "additional unknown factor": 0.01907, "il-4 induced robust janus kinase": 0.00475, "sle disease activity index": 0.01462, "sport activity": 0.02925, "unexpected variability": 0.00025, "world wide web": 0.00021, "human chromosome": 0.03762, "nfatp dephosphorylation": 0.00164, "aldosterone-selectivity": 6e-05, "germinal center formation": 0.00323, "unactivated nuclear extract": 0.01123, "boundary": 0.00025, "ccaag": 6e-05, "comprise region": 0.01467, "structural similarity suggest": 0.01348, "cell line lack oct-2 result": 0.03072, "mpro promyelocytes": 0.00025, "il-6 signal lead": 0.0109, "factor remain cluster": 0.01907, "splice product": 0.00533, "reporter gene transcription": 0.02903, "cachexia": 0.00012, "pro641": 0.00012, "cell cycle machinery": 0.0512, "myeloid development": 0.00633, "anti-ig treatment": 0.01014, "erythroleukemia k562 cell": 0.0512, "brdu incorporation": 0.00068, "ifn-mcp": 0.00056, "rho-regulated receptor clustering": 0.01714, "functional study show": 0.01733, "pentoxifylline-mediated inhibition": 0.01061, "s.": 0.0013, "deletion": 0.00689, "fkhrl1p2": 6e-05, "proinflammatory stimulus": 0.0027, "simple culture condition": 0.00414, "express hla class ii molecule": 0.00738, "warrant": 0.00037, "interleukin": 0.00552, "functional unresponsiveness": 0.00816, "receptor complex relies": 0.01714, "fenton reaction": 0.0022, "activate nf-kappa": 0.01777, "erythrocytic lineage": 0.00366, "macrophage activation": 0.03164, "anti-cd3 treatment": 0.01014, "ap-1 transcription complex": 0.01873, "p50 nf-kappa b1": 0.00943, "hzf 1-10": 0.00019, "erythrocyte duffy protein": 0.03019, "cmat": 0.00025, "critical threshold": 0.00428, "-atpases": 6e-05, "freshly isolate human monocyte decrease": 0.01505, "macrophage cell lineage": 0.0512, "cd23 receptor": 0.02571, "facilitate promoter occupation": 0.01557, "ctl clone": 0.00738, "hsp90": 0.00143, "interleukin-7 upregulates": 0.00043, "beta-catenin alters gene expression": 0.02177, "gata bind site": 0.01445, "enhance apoptosis": 0.00974, "phospholipase": 0.00155, "transcription interact": 0.0281, "consensus octamer motif": 0.00583, "prevented apoptosis induce": 0.01694, "internal ribosomal binding require": 0.00927, "type ii il-1r": 0.00633, "il-10 inhibit": 0.01904, "growth experiment demonstrate": 0.01065, "subunit p65": 0.00484, "0.21-0.33 nm": 0.00093, "raif geha discus recent advance": 0.00056, "chicken gata-1": 0.00413, "k562 target": 0.00825, "constitutive dna binding activity consist": 0.0117, "site show activation": 0.02109, "slp-76-dependent interleukin": 0.00276, "lps-generated signal": 0.01635, "htlv-i infected cell": 0.0512, "dominant negative nf-il6 mutant": 0.00405, "nonresponsiveness": 0.00019, "phosphotyrosines serve": 0.00155, "diminished": 0.00186, "bzlf-1": 0.00019, "deletion analysis": 0.01179, "pancreas organogenesis": 0.00025, "5'-pyctttg-3": 6e-05, "untransformed progestin": 0.00019, "flt-3": 0.00019, "band q34": 0.00102, "ser-36": 6e-05, "transcription factor creb/atf": 0.01907, "tissue-specific late histone h2a-2": 0.00127, "functional glucocorticoid receptor": 0.01714, "atf1": 0.00025, "ap-1-like factor": 0.0286, "anti-kappa": 6e-05, "varicella zoster virus": 0.00591, "3h-e2": 6e-05, "opposite direction": 0.0004, "define sequence": 0.01625, "ifn": 0.00459, "tissue transglutaminase-dependent posttranslational modification": 0.00332, "dna methyltransferase": 0.01483, "competent stat transcription": 0.01873, "bsap sit": 0.00146, "platelet-activating-factor": 6e-05, "housekeeping": 0.00019, "recent work": 0.0014, "eosinophilic granulocyte": 0.00254, "donor anti-pml/rar-alpha cd4": 0.00221, "chromogenic assay": 0.01002, "c-rel inhibition": 0.01061, "eosinophil stimulation": 0.0112, "lp require": 0.01315, "subdomains": 0.00019, "initiator element commonly": 0.01115, "ice-like protease": 0.00177, "ner": 0.00037, "lipopolysaccharide-stimulated mouse splenic": 0.00649, "persistent phosphorylation": 0.00983, "hirak enhance il-1-stimulated activation": 0.01582, "primary peripheral blood lymphocyte": 0.00741, "fourfold decrease": 0.00971, "pdbu-treated hl-60 cell remain viable": 0.03072, "prri": 0.00012, "respective promoter": 0.02336, "cd28 receptor": 0.02571, "microtubule disruption": 0.00087, "pathological model": 0.00422, "primary rna transcript": 0.00492, "-receptor superfamily": 0.00096, "-170/+108": 6e-05, "enhanced differentiation": 0.01179, "precise definition": 0.00065, "leader sequence": 0.01625, "g. vaginalis": 0.00062, "n-acetylcysteine treatment": 0.01014, "c-terminal serine/threonine/proline-rich region": 0.00978, "naive human helper": 0.02508, "regulatory": 0.01365, "single major tr": 0.00383, "oligomerized nfat-1 binding motif": 0.00927, "sp1-related factor": 0.0286, "transactivating region": 0.01467, "inhibition study": 0.01355, "ca2+ dependent step": 0.00258, "transferrin": 0.00037, "negative signal": 0.01635, "r-pk promoter": 0.02336, "srg3": 0.00056, "protein phosphatase inhibitor okadaic acid secrete high level": 0.01132, "u937 myeloid cell model": 0.0384, "immune response regulation": 0.01294, "/xist": 0.00012, "stat4 action": 0.00499, "monocyte-derived cytokine": 0.01123, "tax transformed cell result": 0.0384, "androgen receptor gene lead": 0.02177, "oncogenic rat": 0.00285, "skewedness": 6e-05, "isolated gene": 0.04355, "mechanism underlie signal transducer": 0.00817, "major transactivation region": 0.00978, "cell surface molecule require": 0.0384, "heterogeneous hiv-1 pool": 0.00585, "asthma bronchiale": 0.00161, "consensus zinc finger peptide domain": 0.00483, "lytic infection": 0.0062, "independent mutation event": 0.00395, "poorly immunogenic murine melanoma d5": 0.00249, "stat-1 activation": 0.03164, "interferon up-regulate stat1": 0.00199, "case report": 0.0049, "cell membrane ig expression": 0.0384, "immunocytochemical method": 0.00236, "impaired myelopoiesis": 0.0018, "ap-1 site require": 0.01445, "cell associate": 0.0768, "3t3-l1 adipocytes": 0.00016, "physical linkage": 0.00096, "-induced gm colony formation": 0.00242, "granulocyte-macrophage colony-stimulating factor receptor alpha gene": 0.01452, "y341": 0.0, "express nfatc constitutively": 0.0123, "iron-sulfur center": 0.00112, "insulin secretion": 0.00428, "ru43044": 6e-05, "tetrahexamer sequence": 0.01625, "-dependent": 0.00273, "enhanced level": 0.01821, "intracellular gsh level": 0.01214, "fasl inhibits paclitaxel-induced apoptosis": 0.00445, "tyrosine protein kinase activity": 0.02264, "protooncogene p21ras": 0.00152, "respond beta chain": 0.00449, "elderly donor suggest": 0.01348, "mammalian specie": 0.00183, "inherited mutation": 0.00592, "immunoglobulin heavy-chain promoter": 0.01557, "monocytic cell line u937 calcineurin": 0.03072, "induced promoter activity": 0.0195, "kappa e3": 0.00748, "efficient delivery vehicle": 0.00126, "selective displacement": 0.00267, "biphasic expression": 0.04163, "in-vitro transcription/translation": 0.00012, "encephalomyocarditis virus internal ribosomal entry site rna-protein interaction": 0.00542, "underlie": 0.00434, "feasible strategy": 0.00121, "monocyte-derived dc": 0.00202, "removal occur": 0.00654, "phorbol ester-stimulated cell": 0.0512, "fura chemotherapy": 0.00071, "il-12 induce strong tyrosine phosphorylation": 0.01016, "hiv infection result": 0.01073, "bz1 monoclonal antibody": 0.00596, "vitro binding analysis reveal": 0.00927, "ets site": 0.02168, "functional 5-lox system": 0.00544, "gc gene": 0.04355, "-positive osteoclast-like": 0.00047, "nuclear factor bind": 0.01907, "cell express wild-type tdag51": 0.0384, "jak/stat activation": 0.03164, "gr function": 0.01331, "cd40 antigen": 0.00819, "downstream": 0.00596, "il-2 signaling": 0.01117, "cell count 2-6 mil": 0.0384, "autosomal sex reversal map": 0.00102, "humara gene": 0.04355, "biological characterization": 0.00217, "zinc-inducible vector": 0.00319, "harmful": 6e-05, "primary activation": 0.03164, "radiolabeled hormone/receptor complex": 0.01123, "pma-enhanced lal expression": 0.02775, "common jak/stat pathway": 0.00852, "functional selection": 0.00816, "rxr -raralpha403 heterodimer": 0.00136, "germ-line brca2 mutation": 0.00395, "cd68+": 0.00025, "metastatic property": 0.00397, "tg": 0.00186, "human tissue": 0.03762, "jak-stat signaling pathway": 0.00852, "redox sensitive": 0.00273, "a6h monoclonal antibody": 0.00596, "propylthiouracil": 0.0, "multiple transcript": 0.00689, "ra promote": 0.00596, "defensin resistance": 0.00326, "chloramphenicol acetyltransferase construct reveal": 0.00549, "nonhematopoietic": 0.00043, "nf-kappa b-like sequence": 0.01084, "completion": 6e-05, "variance": 0.00025, "cis-linked regulatory sequence": 0.01084, "inducible autoregulatory pathway": 0.00852, "transfection assay show": 0.01733, "pgg-glucan induce": 0.0254, "monocytic/myeloic gene mrp14": 0.02903, "acute myeloid patient": 0.0111, "recent biochemical study": 0.00904, "augment": 0.00471, "nk cell-target cell interaction": 0.0384, "fgf-1-induced rel/kappab binding protein": 0.02264, "pro-myelocytic leukaemia gene": 0.02903, "il-1 beta mrna detect": 0.00763, "ligand-induced activation event": 0.02109, "transcription activate subunit": 0.01873, "cd20+/cd10-/cd5-": 0.00012, "cd11b promoter activity": 0.0195, "product expression": 0.04163, "stabilizer": 6e-05, "prevent binding": 0.01855, "asm expression": 0.04163, "mnp-2 expression": 0.04163, "late diabetic complication": 0.0017, "zp": 0.00112, "cis-acting dominant negative regulatory effect": 0.00846, "vivo experiment": 0.0053, "nuclear nf-kappa": 0.01684, "upstream site": 0.02168, "mtg8": 6e-05, "nf-kappa b/rel transcription factor family": 0.01144, "express ap-1 dna binding activity": 0.0117, "nf-kappab inhibitory effect": 0.0141, "destabilization": 6e-05, "activate expression": 0.04163, "disease-activated macrophage": 0.00589, "36-kda transcription factor": 0.01907, "ebv-infected lymphoblastoid cell": 0.0512, "tax1-induced activation": 0.03164, "alternative 5'-end": 0.00205, "induce morphological differentiation": 0.01694, "enhanced intracellular prooxidant state": 0.00292, "partial cdna encode": 0.00569, "alu consensus sequence": 0.01084, "critical site": 0.02168, "nm aldosterone": 0.00186, "cognate cdna sequence reveals": 0.00813, "human breast tumour": 0.02508, "host blastocyst-derived erythrocyte": 0.00143, "tumor-derived soluble product": 0.00356, "c-fos/c-jun gene": 0.04355, "lymphocyte metaphase": 0.01483, "bronchoalveolar lavage cellularity": 0.00027, "ebv-transformed lymphoblastoid cell line ebna-5": 0.03072, "cell stimulation-induced expression": 0.0512, "complex biological process": 0.01123, "essential rise": 0.00487, "accessible human cell model": 0.0384, "ra oncogene transformation": 0.00397, "il-12 stimulation": 0.0112, "recombinant human il-2": 0.02508, "sessile peptide bond": 0.00502, "nf-at motif": 0.00875, "young donor": 0.0014, "mild detergent treatment": 0.00676, "q14": 0.00012, "represent membrane receptor": 0.01714, "oligonucleotide comprise": 0.00164, "primitive hpcs": 0.00065, "ketoconazole": 0.0005, "vitro acetylation": 0.00785, "regulate insulin expression": 0.02775, "il-2 promoter bear": 0.01557, "hla-b8-restricted latent epitope": 0.00151, "adhesion molecule important": 0.00569, "thymidine": 0.00136, "cdc42 gtpases": 0.00019, "biotinylated mcp-1": 0.00124, "human tumor": 0.03762, "predominant": 0.00192, "grf40": 0.00074, "yeast transcriptional regulator rpd3p": 0.00575, "increase transendothelial migration": 0.01464, "neutralizing anti-m-csf antibody": 0.00596, "p98": 0.00037, "significant progress": 0.00416, "factor bound": 0.0286, "organ failure": 0.00136, "beta-globin locus": 0.00288, "pi3-kinase inhibitor ly294002 block": 0.00537, "turn regulate": 0.01253, "heterodimerize": 0.00025, "transcription factor c-jun": 0.01907, "anti-inflammatory mediator": 0.00195, "express beta-chain": 0.01846, "activate normal": 0.01777, "inhibit low shear-induced activation": 0.01582, "jak3-deficient severe combine immunodeficiency lymphocyte": 0.00593, "gata-3 involves high affinity binding": 0.00742, "crossreactive cytotoxicity pattern": 0.00366, "dna variation": 0.01483, "indistinguishable kappa": 0.00748, "ce cell": 0.0768, "lpr cd4-cd8-": 0.00025, "/tumor necrosis factor-alpha": 0.00159, "microa motif": 0.00875, "myeloid progenitor cell": 0.0512, "full-length cdna clone encode nf-x2": 0.00341, "d.finzi": 0.00012, "low surface icam-1 expression": 0.02081, "transduced pml/rar alpha fusion gene": 0.01742, "cd28re": 0.00043, "common signal transducer": 0.0109, "pr": 0.00093, "cell hyperreactivity": 0.0768, "e1a-mediated immune suppression": 0.00399, "common type": 0.00949, "sublytic tcc induce ra": 0.0127, "n-myc interactor": 6e-05, "activate hla-dra expression": 0.02775, "biochemical fractionation": 0.0018, "fibroblast cell transformation": 0.0512, "mnp site lead": 0.01445, "undergo signal-induced phosphorylation": 0.00656, "tre-1": 0.00037, "monocytes/macrophages": 0.00136, "il-5 proximal promoter region": 0.01168, "pma-induced phosphorylation": 0.00983, "malaria research": 0.00031, "major ccaat/enhancer-binding protein": 0.03019, "bind protein": 0.04529, "important feature": 0.00689, "purified early hematopoietic progenitor cell": 0.03072, "concurrent follow-up nk activity": 0.01462, "p55tnf-r.": 6e-05, "infected thymocyte population": 0.00205, "inhibited lps-induced e-selectin expression": 0.02081, "cell express gata-binding protein show": 0.03072, "cell line hpb.all": 0.0512, "4,19-substituted steroid": 0.00292, "il-4r alpha-chain": 0.00074, "lmp-2a": 6e-05, "unresponsive": 0.00087, "cell cycle signal": 0.0512, "replicative form": 0.01055, "fourfold increase susceptibility": 0.01464, "d5 tumor cell induce": 0.0384, "enhance p40": 0.00974, "hl-60/vinc cell": 0.0768, "c/ebp-epsilon sense": 0.00062, "c-jun transcription": 0.0281, "function analogous": 0.01331, "radiolabeled double strand oligomers representative": 0.0003, "purified": 0.00521, "raji cell reveal": 0.0512, "erba-binding site confers thyroid hormone responsiveness": 0.00723, "unknown step": 0.00189, "human natural killer cell": 0.0384, "phytohemagglutinin-": 6e-05, "intrauterine contraception": 6e-05, "jak3 activation": 0.03164, "self-tolerance": 6e-05, "nuclear c-rel act": 0.01123, "rapid strategy": 0.00323, "human jurkat": 0.03762, "-300 region": 0.01467, "fos-related protein": 0.04529, "htlv-i basal transcription": 0.01873, "lymphoid marker occur": 0.00436, "propose gain-of-function": 0.00164, "genetic location show": 0.01733, "glucocorticoid receptor-mediated effect": 0.0141, "c-fgr": 0.00012, "rpon mutant": 0.0081, "pel cell line suggest": 0.0384, "gata-1 control cell survival": 0.0384, "-352": 6e-05, "maximum activity": 0.02925, "great proliferation rate": 0.00536, "-445/-366": 0.0, "hydrolytic activity": 0.02925, "ebna2-dependent synthesis": 0.00583, "intact tcr signal pathway": 0.00817, "cell blast pulse": 0.0512, "specific type": 0.01238, "lysp100 cdna isoform": 0.00304, "dna-binding component": 0.00561, "viral protein tax": 0.03019, "macrophage transcription factor pu.1 bind": 0.01144, "chromosomal": 0.00205, "scheuermann": 0.00012, "b-cell stimulation": 0.0112, "/il-4ralpha cytokine receptor chimera potentiate allergic airway disease": 0.00643, "tcr-associated ptk": 0.00053, "exogenous glutathione": 0.00214, "acute myeloid leukemic blast": 0.00231, "acetylated isoforms": 0.00307, "primary sjogren": 0.00738, "major gc-box binding activity a1": 0.0117, "balb/c": 0.00025, ".05": 0.0, "il-8 ap-1": 0.00695, "position -103": 0.00236, "x/46": 0.0, "activated rar alpha": 0.0078, "lymphoblastoid t-cell line": 0.01102, "anti-cd3-stimulated cord blood mononuclear cell": 0.03072, "ut-7 epo cell express alpha-globin": 0.03072, "cgmp-dependent protein kinase": 0.03019, "70-bp ifn-gamma response element": 0.00971, "fk-506 -and csa-sensitive enzyme require": 0.00526, "mitogen phytohemagglutinin": 0.00149, "high affinity il-2 receptor": 0.01286, "endogenous cytokine gene": 0.02903, "signaling molecule": 0.00853, "free cytosolic calcium": 0.00157, "a.rickinson": 6e-05, "putative guanine nucleotide exchange domain": 0.00483, "on-going lps signal": 0.0109, "human type": 0.03762, "pou transcription factor oct-1": 0.0143, "related region": 0.01467, "hiv ltr deletion mutant": 0.00405, "transient reduction": 0.00344, "o.": 0.00019, "polyadenylation site": 0.02168, "document": 0.0018, "oct-2 contributes": 0.00226, "gata-1 transcription": 0.0281, "il-6-responsive colony-forming unit": 0.0007, "molecular origin": 0.0045, "distinct signal": 0.01635, "profound switch": 0.00245, "t/nk-cell subset": 0.00192, "great increase": 0.02196, "beta-globin promoter": 0.02336, "vivo chronic response": 0.01294, "ra synovial cell": 0.0512, "normal ductal epithelium": 0.00806, "tat responsiveness": 0.00323, "heterologous dna bind domain": 0.01013, "cell immunoglobulin production": 0.0512, "ceramides": 0.00012, "0.2-4": 0.0, "vivo role": 0.01328, "erk1 activity": 0.02925, "target expression": 0.04163, "lung condition": 0.0036, "cell leukemia virus type i-transformed human": 0.0256, "tissue factor gene": 0.02903, "tat-mediated effect": 0.02115, "era": 6e-05, "syn-1": 6e-05, "cd39-": 0.00012, "heat labile activity": 0.0195, "camp signal pathway": 0.0109, "cbf site result": 0.01445, "prevent sp-a induced inflammation": 0.0027, "r7-57 reporter cell": 0.0512, "delayed hypersensitivity": 0.00056, "immediate-early gene product egr-1 regulate": 0.01742, "true erythroid environment": 0.00414, "endo": 0.00012, "p75": 0.00074, "transactivating function": 0.01331, "gm-csf transcription": 0.0281, "selenium": 0.00037, "gr-dependent transcription": 0.0281, "granulocyte-macrophage colony-stimulating factor": 0.01907, "2-fold low affinity": 0.00471, "48-kda isgf3gamma protein": 0.03019, "reoxygenation": 6e-05, "study define": 0.01355, "targeted disruption": 0.00087, "r.w.crowley": 0.00012, "median time": 0.00273, "regulated pattern": 0.00549, "support great nfat-directed transcription": 0.01405, "growth stimulation": 0.0112, "pdtc iron complex": 0.01123, "mg/kg iv bolus dos": 0.0006, "immune function": 0.01331, "biomarker": 0.00019, "congenital malformation": 0.00028, "activation structure": 0.03164, "increase il-8 transcription": 0.01873, "integratory secondary messenger": 0.00126, "cd3+ cell": 0.0768, "altered sensitivity": 0.00236, "nuclear factor-kappab activation": 0.02109, "event induce": 0.0254, "bp promoter fragment": 0.01557, "jun kinase": 0.01188, "upstream delta globin regulatory region": 0.00587, "human granulocyte-macrophage colony-stimulating factor gene promoter": 0.01452, "functional icam-1": 0.00816, "pb1 sequence motif": 0.01084, "naf-r-nse": 6e-05, "mouse transgenic line": 0.01102, "sensitive pcr-based technique": 0.00182, "il-1beta cooperate": 0.00223, "class ii major histocompatibility complex promoter play": 0.00667, "unrecognized form": 0.01055, "leader protein": 0.04529, "regulate hbv gene expression constitutive activation": 0.01452, "reactivated virus host": 0.00591, "nuclear receptor superfamily": 0.01714, "lymphoma precursor cell": 0.0512, "mature b-cell line bal-17": 0.00827, "subsequent degradation": 0.00332, "subsequent interaction lead": 0.00664, "kappa b-dependent il-6 promoter activity": 0.0117, "st remission": 0.00071, "clonality analysis": 0.01179, "end result": 0.0161, "secreted chemokine": 0.00105, "underlying mechanism": 0.01058, "growth regulation": 0.01008, "il-12-dependent transactivation": 0.00515, "inhibitory p50/p50 homodimer": 0.00238, "membrane-associated pkc activity": 0.0195, "systemic lupus erythematosus patient": 0.00833, "mitogen-activated protein kinase cascade": 0.02264, "pancreatic cancer": 0.00248, "gamma inhibitory activity suggest": 0.01462, "nfat-driven chloramphenicol acetyltransferase": 0.00066, "unrecognized nfatp-binding site": 0.01445, "hiv gene therapy": 0.02903, "phosphorylates": 0.00087, "19-bp binding site": 0.01445, "basement membrane immunoreactivity": 0.003, "describe lymphocyte-specific dna-binding protein": 0.02264, "probe fr35-ii": 0.00261, "construct": 0.01452, "il-5-": 6e-05, "cell line hsb-2 elucidate": 0.0384, "low bone mineral density": 0.00354, "-inducible nuclear factor": 0.01907, "il-15 induce": 0.0254, "positive case": 0.00468, "pma": 0.00819, "human t-cell lymphotropic virus type": 0.01505, "pzvb70": 0.00025, "part": 0.00304, "tgf-beta1 expression": 0.04163, "regulate retinoid-mediated gene expression": 0.02177, "important regulatory molecule": 0.00569, "c/ebp-epsilon": 0.00124, "p-glycoprotein": 0.00012, "interphase fluorescence": 0.00065, "basal brain": 0.0035, "key inflammatory mediator": 0.00314, "icsat expression": 0.04163, "bl-2 cell": 0.0768, "strain gs": 0.00186, "adenovirus-mediated gene transfer": 0.02903, "rat liver": 0.00285, "hogan": 6e-05, "inhibit development": 0.01904, "tyrosine phosphorylation response": 0.01294, "ran-binding domain": 0.01207, "steroid-resistant group require": 0.00877, "temperature": 0.00043, "major structural role": 0.00885, "tyrosine-phosphorylated lat/pp36/38": 0.00074, "human stat protein activate": 0.02264, "z/r combination": 0.00288, "fmlp result": 0.0161, "control th2-specific expression": 0.02775, "biologic role": 0.01328, "infectivity": 0.00037, "dominant characteristic": 0.00329, "tcr gene associate": 0.02903, "putative helix-loop-helix motif": 0.00583, "v-myb reduces mrp14 promoter activity": 0.0117, ".005": 0.0, "include differentiate hl-60 promyelocytic leukemia cell": 0.0256, "plzf-rar alpha expression": 0.02775, "gggaaattcc": 6e-05, "cd28 surface molecule result": 0.00805, "intracellular signal component": 0.0109, "bond rearrangement": 0.00199, "hiv-1-infected cell": 0.0768, "pro-inflammatory cytokine": 0.01123, "specific event": 0.01238, "oxidative stress-inducing signal": 0.0109, "linker": 0.00087, "express gamma": 0.01846, "otf-1": 0.00062, "bacterial endotoxin": 0.00223, "anti-rabbit hsp90 monoclonal antibody": 0.00447, "interconversion": 0.0, "cell cycle analysis show": 0.0384, "lmp1 expression": 0.04163, "cell receptor require": 0.0512, "ligand-dependent manner": 0.00282, "adult sample": 0.00422, "adenosine receptor stimulation": 0.01714, "papillomaviruses": 0.00012, "-510": 0.00012, "induced hsp70 expression": 0.02775, "proinflammatory lymphokine interleukin-1beta": 0.0011, "amino acid sequence suggest": 0.01011, "ap-1 site bound c-fos/c-jun heterodimers": 0.00867, "t-helper lymphocyte": 0.01483, "reflex-tachycardia": 6e-05, "increase mrna level": 0.01464, "therapeutic concentration": 0.0067, "hiv infection": 0.0062, "affect expression": 0.04163, "fog": 0.00012, "oct-1 dna binding": 0.01237, "il-1 beta message level": 0.0091, "down-modulated": 6e-05, "enhancer comprise": 0.00909, "sugar moiety": 0.0005, "prevent fasl expression": 0.02775, "nfat protein constitute": 0.03019, "nik remain complex-associated": 0.00347, "related kinase inhibitor": 0.00792, "stimulus-dependent nf-at complex correspond": 0.00842, "cell lymphotropic virus type": 0.0384, "rxr": 0.00205, "tax gene product": 0.02903, "representative": 0.00099, "loop structure": 0.00319, "transgenic thymocytes": 0.00257, "alternative phagocyte": 0.00205, "subsequent glucocorticoid replacement": 0.00567, "transfected lymphocyte-specific promoter": 0.01557, "protozoa": 6e-05, "rational strategy": 0.00121, "map kinase signal transduction pathway consist": 0.00545, "erythroblastic hel cell": 0.0512, "element abolish inducibility": 0.01115, "interferon-beta": 0.00019, "cd34+ cb subset": 0.00128, "transmembrane region": 0.01467, "negligible cytotoxic activity": 0.0195, "ig heavy chain enhancer": 0.00454, "rapid activation suggest": 0.02109, "biological activity": 0.02925, "obligatory": 0.00099, "large fraction": 0.00205, "marginal level": 0.01821, "lam-": 0.00012, "jurkat cell constitutively express tax": 0.03072, "major goal": 0.00574, "glrp": 0.00012, "cell size increase": 0.0512, "alternative treatment approach": 0.00676, "factor associate": 0.0286, "functional alteration": 0.00816, "endothelial receptor": 0.02571, "nucleotide -67": 0.00202, "structural feature": 0.00217, "nef express cell": 0.0512, "anti-cd3 activated hut-78": 0.00393, "-2-methylpiperazine": 0.00025, "hybrid bcr/abl mrna level": 0.0091, "protein-tyrosine kinase": 0.01188, "search": 0.00062, "pou domain protein pit-1": 0.02264, "human leukemic cell study": 0.0384, "gamma activate site": 0.01445, "multimerized kappab site": 0.01445, "aldosterone derivative": 0.00192, "bcl-6 lesion": 0.00177, "coproporphyrinogen oxidase": 0.00062, "diurnal variation": 0.00164, "-59": 0.00031, "regulate nfat activity": 0.0195, "lps antibody": 0.00893, "overlap pcr product": 0.00356, "ca2+-stimulated activation": 0.03164, "signal pathway molecule analysis": 0.00817, "cell morphology": 0.0768, "monoclonal anti-d antibody": 0.00596, "mv": 0.00012, "vitro transcription/translation": 0.00785, "formylpeptides": 0.00012, "lack": 0.01266, "il-4r alpha": 0.01169, "ap-1 enhancer factor activity": 0.01462, "management": 0.00019, "interleukin-2-gene expression": 0.04163, "describe": 0.00794, "high concentration": 0.00931, "block effect": 0.02115, "inhibit nf-kappab binding": 0.0127, "medulla": 0.0, "tcl1 expression": 0.04163, "cell survival": 0.0768, "important aspect": 0.00689, "sodium/proton exchanger": 3e-05, "biphasic junb transcription induce": 0.01405, "continuous culture": 0.0062, "octamer independent activation": 0.02109, "potent androgen": 0.00357, "e3330 inhibit": 0.01904, "0.3-2.6": 0.0, "cell require engagement": 0.0512, "c-myc": 0.00447, "ml-1 cell": 0.0768, "turn block": 0.01073, "lef1": 0.00019, "ehrlichial binding": 0.01855, "urinary steroidogram result": 0.01073, "biochemical nature": 0.0018, "cell subtractive library": 0.0512, "cyclin": 0.00186, "heterodimer complex": 0.01684, "pha-p": 6e-05, "vdr antisense transfection suggest": 0.01011, "ifn-gamma": 0.00962, "plb-iiib cell": 0.0768, "mar": 0.00037, "position -50": 0.00236, "unresponsive cell": 0.0768, "uninduced myelomonocytic cell line": 0.0384, "endocrine cell type-specific complex formation": 0.03072, "repress p65-mediated activation": 0.02109, "nullifies": 6e-05, "gene target": 0.04355, "oct2 target gene": 0.02903, "y145": 6e-05, "large": 0.00409, "thrombogenesis": 6e-05, "specific induction": 0.01607, "apc culture": 0.0062, "dimaprit show": 0.02599, "functional collaboration": 0.00816, "m47": 0.00019, "il-2r beta expression": 0.02775, "subgroup display": 0.00499, "interleukin-8 production": 0.01042, "hmg i/y": 0.00068, "ltr-modified tat mutant": 0.0054, "cd14 positive monocytic cell line mono mac": 0.02194, "dihydrotestosterone": 6e-05, "slow kinetics": 0.00167, "11-fold": 6e-05, "t-cell cdna library": 0.00641, "recombinant human soluble dimeric tnf receptor": 0.01254, "cross-reactive specificity": 0.00335, "intracellular camp level": 0.01214, "early show": 0.02599, "programming": 0.00019, "vitro culture system": 0.00523, "small-bowel resection": 0.00028, "insulin-producing": 0.00012, "c-jun y-peptide": 0.00493, "extensive intraductal component": 0.00304, "alpha-tosyl-l-lysine chloromethyl ketone": 0.00021, "vivo regulatory mechanism": 0.00705, "tumor growth": 0.00934, "constitutive sp1 factor": 0.01907, "stat5b protein form distinct fc gamma ri gas binding pattern": 0.00906, "signaling agonist induce myeloid differentiation": 0.01016, "nfkb rescue il2r alpha expression": 0.01665, "hormone binding": 0.01855, "normal upper limit": 0.00806, "j.menezes": 6e-05, "ifngamma response region": 0.01294, "4-": 0.00031, "atopic th2 cell": 0.0512, "fibronectin-": 6e-05, "promoter construct": 0.02336, "stat1 function": 0.01331, "alpha beta": 0.01169, "activation-induced transcription": 0.0281, "include il-2": 0.01439, "glucocorticoid-induced reduction": 0.00295, "secondary factor": 0.0286, "specific granule": 0.01238, "gene transcriptional inhibition": 0.02903, "human th1": 0.03762, "serine phosphorylation response": 0.01294, "immunosuppressive drug cyclosporin": 0.00225, "s.benn": 0.00012, "immunoregulatory protein": 0.04529, "early bud": 0.00828, "scm-1beta": 6e-05, "proliferation and/or differentiation": 0.00786, "junb bind": 0.02025, "curry pigment": 9e-05, "normal monocyte": 0.0121, "vitamin d-resistant": 0.00236, "tat- hiv-1": 0.00878, "gata sequence": 0.01625, "t-lymphocyte development": 0.00633, "notch complex": 0.01684, "infectious pathogen": 0.00096, "th2-type cytokine il-4": 0.00749, "il-2-secreting jurkat": 0.00555, "beta- herpesvirus system": 0.00445, "binary switch affect erythroid cell fate": 0.0256, "patient unilateral": 0.01666, "inverted repeat": 0.00378, "functional response affect": 0.01294, "hypercholesterolemia": 0.00012, "early receptor-triggered biochemical event": 0.00414, "7-day pha-blasts": 0.00016, "homologous gene encode cd11a": 0.02177, "endothelial cell surface adhesion molecule": 0.03072, "cd8 molecule": 0.00853, "intact autophosphorylation site": 0.01445, "cellular transcription factor interact": 0.0143, "vascular endothelial cell": 0.0512, "term octamer-associated protein": 0.03019, "major difficulty": 0.00574, "genital region": 0.01467, "distinct subgroup": 0.00698, "increase protein turnover-degradation correlate": 0.02264, "related disorder": 0.00236, "htlv-i-infected cord blood lymphocyte": 0.00741, "characteristic": 0.00658, "consolidation": 0.00012, "predicted protein": 0.04529, "oncoproteins": 0.00043, "u2": 0.00112, "c57bl/10": 6e-05, "protooncogene product": 0.00533, "thrombin receptor mrna expression": 0.02081, "specific tyrosine phosphorylation": 0.00825, "transcriptional repressor": 0.01151, "cytolytic assay": 0.01002, "thymocytes differs": 0.00257, "eliminate ebna-2 response": 0.01294, "promote tumor progression": 0.00622, "activate nuclear expression": 0.02775, "context-dependent apoptosis regulator": 0.00593, "plzf-rar alpha": 0.01169, "anti-cd28 mab clb-cd28/1": 0.00178, "l428": 0.00012, "isolated human": 0.03762, "fli-1 expression vector show": 0.02081, "synovial lymphocyte": 0.01483, "tumor necrosis factor-alpha promoter": 0.01168, "human cd36-specific antibody okm5": 0.01881, "finding constitute": 0.00226, "human umbilical vein ec provide costimulatory signal": 0.01075, "u2 snrna-encoding gene activation": 0.02177, "peripheral cd4-cd8-": 0.00524, "additional nsaid": 0.00341, "intracellular homology": 0.00583, "immune cell": 0.0768, "cell ig secretion": 0.0512, "kb cell": 0.0768, "lineage-specific transcription factor": 0.01907, "bcd transcript": 0.00599, "b4-2 clone": 0.00738, "zinc finger transcription factor sp1": 0.01144, "monoblast-like u937 cell": 0.0512, "hormonal receptor presence": 0.01714, "hla-dq haplotype encode": 0.00569, "cd23 transcript": 0.00599, "viable alternative": 0.00205, "b-all": 0.00025, "intrinsic kappa": 0.00748, "untreated cml patient": 0.0111, "dq3.3 asp-57-positive mhc molecule": 0.00426, "smx-no": 0.00043, "androgen receptor agonist proteolytic attack": 0.01029, "ezrin/moesin/radixin protein": 0.04529, "nf-kappab protects ebv-infected cell": 0.0384, "distinctive pattern": 0.00549, "clone aly": 0.00738, "antihypertensive therapy": 0.00372, "immunological cross-linking": 0.00242, "postvaccine response": 0.01942, "function regulate": 0.01331, "propose mediator": 0.00195, "dioxin receptor": 0.02571, "anti-inflammatory therapy": 0.00372, "ikaros-null thymocytes": 0.00257, "cell pathway": 0.0768, "diapedesis": 0.00019, "facilitate": 0.00397, "octamer factor variant": 0.01907, "early inhibition": 0.01061, "nfkappab activity": 0.02925, "activate nk cell": 0.0512, "express mafk mrna": 0.0123, "response element binding": 0.01294, "c-rel/p65 heterodimers prevent lps induction": 0.00643, "granulocyte-macrophage pathway": 0.01278, "diagnostic tool": 0.00047, "overexpressed": 0.00174, "ngal gene": 0.04355, "relative": 0.00552, "il-1 upregulate pml transcript": 0.00299, "elevation result": 0.0161, "late gene expression": 0.02903, "octamer-binding protein oct-2a": 0.03019, "putative erythroid-specific cis-acting element include": 0.00669, "cd3 cross-linking induce": 0.01694, "cem cell": 0.0768, "efficient viral dna replication": 0.00741, "retention": 0.00056, "staphylococcal superantigens toxic shock syndrome toxin-1": 0.00091, "differentiation stage": 0.01179, "il-2 induced nuclear translocation": 0.00842, "hiv enhancer": 0.00909, "tumor cell infiltration": 0.0512, "affected cell": 0.0768, "vitro transcription method": 0.01873, "specimen": 0.00105, "cd28 minimal promoter": 0.01557, "murine counterpart": 0.00623, "adipocytes": 0.00025, "ap-1 regulatory element": 0.01115, "gm-csf promoter harbor": 0.01557, "core srf bind site": 0.01084, "off-rate experiment": 0.00397, "nip": 0.00043, "additional significant finding": 0.00277, "malignant lymphoid cell": 0.0512, "hybridoma": 0.0013, "undergone distinct pattern": 0.00465, "micrograms/day": 0.0, "matrix attachment region bind protein": 0.01811, "healthy thyroid gland": 0.00118, "anti-ig crosslinking lead": 0.00664, "splice isoforms": 0.00307, "lmp1 signal transduction": 0.0109, "fk506 rescue b104 cell": 0.0384, "mammalian il2 promoter": 0.01557, "+/- 0.5-fold": 0.00158, "fos -cat construct": 0.00484, "provide long-term protection": 0.0043, "b-lymphocytes": 0.00056, "calcium ionophore induce": 0.01694, "previous localization": 0.00186, "increase il-4": 0.02196, "intracellular il-2 protein": 0.03019, "relevant dna-binding specie": 0.00374, "irf-1-dependent pathway": 0.01278, "nf-kappa b1/rela heterodimer": 0.00943, "culture decrease il-2 promoter activation": 0.01266, "cell adhesion molecule cd62e": 0.0384, "alternative tat function": 0.00887, "pathophysiology": 0.00062, "il-4 activate": 0.01777, "co-immobilized": 0.00019, "transactivate gm-csf": 0.00329, "nuclear kappab dna-binding activity induce": 0.0117, "gtpase ran": 0.00022, "nfat-family protein": 0.04529, "protein result": 0.04529, "-mediated induction": 0.01607, "de novo increase": 0.01464, "gene nuclear topography": 0.02903, "underphosphorylated form": 0.01055, "kv": 0.00043, "intercellular signal network": 0.0109, "interleukin-2 enhancer": 0.00909, "htlv-i-transformed peripheral blood mononuclear cell demonstrate": 0.0256, "il-2 regulates transcription": 0.01873, "hel/s cell": 0.0768, "a6h mab induce": 0.01694, "analyze dna sequence include delta": 0.0065, "peptide-affinity": 0.0, "tax enhances cytokine-induced function": 0.00665, "tat-binding protein": 0.04529, "transcription-enhancer region": 0.01467, "nuclear stat protein": 0.03019, "il-12 induced nuclear factor nf-kappa": 0.01144, "differential cdna clone strategy": 0.00369, "promoter regulation": 0.02336, "basal activity": 0.02925, "related condition": 0.0036, "study platelet": 0.01355, "amino acid sequence": 0.01084, "il-4 induces expression": 0.02775, "unrecognized element": 0.01672, "specific lysis": 0.01238, "uv-induced cyp1a1 gene expression": 0.02177, "dhea": 0.00118, "targeted degradation": 0.00332, "stat6-dependent gene expression": 0.02903, "granulocyte/monocyte lineage": 0.00366, "tlr4": 0.00012, "tumor exhibit strong expression": 0.02081, "retinoic acid activate interferon regulatory factor-1 gene expression": 0.01089, "pmol/l": 0.00012, "follicle-center": 6e-05, "ebs": 6e-05, "trim human pregnancy": 0.02508, "inefficient termination": 0.00025, "pellicciari": 0.00012, "transcription factor nfatp inhibit": 0.0143, "redox modification": 0.00183, "raji cell": 0.0768, "vascular occlusion": 0.00174, "p3hr-1 strain": 0.00186, "activation inducer molecule": 0.02109, "monoblastoid cell undergo tnf-alpha-inuced apoptosis": 0.03072, "ic": 0.00056, "lmp1 expression induces phenotypic change resemble": 0.01388, "kappa b-alpha protein level": 0.02264, "hpb-all": 6e-05, "transport": 0.00136, "precursor interleukin-1 alpha cytokine": 0.00585, "subsequent proliferation": 0.00803, "gh synthesis": 0.00583, "tp2": 6e-05, "inhibit granulocyte colony-stimulating factor": 0.0143, "proximal octamer": 0.00301, "endogenous ptdins": 0.00459, "short c-terminal peptide": 0.00502, "hhv-8+/ebv+ pel": 0.0004, "a-myb transcription factor play central": 0.01144, "report": 0.0098, "pathological immune response": 0.01294, "c5b-7": 0.00019, "inefficient inducer": 0.00136, "src homology": 0.00183, "tether": 0.00037, "paramyxovirus infection induce": 0.01694, "tr expression": 0.04163, "androgen receptor locus": 0.01714, "eosinophilia": 0.00074, "conserved spacing": 0.00136, "gh-n gene": 0.04355, "stimulate human peripheral blood lymphocyte": 0.01505, "human pml expression": 0.02775, "ifn-inducible gene promoter": 0.02903, "molecular event associate": 0.00728, "human major histocompatibility complex class ii-associated invariant-chain gene": 0.01089, "non-t cell": 0.0768, "mutation analysis demonstrate": 0.01065, "southwestern blotting experiment": 0.00265, "tax stimulate": 0.01101, "functional alpha-helices": 0.00816, "nucleus": 0.00639, "htlv": 6e-05, "human peripheral": 0.03762, "hs2 sequence direct": 0.01084, "human cytokine il-4": 0.02508, "nonadherent neutrophil": 0.00496, "protein module": 0.04529, "impaired transcriptional response": 0.01294, "bz1": 0.00037, "sequence element present": 0.01115, "lipopolysaccharide increase viral production": 0.01098, "gal/er": 0.00012, "stimulated purified": 0.00261, "i.e.": 0.00192, "putative regulatory site": 0.01445, "nuclear accumulation": 0.01684, "tf.viia complex": 0.01684, "enzyme cathepsin": 0.0031, "nonlymphoid cell line": 0.0512, "tcr-regulated ptks": 0.00012, "study cytoplasmic": 0.01355, "cell culture system": 0.0512, "octamer-binding protein otf-2 demonstrate": 0.02264, "cell surface maturation-specific antigen": 0.0384, "platelet thromboxane receptor": 0.01714, "13-fold high": 0.00931, "untreated ns-meg cell express mrna": 0.03072, "extended alpha-helical segment": 0.00126, "stabilization assay": 0.01002, "quantitative competitive reverse transcription pcr": 0.01124, "+157": 6e-05, "phosphorylation event": 0.00983, "mammalian cell express": 0.0512, "thyroid hormone receptor form distinct nuclear protein-dependent": 0.00735, "favor vdr/rxr binding": 0.01237, "term e-proteins": 0.00413, "glucocorticoid receptor/s": 0.0085, "regulate cell survival": 0.0512, "cell line represent pro-b": 0.0384, "positive hybridization": 0.00468, "conserved family": 0.00841, "nonerythroid hl-60 cell": 0.0512, "germline epsilon transcript": 0.00399, "dha": 0.00031, "ggggaatctccc": 6e-05, "monoclonal antibody pg-b6": 0.00596, "t24 ha-ras oncogene": 0.00174, "express mnp-1": 0.01846, "pebp2/cbf": 0.00043, "cell form": 0.0768, "bind rfx specie correlate": 0.01013, "cell nuclear factor": 0.0512, "induce gene transcription": 0.02903, "interleukin-6 protein": 0.04529, "distinct b-cell-specific cofactor": 0.00465, "il-12 induce c-myc mrna accumulation": 0.01016, "p59fyn": 0.00074, "protein-coupled transcription factor activation": 0.01582, "nucleoside analog": 0.00109, "cell specific transcription factor bsap": 0.03072, "glucocorticoid receptor change": 0.01714, "activate nuclear factor kappa": 0.0143, "gamma delta": 0.0044, "lysate": 0.00068, "20-70 microm": 0.0013, "discriminatory": 6e-05, "cognate catalytic cofactor": 0.00052, "mip-1 alpha/gos19": 0.00047, "adjacent cis-acting regulatory element": 0.00836, "analogous cell-cycle-regulated phosphorylation": 0.00656, "dual mechanism": 0.01058, "initiate proinflammatory event": 0.00368, "nf-kappab sequence": 0.01625, "gabp factor bind": 0.01907, "pituitary endocrine cell": 0.0512, "transcriptional activity mediate": 0.0195, "vitro tcr stimulation": 0.00746, "core sequence cttgg": 0.01084, "ikk activity": 0.02925, "tpl-2 induces il-2 expression": 0.02081, ".0035": 0.0, "intact gr dna-binding domain": 0.00603, "good model": 0.00422, "phorbol ester rescue": 0.00362, "chemokines": 0.00112, "freshly isolated cell show high level": 0.0256, "strong preference": 0.00347, "high-level bcl-6 expression": 0.02775, "p40 chain": 0.00437, "ifn-alpha-stimulated gene": 0.04355, "young individual": 0.00409, "severe degree": 0.00211, "lymphocyte differentiation": 0.01483, "trp": 0.00031, "single mutation site": 0.01445, "chronic hepatitis b. cytokine profile": 0.00449, "translocation event": 0.00552, "erythroblast express exogenous gata-2": 0.00923, "lymphoid-specific element": 0.01672, "viral gene effect": 0.02903, "squirrel monkey gr express": 0.00923, "pre-b acute lymphoblastic leukemia": 0.0025, "r-htbp-1": 0.00019, "life-long infection": 0.0062, "activation protein": 0.04529, "rank": 0.0005, "potent protein phosphatase inhibitor": 0.02264, "germline transcription": 0.0281, "differential diagnostic purpose": 0.00215, "eukaryotic transcription factor nuclear factor-kappa": 0.01144, "major physiological human glucocorticoid": 0.01881, "isolate cdna clone correspond": 0.00369, "activate ikappab kinase": 0.01185, "anti-igm crosslinking": 0.00065, "transduced cell": 0.0768, "symptom": 0.00136, "sfs": 0.00031, "ifn-gamma mrna level": 0.01214, "receptor down-regulation due": 0.01714, "grb2-related protein": 0.04529, "glucocorticoid receptor antagonist ru": 0.01286, "atttgcat": 0.00012, "secondary tcr ligation": 0.00318, "tcr chain document": 0.00318, "low basal il-2 production": 0.00558, "tumor cell growth": 0.0512, "important molecule": 0.00853, "active promoter region": 0.01557, "proximal nf-kappa": 0.01414, "dose-dependent inhibition": 0.01061, "element identical": 0.01672, "similar downregulation": 0.00673, "mhc class ii homologous protein hla-dma": 0.0151, "cell induces nuclear expression": 0.0384, "small effect": 0.02115, "specific target": 0.01238, "positional specificity": 0.00335, "ras signaling": 0.00558, "integrin gene promoter": 0.02903, "erythroid cell-specific": 0.0062, "isolate nfatx": 0.00416, "sublining": 0.00025, "mhc-i-induced signal transduction": 0.0109, "isoform expression pattern": 0.02775, "describe member": 0.00413, "dexamethasone prevent il-8": 0.00349, "nf-kappab play": 0.00999, "th2 clone suggest": 0.01348, "ap-1 type heterodimeric complex": 0.00842, "retinoic acid receptor action": 0.01286, "exposure duration": 0.0035, "viral gene transactivation": 0.02903, "tgf-beta mrna": 0.01526, "ril-12": 6e-05, "t3 activate caii transcription": 0.01405, "tataaa box": 0.00304, "size similar": 0.00673, "polysomy": 0.00012, "abelson murine leukemia virus": 0.00444, "bovine leucocyte": 0.0009, "human interleukin-2 gene": 0.02903, "basic-leucine zipper domain": 0.00804, "th2 lymphocyte-mediated effect predominate": 0.01058, "75-kda heterodimeric cytokine": 0.00749, "all-trans-retinoic acid": 0.00856, "cellular factor require": 0.01907, "function remain unclear": 0.00887, "term ciita": 0.00413, "prolonged suppression": 0.00416, "normal number": 0.0121, "anion-exchange chromatography": 0.0004, "lymphocyte reveal": 0.01483, "pld activity": 0.02925, "express il-5 mrna": 0.0123, "human granulocyte macrophage-colony stimulate factor promoter": 0.01254, "thrombin-induced tyrosine phosphorylation": 0.00656, "cellular iron availability": 0.00596, "clonogenic assay": 0.01002, "differentiation-associated expression": 0.04163, "isolated tumor cell": 0.0512, "bacterial flagellum": 0.00223, "long term glucocorticoid treatment": 0.00507, "mass-to-charge ratio": 0.00096, "tumor necrosis factor alfa": 0.0143, "activity direct": 0.02925, "constitutively induce": 0.0254, "mhc-class": 0.00012, ".011": 6e-05, "chronic human immunodeficiency virus type": 0.01505, "require monocyte": 0.01315, "estrogen type": 0.00949, "laboratory": 0.00112, "cell-dependent": 0.00025, "p50s": 6e-05, "early lymphoid precursor": 0.00552, "myc promote activation-induced apoptosis": 0.00445, "lymphocyte count": 0.01483, "high turnover": 0.00931, "response remain poorly understood": 0.00971, "70/z3-derived": 6e-05, "l-659,989": 6e-05, "mapk p38": 0.00152, "direct definitive hematopoietic progenitor": 0.0027, "short immunodominant antigenic region": 0.00734, "octamer dna sequence": 0.01084, "myeloid-specific gene encode": 0.02903, "extrinsic": 0.00031, "cell cycle analysis": 0.0512, "negative element": 0.01672, "cd38 expression": 0.04163, "increase intracellular ca2+ concentration": 0.01098, "cd4 transduction pathway": 0.00852, "suppress subsequent occurrence": 0.00407, "aml1a lack": 0.00633, "erk-2": 0.00031, "reporter plasmid": 0.00552, "cell division": 0.0768, "interspecies somatic cell hybrid": 0.0384, "specific cell type": 0.0512, "gd1a": 0.00012, "key macrophage growth factor": 0.0143, "monocyte express high level": 0.00923, "mp": 0.00068, "recent report": 0.0049, "tax-mediated transactivation": 0.00515, "activate p38 mapk": 0.01185, "characterize regulatory sequence important": 0.00813, "lps stimulation lead": 0.00746, "chemoattractant cytokine il-6": 0.00749, "tighter binding": 0.01855, "physical separation": 0.00096, "cd16 -acute leukemia": 0.00333, "human erythrocyte ghost membrane": 0.01881, "mdhm-stimulated pbmo": 0.00019, "non-depressed psychiatric control": 0.00868, "biotin-": 0.00012, "19-chloro-21-acetoxypregn-9": 0.0, "efficient hiv-1 transcription": 0.01873, "gata-3 protein": 0.04529, "hcs downregulates": 0.00068, "second-messenger ca2+ ion": 0.00203, "cognate enhancer element": 0.01115, "late il-6-induced junb transcription wave": 0.01124, "v-src-induced complex comprise": 0.01123, "erythroid-specific activation": 0.03164, "phorbol myristate acetate-activated lymphocyte exhibit decreased binding": 0.0053, "bapta-am": 6e-05, "osteoclastic maturity": 3e-05, "carboxyl end": 0.00059, "nonmacrophage cell": 0.0768, "lymphocyte express": 0.01846, "isgf3 gamma induce": 0.01694, "hyperosmotic shock": 0.00174, "allosteric drug": 0.00338, "affected twin": 0.00099, "mature erythrocyte": 0.00329, "blood transfusion": 0.00592, "co-stimulation": 0.00031, "nf-at complex": 0.01684, "cultured cell": 0.0768, "direct transcription": 0.0281, "cell antigen receptor complex": 0.0384, "hscs": 0.00012, "single mutation": 0.00592, "additional upstream gene segment": 0.02177, "human colony-stimulating factor-1 receptor": 0.01881, "cbf beta-myh11 fusion transcript occur": 0.00262, "murine pro-b cell line ba/f3": 0.03072, "secrete il-2": 0.01117, "prevent tpa-induced c-fos": 0.00349, "isotype switching": 0.00071, "cell signaling": 0.0768, "log10kd increase": 0.02196, "human mononuclear cell isolate": 0.0384, "enhance induction": 0.01607, "distance geometry": 3e-05, "nf-kappa bp65 binding": 0.01237, "fusion protein include": 0.03019, "bear": 0.00205, "ifn-gamma gene": 0.04355, "dissimilar oncogenicities": 6e-05, "il-5 induces": 0.00803, "abnormal thymopoiesis": 0.00195, "megakaryocyte mass": 0.00093, "specific limitation": 0.01238, "interferon-gamma-treated u937": 0.00326, "egr1-expressing": 0.00012, "chemical agent": 0.00422, "considerable data": 0.00254, "ca2+-binding protein": 0.04529, "tcr-mediated activation": 0.03164, "specific cell fate development": 0.0384, "characterize murine b29 promoter": 0.01168, "pbmcs drop": 0.00081, "heat shock induces hiv-1 replication": 0.00351, "protein synthesis independent": 0.03019, "match": 0.0013, "lmp": 0.00074, "immunodominant target": 0.00825, "120-h time": 0.00273, "tr75 surface expression": 0.02775, "turn induces expression": 0.02775, "ctla-4": 0.00031, "myelomonoblasts": 6e-05, "flagellum": 0.00012, "gene mutation": 0.04355, "isre binding": 0.01855, "uv irradiation": 0.00096, "nef-expressing cell": 0.0768, "measured binding": 0.01855, "antigen induce": 0.0254, "delta19": 0.00025, "viral reverse transcriptase": 0.00488, "gene regulation suggest distinct biological role": 0.01452, "pa phosphohydrolase": 0.00047, "zk161422": 0.00019, "il-4 gene expression": 0.02903, "therapeutic approach": 0.00167, "trend approach statistical significance": 0.00082, "ii-2": 0.00012, "c-terminal part": 0.00192, "electron microscopic examination reveal": 0.00549, "paper aim": 0.00065, "differentiate thp-1 cell": 0.0512, "haucl3": 6e-05, "requisite": 0.00025, "full potential": 0.00605, "important mechanism underlie": 0.00705, "antioxidant inhibit tnf -or pma-induced nf-kappa": 0.00635, "strong lps responsiveness": 0.00234, "malt": 0.00012, "primary cell mdhm-induced elevation": 0.0384, "inflammatory liver disease": 0.00449, "molecular mechanism underlie monocytic differentiation induce": 0.00847, "fos family include c-fos": 0.0072, "human disease": 0.03762, "bind myeloid nuclear protein": 0.02264, "cd3-mediated activation": 0.03164, "killer cell-induced lysis": 0.00091, "aagtga": 0.0, "pro-x-pro": 0.0, "antiserum specific": 0.01238, "gal4-eed fusion protein repress transcription": 0.01811, "human fa promoter": 0.02508, "u/ml ifn gamma result": 0.00805, "transfected gr": 0.004, "adolescent demonstrates resistance": 0.00217, "p24 antigen level": 0.01214, "peripheral blood rest cell": 0.0384, "sh": 0.00019, "hepatocyte damage": 0.0009, "estrogen disrupters": 0.00323, "p3hr-1 defective genome": 0.00136, "express similar level": 0.0123, "beas-2b": 0.00019, "nck": 6e-05, "zinc-binding potential transcription factor": 0.0143, "readily detectable": 0.00276, "bronchiolitis obliterans": 9e-05, "protein activation": 0.04529, "mouse homologue": 0.00974, "heterodimer formation": 0.00484, "lysophosphatidylethanolamine": 6e-05, "hgm-csf-dependent cell proliferation": 0.0512, "ionized ca2+": 0.00304, "pg490 inhibition": 0.01061, "b-subunit knock-out": 0.00025, "activate receptor": 0.02571, "hybrid promoter": 0.02336, "important genetic determinant": 0.00459, "p-selectin regulates monocyte chemotactic protein-1": 0.00479, "freshly isolate granulocyte": 0.00277, "inhibit granulocyte differentiation": 0.0127, "j393/cd43 ligation prompt decrease": 0.00485, "inhibit gr-dependent transcription": 0.01873, "human hematopoietic neoplasm": 0.02508, "vitd3 inhibit": 0.01904, "age subject": 0.00354, "tre-dna affinity chromatography result": 0.00805, "include p65": 0.01439, "major constitutive dnase i-hypersensitive site associate": 0.00723, "il-2-driven cell growth": 0.0512, "sap-1 gene": 0.04355, "offer important therapeutic benefit": 0.00344, "defective il-12 response": 0.01294, "great activation": 0.03164, "live hiv-1": 0.00878, "ongoing immune response": 0.01294, "committed mpro promyelocytes": 0.00017, "cortisol-dependent ba": 0.00019, "microg": 0.00012, "atra-induced cytodifferentiation": 0.0005, "lymphocyte response": 0.01942, "fas-regulatory gene": 0.04355, "all-trans-retinoic acid-induced monocytic differentiation": 0.00589, "describe case": 0.00397, "mouse tcf-1 protein": 0.03019, "bacterial peptide-rrkykqii-located": 0.00223, "zfh-1": 0.00012, "phosphorylation state": 0.00983, "phenotypic": 0.00167, "platelet-endothelial cell adhesion molecule-1": 0.0384, "family transcription factor": 0.01907, "indirect manner": 0.00282, "short treatment": 0.01014, "egr-1 promoter-reporter construct": 0.00484, "lymphocyte induce": 0.0254, "specific protein inhibitor": 0.03019, "fibrin deposition": 0.00016, "full function": 0.01331, "feedback regulation": 0.01008, "complete vdr": 0.00233, "p50 subunit": 0.00484, "patient show insufficient suppression": 0.013, "pi-3,4,5-p3": 0.00025, "3t3-l1 cell": 0.0768, "genetic mapping study": 0.00904, "seventeen case reveal distinct immunostaining": 0.00439, "regulate effector molecule": 0.00835, "vivo dna footprinting": 0.00988, "human breast cancer mcf-7 cell": 0.03072, "fluorescent": 0.00031, "high radiosensitivity": 0.00931, "apparent binding affinity": 0.01237, "bulbar muscular atrophy": 0.00019, "cell cytoplasm": 0.0768, "massive monocyte cell death": 0.0384, "block apoptosis": 0.01073, "immune complex require expression": 0.02081, "nf-kappa b-dependent activation": 0.02109, "immunologic": 0.00143, "traf3 bind": 0.02025, "differentiate hematopoietic progenitor": 0.00244, "amino acid": 0.00856, "wheat germ lysate promote": 0.00233, "fork head domain protein": 0.02264, "endothelial cell gssg/gsh": 0.0512, "strong expression": 0.04163, "perturbation": 0.00025, "season": 6e-05, "stimulated human endothelial cell": 0.0384, "tcf1": 6e-05, "nfatp/ap-1 composite element": 0.01115, "low bcl-2": 0.00707, "osm gene expression": 0.02903, "postoperative": 6e-05, "tinur": 0.00019, "major determinant": 0.00574, "glucocorticoid regulate interferon-alpha": 0.00835, "tissue-specific transcriptional control": 0.00868, "diminished proliferative response": 0.01294, "disease activity": 0.02925, "gal4 reporter construct": 0.00484, "il-2 respond": 0.01117, "interleukin-1 receptor": 0.02571, "enhance class ii inducibility": 0.00487, "nuclear factor.kappa": 0.01684, "influenza infection": 0.0062, "stat3-": 6e-05, "-glucan": 0.00012, "total cell lysates": 0.0512, "negative selection": 0.00515, "cell sensitive": 0.0768, "cell line represent endocrine": 0.0384, "prolonged cyclic pressure-stretching strain resemble": 0.00074, "peripheral blood human": 0.02508, "p38 mapk inhibitor sb203580": 0.0045, "g1 cyclins": 0.00109, "surface antigenic profile": 0.00343, "sherry": 0.00019, "special culture condition and/or cytokine": 0.00449, "region gene segment": 0.02903, "ad5 infection": 0.0062, "3h-thymidine uptake procedure": 0.00112, "mouse e2a gene": 0.02903, "mr count": 0.00068, "human monocyte differentiate": 0.02508, "bp relative": 0.00276, "decrease nuclear translocation": 0.01123, "0.92+/-0.42": 6e-05, "hemoglobinopathy": 0.00019, "susceptibility": 0.00292, "gt motif": 0.00875, "transcriptional regulatory protein nf-kappab": 0.02264, "im-9 cell line": 0.0512, "gene control": 0.04355, "human mononulear leukocyte": 0.02508, "cell lymphotropic virus type i. nf-kappa": 0.0256, "rhombotin-2 binding ets transcription factor": 0.01144, "functional antagonism": 0.00816, "respective": 0.0018, "s49 cell apoptosis": 0.0512, "cell proliferate": 0.0768, "cell v-atpase content": 0.0512, "chronic kidney failure": 0.00265, "manic patient": 0.01666, "chicken nf-m": 0.00078, "induce socs-1 gene expression": 0.02177, "normal sensitivity": 0.0121, "low reporter mrna level relative": 0.00728, "unifying hypothesis": 0.00133, "interaction result": 0.0161, "protease play obligate role": 0.00664, "ligand-induced phosphorylation": 0.00983, "differ genetic defect": 0.00192, "strain express phoq": 0.0123, "lpmc": 0.00025, "mutual association": 0.00282, "glial cell": 0.0768, "creb family": 0.00841, "wild type": 0.00949, "undergo proliferation": 0.00803, "hybrid molecule pml/rar alpha": 0.00585, "anti-d": 0.00025, "stimulate nf-kappa": 0.01414, "replicative activity": 0.02925, "concatenated form": 0.01055, "-1954": 0.00012, "form heterodimers": 0.01055, "nk cell": 0.0768, "gata-1 site": 0.02168, "dexamethasone inhibit bind": 0.0135, "quantitative control": 0.01303, "potential": 0.0121, "viral integral membrane protein": 0.02264, "hematopoietic gene expression": 0.02903, "polyclonal ctl line": 0.01102, "act": 0.00993, "phorbol 12-myristate 13-acetate-inducible transcription": 0.01405, "receptor-mediated anti-cd3/anti-cd3+ anti-cd28 stimulation": 0.0056, "distinct regulatory signal": 0.0109, "hla/peptide complex": 0.01684, "respective biological function": 0.00887, "classical interferon-gamma-activated site": 0.01445, "octamer binding factor": 0.01907, "cyclosporin": 0.0044, "express tax": 0.01846, "double-stranded oligonucleotide probe represent": 0.002, "polypeptide product": 0.00533, "cultured human blood mononuclear cell": 0.03072, "e2": 0.00205, "suppress tumor necrosis factor-alpha generation": 0.00373, "point mutation change ylpq": 0.00315, "activate target gene expression": 0.02177, "twin heterozygous": 0.0009, "anti-estrogens enhance": 0.00974, "notch-1": 0.00056, "jak2 associate": 0.01092, "frequent emergence": 0.0005, "transendothelial migration": 0.00155, "altered ccaat box": 0.00203, "combined xp/cs clinical entity": 0.00212, "dexamethasone suppressibility": 0.00394, "receptor kd": 0.02571, "granulocyte antibody": 0.00893, "interleukin-12 fusion protein": 0.03019, "hzf 11-42 reveal": 0.00732, "molecular target": 0.00825, "tax mutant iexl320g": 0.0054, "-3 induced tyrosine phosphorylation": 0.00492, "ets gene family": 0.02903, "osteoporosis": 0.00012, "21-acetoxy-11 beta,19-epoxy-4-hydroxypregnane-3,20-dione": 9e-05, "alpha-helix": 6e-05, "dimer": 0.00205, "mammalian oncogenic virus": 0.00591, "common cis-element": 0.0035, "pa -and": 0.00273, "brother": 0.00019, "human epsilon germline transcription": 0.01881, "inhibit activation-induced apoptosis": 0.0127, "intact carboxyl-terminal cytoplasmic segment": 0.002, "nuclear run-on transcription assay show": 0.01124, "tax associate": 0.01092, "bind creb/atf homodimers": 0.0135, "sepsis": 0.00074, "bp1 bind site": 0.01445, "viral transcriptional pattern similar": 0.00575, "sequence support replication": 0.01084, "effector phase": 0.00276, "proteolytic reaction": 0.0022, "virus isolate": 0.00887, "cellular calcium": 0.00893, "krox-24": 0.00012, "pharmacologic inhibition": 0.01061, "gdsp": 0.00025, "potent transactivation": 0.00515, "l. donovani lead": 0.00664, "reverse transcription pcr assay": 0.01405, "carboxylesterase upstream sequence": 0.01084, "retinoid-like receptor play": 0.01714, "endonuclease": 0.00031, "wild-type ltrs": 0.00378, "tax-induced activation": 0.03164, "wheat germ lysate": 0.00023, "cepharanthine dose": 0.00158, "antiatherosclerotic potential": 0.00605, "lie downstream": 0.00298, "matrix": 0.00261, "affect oct-1 binding": 0.01237, "lef/tcf factor": 0.0286, "tcl1 oncogene activation": 0.02109, "complex form": 0.01684, "camp response element bind protein": 0.01811, "ets-related transcription factor": 0.01907, "hox11": 0.00081, "retinoic acid receptor": 0.01714, "dominant role": 0.01328, "lymphocyte-specific member": 0.00413, "inhibit pkc downstream event": 0.00952, "pulmonary surfactant": 0.00071, "cell-specific": 0.00583, "lymphocyte-specific factor bind": 0.01907, "express er": 0.01846, "wild-type syk": 0.00378, "il-4r alpha chain": 0.0078, "ingestion": 0.00019, "demonstrate cytokine gene specificity": 0.02177, "human endothelial cell demonstrate": 0.0384, "class switching": 0.00642, "time-course experiment show": 0.01733, "human tcr zeta-chain": 0.02508, "antibody specific": 0.01238, "e-selectin mrna": 0.01526, "odds": 0.0, "distinct lymphoid-specific protein": 0.03019, "ap-1 contributes": 0.00695, "sp1 function": 0.01331, "embryonic globin gene": 0.02903, "intracellular ph": 0.00583, "clinical efficacy": 0.00425, "cell infiltrate": 0.0768, "r-394": 0.00012, "fetal development": 0.00633, "tat/s": 0.00012, "synthesize tissue factor": 0.01907, "transient hyperpolarization": 0.00344, "pretreatment level": 0.01821, "extreme evolutionary conservation": 0.00019, "cytokine interleukin-1 beta": 0.00749, "nfatp dna binding activity": 0.01462, "tpl-2 kinase activate": 0.01185, "proteolytic processing": 0.00133, "remain undefined": 0.00521, "b-lymphotropic herpesvirus": 0.00074, "rest cell": 0.0768, "additional major protein-dna interaction": 0.00493, "tcr response": 0.01942, "digital image analysis": 0.00786, "-induced commitment": 0.00186, "steroid/thyroid hormone receptor response element": 0.01029, "undifferentiated embryocarcinoma f9 cell": 0.0384, "oxidative specie capable": 0.00174, "peptide elisa": 0.00754, "smase": 0.00031, "class ii mhc gene": 0.02177, "protein-dna binding study suggest": 0.01011, "augments transcription": 0.0281, "human myeloid leukemic cell": 0.0384, "activator protein-1 cognate dna sequence": 0.0065, "cem c1 cell": 0.0512, "ms-5 stromal cell express": 0.0384, "tax-stimulated nuclear expression": 0.02775, "ca2+ signal": 0.01635, "antigenic stimulation": 0.0112, "progressive increase": 0.02196, "1-2": 0.0005, "induce expression": 0.04163, "stimulate human immunodeficiency virus": 0.01881, "elisa": 0.00124, "pleckstrin homology domain": 0.00804, "tax activate nf-kappa": 0.01185, "arterial endothelium": 0.00062, "lead": 0.01991, "human monocyte suggest": 0.02508, "ikappab-alpha protein level decrease": 0.02264, "hybrid express nuclear nf-kappa": 0.00923, "initial viral latent gene promoter": 0.01742, "mobility-shift": 0.0005, "downstream pkc/ras-mediated pathway": 0.00852, "duffy antigen receptor": 0.01714, "play role": 0.01328, "regulate cp activity": 0.0195, "hl-60 cell constitutively express": 0.0384, "peer": 0.00031, "terminal transactivation domain": 0.00804, "wide role": 0.01328, "ap-2 mediate induction": 0.01071, "early transactivator bzlf1": 0.00552, "cellular cytotoxic assay": 0.00668, "traf-binding member": 0.00413, "17-bp serum response factor": 0.0143, "e1a gene product inhibit ifn-mcp": 0.01742, "human immunodeficiency virus-1 long terminal repeat": 0.01254, "lymphoid marker": 0.00409, "tumor promoter": 0.02336, "mechanism distinct": 0.01058, "cytokine-induced modulation": 0.00257, "abnormality": 0.00478, "chimeric receptor system demonstrate": 0.01286, "human neoplasia": 0.03762, "bp -61": 0.00267, "frameshift": 0.0005, "conditional form": 0.01055, "route": 0.00019, "promoter element": 0.02336, "hypersensitive": 0.00081, "extracellular domain": 0.01207, "adhesion protein": 0.04529, "hil-5r alpha": 0.01169, "il-2 induces": 0.01117, "immunoglobulin enhancer microe5/kappa": 0.00606, "limit expression": 0.04163, "pre-culture condition": 0.0036, "monoblastoid u937 cell line": 0.0384, "gamma chain": 0.0044, "goal": 0.00025, "protein bind property": 0.03019, "vitro phosphorylation": 0.00983, "protein tyrosine kinase activity increase": 0.01811, "overexpressed er": 0.00264, "rel protein": 0.04529, "inhibitory transcriptional activity": 0.0195, "synergism": 0.00056, "tnf alpha gene": 0.02903, "flrgraygl": 0.00012, "antigen receptor induce": 0.01714, "anti-class": 0.00012, "c2h2 type": 0.00949, "n-end rule": 9e-05, "nfat-binding site": 0.02168, "collective": 0.0, "cap site confers erythroid specificity": 0.00867, "bzlf1": 0.00186, "cd30 cross-linking": 0.00242, "differentiated cell": 0.0768, "-10": 0.00099, "lining positive": 0.00468, "monocytic activity": 0.02925, "igh gene": 0.04355, "primary nuclear transcription factor bind": 0.01144, "stat6 activate": 0.01777, "radioligand method": 0.00236, "cd1a+": 6e-05, "human il4 promoter": 0.02508, "ap-1 binding protein": 0.03019, "target cell lysis": 0.0512, "early pro-b cell stage": 0.0384, "mediate nfat activity": 0.0195, "normal maturing granulocyte": 0.00806, "antigen-responsive lymphoid cell": 0.0512, "t-cell type": 0.00962, "genetic": 0.00577, "receptor protein increase": 0.03019, "semisolid": 0.00012, "induce t-all": 0.0254, "post-transcriptional level": 0.01821, "endotoxic effect": 0.02115, "cyclosporin-resistant mutant": 0.0081, "viral protein": 0.04529, "mature burkitt lymphoma cell raji": 0.03072, "exploration": 0.0, "125-133": 0.00012, "creation": 0.00012, "human cytomegalovirus immediate-early enhancer exhibit infectious kinetics similar": 0.00941, "immunoprecipitated kinase": 0.01188, "asp584": 0.00012, "intact p105 precursor": 0.00215, "cxc subfamily": 0.00037, "interferon regulatory factor": 0.01907, "lack bind ability": 0.0135, "id3 cell cycle function": 0.0384, "homologs": 0.00025, "reporter gene regulate": 0.02903, "destruction": 0.00025, "editorial": 6e-05, "antibody inhibit": 0.01904, "mixed": 0.00161, "bzlf1-specific memory": 0.00133, "eliminate tcr alpha enhancer activity": 0.0117, "lipopolysaccharide involves mobilization": 0.00163, "ganglioside": 0.00025, "chimeric animal": 0.00164, "b-cll": 0.00143, "inhibit ifnalpha production": 0.0127, "tat-expressing cell": 0.0768, "oct-2b": 6e-05, "rel/stat complex": 0.01684, "synchronized fibroblast": 0.00338, "adjacent promoter element contribute": 0.01168, "cytokine secretion": 0.01123, "expectation": 0.0, "nfat": 0.00862, "extracellular signal": 0.01635, "synovial cell": 0.0768, "activate tumorigenic": 0.01777, "apparent molecular size": 0.003, "platelet-like particle": 0.00074, "hiv regulatory region": 0.00978, "patient relative": 0.01666, "d3": 0.0049, "dominant control": 0.01303, "low gr number": 0.00471, "environmental carcinogen": 0.00068, "nf-at/ap-1-binding promoter element": 0.01557, "morphologic change": 0.0063, "epstein-barr virus zebra promoter": 0.01168, "e2f dna bind site": 0.01084, "persistent activation": 0.03164, "vivo activation": 0.03164, "analyze expression": 0.04163, "glucocorticoid-resistant cell lack endogenous functional receptor": 0.0256, "aldosterone action": 0.00499, "4-fluorophenyl": 0.00012, "decreased content": 0.0022, "human tfiid polypeptide": 0.02508, "/a23187": 0.00012, "beta globin promoter lead": 0.01168, "bcl-2 muteins": 0.00295, "recent biochemical": 0.0018, "multifunctional yy1 transcription factor": 0.0143, "human retinoblastoma gene": 0.02903, "p65 nf-kappa": 0.01414, "impaired fetal thymocyte development": 0.00316, "versatile molecule": 0.00853, "prolactin receptor": 0.02571, "central nervous system pyramidal cell": 0.03072, "chemiluminescence assay": 0.01002, "distal nuclear factor": 0.01907, "important proximal step": 0.00459, "accessory protein": 0.04529, "early lytic cycle": 0.00552, "tumor cell": 0.0768, "insulin-dependent": 6e-05, "cellular level": 0.01821, "embryonic-fetal phenotype": 0.00366, "complete suppression": 0.00416, "elevated cortisol plasma level": 0.0091, "good linear correlation": 0.00165, "csa-sensitive transcription": 0.0281, "e2f transcriptional activity include": 0.01462, "abrogate tlr2-mediated nf-kappab activation": 0.01582, "commonly": 0.00199, "thp-1 cell": 0.0768, "limit hiv-1 transcription": 0.01873, "fk506 operate": 0.00149, "situ hybridization study": 0.00904, "human disease x-linked agammaglobulinemia": 0.01881, "cytoplasmic factor": 0.0286, "antioxidant inhibit": 0.01904, "transcriptional transactivator protein": 0.03019, "system": 0.01334, "protein tbp": 0.04529, "nf-kb occur": 0.00654, "mouse bone marrow cell": 0.0384, "avian erythroblast cell line hd6": 0.03072, "insertional actin polymerization": 0.0005, "finding": 0.00453, "ligand-induced tyrosine phosphorylation": 0.00656, "measure decay": 0.00388, "therapy aim": 0.00372, "cd40 ligation induce growth inhibition": 0.01016, "lmp1 signal": 0.01635, "cd14-": 6e-05, "lcl-stimulated population": 0.00307, "ad5 e1a-transfected epithelial": 0.00126, "gut hyperabsorption": 0.00034, "epo receptor": 0.02571, "readout": 6e-05, "lmp-1 ebna-2 response element": 0.00971, "glutathione-s-transferase pi": 0.00074, "granulocyte maturation": 0.00254, "nfat transcription factor bind": 0.0143, "downregulates pre-talpha mrna": 0.01017, "erythrocytic": 0.00056, "promoter-plap plasmid": 0.00273, "freshly isolate monocyte express 94-kd stat5a": 0.00615, "paper report": 0.0049, "il-4 down-regulated mrna accumulation": 0.00763, "core tfiid complex": 0.01123, "stimulated cell": 0.0768, "proteinase": 0.00025, "mpds": 0.00012, "cytosolic level": 0.01821, "loading": 0.00012, "estrogen bind site": 0.01445, "bob1 interact": 0.00372, "cytogenetic": 0.00099, "costimulation-induced mitogen-activated protein kinase": 0.02264, "steroid/thyroid hormone nuclear receptor family": 0.01029, "express ciita-specific transcript": 0.0123, "g-rich motif": 0.00875, "dna-binding domain": 0.01207, "viral oncogene": 0.00732, "regulate nuclear matrix attachment": 0.00842, "stable level": 0.01821, "myeloid-specific surface marker": 0.00343, "mineralocorticoid resistance": 0.00326, "ongoing hiv-1 replication": 0.00585, "understand": 0.0031, "half-life study show": 0.01733, "rate-limiting step": 0.00189, "estradiol": 0.0018, "nonresponders": 0.00019, "syk protein tyrosine": 0.03019, "nonspecific serine/threonine protein kinase inhibitor staurosporine": 0.0151, "gamma/delta tcr+ cell": 0.0512, "m0/m1 leukemic cell": 0.0512, "pu.1 interacts": 0.00285, "high relative affinity": 0.0062, "transfected patient": 0.01666, "anti-cd28 mab": 0.00267, "related divalent cation": 0.00157, "shp-1 phosphatase": 0.00264, "jagged1 belongs": 0.00034, "tpa-treated hl-60 cell": 0.0512, "hsp60-specific": 0.00012, "electrophoretic mobility shift assay fail": 0.00401, "dna binding form": 0.01237, "ct": 0.00037, "thymocytes require nf-kappab activation": 0.01582, "mzf-1 represses cat reporter gene expression": 0.01452, "healthy carrier": 0.00177, "severe embryonic development abnormality abolish": 0.00253, "mast cell population": 0.0512, "mhc ii": 0.00726, "mouse lack": 0.00974, "hdl": 0.00012, "rxr-rxr": 0.00025, "enhance gata-3 promoter transactivation": 0.01168, "vitro adherence": 0.00785, "bm": 0.00037, "propose mechanisms": 0.00164, "high-affinity binding site": 0.01445, "peptide synthesis": 0.00754, "ionomycin induce synergistic activation": 0.01582, "-2 promoter activity": 0.0195, "il-6 stimulate": 0.01101, "c-terminal": 0.00385, "inverse": 0.00074, "normal immune system": 0.00806, "cre site": 0.02168, "tax-mediated breakdown": 0.0005, "senescent cd8+": 0.0014, "fifty synthetic retinoids": 0.00134, "go-6976": 0.00012, "vzv product": 0.00533, "genomic sequence show similarity": 0.013, "hsp70 production": 0.01042, "hormone-mediated gene regulation": 0.02903, "acute megakaryoblastic leukaemia": 0.00246, "fasl expression": 0.04163, "freshly isolate nasal": 0.00277, "consensus ap1 motif": 0.00583, "eradication remain": 0.00521, "promyelocytic cell": 0.0768, "fibroblast line": 0.01653, "cd3epsilon": 0.00025, "creb occur": 0.00654, "culture bovine corneal endothelium": 0.0031, "activate gene expression": 0.02903, "h. binding": 0.01855, "negligible effect": 0.02115, "transient expression analysis": 0.02775, "molecular model": 0.0045, "average": 0.00056, "oxidative signal induce": 0.01694, "eml cell": 0.0768, "good candidate": 0.00102, "inhibitory factor": 0.0286, "influence cytokine production": 0.00749, "d. e.": 0.00102, "pre-b": 0.0018, "thymocyte development": 0.00633, "dexamethasone measure": 0.00394, "box region": 0.01467, "dna binding protein": 0.03019, "6-week washout period": 0.00085, "cd40 ligand lead": 0.00664, "model change": 0.0063, "abolish ligand-induced degradation": 0.00236, "inhibit cytokine expression": 0.02775, "control hematopoietic gene transcription": 0.02177, "block activation-induced fa expression": 0.02081, "ebv-associated disease": 0.00673, "inhibit lps-mcd14 binding": 0.0127, "trap+": 0.00019, "hiv-hd": 0.00056, "u2 enhancer construction": 0.00606, "il-1 beta gene": 0.02903, "t-cell-specific activation": 0.03164, "human genetic disorder": 0.02508, "human cd36 gene promoter": 0.02177, "ifn-gamma activity": 0.02925, "immunofluorescence study": 0.01355, "ebv lytic antigen": 0.00546, "steroid-regulated expression": 0.04163, "pmlrar alpha transgenic mouse exhibit impaired neutrophil maturation early": 0.0026, "main regulatory pathway": 0.00852, "tumor exhibit typical morphology": 0.00467, "promonocyte cell line": 0.0512, "prolong submaximal exercise": 0.00072, "immunomodulatory effect": 0.02115, "cellular survival-promoting protein": 0.03019, "cell mediate": 0.0768, "human beta-globin expression": 0.02775, "polyadenylated rna": 0.00456, "inflammatory cytokine": 0.01123, "transfer": 0.0018, "c-rel/p65 heterodimers": 0.00226, "express bcl-6": 0.01846, "decidualization": 0.00012, "gralpha expression vector": 0.02775, "main": 0.00174, ".0001": 6e-05, "3-o-methyl-d-glucose transport": 0.00068, "target spleen": 0.00825, "cord lymphocyte activation exhibit": 0.01582, "observed binding": 0.01855, "cytokine-activated janus kinase-stat signal pathway": 0.00654, "tcr stimulation require": 0.00877, "lymphoblastic leukemia cell suggest": 0.0384, "cd95l proximal promoter sequence": 0.01168, "bq-treated dead cell": 0.0512, "fes tyrosine kinase": 0.00792, "recombinant caspase": 0.00391, "cd3-dependent event": 0.00552, "anoxia/reoxygenation-induced tolerance": 0.00081, "hiv-1 nf-kb probe": 0.00585, "gata-3 promoter activity": 0.0195, "murine interleukin-2 enhancer": 0.00606, "hepor promoter activity": 0.0195, "inverse change": 0.0063, "beta-chemokine family": 0.00841, "phorbol ester-induced up-regulation": 0.00362, "promoter sequence analysis": 0.01557, "camp response element-binding protein": 0.02264, "promoter switch combine": 0.01557, "human genomic clone": 0.02508, "septic shock": 0.00174, "hematopoletic differentiation": 0.01179, "ra-induced change": 0.0063, "deleterious effect": 0.02115, "longer express": 0.01846, "genetic control": 0.01303, "plasma cell line": 0.0512, "specimen test": 0.00487, "guanine nucleotide exchange factor vav": 0.01144, "rex-viral mrna complex": 0.01123, "vivo selection": 0.0053, "block activation": 0.03164, "inhibit il-4/il-13-induced stat6 activity": 0.01462, "discordance": 6e-05, "similar time": 0.00673, "bat box": 0.00304, "mild down-regulation": 0.00195, "patient": 0.03331, "11-": 6e-05, "neutrophil adhesion response": 0.01294, "response element complex formation": 0.00971, "steady state level": 0.01214, "globin promoter interaction": 0.01557, "dna bind experiment": 0.0135, "express cell": 0.0768, "additional signaling molecule": 0.00569, "tissue type": 0.00949, "purified recombinant sp1": 0.00261, "lipopolysaccharide-stimulated neutrophil": 0.00496, "clinical manifestation": 0.00425, "hematopoietic-specific ets family transcription factor": 0.01144, "message-destabilizing element": 0.01672, "active signaling pathway": 0.00852, "ras": 0.00149, "1,25-dihydroxyvitamin d3 receptor": 0.01714, "stimulate gtp bind": 0.0135, "glucocorticoid": 0.017, "high affinity aldosterone bind": 0.01013, "distant homology": 0.00183, "g.visani": 6e-05, "differential mzf-1 modification": 0.00215, "nfat emsa bind complex": 0.01013, "low transcription rate": 0.01873, "potent growth factor": 0.01907, "ap-1 generation": 0.00695, "fura-2-loaded": 6e-05, "include polysaccharide specificity": 0.00959, "-kappa": 0.00056, "stat5a-stat5b heterodimers form": 0.00703, "valine": 0.00019, "unidentified factor bind": 0.01907, "gamma-globin gene": 0.04355, "deletion mapping data suggest": 0.01011, "d1/cdr2-loop ligand": 0.00592, "virus-infected cell": 0.0768, "delay administration": 0.00096, "significant depression": 0.00416, "major histocompatibility complex class ii gene": 0.01452, "human bcl-2 gene": 0.02903, "neutrophil gelatinase-associated lipocalin": 0.00331, "cell assay": 0.0768, "activator protein": 0.04529, "glucocorticoid receptor activation": 0.02109, "cd4 epitope": 0.00332, "acute promyelocytic leukemia pml-retinoic acid receptor alpha": 0.00735, "cell contrast": 0.0768, "induce monocyte differentiation": 0.01694, "unknown mechanism zap-70 tyrosine kinase": 0.00475, "alpha expression": 0.04163, "reduced nf-kappab activation": 0.02109, "nf-at transcription factor": 0.01907, "activate nf-kappa b. phorbol activation": 0.01266, "sequela": 0.00019, "methyl prednisolone": 0.0004, "extracellular signal-regulated protein kinase": 0.02264, "apl patient refractory": 0.0111, "oxidative signalling": 0.00177, "potent mitogen": 0.00357, "inhibit ap-1 activation": 0.02109, "atra-induced neutrophil differentiation": 0.00786, "independent mode": 0.00363, "enhanced transcription": 0.0281, "ltr reporter gene": 0.02903, "monocyte differentiate": 0.01197, "macrophage/monocyte type cell": 0.0512, "tat/as": 6e-05, "gene truncation result": 0.02903, "hiv-1 provirus dna": 0.00988, "increase apoptosis": 0.02196, "great deal": 0.00205, "transcript initiation": 0.00599, "show bind motif": 0.01733, "repressor molecule": 0.00853, "ligand-dependent opening": 0.00025, "t-cell dna": 0.01483, "monocyte differentiation process": 0.00798, "hl-60egr-1": 6e-05, "gene up-regulated": 0.04355, "nf-at2": 6e-05, "camp-regulated gene": 0.04355, "small gtp-binding protein rho potentiate ap-1 transcription": 0.01294, "prb bind": 0.02025, "monoclonal anti-cr1": 0.00279, "short pulse": 0.0013, "human interferon beta": 0.02508, "ets family": 0.00841, "include vimentin": 0.01439, ".0002": 0.00012, "construct strain": 0.00726, "pertinent model": 0.00422, "usa": 0.00037, "dp": 0.00037, "human rar-alpha": 0.03762, "temporal control": 0.01303, "alteration develop": 0.00403, "tpa-induced monocytic differentiation": 0.00786, "micrograms/ml": 0.00037, "hiv-1 demonstrate normal late gene expression": 0.01452, "non-significant trend": 0.00019, "human tf promoter": 0.02508, "intracellular traf2": 0.00583, "require high circulating level": 0.0091, "mature monocyte/macrophage function": 0.00887, "inhibitory mechanism": 0.01058, "so-far-unrecognized sp-1 site": 0.01445, "n-alpha-tosyl-l-phenylalanine chloromethyl ketone": 0.00021, "il-2 cd28re": 0.01117, "tumor/growth suppressor": 0.00105, "generate vitamin d-responsive element": 0.00836, "physico-chemical": 6e-05, "rac mediate response": 0.01294, "beta-galactosidase activity": 0.02925, "suppressive transcriptional effect": 0.0141, "pth level": 0.01821, "anti-tat single-chain intrabodies": 0.00027, "cell cycle-dependent transcription factor": 0.0384, "granulocyte": 0.00509, "lps-induced tnf-alpha factor": 0.01907, "optimal cell differentiation": 0.0512, "pkc stimulation": 0.0112, "+/- sd": 0.00158, "tdag51": 0.00025, "generate anti-tcf-1 antibody": 0.00596, "ra signal pathway": 0.0109, "x-inactivation pattern": 0.00549, "1,25-dihydroxyvitamin d3-responsive protein": 0.03019, "myeloid leukemia impairs neutrophil maturation": 0.002, "large prospective trial": 0.00136, "nik": 0.00068, "butyrate": 0.00043, "virus-exposed cell": 0.0768, "b-cell-specific enhancer element": 0.01115, "immunoblot experiment show": 0.01733, "lewis": 0.00012, "down-regulate cd4 gene expression": 0.02177, "eliminate a. concomitant": 0.00083, "il-8 kappa b-like site": 0.01084, "influence clinical": 0.00471, "icam-1 mrna": 0.01526, "standard technique": 0.00109, "repress alf1 activity": 0.0195, "humara assay": 0.01002, "isolated human peripheral blood lymphocyte": 0.01505, "comedo versus noncomedo variant": 0.00138, "case cytoplasmic p39c-jun": 0.00267, "sequence-related gene": 0.04355, "motor neuron": 0.00022, "mouse carrying target mutation": 0.00487, "cell progression": 0.0768, "rheumatoid synovial tissue": 0.00443, "bind hematopoietin receptor": 0.01714, "human cd34+ hematopoietic progenitor cell": 0.03072, "e-proteins": 0.00019, "e1a expression": 0.04163, "detectable deletion": 0.00344, "sialoadhesin expression": 0.04163, "ebna-2 expression vector": 0.02775, "bacterial peptide ligand": 0.00502, "position -95": 0.00236, "human cancer lncap cell": 0.0384, "rna polymerase ii promoter suggest": 0.00934, "ndp kinase expression serve": 0.02081, "human cytomegalovirus bind": 0.02508, "htlv-1 tax induces expression": 0.02081, "chimeric receptor": 0.02571, "stimulate polymorphonuclear neutrophil": 0.00734, "p75tnf-r": 0.00031, "hiv-mediated nf-kappa": 0.01414, "developing central nervous system": 0.00333, "anti-cd3-induced erk activation": 0.02109, "bone morphogenetic protein-": 0.00143, "fas-mediated apoptosis play": 0.00593, "detect pan/e2a protein": 0.03019, "il-2 promoter element il-2a": 0.01168, "induce cem subclones": 0.01694, "tnf family": 0.00841, "mediate maximal il-2rbeta promoter activity": 0.0117, "hiv-2 display significant difference": 0.0025, "interindividual difference": 0.00425, "inhibit inducible protein kinase": 0.02264, "cell functional phenotype": 0.0512, "mil-2re": 6e-05, "population genetics": 0.00307, "icrf-193-treated cell": 0.0768, "treponema pallidum": 0.00019, "element require gata-1": 0.01115, "locus": 0.00577, "gene regulate": 0.04355, "antibody direct": 0.00893, "dexamethasone suppression test": 0.00325, "early erythroid progenitor cell": 0.0384, "e1a oncogene induction": 0.01071, "functional binding site": 0.01445, "anti-inflammatory activity": 0.02925, "mouse delta protein": 0.03019, "interferon-gamma gene expression": 0.02903, "homeostatic control": 0.01303, "study provide": 0.01355, "key step": 0.00189, "molecule enhance lps-induced nf-kappab": 0.00499, "induced egr-1": 0.0054, "cp result": 0.0161, "jak3 expression correlate": 0.02775, "ifn-gamma induce hla class ii": 0.01016, "inhibitor specific": 0.01238, "oct2ba isoforms": 0.00307, "gata repeat": 0.00378, "native monocyte": 0.01197, "-kinase": 0.00019, "ciprofibrate": 0.00012, "retarded complex form": 0.01123, "retinoid-dependent regulation": 0.01008, "flow-cytometric assay": 0.01002, "yang deficient patient": 0.0111, "gpx": 0.00019, "bind stat protein": 0.03019, "thp-1-hgh-transfected cell culture": 0.0512, "cd27 ligand": 0.00592, "vascular protective property": 0.00265, "amino acid 528-777": 0.00571, "lmp promoter": 0.02336, "so-called octamer transcription factor": 0.0143, "freshly isolate pbmc": 0.00277, "human lim-hox gene": 0.02903, "tal1 activation": 0.03164, "p65 provide considerable protection": 0.00323, "provide support": 0.00645, "human partner": 0.03762, "translocation result": 0.0161, "aids patient": 0.01666, "cbf beta gene": 0.02903, "synovial lymphocyte reactivity": 0.00988, "p50-p56 heterodimer": 0.00205, "glucocorticoid receptor determination": 0.01714, "positive activity": 0.02925, "vcam-1 surface expression": 0.02775, "aes1/2": 0.00043, "gabp alpha": 0.01169, "non-il-2-producing cell": 0.0768, "human gm-csf element": 0.02508, "consensus kappab bind motif": 0.01013, "mutant endotoxin": 0.0081, "mature p50 subunit consist": 0.00242, "coactivator bob.1/obf.1": 0.00149, "selective blockade": 0.00267, "sfllrnp": 6e-05, "silencer sequence": 0.01625, "clone pat": 0.00738, "polarized monolayers": 0.00043, "prednisone": 0.00043, "il-1-dependent manner": 0.00282, "plasmodium vivax malaria parasite": 0.00019, "pma responsive element": 0.01115, "include skeletal muscle": 0.00959, "chloramphenicol acetyltransferase reporter gene link": 0.01742, "raf1": 6e-05, "histamine": 0.00118, "major side effect": 0.0141, "beta-like globin locus": 0.00192, "promoter proximal": 0.02336, "protect mcf-fas cell": 0.0512, "genomic aldosterone effect": 0.0141, "stat activity": 0.02925, "mediate repression": 0.01231, "activated peripheral blood lymphocyte": 0.00741, "asthma patient": 0.01666, "early gene c-jun": 0.02903, "block radiolabeled il-2 binding": 0.00927, "normal leukocyte": 0.0121, "h.-m.chen": 6e-05, "invasive": 0.00037, "one-sixth": 0.00012, "pma-induced hiv-1 p24 antigen production": 0.00417, "m.m.lightfoote": 0.00012, "dna polymerase-associated processivity factor pcna": 0.01144, "tissue test": 0.00664, "nf-kappab-responsive reporter gene": 0.02903, "mediterranean diet": 3e-05, "ccl4": 0.00025, "human retinoic": 0.03762, "apparent contradiction": 0.00192, "lps treatment": 0.01014, "irrespective": 0.00056, "tax-responsive element": 0.01672, "cytokine-mediated inflammatory disease": 0.00449, "multiple biological response": 0.01294, "alpha-globin": 0.00143, "intact human mononuclear leukocyte": 0.01881, "inhibit hiv-1 production": 0.0127, "lowered induction": 0.01607, "gata-3": 0.00335, "anergic cell": 0.0768, "heterodimer partner": 0.00205, "c.j.hetherington": 0.00012, "il-3 withdrawal suggest": 0.01348, "hl60 human leukemia cell": 0.0384, "therapeutic steroid hormone affect": 0.00399, "viral replication": 0.00732, "c-jun nh2-terminal kinase activation": 0.01582, "nf-y binding": 0.01855, "day intervention study": 0.00904, "severe form": 0.01055, "orfs u86": 0.00016, "primary rat astrocyte": 0.00492, "junb phosphorylation": 0.00983, "provide anti-viral": 0.00645, "q32": 0.00025, "primary human monocyte": 0.02508, "rvlps": 6e-05, "monocyte binding": 0.01855, "nf-kappab protects": 0.00999, "il-1alpha promoter construct drive transcription": 0.01124, "palindrome": 0.00025, "age-related impairment": 0.00065, "genetic defect": 0.00288, "early signal transduction pathway recruit": 0.00654, "alpha-chloromethyl": 0.0, "transcription factor gata-1": 0.01907, "upregulates proliferation-associated il-2ralpha": 0.00041, "bja-b cell": 0.0768, "light-chain gene rearrangement": 0.02903, "cell cycle-dependent initiation": 0.0512, "cd15 engagement": 0.00133, "redox signal": 0.01635, "endothelial activation require continuous presence": 0.01266, "multiple endothelial gene product require": 0.01742, "hla dq2-restricted": 0.00192, "tata-less promoter encompass": 0.01557, "cell express high v-abl kinase activity": 0.0256, "il-12r complex": 0.01684, "cd30 signal transduction": 0.0109, "tlr": 6e-05, "premenopausal patient show": 0.01733, "noncoding region": 0.01467, "nrds": 0.00025, "dimeric complex activator protein-1": 0.00842, "rbpi21 act": 0.00496, "aid retrovirus": 0.00161, "tcr-stimulated": 0.00062, "virus envelope": 0.00887, "ligand activation": 0.03164, "calcium ionophore-induced c-myc suppression": 0.00208, "dex-resistant cem cell": 0.0512, "transcription factor nf-il4": 0.01907, "0.2-1.6": 6e-05, "result demonstrate": 0.0161, "caspase-3/cpp32": 6e-05, "mediate t3-responses": 0.01231, "senescent organism": 0.00028, "tcr-like signal": 0.01635, "rat lung induce": 0.01694, "entire cytoplasmic pool": 0.00267, "hypotonic cytosol": 0.00143, "variant octamer motif": 0.00583, "cotton-top tamarin receptor": 0.01714, "dqb1 polypeptide": 0.00136, "il-2-induced beta-casein expression": 0.02775, "eth1 cell": 0.0768, "hepo": 0.00019, "sc170": 6e-05, "c-terminal ta1 transactivation domain": 0.00603, "thyrocyte": 0.00012, "non-b nhl": 0.00028, "bls group": 0.00487, "murine gm-csf gene promoter": 0.02177, "show overt homology": 0.01733, "mitogenic": 0.00211, "distinct hematopoietic lineage": 0.00465, "human ah receptor": 0.02508, "degree relative": 0.00276, "peripheral murine monocyte": 0.00798, "bacterial toxin": 0.00223, "ifn activates de novo synthesis": 0.00233, "autocrine ifn synthesis result": 0.00805, "alpha-galactosidase": 0.00043, "easy": 0.00012, "activation program": 0.03164, "full-length cdna sequence": 0.01084, "human b-lymphocyte cell cycle": 0.0384, "sex determine gene sry": 0.02177, "ciita construct fail": 0.00484, "vitro culture": 0.00785, "nfat complex": 0.01684, "essential step": 0.00487, "c-rel bind": 0.02025, "defective recruitment": 0.00205, "tpo promote hemoglobinization": 0.0031, "nfat component": 0.00456, "promoter induction": 0.02336, "enhanced formation": 0.00484, "regulate transcription": 0.0281, "sulfate polysaccharide": 0.00062, "eliminate unwanted cell": 0.0512, "seventeen patient": 0.01666, "mrna differential display": 0.01017, "stat6 dna-binding activity demonstrate": 0.01462, "display constitutively high level": 0.0091, "deleted promoter lack": 0.01557, "er-negative phenotype": 0.00366, "c-myb transcription factor": 0.01907, "exhibit distinct transcriptional activity": 0.01462, "sequential accumulation": 0.00323, "cn activity": 0.02925, "phu-14": 0.0, "x-inactivation": 0.00037, "body weight": 0.00136, "alpha-globin gene expression": 0.02903, "bzip protein": 0.04529, "cd27/cd70 interaction enhance": 0.00658, "il-13 mrna expression": 0.02775, "cd15": 0.00093, "p75 tumor necrosis factor receptor": 0.01144, "anti-nf-atp": 0.00012, "nf-il6 site mediate induction": 0.01084, "il-3/adenovirus e4 promoter bind protein": 0.01811, "tissue sample": 0.00664, "include nfat": 0.01439, "rest": 0.00533, "specific cooperation": 0.01238, "coligation": 0.00031, "il-3 gene": 0.04355, "clone ltrs": 0.00738, "omega-monomethyl-l-arginine": 6e-05, "hemoglobin accumulation": 0.00323, "direct myeloid-specific expression": 0.02775, "facilitate immobilization": 0.00199, "biological stimulation": 0.0112, "c-jun promoter": 0.02336, "ferredoxins": 6e-05, "major portion": 0.00574, "scatchard plot analysis demonstrate": 0.00799, "vpr induces apoptosis": 0.00593, "early differentiation stage": 0.00786, "natural ligand": 0.00592, "ews/fli-1 fusion protein": 0.03019, "immunomagnetic separation": 0.00053, "interferon consensus sequence": 0.01084, "i-kappa": 0.00025, "tnf-alpha bioavailability": 0.00546, "cytosolic preparation": 0.00152, "ltr activity": 0.02925, "cellular morphological change": 0.00596, "pha-activated": 0.00062, "neutrophil lineage": 0.00496, "il-4 receptor stimulation": 0.01714, "hl-60 myelomonocytic differentiation": 0.00786, "e1a domain": 0.01207, "subsequent cytosolic nf-kappa": 0.00943, "inhibit murine": 0.01904, "southwestern blot analysis": 0.00786, "adverse effect": 0.02115, "multiple cold-air exposure": 0.00459, "xp-d patient": 0.01666, "nf-kappa b. platelet-activating factor": 0.0143, "alpha-deficient mouse": 0.00974, "cd367": 6e-05, "transactivating complex": 0.01684, "peptide bind affinity": 0.0135, "th2 differentiation": 0.01179, "massive overexpression": 0.00382, "express high level": 0.0123, "protein release": 0.04529, "cooperative dna binding": 0.01237, "il-2 promoter activation": 0.02109, "il-2 secrete el4 cell": 0.0384, "procedure suitable": 0.00078, "assaying": 6e-05, "dominant negative helix loop helix factor id3": 0.00817, "substitute peptide abolish": 0.00502, "ovulation induce woman": 0.01694, "purity": 6e-05, "interleukin-4 gene correlate": 0.02903, "recalcitrant asthma": 0.00161, "selective chemical modification": 0.00178, "deacetylated metabolite": 0.00109, "anti-p65 antibody": 0.00893, "stat5 phosphorylation": 0.00983, "reporter gene experiment demonstrate": 0.02177, "endotoxic shock": 0.00174, "represent immunoregulatory cell": 0.0512, "leukemic u937 cell": 0.0512, "regulatory element": 0.01672, "tnfr superfamily": 0.00096, "hypoxic induction": 0.01607, "electron microscopy reveal": 0.00732, "cmv induces il-6 gene expression": 0.01742, "suppress il-2": 0.01117, "forskolin act": 0.00496, "il-2r gene": 0.04355, "viral capsid antigen stain": 0.00409, "cycloheximide": 0.0018, "b-cell-specific complex": 0.01684, "multifunctional target": 0.00825, "nfatc.beta-specific probe detect": 0.00484, "ifns inhibit growth": 0.0127, "arrest": 0.00341, "gm-csf-induced cytokine gene expression": 0.02177, "intracellular sequestration": 0.00583, "supershift analysis reveal": 0.00786, "mid-s phase": 0.00276, "glucose transporter": 0.00078, "target cell genome": 0.0512, "putative regulatory loop": 0.00455, "dp65": 6e-05, "rodent homologs": 0.00043, "situ reverse transcription base polymerase chain reaction": 0.00803, "virus-replicative lesion": 0.00143, "synthesize il-2": 0.01117, "nonhematopoietic lineage": 0.00366, "main difference": 0.00425, "ebna-2 trans-activates cellular": 0.00596, "anti-tumoral agent": 0.00422, "interfollicular bcl-6+ cell": 0.0512, "reverse transcription": 0.0281, "iepsilon promoter": 0.02336, "human u937 promonocytic cell": 0.0384, "ifn-gamma cytoplasmic mrna": 0.01017, "bloodstream": 0.0, "tg epsilon26 fetal liver cell": 0.03072, "membrane localization": 0.0045, "mouse fibroblast": 0.00974, "nuclear inhibitory protein repressor element": 0.01811, "g. vaginalis lysates": 0.00068, "irregular menstruation": 9e-05, "low renin activity": 0.0195, "regulate stat3 dna binding": 0.00927, "peptide bound": 0.00754, "optimum time": 0.00273, "form high intracellular level": 0.0091, "kappa b-alpha mrna": 0.01017, "tcf-1 identified": 0.00189, "performance": 0.00025, "tenfold increase": 0.02196, "distinguish es cell-derived erythrocyte": 0.00065, "characterize": 0.0085, "block transcriptional activation": 0.02109, "regulate monocyte production": 0.00835, "age-related hyporesponsiveness": 0.00065, "il-1r-associated kinase": 0.01188, "unphosphorylated 27-kda protein": 0.03019, "alveolar macrophage": 0.00589, "14-kd protein": 0.04529, "gata-1 gene disruption": 0.02903, "erythroid cell transcription factor ef1": 0.03072, "growth factor deprivation": 0.01907, "slight transient increase": 0.01464, "rxr-rxr pathway": 0.01278, "-795 bp exhibit": 0.00443, "gm-csf-induced proinflammatory cytokine gene expression": 0.01742, "glycine": 0.00019, "brain cell": 0.0768, "structure-function study": 0.01355, "doxycycline": 0.0, "form": 0.02109, "promoter activation": 0.03164, "nfat protein": 0.04529, "mrna level determine": 0.01214, "position p1": 0.00236, "human tsp": 0.03762, "estrogen receptor concentration": 0.01714, "link fgf receptor-1 engagement": 0.00174, "g12v": 0.00019, "cdk-2-dependent phosphorylation": 0.00983, "cluster": 0.00242, "cdna clone encode interferon": 0.00426, "r-pk minimal promoter": 0.01557, "sds-page analysis": 0.01179, "prevent disease relapse": 0.00449, "mip-1beta": 0.00019, "x1": 0.00062, "clinical data": 0.00425, "increase transcription": 0.0281, "huvecs release superoxide anion": 0.00242, "production induce": 0.0254, "starting point": 0.00183, "erythrocyte": 0.00261, "subcytotoxic concentration": 0.0067, "high number": 0.00931, "uncommon phenomenon": 0.00093, "nf-munr enhancer repressor": 0.00606, "monocyte-specific transcription": 0.0281, "leukemia breakpoint region": 0.00978, "uncomplicated pregnancy": 0.0009, "nucleotide sequence responsible": 0.01084, "physician": 0.00012, "cell lymphoma": 0.0768, "alpha b1": 0.01169, "diverse biologic effect": 0.0141, "retinoic acid-alpha receptor": 0.01714, "cmpd1/sra1 patient": 0.01666, "increase c-jun gene transcription": 0.02177, "endogenous transcription factor": 0.01907, "bioactive m-csf protein": 0.03019, "mutant mouse lack functional ikaros transcription factor": 0.00817, "globin gene transcription": 0.02903, "mhc class ii molecule transduce": 0.00341, "cd28-specific pathway": 0.01278, "inflammatory synovial microenvironment": 0.00314, "trident mrna": 0.01526, "e3330 decrease transcriptional activation": 0.01582, "nef": 0.0023, "lung damage": 0.00195, "tcr-induced apoptosis": 0.0089, "gel-shift analysis demonstrate": 0.01065, "hla-dra expression": 0.04163, "dna cotransfection experiment": 0.00988, "n-terminal regulatory region": 0.00978, "receptor quantitation": 0.02571, "wehi-3b/d+": 6e-05, "nfat site center": 0.01445, "base upstream": 0.00369, "bcl-xl": 0.00136, "optimal neutrophil": 0.00496, "anionic phospholipid surface": 0.00343, "induces expression": 0.04163, "alpha b2": 0.01169, "gh-induced inhibitory effect": 0.0141, "chimeric oncoprotein e2a-hlf": 0.0011, "pancreatic beta cell": 0.0512, "radioimmune assay": 0.01002, "microscopic examination": 0.00047, "p1 site": 0.02168, "viral ltr": 0.00732, "gst-pi": 0.00037, "anf-e2 promoter": 0.02336, "differentiation-inducing concentration": 0.0067, "bipotential capacity": 0.00329, "kappa immunoglobulin light chain gene require developmental-": 0.01244, "nf-kappa b1 promoter": 0.01557, "leukocyte integrin gene cd11c": 0.02177, "olomoucine": 6e-05, "wild-type chinese hamster ovary": 0.00189, "vitro transfection assay": 0.00668, "transfer high-level lymphoid-specific responsiveness": 0.00161, "uninfected monocyte": 0.01197, "lef-1-binding site inhibit": 0.01445, "mouse macrophage inflammatory protein-1alpha": 0.00487, "c/ebp epsilon mrna": 0.01017, "na+/h": 0.0, "review recent finding": 0.00151, "il-4 binding site": 0.01445, "distinct cytokine expression pattern": 0.02081, "gm-csf result": 0.0161, "mouse gene": 0.04355, "dra gene transcription": 0.02903, "morning": 0.00068, "control animal": 0.01303, "-induced monocytic differentiation": 0.00786, "variable region": 0.01467, "proportion": 0.00192, "t-cell determinant": 0.00962, "28-bp core region": 0.00978, "stat5 isomer": 0.00254, "glucocorticoid-evoked cell death": 0.0512, "support hiv replication": 0.00395, "csa inhibited synthesis": 0.00389, "divergent protein kinase": 0.03019, "paralysis": 0.0, "structural motif": 0.00875, "northern blot analysis suggest": 0.01011, "toremifene": 0.00031, "group receive prenatal steroid treatment": 0.00406, "vivo model": 0.0053, "biomedical importance": 0.0013, "dre 1-binding protein": 0.03019, "mbp promoter region": 0.01557, "100-500 microm op": 0.00087, "gm2": 0.00037, "aeca": 6e-05, "kappa b-specific binding factor present": 0.01144, "site mutation": 0.02168, "ap-1-regulated gene": 0.04355, "ctf/cbp": 6e-05, "epinephrine-to alter": 0.00378, "interleukin-2 nfat-driven reporter gene": 0.02177, "motheaten mouse": 0.00974, "p50/p65 dimer": 0.00105, "early gene c-fos": 0.02903, "vivo modulation": 0.0053, "ap-1 activity": 0.02925, "aramburu": 0.00012, "land": 0.00037, "p21/cip1": 0.00019, "lps treatment enhance": 0.00676, "beta-globin gene transcription": 0.02903, "a-myb expression": 0.04163, "vitro-differentiated embryonic stem cell": 0.0384, "cell cycle entry event": 0.0384, "malignant cell cytokine production": 0.0384, "l-selectin mrna": 0.01526, "camp abolish": 0.00354, "cytokine responsiveness": 0.01123, "show diurnal change": 0.01733, "histidine residue": 0.00226, "bcl-3 interferes": 0.00031, "c-rel/p65 dimer": 0.00102, "work present": 0.00735, "concomitant elevation": 0.00112, "pwm regulate egr-1 gene expression": 0.01742, "human impdh type ii gene": 0.01742, "breakpoint": 0.00037, "ciita expression plasmid": 0.02775, "induce hsp70": 0.0254, "enhancerless plasmid": 0.00273, "megakaryocytic marker": 0.00382, "5-azacytidine": 0.00012, "activate cd4": 0.01777, "dna element": 0.01672, "experiment show": 0.02599, "stress response": 0.01942, "wide variety": 0.00202, "regulate cell fate decision": 0.0384, "dg75": 6e-05, "il-7 effect": 0.02115, "equimolar heterodimerization": 0.00059, "genomic action": 0.00499, "-3134": 0.00019, "human germ-line": 0.03762, "ten in-vitro-stimulated normal adult peripheral blood lymphocyte sample": 0.00371, "stat protein activate": 0.03019, "discordant expression": 0.04163, "include cd2": 0.01439, "transient-transfection experiment demonstrate": 0.01065, "putative transactivation domain": 0.00804, "spacing": 0.00025, "erythroid cell line": 0.0512, "diagnostic": 0.00019, "human pathology": 0.03762, "steady-state immunoglobulin heavy-chain mrna": 0.00763, "native il-2 enhancer": 0.00744, "il-10 binding": 0.01855, "h2 receptor desensitization": 0.01714, "mrna half-life": 0.01526, "switching": 0.00143, "nf-kb factor": 0.0286, "hnf-4alpha play": 0.0071, "mediate differentiation": 0.01231, "total igg-aeca": 0.00161, "erythroid colony consist": 0.00414, "lymphocyte induce protein tyrosine phosphorylation": 0.01811, "ccaat bind protein nf-y": 0.02264, "primary rat microglia": 0.00492, "nf-kappa b-directed luciferase activity increase": 0.0117, "anti-topoisomerase drug": 0.00338, "define e2f complex": 0.01123, "clinical remission induce": 0.01694, "fibrinogen trigger activation": 0.02109, "human il-4r alpha": 0.02508, "abrogated il-4-induced germline cepsilon transcription": 0.01124, "cat reporter construction": 0.00368, "element term": 0.01672, "p450ia1": 0.00012, "er-mediated repression": 0.00211, "post-stimulation": 6e-05, "il-2 induced tyrosine phosphorylation": 0.00558, "mononucleosis": 0.00012, "isre oligonucleotide probe": 0.00174, "gammac enhance il-4-mediated response include stat6 phosphorylation": 0.00555, "express differentiation marker": 0.0123, "lsf participate": 0.0013, "g0s3": 6e-05, "midbrain patterning": 6e-05, "ifn-gamma activation site-like dna sequence element": 0.01055, "isotype-specific transcription factor": 0.01907, "c-myb gene": 0.04355, "neotropical primate": 0.00056, "phosphatase 2a-sensitive site": 0.01445, "current structural classification": 0.0012, "interferon family": 0.00841, "single cd34+thy-1+ cell": 0.0512, "anti-inflammatory capacity": 0.00329, "single strand conformation polymorphism analysis": 0.00471, "trans-dimers": 0.0, "unfractionated peripheral blood mononuclear cell": 0.03072, "murine il-2 nfat recognition sequence": 0.0065, "fusion protein e2a-hlf": 0.03019, "coup protein": 0.04529, "gata-1 play important": 0.00474, "age-associated impairment": 0.00034, "inhibit nfat activation": 0.02109, "receptor number": 0.02571, "control basal human t-cell lymphotropic virus type": 0.01075, "inhibit tat-mediated transactivation": 0.0127, "leukemic cell infiltration": 0.0512, "reproductive": 0.00031, "phorbol ester-sensitive protein kinase c.": 0.01811, "salmonella typhimurium": 0.00012, "hazardous specificity": 0.00335, "soluble cd40l fusion protein up-regulated": 0.01811, "egr-2": 0.00043, "myelomonocytic leukemia": 0.00499, "interleukin-2 receptor alpha chain": 0.01286, "permissiveness": 0.00025, "immortalization": 0.00124, "tcr-signalling event": 0.00552, "phorbol ester vary": 0.00362, "potentiation process": 0.00444, "entamoeba histolytica infection": 0.00414, "2-kb vdr cdna insert": 0.00228, "-induced signal": 0.01635, "osteoclast differentiation factor": 0.01907, "hiv-1 variant": 0.00878, "prevent": 0.01048, "true il-12 induce developmental stage": 0.01016, "intracellular dioxin receptor mediate signal transduction": 0.00857, "affect ifn-alpha-induced growth arrest": 0.00409, "j.l.": 0.0, "-571 bp": 0.00267, "lymphocyte growth transformation": 0.00988, "long disease duration": 0.00449, "t-cell nucleus": 0.00962, "topoisomerase associate": 0.01092, "vincristine-selected": 0.00012, "trapping": 0.00012, "ap-2": 0.00236, "hiv-1 gene regulation": 0.02903, "deoxyguanosine residue": 0.00226, "apoptosis effector": 0.0089, "recent experimental evidence suggest": 0.01011, "hsf2-beta": 0.00056, "ifngamma-inducible gene": 0.04355, "influence cell growth": 0.0512, "airway inflammation": 0.00316, "ptk inhibition": 0.01061, "synthetic glucocorticoid": 0.0085, "ciita expression": 0.04163, "develop spleen occurs": 0.00269, "rare heterozygous dna variation": 0.00741, "expression plasmid": 0.04163, "nf-matp35": 0.00037, "tcr gene rearrangement": 0.02903, "nf-at dna binding complex": 0.00927, "/rel transcription factor": 0.01907, "-y": 0.0, "hgr-ile": 6e-05, "immune system represent": 0.00445, "apoptosis signal pathway": 0.0109, "ig class switching": 0.00428, "maximal translational suppression": 0.00277, "rcc patient": 0.01666, "vivo footprinting experiment": 0.00354, "il-7r complex": 0.01684, "electrophoretic mobility gel shift assay": 0.00401, "b10": 0.00012, "regulatory element upstream": 0.01115, "drug result": 0.0161, "numerous atypical clinical feature": 0.00212, "gene express early": 0.02903, "dm regulate il-2r alpha gene expression": 0.01452, "selective negative regulator": 0.00343, "clinical importance": 0.00425, "cd25": 0.00093, "sum": 6e-05, "ionomycin-induced activation": 0.03164, "glucocorticoid-dependent stimulation": 0.0112, "primary b-cells": 0.00738, "dna bind domain": 0.0135, "transcription analysis": 0.0281, "tshr antibody": 0.00893, "tcdd receptor": 0.02571, "y518": 0.00012, "expression peak": 0.04163, "adherent": 0.00143, "cell line lif increase nf-kb activity": 0.0256, "non-clonal": 0.00019, "tpck inhibits phosphorylation": 0.00656, "plasma sialyltransferase": 0.00375, "major depressive disorder": 0.00383, "plasma 18-hydroxycorticosterone": 0.00375, "demonstrated importance": 0.0013, "monoallelic": 0.00043, "oligonucleotide probe correspond": 0.00174, "internal peptide": 0.00754, "b-lymphoblastoid cell line": 0.0512, "kappa b-like site": 0.01445, "phosphorylated c-jun": 0.00493, "sequence motif": 0.01625, "epstein-barr virus lmp1 domain important": 0.00483, "term b1": 0.00413, "tr75": 0.00031, "show antagonistic activity": 0.0195, "breast carcinoma": 0.00257, "e1b": 0.00087, "cd4-cd8- double-negative stage": 0.00165, "e3 sequence motif": 0.01084, "rela induce jagged1 gene expression": 0.01742, "24,25-": 6e-05, "half-sites": 6e-05, "okadaic acid-induced c-jun transcription": 0.01405, "1-wk": 0.0, "saturable capacity": 0.00329, "induce transactivation": 0.0254, "recombinant human tumor necrosis factor": 0.01505, "immune stimulus": 0.00599, "nfkappab": 0.00378, "light-regulated biological rhythm": 0.00145, "ebv lmp1": 0.00565, "induce nf-kappab activity": 0.0195, "control hiv replication": 0.00868, "human ifn-gamma promoter": 0.02508, "complex tissue-specific structure": 0.01123, "separated": 6e-05, "-2-receptor expression": 0.04163, "fluorouracil": 0.00012, "helix iii": 0.00087, "affect level": 0.01821, "splenic cdna library": 0.00304, "ebv receptor": 0.02571, "peripheral": 0.01048, "inflammatory disease": 0.00673, "transcription signal pathway": 0.01873, "peptide-loaded dendritic cell": 0.0512, "tpa-induced differentiation": 0.01179, "functional kappa": 0.00816, "act sequence": 0.01625, "hematopoietic": 0.00732, "subsequent protein conjugation": 0.03019, "protein family member": 0.03019, "cell tumor": 0.0768, "beta-tubulin": 6e-05, "decrease tnf -and lps-stimulated increase": 0.00878, "nfatc family member": 0.0056, "human platelet-activating factor receptor": 0.01881, "temporal artery": 0.00059, "sequence span": 0.01625, "g1 transition": 0.00109, "vasculature": 0.0, "anti-cd8 mab": 0.00267, "renaturation": 0.00025, "downregulates mip-1 alpha gene expression": 0.01742, "human mononuclear phagocyte": 0.02508, "human tumor necrosis factor alpha gene": 0.01452, "rac-1 mediated pathway": 0.00852, "heptamer site": 0.02168, "isoforms demonstrate": 0.01597, "methylated": 0.00025, "dominant inhibitory ikappab mutant": 0.00405, "human counterpart": 0.03762, "late promoter-reporter fusion": 0.00217, "epstein-barr viral dna": 0.00988, "independent form": 0.01055, "rat thymus": 0.00285, "cd11a/cd18": 6e-05, "cdc10/ankyrin motif": 0.00875, "lps stimulation increase": 0.01464, "diverse cell lineage": 0.0512, "leukemic clone characterize": 0.00492, "pbr": 0.0, "physiologic": 0.00143, "il-3-dependent": 0.00031, "immune complex lead": 0.01123, "lymphoproliferation": 6e-05, "cotransfection analysis": 0.01179, "clinical stigma": 0.00425, "-3h-1,2-dithiol-3-thione": 6e-05, "htlv-i-transformed human lymphocyte line": 0.01881, "c4 zinc finger dna bind domain": 0.00675, "immunoglobulin gene expression": 0.02903, "gene-targeted mouse": 0.00974, "rcc explants": 0.00034, "a6h antigen": 0.00819, "occasion": 0.0, "human ccr-4": 0.03762, "cell express dephosphorylated prb": 0.0384, "uv cross-linking study": 0.00904, "cd2 receptor activation": 0.02109, "alpha-naphthyl acetate esterase": 0.00066, "functional modulation": 0.00816, "dfx treatment": 0.01014, "emsa reveal": 0.01098, "insight": 0.0013, "major signal-mediating kinase": 0.00792, "nf-m play": 0.0071, "immune tissue": 0.00664, "ectopic overexpression": 0.00382, "tat-responsive element corresponds": 0.01115, "immunoreactive product": 0.00533, "dna-binding assay": 0.01002, "10-100 nm dexamethasone": 0.00263, "hiv glycoprotein": 0.00592, "comment": 0.00161, "complex comprise": 0.01684, "complementary role": 0.01328, "mouse il-2r alpha gene": 0.02177, "-like site": 0.02168, "antigen receptor trigger": 0.01714, "chimeric tcr gene": 0.02903, "separate activity": 0.02925, "kappa b-specific complex": 0.01123, "xp-b": 0.00025, "phosphotyrosine": 0.00068, "hiv-1 ltr respond": 0.00585, "monoallelic activation": 0.03164, "dividing immature single positive cell": 0.03072, "il-1ra protein secretion": 0.03019, "redox change induce": 0.01694, "transformed b-cells": 0.00093, "pathological condition include breast cancer": 0.00576, "activate pml-dependent pathway": 0.01185, "rhinitis": 0.00043, "abnormal karyotype": 0.00195, "affect function": 0.01331, "prolong xenograft survival": 0.00157, "trap activate nf-kappa": 0.01185, "guanine nucleotide bind protein": 0.02264, "phosphatidylserine": 0.00031, "arachidonic acid stimulation": 0.00746, "intestinal epithelial cell": 0.0512, "biological oxidation": 0.00217, "icam-1 occur": 0.00654, "protein-dna interaction important": 0.00658, "leukocyte biology": 0.00478, "class ii trans-activator": 0.00484, "wild-type cem cell": 0.0512, "normal epidermis": 0.0121, "transient transfections": 0.00344, "cell-specific bifunctional role": 0.00885, "bal cell": 0.0768, "living cell": 0.0768, "monocyte occurs": 0.01197, "phorbol-di-butyrate-treated cell": 0.0768, "assembly mechanism": 0.01058, "bko": 0.00025, "vitro synthesize gr": 0.00523, "interleukin-1alpha promoter": 0.02336, "dy": 0.00019, "alphabeta lineage": 0.00366, "er-positive mcf-7": 0.00019, "human u-937 leukemia cell differentiate": 0.03072, "cd2/cd4-positive": 6e-05, "zap-70": 0.0031, "augment il-2 promoter activity": 0.01462, "phorbol ester-induced cell": 0.0512, "mpl receptor binding": 0.01714, "induces tyrosine phosphorylation": 0.00656, "longer doubling time": 0.00182, "female steroid receptor play": 0.01286, "p50 heterodimer": 0.00288, "include expression": 0.04163, "human fra-1": 0.03762, "gel retardation analysis": 0.00786, "-177 bp relative": 0.00184, "lineage differentiation": 0.01179, "finding present": 0.00735, "phorbol 12-myristate 13-acetate stimulation augment": 0.00448, "primary human adult erythroid cell": 0.03072, "stress activation pathway": 0.02109, "gram-negative bacterial endotoxin": 0.00149, "hpfh syndrome": 0.00273, "signal-coupled depletion": 0.00121, "cd4 positive": 0.00468, "htlv-i-infected t-cell line": 0.01102, "hiv-1/siv": 6e-05, "mark impact": 0.00074, "nucleosome-free region center": 0.00978, "rna polymerase ii": 0.00484, "il-13 suppresses il-2-induced nk cytolytic": 0.00146, "mimic receptor engagement": 0.01714, "parental cell": 0.0768, "imbalance": 0.00043, "abolish inducible phosphorylation": 0.00656, "tuberous sclerosis gene": 0.02903, "alpha-globin hs-40 enhancer": 0.00606, "resistant patient": 0.01666, "thr102 and-": 0.00016, "biological property": 0.00397, "human cleo": 0.03762, "-dr transfectants": 0.00099, "sustained stat3 activation suggest": 0.01582, "cytokine receptor superfamily": 0.01714, "abbreviated tsp": 0.00034, "pre-existing mcp-1": 0.00124, "clonal anergy induction": 0.01071, "stat protein capable": 0.03019, "cmv transactivator affect elongation": 0.00399, "cell receptor signal": 0.0512, "ap-1": 0.0139, "low-density lipoprotein decrease early production": 0.00417, "specificity": 0.0067, "il-1 beta-stimulated huvec": 0.00221, "decidualized endometrial stromal cell": 0.0384, "heterologous system": 0.00667, "lymphocytic cell": 0.0768, "apoptosis pathway": 0.01278, "rna elongation": 0.00456, "tbg": 0.00012, "gata-2 transcription factor": 0.01907, "shc adaptor protein": 0.03019, "human beta-globin gene locus": 0.02177, "necrosis": 0.00478, "trans-dominant form": 0.01055, "cellular dna-binding protein": 0.03019, "situ hybridization": 0.00155, "microb element": 0.01672, "differentiated lymph node": 0.0006, "ig-expressing hybrid": 0.00171, "1-2 min": 0.00127, "picture": 0.00062, "lipopolysaccharide induces phosphorylation": 0.00656, "negative regulatory region": 0.00978, "essential genetic element support": 0.00836, "nf-kappa b/ap-1": 0.01414, "alter adhesion property": 0.00387, "cis-acting regulatory sequence": 0.01084, "dna bind form": 0.0135, "cell activate": 0.0768, "protein phosphatase": 0.04529, "pathological evaluation reveal": 0.00732, "normal ifn-gamma induction": 0.01071, "nfkb2 precursor": 0.00323, "cd34 promoter": 0.02336, "persistent adenovirus infection": 0.00414, "enhancer element decrease": 0.01115, "constitutive protein": 0.04529, "protein level increase": 0.03019, "primary amino acid sequence": 0.00813, "cell receptor transgenic mouse": 0.0384, "hsv/vzv recombinant": 0.00391, "lak": 0.0005, "low binding affinity": 0.01237, "pge2": 0.00273, "eed": 0.0005, "adjacent regulatory motif": 0.00583, "hexon primer": 0.00081, "core binding motif": 0.01237, "tax protein abrogate interleukin-2 dependence": 0.01811, "block il-10-induced stat3 phosphorylation": 0.00537, "cycloheximide response": 0.01942, "epstein-barr virus latent membrane protein-1": 0.00355, "pulsewise": 6e-05, "increase success": 0.02196, "glucocorticoid receptor antagonist": 0.01714, "tfiie alpha": 0.01169, "granulocyte-macrophage colony-stimulating factor gene": 0.02177, "lck expression": 0.04163, "x2bp": 0.00012, "genotypic variation": 0.00164, "direct substrate": 0.0054, "generate permanent clone": 0.00492, "transactivating rar-rxr response element": 0.00971, "family protein": 0.04529, "progesterone act": 0.00496, "non-hodgkin lymphoma exhibit plasmacytoid differentiation": 0.00471, "metastatic potential": 0.00605, "calyculin": 0.00062, "antiapoptotic role": 0.01328, "mouse genomic dna clone": 0.00741, "5-80 micrograms/ml": 0.00019, "mnp-2": 0.00037, "tr alpha": 0.01169, "peptidyl prolyl cis-trans isomerase activity": 0.0117, "mad3 protein": 0.04529, "dor1 augments il-2 secretion": 0.00558, "messenger mediate": 0.01231, "periphery": 0.00012, "important gene": 0.04355, "-319": 0.00012, "control cell fate decision": 0.0384, "rwleu-4": 0.00031, "atl cell constitutively": 0.0512, "dtcs biological activity": 0.0195, "glucocorticoid-mediated autoregulation": 0.00047, "induced nuclear nf-kappab": 0.01123, "notion": 0.00062, "receptor kinetics": 0.02571, "gf-1": 6e-05, "men show equivalent level": 0.013, "amino acid level": 0.01214, "neoplastic tissue": 0.00664, "initial genotype screening": 0.00126, "rat prolactin": 0.00285, "restriction enzyme": 0.0031, "predominant e2f component": 0.00304, "decreased creb binding": 0.01237, "major stat complex activate": 0.00889, "69-bp proximal promoter fragment": 0.01168, "n-alpha-tosyl-l-lysine chloromethyl ketone": 0.00021, "t-cell transformation": 0.00962, "gene repression": 0.04355, "cellular parameter": 0.00893, "newborn daughter": 0.00025, "major product": 0.00574, "human member": 0.03762, "5-chloronaphthalene-1-sulfonyl": 0.00012, "ap-1/c-jun expression vector result": 0.02081, "oct-1 binding protein remain similar": 0.01811, "immunosuppressant target": 0.00825, "express alpha": 0.01846, "thesis marker decrease": 0.00647, "alteration affect": 0.00797, "disease progression": 0.00673, "cd28+": 0.00025, "differentiation inhibitory factor": 0.01907, "lt-betar": 0.00019, "endogenous gm-csf gene": 0.02903, "pre-t cell": 0.0768, "30-bp sequence": 0.01625, "specific gene regulatory": 0.02903, "ets transcription factor": 0.01907, "transactivates promoter": 0.02336, "differentiated macrophage": 0.00589, "testosterone due": 0.00369, "cell express mhc class ii": 0.03072, "cytokine signal network": 0.0109, "anti-cd40 mab": 0.00267, "tcr-mediated signaling threshold": 0.00372, "represent valuable tool": 0.00267, "single class": 0.00642, "sl3 virus": 0.00887, "strong decrease": 0.00971, "murine p388d1 macrophage cell line": 0.03072, "transcriptional activation require": 0.02109, "freshly isolate tumor-draining ln": 0.00208, "balanced": 0.00031, "recent characterization": 0.0018, "cytosolic signal transducer": 0.0109, "inductive effect": 0.02115, "protein": 0.09057, "strong transcriptional activator": 0.00767, "hela-tat cell": 0.0768, "binding motif": 0.01855, "2-3-fold decrease": 0.00971, "soluble antigen": 0.00819, "endogenous thymocyte-specific gene": 0.02903, "high": 0.01861, "anti-zebra": 0.00019, "antibody cross-linking": 0.00893, "exogenous hgfs": 0.00214, "significant increase": 0.02196, "division": 0.0005, "drug development": 0.00633, "superaddition": 0.0, "ap-1 mutant construct": 0.0054, "cd11c promoter-luciferase construct": 0.00484, "differentiated phenotype": 0.00366, "receptor complex": 0.02571, "androgen insensitive human prostatic carcinoma cell line": 0.02194, "sustained expression": 0.04163, "hpcs": 0.00087, "porphyromonas gingivalis lp": 0.00236, "transcriptional regulatory protein distinct": 0.02264, "enhanced hemin response": 0.01294, "process require": 0.01315, "antioncogenic transcription factor interferon regulatory factor": 0.00937, "program": 0.00341, "low": 0.01414, "agonist induce ca2+ release": 0.0127, "hiv-1 transactivator tat": 0.00585, "pax-5 gene": 0.04355, "tnfalpha treatment": 0.01014, "cd40 lack intrinsic tyrosine kinase activity": 0.00975, "bcl-2 gene": 0.04355, "downstream event": 0.00552, "lethal dosage": 0.00016, "metabolized transcription factor protein": 0.02264, "-275": 6e-05, "human t-cell line jurkat carry": 0.01505, "positive control": 0.01303, "bimodal pattern": 0.00549, "bp hepor promoter exhibit high": 0.00934, "lineage-dependent maintenance": 0.00099, "jun kinase activation": 0.02109, "murine adult hpcs transduce": 0.00312, "epstein-barr virus zebra protein separate": 0.01811, "mz": 0.00025, "block erythropoiesis": 0.01073, "plastic": 0.00056, "il-6 secretion": 0.00428, "cis-elements bound specific protein factor": 0.01811, "healthy female age": 0.00151, "nf-at expression vector show": 0.02081, "staphylococcal exotoxin toxic shock syndrome toxin-i": 0.00091, "2.5-kilobase sequence upstream": 0.01084, "respect": 0.00205, "sickle cell": 0.0768, "heterologous gene": 0.04355, "include alpha-": 0.01439, "finding reveal": 0.01098, "cd40 ligand express": 0.0123, "egr-1 antisense oligomers": 0.00172, "present show": 0.02599, "hiv-tf1-binding site induce": 0.01694, "fetal hemoglobin": 0.00214, "sit recruit": 0.00143, "putative protein kinase": 0.03019, "tandem ap-1-binding site": 0.01445, "irf-1 gene promoter": 0.02903, "anti-tnf-alpha": 0.0005, "subunit act": 0.00496, "gcr treatment": 0.01014, "tshr molecule": 0.00853, "animal": 0.00236, "eth1": 0.00031, "igg-positive cell": 0.0768, "pgi2": 6e-05, "analyze de novo radiation-induced translocation": 0.00206, "major initiation site": 0.01445, "ifn-alpha lead": 0.00996, "cell growth factor change": 0.0384, "high-dose pulse glucocorticoid therapy": 0.00425, "nonlinear relationship": 0.00158, "hla-dm gene transcription": 0.02903, "65-75": 6e-05, "suitable": 0.0005, "footprinting demonstrate": 0.01597, "transcription factor gene expression": 0.02177, "human cd3-cd16+ natural killer cell express": 0.0256, "thyroid hormone receptor": 0.01714, "anlage": 6e-05, "ar gene": 0.04355, "long": 0.00552, "methionine": 0.00037, "bhlh antagonist": 0.00242, "viable cell": 0.0768, "recent demonstration": 0.0014, "ebv-negative primary effusion lymphoma cell line": 0.0256, "-38 result": 0.0161, "c-myb mrna": 0.01526, "detailed characterization": 0.0018, "tumor suppression": 0.00934, "cellular transcription factor": 0.01907, "low affinity site": 0.01445, "cis-trans prolyl isomerase": 0.00027, "nf-kappab-dependent promoter activity": 0.0195, "vitro system": 0.00785, "cell deficient": 0.0768, "reed-sternberg cell": 0.0768, "cell line bear dqa1*0201/dqb1*0201": 0.0384, "pkc isotypes": 0.00332, "unrelated antioxidant agent pyrrolidine dithiocarbamate": 0.00169, "cd14 lp receptor": 0.01714, "trans-factor": 6e-05, "ad3": 0.0, "recombination-activating gene": 0.04355, "major transcription start site": 0.01405, "enhanced steroid sensitivity": 0.00194, "enhance il-1-induced nf-kappa b-dependent gene transcription": 0.01452, "nf-kappa b-dna complex": 0.01123, "t-cell proliferation": 0.00962, "population show detectable deviation": 0.013, "synergy": 0.00186, "b104 cell growth induce": 0.0384, "protein family": 0.04529, "ifn-beta promoter occur": 0.01557, "nf-at family": 0.00841, "pindolol": 6e-05, "adhesion protein mac-1": 0.03019, "-3 dna binding": 0.01237, "overlap activity": 0.02925, "transcriptional defect": 0.01151, "caax": 0.00012, "btk gene": 0.04355, "cd70 transfectants": 0.00099, "nfkb2": 0.00112, "human icam-1 promoter": 0.02508, "recombinant mzf-1 protein": 0.03019, "goat anti-mouse igg ab": 0.00084, "permissive state": 0.00267, "propose pathway": 0.01278, "helper type": 0.00949, "5-bromo-2'-deoxyuridine incorporation": 0.00068, "human leukocyte membrane": 0.02508, "express cdc2 mrna": 0.0123, "steroid-resistant asthmatic patient": 0.0111, "priming period": 0.00127, "transforms haematopoietic cell": 0.0512, "calyculin a-induced": 0.00034, "agent test induced expression": 0.02081, "continuous presence": 0.00524, "stat family": 0.00841, "dyn/cm2": 0.0, "restricts differentiation": 0.01179, "amyloid-beta": 6e-05, "histone h4 gene transcription": 0.02177, "hl-60-": 6e-05, "emphasis": 6e-05, "sixfold increase": 0.02196, "chimeric": 0.00329, "er level play": 0.01214, "interleukin-10 increase": 0.02196, "elderly donor": 0.0014, "adult mouse tissue include lymphatic organ": 0.0048, "nfat protein migrate": 0.03019, "rodent thermosensitive mutant cell": 0.0384, "ltr sequence change": 0.01084, "steroid hormone activation": 0.02109, "12-24": 6e-05, "culture transfected": 0.0062, "e2a-pbx1 result": 0.0161, "similar condition": 0.00673, "immunoradiometric assay": 0.01002, "murine member": 0.00623, "cdc2 mrna expression": 0.02775, "transcription rate": 0.0281, "mediate gata-1-induced erythroid cell survival": 0.03072, "anti-calla-fitc": 6e-05, "cu2+ result": 0.0161, "low capacity": 0.00707, "oct protein": 0.04529, "cbf beta-148": 0.00146, "polymerase chain reaction methodology": 0.00219, "anti-inflammatory effect": 0.02115, "epidermal neoplasm": 0.0004, "entire interleukin-2 enhancer show bimodal expression pattern": 0.01189, "nfkappab/inhibitor-kappab": 0.00012, "experiment demonstrate": 0.01597, "inhibitory function": 0.01331, "p95vav synergizes": 0.00043, "5'-positive regulatory unit": 0.00455, "rel/nfkappab": 0.00012, "inducible complex": 0.01684, "cell adhesion include paxillin": 0.0384, "direct vascular antiatherogenic mechanism": 0.00529, "tnfrp75": 0.00025, "stat3 constitutively phosphorylated": 0.00271, "immunodeficiency": 0.00434, "altered erythrocyte phenotype": 0.00244, "single complex": 0.01684, "increase mmp9 mrna level": 0.01098, "granulocytic hpcs": 0.00143, "variant translocation": 0.00515, "inflammatory cytokine gene include tnf": 0.01742, "tumor necrosis factor-alpha-induced nf-kappa b1 transcription": 0.00937, "t.-w.chun": 0.00012, "ligand-occupied conformers": 6e-05, "adult lineage": 0.00422, "cell line bear htlv-i": 0.0384, "17-amino acid epitope": 0.00571, "inducible dna-protein interaction": 0.00658, "resultant dna demethylation": 0.00988, "ets1 specific": 0.01238, "gc treatment": 0.01014, "linearity": 6e-05, "subunit p65 mrna accumulation": 0.00763, "synovial fluid": 0.00084, "upstream nf-kappab site": 0.01445, "cd4+/cd45ro": 0.00012, "hsv-1 strain": 0.00186, "bipartite motif consist": 0.00583, "cd40-dependent": 0.00025, "cyclins": 0.00037, "otf2 interaction": 0.00986, "active globin gene promoter": 0.02177, "gp91-phox": 0.00012, "b-cell apoptosis": 0.0089, "cmpd1 translocation case": 0.00343, "remote il-2 enhancer": 0.00744, "constitutive mrna level": 0.01214, "important cytokine": 0.01123, "-1alpha": 0.00025, "rna-positive": 0.0, "progesterone receptor status": 0.01714, "cell-mediated immune response versus": 0.00971, "adult hematopoietic population show": 0.013, "upstream region uas3": 0.00978, "blast-crisis cdna library": 0.00304, "abnormal expression": 0.04163, "western blot experiment": 0.00265, "cell mass": 0.0768, "ca2+/calcineurin pathway": 0.01278, "irf-1": 0.00261, "include virus-induced tumorigenesis": 0.00959, "nuclear level": 0.01821, "fluorescence-activated cell sorter": 0.0512, "coexpression": 0.00143, "long bind p300/cbp": 0.0135, "supraoptimal concentration": 0.0067, "inherited disorder ataxia telangiectasia": 0.00112, "p53-mediated apoptosis": 0.0089, "cd36 gene": 0.04355, "rodent central nervous system": 0.00333, "injury-induced apoptosis": 0.0089, "due": 0.00738, "normal activate": 0.01777, "translated protein": 0.04529, "osteoclastogenic cytokine tnf-alpha": 0.00749, "specific transcriptional regulatory protein": 0.02264, "ar mrna": 0.01526, "anxiety": 6e-05, "transcriptional co-activators cbp/p300 bind": 0.01013, "nf-kb plasmid": 0.00273, "sp1 site mediates monocytic specific promoter activity": 0.00836, "malignant": 0.00316, "specific protein": 0.04529, "active metabolite": 0.00592, "axis function": 0.01331, "critical event": 0.00552, "1-bp difference": 0.00425, "jak3-dependent": 0.00012, "viral bind": 0.02025, "nontolerant cell": 0.0768, "growth factor-beta expression": 0.02775, "-365/-264": 6e-05, "lactosylceramide": 0.00019, "electron-dense structure": 0.00319, "detect residual pml/rar alpha mrna-containing cell": 0.0256, "-positive patient lack la": 0.00833, "stat complex": 0.01684, "peptide-pulsed lymphoblastic cell line": 0.0384, "discrete polymorphism": 0.00177, "reverse transcriptase assay": 0.00668, "cd4 promoter activation": 0.02109, "androgen receptor gene show unbalanced inactivation": 0.01452, "il-2 promoter construct downregulated": 0.01168, "separation": 0.00105, "5-isoquinolinyl sulfonyl": 6e-05, "attention": 0.00031, "mixed cytosol show": 0.01733, "signal capacity": 0.01635, "hco3-": 6e-05, "molecular biology": 0.0045, "major challenge": 0.00574, "human peripheral leukocyte": 0.02508, "human myeloperoxidase promoter suggest": 0.01881, "ca2+ ionophores mimic": 0.00203, "skin": 0.00155, "tad-a activity": 0.02925, "total cell lipid": 0.0512, "adult control": 0.01303, "vitamin d-dependent rickets type ii": 0.0038, "atypical pkc-zeta": 0.00074, "trigger cellular nf-kappa": 0.00943, "control gene expression": 0.02903, "abnormal cytokine": 0.01123, "study transcriptional regulation": 0.00904, "pronounced change": 0.0063, "express class ii molecule": 0.00923, "factor activate": 0.0286, "ara-c activate smase": 0.01185, "oncoprotein": 0.0023, "c-rel correlate": 0.00654, "cell tumor display gc": 0.0384, "h.c. lane": 6e-05, "filopodia formation": 0.00484, "trans-dominant negative expression vector": 0.02081, "holo-tfiia": 0.00012, "phosphoamino acid analysis reveal": 0.00589, "t/nk-cell phenotype": 0.00366, "chloramphenicol acetyltransferase assay": 0.00668, "nef expression vector": 0.02775, "cycloheximide lead": 0.00996, "death receptor": 0.02571, "individual homodimeric rel-related protein": 0.02264, "gh stimulate": 0.01101, "dna repair enzyme uracil-dna glycosylase": 0.00593, "low normal range": 0.00806, "astrocytoma cell line": 0.0512, "squamous cell carcinoma show": 0.0384, "nf-kappab p50/p65 heterodimer": 0.00666, "signal contribute": 0.01635, "tsc2": 0.00074, "adrenocorticotropic hormone test": 0.00325, "cd7": 0.00031, "-transport": 6e-05, "dimethylpimelimidate": 6e-05, "proximal sequence element": 0.01115, "nf-munr": 0.00043, "infectious virus": 0.00887, "rapid effect": 0.02115, "il-1 receptor type": 0.01714, "jeg-3 human choriocarcinoma cell line supernatant": 0.0256, "whole-cell competitive binding assay": 0.00927, "human b7.1 gene": 0.02903, "clear correlation": 0.00248, "ligand-receptor interaction": 0.00986, "chromosome band 7q21-q22": 0.00196, "unexpected functional redundancy": 0.00544, "advantage": 0.00043, "normal breast duct": 0.00806, "erythroblastic": 0.00025, "comparable functional effect": 0.0141, "cell-type specificity": 0.00335, "squirrel monkey cell": 0.0512, "uremia": 6e-05, "wild type p53": 0.00633, "human histiocytic u937 cell mrna": 0.03072, "haematopoiesis": 0.00012, "oppose cd28-mediated costimulation": 0.00114, "e. coli rpos gene": 0.02177, "purified jurkat protein": 0.03019, "stat5 homologues": 0.00254, "safe peptide-based vaccine": 0.00035, "surgery": 0.00099, "leukaemia-associated e2a-hlf chimaeric transcription factor": 0.01144, "cancer patient": 0.01666, "recombinant n-terminal fragment": 0.00261, "affinity-purified": 0.00012, "xlh patient": 0.01666, "regulatory sequence": 0.01625, "constitutively display": 0.00499, "otf-1-enriched protein fraction": 0.03019, "autocrine role": 0.01328, "ra effect": 0.02115, "chimeric ebna2 gene": 0.02903, "gene sequence": 0.04355, "cell ag receptor complex": 0.0384, "superantigen injection": 0.00043, "isotype": 0.00093, "cd28 response complex transcription factor": 0.01144, "concomitant downregulation": 0.00112, "ile50-bearing pbmc": 0.00236, "lytic transcript": 0.00599, "important transcription factor require": 0.0143, "nfkappab binding activity": 0.0195, "nucleosome-assembled dna": 0.01483, "protein-binding region": 0.01467, "transcription factor stat-3": 0.01907, "mouse transgenic": 0.00974, "sp1-regulated promoter": 0.02336, "precise sequence": 0.01625, "primary human cell": 0.0512, "jurkat t-cells": 0.00555, "upstream sequence couple": 0.01084, "detect cytokine signal abnormality": 0.00817, "dna mobility shift": 0.00988, "stimulate granulocyte-macrophage colony-stimulating factor": 0.0143, "abolish factor binding": 0.01907, "group suggest": 0.02022, "conclusion": 0.00192, "tax gene": 0.04355, "distal octamer": 0.00195, "factor-mediated suppression early": 0.00552, "cyclosporin a. dna-binding phosphoprotein induce": 0.01016, "keratin": 6e-05, "clinical practice": 0.00425, "estrogen receptor gene": 0.02903, "guardian": 6e-05, "lipid anabolism": 0.00124, "allosteric effect": 0.02115, "j.virol.64:313-321": 6e-05, "cos-1": 0.00031, "c-fes": 0.00105, "partial proteolysis profile": 0.00101, "sodium fluoride-resistant- alpha-naphthyl-acetate-esterase": 0.00124, "ap-1 reporter": 0.00695, "similar dna binding domain": 0.00927, "5'-ttgtcccgtggacaaatgtcc-3": 6e-05, "c-fos increase": 0.02196, "intracellular peroxide level": 0.01214, "membrane phospholipid": 0.0045, "luciw": 0.00012, "eia": 0.00019, "consensus dna sequence": 0.01084, "natural compound": 0.00233, "unrearranged 2.3-kb tcr delta transcript": 0.00239, "early apoptotic event": 0.00552, "intracellular free calcium concentration": 0.00335, "inflammatory vasculopathy": 0.00471, "med.324:308-317": 0.0, "rel family protein": 0.03019, "thymic selection": 0.00121, "nuclear protein nf-kappa": 0.03019, "phase prl response": 0.01294, "sequence identity": 0.01625, "western blot analysis reveal": 0.00589, "cck-8": 0.00031, "enhanced bind activity": 0.0195, "disparate stimulus-": 0.00031, "nuclear transcription factor kb": 0.0143, "p105 mrna level": 0.01214, "induced mrna": 0.01526, "nervous system-derived": 0.00037, "physiological relevance": 0.00183, "kappab-sp1 element document": 0.01115, "genomic sex": 0.0027, "chronic lymphatic leukemia": 0.00333, "cd40-mediated fra-1 induction": 0.01071, "detect ebv": 0.00726, "stat1-dependent": 0.0005, "707-base pair silencer": 0.00143, "cell-specific transcriptional coactivators": 0.00767, "recent analysis": 0.01179, "human blood mononuclear cell": 0.0384, "ap2 mrna": 0.01526, "inhibitory molecule": 0.00853, "carboxyl-terminal portion": 0.00074, "dna-binding capacity": 0.00561, "ebna3c": 0.00093, "non-pregnant individual": 0.00409, "bacterial pathogen": 0.00223, "integral membrane protein": 0.03019, "fgf-1 signaling": 0.00558, "cross-linked anti-cd3epsilon mab okt3": 0.00133, "ces-2 cell-death specification protein": 0.02264, "measure": 0.00775, "week show": 0.02599, "reactive nitrogen intermediate": 0.00141, "tnf-induced": 0.00062, "t-lineage cell": 0.0768, "gata protein": 0.04529, "jun/fos family": 0.00841, "fibre-exposed monocyte increase inflammatory cytokine-mrna level": 0.00732, "neural development": 0.00633, "intensity": 0.00037, "affect dra gene transcription": 0.02177, "cytokine system": 0.01123, "normal human monocyte activate": 0.01881, "drosophila homeodomain": 0.00121, "fcr-mediated mapk activation": 0.02109, "thp-1 cell c-jun mrna expression increase": 0.0256, "mammalian homeodomain protein": 0.03019, "-109": 6e-05, "pax1": 0.0, "gene target experiment": 0.02903, "ebna2 mediate transactivation": 0.00821, "increase ige level": 0.01464, "il-4 induce": 0.0254, "result point": 0.0161, "entire ligand binding domain": 0.00927, "human spleen": 0.03762, "human b-cell lymphoma": 0.02508, "kappa b-dependent pathway": 0.00852, "5'-flanking region": 0.01467, "lck promoter ets site": 0.01168, "early protein test": 0.03019, "sigm": 0.00043, "il-1 beta release": 0.00449, "arg143gln": 6e-05, "intron": 0.00118, "jun nh": 0.00167, "plasmid express nf kappa": 0.00923, "high titer igg autoantibody": 0.00465, "hcd57 cell correlate": 0.0512, "recombinant sp1": 0.00391, "pmlrar alpha impairs neutrophil differentiation": 0.00471, "common precursor": 0.0035, "human multiple myeloma cell line": 0.03072, "minimal repression domain": 0.00804, "4-6": 0.00019, "bone marrow progenitor cell compartment": 0.03072, "oestrogen receptor": 0.02571, "nonlymphoid cell trans-activated reporter plasmid": 0.03072, "negative-acting element": 0.01672, "secondary hyperparathyroidism": 0.00189, "nlphd": 0.0005, "viral rna partition": 0.00488, "detail": 0.00037, "sm": 0.00068, "adult mouse activates cd4+": 0.00487, "c/ebp protein play": 0.03019, "panoply": 6e-05, "human antigen-specific": 0.03762, "peripheral blood t-cells exhibit significant proliferation": 0.00268, "pit": 0.0, "estradiol inhibits polymorphonuclear leukocyte chemotaxis": 0.00212, "receptor expression induces apoptosis": 0.02081, "proteasome inhibitor mg-132 block tnf -and lps-stimulated u-937 cell adhesion": 0.01536, "ra synovitis": 0.00596, "gata-associated site": 0.02168, "essential regulatory element": 0.01115, "72-kda isoform": 0.00171, "activated lymphocyte": 0.01483, "ig secretion": 0.00428, "tumor suppressor gene": 0.02903, "lfa-3 result": 0.0161, "il-13-treated human peripheral monocyte nuclear extract": 0.01254, "kinase activity": 0.02925, "selective manner": 0.00282, "hybrid receptor": 0.02571, "t-cell antigen receptor-cd3 complex signal pathway": 0.00561, "stat3 complex": 0.01684, "brlf1 trigger expression": 0.02775, "acute ethanol treatment": 0.00676, "species-specific regulation": 0.01008, "hb24 expression": 0.04163, "endogenous corticosteroid": 0.00459, "sequence ii": 0.01625, "gamma-chain expression": 0.04163, "rb": 0.00335, "determination fail": 0.00347, "calcium dependent activation": 0.02109, "translocation adjacent": 0.00515, "class ii gene expression": 0.02177, "restricted expression pattern": 0.02775, "drip coactivator complex binding": 0.00927, "renal insufficiency": 0.00115, "er-alpha": 0.00019, "t. annulata-infected leucocyte": 0.00045, "key leukemogenetic role": 0.00885, "influence gene expression": 0.02903, "-70 gata site": 0.01445, "14.7-18.7": 0.00012, "cell surface marker expression": 0.0384, "anti-viral capsid antigen": 0.00546, "cell 110-kda nuclear protein": 0.0384, "gender": 0.00025, "functional domain": 0.01207, "inherent problem": 0.00037, "immediate-early protein": 0.04529, "lmp1 -induced effect": 0.0141, "delay kinetics": 0.00167, "mbc represent": 0.004, "fe2+/cu2+ ion": 0.00062, "b95-8 cell": 0.0768, "activation require interaction": 0.02109, "participant": 0.00025, "divalent gold ion": 0.00041, "partial functional disomy": 0.00544, "cd95 ligand promoter": 0.01557, "bcl-2 expression vector show": 0.02081, "udg": 0.00087, "myocytes": 6e-05, "tcr gene": 0.04355, "result displacement": 0.0161, "oestrogen concentration": 0.0067, "ligation induces protein tyrosine phosphorylation": 0.01811, "architecture": 0.00031, "laser": 0.00019, "transcriptional factor c-fos/c-jun ap-1": 0.0143, "nasopharyngeal carcinoma": 0.0018, "atra-induced granulocytic differentiation": 0.00786, "alpha-ifn occurs": 0.0009, "small cell": 0.0768, "interleukin-2 receptor alpha chain expression": 0.01665, "oncogene induces neoplasia": 0.00536, "enhance cell survival": 0.0512, "single mhc/peptide complex": 0.01123, "purine-rich motif": 0.00875, "human bactericidal/permeability-increasing protein": 0.03019, "functional rb rescue ifn-gamma-induced class ii gene expression": 0.01089, "major gene": 0.04355, "enhanced cytokine effect": 0.0141, "final ethanol concentration": 0.00447, "3,2-b": 0.00012, "implicate bsap": 0.0035, "linear configuration": 0.00037, "express lmp-1": 0.01846, "l-n-monomethyl-arginine": 0.00012, "htlv-1-transformed t-cell line express high amount": 0.00615, "explants": 0.00037, "tumor-derived gangliosides": 0.00062, "combinatorial activation": 0.03164, "labial salivary gland": 0.00058, "induce pathology": 0.0254, "nontransformed": 0.00043, "human thp-1 promonocytic cell": 0.0384, "intact 2.3-kb lcr": 0.00159, "alg-4": 0.00019, "n9 microglial cell line": 0.0384, "vla-5 fibronectin receptor": 0.01714, "txa2": 6e-05, "b-cell type": 0.00949, "basic fibroblast growth factor": 0.0143, "nfat3 protein": 0.04529, "unique biological function": 0.00887, "dmso": 0.00068, "peripheral blood polymorphonuclear cell": 0.0384, "reduces nuclear factor": 0.01907, "increase pulmonary leukostasis": 0.01464, "culture result": 0.0161, "biochemical signal lead": 0.0109, "human nk cell provide": 0.0384, "potent site": 0.02168, "resistant asthmatic patient": 0.0111, "ap-1 reporter plasmid": 0.00463, "terminal": 0.00664, "myelomonocytic cell specific gene": 0.0384, "long period": 0.00276, "b4-2": 0.00043, "cag repeat length variation": 0.00189, "osteoblast nuclear extract-dna complex": 0.00842, "pro-myelocytic leukaemia": 0.00087, "lymphocyte cytosolic protein": 0.03019, "import": 0.00068, "distinct dna binding complex": 0.00927, "inhibited growth": 0.00819, "putative nf-kappab-binding site": 0.01445, "integrated hiv provirus": 0.00395, "-244": 6e-05, "phorbol ester response element": 0.00971, "tyrosine phosphatase specific inhibitor pervanadate": 0.00495, "latent ebv genome": 0.00376, "dra promoter bearing cluster point mutation": 0.00779, "25-kda lipocalin": 0.00025, "sre-": 6e-05, "fos kinase activity": 0.0195, "regulate stat serine phosphorylation": 0.00627, "dex-resistant clone": 0.00738, "growth control": 0.01303, "microdissected ovarian tumor cell": 0.0384, "leukotriene b4": 0.00034, "cd40 molecule": 0.00853, "glucocorticoid dexamethasone inhibit tpa-induced increase": 0.00878, "bind response element present": 0.01013, "inhibit pma-stimulated activation": 0.02109, "il-6-mediated mm cell growth": 0.0384, "alpha synthesis secondary": 0.0078, "express endogeneous tal1": 0.0123, "review": 0.00155, "sp1-like binding protein": 0.03019, "cp/wp promoter": 0.02336, "hla dq2 heterodimers vary": 0.00113, "class ii+": 0.00642, "il-12 signaling": 0.00558, "weak activity": 0.02925, "antigen-specific": 0.00136, "effect remain unclear": 0.0141, "great stimulation": 0.0112, "vivo": 0.01061, "lps-mediated viral production": 0.00695, "viral binding induce": 0.01694, "inhibit ikk kinase activity": 0.01462, "ceanorhabditis elegans": 0.00025, "inducible transcriptional activity": 0.0195, "full differentiation response": 0.01294, "ionophore": 0.00155, "regulate nf-at activity": 0.0195, "follicle": 0.00062, "increase pld activity": 0.0195, "biphasic time-dependent expression": 0.02775, "marcks": 6e-05, "pronounced reduction": 0.00295, "2-week captopril treatment": 0.00676, "multiple binding site": 0.01445, "lymphocyte treatment": 0.01483, "cysteine-rich secreted protein": 0.03019, "crucial role": 0.01328, "physiological involution": 0.00183, "rar agonist": 0.0022, "non-dna-binding dimer": 0.00102, "stimulate guanine nucleotide exchange": 0.00551, "glucocorticoid therapy": 0.0085, "excess alpha-globin chain": 0.00292, "fuse ht-2 cell express": 0.0384, "underlie difference": 0.00425, "cd95 ligand": 0.00592, "201-bp core promoter region": 0.01168, "show thrombin generation": 0.01733, "transplant recipient": 0.0004, "posttranscriptional effect": 0.02115, "inflammatory gene product": 0.02903, "co-transfection experiment": 0.00397, "nf kappab": 0.00288, "staurosporin": 0.00019, "protein activate transcription": 0.03019, "mn-sod": 0.0005, "positioning": 0.00012, "mrna level": 0.01821, "physiological target cell": 0.0512, "se": 0.00167, "progesterone receptor gene": 0.02903, "ifn-gamma-induced icam-1 message": 0.00178, "benzidine-positive cell": 0.0768, "membrane-bound deltae": 0.0004, "healthy woman": 0.00233, "recurrent malignant astrocytomas": 0.00105, "weak cross-reactivity": 0.00174, "flow cytometric sorting": 0.00101, "growth factor-stimulated cell proliferation": 0.0384, "alpha,25-dihydroxyvitamin d3 co-operate": 0.00163, "lymphoid specific gene expression": 0.02177, "smx hypersensitivity": 0.00037, "membrane sensor kinase": 0.00792, "pxp motif": 0.00875, "ifn-gamma-activated stat molecule": 0.00569, "drop-mediated transfer": 0.0009, "tax-mediated apoptosis": 0.0089, "cos-7 cell": 0.0768, "nfat regulatory domain": 0.00804, "positive reaction": 0.00468, "mhc": 0.0049, "observation prompt": 0.00149, "rxr -and rar-specific agonist": 0.00136, "egr2": 0.00025, "immunoreactive ikappab alpha": 0.0078, "intense physical exercise": 0.00064, "blotting assay": 0.01002, "additional distinguishing characteristic": 0.00227, "bob1 bind": 0.02025, "il-2 promoter-driven transcription": 0.01873, "weakly nf-kappa b1 homodimers": 0.00707, "balb/cbyj": 6e-05, "skeletal muscle express": 0.0123, "nuclear targeting": 0.01684, "affect e2f-mediated regulation": 0.00672, "factor/dna interaction": 0.00986, "cultured human fibroblast": 0.02508, "reporter gene activation": 0.02903, "tsc2 messenger rna expression": 0.02081, "abolish induction": 0.01607, "heterologous promoter construct": 0.01557, "serum phosphate": 0.00378, "nih-3t3 cell": 0.0768, "linker substitution": 0.00112, "50-kda form": 0.01055, "liposome-encapsulated dichloromethylene diphosphonate": 6e-05, "morphological study demonstrate characteristic feature": 0.00639, "multimerized octamer enhancer element": 0.00836, "htlv-i tax couple": 0.00318, "putative g0/g1 switch regulatory gene": 0.01742, "c-rel complex": 0.01684, "hydroxyanisole": 0.00012, "2,3,7,8-tetrachlorodibenzo-p-dioxin": 0.00031, "rule": 0.00019, "adaptor protein": 0.04529, "xenogeneic serum": 0.00378, "recombinant ptf beta": 0.00449, "cell-specific control": 0.01303, "cellular stress agent": 0.00596, "mouse aml1/pebp2 alpha": 0.0078, "human astroglioma cell line crt": 0.03072, "human peripheral blood monocyte bind": 0.01505, "hsv-1 icp4 promoter": 0.01557, "gg compete": 0.00078, "gel": 0.00329, "polymerase": 0.00261, "include c-jun": 0.01439, "metabolism": 0.00149, "nodular lymphocyte predominance hodgkin": 0.00741, "classical metaphase analysis": 0.00786, "b-cell": 0.00918, "fat": 0.0005, "sucrose gradient": 0.0005, "numerous cellular": 0.00893, "broad sense": 0.00047, "-24": 0.00012, "leucine zipper": 0.00059, "atf4/creb2": 0.0, "induce nf-at": 0.0254, "small intestine": 0.00313, "celiac sprue": 0.00012, "isoenzymes": 0.00031, "stat3 serine phosphorylation": 0.00656, "ebv transcription factor": 0.01907, "gas sequence": 0.01625, "similar mode": 0.00673, "zip site": 0.02168, "thymic microenvironment": 0.00118, "porcine mhc class ii expression": 0.01665, "form myeloid cell": 0.0512, "-like gene suggest": 0.02903, "terminal complement complex": 0.01123, "usf2 up-regulate gene expression": 0.02177, "band range": 0.00202, "endocrine status change": 0.0042, "cdc2 mrna transcript": 0.01017, "idiopathic hypereosinophilic syndrome": 0.00182, "p50 correlate": 0.00654, "ap-1 enhancer element": 0.01115, "transcription factor nf-kappab play": 0.0143, "slp-76-deficient": 6e-05, "splenocytes": 0.00019, "dithiocarbamates involves": 0.00081, "autologous thymic epithelial cell": 0.0384, "widespread": 0.00031, "oca-b provide": 0.00645, "campomelic dysplasia": 0.00016, "glucocorticoid fail": 0.0085, "transcription factor bind site": 0.0143, "cd40-mediated cell survival proceeds": 0.0384, "block nuclear factor": 0.01907, "detectable nf-at protein expression": 0.02264, "human csf-1r": 0.03762, "rapid modulation": 0.00323, "crucial pi3k/pkb-mediated link": 0.00232, "activate stimulus": 0.01777, "lps-induced proteolytic degradation": 0.00221, "pb1": 0.00056, "ci element": 0.01672, "wild-type p53": 0.00378, "il-4 suppress cytokine synthesis": 0.00561, "production require": 0.01315, "adenovirus": 0.00378, "nef region": 0.01467, "genuine octamer-binding site abrogate": 0.01084, "arnt": 0.00043, "gsh-to-gssg ratio": 0.00096, "epo-r mrna": 0.01526, "selectively upregulate delayed-early viral gene": 0.01742, "acute hiv-1 infection": 0.00585, "increase promotor strength": 0.01464, "sp1/nf-at binding site": 0.01445, "isolate sequence": 0.01625, "deliver": 0.00155, "control rest cell": 0.0512, "ire element": 0.01672, "oxldl prevent": 0.00524, "implicate e2f": 0.0035, "importance": 0.00261, "-182": 0.00012, "tyrosine phosphorylated jak1": 0.00474, "protein-tyrosine kinase zap-70": 0.00792, "branch site critical": 0.01445, "platelet ca2+ transport": 0.00248, "intracellular signal cascade": 0.0109, "gene encode fa": 0.02903, "octamer-like": 0.00019, "poz/zinc-finger protein": 0.04529, "rbpi21": 0.00037, "induce anomaly": 0.0254, "-induced gene expression": 0.02903, "early-stage breast cancer patient": 0.00833, "lysp100-associated nuclear domain": 0.01123, "deduced amino acid show": 0.013, "potentiate immunological function": 0.00887, "gsh-to-oxidized glutathione": 0.00105, "il-12 stimulates formation": 0.00323, "co-repressors": 0.00012, "g-protein-coupled serpentine receptor": 0.01714, "20-epi analogue point": 0.00122, "inhibit h2o2 induced activation": 0.01582, "clonal pattern": 0.00549, "hiv-enhancer domain": 0.01207, "m-1": 0.0, "il-2 activates nf-kappa": 0.00943, "rapamycin-sensitive component": 0.00456, "dose response": 0.01942, "stat5a/b": 0.0, ",1 beta": 0.00673, "decrease lps-induced il-1ra synthesis": 0.00485, "manner": 0.00565, "vitro transcription": 0.0281, "alternative la mrna": 0.01017, "hemoglobin-encoding gene": 0.04355, "rabbit uterine": 0.00071, "tyr-705": 6e-05, "monocyte/macrophage receptor": 0.02571, "enhance il-4-induced gene transcription": 0.02177, "overt hypo -or hyperthyroidism": 0.00043, "spontaneous ebv-transformed lymphoblastoid cell line": 0.03072, "-regulation": 6e-05, "extracellular dehydration": 0.00167, "igm+ igd+ cl-01 cell": 0.0384, "equivalent": 0.00161, "monokine induction": 0.01607, "sbma x-chromosomes": 0.00019, "nf-kb support": 0.00409, "enzyme associate": 0.01092, "nf-il-6 dna binding activity": 0.01462, "tlr2 lack c-terminal": 0.00422, "protein correlate": 0.04529, "respiratory failure": 0.00136, "mnp protein": 0.04529, "interacting surface": 0.00515, "self-renewing": 0.00031, "normal kinetics": 0.0121, "ebv promoter": 0.02336, "single mrna transcript": 0.01017, "bcl-2": 0.00589, "year": 0.00118, "density": 0.0023, "analyze transcription activity": 0.0195, "substitution represent": 0.004, "germinal center": 0.00112, "nf-kappa b-independent suppression": 0.00943, "regulatory enhancer region": 0.00978, "t3": 0.00236, "separate epitope": 0.00161, "constitutively express cepsilon germline transcript": 0.00738, "e1a protein": 0.04529, "cell counting": 0.0768, "i.e": 0.00074, "oropharynx": 6e-05, "mild hypertension": 0.00059, "precise point": 0.00183, "cd5 surface expression correlate": 0.02081, "nf-il6 protein": 0.04529, "purified nf-gm2 activate": 0.01185, "cell-deficient mouse": 0.00974, "glucocorticoid sensitivity": 0.0085, "stressed ec": 0.00254, "bind cholesterol": 0.02025, "freshly isolated primary nk cell": 0.03072, "alteration": 0.00459, "buthionine sulfoximine": 9e-05, "ifn-gamma-treated cell": 0.0768, "close relationship": 0.00158, "yy-bu": 6e-05, "neomycin": 0.00019, "traf5": 0.00012, "activate heat shock transcription factor": 0.01144, "myeloid cell line u937": 0.0384, "proinflammatory lp receptor": 0.01714, "display undetectable nf-kappa": 0.00943, "viral pathogen": 0.00732, "promoter associate": 0.02336, "cooh-terminal domain feed": 0.00804, "p60 phosphorylation": 0.00983, "host": 0.00428, "mtcp1 rearrangement": 0.00199, "concomitant transendothelial migration": 0.00103, "l227": 0.00012, "glucocorticoid receptor positive cell population": 0.03072, "minimal inhibition": 0.01061, "nf-kb 1,25-dihydroxyvitamin d3 receptor": 0.01286, "cytokine secretion study": 0.00904, "u937 cell cotransfected": 0.0512, "1alpha,25-dihydroxy-lumisterol3": 0.00012, "dh42": 6e-05, "vasoactive peptide ang ii": 0.00377, "murine basic helix-loop-helix transcription factor gene express": 0.01244, "stimulated il-2 secreting cell": 0.0384, "mt-2": 0.00062, "hrar alpha-lbd": 0.00012, "vitro study demonstrate": 0.01065, "extravasation": 0.00012, "il-12-stimulated nk cell": 0.0512, "glucocorticoid inhibit reactive oxygen specie": 0.00762, "cell repertoire": 0.0768, "independent assay": 0.01002, "distinct epitope": 0.00698, "endothelial-raw264.7 cocultures": 0.00016, "il-6 mrna stability": 0.01017, "c/ebp alpha regulate": 0.00835, "inhibits tumor cell apoptosis": 0.0384, "block response": 0.01942, "afternoon": 6e-05, "tumour burden": 0.00183, "documented case": 0.00363, "rakfkqllq-specific ctl precursor frequency": 0.00161, "mutational removal": 0.0004, "vitamin d3-": 0.00236, "proteinsmay occur": 0.00654, "isolated case": 0.00363, "actual binding": 0.01855, "hyper-sensitivity": 6e-05, "paper present": 0.00735, "quiescent endothelial cell": 0.0512, "complement receptor cr1": 0.01714, "express transcription factor": 0.01907, "haemoglobin production": 0.01042, "biol.14:373-381": 0.0, "e1b mutant": 0.0081, "t-cell mitogenesis": 0.00962, "alternate immune system target": 0.00413, "present work show": 0.01733, "a/r-tolerant cell": 0.0768, "ig gene expression cease": 0.02177, "nuclear envelope": 0.01684, "oxidant stress similar": 0.00449, "undernutrition": 6e-05, "differentiate human dc": 0.02508, "aml m5": 0.00087, "interferon regulatory factor-1 gene": 0.02177, "atra therapy": 0.00372, "cell receptor-derived type": 0.0512, "massive enhancement": 0.00233, "potent oligonucleotide sequence": 0.01084, "concentration require": 0.01315, "mature erythroid cell": 0.0512, "stimulate primary murine bone marrow cell": 0.0256, "pha stimulates productive lai replication": 0.00189, "kb downstream": 0.00298, "transfected human colonic carcinoma cell line ht29 activate transcription": 0.01707, "rat tissue": 0.00664, "rel homology domain": 0.00804, "pre-b cell line up-regulated cd19 expression": 0.0256, "full cell cycle": 0.0512, "ciita associate": 0.01092, "neutrophil il-8 release": 0.00331, "cell cytoskeleton": 0.0768, "sp1/ap-2 site decrease promoter activity": 0.0117, "progesterone-dependent immunomodulation": 9e-05, "control level": 0.01821, "erythroid transcription factor p45 nf-e2 mrna": 0.00953, "mds progression": 0.00164, "express gata-2/er": 0.01846, "primary structure analysis show": 0.013, "great diversity": 0.00205, "transmission": 0.00105, "stage i-iii breast cancer": 0.00129, "cn inhibition": 0.01061, "ick-1 family": 0.00841, "so-called pu box": 0.00203, "human alpha-like globin gene": 0.02177, "increased glucocorticoid receptor bind site": 0.01029, "2-4-fold increase": 0.02196, "size variant": 0.00276, "vcam-1 dependent": 0.00388, "threonine residue": 0.00226, "activates nuclear calcium/calmodulin-dependent protein kinase ii": 0.0151, "cell-specific nuclear factor otf-2": 0.0143, "lipopolysaccharide-activated toll-like receptor": 0.01714, "il-2 reporter": 0.01117, "facs analysis": 0.01179, "anti-vca antibody": 0.00893, "allogeneic dc result": 0.01073, "hexamethylene bisacetamide": 6e-05, "healthy laboratory employee": 0.00118, "p107": 0.00068, "functional response": 0.01942, "tissue-specific regulatory region": 0.00978, "opgl": 6e-05, "neuro-immuno interaction": 0.00986, "macrovascular ec": 0.00254, "trend": 0.00037, "mpl concentration": 0.0067, "cd19 expression": 0.04163, "competitive silencing": 0.0009, "methylprednisolone treatment": 0.01014, "flank dna": 0.01483, "antigen-driven clonal expansion": 0.00112, "kappa b-alpha protein": 0.03019, "cyclin a-cdk2-dependent phosphorylation": 0.00656, "cgmp analogue": 0.0005, "n-acetylcysteine inhibition": 0.01061, "dd": 0.00037, "regulate cd95 ligand gene expression": 0.01742, "duplicated dna regulatory motif": 0.00741, "specific autoantibody": 0.01238, "impossible": 6e-05, "t-cell-restricted marker": 0.00382, "ad": 0.00217, "ifn-gamma-activated factor": 0.0286, "dihydropyrimidine dehydrogenase": 0.00053, "promyelocytic leukemia gene": 0.02903, "therapeutic potential": 0.00605, "bind poorly": 0.02025, "kda id-3 protein term id-3l": 0.01811, "full-length protein": 0.04529, "pu-1": 6e-05, "tumor necrosis factor gene": 0.02177, "ap-2 prevent": 0.00524, "gata-1.05": 0.00031, "encoded factor": 0.0286, "redundancy": 0.00062, "polyclonal antiserum direct": 0.0036, "apoptosis suppressor protein bcl-xl": 0.02264, "inducible proximal enhancer": 0.00606, "damage": 0.0018, "nf-e2/ap1 motif": 0.00875, "hematology class ii transactivator-independent endothelial cell mhc class ii gene activation induce": 0.0128, "chronic renal failure": 0.00265, "prolong clinical benefit": 0.00283, "apoptotic cell body": 0.0512, "relative ease": 0.00276, "include nuclear factor kappa": 0.0143, "mcl-1": 6e-05, "supt1": 0.00012, "pub2": 6e-05, "il-4-secreting th2 cell": 0.0512, "trep complex": 0.01684, "increase tumor cell": 0.0512, "n-cor": 0.00012, "increase dna binding": 0.01464, "nuclear protein isolate": 0.03019, "hb24 mrna": 0.01526, "disturb microtubule function": 0.00887, "peak": 0.00285, "express immunoreactive gh": 0.0123, "germinal center region": 0.00978, "antiallergic": 6e-05, "gata-binding family protein": 0.03019, "tcr signal synergize": 0.0109, "viral latency": 0.00732, "teflon": 0.00031, "b7-negative": 6e-05, "productive infection": 0.0062, "pml locus": 0.00288, "atf-1": 0.00062, "vivo involves phosphorylation": 0.00656, "zta": 0.00099, "constitutive nuclear factor": 0.01907, "substantial increase": 0.02196, "attributable": 0.00074, "t-cell-expressed cytokine gene": 0.02903, "sequester limit activate transcription factor": 0.01144, "precursor cell": 0.0768, "lp signal cascade": 0.0109, "episomal dna": 0.01483, "early signaling event": 0.00552, "conserved rel homology domain": 0.00603, "cdna microarrays": 0.00456, "transfected ifn-beta promoter respond": 0.01168, "regulated process": 0.00444, "important gene dorsal": 0.02903, "diminished production": 0.01042, "compensatory response": 0.01942, "endogenous gata-1 gene": 0.02903, "complete respiratory burst": 0.00114, "mip-1alpha": 0.00068, "direct inhibition": 0.01061, "anti-jund": 6e-05, "protein e2a": 0.04529, "p65 mrna accumulation": 0.01017, "computer algorithm capable": 0.00174, "nm23 expression": 0.04163, "colon respond": 0.00251, "progesterone binding": 0.01855, "defective dna binding": 0.01237, "cd19 protein": 0.04529, "heat shock protein show typical native receptor characteristic": 0.01132, "insulin receptor substrate": 0.01714, "induce k562 cell": 0.0512, "13-cis ra": 0.00596, "vary": 0.00192, "viral rna production": 0.00695, "cell express p40": 0.0512, "sledai": 6e-05, "pebp2beta smmhc chimeric fusion protein": 0.01811, "b-cell marker": 0.00459, "electro mobility shift assay": 0.00501, "time": 0.00546, "megakaryocytic-specific promoter": 0.02336, "macrophage colony-stimulating factor receptor": 0.0143, "trypan blue exclusion": 0.00014, "-90/-82": 0.00012, "peripheral lymphoid tissue": 0.00443, "ii molecule": 0.00853, "impaired nf-kappab activation": 0.02109, "h. dna-binding activity": 0.0195, "ccaat-box binding factor": 0.01907, "enhance il-6 release": 0.00649, "potent therapeutic agent": 0.00281, "granulomatous disease": 0.00673, "apl blast": 0.00127, "gentle elution condition": 0.0024, "consensus sequence characteristic": 0.01084, "aml1-": 6e-05, "differential expression": 0.04163, "monocytoid": 0.00099, "distinguish b-cll cell": 0.0512, "yeast saccharomyces cerevisiae": 0.00103, "cd23 cross-linking": 0.00242, "tramp-induced cell death": 0.0512, "phospholipase c/protein kinase": 0.00792, "rapid accumulation": 0.00323, "unidentified target gene": 0.02903, "support proper regulation": 0.00672, "cytokine receptor activation": 0.02109, "glucocorticoid-induced cell death": 0.0512, "provide evidence showing": 0.0043, "semimature": 6e-05, "cytolytic susceptibility": 0.00146, "il-13 phosphorylated insulin response substrate-1": 0.00777, "cox-2 enzyme": 0.0031, "organizer": 6e-05, "display significant homology": 0.00333, "5-day": 0.00056, "il-5 production": 0.01042, "effective dose": 0.00164, "c-myb gene product": 0.02903, "-sensitive factor": 0.0286, "il-1beta-induced il-6 production": 0.00695, "inhibit proliferation drive": 0.0127, "oxidant stress-induced signaling result": 0.00805, "human vacuolar": 0.03762, "cell growth-regulated expression": 0.0512, "evasion": 0.00025, "specific steroid binding site": 0.01084, "recombinant ghf-1 interact": 0.00261, "cd3/cd28": 0.00025, "-kappa b. activation": 0.02109, "subdominant epitope": 0.00161, "tissue-specific expression": 0.04163, "target site": 0.02168, "vogel": 0.00012, "transfection experiment": 0.00397, "toxic side effect": 0.0141, "myricetin": 0.00012, "secrete tnf alpha play": 0.00585, "cell-mediated immune response": 0.01294, "surface plasmon resonance": 0.00343, "b-cell-specific activator protein-binding site": 0.01084, "diverse group": 0.00487, "provide formal proof": 0.0043, "dna ladder formation": 0.00988, "gm-csf stimulation": 0.0112, "inhibit apoptosis": 0.01904, "tenacious": 0.00012, "radical scavenger": 0.00059, "120-125 kda": 0.00109, "viral titre": 0.00732, "transgenic mouse result": 0.01073, "asthmatic subject": 0.00354, "gata-1 activity occur": 0.0195, "bone marrow depression": 0.00143, "enhancer-dependent effect": 0.02115, "elisa assay system": 0.00668, "integrin-mediated adhesion control leukocyte arrest": 0.00521, "putative tumour suppressor gene fhit": 0.01742, "endotoxin": 0.00205, "pulse-chase experiment": 0.00397, "type 2-": 0.00949, "leukemic cell line k562": 0.0384, "human macrophage inflammatory protein-1alpha": 0.01881, "major aspect": 0.00574, "express p50 nf-kappa b. stimulation": 0.00738, "mbp-hbd": 6e-05, "rap1 protein expression": 0.03019, "zebra-responsive promoter": 0.02336, "55-": 0.00012, "cell enter retrodifferentiation": 0.0512, "gm-csf-responsive cell line": 0.0512, "control immune response": 0.01294, "intracellular calcium level": 0.01214, "raji pattern": 0.00549, "tnf production": 0.01042, "chronic rheumatoid arthritis pathogenesis": 0.00199, "human mcm6 promoter": 0.02508, "-beta protein": 0.04529, "tumor exhibit": 0.00934, "lack myd88": 0.00633, "antisense tat": 0.00257, "runt polypeptide": 0.00136, "human erythroid ala gene reveal": 0.01742, "sequential": 0.00068, "il-5 transcription": 0.0281, "induce glycation": 0.0254, "nongenomic mechanism": 0.01058, "egta": 0.00031, "adrenal gland": 0.00087, "constitutively active": 0.00592, "multiple cytokine receptor": 0.01714, "macrophage promote induction": 0.01071, "neoplastic t-lineage lymphocyte": 0.00988, "perceived support factor": 0.01907, "p39c-jun expression": 0.04163, "human t-cell leukemia virus type-i": 0.01505, "k562 cell constitutively express c-myb mrna": 0.0256, "complex formation": 0.01684, "cpp32/yama/apopain": 6e-05, "tnf-alpha transcription": 0.0281, "short t1/2": 0.0013, "dqa1*0501/dqb1*0302 trans class ii heterodimer": 0.0029, "cytokine gene induction": 0.02903, "ap-1 element": 0.01672, "mutant glucocorticoid receptor": 0.01714, "direct modification": 0.0054, "dna-protein kinase": 0.01188, "circulation": 0.00019, "functional difference": 0.00816, "dna-transfected u-937 cell": 0.0512, "dna bind state": 0.0135, "tpo receptor": 0.02571, "inhibitory subunit ikappabalpha": 0.00323, "fosb mrna increase": 0.01464, "separate cis-acting regulatory element": 0.00836, "euthyroidism": 6e-05, "anti-oxidative effect": 0.02115, "bzip": 0.00068, "embryoid body": 0.00136, "activate lymphokine gene expression": 0.02177, "mimic": 0.00347, "initial change": 0.0063, "minor groove": 0.00053, "sub-optimal neutrophil differentiation": 0.00786, "include sp1": 0.01439, "il-1r gene expression": 0.02903, "classic glucocorticoid prednisolone": 0.00567, "nuclear extract": 0.01684, "human tumor cell line": 0.0384, "stringent control": 0.01303, "bind motif": 0.02025, "cd3/t-cell antigen receptor": 0.01714, "cd28-dependent induction": 0.01607, "cell reporter construct": 0.0512, "h7-inhibitable pathway": 0.01278, "increase oxidative stress": 0.01464, "prognostic factor": 0.0286, "mab fail": 0.00347, "monocyte/macrophage system": 0.00667, "inducible transcription": 0.0281, "apoptosis resembles": 0.0089, "oxidant-regulation": 6e-05, "additional function": 0.01331, "bsmi": 0.00012, "level": 0.03641, "patient show similar number": 0.013, "average gr concentration": 0.00447, "gabp expression": 0.04163, "tarsal": 0.00012, "tight correlation": 0.00248, "biological role": 0.01328, "term fos kinase": 0.00792, "s-phase fraction": 0.00171, "cellular organelle": 0.00893, "differentiation-associated pattern": 0.00549, "mouse ets-1 cdna clone": 0.00487, "mekk1": 6e-05, "dqb-w region": 0.01467, "granule": 0.00223, "isomerase activity": 0.02925, "human peripheral-blood monocyte": 0.02508, "instance": 0.00019, "similar dna binding activity": 0.01462, "hinge region": 0.01467, "cognate nuclear factor": 0.01907, "nk cell line": 0.0512, "granulocyte- macrophage colony-stimulating factor": 0.0143, "creb-": 6e-05, "enhance mrna expression": 0.02775, "adult mammal": 0.00422, "human atherosclerotic disease": 0.02508, "interferon-gamma activation sequence": 0.02109, "pathway require roi production": 0.00658, "surface marker": 0.00515, "dna bind region": 0.0135, "active death effector": 0.00395, "ab": 0.00335, "20-methyl-": 6e-05, "stats": 0.00099, "depression": 0.00081, "viral control element": 0.01115, "human blood-derived mo": 0.02508, "pivotal role": 0.01328, "detectable dpd activity": 0.0195, "normal resting": 0.0121, "simple activation": 0.03164, "cd33": 0.00043, "transcription factor yb-1": 0.01907, "homeostasis": 0.00118, "interferon-alpha /beta-induced tyrosine phosphorylation increase": 0.00878, "pnu156804 action": 0.00499, "wgatar": 0.00019, "induce nf-chi": 0.0254, "nf-at occurs": 0.00397, "tumour cell carry ebv genome": 0.03072, "soluble factor independent": 0.01907, "asparagine bond rearrangement": 0.00132, "unstimulated human peripheral": 0.02508, "bandshift assay": 0.01002, "upregulate icam-1 expression": 0.02775, "pybf-binding site": 0.02168, "pdx-1/ipf1/stf-1": 6e-05, "psa secretion": 0.00428, "human lipopolysaccharide-stimulated peripheral blood mononuclear": 0.01505, "47-kd mature glycoprotein": 0.00219, "gliotoxin": 0.00019, "cd28 lead": 0.00996, "gata-1": 0.00825, "target tissue": 0.00825, "nf-kappab/nfat protein play": 0.03019, "pgg-glucan": 0.00056, "neutrophilic differentiation": 0.01179, "t-cell receptor alpha": 0.01714, "cyclophilin gene": 0.04355, "hydrophobic moiety": 0.0005, "cell-mediated immunity": 0.00112, "properly activate": 0.01777, "mononucleated cell": 0.0768, "e1a-binding protein": 0.04529, "-178": 6e-05, "human rar alpha": 0.02508, "probe blot": 0.00261, "cd40-ligand+": 0.00012, "cell line lack jak3": 0.0384, "reporter chloramphenicol acetyltransferase plasmid link": 0.00221, "simple model": 0.00422, "e1a gene demonstrate": 0.02903, "il-6 regulation occur": 0.00672, "protect vascular injury": 0.00116, "require tpa/ca": 0.01315, "lymphoid progenitor cell": 0.0512, "htlv-i-bearing cell line": 0.0512, "cis-cloned synthetic oligodeoxyribonucleotides": 0.00134, "nephrotoxicity": 0.00012, "melanoma cell": 0.0768, "early inflammatory response": 0.01294, "factor activate transcription": 0.01907, "pkb": 0.00019, "rpon sigma factor": 0.01907, "ferrous": 0.00012, "inhibit mcp-1 secretion": 0.0127, "hm-induced differentiation": 0.01179, "acute exposure": 0.00369, "5-": 0.00056, "sp1/egr-1 binding site": 0.01445, "alpha,25-dihydroxycholecalciferol": 6e-05, "stat3 antibody direct": 0.00596, "bind specific member": 0.0135, "lambda gene": 0.04355, "potential importance": 0.00605, "negative": 0.0103, "pi3-kinase activity": 0.02925, "c-jun gene transcription": 0.02903, "jn": 0.00019, "toto": 0.0, "transduced hiv-1 long terminal repeat": 0.00351, "pathophysiologic amount": 0.00285, "baseline interview": 0.0004, "aggressive histologic type": 0.00633, "mzf-1 activates cat reporter gene expression": 0.01452, "cell type-specificity": 0.0768, "squirrel monkey lymphocyte": 0.00988, "negative fashion": 0.00515, "nf-kb dna binding activity": 0.01462, "general model": 0.00422, "r24-stimulated increase": 0.02196, "ligand fkbp12": 0.00592, "ba-induced cell growth inhibition": 0.0384, "il-4 gene control": 0.02903, "intercellular interaction": 0.00986, "t-cell cycle entry": 0.00641, "lps receptor complex": 0.01714, "subject young": 0.00354, "antibody supershift assay": 0.00668, "assay conditions-concentration": 0.01002, "laminar flow": 0.00152, "apparent effect": 0.02115, "dtt": 0.00012, "southern and/or slot blot technique": 0.0018, "crucial factor": 0.0286, "ifn-gamma-hcmv coincubation": 0.00028, "cd1+relb+dc": 6e-05, "cell development test": 0.0512, "growth stimulate": 0.01101, "parental": 0.00149, "bhlh-pas partner factor arnt express": 0.01144, "additional putative regulatory site": 0.01084, "renin suppression": 0.00416, "early signal event initiate": 0.00817, "basic hlh protein": 0.03019, "ebna2 interacts": 0.0014, "rb-defective line": 0.01653, "human pre-b-cell line": 0.02508, "human myeloid leukemia cell induce": 0.03072, "nm tpa": 0.00189, "embryonic fibroblast": 0.00338, "gel shift assay": 0.00668, "16-bp cyclic amp response element": 0.00777, "lymphoid precursor cell": 0.0512, "il-1-induced nf-kappa": 0.01414, "cis-elements responsible": 0.00279, "inhibit lipopolysaccharide-induced gene transcription": 0.02177, "cell line exhibit": 0.0512, "paradoxical": 6e-05, "cd437": 0.00012, "ap1 consensus motif": 0.00583, "mmp-1": 6e-05, "leucine-rich domain": 0.01207, "transgenic experiment": 0.00397, "surrounding": 0.0, "c.botulinum toxin": 0.00053, "dna link": 0.01483, "vincristine resistance confers insensitivity": 0.00163, "cell-specific activating protein": 0.03019, "estimate molecular mass": 0.003, "substantial role": 0.01328, "hepatocytes": 0.00043, "hiv-1 transmembrane glycoprotein": 0.00585, "transient action": 0.00499, "group ii type ii mhc cid": 0.00316, "biomarker abnormality": 0.00239, "2-3 fold increase": 0.01464, "serum calcitriol": 0.00378, "support nf-kappab-dependent transcriptional activation": 0.01582, "all-trans retinoic acid": 0.00571, "cytoplasmic tyrosine kinase": 0.00792, "human il-7r alpha": 0.02508, "promoter assay reveal cd28-dependent effect": 0.00934, "leukemia/b lymphoma cell line": 0.0384, "regulate hiv-1 gene expression": 0.02177, "regulate lineage-specific gene": 0.02903, "dna-binding factor specific": 0.01907, "nonproliferating": 0.00025, "sequence responsible": 0.01625, "vitro mutagenesis": 0.00785, "gamma/delta tcr-bearing lymphocyte": 0.00988, "b-cell lineage": 0.00459, "germline transcriptional activation": 0.02109, "carboxyl terminus": 0.00071, "calcium-stimulated": 0.00012, "pre-i-thymidine kinase": 0.01188, "malignant expansion": 0.00158, "major phorbol ester-responsive motif": 0.00437, "csa similarly mediate": 0.00821, "disulfide bridge": 0.00043, "couple p21ras": 0.00152, "differentiation antigen": 0.01179, "tax promotes": 0.00478, "monocyte-": 0.00012, "82+/-6": 6e-05, "e2a-hlf prevents apoptosis induce": 0.0127, "share regulatory task": 0.00455, "pu.1 distinguish": 0.00285, "gallo": 6e-05, "il-1 receptor/toll-like receptor": 0.01714, "proliferate": 0.00174, "camp-dependent protein kinase specific inhibitor h-89": 0.0151, "human cd34+": 0.03762, "a/r-induced pmn adhesion": 0.00387, "lipopolysaccharide/interferon-gamma": 6e-05, "cell type and/or differentiation step": 0.03072, "lymphotoxin-beta": 0.00019, "salt-transformed receptor": 0.02571, "form latent complex": 0.01123, "predominant transcript": 0.00599, "627-bp full-length promoter fragment": 0.01168, "pg490": 0.00056, "genetic program underlying monocytic differentiation": 0.00471, "nonmyeloid cell line": 0.0512, "proximal promoter region span position -78": 0.00779, "nuclear factor kappa": 0.01907, "glutathione-depleting agent diethyl maleate": 0.00211, "promoter dependent": 0.02336, "basis": 0.00285, "diverse subpopulation": 0.00155, "reliable tool": 0.00047, "endothelial leukocyte adhesion molecule": 0.00426, "t-lymphocyte cell lineage": 0.0512, "th1-to-th2 shift": 0.00183, "gene association": 0.04355, "defective pathway": 0.01278, "nuclear factor evi-1": 0.01907, "130-kd member": 0.00413, "subcellular distribution": 0.00115, "nf-at-binding activity": 0.02925, "natural hormone": 0.00444, "t-cell transcription factor nf-at": 0.0143, "suppress il-5 synthesis": 0.00407, "recombinant c/ebpbeta protein": 0.03019, "reactive oxygen intermediate production": 0.00521, "alpha-tcp effect": 0.02115, "functional il-6 protein": 0.03019, "synthetic oligodeoxyribonucleotide": 0.00202, "transcription factor c-myb": 0.01907, "nf-kappab-mediated up-regulation": 0.00276, "chicken il2 promoter": 0.01557, "important cellular mediator": 0.00596, "minimum essential core region require": 0.00587, "side": 0.00074, "cellular product": 0.00893, "apoptotic human vsmcs": 0.02508, "include brlf1": 0.01439, "vascular endothelium": 0.00174, "heterologous cytoplasmic domain": 0.00804, "clathrin assembly lymphoid myeloid leukemia gene": 0.01452, "megakaryocytic gene": 0.04355, "key transcription factor mediate il-2-induced t-cell proliferation": 0.00817, "box enhancer element": 0.01115, "ranq69l preincubation lead": 0.00664, "rar-alpha": 0.00037, "formalin-resistant epitope": 0.00161, "co-transfection": 0.00074, "th2 phenotype": 0.00366, "exocrine gland": 0.00087, "rb result": 0.0161, "derangement": 6e-05, "solubilization": 0.0, "factor promote il-4 gene expression": 0.01742, "transcription level": 0.0281, "cellular activation agent": 0.02109, "nuclear factor kb": 0.01907, "-236": 6e-05, "gtp-bound ra": 0.00596, "nfat-luc assay": 0.01002, "electrolyte": 0.00099, "passaging": 0.00012, "ifn-alpha/beta": 0.00062, "healthy age subject": 0.00236, "translation efficiency": 0.00109, "measure nucleoprotein dna-binding activity regulate gene expression": 0.01244, "define interferon stimulate response element": 0.00777, "nh2cl-treated neutrophil show": 0.01733, "e2a-pbx1-induced apoptosis": 0.0089, "hour pulse-treatment": 0.00115, "discrete subregions": 0.00059, "myeloid-committed eosinophil cell line": 0.0384, "negative regulatory mechanism": 0.00705, "mody1": 0.0, "estrogenic effect": 0.02115, "type ii receptor": 0.01714, "normal human": 0.03762, "ig superfamily": 0.00214, "s.l.zeichner": 0.00012, "pkb/akt": 0.00043, "-at": 0.00012, "csa-resistant cd28-signaling pathway": 0.00852, "signal initiate": 0.01635, "kbf1 factor": 0.0286, "hemopoietic system": 0.00667, "igh regulatory element": 0.01115, "ranking": 0.0, "mitogen-activated protein kinase family member extracellular-regulated kinase": 0.01294, "situ hybridisation": 0.00084, "hypophosphatemia": 6e-05, "counterbalance": 6e-05, "il-10 inhibits th1 function": 0.00665, "immunogenotypic study document": 0.00904, "rest normal human pbl": 0.01881, "low frequency": 0.00707, "sivsmmpbj14": 0.0005, "measure effect": 0.02115, "ap-1 fo": 0.00695, "typical morphology reveal": 0.00732, "il-11 mrna": 0.01526, "significant change": 0.0063, "affinity-driven peptide selection": 0.00502, "t-cell cycle progression": 0.00641, "receptor contributes": 0.02571, "complex regulation": 0.01684, "cytokine profile": 0.01123, "nuclear protooncogenes": 0.01684, "ca2+/calmodulin kinase type iv/gr": 0.00594, "p100 inhibition": 0.01061, "dose-response experiment suggest": 0.01348, "minimal transactivation": 0.00515, "transcription factor nfatc": 0.01907, "steroid ligand": 0.00592, "pma induced activity suggest": 0.01462, "creb-1 bind": 0.02025, "efficient c-fos induction": 0.01071, "vivo survival": 0.0053, "bianchi": 0.00012, "human b-cell specific transcription factor": 0.01505, "expressed gene": 0.04355, "c-myc mrna": 0.01526, "scmv mie enhancer": 0.00606, "g-csf-induced colony formation": 0.00323, "trigger event lead": 0.00664, "cytokine pathway lead": 0.00852, "ebv nuclear protein": 0.03019, "cord": 0.00205, "co-migrating": 0.00019, "selective interaction": 0.00986, "5'-untranslated leader region": 0.00978, "ebf homologous sequence": 0.01084, "large-sized artery": 0.0004, "translocation process couple": 0.00343, "m. rowe": 0.00115, "linkage analysis": 0.01179, "sustained ca2+ influx": 0.00203, "ap3-l site": 0.02168, "eosinophil cationic protein": 0.03019, "operative kinase": 0.01188, "eosinophil apoptosis": 0.0089, "regulate signal transduction": 0.0109, "selective ability": 0.00431, "abs": 0.00012, "bmrf1 promoter": 0.02336, "immature cell express cd21": 0.0384, "nf-kappab binding site": 0.01445, "conclusion hypercortisolaemia": 0.00096, "hormone data": 0.00444, "hla-dralpha": 0.00012, "glucocorticoid receptor-ligand bind study": 0.01013, "lack cd40 ligand": 0.00422, "fm patient": 0.01666, "il-6 gene transcription": 0.02903, "activate phenotype": 0.01777, "phorbol myristate acetate/ionomycin": 0.00362, "purified human monocyte": 0.02508, "transfections": 0.00056, "kv current": 0.00084, "significant e2a protein expression": 0.02264, "subunit": 0.00968, "upstream nuclear factor-kappa": 0.01123, "result hybridoma proliferate": 0.01073, "bind kappa": 0.02025, "mature lymphoid cell": 0.0512, "10,000-fold": 0.00012, "transcriptional inducibility": 0.01151, "dose range": 0.00202, "u3": 0.00012, "early proliferative sample": 0.00552, "c1-c3 formation": 0.00484, "beta-gal expression": 0.04163, "-1 receptor": 0.02571, "degradative enzyme": 0.0031, "mitogen-activated protein kinase-1 extracellular-regulated kinase-kinase": 0.01811, "eb overlap": 0.00177, "disease develop": 0.00673, "phospholipase cy1": 0.00078, "induce cat activity": 0.0195, "potential advantage": 0.00605, "il-2 inducibility": 0.01117, "show pharmacological": 0.02599, "peptide recognition": 0.00754, "megadoses": 6e-05, "androgen receptor bind assay": 0.01286, "conventional b-2 cell": 0.0512, "jun-fos heterodimers": 0.00226, "con a-treated": 0.00019, "isozymes show": 0.02599, "mrd-/lt": 0.00019, "tal-1 gene specifies": 0.02903, "a/r induces": 0.00803, "high proliferative potential": 0.0062, "cell model system": 0.0512, "host cell": 0.0768, "prdii element decrease": 0.01115, "tumor suppressor": 0.00934, "unique phenotype": 0.00366, "indigenous bacteria": 0.00037, "marmoset t-lymphocyte transformation": 0.00192, "scm-1-producer": 0.00012, "specific zinc-mediated immune modulation": 0.00619, "adult de novo acute myeloid leukemia": 0.00166, "beta-catenin": 0.00093, "nf-kappa b-regulated promoter": 0.01557, "glycosphingolipid beta-": 0.00059, "high content": 0.00931, "jcam/lck": 6e-05, "peptide binding": 0.01855, "prolonged activation": 0.03164, "phosphorothioate oligonucleotide": 0.00164, "transcription factor determine lineage specification": 0.01144, "h2o2 potentiate nf-kappab activation": 0.01582, "tce": 0.00012, "potential role": 0.01328, "base -107": 0.0031, "tumor-infiltrating lymphocyte": 0.01483, "homeodomain": 0.00087, "pgd41 clone trans-activated": 0.00492, "select a-t patient": 0.0111, "mg/day": 0.00012, "ym268 facilitate": 0.00199, "phosphorylated tyrosine residue": 0.00474, "cell surface interaction": 0.0512, "immunological disease include allergy": 0.0072, "mutant": 0.01619, "cord blood cd4+": 0.00395, "genomic event": 0.00552, "ptf beta": 0.00673, "reduced pathogenicity": 0.00208, "clinical action": 0.00499, "polyomavirus enhancer-binding protein 2/core-binding factor": 0.01811, "purine-rich element": 0.01672, "t-cell costimulation": 0.00962, "weakly positive": 0.00468, "wild-type cbl": 0.00378, "protein synthesis lead": 0.03019, "41-kda nuclear protein": 0.03019, "non-ashkenazi jewish group": 0.00325, "b7-independent": 0.00012, "targeted expression": 0.04163, "multiple ap2": 0.00689, "exogenous ligand": 0.00592, "significant p42/44": 0.00416, "pancreatic tissue": 0.00664, "u937 cell differentiate": 0.0512, "diminished expression": 0.04163, "cytokine include interferon-gamma": 0.00959, "lipopolysaccharide stimulation": 0.0112, "related protein-tyrosine kinase syk": 0.00594, "prrii": 6e-05, "sea urchin function": 0.00887, "stat dna-binding activity": 0.0195, "human myelodysplastic syndrome": 0.02508, "ca2+ ionophore a23187": 0.00203, "common occurrence": 0.0035, "extracellular domain fuse": 0.00804, "ra start": 0.00596, "class ii trans- activator": 0.00363, "general effect": 0.02115, "targeted gene disruption": 0.02903, "carboxyl-terminal end": 0.00059, "direct transgene expression": 0.02775, "healthy donor show": 0.01733, "hla dr alpha promoter": 0.01168, "scl expression": 0.04163, "flow cytometry analysis": 0.00786, "99-bp": 6e-05, "frequent target": 0.00825, "inhibit lck gene expression": 0.02177, "human interleukin-4": 0.03762, "upregulate hiv-1 expression": 0.02775, "affect erk1": 0.00797, "study transcription": 0.0281, "zap-70 signal function lead": 0.00817, "pat": 0.00043, "direct phosphorylation": 0.00983, "dg/sa": 6e-05, "e1a-negative": 0.00025, "immunologic function": 0.01331, "il-1rii mrna level": 0.01214, "chromosome breakpoints": 0.00295, "anti-cd3-mediated response": 0.01942, "loop length restriction": 0.00072, "timp-1 suppression": 0.00416, "phorbol 13-myristate acetate": 0.00362, "maximal induction": 0.01607, "human t-cell receptor delta gene enhancer": 0.01452, "scl/tal-1": 0.00012, "functional release": 0.00816, "pu.1 consensus site": 0.01445, "potent differentiation inducer": 0.00786, "protein product": 0.04529, "prior incubation": 0.00208, "multivariate": 0.00019, "transcription factor atf2": 0.01907, "autoimmune": 0.00161, "p65 mutant reveal": 0.00732, "increase camp": 0.02196, "sir": 6e-05, "early b-lymphocyte development": 0.00552, "hemin-treated k562 cell undergo erythroid differentiation": 0.0256, "ser": 0.00025, "retinoidal antagonist": 0.00242, "rando": 0.00012, "extent pkc-alpha": 0.00115, "hla-dq": 0.00155, "tnfr-1": 0.00012, "alpha-naphthyl butyrate esterase staining": 0.00088, "sensorgrams": 6e-05, "cepsilon germline transcript": 0.00399, "repeat attack": 0.00378, "il-10 inhibits nuclear factor-kappa b/rel nuclear activity": 0.00836, "dna-binding heterodimer nf-kappa": 0.00943, "cellular extract": 0.00893, "ml antigen": 0.00819, "chronic low": 0.00707, "structural versatility": 0.0018, "nucleated cell": 0.0768, "long terminal repeat quasispecies differ": 0.00151, "activator protein-1 binding activity": 0.01462, "jak2 janus kinase": 0.00792, "constitutively overexpressed": 0.00406, "hiv-infected human macrophage": 0.02508, "spd": 0.00031, "hotspot": 0.00031, "high eukaryotic gene": 0.02903, "pyramidal cell": 0.0768, "dna fail": 0.01483, "activin a-mediated signaling": 0.00372, "required": 0.00037, "porcine b-cell line l23 show": 0.0104, "endocytic pathway": 0.01278, "activate protein kinase c.": 0.02264, "paul scholl": 6e-05, "mammalian sex-determining gene sry": 0.02177, "wbjun": 0.00019, "cat reporter gene": 0.02903, "enhancer shuffling": 0.00909, "posttransplant lymphoproliferative disorder": 0.00149, "mouse lack nnos responds": 0.00487, "induce tf gene transcription": 0.02177, "collagenase-1": 0.00062, "tumor site": 0.02168, "dl337-infected cell": 0.0768, "th1 response": 0.01942, "nf-kappa b1 encode transcript": 0.00707, "arthritis patient": 0.01666, "nf-y protein": 0.04529, "human": 0.07525, "basic domain": 0.01207, "polyamine concentration": 0.0067, "human neutrophil-mediated tumor cell cytostasis": 0.03072, "specific bind complexes relative": 0.01013, "bone growth": 0.00819, "cadmium-pretreated cell": 0.0768, "nf-kappab transcription factor binding": 0.0143, "pml-rar-containing leukemic cell": 0.0512, "block ca2+ flux stimulate": 0.00551, "phosphorylation and/or degradation": 0.00656, "mother": 0.00037, "light-chain gene structure": 0.02903, "quiescent cell form": 0.0512, "glucocorticoid-sensitive": 0.00037, "nuclear factor il-6": 0.01907, "data provide": 0.00645, "recruit distinct histone deacetylase complex": 0.00674, "nf-kappab regulatory effect": 0.0141, "synovial macrophage": 0.00589, "pma-induced mrna": 0.01526, "increase il-4 gene expression": 0.02177, "ig gene superfamily": 0.02903, "study minimal residual disease": 0.00678, "fine mutagenesis": 0.00081, "dna binding site": 0.01445, "base pair": 0.0031, "jun-": 6e-05, "rac gtp-binding protein provide": 0.02264, "ionomycin-stimulated": 0.00019, "bp2": 0.00012, "corticotropin": 0.00019, "translocate": 0.00149, "rnazol": 6e-05, "forced expiratory volume": 0.00021, "full length promoter construct": 0.01168, "functional ebf-binding site": 0.01445, "lbp patient": 0.01666, "lymphoid leukemia cell line": 0.0384, "consensus c/ebp site": 0.01445, "full-length alg-4 induced transcription": 0.01405, "individual reactivity": 0.00409, "-79": 0.00031, "p21ras play": 0.0071, "transcription factor regulate activity": 0.01462, "maximal oxygen uptake": 0.00122, "bead-1 block": 0.01073, "p65- select kappa": 0.00498, "bfu-e-derived colony increase": 0.01464, "leu": 0.00025, "ng/10": 6e-05, "labile": 0.00074, "significant positive correlation": 0.00312, "p55 interaction": 0.00986, "prevent adherence": 0.00524, "regulate plc gamma": 0.00835, "p21ras signal": 0.01635, "secrete tnf-alpha regulate": 0.00835, "isolated white blood cell": 0.0384, "clonal derivative alpha b5a": 0.00585, "immunoprecipitation": 0.00149, "capacity": 0.00658, "lineage-specific factor act": 0.01907, "transcription factor vp16": 0.01907, "subdiploid population": 0.00307, "chloram-phenicol acetyltransferase": 0.00099, "mhc class ii dra promoter": 0.00934, "induce significant amount": 0.01694, "cd62": 0.00012, "il-10 pretreatment": 0.00422, "stimulation condition": 0.0112, "well-differentiated th1 cell": 0.0512, "inducible nuclear component": 0.01123, "inhibit endothelial activation": 0.02109, "pleckstrin phosphorylation": 0.00983, "previous data regard ebv latency": 0.00226, "sac": 0.00043, "octamer binding protein": 0.03019, "human monocyte binding": 0.02508, "monocyte il-1ra secretion": 0.00798, "u373 mg cell": 0.0512, "distal site": 0.02168, "substantial affect": 0.00797, "e-cadherin": 6e-05, "epitope": 0.00323, "cell activation induce": 0.0512, "c2": 0.00019, "camp-induced quiescence": 0.00012, "97-kda protein": 0.04529, "relative level": 0.01821, "mycobacterial cell wall": 0.0512, "induced differentiation occur": 0.00786, "basal level expression": 0.02775, "growth-promoting effect": 0.02115, "cytokine mrna": 0.01526, "down-regulated sequence": 0.01625, "trans-gene expression": 0.04163, "inhibit induction": 0.01904, ":26721": 6e-05, "fluid": 0.00155, "cp-2": 0.0, "proteoglycan associate": 0.01092, "topic": 0.0, "high intracellular activity": 0.0195, "fibronectin receptor": 0.02571, "camp-responsive element": 0.01672, "icam": 0.00012, "dependent adhesion": 0.0058, "delayed fashion": 0.00161, "programmed series": 0.00161, "induces increase expression": 0.02775, "il-6 treatment": 0.01014, "consensus sequence ctcacntnc": 0.01084, "antigen-activated human": 0.03762, "salt-losing episode": 0.00019, "induce eosinophil apoptosis": 0.01694, "br4": 6e-05, "cell-specific protein neg-1": 0.03019, "ovulation": 0.00037, "random fine needle aspiration": 0.00022, "regulate map kinase": 0.00835, "high-level promoter activity": 0.0195, "cax repeat": 0.00378, "ifngamma exert": 0.00292, "t-cell lineage": 0.00962, "hematopoietin receptor superfamily lack intrinsic kinase activity": 0.00836, "ets-related transcriptional regulator express": 0.00923, "divided dos": 0.00121, "definite coagulopathy": 9e-05, "transient chloramphenicol acetyltransferase assay reveal": 0.00439, "normal rh": 0.0121, "fn action": 0.00499, "leukemic myeloid progenitor cell express mrna": 0.0256, "10-fold expansion": 0.00099, "il-1 gene expression": 0.02903, "steady state": 0.00267, "activator cell": 0.0768, "pathological alteration": 0.0023, "vdr retention": 0.00233, "broad spectrum": 0.00053, "il-13r alpha chain": 0.0078, "human monocyte nuclear factor-kappab": 0.01881, "il-2-dependent cell": 0.0768, "ranbp2": 0.00019, "large part regulate": 0.00835, "suppressive activity": 0.02925, "-10 inhibits nuclear factor kappa": 0.01144, "epstein-barr virus dr promoter": 0.01168, "human inflammatory pathology": 0.02508, "result demonstrate physical": 0.01073, "multiple copy": 0.00689, "glucocorticoid-mediated apoptosis correlate": 0.00593, "gamma-globin expression": 0.04163, "p.k.": 0.00012, "tgfs play important role": 0.00664, "contradict observation": 0.00149, "experimental pancreatitis": 0.00084, "require mek1 kinase activity": 0.01462, "lps induction": 0.01607, "collagen fibril": 0.00025, "mix": 0.00019, "bind traf3": 0.02025, "transcription factor regulate expression": 0.02081, "compound induce granulocytic maturation": 0.0127, "anti-proliferative activity": 0.02925, "human monocyte-derived macrophage inhibit mmp-9 gelatinolytic activity": 0.01075, "deflazacort": 6e-05, "roi": 0.00112, "primary cortisol resistance": 0.00492, "malfunction": 0.0, "human ciita construct": 0.02508, "measure natural killer": 0.00258, "tcdd-induced increase": 0.02196, "5-fold stimulation": 0.0112, "up-regulated tgf-beta1 mrna": 0.01017, "antioxidant-mediated inhibition": 0.01061, "plasma il-1": 0.00375, "22-bp duplication": 0.00019, "integrated human immunodeficiency virus type": 0.01505, "indirect immunofluorescence": 0.00059, "reverse transcription-polymerase chain reaction": 0.00219, "-1 family protein interact": 0.02264, "k-ras protein": 0.04529, "tfiid-dependent rna polymerase ii transcription system": 0.00937, "response acquisition": 0.01942, "0.4-1.9": 0.0, "cd20 promoter": 0.02336, "rev ltrs work": 0.00054, "signal-dependent activation": 0.03164, "de novo viral protein synthesis occur": 0.0151, "nuclear factor-chi": 0.01684, "pediatric age range": 0.00151, "human intestine": 0.03762, "herpes simplex tegument protein": 0.02264, "'conditional phenotype": 0.00366, "major positive ci element": 0.00836, "il-4 affect": 0.00797, "thyroid system": 0.00667, "eth2 cell": 0.0768, "decade": 0.00012, "hiv-1 antigen expression": 0.02775, "inversion associate": 0.01092, "tcf-1 bind strong": 0.0135, "desulfation": 0.0, "beta-globin": 0.00261, "regulate bcl-2 expression": 0.02775, "cellular programme drive proliferation": 0.00447, "human germinal center express bcl-6 mrna": 0.01254, "sequence-specific dna binding activity": 0.01462, "vzv ge express": 0.0123, "nf-kappa b2": 0.01414, "mouse show approx": 0.01733, "dna bind protein nf-kb": 0.02264, "atp-depleted platelet": 0.00372, "release il-6": 0.00484, "locus control region": 0.00978, "cd40 cytoplasmic domain": 0.00804, "differential therapeutic strategy base": 0.00161, "el4": 0.00043, "enhance granulopoiesis": 0.00974, "molecule impair": 0.00853, "cd3 epsilon enhancer": 0.00606, "hypermethylation": 6e-05, "murine b-cell specific coactivator mbob1": 0.00495, "isolate short cdna sequence tag": 0.0065, "pma-dependent activation": 0.03164, "jcam cell": 0.0768, "essential gata": 0.00487, "porphobilinogen deaminase": 0.00016, "vsmc-myc cell maintain": 0.0512, "myometrium": 0.00025, "rise activate": 0.01777, "s186a": 0.0, "antisense gata-3 rna inhibit il-5": 0.00762, "signal transduction": 0.01635, "antigen drive response": 0.01294, "mm concentration induce": 0.01694, "daily": 0.00087, "human gata-3 gene": 0.02903, "non-acutely pathogenic strain": 0.00124, "sp3 participates": 0.00047, "human acute monocytic leukemia cell line": 0.0256, "proximal p0 site": 0.01445, "migrate b1 complex": 0.01123, "x2 box": 0.00304, "sp100 homology region": 0.00978, "i.": 0.00043, "polyclonal signal": 0.01635, "jpx-9 cell": 0.0768, "enhance": 0.01948, "induce renewal": 0.0254, "sustained": 0.00161, "b-cll cell bind il-10": 0.0384, "ifn-gamma-treated human cell": 0.0512, "inhibitable": 0.00025, "-mediated nf-kappab activation": 0.02109, "alpha degradation": 0.01169, "nfat activation induce": 0.02109, "subtoxic concentration": 0.0067, "pparalpha": 0.00105, "permissive enhancer/promoter interaction": 0.00658, "cutaneous carcinogenesis remain": 0.00347, "affinity 10-fold low": 0.00471, "impaired binding": 0.01855, "nf-kappab nuclear activation": 0.02109, "th2 cytokine gene expression": 0.02177, "tandem repeat": 0.00378, "1a9-m cell express human bcl2": 0.03072, "determine mzf-1 transcriptional regulatory function": 0.00532, "derivates": 0.0, "cell show similar roi formation": 0.03072, "stimulate cell reveal specific protein bind site": 0.02194, "bind dna": 0.02025, "term gcr-alpha": 0.00413, "early glucocorticoid": 0.0085, "strong transcriptional activating effect": 0.01058, "bmlf1 protein": 0.04529, "inhibit il-1-induced production": 0.0127, "x.": 0.00012, "thalassaemia": 0.00019, "intracellular localization": 0.00583, "residue decrease": 0.00971, "membrane-proximal portion": 0.00074, "conserved sequence element": 0.01115, "inhibit il-2 transcription": 0.01873, "activity variance": 0.02925, "hsp60 expression": 0.04163, "tnf-alpha rna": 0.00546, "-trihomo-1alpha,25": 6e-05, "activated coagulation factor": 0.01907, "constitutive complex bound": 0.01123, "gata1": 0.00056, "thymidine kinase promoter-driven reporter construct": 0.00475, "superior": 0.00012, "human express sequence tag isolate": 0.01505, "transfected dprl promoter": 0.01557, "e. chaffeensis induce": 0.01694, "preassociation": 6e-05, "raf": 0.00043, "gr": 0.008, "osteoarthritis": 0.00019, "show failure": 0.02599, "nuclear extract distinguishes": 0.01123, "htlv-i promoter central": 0.01557, "lipopolysaccharide induction": 0.01607, "vulnerability": 0.00012, "mouse el-4 cell": 0.0512, "specific increase": 0.02196, "develop hypotetraploid dna": 0.00988, "stimulated release": 0.00484, "transcriptional silencing": 0.01151, "immature cd34+thy-1+ cb subset": 0.00096, "n-terminal poz domain": 0.00804, "redox-sensitive": 0.00012, "mechanical stress": 0.0031, "southwestern blot": 0.00109, "activated gralpha": 0.00589, "transcription factor-1": 0.0281, "pre-i site": 0.02168, "comprehensive screening": 0.00062, "recent molecular evidence point": 0.00225, "vdr gene": 0.04355, "specific intracellular receptor": 0.01714, "electrostatic interaction": 0.00986, "iono": 0.00031, "nf-kappab transcriptional activity": 0.0195, "elf-1-mediated transcription": 0.0281, "beta-galactosidase gene": 0.04355, "monocyte stimulate": 0.01197, "vessel wall": 0.00056, "divergent": 0.00087, "tumor necrosis factor-induced nf-kappab binding": 0.00742, "increase interleukin-1 beta": 0.01464, "il-4r p140": 0.00074, "gp41 induce camp accumulation": 0.0127, "complete coding sequence": 0.01084, "activate ppargamma": 0.01777, "tetracycline-regulatable system": 0.00667, "vpr act": 0.00496, "cellular signal": 0.01635, "high risk": 0.00931, "rest b-cell preparation": 0.00306, "neu oncogene-initiated rat mammary carcinoma": 0.00114, "klug": 0.00012, "transduced stem cell": 0.0512, "hypo-acetylation": 0.00012, "ifn-gamma activation": 0.03164, "positive regulatory region": 0.00978, "il-12p40 mrna expression": 0.02775, "conserved c4 zinc finger dna-binding domain": 0.00402, "fresh pbl": 0.00096, "-93": 0.00012, "94-kd stat5a": 0.00071, "signaling": 0.01117, "trimester": 0.0, "egr-1 mrna activating signal": 0.00817, "tyloxapol": 0.00037, "competent transcriptional activator": 0.00767, "review support": 0.00409, "il-2 receptor promote": 0.01714, "heptp act": 0.00496, "paper review": 0.00078, "experiment provide": 0.00645, "activate gene": 0.04355, "escherichia coli express": 0.0123, "bcl-2 exerts": 0.00295, "anti-hapten single-chain ab variable fragment fuse": 0.00116, "monoctyes": 0.0, "cell remain poorly understood": 0.0384, "alpha granule": 0.01169, "mt-2 cell": 0.0768, "potential therapeutic drug": 0.00403, "-258": 0.00012, "steroid-regulated gene network": 0.02903, "cni-1493": 0.00043, "phase-1 neutrophil adhesion": 0.00387, "cellular surface": 0.00893, "hsv-2": 0.00143, "retinoid": 0.00118, "autopsy-": 0.00012, "n-acetyl-cysteine": 0.00019, "sex differentiation": 0.01179, "calcineurin activity": 0.02925, "low serum": 0.00707, "vitro clonal growth assay": 0.00501, "erythroid gene": 0.04355, "pml/rar alpha": 0.01169, "dioxin receptor function": 0.01714, "class ii gene regulation": 0.02177, "hiv rna expression": 0.02775, "sivmac239 bear deletion": 0.0023, "ltb4 stimulation": 0.0112, "pecam-1 phosphorylation": 0.00983, "/cd3": 0.00037, "delta99": 0.00025, "soluble form": 0.01055, "consistent effect": 0.02115, "intracellular domain close": 0.00804, "critical cell function": 0.0512, "specific marker": 0.01238, "antiandrogen drug": 0.00338, "anti-cd28 monoclonal antibody": 0.00596, "isomerization": 6e-05, "ifns mediate": 0.01231, "induce tyrosine phosphorylation": 0.01694, "nf-kappab-controlled gene": 0.04355, ":1830": 0.00012, "gene": 0.0871, "hpv": 0.00019, "mammary gland": 0.00099, "p70i kappa": 0.00748, "downregulates cytokine-induced tnf gene expression": 0.01742, "transglutaminase type ii": 0.00633, "induced rar-beta expression": 0.02775, "nuclear factor-kappab control": 0.01123, "sequence motif represent": 0.01084, "gel-retardation experiment show": 0.01733, "affected factor operate": 0.01907, "calmodulin binding": 0.01855, "aberrancy": 0.00037, "beta-casein": 0.00068, "subsequent therapy": 0.00372, "important region": 0.01467, "t-antigen": 0.00043, "membrane extract detect": 0.00484, "1-3": 0.00031, "normal individual": 0.0121, "form granulocytic colony": 0.00703, "complete disappearance": 0.00171, "stimulate cytokine production": 0.00749, "mrd+/lt patient": 0.01666, "saos-2": 0.00012, "human leukaemia cell carry": 0.0384, "mnc nuclear extract decrease": 0.00842, "dr alpha": 0.01169, "b104 cell death induce": 0.0384, "cell infiltrate human genital herpes lesion": 0.0256, "unconventional cell surface receptor": 0.0384, "activate t-lymphocytes": 0.01777, "hl-60 cell": 0.0768, "strong transactivation domain present": 0.00603, "chang": 6e-05, "phosphatase inhibitor": 0.009, "major cell wall component": 0.0384, "vivo transgenic model": 0.00354, "induce erythroid differentiation": 0.01694, "r24 stimulation": 0.0112, "kappa b-fos-cat": 0.00748, "database reveal": 0.01098, "gf": 0.00037, "pertussis toxin inhibit": 0.0127, "formal demonstration": 0.00065, "hiv-1 replication describe": 0.00585, "il-2 receptor beta chain": 0.01286, "restricted protein kinase": 0.03019, "p3hr-1-infected cell": 0.0768, "tax gene develop fibroblastic tumor": 0.01742, "human cd34+ hematopoietic progenitor cell isolate": 0.0256, "microenvironment work": 0.00081, "pre-b cell line": 0.0512, "chromosome analysis reveal": 0.00786, "effect require": 0.02115, "include p50": 0.01439, "1-231": 0.00019, "traf6": 0.00081, "developmental-specific expression": 0.04163, "induce hla class ii molecule": 0.01016, "fgf receptor-bearing jurkat": 0.0037, "nonstimulated": 0.0005, "cd3+/cd4+": 0.00019, "immunosuppressive agent cyclosporin": 0.00281, "patient generate": 0.01666, "shift prb": 0.00183, "myeloid cell precursor": 0.0512, "nfat-1 regulatory element link": 0.00836, "alpha2 integrin subunit": 0.00323, "decrease pbmc capacity": 0.00647, "pu.1 promoter": 0.02336, "tcells": 0.00019, "extra taqi restriction site": 0.01084, "heterokaryons form": 0.01055, "underlying regulatory mechanism": 0.00705, "75-kd protein": 0.04529, "tyrosine-phosphorylated peptide": 0.00754, "transcript stabilization": 0.00599, "cd95-dependent": 6e-05, "mar-binding protein": 0.04529, "pma increase": 0.02196, "tax expression vector": 0.02775, "e. histolytica-infected intestinal xenograft": 0.00051, "tnf-alpha mrna transcript": 0.01017, "time-dependent release": 0.00484, "valuable": 0.00031, "frequent hypermutation": 0.0005, "proinflammatory cytokine": 0.01123, "mg bolus": 0.0004, "invertebrate": 0.00019, "suggest mechanism": 0.02022, "ileum": 0.00012, "obvious exception": 0.0004, "il-9 gene expression": 0.02903, "lymphoid-specific immunoglobulin mu heavy chain gene enhancer": 0.01244, "deltorphin": 0.00043, "hydrogen peroxide": 0.00034, "maximal": 0.00366, "fdcp-2 cell": 0.0768, "r7-57 reporter line": 0.01102, "gata-3 gene": 0.04355, "htafii105 selectively": 0.00292, "selenium-deprived jurkat": 0.00555, "ultrafiltration": 0.00012, "c-fos mrna expression": 0.02775, "deletional vcam-1 promoter construct": 0.01168, "potent drug": 0.00357, "blocker": 0.0005, "anoxia/reoxygenation-induced neutrophil adherence": 0.00331, "analyze regulatory region": 0.00978, "infected cd4+ lymphocyte": 0.00988, "transcription factor binding": 0.01907, "short nf-atc isoform": 0.00114, "vitality": 6e-05, "encode p16": 0.00853, "immobilized antibody": 0.00893, "cell type": 0.0768, "vitd3 selectively inhibit": 0.0127, "krox-20": 6e-05, "study nfat regulation": 0.00904, "e2f activation": 0.03164, "include gamma-globin": 0.01439, "motif-1/lymphotactin promoter": 0.02336, "general transcription complex tfiid": 0.01405, "allergen provocation": 0.00016, "detectable cell toxicity": 0.0512, "ccr-4": 0.00019, "ikappab expression": 0.04163, "patient receive 5-fluorouracil": 0.0111, "gata-3 activity": 0.02925, "haemolytic disease": 0.00673, "mnfatc complexed": 0.00034, "flanking dna": 0.01483, "conserved cis-acting sequence": 0.01084, "il-4 inhibited lps-induced ap-1 binding activity": 0.00975, "gr-mediated induction": 0.01607, "extended region": 0.01467, "molecular structure": 0.0045, "close match": 0.00068, "mechanism direct": 0.01058, "monoblastoid cell line u937": 0.0384, "flank region include": 0.00978, "prd": 0.00012, "il-1alpha gene": 0.04355, "age-associated immune dysfunction": 0.00399, "eightfold increase": 0.02196, "il-1 alpha": 0.01169, "cfu-m": 6e-05, "ribosomal protein sequence": 0.03019, "time-course study reveal": 0.00904, "cell influence constitutive": 0.0512, "fc gamma ri-": 0.00294, "bind stat5": 0.02025, "precise congruence": 0.00065, "hela cell hiv-1 tat suppress": 0.03072, "prolyl isomerase inhibitor": 0.006, "physiological regulation": 0.01008, "antiviral activity": 0.02925, "endometrium": 0.00068, "lipid-lowering agent": 0.00422, "competitive enzyme-linked immunosorbent assay": 0.00501, "mass action law": 0.00333, "de novo induction": 0.01071, "uncertain": 0.00012, "antibody titre": 0.00893, "aldosterone antagonist canrenone": 0.00161, "cytoplasmic tail underwent apoptosis": 0.00445, "abolish il-4-induced upregulation": 0.00236, "cfu-il6": 6e-05, "phytohemaglutinin": 0.00012, "mda-mb-231": 0.00031, "blood cell constitutively express important gene": 0.0256, "ltr-chloramphenicol acetyltransferase-encoding gene chimera": 0.02177, "alpha2 integrin gene": 0.02903, "c3a": 0.00099, "host factor": 0.0286, "cell-specific coactivators": 0.00292, "ap-1-mediated transcription": 0.0281, "promoter-proximal element": 0.01672, "myeloid cell line confers resistance": 0.03072, "hypothyroid relative": 0.00276, "block proliferation": 0.01073, "ciita allele bore": 0.00196, "specific mechanism": 0.01238, "specific calcitropic effect": 0.0141, "fusion complementary dna": 0.00988, "globin mrna": 0.01526, "c/ebpalpha-deficient hematopoietic cell": 0.0512, "prevent high level induction": 0.0091, "-dq": 0.00025, "blocked activation": 0.03164, "cell study express": 0.0512, "sodium/proton-exchanger": 0.0, "htlv-1-associated disease": 0.00673, "hematopoietic origin": 0.00366, "cell surface ganglioside": 0.0512, "unique human protein": 0.03019, "ie2": 0.00056, "hel/s": 0.00019, "stable tetrameric dcoh-hnf-1 alpha complex": 0.00674, "human genomic sterol regulatory element": 0.01505, "lymphomagenic akv": 0.00022, "dose-dependent shift": 0.00183, "u937 adhesion": 0.0058, "rare bcl-2+ cell": 0.0512, "4,21-diacetoxy-11 beta,19-epoxy-3-hydroxypregnan-20-one": 3e-05, "human adenovirus type": 0.02508, "box promoter element": 0.01557, "48-h": 0.00012, "cis-acting region span": 0.00978, "proto-oncogene express": 0.01846, "usa-derived pc2": 6e-05, "early event lead": 0.00664, "silica": 0.00012, "trophoblast cell": 0.0768, "elevated nf-il6": 0.00112, "tumor select": 0.00934, "hereditary hypercholesteremia": 0.00016, "stimulated proliferation": 0.00803, "molecular event occur": 0.00436, "kappa gene promoter": 0.02903, "well-characterized ets family member": 0.0042, "burkitt lymphoma raji cell": 0.0384, "human sr 31747a-binding protein": 0.02264, "lung nf-kappab": 0.00999, "efficient entry": 0.00189, "adp-activated platelet": 0.00372, "human blood": 0.03762, "tolerant cell": 0.0768, "chronic hepatitis c. functional b-cell response": 0.00647, "stat-related transcription factor": 0.01907, "jurkat cell activate": 0.0512, "translocation breakpoints": 0.00515, "programmed cell death": 0.0512, "latency break activity": 0.0195, "emsa": 0.00093, "immunoprecipitation analysis reveal": 0.00786, "cml": 0.0013, "erythroleukemia cell line": 0.0512, "reversible dose-dependent inhibition": 0.00707, "alpha-lipoic acid": 0.00856, "post": 0.00019, "ilt-mat cell": 0.0768, "prior study": 0.01355, "human leukemic cd4+ t-lymphocyte cell line": 0.0256, "constitutive overexpression": 0.00478, "signal": 0.03269, "dna-binding homeodomain": 0.00561, "tax-dependent transcriptional control": 0.00868, "extravascular compartment describe": 0.00265, "nf-at-oct": 6e-05, "cd28 adhesion molecule induce long-term nuclear expression": 0.01189, "inducing transcription": 0.0281, "negative modulatory mechanism control": 0.00651, "parathyroid hormone-related protein gene promoter": 0.01811, "non-fusion protein": 0.04529, "ran mutant": 0.0081, "regulate cytokine-induced": 0.01253, "nuclear c-rel expression": 0.02775, "androgen receptor gene": 0.02903, "recombinant ebna-2 expression vector": 0.02081, "nonleukemogenic virus": 0.00887, "small deletion hotspot": 0.0023, "recent result": 0.0161, "ras activity": 0.02925, "asthmatic proband": 0.00081, "mgf-stat5-like transcription factor": 0.01907, "c-myc regulation": 0.01008, "murine embryogenesis": 0.00623, "kappa b-dependent manner": 0.00498, "enhanced virion production": 0.00695, "nf-kappab signaling pathway": 0.00852, "non-lymphoid cell line": 0.0512, "site molarity": 0.02168, "develop retroviral vector": 0.00269, "homodimeric p49": 0.00031, "fcepsilonriib receptor": 0.02571, "ro 25-6603": 0.0009, "nf-il-6": 0.00081, "subsequent binding": 0.01855, "housekeeping ala mrna": 0.01017, "blk promoter": 0.02336, "cell belong": 0.0768, "regulate erythroid-expressed gene": 0.02903, "selectively activate": 0.01777, "e-box motif upstream": 0.00583, "promyelocyte cell line": 0.0512, "recloning capacity": 0.00329, "immunoprecipitated jak": 0.00068, "flank negative-acting element": 0.01115, "hiv-hd express cd40": 0.0123, "binding characteristic": 0.01855, "tax-expressing cell line": 0.0512, "hiv-1 parasitism": 0.00878, "tata-like motif": 0.00875, "stat3 promote": 0.00465, "amplification": 0.00149, "key cytokine induce": 0.01694, "theoretical pathway": 0.01278, "normal ltr transcription": 0.01873, "long-term treatment": 0.01014, "inhibitory effect": 0.02115, "study intracellular signal event": 0.00817, "gpix ets site": 0.01445, "murine ba/f3 cell": 0.0512, "neuroblastoma cell line": 0.0512, "inhibit gene expression": 0.02903, "independent pathway": 0.01278, "octamer motif require": 0.00877, "express zeta-globin": 0.01846, "protein-protein level": 0.01821, "monocytic thp-1 cell transfected": 0.0384, "serum osteocalcin decrease": 0.00647, "predictor": 0.00062, "lmp1-induced cell size increase": 0.0384, "recruitment phenomenon": 0.00164, "chronic rheumatoid arthritis patient": 0.00833, "simultaneous analysis": 0.01179, "leukocyte-mediated tissue damage": 0.00443, "ad12 e1a domain": 0.00804, "tnf-alpha independent": 0.00546, "tnf-alpha-stimulated cell": 0.0768, "hla antigen": 0.00819, "zinc finger protein": 0.03019, "detect ebv replicative gene product": 0.01742, "eosinophil granule major basic protein": 0.01811, "pulsed field gel electrophoresis analysis": 0.00471, "generate high level": 0.01214, "terminal lmp1 ct aa": 0.00166, "-associated tumor": 0.00934, "significant systemic effect": 0.0141, "transcriptional activator implicate": 0.00767, "confers il-2 responsiveness": 0.00744, "calmodulin-binding domain": 0.01207, "human ige germline gene": 0.02177, "pha-activated cell": 0.0768, "pathway distinct": 0.01278, "itt": 0.00012, "low constitutive level": 0.01214, "dm gene share": 0.02903, "reality": 0.0, "hla-cw*0702": 0.00019, "antiproliferative effect": 0.02115, "abrogate binding": 0.01855, "/45": 6e-05, "transcriptional activity relative": 0.0195, "affect lps-mediated activation": 0.02109, "nf-at-driven transcription stimulate": 0.01873, "dominant negative ra": 0.00397, "cell transformation": 0.0768, "fresh peripheral blood mononuclear cell": 0.03072, "intracellular sodium": 0.00583, "coordinated induction": 0.01607, "cell contact": 0.0768, "dna band-shift analysis reveal nf-kappa": 0.00593, "isoflavones": 6e-05, "type alpha": 0.01169, "general initiation factor": 0.01907, "reduced expression": 0.04163, "anti-atherogenic effect": 0.02115, "true protein kinase c-mediated signal transduction event": 0.01294, "protein-coupled receptor": 0.02571, "regulate granulocyte functionality": 0.00835, "ebna2 dependent cis-acting element": 0.00836, "cd45 -t cell": 0.0512, "specific nfat binding activity": 0.01462, "notch": 0.00062, "oxidative": 0.00354, "serotonin": 0.00031, "estrogen bind site exist": 0.01084, "native rfx activity": 0.0195, "activate granulocyte-colony-stimulating factor": 0.01907, "classical vitamin": 0.00236, "express ad5e1a": 0.01846, "emergence": 0.00068, "form motif capable": 0.00703, "hck": 0.00031, "inactive analog methylthiogliotoxin": 0.00108, "young sister": 0.00074, "delay il-2 receptor expression": 0.02081, "functional element": 0.01672, "monocyte chemoattractant protein": 0.03019, "tnf signaling": 0.00558, "autoimmune patient": 0.01666, "constitutive hiv production": 0.00695, "influence cell": 0.0768, "bind recombinant bcl-6": 0.0135, "glucocorticoid-induced membrane perturbation": 0.003, "anti-cd3": 0.00416, "hemopoiesis": 0.00012, "gc-box": 0.00037, "atopics": 0.00012, "b-cll cell result": 0.0512, "membrane receptor expression": 0.02775, "hsfe induce": 0.0254, "consecutive glutamine residue": 0.00151, "epstein-barr virus interacts": 0.00591, "g-csf induced tyrosine phosphorylation": 0.00492, "respective protein": 0.04529, "fc receptor": 0.02571, "tnf alpha-activated nf-kappa": 0.00943, "exclusive binding": 0.01855, "human il-4 gene": 0.02903, "cellular target": 0.00893, "ddpcr": 0.00037, "immediate-early activation gene expression": 0.02177, "depends": 0.00012, "discharge": 0.00012, "human leukemic cell line model": 0.03072, "defective gene": 0.04355, "yin-yang": 6e-05, "pathologic process": 0.00444, "heat shock protein glycoprotein 96-chaperoned antigenic peptide release": 0.01132, "thapsigargin treatment": 0.01014, "janus family tyrosine kinase jak3": 0.00475, "huvecs demonstrate": 0.01597, "activation cascade": 0.03164, "hybrid cell show": 0.0512, "critical early event": 0.00552, "switch dna recombination": 0.00988, "upregulate il-1 receptor antagonist": 0.01286, "affect lmp1 expression": 0.02775, "t- lymphocyte development": 0.00988, "reporter gene encode chloramphenicol acetyl transferase": 0.01452, "gm-csf receptor beta common subunit": 0.01029, "gr sit": 0.004, "activate neutrophil": 0.01777, "ifn-gamma-activated stat1": 0.00285, "c-maf induces monocytic differentiation": 0.00589, "ra induce": 0.0254, "dr. dezube": 9e-05, "raf/rac-signaling pathway": 0.01278, "readily form": 0.01055, "tobacco smoking": 0.00012, "lt-4 detect": 0.00726, "retinoids inhibit": 0.01904, "virus": 0.01774, "inhibits monocyte adhesion": 0.00798, "initial increased expression": 0.02775, "thrombosis": 0.00019, "astrocyte-derived kappa b-binding factor activate transcription": 0.00953, "tat- human immunodeficiency virus": 0.01881, "cyclic-amp responsive element bind factor": 0.01144, "m-csf-induced expression": 0.04163, "endogenous ifn activity equivalent": 0.01462, "p24 gag protein release": 0.02264, "early b-cell differentiation": 0.00786, "direct effect": 0.02115, "small deletion model": 0.00281, "pax-5b": 0.00043, "high mitotic rate": 0.0062, "dmso treatment": 0.01014, "acla": 0.00019, "ino attenuates inos expression": 0.02081, "encompass bind site": 0.01445, "promoterless construct": 0.00726, "tf gene": 0.04355, "require p56": 0.01315, "dominant component": 0.00456, "pmn infiltration": 0.00143, "determine t-cell differentiation": 0.00786, "traf3-mediated signal transduction pathway": 0.00817, "hla-dqa1*0501/dqb1*0302": 0.00012, "t-cell antigen receptor express": 0.01286, "pyg box mutation": 0.00395, "prevent ap-1 binding": 0.01237, "lymphoblastic tumor cell line": 0.0384, "n-terminal activation domain": 0.02109, "cell stimulus": 0.0768, "patient demonstrate": 0.01666, "budesonide": 0.00037, "azeptin": 0.00025, "isolated synovial fibroblast": 0.00225, "ion channel": 0.00062, "effector cell characterize": 0.0512, "express histone h2b promoter": 0.01168, "histone promoter-driven beta-galactosidase gene": 0.02177, "enhanced frequency": 0.00285, "rgd-adherent monocyte": 0.01197, "increase concentration": 0.02196, "immune surveillance": 0.00599, "spleen focus-forming virus-induced murine erythroleukemias": 0.00249, "kd tax1 antigen molecule": 0.00426, "il-6 induces activation": 0.02109, "pml-rar positive cell": 0.0512, "alpha remain": 0.01169, "primary human astrocyte": 0.02508, "genomic tnf gene": 0.02903, "1,25-dihydroxyvitamin d3 induces differentiation": 0.00589, "primed cd4": 0.00332, "-induced increase": 0.02196, "ebna3c contribute": 0.00378, "cross-linking increase camp detect": 0.01098, "sr 31747a-binding protein": 0.03019, "germline cepsilon transcription": 0.01873, "important il-2 cis-regulatory element": 0.00836, "specific polymerase chain reaction": 0.00619, "recombinant murine": 0.00623, "cd28 signalling": 0.00323, "bp -88": 0.00267, "il-6 mrna level": 0.01214, "inflammatory effect": 0.02115, "kappa light chain gene enhancer": 0.01742, "200-500 nm": 0.00093, "natural killer": 0.00233, "anti-cd40 mab-mediated up-regulation": 0.00184, "il-1 beta message induction": 0.00803, "transactivating": 0.0023, "non-erythroid gene": 0.04355, "megakaryocyte differentiation": 0.01179, "significant age-related alteration": 0.00277, "rdna": 0.00012, "hiv-protease expressing cell": 0.0512, "dermal activation": 0.03164, "biological marker": 0.00382, "early event induce": 0.01694, "lmp1 chimera": 0.0027, "syphilis": 0.00012, "fetal thymic organ culture": 0.0031, "human monocyte il-1 receptor antagonist": 0.01505, "gel mobility shift assay demonstrate": 0.00639, "nuclear-located kruppel-type zinc finger protein": 0.01811, "arterial": 0.00062, "oct-1 proximal": 0.00301, "pp-1": 0.0, "selectable marker": 0.00382, "nontuberculous lung disease": 0.00449, "affected": 0.00199, "granulocyte-macrophage colony-stimulating factor promoter activity": 0.0117, "phorbol ester stimulation": 0.00746, "potential therapeutic index": 0.00403, "northern hybridization data show": 0.013, "cell type-specific alternative messenger rna splicing": 0.0256, "c/ebps": 6e-05, "adipocyte fatty acid bind protein": 0.01811, "chromosomal protein": 0.04529, "isolate human": 0.03762, "adolescent major depressive disorder": 0.00287, "transcription protein represent multiple dna binding": 0.0151, "nip site": 0.02168, "unrestricted expression": 0.04163, "eklf heterozygote": 0.00087, "multidrug-resistant hl-60 cell": 0.0512, "genuine nf-e2 complex": 0.01123, "20-bp region": 0.01467, "binding activity display": 0.0195, "intrafollicular t-cell population": 0.00641, "signal system lead": 0.0109, "dhea bind site": 0.01445, "inhibit il-1-dependent nfkappab activity": 0.01462, "primary rhesus monkey alveolar macrophage": 0.00295, "activation pyrrolidine dithiocarbamate": 0.02109, "il-3-dependent murine pro-b cell": 0.0384, "molecule study": 0.01355, "progesterone-treated pregnancy lymphocyte": 0.00988, "southern hybridization analysis": 0.00786, "core ets bind site": 0.01084, "lmp2b mrna": 0.01526, "immune hyperactivation": 0.00599, "fetal blood cell": 0.0512, "anti-cd3 activation": 0.03164, "nuclear factor kappa b. oxidoreductive regulation": 0.00953, "lmp-1 molecule": 0.00853, "gata-1.05 mutant hematopoietic progenitor cell": 0.03072, "radiologic finding": 0.00226, "healthy men": 0.00177, "form heteromeric kappa b-binding complex": 0.00674, "3-": 0.00019, "nonepithelial mineralocorticoid receptor": 0.01714, "multiple p21ras effector pathway regulate nuclear factor": 0.00817, "lmp-1 effect": 0.02115, "homologue 38-kd murine map kinase homologous": 0.00396, "transcriptional factor present": 0.01907, "active nuclear relb": 0.01123, "nuclear phosphoprotein": 0.01684, "223-amino acid protein": 0.03019, "co-immunoprecipitation": 0.00031, "cell gr": 0.0768, "nf-ya subunit abolish": 0.00323, "synchronous recognition": 0.00257, "alpha-tocopherol acetate": 0.00099, "camp lead": 0.00996, "translocation lie": 0.00515, "regulate cell differentiation": 0.0512, "micrograms/ml phytohemagglutinin": 0.00078, "runt isoforms": 0.00307, "gst control": 0.01303, "double-stranded phosphorothioate oligonucleotides": 0.00122, "surgical treatment": 0.01014, "preinjured": 0.00012, "describe clone": 0.00738, "sigm-": 0.00019, "retrovirus-transduced oncogenic version": 0.0006, "ifn stimulation": 0.0112, "-870": 0.0, "enhancer element undergoes differential modification": 0.00669, "b-cell-derived subtype": 0.00034, "northern analysis": 0.01179, "cell enhance": 0.0768, "rela/p50": 0.0, "granzyme": 0.00068, "stat protein induce": 0.03019, "lmps": 6e-05, "intercellular adhesion molecule-1": 0.00387, "limited gene rearrangement": 0.02903, "hematopoietic human erythroleukemia cell": 0.0384, "clone member": 0.00738, "cell precursor": 0.0768, "hsv-2 type-specific t-cell clone": 0.00481, "eed bind": 0.02025, "pge2 enhance": 0.00974, "signaling process": 0.00558, "limulus amoebocyte lysate": 0.00023, "subunit confirm": 0.00484, "lymphocyte activation result": 0.02109, "agent inhibit": 0.01904, "activator protein-1 transcription factor expression": 0.01665, "receive all-trans ra": 0.00397, "positive cell": 0.0768, "mutant hcamkiv": 0.0081, "screen": 0.00199, "msin3 family": 0.00841, "somatic mutation": 0.00592, "intense": 0.00118, "integral component": 0.00456, "stat activation": 0.03164, "human g-csfr": 0.03762, "yy-1 binding site": 0.01445, "irf-1 level": 0.01821, "1,25-dihydroxyvitamin d3 receptor rna": 0.01286, "patient antioxidant inhibit monocyte adhesion": 0.00762, "inflammatory effector gene product similar": 0.01742, "156.7+/-27.3 cells/mm2": 0.00012, "single intraperitoneal injection": 0.0024, "dna rearrangement": 0.01483, "potential antagonism": 0.00605, "normal cell cycle activation program": 0.03072, "inhibition prevent": 0.01061, "hiv-1 genome": 0.00878, "factor": 0.0572, "bivalent mab j393": 0.00178, "constitutive apoptosis": 0.0089, "hbx-specific peptide elisa": 0.00502, "apr": 6e-05, "transgenic megakaryocyte": 0.00199, "dna sequence": 0.01625, "regulate nk": 0.01253, "non-syntenic trans-active locus": 0.00192, "steroid receptor": 0.02571, "peptide antigen": 0.00819, "lymphocyte dna": 0.01483, "p21ras initiate rac-1": 0.00242, "lymphocyte-specific defect": 0.00279, "human pbmcs": 0.03762, "clone mibp1 gene": 0.02903, "pip site": 0.02168, "inhibited hiv-1 ltr activity": 0.01462, "kappa light chain locus": 0.00374, "filament expression": 0.04163, "ligand engagement": 0.00592, "mitotic signaling": 0.00558, "necrotic cell death": 0.0512, "human b-cell transcription factor oct-2": 0.01505, "zp activation": 0.03164, "enhance viral replication": 0.00649, "transcription factor regulate gene": 0.02177, "murine splenic": 0.00623, "helper activity": 0.02925, "increase accumulation": 0.02196, "pharmacological control": 0.01303, "jnk2": 0.00012, "obf-1": 0.0005, "sp1/egr-1 site term": 0.01445, "active c-fos/c-jun ap-1": 0.00463, "lineage-restricted ets transcription factor": 0.0143, "il-15": 0.00074, "inhibit hla class ii constitutive expression": 0.01388, "sedimenting complex": 0.01684, "immune-endocrine interplay": 0.00028, "acute hiv infection": 0.00414, "il-4-inducible reporter": 0.00552, "nuclear factor atf-2": 0.01907, "hiv adenopathy": 0.00592, "activated human lymphocyte": 0.02508, "pml/raralpha transgenic mouse": 0.00649, "mycobacterial response element": 0.01294, "spread": 0.00081, "include granuloma formation": 0.00959, "intracellular pool": 0.00583, "enzyme implicate": 0.0035, "leucine zipper dna bind motif": 0.0081, "r24 mab affect": 0.00531, "eb": 0.00062, "benign clinical behavior": 0.00283, "artificial construct": 0.00726, "und": 0.0, "epstein-barr virus latent infection": 0.00444, "rest state": 0.00267, "20-methyl analogue": 0.0005, "ifn-gamma-producing cell": 0.0768, "leukemia virus type": 0.00633, "secrete il-1beta": 0.00223, "bind": 0.04051, "trifluoromethylketones": 6e-05, "reactivation": 0.00149, "neutrophilia": 0.00019, "oxldls lead": 0.00996, "multipotential hemopoietic stem cell": 0.0384, "immunoregulatory function": 0.01331, "b-lineage commitment": 0.00096, "lymphoblast express high level": 0.00923, "single strand oligonucleotides": 0.0024, "palpha": 0.00012, "subunit p50": 0.00484, "play key role": 0.00885, "integrin alpha": 0.01169, "lps-induced endothelial cell adhesiveness": 0.0384, "interleukin 3-mediated survival": 0.00184, "nuclear compartment": 0.01684, "dna-dependent atpase activity": 0.0195, "reduced enhancer activity": 0.0195, "transcriptional effect": 0.02115, "term cord blood": 0.00395, "erythrocyte polyamines level": 0.01214, "virus-bhrf1": 0.00012, "potential mechanism": 0.01058, "primitive gut": 0.00065, "ix": 0.00025, "interstitial deletion": 0.00344, "nuclear export receptor crm1": 0.01286, "toxin affect kappab binding activity induce": 0.00975, "prolonged time": 0.00273, "irregular": 0.00019, "tyrosine phosphatase inhibitor pervanadate": 0.0045, "alpha b1/alpha b2 ratio": 0.00585, "e1 binding protein": 0.03019, "full range": 0.00202, "rars": 0.00068, "express major histocompatibility complex": 0.00923, "reactive lymph node": 0.00141, "colorectal cancer": 0.00248, "support specific dna binding": 0.00927, "k.": 0.00025, "at-xq28": 6e-05, "cho-dr/b7/lfa-3 triple transfectant induce": 0.0127, "e1a sensitization": 0.00248, "tat mutation": 0.00592, "heme": 0.00043, "talk": 0.00019, "activate hiv-1 gene expression": 0.02177, "anti-cd3 mab-induced proliferation": 0.00536, "pp-2a": 0.00012, "resembles 'latency": 9e-05, "include hyperresponsiveness": 0.01439, "control individual": 0.01303, "stochastic": 0.00012, "harbor scl gene rearrangement": 0.02177, "tissue transplantation": 0.00664, "severe phenotype characterize": 0.00283, "early b-cell development": 0.00552, "cdk inhibitor": 0.009, "variable vdr expression": 0.02775, "x-linked combined immunodeficiency disease": 0.00337, "ig hypermutation process": 0.00296, "rac": 0.00074, "upstream nf-kappab": 0.00999, "jak kinase pathway": 0.00852, "lck-negative jcam1 cell": 0.0512, "female patient": 0.01666, "polymorphic allele": 0.0022, "synthetic glucocorticoid vary": 0.00567, "cell activity": 0.0768, "comparison": 0.00354, "intron/exon junction": 3e-05, "asthma pathogenesis": 0.00171, "variant sequence": 0.01625, "htlv-i p40tax": 0.00276, "rflp genotype": 0.0004, "inorganic lead": 0.00996, "blockade": 0.00136, "contained mutation": 0.00592, "impromidine": 6e-05, "pluripotent endocrine culture": 0.00414, "monocytoid leukemia cell line u937": 0.03072, "hiv-enhancer activity concomitant": 0.0195, "drosophila extra sex comb gene display transcriptional repressor activity": 0.00968, "hematopoietin receptor superfamily": 0.01714, "type ii ifns suppress il-4/il-13-inducible gene expression": 0.01244, "2-vitamin d3": 0.00245, "cytolytic activity": 0.02925, "synthetic ceramide analog result": 0.00805, "atra-induced expression": 0.04163, "radiotherapy remains": 0.00037, "chicken cytokine": 0.01123, "triplet": 6e-05, "r.c": 0.0, "perceptible": 6e-05, "cell culture experiment demonstrate": 0.0384, "plap reporter gene": 0.02903, "igg": 0.00167, "philip tl20/12rs sun lamp": 5e-05, "rutin": 0.00025, "leucine incorporation": 0.00068, "fetal murine thymus exhibit": 0.00332, "adult human": 0.03762, "hu stimulate": 0.01101, "p65/p50 nf-kappab": 0.00999, "hepatic gr": 0.004, "transfected nonlymphoid hela cell": 0.0384, "success": 0.00012, "represent redox stabilization": 0.00267, "prb protein": 0.04529, "band q26": 0.00102, "ligand-dependent repression": 0.00211, "eventual program cell death": 0.0384, "kd bind": 0.02025, "flow cytometry show": 0.01733, "e2f-1 block terminal differentiation": 0.00589, "major regulatory function": 0.00887, "helper cell result": 0.0512, "h-7-sensitive kinase": 0.01188, "p13mtcp1 normal lymphoid tissue": 0.00605, "tr55 expression": 0.04163, "mutation occur": 0.00654, "activate stat6": 0.01777, "uneven": 6e-05, "kiaa0144": 6e-05, "signal growth inhibition": 0.0109, "acute myeloid leukemia characterize": 0.0025, "rb protein expression": 0.03019, "cat protein": 0.04529, "proximal mouse chromosome": 0.00649, "up-regulates": 0.00112, "gangliosides suppress tumor necrosis factor production": 0.00953, "fatty acid": 0.00856, "promoter commonly": 0.02336, "fish technique": 0.00109, "-dependent phosphorylation system": 0.00656, "amide-containing amino acid": 0.00571, "immunosuppression": 0.00124, "human enhancer": 0.03762, "b2 factor": 0.0286, "ctla-4-mediated inhibition": 0.01061, "promoter element require": 0.01557, "embryonic zeta": 0.00127, "immunologic feature": 0.00217, "inducible nitric oxide": 0.00323, "impdh type ii gene expression": 0.01742, "t-lymphocyte proliferation": 0.00803, "soluble preparation": 0.00223, "vitro exposure": 0.00785, "cd8+ t-cell subpopulation fail": 0.00481, "cd68": 0.00012, "multiple gene": 0.04355, "serum response element": 0.01294, "triggering": 0.00074, "low cd4+ cell count": 0.0384, "sophisticated control": 0.01303, "ttk": 0.00019, "identification": 0.00248, "htlv-1 tax": 0.00478, "b27 antigen incidence": 0.00546, "erythroid k562 cell": 0.0512, "exhibit high affinity": 0.0062, "elevation": 0.00186, "100-fold low": 0.00707, "domain center": 0.01207, "il-2 mrna response": 0.01294, "il-6-induced apoptosis": 0.0089, "gastric carcinoma cell": 0.0512, "lipopolysaccharide-induced tnf-alpha production": 0.00695, "protein increase": 0.04529, "activate myeloid leukocyte": 0.01185, "minimal cd4 silencer": 0.00221, "replicative senescence": 0.00112, "ngal level": 0.01821, "freshly prepared human": 0.02508, "pronounced effect": 0.02115, "human mhc class ii gene transcription direct": 0.01244, "red cell-specific transcriptional activator": 0.00575, "/cd38-": 0.0, "fas/fas ligand": 0.00592, "term olf-1": 0.00413, "regulate lps/ifn-gamma induced expression": 0.02081, "cd40l engagement": 0.00133, "ptk inhibitor herbimycin": 0.006, "basic domain-leucine zipper region": 0.00734, "short promoter region": 0.01557, "influence msr level": 0.01214, "class ii gene transactivator": 0.02177, "a1/bfl-1": 6e-05, "microorganism": 0.00012, "tbp-containing complex": 0.01684, "achievable concentration": 0.0067, "hypothalamo-pituitary-adrenal axis function": 0.00887, "spliced rna": 0.00456, "low nuclear expression": 0.02775, "restores ra sensitivity": 0.00397, "e2f-dependent regulation": 0.01008, "antigen present cell": 0.0512, "intact nuclear matrix preparation": 0.00842, "finding show": 0.02599, "gcr binding affinity": 0.01237, "g0/g1 switch gene": 0.02903, "airway epithelial cell provide": 0.0384, "stimulate enzymatic process include kinase": 0.00576, "co-transfected il-2 promoter": 0.01557, "cell type-specific permissiveness": 0.0512, "deletion mutation": 0.00592, "frequent": 0.00099, "jak-3": 0.00031, "glycoprotein hormone erythropoietin": 0.00296, "cooperative activation": 0.03164, "47-kda protein": 0.04529, "clone human": 0.03762, "range": 0.00403, "a/t": 0.00037, "estrogen-dependent lymphoblastoid cell line express": 0.03072, "nf-kappab transcriptional activation": 0.02109, "e3": 0.00149, "deleterious": 0.00031, "and/or protein kinase": 0.03019, "general transcription factor": 0.01907, "intracellular signalling network": 0.00389, "proximal promoter": 0.02336, "dominant negative mutant": 0.0054, "intact paired domain": 0.00804, "powerful": 0.00099, "microm cadmium chloride": 0.00087, "pkc activator": 0.00552, "electrophoretic dna mobility shift assay": 0.00593, "cd28 coligation": 0.00323, "cd19 signaling": 0.00558, "recurrent infection": 0.0062, "present study demonstrate": 0.01065, "interleukin-2 gene": 0.04355, "j.c.alwine": 6e-05, "mouse tissue demonstrate": 0.01065, "heat shock element-containing reporter construct": 0.0029, "tnf-alpha level": 0.01821, "fatty acid-binding protein": 0.03019, "pc-3": 0.00019, "em analysis": 0.01179, "repress gene expression": 0.02903, "hybrid promoter construct demonstrate": 0.01168, "ubiquitous transcriptional regulator": 0.00767, "tpa/ca": 6e-05, "pattern dominant": 0.00549, "nfat-containing complex devoid": 0.01123, "slope factor": 0.0286, "putative intracellular receptor": 0.01714, "southern blot analysis": 0.00786, "show similarity": 0.02599, "//compel.bionet.nsc.ru/funsite/compelscan.html": 6e-05, "il-4 costimulation": 0.00667, "data shed light": 0.0017, "tnf-alpha": 0.01092, "fn-induced il-1beta response": 0.01294, "essential protein": 0.04529, "anti-cr3 ab": 0.00167, "intrinsic dna-binding activity": 0.0195, "mantle zone": 0.00034, "interference": 0.0018, "heterogeneous group": 0.00487, "kappab3 sit": 0.00143, "magnetic separation": 0.00053, "myocyte-enhancer factor": 0.0286, "transient heterokaryon system": 0.00445, "cre reporter plasmid": 0.00368, "stat protein phosphorylation": 0.03019, "oligo stimulation": 0.0112, "enhances myeloid": 0.00462, "mutant allele": 0.0081, "developmental process": 0.00444, "kruppel-related zinc finger protein express": 0.01811, "intestinal calcium": 0.00236, "present increase serum transaminase": 0.01098, "csa lead": 0.00996, "site-directed mutation": 0.00592, "bcl-xs": 0.00012, "defensin sensitivity": 0.00236, "activate src": 0.01777, "hypothalamic-pituitary-adrenal function intact": 0.00887, "alpha g2s exhibit increased expression": 0.01665, "blood monocyte": 0.01197, "important mediator": 0.00689, "gam": 0.00012, "initiation bind repressor": 0.0135, "coculture": 0.00056, "pharmacologic control": 0.01303, "display constitutive nf-kappab activity": 0.01462, "kb mrna": 0.01526, "prediction": 0.00025, "gh": 0.00118, "mdd patient": 0.01666, "chemokine family": 0.00841, "endothelial surface": 0.00515, "murine pro-b cell line baf3": 0.03072, "primary t-all cell": 0.0512, "specific nf-kappa b/rel subunit": 0.00707, "agent": 0.00844, "pair": 0.00428, "annexinv labeling": 0.0005, "igh gene expression": 0.02903, "antisense myb rna expression suppress hm-induced differentiation": 0.01189, "residue lead": 0.00996, "predictive": 0.00025, "prolonged corticosteroid treatment result": 0.00805, "stat5 target gene": 0.02903, "composite nf-at/": 0.00068, "functional conservation": 0.00816, "ro generation inhibition parallel nf-kappab level": 0.00607, "nf-kappab-dependent intracellular signal pathway": 0.00817, "0.5-": 0.00012, "clonogenetic fetal calf serum-supplemented": 0.00107, "transfected il-2 promoter": 0.01557, "replaced enhancer": 0.00909, "early b-cell precursor": 0.00552, "intranuclear localization": 0.00186, "cooperative stabilization": 0.00068, "tolerant murine p388 macrophage": 0.00312, "htlv-i-associated disease": 0.00673, "ikappab-alpha transfer": 0.00112, "4.3-fold": 6e-05, "innate immune response": 0.01294, "tcr transduction mechanism": 0.00705, "hgf": 0.00012, "distinct molecule": 0.00853, "specific sequence": 0.01625, "urinary free cortisol excretion": 0.00147, "rest human peripheral blood monocyte": 0.01505, "negative regulatory protein kinase glycogen synthase kinase-3beta": 0.01294, "polyclonal activator phorbol ester": 0.00276, "transcriptional competence": 0.01151, "controversy": 6e-05, "nonmonocytic cell line hela": 0.0384, "cipro": 0.00037, "ikappab alpha regulation reveal": 0.00585, "gcr-alpha dna binding capacity": 0.00927, "zona glomerulosa": 3e-05, "morbidity": 0.00019, "viral peptide": 0.00754, "patient undergoing elective ptca": 0.00833, "increase virus production": 0.01464, "kg-1": 0.00043, "vitro footprinting": 0.00785, "8-fold increase": 0.02196, "sterile culture medium serve": 0.0031, "cellular transformation": 0.00893, "primary ovarian carcinoma": 0.00492, "tcr-cd3": 0.00025, "target mutational analysis demonstrate": 0.00799, "ketoconazole treatment": 0.01014, "induction phase": 0.01607, "nf-kappab/nfat protein": 0.04529, "nf-il6 mrna level": 0.01214, "nk cell induce hla-dr": 0.0384, "conservation": 0.00056, "ebv genome": 0.00565, "stat nuclear protein": 0.03019, "beth israel hospital": 6e-05, "large dos": 0.00205, "kinase inhibitor staurosporine": 0.00792, "5-lox enzyme": 0.0031, "transfection-cocultivation": 6e-05, "ica-positive first-degree relative": 0.00184, "immune reaction": 0.00599, "prevent nf-y binding": 0.01237, "colleague": 6e-05, "gene mark patient": 0.02903, "map unit": 0.00205, "il-12 activate stat4": 0.01185, "distinct gene": 0.04355, "human tfiid protein share": 0.02264, "ctls": 0.00062, "human monocyte induces immunoregulatory gene expression": 0.01452, "defective translocation": 0.00515, "target structure": 0.00825, "develop prostate cancer": 0.00269, "nf-at binding site": 0.01445, "bcl-2 upregulation": 0.00295, "soundness": 6e-05, "chronic hepatitis c.": 0.00265, "35s-tr": 0.00025, "intracytoplasmic signalling cascade": 0.00143, "heart failure": 0.00136, "high-level e1a oncoprotein expression": 0.02081, "clone mouse embryonic ectoderm development gene": 0.01452, "catalase inhibit phase-1 adhesion": 0.00952, "-positive virus carrier": 0.00591, "homology": 0.00366, "cytofluorometry analysis": 0.01179, "native b. burgdorferi ospa": 0.00081, "il-12r": 0.00056, "northern blot": 0.00109, "lck": 0.0023, "ebna2-deficient epstein-barr virus strain p3hr1": 0.00355, "classical competition binding assay": 0.00927, "il-2 receptor alpha expression": 0.02081, "15-lo promoter": 0.02336, "hgr level": 0.01821, "general correlation": 0.00248, "study intracellular signal transduction": 0.00817, "mitogen-activated protein kinase-targeted hematopoietic tyrosine phosphatase": 0.0151, "menopausal period": 0.00127, "genbank database": 0.00012, "bind sequence": 0.02025, "nuclear membrane protein": 0.03019, "determine": 0.01557, "o2-": 0.00012, "rel oncogene": 0.00261, "lmp1 signaling": 0.00558, "nonrelated cell": 0.0768, "vitro assay": 0.01002, "ibf": 6e-05, "t3 suppressibility": 0.00118, "nf-il6 gene": 0.04355, "ltr result": 0.0161, "self-distructed immune response": 0.01294, "internal ribosome bind": 0.0135, "hsf-1": 0.00019, "conserved structural motif": 0.00583, "atgcaaat octamer sequence": 0.01084, "immunotherapeutic target": 0.00825, "detect stat protein": 0.03019, "nuclear factor implicate": 0.01907, "s. cerevisiae": 0.00065, "infected cell fail": 0.0512, "nf-kappa b1": 0.01414, "reflection": 0.0, "cell line nb4": 0.0512, "monocytic thp-1 cell tnf-alpha induced": 0.03072, "fibrinogen-binding integrins": 0.00034, "vdre binding complex": 0.01237, "human tuberculosis": 0.03762, "gm-csf transcription initiation site": 0.01405, "arachidonic acid liberation demonstrate": 0.00799, "cd23 expression": 0.04163, "ap-1 transcriptional factor": 0.01907, "30-50 microm": 0.0013, "rheumatoid synovial": 0.00093, "hla-dr-constitutive": 0.00012, "mouse b29 promoter": 0.01557, "ril-2": 6e-05, "increase hiv-1 steady-state mrna level": 0.00878, "il-6-responsive gene element": 0.02903, "basal gene expression": 0.02903, "proximal c-jun tre-like promoter element": 0.00934, "cpg dinucleotide": 0.00016, "mediate neutrophil adhesion": 0.00821, "9-cis-ra": 0.00037, "huvec nuclear protein reveal": 0.02264, "spondyloarthropathies": 6e-05, "increased adhesion": 0.0058, "mediate low level": 0.01214, "gamma": 0.00881, "alpha receptor": 0.02571, "activated t-cell clone": 0.00641, "dominant-negative rxr-retinoic acid receptor alpha403 heterodimers": 0.00857, "support": 0.00819, "sscp": 0.00019, "hla-dr3": 0.00025, "hla-dr antigen express": 0.0123, "il-2 promoter require activity": 0.01462, "term caspase": 0.00413, "integrity": 0.00031, "hs2 enhancer": 0.00909, "z-lll-h-insensitive transcriptional": 0.01151, "clone": 0.01476, "augmented biological effect": 0.0141, "mnl isolate": 0.00416, "atl-derived cell line": 0.0512, "radiation-induced activation": 0.03164, "er27191": 6e-05, "anti-estrogenic action": 0.00499, "thp-1 mononuclear phagocyte cell line": 0.03072, "pathway dependent": 0.01278, "box-binding activity lef1/bcf1": 0.0195, "raw264.7 macrophage cell": 0.0512, "m-csf induction": 0.01607, "cox": 0.00031, "cell surface protein implicate": 0.0384, "recent functional analysis": 0.00786, "pml-rar gene expression": 0.02903, "tax mutant": 0.0081, "otf interaction": 0.00986, "bind activity": 0.02925, "competitive model": 0.00422, "histone h4": 0.00133, "dbf-sites": 6e-05, "lymphoid cell-specific factor otf2": 0.0143, "stable retinobenzoic derivative": 0.00128, "decreased": 0.0044, "dexter-type long-term culture": 0.00414, "schizosaccharomyces pombe mc mating type gene": 0.01452, "signal induced activity": 0.0195, "great part": 0.00205, "cord lymphocyte proliferation rate": 0.00741, "dimeric gata-1 binding site": 0.01084, "complex interaction occur": 0.01123, "specific t-cell tolerance induction": 0.00803, "megakaryocyte lineage": 0.00366, "cell receptor cross-linking": 0.0512, "resident": 0.00068, "lipopolysaccharide effect": 0.02115, "phrase": 0.00012, "initial diameter": 0.00189, "esterified egta": 0.00016, "140+/-25": 0.00012, "natural cytotoxicity exert": 0.00194, "microe5/kappa": 0.00025, "interleukin-10 stabilizes inhibitory kappab-alpha": 0.00178, "egr1 bind motif": 0.0135, "il-6 induced macrophage-differentiation": 0.0036, "lymphoid lineage commitment": 0.00273, "key role": 0.01328, "specific transcription factor": 0.01907, "potential inhibitor": 0.009, "recessiveness": 0.0, "stimulate endothelial cell": 0.0512, "arrangement": 0.00025, "cross-linking antibody": 0.00893, "tissue-specific activation": 0.03164, "g-protein-coupled receptor": 0.02571, "helper cell cytokine production play": 0.03072, "interleukin-2 induces tyrosine phosphorylation": 0.00492, "exogenous gata-1": 0.00413, "ar assay": 0.01002, "human lymphoblastic jurkat": 0.02508, "colon cancer cell": 0.0512, "interleukin-4 induced vdr": 0.0036, "erythroid transcription factor gata-1": 0.0143, "h. jak1": 0.00124, "louckes": 6e-05, "clinical parameter": 0.00425, "pparbeta": 0.00012, "allergy": 0.00062, "upstream portion": 0.00369, "il5": 0.0, "mlv transcriptional activity": 0.0195, "apoptotic response": 0.01942, "soluble tn inhibits proliferation": 0.00402, "macrophage transcription factor pu.1 direct tissue-specific expression": 0.01189, "specific 32p-labelled oligonucleotide": 0.00825, "chromosome translocation associate": 0.00728, "physiological receptor-mediated agonist gm-csf": 0.00164, "ltr-driven proviral transcription unit": 0.01405, "cell express squirrel monkey fkbp51": 0.03072, "t-all cell line": 0.0512, "up-regulated endogenous fasl mrna": 0.00763, "active ne": 0.00592, "inhibitory sequence": 0.01625, "specific bind site": 0.01445, "signal cascade": 0.01635, "jun family protein": 0.03019, "microglia": 0.00068, "orientation-specific manner": 0.00282, "display mutation": 0.00592, "m-csf induces": 0.00803, "translational initiation": 0.00211, "jurkat": 0.0111, "receptor coupling": 0.02571, "bhlh": 0.00136, "murine b-cell specific transcriptional coactivator bob1": 0.00413, "organized tissue microenvironment remain undefined": 0.00266, "nef protein down-regulates": 0.03019, "regular border": 0.00025, "phosphotyrosine-containing peptide": 0.00754, "il-6-type cytokine": 0.01123, "coordinate activation": 0.03164, "absolute requirement": 0.00264, "okt8+": 0.00012, "c-myc protein": 0.04529, "mutant p53 cooperate": 0.0054, "ra oncogene block terminal differentiation": 0.00471, "dexamethasone-resistant human leukemic": 0.02508, "characterize pou-domain": 0.00425, "local immunosuppression": 0.00081, "binding site show": 0.01733, "human interleukin-5": 0.03762, "alpha-dependent mechanism": 0.01058, "present result": 0.0161, "prl-secreting": 6e-05, "up-": 6e-05, "critical regulator": 0.00428, "sibling cell level": 0.0512, "tumour sample": 0.00208, "tolerant": 0.00068, "transcription factor nuclear factor": 0.01405, "dna binding specificity": 0.01237, "tcr stimulation": 0.0112, "calcineurin potentiate activation": 0.02109, "cell line influence": 0.0512, "vitro transendothelial migration": 0.00523, "hiv-1 nf kappa": 0.00585, "lysopc content": 0.00158, "lps initiate monocyte activation": 0.01582, "'naive": 6e-05, "deltanfkappabdeltasp1": 0.00012, "cell leukemia induce": 0.0512, "estrogen response element": 0.01294, "megakaryocytic transcript": 0.00599, "overlap functional response": 0.01294, "second-site ltr revertants": 0.00207, "biological modification": 0.00217, "regulatory immediate-early gene": 0.02903, "fos gene family member": 0.02177, "single-cell level consisting": 0.01214, "c-fos/c-jun ap-1": 0.00695, "accounting": 0.00019, "n-terminal domain confers calcium-signaling dependence": 0.00483, "bcl6 gene encode": 0.02903, "c-myb oncogene product": 0.00356, "9-29 ppt i-te": 0.00014, "dominant-negative": 0.00205, "healthy person": 0.00177, "tnf-alpha-inducible promoter activity": 0.0195, "inducible protein": 0.04529, "mouse th2 d10 cell": 0.0384, "promonocytic thp-1 cell require prestimulation": 0.03072, "jun gene show": 0.02903, "mutant kappab site": 0.01445, "minority": 0.00025, "reporter gene assay": 0.02903, "il-2 level remain low": 0.0091, "orf2": 0.00025, "electrophoretic mobility shift assay and/or": 0.00401, "rb bind site": 0.01445, "affect er mrna expression": 0.02081, "sucrose gradient assay": 0.00668, "globin gene": 0.04355, "ikappab-epsilon disappearance": 0.00019, "rel-related": 0.00099, "mutant form": 0.01055, "interdependent": 6e-05, "cotton top tamarin": 0.00014, "two-fold": 0.00019, "secrete measurable amount": 0.0019, "vicinity": 0.00012, "require phosphorylation": 0.01315, "glucocorticoid hormone": 0.0085, "murine thymoma cell": 0.0512, "specific biological function": 0.00887, "intact human il-4 promoter": 0.01881, "germinal center gc": 0.00207, "diverse tissue": 0.00664, "iddm serum": 0.00378, "platelet morphogenesis": 0.00372, "lipid oxidation": 0.00124, "migrates": 0.00019, "neutrophil commitment": 0.00496, "human bruton": 0.03762, "helix-loop-helix family": 0.00841, "alternative receptor complex": 0.01714, "jurkat t-cells stimulate": 0.00734, "important class": 0.00689, "similar role": 0.01328, "female population": 0.00307, "peripheral mononuclear leukocyte provide": 0.00323, "tandem domain": 0.01207, "granulocytic lineage": 0.00366, "fn-induced il-1beta response remain unclear": 0.00777, "tre-like camp-responsive dse site": 0.01084, "complete maturation": 0.00251, "strong deoxidizing activity": 0.0195, "bcl-2 promoter": 0.02336, "quantitative assay demonstrate": 0.01065, "sp1 play": 0.0071, "reporter gene construct": 0.02903, "n-terminal conserved region": 0.00978, "select transfected clone": 0.00492, "jurkat cell downmodulates": 0.0512, "p70 production": 0.01042, "technology": 0.00019, "culture stimulate": 0.01101, "t-cell epitope": 0.00962, "include aml1/cbf beta": 0.00959, "ap-1 family": 0.00841, "tissue rich": 0.00664, "ten mutant": 0.0081, "paxillin": 0.00025, "molecular chaperone hsp90": 0.003, "lyme disease": 0.00673, "mammalian il2s": 0.00174, "deamidation": 0.00019, "standard method": 0.00236, "molecular mechanism underlie": 0.00705, "distinct role": 0.01328, "affect vascular remodeling": 0.00531, "chronic mpds": 0.00397, "prototypical form": 0.01055, "consecutive il-1beta-": 0.00031, "cell-intrinsic mechanism": 0.01058, "peptide vaccination": 0.00754, "creb bind protein": 0.03019, "human myeloid-selective ccaat/enhancer bind protein gene": 0.0151, "fetal antigen": 0.00819, "biotinylated hsie probe": 0.00174, "activate interleukin-2": 0.01777, "-binding protein complex include alf1": 0.01811, "irs-1": 0.00012, "cytosolic extract": 0.00459, "hiv-1 production": 0.01042, "octamer motif act": 0.00583, "contributes": 0.00217, "il-7r alpha chain": 0.0078, "stable lmp1+ clone": 0.00492, "normal cell growth": 0.0512, "kappa b-binding protein": 0.03019, "agonist-dependent phosphorylation": 0.00983, "sentman": 6e-05, "untreated k562 cell": 0.0512, "alanine mutagenesis analysis": 0.00786, "threshold": 0.00124, "ap-1 sequence": 0.01625, "grb2": 0.00118, "complete arrest": 0.00171, "cell-permeable proteasome inhibitor": 0.006, "giant cell arteritis": 0.0512, "cell line deficient": 0.0512, "interferon affect nuclear protein": 0.02264, "matrix metalloproteinase": 0.0013, "hdg-1": 0.0, "rac1": 6e-05, "substantial kappa b-binding activity": 0.01462, "repetitive activation": 0.03164, "c1": 0.00043, "spi-b gene expression increase": 0.02177, "natural cytotoxicity program regulate ap-1 expression": 0.01388, "nf-kappa b-mediated gene transcription": 0.02177, "suppressor activity": 0.02925, "rate": 0.00558, "large cohort": 0.00205, "alg-4f": 0.0, "express sialoadhesin": 0.01846, "vary time interval reveal": 0.00549, "relb protein": 0.04529, "constitutive virus expression": 0.02775, "atopic disease": 0.00673, "activate effect": 0.02115, "integrin ligation lead": 0.00664, "rest human": 0.03762, "simultaneous incubation": 0.00208, "gal4 dna-binding domain": 0.00804, "pecam-1 gene": 0.04355, "salmonella typhimurium strain": 0.00124, "distinct pathway": 0.01278, "myeloid/monocytic differentiation": 0.01179, "nontransgenic mouse": 0.00974, "dna precursor pathway enzyme": 0.00741, "htlv-i gene expression": 0.02903, "suggest persistence": 0.02022, "putative mammalian sex-determining gene sry": 0.01742, "impaired immunoglobulin gene expression": 0.02177, "experimental group show increase basal plasma corticosterone level": 0.0065, "fm gene": 0.04355, "chimera": 0.00161, "multiple human tissue": 0.02508, "apparent molecular mass": 0.003, "latent adenovirus": 0.00226, "anti-cd4-fitc": 0.00012, "real time": 0.00273, "tcf-1 belongs": 0.00189, "single-strand conformation polymorphism analysis": 0.00589, "tfe-3": 6e-05, "transcriptional enhancement": 0.01151, "active v-abl protein tyrosine kinase block immunoglobulin light-chain gene rearrangement": 0.00906, "hiv-hd express": 0.01846, "upper range": 0.00202, "12-o-tetradecanoylphorbol-13-acetate induced differentiation": 0.00786, "ifn-beta treatment": 0.01014, "expression construct": 0.04163, "cd28-responsive complex": 0.01684, "phospholipase cgamma1": 0.00078, "relocation": 0.00012, "infiltration": 0.00285, "prevent t-cell proliferation": 0.00641, "direct bearing": 0.0054, "vbeta usage": 0.00016, "pparalpha activator inhibit cytokine-induced vascular cell adhesion molecule-1 expression": 0.01707, "ciita mrna induction level": 0.0091, "cref cell": 0.0768, "hsp expression": 0.04163, "ets-family": 0.0, "nucleated erythroblast": 0.00105, "classical banding technique": 0.00114, "switch recombination": 0.00245, "lung vascular leak": 0.0013, "mitogen-inducible gene product": 0.02903, "nf-kappab directs expression": 0.02775, "vwf production": 0.01042, "pnu156804 inhibition": 0.01061, "enhanced expression": 0.04163, "protein synthesis-independent": 0.04529, "maximal physical exercise": 0.00122, "ge": 0.00019, "n-terminal pou-specific domain": 0.00804, "androgen binding site": 0.01445, "gig18": 0.00025, "cre bind protein": 0.03019, "tryptophan solution": 0.00056, "non-t immune cell": 0.0512, "homing receptor blr1": 0.01714, "mycotoxin alpha-zearalenol": 9e-05, "idcs": 0.00012, "loss-": 6e-05, "exogenous 1,25-": 0.00214, "fos/g0s7 mrna": 0.01526, "rapid non-genomic effect": 0.0141, "c-fos sre cross-competed": 0.00314, "nuclear protein require": 0.03019, "mouse tumorigenicity assay": 0.00668, "il-2 promoter cd28 response element/ap-1 sequence": 0.00779, "study putative teratogenic effect": 0.01058, "reveal distinct region important": 0.00734, "large amount": 0.00285, "rank order": 0.00124, "ebv-positive endemic bl": 0.00041, "tumor necrosis factor/nerve growth factor receptor superfamily": 0.00817, "combinatorial peptide library base": 0.00377, "prototype class ii gene": 0.02177, "acute myeloid leukemia gene": 0.02177, "functional copy": 0.00816, "il-2 share common control mechanism": 0.00521, "creb/atf transcription factor": 0.01907, "b-2 cell": 0.0768, "il-6 promoter responsive": 0.01557, "immunoglobulin secretion": 0.00428, "x-linked human androgen receptor": 0.01881, "cell response induce": 0.0512, "stat1 play": 0.0071, "globin promoter activity": 0.0195, "designation": 0.00012, "invariant chain-derived peptide": 0.00502, "altered memory": 0.00161, "p56": 0.00149, "tumor-suppressor protein prb": 0.03019, "scant cytoplasm": 0.00062, "exert effect": 0.02115, "recombinant zebra protein": 0.03019, "u2 dna-protein complex": 0.01123, "epsilon bp": 0.00267, "h5sub304 infection": 0.0062, "longer": 0.00099, "subtractive cloning": 0.00071, "pb-induced immunotoxicity": 9e-05, "interferon-stimulated gene induce": 0.02903, "relevant chromosome": 0.00295, "erythroid progenitor cell growth": 0.0384, "human il-2 gene": 0.02903, "nf-kappab translocates": 0.00999, "pou-homeodomain": 6e-05, "pseudohypoaldosteronism": 0.00037, "cd5 surface expression": 0.02775, "dibenzo-p-dioxins": 6e-05, "common human malignancy": 0.02508, "mnp-1": 0.00062, "inducibility/cell type specificity": 0.00633, "pkc inhibitor h7": 0.006, "tnf mrna": 0.01526, "cell type responsible": 0.0512, "p47": 0.00012, "unique pml/raralpha": 0.00261, "p50/p65 induce": 0.0254, "normal cd34+ bone marrow cell": 0.03072, "trans-activating domain": 0.01207, "human immunodeficiency virus type": 0.01881, "perpetuation": 0.00019, "primary approach": 0.00738, "regulate important aspect": 0.00835, "so-called pml nuclear body": 0.00842, "activate ec": 0.01777, "recent progress": 0.0014, "present study": 0.01355, "e2 response": 0.01942, "activate stat1alpha": 0.01777, "prip": 6e-05, "zinc-binding protein": 0.04529, "tcf-1 knock-out mouse": 0.00649, "classical intracellular ar": 0.00389, "calcium signal": 0.01635, "acute promyelocytic leukemia cell": 0.0384, "jnk map kinase": 0.00792, "binds nuclear protein": 0.03019, "gender-specific difference": 0.00425, "mediate induction": 0.01607, "cytokine mrna expression": 0.02775, "vdr": 0.00465, "pebp2 alpha a1": 0.0078, "il-2-induced phosphorylation": 0.00983, "dna topoisomerase ii inhibitor": 0.00741, "mast cell proliferation": 0.0512, "low binding capacity": 0.01237, "xenopus hepatocytes": 0.00025, "human er mrna": 0.02508, "specific ligand": 0.01238, "reconstitution condition": 0.0036, "e2f binding site": 0.01445, "endothelial adhesion molecule": 0.00569, "il-2-alpha receptor expression": 0.02775, "show glutamine synthetase induction": 0.013, "part dependent": 0.00388, "bcr signal transduction": 0.0109, "cd8 antigen": 0.00819, "dexamethasone abolish": 0.00394, "pathway participate": 0.01278, "bone-sparing effect": 0.02115, "dlcl case": 0.00363, "functional trans-activation domain": 0.00804, "cell undergo activation": 0.0512, "mpl": 0.00087, "close correlation": 0.00248, "form ifn-gamma-activated sequence-binding complex": 0.00842, "hla-b8": 0.00012, "transient response": 0.01942, "human activate monocyte": 0.02508, "cd40/cd40l interaction": 0.00986, "protein-coupled receptor agonist thrombin": 0.01286, "cona": 6e-05, "transcription-regulating protein": 0.04529, "hl-60 eosinophilic sublines": 0.0013, "gp ib-ix-v complex": 0.01123, "age-related immune deficiency": 0.00399, "primary hemopoietic cell": 0.0512, "dc express high level": 0.00923, "ikappab alpha": 0.01169, "pip binding site": 0.01445, "aml1 gene": 0.04355, "cd11c promoter result": 0.01557, "transient transfection": 0.00344, "platelet": 0.00744, "stringency": 0.00031, "result link regulatory factor critical": 0.01144, "h2 agonist": 0.0022, "cocultures": 0.00025, "dhea effect": 0.02115, "biallelic mode": 0.00074, "c-terminal activating": 0.00192, "region bind": 0.02025, "physiological molecule": 0.00853, "ras-related gtp-binding protein": 0.03019, "delta promoter": 0.02336, "induce apoptosis": 0.0254, "high male breast cancer mortality rate": 0.0031, "antigen receptor signal": 0.01714, "polymorphonuclear leukocyte bind": 0.0135, "gamma gene": 0.04355, "ovarian cancer": 0.00248, "non-hodgkin lymphoma": 0.00226, "socs/ ssi/cis gene family": 0.02177, "clinical investigation": 0.00425, "studied model": 0.00422, "mtetra-induced il-6 mrna expression": 0.02081, "adult rat": 0.00422, "rrlpif": 0.0, "study present": 0.01355, "xci": 0.00025, "uninfected jurkat cell line": 0.0384, "immediate-early locus": 0.00288, "translational component regulate": 0.00835, "inflammatory complication": 0.00471, "cell gene cd21": 0.0512, "-diene-3,20-dione": 0.0, "selective appearance": 0.00267, "critical determinant": 0.00428, "culture-adapted tax-transformed fibroblast": 0.00225, "exert significant influence": 0.00314, "common marmoset": 0.0035, "stat1 alpha": 0.01169, "mineralocorticoid effector mechanism": 0.00705, "normal cell type": 0.0512, "interleukin-6 level": 0.01821, "human cell line model": 0.0384, "nfat activation": 0.03164, "ubiquitin carrier enzyme": 0.00207, "nuclear factor-il6 activate": 0.01185, "processing": 0.00267, "dcr": 6e-05, "heterogeneous clinical manifestation": 0.00283, "gata family": 0.00841, "oct-2a binding site": 0.01445, "lps-induced transcription factor": 0.01907, "p50/c-rel complex": 0.01684, "okt3 antibody": 0.00893, "pax-5": 0.00105, "fibrinogen activate nf-kappa": 0.01185, "cd16 ligand induce nfat-like dna binding activity": 0.00836, "pbmcs": 0.00161, "oncogene express fibroblast similarly trigger phosphoinositide hydrolysis": 0.00527, "efficient interaction": 0.00986, "cell selectively enhance il-4 expression relative": 0.0256, "precursor": 0.00645, "lymphoid cell resistance": 0.0512, "major late promoter": 0.01557, "constitutively activate": 0.01777, "allergic patient": 0.01666, "cd4 receptor play": 0.01714, "cell membrane expression": 0.0512, "cre-loxp recombination system": 0.00445, "indomethacin": 0.00056, "nf-e2 transcription factor": 0.01907, "limited portion": 0.00081, "immunosuppressant cyclosporin": 0.0022, "cd40-activated monocyte": 0.01197, "bcl-6 gene product": 0.02903, "e1b-19 kda protein suggest": 0.02264, "m. vignoli": 0.00115, "normoxia": 0.00012, "inverse relationship": 0.00158, "small animal model": 0.00281, "positive regulatory activity": 0.0195, "low multinuclearity": 0.00707, "human il-2r beta": 0.02508, "relevant dose": 0.00158, "phi": 0.00031, "-52": 0.00025, "erythrocytic progenitor": 0.00276, "hemopoietic myeloid cell differentiation": 0.0384, "hormone-activated transcription factor": 0.01907, "proteasome play": 0.0071, "determinant": 0.00236, "plasmid bear": 0.00273, "complex link": 0.01684, "neutrophil maturation occur": 0.00436, "triiodothyronine receptor mrna": 0.01714, "abolish il-9-induced cell proliferation": 0.0384, "n'-tetrakis": 6e-05, "pld stimulation": 0.0112, "adolescent": 0.00074, "hormone-mediated survival": 0.00236, "htlv-i": 0.00552, "-cd3 complex result": 0.01123, "normal peripheral blood mononuclear cell": 0.03072, "c/ebp activate": 0.01777, "screening system": 0.00667, "proliferative signal": 0.01635, "epithelial cell": 0.0768, "cell cycle": 0.0768, "glucocorticoid receptor binding": 0.01714, "ad1": 6e-05, "virus-encoded": 0.00068, "cml cytoplasmic protein": 0.03019, "cdk6": 0.00012, "17beta-estradiol": 6e-05, "mthc": 0.00037, "gata-responsive element": 0.01672, "monocyte/macrophage leukemia line": 0.01102, "cell-surface receptor": 0.02571, "tax-independent mechanism": 0.01058, "mature cell line": 0.0512, "hla bind characteristic": 0.0135, "mediate signal downstream": 0.0109, "gata-1 -mutant embryonic stem cell": 0.03072, "differential contribution": 0.00323, "efficacy": 0.00081, "specific negative regulation": 0.00825, "atf-2": 0.00068, "frequent absence": 0.0031, "inefficient dna replication": 0.00988, "leukemic lymphoblast": 0.00251, "northern blot hybridization": 0.00103, "stimulate cd40 response": 0.01294, "mouse cd19 gene": 0.02903, "beta isoform": 0.00673, "nonpermissive monocyte-like u-937 cell culture": 0.03072, "bind site contributes": 0.01445, "c-erbb2": 0.00037, "tcf-1 alpha": 0.01169, "empty expression vector": 0.02775, "bmlf1": 0.00062, "optimal induction": 0.01607, "hla class i-mediated induction": 0.00803, "pmn neutrophil granulocyte": 0.00331, "steel": 0.00068, "promote viability and/or proliferation": 0.00402, "taxi gene": 0.04355, "htlv-i tax expression vector induce galectin-3 expression": 0.00726, "e-protein family member": 0.0056, "complete activation": 0.03164, "rna": 0.00912, "mr.": 6e-05, "murine macrophage": 0.00623, "alter immune responsiveness": 0.00399, "sds-polyacrylamide gel electrophoresis": 0.0011, "protozoan host": 0.00214, "thyroid hormone": 0.00444, "nnos": 0.0005, "elderly person": 0.00068, "diverse host cell type": 0.0384, "increase hb24 mrna level": 0.01098, "cell line ce demonstrate": 0.0384, "cell require cooperative binding": 0.0384, "open-label study": 0.01355, "anti-cd2 mab": 0.00267, "enhanced il-4 gene transcription": 0.02177, "prevented additional complex formation": 0.00842, "zebra activation domain": 0.02109, "vimentin": 0.00081, "thymidine kinase": 0.01188, "show delayed transcriptional activation": 0.01582, "marked change": 0.0063, "co-renaturation experiment": 0.00397, "a-myb n-terminal domain": 0.00804, "cfp": 0.00031, "adaptive mechanism": 0.01058, "il-2 -but": 0.01117, "glucose homopolymer": 0.00078, "benzene include benzoquinone": 0.00959, "cd23 gene expression": 0.02903, "e1a copy number": 0.00354, "representative factor": 0.0286, "rabbit 59-kda protein react": 0.02264, "ikappab alpha kinase": 0.00792, "bind gm5": 0.02025, "suppress hiv-1 ltr-driven gene expression": 0.01742, "ebv entry": 0.00565, "influence b-cell development": 0.00422, "normal cd40-induced monocyte activation": 0.01582, "gene truncation": 0.04355, "increased cd+8 t-cell number": 0.00481, "work aim": 0.00081, "tax-dependent manner": 0.00282, "premature age syndrome": 0.00182, "immunoglobulin heavy chain": 0.00292, "tissue inflammation": 0.00664, "t3so4 display": 0.00499, "ebf bind site": 0.01445, "total rna": 0.00456, "gata/er chimeric factor": 0.01907, "mbp gene": 0.04355, "monocytic characteristic": 0.00403, "dual cyclooxygenase/5-lipoxygenase anti-inflammatory compound": 0.0011, "protein level": 0.04529, "glucocorticoid receptor bind characteristic": 0.01286, "biologic action": 0.00499, "key signal intermediate calcineurin": 0.00817, "l-mpl rat return": 0.0019, "full-length scl protein": 0.03019, "selective agonist wy": 0.00178, "gata-1 dna binding activity": 0.01462, "block tnf-alpha transcription": 0.01873, "stimulate cell proliferation": 0.0512, "protein tyrosine phosphorylation-dependent event": 0.02264, "subject": 0.00707, "thr729-leu765 sequence": 0.01625, "ubiquitin-proteasome system": 0.00667, "activate effector function": 0.01185, "tumor promoter pma": 0.01557, "hybrid express": 0.01846, "c5mj2": 0.00019, "membrane glycoprotein cd36": 0.003, "mouse il-4 gene": 0.02903, "proximal gamma-globin promoter": 0.01557, "il-10-stimulated stat protein": 0.03019, "profilin": 6e-05, "40-fold": 0.00031, "lymphoid malignancy": 0.00409, "b-cell-specific transcription factor": 0.01907, "lymphocyte resistant": 0.01483, "local estrogen metabolism": 0.00215, "ebna-2 expression": 0.04163, "curcuma longa": 6e-05, "ra-inducible cd23 expression": 0.02775, "secondary aml": 0.00189, "mobility-shift assay": 0.01002, "primitive erythroid environment": 0.00414, "acth": 0.00112, "kbf1/p50 homodimer": 0.00081, ".0007": 0.0, "synovial compartment": 0.00087, "multiple polypeptide subunit": 0.00459, "dqa1 locus": 0.00288, "trans-dimer encode": 0.00853, "cell-cycle motif": 0.00875, "phenolic": 0.00019, "mip-1 alpha transcription": 0.01873, "thp-1 differentiation": 0.01179, "potential cis-acting element": 0.01115, "decreased cytokine generation": 0.00749, "jak3 represent": 0.004, "p38alpha": 0.00081, "cd30-mediated nf-kappa": 0.01414, "rapid increase": 0.02196, "human promoter": 0.03762, "oncogenic virus": 0.00887, "-aldosterone": 6e-05, "adult alpha-globin promoter activity": 0.01462, "macrophage marker": 0.00589, "human androgen receptor": 0.02508, "androgen-responsive prostate tumour cell": 0.0384, "similar molar amount": 0.00449, "antiapoptotic activity": 0.02925, "-specific inhibitor herbimycin": 0.006, "il-4-induced nuclear-activating factor": 0.01907, "dampened limbic-hippocampal glucocorticoid type ii receptor": 0.00857, "activating factor": 0.0286, "unexpected finding": 0.00226, "jak/stat signaling": 0.00558, "il-2 induce comparable formation": 0.0127, "suggest tnfalpha": 0.02022, "autoimmunity": 0.00062, "cd-associated hla class ii molecule": 0.00341, "weakly active": 0.00592, "prostaglandin e2 show": 0.01733, "atypical abnormal eosinophil": 0.00196, "pan/e2a protein": 0.04529, "regulate cd43-mediated pathway": 0.00852, "dual color confocal microscopy reveal": 0.00439, "dose-dependent tyrosine phosphorylation": 0.00656, "normal range": 0.0121, "tenascin": 0.00019, "kappa gene": 0.04355, "cd102": 0.00012, "-107 bp upstream": 0.00246, "serve": 0.0031, "predicted protein sequence": 0.03019, "responsive element": 0.01672, "estrogen participate": 0.00323, "stimulate octamer-dependent enhancer element": 0.00836, "immunomodulatory stress response": 0.01294, "nuclear factor kappab activation": 0.01582, "g.nabel": 6e-05, "protein complex": 0.04529, "experimental anemia": 0.00084, "distinct stat5 protein": 0.03019, "il-6-responsive element": 0.01672, ":1709": 6e-05, "tax protect": 0.00478, "human ciita cdna": 0.02508, "low transactivation activity": 0.0195, "increase mrna transcript": 0.01464, "//transfac.gbf.de/dbsearch/funsitep/s_comp.html": 6e-05, "kilobases upstream": 0.00369, "phorbol ester-activated jurkat cell": 0.0384, "cortisol resistance": 0.00326, "degenerative neurologic syndrome term tropical spastic paraparesis": 0.00118, "show intense positive staining": 0.013, "enhancement": 0.00465, "p100": 0.0013, "host natural killer": 0.00155, "stress-activated kinase pathway": 0.00852, "include ifn-gamma": 0.01439, "huvec adhesion molecule": 0.00569, "ovary": 0.00074, "c5a-induced interleukin-8 gene expression": 0.02177, "hl-60/vinc/r cell demonstrate translocation": 0.0384, "suppress il-4/il-13-inducible gene expression": 0.02177, "contingent signal": 0.01635, "alpha-globin gene": 0.04355, "late phase response": 0.01294, "isre probe": 0.00261, "functional region": 0.01467, "ea": 6e-05, "retinoic acid-synthesizing enzyme aldehyde dehydrogenase": 0.00124, "replicative function": 0.01331, "35-fold decrease": 0.00971, "virus-host cell protein interaction": 0.0384, "severe nausea": 0.00211, "clone downstream": 0.00738, "nucleus occur": 0.00654, "abolish vp16-mediated transcription": 0.01873, "growth inhibition": 0.01061, "eosinophilic characteristic": 0.00329, "motif-1": 0.00012, "thp-1 cell start": 0.0512, "ala isozymes": 0.00047, "danazol bound": 0.00292, "neutrophil binding": 0.01855, "approved nomenclature": 6e-05, "peripheral end-effectors": 0.00524, "il production": 0.01042, "cd4+ lymphocyte": 0.01483, "14-day colony": 0.00171, "p50 dna bind domain": 0.01013, "promoter proximal region": 0.01557, "fc block pma induction": 0.00803, "tcr cross-linking": 0.00478, "synergistic interaction": 0.00986, "human peripheral blood mononuclear cell response": 0.0256, "pbmc culture": 0.0062, "egr-1 transcription": 0.0281, "egr-1 mrna expression induce": 0.02081, "differentiation inhibitory activity": 0.0195, "sp1 element": 0.01672, "mammal pyruvate kinase": 0.00792, "human fosb gene": 0.02903, "molecular probe": 0.0045, "ethyl-methanesulfonate-treated cem subclones correlate": 0.00327, "severe thrombocytopenia": 0.00211, "urinary cortisol concentration": 0.00447, "2.3-kb cdna": 0.00456, "gene constitutively": 0.04355, "reticuloendotheliosis virus": 0.00887, "ca2+ mobilization": 0.00304, "specific trans-acting factor": 0.01907, "hiv type": 0.00949, "mutation abolish": 0.00592, "cis-acting element": 0.01672, "study carry": 0.01355, "early activator protein": 0.03019, "serine protease": 0.00177, "astrocyte pdtc": 0.00112, "direct dna bend induce": 0.0127, "pi 3-kinase": 0.00109, "immunoglobulin heavy-chain enhancer": 0.00606, "ltb4 act": 0.00496, "/fk506-sensitive nuclear factor": 0.01907, "ltr size variation": 0.00207, "ip-10 gene": 0.04355, "a/g": 0.00012, "tpa-treated u-937": 0.0013, "t-cell nuclear extract-dna complex": 0.00842, "display constitutive nf-kappab dna binding activity": 0.00975, "receptor interaction": 0.02571, "leukaemic clone": 0.00738, "cytoplasmic portion": 0.004, "pkc- dependent": 0.00388, "prevent dehydration": 0.00524, "cross-reactive signaling pathway": 0.00852, "breast/ovarian cancer": 0.00248, "serine/threonine kinase raf-1": 0.00792, "salicylate inhibit lipopolysaccharide-induced transcriptional activation": 0.01266, "aitl/gc": 0.00031, "human beta-globin promoter chromatin structure": 0.01505, "minimal region responsible": 0.00978, "salicylate inhibit lps induction": 0.00952, "agonist-induced phosphorylation": 0.00983, "acetylsalicylate": 0.00012, "c-jun protein isolate": 0.03019, "phenotypic drift": 0.00084, "nk cell inhibitory receptor": 0.0384, "specific response": 0.01942, "ets-2": 6e-05, "ige switching": 0.00189, "promote transcription": 0.0281, "cell biology": 0.0768, "type ii interferon induce expression": 0.01665, "alpha a-gene product": 0.0078, "p-creb level": 0.01821, "oxidative event": 0.00552, "friend virus-induced murine erythroleukemia": 0.00312, "aid therapeutic": 0.00167, "ile": 0.00012, "transient pulse": 0.00344, "splice env mrna": 0.01017, "chronic pulmonary heart disease": 0.00337, "bacille calmette-guerin vaccine": 0.00035, "fibrosis mechanism": 0.01058, "independence": 0.00025, "inhibited": 0.00521, "hpr": 0.00025, "thrombin-generating potential": 0.00605, "low concentration": 0.00707, "fusion protein aml1/mds1/evi1": 0.03019, "tf mrna expression": 0.02775, "northern blot experiment": 0.00265, "inv14": 0.00012, "cell origin": 0.0768, "p.m.lieberman": 0.00012, "betagamma subunit": 0.00484, "human class i-restricted cytotoxic": 0.01881, "tnf-treated": 0.00043, "cell antigen receptor": 0.0512, "molar ratio": 0.00096, "kappa b-like site mediate lps induction": 0.00723, "include antagonic": 0.01439, "dbcamp": 6e-05, "tumour suppressor p53": 0.00122, "e1a block ifn": 0.00715, "adhered monocyte": 0.01197, "fra-1 gene": 0.04355, "ligand bind avidity": 0.0135, "th2 type cytokine respond": 0.00561, "related protein bcl-2": 0.03019, "cags": 0.0, "reporter vector": 0.00552, "t-cell oncogene": 0.00962, "avian erythroid progenitor": 0.00414, "tax-induced expression": 0.04163, "serine protease xa": 0.00118, "unique capacity": 0.00329, "viral protein tax induce": 0.02264, "sp3 bound": 0.00292, "tumour necrosis factor": 0.01907, "important constituent": 0.00689, "exocytosis": 0.00025, "age-related decrease": 0.00971, "total daily dose": 0.00108, "antigenic specificity": 0.00335, "human lymphocyte activation": 0.02508, "stat1 pathway": 0.01278, "cooperative nf-kappa": 0.01414, "il-13/il-4 gene locus": 0.02903, "fragment": 0.00695, "enhance production": 0.01042, "nuclear factor-kappa": 0.01684, "sek/jnk/c-jun/ap-1 pathway": 0.01278, "alternative splice form": 0.00703, "dose-related increase": 0.02196, "direct interaction": 0.00986, "'default": 6e-05, "cho cell express": 0.0512, "e.flory": 0.00012, "leukemic spread": 0.00251, "plasma anh level": 0.01214, "rxr-specific agonist": 0.0022, "regard signal transduction event": 0.00817, "inosine-5'-monophosphate dehydrogenase type ii gene expression": 0.01452, "dna triplex formation selectively inhibit granulocyte-macrophage colony-stimulating factor gene expression": 0.00871, "responsive cell": 0.0768, "b-lymphocyte development": 0.00633, "zinc finger protein bind region": 0.01811, "urinary cortisol": 0.00295, "h2o2 treatment": 0.01014, "atd": 0.00019, "e2f dna site": 0.01445, "activated t-cell nuclear extract": 0.00842, "csa-treated leukocyte stimulate": 0.00734, "major cell reservoir": 0.0512, "e4": 0.00019, "cytokine production": 0.01123, "epo receptor expression": 0.02775, "case er enzyme immunoassay": 0.00181, "reinitiated proliferation": 0.00803, "il-11": 0.00037, "weak effect": 0.02115, "consequent up-regulation": 0.00276, "neutrophil elastase": 0.00496, "bob.1/obf.1 contribute": 0.00378, "janus kinase-1-deficient cell line u4a express hla-dr alpha mrna": 0.01707, "characteristic plasmalemmal localization": 0.00219, "ap2 binding site/s": 0.01237, "patient allergic": 0.01666, "t-cell activator": 0.00962, "breast cancer development": 0.00422, "reduced tf activity": 0.0195, "retinoid response pathway": 0.01294, "infectious hiv-1 molecular clone": 0.00439, "140-kda surface antigen": 0.00546, "molecular weight": 0.0045, "heat shock factor": 0.01907, "affect proliferation": 0.00803, "ifns": 0.00155, "separate exon": 0.00155, "virus genome encode": 0.00591, "matrix-associated region": 0.01467, "p56 src family non-receptor tyrosine kinase": 0.00396, "gata-4 selectively regulate": 0.00835, "nf-at binding site show": 0.013, "cytoplasmic membrane": 0.0045, "reduced monocyte adhesion": 0.00798, "phd/ttc domain": 0.01207, "multiple exogenous stimulus": 0.00459, "preeclamptic woman": 0.00233, "decrease blood viscosity": 0.00647, "chloramphenicol acetyltransferase activity": 0.0195, "cd11b promoter": 0.02336, "kox": 0.00031, "convenient generation": 0.00242, "mapk cascade": 0.00214, "multidrug resistance": 0.00326, "nonpeptidyl small molecule sb": 0.00426, "il-12 induces ifn regulate factor-1": 0.00501, "mandatory proximal step": 0.00201, "cd11c": 0.00062, "study support": 0.01355, "series cell resemble": 0.0512, "cell receptor-bearing lymphocyte": 0.0512, "normal autoregulatory sequence": 0.01084, "ikappab phosphorylation/proteolysis": 0.00136, "disease condition": 0.00673, "receptor-retinoid": 0.00012, "zpcat reporter gene construct": 0.02177, "transcriptional control": 0.01303, "nonpilus adhesins": 6e-05, "p53": 0.00298, "pathways": 0.00136, "marker specific": 0.01238, "dithiocarbamates": 0.00025, "c-terminal sequence control degradation": 0.00813, "bacterial lysates": 0.00223, "gch molecule exert": 0.00569, "pivotal gene": 0.04355, "dna recognition": 0.01483, "ro 09-2210 exhibit potent anti-proliferative effect": 0.00705, "nonreceptor tyrosine kinase": 0.00792, "runt expression": 0.04163, "six-base-pair consensus sequence": 0.01084, "v-j recombination": 0.00093, "similar potentiation": 0.00673, "e3 alpha": 0.01169, "ketoconazole therapy": 0.00372, "proteasome inhibitor block": 0.00715, "dev": 6e-05, "zidovudine": 6e-05, "nfat homology domain": 0.00804, "undergo apoptosis": 0.0089, "induced nuclear translocation": 0.01123, "common gamma chain": 0.00294, "pma release": 0.00484, "pro-inflammatory cytokine play": 0.00749, "show evidence": 0.02599, "receptor tyrosine phosphorylation": 0.01714, "unstimulated huvec monolayers": 0.00091, "tcl1 mrna": 0.01526, "low-level constitutive expression": 0.02775, "induced il-2": 0.01117, "pma treatment": 0.01014, "labile inhibitory factor": 0.01907, "bcl-2 protein decrease": 0.03019, "combination induce": 0.0254, "diploid": 0.00025, "src kinase p56": 0.00792, "nfatc transcription factor": 0.01907, "calcium/calmodulin-dependent protein kinase": 0.03019, "stem cell disorder": 0.0512, "protease inhibitor block lipopolysaccharide induction": 0.00643, "human cdna clone encode": 0.01881, "nm23 protein": 0.04529, "ltb4 induce adhesive interaction": 0.0127, "class ii-deficient": 0.00642, "l. j.": 0.00056, "t-all": 0.00087, "hiv-1 expression": 0.04163, "tcr ligation": 0.00478, "significant improvement": 0.00416, "heterodimeric activator protein-1 transcription complex": 0.01124, "cd4 cell": 0.0768, "fas ligation induces apoptosis": 0.00445, "simultaneous study": 0.01355, "describe human coactivator bob1": 0.01881, "age-related reduction": 0.00295, "viral function": 0.01331, "tal-2": 0.00012, "distal position": 0.00236, "b-lymphocyte differentiation": 0.01179, "erbstatin": 0.00012, "impaired silencing": 0.0018, "slight augmentation": 0.00056, "defect lead": 0.00996, "glucocorticoid binding site": 0.01445, "regulate basal htlv-i transcription": 0.01405, "cell-associated surface molecule cd40 function": 0.00532, "normal myeloid": 0.0121, "term dse": 0.00413, "low risk woman": 0.00471, "hcmv binding": 0.01855, "atypical presentation": 0.00074, "bcl-6-/cd40l+ phenotype": 0.00366, "dcs lack sp1": 0.00422, "normal human tonsil": 0.02508, "murine transcription factor": 0.01907, "ig enhancer": 0.00909, "receptor mutant subclones": 0.01714, "human leukemic cell line k562": 0.03072, "cycloheximide resistant": 0.00211, "ebv sm protein": 0.03019, "leukemic cell line u-937": 0.0384, "cis-acting genetic cis-acting segment": 0.00144, "consensus sequence-binding protein": 0.03019, "immature myelomonocytic cell": 0.0512, "return": 0.00136, "phosphorylation defect": 0.00983, "basal transcription machinery": 0.01873, "induce functional interaction": 0.01694, "1.4-kb human tnf-alpha promoter": 0.01881, "exquisite sensitivity": 0.00236, "disease-susceptible rhesus macaque": 0.00019, "kruppel-like": 0.00043, "box sequence": 0.01625, "human gata3 transcription unit": 0.01881, "cytokine control growth": 0.00868, "adult t-cell leukemia/lymphoma": 0.00641, "plant flavonoid": 0.00031, "normal parent molecule": 0.00806, "a1": 0.00081, "iddm": 0.0005, "nf-at-dependent transcription": 0.0281, "large stimulatory effect": 0.0141, "cell display low level": 0.0384, "serine residue present": 0.0049, "transcriptional synergy": 0.01151, "specific protein substrate": 0.03019, "algorithm": 0.00025, "late hpc": 0.00254, "human myelomonocytic cell line u-937": 0.03072, "constitutive induction": 0.01607, "bactericidal/permeability-increasing protein": 0.04529, "gata transcription factor associate": 0.0143, "selective block": 0.01073, "defective gamma": 0.0044, "artificial promoter": 0.02336, "early g1-regulating protein": 0.03019, "cell overexpressed": 0.0768, "relevant gene": 0.04355, "human myelomonocytic cell line": 0.0384, "ap-1 polypeptide": 0.00695, "daudi": 0.00118, "v3-bh10 enhance il-2-induced mrna expression": 0.01665, "functional il-13r alpha1": 0.00544, "ets bind motif": 0.0135, "granulocyte/macrophage colony stimulate factor": 0.0143, "induced activity downstream": 0.0195, "neutrophil decline": 0.00496, "nf1": 0.00012, "platelet endothelial cell adhesion molecule": 0.03072, "c/ebp epsilon mrna expression": 0.02081, "additional costimulatory signal deliver": 0.00817, "h19": 6e-05, "transcription-dependent surface expression": 0.02775, "ap-1 binding": 0.01855, "human adult globin": 0.02508, "rxrs form heterodimers": 0.00703, "broad role": 0.01328, "single element": 0.01672, "activin a-inducible antagonist": 0.00161, "chemokine superfamily": 0.00105, "bzlf1 transcription": 0.0281, "cd23 transcription": 0.0281, "ikaros isoforms unable": 0.00205, "spi-1 oncogene": 0.00261, "tnf-alpha protein": 0.04529, "monocyte apoptosis": 0.01197, "inhibitory activity": 0.02925, "tumor necrosis factor induce nf-kappa": 0.01144, "cell drive": 0.0768, "polymerase chain reaction assay": 0.00501, "active binding heterodimers": 0.01237, "proerythroblasts": 0.00012, "p-145 antigen": 0.00819, "form functional heterodimers": 0.00703, "additional nf-il6 binding site": 0.01084, "encode cytokine": 0.01123, "dramatic response": 0.01942, "cd69 antigen": 0.00819, "induces nf kappab activation": 0.01582, "maeca-treated ec": 0.00254, "cai": 0.00012, "sequester calcineurin": 0.00316, "ostensible immune stimulation": 0.00746, "4-24": 0.0, "cd3 -and cd28-activated": 0.00182, "-mediated activation": 0.03164, "human tcr beta gene uncovers": 0.01742, "porcine vascular endothelial cell line piec": 0.0256, "mzf-1 represses reporter gene expression": 0.01742, "delta exon": 0.00211, "sense sequence": 0.01625, "alpha/mad-3 gene": 0.04355, "83-kda carboxyl-terminal": 0.00053, "effective immune response": 0.01294, "differentiated hl60 cell": 0.0512, "gabp alpha/gabp beta": 0.00449, "divergent x2-box": 0.00043, "miyatake": 0.00025, "one-half": 0.0, "significant sequence similarity": 0.01084, "vitro transformation": 0.00785, "igg+ plasma cell": 0.0512, "distinct family": 0.00841, "activation and/or translocation": 0.02109, "lymphocyte subset": 0.01483, "pml/rar alpha hybrid protein induce": 0.01811, "pharmacological mimic": 0.00174, "promonocytic leukemia cell u937": 0.0384, "dysregulated cytokine expression": 0.02775, "bcl-2+": 0.00019, "activate octamer-dependent promoter": 0.01557, "decrease monocyte": 0.01197, "age-related change": 0.0063, "small subset": 0.00313, "apoptotic pathway reveal": 0.00852, "il-2r alpha chain": 0.0078, "p105/nf-kappa b1": 0.00102, "motif respond": 0.00875, "receptor abnormality": 0.02571, "primary adult t-cell leukemia cell": 0.03072, "nf kappa": 0.00748, "weak competitor": 0.00174, "molecular mechanism lead": 0.00705, "sp1 binding element": 0.01237, "hla-dr4": 0.00012, "bhlh transcription factor": 0.01907, "inhibit granzyme": 0.01904, "specific antiserum": 0.01238, "tyrosine phosphatase activity": 0.0195, "serine-727": 0.00012, "transfected target cell exhibit cytolytic susceptibility": 0.0256, "heterozygous cell line nb4": 0.0384, "cd4-expressing": 0.0, "all-trans ra": 0.00596, "result present": 0.0161, "n-terminal signal sequence": 0.0109, "mutant motif": 0.00875, "nf-kappab enhancer element activity": 0.01462, "intratracheal instillation": 0.00025, "mammalian histone deacetylase": 0.00116, "hmg motif": 0.00875, "virus multiplication": 0.00887, "gata-3 transcription factor": 0.01907, "icam-1 surface expression": 0.02775, "normal human lung fibroblast": 0.01881, "express cbf alpha 2-encoded subunit": 0.00738, "cd4 silencer": 0.00332, "icam-1 expression": 0.04163, "ea/s motif contribute": 0.00583, "anomalous activation": 0.03164, "soluble nuclear protein": 0.03019, "specific gene": 0.04355, "remain wild-type allele": 0.00347, "p65 rel": 0.00388, "gr binding": 0.01855, "dense body": 0.00136, "calycin protein superfamily": 0.03019, "110,000-molecular-weight prb form": 0.00703, "mrna specie": 0.01526, "efficient mechanism": 0.01058, "20-fold reduction": 0.00295, "elongation block": 0.01073, "cell-specific function": 0.01331, "protein glycation": 0.04529, "alternative splicing": 0.00205, "transfected erythroid cell": 0.0512, "breast conservation": 0.00257, "cell growth activation": 0.0512, "p6": 0.00012, "cd28-mediated activation": 0.03164, "increase ap-1 binding activity": 0.01462, "okadaic acid-sensitive serine/threonine phosphatase": 0.00132, "c5a-induced il-8 expression": 0.02775, "putative binding site": 0.01445, "kinase zap-70 induces": 0.00792, "show binding": 0.02599, "zn2+": 0.00012, "cell-associated recognition molecule": 0.00569, "dexamethasone inhibit lps-induced bioactive il-12 production": 0.00635, "glucocorticosteroids": 0.0005, "p65 subunit provide": 0.0043, "wk": 6e-05, "j.exp.med.183:39-48": 6e-05, "cd4 t-cells": 0.00332, "17beta-": 0.00012, "ngal-expressing tumor": 0.00934, "extrarenal receptor-effector-mechanisms": 0.00016, "metallothionein promoter lead": 0.01557, "karyotype": 0.00031, "interferon-gamma promoter mediates selective expression": 0.01665, "beta subunit": 0.00673, "monoclonal antibody direct": 0.00596, "real-time study": 0.01355, "lag": 0.0, "mimic alteration": 0.0023, "human beta-globin dominant control region function": 0.01254, "male combat vietnam veteran": 0.0004, "mutated receptor": 0.02571, "peroxidase-antiperoxidase technique": 0.00109, "serine-36": 6e-05, "beta- chain": 0.00437, "cell manifest": 0.0768, "ig kappa": 0.00748, "selectively induce": 0.0254, "k.r.": 0.00012, "adenocarcinoma reactive human-mouse chimeric monoclonal antibody": 0.00298, "exhibit transcription-enhancing activity": 0.0195, "pathologic sign": 0.0004, "ie62": 0.00031, "cell line demonstrate": 0.0512, "apoptotic stimulus": 0.0027, "tfiia expression vector enhance tax-activated transcription": 0.01388, "black woman": 0.00233, "cd3 delta": 0.00211, "tat activation": 0.03164, "primary erythroid cell": 0.0512, "ifn-gamma receptor": 0.02571, "mononuclear phagocyte": 0.00304, "steroid antagonist ru-486": 0.00194, "macrophage-competent derivative": 0.00192, "nuclear run": 0.01684, "tced": 0.00056, "transfected": 0.00738, "9-cis ra induce c/ebp epsilon mrna accumulation": 0.00726, "cell progenitor": 0.0768, "growth-inhibitory": 0.00031, "immunohistochemical staining demonstrate relb": 0.00799, "apoptotic cascade lead": 0.00664, "menses": 0.00019, "mouse ada": 0.00974, "naturally-occurring phenolic compound": 0.00147, "ici": 0.00019, "vimentin mrna": 0.01526, "patient maintain euthyroid": 0.0111, "ikappabalpha phosphorylation": 0.00983, "specific intracellular signaling pathway mediate specific event": 0.00365, "cell-specific blk gene promoter": 0.02177, "human cd14-transfected chinese hamster ovary fibroblast": 0.01254, "cre pathway": 0.01278, "linear ebv dna": 0.00988, "tpa-resistant u-937 cell variant": 0.0384, "cell activation-induced apoptosis": 0.0512, "substance": 0.00093, "sodium dodecyl sulfate polyacrylamide gel electrophoresis": 0.00062, "gene confers responsiveness": 0.02903, "phosphotyrosine-containing protein bound": 0.03019, "somatic cell hybrid": 0.0512, "transcription factor nf-e2": 0.01907, "chromatin structure lead": 0.00664, "nf-kappab subunit p50": 0.00666, "similar increase": 0.02196, "tbp7": 0.00025, "ocim1 cell": 0.0768, "beta-adrenergic receptor": 0.02571, "weak binding site": 0.01445, "biology": 0.00074, "ra-resistant cell": 0.0768, "il-4-induced dna synthesis": 0.00988, "eutopic": 0.00056, "fasl promoter": 0.02336, "ifnalpha-stimulated tyrosine phosphorylation": 0.00656, "lbf5": 0.00012, "block chromatin fragmentation": 0.00715, "inflamed tissue": 0.00664, "phosphotyrosine-containing protein": 0.04529, "dna binding activity": 0.0195, "vitro-activated t-lymphocytes": 0.00146, "r.l.": 0.00012, "cd30l": 6e-05, "tetracycline-regulated lmp-1 allele": 0.00147, "independent evidence": 0.00422, "ubiquitin-mediated processing": 0.00133, "chromosome-containing sperm": 0.00022, "nuclear transcription factor": 0.01907, "peritoneal macrophage": 0.00589, "immunosuppressant": 0.00093, "potential nfat-binding site": 0.01445, "dqa1 polymorphism": 0.00177, "paracrine growth": 0.00819, "abrogate interleukin-1beta gene transcription": 0.02177, "benign": 0.00062, "cytosolic factor": 0.0286, "protein derivative": 0.04529, "mammalian development": 0.00633, "immune-specific manner": 0.00282, "increase delta globin gene expression": 0.01742, "pd-c hydrogenation": 6e-05, "single cytokine": 0.01123, "generate antibody": 0.00893, "jurkat leukemic": 0.00555, "nonpermissive temperature lead": 0.00664, "cd4+ cd8int/- cell population": 0.0384, "tramp": 0.00031, "encode cbf": 0.00853, "radioactive iodine therapy": 0.00248, "2.3-kb lcr": 0.00056, "cmat complex": 0.01684, "impaired ap-1 dna binding activity": 0.0117, "extensive mutagenesis": 0.00118, "bsap expression": 0.04163, "concentration consistent": 0.0067, "acute lymphoblastic leukemia result": 0.00805, "undetectable level": 0.01821, "transient transfection experiment": 0.00265, "ifn-alpha-activated protein": 0.04529, "profound implication": 0.00158, "dox": 0.00012, "immune factor": 0.0286, "pma-activated haecs": 0.00025, "il-2-mediated survival": 0.00236, "detail histogenetic characterization": 0.0012, "inflammatory model": 0.00471, "auxiliary receptor cd28": 0.01714, "phorbol 12-myristate 13-acetate readily stimulate": 0.0044, "viral p24 antigen": 0.00546, "refractory": 0.00062, "alpha-globin promoter activity": 0.0195, "val10-gln22": 0.00012, "erythroid specific enhancer": 0.00825, "suppress il-2 promoter activation": 0.01582, "ii breast cancer patient": 0.00833, "correspond": 0.00354, "p15": 0.00031, "th1 clone": 0.00738, "cd5+": 0.00012, "glucocorticoid receptor mrna expression": 0.02081, "nuclear pool": 0.01684, "survanta suppress tnf mrna": 0.00763, "general coping strategy": 0.00103, "describe result": 0.0161, "yac span": 0.00152, "protection": 0.00161, "enhanced activation": 0.03164, "m.malnati": 0.00012, "cd138/syndecan-1": 6e-05, "pouhd solution structure": 0.00213, "sense": 0.00093, "human placental cdna": 0.02508, "classical paradigm": 0.00171, "include overrepresentation": 0.01439, "il-3 mediates cell survival": 0.0384, "p65 delta": 0.00388, "regulate chemokine": 0.01253, "base -280": 0.0031, "transient pseudo-hypoaldosteronism": 0.00344, "dna fragment interact": 0.00988, "hypochlorous acid": 0.00856, "autoimmune serum": 0.00378, "reactive oxygen intermediate": 0.00141, "jnk pathway-dependent activation": 0.02109, "sequence specific oligonucleotide type": 0.00813, "assessed group": 0.00487, "proteolysis-resistant inhibitor": 0.009, "international-toxicity equivalencies": 6e-05, "pma -but": 0.00409, "jak3 kinase": 0.01188, "perivascular dc migrate": 0.00134, "mediate phorbol myristate acetate induction": 0.00643, "early hematopoiesis": 0.00828, "monocyte infiltration critical": 0.00798, "gc suppress il-5 production": 0.00521, "tnf receptor system": 0.01714, "-40 base pair": 0.00207, "-2 neutrophil adhesion response": 0.00971, "cysteine deficiency": 0.00124, "kn-62": 0.00012, "differential rescue": 0.00323, "camk": 0.00012, "c/ebp beta staining": 0.00449, "vitellogenin gene b1 promoter": 0.02177, "nitric oxide decrease cytokine-induced endothelial activation": 0.01055, "classical mineralocorticoid antagonist": 0.00161, "transgenic mouse develop splenomegaly due": 0.0039, "occur splice variant": 0.00436, "hiv-1 tat cdna": 0.00585, "tissue-specific structure": 0.00319, "characterization": 0.0036, "constitutive pag activation": 0.02109, "ramification": 0.00012, "interact basic helix-loop-helix protein": 0.02264, "reduced promoter activity": 0.0195, "lymphoid-specific": 0.00155, "overexpressed p65": 0.00388, "hormone": 0.00887, "yield": 0.00323, "reinfection kinetics show": 0.01733, "substitution mutation": 0.00592, "median follow-up": 0.00025, "bp ebna2 responsive region": 0.00734, "e1a reiteration mutant": 0.0054, "pharmacological profile": 0.00152, "block tnf-dependent nf-kappa": 0.00943, "kg/m2": 6e-05, "drive efficient": 0.00189, "single type": 0.00949, "transcription factor ciita": 0.01907, "acidic activation domain": 0.02109, "cytotoxic granule": 0.00174, "reciprocal elevation": 0.00093, "determine t-cell function": 0.00887, "nadph oxidase activity": 0.0195, "nuclear export complex": 0.01123, "t-lymphocyte differentiation": 0.01179, "ifn-beta promoter transcription": 0.01873, "strand hgr cdna": 0.00304, "drosophila developmental control protein": 0.02264, "apl cell line": 0.0512, "actin mrna": 0.01526, "beta gene require dna sequence": 0.01742, "high potency synthetic glucocorticoid": 0.00465, "disorder associate": 0.01092, "distinguish": 0.00223, "minimal beta-casein stat5 element": 0.00836, "human peripheral mononuclear": 0.02508, "ec epitope bind specificity": 0.01013, "core nfat complex consisting": 0.00842, "relative ratio": 0.00276, "pdp motif": 0.00875, "aminoenhancer": 6e-05, "negative regulatory role": 0.00885, "kb 5'-flanking region": 0.00978, "fasl promoter enhance": 0.01557, "gp130-induced activity": 0.02925, "cyclic amp inhibition": 0.00707, "stationary phase": 0.00276, "perforin-expressing lymphocyte": 0.01483, "glucocorticoid metabolism": 0.0085, "plastic dish": 0.00028, "atheogenic lipoprotein": 0.00118, "gene carry": 0.04355, "tax activate": 0.01777, "9-cis ra inhibit virus replication": 0.00762, "unbound ligand": 0.00592, "lpr/lpr": 0.00019, "gel retardation assay provide evidence": 0.00401, "surface antigen cd8": 0.00546, "twofold increase": 0.02196, "hsv-2 gene encode hsv-2 type-specific cd4+ antigen": 0.01244, "bone marrow cell": 0.0512, "traf bind site exhibit selective binding": 0.00723, "apoptosis resistance": 0.0089, "normal blood donor": 0.00806, "ut-7 epo cell": 0.0512, "body temperature": 0.00136, "variant specie": 0.00276, "combinatorial effect": 0.02115, "apoptotic injury": 0.00189, "-540": 6e-05, "discrete cell-surface isoforms": 0.00205, "proline-rich carboxy terminus": 0.00048, "immunosuppressive drug cyclosporine": 0.00225, "great migration": 0.00205, "cooperative transcription complex": 0.01873, "c-rel protein complex": 0.03019, "ltr variant": 0.0031, "cell transcriptional activation": 0.0512, "u1rnp": 0.0, "acute adrenal failure": 0.00246, "lox-1 gene": 0.04355, "blood-glucose": 0.00012, "growth factor-dependent cell line express": 0.03072, "cd28-associated signaling pathway lead": 0.00639, "express cd40 antigen": 0.0123, "polyomavirus enhancer binding-protein": 0.00606, "human nfil3/e4bp4 cdna promote": 0.01881, "latent membrane protein-1": 0.003, "natural ligand cd80": 0.00395, "inhibit clustering": 0.01904, "tnf-alpha-induced hiv-1 expression": 0.02775, "bzlf1 gene": 0.04355, "crude estimate": 0.0005, "helix-loop-helix protein id3": 0.03019, "ig locus": 0.00288, "peripheral leukocyte": 0.00524, "bind avidity": 0.02025, "include ra synovitis": 0.00959, "transcription factor gene family": 0.02177, "l1": 0.00012, "mimic phosphorylation": 0.00983, "tcr-initiated signal": 0.01635, "human gamma": 0.03762, "inversion": 0.00037, "viral infectivity": 0.00732, "anthropometric": 6e-05, "cell lysates": 0.0768, "unicellular": 0.00031, "glycosphingolipid lactosylceramide": 9e-05, "low-dose chemotherapeutic drug": 0.00225, "clinical parameter comprise": 0.00283, "antiviral protein": 0.04529, "low molecular weight transmembrane adaptor": 0.00283, "reverse sequence": 0.01625, "tissue homeostasis": 0.00664, "childhood acute lymphoblastic leukemia": 0.0025, "developmental stage-specific nuclear factor-dna complex": 0.00674, "raabe": 0.00012, "murine melanoma cell line": 0.0384, "c-jun messenger rna": 0.00329, "il-10 receptor": 0.02571, "deiodination": 6e-05, "dc": 0.00403, "-3079": 6e-05, "pain": 0.00025, "classical pkc-alpha": 0.00171, "induced complex": 0.01684, "fundamental aspect": 0.00124, "human epo-dependent cell line": 0.0384, "proliferation induction": 0.01607, "cck": 0.00031, "calcineurin-nfat interaction": 0.00986, "503-amino-acid-long acidic protein": 0.03019, "diabetes": 0.00062, "xist dna": 0.01483, "corticosterone level": 0.01821, "compound": 0.0044, "asymmetric molecule": 0.00853, "ifn-gamma-induced mhc class ii expression": 0.01665, "truncated er": 0.00264, "secondary": 0.00378, "hbxag stimulation": 0.0112, "epor activate": 0.01777, "target gene transcription": 0.02903, "tcr zeta": 0.00478, "transmission electron microscopy": 0.00035, "il-2r alpha promoter construct": 0.01168, "thr isotype": 0.00047, "construction": 0.00068, "il-2 receptor signal transduction": 0.01286, "nf-kappab involves activation": 0.02109, "fmet-leu-phe": 0.0, "potentiated phagocytosis": 0.00047, "similar structural protein sequence": 0.02264, "hpc stimulate": 0.01101, "require dna replication": 0.00988, "study support previous clinical observation": 0.00542, "caat motif": 0.00875, "dil": 0.0, "p. g.": 0.00065, "unique band": 0.00261, "induce cellular cd23 gene expression": 0.01742, "rifn-alpha": 6e-05, "glucocorticoid induce apoptosis": 0.01694, "pp1": 0.00025, "mixed 20-mer oligonucleotide probe synthesize": 0.00104, "myeloid integrin cd11b": 0.00308, "stimulus-induced expression": 0.04163, "u1": 0.00186, "s. miyatake": 0.00065, "follicular border": 0.00071, "gel retardation technique": 0.0011, "cellular mrna": 0.01526, "increased tumorigenicity": 0.00363, "dibutyryl cyclic amp": 0.00099, "human monocytic cell line show": 0.03072, "calcineurin synergize": 0.00316, "ile761": 6e-05, "agent inhibit lps-induced tk activity": 0.0117, "ap-1-binding site influence il-2 promoter activity": 0.00975, "score": 0.00062, "tat -virus": 0.00257, "increased amount": 0.00363, "defective transcription": 0.0281, "pharmacological effect": 0.02115, "late g1-to-s phase transition": 0.00138, "bi-directional discourse": 3e-05, "cis-acting regulatory element": 0.01115, "group ii": 0.00726, "demonstrate evidence suggest": 0.01348, "transcript encode protein differ": 0.02264, "il-2-driven proliferation": 0.00803, "bind zeb": 0.02025, "suggest direct control": 0.01348, "variant octamer": 0.00276, "cytokine synthesis inhibitory activity": 0.01462, "human pebp2 alpha": 0.02508, "steroid sensitive": 0.00292, "p24 antigen measurement": 0.00546, "bax": 0.00043, "ebna2-ebna6": 6e-05, "-induced ifn alpha production": 0.00585, "correction": 0.00019, "kappab-dependent transcription": 0.0281, "potent stimulator": 0.00357, "force": 0.00031, "cytoplasmic ikappab inhibitor": 0.006, "human t-cell leukemia virus type 1-infected human": 0.00537, "reconstituted system": 0.00667, "cd-40 pathway": 0.01278, "important consequence": 0.00689, "shp1-deltash2": 0.00019, "fetal globin express cell": 0.0384, "e2f1": 0.0005, "amino acid substitution": 0.00571, "darc": 0.00025, "virus mimic": 0.00887, "induced gene product": 0.02903, "cos7 cell": 0.0768, "antioxidant-dependent manner": 0.00282, "multiple stimulus": 0.00689, "il-beta": 6e-05, "nf-kappa b/rel subunit": 0.00943, "micromolar amount": 0.00285, "anti-igd ab": 0.00167, "aid vaccine": 0.00161, "gene encode general initiation factor": 0.01742, "t-derived lymphoid cell": 0.0512, "hypoxic tissue": 0.00664, "active cre site": 0.01445, "ctl memory": 0.00133, "multimers": 0.00031, "subunit amplification": 0.00484, "dimethyldithiocarbamate inhibits": 0.0053, "selective phosphatase inhibitor": 0.006, "intrapulmonary accumulation": 0.00323, "calpain play critical role": 0.00664, "optimal enhancer function": 0.00887, "transfected tal1": 0.00369, "high nuclear translocation": 0.01123, "polymorphism change": 0.0063, "hgata-3": 0.00087, "culture supernatant": 0.0062, "ie-1 peptide-specific induction": 0.01071, "nf-microb": 0.0, "cell surface protein expression": 0.0384, "substitute il-12": 0.00313, "c-kit ligand": 0.00592, "ihiv-1": 0.00025, "estrogen": 0.00645, "activate normal human lymphocyte": 0.01881, "phorbol myristake acetate-a23187 stimulation": 0.0056, "biological process share": 0.00296, "cytoplasmic extract": 0.00459, "transcriptional complex ap-1": 0.01123, "stimulate interleukin-2": 0.01101, "egfp": 6e-05, "igg fc receptor type ic gene": 0.01452, "macrophage maturation": 0.00589, "differentiation-blocked erythroblast": 0.00105, "c-myc expression": 0.04163, "myeloma cell line": 0.0512, "isoleucine-mutated lmp1": 0.0027, "functional cp": 0.00816, "apoptosisprone cell": 0.0768, "pleiotropic transcription factor nf-kappa": 0.0143, "endoplasmic reticulum": 0.00012, "globin mrna express": 0.0123, "construct show": 0.02599, "induce hiv replication": 0.01694, "enhancerless construct": 0.00726, "phorbol ester-induced monocytic differentiation": 0.00589, "mrna decrease": 0.01526, "rotamase activity": 0.02925, "ly-": 6e-05, "defective il-2 gene transcription": 0.02177, "ets gene family encode": 0.02177, "receptor cross-linking": 0.02571, "dimer consist": 0.00183, "naive cd4+ cell": 0.0512, "personality characteristic": 0.00329, "regulate epsilon germline expression": 0.02081, "kappa b-dependent gene": 0.02903, "dupuytren": 0.00012, "mrd-": 0.00012, "alpha map": 0.01169, "tcf-1 alpha activity": 0.0195, "sibling cd34": 0.00087, "positive region": 0.01467, "induce phenotype reversal": 0.01694, "paternal expression": 0.04163, "d1/cdr3-loop": 6e-05, "endothelial protein": 0.04529, "induce luciferase expression": 0.02775, "neutrophilic inflammation": 0.00316, "large body": 0.00205, "culture system": 0.00667, "pma/ionomycin induction": 0.01607, "vivo phosphorylation": 0.00983, "il-2 autocrine human": 0.02508, "causal role": 0.01328, "monocyte-binding receptor e-selectin": 0.01714, "mouse thymoma line el-4 cell": 0.03072, "transcription activation": 0.03164, "phytohemagglutinin-activated peripheral blood lymphocyte": 0.00741, "current opinion suggests": 0.00056, "c-myb regulated target": 0.0055, "mouse deficient": 0.00974, "t-cell receptor activation": 0.02109, "sodium-proton-antiport": 6e-05, "nf-at1 mrna": 0.01526, "inhaled fluticasone propionate": 0.00023, "endogenous ceramide release": 0.00323, "recombinant b-cells": 0.00391, "nfat-like element exist": 0.01115, "enhanced tumor outgrowth": 0.00622, "erythroid differentiation program": 0.00786, "hyon cell": 0.0768, "growth arrest occur": 0.00546, "multiple traf3 bind site": 0.01084, "murine c-fos promoter": 0.01557, "tyrosine kinase-linked receptor agonist collagen": 0.01029, "heme synthesis": 0.00583, "sephacryl g-200 ultrafiltration": 6e-05, "macrophage colony-stimulating factor gene": 0.02177, "preferential gas-like dna binding pattern": 0.00742, "-2 homology nfat-1 region": 0.00734, "md": 6e-05, "inhibit wild-type rev activity": 0.01462, "cellular production": 0.01042, "ebv latent infection membrane protein lmp1": 0.0151, "non-viral oncogene-expressing": 6e-05, "cat expression direct": 0.02775, "chronic myeloproliferative disease": 0.00449, "mip-1 alpha promoter": 0.01557, "alu repeat": 0.00378, "bacterial lipopolysaccharide": 0.00245, "cya": 0.0005, "tnf-alpha-stimulated": 0.0005, "palmar fibromatosis": 6e-05, "-independent activity": 0.02925, "vitro increase nf-kappa": 0.01464, "nonmyeloid cell": 0.0768, "anti-ea-restricted": 0.00012, "thymidine kinase/chloramphenicol acetyltransferase": 0.00066, "sex-matched healthy control": 0.00868, "increase gm-csf expression": 0.02775, "host defence response": 0.01294, "4-fold": 0.00019, "protein selectively": 0.04529, "oligonucleotide probes": 0.00164, "snrna gene": 0.04355, "suppress hiv replication": 0.00407, "ad patient": 0.01666, "signal leading": 0.01635, "serum-free culture": 0.0062, "-286": 0.00012, "3-6 month": 0.00068, "physiologic oxidative condition": 0.0024, "hiv-1 gp120": 0.00878, "monocyte culture": 0.01197, "pluripotent hemopoietic progenitor": 0.00184, "stat1 transcription factor": 0.01907, "age-related defect": 0.00279, "adjacent binding site": 0.01445, "tf expression": 0.04163, "cathepsin d.": 0.00062, "intermediate stage": 0.00248, "human interleukin-1 beta promoter confers preferential transcriptional activity": 0.00941, "somatic hypermutation": 0.0009, "ire motif form": 0.00703, "egr-1-expressing ramos cell show reduced level": 0.0256, "rat lung": 0.00285, "il-8 concentration": 0.0067, "lymphocyte stimulation": 0.01483, "interaction require atp/mg2+": 0.00877, "normal lymph node": 0.00806, "analogous": 0.00093, "ld78": 6e-05, "prb block transition": 0.00715, "fp": 0.00056, "5'-cc": 0.0, "elf-2 transcript": 0.00599, "differential expression model": 0.02775, "combined oap/octamer cis-element": 0.00066, "lps-free": 6e-05, "active cn": 0.00592, "tsh-r": 0.00043, "peptide-specific t-cell line": 0.01102, "significant thrombin-generating capacity secondary": 0.00208, "epitope mapping": 0.00161, "cell activation marker icam-1": 0.0384, "major nfat family member responsible": 0.00336, "escherichia coli stress": 0.00207, "immature class ii heterodimers": 0.00363, "single transcription initiation site": 0.01405, "synthetic analog": 0.00202, "protein hlf fuse": 0.03019, "gr bind parameter": 0.0135, "10-bp insertion": 0.00065, "4-acetoxy derivative": 0.00192, "early change": 0.00828, "tam": 0.00056, "injection": 0.00087, "migrate complex": 0.01684, "fc gammari promoter element": 0.01168, "oct2-positive clone": 0.00738, "tracey": 0.00012, "newborn mouse": 0.00974, "adult tonsil": 0.00422, "useless": 0.00012, "putative transcription factor": 0.01907, "special leukocyte function": 0.00887, "delayed kinetics": 0.00167, "stimulate granulocyte": 0.01101, "severe phenotype": 0.00366, "age-matched control subject": 0.00868, "chronic myelogenous leukemia patient": 0.00833, "subcellular localization analysis": 0.00786, "cd14 expression": 0.04163, "remain residing": 0.00521, "-186": 0.00025, "act-1 site analogous": 0.01445, "ebna2 positive cell extract": 0.0384, "kappa b/mad3": 0.00748, "induced gamma": 0.0054, "heparin": 0.00056, "specific nuclear factor-dna complex": 0.00842, "immunoregulatory": 0.00186, "plasma tpo level": 0.01214, "plasmid": 0.00546, "optimal dna-binding motif": 0.00583, "lymphocyte development suggest": 0.01348, "dideoxy atp": 0.0004, "virtue": 0.00031, "high-risk patient": 0.01666, "70z/3-derived pre-b-cell line": 0.01102, "low-mobility complex": 0.01684, "monocyte-specific expression": 0.04163, "il-4ralpha abolish signaling": 0.00372, "specific dna motif": 0.00988, "tpa-mediated translocation": 0.00515, "selection procedure": 0.00121, "receptor-interacting protein": 0.04529, "activated human": 0.03762, "genetic variant": 0.00288, "germline": 0.00273, "hc11 mammary epithelial cell": 0.0384, "dna reiteration": 0.01483, "human peripheral-blood granulocyte": 0.02508, "represent potential regulator": 0.00403, "plzf nuclear protein": 0.03019, "diffuse large cell subtype": 0.0384, "virus bind": 0.02025, "human mzf-1": 0.03762, "camp signal inhibited stat1": 0.00817, "taci-specific antibody lead": 0.00664, "cd3 zeta tyrosine phosphorylation": 0.00492, "exert regulatory effect": 0.0141, "cd44 promoter-chloramphenicol acetyltransferase reporter construct": 0.0029, "early gene product": 0.02903, "good level": 0.01821, "peripheral blood t-lymphocytes transduce": 0.00296, "oligonucleotides": 0.00366, "-lp": 0.0, "cd45-": 0.00019, "proline-rich domain": 0.01207, "bulk": 0.00012, "study focus": 0.01355, "-516 motif": 0.00875, "tax-response element": 0.01672, "lps signaling": 0.00558, "potentiate": 0.0036, "beta e2": 0.00673, "hemopoietic cell line": 0.0512, "acute nonlymphocytic leukemia": 0.00333, "experimental condition": 0.0036, "anti-cd2": 0.00087, "delta-domain": 0.00031, "ni2+-blockable ca2+ channel": 0.00203, "functional promoter region": 0.01557, "circular permutation": 0.00019, "analysis reveals": 0.01179, "myogenic transcription factor": 0.01907, "alphacd28": 6e-05, "5'-utr": 0.00025, "okadaic acid-induced il-6 gene expression": 0.01742, "relative role": 0.01328, "tnf-mediated cytotoxicity": 0.00143, "isotype switch": 0.00245, "c-fos-positive lymphocyte infiltrate": 0.00988, "hypereosinophilic syndrome": 0.00273, "bacterial lipopolysaccharide-stimulated macrophage": 0.00393, "transcriptional transactivation function encode": 0.00665, "sequence contiguous": 0.01625, "-92 bp": 0.00267, "sulfhydryl agent": 0.00422, "resultant cell line": 0.0512, "ach-2 cell line": 0.0512, "transient expression": 0.04163, "define genetic alteration commonly associate": 0.00437, "functional il-2r": 0.00816, "anti-hbx antibody titer": 0.00596, "normal hematopoietic cell": 0.0512, "pleiotropic regulator": 0.00304, "octamer enhancer": 0.00909, "program commonly": 0.00171, "p0-compatible nfat activity": 0.0195, "c. albicans": 0.00143, "death program": 0.00254, "hematopoietic growth factor": 0.01907, "hepatitis": 0.00112, "cr2 complement receptor": 0.01714, "spxx motif": 0.00875, "b7": 0.00068, "mgus patient": 0.01666, "subnuclear fractionation reveals": 0.00066, "vertebral": 6e-05, "identical signal pathway": 0.0109, "transgenesis": 0.00012, "double-transgenic mouse": 0.00974, "transactivation activity": 0.02925, "ecdysone-inducible drosophila transcription factor require": 0.01144, "reactive metabolite": 0.00211, "ra-resistant uf-1 cell": 0.0512, "transcriptional response": 0.01942, "spi-b remains unknown": 0.00116, "recombinant nfatp demonstrate": 0.01065, "lysis pathway": 0.01278, "multiple phosphorylations": 0.00689, "serine/threonine protein kinase": 0.03019, "62-97 yr": 0.00022, "specific nf-kappab oligoprobe": 0.00825, "lmp1 function": 0.01331, "somatic cell hybrid panel": 0.0384, "analogy htlv-ii p24rex": 0.00029, "threatened pre-term delivery": 0.00039, "hhv-6 upregulates zebra gene transcription": 0.01742, "dna-cellulose occur": 0.00654, "mitogenic stimulation": 0.0112, "decrease mn-sod expression": 0.02775, "c-fos mutant protein include wbjun": 0.01811, "ifn alpha production": 0.0078, "hypopigmented skin show significant inactivation": 0.0104, "diabetic nephropathy show high nf-kappab binding activity": 0.00836, "common detectable abnormality": 0.00234, "ap1 factor": 0.0286, "affect measure il-7r signal event": 0.00654, "master gata1 gene": 0.02903, "deltae": 0.00019, "correlate change": 0.00654, "control-transduced pre-t cell": 0.0512, "r-h tbp-1": 9e-05, "cell il3 gene expression": 0.0384, "rxr-alpha": 0.00068, "include presentation": 0.01439, "hematopoietic progenitor": 0.00366, "helper 1-type cytokine": 0.00749, "large protein": 0.04529, "duplicated cysteine-rich lim domain": 0.00603, "antiphosphotyrosine immunoblotting show": 0.01733, "n-terminal region": 0.01467, "activator pma": 0.00552, "class switch": 0.00642, "and/or activate protein-1": 0.01185, "murine t-cell line": 0.01102, "free heparin": 0.00127, "nuclear component": 0.01684, "transactivator htlv-i tax activate": 0.00889, "ifn-gamma-induced mhc class ii gene expression": 0.01452, "permit": 0.00161, "mutant sequence": 0.01625, "discrete fourier transformation": 0.00192, "class ii transactivator-encoding air-1 locus": 0.0029, "scl mrna level": 0.01214, "wild-type gene": 0.04355, "rest human tonsillar": 0.02508, "lavage t-lymphocytes express": 0.0123, "beta inhibitor": 0.009, "cytoplasmic rela": 0.004, "nf-kappa b/rel family": 0.00943, "nuclear transcription factor-kappa": 0.01873, "transformation-competent ebna-2 deletion mutant": 0.00405, "low gcr number": 0.00471, "cav isolates": 0.00047, "lie approx": 0.00047, "c-fos/c-jun heterodimers": 0.00226, "complication": 0.00031, "pu.1-interaction partner": 0.00081, "human ec": 0.03762, "regulate inducible t-cell gene expression": 0.01742, "nuclear complex": 0.01684, "single nucleotide insertion result": 0.00805, "chromosome constitution": 0.00295, "upregulate c-fos promoter activity": 0.01462, "flexible linker": 0.00043, "e1b mutant genome": 0.0054, "pit-1 gene": 0.04355, "potentiate threshold": 0.0018, "recruitment": 0.00329, "immunoregulatory cytokine": 0.01123, "case lack": 0.00633, "potential transcriptional regulator": 0.00767, "jak phosphorylation": 0.00983, "specific adhesion molecule": 0.00825, "hl-60/vinc/r cell": 0.0768, "activate nf-kappa b-mediated gene transcription": 0.01742, "helper lymphocyte": 0.01483, "xenogeneic human serum": 0.02508, "unknown event": 0.00552, "endogenous il-4 mrna": 0.01017, "smad6": 0.00043, "anti-human cd14 antibody": 0.00596, "authentic nfat": 0.00431, "distinct bind site": 0.01445, "aitl/gc differ": 0.00192, "high order nf-atp/ap-1 complex": 0.00842, "rapid rise": 0.00323, "tp1": 0.00043, "ltb4": 0.00192, "calmodulin- dependent phosphatase calcineurin": 0.00194, "sequence-specific hmg-box": 0.00105, "apparent complete remission": 0.00128, "heterodimer suggest": 0.02022, "formalin-fixed paraffin section": 0.00021, "rel/nf-kappa": 0.00068, "interleukin-1 receptor type": 0.01714, "inhibit active nf-kappab formation": 0.00952, "ebv gene expression": 0.02903, "tumor necrosis factor receptor-associated protein tradd": 0.0151, "myh11 gene encode": 0.02903, "creb/atf-1 family": 0.00841, "membrane-bound enzyme": 0.0031, "primary nk": 0.00738, "specific stat protein": 0.03019, "ranbp1": 0.00025, "gr bind capacity": 0.0135, "vca": 0.00019, "lymphocyte glucocorticoid receptor bind": 0.01286, "activate hsf1": 0.01777, "receptor-associated tyrosine kinase": 0.00792, "nf-kb motif": 0.00875, "selectively methylated": 0.00292, "tcr-mediated signal event": 0.0109, "biochemical pathway": 0.01278, "pml/rar alpha transcript": 0.0078, "cytoplasmic store": 0.004, "position -53": 0.00236, "repressor raz": 0.00223, "cell show reduced number": 0.0384, "human stomach cancer cell line": 0.03072, "steady-state mrna level": 0.01214, "cytokine-induced function": 0.01331, "s6k": 0.00012, "hiv long terminal repeat activity": 0.0117, "gamma globin": 0.0044, "htlv-1 promoter": 0.02336, "cyclophilin ligand": 0.00592, "native-western analysis": 0.01179, "suppress il-6 secretion": 0.00407, "human monocytic cell express interleukin-1beta": 0.03072, "hiv-1 nf-kappab site": 0.01445, "hla class ii dr11-restricted fashion": 0.0029, "t-cell clone activate": 0.01185, "interphase nucleus": 0.00319, "key immediate-early protein": 0.03019, "camp-dependent gene": 0.04355, "activation domain constitute": 0.02109, "human t-cell leukemia": 0.02508, "purified octamer transcription factor": 0.0143, "protective ctl-mediated immunity": 0.00074, "difference": 0.0085, "intimate interaction": 0.00986, "p53-dependent cyclin kinase inhibitor p21/cip1": 0.00475, "cysteamine treatment inhibit": 0.0127, "human gasd element": 0.02508, "reactive oxygen intermediate release": 0.00242, "transcription factor participate": 0.01907, "unbound": 0.00025, "initiate tal-1 transcription": 0.01873, "ltr construct": 0.00726, "aiolos set": 0.0014, "specific rna target term tar": 0.00495, "urinary cortisol level": 0.01214, "anti-e-selectin monoclonal antibody": 0.00596, "jnk enzymatic activity": 0.0195, "k562 leukemia cell": 0.0512, "transmembrane signaling": 0.00558, "hormone exert": 0.00444, "induce pro-oxidative condition": 0.01694, "parallel mitogen-activated protein kinase signal pathway mediate": 0.01294, "29-kda fragment": 0.00347, "hyperlipidemic patient": 0.01666, "amount": 0.00571, "transformed lymphoblast": 0.00084, "partition": 0.00043, "il-1alpha": 0.00093, "nf-kappa b-like binding activity": 0.01462, "extensive upstream": 0.00369, "activated activator protein-1-dependent transcription": 0.01405, "early peak": 0.00828, "nf-kappab family protein": 0.03019, "paf bind": 0.02025, "transcription factor pu.1": 0.01907, "i-factor": 6e-05, "nf-y play": 0.0071, "early region": 0.01467, "influx": 0.00074, "aid iblp tissue sample analyze": 0.00266, "c5b-8": 6e-05, "cytokine release": 0.01123, "beta-globin chain": 0.00437, "differentiation/retrodifferentiation": 0.00012, "ectopic alf1": 0.00081, "human tafii": 0.03762, "pleiotropy": 0.00012, "jak/stat signal pathway": 0.0109, "erythroid progenitor": 0.0062, "rela-i kappa": 0.00748, "promoter site": 0.02336, "int-2": 6e-05, "pro-b-cell development": 0.00633, "3-fold great effect": 0.0141, "inhibit gata-3 promoter activity": 0.01462, "4-trifluoromethyl derivative": 0.00192, "dexamethasone-mediated inhibition": 0.01061, "enhancer consist": 0.00909, "double infection": 0.0062, "human androgen receptor gene": 0.02177, "footprinting agent": 0.00422, "pre-i enhancer element": 0.01115, "thp-1 cell line": 0.0512, "describe interaction": 0.00986, "sne motif": 0.00875, "htlv-iii bh10 clone": 0.00492, "tyrosine phosphoryl group": 0.00474, "polypeptide": 0.00273, "gene expression mediate": 0.02903, "r24": 0.00062, "serine/threonine-specific protein phosphatase": 0.03019, "pr complex": 0.01684, "ifngamma-induced dna binding complex": 0.00927, "storage": 0.00019, "single egr1 bind motif": 0.01013, "low cytoplasmic level": 0.01214, "hl-60/vinc revertant": 0.00025, "stimulate production": 0.01101, "mbp-selected line": 0.01653, "cross-talking": 6e-05, "eccrine poromas": 6e-05, "nfat complex formation": 0.01123, "rapid growth": 0.00819, "molecular immunology": 0.0045, "nucleotide sequence requirement": 0.01084, "oxidative stress inhibits fasl induction": 0.00643, "expression remain": 0.04163, "reticuloendotheliosis virus long terminal repeat element": 0.00557, "determine hormone receptor status": 0.01286, "specific mitogen": 0.01238, "genetic diversity": 0.00288, "human p40 gene form": 0.02177, "y319": 0.00019, "autocrine fashion": 0.00161, "htlv-i tax-mediated trans-activation": 0.00184, "syncytium formation": 0.00484, "sustained high": 0.00931, "axillary lymph node involvement": 0.00127, "regulate gene transcription": 0.02903, "vary concentration": 0.0067, "/cd3 engagement result": 0.01073, "nfat regulation": 0.01008, "healthy men age 21-66 yr": 0.00091, "isolation": 0.00099, "multiple transcription factor require": 0.0143, "mp treatment": 0.01014, "viral isolates": 0.00732, "essential": 0.00974, "dominant negative ra abrogate": 0.00298, "chemokines il-8": 0.00189, "chromosomal rearrangement": 0.00199, "x2 interaction": 0.00986, "remain unaltered": 0.00521, "antioxidant inhibit nf-kappa": 0.0127, "hla-b27": 0.00012, "promote lymphokine gene expression": 0.02177, "nuclear factor kappab": 0.01907, "reactive oxygen intermediate-release": 0.00141, "lymphoid-related": 6e-05, "infrequent": 0.00012, "chain mrna level": 0.01214, "e1a mutant protein": 0.03019, "class ii-positive": 0.00642, "hsp70 induction": 0.01607, "human osteosarcoma": 0.03762, "gpiiia": 6e-05, "interferon-alpha induction": 0.01607, "affect nf-il-6 activity": 0.0195, "human swi2 protein": 0.03019, "fivefold enhance il-2-mrna accumulation": 0.00487, "mifepristone": 0.00019, "suramin": 6e-05, "oligonucleotide primer base": 0.00207, "thrombopoiesis": 6e-05, "gamma/delta": 0.00087, "redox-regulatory mechanism": 0.01058, "bcl-2 protein inhibit bufalin-induced apoptosis": 0.01811, "functional core": 0.00816, "myf6": 0.0, "anti-cd2 antibody stimulate viral production": 0.0044, "pre-existing cytoplasmic subunit": 0.00323, "early g1 protein p27": 0.02264, "monoblastoid u937 cell": 0.0512, "coordinate expression": 0.04163, "nsaid": 0.00087, "nonhematopoietic cell": 0.0768, "transduce intracellular signal": 0.0109, "neutrophil": 0.00993, "rapamycin-resistant p70": 0.00065, "human taf subunit": 0.02508, "human dpa gene": 0.02903, "mitotic recombination event": 0.00368, "activate relb": 0.01777, "inactivation analysis": 0.01179, "ifn-induced nk cell": 0.0512, "cd28re/ap-1 sequence": 0.01625, "implicate activation": 0.03164, "nonerythroid cell": 0.0768, "hiv-1 ltr region": 0.00978, "kd protein": 0.04529, "induce nf-kb nuclear translocation": 0.0127, "rest platelet": 0.00372, "inhibit c-jun induced expression": 0.02081, "cellular adhesion": 0.00893, "j.m.hardwick": 0.00012, "af10": 0.00043, "induce g1 arrest": 0.01694, "molybdate": 0.00019, "ig mutation": 0.00592, "heritable variation": 0.00164, "viral response": 0.01942, "creb-induced trans-activation": 0.00078, "modest increase": 0.02196, "stat6 interacts": 0.00233, "il-16 promoter": 0.02336, "bcl-2 mrna": 0.01526, "induce reporter gene transcription": 0.02177, "commonly prescribed anti-inflammatory drug": 0.00169, "total rap1": 0.00161, "nk-cell": 6e-05, "gm-csf-stimulated cell": 0.0768, "cytogenetic study": 0.01355, "complete degradation": 0.00332, "carg": 0.00031, "de novo inactivation": 0.00116, "chronic hepatitis c. intrahepatic lymphoid follicle": 0.00136, "kit/il-4r alpha": 0.01169, "inactive": 0.00323, "stimulate ikk-beta activity": 0.0195, "scid-hu- int mouse block": 0.00537, "vivo il-2 administration": 0.00744, "microsomal antibody level decrease": 0.0091, "binding factor": 0.0286, "activate transcription factor nf-kappab": 0.0143, "transcription repressor evi1": 0.01873, "inhibit il-2 promoter": 0.01557, "precise factor": 0.0286, "il-4/il-13-stimulated monocyte": 0.01197, "thromboxane receptor gene promoter": 0.02177, "information exist link": 0.00232, "nfatc.beta differs": 0.00078, "p93fes catalytic activity": 0.0195, "mll": 0.00019, "ief-1": 0.0, "p50/p65-": 0.00012, "u2 snrna": 0.00056, "independent interaction": 0.00986, "p54": 0.00019, "erythroid progenitor show mosaicism": 0.013, "p50 protein": 0.04529, "mutant ach clone": 0.0054, "benzoquinone cytotoxicity": 0.00143, "cd34+ cell": 0.0768, "receptor density": 0.02571, "cyclic amp-responsive element-dependent activation": 0.01582, "gain-of-function mutation reveal": 0.00732, "disease status": 0.00673, "multiple cdna encode mouse oct2": 0.0039, "protein tyrosine": 0.04529, "bifunctional role": 0.01328, "exist": 0.00285, "accelerate export": 0.00074, "aberrant retinoic acid metabolism ctla-4-mediated inhibition": 0.00354, "opsonized yeast": 0.00155, "cd16- myeloid/natural killer cell acute leukemia": 0.0256, "c5b-9": 0.00025, "nfatc- specific antibody": 0.00825, "hiv-1 long terminal repeat show": 0.0104, "decreased amount": 0.00285, "induce inflammatory cytokine": 0.01694, "gene express": 0.04355, "i/y bind": 0.02025, "mcd14 ligand": 0.00592, "increased interleukin-2": 0.00363, "dissociation": 0.00205, "activation dependence": 0.03164, "deoxycorticosterone acetate": 0.00099, "ph variation": 0.00164, "exchange": 0.00149, "post-transcriptional regulation": 0.01008, "complex upstream element": 0.01123, "postmenopausal female": 0.00158, "elucidate normal immunoregulation": 0.00806, "ets-1 bind site": 0.01445, "early sign": 0.00828, "hmds": 0.00012, "constitutive transcription": 0.0281, "1,25d3-resistant variant": 0.00276, "fish result": 0.0161, "nfat-binding element p0": 0.01115, "heterodimers show distinct dna-binding specificity": 0.0104, "far-western blot assay": 0.00668, "e3 promoter": 0.02336, "157.6+/-25.1 cells/mm2": 0.00012, "h2b-2 gene": 0.04355, "pairwise combination": 0.00288, "translocate autosome irrespective": 0.0005, "hla dq": 0.00192, "functional synergy": 0.00816, "multiple factor include stat5": 0.0143, "il-2r gamma chain": 0.00294, "p50 homodimers": 0.00288, "moderate form": 0.01055, "paired motif": 0.00875, "complementation analysis": 0.01179, "basophilic granulocyte": 0.00254, "distinct apoptosis signal pathway": 0.00817, "ibr": 0.00037, "malignant tumor material substantial quantity": 0.00373, "ras-like gtpase": 0.00022, "bcl-6 expression": 0.04163, "tumor necrosis factor alpha": 0.0143, "il-1-induced synthesis": 0.00583, "p3hr-1-infected burkitt": 0.00065, "major increase": 0.02196, "pan molecule": 0.00853, "ccacc/sp1 family": 0.00841, "viral survival-promoting protein": 0.03019, "j.steroid biochem.mol.biol.57": 6e-05, "gata3 bind": 0.02025, "preleukemic condition": 0.0036, "cellular cytoplasm": 0.00893, "il-4 response element": 0.01294, "1-60": 0.00019, "p80c-rel": 0.0005, "mediate glucocorticoid-induced apoptosis": 0.00821, "bu/ml": 0.0, "jak kinase family": 0.00792, "ciita trans-activator": 0.00295, "positive action": 0.00499, "anti-cd28-stimulated": 6e-05, "phorbol 12-myristate 13-acetate+phytohemagglutinin": 0.00362, "immune homeostasis": 0.00599, "fetal liver library": 0.00143, "hla-b8-restricted peptide": 0.00754, "deletional": 0.0005, "radiolabeled vdr": 0.00233, "tandem dinucleotide repeat": 0.00252, "listeria monocytogenes": 0.00016, "stroma cell line": 0.0512, "vitro protein-dna binding study": 0.00927, "hla-dra promoter activity": 0.0195, "polymorphism detect": 0.00726, "estrogen receptor": 0.02571, "epstein-barr virus-transformed": 0.00285, "wound healing": 0.00019, "compensatory gr upregulation due": 0.002, "pbmo": 0.00037, "primary human": 0.03762, "nm ra": 0.00596, "study describe": 0.01355, "exogenous e1": 0.00214, "weakly responsive": 0.00223, "friend virus": 0.00887, "embryonic/fetal erythroid k562 cell": 0.0384, "safe drug": 0.00338, "export": 0.00093, "p105 occur constitutively": 0.00436, "thr residue": 0.00226, "normal bone marrow cell document expression": 0.0256, "rearranged tcr gene develop": 0.02177, "hs-40 enhancer-mediated activity": 0.0195, "variation": 0.00329, "combined stimulation": 0.0112, "adjacent normal kidney tissue": 0.00605, "cultured": 0.00292, "renal function": 0.01331, "bmt structure reveal": 0.00732, "b-cell-specific regulation": 0.01008, "c-fos gene product": 0.02903, "human fetal globin expression": 0.02081, "set": 0.00279, "neutrophil recruitment": 0.00496, "carbazole": 0.00012, "nk cell membrane extract": 0.0384, "molecular change associate": 0.00728, "acetate-induced differentiation": 0.01179, "cosignaling": 0.00012, "mitogen increase": 0.02196, "conserved signaling pathway": 0.00852, "5-day human monocyte-derived macrophage": 0.01881, "tpa-differentiated u-937 cell": 0.0512, "initiate transcription": 0.0281, "primed cell": 0.0768, "include c-fos": 0.01439, "-2 gene expression": 0.02903, "erythropoietin- induced erythroid differentiation": 0.00589, "fyb": 6e-05, "human endometrium": 0.03762, "traf binding": 0.01855, "atrophy induction": 0.01607, "cd86": 0.0005, "mnda expression occur": 0.02775, "multiple response region demonstrate": 0.00971, "proinflammatory cytokine tnf-alpha": 0.00749, "cell differentiate": 0.0768, "block ifngamma-driven": 0.01073, "hb9 rna transcript": 0.00399, "tissue-specific transcriptional activator": 0.00767, "rna isolate": 0.00456, "tsc2 messenger rna": 0.00304, "limiting-component transcription assay": 0.01873, "tpa/ca2+": 6e-05, "pleiotropic effect": 0.02115, "transcriptional stimulation": 0.01151, "lineage-": 0.00031, "nuclear nf-kappab dna-binding activity": 0.01462, "inhibited terminal differentiation": 0.00786, "express beta-globin": 0.01846, "base difference": 0.00425, "tcr delta": 0.00478, "glut4": 0.00012, "nfat-1-mediated transcription": 0.0281, "fusing cell": 0.0768, "high-affinity binding": 0.01855, "nuclear periphery": 0.01684, "e2f bind site": 0.01445, "simultaneous translocation": 0.00515, "separate prl-responsive element": 0.01115, "dlcl pathogenesis": 0.00171, "papilloma": 0.00012, "lcr hs4 demonstrate": 0.01065, "lung interstitium": 0.00195, "neutrophil-endothelial cell adhesion induce": 0.0384, "half": 0.00081, "differential function": 0.01331, "monocyte fraction": 0.01197, "suppress ifn-gamma-induced stat activation": 0.01582, "provide strong evidence": 0.0043, "v-abl protein tyrosine kinase": 0.02264, "defect": 0.00558, "increase crh promoter activity": 0.01462, "t-cell line test": 0.01102, "p38 mapk isoforms study": 0.00678, "ets-1 protein": 0.04529, "hlf bzip domain": 0.00804, "cd16-induced fasl expression": 0.02775, "cd40l-transfected murine l-cells": 0.00416, "strong correlation": 0.00347, "leukemia cell line transient overexpression": 0.03072, "sh-sy5y neuroblastoma cell line": 0.0384, "u937": 0.00651, "inducible nuclear factor bind": 0.0143, "transcription factor aml1": 0.01907, "kinase assay show": 0.01733, "lipopolysaccharide-stimulated": 0.00167, "lack lymphoid": 0.00633, "vddr-ii": 0.00019, "coherent expression pattern": 0.02775, "stimulating agent": 0.00422, "cell line jurkat j6": 0.0384, "transactivation": 0.0103, "include normal plasma cell": 0.0384, "mass spectrometry study": 0.00904, "siv tata box": 0.00203, "endogenous cholesterol synthesis": 0.00389, "terminal event": 0.00552, "mesenchymal cell": 0.0768, "hiv-1 promoter": 0.02336, "granulocyte-macrophage colony-stimulating factor require sequence": 0.01144, "nf-kappab abolished cd40-induced up-regulation": 0.00499, "la mrna due": 0.01017, "immune mediate reaction": 0.00821, "endothelial cell adhesion molecule": 0.0384, "blin-1 cell result": 0.0512, "bk virus vector": 0.00591, "cd40-traf2 interaction": 0.00986, "fc receptor lead": 0.01714, "1.1-4.4": 6e-05, "transfected reporter gene": 0.02903, "activated normal human lymphocyte": 0.01881, "antisense oligonucleotide": 0.00164, "normal germinal center": 0.00806, "-cd3 complex induce": 0.01694, "mediate tyrosine phosphorylation": 0.00821, "malignant phenotype": 0.00366, "overlap pathway": 0.01278, "recombinant sivs": 0.00391, "enzyme inhibitor suggest": 0.01348, "il-1 receptor complex": 0.01714, "ovarian carcinoma": 0.0018, "6-8": 6e-05, "kda stat5b protein": 0.03019, "nf-kappab-driven reporter activation": 0.02109, "normal hematopoietic progenitor": 0.00806, "mutant mrna": 0.01526, "nucleoporins": 0.0, "direct": 0.01079, "activate transcription factor responsible": 0.0143, "cell hybridoma confirm": 0.0512, "potent competitor": 0.00357, "culture endothelial cell": 0.0512, "kappa b-like site binding complex": 0.00867, "isolated cd48 nf-kappa": 0.00943, "low dos": 0.00707, "-/st patient": 0.01666, "apc function": 0.01331, "bind specific transcription factor": 0.0143, "potential ttg substrate": 0.00403, "crossreactions show": 0.02599, "replicative gene": 0.04355, "nonoptimal binding site": 0.01445, "lm-pcr": 0.00019, "egr-1 expression": 0.04163, "dna-binding protein": 0.04529, "dna binding characteristic": 0.01237, "tlr2": 0.00112, "haec model": 0.00422, "paired domain protein": 0.03019, "lymphocytic infiltration": 0.00143, "long-term human lymphoid cell": 0.0384, "inositoltrisphosphate generation": 0.00242, "atra": 0.00254, "cyp1a1 mrna": 0.01526, "z-lll-h": 6e-05, "360-d head-down bed rest": 0.00133, "tcr-mediated gene transcription": 0.02903, "replication-competent": 0.00025, "cytoplasmic nf-kappab": 0.00999, "microb motif": 0.00875, "purified human peripheral blood": 0.01881, "basic property": 0.00397, "myeloid-specific factor": 0.0286, "nucleotide -276": 0.00202, "evident": 0.00093, "intimate": 0.00012, "prevalent": 0.00012, "1-oleoyl-2-acetyl-sn-glycerol": 0.00012, "lt promoter activity": 0.0195, "surface marker expression": 0.02775, "chamissonolid": 0.00012, "cell-independent culture system": 0.00445, "intracellular thiols": 0.00583, "human immunodeficiency virus-type": 0.02508, "alternative model": 0.00422, "syk kinases-interacting protein": 0.03019, "transcriptional activation describe": 0.02109, "negative estrogen receptor status": 0.01286, "transmembrane protein": 0.04529, "receptor-negative line": 0.01653, "phosphocreatine administration": 0.00093, "partial variable monosomy": 0.00103, "myelomonocytic differentiation": 0.01179, "low level": 0.01821, "variant nf-kappa": 0.01414, "recall infection": 0.0062, ":735": 6e-05, "decrease downstream nf-kappab activation": 0.01582, "c-jun expression plasmid": 0.02775, "site display disparate effect": 0.01084, "hsv-specific cd4+ t-cell clone": 0.00481, "inhibit nuclear translocation": 0.0127, "proximal promoter region": 0.01557, "janus kinase-signal transducer activator": 0.00276, "gata-3 site abolish antigen-": 0.01084, "cd44 activate": 0.01777, "normal developmental regulation": 0.00806, "tissue transglutaminase": 0.00664, "il-12 production": 0.01042, "vitd3 -and ra-induced monocytic differentiation": 0.00471, "cellular disposition": 0.00893, "defective nf-chi": 0.00205, "nfat group": 0.00487, "tar loop": 0.00109, "protein translocate": 0.04529, "ilf": 0.00012, "rfx5 fusion protein": 0.03019, "lipopolysaccharide result": 0.0161, "zebra protein require": 0.03019, "lipopolysaccharide induces synthesis": 0.00536, "oct-1/oca-b": 6e-05, "activated nk cell": 0.0512, "fetal globin gene": 0.02903, "induce clinical remission": 0.01694, "pattern": 0.01098, "reduced nuclear localization": 0.01123, "share early signal transduction event": 0.00654, "normal primitive myeloid progenitor cell": 0.03072, "microsatellite instability": 0.00016, "inflammatory response": 0.01942, "bzip family": 0.00841, "tpl-2-mediated nfat activation": 0.02109, "signaling pathways": 0.00558, "ad5/animal": 6e-05, "key mediator": 0.00195, "c-jun protein": 0.04529, "scd4": 0.00012, "study concomitant modification": 0.00904, "hla b8-restricted peptide": 0.00502, "antitumor antibiotic": 0.00034, "pth": 0.00037, "cryptic promoter": 0.02336, "cell-extracellular matrix interaction": 0.00658, "specific cytokine": 0.01238, "intracellular binding protein": 0.03019, "sensation": 0.0, "-c-c family": 0.00841, "gc-rich": 0.00019, "human receptor": 0.03762, "phenylpyrazolo glucocorticoid": 0.0085, "maintain": 0.00478, "surface igd": 0.00515, "infectious hiv-1 provirus carry point mutation": 0.00293, "canrenone": 0.00019, "abnormal nuclear morphology indicative": 0.00842, "mouse chromosome": 0.00974, "inhibitory": 0.00713, "okadaic acid occur": 0.00571, "multimerized copy": 0.00078, "anti-hla-dr abrogated proliferation": 0.00536, "plasma membrane": 0.0045, "r/u5 region": 0.01467, "cis element demonstrate": 0.01115, "neuroendocrine-immune interaction": 0.00986, "tal1 promote": 0.00465, "platelet parameter": 0.00372, "ikk1": 0.0005, "immune gene": 0.04355, "mf": 6e-05, "study cellular signal pathway": 0.00817, "inactive nf-kappa": 0.01414, "ig/tcr gene rearrangement": 0.02903, "optimal transactivation": 0.00515, "block hiv-1 replication": 0.00715, "transcription factor nfat1": 0.01907, "lymphocyte-specific protein": 0.04529, "transcription activate": 0.0281, "immediate-early activation gene family": 0.02177, "base pair cis-acting regulatory element": 0.00669, "cbp abolish": 0.00354, "v-rel": 0.00031, "nh": 6e-05, "tumor necrosis factor-alpha secretion": 0.00467, "underlie signaling pathway": 0.00852, "c-fos promoter": 0.02336, "cd40 signal": 0.01635, "sry-related protein sox-4": 0.03019, "pma-unresponsive subline kg1a reveals difference": 0.0017, "l.thompson": 0.00012, "intrinsic abnormality": 0.00239, "src family kinase lck": 0.00594, "corticosteroid receptor regulation": 0.01714, "initial phase": 0.00276, "cell protein": 0.0768, "adequacy": 6e-05, "mature macrophage": 0.00589, "bacillus calmette-guerin": 0.00012, "macrophage express": 0.01846, "nonstimulated ramos": 0.00034, "cell immunity": 0.0768, "cell nuclear protein": 0.0512, "calpain": 0.00037, "cellular basis": 0.00893, "hrxr alpha receptor": 0.01714, "catalytic sub-unit": 0.00059, "normal adult peripheral blood": 0.00605, "regulate cellular function": 0.00887, "cho-dr/b7/lfa-3": 0.00019, "increased viral rna synthesis": 0.00366, "aged runner": 0.0005, "th2- specific gene expression remain": 0.01742, "phop/phoq two-component virulence regulon": 0.00011, "heat shock lead": 0.00664, "epstein-barr virus replicative gene transcription": 0.01742, "effective indicator": 0.00164, "exhibit pleiotropic effect": 0.0141, "human il-1alpha promoter": 0.02508, "stimulate origin replication": 0.00734, "present data": 0.00735, "fundamental difference": 0.00425, "nfkb2 synthesis": 0.00583, "distinct growth factor-regulated signal pathway": 0.00654, "regulate germline": 0.01253, "pre-b leukemia cell nalm-6": 0.0384, "extensive analysis": 0.01179, "interleukin-8": 0.00105, "unstimulated monocyte": 0.01197, "fcrfgamma": 0.00012, "include cytokine": 0.01439, "cytotoxic chemotherapy": 0.00174, "hypothalamic-pituitary-gonadal axis": 0.0005, "xp": 0.00025, "fc-derived non-hodgkin lymphoma": 0.00151, "mononuclear leukocyte": 0.00478, "u3 region": 0.01467, "dioxin receptor system provide": 0.01286, "ifn stimulus response element": 0.00971, "immune system": 0.00667, "cdna sequence": 0.01625, "regulate cytokine-induced proliferation demonstrate": 0.00799, "nf-kappab-dependent up-regulation": 0.00276, "chromatin configuration": 0.00118, "long terminal repeat": 0.00252, "tmd": 0.00031, "central issue": 0.00109, "cytoplasmic nf-kappa b/rel complex": 0.00842, "organism avirulent": 0.00025, "show pu box-dependent transactivation": 0.013, "induce neutrophil differentiation": 0.01694, "mm cell": 0.0768, "il-2 promoter activity": 0.0195, "data demonstrate": 0.01597, "nucleated fetal blood cell": 0.0384, "proximal promoter element": 0.01557, "similarly induce": 0.0254, "lp": 0.00707, "intracellular gsh pool": 0.00389, "il-13 treatment": 0.01014, "bh2": 0.00012, "vcam-1-mediated adhesion": 0.0058, "present evidence indicating": 0.0049, "divergent reaction": 0.0022, "high glutathione level": 0.01214, "pathogenesis": 0.00341, "selectively increase cell regulatory property": 0.03072, "receptor common gamma chain": 0.01286, "drastic change": 0.0063, "creb binding site oligonucleotides demonstrate": 0.00867, "rightward transcript": 0.00599, "increase extracellular concentration": 0.01464, "biological response include": 0.01294, "allele-specific regulation": 0.01008, "junb mrna peak": 0.01017, "fl hematopoiesis": 0.00071, "induce target cell apoptosis": 0.0384, "atherosclerotic plaque development": 0.00422, "self-antigen": 0.00012, "semiquantitative rt-pcr": 0.00087, "control cell culture": 0.0512, "airway instillation": 0.0009, "dra gene regulatory sequence": 0.02177, "phase-2 response": 0.01942, "potent peptide chemoattractant": 0.00502, "nef gene": 0.04355, "increase nk activity": 0.0195, "treatment sufficient": 0.01014, "polymorphonuclear leukocyte require": 0.00877, "transcription factor induce": 0.01907, "35-kda fragment": 0.00347, "liver pcd/dcoh": 0.00118, "inhibition note": 0.01061, "oct2b isoforms": 0.00307, "complex and/or interferes": 0.01123, "calcium ionophore ionomycin": 0.00157, "up-regulated": 0.00267, "subsequent induction": 0.01607, "delayed-type hypersensitivity response": 0.01294, "direct pkc activation": 0.02109, "ets-1 site": 0.02168, "map kinase-related kinase": 0.00792, "asymptomatic twin": 0.00034, "tec": 0.00056, "disease show positive reaction": 0.013, "natl": 0.00019, "prominent constitutive binding": 0.01237, "predictive protein-coding region": 0.00978, "so-called au-rich element": 0.01115, "single theory": 0.0036, "low activation": 0.03164, "rescue cell": 0.0768, "fas upregulation": 0.00192, "n-acetyl-l-cysteine": 0.00062, "mutagenesis result": 0.0161, "interferon-gamma treatment": 0.01014, "lps +/- ifn-gamma": 0.00321, "gm2/gc-box sequence": 0.01625, "human rel family protein": 0.02264, "histamine receptor": 0.02571, "cell express tcrzeta": 0.0512, "uninfected pbmcs": 0.00081, "progressive decline": 0.00121, "tal1 mrna": 0.01526, "spontaneous il-1ra production": 0.00695, "atherosclerosis": 0.00112, "mzf-1 suggests": 0.00102, "human b-lcl": 0.03762, "fixed tissue confirm mnda expression": 0.01665, "icsat/pip/lsirf": 6e-05, "cell-permeable diacylglycerol": 0.00031, "ro 25-7386": 0.0009, "infecting baboon": 6e-05, "platelet fibrinogen receptor": 0.01714, "trafs": 0.00056, "transforming latent membrane protein-1": 0.00225, "-1 surface expression": 0.02775, "common region": 0.01467, "ligand binding affinity": 0.01237, "ifngamma-induced ip-10 mrna": 0.01017, "activated state": 0.00589, "cell surface marker": 0.0512, "increase ra concentration": 0.01464, "related factor ets1": 0.01907, "postanoxic huvecs": 0.00081, "ap1 family member": 0.0056, "lymphocyte-specific enhancer element": 0.01115, "9-cis ra cooperate": 0.00397, "enhanced release": 0.00484, "zinc finger/homeodomain protein": 0.03019, "il2": 0.0013, "transactivator rela": 0.00161, "hrf": 0.00019, "v3-bh10": 0.0005, "affect receptor clustering": 0.01714, "sla-dr": 0.00031, "transcription factor activity": 0.0195, "ccaat sequence": 0.01625, "tal-1 transcription": 0.0281, "antiapoptotic factor": 0.0286, "caenorhabditis elegans cell death gene ced-3": 0.0256, "phosphatidylinositol 3-kinase-linked pathway": 0.00852, "hepor transcription activity": 0.0195, "nac": 0.00211, "tbars": 6e-05, "deliver nf-kappab": 0.00999, "s-100 protein": 0.04529, "transcription factor product play": 0.0143, "il-1 beta level": 0.01214, "important determinant": 0.00689, "ifn-gamma-induced transcription": 0.0281, "membrane-bound tnf-alpha": 0.00546, "aml1/mds1/evi1 block differentiation result": 0.00805, "plasma membrane impermeable testosterone-bsa conjugate induces": 0.00268, "english-language literature": 0.00016, "specific set": 0.01238, "tnf-alpha-induced icam-1 transcription": 0.01873, "tf induction": 0.01607, "eosinophil life-prolonging effect": 0.0141, "nf-kb site": 0.02168, "mg-132": 0.00025, "cns-derived cell tat": 0.0512, "sodium salicylate block": 0.00715, "human sequence": 0.03762, "cell-free assay": 0.01002, "localized region": 0.01467, "individual heterozygous": 0.00409, "chronic gut inflammation": 0.00265, "ag-induced": 0.00012, "cellular oncogene c-myb": 0.00596, "wild-type tax": 0.00478, "octamer motif": 0.00875, "elution": 0.00062, "c/ebp consensus bind site": 0.01084, "isolated thymic": 0.00189, "dual-function protein": 0.04529, "tcl1 protein expression": 0.03019, "thymic development": 0.00633, "active state": 0.00592, "metal-ion chelating activity": 0.0195, "enhanced": 0.00571, "human aml1": 0.03762, "moderate increase": 0.02196, "c-erbb2 amplification": 0.00074, "ilfs": 0.00037, "ige class switching": 0.00428, "pharmacodynamic modeling": 0.00012, "-inducible gene": 0.04355, "proper expression": 0.04163, "nuclear receptor protein": 0.03019, "bcr-abl chimera": 0.00081, "kappa b-like sequence": 0.01084, "high-affinity calcineurin-binding peptide": 0.00502, "nfat-1": 0.00254, "galectin-3 level": 0.01821, "potential mechanism underlie ebv-mediated": 0.00529, "eosinophilic cell": 0.0768, "induced dna-binding activity": 0.0195, "apoptosis induction": 0.01607, "0.5-2.5": 0.0, "dq0302": 0.00031, "phosphonoacetic acid": 0.00856, "leu42-pro49": 6e-05, "ciita protein": 0.04529, "lps-specific ab": 0.00167, "suppress toxic/septic shock": 0.00407, "lymphokine receptor gene": 0.02903, "physiological coculture cellular assay system": 0.00401, "tegument protein vp22": 0.03019, "lymphocytic transformation": 0.00288, "stat6": 0.00465, "transactivation responsive": 0.00515, "alignment": 0.00019, "viral genome": 0.00732, "phop-phoq regulon": 0.00022, "parallel mitogen-activated protein kinase pathway": 0.01811, "domain analysis": 0.01207, "similar manner": 0.00673, "effect p70": 0.02115, "cell activation result": 0.0512, "herpes simplex virus-1": 0.0005, "increased myeloperoxidase activity": 0.0195, "finding provide": 0.00645, "rb expression lead": 0.02775, "promoter": 0.04671, "v-erba overexpression": 0.00382, "tpa treatment": 0.01014, "ku812": 0.00012, "ikk complex-associated protein": 0.03019, "internal atgs": 0.00087, "mediates transcriptional activation": 0.02109, "stat6 activation": 0.03164, "-binding transcription factor": 0.01907, "indication point": 0.00183, "receptor synthesis": 0.02571, "lt-alpha1beta2 expression": 0.04163, "pervanadate induce activation": 0.02109, "cell cdna library": 0.0512, "human aortic endothelial cell": 0.0384, "human herpesvirus type-8": 0.02508, "z29": 0.00025, "truncated": 0.00149, "human umbilical arterial endothelial cell": 0.03072, "r-pk dna fragment": 0.00988, "t-lymphocyte cell line": 0.0512, "tumor transformation": 0.00934, "pathological situation": 0.00056, "ck-1/cd28re": 0.00012, "okt8+ suppressor/cytotoxic": 6e-05, "active v-abl protein": 0.03019, "glucocorticoid receptor content": 0.01714, "defective transcription factor": 0.01907, "acidic residue": 0.00226, "nf-kb binding protein": 0.03019, "weak octamer-binding site": 0.01445, "hl-60 promyelocytes": 0.00195, "western blotting": 0.00084, "response": 0.03883, "up-regulate il-1beta expression": 0.02775, "cell-derived coactivator potentiate": 0.0012, "morphological analysis": 0.01179, "-beta demonstrate": 0.01597, "laboratory demonstrate": 0.01597, "dramatic increase": 0.02196, "polyclonal antiseras": 0.00115, "proteasome complex": 0.01684, "recent study": 0.01355, "0.5-gy exposure": 0.0035, "dna bind nfkb2": 0.0135, "schedule": 0.00012, "pomc": 0.00012, "exercise": 0.00099, "lack expression": 0.04163, "cell-type-specific trans-acting factor": 0.01907, "bcl-6 reveal": 0.01098, "fh": 0.00031, "delta sequence": 0.01625, "ifn-induced tyrosine phosphorylation": 0.00656, "p42/44": 0.00012, "exon": 0.00254, "reiterated splicing site": 0.01445, "inhibit dissociation": 0.01904, "xpb gene": 0.04355, "j.exp.med.": 0.0, "bind capacity": 0.02025, "affect neoplastic transformation": 0.00531, "70-": 0.00012, "q22": 0.00043, "apc protein": 0.04529, "cd40 induction": 0.01607, "calcium": 0.00471, "detailed molecular analysis": 0.00786, "friend erythroleukemia result": 0.01073, "erk pathway-specific inhibitor pd98059 inhibit il-6 secretion": 0.00544, "human factor": 0.03762, "transcription factor nf-kappa b. endothelial cell activation": 0.02194, "glucocorticoid receptor characteristic": 0.01714, "activate pbmc maintain": 0.01185, "familial": 0.00074, "molecular genetic basis": 0.003, "c-sis/pdgf-b proto-oncogene": 0.0013, "cytokine regulation": 0.01123, "partial differentiation": 0.01179, "synergizing": 0.00025, "gene-targeted mice deficient": 0.00091, "neural cell nf-kappa": 0.0512, "transfected jurkat cell": 0.0512, "consensus gata-binding site": 0.01445, "lineage switch": 0.00366, "antimouse alpha a1 antibody": 0.00585, "post-translational regulation": 0.01008, "capability": 0.00062, "macrophage play": 0.0071, "tyrosine kinase activate": 0.01185, "block human lymphocyte proliferation": 0.01881, "suppress replication": 0.00611, "sequence 5'-ggccaatggg-3": 0.01625, "major proinflammatory cytokine": 0.00749, "alpha expression increase constitutive": 0.02081, "dephosphorylation": 0.0018, "feature": 0.00434, "beneficial inflammation": 0.00316, "dna accessibility": 0.01483, "uterine cavity": 0.0004, "primary case": 0.00738, "post-translationally process": 0.00444, "k. arai": 0.00012, "strong positive regulatory effect": 0.01058, "gene fusion": 0.04355, "high hbf": 0.00931, "immunomodulatory cytokine": 0.01123, "adhesion study": 0.01355, "clevers": 6e-05, "n-terminal peptide": 0.00754, "u937 macrophage cell line": 0.0384, "nuclear factor-kappab translocation": 0.01123, "genome-positive": 0.00012, "icam-1 promoter-dependent transcription": 0.01873, "catalytic core": 0.0022, "cd4 trigger": 0.00409, "augment il-1 beta mrna level": 0.00728, "vd response element": 0.01294, "sp140 mrna": 0.01526, "irf-1/isgf2": 6e-05, "tcr-mediated induction": 0.01607, "remain open": 0.00521, "cellular dna damage": 0.00988, "internal site": 0.02168, "efficient dna replication": 0.00988, "trophic effect result": 0.0141, "nf-il6 binding activity": 0.0195, "sp-1 element": 0.01672, "raralpha/pml fusion protein": 0.03019, "fcs-": 0.00025, "redox change": 0.0063, "poor response": 0.01942, "t-lymphocyte anergy": 0.00093, "bent dna": 0.01483, "hexasaccharide chain": 0.00437, "distinct stat protein": 0.03019, "functional nuclear localization signal present": 0.00674, "ifn-alpha/beta act": 0.00496, "biochemical consequence": 0.0018, "mechanism influence human immunodeficiency virus replication": 0.01254, "intracellular action": 0.00583, "human t-cell line iarc": 0.01881, "e2a moiety": 0.00102, "as2o3 induce pml": 0.01694, "suggest": 0.04045, "exclusive": 0.00062, "pertussis toxin block": 0.00715, "lambda5 promoter/enhancer region": 0.00978, "basal redox equilibrium": 0.00234, "theileria-infected cell": 0.0768, "biological evaluation": 0.00217, "proteasome inhibitor": 0.009, "deltanfkappabdeltaspl234": 0.00025, "chromosome lie": 0.00295, "intrinsic transcriptional activation motif": 0.01582, "double-stranded rna-dependent manner": 0.00188, "bacterial constituent": 0.00223, "effector molecule": 0.00853, "progesterone contributes": 0.00164, "pituitary transcription factor pit-1b": 0.0143, "tcr beta-chain": 0.00478, "e1a sequence": 0.01625, "granular sudan black": 0.00017, "signal requirement": 0.01635, "distal box": 0.00304, "muscle contraction": 0.00065, "liposomal transfection": 0.00276, "dnase-i-hypersensitive": 6e-05, "lai expression": 0.04163, "restriction enzyme digestion": 0.00207, "low tcrzeta level": 0.01214, "nk cell-mediated cytolysis": 0.00244, "megakaryocytic lineage cell": 0.0512, "intracellular il-2 receptor expression": 0.02081, "poorly define": 0.00323, "differentiation": 0.02357, "peripheral blood lymphocyte": 0.00988, "include rela": 0.01439, "substitution": 0.00223, "correspond specific bind": 0.0135, "exogenous pge2 mimic": 0.00143, "hb-synthesizing cell": 0.0768, "hypoactivity": 0.00012, "cysteamine treatment": 0.01014, "trigger multiple signal pathway": 0.00817, "anti-cd2 activated": 0.00589, "direct cytotoxic effect": 0.0141, "mab l243": 0.00267, "play crucial role": 0.00885, "transcription control": 0.0281, "igm": 0.00118, "gut": 0.00068, "immune reactivity": 0.00599, "helper cell subset": 0.0512, "proinflammatory neutrophil stimulus": 0.00331, "determine specific gene activation": 0.02177, "genetic target": 0.00825, "rt-pcr demonstrate": 0.01597, "reduced ability": 0.00431, "regulate fasl expression": 0.02775, "interferes": 0.00062, "rfx1": 0.00074, "-150 proximal ap-1 site": 0.01084, "immune mechanism": 0.01058, "potential regulation": 0.01008, "pcd41": 0.0005, "express cd40": 0.01846, "allergen-specific human t-cell clone": 0.01881, "tegument protein": 0.04529, "tyrphostin ag-490 inhibits cytokine-mediated jak3/stat5a/b signal transduction": 0.00467, "nf-kappa b/rel/nfat transcription factor": 0.0143, "elam mrna": 0.01526, "-201/-184 nxs": 0.00012, "protein regulate gene transcription": 0.02264, "low affinity il-2rs": 0.00471, "murine bone marrow-derived macrophage": 0.00312, "oct coactivator": 0.00149, "myd88": 0.00056, "phosphorylated tyrosine": 0.0071, "endothelial cell adhesive property": 0.0384, "maintain cellular homeostasis": 0.00596, "indirect immunofluorescence show": 0.01733, "l2": 0.00025, "-dependent signal-transduction pathway": 0.00852, "switch c-jun": 0.00493, "-h+ antiport": 3e-05, "sm protein": 0.04529, "ets-1 bend mu enhancer dna": 0.00593, "significant fraction": 0.00416, "wild-type par protein": 0.03019, "drug regimen": 0.00338, "haematopoietic differentiation": 0.01179, "regulatory cytokine": 0.01123, "mixed/erythroid/monocytic": 0.00012, "cell receptor": 0.0768, "human monocyte/macrophage function": 0.02508, "sla-dq antigen expression": 0.02775, "il-5 activate": 0.01777, "translation-dependent degradation mechanism": 0.00705, "carry infection": 0.0062, "gm2 define": 0.00323, "double-stranded dna target": 0.00988, "il-1 signaling": 0.00558, "interleukin-10": 0.00112, "play essential role": 0.00885, "protein recruitment": 0.04529, "impaired activation": 0.03164, "regulate rag gene expression": 0.02177, "constitutively activate jak-stat pathway": 0.00889, "form metastatic tumor": 0.00703, "study hematopoietic development": 0.00904, "nfat reporter": 0.00552, "bind parameter": 0.02025, "ten hiv-infected patient": 0.0111, "dominant ikappab": 0.00245, "tata": 0.00149, "importin": 6e-05, "weak constitutive activation": 0.02109, "nuclear p62c-fos": 0.01684, "cell death": 0.0768, "hpa axis regulation": 0.00672, "viral oncogenesis": 0.00732, "distal interleukin": 0.00276, "il-10 stimulate activate protein-1": 0.00889, "cortisol receptor function": 0.01714, "anti-p-145": 0.00012, "gas-motif sequence": 0.01625, "c-myb mrna induce": 0.01694, "merit": 0.00019, "box binding": 0.01855, "industrial": 0.00037, "individual mutation": 0.00592, "l540 cell": 0.0768, "alpha cp1": 0.01169, "control tnf-alpha gene transcription": 0.02177, "tax-expressing t-cell line": 0.01102, "observation": 0.00298, "-dp transcription": 0.0281, "cytoplasmic cat mrna": 0.01017, "immaturity": 0.0, "hsf2 consist": 0.00183, "rantes": 0.0013, "cancerous cell line": 0.0512, "exclusive tax-induced expression": 0.02775, "galectin-3": 0.00074, "cytoskeletal integrity": 0.00025, "human t-cell leukemia virus type": 0.01505, "maltolato": 0.00012, "ip-10 expression": 0.04163, "junb transcription": 0.0281, "cell line jurkat": 0.0512, "e1a expression mark cell": 0.0384, "steel factor-induced erythroid proliferation": 0.00402, "specific dna-binding activity": 0.0195, "immunoglobulin variable region promoter": 0.01168, "beta1": 0.00043, "glucocorticoid receptor concentration": 0.01714, "tax1 mutant": 0.0081, "-pcr analysis demonstrate gh mrna": 0.00639, "calcium-dependent signal": 0.01635, "constitutively": 0.00813, "vesicle": 0.00043, "gamma-interferon": 0.00043, "ad12 e1a-transfected cell line": 0.0384, "myeloid blast cell": 0.0512, "result": 0.0322, "activated immature": 0.00589, "thapsigargin stimulation": 0.0112, "cytosolic nf-kappa": 0.01414, "implicate caml": 0.0035, "il-2r beta gene": 0.02903, "cd8+ t-cells": 0.00211, "cytotoxic lymphocyte": 0.01483, "sufficient": 0.00478, "mutant collagenase-1 promoter display ap-1 independent pma-mediated transactivation": 0.00584, "activation induce": 0.03164, "pxqxt/s": 0.00031, "tinur bind": 0.02025, "observation suggest": 0.02022, "cell induce robust phosphorylation": 0.0384, "c/ebpalpha increase": 0.02196, "screen method": 0.00236, "growth signal": 0.01635, "cd40-mediated up-regulation": 0.00276, "il-3 promoter-linked reporter construct": 0.00363, "alpha-rb oligomers inhibit": 0.0127, "molecular difference": 0.0045, "idiopathic myelofibrosis": 0.00019, "gonadotropin": 0.00019, "enhances viral replication": 0.00488, "hiv-2 enhancer element": 0.01115, "homocysteine": 6e-05, "limited requirement": 0.00264, "increase processing": 0.02196, "gata-1 regulate red cell gene": 0.03072, "nmax": 0.00019, "decreased number": 0.0053, "endothelium lead": 0.00996, "d.schwartz": 6e-05, "sporadic androgen insensitivity syndrome": 0.00136, "40-kda transforming protein": 0.03019, "tr2 orphan receptor": 0.01714, "estrogen receptor content": 0.01714, "transactivate lmp1": 0.0027, "urine": 0.00025, "mrp14": 0.00056, "cell antigen receptor-induced activation": 0.0384, "inhibit vascular cell adhesion molecule": 0.03072, "blood transfusion recipient": 0.00395, "human immunodeficiency virus-1 tat protein": 0.01811, "leukocyte migration": 0.00478, "lavage": 0.00081, "nfat transcription factor": 0.01907, "detergent lysates": 0.00102, "concomitant down-regulation": 0.00195, "stat protein heterocomplexes exist prior": 0.01811, "lmp1 gene": 0.04355, "grbeta-mediated antiglucocorticoid activity": 0.0195, "stimulatory condition": 0.0036, "interleukin-2 gene expression": 0.02903, "ebers": 0.00012, "transfected jurkat": 0.00555, "kappa b-alpha/mad-3": 0.00748, "r. k.": 0.00022, "express ig": 0.01846, "ebv binding": 0.01855, "behaviour": 0.00025, "15-lox gene": 0.04355, "theileria annulata infects bovine leucocyte": 0.00036, "interleukin-5 signaling": 0.00558, "steroid sparing": 0.00292, "alpha-tocopherol treatment": 0.01014, "well-recognized adhesive role": 0.00885, "aids-associated lesion characterize": 0.00283, "left adnexal region": 0.00978, "human ptf": 0.03762, "oppose": 0.00124, "bronchitis": 0.00031, "healthy virus carrier": 0.00591, "vivo th1 response": 0.01294, "-120": 0.00019, "downstream event important": 0.00459, "antiinflammatory alkaloid": 0.00062, "cell co-cultures increase": 0.0512, "cross-linking cd19": 0.00242, "mediate il-4-": 0.01231, "partial cortisol receptor resistance": 0.01286, "tyrosine kinase activation": 0.02109, "tat activity": 0.02925, "immunoreactive c-jun": 0.00493, "transcription factor bsap": 0.01907, "endogenous virus isolates": 0.00591, "p40": 0.00149, "aid": 0.00323, "tafii105": 0.00025, "asp amino acid": 0.00571, "immunotoxicity": 6e-05, "nuclear nf-kb expression": 0.02775, "theileria annulata induces expression": 0.02081, "cell viability": 0.0768, "gene lead": 0.04355, "functional t-cell receptor signal pathway": 0.01029, "vdre-binding protein": 0.04529, "gtt": 0.00012, "type ii bare lymphocyte syndrome-associated factor": 0.00953, "enhancer mutation": 0.00909, "jul": 6e-05, "25-fold increase": 0.02196, "dysregulation": 0.00081, "tgf-beta1 mrna synthesis": 0.01017, "hydroxylamine": 6e-05, "non-proliferating cell": 0.0768, "induction mechanism remain unknown": 0.00803, "mhc class ii protein": 0.02264, "35-year-old": 0.00012, "differential effect": 0.02115, "c-fos/c-jun": 0.00105, "occur breakdown product": 0.00436, "molecular cue deliver": 0.003, "apoptotic neutrophil": 0.00496, "alpha subunit expression": 0.02775, "medline search": 0.00031, "tax mutant m22": 0.0054, "cell malignancy": 0.0768, "cholesterol feedback mechanism": 0.00705, "unique feature": 0.00261, "inheritance": 0.0005, "e4bp4": 0.0, "tgf beta": 0.00673, "stimulate elongation": 0.01101, "receptor bind study": 0.01714, "eightfold": 0.00043, "abbott pgr-eia monoclonal": 0.00186, "total nf-kappa": 0.01414, "xenotransplanted tissue": 0.00664, "embryonic and/or fetal origin": 0.00225, "express interleukin-2": 0.01846, "bandshift analysis": 0.01179, "major histocompatibility class": 0.00428, "fn-induced il-1beta protein production": 0.02264, "demonstration": 0.0013, "macrophages/monocytes": 6e-05, "ewg": 6e-05, "isgf3-independent response": 0.01942, "hsv-2 buttock": 0.00071, "time hbxag": 0.00273, "physiologic product": 0.00533, "u-373 mg cell": 0.0512, "rela homodimer": 0.0014, "monoclonal anti-endothelial cell antibody": 0.0384, "cd28 activation trigger": 0.02109, "cholecystokininb receptor": 0.02571, "receptor-dependent process": 0.00444, "erythroid cell development": 0.0512, "bind th2-specific complex": 0.0135, "ecs-dependent luciferase reporter gene activation": 0.01742, "continuous monitoring": 0.00078, "distinct member": 0.00698, "hiv ltrs": 0.00592, "twelve amino acid": 0.00571, "cell proliferation": 0.0768, "churg-strauss syndrome": 0.00273, "lef-1 hmg protein": 0.03019, "c-jun rna": 0.00493, "intracellular mediator": 0.00583, "il-3/il-5/gm-csf receptor beta-subunit": 0.01714, "anti-ras immunoprecipitates": 9e-05, "aml m4eo": 0.00087, "c-fos upregulation mediate": 0.00821, "3'-most site": 0.02168, "proto-oncogene encoding": 0.0013, "delineation": 6e-05, "lt gene expression": 0.02903, "mediate cell death": 0.0512, "24-hour incubation": 0.00208, "cd2 signal pathway": 0.0109, "fas ligand regulatory element": 0.00836, "documented typical junb mrna": 0.00763, "glycophorin": 0.00031, "b7-transfected cho cell induce": 0.0384, "tnf-alpha activity": 0.02925, "interleukin-6": 0.00143, "nuclear import process": 0.01123, "cellular/molecular event": 0.00552, "long-lived state": 0.00267, "human hla-dq heterodimer": 0.02508, "cell/monocyte surface antigen": 0.00546, "cell component": 0.0768, "deletion analysis reveal": 0.00786, "hb24 transfectants reveal constitutive expression": 0.01665, "dose-sparing": 6e-05, "limit blood cell formation": 0.0384, "igh promoter": 0.02336, "rapid intracellular formation": 0.00389, "b-1 cell": 0.0768, "normal constituent": 0.0121, "ec costimulation": 0.00254, "lymphocyte cell line": 0.0512, "electrophoretic mobility shift assay complex": 0.00674, "northern analysis confirm": 0.00786, "epo": 0.00341, "sequence-specific transcription factor": 0.01907, "ecp": 0.00019, "ltb4 induce great ap-1-binding activity": 0.0117, "human il-2r alpha promoter": 0.01881, "carbon-20 position": 0.00236, "open reading frame": 0.00048, "hsf2-beta isoforms": 0.00307, "granulocyte colony-stimulating factor activate": 0.0143, "lac operon": 0.00022, "canonical egr-1 binding site": 0.01084, "direct significant correlation": 0.0036, "alpha molecule": 0.01169, "noticeable side-effects": 9e-05, "alpha1 promoter activates transcription": 0.01405, "tre-dna fragment": 0.00347, "ap-1/octamer composite element": 0.01115, "direct genetic target": 0.0055, "ice": 0.00019, "tr75 expression": 0.04163, "small alteration": 0.00313, "receptor content": 0.02571, "smear": 6e-05, "bcl-2 promoter implies": 0.01557, "supratherapeutic concentration": 0.0067, "interleukin-9-mediated cell proliferation": 0.0512, "regulated degradation": 0.00332, "purified viral ligand binding": 0.00927, "protein mediate signal transduction": 0.02264, "high capacity": 0.00931, "protein-coupled pathway": 0.01278, "sfv intrabody": 0.00025, "transcriptional transactivator": 0.01151, "mediate il-6 gene expression": 0.02177, "gata-1 common": 0.00413, "1-10 microm": 0.0013, "thymus": 0.00223, "ap-2 dna bind": 0.0135, "composite octamer motif": 0.00583, "phospholipase a2": 0.00078, "65-year-old woman": 0.00233, "active tetrameric complex": 0.01123, "signal derived": 0.01635, "ra induce apoptosis": 0.01694, "entire dna-binding domain": 0.00804, "th0-type human": 0.03762, "-alpha beta nls receptor complex": 0.01029, "j-c intron": 0.00059, "notable difference": 0.00425, "cytoplasmic tyrosine kinase require": 0.00658, "adult globin gene": 0.02903, "heterodimeric receptor induces activation": 0.01582, "polyomavirus enhancer-binding protein": 0.03019, "adult globin gene expression": 0.02177, "-579": 0.00012, "alveolar exudate": 0.00096, "terminal phase": 0.00332, "alpha tcr": 0.01169, "sp1": 0.0072, "aclacinomycin": 6e-05, "crel correlate": 0.00654, "support cell survival": 0.0512, "mouse mhc class": 0.00649, "cd25 promoter": 0.02336, "additive combination": 0.00288, "cml patient": 0.01666, "potent suppressor": 0.00357, "physiological upper limit": 0.00122, "epo-dependent human cell line": 0.0384, "amino acid change": 0.00571, "select instance": 0.00195, "transcriptional capacity": 0.01151, "anti-mhc class ii antibody": 0.00447, "vertebrate gene encode": 0.02903, "transactivating domain": 0.01207, "activation occur": 0.03164, "il-2-induced heterodimerization": 0.0013, "gentle recovery": 0.0005, "arp2/3 complex": 0.01684, "intact gp130 cytoplasmic tail": 0.002, "threefold": 0.00056, "lymphocyte activation enhances bind": 0.01582, "php": 0.00019, "aberrant retinoic-acid receptor type alpha": 0.01029, "enhance hiv-1 replication": 0.00649, "activate interleukin-2 production": 0.01185, "important nf-kappab binding activity": 0.01462, "intriguing issue": 0.00019, "multiple region": 0.01467, "irf-2 promoter region": 0.01557, "dose-response study show": 0.01733, "pma-stimulated t-cell line": 0.01102, "functional stimulation": 0.0112, "breast cancer patient": 0.0111, "cem c1": 0.00109, "tcl1 genomic locus": 0.00192, "lps-induced tf gene expression": 0.02177, "bp deletion": 0.00344, "region enhance": 0.01467, "hsf activation": 0.03164, "zk157202": 0.00019, "signal transduction study": 0.0109, "gtpase rac": 0.00037, "hacat cell": 0.0768, "messenger ribonucleic acid": 0.00571, "translocation step": 0.00515, "multiple signal transduction pathway": 0.00817, "spontaneous stimulation": 0.0112, "zinc-finger-encoding gene show coordinate induction": 0.01742, "neuroendocrine cell characteristic": 0.0512, "restimulated": 0.00012, "collection": 0.00012, "mono": 0.00099, "non-clonal progenitor cell": 0.0512, "bzlf1-encoded transcription factor": 0.01907, "severe heart failure": 0.00141, "hemin increase": 0.02196, "epsilon gas dna-protein binding complex": 0.00742, "ap-1 response": 0.01942, "normal platelet": 0.0121, "cell prolymphocytic leukemia": 0.0512, "sex difference": 0.00425, "abolishes": 0.00074, "reporter plasmid dependent": 0.00368, "inducible phosphorylation": 0.00983, "devd-cleavable caspase activity": 0.0195, "human cd34+ erythroid progenitor cell": 0.03072, "related c-c chemokine receptor-like gene reside": 0.01452, "nf-kb": 0.00316, "membrane permeable ca2+ chelator": 0.00225, "detectable binding": 0.01855, "proximal short arm": 0.00201, "il-3 ck-1/ck-2 element": 0.01115, "constant": 0.00174, "megakaryoblastic permanent cell line": 0.0384, "dntps": 6e-05, "il-7-induced proliferation": 0.00803, "active p50/rela": 0.00592, "standard gel retardation assay": 0.00501, "tax transactivates": 0.00478, "cd2 receptor stimulation": 0.01714, "akv mlv transcriptional activity": 0.01462, "and/or growth": 0.00819, "require expression": 0.04163, "dominant negative rac": 0.00343, "monocyte/macrophage-like cell line": 0.0512, "prion protein": 0.04529, "work": 0.00161, "bcl-2 overexpression lead": 0.00664, "protoenhancers": 6e-05, "suppress surface expression": 0.02775, "factor bind site": 0.01907, "-dependent manner": 0.00282, "increase il-2 transcription": 0.01873, "normocalcemic patient": 0.01666, "fungal metabolite gliotoxin": 0.00072, "absent mhc class ii expression": 0.01665, "s-adenosylhomocysteine hydrolase inhibit bacterial lipopolysaccharide-induced transcription": 0.00937, "hla-dq isotype-specific trans-acting factor": 0.0143, "granulocyte-macrophage csf": 0.00118, "vitro production": 0.01042, "-exchanger": 6e-05, "human baf170": 0.03762, "phase s.": 0.00276, "enhancer bind protein isolate": 0.02264, "context-dependent coactivator": 0.00149, "endocrine compartment": 0.0009, "vitamin d-responsive element-regulated reporter gene": 0.01742, "detect red cell": 0.0512, "ras-related gtpase rac-1": 0.00035, "cmv pneumonitis": 0.00118, "atra induces": 0.00803, "dysmenorrhoea": 6e-05, "cell lead": 0.0768, "abdominal obese": 0.00019, "gst-pi expression": 0.04163, "tax-mediated dna damage": 0.00988, "reporter gene assay reveal": 0.02177, "play critical role": 0.00885, "cell type-specific tfiid subunit": 0.0384, "scid-hu-int": 0.00019, "hiv reverse transcription": 0.01873, "macaque": 0.00056, "activation-dependent tyrosine phosphorylation": 0.00656, "il-5 control development": 0.00868, "cell lineage-specific activator protein": 0.0384, "epo-dependent differentiation": 0.01179, "lmp-1 protein level": 0.03019, "uc": 6e-05, "bv": 0.00012, "previous study reveal": 0.00904, "g60": 6e-05, "immune receptor": 0.02571, "hla dq2-associated autoimmune disease": 0.00337, "render unresponsive": 0.00152, "peptide decrease": 0.00971, "octamer sequence atgcaaat": 0.01084, "dza inhibit": 0.01904, "ikaros site": 0.02168, "superoxide release stimulate": 0.00734, "cyclooxygenase-2 expression": 0.04163, "mbcl6": 0.00019, "phase transition": 0.00276, "antioxidant stimulus": 0.0027, "remain cd4+": 0.00521, "-1": 0.00217, "cytosolic c-rel/p65 heterodimers": 0.00151, "reveal gene": 0.04355, "affect intracellular il-2 signaling": 0.00558, "transcription factor nf-kappa": 0.01907, "soluble interleukin-2 receptor-alpha": 0.00221, "bcd gene": 0.04355, "yeast polypeptide": 0.00155, "slp-76-associated phosphoprotein": 0.00053, "potent acid activation region": 0.01582, "t-cell proliferation study": 0.00904, "alter fibroblast collagenase expression": 0.02081, "trigger lead": 0.00996, "tetrahydrocortisone": 6e-05, "transfection data": 0.00276, "zp respond": 0.00251, "protein kinase c-zeta": 0.03019, "inflammatory reaction": 0.00471, "neoplastic epidermal cell": 0.0512, "zinc finger range": 0.00134, "potent activator": 0.00552, "clinical": 0.0085, "prospective longitudinal study": 0.00904, "representational difference analysis": 0.00786, "map": 0.00409, "inflammatory effector gene": 0.02903, "terminus reveal": 0.01098, "micromol/l": 0.00043, "marked suppression": 0.00416, "interferon-responsive factor": 0.0286, "ap1 transcriptional complex": 0.01123, "12.5-kb upstream": 0.00369, "human accessory cell": 0.0512, "nf-kb level": 0.01821, "active nfat-like element": 0.01115, "total serum": 0.00378, "down-regulate wild-type ciita activity": 0.01462, "ldl": 0.00167, "620-bp human gm-csf promoter-luciferase reporter construct": 0.01254, "detect single strand nick": 0.00363, "ln": 0.0005, "rodent plasmacytoma": 0.00047, "rta lead": 0.00996, "cpre": 0.00012, "c-rel-expressing cell monolayers lead": 0.0384, "human gr": 0.03762, "nf-kappab/ikappabalpha": 6e-05, "abnormal clone": 0.00738, "nodular lymphocyte predominance subtype": 0.00741, "granulocyte colony-stimulating factor receptor promoter": 0.01144, "endogenous": 0.00918, "cyclic amp production": 0.00695, "sivmac": 0.00025, "lipopolysaccharide-induced depletion": 0.00121, "maf status": 0.00217, "surface immunoglobulin-triggered b-cell activation": 0.01582, "-550": 0.0, "g1-s-associated dna": 0.01483, "b-cell-specific response": 0.01942, "decreased promoter strength": 0.01557, "world primate": 0.00056, "oxidant stress": 0.0031, "h9": 0.00068, "familial tuberous sclerosis": 0.00025, "nfat-driven minimal promoter": 0.01557, "nf-kappab content": 0.00999, "u.v": 6e-05, "latent protein": 0.04529, "recombination activate gene": 0.02903, "oligonucleotides span": 0.00183, "myeloid cell": 0.0768, "class ii protein": 0.03019, "lps injection": 0.0035, "fetal progenitor": 0.00276, "cell signal pathway": 0.0512, "stat1-like factor bind": 0.01907, "pbm differentiate": 0.00267, "hematopoietic system": 0.00667, "describe receptor ebi1": 0.01714, "conserved role": 0.01328, "anti-cd3 activated": 0.00589, "il-4 receptor subunit alpha": 0.01286, "subsequent action": 0.00499, "nf-il6 motif": 0.00875, "ttg": 0.00043, "cd28 responsive complex": 0.01123, "physiological cell death pathway": 0.0384, "methyl": 0.00043, "case test lack": 0.00422, "productive hiv infection": 0.00414, "cultured human dermal endothelial cell": 0.03072, "il-5-producing t-cell clone": 0.00641, "lt": 0.0013, "simultaneous binding": 0.01855, "template": 0.00037, "site-specific mutation": 0.00592, "ml-9-induced differentiation": 0.01179, "raf/mek pathway": 0.01278, "interleukin-3 locus": 0.00288, "rapid posttranslational activation": 0.02109, "histone acetyltransferase": 0.00133, "bacteria": 0.00074, "zinc finger protein express": 0.02264, "permissive b-cell line": 0.01102, "combined dexamethasone-crh test": 0.00325, "constitutively active mutant": 0.0054, "p54 isoforms": 0.00307, "aes protein": 0.04529, "gpiib gene": 0.04355, "prpneo-sl3": 0.0, "phorbol ester induce additional": 0.0127, "specific kappa": 0.01238, "ifn response": 0.01942, "wild-type ad": 0.00378, "ca2+ transport": 0.00304, "activator": 0.01104, "hlh protein": 0.04529, "immunoglobulin beta-chain": 0.00276, "full activation": 0.03164, "lymphoid cell type": 0.0512, "p95vav overexpression": 0.00382, "igd antibody": 0.00893, "diversity generation": 0.00242, "cognate antigen": 0.00819, "phase-1": 0.00031, "related family member": 0.0056, "mouse osteopontin gene promoter": 0.02177, "transactivating hhv-6": 0.00115, "dna sequence-": 0.01483, "variable degree": 0.00155, "identical dual signal requirement": 0.00817, "phenotypic analysis": 0.01179, "moderate number": 0.0053, "immunoglobulin heavy-chain mu e1 site": 0.00867, "undesirable activation": 0.03164, "hpfh": 0.00019, "detailed study": 0.01355, "positive selection": 0.00468, "folding": 6e-05, "consequent differential activation": 0.02109, "genetic marker": 0.00382, "developmental choice": 0.00127, "distinction": 0.00012, "kd polypeptide": 0.00174, "cd40-inducible molecule": 0.00853, "ctla-4 engagement inhibit progression": 0.00952, "mix study": 0.01355, "chronic asthma": 0.00397, "specific antibody induction": 0.01071, "jak3 result": 0.0161, "cell serve": 0.0768, "gata zinc finger domain": 0.00603, "transcript encode gp350/220": 0.00569, "oct-1-responsive octamer sequence atgcaaat": 0.00813, "processed product p50": 0.00356, "data correlate": 0.00654, "14-amino acid serine-rich insertion present": 0.00342, "antiapoptotic regulatory factor": 0.01907, "m.hall": 6e-05, "process unique": 0.00444, "infectious progeny": 0.00096, "oncogene rel": 0.00261, "17-bp gas homology": 0.00122, "sex": 0.0013, "foam cell": 0.0768, "cyclosporin a-sensitive": 0.0022, "gene reveal": 0.04355, "antioxidant mechanism": 0.01058, "underlying mechanism remain unclear": 0.00529, "class ii-clip complex": 0.01123, "adaptive change": 0.0063, "liuwei dihuang pill": 8e-05, "cd41a": 0.00012, "subclone jct6": 0.0004, "mediate specific dna binding": 0.00927, "hha": 0.00012, "normal menstrual history": 0.00806, "3'-end": 0.0, "case correlate": 0.00654, "normal artery specimen": 0.00806, "remain inactive state": 0.00347, "mg/24h": 0.0, "extracellular matrix protein": 0.03019, "lowered number": 0.0053, "endogenous gene": 0.04355, "kd tnf receptor": 0.01714, "intracellular signal molecule include tradd": 0.00654, "htlr2": 0.00019, "epsilon": 0.00242, "block nf-kappab": 0.01073, "interferon-alpha": 0.00112, "nk cell activation": 0.0512, "bak": 0.00037, "rbp-jkappa response element": 0.01294, "b-lymphoid cell": 0.0768, "pao": 0.00068, "octamer transcription factor oct-1": 0.0143, "mutated androgen receptor": 0.01714, "tnf-alpha-dependent induction": 0.01607, "gm-csf promoter activity": 0.0195, "c-myb site": 0.02168, "initiate t-cell activation": 0.02109, "protein expression": 0.04529, "induce pge2 production": 0.01694, "subsequent recurrence": 0.00304, "phenyl": 0.00019, "time high level": 0.01214, "hiv-1 mutant virus": 0.00591, "human genomic library": 0.02508, "nuclear run-on assay demonstrate": 0.00842, "c-jun proto-oncogene product": 0.00356, "epstein-barr virus latent membrane protein-1 trigger ap-1 activity": 0.00731, "hla-do block dm function": 0.00665, "inhibit tax induction": 0.0127, "nf-kappab dna-binding activity": 0.0195, "ikaros": 0.00211, "endogenous il-1": 0.00459, "val": 0.00025, "unique target": 0.00825, "box element": 0.01672, "transduce": 0.00329, "alpha-chemokine": 6e-05, "biol": 0.00037, "hsf2-beta act": 0.00496, "commitment": 0.00192, "cell localization": 0.0768, "vitro bandshift assay reveal": 0.00549, "short dna sequence": 0.01084, "fp4-3": 6e-05, "21.4-kb dna clone": 0.00988, "tcr mediate activation": 0.02109, "specific pkc inhibition": 0.00825, "nf-il-6 binding activity": 0.0195, "normal role": 0.01328, "class ii antigen": 0.00546, "il-4/il-13-induced il-1r gene expression": 0.02177, "ventilated macrophage": 0.00589, "steroid resistant": 0.00292, "hiv-mediated mechanism result": 0.01073, "designated hl-60r": 0.00012, "selective mobilization": 0.00267, "statl": 6e-05, "disabling disorder": 0.00223, "primary human peripheral blood lymphocyte": 0.01505, "chronic hyperactivity": 0.00397, "vivo proliferative response": 0.01294, "ig level decrease": 0.01214, "dose responsiveness": 0.00323, "crucial event": 0.00552, "positive transcription factor bind": 0.0143, "subtle difference": 0.00425, "share": 0.00577, "adult bone marrow": 0.00281, "mutant protein": 0.04529, "nfatp/c-binding site": 0.02168, "heterotrimeric nfatp": 0.00164, "recombinant nfat1": 0.00391, "potentiate interleukin-3": 0.0018, "readily inducible": 0.00484, "cell-surface heparan sulphate": 0.00037, "human c/ebpepsilon gene": 0.02903, "pi3-kinase pathway": 0.01278, "translational suppression": 0.00416, "antigen peptide analog": 0.00546, "a-myb gene encode": 0.02903, "glucocorticosteroid receptor play": 0.01714, "3,5-dichloro-2-hydroxy-4-methoxy-6-n-propylbenzoic acid": 0.00856, "decay": 0.00019, "express tal-1": 0.01846, "event": 0.01104, "autophosphorylation": 0.00056, "specific promoter": 0.02336, "overexpression induce transcriptional activation": 0.01582, "induces lymphocyte aggregation": 0.00988, "sedimenting gradient show": 0.01733, "single major transcription start site": 0.01124, "ifn-gamma gene transcription": 0.02903, "differential diagnostic": 0.00323, "provide specific target": 0.00825, "prolonged cyclic pressure-stretching load": 0.00074, "increase il-2 production": 0.01464, "tpa response element demonstrate": 0.00971, "bcl-6 gene": 0.04355, "clear difference": 0.00425, "virulence characteristic control": 0.00868, "pxqxt/s core sequence": 0.01084, "mediate signal transduction": 0.0109, "abelson murine leukemia virus result": 0.00644, "polyamine metabolism": 0.00074, "osteoclast": 0.00068, "ap-1 transrepression model": 0.00463, "plasma cell pathway": 0.0512, "agent induce transcription": 0.01873, "longer-term potentiation": 0.00037, "u937 cell transduce": 0.0512, "tpp17": 6e-05, "disease characterize": 0.00673, "electromobility shift assay": 0.00668, "steady-state fluorescence anisotropy": 0.00043, "diverse etiology": 0.00155, "monocyte activation": 0.03164, "phosphorylated bcl-2": 0.00295, "il-2r alpha transcript": 0.0078, "sle disease activity index system": 0.0117, "noncanonical gata site": 0.01445, "fasl gene activation": 0.02903, "cortisol inhibition": 0.01061, "h. human fibroblast": 0.02508, "non-malignant reactive lymph node": 0.00105, "sequence demonstrate binding": 0.01237, "phosphorylated form": 0.01055, "atl cell line": 0.0512, "-oestrogen receptor fusion": 0.01714, "tyrosine kinase enzymatic activity": 0.01462, "prior modification": 0.00183, "remain constant": 0.00521, "pivotal promoter element": 0.01557, "transfected eosinophil-committed hl-60-c15 cell": 0.0384, "amino-acid protein": 0.04529, "bufalin": 0.00043, "camp response element-binding protein/activation transcription factor": 0.00953, "heterodimerization": 0.00118, "bamhi-q promoter activity": 0.0195, "maximal mrna level": 0.01214, "long-standing notion": 0.00031, "glucocorticoid receptor mrna": 0.01714, "cytotoxic marker": 0.00382, "decrease receptor concentration": 0.01714, "death mediate": 0.01231, "dna methylation change": 0.00988, "major property": 0.00574, "1-5 nm": 0.00093, "gata-1 bind": 0.02025, "bcl6+/cd3+/cd20-/cd57-": 0.00012, "human cd4+ t-cell clone": 0.01881, "viral lytic cycle": 0.00488, "alpha-thrombin": 6e-05, "malignant lymphocytic cell": 0.0512, "compete ds-oligonucleotides": 0.00078, "il-1alpha promoter activity": 0.0195, "leiomyosarcoma": 0.00012, "kb sequence": 0.01625, "stat1alpha-dna complex": 0.01684, "microglia stimulate": 0.01101, "-antiport": 0.0, "area": 0.00099, "nbt": 0.00012, "clsm": 6e-05, "mg/dl": 0.0, "hirsute woman": 0.00233, "steady-state": 0.00118, "positive selection refers": 0.00312, "compound affect": 0.00797, "uninfected t-cell line": 0.01102, "pml gene": 0.04355, "nf-kappab regulate fas/apo-1/cd95-": 0.00835, "uas3": 0.00019, "full-length mzf-1 coding region": 0.00734, "human ec express pparalpha": 0.01881, "allogeneic organ transplant": 0.00079, "human immunodeficiency virus-1": 0.02508, "lineage-restricted transcription factor gata-1": 0.0143, "rar beta-": 0.00155, "mitotic arrest assay": 0.00668, "thrombopoietin support": 0.00409, "cd4 negative": 0.00515, "trans-activator protein-responsive promoter": 0.01557, "32-34 kda protein": 0.03019, "diverged human homeobox gene": 0.02177, "rna splice": 0.00456, "sfv": 0.0005, "immediate-early gene induce": 0.02903, "underwent hyperphosphorylation": 0.00065, "ap-1 tre": 0.00695, "bp -850 upstream": 0.00246, "max": 0.00019, "hmg i/y stimulate oct-2a binding": 0.00742, "rbc": 0.00068, "il-8 antigen": 0.00819, "element distinct": 0.01672, "dm+": 0.00012, "glucocorticoid-resistance": 6e-05, "form multiple dna bind homo-": 0.0081, "ms-like disease": 0.00673, "retinoblastoma protein expression lead": 0.02264, "hla-dr alpha": 0.01169, "sarco": 6e-05, "succinimide-containing peptide show": 0.01733, "lymphoid-specific octamer-binding factor": 0.01907, "soluble peptide inhibitor render": 0.0045, "adenovirus antigen stimulation": 0.00746, "induces differentiation": 0.01179, "upstream regulatory sequence similar": 0.00813, "early viral protein and/or viral dna": 0.0151, "express cdna": 0.01846, "lymphoid lineage": 0.00409, "pha-stimulated": 0.00031, "id": 0.00012, "histamine receptor subtypes": 0.01714, "il-10 suppress seb induction": 0.00803, "ccaat motif": 0.00875, "il-10-activated stat1": 0.00285, "express d-type cyclins": 0.0123, "fibronectin-induced interleukin-beta gene transcription": 0.02177, "cell tumor line": 0.0512, "alds induce qr activity": 0.01462, "ovtal": 6e-05, "th2 clone": 0.00738, "twenty-two patient": 0.01666, "express fc receptor": 0.01714, "mrd+": 0.00019, "early myeloid cell line": 0.0384, "karyotypic abnormality": 0.00239, "quantitative determination": 0.00096, "gcr bind affinity": 0.0135, "inflammatory mechanism": 0.01058, "thr": 0.00081, "quantification": 0.00037, "sensitive": 0.00546, "tyrosine-phosphorylated substrate": 0.00199, "cellular system": 0.00893, "important cell membrane constituent": 0.0384, "nm inhibited hiv production": 0.00521, "20-": 0.00019, "define ikaros": 0.00323, "protein stabilization": 0.04529, "live-attenuated human immunodeficiency virus": 0.01881, "human proteasome": 0.03762, "distal nf-at site": 0.01445, "vitro transcription activity": 0.0195, "span": 0.00304, "band-shift assay indistinguishable": 0.00668, "induce monocytic cell differentiation": 0.0384, "select group": 0.00487, "p27kip1 mrna": 0.01526, "increase cell apoptosis": 0.0512, "sequence": 0.03251, "oct-2a expression vector": 0.02775, "nfat bind": 0.02025, "pu.1/pip": 6e-05, "human gata3 gene": 0.02903, "udg promoter": 0.02336, "12-o-tetradecanoyl 12-phorbol 13-acetate-stimulated": 0.00019, "endonuclease analysis": 0.01179, "gc": 0.0062, "recombinant full length tf": 0.00195, "butyric-acid-treated yy-1": 0.00025, "htlv-1 pathogenesis": 0.00171, "odn": 0.00012, "death": 0.00509, "cationic protein": 0.04529, "gm1": 0.0, "tandem cysteine-rich lim domain": 0.00603, "il-2 gene promoter": 0.02903, "hypotonic extract": 0.00459, "decrease secondary": 0.00971, "-7": 0.0005, "-2 promoter": 0.02336, "human pterin carbinolamine dehydratase/dimerization cofactor": 0.01505, "augment th2-specific cytokine": 0.00749, "serine residue": 0.00226, "signal isoform": 0.01635, "il-10 gene polymorphism": 0.02903, "develop mice transgenic": 0.00269, "fkhrl1 gene": 0.04355, "direct activator": 0.00552, "analyze potential cross point": 0.00302, "neoplastic counterpart": 0.0009, "35-55": 6e-05, "observation correlate": 0.00654, "17-29 day": 0.00146, "human major histocompatibility complex": 0.01881, "nf-il6": 0.00217, "mitogen-stimulated incorporation": 0.00068, "-1beta": 0.00012, "c-jun phosphorylation": 0.00983, "gata-1 focus": 0.00413, "methylation": 0.00124, "transmembrane domain": 0.01207, "chimera plasmid": 0.00273, "thrombopoietin induce tyrosine phosphorylation": 0.0127, "transcription factor play": 0.01907, "stimulate hiv-1 replication": 0.00734, "anti-c/ebpbeta": 6e-05, "malignant lymphoma": 0.00226, "inflammation response": 0.01942, "cell-dependent pathway": 0.01278, "non-t": 0.00043, "pathway activate": 0.01777, "cell line form": 0.0512, "over-riding determinant": 0.00118, "upstream promoter region": 0.01557, "transrepressive effect": 0.02115, "decrease bcl-6 mrna expression": 0.02081, "selective downregulation": 0.00267, "cat assay": 0.01002, "traf-binding site": 0.02168, "tat exert": 0.00292, "peptide-rskfrqiv-located": 0.0, "inducible gene": 0.04355, "igm production": 0.01042, "cd4 promoter occur": 0.01557, "m.feldman": 6e-05, "paracrine effect": 0.02115, "cd95 receptor": 0.02571, "activated dra transcription": 0.01873, "apl cell express pml-rar": 0.0384, "reversal": 0.00068, "d3 uptake": 0.00245, "vivo expansion": 0.0053, "nuclear factor-kappab-mediated phenomenon": 0.01123, "rna sample isolate": 0.00304, "proximal": 0.00602, "stat-3 isoform lack": 0.00422, "early development": 0.00828, "alveolus": 0.00012, "express hla-dr molecule": 0.0123, "mammalian": 0.00347, "m10-expressing cem clone": 0.00492, "specific cd4 promoter mutant": 0.01168, "mixed cytosol": 0.00143, "spliced variant": 0.00276, "promote cell-mediated immune response": 0.00971, "myeloid differentiation primary response": 0.00971, "age-matched control": 0.01303, "xenotransplantation": 0.00019, "att": 6e-05, "-alpha subunit": 0.00484, "proliferation cessation": 0.00803, "significant quantity": 0.00416, "non-lymphoid cell": 0.0768, "baseline condition": 0.0036, "study genomic dna": 0.00988, "cd19/vav/phosphatidylinositol-3 kinase complex": 0.01123, "p52 correlate": 0.00654, "+/- se": 0.00158, "distinct electrophoretic mobility": 0.00465, "affinity close": 0.00391, "corticosteroid-sensitive": 6e-05, "cu2+ interferes": 0.00031, "dramatic coordinate induction": 0.01071, "effect distinguish th1": 0.0141, "il-4 inhibit lps-induced il-6 mrna": 0.00762, "monoclonal antibody ki-67": 0.00596, "55-kda isoform": 0.00171, "strict guideline": 0.00016, "subsequent increase": 0.02196, "p24rex": 0.00031, "radioligand": 0.00031, "0.2-kb irf-cat construct": 0.00484, "specific test": 0.01238, "m.nugeyre": 0.00012, "nt3r": 0.00012, "vav": 0.00136, "advanced rcc": 0.00037, "her-2/neu activation": 0.03164, "44-55 year": 0.00059, "active phorbolester": 0.00592, "vitro transcription analysis": 0.01873, "monocyte-macrophage differentiation": 0.01179, "principle": 0.00043, "kappa b-alpha protein act": 0.02264, "bcl-2 deficient": 0.00295, "tesmer": 6e-05, "cotransfections": 6e-05, "il-2-producing cell": 0.0768, "interferon gamma stimulation": 0.00746, "thymic locus control region": 0.00734, "bacterial infection": 0.0062, "concentration-": 6e-05, "3'-ends": 6e-05, "vd receptor": 0.02571, "68-kda cleavage product": 0.00356, "il-10 inhibit il-6 production": 0.00952, "interleukin-5": 0.00068, "24-hour urinary cortisol excretion": 0.00147, "altered ligand": 0.00592, "mutation parallel": 0.00592, "hiv": 0.01185, "well-defined genetic entity": 0.00192, "untreated patient": 0.01666, "developmental expression": 0.04163, "phosphotyrosine antibody": 0.00893, "region resemble": 0.01467, "individual nfat composite element": 0.00836, "injury": 0.00143, "discrepancy": 0.00019, "irs": 0.00025, "globular": 6e-05, "hemoglobin switching": 0.00071, "cf": 0.00074, "pnu156804": 0.00074, "feto-maternal interface": 6e-05, "vivo expression study": 0.02775, "nad": 0.0, "low effect": 0.02115, "'octamer": 6e-05, "high-level il-4 production": 0.00695, "monocytic cell line": 0.0512, "b-lymphocyte cell": 0.0768, "cell correlate": 0.0768, "site adjacent": 0.02168, "nonsmoking asthmatic patient": 0.0111, "therapeutic response": 0.01942, "inhibited monocyte chemotactic activity": 0.01462, "intranasal glucocorticoid": 0.0085, "major immediate-early gene": 0.02903, "require participation": 0.01315, "ciglitazone": 0.0, "sesquiterpene lactones": 0.00016, "il-10 cytokine": 0.01123, "ten-day exposure": 0.0035, "rel protein play": 0.03019, "methylation study": 0.01355, "cotranslated wild-type": 0.00378, "gd2-specific cd4+ clone": 0.00492, "proximal nf-at": 0.00397, "tyrosine kinase-dependent pathway reveal": 0.00639, "iepsilon": 0.00012, "specific mrna level": 0.01214, "tumor necrosis factor receptor superfamily": 0.01144, "inhibit mip-1 alpha expression": 0.02081, "breast cancer reactive antibody-dependent cellular cytotoxicity facilitate antibody": 0.00223, "autoregulatory enhancer": 0.00909, "cd3.tcr complex": 0.01684, "similar effect": 0.02115, "growth-related metabolism": 0.00074, "serum-supplemented medium": 0.0014, "light-chain gene": 0.04355, "hiv-1 dse bind heterodimers": 0.01013, "study plasma aldosterone": 0.00904, "efficient transcriptional activation": 0.02109, "protein synthesis-dependent": 0.04529, "major groove": 0.00574, "prolonged": 0.00149, "phospholipid analysis": 0.01179, "energy substrate": 0.00199, "depressed": 0.00093, "-0.63": 0.0, "nf-kappa b. tnf-alpha signal lead": 0.00654, "subsequent tnf-alpha release": 0.00364, "endogenous long terminal repeat transcriptional activity": 0.00975, "ikappab-alpha protein": 0.04529, "retinoblastoma gene product": 0.02903, "steroid hormone receptor family": 0.01286, "anti-cd3 mab okt3": 0.00178, "unknown function": 0.01331, "interleukin-9 receptor": 0.02571, "14.3-kda protein": 0.04529, "specific responsive element il-4re": 0.00836, "ipr cd4-8-": 0.00031, "oxidative stress-induced signal": 0.0109, "characterize ebv-infected": 0.00425, "cell nuclear extract bound": 0.0384, "pou-specific": 0.00043, "result neutrophil-mediated tissue damage": 0.00805, "transcription factor requirement": 0.01907, "ire motif": 0.00875, "stat3 inhibit": 0.01904, "t-lymphocytes activate gene expression": 0.02177, "macrophage represent extreme phenotype": 0.00295, "c-myc promoter": 0.02336, "mediate cd40l": 0.01231, "compelling": 0.0, "deletion mapping": 0.00344, "transactivating protein": 0.04529, "early viral rna splice pattern": 0.00331, "cytokine il-4": 0.01123, "hs-40 motif": 0.00875, "specific nfatp polyclonal antibody": 0.00619, "il-4 induces": 0.00803, "clonality analysis method": 0.00786, "fibre exposure": 0.0035, "hbx-antigen": 0.00012, "triiodothyronine": 0.00062, "30-40 torr": 9e-05, "nonglucocorticoid steroid aldosterone": 0.00194, "study variation": 0.01355, "separate surface": 0.00515, "modified sperm type protocol": 0.00475, "enhancer activity": 0.02925, "traf bind sequence": 0.0135, "element correlate": 0.01672, "allergic inflammatory disease include asthma": 0.00576, "ifn regulatory factor-1": 0.00455, "chd": 0.00031, "cell membrane protein": 0.0512, "il-4r": 0.00149, "core traf bind motif": 0.01013, "wild-type promoter construct": 0.01557, "low degree": 0.00707, "-1 alpha-stimulated vcam-1 expression": 0.02081, "mgr": 0.0, "fk506 suggest": 0.02022, "marked contrast": 0.00546, "indirect": 0.00105, "cns": 0.00043, "defect require": 0.01315, "activate stat1 correlate": 0.01185, "reverse-transcriptase polymerase chain reaction": 0.00219, "proximal upstream element": 0.01115, "mtiia": 0.00012, "abnormal renal tubular phosphate transport": 0.00078, "erythrocytic lineage share specific transcription factor": 0.00953, "hdn": 0.00012, "bcl-6 protein expression": 0.03019, "promoted upregulation": 0.00192, "primate cytomegalovirus major immediate-early promoter": 0.00934, "syncytia-forming capacity": 0.00329, "promote eosinophil apoptosis": 0.00593, "granulocyte-macrophage colony-stimulating factor-pretreated": 0.00079, "sequence analysis favour": 0.01084, "alpha-bound kinase activity": 0.0195, "membrane potential change secondary": 0.00315, "entire nh2 regulatory domain": 0.00603, "nf-kappa b-dependent-genes": 0.01414, "repertoire selection": 0.00121, "high wt1 expression": 0.02775, "coupling": 0.0005, "turn contribute": 0.00378, "healthy blood donor": 0.00395, "postmenopausal patient risk": 0.0111, "il-7": 0.00236, "selective suppression": 0.00416, "bcd": 0.00056, "systemic symptom include hemodynamic instability": 0.00576, "specific ag": 0.01238, "class ii gene": 0.02903, "phosphatidylcholine": 6e-05, "terminal section": 0.00332, "jak-stat pathway": 0.01278, "lesion": 0.00285, "pth cell": 0.0768, "anti-inflammatory agent": 0.00422, "mitogenic response": 0.01942, "remain novelty": 0.00521, "potentiate il-3-mediated commitment": 0.0012, "fgfs": 6e-05, "bhlh-hsp90 interaction": 0.00986, "v-atpase occurs": 0.0009, "prostaglandin e2 remain unaltered": 0.00261, "vivo protein bind": 0.03019, "weakly c-jun": 0.00493, "signal capability": 0.01635, "include c-myc": 0.01439, "bind rbtn-2": 0.02025, "pmncs": 0.00019, "macrophage-specific cdna": 0.00456, "promoter respond": 0.02336, "cbf site form": 0.01445, "similar phenomenon": 0.00673, "e1b-specific ctls": 0.00031, "promonocytic cell line": 0.0512, "cytokine modulation": 0.01123, "human t-cell leukemia virus type ii rex gene": 0.01089, "chronic lymphocytic leukaemia": 0.00265, "dna protein interaction": 0.03019, "nf-at4 mrna": 0.01526, "nf kappa b1": 0.00498, "deficient in-leucyl-trna synthetase": 0.00091, "couple": 0.00261, "jun component": 0.00456, "enhance leukocyte anti-infective activity": 0.01462, "stat3": 0.00707, "enhance capacity": 0.00974, "hbxag-specific stimulation": 0.0112, "lymphocyte sample": 0.01483, "homologous region": 0.01467, "activation protein 1-dependent transcriptional activation": 0.01811, "supplementation": 0.00056, "homodimer junb": 0.00124, "il-6 synthesis": 0.00583, "endogenous nfat activity": 0.0195, "eukaryotic dna-binding protein": 0.03019, "relative formation": 0.00484, "nm23-h1": 0.00031, "functional molecular clone": 0.00544, "combination hormonal": 0.00288, "25-35": 6e-05, "paracrine manner": 0.00282, "specific receptor": 0.02571, "b1 complex": 0.01684, "input function": 0.01331, "intracellular-free calcium ion": 0.00157, "native hugata-3": 0.00149, "differentiation control": 0.01303, "zinc finger transcription factor egr-1": 0.01144, "human p40 promoter region": 0.01881, "hr induce c/ebpepsilon mrna level": 0.01016, "provide additional information regard": 0.00323, "inhibit transcriptional activation": 0.02109, "murine calcineurin render": 0.00416, "c-erbb induce": 0.0254, "maintain ctl-specific expression": 0.02775, "il-2r alpha promoter": 0.01557, "transfection assay": 0.01002, "suppress cytokine gene transcription": 0.02177, "gg": 0.00037, "winged-helix transcription factor trident": 0.0143, "binding site": 0.02168, "p65 restores intracellular inhibition": 0.0053, "human platelet": 0.03762, "respective factor result": 0.01907, "dominant susceptibility": 0.00245, "individual study": 0.01355, "cemx174 culture": 0.0062, "lymphocyte gene regulation": 0.02903, "reporter construct il-1beta": 0.00484, "gr protein": 0.04529, "gel supershift assay": 0.00668, "signal transducing adaptor molecule": 0.00817, "lt-4": 0.00043, "c-terminal half": 0.00192, "i-kappabbeta level": 0.01821, "cd80 ag": 0.00158, "mla": 0.0, "fusion region": 0.01467, "il-1": 0.00664, "nonerythroid nucleus": 0.00319, "tinur gene": 0.04355, "8-15": 0.0, "reliable surrogate": 0.00047, "activated transcription": 0.0281, "reverse-transcription pcr differential display": 0.0025, "cd4/cd8": 6e-05, "er codon": 0.00264, "v3-bh10 generate": 0.00453, "reveal specific binding": 0.01237, "downstream positive regulatory element": 0.00836, "hormone-responsive block": 0.01073, "p50/p105-nf-kappa": 6e-05, "c. elegans": 0.00143, "enhance dna binding activity": 0.01462, "purified protein": 0.04529, "active nf-kappab": 0.00999, "monocyte/macrophage-like clone cell line": 0.0384, "b. domain": 0.01207, "complement signal": 0.01635, "fine specificity": 0.00335, "active transcription factor creb": 0.0143, "androgen insensitivity": 0.00161, "il-2-treated cell": 0.0768, "anti-vla-5": 6e-05, "normal erythropoiesis": 0.0121, "inducible t-cell gene": 0.02903, "apoptosis-associated protein test": 0.03019, "nf-kappab/rel protein": 0.04529, "rheumatoid synovitis": 0.00093, "granulocyte-macrophage colony stimulate factor": 0.0143, "mitogen stimulate": 0.01101, "usage": 0.00031, "haecs": 0.00025, "megakaryocytic lineage": 0.00366, "choriocarcinoma": 0.00031, "lfa-3 costimulation": 0.00171, "mhc class ii": 0.00484, "nonatopic individual": 0.00409, "tyrosine-phosphorylated docking site": 0.01445, "ifn-gamma pretreatment": 0.00481, "data provide important fundamental insight": 0.00275, "kda sterol regulatory element bind factor": 0.00953, "common messenger": 0.0035, "gm-csf enhancer": 0.00909, "il-6 production": 0.01042, "autoimmune disease": 0.00673, "inducible trans activation": 0.02109, "subsequent release": 0.00484, "vitro exhibit high affinity": 0.00465, "cd40 antigen expression": 0.02775, "6-": 0.00012, "heterogeneous pattern": 0.00549, "pma stimulation": 0.0112, "5'-": 0.00019, "sh2 domain leukocyte protein": 0.02264, "increased rate": 0.00363, "tata-less interferon-regulated gene": 0.02903, "large cell lymphoma show laz3/bcl6 expression": 0.0256, "cd28 augmentation": 0.00323, "commonly inducible": 0.00484, "anti-inflammatory effect differs": 0.0141, "conventional chemotherapy": 0.00071, "-2729 bp upstream": 0.00246, "alveolar cell": 0.0768, "transformation": 0.00577, "promote intestinal epithelial cell apoptosis": 0.03072, "progesterone receptor": 0.02571, "lysosomal acid lipase": 0.00571, "tcr/cd3 signal": 0.01635, "traf6 interact": 0.00372, "cystine concentration": 0.0067, "recent advance": 0.0014, "ifn-stimulated gene expression": 0.02903, "relevant concentration activate nf-kappa": 0.00889, "cell represent": 0.0768, "inhibit cell growth": 0.0512, "unique inhibitory role": 0.00885, "molecular biology study": 0.00904, "double-stranded rna-binding protein": 0.03019, "repressor": 0.00447, "epo-dependent hcd57 erythroid cell": 0.0384, "dep-pahs": 0.00025, "germinal center reaction": 0.00147, "thrombin-stimulated platelet": 0.00372, "uv-induced signal transduction": 0.0109, "hiv-1-infected": 0.00161, "recurrent": 0.00167, "identical signal cascade": 0.0109, "f774l": 0.00025, "numerous": 0.0018, "ah receptor complex": 0.01714, "examined": 0.00012, "gel renaturation experiment": 0.00265, "soluble surface domain": 0.00804, "human factor yy1": 0.02508, "tnf-alpha prevent": 0.00546, "normal increase": 0.02196, "bamhi zlf-1 gene product": 0.02177, "ebv-immortalized b-cell line": 0.01102, "tnf-alpha treated": 0.00546, "il-2 protects": 0.01117, "susceptible": 0.00143, "rba": 6e-05, "apoptosis-linked gene": 0.04355, "gamma-ifn responsive gene": 0.02903, "t-lymphoid cell": 0.0768, "robust tyrosine phosphorylation": 0.00656, "/ca": 6e-05, "ssb reactivity": 0.0013, "polymorphonucleate cell": 0.0768, "vwf": 0.00037, "rj2.2.5 dqb gene": 0.02903, "cem-icr": 6e-05, "jak3 present": 0.00735, "tumour cell": 0.0768, "il-4 show": 0.02599, "ag exposure": 0.0035, "c-jun mrna": 0.01526, "y315": 0.00012, "hierarchical structure similar": 0.00449, "factor participate": 0.0286, "neutrophil-mediated tumor cell cytostasis": 0.0384, "icam-1 promoter luciferase reporter gene": 0.01742, "challenge cell": 0.0768, "tcf-1 site": 0.02168, "alloantigens": 0.00012, "inducible il-2 receptor alpha chain": 0.01029, "elk-1 point": 0.00183, "describe method": 0.00397, "ra-stimulated formation": 0.00484, "kinetic analysis demonstrate": 0.01065, "ebna2-oestrogen receptor fusion protein": 0.02264, "xenogeneic serum promotes leukocyte-endothelium interaction": 0.00395, "apoptosis": 0.0178, "il-4r alpha show": 0.01733, "induce cd69 expression": 0.02775, "cell line k46": 0.0512, "include ards": 0.01439, "carboxyl-terminal cytoplasmic domain": 0.00804, "clinical disease": 0.00673, "isg15 ltr": 0.0031, "extrathymic t-cell population include cell express elevated level": 0.0192, "differential gene expression": 0.02903, "kilodaltons": 0.00012, "cross communication": 0.00034, "induce nf-kappa": 0.0254, "p2l": 0.00012, "fas signaling": 0.00558, "hiv-1 tat affinity column": 0.00439, "p-like element": 0.01672, "xeroderma pigmentosum group": 0.00325, "unusual cd56+ cd16- egls present": 0.00294, "cytoplasmic compartment": 0.004, "nm23 gene": 0.04355, "human embryonic/fetal hematopoiesis": 0.02508, "pebp2betamyh11 transgenic mouse": 0.00649, "protease expression vector": 0.02775, "process require calcium-dependent dephosphorylation": 0.00658, "inflammatory bowel disease": 0.00449, "isolated cooh-terminal domain": 0.00804, "h3-antagonist": 6e-05, "renesto": 6e-05, "plzf poz domain": 0.00804, "microdissected lesional tissue": 0.00443, "tax induce lt-293 activity": 0.01462, "reactive ctl clone": 0.00492, "cd45ra+ cell": 0.0768, "extracellular cue": 0.00167, "tumor necrosis": 0.00934, "manic": 0.00019, "rhom-2 mrna": 0.01526, "aldosterone receptor": 0.02571, "alphaiibh": 0.00019, "elevated stat1alpha": 0.00112, "cbfalpha2": 0.00012, "disorder suggest": 0.02022, "stimulate interleukin-10": 0.01101, "rela/nfkappab1-binding activity": 0.02925, "glycogen synthase kinase-3": 0.00054, "parent promoter": 0.02336, "ligand-specific alpha chain": 0.0078, "okamura": 0.00012, "natural history": 0.00233, "ebv-encoded member": 0.00413, "drosophila melanogaster extra sex comb": 0.00048, "msr": 0.00105, "class ii-negative hela cell": 0.0384, "variant size": 0.00276, "+/-": 0.00316, "hhv-6 infected": 0.00167, "population": 0.00614, "cellular change induce": 0.01694, "hiv-1 replication": 0.00878, "aspect": 0.00248, "block signal": 0.01635, "inhibit stat-dependent early response gene expression induce": 0.01244, "calcium influx signal": 0.0109, "oncogenic ets transcription factor fli-1": 0.01144, "mol wt": 0.00016, "arh77": 0.00012, "purine-rich stretch": 0.00034, "flank sequence": 0.01625, "vacuolar": 0.00025, "cd4 cell number": 0.0512, "interleukin-1beta require 5-lipoxygenase": 0.00877, "quantitative immunofluorescence": 0.00096, "th2 cytokine profile": 0.00749, "affect gene expression": 0.02903, "male patient": 0.01666, "proliferative effect": 0.02115, "ick-1 site": 0.02168, "c-fos mrna induction": 0.01071, "induce nf-kappa b/rel nuclear activity": 0.0117, "split": 0.00031, "binding data": 0.01855, "major stat complex": 0.01123, "hcss": 0.00019, "alpha/mad-3 mrna level": 0.01214, "mumol/l pdtc": 0.00112, "e2f-4 profile": 0.00152, "kappa b-specific dna-binding activity": 0.01462, "intracellular redox status control nf-kappa": 0.00566, "p130 complexes e2f-4": 0.00027, "jnk1 show": 0.02599, "flcs": 0.00025, "splice hiv mrna": 0.01017, "regulate cytokine secretion": 0.00835, "mutant p85 allele": 0.0054, "require morning": 0.01315, "nfat-mediated transcriptional activation": 0.02109, "show wild-type phenotype": 0.01733, "tes2 interact protein": 0.03019, "ultrastructural study": 0.01355, "distal promoter element regulate transcriptional induction": 0.00779, "bone marrow progenitor": 0.00184, "trigger il-4-mediated response": 0.01294, "lysis mechanism": 0.01058, "qr gene": 0.04355, "yb-1": 0.00031, "glucocorticoid-mediated inhibition": 0.01061, "cdna encode protein": 0.03019, "site beta -but": 0.01445, "colony-forming unit monocyte": 0.00798, "rfx-b complement": 0.00099, "pma dose dependent": 0.00273, "total workload": 0.00161, "mapk activity": 0.02925, "arbitrary unit": 0.00105, "nov": 6e-05, "isoproterenol": 0.00019, "nfat-1 complex": 0.01684, "vitro analysis": 0.01179, "tpo induce tyrosine phosphorylation": 0.0127, "cd28 cell surface molecule": 0.0384, "herpesvirus saimiri associate": 0.00728, "aldosterone membrane receptor": 0.01714, "endogenous gm-csf": 0.00459, "early-response gene": 0.04355, "cd4 dimerization": 0.00332, "erythrocyte gene": 0.04355, "report socs-3 expression": 0.02775, "retinoblastoma phosphorylation": 0.00983, "tax-protein": 0.0, "murine monoclonal antibody": 0.00596, "hemin-": 0.00012, "10-": 0.00019, "control megakaryocytopoiesis": 0.01303, "arginine mutation": 0.00592, "tcrzeta": 0.00081, "dr-nm23 mrna": 0.01526, "leukemic blast": 0.00251, "induced ml-1 cell": 0.0512, "cell growth factor": 0.0512, "neonatal cell": 0.0768, "oct-2": 0.00453, "viremia": 0.00012, "gm-csfralpha mutant": 0.0081, "p50.p65": 0.00012, "express aml1/eto": 0.01846, "ligand signal": 0.01635, "normal myeloblast": 0.0121, "human immunodeficiency virus promoter": 0.01881, "bcl-6 mutation": 0.00592, "composite site": 0.02168, "respond": 0.00502, "lymphoid cell-specific transcription factor ets-1": 0.01144, "nf-y expression": 0.04163, "gamma interferon signal transduction": 0.00817, "immune parameter": 0.00599, "regional localization": 0.00186, "prl-": 6e-05, "cr": 0.00068, "prdii": 0.00081, "xp-d": 0.00025, "cell membrane": 0.0768, "cd28rc": 0.00019, "position": 0.00471, "murine fra-1": 0.00623, "related progesterone": 0.00236, "body burden reference": 0.00091, "camp/pka pathway": 0.01278, "th1 cell lack": 0.0512, "gata consensus site": 0.01445, "integrin-mediated cell adhesion": 0.0512, "augmented susceptibility": 0.00146, "hepatic leukemia factor": 0.01907, "dorsal": 0.00025, "indomethacin block pge2 release": 0.00537, "e2a-hlf chimeric protein induce t-cell apoptosis": 0.0151, "competition experiment analyze": 0.00304, "tcf-1 knock-out mouse readily yield antiserum titer": 0.00278, "gene activation induce": 0.02903, "b-lymphoid line": 0.01653, "tpa/calcium-activated ap-1/oap element": 0.01115, "cd68+ cell": 0.0768, "recovery": 0.00099, "coffman": 0.00012, "active p50/c-rel": 0.00592, "ebf": 0.00149, "amino acid identity": 0.00571, "megakaryoblastic/erythroid cell line": 0.0512, "gene amplification": 0.04355, "tandem": 0.00242, "synthetic ppargamma agonist induce time-": 0.01016, "interleukin-4-induced cd23b mrna": 0.01017, "dp2": 0.00012, "specific regulation": 0.01238, "2-22-ene-24-cyclopropyl-vitamin d3": 0.00245, "il-3 enhancer span": 0.00606, "cis-regulatory element": 0.01672, "time-dependent tyrosine phosphorylation": 0.00656, "nuclear export": 0.01684, "vivo effect": 0.02115, "tgf-beta regulates iga production": 0.00521, "j.babin": 6e-05, "bl": 0.00124, "position -30": 0.00236, "strong negative association": 0.00343, "cytokine message": 0.01123, "kinase-deficient mutant": 0.0081, "il-2-independent cell line": 0.0512, "stat-binding oligonucleotides show": 0.01733, "physiologic role": 0.01328, "il-1 secretion": 0.00428, "cellular fraction": 0.00893, "current finding open": 0.00151, "alpha-": 0.00105, "positive": 0.00937, "mcm": 0.00099, "b-cell-restricted": 0.00025, "oxidized low-density lipoprotein modulation": 0.00129, "play significant role": 0.00885, "loss-of-function mutation": 0.00592, "atf1 isoforms": 0.00307, "childhood": 0.0005, "20-50": 6e-05, "finding provide direct": 0.0043, "neutrophilic granulocyte": 0.00254, "influence and/or limit expression": 0.02081, "decreased transactivation": 0.00515, "functional cre site": 0.01445, "jun family": 0.00841, "2-pyridylmethyl": 0.00012, "undefined differentiation-promoting gene": 0.02903, "hiv1-infected": 0.00043, "inhibit signal transduction": 0.0127, "viral structural protein expression": 0.02264, "inhibit hiv-1 replication": 0.0127, "nfatx1": 0.00112, "dexamethasone bind site": 0.01445, "notable participant": 0.00012, "tcr beta locus": 0.00449, "jnk1 protein level increase": 0.02264, "tnf-mediated induction": 0.01607, "confers inducibility": 0.00146, "pathogenic process similar": 0.00449, "dexamethasone require": 0.01315, "thr beta-ppar": 0.0004, "karyotypic male": 0.00081, "co-cultured bm": 0.00025, "janus kinase family": 0.00792, "otf-1 regulate": 0.01253, "xla": 6e-05, "kappa3 element": 0.01672, "transcription factor stat1 activity": 0.01462, "high proline content": 0.0062, "considerable tissue-specific interindividual variation": 0.00109, "normal erythroid progenitor": 0.00806, "prevent nuclear uptake": 0.01123, "normal gamma": 0.0121, "inhibit erythroid differentiation": 0.0127, "ikappab kinase": 0.01188, "strong transcriptional repressor": 0.00767, "daidzein": 0.00019, "early biochemical event associate": 0.00546, "epidermal growth factor": 0.01907, "cd28-responsive element": 0.01672, "subsequent": 0.00608, "plasmid express": 0.01846, "so-called tced": 0.00068, "th1 cell": 0.0768, "dopamine stimulate expression": 0.02775, "observation provide": 0.00645, "impaired function": 0.01331, "t-cell mitogen": 0.00962, "normal cellular function": 0.00887, "dbf site": 0.02168, "t-cell clone specific": 0.00825, "undergo granulocytic differentiation": 0.00786, "mature form": 0.01055, "form sequence-specific dna-bound complex": 0.00842, "cd28 change": 0.0063, "isolated cytosol": 0.00189, "anti-i kappa b-alpha antibody": 0.00447, "local cellular immune response": 0.00971, "tissue support effective immune response": 0.00777, "transcriptional control activity": 0.0195, "7050+/-1122 iu/ml": 9e-05, "diamide": 0.00043, "polyclonal pattern": 0.00549, "affected and/or": 0.0045, "t-lymphocyte cytoplasm": 0.00093, "determine calcineurin x-ray crystal structure": 0.00311, "4-hydroxytamoxifen": 6e-05, "erythroid cell express": 0.0512, "eckhard stuber": 6e-05, "signal downstream event": 0.0109, "p65-containing nf-kappa": 0.01414, "quiescent haemopoietic cell": 0.0512, "'perfect": 6e-05, "nfat dna-binding activity": 0.0195, "mutated version": 0.00093, "important adaptor": 0.00689, "semi-dominant": 6e-05, "hl-60/vinc/r cell respond": 0.0512, "p95 share homology": 0.00192, "tnt system": 0.00667, "suppress core promoter activity": 0.01462, "immunodepletion study show": 0.01733, "structural domain": 0.01207, "membrane alteration": 0.0045, "normal ln": 0.0121, "50-kda specie": 0.00183, "chronic allergic disease associate": 0.00546, "interferon-regulated gene": 0.04355, "synthetic e6 motif detect": 0.00437, "vdr halflife": 0.00233, "e2a protein require": 0.03019, "elk-1": 0.00143, "dem": 0.00025, "longer affect mn-sod expression": 0.02081, "epo stimulation": 0.0112, "maxillary sinus": 3e-05, "lymphocyte ca2+": 0.01483, "chimeric surface receptor consist": 0.01286, "epithelial cell-specific fashion": 0.00194, "full promoter function": 0.01557, "hepor promoter": 0.02336, "connective tissue turnover": 0.00443, "lymphoid cell differentiation relies": 0.0384, "single ala": 0.0036, "unprimed cd4": 0.00332, "proximal mechanism": 0.01058, "stable maintenance": 0.00171, "pathogen": 0.00081, "lytic transition": 0.00161, "normal bone marrow show mnda expression": 0.01388, "systemic symptom": 0.00102, "c-fos expression induce": 0.02775, "uremic animal": 0.00118, "attainable goal": 0.00012, "tolerant cell show": 0.0512, "post-receptor mechanism": 0.01058, "distinct il-4 signaling pathway exist": 0.00511, "cho": 0.00056, "cis-acting sequence require": 0.01084, "distinctive eosinophil abnormality": 0.00196, "s49 cell": 0.0768, "pkc activation act": 0.02109, "intracrine mechanism": 0.01058, "synthetic": 0.00403, "tg induces il-2r alpha": 0.00585, "granulocytic colony": 0.00171, "il-4 signal transduce": 0.0109, "increase ap-1 dna-binding activity": 0.01462, "pdtc parallel": 0.00205, "class ii dimer": 0.00484, "node-positive patient": 0.01666, "wild-type fragment": 0.00378, "human monocytic cell result": 0.0384, "recognizes": 0.00012, "pure": 0.0005, "nfat promoter activity": 0.0195, "tal1 allele": 0.0022, "absence": 0.0062, "symmetric nf-kappa": 0.01414, "mhc-i ligation": 0.0018, "proximal signal transduction defect": 0.00817, "turner mosaic pattern": 0.00366, "n-acetylglucosaminyl-1,6-anhydro-n-acetylmuramyl-l-alanyl-d- isoglutamyl-m-diaminopimelyl-d-alanine": 6e-05, "consensus heat shock element": 0.00836, "ifn-gamma decrease basal expression": 0.02081, "anti-tax1 monoclonal antibody lt-4": 0.00447, "osteoprotegerin ligand": 0.00592, "sod": 0.0005, "include lymphocyte": 0.01483, "fadd": 0.00019, "general coactivators": 0.00155, "distinct phase": 0.00698, "il-2 receptor expression": 0.02775, "bacterial peptidoglycan induces cd14-dependent activation": 0.01266, "terminal maturation": 0.00332, "failed expression": 0.04163, "cd19 promoter": 0.02336, "common deleted region": 0.00978, "co-stimulatory activity": 0.02925, "trypsin-resistant fragment": 0.00347, "adenovirus nucleotide sequence": 0.01084, "c-type lectin receptor express": 0.01286, "double stain": 0.00096, "htlv-ii p37tax": 0.00043, "increase camp level": 0.01464, "cd40-positive mm": 0.00118, "ebv virus": 0.00887, "insulin-stimulated triglyceride accumulation": 0.00215, "induced": 0.01079, "sos1": 0.00037, "dq3.2-peptide complex": 0.01684, "fc gamma ric gene": 0.02177, "synergizes early": 0.00828, "intact microtubule": 0.00239, "lymphocyte-specific immunoglobulin mu heavy-chain gene intronic enhancer": 0.01244, "vdr cdna": 0.00456, "tcf-1 defines": 0.00189, "intermediary link bcr-derived signal": 0.00817, "gssg": 0.00087, "uas1": 0.00056, "free e2f bound": 0.00194, "cd23": 0.00248, "defensin resistance phenotype associate": 0.00546, "il-4 luciferase reporter gene": 0.02177, "cho/cd14 cell resemble": 0.0512, "il-2 production": 0.01117, "ets-like factor": 0.0286, "creb mutant": 0.0081, "homologous gene encode scm-1alpha": 0.02177, "80-kd stat5a isoform": 0.00114, "varicella vaccine": 0.00053, "quiescent human-peripheral-blood": 0.00115, "creb/atf pathway": 0.01278, "human blood platelet": 0.02508, "fusion": 0.00651, "mosaicism": 0.00019, "differential autoregulation": 0.00323, "conventional responsiveness": 0.00323, "unfused ebna3c": 0.00047, "induce lytic ebv expression": 0.02081, "dq molecule encode": 0.00569, "reorganization require": 0.01315, "early developmental stage": 0.00552, "human leukemia": 0.03762, "normal wound healing": 0.00806, "primary blood monocyte": 0.00798, "c/ebp alpha reveal": 0.0078, "uniformly": 0.00037, "usf-related transcription factor": 0.01907, "appreciable effect": 0.02115, "sustained nf-kappa": 0.01414, "cell antigen receptor function": 0.0384, "rhom-2": 0.00019, "cytokine secrete": 0.01123, "prototypic nuclear factor kappab": 0.0143, "myf3 show intensive hybridization signal": 0.0104, "brca2 mutation": 0.00592, "constitutively increased nf-kappab activity": 0.01462, "p3hr1 cell": 0.0768, "mrna stability assay": 0.01017, "sds gel electrophoresis": 0.0011, "lipoxygenase": 0.00043, "il-2r alpha expression correlate": 0.02081, "combined immunochemistry": 0.00099, "clone delta-opioid receptor": 0.01714, "lymphocytic cell line": 0.0512, "increased predisposition": 0.00363, "target non-ig sequence": 0.01084, "e2-stimulated er+ cell": 0.0512, "serum hormone level": 0.01214, "recombinant human tshr extracellular domain": 0.01505, "allogeneic endothelial cell": 0.0512, "enhance surface expression": 0.02775, "freshly isolate thymocytes": 0.00277, "chromosome sequence": 0.01625, "fragment extending": 0.00347, "congenital absence": 0.0031, "dioxyvit": 0.00025, "il-13-induced regulatory factor": 0.01907, "stat5a dna bind activity": 0.01462, "p9": 6e-05, "anti-igm antibody": 0.00893, "transcription mediate": 0.0281, "level remain": 0.01821, "cell-receptor engagement": 0.00133, "event-free": 0.0, "p-creb": 0.00037, "na": 0.0, "inhibit nf-kappab translocation": 0.0127, "slide": 0.00019, "good definition": 0.00102, "induces abnormal growth": 0.00546, "noncomedo variant": 0.00276, "transient ca2+ signal": 0.0109, "mrna indicating": 0.01526, "early growth response": 0.01294, "dual signal pathway": 0.0109, "culture system report": 0.00445, "zipper mutation": 0.00592, "vitro cultivation": 0.00785, "single hmg box": 0.0024, "octamer-binding": 0.0018, "twentyfold increase": 0.02196, "ectopic site": 0.02168, "gene therapy vector": 0.02903, "retinoid analog": 0.00109, "hla-dq alpha": 0.01169, "individual": 0.00819, "androgen bind site": 0.01445, "chronic": 0.00794, "mmol/l": 0.00019, "cat": 0.00347, "c-jun/ap-1": 6e-05, "induce agent": 0.0254, "euthymic": 0.00025, "wild-type zap-70": 0.00378, "-52 region": 0.01467, "defensins np-1": 0.00012, "stimulate il-2 production": 0.00744, "porcine mhc class ii antigen": 0.00328, "cd3": 0.00323, "j.leahy": 6e-05, "cell precursor acute leukemia": 0.0384, "mcd14-mediated lp uptake": 0.00236, "dominant-negative activity": 0.02925, "cancer development": 0.00633, "cd19 cross-linked": 0.0013, "ad5 e1a protein": 0.03019, "altered regulation": 0.01008, "develop hypercortisolism": 0.00403, "nf-y subunit expression": 0.02775, "monitor disease activity": 0.0195, "jak3-mediated type ii signal pathway": 0.00654, "protective role": 0.01328, "pbmc resistance": 0.00326, "neutrophilic cell": 0.0768, "jnk phosphorylation site": 0.01445, "affect interleukin": 0.00797, ".04": 0.0, "multiple leukocyte lineage": 0.00459, "ru-486": 0.00019, "direct assessment": 0.0054, "syngeneic mouse": 0.00974, "ap-1 -binding activity increase": 0.01462, "h9 cell": 0.0768, "cell toxicity": 0.0768, "t-cell signal": 0.01635, "erythrocyte-specific gene": 0.04355, "pancreatic beta-cell type-specific complex": 0.00842, "rare interfollicular zone cell": 0.0384, "weak staining comparable": 0.00118, "vitro show": 0.02599, "plasma lipase": 0.00375, "inhibitory step": 0.00357, "nf-y activity": 0.02925, "distinct subunit": 0.00698, "steroid binding assay": 0.01237, "-induced tf expression": 0.02775, "dna-binding motif": 0.00875, "g0/g1 switch": 0.00245, "mouse strain": 0.00974, "potentiated aggregation": 0.00096, "nf-kappab activity inhibit": 0.0195, "correlation": 0.00496, "n19rhoa": 0.00025, "active pulmonary tuberculosis": 0.00395, "anti-cd2-mediated activation": 0.03164, "hiv-1 tat induce": 0.01694, "tpen": 6e-05, "down-modulate inflammation": 0.00316, "gata-1 -red cell": 0.0512, "increase interest": 0.02196, "subsequent study": 0.01355, "ctl epitope": 0.00161, "cytokine pleiotropy": 0.01123, "nonhuman primate model": 0.00281, "phorbol myristate acetate-stimulated hela cell": 0.03072, "augment viral replication": 0.00488, "transcriptional activating protein": 0.03019, "th1 cytokine": 0.01123, "augment vcam-1 expression": 0.02775, "heteromers": 6e-05, "responsive": 0.00447, "occurs": 0.0018, "ros generation": 0.00242, "distinct dna-binding protein": 0.03019, "fasl-": 0.0, "cell p50 nf-kappa": 0.0512, "okadaic acid exposure": 0.00571, "human transcription factor sp1": 0.01881, "'aged": 0.00012, "hiv-1 ltr-driven gene expression": 0.02177, "myb family": 0.00841, "sterol regulatory element": 0.01115, "exclusive role": 0.01328, "sigm-crosslinking": 6e-05, "e74-like factor": 0.0286, "rar antagonist": 0.00242, "epidemiological evidence implicate htlv-i": 0.00211, "epipodophyllotoxin etoposide": 0.00037, "substrate": 0.00397, "spleen primordium prior": 0.00103, "gene family member nfatc": 0.02177, "increase adhesion": 0.02196, "tested agent": 0.00422, "unprecedented": 0.00012, "biochemical parameter": 0.0018, "postulated role": 0.01328, "defined medium": 0.0014, "analysis show": 0.02599, "pbmc activate": 0.01777, "n-acetyl-cysteine treatment prevent": 0.00676, "defective": 0.00409, "fcr": 0.00025, "tcr-signal transduction": 0.00425, "aspirin inhibits nf-kappa": 0.00943, "mb-1 promoter": 0.02336, "hmr": 0.00031, "cell receptor involvement": 0.0512, "cd28re sequence reveals similarity": 0.00813, "negative-acting segment": 0.00189, "physiological state": 0.00267, "stimulation-dependent manner": 0.00282, "translation initiation": 0.00211, "ascorbate phosphate": 0.00065, "thymocyte-specific gene expression": 0.02903, "nh2 terminus": 0.00071, "lytic cascade": 0.00214, "arachidonic acid aggregation": 0.00571, "kappa immunoglobulin enhancer": 0.00606, "hela-cell extract": 0.00459, "kox gene": 0.04355, "weak up-regulation": 0.00276, "immune modulating effect": 0.0141, "thapsigargin sensitive": 0.00273, "selective kappa": 0.00748, "c-fms proto-oncogene": 0.0013, "ecv304 cell activate": 0.0512, "action glucocorticosteroids": 0.00499, "transformation-associated viral gene demonstrate mark sequence divergence": 0.01244, "avascular necrosis": 0.00239, "relb protein nuclear localization": 0.02264, "jun gene family": 0.02903, "hypercortisolemic": 0.00031, "granulocyte-macrophage lineage": 0.00366, "tp1 promoter tap": 0.01557, "sequester nf-kappa": 0.01414, "hormone response": 0.01942, "synergistic enhancement": 0.00233, "hgr down-regulates": 0.00081, "c-rel activity": 0.02925, "hiv reporter plasmid": 0.00395, "virus-specific cd4+ clone": 0.00492, "host cell genome": 0.0512, "vitro cortisol-induced inhibition": 0.00707, "pih-group": 0.0, "deletion derivative": 0.00344, "priming": 0.00087, "lymphocyte precursor": 0.01483, "receptor rna": 0.02571, "27th week": 0.00034, "cdna end": 0.00456, "encode fos-related ag": 0.00569, "oncogenic herpesviruses": 0.0009, "intestinal mucosa": 0.00078, "ifn alpha level": 0.01214, "pb1 element": 0.01672, "bacterial cell wall": 0.0512, "homolog": 0.00093, "activin a-induced growth arrest": 0.00409, "jun proto-oncogene family": 0.0056, "500-fold excess": 0.0005, "fibroblast fail": 0.00347, "nres": 6e-05, "purified p50": 0.00288, "normal pbmc": 0.0121, "il2 transcription": 0.0281, "dibenzofurans": 0.00012, "murine pro-b lymphocyte": 0.00988, "duffy polymorphic antigen": 0.00546, "initial a/r challenge": 0.00126, "cell harvester correlate": 0.0512, "-dependent cell line": 0.0512, "stat1 signaling": 0.00558, "15-lo promoter dna": 0.01557, "xpb": 0.0005, "early commitment step": 0.00552, "-69 relative": 0.00276, "chimeric transcription factor": 0.01907, "tyrosine kinase-dependent": 0.0071, "specific complex bound": 0.01123, "hpaii": 0.00025, "lymphocyte glycoprotein surface molecule mediate": 0.00593, "protein production": 0.04529, "il-1 beta expression": 0.02775, "core sequence": 0.01625, "human epithelial cell": 0.0512, "meistrell": 0.00012, "vsmc-myc": 0.00025, "e74 target sequence": 0.01084, "gp120-mediated enhancement": 0.00233, "affect change": 0.00797, "j.": 0.00112, "hgata-3 transcriptional activation domain abolish gata-dependent hiv-1 trans-activation": 0.00791, "include f6t": 0.01439, "cryostat": 0.0, "active process": 0.00592, "latent membrane protein gene promoter-binding protein": 0.01452, "il-13-induced gene expression": 0.02903, "early growth response-1 gene expression": 0.01742, "promoter regulate": 0.02336, "il-4-binding il-4ralpha chain": 0.00292, "mol.med.1": 6e-05, "advantageous": 0.0, "gr binding capacity": 0.01237, "il-2 concentration": 0.01117, "epithelial level": 0.01821, "t-cell lineage express oct-2": 0.00923, "gamma-promoter activity": 0.02925, "cd56": 0.00019, "memory rest": 0.00267, "predominant isoform constitutively express": 0.00923, "40-kda polypeptide": 0.00136, "hsie-oligonucleotide probe": 0.00261, "pma exposure": 0.00409, "multi-protein hematopoietic-specific transcription factor complex": 0.01144, "reticulocyte-type 15-lipoxygenase": 0.00034, "endocytic compartment": 0.00087, "p21ras signal act": 0.0109, "immunolabeling": 0.00012, "inhibit il-2 gene transcription": 0.02177, "pre-existing nf-at-binding factor": 0.01907, "diversity selection": 0.00121, "human myeloid-cell-specific c/ebp-epsilon transcription factor": 0.01505, "etoposide-treated cell": 0.0768, "cell protein bind": 0.0512, "jak kinase specific antibody": 0.00619, "mediate signal": 0.01635, "tnfr-associated factor": 0.0286, "important ebf": 0.00689, "specific mrna": 0.01526, "undergoing activation": 0.03164, "receptor antagonist pd-135,158": 0.01714, "immune-related disease": 0.00673, "il-2 enhancer": 0.01117, "gtp-cyclohydrolase": 0.00012, "profound inhibition": 0.01061, "hla class ii antigen processing": 0.00328, "study reveal": 0.01355, "il-2 -and prl-induced dna-binding protein": 0.01811, "nf-kappa b/rel family protein": 0.02264, "human chromosome 5q23-31": 0.02508, "exon suggest": 0.02022, "nf-kappa b/kbf1 p50": 0.00943, "nf-at transactivation": 0.00515, "cd45ra+": 0.00019, "cross competition experiment": 0.00265, "natural antagonist": 0.00242, "lymphocyte-specific gene expression": 0.02903, "vivo gc receptor down-regulation": 0.01286, "show induction": 0.02599, "transcriptional activation": 0.03164, "activate tcf-dependent transcription": 0.01873, "endometrial stroma": 0.00034, "parental u937 cell stimulate": 0.0384, "associate": 0.02184, "obligatory requirement": 0.00264, "hardy-weinberg distribution": 0.00115, "adult hematopoietic cell": 0.0512, "inhibits early mrna expression": 0.02081, "ultrastructure": 6e-05, "rapamycin regulate t-cell cycle progression": 0.00501, "cross titration analysis": 0.00786, "3'-azido-3'-deoxythymidine": 6e-05, "+12 construct": 0.00726, "diterpene triepoxide": 6e-05, "hsp70 overexpression": 0.00382, "kappa b-binding activity": 0.0195, "hiv-1 replication occur": 0.00585, "peptide presentation": 0.00754, "leucine transport selection": 0.00081, "ethyl-methanesulfonate-derived subclones": 0.0005, "poxvirus protein": 0.04529, "simultaneous treatment": 0.01014, "exogenous": 0.00428, "related gene provide insight": 0.02177, "biomedical research": 0.00028, "clonality assay": 0.01002, "number": 0.01061, "tal1 gene": 0.04355, "bronchoalveolar lavage": 0.0004, "insertion mutation": 0.00592, "multipotential cell": 0.0768, "immuno-histochemical analysis confirm": 0.00786, "oct2-deficient": 0.00012, "allogeneic stimulation": 0.0112, "il-4-triggered activation": 0.03164, "platelet aggregation affect thrombin-induced activation": 0.01266, "mature t-cell leukemia": 0.00641, "selectin family": 0.00841, "tal-1 gene": 0.04355, "bind factor ii": 0.01907, "complementation assay": 0.01002, "vitro footprinting analysis": 0.00786, "prone": 0.00012, "mycobacterial component": 0.00456, "remodeling": 0.0005, "extensive deletion": 0.00344, "proliferative response display": 0.01294, "cross-reacts": 0.00012, "mn": 0.00056, "differentiation-dependent mechanism": 0.01058, "lipocalin ngal": 0.00043, "cell-specific inducibility": 0.00292, "neutral": 0.00081, "decoy oligodeoxynucleotides": 0.00022, "macrophage receptor isoforms": 0.01714, "cell co-transfected": 0.0768, "b-cell-specific pu.1 transcription factor": 0.0143, "visceral": 0.00025, "isoquinoline derivative h7 abolishes induction": 0.00643, "activated gr": 0.00589, "67-bp mnli-alui fragment": 0.00232, "subendothelial space": 0.00022, "mammalian response": 0.01942, "concatenated linear ebv dna molecule": 0.00593, "effect mediate": 0.02115, "activate protein-1 binding": 0.01237, "increase hiv rna expression": 0.02081, "human myeloid leukemia cell": 0.0384, "inhibited nuclear nf-kappab activity": 0.01462, "m.laplaca": 6e-05, "northern": 0.00192, "suppress lps-induced tnf mrna accumulation": 0.0061, "report case": 0.0049, "peptide substrate": 0.00754, "cell-specific difference": 0.00425, "27-kda unphosphorylated form": 0.00703, "optimized cell-free rna transcription assay": 0.01124, "negative feedback": 0.00515, "interleukin-1 gene transcription": 0.02903, "define steroid-resistant bronchial asthma": 0.00161, "induce jagged1 gene expression": 0.02177, "3,4-diacetoxy derivative": 0.00192, "-mediated defect": 0.00279, "takayasu arteritis": 0.00025, "agonistic anti-cd30 monoclonal antibody": 0.00447, "cortisol": 0.00589, "nonatopic control subject": 0.00868, "anti-tnf-alpha inhibit hiv-1 long terminal repeat": 0.00635, "clinical feature": 0.00425, "g-csf stimulation result": 0.01073, "2'-5": 0.00012, "u-937": 0.00261, "human cytomegalovirus ul44 gene": 0.02177, "pilot gene": 0.04355, "ikk2 inhibit lps induction": 0.00952, "raw264.7": 0.0005, "optimal transcriptional activity require": 0.01462, "common site": 0.02168, "major human class ii gene": 0.01742, "thymic cellularity": 0.00118, "stable expression": 0.04163, "intact n-terminal half": 0.00159, "biochemical defect correlate": 0.00436, "primary immunization": 0.00738, "individual repeat": 0.00409, "lymphocyte nuclear t3 receptor": 0.01286, "deltaspi-b product": 0.00533, "cell induce il-5": 0.0512, "include hematological malignancy": 0.00959, "tal-1 expression": 0.04163, "cytoplasmic domain heterogeneity": 0.00804, "ra-induced differentiation": 0.01179, "present tg": 0.00735, "tnf-stimulated huvecs": 0.00081, "tpa induction increase": 0.01464, "cell line express increased level": 0.03072, "jak3 jh4 domain": 0.00804, "tal1 mutant": 0.0081, "single chromosome": 0.0036, "enhance replicative gene expression": 0.02177, "surface signaling": 0.00558, "thirteen preterms": 9e-05, "glucocorticoid recognition sequence": 0.01084, "recombinant ebf": 0.00391, "mononuclear leukocyte correlate": 0.00436, "transactivated": 0.00161, "t-cell growth": 0.00962, "tsc": 0.00025, "bcl-6 protein": 0.04529, "functional capability": 0.00816, "cfms mrna": 0.01526, "aminoterminal region": 0.01467, "immunoregulatory response play": 0.01294, "critical transactivating component": 0.00304, "cell display high level": 0.0384, "endothelial vcam-1": 0.00434, "professional antigen present cell": 0.0384, "viral lytic cascade": 0.00488, "aml": 0.00174, "result offer insight": 0.01073, "3-o-methyl-d-glucose": 0.00037, "process critical": 0.00444, "lymphocyte line express negligible level": 0.00738, "analyze granulocyte": 0.00456, "ap-1 dna binding": 0.01237, "tumor show high radiosensitivity": 0.013, "dr": 0.00118, "gc-motif": 6e-05, "ovarian cancer patient": 0.0111, "non-antigen-selected human": 0.03762, "condition huvec adhesion molecule": 0.00426, "basal promoter": 0.02336, "c-11": 0.00019, "nf-kappab-mediated induction": 0.01607, "coordinate": 0.0018, "ifn-gamma induction": 0.01607, "reporter gene luciferase": 0.02903, "alternative rna splice generates": 0.00228, "modular structure": 0.00319, "human peripheral blood mononuclear cell": 0.03072, "stimulate il-2r alpha": 0.0078, "molecular mechanism responsible": 0.00705, "beta-galactosidase": 0.00081, "anti-human immunodeficiency virus type": 0.00475, "sustained transactivation": 0.00515, "displacement": 0.0005, "commonly display multiple somatic mutation cluster": 0.0023, "nf-il-2b binding activity": 0.0195, "icp4": 0.00019, "human pbl-t": 0.03762, "hematopoietic cell-specific transcription factor": 0.0143, "aml sample": 0.00208, "cytoplasmic proteic inhibitor": 0.006, "xic/xist": 0.00031, "specific subdomains": 0.01238, "helix-loop-helix protein function": 0.03019, "indistinguishable": 0.0013, "affect dna binding": 0.01237, "rxr facilitate monocyte differentiation": 0.00599, "cytochalasin": 0.00037, "e1a- replication-deficient vector replicating": 0.0016, "hungarian male breast cancer patient": 0.00666, "u-937 monoblastic cell line": 0.0384, "dysrhythmia": 0.0, "region -158/-90 reveal": 0.00978, "cd28 and/or cd2": 0.003, "polyclonal reactive process": 0.00296, "aes peptide g75": 0.00502, "allergy-driven overproduction": 0.00025, "increase ra sensitivity": 0.01464, "allele": 0.0044, "chemist": 0.00012, "cd27-": 0.00012, "dna consensus bind site": 0.01084, "isolated elk-1-specific genomic phage clone": 0.00295, "cell activation factor nf-atc": 0.0384, "gene product": 0.04355, "bat box-deleted cd20-cat construct": 0.00363, "positive functional role": 0.00885, "creb": 0.00471, "human hematopoiesis": 0.03762, "pgn induced phosphorylation": 0.00656, "decidualized endometrial stroma": 0.00023, "rare hybrid": 0.00171, "mature protein": 0.04529, "formation": 0.00968, "biochemical sign": 0.0018, "kappa b-like motif": 0.00583, "amino-terminal rel-related domain": 0.00804, "c-fos early response gene": 0.02177, "cytotoxic cytokine synthesis": 0.00749, "eosinophil express mrna": 0.0123, "ebnas": 0.00012, "bind mip-1alpha": 0.02025, "hiv hyperplastic lymph node": 0.00296, "distal marker": 0.00382, "pou domain transcription factor": 0.0143, "progenitor develop": 0.00403, "cell surface cd4": 0.0512, "glucocorticoid drug gcr count": 0.00425, "philadelphia chromosome-positive chronic myelogenous leukemia cell line": 0.02194, "activate erk mapks": 0.01185, "freshly isolated memory": 0.00126, "moderate ubiquitous activation": 0.02109, "activator protein-1 family protein": 0.02264, "mycobacterium tuberculosis": 0.00105, "p90rsk": 6e-05, "induced dissociation": 0.0054, "cmpd1": 0.00019, "endogenous glucocorticoid": 0.0085, "human ehrlichiosis": 0.03762, "translocates": 0.0005, "potent transcription activator": 0.01873, "functional state": 0.00816, "cell leukemia/lymphoma development": 0.0512, "mu/l": 0.00012, "mechanism accounting": 0.01058, "leukocyte differentiation antigen": 0.00786, "activate": 0.03555, "paired domain protein pax-1": 0.02264, "unique significance": 0.00261, "bulbar conjunctiva": 0.00022, "specific extracellular matrix process": 0.00619, "threefold increase": 0.02196, "tandem pair": 0.00214, "rag": 0.0005, "t-cell biology": 0.00962, "camp-inducing agent": 0.00422, "vivo study define": 0.00904, "stress commonly increase opioid level": 0.00878, "single-positive population": 0.00307, "nonsteroidal anti-inflammatory drug": 0.00225, "severe ner defect": 0.00186, "hiv-infected monocyte": 0.01197, "orphan receptor": 0.02571, "ara-c": 0.00043, "microarchitecture": 6e-05, "induces rapid tyrosine phosphorylation": 0.00492, "nuclear factor include nfat-1": 0.0143, "core sp1 consensus element abolish footprinting": 0.00557, "insensitive": 0.00037, "drug": 0.00676, "shut-down": 6e-05, "4-week-old adult mouse": 0.00649, "c5a-induced kappab bind activity": 0.01462, "bash": 0.00031, "membrane-associated elam-1": 0.00025, "ebna2 activation": 0.03164, "putative": 0.00744, "nf-atp copurifies": 0.00074, "positional effect relative": 0.0141, "peripheral venous blood sample": 0.00296, "extravascular tissue": 0.00664, "monocytic cell maturation": 0.0512, "jiang": 0.0, "mrna product": 0.01526, "hsv-1 strain ko": 0.00124, "hiv-1 transactivator": 0.00878, "study cd14 gene regulation": 0.02177, "intricate arrangement": 0.00012, "binding interaction": 0.01855, "cell coactivator obf-1/bob1/oca-b": 0.0512, "pr antibody": 0.00893, "hiv-2": 0.00192, "transcription factor nf-kappab regulation": 0.0143, "il-4-dependent activation": 0.03164, "absent p65 protein level": 0.02264, "pcd/dcoh": 0.00056, "virus exposure": 0.00887, "a10": 0.00012, "dominant neoplastic clone": 0.00492, "pha-": 6e-05, "low il-4": 0.00707, "repair/transcription factor tfiih": 0.01907, "truncated hil-4r alpha": 0.0078, "high homology": 0.00931, "thymus-dependent humoral immune response": 0.00971, "lung fibroblast": 0.00338, "human exhibit": 0.03762, "nf-y mediate": 0.01231, "urine catecholamine": 0.00022, "ifn-beta inhibited il-2 deprivation apoptosis": 0.00447, "japan": 0.00012, "myeloma line": 0.01653, "octamer": 0.00391, "p50 steady-state protein level": 0.02264, "mammalian cell transfection": 0.0512, "assay performance": 0.01002, "cxc chemokines": 0.00056, "transcriptional regulatory property": 0.00767, "ngf-responsive rat pheochromocytoma cell line": 0.03072, "retinoic acid-induced monocytic differentiation": 0.00589, "human monocytic cell line": 0.0384, "isolated nucleus": 0.00319, "human carboxylesterase gene": 0.02903, "density-gradient centrifugation": 0.00012, "polarized intestinal epithelial cell direct": 0.03072, "rel/nf-kappab": 0.00037, "isotype specificity": 0.00335, "corticosteroid treatment": 0.01014, "domain-containing intracellular molecule": 0.00569, "m-csf gene": 0.04355, "mutational": 0.00081, "individual binding site reveals": 0.01084, "constitutively associate": 0.01092, "d1a": 0.0, "ah receptor dependent": 0.01714, "slow migrating complex": 0.01123, "common allelic variant": 0.00234, "nfkappab activation occur": 0.02109, "phosphatidylinositides": 6e-05, "condition medium": 0.0036, "dimerization": 0.00143, "p50p50": 0.00031, "oca-b associate": 0.01092, "germinal centre": 0.00062, "cell culture increase": 0.0512, "great variety": 0.00205, "t-cell-specific elf-1 factor": 0.01907, "chicken": 0.00155, "constitutive nuclear nf-kappa": 0.01123, "major phosphorylation site": 0.01445, "cd28-mediated induction": 0.01607, "nuclear mobilization": 0.01684, "alpha-dihydroxicholecalciferol": 6e-05, "mite-specific helper": 0.00105, "dbf": 0.00025, "permissive condition": 0.0036, "c-jun n-terminal kinase activation": 0.01582, "il-2 binding": 0.01855, "igd": 0.00037, "e6": 0.00043, "paec": 0.00025, "free thiols": 0.00127, "radioactive iodine": 9e-05, "underlie molecular mechanism": 0.00705, "endothelial cell activation": 0.0512, "inhibited expression": 0.04163, "express icsat": 0.01846, "phorbol-12-myristate-13-acetate increase": 0.02196, "activate signal": 0.01777, "nf-kappab family member": 0.00666, "differentiated thp-1 cell": 0.0512, "subpopulation": 0.00112, "ntf": 0.00025, "stimulate nfat activity": 0.0195, "free radical production/oxidative stress": 0.00155, "transcriptional enhancer element": 0.01115, "primary culture": 0.00738, "kappab-binding activity": 0.02925, "metastatic ability": 0.00431, "entire extracellular domain": 0.00804, "intense study": 0.01355, "igg response": 0.01942, "major histocompatibility complex": 0.01123, "cell release": 0.0768, "human papillomavirus e6": 0.02508, "c3a-mediated enhancement": 0.00233, "base-pair substitution": 0.00112, "endocrine beta-cells detect pan protein": 0.01811, "alpha-methyl-1 alpha,25-": 6e-05, "inhibit gm-csf gene transcription": 0.02177, "lymphocyte development induce": 0.01694, "arachidonic acid liberation": 0.00571, "nf-kappab-containing nuclear extract": 0.01123, "cultured erythroid progenitor": 0.00414, "macrophage pathway": 0.01278, "elevated tnf-alpha": 0.00546, "pma-induced tyk2 dephosphorylation": 0.00091, "tnf alpha contribute": 0.0078, "normal pbm": 0.0121, "transfected cell": 0.0768, "alpha-tocopheryl succinate": 0.00025, "variation thereof": 0.00164, "ref": 6e-05, "il-2-dependent cell line": 0.0512, "integrin expression": 0.04163, "ap-1 activation": 0.03164, "evolution": 0.00043, "basal transcriptional activity": 0.0195, "enhance gene expression": 0.02903, "propidium iodide": 0.00016, "nonatopic asthma": 0.00161, "calcium-dependent induced gene product": 0.02177, "require calcineurin": 0.01315, "nat.med.1:1284-1290": 6e-05, "prevent nf-kappab": 0.00999, "observed increase": 0.02196, "normal menstrual cycle": 0.00806, "rel family": 0.00841, "self-perpetuating loop": 0.00109, "translocation induce": 0.0254, "efficient viral transcription": 0.01873, "myf5": 6e-05, "c-rel homodimers": 0.00245, "promoter upstream": 0.02336, "positive case express granular er staining": 0.00615, "suicidal inversion": 0.00019, "allograft": 0.00025, "nfat1 act": 0.00496, "cell require host cell activation": 0.01536, "cf sputum": 0.00037, "pa": 0.00093, "3.8-kb ecori genomic fragment encode": 0.00341, "animal study": 0.01355, "gammac basal promoter activity": 0.01462, "gene study": 0.04355, "histological grade": 0.0004, "se stimulation": 0.0112, "cell inhibit": 0.0768, "lif induce": 0.0254, "undergo post-translational acetylation": 0.00153, "major site": 0.02168, "transcriptional initiation site": 0.01445, "human b-lymphocyte precursor cell": 0.0384, "endotoxin selectively induce monocyte mn superoxide dismutase": 0.00726, "basal transcription": 0.0281, "noteworthy": 0.0, "antiproliferative activity": 0.02925, "maternal": 0.00062, "n-wasp interacts": 0.00136, "yeast two-hybrid interaction system": 0.00493, "calcitriol receptor": 0.02571, "lps induces nuclear expression": 0.02081, "cd3 cross-linking increase binding": 0.01098, "prominent e2f activity": 0.0195, "transcription factor junb": 0.01907, "n.p.salzman": 6e-05, "allele distribution": 0.0022, "steroid binding test": 0.01237, "granulocytic": 0.00285, "immunologic machinery": 0.00071, "direct leukocyte traffic": 0.0036, "3-carboranyl-substituted compound": 0.0022, "reproductive tissue": 0.00664, "mean+/-se": 0.0, "putative ap-2": 0.00372, "jurkat hb24 transfectants proliferate": 0.00278, "blood estrogen level": 0.01214, "design future therapeutic strategy aim": 0.00067, "anti-cd18 antibody": 0.00893, "small cis-acting element": 0.01115, "adjunct": 6e-05, "junb gene expression": 0.02903, "transient transfection study demonstrate": 0.00799, "non-cytokine gene": 0.04355, "multiple nonlymphoid tissue": 0.00459, "-50": 0.00025, "cd40-induced nf-kappa": 0.01414, "transient transfectin experiment": 0.00265, "flow cytometry evaluation": 0.00101, "similarly reverse": 0.00236, "coordinated binding": 0.01855, "putative protein express": 0.03019, "gene include interferon regulatory factor": 0.01742, "heterodimer": 0.00409, "early transfected cell": 0.0512, "transient-transfection assay show": 0.01733, "drug-induced apoptosis": 0.0089, "trans-activates": 0.00019, "/syn-1": 0.0, "target gene il-8": 0.02903, "tnf-alpha lead": 0.00996, "report amino-terminal sequence": 0.01084, "roi-": 6e-05, "32p-labeled oligonucleotides correspond": 0.00122, "preferential activation": 0.03164, "default pathway lead": 0.00852, "ab direct": 0.0054, "murine immunoglobulin heavy-chain": 0.00416, "class ii-negative bare lymphocyte syndrome": 0.00593, "gata site": 0.02168, "transmembrane receptor term blr2": 0.01286, "atl cell": 0.0768, "reversible": 0.00136, "il-2r alpha gene": 0.02903, "recombinant hbxag protein": 0.03019, "eukaryotic cell": 0.0768, "ppe": 6e-05, "maximal accumulation": 0.00323, "phosphate-supplemented patient": 0.01666, "succinimide derivative": 0.00192, "candida albicans": 0.00012, "csa treatment": 0.01014, "human remain": 0.03762, "cell-associated surface molecule cd40 play": 0.00341, "block transcript degradation": 0.00715, "fragmented dna": 0.01483, "osteoblast-specific gene": 0.04355, "beta-globin switch": 0.00245, "autologous lymphoblastic cell line pulse": 0.03072, "event test": 0.00552, "primary human erythroid cell": 0.0384, "induce multiple gene reporter": 0.02177, "gene encode hnf-3alpha": 0.02903, "cell line kg-1": 0.0512, "hla-c allele": 0.0022, "prevent degradation": 0.00524, "p.": 0.0013, "pma-induced promoter activity": 0.0195, "p-lps-mediated signal-transducing mechanism": 0.00705, "research group": 0.00487, "nf-e2": 0.00192, "-454": 6e-05, "spleen lymphocytic cell": 0.0512, "ppargamma induce": 0.0254, "primary tcr activation": 0.02109, "h2o2-promoted stat3 nuclear translocation": 0.00842, "osteoclast-like cell": 0.0768, "tunel assay": 0.01002, "b-cell mitogenesis": 0.00459, "armamentarium": 0.0, "nrl": 0.00025, "mammary reduction": 0.00295, "nuclear matrix-bound rb": 0.01123, "previous": 0.00267, "mnda positive cell": 0.0512, "suppress insulin gene transcription": 0.02177, "human megakaryocytic cell line": 0.0384, "u-937 cell": 0.0768, "increase transcriptional activation": 0.02109, "genomic change": 0.0063, "gata-4": 0.00043, "normal human monocyte": 0.02508, "synthase": 0.00161, "pma-differentiated cell displayed agonist activity": 0.03072, "sh2 domain enhance basal nfat activity": 0.00975, "rescue mhc-restricted thymocytes": 0.00172, "novo mutation": 0.00592, "pancreas development": 0.00633, "activate stat3alpha": 0.01777, "ras-dependent signaling pathway": 0.00852, "mammalian tissue": 0.00664, "high order complex": 0.01123, "ebv remain": 0.00565, "fy": 0.00019, "bivalent cation": 0.00012, "activate t-cells": 0.01777, "acute lung inflammatory injury": 0.00236, "fluorescence intensity": 0.00065, "multipotent eml cell": 0.0512, "immunohistochemical staining": 0.00177, "acute promelocytic leukemia": 0.00333, "cd34 gene": 0.04355, "deliver enhancer bind protein": 0.02264, "unique characteristic": 0.00329, "hnfs suggests": 0.00028, "mobility shift assay show": 0.013, "a-myb transcription factor": 0.01907, "phosphoform": 0.0, "recombinant b4-2": 0.00391, "self-renewal capacity": 0.00329, "protein kinase c-dependent": 0.03019, "asparagine side chain": 0.00292, "regulated process require phosphorylation": 0.00658, "seminoma": 6e-05, "unique transcriptional mechanism distinct": 0.00575, "tfiih": 0.0005, "proto-oncogene product c-fos": 0.00356, "viral cycle": 0.00732, "stat6 activity": 0.02925, "zebra promoter": 0.02336, "compound r24571": 0.0022, "gas-like dna-protein binding complex": 0.00927, "glucocorticoid response element binding": 0.00971, "calcium-": 0.00019, "future prognosis": 0.00028, "de novo protein synthesis": 0.02264, "inducible n-terminal transactivation domain": 0.00603, "efficient hormonal control": 0.00868, "alternative signal transduction pathway distinct": 0.00654, "develop th1 cell": 0.0512, "target c-fos": 0.00825, "place upstream": 0.00369, "similar reduction": 0.00673, "facilitate virus spread": 0.00591, "bcl-3 protein": 0.04529, "nip repressor site": 0.01445, "growth factor stimulation": 0.01907, "+/- 0.58-fold": 0.00158, "tissue site": 0.02168, "expression study": 0.04163, "5-fold": 0.00087, "early replicating pseudoautosomal segment": 0.00414, "dansylcadaverine": 6e-05, "important difference": 0.00689, "include chemokines": 0.01439, "lytic ebv dna replication": 0.00741, "kappa recognition sequence": 0.01084, "responsive gene": 0.04355, "vp16 interaction": 0.00986, "calcineurin stimulate": 0.01101, "cytokine interleukin": 0.01123, "portion": 0.00149, "thrombin activation require assembly": 0.01582, "apparent difference": 0.00425, "impaired expression": 0.04163, "disease suggest adenovirus": 0.01348, "upregulates": 0.00087, "bcl-2 act downstream": 0.00331, "ebv": 0.01129, "constitutive phosphorylation": 0.00983, "il-1 receptor-like nf-kappab signal cascade": 0.00654, "adaptor function": 0.01331, "analysis demonstrate": 0.01597, "protein substrate": 0.04529, "menopausal type ii diabetes": 0.00475, "ac": 0.00019, "complementary dna": 0.01483, "adult sample reveal similar maximal increase": 0.00732, "inflammatory response increase level": 0.01098, "stat3 isoform": 0.00354, "j.jhan": 0.00012, "beneficial": 0.00056, "block calcineurin-dependent signaling": 0.00715, "u-937 myeloid leukemia cell": 0.0384, "expression level": 0.04163, "tnf-related apoptosis-inducing ligand": 0.00395, "early lytic transcript": 0.00552, "tunel": 0.00031, "high density": 0.00931, "normal gene": 0.04355, "il-2 induces bcl-2 expression": 0.02081, "-220": 0.00019, "e2a-pbx1 initiate program cell death": 0.03072, "cell cycle control": 0.0512, "stat5": 0.00509, "prolong treatment": 0.01014, "yeast": 0.0031, "cd30-dependent degradation": 0.00332, "cd30 ligation induces nuclear factor-kappa": 0.00674, "induction mediate": 0.01607, "immunosuppressive drug pnu156804 block il-2-dependent proliferation": 0.00358, "functional activity": 0.02925, "phase progression": 0.00276, "beta-casein gene regulate": 0.02903, "positive selection marker": 0.00312, "nitric oxide synthetase activity": 0.01462, "upstream element include": 0.01115, "transcription factor oct-1": 0.01907, "vertebrate t-cell-specific transcriptional regulation": 0.00575, "inhibit vdr-rxr-vdre complex formation": 0.00952, "anti-cd3 ab": 0.00208, "ontogeny": 0.00019, "stable jurkat cell clone provide": 0.03072, "cellular activation event occur": 0.01582, "mdd group": 0.00487, "polyomavirus reactivations": 0.0004, "-induced hla-dr expression": 0.02775, "split protein": 0.04529, "level comparable": 0.01821, "circadian variation": 0.00164, "peripheral leucocyte": 0.00524, "monocyte-derived macrophage culture": 0.00414, "mouse show marked splenic lymphocyte depletion": 0.00866, "osteoarthritis tissue": 0.00664, "suggesting": 6e-05, "monocyte tethering": 0.01197, "result lend": 0.0161, "cell cycle regulate": 0.0512, "impaired cortisol bind": 0.0135, "immunomodulator": 0.00012, "differential dependency": 0.00323, "enhance eklf": 0.00974, "clonotypes": 0.0005, "-induced mononuclear differentiation": 0.00786, "ra-dependent enhancer": 0.00909, "inherited over-expression": 0.00022, "main model report": 0.00327, "serine protease granzyme": 0.00118, "cell subset": 0.0768, "cd8/hla class i-restricted response": 0.00971, "stat-6 binding site": 0.01445, "cd21 promoter reveal": 0.01557, "dioxin-mediated alteration": 0.0023, "pka transduction pathway": 0.00852, "infection inhibit": 0.01904, "myelomonocytic cell line arrest": 0.0384, "sla-dq expression": 0.04163, "indirect observation": 0.00149, "include plasma hormone": 0.00959, "inducible protein complex": 0.03019, "lambda": 0.00112, "virus production": 0.01042, "proximal tnf-alpha promoter": 0.01557, "functional redundancy": 0.00816, "v-erba": 0.00074, "freshly isolate cd34": 0.00277, "remarkable qualitative": 0.00031, "independency": 0.0, "series resistant cell": 0.0512, "immediate-early ebv zebra gene": 0.02177, "cell damage": 0.0768, "ductal carcinoma": 0.0018, "mixed leucocyte": 0.00081, "author demonstrate": 0.01597, "pkc-alpha": 0.0005, "migrate": 0.00099, "ra-mediated apoptosis": 0.0089, "camp-": 0.00043, "end growth": 0.00819, "cd3-directed cytolysis correlate": 0.00436, "tyrosine kinase receptor": 0.01714, "heterogeneous expression": 0.04163, "normal lymph node cell result": 0.03072, "c-fos promoter sis-inducible element probe show": 0.00866, "bp -128": 0.00267, "calcineurin": 0.00633, "c/ebp-epsilon expression plasmid increase cell growth": 0.0256, "biopsy enter lytic cycle": 0.00154, "e1a-specific primer": 0.00081, "transcriptional transactivation": 0.01151, "mark increase": 0.02196, "o'-bismyristoyl esterification": 9e-05, "donor test": 0.00487, "genomic lmp1 dna fragment enhance lmp1 expression": 0.01189, "severe fura toxicity secondary": 0.00105, "kinase inhibitor h7 lead": 0.00594, "cytokine-induced ec-mn adhesion": 0.00387, "populated gc": 0.0031, "b-1 lymphocyte": 0.01483, "nf-kappab/rel family": 0.00841, "calmodulin-regulated kinase": 0.01188, "internal labeling": 0.00087, "mdd show baseline lymphocyte gcii sit": 0.00866, "relb remains unaffected": 0.00099, "suppressive effect": 0.02115, "anti-rheumatic compound aurothioglucose inhibits tumor necrosis factor-alpha-induced hiv-1 replication": 0.00207, "g2/m phase": 0.00276, "nonstructural trans-acting regulatory gene": 0.02177, "nucleotide": 0.00403, "initiate il-4-induced tyrosine phosphorylation": 0.00492, "cell wall": 0.0768, "p-creb level remain": 0.01214, "chronic infection": 0.0062, "cd30 induces hiv expression": 0.02081, "v-abl kinase activity": 0.0195, "transcription factor ap1": 0.01907, "early hematopoietic stage": 0.00552, "suppress erythropoiesis": 0.00611, "clinical significance": 0.00425, "trna gene transcription": 0.02903, "amelioration": 6e-05, "24-hydroxylase mrna level": 0.01214, "increased 10-fold": 0.00363, "rel-related nf-kappa b2 gene": 0.02177, "aml1a-transfected k562 cell": 0.0512, "dna helix": 0.01483, "stat1 protein start": 0.03019, "ifn-alpha correlate": 0.00654, "stimulate ipr cd4-8-": 0.00734, "cd40 signal up-regulate c-jun": 0.00817, "membrane-bound": 0.00081, "platelet membrane vesicle": 0.003, "overt leukemia": 0.00499, "major susceptibility gene control total serum ige level": 0.01089, "puc": 0.0, "alternative pax-5 transcript": 0.00399, "hiv-1-infected peripheral blood": 0.00395, "de novo synthesize dioxin receptor": 0.01029, "phosphorylation level change": 0.01214, "cells/cm2": 0.0, "one-hybrid assay": 0.01002, "immune": 0.01197, "il-10 potentiate": 0.00422, "myeloblastoid": 6e-05, "process essential": 0.00487, "uncharted dna sequence": 0.01084, "hsi": 0.00012, "1a9-m cell": 0.0768, "cell-free extract": 0.00459, "exogenous addition": 0.00673, "h7": 0.00081, "induce cd4 gene transcription": 0.02177, "over-representation": 6e-05, "hypoxic lung tissue": 0.00443, "e1a-positive cell": 0.0768, "prominent protein kinase": 0.03019, "nh2-": 6e-05, "evidence show physical": 0.01733, "gata-1 allele": 0.00413, "inhibit neutrophil apoptosis": 0.0127, "observed effect": 0.02115, "well-established risk factor": 0.01907, "non-htlv-i-infected": 0.00012, "burst-forming unit-erythroid": 0.00025, "freshly isolate ipr cd4-8-": 0.00208, "janus kinase 3-stat5a pathway": 0.00639, "alu sequence": 0.01625, "alpha-tosylphenylalanyl chloromethyl ketone": 0.00021, "qi-invigorating": 0.00012, "ra sensitivity": 0.00596, "gamma-interferon mediate cell activation": 0.0384, "death induce": 0.0254, "gata-1 mrna concomitant": 0.01017, "tnf-alpha protein presence": 0.03019, "c.gregory": 0.00012, "rxr-specific effect": 0.02115, "caprine arthritis-encephalitis virus long terminal repeat": 0.00296, "favour": 0.00031, "antigen receptor response element": 0.01286, "vzv peptide induce": 0.01694, "reporter lack": 0.00633, "jak3 jh2 domain": 0.00804, "temperature-induced down-regulation": 0.00195, "p60": 0.00031, "t-cell line jurkat": 0.01102, "dose-dependent fashion": 0.00161, "respective transcript": 0.00599, "-2 gene induction": 0.02903, "p50-p65 heterodimer": 0.00205, "gcs-untreated patient": 0.01666, "il-2r expression lead": 0.02775, "upregulated il-4 expression": 0.02775, "cis-active relationship": 0.00158, "thyroid hormone response element": 0.00971, "endogenous c-fos mrna expression": 0.02081, "sulindac repress": 0.0022, "noninvasive": 0.00019, "sequence specificity": 0.01625, "cortical": 0.00025, "dalton": 0.0, "immunoglobulin heavy-chain enhancer mu e1 site": 0.00723, "tnf-alpha play": 0.0071, "eosinophilic inflammation": 0.00316, "reduced crh synthesis": 0.00389, "inhibit stimuli-induced hiv-1 expression": 0.02081, "-mediated signal transduction": 0.0109, "ctcf": 0.00056, "cell-surface protein": 0.04529, "mrna stability study demonstrate": 0.00799, "2-d5-previtamin d3": 0.00245, "predominant isoforms express": 0.0123, "b2 isoform": 0.00171, "intracellular oxidant activity": 0.0195, "tyrosine-phosphorylated dna bind protein": 0.02264, "high rate": 0.00931, "nuclear factor specific": 0.01907, "cell-specific enhancer": 0.00909, "apl encode factor": 0.01907, "recent experiment suggest": 0.01348, "intracellular glucocorticoid receptor": 0.01714, "transcriptional cooperativity": 0.01151, "nf kappa b1 site respond": 0.00867, "polycythemia vera": 6e-05, "critical threshold level": 0.01214, "gm-csf cytoplasmic mrna": 0.01017, "induce ad5e1a-specific immunity": 0.01694, "mast cell activation signal deliver": 0.03072, "methane": 0.00012, "male breast cancer": 0.00172, "c-sis/platelet-derived growth factor-b": 0.00546, "serum": 0.00757, "redox-regulated step": 0.00189, "small population": 0.00313, "polymorphonuclear": 0.00186, "systemic lupus erythematosus": 0.00068, "potentiate stat-dependent transcription": 0.01873, "mg/d": 0.0, "synthetic peptide mapping": 0.00502, "synthesize": 0.00316, "lymphoblastoid t-cell-line-expressing wild-type": 0.00252, "cos7 cell reveal": 0.0512, "developmental stage-specificity": 0.00127, "nf kappa b2": 0.00498, "-285/-254": 0.0, "pou domain contribute": 0.00804, "w.q": 6e-05, "intrapulmonary instillation": 0.00025, "erythroid precursor cell": 0.0512, "monocyte-like": 0.00043, "lef1/bcf1": 0.00031, "erk-independent pathway": 0.01278, "eventual progression": 0.00164, "gc-insensitive asthma express": 0.0123, "two-dimensional gel electrophoresis system": 0.00333, "cosmid": 0.00025, "gene encode interleukin-2": 0.02903, "leukocyte clearance mechanism": 0.00705, "protein kinase c-zeta mediates nf-kappa": 0.01811, "human breast carcinoma cell line": 0.03072, "g1 phase": 0.00276, "intertypic recombinant virus": 0.00591, "x-chromosome inactivation": 0.00174, "overview": 6e-05, "f.lori": 0.00012, "pml/rar alpha mrna": 0.01017, "gd3": 0.00019, "inducible factor nf-gm2": 0.01907, "human nk cell activate porcine ec": 0.0256, "erythropoietin-dependent manner": 0.00282, "typical": 0.00236, "substantial evidence": 0.00422, "related dna sequence": 0.01084, "cos-7 cell transfected": 0.0512, "factor nf-kappa": 0.0286, "reverse blood pressure pattern": 0.00296, "receptor-ligand affinity": 0.00391, "nuclear hormone receptor": 0.01714, "increase level": 0.02196, "excess unlabeled": 0.0005, "rapid activation": 0.03164, "altered specificity tbp": 0.00223, "leukemic entity": 0.00251, "manifestation": 0.00056, "enhance tr75 expression": 0.02775, "n-oct": 0.00019, "spontaneous tumorigenesis": 0.00093, "viral protein epitope": 0.03019, "structure": 0.00639, "rna polymerase ii repeat report": 0.0029, "annealing": 6e-05, "ebv gene": 0.04355, "express late": 0.01846, "pml": 0.00335, "dna-protein complex common": 0.01123, "functional characterization": 0.00816, "small proportion": 0.00313, "monoblast": 0.00043, "calcineurin active site": 0.01445, "gasd element": 0.01672, "sexual transmission": 0.00053, "tax transfected jurkat cell line": 0.03072, "important component": 0.00689, "vivo enhancer activity": 0.0195, "silencer activity": 0.02925, "isre bind factor": 0.01907, "proto-oncogene include c-jun": 0.00959, "mouse nm23-m1": 0.00974, "mitogen-inducible": 0.00074, "present in-vitro experiment": 0.0049, "eukaryotic nucleus": 0.00319, "creb binding protein increase transcription": 0.01811, "nuclear estrogen receptor content": 0.01286, "hla class ii": 0.00484, "er-negative breast cancer cell line": 0.03072, "potential clinical relevance": 0.00403, "acetylation": 0.00043, "bind factor": 0.0286, "spectrum": 0.00105, "myocardial infarction": 0.00022, "pro-b cell stage": 0.0512, "il-8 expression": 0.04163, "ap-1 motif": 0.00875, "autoreactive t-cells": 0.00211, "utility": 0.00025, "murine sequence": 0.01625, "process form": 0.01055, "tal1 gene product": 0.02903, "compensation mechanism": 0.01058, "allergic asthma": 0.00161, "interferon gamma induction pathway": 0.00803, "vdres": 0.0, "enhanced tyrosine auto/transphosphorylation": 0.00474, "large granular lymphocyte": 0.00988, "il-8 gene expression": 0.02903, "promoter proximal repeat": 0.01557, "low abundance": 0.00707, "5-fold reduced level": 0.01214, "platelet production": 0.01042, "mechanism similar": 0.01058, "86-amino acid fragment": 0.00571, "similar ra binding affinity": 0.00927, "differentiation marker": 0.01179, "comparable enhancer element": 0.01115, "screening": 0.00124, "potent immunogen": 0.00357, "dr+2": 6e-05, "tgf-beta1-transcribing macrophage": 0.00589, "isolated nk cell-derived granule": 0.00183, "maximum transactivation activity": 0.0195, "detectable cytokine": 0.01123, "dc stimulation": 0.0112, "er bind": 0.02025, "gene-modified": 0.00012, "p45 nf-e2 protein inhibit": 0.02264, "high luciferase activity": 0.0195, "low affinity specific bind site": 0.00867, "underrepresented": 0.0, "bi": 0.00025, "intervention": 0.00031, "rars patient show monoclonal pmncs": 0.0104, "fragmentation require ongoing protein synthesis": 0.01811, "site-specific activator cyclic amp-responsive element-binding protein": 0.0151, "mononuclear phagocyte/neutrophil series": 0.00203, "hela cervical carcinoma cell": 0.0384, "vdr concentration": 0.0067, "ap-1 dna binding activity": 0.01462, "current state": 0.00267, "proband": 0.00025, "eosinophilic phenotype": 0.00366, "e2f regulation": 0.01008, "3-fold": 0.00081, "possess therapeutic potential": 0.00403, "p85": 0.00087, "diacetate": 0.0, "epo-responsiveness": 6e-05, "epstein-barr virus bzlf1 transactivator protein": 0.01811, "increase camp concentration": 0.01464, "s-adenosylhomocysteine hydrolase inhibitor": 0.006, "r24 treatment": 0.01014, "1.4+/-0.8": 0.0, "binding specificity": 0.01855, "minimal region": 0.01467, "retinoic acid receptor-alpha": 0.00571, "selective deletion": 0.00344, "desferrioxamine": 0.00019, "tcr-coupled phosphoinositide turnover": 0.00074, "critical control point": 0.00868, "suggest ceramide release occur proximal": 0.00809, "-associated disease": 0.00673, "long-term regulatory mechanism": 0.00705, "pu.1 induces expression": 0.02775, "epstein-barr virus dna polymerase activity": 0.0117, "promyelocytic leukemia zinc finger/rar alpha fusion transcript": 0.00334, "cd69 gene": 0.04355, "cd45-negative variant": 0.00276, "colinear triplex formation act": 0.00248, "stromal cell stimulate": 0.0512, "induce il-2 expression": 0.02775, "precursor protein": 0.04529, "quantitative reverse transcription-pcr assay": 0.00501, "restriction enzyme analysis": 0.00786, "15-base oligonucleotide": 0.00164, "phosphorylated p42/p44 mitogen-activated protein kinase": 0.01811, "coordinated expression": 0.04163, "-associated herpesvirus": 0.00074, "calcium mobilization": 0.00236, "c-fos transcription": 0.0281, "ligand-induced degradation": 0.00332, "cdna clone encode": 0.00569, "phorbol ester pkc agonist": 0.00271, "total serum ige level": 0.0091, "srf": 0.00105, "detailed information": 0.00053, "potent effector": 0.00357, "ligand-activated il-10 receptor": 0.01714, "open binding site": 0.01445, "stimulate gene transcription": 0.02903, "k.j.": 0.00012, "endogenous glucocorticoid peripheral": 0.00567, "separate sequence element": 0.01115, "5306-5309": 0.0, "actin filament": 0.00074, "conventional stain": 0.00096, "signal transduction molecule": 0.0109, "transcriptional repression domain": 0.00804, "granulocyte macrophage-csf": 0.00254, "dqb y-box": 0.00031, "alpha-cd3": 0.0, "ra-induced regulation": 0.01008, "amino acid domain": 0.00804, "chimeric il-6 receptor": 0.01714, "permanent nf-kappab translocation induce": 0.0127, "include adhesion-dependent pathway": 0.00959, "lymphomagenesis": 0.00025, "recruit naive": 0.00133, "activated human cd4": 0.02508, "increase cytokine secretion": 0.01464, "undefined serine kinase": 0.00792, "pax-5b protein": 0.04529, "signal-transducing function": 0.01331, "cd41 immunofluorescence": 0.00059, "epsilon transcription": 0.0281, "non-il-5-producing cell line activate": 0.0384, "dependent transcription": 0.0281, "apoptotic machinery": 0.00189, "well-known il-2-dependent cell transformation": 0.0384, "125i-il-4": 6e-05, "sffv": 0.00012, "mouse cell": 0.0768, "neutrophil property": 0.00496, "t-": 0.00105, "glucocorticoid resistance": 0.0085, "mthc system": 0.00667, "pediatric oncology group study": 0.00678, "hcs": 0.00019, "regulate interleukin-4 expression": 0.02775, "slp-76 function": 0.01331, "cd36 gene promoter": 0.02903, "h2o2 scavenger pyrrolidine dithiocarbamate": 0.00073, "disease process": 0.00673, "reduced gr level": 0.01214, "mediate apoptosis": 0.01231, "gel retardation experiment": 0.00265, "ppargamma ligand": 0.00592, "actinomycin d. consistent": 0.00136, "glia inhibits": 0.0053, "ribosomal complex": 0.01684, "ra inhibits ige production": 0.00521, "alter pathologic immune response": 0.00971, "target quantity increase": 0.01464, "leukocyte recruitment": 0.00478, "human zeta": 0.03762, "subsequent cross-linking": 0.00304, "interleukin-1 stimulate u-937 cell adhesion": 0.03072, "socs/cis/ssi family": 0.00841, "mg flutamide": 0.0004, "nf-kappab/rel binding site": 0.01445, "bamhi-a region": 0.01467, "preosteoclast/osteoclast phenotypic property": 0.00265, "cell line express": 0.0512, "high-density pbmc culture": 0.00414, "close": 0.00136, "basal promoter activity": 0.0195, "mutant ebv strain lack": 0.00405, "double-blind placebo-controlled crossover study": 0.00678, "low-stringency condition": 0.0036, "low gcr": 0.00707, "inducible pb1 nuclear protein complex": 0.01811, "opposite phenotype": 0.00366, "ad vector lack immunodominant antigen": 0.00328, "tat-induced tar-independent loop": 0.00072, "pbmc specimen": 0.00236, "stimulate bcl-xl expression": 0.02775, "xeroderma pigmentosum": 0.00019, "bifunctional regulator": 0.00304, "n-terminal leu substitute": 0.00134, "pre-mrna generate": 0.00453, "dna binding function": 0.01237, "context-dependent manner": 0.00282, "protooncogenes": 0.00037, "biologic level": 0.01821, "pmlraralpha transgene initiate murine acute promyelocytic leukemia": 0.00178, "transfected u937 cell": 0.0512, "ml": 0.00031, "cll patient": 0.01666, "hiv protease": 0.00592, "monocyte enhances lps-induced tnf production": 0.00479, "hbg1": 6e-05, "cell-specific promoter": 0.02336, "inhibit agonist-induced monocytic cell adhesion": 0.03072, "rheumatoid peripheral blood": 0.00395, "lat": 0.00025, "c-cerba/thyroid hormone receptor regulate erythroid cell growth": 0.02194, "ccl4-induced hepatotoxicity": 0.00016, "numerous cellular gene": 0.02903, "stem cell proliferation": 0.0512, "cell communication": 0.0768, "u-937 human promonocytic cell": 0.0384, "three-": 6e-05, "vzv ie62": 0.00065, "p50/p50 kbf1 factor": 0.01907, "decrease ltr transcription": 0.01873, "dominant-active inhibitor": 0.009, "t-lymphoid": 0.0005, "histone acetyltransferases": 0.00133, "il-1 beta mrna": 0.01017, "anti-fos mab demonstrate": 0.01065, "nf-chi": 0.0005, "n-terminal sh2 domain": 0.00804, "potential open reading frame": 0.00302, "cell receptor complex": 0.0512, "vitro synthesize human glucocorticoid receptor": 0.01505, "ikappabalpha kinase": 0.01188, "hematopoietic transcription factor": 0.01907, "il-5 gene-nonexpressing t-cell line": 0.00827, "mutant stat3 incapable": 0.0054, "km-h2 cell": 0.0768, "x-linked spinal": 0.00068, "v-erb": 0.00037, "include pkc": 0.01439, "induce alpha-naphthyl acetate esterase": 0.0127, "apparent high frequency": 0.0062, "nf-kappa b-dependent cytokine gene expression": 0.01742, "inherent feature": 0.00217, "3'-utr": 0.00025, "relevant nf-kappa": 0.01414, "conserved dna-binding domain": 0.00804, "host cytotoxic t-cell surveillance": 0.00481, "steroid/thyroid hormone receptor family": 0.01286, "luciferase reporter drive transcription": 0.01405, "hl-60-c15 cell": 0.0768, "il-7 induce heterodimerization": 0.01694, "cytoplasmic pool": 0.004, "m-tat/epo cell culture decrease": 0.0384, "m-csf": 0.0036, "important regulator": 0.00689, "kappab alpha degradation": 0.0078, "p56 exists": 0.00074, "pituitary prl expression": 0.02775, "analogous molecular framework": 0.003, "corticoid": 0.00019, "tyrosine phosphatase": 0.0071, "lymphoid cell line": 0.0512, "positive-acting factor": 0.0286, "androgen insensitivity syndrome": 0.00182, "nfkb2 alters": 0.00068, "lps induce": 0.0254, "cell immunopoiesis occur": 0.0512, "mediate transcriptional activation": 0.02109, "distinct": 0.01396, "adjacent": 0.00279, "tr expression occur": 0.02775, "malignant cell population": 0.0512, "nfatc family": 0.00841, "include sensitivity": 0.01439, "anti-igm ab-induced b104 growth inhibition": 0.00424, "sp bind site": 0.01445, "ptx": 0.00019, "differentiating agent": 0.00422, "study period": 0.01355, "curcumin affect": 0.00797, "roi production": 0.01042, "transcription factor implicate": 0.01907, "transcriptional complex": 0.01684, "gad": 0.00012, "block tpa-induced adherence": 0.00715, "insulin receptor substrate-2": 0.01714, "resection": 0.00056, "isgf3 alpha": 0.01169, "ciita cdna": 0.00456, "complex enhancer": 0.01684, "/alpha-cd28 stimulation": 0.0112, "stress system": 0.00667, "kinetic difference": 0.00425, "reactive oxygen intermediate formation": 0.00242, "mastocytic/basophilic lineage": 0.00366, "dex act": 0.00496, "phenotype similar": 0.00673, "cck-8-induced luciferase activity": 0.0195, "oxidative stress trigger stat3 tyrosine phosphorylation": 0.00328, "mhc ii transcript": 0.00484, "t-cell-activating superantigen staphylococcal enterotoxin": 0.00022, "antiapoptotic effect": 0.02115, "function test": 0.01331, "x-ray-treated cell": 0.0768, "okt3 require": 0.01315, "target site specificity": 0.01445, "peripheral blood neutrophil count": 0.00296, "mesencephalon": 6e-05, "prior breast cancer": 0.00172, "pulse": 0.00136, "equilibrium": 0.00025, "hypercortisolism": 0.00025, "il-5 signal transduction mechanism": 0.00817, "hypersensitivity site": 0.02168, "infectious mononucleosis patient": 0.0111, "sequence similarity": 0.01625, "chromatin fragmentation": 0.00118, "up-regulate mnda mrna": 0.01017, "gammac mutation": 0.00592, "prevent tnf-alpha-induced apoptosis": 0.00593, "granulocytic dysplasia": 0.00143, "reporter gene drive": 0.02903, "fk506 block": 0.01073, "concomitant": 0.00223, "fcgamma receptor-mediated mitogen-activated protein kinase activation": 0.0151, "common feature": 0.0035, "gliotoxin-inhibitable activation": 0.03164, "ebv genome contributes": 0.00376, "defensin require": 0.01315, "pan protein": 0.04529, "cell nuclear extract": 0.0512, "aes": 0.00037, "astrocyte factor-dependent manner": 0.00188, "diseased tissue": 0.00664, "mediate transcriptional control": 0.00868, "recombinant hugata-3": 0.00391, "pf": 0.00043, "receptor function require": 0.01714, "liposarcoma": 0.0, "-associated box": 0.00304, "h. total mrna": 0.01017, "c-kit/epo-r": 0.00012, "prolong acute": 0.00369, "ets member": 0.00413, "archetypal t-cell-specific gene": 0.02903, "phorbolmyristate-acetate-stimulated il-1 receptor antagonist secretion": 0.01029, "pkc/ras-": 0.00012, "pituitary-specific start site": 0.01445, "signal transduction capacity": 0.0109, "il-2 stimulate jak3": 0.00744, "charybdotoxin-resistant component": 0.00456, "j393/cd43": 0.00025, "heat": 0.00378, "pro-inflammatory mediator": 0.00195, "gene encode proinflammatory cytokine": 0.02177, "cd45ra": 0.00031, "potential regulatory element": 0.01115, "egr-1 gene expression": 0.02903, "balanced viral load": 0.00488, "undescribed point mutation": 0.00395, "scid-hu-int mouse": 0.00974, "corticosterone": 0.00043, "non-leukaemic": 0.00012, "up-regulation": 0.00552, "hsf": 0.00037, "prior study suggest": 0.01348, "pl/im": 6e-05, "ras activation": 0.03164, "rt-pcr base approach": 0.00207, "rel homology family": 0.0056, "immunophilins": 0.00037, "mouse il-2 enhancer construct show": 0.0104, "endotoxin-stimulated thp-1": 0.00239, "epithelial cell fusion partner": 0.0384, "intravenous injection": 0.00043, "scmv snes": 0.00019, "pma/a23187": 0.00031, "principal il-2-inducible component bear significant relatedness": 0.00152, "myeloid specific": 0.01238, "camp response element": 0.01294, "anti-cd3 mab": 0.00267, "rapid shuttling": 0.00323, "immunosuppressive factor": 0.0286, "activate stat-5": 0.01777, "bear val50": 0.00102, "functional receptor number": 0.01714, "major virus reservoir": 0.00591, "glucocorticoid therapy resolve clinical symptom": 0.0034, "5'-untranslated": 0.00031, "stop codon mutant": 0.0054, "high ratio": 0.00931, "autologous cell pulse": 0.0512, "vcam-1 gene expression": 0.02903, "pu.1 expression": 0.04163, "downregulates expression": 0.04163, "gm-csf gene transcription": 0.02903, "metastasis-suppressor gene": 0.04355, "genetic change": 0.0063, "mf individual": 0.00409, "q11": 0.00037, "jun/jun": 0.00012, "yy1 nuclear factor": 0.01907, "unresuscitated": 6e-05, "uncharacterized transcription factor": 0.01907, "fork head gene subfamily": 0.02177, "ap-2 consensus bind sequence": 0.01013, "natural bacterial cell wall breakdown product": 0.0256, "mol/l 9-cis ra increase level": 0.00878, "proinflammatory regulator": 0.00304, "monocytic cell line thp-1": 0.0384, "active raf-1 phosphorylates": 0.00395, "gh/prl-": 0.00012, "tnf gene": 0.04355, "bhlh protein": 0.04529, "hormone condition": 0.00444, "pertussis toxin block fmlp-induced activation": 0.01266, "cd3-stimulated": 0.00025, "ahr mrna": 0.01526, "gene encode tissue-specific component": 0.02177, "inhibits tnf gene expression": 0.02177, "nf-at induction": 0.01607, "primary human lymphocyte activation": 0.01881, "pma induce il-2r alpha": 0.0127, "anti-human lt serum": 0.00252, "sis-inducible element": 0.01672, "neuron-specific mediator": 0.00195, "cytolytic effector molecule granzyme": 0.00426, "unoccupied": 0.00019, "epithelial fusion partner": 0.00217, "open-reading frame": 0.0004, "c-fps/fes": 0.00012, "nuclear factor-il6": 0.01684, "stp-c488 induced nf-kappab activation": 0.01582, "vitro response": 0.01942, "actinomycin-d reveal": 0.01098, "diverse tcr repertoire": 0.00318, "great extent": 0.00205, "tp1 promoter": 0.02336, "endogenous ig heavy chain enhancer": 0.00364, "result show high gata-1 binding activity": 0.00975, "sp1 site contribute": 0.01445, "apoptotic cell": 0.0768, "immature hematopoietic cell": 0.0512, "transient cotransfection experiment": 0.00265, "lymphocyte responsive": 0.01483, "active stage": 0.00592, "regulatory domain": 0.01207, "immune inflammatory state associate": 0.00546, "observation implicate c-rel": 0.00234, "maximal suppression": 0.00416, "unfused fibroblast": 0.00338, "e1a- adenovirus": 0.00189, "mo t-lymphoid htlv-ii infected cell": 0.03072, "heterologous competition curve": 0.00085, "inflammatory signal": 0.01635, "transfection": 0.00552, "il-12 mediate": 0.01231, "tight regulatory control": 0.00868, "cell-specific steroid-regulated gene": 0.02903, "moment": 0.0, "cellular protein synthesis": 0.03019, "form complexed": 0.01055, "megakaryocytic differentiation": 0.01179, "phytohemagglutinin stimulate lymphocyte": 0.00988, "protein/protein interaction": 0.00986, "th2 type response play": 0.00971, "lipopolysaccharide-induced interleukin-1 beta protein production": 0.01811, "regulatory p85 subunit": 0.00455, "nuclear hormone receptor retinoid": 0.01286, "rapamycin-mediated inhibition": 0.01061, "mitogen-activated protein kinase erk2": 0.02264, "t-lymphocytes": 0.00292, "cr1": 0.00043, "secondary tcr stimulation": 0.00746, "cell receptor/cd3 complex": 0.0512, "decrease nf-at accumulation": 0.00647, "recurrent abnormality": 0.00239, "hl-60/vinc/r": 0.0005, "include ikappabalpha": 0.01439, "vitro study": 0.01355, "alpha cd3": 0.01169, "aml-1 protein": 0.04529, "calcineurin-dependent process": 0.00444, "tfiiib90": 0.00012, "high degree": 0.00931, "immune suppression": 0.00599, "gc2-": 6e-05, "il-12 induces stat4": 0.00536, "bind site selection reveal": 0.01084, "anti-ikappabalpha antibody": 0.00893, "tyrosine kinase csk": 0.00792, "genetic evidence": 0.00422, "essential element": 0.01672, "convenient": 0.00019, "low relative binding affinity": 0.00927, "gd": 0.00031, "approximate map region": 0.00978, "human il-5": 0.03762, "bsap fail": 0.00347, ".01-.02": 0.0, "receptor dimerization process and/or": 0.01286, "tubulointerstitial disease": 0.00673, "aids-gr patient show high il-2": 0.0104, "mediate t-cell signal transduction": 0.00817, "relb+ apc": 0.00093, "antisense orientation": 0.00161, "rel": 0.00223, "cre-binding protein": 0.04529, "cd34+thy-1+ single cell": 0.0512, "piec line": 0.01653, "ill define": 0.00323, "hemin induction act": 0.01071, "ngfi-a/egr-1": 0.00012, "m.c.re": 0.00012, "active factor": 0.0286, "oct-2a effector region": 0.00978, "leucine-rich repeat": 0.00378, "oct-2 mrna level": 0.01214, "native peptide ligand": 0.00502, "hpa axis function": 0.00887, "homotypic aggregation": 0.00096, "nf-kappa b-independent activity": 0.0195, "pooled human serum": 0.02508, "concentration range": 0.0067, "c-jun heterodimerize": 0.00493, "classical genomic effect": 0.0141, "epsilon germline transcription": 0.01873, "effector plasmid express human trx": 0.01505, "rickets-like disease": 0.00673, "human peripheral blood monocyte respond": 0.01505, "granulocyte/macrophage colony-stimulating factor basic promoter": 0.01144, "granulocyte fraction": 0.00254, "dex induces gr mrna": 0.00763, "reporter construct il-1beta/cat": 0.00484, "mitogenic effect": 0.02115, "hematopoietic transcription factor belong": 0.0143, "tcrs": 6e-05, "chimeric cytokine receptor": 0.01714, "heterologous viral transcription-activating domain": 0.00603, "erythroid marker expression": 0.02775, "etv6-evi1 fusion": 0.00326, "nuclear ap-1/oap": 0.01684, "pro-inflammatory function": 0.01331, "preleukemic clonal cell": 0.0512, "htlv-i-positive mt-2 cell": 0.0512, "cognate site": 0.02168, "chemokine": 0.00211, "recent finding suggest": 0.01348, "slow rate": 0.00279, "isoforms encode": 0.00853, "cmv transactivation": 0.00515, "experimental approach": 0.00164, "macrophage chemotactic protein-1": 0.00393, "macrophage-like cell result": 0.0512, "clinical stage i-ii patient": 0.00833, "spleen": 0.00267, "murine baf3 cell": 0.0512, "ferriman-gallwey score": 0.00031, "initial": 0.00378, "long arm": 0.00276, "toxic effect": 0.02115, "cck-8 induced il-2 expression": 0.02081, "bp -30": 0.00267, "pma/ionomycin dependent manner": 0.00258, "-110 bp": 0.00267, "vdr genotype": 0.00233, "e2a-hlf induced t-cell apoptosis": 0.00481, "prior steroid treatment": 0.00676, "homeotic gene": 0.04355, "pma-ionomycin-induced synthesis": 0.00583, "include mmp-9": 0.01439, "ubiquitous cellular transcription factor": 0.0143, "potential cis-elements": 0.00605, "average number": 0.0053, "shape": 0.00025, "kappa b-related sequence": 0.01084, "bp -60": 0.00267, "daily oral replacement dose": 0.00079, "high-level zeta": 0.00084, "patient express transcript": 0.0123, "recombinant ssb": 0.00391, "il-2 receptor activation": 0.02109, "human interleukin-3": 0.03762, "common multi-point scatchard analysis": 0.00589, "receptor-mediated effect": 0.02115, "heat-inactivated hiv-1": 0.00878, "augment lymphocyte activation": 0.02109, "truncated ltrs confirm": 0.00223, "repeated cycle": 0.00307, "ifn gene": 0.04355, "-dependent murine pro-b cell": 0.0384, "unexplained": 0.00031, "soft agar": 0.00016, "ptpase inhibitor": 0.009, "transduce human hematopoietic cell line": 0.03072, "il-1-": 0.00012, "cortivazol lead": 0.00996, "myelomonocytic": 0.00192, "early pregnancy show": 0.01733, "c-type animal lectin superfamily": 0.00059, "r272a mutation show": 0.01733, "biochemical response": 0.01942, "5-20": 0.00012, "erythroblastic progeny": 0.0005, "105-kda protein": 0.04529, "-392": 6e-05, "nfatp affect": 0.00797, "cell specificity repertoire": 0.0512, "small adherent colony": 0.00209, "alternative pathway": 0.01278, "element include bind site": 0.01084, "weak inhibition": 0.01061, "pronounced": 0.00056, "fatal adenoviral infection": 0.00414, "latent hiv-1 harbor": 0.00585, "caccc box": 0.00304, "nuclear appearance": 0.01684, "trigger stat phosphorylation": 0.00656, "initial experiment": 0.00397, "active factor mediate": 0.01907, "interferon-y": 0.00012, "radiation exposure": 0.0035, "suppressed activity": 0.02925, "ankyrin motif": 0.00875, "oleic acid inhibits endothelial activation": 0.01266, "ap3": 6e-05, "human peripheral blood burst-forming unit-erythroid": 0.01505, "cbf beta-myh11 positive": 0.00312, "ocim1": 0.00043, "transcription factor nf-chi": 0.01907, "plb-985": 0.00037, "murine myeloid precursor cell line": 0.03072, "12-fold induction": 0.01607, "native ifn-gamma locus": 0.00321, "random replacement": 0.00043, "replicative gene expression": 0.02903, "mineralocorticoid receptor decrease": 0.01714, "il13 receptor share": 0.01714, "active nf-kappab dna-binding complex": 0.00842, "marked inhibition": 0.01061, "1a9-m": 0.00043, "fc gamma ri": 0.00294, "rfx family": 0.00841, "vivo testing": 0.0053, "lymphoblastoid cell outgrowth": 0.0512, "single 68-amino-acid domain": 0.00804, "c-rel gene": 0.04355, "cyclic nucleotide-dependent protein kinase inhibitor ha-1004": 0.0151, "major inducer": 0.00574, "-3beta": 0.00019, "shbg": 0.00012, "augmented expression": 0.04163, "tip": 0.0005, "dehydroepiandrosterone": 0.00043, "k562 cell express endogenous wt1": 0.03072, "microm ru": 0.0013, "peptide": 0.01507, "dextran-coated charcoal assay": 0.00668, "fasl": 0.00298, "acute phase protein": 0.03019, "ca2+ channel blocker": 0.00203, "butyric acid-induced erythroid differentiation": 0.00589, "cotransfection study": 0.01355, "d.g": 6e-05, "kappa b-induced nuclear exclusion": 0.00842, "neonatal morbidity": 0.00102, "camp-activated th2 cell": 0.0512, "rest monocyte": 0.01197, "-gamma delta chain bind": 0.01013, "yy1-mediated inhibition": 0.01061, "ic inhibits calcineurin-mediated expression": 0.02081, "bzlf-1-dependent mechanism": 0.01058, "c3a stimulation": 0.0112, "medullary region": 0.01467, "dcoh": 0.00019, "oct-1 pou domain": 0.00804, "human 15-lipoxygenase gene promoter": 0.02177, "anti-lps ab": 0.00167, "ciita b-cell-specific promoter suppression": 0.01168, "level induce": 0.0254, "zebra": 0.00261, "proband ii-2": 0.00012, "proliferative potential": 0.00605, "nf-kappa b-dependent gene": 0.02903, "common cytokine receptor gamma chain": 0.01029, "integrins mediate cell-cell": 0.00821, "human phagocyte": 0.03762, "dza": 0.0005, "hbb": 0.00037, "rap1 base": 0.0031, "target sequence": 0.01625, "positive clone isolate": 0.00492, "normal comparison group": 0.00806, "depressed group suggest": 0.01348, "cytokine-inducible sh2-containing protein": 0.03019, "potent immunosuppressive activity": 0.0195, "vigorous tyrosine phosphorylation": 0.00656, "hematopoetic cell line": 0.0512, "il-7 signaling": 0.00558, "conservation therapy": 0.00372, "enhanced gr expression": 0.02775, "xenopus embryo": 0.00034, "anergy": 0.00136, "co-stimulatory molecule b7.1": 0.00569, "cyclin-dependent kinase": 0.01188, "b95-8 cytosol inhibit specific binding": 0.00762, "tcr-mediated stimulation": 0.0112, "splenocyte proliferation": 0.00803, "ap-1 driven reporter construct": 0.00363, "quiescent non-proliferative state": 0.00178, "megakaryopoiesis/thrombopoiesis": 6e-05, "kruskal-wallis": 6e-05, "implicate cyclophilin": 0.0035, "plasma sialyltransferase activity": 0.0195, "ra resistance": 0.00596, "human peripheral blood mononuclear precursor": 0.01505, "nfkb": 0.00037, "il-2ralpha expression": 0.04163, "t3 nuclear receptor site": 0.01286, "ul75": 6e-05, "activated human polymorphonuclear leukocyte": 0.01881, "induce proliferation": 0.0254, "include chemotherapy drug": 0.00959, "mmp-9": 0.0005, "ap-1-dependent luciferase expression": 0.02775, "oxidant scavenger": 0.00105, "ar allele": 0.0022, "il-4 relies": 0.00667, "part result": 0.0161, "plasma cortisol level": 0.01214, "mhc class ii gene expression": 0.01742, "potential treatment": 0.01014, "t-cell-receptor-mediated t-cell activation": 0.02109, "wild-type kinetics": 0.00378, "human cbfa2 locus": 0.02508, "ifngamma promote": 0.00465, "il-8 promoter": 0.02336, "pb": 0.00087, "pivotal": 0.00062, "il-7 induced substantial amount": 0.0027, "bipartite system": 0.00667, "simian ebv share considerable genetic": 0.00226, "epithelial cell-initiated inflammation play": 0.00355, "intravascular coagulation activation": 0.02109, "tcccctcccct motif": 0.00875, "deletion upstream": 0.00369, "chemically-exposed group": 0.00487, "tnf receptor": 0.02571, "ebna-2-positive cell": 0.0768, "-induced supernatant": 0.00186, "ccaat site": 0.02168, "unlabeled trep result": 0.01073, "transgenic bone marrow cell": 0.0384, "anti-silencer": 0.0, "c-fos serum response element": 0.00971, "cmv infection": 0.0062, "widespread extinction": 0.00043, "human rxr alpha": 0.02508, "gene exist": 0.04355, "mouse primary": 0.00974, "p50/nf-kappa": 0.00031, "transactivating reporter drive": 0.00368, "augment il-2 mrna production": 0.00763, "adrenal cortisol suppression": 0.00277, "30-fold increase": 0.02196, "pd-98059": 6e-05, "cellular analysis": 0.01179, "human bronchial epithelial cell": 0.0384, "m-csf increase c-fos mrna level": 0.00878, "apparent change": 0.0063, "reduction": 0.00589, "ibd group": 0.00487, "-dq beta transcription": 0.01873, "serum lipoprotein": 0.00378, "process dependent": 0.00444, "activate protein kinase": 0.03019, "kb fragment": 0.00347, "thp-1 human monocytoid cell": 0.0384, "gene activation": 0.04355, "lipid-soluble": 0.00012, "kappa locus": 0.00748, "dp-1": 0.00025, "trapoxin affinity matrix": 0.00261, "oct1": 0.00068, "submaximal physical exercise": 0.00064, "increased plasma aldosterone level": 0.0091, "related antiapoptotic molecule": 0.00569, "lysis": 0.00273, "geist": 0.00012, "dl312 virus defective": 0.00591, "aml-m7": 6e-05, "gel shift analysis": 0.00786, "nf-kappa b/rel family member regulate": 0.00566, "gc-r bmax": 0.00043, "dominant negative mutant mek1s218/222a": 0.00405, "e2-f1": 6e-05, "element link": 0.01672, "affect nf-kappab dna binding activity": 0.0117, "15-amino acid transactivation sequence": 0.00813, "remote enhancer position require": 0.00658, "il1-induced activity": 0.02925, "unique protein": 0.04529, "kh1060": 0.00031, "calcineurin-regulated inhibitory domain": 0.00804, "cell induce": 0.0768, "cell exhibit": 0.0768, "small 95-bp fragment": 0.00232, "human neonate": 0.03762, "host mechanism regulate": 0.00835, "ets-related gene constitute": 0.02903, "myeloid-specific expression": 0.04163, "hxbp-1": 0.00025, "enhance cytoplasmic inhibitory ikbalpha protein degradation correlate": 0.01294, "disease marker provide": 0.00449, "transplanted preleukemia": 0.00031, "urs": 6e-05, "granulocytic differentiation induce": 0.01694, "region reveal": 0.01467, "amino acid 29cp-as": 0.00571, "bind ga-binding protein alpha": 0.02264, "human full-length il-1beta promoter": 0.01881, "stable binding": 0.01855, "granulocyte-colony stimulating factor": 0.01907, "aml1 expression level": 0.02775, "cytotoxic protein secrete": 0.03019, "estrogen responsive element": 0.01115, "inhibitory effect exert": 0.0141, "part require": 0.01315, "specific cell target result": 0.0384, "procedure": 0.00155, "c5a receptor": 0.02571, "fold increase": 0.02196, "stat3gamma": 6e-05, "disease virus": 0.00887, "htlv-i encodes": 0.00276, "dose-dependent stimulation": 0.0112, "dl-nf": 6e-05, "viral binding": 0.01855, "fibroblast growth factor-1": 0.00546, "long prevents bind": 0.0135, "signal transduction system": 0.0109, "glycoprotein": 0.00304, "reticulocyte lysate": 0.00056, "eicosanoids": 0.00037, "moreau-gachelin": 0.00012, "platelet gpiib gene": 0.02903, "proliferative status": 0.00217, "potential therapy": 0.00605, "jund": 0.00087, "signal event induce": 0.01694, "ebf represent": 0.004, "mouse lymphocyte": 0.01483, "rbd": 0.00031, "sertraline responder": 0.00037, "interleukin-6-induced apoptosis": 0.0089, "high risk woman": 0.0062, "spi-1": 0.00155, "human gene therapy protocol": 0.02177, "whole-cell method": 0.00236, "direct information": 0.0054, "enhanced intestinal calcium absorption": 0.00143, "active pkc-alpha": 0.00592, "inhibit t-cell activation": 0.02109, "combinatorial differentiation switch": 0.00786, "murine embryonic stem": 0.00416, "sequence analysis reveals putative sp1": 0.0065, "junb protein": 0.04529, "anti-cd3-stimulated cell": 0.0768, "p72": 6e-05, "pma-a23187": 6e-05, "jak1-binding proline-rich box1 region": 0.00734, "cell-specific influence": 0.00471, "murine erythroleukemia cell": 0.0512, "amino acid 26-137": 0.00571, "glutathione s-transferase-tax1 fusion protein": 0.02264, "model ag": 0.00422, "emsa displacement study": 0.00904, "recent data implicate gata-1 function": 0.00532, "include p53": 0.01439, "+89 nucleotide": 0.00202, "female somatic cell": 0.0512, "execution": 6e-05, "good tolerance": 0.00102, "otafii110": 6e-05, "intracellular pathway": 0.01278, "tissue-specific down-regulation": 0.00217, "paracrine fashion": 0.00161, "lt promoter": 0.02336, "decrease enhancer-mediated activation": 0.02109, "stat1 phosphorylation": 0.00983, "immature": 0.00323, "icam-1 kappa b-reporter construct": 0.00374, "scl protein display cell-specific heterogeneity": 0.01811, "tnfalpha release": 0.00484, "peripheral blood mononuclear cell compartment": 0.03072, "minor effect": 0.02115, "suggest phosphorylation require antecedent activation": 0.01266, "ala mrna": 0.01526, "non-sequence-specific c-terminal hmg box": 0.00152, "human immunodeficiency virus-associated hodgkin": 0.01881, "increase gm-csf production associate": 0.01098, "thesis result": 0.0161, "ciita prior": 0.00295, "killing": 0.0005, "study population include": 0.00959, "promote cell-cell": 0.00465, "kcl result": 0.0161, "basal enhancement": 0.0035, "catalytic activation": 0.03164, "nf-kappab suppression": 0.00999, "tumor specific antigen": 0.00825, "log10mbc increase": 0.02196, "cell regulation": 0.0768, "2-fold increase": 0.02196, "hypopigmented skin sample": 0.00139, "patient reveal": 0.01666, "ongoing protein synthesis": 0.03019, "individual granulocyte colony": 0.00273, "atf/creb family member": 0.0056, "gene expression pattern": 0.02903, "danazol therapy": 0.00372, "32.2-kda protein": 0.04529, "cytoplasmic effector protein": 0.03019, "-12": 0.00031, "c3/5 cell develop specific proliferation": 0.03072, "140-kda protein": 0.04529, "ig synthesis": 0.00583, "characterize erythroid maturation": 0.00414, "potent dominant-negative suppressor": 0.00238, "tnf 5'-region show": 0.01733, "protein kinase a-related camp response element": 0.0151, "oligomer": 0.00043, "dependent reporter gene construct": 0.02177, "ngal level vary": 0.01214, "dna-mobility shift": 0.00183, "6-induced": 0.00043, "unrelated antioxidant": 0.00251, "dbp": 6e-05, "tsst-1": 6e-05, "brlf1": 0.00081, "cd3-t-cell receptor complex": 0.01714, "3h-dex": 6e-05, "relevant functional interaction": 0.00658, "inhibit hematopoietic stem cell": 0.0384, "fibronectin induced il-2 message": 0.00558, "fertile woman remarkable change": 0.00315, "early promoter": 0.02336, "t-cell-mediated recognition": 0.00257, "support differentiation": 0.01179, "arachidonic acid": 0.00856, "d.-e.": 0.00012, "activated p21": 0.00589, "internal repression domain": 0.00804, "specific strategy": 0.01238, "vdrs": 0.00012, "vitro experimental study": 0.00904, "high expression": 0.04163, "substspl2": 0.00019, "activate hiv transcription": 0.01873, "dse sit abrogate": 0.0017, "nonhematopoietic cell line": 0.0512, "upregulate interleukin-2": 0.00332, "hs i-iii": 0.00022, "rt": 0.00037, "human monocyte/neutrophil elastase inhibitor": 0.01881, "angiotensin ii activate": 0.01185, "attempt": 0.00025, "stat3 recruitment": 0.00354, "ebv transformation": 0.00565, "endocytosed bsa": 6e-05, "10-100 microg/ml": 0.00012, "ab blocking": 0.00167, "synthetic hormone": 0.00444, "avian cell": 0.0768, "ets-related protein": 0.04529, "e2f-containing dna-binding complex": 0.01123, "freshly isolate human monocyte": 0.01881, "fibroblast context": 0.00338, "uninduced extract": 0.00459, "transcription factor activator protein-1": 0.0143, "successful generation": 0.00242, "autoregulatory mechanism": 0.01058, "ligand-binding experiment": 0.00397, "precise mechanism": 0.01058, "jak2/stat5 pathway": 0.01278, "anlage evaginate": 3e-05, "putative tissue-": 0.00372, "apoplexy": 6e-05, "tur": 0.00012, "simian": 0.00136, "stage-specific expression": 0.04163, "mar associate": 0.01092, "morphologic differentiation": 0.01179, "activator protein-1-responsive gene activation": 0.02177, "heterodimer consisting": 0.00205, "multiple prolactin-responsive element mediate g1": 0.00669, "biological system": 0.00667, "high affinity binding": 0.01237, "nonlymphoid tumor": 0.00934, "initial enzyme": 0.0031, "induce hemoglobinization": 0.0254, "chromosomal damage": 0.00102, "erythroid colony growth": 0.00546, "tnf mrna induce": 0.01694, "hemin": 0.00081, "cell activate signal": 0.0512, "autologous bone marrow transplantation": 0.00107, "derivative tcp succinate prevents monocytic cell adhesion": 0.02194, "50-kda heterodimer": 0.00205, "gtp-gdp state": 0.00267, "identical reaction": 0.00226, "bcl-2-mediated drug resistance": 0.00225, "self-renewal event": 0.00552, "mnc": 0.00093, "selectively": 0.00583, "raw": 0.00056, "pituitary": 0.0013, "mycobacterium tuberculosis cell wall component lipoarabinomannan": 0.0256, "diverse set": 0.00155, "four-subunit ptf": 0.0005, "endothelial": 0.00868, "present study describe parasite-induced change": 0.00542, "adult induce decrease": 0.01694, "-csf receptor alpha subunit": 0.01286, "normal vitamin": 0.0121, "pma/pha stimulate tax transfected cell correlate": 0.0256, "lymphocyte maturation": 0.01483, "chronological sequence": 0.01625, "histochemical stain": 0.00096, "gsk-3beta": 0.00068, "il-18-mediated function": 0.01331, "bending": 6e-05, "rfx-deficient": 6e-05, "icam-i": 0.00056, "pluripotent activator": 0.00552, "wild type cell line": 0.0384, ":33705": 6e-05, "cytokine cell cycle analysis": 0.0384, "p65 constitute": 0.00388, "promoter expression": 0.04163, "downstream effector": 0.00298, "+44": 6e-05, "close link": 0.00347, "liver injury": 0.00118, "monoallelic expression": 0.04163, "stat1 protein": 0.04529, "t-cell line transfected": 0.01102, "18-fold-lower affinity": 0.00391, "cmv induce": 0.0254, "senescence": 0.00037, "single cell type": 0.0512, "unrecognized function": 0.01331, "dna fragmentation factor-45": 0.00988, "specific proteolytic activity": 0.0195, "tissue macrophage express detectable hiv protein": 0.0151, "nfat complex present": 0.01123, "literature": 0.00031, "favor continuous viral replication": 0.00366, "foliosa": 0.0, "clonal expansion": 0.00167, "remain": 0.01042, "essential role": 0.01328, "e2fs": 6e-05, "ctcf down-regulation": 0.00195, "anti-cd3 mabs": 0.00208, "biological function": 0.01331, "c-myb target gene": 0.02903, "c196": 0.00012, "lmo-dependent transcriptional activation": 0.02109, "tyrosine kinase activity induce late": 0.0117, "cat gene": 0.04355, "low salt concentration": 0.00471, "immunosuppression-inducing capacity": 0.00329, "pkc-dependent linkage": 0.00037, "accurate criterion": 0.00047, "erythropoietin induces tyrosine phosphorylation": 0.00492, "allergen-specific population": 0.00307, "ventilatory strategy": 0.00121, "activin-mediated growth arrest": 0.00546, "mitogen-mediated transcriptional activation": 0.02109, "altered kappa b-binding activity": 0.01462, "steady state mrna level equivalent": 0.00728, "platelet-activating factor induces phospholipid turnover": 0.01144, "human peripheral blood neutrophil": 0.01881, "corticoid resistance": 0.00326, "ino synthase": 0.00081, "nuclear factor-90": 0.01684, "nef protein down-regulates transcription factor nf-kappa": 0.0151, "fusion protein present": 0.03019, "dibutyryl camp inhibit cell growth": 0.03072, "signal mediate": 0.01635, "inhibit cytokine mrna accumulation": 0.00952, "environmental lighting": 0.00068, "activation mechanism": 0.03164, "human myeloid cell": 0.0512, "d3-24-hydroxylase activity": 0.02925, "rel-/- splenic": 0.00087, "untreated u937 cell": 0.0512, "endotoxin tolerance": 0.00102, "induce jak2": 0.0254, "human differentiated cell": 0.0512, "q25": 0.0, "fasl versus cytokine gene expression": 0.01742, "transcription factor complex": 0.01907, "platelet integrin alphaiibbeta3": 0.00248, "ri-i": 0.00025, "enhancer element require": 0.01115, "atl-16t nuclear extract": 0.01123, "controversial": 0.00025, "glucocorticoid-resistant primate": 0.00056, "tax corresponds": 0.00478, "zeta-globin promoter": 0.02336, "19-bp site": 0.02168, "pretreatment": 0.00292, "unknown host intracellular event overcomes": 0.00233, "u1 cell stimulate": 0.0512, "ap1 transcriptional regulator": 0.00767, "ebv-b cell clone": 0.0512, "250-fold": 0.0, "human myeloid zinc finger protein": 0.01811, "functional cooperation": 0.00816, "detectable mnda": 0.00276, "include nf-at": 0.01439, "continuous t-leukemia cell line": 0.0384, "anti-inflammatory property": 0.00397, "mr-count": 0.0, "lytic effect": 0.02115, "cd8+ leukocyte": 0.00478, "phenotypic differentiation": 0.01179, "vitro model": 0.00785, "transcription factor ap-2 activates gene expression": 0.01452, "nf-kappab dna binding activity": 0.01462, "relative low bind affinity": 0.01013, "primed ctl": 0.00115, "chimeric g-csf-r/il-7r alpha": 0.0078, "reduced glutathione": 0.00208, "-independent stimulus": 0.0027, "functional tcr delta mrna": 0.00763, "purified nf-kappa": 0.01414, "p14tcl1 form": 0.01055, "tal1 expression": 0.04163, "past year": 0.00059, "secretion correlate": 0.00654, "high ligand bind affinity": 0.01013, "c-rich": 6e-05, "poorly induce": 0.0254, "virus transcription": 0.0281, "al": 0.00037, "rho enhances ap-1 activity": 0.01462, "efficient transcription": 0.0281, "category": 0.0005, "present finding suggest": 0.01348, "granule population": 0.00307, "neoplastic clone": 0.00738, "cultured lymphocyte": 0.01483, "protein range": 0.04529, "cytokine tumor necrosis factor-alpha": 0.00561, "tramtrack": 0.00012, "lymphoid cell-specific nuclear factor": 0.0143, "phosphorothioate oligonucleotides complementary": 0.00122, "integrity determine normal": 0.00806, "retinoid-dependent differentiation marker": 0.00786, "jund lead": 0.00996, "il-4r alpha-associated kinase jak-1": 0.00594, "beta-globin reporter gene": 0.02903, "surface protein": 0.04529, "mab activate hiv-1 gene expression": 0.01742, "direct activate effect": 0.0141, "cytokine dysregulation": 0.01123, "high c-erb b-2": 0.0062, "control nf-at unrelated pathway": 0.00651, "ne": 0.00124, "important protein": 0.04529, "phosphatase play important role": 0.00664, "24.6+/-2.4 versus 17.5+/-1.7 nmol/l": 0.00068, "partial ecori": 0.00143, "affect induction": 0.01607, "5'hs1-5": 0.00012, "grb2-related adaptor protein": 0.03019, "eiconsanoids thromboxane a2": 0.00025, "nfat differ": 0.00431, "specific translocation": 0.01238, "require tradd residue": 0.00877, "selectively express": 0.01846, "impair human immunodeficiency virus replication": 0.01505, "investigation": 0.00081, "stress-induced apoptosis": 0.0089, "immunoblot assay eightfold": 0.00668, "c-rel nf.kappa": 0.00245, "inducible camp early repressor": 0.00414, "dmp prior": 0.00155, "bone": 0.00428, "superfamily": 0.00192, "culture correlate": 0.00654, "increase survival": 0.02196, "coordination": 0.00031, "exogenous peptide": 0.00754, "nk cell line nk92": 0.0384, "virtual abrogation": 0.00025, "similar sequence": 0.01625, "cd3 antigen-derived signal": 0.0109, "eb1089": 0.00012, "lymphoid tissue show": 0.01733, "allergic eosinophilic disease": 0.00449, "mink cell focus-forming murine leukemia virus": 0.0256, "potential nf-kappab binding sequence": 0.00927, "actinomycin d.": 0.00062, "specific granulomonocyte-associated lysosomal protein myeloperoxidase": 0.01811, "pathologic condition": 0.0036, "p13q22": 0.0, "lymphocyte subpopulation": 0.01483, "nk cell lysis": 0.0512, "stress-responsive hsp70 protein": 0.03019, "mcm member": 0.00413, "suppress lps-stimulated tnf production 5-fold": 0.00417, "g0/g1 prolongation": 0.00047, "hepatoma cell": 0.0768, "specific member": 0.01238, "recruit selectively": 0.00292, "lymphocyte homeostasis": 0.01483, "a/r": 0.00087, "unique brca1 change": 0.0042, "activate protein": 0.04529, "cd4 cytoplasmic tail": 0.00267, "cell mitogen": 0.0768, "nf90": 0.00025, "drug resistant marker": 0.00254, "-8": 0.00031, "zinc": 0.00354, "significant homology": 0.00416, "indispensable": 0.00012, "year gail risk": 0.00072, "increase 3.2-fold": 0.02196, "il-2 therapy": 0.01117, "cd40-mediated nf-kappab activation": 0.02109, "hck expression": 0.04163, "variety": 0.00403, "transcriptional activator": 0.01151, "-1 replication": 0.00471, "adrenal cortex": 0.00062, "stringent regulation": 0.01008, "alpha4 integrin": 0.00112, "isoforms regard": 0.00307, "augmented capacity": 0.00329, "oxidative specie": 0.00183, "inflammation initiate": 0.00363, "murine cyclin-dependent kinase inhibitor gene p27kip1": 0.01452, "tnfalpha cooperates": 0.00136, "early human": 0.03762, "il-2r chain": 0.00437, "normal brother": 0.0121, "nf-kappab-dependent transcription": 0.0281, "ascribable": 0.0, "total human dna": 0.02508, "sensitive chronic myelogenous leukemia patient": 0.00666, "uv-induced activation": 0.03164, "rapid disappearance": 0.00323, "ap-1 part": 0.00695, "inhibit activation": 0.03164, "full-length erp express": 0.0123, "hsv-specific cd4": 0.00332, "orientation": 0.00031, "specific mutation": 0.01238, "restriction analysis reveal": 0.00786, "tata-binding protein": 0.04529, "p55tnf-r": 0.0, "environment": 0.00087, "rabbit reticulocyte lysate": 0.00048, "cd27/cd70 interaction augments ige secretion": 0.00395, "heterozygosity": 0.0005, "fab type": 0.00949, "restriction mapping show": 0.01733, "jun-d expression": 0.04163, "fibroblast condition medium": 0.0024, "ribophorin i-evi1 fusion": 0.00217, "combined effect": 0.02115, "describe protocol simplifies": 0.00265, "d20s5": 0.00019, "granulocyte count": 0.00254, "cd28 costimulatory receptor": 0.01714, "apl cell": 0.0768, "specific transcription factor function": 0.0143, "numerous gene": 0.04355, "peripheral blood monocyte": 0.00798, "gata-2 mrna remain": 0.01017, "platelet/endothelial cell adhesion molecule-1": 0.0384, "homodimerization": 0.00037, "-160 site": 0.02168, "follicular phase": 0.00276, "cbp": 0.00105, "classical ar present": 0.0049, "proviral dna": 0.01483, "htafii130": 0.00012, "h2o2": 0.00292, "putative membrane-spanning domain": 0.00804, "low nuclear stat6 activity": 0.01462, "active sle": 0.00592, "distinct action": 0.00698, "negative regulatory circuit": 0.00455, "il-4 regulated": 0.00667, "herbimycin": 0.00087, "primary pbmc": 0.00738, "tat1-72": 6e-05, "bioassay": 6e-05, "lcls": 0.00031, "substantial amount": 0.00285, "-induced proliferation": 0.00803, "maximum binding capacity": 0.01237, "study p65": 0.01355, "camp-phosphodiesterase activity": 0.02925, "cavia porcellus": 6e-05, "fetal allograft": 0.00214, "cd45": 0.00136, "regulate zap-70 function": 0.00887, "tf activity generate": 0.0195, "ebv origin": 0.00565, "increase glucocorticoid responsiveness": 0.01464, "c-jun transcript": 0.00599, "epstein-barr virus oncogene product latent membrane protein": 0.01294, "limit dilution assay": 0.00668, "putative promoter area": 0.01557, "low pkc protein expression": 0.02264, "immunopathogenesis": 6e-05, "specific protein interaction": 0.03019, "lymph node": 0.00078, "rare semen sample": 0.00139, "mineralocorticoid": 0.00261, "d.e": 6e-05, "glucocorticoid receptor regulate leukocyte adhesion": 0.01029, "saf-like transcription factor": 0.01907, "t-cell lysates": 0.00962, "pahs": 0.00012, "inhibit stat6 activity provide": 0.01462, "biallelic expression": 0.04163, "differentiated monocyte-like": 0.0009, "mobility assay": 0.01002, "general inhibitor": 0.009, "stat5-regulated gene": 0.04355, "common downstream signal event": 0.00817, "hstat5": 0.0, "eb motif": 0.00875, "severe malaria": 0.00211, "constitutive promoter": 0.02336, "gel-shift analysis": 0.01179, "gene responsive": 0.04355, "differentiating erythroid progeny": 0.00414, "ebv-positive gastric carcinoma": 0.0012, "pro-b-cell": 0.00037, "c-rel augments": 0.00245, "cloning": 0.00143, "tnfr1 require tradd residue": 0.00658, "direct contribution": 0.0054, "control ifn-gamma expression": 0.02775, "line": 0.03306, "alter mr status": 0.00252, "enhance ig synthesis": 0.00649, "prostaglandin e2": 0.00102, "nf-kappab inhibitory subunit": 0.00666, "patient receive ketoconazole": 0.0111, "endotoxin secrete": 0.00208, "adhesion molecule expression associate": 0.02081, "myeloid cell nuclear differentiation antigen": 0.03072, "heredity": 6e-05, "q28": 6e-05, "unique involvement": 0.00261, "calcium pathway": 0.01278, "proteasome activation correlate": 0.02109, "positive c-jun expression": 0.02775, "il-2 receptor": 0.02571, "fl5.12 line": 0.01653, "cd28 receptor ligation": 0.01714, "micromolar concentration": 0.0067, "leukocyte": 0.00955, "activate nfkappab": 0.01777, "cell dexamethasone bind assay": 0.0384, "pma-induced jnk activation": 0.02109, "dramatic decrease": 0.00971, "c57 mouse": 0.00974, "p38alpha mitogen-activated protein kinase": 0.02264, "surfactant decrease activation": 0.02109, "murine multipotential fdcp-mix a4 cell": 0.03072, "2-": 0.00025, "complete loss": 0.00298, "promoter occupation": 0.02336, "g0/g1 phase": 0.00276, "canonical dna sequence canntg": 0.00813, "intron structure": 0.00319, "atra-responsive true apl": 0.00083, "b-cell specific transcription factor": 0.0143, "bsap belongs": 0.00146, "mll region": 0.01467, "oxovanadium-iv enhance cell death": 0.0384, "bacterial actin-based motility": 0.00149, "longer acting response": 0.01294, "control group consist": 0.00868, "lineage": 0.00732, "co-cultured blood monocyte": 0.00798, "hiv-1 long terminal repeat promoter": 0.00934, "t-cell-specific transcriptional regulator": 0.00767, "cell anergy": 0.0768, "antigen receptor lead": 0.01714, "leukaemic transformation": 0.00288, "doxepin-sensitive h1-histamine receptor": 0.01714, "tcr beta clonotypes": 0.00449, "anti-cd40": 0.00087, "chimeric transcriptional property": 0.00767, "e7 protein": 0.04529, "p45 subunit": 0.00484, "culture condition": 0.0062, "il-2r-associated": 6e-05, "background level": 0.01821, "gata regulatory element": 0.01115, "bik promotes cell death": 0.0384, "gc receptor-binding abnormality": 0.00207, "x-ray activation": 0.03164, "ea/s": 0.00019, "human retinoid-x receptor alpha": 0.01881, "cdna cloning": 0.00456, "signal transduction pathway mediate nf-kappa": 0.00654, "ap-1 complex": 0.01684, "subject group": 0.00487, "il-10 preincubation result": 0.01073, "-responsive enhancer element": 0.01115, "multiple serine-specific protein kinase": 0.02264, "tissue distribution": 0.00664, "regulate leukocyte gene expression": 0.02177, "hdlm-1 cell": 0.0768, "anti-egr-1 antiserum": 0.00074, "prevention": 0.00068, "mutagenesis study": 0.01355, "modulatory effect": 0.02115, "recoverable": 0.0, "copy": 0.00155, "il-2 receptor beta-chain": 0.01714, "fdc cluster": 0.00121, "endothelial leukocyte adhesion molecule-1": 0.0029, "superoxide anion": 0.00053, "tnfalpha stimulation": 0.0112, "sn-50": 6e-05, "4.5-kilobase pair mrna": 0.01017, "efficient propagation": 0.00189, "mature lymphoid t-cell proliferation": 0.00481, "tartrate-resistant acid phosphatase-positive osteoclast-like": 0.00428, "palindromic octamer sequence": 0.01084, "5-based vector": 0.00319, "submandibular gland": 0.00087, "hb9 gene": 0.04355, "abolishes constitutive": 0.00478, "profound influence": 0.00471, "preferential coupling": 0.00037, "situ hybridization histochemistry technique": 0.00078, "cd28": 0.00645, "ikaros protein correlate": 0.03019, "cyclin-dependent kinase inhibitor p27kip1 play": 0.00475, "non-mammalian cytokine gene": 0.02903, "erythroid-specific gene expression": 0.02903, "stem cell factor-dependent erythroid progenitor": 0.03072, "cyclosporine resistant": 0.00211, "ea-r": 0.00012, "suppress mn-sod expression": 0.02775, "pha activation": 0.03164, "ubiquitous factor": 0.0286, "clonal assay show": 0.01733, "2.5-fold": 0.00025, "rest g0/g1 configuration": 0.00178, "enter": 0.0013, "chronic myeloid leukaemia": 0.00308, "hiv-infected adult": 0.00422, "alkylation": 6e-05, "rasn17": 6e-05, "cdr2-loop": 0.00012, "nf-kappab regulation": 0.01008, "vla-4/vcam-1 pathway result": 0.01073, "gr density": 0.004, "lipopolysaccharide-induced expression": 0.04163, "situ lysing gel reveal": 0.00549, "sig+ b-acute lymphoblastic leukemia": 0.0025, "immediate-early transcript": 0.00599, "sibling": 0.00037, "reduced activation": 0.03164, "hiv-1 gene expression": 0.02903, "early lesion": 0.00828, "anti-atherosclerotic agent": 0.00422, "ig receptor": 0.02571, "hypertension": 0.00118, "fibrinogen": 0.00087, "cd2 antibody": 0.00893, "recognition nfat composite element": 0.00836, "transfected clone": 0.00738, "cdna encode octamer-binding protein": 0.02264, "interruption": 6e-05, "suggest cooperative action": 0.01348, "nk activity": 0.02925, "yeast cell wall derivative": 0.0384, "rapamycin-regulated signal": 0.01635, "beta-glucan": 6e-05, "experiment exhibit": 0.00664, "display impaired humoral immunity": 0.0025, "direct high-level expression": 0.02775, "bcl-2-transduced cell": 0.0768, "considerable proportion": 0.00096, "erythroid delta-aminolevulinate synthase": 0.00414, "prl-inducible beta-casein expression": 0.02775, "first-": 6e-05, "egr-1-overexpressing transfectants": 0.00099, "con": 0.00025, "analyze nuclear nf-kappa": 0.01123, "early-induced burst": 0.00053, "-105": 0.00012, "lps trace": 0.0035, "non-abortive maternal infection": 0.00414, "healthy individual": 0.00409, "e2f sit fail": 0.00232, "cell line af10": 0.0512, "transplanted cell": 0.0768, "grb2-associated tyrosine-phosphorylated protein": 0.03019, "nf-kappab control highlight": 0.00868, "short-term": 0.00062, "okadaic acid augments pma-": 0.00428, "down-regulate": 0.00093, "tcr alpha beta lineage": 0.00585, "stromal-derived cytokine interleukin-7": 0.00749, "provide insight": 0.00645, "corticosteroid receptor": 0.02571, "rat pancreas": 0.00285, "cmv transactivator": 0.00161, "glucocorticosteroid action": 0.00499, "mar-bp1/enhancer interaction": 0.00986, "expansion": 0.00199, "ebna-lp": 0.00019, "protein footprint": 0.04529, "cdna microarray technology": 0.00304, "demonstrate graft infiltration": 0.01065, "vitro transcription study demonstrate": 0.01405, "screen cdna library": 0.00304, "synthetic nf-kappab-dependent promoter": 0.01557, "immune response direct": 0.01294, "cd40 express": 0.01846, "increase stat1 binding activity": 0.01462, "11alpha,13-dihydrohelenalin": 0.00019, "dp alpha element": 0.01115, "729-766": 6e-05, "nf-at-binding": 0.00062, "deregulation": 0.00037, "tandem ap-1 consensus sequence": 0.00813, "lymphocyte transcriptional activator sox-4": 0.00741, "primary leukemic cell": 0.0512, "decreased binding affinity": 0.01237, "e2a-hepatic leukemia factor": 0.01907, "subcellular fractionation": 0.0004, "stimulate immunoglobulin promoter activity": 0.01462, "macrophage-like hl-60 differentiation": 0.00786, "bcc": 0.0, "stat1 alpha activation": 0.02109, "hiv-1 laboratory isolates": 0.00585, "quiescent mantle zone": 0.00077, "t-cell homeostasis": 0.00962, "freshly": 0.00211, "human fkbp cdna": 0.02508, "ebv encode": 0.00853, "packaging": 0.00012, "vivo migration": 0.0053, "epstein-barr virus-transforming protein latent infection membrane protein": 0.00647, "parameter regulate": 0.01253, "reproductive target tissue": 0.0055, "nf kappab-regulated gene": 0.02903, "h2o2 induce lipid peroxidation": 0.0127, "grade": 0.00081, "nonstatic assay": 0.01002, "activate human": 0.03762, "ra receptor activation": 0.02109, "oct2 expression": 0.04163, "hlf consensus bind site": 0.01084, "additional testing": 0.00341, "optimization": 6e-05, "mutant ltr": 0.0081, "proto-oncogenes c-jun": 0.00493, "related inhibitor": 0.009, "ionomycin-evoked ca2+ release": 0.00323, "bacterial motility assay": 0.00668, "msv ltr promoter": 0.01557, "lymphoblast": 0.00087, "demonstrate abnormality": 0.01597, "normal t-cell activation": 0.02109, "strength": 0.00043, "monocyte adherent": 0.01197, "peak csa drug level": 0.0091, "render cytolytic susceptible": 0.00101, "serine/threonine protein phosphorylation": 0.03019, "gene link": 0.04355, "show structural alteration": 0.01733, "differential": 0.00645, "human antigen-specific cd4+ t-cell line": 0.01505, "bacterial ligand require": 0.00877, "independent signal distinct": 0.0109, "g0s2 mrna": 0.01526, "fine mapping": 0.00099, "mab enhancement": 0.00267, "thp-1 cell result": 0.0512, "tsc2 gene": 0.04355, "advanced stage": 0.00248, "optimal tyrosine phosphorylation": 0.00656, "pmn adhesion": 0.0058, "progenitor growth": 0.00819, "overlap expression pattern": 0.02775, "productive human immunodeficiency virus type": 0.01505, "glucocorticosteroid response element": 0.01294, "steroid": 0.00583, "mitogen-activated": 0.00223, "c-terminal sh2 domain": 0.00804, "differential priming": 0.00323, "candidate oncoprotein bcl-3": 0.00077, "nmi augments stat-mediated transcription": 0.01405, "timp-1 upregulation induce expression": 0.02081, "significant defect": 0.00416, "differentiate human": 0.03762, "interaction remain unchanged": 0.00658, "oxidative stress suppresses transcription factor activity": 0.00975, "early b-cell factor": 0.01907, "consensus sequence 5'-gttacgtaat-3": 0.01084, "tpo induce fetal": 0.01694, "m-tat/epo cell": 0.0768, "cis-regulatory dna element": 0.01115, "interleukin-1beta transcription": 0.0281, "6352+/-1697 sites/cell": 0.00043, "differentiation dose-response": 0.01179, "cytokine-induced e-selectin": 0.00136, "cysteine-": 0.00012, "vitro": 0.01569, "ige synthesis": 0.00583, "pbc.m2": 0.00012, "p94": 0.00012, "tumor necrosis factor alpha gene": 0.01742, "autosomal xy sex reversal": 0.00033, "nested primer": 0.00081, "g61": 6e-05, "time test": 0.00487, "bat box sequence": 0.01084, "mhc i+/mhc iibright/cd83+/cd86+/cd14- surface ag expression": 0.01388, "competitive": 0.0018, "ubiquitinylation": 0.00043, "c-cbl": 0.0, "cyclosporin a. calcineurin mutant render": 0.00324, "anionic phosphatidylserine": 0.00022, "sn50-mediated apoptosis": 0.0089, "pd98059 inhibit gm-csf-dependent proliferation": 0.00952, "-260": 0.00012, "mei": 0.00019, "eosinophil differentiation": 0.01179, "egr-1 mrna": 0.01526, "endogenous nf-kappa": 0.01414, "apparent inconsistency": 0.00192, "tosyl-phechloromethylketone": 6e-05, "s6": 0.00081, "hla class i-mediated inactivation": 0.00321, "rapid turnover rate": 0.00215, "mu enhancer activation": 0.02109, "heterozygosity rate approach": 0.00186, "cell-type-specific interleukin-2 receptor alpha-chain gene expression": 0.01452, "dna-receptor complex formation": 0.01123, "ox ldl": 0.00084, "alpha complex": 0.01684, "kappa b-1": 0.00748, "wt1": 0.00112, "virtual absence": 0.0031, "high-level expression": 0.04163, "interleukin-4-responsive element": 0.01672, "rapidity": 6e-05, "adherence parameter": 0.00127, "iexc29s": 0.00025, "hla class ii antigen": 0.00409, "constitutive basal phosphorylation": 0.00656, "apoptotic signal": 0.01635, "relevant concentration": 0.0067, "preactivated pbl": 0.00096, "proinflammatory cytokine pathway": 0.00852, "serum response factor": 0.01907, "spi-b expression": 0.04163, "bzlf1 protein": 0.04529, "pharmacodynamic response": 0.01942, "affinity similar": 0.00673, "up-regulating": 0.00025, "cell important": 0.0768, "colony formation": 0.00484, "gm-csf gene activation": 0.02903, "scmv mie": 0.00019, "sp1 show": 0.02599, "ebv type": 0.00949, "minus clone": 0.00738, "e47 participate": 0.0013, "interleukin-2-receptor alpha-subunit enhancer": 0.00606, "vertebrate": 0.00062, "vitro-translated nf-yb": 0.00016, "recruit factor": 0.0286, "rela subunit": 0.00484, "protein derivative induce": 0.03019, "k562": 0.0036, "ec-mn": 0.00025, "ltalpha": 0.00012, "ikappab-alpha impairs": 0.00112, "glutathione precursor": 0.00323, "nfatp result": 0.0161, "impairs oct-1": 0.00146, "e1a-positive sarcoma cell": 0.0512, "permissive": 0.00087, "specific program": 0.01238, "oppose signal relief": 0.0109, "tumeric": 0.00012, "cycloheximide-sensitive manner": 0.00282, "pi3k inhibits phosphorylation": 0.00656, "cyclosporin treatment": 0.01014, "7-o-glucuronides": 6e-05, "-213": 0.00012, "sequence-specific hmg box": 0.00203, "-alpha control t-cell activation": 0.01582, "early initiation": 0.00828, "ubiquitous protein oct-1": 0.03019, "robust il-2-induced proliferation": 0.00536, "enforced expression": 0.04163, "induction": 0.03213, "cbl-b undergoes rapid tyrosine phosphorylation": 0.00393, "competition assay reveal": 0.00732, "ebv induces il-12 expression": 0.02081, "hiv-1 mrna": 0.01526, "natural agonist": 0.00233, "tfiihwt": 0.00019, "protein factor present": 0.03019, "purified human nf-kappa": 0.02508, "5-8 day": 0.00146, "v-jun": 0.0, "hetero-oligomeric mr form": 0.00703, "human serum": 0.03762, "cell sensitization": 0.0768, "enhancer element function": 0.01115, "clonal deletion": 0.00344, "ppargamma activation induce": 0.02109, "ebv episomal vector pmep4": 0.00282, "aml1 protein play": 0.03019, "enhance type": 0.00974, "death domain": 0.01207, "activate platelet induce monocyte chemotactic protein-1 secretion": 0.00726, "pge2 vary": 0.00136, "lymphoid enhancer factor": 0.01907, "varicella-zoster virus peptide": 0.00591, "15-lo expression": 0.04163, "cd49d/cd29": 6e-05, "normal human neutrophil": 0.02508, "prolong survival": 0.00236, "adult tissue demonstrate hb9 transcript": 0.00639, "similar form": 0.01055, "pbls reveal": 0.01098, "nf-at-binding site directs transcription": 0.01405, "purified bovine gangliosides": 0.00174, "2-amino-3'-methoxyphenyl": 6e-05, "activate dna bind similar": 0.01013, "host defense mechanism": 0.00705, "oxidative signal": 0.01635, "substnfkappab": 0.00019, "mitochondrial transmembrane potential": 0.00403, "membrane-proximal proline-rich sequence motif": 0.00813, "individual nsaid family member": 0.0042, "generate cell clone express": 0.0384, "october sequence": 0.01625, "human csf-1": 0.03762, "require": 0.0263, "nondetectable": 0.0, "litaf play": 0.0071, "comparable sensitivity": 0.00236, "il-6 transcription rate": 0.01873, "minimal promoter region": 0.01557, "site contribute": 0.02168, "transcriptional enhancer": 0.01151, "application": 0.00056, "anatomy": 6e-05, "sk": 0.00019, "kda variant": 0.00276, "autologous cd4+": 0.00288, "human toll signal pathway": 0.01881, "mediate nf-kappab": 0.01231, "g-csf-r/il-7r alpha": 0.01169, "additional small region show homology": 0.0104, "inhibition experiment": 0.01061, "oestradiol": 6e-05, "ebv-transformed cell": 0.0768, "immature thymocytes": 0.00257, "ra target gene": 0.02903, "adrenocorticotropic hormone test remain normal": 0.00484, "isolated ets-1 protein": 0.03019, "pregnancy-induced hypertension": 0.00059, "on-off switch": 0.00245, "ra": 0.01191, "important primary mechanism": 0.00705, "concentration-dependent inhibition": 0.01061, "3-fold low": 0.00707, "ubiquitous otf-1": 0.00118, "64,000-m": 0.0, "immune deficiency syndrome": 0.00399, "phenotypic dc characteristic": 0.00219, "myelomonoblastic plb-985 cell": 0.0512, "direct action": 0.0054, "b-cll patient": 0.01666, "il-2 -and ifngamma-mediated signaling": 0.00558, "sulphamethoxazole": 0.00019, "human granulocyte-macrophage csf": 0.02508, "delayed-type hypersensitivity": 0.00037, "nuclear run-on experiment demonstrate decreased transcription": 0.00937, "caspase": 0.00136, "gm-csf receptor alpha promoter": 0.01286, "viable": 0.00093, "heterokaryons fail": 0.00347, "human sp1": 0.03762, "wild-type shp1": 0.00378, "somatic dna": 0.01483, "il-12-mediated activation": 0.03164, "nfat4/x": 0.0, "domain bind megakaryocyte-specific nuclear protein act": 0.0151, "il-2r stimulation": 0.0112, "statg": 0.00025, "ubiquitous ap-1 factor": 0.01907, "tnf-alpha-induced hiv activation": 0.02109, "lack bcl-6 function due": 0.00665, "viral fusion/entry process": 0.00488, "ap-1 complex induce": 0.01694, "increase nuclear triiodothyronine receptor": 0.01286, "isoleucine-mutated tes2": 0.00025, "proximal il-4 promoter": 0.01557, "p45 nf-e2 expression": 0.02775, "activate stat3": 0.01777, "receptor antagonist": 0.02571, "thp-1 cell initiate": 0.0512, "htlv-1 transactivator protein": 0.03019, "il-6 luciferase activity occur": 0.01462, "free drug": 0.00338, "nf-kappa b-binding motif": 0.00943, "forty animal": 0.00118, "universal ra effector molecule": 0.00426, "basosophilic lineage": 0.00366, "primary response gene": 0.02903, "adherence": 0.00236, "constitutive binding protein": 0.03019, "immature morphology": 0.00161, "antioxidant vary": 0.00251, "surface receptor associate": 0.01714, "gata site implies": 0.01445, "o-aminophenoxy": 0.00012, "skw6.4 cell": 0.0768, "interferon alpha regulate nuclear protein express": 0.0151, "transcriptional regulatory domain": 0.00804, "mc1627": 0.00012, "transcription factor nfat": 0.01907, "al1": 0.00025, "dna-binding protein gata-1": 0.03019, "dna bind protein nuclear factor": 0.01811, "msr promoter-reporter gene construct demonstrate decreased activity": 0.01244, "longer life span": 0.00101, "coexpressed": 0.00074, "functional dc characteristic include fluid phase macromolecule uptake": 0.0036, "cell immortalization": 0.0768, "hpv-16": 0.0, "pancreatic endocrine-lineage possess": 0.00091, "central part": 0.00152, "specific nucleosome": 0.01238, "pu.1 bind site": 0.01445, "qr": 0.00037, "differentiation arrest": 0.01179, "plzf-rar alpha expression block terminal differentiation": 0.01388, "typical speckled pattern": 0.00366, "pharmaceutical agent": 0.00422, "maximum inhibition": 0.01061, "important common event": 0.00459, "gene transcription": 0.04355, "oxidant-initiated": 0.00012, "nuclear nf-atp": 0.01684, "htlv-ii-bearing cell line": 0.0512, "jy25": 0.00019, "htlv-1-transformed": 0.00031, "48-hr media-stimulated t-cells": 0.00141, "cell enhancer site": 0.0512, "sertraline response": 0.01942, "tad-b": 0.00031, "breast cancer show": 0.01733, "lymphoid differentiation": 0.01179, "92-kd stat5b": 0.00059, "cell-receptor-induced fasl upregulation": 0.00128, "latency iii": 0.0014, "hsv-specific": 0.0005, "nuclear rna": 0.01684, "p65-mediated transcriptional activation": 0.02109, "shift": 0.00366, "lectin": 0.00143, "release nf kappa b. cu2+": 0.00299, "protein-coding sequence": 0.01625, "locus encode": 0.00853, "divergence": 0.00062, "gammac gene": 0.04355, "universal": 0.00012, "differentiation capacity": 0.01179, "functional": 0.01632, "lmp1": 0.0054, "kappa light chain enhancer": 0.00454, "anti-fas antibody": 0.00893, "structural order": 0.0018, "nuclear transcription factor kappa": 0.0143, "regulate induction": 0.01607, "il-10 effect": 0.02115, "brlf1 product rta function": 0.00665, "peptide represent": 0.00754, "recruit irak": 0.00099, "oct2": 0.00161, "human islet": 0.03762, "maturation occur": 0.00654, "monolayers": 0.00081, "il-4 stat": 0.00667, "anti-e. chaffeensis immunoglobulin": 0.00184, "cellular mechanism": 0.01058, "putative nf-kappab binding site": 0.01084, "il-2r-alpha expression": 0.04163, "aml-m5": 0.0, "gata-1 modulates": 0.00413, "nuclear induction": 0.01684, "monocytic cell lineage": 0.0512, "dimerization cofactor": 0.00078, "nm23": 0.00087, "pbsc": 0.00043, "ras express tumor": 0.0123, "constitutive dimerization": 0.00478, "adhesion molecule test": 0.00569, "tissue-damaging granulocyte undergo apoptosis": 0.00445, "moderate correlation": 0.00248, "hour time culture": 0.00414, "unlabeled ligand": 0.00592, "general": 0.0031, "strong suppression": 0.00416, "p52/nf-kappab": 6e-05, "mast cell line": 0.0512, "vivo modification": 0.0053, "jak3 activation occur": 0.02109, "antisense": 0.00323, "120,000-140,000 mw antigen": 0.00546, "monitor oct-2 expression": 0.02775, "vacuolar h+-atpase b2 subunit": 0.00242, "lps induces ikk activity": 0.01462, "traf association": 0.00282, "adhesion process": 0.0058, "approx": 0.00025, "intracellular roi": 0.00583, "isolate tfiih": 0.00416, "control general octamer site-dependent transcription": 0.01124, "similar dna motif": 0.00988, "e2a gene": 0.04355, "suppressor-inducer": 0.00012, "iv isoforms": 0.00307, "thymic cortex": 0.00118, "progesterone induces decidual transformation": 0.00402, "human collagenase-1 promoter": 0.02508, "mad3": 0.00043, "intracellular store": 0.00583, "cell complementary dna": 0.0512, "cytokine-induced signal transduction pathway": 0.00817, "effective humoral immune response": 0.00971, "short osteocalcin promoter": 0.01557, "akv": 0.00043, "e2f-1 expression": 0.04163, "lymphotoxin-beta receptor stimulate hiv-1 replication": 0.01029, "fas-mediated death": 0.00254, "antioxidant thioctic acid": 0.00571, "unstimulated pbl": 0.00136, "human class ii trans-activator construct lack": 0.01254, "cutaneous": 0.0005, "transcriptional state": 0.01151, "increased transcription": 0.0281, "caspase-3 activation": 0.03164, "lysosomal enzyme acid sphingomyelinase": 0.00428, "ebv-negative individual": 0.00409, "ald induce": 0.0254, "murine macrophage 12-lipoxygenase": 0.00416, "block lps-induced nf-kappa": 0.00943, "thrombin result": 0.0161, "typical binding pattern": 0.01237, "regulates gene": 0.04355, "mo7e cell": 0.0768, "render replication deficient": 0.00314, "cell transcriptional event": 0.0512, "treated cell": 0.0768, "minor salivary gland": 0.00058, "cis-acting regulatory motif": 0.00583, "brca2 gene": 0.04355, "experiment report": 0.0049, "upstream element": 0.01672, "high affinity bind": 0.0135, "pparalpha activator fenofibrate": 0.00368, "electrophoretic mobility shift assay confirm": 0.00401, "native peptide": 0.00754, "activate distinct set": 0.01185, "cytoplasmic/nuclear signaling": 0.00558, "disease susceptibility": 0.00673, "internal functional promoter": 0.01557, "abundant expression": 0.04163, "labeled probe": 0.00261, "human lymphoid cell line": 0.0384, "stat1 binding activity": 0.0195, "ria": 0.00019, "c3a induce nuclear factor kappab activation": 0.01055, "multiple nuclear factor bind": 0.0143, "ccaat/enhancer-binding protein-beta": 0.00016, "400-base pair meta region": 0.00734, "myeloid leukemic cell line": 0.0384, "1.3-kb transcript": 0.00599, "nmi interacts": 0.00136, "u1 promonocytic cell": 0.0512, "anti-ig-mediated zp activation": 0.02109, "normal woman": 0.0121, "human cd4+ lymphocyte": 0.02508, "ifn-alpha/beta rescue": 0.00133, "restricted recognition": 0.00257, "polarization": 6e-05, "adjuvant chemotherapy": 0.00071, "preliminary experiment yield": 0.00265, "endogenous c-myb expression": 0.02775, "gross abnormality": 0.00239, "inhibit lps enhancement": 0.0127, "3-methylcholanthrene-induced rat liver microsome": 0.00143, "c-rel- responsive promoter": 0.01557, "vivo footprinted dna motif": 0.00741, "endothelial cell condition medium induces oxidant stress lead": 0.0192, "lineage-restricted transcription factor": 0.01907, "adult cell": 0.0768, "whole-blood cell culture": 0.0512, "determine change": 0.00779, "anti-ar antibody direct": 0.00596, "adult erythroid cell": 0.0512, "virus latency": 0.00887, "pao result": 0.0161, "cdna encode human sr-bp show": 0.01505, "ldl receptor gene expression": 0.02177, "thymic choice": 0.00118, "rccs": 0.00012, "include tumor necrosis factor-alpha": 0.0072, "important medication": 0.00689, "human im-9 lymphocyte": 0.02508, "expression pattern": 0.04163, "senescent human": 0.03762, "regulate lymphocyte growth": 0.00988, "previous experiment": 0.00397, "primary leukemic": 0.00738, "regulate gpix promoter expression": 0.02081, "cd26": 0.00019, "rip participate": 0.0013, "translational machinery": 0.00065, "atf/creb recognition motif": 0.00583, "include vpreb1": 0.01439, "a.": 0.00161, "cell-specific binding": 0.01855, "independent fusion": 0.00363, "stimulate transcription drive": 0.01873, "nsaid induce hsp70 mrna specie": 0.01016, "important step": 0.00689, "dna bind protein": 0.03019, "p21ras": 0.00304, "native molecular weight": 0.003, "d. t-helper-cell determinant": 0.00079, "il1b promoter": 0.02336, "factor interact": 0.0286, "cap site": 0.02168, "developmental stage-specific gene expression": 0.02177, "thrombopoietin": 0.00062, "post hiv-1 entry": 0.00585, "report property": 0.0049, "small gtp-binding protein": 0.03019, "ro 09-2210": 0.0009, "stimulant": 0.0, "agar culture": 0.0062, "id3 ala5 mutant": 0.0054, "pair box": 0.00304, "regulate homeostasis": 0.01253, "transfected ikappabalpha": 0.00369, "nf-kappab inhibitory molecule ikappabalpha": 0.00499, "chimeric gene": 0.04355, "qr-specific inhibitor": 0.009, "jak tyrosine kinase": 0.00792, "myeloproliferative disorder": 0.00223, "vd": 0.00124, "lps-activated thp-1 cell": 0.0512, "phagocyte recognition": 0.00257, "transcript code": 0.00599, "provide evidence": 0.00645, "rantes expression": 0.04163, "aminotriazole": 0.00012, "degenerate oligonucleotides": 0.00183, "human embryonic kidney": 0.02508, "stp-a11": 0.00012, "subject show": 0.02599, "loop region": 0.01467, "immunosuppressive therapy": 0.00372, "reconstituted sequence": 0.01625, "mitogenic stimulus": 0.0027, "latent membrane protein-1 induces cyclin d2 expression": 0.01189, "pulse exposure": 0.0035, "multifactorial disease": 0.00673, "isolate false-positive dests": 0.00277, "spi-c": 0.00043, "class ii gene transcription": 0.02177, "activated platelet": 0.00589, "attenuated activity": 0.02925, "full-length gag/pol": 0.00124, "normal myeloid progenitor cell": 0.0384, "recombinant xpb protein": 0.03019, "confirmation": 0.0, "uv-irradiation": 0.0, "similar extent": 0.00673, "rela-p100 cytoplasmic complex": 0.01123, "-155": 0.00012, "pan-1": 0.00012, "paper": 0.00074, "spinal cord": 0.00102, "oct-2 mediate": 0.01231, "e6 motif stimulate transcription": 0.01405, "pcl gamma": 0.0044, "gp41-induced il-10 up-regulation": 0.00281, "effective site": 0.02168, "mimic activated p21ras": 0.00393, "box dna-binding protein": 0.03019, "proliferation index": 0.00803, "show elevated circulating level": 0.013, "transient nf-kappab response": 0.01294, "normal control group": 0.00868, "polymorphonuclear leukocyte adhesion": 0.00387, "body induce inflammatory process": 0.0127, "k197s": 0.0, "cd11/cd18 integrins": 0.00034, "sulindac activate": 0.01777, "cancer": 0.00496, "human irf-1 gene link": 0.02177, "calcium flux": 0.00236, "bzlf1 transcript": 0.00599, "potent transactivation domain": 0.00804, "lt-kappa": 0.00019, "participates": 0.00062, "attractive candidate": 0.00059, "coexpressed gene": 0.04355, "insertion": 0.0013, "-3-": 6e-05, "heterodimer p50-p65": 0.00205, "intracellular accumulation": 0.00583, "important autoregulatory inhibitor": 0.006, "late stage": 0.00254, "il-13 promoter activity": 0.0195, "pge2 induces specific bind activity": 0.0117, "uninfected cell": 0.0768, "t-cell maturation": 0.00962, "amino acid difference": 0.00571, "hodgkin": 0.00105, "-responsive nf-kappab/c-ebp composite element": 0.00836, "key nuclear factor": 0.01907, "purine-rich il-2 promoter element": 0.01168, "antiinflammatory agent": 0.00422, "age dependence": 0.00226, "anti-cancer drug": 0.00338, "interferon-gamma inducible": 0.00484, "reduces": 0.00155, "heterologous reporter gene": 0.02903, "inhibit il-2-mediated proliferative growth": 0.00952, "t-lymphocytes nfat-1 activity": 0.0195, "phosphoinositide hydrolysis": 0.00031, "m.c.psallidopoulos": 0.00012, "cell receptor alpha/delta locus": 0.0384, "il-7 reconstitutes multiple aspect": 0.00344, "finding demonstrate": 0.01597, "ttcaaag motif": 0.00875, "dna bind activity": 0.0195, "selective": 0.00533, "dominant-negative mutant": 0.0081, "thyroid state": 0.00267, "nfkappab represent": 0.004, "epstein-barr virus mutant conditional": 0.00444, "e1a-immortalized cell": 0.0768, "potent il-1/tumor necrosis factor-responsive element": 0.00669, "3'-region reveal": 0.01098, "ifna": 0.00025, "immunomodulatory agent": 0.00422, "s-phase": 0.00031, "normal lymphoid development": 0.00806, "synergize": 0.00167, "ru-1881": 0.0, "protein include": 0.04529, "il-5-producing": 0.00037, "nf-kappa b. nf-kappa": 0.00471, "motor neuron disease": 0.00449, "hut78": 6e-05, "catalytic subunit": 0.00484, "signal transduction event trigger": 0.00817, "il-4re": 0.00012, "gggactttcc": 0.00012, "d3 analog mc903": 0.00163, "il-2r beta-chain": 0.00251, "tax mutant show": 0.01733, "dsl family": 0.00841, "erratum": 0.0, "lymphoid/dc precursor": 0.00323, "vcam-1 lead": 0.00996, "-226": 6e-05, "distinct subset": 0.00698, "psa level": 0.01821, "ccaat/enhancer bind protein epsilon": 0.02264, "interferon": 0.00596, "promoter methylation suggest": 0.01557, "follicular": 0.00143, "specific role": 0.01328, "subsequent activation": 0.03164, "nf-kappa b/rel binding site": 0.01084, "ataxia-telangiectasia": 6e-05, "transcriptional regulator nuclear factor-kappab": 0.00842, "block element alpha/delta": 0.01115, "eosinophil remains": 0.00295, "human t-cell clone reactive": 0.01881, "tax play": 0.0071, "m32": 0.00025, "mutant study": 0.01355, "typical th1-dominated chronic inflammation": 0.00199, "daughter pair": 0.00214, "specific feature": 0.01238, "large vessel": 0.00205, "il-5 mrna": 0.01526, "pan-t-lineage marker": 0.00382, "ter": 0.00025, "distinct regulatory pathway": 0.00852, "transcription initiation": 0.0281, "long-lasting tyrosine": 0.0071, "nuclear binding protein": 0.03019, "ifn-alpha therapy": 0.00372, "enhanced affinity": 0.00391, "hiv-1 harboring mutation": 0.00585, "binding": 0.0371, "nonmyeloid cell type": 0.0512, "po-b dna binding": 0.01237, "nfatx3": 6e-05, "il-1 beta promoter/enhancer sequence": 0.00813, "monocytoid differentiation": 0.01179, "5'-end": 0.00012, "pyg box": 0.00304, "oct-2 expression": 0.04163, "body": 0.00273, "camp-regulated transcriptional activity": 0.0195, "eosinophil cationic protein show": 0.02264, "strong positive effect": 0.0141, "observed gene expression pattern": 0.02177, "term early b-cell factor": 0.0143, "parasite survival strategy": 0.00157, "tax activation": 0.03164, "prominent increase": 0.02196, "ach-2": 0.00031, "u-937 cell adhesion": 0.0512, "potent synergist hx630": 0.00238, "monocytic cell": 0.0768, "normal wild type er": 0.00605, "im-9": 0.00081, "include pre-b acute lymphoblastic leukemia": 0.00576, "germ-line epsilon transcript": 0.00399, "ifnalpha": 0.00019, "subtle": 0.00062, "transactivators": 0.00143, "elastase inhibitor": 0.009, "adenovirus e1a inhibit ifn-induced resistance": 0.00762, "affect production": 0.01042, "aged adrenal cortex": 0.00041, "il-10r": 0.00062, "recruit src homology": 0.00122, "intracellular killing": 0.00583, "mature leukocyte": 0.00478, "pregnancy": 0.0018, "immunofluorescence": 0.00118, "transduce jak1-dependent intracellular signal": 0.00817, "prolactin receptor signal transduction": 0.01286, "c-rel homodimer": 0.00245, "half-maximal induction": 0.01607, "cc": 0.00012, "uncultured leukemic cell": 0.0512, "human leukemia cell": 0.0512, "transformation effector site": 0.01445, "reporter construct span portion": 0.00363, "hexameric receptor bind site space": 0.01029, "fos gene expression": 0.02903, "related gene": 0.04355, "peak level": 0.01821, "skin defect": 0.00279, "ea-d promoter": 0.02336, "target degradation": 0.00825, "tpa-treated u-937 cell": 0.0512, "er-beta": 0.0, "candidate compound": 0.0022, "situ hybridization show expression": 0.02081, "inappropriate cell": 0.0768, "nonradioactive oligonucleotides": 0.00183, "conversion": 0.00031, "familial ovarian cancer patient reveal": 0.00666, "precise role": 0.01328, "dmdtc": 0.00056, "oxidation": 0.00056, "macrophage gene regulation": 0.02903, "vdr secondary": 0.00233, "intranuclear targeted delivery": 0.00043, "hla-molecules": 6e-05, "human primary": 0.03762, "ikappab-alpha degradation": 0.00332, "mechanism underlie": 0.01058, "experimental agent": 0.00422, "ligation": 0.0036, "unusual transcription element tar": 0.01405, "b-cell differentiation": 0.01179, "tyrosine phosphatase cd45": 0.00474, "separate signalling complex prior": 0.00842, "proliferation factor": 0.0286, "intron-exon organization": 0.0004, "primary binding site": 0.01445, "neuropeptides": 0.0, "reveal constitutively phosphorylated p65": 0.00549, "il-4 stimulate nuclear factor-kappab nuclear translocation": 0.00367, "detectable activation": 0.03164, "saa": 0.00043, "hemopoietic growth factor": 0.01907, "fosb": 0.00068, "cellular component": 0.00893, "alpha-tocopheryl succinate inhibits monocytic cell adhesion": 0.0256, "1-2 hr": 0.00059, "tetrahydrocortisol": 0.00031, "activated endothelium": 0.00589, "interaction site": 0.02168, "ebna-2 gene": 0.04355, "virus-transformed cell": 0.0768, "isomer 9-cis ra": 0.00397, "protect animal": 0.0014, "discordant xenograft rejection": 0.00031, "main transcriptional co-activator": 0.00767, "lymphoid-specific transcription factor": 0.01907, "activates p93fes": 0.00164, "g-csf-r": 6e-05, "double-stranded": 0.00136, "proteolytic event": 0.00552, "pif": 0.00043, "ra -and vitd3-signaling pathway": 0.00639, "intestine": 0.00025, "epidemiologic feature": 0.00217, "major transcription initiation sit": 0.01405, "dna target sequence": 0.01084, "purified synovial": 0.00261, "japanese population": 0.00307, "ap-1-binding activity": 0.02925, "influence il-1-mediated nf-kappa": 0.00943, "effective treatment": 0.01014, "nuclear staining": 0.01684, "interferon-gamma activated site": 0.01445, "pma/alphacd28": 0.00012, "tumor gene": 0.04355, "property regard phosphorylation": 0.00656, "x-linked marker": 0.00382, "t3+ group": 0.00487, "glutamine synthetase": 0.00037, "subtypes express ebnai": 0.0123, "sublethal level": 0.01821, "promoter demonstrate": 0.02336, "simian immunodeficiency virus": 0.00591, "extensive clinical application": 0.00283, "differentiation/maturation process": 0.00444, "consequence": 0.0023, "dna response element": 0.01294, "immune glomerulopathy": 0.00599, "polymorphism represent": 0.004, "inactive calcineurin": 0.00316, "nf-kappa b.i kappa": 0.00943, "chicken c/ebp beta": 0.00449, "t-lymphocyte activation": 0.03164, "cleo define": 0.00323, "receptor down-regulation": 0.02571, "increase hydrolytic activity": 0.0195, "/stress protein": 0.04529, "zr-75-1 cell line show": 0.0384, "phosphatidyl inositol": 0.00043, "ml-9 induce nitroblue tetrazolium": 0.0127, "ser-727": 0.00019, "stimulate viral gene expression": 0.02177, "rapid desensitization": 0.00323, "box recognition sequence": 0.01084, "native promoter construct": 0.01557, "alf1 transactivated transcription": 0.01873, "cellular transcriptional coactivator": 0.00767, "heart suggest": 0.02022, "gene encode il-2": 0.02903, "dnd39 cell": 0.0768, "p45 nf-e2 protein increase": 0.02264, "epstein-barr virus gene expression": 0.02177, "fifty-three case": 0.00363, "human inducible nitric oxide synthase gene": 0.01452, "m47 mutation": 0.00592, "clone gene": 0.04355, "paf-stimulated kappa": 0.00748, "stationary-phase sigma factor rpos": 0.0143, "monochloramine derivative": 0.00192, "identical nucleotide sequence": 0.01084, "experimental evidence": 0.00422, "constitutively activate stat3": 0.01185, "link b-cell antigen receptor": 0.01286, "extracellular ca2+": 0.00304, "prior analysis": 0.01179, "ap-1 binding protein require costimulation": 0.01811, "r.": 0.00043, "il4 transcription initiation site": 0.01405, "case test show functional nk cell-mediated cytotoxicity": 0.00743, "functional pafr transcript": 0.00544, "mature normal myeloid cell": 0.0384, "k562 cell synthesize hb": 0.0384, "human adenosine deaminase": 0.02508, "bind study": 0.02025, "syndrome related antigen la": 0.00409, "h.": 0.00236, "biophysical property": 0.00397, "saturable binding": 0.01855, "nur77 alpha": 0.01169, "active p65-50 heterodimer": 0.00395, "similar finding": 0.00673, "human jurkat t-cells": 0.02508, "vol/vol": 0.0, "cell lymphoma line result": 0.0384, "block": 0.02146, "e-box-dependent reporter gene function": 0.02177, "ciprofloxacin increase": 0.02196, "cell lineage": 0.0768, "il-4-stimulated cell": 0.0768, "minimum sequence": 0.01625, "cd34+/cd38": 6e-05, "ducy": 0.00012, "maintain variation": 0.00239, "serum acth": 0.00378, "decrease transcriptional activation": 0.02109, "typical aml m4eo": 0.00079, "nucleotide upstream": 0.00369, "carboxyl-terminal 15-amino acid sequence": 0.00813, "cortisol binding": 0.01855, "alpha thf/thf": 0.01169, "enhancer activation": 0.03164, "intraluminal administration": 0.00093, "androgen": 0.00323, "eosinophil gene expression": 0.02903, "pwm-generated b-cell proliferation": 0.00536, "cdc42 protein": 0.04529, "tfiihmut show": 0.02599, "facilitate activation": 0.03164, "vivo footprinting": 0.0053, "immobilized grr element": 0.01115, "nuclear nfkappab correlate": 0.01123, "autoinduction": 0.00019, "phase regulate gene": 0.02903, "lal promoter": 0.02336, "s. zalani": 0.00065, "c57bl/10snj": 0.00012, "human pro-monocytic cell line": 0.0384, "inhibited transcription activate": 0.01873, "potent monocyte regulatory cytokine": 0.00599, "lef/tcf transcription factor family": 0.0143, "dihydroxyvitamin d3": 0.00245, "formalin-fixed": 0.00031, "mouse spleen cell hybrid": 0.0384, "murine gammac promoter gene": 0.02177, "2d3-induced g1 arrest": 0.00114, "alphaiibbeta3": 0.0005, "nf-at signal transduction event": 0.00817, "pyrrolidine dtc": 0.00047, "blood cell": 0.0768, "igg level": 0.01821, "infection induce interleukin-8": 0.01694, "e2a gene product": 0.02903, "aging": 6e-05, "gm-csf proximal promoter": 0.01557, "il-2r induced tyrosine phosphorylation": 0.00492, "zfp36": 0.0, "microtubule mediate cellular 25-hydroxyvitamin d3 trafficking": 0.0041, "haematopoietic system": 0.00667, "site-directed mutagenesis": 0.00081, "htlv-i-negative human t-cell line": 0.01881, "induce cytokine expression": 0.02775, "usf/c-myc": 0.00056, "inducible transcriptional regulator": 0.00767, "induce hl-60 monocytic differentiation": 0.0127, "smooth muscle myosin heavy chain": 0.00175, "transfected c-jun": 0.00493, "tcr activate": 0.01777, "activity reside": 0.02925, "infected patient": 0.01666, "murine bone marrow cell": 0.0384, "gcrbeta expression": 0.04163, "rpmi": 0.00037, "sl3 enhancer factor": 0.01907, "linear template": 0.00037, "related hepatocyte nuclear factor hnf-1alpha": 0.01144, "similar circadian rhythm": 0.00449, "wy": 0.00025, "nuclear factor recruitment": 0.01907, "ifn-gamma induced irf-1 gene expression": 0.01742, "trifluoperazine": 0.00012, "dna replication require": 0.00988, "fdc": 0.00074, "initiate dna-unwinding": 0.00363, "conducive": 0.00012, "systemic hgr level": 0.01214, "interleukin-2 sequence specific oligonucleotide probe": 0.0065, "p50-nf-kappa": 0.00012, "age-related difference": 0.00425, "unspliced viral mrna": 0.01017, "supershift analysis show": 0.01733, "plasma interleukin-1": 0.00375, "exocrine precursor cell bud": 0.0384, "southwestern blotting": 0.00056, "chromatin-integrated construct": 0.00726, "squirrel monkey liver": 0.00079, "overlap egr-1/sp1 site": 0.01445, "major cytoplasmic inhibitor": 0.006, "ebv-infected epithelial cell": 0.0512, "intracellular ca2+ mobilization": 0.00389, "parallel decline": 0.00205, "compatible": 0.00062, "lineage-dependent abrogation": 0.00019, "il-2 mrna accumulation": 0.01017, "terminal deoxynucleotidyl transferase labeling": 0.00166, "camp-dependent protein kinase": 0.03019, "box-dependent transcriptional pathway": 0.00852, "proto-oncogene product": 0.00533, "malignant lymphocytic cell line": 0.0384, "bp -72": 0.00267, "enhanced il-5 production": 0.00695, "sooty mangabey": 0.00012, "trypsin sensitive": 0.00273, "lymphocyte require": 0.01483, "low shear-induced vcam-1 expression": 0.02081, "egr-3": 0.00043, "k3t": 6e-05, "b1 transcript": 0.00599, "burden": 0.00087, "endonuclease activity": 0.02925, "protein/dna interaction": 0.00986, "asymptomatic": 0.00068, "remote position": 0.00236, "cell express multiple isotypes": 0.0384, "ionomycin-stimulated eosinophil": 0.00295, "cellular composition": 0.00893, "p65 require": 0.01315, "situation": 0.00037, "toxicity": 0.00112, "il-2-induced stat3 activation": 0.02109, "spi-1 and/or fli-1 transcription factor": 0.01144, "gene topography independent": 0.02903, "il-12 induction": 0.01607, "ltr activation remain obscure": 0.01582, "-kappab pathway": 0.01278, "lymphocyte-activating cytokine include": 0.00959, "centrocytes": 0.00012, "pml mrna": 0.01526, "high-dose ra induce": 0.01694, "observed difference": 0.00425, "flice": 0.0, "stat4-containing complex": 0.01684, "tumour size": 0.00183, "anti-sense oligonucleotides": 0.00183, "anti-ssb": 0.00012, "precise deletion": 0.00344, "sea urchin pax-258 protein": 0.02264, "transactivates interleukin-2": 0.00332, "paired t-test": 0.00034, "induce c-fos": 0.0254, "counter-anion thioglucose": 6e-05, "human acute lymphoblastic t-cell line": 0.01505, "uterine pregnancy": 0.0009, "activation-dependent expression": 0.04163, "nf-kappab dna binding increase": 0.01098, "hypophyseal": 6e-05, "non-cultured peripheral lymphocyte": 0.00988, "il-4-mediated proliferation": 0.00803, "growth-modulating effect": 0.02115, "subsequent cellular response": 0.01294, "b29 gene": 0.04355, "gene erythroid promoter": 0.02903, "purine-rich binding site": 0.01445, "cell require": 0.0768, "kbf": 0.00012, "hox": 0.00019, "clone tcl1 gene": 0.02903, "f-actin": 0.00012, "retinoblastoma protein": 0.04529, "genetic lesion associate": 0.00728, "pml/rar-alpha hybrid protein": 0.03019, "nfat gene family": 0.02903, "hla dqa1*0501/dqb1*0201": 0.00192, "lps-induced dna-binding activity": 0.0195, "tt4": 6e-05, "/ap3-l": 6e-05, "maintain polarized t-helper cell": 0.0384, "rnase protection analysis": 0.00786, "mouse ig heavy-chain enhancer": 0.00487, "ubiquitinylation pathway": 0.01278, "display bind consistent": 0.0135, "inflammatory cytokine production": 0.00749, "term gralpha": 0.00413, "cross coupling": 0.00034, "primary tool": 0.00738, "hepatocyte nuclear factor-1 alpha": 0.00842, "parental jak1-expressing counterpart": 0.0005, "6-keto-pgf1 alpha": 0.01169, "cd8 contribution": 0.00081, "human carotid artery ec express pparalpha": 0.01254, "combined influence": 0.00471, "qualitative": 0.00025, "male breast cancer case": 0.00181, "cd34+ myelomonocytic cell line kg1 differentiate": 0.0256, "long term culture": 0.00414, "isre": 0.00074, "bob1": 0.00074, "mechanims": 0.00012, "pig": 0.00031, "xq13 region carry xic/xist": 0.00734, "hpp-cfcs": 6e-05, "nf-kappab-dependent activation": 0.03164, "lytic origin": 0.00161, "express comparable level": 0.0123, "murine ra-inducible mpro promyelocyte cell line": 0.0256, "bind protein-1": 0.02025, "human genomic dna": 0.02508, "c-fos antibody": 0.00893, "mab okt3": 0.00267, "lymphocyte function-associated ag-3": 0.00988, "suppress tumor necrosis factor-alpha": 0.00467, "ck-1 element": 0.01672, "additional work": 0.00341, "stat3 protein": 0.04529, "cell line study": 0.0512, "mtcp1 putative oncogene": 0.00248, "fmol/million cell": 0.0768, "neutralizing anti-tnf alpha monoclonal antibody": 0.00468, "monocyte surface marker": 0.00798, "gastrointestinal tract": 0.00016, "immunological function": 0.01331, "early gene upregulate interleukin-6 gene expression": 0.01388, "rabbit 15-lipoxygenase gene": 0.02903, "il-7r alpha": 0.01169, "hypercorticism": 6e-05, "tcr- mediated apoptosis": 0.00593, "lytic": 0.00323, "expected dramatic increase": 0.01464, "flanking sequence": 0.01625, "kinase domain": 0.01207, "cd28 costimulation augments il-2 secretion": 0.00447, "differentiate phenotype": 0.00366, "dyad symmetry element control": 0.00836, "b-cell origin": 0.00459, "70-bp motif": 0.00875, "gram-negative bacteria-induced sepsis syndrome": 0.00136, "direct transcriptional repressive effect": 0.01058, "mitogenesis": 0.00081, "cellular srf": 0.00893, "nf-matp35 show excellent correlation": 0.013, "42-nucleotide repeat element": 0.01115, "caev ltr": 0.0031, "cytoplasmic side": 0.004, "natural killer cell receptor": 0.0384, "-30 promoter region upstream": 0.01168, "multicopy nfat -and il-2 promoter-beta-galactosidase reporter gene construct": 0.01089, "blood monocyte number": 0.00798, "common octamer motif": 0.00583, "immune disorder characterize": 0.00399, "u937 monocytic line": 0.01102, "oct2-mediated enhancer activation": 0.02109, "ci": 0.00099, "thirteen": 6e-05, "tax act": 0.00496, "th1-": 0.00025, "monitor minimal residual disease": 0.00337, "induce retinaldehyde dehydrogenase": 0.01694, "myelomonocytic cell line study": 0.0384, "distinct complementation group": 0.00465, "aberrant tcl1 expression": 0.02775, "hyon": 0.00025, "ebv transactivating factor": 0.01907, "activated shp1": 0.00589, "objective": 0.00037, "histone deacetylase complex": 0.01123, "authentic kappa": 0.00748, "kinase": 0.02376, "n-oct-factors": 0.0, "include nik": 0.01439, "b-cell-specific footprint": 0.00121, "lysosome": 6e-05, "orf-a": 0.00019, "lal": 0.00031, "tal1-": 6e-05, "induce hiv-1 expression": 0.02775, "maintains proliferation": 0.00803, "scientific": 6e-05, "4-9": 0.0, "b2 promoter": 0.02336, "saturated fatty acid": 0.00571, "sapk/jnk": 6e-05, "localized": 0.00074, "gel mobility shift": 0.00122, "secondary granule protein": 0.03019, "quantitative reverse": 0.00236, "important lymphokine require": 0.00877, "gestation": 6e-05, "activation": 0.06328, "attachment": 0.00062, "p105 transcript": 0.00599, "dominant-negative caml mutant": 0.0054, "redox control mechanism mediate": 0.00651, "proliferation response": 0.01942, "functional analogue": 0.00816, "nasal t/nk-cell lymphoma": 0.00151, "alpha b1 enhance": 0.0078, "primary isolates": 0.00738, "tumor cell show": 0.0512, "spi-b": 0.00217, "key cell cycle regulator": 0.0384, "simultaneous exposure": 0.0035, "increase proliferation": 0.02196, "transdominant mutant": 0.0081, "potential stat-binding site": 0.01445, "ah receptor ligand": 0.01714, "antenatal steroid treatment": 0.00676, "distinct domain": 0.01207, "cellular factor cbf1/rbp-jkappa": 0.01907, "neonatal immune response": 0.01294, "crosslinkage": 0.0, "cerebral malaria": 0.00031, "serine/threonine kinase akt/pkb": 0.00792, "c-myb protein": 0.04529, "mhc class ii antigen induction": 0.00643, "role": 0.02655, "measurement": 0.00099, "thrombin stimulate tyrosine phosphorylation": 0.00551, "signaling requirement": 0.00558, "gal4 dna bind domain": 0.01013, "protein exhibit": 0.04529, "myd88-/- th1-developing cell": 0.0512, "co-operativity": 6e-05, "red cell viability": 0.0512, "protect virus-infected cell": 0.0512, "normal cell mimic clonal cell growth": 0.0128, "translocation cell proliferate": 0.0512, "wild-type reversion": 0.00378, "activate stat5": 0.01777, "nonradioactive quantification": 0.00019, "central regulator": 0.00304, "jpx-9": 0.00019, ":8154": 0.00012, "xpa": 6e-05, "pha-induced kappab-dependent reporter activity": 0.01462, "gammac": 0.00124, "p50 form": 0.01055, "process require direct interaction": 0.00658, "control pbmc": 0.01303, "cell cycle-stimulatory activity": 0.0512, "gcrbeta immunoreactivity": 0.00028, "autologous lymphoblastoid cell line": 0.0384, "reactive intermediate": 0.00211, "differential rna display identifies": 0.0025, "okadaic acid suggest": 0.01348, "kappa b-3": 0.00748, "constitutively active cbl mutant": 0.00405, "heretofore": 0.0, "transgenic": 0.00397, "inhibitory effect vary": 0.0141, "recombinant human nm23-h1": 0.02508, "inflammatory infiltrates": 0.00471, "tcr/cd3 ligation": 0.0018, "yeast colony": 0.00171, "constitutively express fc epsilon ri- gamma chain transcript": 0.00461, "nordihydroquairetic acid": 0.00856, "antagonize expression": 0.04163, "potential application": 0.00605, "deviation": 0.00019, "additional factor": 0.0286, "non-aids iblp": 0.00019, "fresh case": 0.00363, "antigenic challenge": 0.00102, "cytokine-stimulated endothelial cell": 0.0512, "mhc class ii molecule result": 0.00644, "acidic nh2 terminus": 0.00072, "aid pathogenesis": 0.00171, "hiv-1 nef lead": 0.00664, "stat3-containing complex": 0.01684, "camp-dependent intracellular signaling pathway": 0.00639, "cell-specific gene transcription": 0.02903, "unique chromatin structure": 0.00213, "induce il-12r beta": 0.01694, "nuclear pore complex": 0.01123, "htlv-1 infected human": 0.02508, "mrna level peak": 0.01214, "unidentified cellular factor": 0.01907, "e2f-1 transcription factor": 0.01907, "limit amount": 0.00285, "antigenic": 0.00205, "mosaic": 0.00025, "neoplastic myelomonocytic cell": 0.0512, "enhancerless promoter": 0.02336, "transcription factor pertinent": 0.01907, "gata-3-dependent enhancer activity": 0.0195, "rhodamine": 6e-05, "flunisolide": 6e-05, "enhancer-like element": 0.01672, "nfat dna binding": 0.01237, "notable exception": 0.0004, "sv40 early": 0.00828, "m-tat/gm-csf cell increase": 0.0512, "consistent involvement": 0.00254, "single cell layer": 0.0512, "eklf-/- colony": 0.00171, "tnf-alpha-activated endothelium": 0.00062, "bi-": 0.00012, "act-1-activating region": 0.01467, "mechanism common": 0.01058, "latent membrane protein-1 lead": 0.00498, "target promoter": 0.02336, "increase kappa": 0.02196, "tumor-suppressor gene expression": 0.02903, "study globin gene expression": 0.02177, "non-tumorous cavity fluid": 0.00052, "polymorphic dinucleotide repeat": 0.00252, "alpha-methyl": 0.0, "important intracellular signaling molecule": 0.00426, "virus particle": 0.00887, "direct th2-specific activity": 0.0195, "sodium phenylacetate": 0.00186, "local metabolism": 0.00081, "respective region": 0.01467, "detrimental": 6e-05, "embryonic cardiac cell": 0.0512, "cd2 receptor": 0.02571, "dose-": 0.00031, "substantial decrease": 0.00971, "cell system describe": 0.0512, "cellular element": 0.01672, "full-length human ciita construct result": 0.01505, "minimal element inducible": 0.01115, "bzlf 1-containing cell lysates": 0.0384, "repress": 0.0044, "hip bone density": 0.00143, "ppar activator 15-deoxy-delta": 0.00368, "synovial tissue": 0.00664, "transfection study reveal": 0.00904, "induce low level": 0.01694, "pkb/akt activity": 0.02925, "ifn-gamma treatment induce increased occupancy": 0.01016, "th2 cytokine": 0.01123, "genital tract": 0.0005, "specific peptide result": 0.01073, "aly": 0.00068, "optimal activation": 0.03164, "cytokine network": 0.01123, "strong interaction": 0.00986, "menopausal status": 0.00217, "include protein kinase": 0.03019, "cell ag receptor": 0.0512, "nuclear presence": 0.01684, "erythroid factor gata-1": 0.01907, "filarial inflammatory disease": 0.00449, "tgf-specific elisa": 0.00062, "trp enhance cd69 expression": 0.02081, "intergenic fusion transcript": 0.00399, "immunological disease": 0.00673, "include 15-deoxy-delta12,14-prostaglandin j2": 0.00959, "minimal adenovirus e1b promoter-luciferase gene": 0.01742, "t-cell signaling": 0.00962, "osf2": 0.00019, "a1-vdr": 0.00025, "negative transcriptional effect": 0.0141, "well-characterized": 0.00043, "pkc substrate": 0.00332, "nf-kappa b-independent hiv promoter domain activity": 0.00975, "histamine induce mrna expression": 0.02081, "mature cell culture": 0.0512, "transcriptional regulator nuclear factor": 0.0143, "lai replicates": 0.00028, "genetic variant alter message stability": 0.00151, "limited activation": 0.03164, "erythroid differentiation": 0.01179, "-3059": 0.00012, "balachandran": 0.00012, "adenoviral e1a oncoprotein": 0.00165, "human gene encode": 0.02903, "nf-kappab subunit": 0.00999, "retinoblastoma susceptibility gene product": 0.02177, "zymogen plasma factor vii": 0.0143, "prestimulated": 0.00037, "proc.natl.acad.sci": 6e-05, "leukocyte cell membrane mediate": 0.0384, "il-5 promoter": 0.02336, "tata element": 0.01672, "thymic lymphoma-derived hybridoma": 0.00079, "nr2": 6e-05, "fetal developmental stage": 0.00165, "weakly express": 0.01846, "specific pan-pkc inhibitor bisindolylmaleimide": 0.00619, "retinoic acid treatment": 0.00676, "il-12 induced stat4": 0.0036, "important respiratory pathogen": 0.00459, "functional specificity": 0.00816, "late stage cell include peripheral blood monocyte": 0.02194, "proteasome-mediated degradation": 0.00332, "hsv-2 epitope mapping": 0.00108, "ebna gene promoter": 0.02903, "enhance bind activity": 0.0195, "human t-cell leukemia virus type i-infected cell": 0.02194, "correct temporal order": 0.00083, "syphilitic chancre": 6e-05, "hyperphosphorylated e2f-4": 0.00034, "function-": 6e-05, "therapy": 0.00744, "hla class ii molecule distal": 0.00341, "understand gata3 gene regulation": 0.02177, "oncogene": 0.00521, "jun-d expression vector": 0.02775, "cl- channel": 0.00062, "rare form": 0.01055, "transcription factor sp-1": 0.01907, "combination": 0.00577, "zeb": 0.0005, "clonal eosinophilia": 0.00167, "equivalent degree": 0.00146, "il-12-nonresponsive": 0.00012, "potentiate th2-regulated response": 0.01294, "canonical tata": 0.00074, "human gammaherpesvirus": 0.03762, "proximal mouse chr": 0.00649, "c-akt": 0.0, "vav lead": 0.00996, "functional lymphoid tissue": 0.00544, "tcl1 gene sequence": 0.02903, "enhanced ikappabalpha degradation": 0.00221, "defective transport": 0.00205, "tap-deficient cell line lack antigenic er peptide": 0.02194, "a/r-induced hyperadhesion": 0.00012, "multifactorial process affect": 0.00531, "summary": 0.00019, "sensitization": 0.00105, "atll": 0.00031, "gm-csf induces": 0.00803, "differentiation process": 0.01179, "ctx": 0.00043, "isoforms pax-5b": 0.00307, "pkc-zeta": 0.00149, "differential nf-kappab subunit activation": 0.01582, "erk2 protein level remain constant": 0.01811, "q23-31 region": 0.01467, "hsf1 overexpression": 0.00382, "stimulus induces cord blood": 0.00402, "globin": 0.00403, "ap-1 enhancer activity result": 0.01462, "rb antisense": 0.00167, "tumor necrosis factor-associated factor": 0.0143, "accelerate cd4-positive lymphocyte cytotoxicity": 0.00741, "protein dimerization domain": 0.03019, "negative regulatory sequence": 0.01084, "ebv sm": 0.00565, "gggatttcacc motif abolish": 0.00583, "acidic sphingomyelinase signal": 0.0109, "increase 4e-bp2 amount": 0.01464, "aids-related primary effusion lymphoma": 0.00369, "grb2 family member": 0.0056, "position -44": 0.00236, "intron downstream": 0.00298, "untreated control": 0.01303, "70z/3-mediated induction": 0.01607, "white blood cell": 0.0512, "il-2 growth hormone": 0.00744, "gpltplpv": 0.00012, "ku": 0.00019, "northern blot analysis fail": 0.00589, "rantes increase": 0.02196, "tnf alpha gene promoter": 0.02177, "cell-specific microenvironment": 0.00292, "catecholamine": 0.00043, "apparent affinity": 0.00391, "mutated lt-kappa": 0.00093, "erythroid-enriched nf-e2 factor": 0.01907, "gpix promoter/reporter construct": 0.00484, "mut": 6e-05, "virus-infected t-cells": 0.00211, "human cell line k562": 0.0384, "c-rel induction": 0.01607, "immediate-early gene egr-1 encode": 0.02177, "expression plasmid encode region": 0.02081, "p53-mediated interference": 0.0009, "isolate blood leukocyte": 0.00395, "influence hiv-1 replication": 0.00585, "pil-5": 0.00012, "chromosome band 15q21.1-21.2": 0.00196, "lipopolysaccharide-stimulated u937 cell": 0.0512, "unstimulated mrl-lpr/lpr": 0.00136, "similar tyrosine-phosphorylated motif": 0.00583, "20-epi analogue": 0.0005, "subject heterozygotic": 0.00354, "spi-1/pu.1": 0.00062, "tf antigen expression": 0.02775, "il-4 affect bind activity": 0.01462, "parental ut-7 cell": 0.0512, "beta-chain promoter": 0.02336, "p21ras regulation": 0.01008, "ldl-receptor gene transcription": 0.02903, "irf-1 gas": 0.0013, "mody and/or late-onset type": 0.00475, "myosin light chain kinase prevent": 0.00475, "distinct isoforms": 0.00698, "resuscitation": 6e-05, "wilms": 0.00012, "end noncoding sequence": 0.01084, "encode p105": 0.00853, "protein phosphorylation pattern": 0.03019, "term pod": 0.00413, "kidney insufficiency": 0.00059, "hematopoietic cell line": 0.0512, "pkc-zeta belongs": 0.00074, "stimulus induce": 0.0254, "down-regulation": 0.00391, "maeca possess high activity": 0.01462, "anti-cd4 monoclonal antibody": 0.00596, "ets motif": 0.00875, "intermediate filament protein vimentin": 0.02264, "human leukemia cell line hl-60": 0.03072, "endogenous thyroid hormone": 0.00306, "nf-kappab motif": 0.00999, "profound state": 0.00267, "pyrimidine-rich element": 0.01672, "alpha cd3/il-2": 0.01169, "disease susceptibility marker": 0.00449, "suppression phenomenon": 0.00416, "gr-mediated response": 0.01942, "saguinus oedipus": 6e-05, "c/ebpalpha-/- mouse": 0.00974, "background": 0.0023, "il-6 promoter demonstrate": 0.01557, "lysp100 structure": 0.00319, "acute lung injury": 0.00246, "proximal hil-5 promoter": 0.01557, "platelet-activating factor stimulate transcription": 0.0143, "ih": 0.00019, "30.3+/-2.5 versus 19.2+/-2.4 nmol/l": 0.00068, "similar action": 0.00673, "dna bind protein complex": 0.02264, "simultaneous early expression": 0.02775, "phorbol ester activation": 0.02109, "probe cysteamine": 0.00261, "metabolic consequence": 0.00115, "recurrent genital herpes simplex virus type": 0.00316, "classical nfkappab site": 0.01445, "ala": 0.00093, "5.86-6.74": 0.00012, "increase induction": 0.02196, "mutant virus result": 0.01073, "corticosteroid response": 0.01942, "virus carrier": 0.00887, "ebna expression": 0.04163, "abortive stimulation lead": 0.00746, "nfatp bind": 0.02025, "j. virol": 0.00056, "catalytic domain": 0.01207, "d20s17": 0.00012, "low affinity binding": 0.01237, "atf/cre motif": 0.00875, "mouse harbor": 0.00974, "close donor": 0.0014, "daily phosphate supplementation": 0.00043, "relief": 6e-05, "nonhuman primate siv infection": 0.0031, "wild-type receptor": 0.02571, "hml": 0.00099, "classical thyroid hormone response element": 0.00777, "prognostic importance": 0.0013, "transcription factor nf kappa": 0.0143, "critical guanine nucleotide": 0.00285, "il2 regulatory region": 0.00978, "normal limit": 0.0121, "induce dna binding": 0.01694, "renal transplant": 0.00115, "growth retarding": 0.00819, "phorbol ester nonresponsive atypical protein kinase": 0.0151, "human toll transfected": 0.02508, "cell killing": 0.0768, "array": 0.00068, "bind affinity": 0.02025, "resting": 0.00068, "neutralizing anti-tumor necrosis factor alpha": 0.01144, "fetal": 0.00428, "transcript": 0.01197, "10-fold increase": 0.02196, "antisense phosphorothioate oligodeoxynucleotides complementary": 0.00081, "extract": 0.00918, "hemopoietic-derived tissue": 0.00664, "luciferase reporter plasmid regulate": 0.00627, "efficient induction": 0.01607, "productive lai replication": 0.00314, "androgen receptor gene transcription": 0.02177, "edn": 0.00025, "preleukemic": 0.00037, "hyaluronic acid": 0.00856, "il-8 gene reveal": 0.02903, "slgm-": 6e-05, "epstein-barr virus immediate-early transcript": 0.00444, "cd3 ligation": 0.0018, "compound zk161422": 0.0022, "intron-exon structure": 0.00319, "zeb-like repressor": 0.00223, "nk cell-mediated lysis": 0.00244, "bind sites/cell": 0.02025, "elk-1 expression": 0.04163, "display heterogeneity": 0.00499, "demonstrable": 0.00019, "generate benzidine-positive cell": 0.0512, "regulate multiple t-cell gene": 0.02177, "express mnda exhibit myeloid cell feature": 0.0256, "x- chromosome inactivation pattern": 0.00275, "human c-fes transgene exhibit high level": 0.01254, "express pu.1": 0.01846, "renin-angiotensin system": 0.00667, "il-2 receptor complex": 0.01714, "inflammatory cytokine expression": 0.02775, "altered cellular response": 0.01294, "caspase-dependent": 0.00012, "putative zinc finger protein": 0.02264, "cytoplasmic region": 0.01467, "il-1beta message": 0.00223, "stat1-dependent immune-response gene": 0.02903, "rheumatoid arthritis synovial fluid": 0.00047, "cd40-positive immunogenic human mm": 0.01881, "early inflammatory event": 0.00552, "potential agonist": 0.00605, "15-fold": 0.0, "dominant negative effect": 0.0141, "exogenous c-erba/tr-alpha": 0.00214, "class ii transactivator ciita": 0.00363, "platelet-activating factor induce arachidonic acid release": 0.00953, "9-cis retinoic acid": 0.00571, "50-fold great affinity": 0.00261, "thrombin generation": 0.00242, "bcl-x promoter": 0.02336, "significant inhibition": 0.01061, "il-5-nonproducing t-cell clone": 0.00641, "ar-5 cell": 0.0768, "alpha g2s show": 0.01733, "lps responsiveness": 0.0035, "-207 region show": 0.01733, "steroid-thyroid hormone receptor superfamily": 0.01286, "positive case occur": 0.00436, "autoimmune thyroid disease": 0.00449, "high-level ebv replication": 0.00376, "vzv": 0.0013, "primary macrophage culture": 0.00492, "augment cytokine-induced vcam-1 expression": 0.02081, "her-2/neu protein": 0.04529, "cd33+": 0.00043, "human tcr delta": 0.02508, "secretion": 0.00856, "murine genomic dna": 0.00988, "synergistic antigen receptor initiate signal": 0.01029, "retinoic acid receptor type alpha": 0.01029, "fcr-mediated nuclear factor activation": 0.01582, "mek1": 0.00074, "impaired rel-a translocation": 0.00343, "mouse interleukin-2 receptor alpha gene expression": 0.01452, "ggaaagtccc": 0.00012, "p65 confers resistance": 0.00258, "nephrotic syndrome": 0.00273, "enhancer/promoter region": 0.01467, "dimer encode": 0.00853, "upregulate virus transcription": 0.01873, "nre-i": 0.00019, "insignificant extent": 0.00115, "enhanced responsiveness": 0.00323, "monensine": 6e-05, "spinal": 0.00031, "ns-meg": 0.00037, "function": 0.02661, "fa": 0.00205, "physiological substrate": 0.00199, "consensus nf-kappab- reporter construct": 0.00363, "integrin-dependent cell adhesion": 0.0512, "inhibit raf-1": 0.01904, "hiv-1 transcriptional induction": 0.01071, "infiltrating primary melanoma": 0.00492, "congenital immunodeficiency disease characterize": 0.00337, "nucleotide substitution": 0.00202, "adhesion molecule show": 0.01733, "tata box bind protein": 0.02264, "-induced cytotoxic t-lymphocyte": 0.00124, "study implicate il-4r": 0.00904, "cross-species effectiveness": 0.00019, "16-96": 6e-05, "bacterial chloramphenicol acetyltransferase gene link": 0.01742, "upregulated": 0.00217, "estradiol-dependent activation": 0.03164, "polar substitution": 0.00112, "u937 human monoblastic cell": 0.0384, "jak2 kinase": 0.01188, "unilineage erythropoietic differentiation": 0.00786, "cytokine promoter region": 0.01557, "activator capable": 0.00552, "hsc/ primitive hpc proliferation": 0.00402, "erythroid-specific 5-aminolevulinate synthetase transcript": 0.00299, "proteolysis product": 0.00533, "induce il-2r alpha expression": 0.02081, "increase latent proviral transcription": 0.01405, "glia": 0.0005, "il-4 enhance cd11b": 0.00649, "differential regulation": 0.01008, "active treatment": 0.01014, "vav protooncogene product": 0.00356, "mammalian runt product": 0.00356, "develop pha": 0.00403, "clonal cd3-cd16+ natural killer": 0.00116, "inhibit nfkappab": 0.01904, "bronchial asthma child age": 0.00113, "rest human t-cells": 0.02508, "pos-1a": 0.0, "recognizable association": 0.00282, "latent membrane antigen lmp": 0.00409, "dm regulates": 0.00099, "icam-1 pire": 0.00267, "marked accumulation": 0.00323, "chemotaxis": 0.00093, "c5b6": 0.00012, "mononuclear differentiation include change": 0.0072, "2-5 fold increase": 0.01464, "dna consensus sequence": 0.01084, "positive erythroid": 0.0062, "polymorphonuclear cell stimulate": 0.0512, "delicate balance": 0.00065, "uv required expression": 0.02775, "inducible rel": 0.00484, "kappab3 site": 0.02168, "protective response": 0.01942, "human aml1 gene detect": 0.02177, "erythroid/megakaryocytic cell line": 0.0512, "il-10 inhibition": 0.01061, "individual rel-related protein": 0.03019, "parallel activation": 0.03164, "legionella pneumophila": 0.00019, "human immunoglobulin gene": 0.02903, "acute inflammatory reaction": 0.00314, "il-7 receptor": 0.02571, "cytoplasmic mrna": 0.01526, "lcr holocomplex": 0.00056, "tre site": 0.02168, "partial cn inhibition": 0.00707, "monocyte/macrophage cell line": 0.0512, "chinese hamster ovary cell express human recombinant alphaiibbeta3": 0.0192, "reliable": 0.00031, "atra increase": 0.02196, "virus-induced nf-kappa": 0.01414, "hiv1-infected u937 cell": 0.0512, "vitro tyrosine kinase activity associate": 0.0117, "granulocyte-colony-stimulating factor": 0.0286, "2d3-vdr interaction": 0.00986, "determine clinicopathological aspect": 0.00519, "influenza virus antigen": 0.00591, "c5a-induced calcium mobilization": 0.00157, "phospholipid": 0.00099, "autoimmune feature": 0.00217, "receive": 0.00223, "tyrosine-containing stat": 0.00282, "rbtn-2": 0.00056, "g28-5 igg": 0.00084, "similar infection": 0.00673, "describe upregulation": 0.00397, "clinical endpoint": 0.00425, "cd40 activation": 0.03164, "nf-kappab system": 0.00999, "inhibit nfkappab activity correlate": 0.01462, "occur mutation": 0.00654, "specie barrier": 0.00183, "repress ap-1 activity": 0.0195, "significant response": 0.01942, "interfollicular area": 0.0005, "genetic program mediating normal t-cell activation": 0.01055, "fcs+ culture": 0.0062, "protein synthesis inhibitor anisomycin": 0.02264, "tcr affinity": 0.00478, "blr1 expression": 0.04163, "oral hairy leukoplakia": 0.0005, "hmg-y": 0.00012, "haptenized lysis synthetic substrate": 0.00101, "csf-1r": 0.00031, "characterize alter expression": 0.02775, "pp repeat": 0.00378, "inflammatory cell": 0.0768, "human g0/g1 switch gene": 0.02177, "lim domain": 0.01207, "hbv mrna": 0.01526, "severe 5-fluorouracil toxicity secondary": 0.00105, "receptor status": 0.02571, "authentic enhancer": 0.00909, "mcp": 0.00012, "dna bind specificity": 0.0135, "pa-derived diacylglycerol formation": 0.00323, "isgs": 0.00012, "carboxy-terminal cytoplasmic domain essential": 0.00603, "vitro polyclonal": 0.00785, "12-o-tetradecanoylphorbol 13-acetate": 0.00068, "nf-kb2/p52": 0.0, "t-cell-specific factor nf-at": 0.01907, "nonthyroidal disease": 0.00673, "gene encode cytoskeletal": 0.02903, "caat box": 0.00304, "gag": 0.00087, "alpha1 germ-line promoter": 0.01557, "cbf alpha subunit": 0.0078, "receptor subunit": 0.02571, "transcription factor nfat-1": 0.01907, "helix-loop-helix transcription factor encode": 0.0143, "pkc isoenzymes alpha": 0.0078, "differentiated hl60": 0.00127, "vivo due": 0.0053, "hbx protein": 0.04529, "reside": 0.00056, "il-1ri-associated kinase similarly impair": 0.00594, "time-dependent differentiation": 0.01179, "-3gamma": 0.00012, "stop": 0.00037, "independent role": 0.01328, "buffy coat preparation": 0.0005, "double-stranded gire sequence": 0.01084, "glutamic acid decarboxylase": 0.00571, "cell type analyze": 0.0512, "cellular environment": 0.00893, "c-erba activity": 0.02925, "nfkappab activation": 0.03164, "common gamma-chain": 0.0035, "positive sample": 0.00468, "phospholipase cgamma": 0.00078, "generate transgenic mouse carry": 0.00487, "human cd4+": 0.03762, "alpha chain": 0.01169, "lysophospholipid": 0.0, "latent antigen-specific memory": 0.00151, "aggregate": 0.00043, "action": 0.00999, "nonepithelial cell": 0.0768, "impaired": 0.0036, "stat1 nuclear import": 0.01123, "src family tyrosine kinase lck": 0.00475, "small maf family protein": 0.02264, "binding require": 0.01855, "ligand-induced receptor heterodimerization": 0.01714, "nm23h2 protein": 0.04529, "imperfect repeat": 0.00378, "usf-": 0.00012, "unstained": 0.00012, "c-maf protein lead": 0.03019, "dna-binding factor": 0.0286, "anti-inflammatory corticosteroid": 0.00143, "nf-kappa b-related protein": 0.03019, "costimulation result": 0.0161, "hcd57 cell": 0.0768, "ras pathway": 0.01278, "linear relationship": 0.00158, "induce e2f activity": 0.0195, "gamma-chain": 0.00019, "sry protein dna bind ability": 0.01811, "mlv transcriptional regulation": 0.00767, "inhibit tnfalpha": 0.01904, "half-lives": 6e-05, "rapid up-regulation": 0.00323, "lymphokine production": 0.01042, "cem cell exhibit": 0.0512, "pma-induced differentiation": 0.01179, "rj2.2.5": 0.00056, "gm-csf-stimulated hiv expression": 0.02775, "fab aml-m3v": 0.00012, "bdp": 0.00025, "insulin gene promoter": 0.02903, "proliferative control": 0.01303, "viral transactivator activity": 0.0195, "affected male": 0.00099, "coimmunoprecipitation experiment": 0.00397, "express relb": 0.01846, "critical signaling molecule": 0.00569, "adt pretreatment": 0.00146, "jund/c-fos heterodimers": 0.00226, "radioassay": 0.00012, "electrophoretic mobility shift analysis reveal": 0.00471, "start": 0.00236, "ca2+ concentration": 0.0067, "common consensus motif": 0.00583, "pleiotropic immunomodulatory molecule": 0.00569, "normal rar alpha": 0.00806, "activation-induced p65/p50 nf-kappab heterodimer binding": 0.00742, "similar transfection analysis": 0.00786, "unexpected": 0.0005, "microg/ml": 0.00025, "paf receptor antagonist": 0.01714, "trophoblast": 0.00043, "block superoxide anion production": 0.00537, "generation": 0.00484, "activate camp production": 0.01185, "ifn-gamma-induced complex": 0.01684, "major costimulatory signal": 0.0109, "point mutation suppress gabp binding": 0.00742, "dra promoter discriminates": 0.01557, "low fat level": 0.01214, "human tfiid protein": 0.03019, "related steroid": 0.00292, "smad3": 6e-05, "classical negative feedback loop": 0.00257, "chemotherapy": 0.00143, "murine fdc-p1-derived cell line wt-19 transfected": 0.0256, "pol": 0.00012, "genomic region": 0.01467, "c-terminal domain share": 0.00804, "activates transcription factor nf-kappab": 0.0143, "pervanadate activate nf-kappa": 0.01185, "proinflammatory cytokine il-1 beta": 0.00561, "erythroid gene occur": 0.02903, "haplotype analysis": 0.01179, "anti-zebra activity": 0.02925, "p24 production": 0.01042, "vitro-differentiated bcl-xl-/- embryonic stem cell fail": 0.0256, "kb-enhancer target sequence": 0.01084, "report data": 0.0049, "reference": 0.00012, "related effector mechanism": 0.00705, "data warrant prudence": 0.0017, "androgen receptor gene mutation": 0.02177, "drug bind": 0.02025, "transient transfection system": 0.00445, "cd19 gc box": 0.00207, "tyrosine kinase inhibitor": 0.00792, "tested molecule capable": 0.00569, "feature control": 0.01303, "limiting element": 0.01672, "tumor necrosis factor-alpha mrna accumulation": 0.0061, "unrelated family": 0.00841, "il2r gamma": 0.0044, "mad-3 cdna encodes": 0.00304, "cd4 promoter transactivation": 0.01557, "-independent": 0.00105, "asymmetric division": 0.00025, "active transcriptional complex": 0.01123, "virion": 0.00031, "intrinsic ability": 0.00431, "inhibited il-2 production induce": 0.0127, "activation marker cd44": 0.02109, "nf-gm2": 0.00087, "nfat1/nfatp": 0.00012, "functional expression": 0.04163, "lymphocyte function-associated ag-3 pathway": 0.00741, "human epor gene": 0.02903, "prevent virus reactivation": 0.00591, "cytokine-dependent upregulation": 0.00192, "antigen receptor agonism": 0.01714, "fetus": 0.00012, "af10 breakpoint": 0.00022, "feature characteristic": 0.00329, "variable region beta chain": 0.00734, "internal store": 0.00087, "cell receptor gamma": 0.0512, "equivalent level": 0.01821, "proteolytic clip bandshift assay": 0.00501, "heat labile": 0.00189, "isogenic control ltr": 0.00868, "anti-cd28 ab": 0.00167, "rabbit reticulocyte lysates display": 0.0025, "es-derived embryoid body express": 0.00923, "functional analysis": 0.01179, "nuclear expression": 0.04163, "intracellular signal agent": 0.0109, "related octamer-binding protein": 0.03019, "competitive polymerase chain reaction": 0.00219, "small": 0.00627, "early phase": 0.00828, "express mutant form": 0.0123, "minus u937 clone": 0.00492, "transcriptionally-active conformation": 0.00053, "id50": 0.00012, "position -79": 0.00236, "transformed mr state": 0.00178, "sodium n-butyrate": 0.00186, "differentiated hl-60 granulocyte": 0.0017, "htlv-1 tax gene": 0.02903, "im-9 cell cytosol": 0.0512, "generalized": 0.00031, "kappab-regulated luciferase encode vector": 0.00426, "atra-nonresponsive case": 0.00363, "p50 homodimers coincides": 0.00192, "c6.1b/mtcp1 a1 transcript": 0.00399, "membrane receptor": 0.02571, "tes1": 0.00031, "pml-rar alpha": 0.01169, "proximal 5'-flanking region": 0.00978, "pfp9a20": 0.00012, "excessive lyonization": 0.00016, "intracellular signalling event": 0.00389, "propensity": 0.00012, "tcf-1 alpha cdna": 0.0078, "comparable decrease": 0.00971, "phosphorylates nfat4": 0.00043, "bp downstream": 0.00298, "activity remain absent": 0.0195, "chemoattractants": 0.00043, "complementary single-residue substitution": 0.00074, "sendai virus induced extract": 0.00444, "lymphoid-specific transcription factor oct-2a": 0.0143, "colony size": 0.00171, "thiol-reducing compound": 0.0022, "ikappabalpha mrna": 0.01526, "inhibit lps-induced tnf-alpha production": 0.00952, "immunoreaction": 6e-05, "tcr locus": 0.00478, "clonogenicity": 0.0, "nineteen healthy woman age 22-60 yr": 0.00078, "primary transcript": 0.00738, "arnt heterodimerization": 0.00059, "sign": 0.00081, "rao": 0.00012, "pge2 formation": 0.00484, "proper balance": 0.00065, "ubiquitin-protein ligase": 0.00019, "ets-like motif": 0.00875, "pecam-1": 0.00081, "promoter chromatin structure": 0.01557, "nur77 beta": 0.00673, "zap-70 regulates": 0.00155, "cell nearby": 0.0768, "high eukaryote": 0.00931, "organized structure": 0.00319, "stat1-related factor": 0.0286, "transfected human monocytic thp-1 cell": 0.03072, "plasma prednisolone": 0.00375, "biologic mediator": 0.00195, "anti-cd28 mab result": 0.01073, "abnormal apoptosis": 0.0089, "analogy": 0.00025, "leucine charge domain": 0.00804, "replicative infection": 0.0062, "mitochondrial enzyme": 0.0031, "vascular disease": 0.00673, "nfat dna binding activity": 0.01462, "apl-derived cell line": 0.0512, "cell type-specific enhancer": 0.0512, "stat6 inhibits human interleukin-4 promoter activity": 0.01254, "prl": 0.00174, "osteoblast nuclear extract": 0.01123, "quantitative reverse transcriptase-polymerase chain reaction": 0.00175, "bone marrow-derived mip-1 alpha/gos19 inhibits primitive hematopoietic stem cell": 0.01707, "stat1 mab": 0.00285, "moderate decrease": 0.00971, "data prompt": 0.00254, "periodic acid-schiff": 6e-05, "random migration": 0.00155, "precursor cd4+": 0.00323, "healthy male": 0.00177, "additional taqi restriction site": 0.01084, "recombinant c-jun": 0.00493, "transient decrease": 0.00971, "maintain immunological memory": 0.00159, "delta promoter fragment lead": 0.01168, "lampf lead": 0.00996, "hla-dqb": 6e-05, "sampling": 0.00012, "individual transcriptional property": 0.00767, "premenopausal": 0.00031, "-685": 0.00012, "tcr-beta": 0.00012, "p85 bind": 0.02025, "thiol compound": 0.0022, "nf.kappa": 0.00031, "ductal breast carcinoma": 0.00172, "cellular regulation": 0.01008, "nfat activity": 0.02925, "mucosa-associated lymphoid tissue": 0.00443, "healthy subject": 0.00354, "describe marked alteration": 0.00265, "sox9": 0.00031, "behavior": 0.00118, "serum-starved mm patient cell": 0.0384, "cd11b/cd18 expression": 0.04163, "regulate collagenase-1 transcription": 0.01873, "cd21": 0.00062, "proper lymphoid development": 0.00422, "nk cell nfat": 0.0512, "signal receptor": 0.02571, "cross-talk": 0.00074, "mnp-2 weakly": 0.00081, "double immunostaining technique": 0.00072, "dna": 0.02965, "carboranes": 6e-05, "ongoing study": 0.01355, "minimal extent": 0.00214, "ciita activate": 0.01777, "long-term exposure": 0.0035, "zymogen plasma factor": 0.01907, "janus kinase/stat signal pathway": 0.00817, "downstream signal event": 0.0109, "include glucocorticoid receptor": 0.01714, "g28-5 sfv augment cd40 response": 0.00777, "multiple cis-acting regulatory site interact": 0.00867, "antidiabetic agent troglitazone": 0.00281, "methodology": 0.00019, "nik inhibited stimulus-induced kappab-dependent transcription": 0.01124, "negative influence": 0.00515, "include 5-lipoxygenase": 0.01439, "cd4 cell induce": 0.0512, "sp1 transcription factor bind": 0.0143, "lymphoma cell ri-i": 0.0512, "nf-kappa b/sp1 enhancer": 0.00943, "bcl6 molecule": 0.00853, "human bone morphogenetic protein-2": 0.01881, "nf-kappa b-related transcription factor": 0.0143, "class switch recombination": 0.00428, "control transcription factor": 0.01907, "oct-dna interaction reveals": 0.00658, "flutamide treatment": 0.01014, "thymic maturation": 0.00251, "recombinant retrovirus vector": 0.00261, "gro-alpha immobilization": 0.00012, "critical cysteine residue": 0.00285, "signal transducing pathway lead": 0.00817, "htlv-i promoter": 0.02336, "ikappab-alpha": 0.00223, "pml protein": 0.04529, "phi ingestion": 0.00016, "chinese prescription": 0.00047, "gold compound autg": 0.00147, "p50 nfkappab1": 0.00288, "oxidative stress condition": 0.0024, "uptake and/or binding": 0.01237, "incomplete suppression": 0.00416, "il-2 gene promoter region": 0.02177, "cell stimulation": 0.0768, "late treatment": 0.01014, "cytoplasmic transcription factor": 0.01907, "translocation support": 0.00515, "calcium-mobilizing potency": 0.00068, "nuclear localization": 0.01684, "malignant cell": 0.0768, "chromosomal localization": 0.00186, "-176": 0.00019, "yae antibody": 0.00893, "derivation": 0.00019, "j.virol.70:2260-": 6e-05, "e47 collaborate": 0.00037, "interleukin-15 promotes extrathymic development": 0.00316, "adeno-associated virus": 0.00887, "overlap cd40l": 0.00177, "simple tandem repeat dna polymorphism": 0.00593, "tetrahydropapaveroline": 6e-05, "parental myeloblast": 0.00074, "unexpected expression": 0.04163, "culture protein filtrate": 0.03019, "cd65s+": 6e-05, "gal4 dna bind domain reveals": 0.0081, "suppress lymphocyte proliferation": 0.00988, "ascorbate oxidation": 0.00059, "oligos": 0.00012, "ciclosporin": 0.00019, "normal hemopoiesis": 0.0121, "immunodeficiency syndrome therapy": 0.00248, "isoelectric focusing demonstrate": 0.01065, "nmr model": 0.00422, "ap-1 enhancer activity induce": 0.01462, "ad lend support": 0.00273, "cell receptor-beta": 0.0768, "u9-iiib cell": 0.0768, "oct-2-directed transcription": 0.0281, "igg immune complex model": 0.00842, "protein expression parallel": 0.03019, "peptide match cover": 0.00502, "cyclophosphamide": 0.00012, "crucial mhc class ii gene regulatory factor": 0.01244, "gene activation show": 0.02903, "disease-resistant sooty mangabey": 8e-05, "cellular immune function": 0.00887, "pb mononuclear cell population": 0.0384, "general transcription machinery": 0.01873, "detectable nfatc protein": 0.03019, "respective gene": 0.04355, "hiv-1 provirus correlate": 0.00585, "slight effect": 0.02115, "dexamethasone kd": 0.00394, "activated": 0.01179, "integrin-mediated tyrosine phosphorylation": 0.00656, "nf-kappab confers": 0.00999, "increase raf-1 kinase activity maximum 3.3-fold": 0.00975, "enhancer present": 0.00909, "b-cell-specific gene": 0.04355, "correlative ltr transactivation": 0.00343, "prevailing hypothesis": 0.00133, "classical p50/p65 heterodimer": 0.00136, "tissue leukostasis": 0.00664, "positive induction": 0.01607, "upregulated p50 homodimers": 0.00192, "opioids affect": 0.00797, "comparative study": 0.01355, "decreased p65-rela protein expression": 0.02264, "cell-sorted monocyte": 0.01197, "anti-c/ebp beta ab": 0.00449, "influenza virus-exposed": 0.00037, "hla-dq-restricted": 0.00012, "ca2+-modulating cyclophilin ligand": 0.00395, "n-acetyl cysteine": 0.00124, "apparent glucocorticoid resistance": 0.00567, "p/i stimulation": 0.0112, "35-kda": 0.00012, "cellular gene": 0.04355, "receptor tyrosine kinase c-erbb": 0.01286, "unequal": 0.00012, "egr-1 correlate": 0.00654, "thapsigargin": 0.0005, "detailed understanding": 0.00062, "oxidative-stress sensitive transcription factor nf-kappab": 0.01144, "eosinophilic abnormality": 0.00239, "il-1beta/sv40 promoter/cat": 6e-05, "c/ebp-epsilon transcription factor": 0.01907, "progesterone binding structure": 0.01237, "death domain-containing receptor": 0.01714, "prolonged treatment": 0.01014, "positive effect": 0.02115, "lung cell type": 0.0512, "reverse transcriptase-polymerase chain reaction": 0.00219, "t-cell receptor gene": 0.02903, "neutrophil interleukin-8 production": 0.00695, "rabbit anti-c/ebp-epsilon antibody": 0.00596, "ifn-gamma secretion": 0.00481, "multiple potential binding site": 0.01084, "prooxidant condition": 0.0036, "cell volume": 0.0768, "distinct gene encode": 0.02903, "nutritional component": 0.00456, "poz/zinc finger transcriptional repressor express": 0.00738, "potential phosphatidylinositol 3-kinase": 0.00403, "-395": 6e-05, "il-2 target": 0.01117, "v-abl protein": 0.04529, "-kb": 0.00012, "specific glucocorticoid receptor blocker": 0.01286, "tnf-alpha gene": 0.04355, "semiquantitative competitive hybridization assay": 0.00501, "culture medium block macrophage differentiation": 0.00471, "pge2-mediated activation effect": 0.02109, "noninvasive delivery": 0.00059, "er level": 0.01821, "sodium salicylate suppress nf-kappa": 0.00707, "hiv regulation": 0.01008, "molecular defect": 0.0045, "intravenous glucocorticoid": 0.0085, "cytokine effect": 0.02115, "htlv-i-infected": 0.00062, "sr. gel retardation assay": 0.00501, "active woman": 0.00592, "candidate repressor/activator": 0.00059, "study mechanism responsible": 0.00904, "replication competent": 0.00471, "increase transcriptional activity": 0.0195, "proinflammatory cytokine secrete": 0.00749, "bioavailability": 0.00031, "genomic clone pgd41": 0.00492, "mutation frequency": 0.00592, "cell antigen receptor stimulation": 0.0384, "mrna specie express": 0.0123, "functional importance": 0.00816, "adhesion": 0.0116, "abnormal renal sodium handling": 0.00098, "combined action": 0.00499, "tcr/cd3": 0.00099, "hl60r cell": 0.0768, "chronic inflammation": 0.00397, "stress": 0.0062, "beneficial profile": 0.00152, "narrow range": 0.00202, "p1": 0.00056, "ngre": 6e-05, "augment vcam-1": 0.00236, "gld/gld cd4": 0.00332, "s.e.derocco": 0.00012, "raf-mediated enhancement": 0.00233, "hydrolase require": 0.01315, "t3-responsive reporter gene": 0.02903, "human eosinophil initiate": 0.02508, "calcineurin independent manner": 0.00242, "heteromeric interaction": 0.00986, "cbf consist": 0.00183, "particulate activator": 0.00552, "major apoptotic mechanism": 0.00705, "truncated tnf-alpha promoter": 0.01557, "enhance lyn mrna production": 0.00763, "1,2-bis": 0.00012, "garlic compound": 0.0022, "maturation result": 0.0161, "dephosphorylated prb": 0.00136, "her-2/neu": 0.00068, "cross-linking cd40 support nf-kappa b-dependent gene expression": 0.01244, "double transfectants": 0.00099, "ifn alpha-containing regimen": 0.00153, "hypersensitive site-forming element": 0.01115, "reticulocyte lysate-synthesized trs": 0.00037, "subsequent rolling": 0.00304, "analog rad": 0.00109, "upregulate nf-kappa": 0.01414, "gp120-anti-gp120 immune complex": 0.01123, "blood histamine": 0.00592, "tnf lead": 0.00996, "kappa b-alpha degradation": 0.00498, "regulate late gene expression": 0.02177, "ags": 0.00025, "sterol dependent ldl-receptor gene transcription": 0.01742, "timp": 0.00025, "negative regulator": 0.00515, "phenotypic conversion": 0.00084, "hplc": 0.00037, "zhang": 0.00037, "jun protein complex": 0.03019, "normal human peripheral blood": 0.01881, "independent gene": 0.04355, "actin": 0.00149, "b-lcl": 0.00019, "reverse profile": 0.00236, "steroid-sensitive asthma": 0.00161, "2-phase neutrophil-endothelial adhesion response": 0.00971, "mrna stabilization": 0.01526, "pebp-2alpha": 6e-05, "nf-kappa b-mediated gene expression": 0.02177, "htlv-i ltr": 0.0031, "partial receptor occupancy": 0.01714, "anti-cd3 antibody": 0.00893, "chicken t-cells": 0.00211, "human interleukin-7 receptor complex": 0.01881, "adenosine": 0.00074, "placental cell": 0.0768, "early antigen": 0.00828, "cellular tumor necrosis factor receptor-associated factor": 0.00477, "humoral immunity": 0.00112, "intracellular tyrosine phosphatase": 0.00474, "adrenal pituitary axis": 0.00043, "antiviral": 0.0013, "oxygen radical scavenger": 0.00066, "intracellular granule": 0.00583, "gtp-binding protein function": 0.03019, "rxr-specific ligand": 0.00592, "t3+ subject": 0.00354, "lps addition": 0.00673, "rna polymerase ii transcription": 0.01405, "blood pressure": 0.00592, "joint requirement": 0.00264, "ra response element": 0.01294, "preactivated primary nk": 0.00492, "express gene": 0.04355, "t-cell stimulation": 0.0112, "enhancer core": 0.00909, "fibromyalgia": 0.00019, "core sequence taat": 0.01084, "interferon-alpha activates multiple stat protein": 0.01811, "immediate-early t-cell specific gene include interleukin-2": 0.01452, "intracellular cholesterol synthesis": 0.00389, "general coactivator requirement show": 0.013, "vdr polymorphism": 0.00233, "bind data": 0.02025, "heavy": 0.00174, "biologic activity": 0.02925, "rel transcription factor family": 0.0143, "surrogate tg receptor": 0.01714, "temporal analysis": 0.01179, "dual activity": 0.02925, "thymic atrophy induce": 0.01694, "affect rho-induced ap-1 activity": 0.01462, "-509": 6e-05, "cd8-negative subtype": 0.00034, "hematopoietic-specific transcript": 0.00599, "nf-kappa-b": 6e-05, "sequencing": 0.00062, "phenylpyrazol fuse": 0.00149, "receptor-mediated mechanism": 0.01058, "cd95/apo-1": 0.00019, "altered cytokine profile": 0.00749, "suppressor": 0.00211, "shigella movement": 0.00022, "display": 0.00999, "acute promyelocytic leukemia patient": 0.00833, "proliferating": 0.00019, "induce myeloid differentiation": 0.01694, "antigenic site": 0.02168, "il3 gene expression": 0.02903, "egfr": 0.00025, "tnf -or pma- induce hiv replication": 0.00847, "target disruption": 0.00825, "tcf-1 consists": 0.00189, "disturbance": 0.00025, "ischemia/reperfusion": 6e-05, "lipoprotein-lipopeptide-induced immune cell signal event": 0.03072, "normal rbc show": 0.01733, "independent": 0.00726, "transfected cell line": 0.0512, "discernible effect": 0.02115, "c-rel proto-oncogene": 0.00245, "mastectomy": 0.0, "human diploid fibroblast": 0.02508, "chimeric animal suggest": 0.01348, "putative additional lymphoid-specific transcription factor": 0.01144, "normal immature human myeloid cell": 0.03072, "minimacs separation unit": 0.0007, "ii chain": 0.00726, "phosphotyrosine phosphatase activity": 0.0195, "il-5-specific regulatory mechanism": 0.00705, "transcriptional transrepressive activity": 0.0195, "fkhrl1 gene product": 0.02903, "sepsis-associated disease": 0.00673, "camp-responsive element bind protein": 0.02264, "chi2=6.25": 6e-05, "promyelocyte-late myeloblast-derived lambda gt11 library": 0.00037, "transactivation function": 0.01331, "proenkephalin transcription": 0.0281, "epidermal basal cell": 0.0512, "tnfalpha simulation": 0.00136, "tcr signaling": 0.00558, "open": 0.00143, "-glucan receptor": 0.02571, "rar/rxr heterodimer": 0.00205, "unseparated lavage cell": 0.0512, "t3so4 fail": 0.00347, "40-kd tax protein": 0.03019, "lps-responsive enhancer element": 0.01115, "inos expression": 0.04163, "mtetra induces il-1 beta": 0.00402, "tcf-1 mrna": 0.01526, "deletion mark": 0.00344, "subunit bind domain": 0.0135, "gamma chain gene": 0.02903, "gene implicate": 0.04355, "monocyte adherence": 0.01197, "subcellular redistribution": 0.0004, "b7 costimulatory molecule": 0.00569, "gpiib promoter": 0.02336, "viral gene regulatory mechanism": 0.02177, "ut-7/gm cell": 0.0768, "low-affinity receptor": 0.02571, "intracellular ca2+": 0.00583, "chronic kidney insufficiency": 0.00265, "study trident expression": 0.02775, "pebp2 alpha": 0.01169, "tumor-specific rearrangement": 0.00199, "nk": 0.00732, "correspondence": 0.00012, "adjacent sp 1-binding site": 0.01084, "differentiated monocyte phenotype characterize": 0.00599, "genomic clone": 0.00738, "survivor cell line": 0.0512, "rp1 gene": 0.04355, "nh2 regulatory": 0.00682, "consists": 0.00081, "vdr-retinoid": 0.00012, "simian ebv lmp1s": 0.00376, "membrane structural order": 0.003, "eliminate ro": 0.00124, "il-1/il-1ra system": 0.00667, "-21/-12": 6e-05, "arginine element": 0.01672, "scl protein production": 0.03019, "bcr-cross-linking": 6e-05, "viral replication rate": 0.00488, "disturbed fetal brain development due": 0.00253, "defect downstream": 0.00298, "dna bind nf-kappa": 0.0135, "tnf-alpha gene expression": 0.02903, "macrophage-": 6e-05, "src-family": 0.00031, "stat3alpha serine": 0.0014, "glucocorticoid-induced cell death require autoinduction": 0.03072, "tfg-beta": 6e-05, "block cd8 interaction": 0.00715, "adoptive transfer": 0.0009, "nfatp bound": 0.00292, "select patient": 0.01666, "pbeta": 6e-05, "unique c-terminal domain": 0.00804, "human chronic myelogenous leukemia cell line rwleu-4": 0.02194, "pp2a": 0.00043, "accessory receptor": 0.02571, "b-cell line": 0.01653, "e2f-1 gene": 0.04355, "affect a-myb transcription": 0.01873, "intact il-2 promoter": 0.01557, "relevant cis-elements": 0.00143, "transduction/transcription factor": 0.0286, "octamer dna motif": 0.00988, "erythroid-specific dnase": 0.00136, "tetracycline trans-activator protein": 0.03019, "signal transducer molecule": 0.0109, "yield constitutive repressor": 0.00318, "data": 0.00509, "transforming growth factor-beta family": 0.0042, "zinc finger gene": 0.02903, "prostaglandin": 0.00099, "antigen-": 0.00037, "acute infection": 0.0062, "cell apc": 0.0768, "stress responsive hsp70b promoter": 0.01168, "postmenopausal patient": 0.01666, "typical ap-1 site": 0.01445, "retinoid-induced differentiation program": 0.00786, "hela nonpituitary cell": 0.0512, "-mediated proliferation": 0.00803, "c-terminal amino acid": 0.00571, "ngfi-b/nur77": 0.00043, "cross-linking cd3": 0.00242, "tcrg mrna level": 0.01214, "dor1 ligation": 0.0018, "gst-construct": 0.0, "blastocyst": 0.0, "gld/gld mouse": 0.00974, "atypical pkc-zeta isoforms": 0.00205, "cell supernatant": 0.0768, "epstein-barr virus latent membrane protein lmp1": 0.0151, "1,25-dihydroxyvitamin d3": 0.00245, "dna-binding site abolish binding": 0.01084, "myeloid cell development": 0.0512, "neoplastic b-cell development": 0.00422, "human myeloid leukemia cell line": 0.03072, "multiple nuclear factor bind motif": 0.01144, "immunoprecipitation experiment fail": 0.00265, "lymphokine secretion": 0.00428, "gata-3 inhibits th1 cytokine": 0.00561, "plant kingdom": 0.00016, "gp+e-86": 0.00012, "myb-like dna bind domain": 0.01013, "sv40 t-antigen": 0.00047, "camp include": 0.01439, "synthetic lipid": 0.00202, "transcription factor stat1": 0.01907, "large germline deletion": 0.0023, "confocal fluorescence microscopy": 0.00043, "b1 vitellogenin gene": 0.02903, "nm23-h2 protein": 0.04529, "construct test": 0.00726, "bzlf1 gene promoter": 0.02903, "express rp1 protein reveal specific bind": 0.0151, "hiv ltr-driven luciferase expression construct": 0.01665, "extracellular signal induce phosphorylation": 0.0127, "nf-kappab inhibitor": 0.00999, "generate estrone": 0.00453, "a-to-g transition": 0.00059, "xist locus": 0.00288, "pu-sf": 0.00019, "resident gene": 0.04355, "enhancer result": 0.0161, "pebp2 alpha/aml-1 transcription factor": 0.0143, "bcp-all": 0.00031, "computer enhancement": 0.00233, "major transactivation sequence require": 0.00813, "stress- activated protein kinase": 0.02264, "myristoyl fatty acid": 0.00571, "cell express exogenous bcl-2": 0.0384, "hl-60 leukemia cell": 0.0512, "ebna-2 type": 0.00949, "gata3": 0.00105, "centromere": 0.00025, "affect lps-induced tf activity": 0.01462, "il-4-independent fashion": 0.00161, "human beta-globin gene": 0.02903, "form specific dna-protein complex": 0.00842, "pma-treated cell": 0.0768, "aberrant intracellular signaling": 0.00389, "promote peptide exchange": 0.00502, "immunomodulatory cytokine il-4 affect cell": 0.03072, "ebna2 expression vector": 0.02775, "cell protein tcf-1": 0.0512, "inflammatory process": 0.00471, "c-jun gene 1.4-fold": 0.02903, "tissue resistant": 0.00664, "proximal ghf-1/pit-1 binding site": 0.01084, "high proportion": 0.00931, "ala-substituted peptide": 0.00754, "directs": 0.00043, "mature erythroblast": 0.00329, "9-cis retinoic acid induces monocyte chemoattractant protein-1 secretion": 0.00299, "cell enter": 0.0768, "cd28 response complex": 0.01294, "jurkat crude extract": 0.0037, "increased surface expression": 0.02775, "iii": 0.00174, "c5a-induced il-8 gene expression": 0.02177, "transgenic expression": 0.04163, "il-12-stimulated cell": 0.0768, "pathologic picture": 0.00031, "nfat-dependent transactivation": 0.00515, "induce fasl promoter-dependent reporter construct": 0.01016, "lymphocyte culture stimulate": 0.00988, "reduced circulating t4": 0.00139, "nf-kappab/rel family protein": 0.03019, "cell morphology show dendritic process": 0.03072, "mycoplasma-derived material mdhm": 0.0005, "transcription factor dna-binding activity": 0.01462, "low copy repeat detect": 0.00363, "major positive regulatory role": 0.00664, "receptor binding study": 0.01714, "anti-runt box antiserum": 0.00203, "eklf-/-": 0.00031, "increase awareness": 0.02196, "pmn-mediated lung injury": 0.0013, "cd3/tcr-dependent signal transduction": 0.0109, "anaphylatoxin c3a": 0.0005, "nf-kappab activation/translocation occur": 0.00666, "phosphonate-containing liposome": 6e-05, "il-4 enhances mrna degradation": 0.00763, "fasl-mediated apoptosis": 0.0089, "cellular pathway": 0.01278, "yac contig": 0.00012, "tbp-associated factor tafii250": 0.01907, "enhance cat activity": 0.0195, "patient respond": 0.01666, "sixfold": 6e-05, "il-2ralpha": 0.00124, "gtp-binding activity": 0.02925, "ligand-induced transient membrane hyperpolarization": 0.00225, "molecular detail": 0.0045, "target-": 6e-05, "require constant surveillance": 0.00877, "multiple allelic form": 0.00703, "polypeptide range": 0.00202, "pha stimulate il-2r alpha-": 0.00551, "phorbol 12-myristate 13-acetate-differentiated u-937 cell": 0.03072, "unique model system": 0.00445, "control transcriptional activity": 0.0195, "difficult": 0.00019, "murine leukemia virus transcription": 0.01405, "zinc finger type": 0.00633, "human c-rel": 0.03762, "transfected jurkat cell clone": 0.0384, "finding demonstrate differential lineage requirement": 0.00639, "ebv nuclear": 0.01684, "hmg-i": 0.00112, "productive": 0.0013, "detectable tax expression": 0.02775, "electrophoretic mobility": 0.00146, "wild type 430-444": 0.00633, "-1 long terminal repeat": 0.00189, "tcl1": 0.00143, "core 5'-ggaa-3": 0.0022, "lymphocyte activation": 0.03164, "cd14+ monocyte": 0.01197, "t-cell antigen": 0.00962, "human immunodeficiency virus transmission": 0.01881, "bukrinsky": 0.00019, "central importance": 0.0013, "recombinant": 0.00782, "physiologic mechanism control reactvation": 0.00651, "inhibitory drug interaction affect": 0.00493, "purified phytohemagglutinin": 0.00261, "site iv": 0.02168, "potent interleukin": 0.00357, "estrogen receptor-negative tumor status": 0.00467, "ca2+-induced activation": 0.03164, "direct t-cell control": 0.00868, "stat4 inducible protein": 0.03019, "rest pbl-t suppresses binding": 0.00927, "-260 relative": 0.00276, "increase resistance": 0.02196, "t-cell antigen receptor": 0.01714, "untreated hl-60 leukemic cell": 0.0384, "clone tcf-1 alpha protein": 0.02264, "occasional lymphoid aggregate formation": 0.00242, "translocated": 0.00025, "definitive erythroid": 0.0062, "basal level gr expression": 0.02081, "cell-specific tyrosine kinase gene": 0.02177, "biochemical mechanism": 0.01058, "delta-ala. epo": 0.00171, "zeta-globin mrna cap site": 0.01084, "ramos": 0.00068, "functional ets site": 0.01445, "atra fail": 0.00347, "block lmp1": 0.01073, "indirect evidence provide": 0.0043, "octamer-binding protein": 0.04529, "dna binding reveal": 0.01237, "retroviral vector-mediated transduction": 0.00283, "initial decrease": 0.00971, "synthetic oligonucleotide probe": 0.00174, "c-rel/p65 heterodimers selectively bound": 0.00146, "human t-cell leukemia virus-infected human": 0.00752, "il-15r": 0.0, "primitive cell": 0.0768, "neuropeptide enkephalin": 6e-05, "p100-mediated cytoplasmic sequestration": 0.00267, "display normal number": 0.00806, "hsp": 0.00037, "human pax-5 gene": 0.02903, "cell trigger": 0.0768, "apo-1": 6e-05, "splenic erythroblast": 0.00105, "repress nfkappab-mediated cytokine production": 0.00561, "nfat sequence fail": 0.01084, "modulation": 0.00515, "tripterygium wilfordii hook": 6e-05, "shigella icsa protein": 0.03019, "lung transplantation include": 0.00959, "cre-containing promoter": 0.02336, "sublining cell": 0.0768, "-46": 0.00019, "pcd": 0.00012, "recombinant pc4": 0.00391, "phosphorylation profile": 0.00983, "sensitive mutation screen assay": 0.00501, "stimulate mitogen-": 0.01101, "transcription factor nf-kappab regulates inducible oct-2 gene expression": 0.01089, "cat reporter gene suggest increased activity": 0.01452, "stat-related protein": 0.04529, "g1 specific cellular response": 0.00971, "persistent nf-kappa": 0.01414, "phorbol ester induces monocyte differentiation": 0.00479, "beta t-cell receptor": 0.01714, "animal specie": 0.00183, "microvascular ec": 0.00254, "permit dissection": 0.00081, "induce enzyme expression": 0.02775, "mrd-positive": 0.00019, "ata": 0.0, "nf kappa b-binding site": 0.01084, "anti-cd3-stimulated ap-1 enhancer activity": 0.01462, "tf promotor": 0.00174, "ba/f3 cell": 0.0768, "tnf-stimulated cell block": 0.0512, "'box1": 6e-05, "tfiihmut": 0.00019, "maturation": 0.00502, "e.g": 0.00074, "adherent human igg": 0.02508, "peroxisome proliferator activate receptor": 0.01286, "tissue-specific promoter": 0.02336, "-0.821": 0.0, "naive pbl": 0.00133, "s727 stat1 phosphorylation": 0.00656, "enhance degradation": 0.00974, "dna sequencing": 0.01483, "salicylate": 0.0013, "tnf gene expression": 0.02903, "spi-1 overexpression result": 0.01073, "viral target": 0.00825, "b-cell-specific coactivator oca-b": 0.00099, "epo-induced erythroid differentiation": 0.00786, "imbalanced expression": 0.04163, "srg3 mrna": 0.01526, "anti-apoptotic transcription factor": 0.01907, "immunopoiesis": 0.00019, "endogenous tnf-alpha": 0.00546, "ubiquitous ap1 factor": 0.01907, "front": 6e-05, "tnf-alpha selectively activate": 0.01185, "signal transduction pathway induce": 0.0127, "clinical implication": 0.00425, "multiple level": 0.01821, "develop thymocytes": 0.00403, "common property": 0.00397, "epo-induced differentiation": 0.01179, "saccharomyces cerevisiae": 0.00019, "mature immunocompetent cell": 0.0512, "delta promoter activate": 0.01557, "mediate anti-inflammatory": 0.01231, "lipoxygenase metabolite activate roi formation": 0.00711, "distinct signal pathway lead": 0.00817, "mg protein": 0.04529, "kda stat5 protein": 0.03019, "ic50": 0.00143, "cytosolic calcium": 0.00236, "stat5 recruitment": 0.00254, "time-dependent manner": 0.00282, "human genome evolution": 0.02508, "ifn-alpha exerts": 0.00146, "positive regulatory element": 0.01115, "demonstrate reconstitution": 0.01597, "differential response": 0.01942, "gene hypermethylation": 0.04355, "primary b-lymphocytes": 0.00738, "delta subunit": 0.00484, "micrococcal nuclease": 0.00019, "cell cycle prior": 0.0512, "gm-csf reporter construct": 0.00484, "young subject stimulate": 0.00734, "p53 lead": 0.00996, "transactivates latent membrane protein lmp1": 0.01811, "okadaic acid treatment": 0.00676, "squirrel monkey express": 0.0123, "activation associate": 0.03164, "low transcription enhancement": 0.01873, "m. yoshida": 0.00115, "hrs c-fos expression decline": 0.02081, "total protein content": 0.03019, "intronic enhancer stimulates transcription": 0.01405, "antioxidant condition": 0.0036, "estrone potentiate myeloid cell differentiation": 0.03072, "two-fold increase": 0.02196, "increase transcriptional initiation": 0.01464, "question": 0.00019, "rephosphorylation": 6e-05, "supershifts": 0.00019, "induces tumor": 0.00934, "major subunit": 0.00574, "subject endometrium": 0.00354, "rare-mediated transcription": 0.0281, "altered composition": 0.00161, "iv dose": 0.00158, "peripheral lymphoid organ": 0.00349, "include il2": 0.01439, "il-1 -and lps-induced nf-kappab-luciferase activity": 0.0117, "t-cell receptor": 0.02571, "lysozyme": 0.00031, "igm-secreting cell": 0.0768, "escherichia coli lac operator": 0.00034, "physical exercise": 0.00096, "faster-migrating complex": 0.01684, "distinct specie": 0.00698, "downstream interactor": 0.00298, "osteoclast marker": 0.00382, "random breast aspirate": 0.00172, "gonzalez": 0.00012, "bfl-1/a1": 0.00012, "common member": 0.00413, "family member": 0.00841, "lp stimulate vascular cell adhesion molecule": 0.0256, "major focus": 0.00574, "cellular factor": 0.0286, "cd4-cd8-double-negative": 6e-05, "glucocorticoid receptor number": 0.01714, "t/nk developmental checkpoint": 0.00085, "retroviral transduction": 0.00425, "g0s2 mrna level": 0.01214, "gamma-ifn": 0.00112, "blood relative": 0.00592, "29-kda protein phosphorylated": 0.03019, "human il-2": 0.03762, "induce irs": 0.0254, "cytokine gene express": 0.02903, "thymocyte-thymic epithelial cell interaction lead": 0.03072, "protein-free": 6e-05, "cell-cell adhesion": 0.0058, "chain": 0.00875, "transcriptional function": 0.01331, "memory phenotype": 0.00366, "bp repetitive stretch": 0.00178, "lymphoid-specific transcription factor oct-2a play": 0.01144, "fludarabine": 0.00031, "cd40/cd40 ligand interaction play": 0.00493, "purified human p65 nf-kappa": 0.01881, "transcription factor activate": 0.01907, "5-25": 6e-05, "maintenance": 0.00199, "interleukin-6 gene expression": 0.02903, "agonist binding": 0.01855, "element require": 0.01672, "activate stat protein": 0.03019, "approximate location": 0.00028, "constitutive nuclear expression": 0.02775, "important protective cellular mechanism": 0.00529, "htlv-i immortalized tax-expressing human t-lymphocyte line": 0.01254, "mediate epstein-barr virus latent membrane protein": 0.0151, "and/or elf-1": 0.0045, "distinct e2f dna-binding protein": 0.02264, "human alpha-like globin promoter": 0.01881, "-positive individual": 0.00409, "granulosa cell tumor": 0.0512, "unspliced mrna": 0.01526, "steroid/thyroid hormone receptor family include": 0.01029, "hb-egf mrna": 0.01526, "protein kinase a. activation": 0.02264, "fibrosarcoma": 0.00025, "inducible transcription factor ap-1": 0.0143, "variant er form remain": 0.00527, "degenerate primer correspond": 0.00118, "single gene trans-activation": 0.02903, "show increased sensitivity": 0.01733, "potential tool": 0.00605, "significant age-related decline": 0.00277, "isgf3": 0.0013, "interleukin-1beta": 0.00143, "induces c-fos": 0.00803, "cell surface molecule cd28 bind": 0.03072, "retroviral transgene": 0.00071, "ku autoantigen p70 subunit": 0.00242, "nf kappa b-i kappa": 0.00187, "rna transcript encode": 0.00569, "il-5 signaling": 0.00558, "ccgccc bind protein": 0.03019, "mab": 0.00533, "cc chemokine": 0.00105, "u937 cell": 0.0768, "cyclic amp-responsive element": 0.01115, "color flow cytometry analysis": 0.00589, "murine thy-1 gene promoter": 0.02177, "gp160-mediated activation": 0.03164, "express pan transcript": 0.0123, "hyperthyroidism": 0.00037, "gamma interferon-inducible fashion": 0.00294, "anti-cd3 monoclonal antibody-induced t-cell proliferation": 0.00385, "nf-kappab binding sequence": 0.01237, "protein-binding eb1 gene family": 0.02177, "unregulated expression": 0.04163, "phenyl ring": 0.00022, "human abf-1": 0.03762, "caspase activity measure": 0.0195, "identical half-life": 0.00226, "potential clinical significance": 0.00403, "icer": 0.00031, "functional b-cell response": 0.01294, "evolutionary": 0.00037, "protein exist": 0.04529, "decreased tyrosine phosphorylation": 0.00656, "cortivazol": 0.00062, "recurrence": 0.00037, "intrafollicular t-cells": 0.00211, "non-ig gene hypermutation": 0.02903, "reconstitution": 0.00068, "glucocorticoid provide": 0.0085, "functional motif": 0.00875, "il": 0.0018, "ulrich": 0.00012, "freshly extract human thymocytes": 0.01881, "t-lymphocyte activation mechanism": 0.02109, "immunologic crossreactivity": 0.00071, "ifn-alpha/b-stimulated early response gene": 0.02177, "flexi-12": 0.00031, "tpa inducibility": 0.00189, "gata-1 transcription factor": 0.01907, "conventional id-3": 0.00065, "ileal resection": 0.00028, "amino acid alanine": 0.00571, "child": 0.00136, "xenopus": 0.0005, "nf-kappab1 p105 precursor protein": 0.02264, "tcr-induced il-2 production": 0.00744, "inhibit h2o2 release": 0.0127, "divergent site": 0.02168, "secondary virus infection": 0.00591, "human t-cell lymphotrophic virus type-i tax gene induces secretion": 0.00968, "p50/rela dimer": 0.00102, "good characterize": 0.00425, "antigen result": 0.0161, "tt-selected line": 0.01653, "entrance": 6e-05, "hiv-1 transactivation": 0.00878, "amebic infection": 0.0062, "thrombin-stimulated": 0.00019, "minute posttreatment": 0.00043, "dicarba-closo-dodecaboranes": 0.0, "heterogeneous": 0.00136, "protein-dna complex": 0.01684, "combination isoform": 0.00288, "hiv-1 promoter transcription": 0.01873, "dqa1*0501": 0.00012, "precise alignment": 0.00065, "bmt inhibit": 0.01904, "nonerythroid nih3t3 cell": 0.0512, "silencer contribute": 0.00378, "100-fold": 0.0005, "additional binding site": 0.01445, "-beta subunit expression": 0.02775, "increase mrna": 0.02196, "ros pathway": 0.01278, "antisense oligomers target pml mrna": 0.0061, "hiv-1 transfected": 0.00878, "rxr-specific": 0.00025, "active phosphorylated creb protein": 0.02264, "ap-1/cat activity": 0.02925, "coagulation protease cascade": 0.00143, "dnd39": 0.00031, "gene important": 0.04355, "process": 0.00887, "common therapeutic": 0.0035, "cd8+ cytotoxic": 0.00174, "af-10": 0.0, "activation domain requirement": 0.02109, "transfected nf-kappa b-regulated promoter": 0.01168, "c-myb expression": 0.04163, "murine tnf promoter": 0.01557, "define minimal enhancer": 0.00606, "similar interaction": 0.00986, "eosinophil-depleted leukocyte": 0.00478, "altered distribution": 0.00161, "rest g0/g1 state": 0.00178, "persistence": 0.00112, "cell-types": 0.0, "considerable extent": 0.00115, "tyr396": 6e-05, "pro-il-16": 0.00012, "adipocyte differentiation": 0.01179, "c-jun protooncogene": 0.00493, "tap associate": 0.01092, "sml": 0.00056, "60-min time": 0.00273, "chemically-reactive metabolite": 0.00109, "distinct transcriptional activity": 0.0195, "il-2 binding analysis demonstrate": 0.00927, "pkc isoforms": 0.00332, "duffy blood group antigen": 0.00409, "primary lymphoid cell": 0.0512, "resultant primer product": 0.00356, "ebv alter": 0.00565, "tnf-alpha mrna accumulation": 0.01017, "posttranslational mechanism": 0.01058, "alpha a1": 0.01169, "lsp-1": 0.00012, "ciprofloxacin": 0.00074, "bat box bind protein": 0.02264, "epo-induced phosphorylation": 0.00983, "oct-2 c-terminal domain": 0.00804, "inverse correlation": 0.00248, "pebp2 alpha/aml-1-related factor increase osteocalcin promoter activity": 0.00836, "diethylstilbestrol": 0.00025, "human cytomegalovirus induces interleukin-8 production": 0.01505, "drosophila gene runt": 0.02903, "ifn-gamma production": 0.01042, "breast tissue biomarkers": 0.00443, "ea-d/bhlf1/noti": 6e-05, "high hybridization accessibility": 0.0062, "suggest nfat1": 0.02022, "include tumor necrosis factor alpha": 0.01144, "parallel series": 0.00205, "host immune mechanism select": 0.00529, "protected region": 0.01467, "require synthesis": 0.01315, "gr6": 0.00019, "describe transcription factor pat": 0.0143, "immuno-cytochemistry": 0.0, "premature stop codon": 0.00048, "ru24858": 0.00012, "inhibit phorbol ester/ionomycin-induced activation": 0.01582, "epstein-barr virus nuclear antigen": 0.00842, "inhibitory domain determine": 0.00804, "kappab-mutated": 6e-05, "musculin": 0.00025, "phosphotyrosine labeling": 0.0005, "myb-ets oncoprotein": 0.00115, "viral dna": 0.01483, "ro": 0.0018, "cd14 induction": 0.01607, "human lymphoid cell": 0.0512, "hallmark": 0.00037, "downstream kinase": 0.01188, "corticosteroid-resistant bronchial asthma": 0.00108, "normal mouse il-2 enhancer": 0.00605, "stat3 phosphorylated": 0.00354, "vascular cell adhesion molecule-1": 0.0384, "phosphatidyl inositol turnover": 0.00074, "rupture": 0.00031, "rt-pcr resulting": 0.00087, "describe receptor-associated protein kinase": 0.02264, "preparation": 0.00149, "il-13 up-regulated": 0.00183, "egr-1 base": 0.0031, "cd27+": 0.00012, "enhance b-cll differentiation": 0.00786, "tissue section": 0.00664, "itk mutant": 0.0081, "normal subject": 0.0121, "-429": 0.00012, "synthesize ie1": 0.00158, "oxidant-induced nf-kappa": 0.01414, "multiparameter flow cytometric": 0.00101, "rela-overexpressing cell": 0.0768, "nf-kappab nuclear translocation correlate": 0.00842, "rap1": 0.00112, "5'-most ets sit": 0.00139, "cytokine gene expression differs": 0.02177, "site selection analysis": 0.01445, "oral prednisone": 0.00074, "parental hl60 cell": 0.0512, "epsilon exon": 0.00127, "growth rate": 0.00819, "characteristic similar": 0.00673, "control progression": 0.01303, "intraductal carcinoma": 0.0018, "human nk cell membrane-bound lt signal": 0.0256, "caat element": 0.01672, "human il-13 gene": 0.02903, "inhibit long-term beta-globin gene silencing": 0.01742, "low cd3+cd28-induced interleukin-2 production correlate": 0.00417, "induce specific lineage maturation": 0.0127, "cd56+ cell population": 0.0512, "wild-type grf40": 0.00378, "type ii diabetes": 0.00633, "renewal": 0.00019, "fhit transcript": 0.00599, "variable anemic severity": 0.00103, "putative chicken shc homologue": 0.00186, "ami": 0.00025, "ctcf mrna": 0.01526, "mononitrosyl iron complex": 0.01123, "century": 6e-05, "lymphotoxin promoter": 0.02336, "oestrogen antagonist": 0.00242, "proliferative state": 0.00267, "interleukin-7 signaling": 0.00558, "vdr message": 0.00233, "nonatopic subject": 0.00354, "direct link": 0.0054, "transgenic-mouse model": 0.00422, "ea-d promoter demonstrate": 0.01557, "tcr-induced phosphorylation": 0.00983, "activate early signal event": 0.00889, "multigene family": 0.00841, "functional promoter activity": 0.0195, "cloned genome": 0.0014, "dor1 signal increased": 0.0109, "-417": 0.00031, "up-regulated beta-": 0.00133, "p57": 0.00025, "inhibit event downstream": 0.0127, "functional aiolos-binding site": 0.01445, "potential pathway": 0.01278, "flank genomic clone": 0.00492, "-beta activity": 0.02925, "mds1/evi1": 0.00056, "nordihydroguaiaretic acid": 0.00856, "d584aqpqagr": 6e-05, "tnf-alpha-": 0.00056, "reverse transcription pcr": 0.01873, "site result": 0.02168, "vivo footprint": 0.0053, "facet": 0.0, "nk cell mediate cytolysis": 0.0384, "endogenous tyrosine kinase receptor c-kit": 0.01029, "chd display": 0.00499, "vasp": 0.0, "antibody induces tyrosine phosphorylation": 0.00492, "natural context": 0.00233, "17beta-hsd iv": 0.00078, "intact cell": 0.0768, "pbmc sensitivity": 0.00236, "okadaic acid": 0.00856, "procedure describe": 0.00397, "cell lymphoid malignancy": 0.0512, "activation and/or differentiation stage": 0.01582, "potential phosphorylation site include": 0.01084, "favorable clinical": 0.00425, "class ii-negative t-cell line exhibit": 0.00661, "proliferative signaling": 0.00558, "icn": 0.00012, "pma-pha combination": 0.00288, "aromatic amino acid hydroxylases": 0.00428, "mouse t-lymphoma cell line": 0.0384, "il-4 inhibit cytokine production": 0.00952, "short 40-bp region encompass": 0.00734, "zinc finger": 0.00177, "specific mhc molecule": 0.00825, "inflamed colonic mucosa": 0.00021, "granulocyte maturation block": 0.00715, "normal splenic": 0.0121, "develop vessel": 0.00403, "stat-1": 0.00112, "repeat": 0.00757, "immediate-early viral gene": 0.02903, "enhance ubiquitinylation": 0.00974, "keratinocyte-derived human cell": 0.0512, "culture human ec": 0.02508, "tyrosine phosphorylated": 0.0071, "nf-kappab element": 0.01672, "inflamed endothelium": 0.00062, "anti-apoptotic protein bcl-xl": 0.03019, "human dendritic cell": 0.0512, "macrophage colony-stimulating factor": 0.01907, "hla dqa1*0201/dqb1*0201": 0.00192, "major response": 0.01942, "normal tonsil": 0.0121, "tax/rex mrna": 0.01526, "transactivate": 0.00248, "probability": 0.00043, "climacteric syndrome patient": 0.0111, "dmdtc-treated": 0.00012, "decrease survival rate": 0.00647, "nf-ya subunit": 0.00484, "nf-atp-deficient mouse": 0.00974, "exert strong ap-1 inhibition": 0.0053, "thermosensitive sv40": 0.00047, "phosphatidylinositol-3-kinase": 6e-05, "u1 promonocytic culture": 0.00414, "nf-kappab/rel protein translocate": 0.03019, "mb-1": 0.00031, "il-6 luciferase activity": 0.0195, "increase il-6 protein expression": 0.02264, "permanent virus transcription": 0.01873, "sustained proliferation": 0.00803, "single point mutation": 0.00395, "human immunodeficiency virus type-1 transcription": 0.01505, "cbp rescue camp inhibition": 0.0053, "tumor necrosis factor gene expression": 0.01742, "human lymphocyte": 0.03762, "pi3-k inhibitor": 0.009, "reversed lighting regimen": 0.00021, "proto-oncogene": 0.00261, "80-kda protein": 0.04529, "human monocytic cell line u937": 0.03072, "murine myeloma": 0.00623, "a. estrogen": 0.00323, "t-cell population": 0.00962, "interleukin-2 promoter/reporter gene construct": 0.02177, "gammac lead": 0.00996, "isoform-specific c-terminal antibody reveal": 0.00549, "p39c-jun ap-1 activity": 0.0195, "high malignancy human melanoma": 0.01881, "local host defense": 0.00143, "major": 0.01148, "ml-3": 6e-05, "wild-type tes2": 0.00378, "ltr modification": 0.0031, "tuberculosis patient": 0.01666, "gene expression direct": 0.02903, "cellular transactivation factor nf-kb": 0.0143, "increase 2-fold": 0.02196, "normal human peripheral blood mononuclear cell": 0.0256, "free t4": 0.00127, "cathepsin": 0.00099, "oct-2-dependent cis-regulatory function": 0.00887, "important sequence": 0.01625, "nuclear extract assay": 0.01123, "tf promoter activity": 0.0195, "inducible transcription factor nf-kappa": 0.0143, "tlr2 complex": 0.01684, "hiv-1 nef protein inhibit": 0.02264, "fibroblast reveal": 0.01098, "scl protein": 0.04529, "annexin": 0.00019, "vitamin d-binding protein": 0.03019, "heavy-chain locus": 0.00288, "abrogation": 0.00037, "protein kinase c-independent mechanism": 0.02264, "transactivate btk expression": 0.02775, "fk506-binding protein": 0.04529, "tal-1": 0.00199, "il-12 induces tyrosine phosphorylation": 0.00492, "surfactant lipid": 0.00124, "extended family": 0.00841, "lef-1/gal4": 6e-05, "parasitic disorder": 0.00223, "t-cell nuclear protein complex": 0.02264, "anti-hcmv immunoglobulin g-seropositive donor": 0.00138, "intragenic suppressor": 0.00105, "dna bind site": 0.01445, "include myd88": 0.01439, "pigment": 0.00019, "autg": 0.00037, "p105 mrna": 0.01526, "primary structure": 0.00738, "interleukin-2 receptor-gamma": 0.00332, "n-": 0.00012, "inhibit phytohemagglutinin-induced peripheral blood mononuclear cell proliferation": 0.02194, "p39c-jun": 0.00074, "cell contact-delivered signal": 0.0512, "troglitazone": 0.00025, "lps express e-selectin": 0.0123, "u2 snrna transcription": 0.01873, "hiv-1 iiib-infected monocytoid cell": 0.0384, "include ascorbic acid": 0.00959, "p130 form": 0.01055, "slight hypertension": 0.00059, "free sulfhydryl group": 0.00325, "molecular switch": 0.0045, "degradative loss": 0.00298, "tepoxalin": 0.00081, "kd": 0.00347, "il-6 mrna expression": 0.02775, "mitotic recombination": 0.00093, "result provide": 0.0161, "hiv protease cleavage site": 0.01084, "cell-type-specific manner": 0.00282, "roi-nf-kappa": 0.00012, "analogue": 0.00099, "+195": 6e-05, "cotransfection experiment": 0.00397, "supershift": 0.00161, "tissue-specific manner": 0.00282, "differentiation-specific expression": 0.04163, "anti-cd40 monoclonal antibody": 0.00596, "factor control": 0.0286, "c-raf": 0.00025, "cellular event lead": 0.00664, "decrease growth rate": 0.00647, "tnt couple reticulocyte lysate system": 0.00267, "graf": 0.00019, "twenty-four hour treatment": 0.00676, "previous transfection analysis": 0.00786, "ifn-mediated cytoprotection": 0.00012, "repress expression": 0.04163, "jun heterodimers": 0.00226, "induce hyperproduction": 0.0254, "include distinct domain": 0.00959, "recent data show": 0.01733, "endogenous gc production": 0.00695, "murine bcl6": 0.00623, "immunosuppressant drug cyclosporin": 0.00225, "br3 sequence": 0.01625, "retinoic acid inhibits cd40": 0.00428, "allergic rhinitis": 0.00096, "murine thymocytes": 0.00623, "rapid signal-transduction pathway": 0.00852, "spi-b mrna": 0.01526, "specific dna-protein complex": 0.01123, "motif contiguous": 0.00875, "luciferase assay": 0.01002, "escherichia coli": 0.00068, "growth factor receptor": 0.01907, "cni-": 6e-05, "nuclear factor resemble": 0.01907, "jak3 messenger rna": 0.00304, "protein truncation test": 0.03019, "centromeric": 6e-05, "pathogenic role": 0.01328, "chronic lymphocytic leukemia": 0.00333, "prevalence": 0.00056, "require nf-kappa": 0.01414, "cell growth regulator": 0.0512, "exon 5-13": 0.00127, "t-cell apoptosis": 0.00962, "characterize atherosclerosis": 0.00425, "29-kda protein": 0.04529, "ad12": 0.0005, "macrophage-lymphocyte interaction": 0.00986, "lymphocytic": 0.00236, "b104": 0.00074, "breast cancer control": 0.00868, "fused fragment encompass": 0.00232, "il-4-producing th2 cell": 0.0512, "organogenesis": 0.00019, "vaginal fluid": 0.00078, "characterize nfat function": 0.00887, "genotype": 0.00081, "small number": 0.0053, "tat protein": 0.04529, "single kappa": 0.00748, "at464": 0.0, "mitogen-stimulated rel-/-": 0.00031, "mpc11 plasmacytoma": 0.00047, "early mouse development": 0.00649, "inhibited nuclear factor-kappab activation": 0.01582, "nonadherent culture": 0.0062, "fos peptide": 0.00754, "complement c5a": 0.00099, "ym268-stimulated glucose uptake": 0.00112, "persistent expression": 0.04163, "human leukemic k562 cell": 0.0384, "cyclic amp signal pathway": 0.00817, "drive": 0.00329, "serum induction": 0.01607, "regulatory element consist": 0.01115, "platelet-progenitor cell": 0.0768, "cytogenetic analysis": 0.01179, "il-2 increase": 0.02196, "e1-deleted ad vector": 0.00213, "early report": 0.00828, "transactivation response element": 0.01294, "cyclin e-mediated inactivation": 0.00116, "-36 bp relative": 0.00184, "calcium ionophore a23187": 0.00157, "therapeutic": 0.00335, "cortivazol act": 0.00496, "somatic cell hybridization approach": 0.0384, "full-sized notch1": 0.00028, "specific dna-protein complex form": 0.00842, "ebna3c abrogate repression": 0.0017, "lipid tail": 0.00124, "5-aminolevulinate synthase": 0.00081, "gal4-p65": 0.00025, "distinct adhesion molecule": 0.00569, "beta-like globin gene": 0.02903, "tumor endocrine status": 0.00622, "il-2-driven": 0.00037, "f.r.": 0.00012, "ncl": 0.00025, "ferritin h-gene promoter": 0.01557, "lymphocyte stimulate": 0.01483, "er status": 0.00264, "notch receptor": 0.02571, "augment coactivator protein recruitment": 0.02264, "ebv-transformed lcls": 0.0005, "b-lymphocyte": 0.00155, "adjacent ap-1 site": 0.01445, "ec suggest": 0.02022, "cognate viral peptide": 0.00502, "nonspecific toxicity": 0.00056, "decrease gsh level": 0.01214, "control program cell death": 0.0384, "transactivates": 0.00099, "consequent leukocyte adhesion": 0.00387, "tal-1 mouse": 0.00974, "human peripheral blood": 0.02508, "eosinophilopoiesis": 6e-05, "spi-1/pu.1-family member": 0.00413, "epithelial icam-1": 0.00267, "adenoid": 6e-05, "ccaat-binding factor nf-y": 0.01907, "alpha-hydroxylase": 6e-05, "distinct signal pathway": 0.0109, "statistical evaluation": 0.0005, "placebo treatment period": 0.00676, "a-b-": 0.00012, "c/ebp medial": 0.00223, "viral evasion mechanism": 0.00705, "il-2-induced monocyte-derived nuclear protein confers reporter gene": 0.01294, "fos": 0.0018, "point mutation": 0.00592, "autoantigen la/ss-b": 0.00031, "defined acidic transcriptional activation domain": 0.01266, "augment il-2 secretion": 0.00744, "tissue fibrosis": 0.00664, "lfa-3 induced moderate level": 0.0091, "gene report": 0.04355, "scc": 0.00043, "wild-type level": 0.01821, "rbd increase": 0.02196, "immunoglobulin kappa enhancer": 0.00606, "gene regulation": 0.04355, "hrbc": 0.00025, "distinct transcription factor": 0.01907, "radioiodine uptake": 0.00167, "g-csf receptor lack intrinsic tyrosine kinase activity": 0.00836, "picogram": 0.00012, "stat2": 0.00056, "glucocorticoid-": 0.00012, "cultured genital skin fibroblast": 0.00169, "htlv-i tax transactivator": 0.00318, "-65": 0.00031, "pkc inhibitor staurosporine": 0.006, "nuclear factor kappa-b": 0.01907, "-dependent factor nf-atp play": 0.0143, "complex consist": 0.01684, "threefold rise": 0.00068, "alpha-dihydrotestosterone": 0.0, "phosphorylation level": 0.01821, "mediate immune responsiveness": 0.00821, "sequence motif occur": 0.01084, "tax mutant express": 0.0123, "pan-2": 6e-05, "activate recombinant p38 mapk": 0.00889, "galectin-3 promoter": 0.02336, "nuclear antigen": 0.01684, "skeletal muscle": 0.00065, "steroid-resistant group range": 0.00325, "transfected fibroblast": 0.00369, "1p21-22": 0.00012, "host interaction": 0.00986, "p-like element reveal element-specific": 0.00836, "high-resolution": 0.00019, "cell fate": 0.0768, "specific polyclonal antiserum": 0.00825, "lymphoid-specific protein bind": 0.03019, "nuclear matrix associate": 0.01123, "b-cells": 0.00186, "decreased binding capacity": 0.01237, "cortical thymocytes undergo negative selection": 0.00206, "repression event": 0.00552, "pathways mediate cd23-triggered nf-kappab activation": 0.01266, "positive element active": 0.01115, "xp-d lymphoblastoid cell": 0.0512, "polycystic ovary syndrome": 0.00182, "alter phosphatidyl inositol level": 0.0091, "adherence-isolated monocyte show constitutive dna bind activity": 0.00836, "stat5-mediated gene expression": 0.02903, "hospital": 0.00019, "induced nf kappa": 0.00498, "cryptococcosis": 0.00012, "monoclonal anti-mbp antibody": 0.00596, "hiv-1 strain iiib": 0.00585, "cytokine inducible": 0.01123, "bacterial product": 0.00533, "direct participation": 0.0054, "classic glucocorticoid": 0.0085, "potent inhibition": 0.01061, "condition link": 0.0036, "retinoic acid correlate": 0.00571, "oka": 0.00056, "trans-activator": 0.00186, "activate human umbilical vein endothelial cell": 0.0256, "parallel": 0.00409, "basal transcription unaffected": 0.01873, "nuclear egr1 protein": 0.03019, "murine splenocytes": 0.00623, "periodontitis": 0.00012, "continued increase": 0.02196, "weak oxidative stress": 0.00207, "tar loop sequence": 0.01084, "monoclonal antibody alphacd3": 0.00596, "anti cd2": 0.00146, "cell culture": 0.0768, "key event underlie lymphocyte action": 0.00593, "inactive cytoplasmic complex": 0.01123, "beta-phenyl": 0.0, "early thymocyte development": 0.00552, "moloney murine sarcoma virus": 0.00444, "basophil measure": 0.00388, "cellular phenotype": 0.00893, "precursor present": 0.00735, "erythropoietin-induced signal transduction": 0.0109, "measure blood plasma triidothyronine": 0.00296, "molt-4": 0.0005, "northern analysis reveal expression": 0.02081, "affect promoter activity": 0.0195, "fk506 action": 0.00499, "squamous cell carcinoma show slight expression": 0.0256, "myelomonocytic cell line": 0.0512, "4.5-fold high": 0.00931, "junb mrna": 0.01526, "edge": 0.00019, "footprint": 0.00167, "eosinophil infiltrate hamster cutaneous wound": 0.00118, "temperature-sensitive mutant": 0.0081, "complete sequence": 0.01625, "oct-1-binding phenotype remain stable": 0.00261, "bcl-2 protein": 0.04529, "anti-immunoglobulin-treated": 0.00012, "single dna-binding hmg box": 0.00281, "cell lineage-independent manner": 0.0512, "mature cd4": 0.00332, "anti-stat": 0.00043, "110-kda protein": 0.04529, "hla-a3 molecule": 0.00853, "nuclear factor ms-2": 0.01907, "rapamycin": 0.00124, "er inhibit regulation": 0.0127, "hypercortisolemia": 6e-05, "cell factor-1": 0.0768, "il-2-": 0.00062, "-300 relative": 0.00276, "mouse lack rel": 0.00649, "hiv promoter construct": 0.01557, "c-": 0.00043, "il-5-inducible gene": 0.04355, "clinical outcome": 0.00425, "androgen-sensitive prostate cancer lncap cell": 0.03072, "glucocorticoid-insensitive asthma": 0.00161, "molecular action": 0.00499, "previous protein-dna binding study": 0.00927, "molecular dissection": 0.0045, "hpr cdna region-specific probe": 0.00228, "captopril treatment": 0.01014, "il-12 action": 0.00499, "zn++ ion": 0.00062, "viral episomal maintenance": 0.00488, "inhibit cox-2-mediated prostaglandin e2": 0.00952, "apoptosis sensitivity": 0.0089, "elk-1 promoter activity": 0.0195, "bind estrogen-": 0.02025, "electrophoretic mobility-shift assay": 0.00668, "purified natural gc": 0.00207, "cem-c7 cell exhibit increased steroid responsiveness": 0.0256, "p50 gene": 0.04355, "erythroid pathway": 0.01278, "rh:33 cell": 0.0768, "cd3 and/or cd2 protein": 0.02264, "p40 monomer": 0.00074, "pu.1/elf-1 site": 0.02168, "lps-stimulated monocyte": 0.01197, "nf-kappa b-dependent gene expression": 0.02177, "skin fibroblast": 0.00338, "il-2r beta": 0.00673, "anti-peptide antibody": 0.00893, "increase viral transcription initiation": 0.01405, "11.5+/-7.1 pg/ml": 0.00012, "phop": 0.00062, "scl protein level": 0.03019, "activation-dependent fa promoter induction": 0.01168, "megakaryocyte": 0.00186, "late time point": 0.00182, "cell nfatc reveal": 0.0512, "guanylate binding protein": 0.03019, "signal intermediate": 0.01635, "hemopoietic lineage commitment": 0.00244, "flutamide": 0.00062, "vitro colony formation assay show": 0.0104, "allergen-specific t-cell clone": 0.00641, "affected tyrosine residue": 0.00474, "additional mechanism": 0.01058, "physiology": 0.00031, "e14": 0.00012, "functional implication": 0.00816, "n-irak": 6e-05, "decoy oligodeoxynucleotide": 0.00016, "ferritin h-chain gene promoter regulation": 0.01742, "transcription factor include nf-il-6": 0.0143, "allogen-specific human cd4+": 0.02508, "c-myc mrna level": 0.01214, "il-4-stimulated": 0.00012, "mouse l929 cell": 0.0512, "thiamine": 0.00025, "differentiation-dependent change": 0.0063, "12-lipoxygenase activity": 0.02925, "vaginal host defense": 0.00143, "pparalpha activator decrease cytokine-induced vcam-1 mrna expression": 0.01189, "down-regulatory capacity": 0.00329, "myeloid-promyelocytic lineage": 0.00366, "demonstrate": 0.03195, "late erythropoiesis": 0.00254, "pbmc": 0.00471, "neglect": 6e-05, "hsf exhibit": 0.00664, "chemical nature": 0.00056, "m-csf mrna": 0.01526, "vitro supershift study": 0.00904, "induce significant internucleosomal dna fragmentation": 0.01016, "duffy-negative individual": 0.00409, "pathogen invasion": 0.0004, "oncogenic protein": 0.04529, "efficient inhibitor": 0.009, "efficient precursor": 0.00323, "proximal il-2 promoter-enhancer": 0.00744, "monocytoid cell line": 0.0512, "classical c-fos promoter serum response element": 0.00779, "pkc delta": 0.00332, "endocrine function": 0.01331, "herpesvirus papio": 0.00074, "retinoic acid signalling": 0.00571, "effective suppressor": 0.00164, "fc epsilon ri-gamma chain": 0.00219, "cell type parallel": 0.0512, "g2": 0.00025, "il-2r alpha expression demonstrate": 0.02081, "isolate daudi": 0.00416, "steroid-responsive cell": 0.0768, "require p53": 0.01315, "activating": 0.00093, "designated kappab3": 0.00016, "lmp-1 activate nf-kappa": 0.01185, "region c. spi-c interacted": 0.00734, "present": 0.0147, "il-7r signaling": 0.00558, "immunological memory": 0.00133, "msv": 0.00025, "viral gene include hiv": 0.02177, "calcium-modulator": 0.00012, "ru486": 0.00043, "naive human": 0.03762, "tcralpha beta": 0.00673, "mutagenized promoter": 0.02336, "constitutively express": 0.01846, "increase hiv promoter activity": 0.01462, "c/ebp beta regulation": 0.00672, "-terminal domain": 0.01207, "bovine colostrum block activation": 0.01582, "mitogenic coactivator": 0.00149, "gene encode human inosine- 5'-monophosphate dehydrogenase": 0.01452, "syncytium-forming capacity": 0.00329, "tar": 0.00105, "spi-1 expression vector": 0.02775, "endogenous corticosterone": 0.00459, "ventilatory response": 0.01942, "clone human nur77 beta cdna": 0.01505, "initial depletion": 0.00189, "express chimeric receptor consist": 0.01286, "ovulation induction": 0.01607, "aldosterone specificity": 0.00335, "nuclear p65": 0.01684, "th2 clone nfat-containing complex": 0.00842, "nf-at protein complex": 0.03019, "srf binding": 0.01855, "pthrp promoter": 0.02336, "multiple protein": 0.04529, "cpo": 0.0005, "tnfalpha induce": 0.0254, "membrane result": 0.0161, "oncogenesis": 0.00043, "mhc-diverse human population": 0.02508, "b6d2f1 mouse uterine cytosol": 0.00487, "nf-atc interacts": 0.00136, "human mm cell line": 0.0384, "tissue hypoxia": 0.00664, "human t-": 0.03762, "chronic bronchitis": 0.00397, "subject receive t3": 0.00236, "infected": 0.00335, "schizophrenia": 6e-05, "alteration increase": 0.02196, "preferential induction": 0.01607, "bxb": 6e-05, "express replicative gene product": 0.02177, "gamma-interferon-": 6e-05, "tpa-gr synergism": 0.00028, "-70 bp": 0.00267, "constitutive association": 0.00478, "addition spi-b": 0.00673, "gos19 promoter": 0.02336, "il-12-induced phosphorylation": 0.00983, "southwestern": 0.0005, "reciprocal mechanism": 0.01058, "u937 cell act": 0.0512, "cem-4r4": 0.00012, "genomic organization": 0.0027, "include bone marrow cell": 0.0384, "translocated c-myc": 0.00223, "complexed": 0.00068, "adenomyosis": 6e-05, "normal mouse bone marrow generate hematopoietic growth factor-dependent cell line": 0.01536, "atopic immune response": 0.01294, "type-ii estrogen bind site": 0.01084, "permanent nf-kappa": 0.01414, "key vdr target gene": 0.02177, "human blood monocyte": 0.02508, "disturb microtubule dynamic": 0.00025, "il-2-independent growth correlate": 0.00546, "lymphocyte ig production": 0.00988, "follicular hyperplasia": 0.00071, "developmental stage-specific manner": 0.00188, "il-3-responsive gene": 0.04355, "lymphocyte-specific protein tyrosine kinase": 0.02264, "rb sense": 0.00167, "in-frame splice": 0.00093, "vector": 0.00639, "mitogen-induced increase": 0.02196, "nfatp/c": 0.0, "distal enhancer element span": 0.00836, "chromatin domain": 0.01207, "disease variable": 0.00673, "endothelial expression": 0.04163, "anti-stat3 ab": 0.00167, "cyclin e-dependent kinase activity mediate rb inactivation": 0.00836, "phenotypic female": 0.00158, "sixteen anorexic patient": 0.0111, "cyclosporin a-induced il-2r alpha inhibition": 0.00468, "cdiia": 0.00012, "pu box": 0.00304, "anchor residue": 0.00226, "pma-differentiated u937 cell": 0.0512, "growth factor-beta": 0.00819, "b-lymphocyte growth transformation": 0.00546, "description": 6e-05, "retrodifferentiated cell": 0.0768, "rest peripheral blood mononuclear cell": 0.03072, "p105/p50 mrna synthesis": 0.01017, "wide spectrum": 0.00053, "polymorphic short tandem repeat": 0.00189, "cell-specific transcription factor": 0.01907, "complex regulatory mechanism": 0.01123, "interleukin-2 receptor alpha-chain gene": 0.02177, "disease parameter": 0.00673, "intentional stimulation": 0.0112, "cellular macromolecular synthesis": 0.00596, "nuclear factor regulate": 0.01907, "antioxidant molecule": 0.00853, "collagen-stimulated platelet": 0.00372, "progeny virion": 0.0005, "human neutrophil gene expression": 0.02177, "turn activates p38alpha mapk": 0.00082, "short form": 0.01055, "c-myc puf site": 0.01445, "advanced age": 0.00226, "hb9": 0.00062, "blr2-specific mrna": 0.01526, "cytokine stimulation": 0.01123, "affected infant": 0.00099, "coreceptors": 0.00019, "bl2": 0.0, "lymphocytic origin demonstrate": 0.01065, "c26 subfragment": 6e-05, "bone marrow-derived cell": 0.0512, "mcd14": 0.00056, "enhance il-2 gene transactivation": 0.02177, "rb gene": 0.04355, "pu.1 site": 0.02168, "asymmetric cell division": 0.0512, "thymocyte maturation": 0.00251, "er positive cell": 0.0512, "anti-tumor immune response": 0.01294, "developmental pathway control vh-to-dhjh recombination": 0.00521, "unknown member": 0.00413, "gel shift analysis reveal binding": 0.00742, "temporal artery-scid chimera": 0.00054, "mll rearrangement": 0.00199, "huvec": 0.00167, "recombinant ori lyt element": 0.00836, "gc receptor": 0.02571, "rna splicing": 0.00456, "independent criterion": 0.00363, "assembly": 0.00329, "electrophoresis mobility shift": 0.00122, "synthetic metalloproteinase inhibitor": 0.006, "cell enhance transcription factor": 0.0384, "negative selection refers": 0.00343, "24,25-dihydroxy-vitamin d3": 0.00245, "critical involvement": 0.00428, "in-vitro-translated 20-kda protein": 0.03019, "mm n-acetylcysteine": 0.00118, "fetal bovine serum-containing medium": 0.00107, "vdre": 0.00025, "long terminal repeat-driven secrete alkaline phosphatase activity": 0.00836, "cam": 0.00068, "severe hyperkalemia": 0.00211, "conserved loop": 0.00136, "tissue-specific": 0.00434, "tumour necrosis factor alpha": 0.0143, "high il-4": 0.00931, "oxypurinol": 6e-05, "csf": 0.00043, "disease": 0.01346, "gain function": 0.01331, "schindler": 0.00012, "pili": 0.00019, "tyrosine phosphoprotein": 0.0071, "afternoon acth": 0.00056, "ankyrin protein": 0.04529, "6,7-3h": 6e-05, "induce activation": 0.03164, "hsfs reveals": 0.00099, "transfected monocyte": 0.01197, "adenoviral technique": 0.00109, "immunogenic protein": 0.04529, "low anabolic/catabolic balance": 0.00471, "grb2-like adaptor molecule": 0.00569, "multimerized region ii sequence element enhance": 0.00557, "p50/p65 heterodimers": 0.00226, "potent chemotactic factor": 0.01907, "mantle cell lymphoma": 0.0512, "nonphlogistic degradation": 0.00332, "calcineurin activate transcription": 0.01873, "forty primary fm patient": 0.00833, "phorbol 12-myristate-13 acetate": 0.00362, "apls": 0.00025, "mimetic molecule": 0.00853, "-dp": 0.00012, "physiological inhibitor": 0.009, "glucocorticoid binding": 0.01855, "cellular expression": 0.04163, "2.0-kb region": 0.01467, "optimal response": 0.01942, "chimeric oncoprotein e2a-pbx1 induces apoptosis": 0.00356, "include ets1": 0.01439, "ciita promoter": 0.02336, "potential stati dna bind element": 0.0081, "high transcriptional activity": 0.0195, "induce myeloid cell differentiation": 0.0384, "icam1": 0.0, "hla-dra mrna expression": 0.02775, "retinoblastoma family": 0.00841, "arsenic": 0.00043, "chromosomal breakpoint": 0.00102, "clinical progression": 0.00425, "-independent pi 3-kinase activation": 0.01582, "pecam-1 occurs": 0.0009, "infected cd4+ t-lymphocytes": 0.00192, "cellular camp level inhibit": 0.00952, "h2o2 release tumour necrosis factor-alpha": 0.00194, "erythroid-specific aminolaevulinic acid synthase": 0.00428, "plc-gamma1": 0.00012, "jh": 6e-05, "oxidative suppression": 0.00416, "peptide epitope": 0.00754, "induce fas expression": 0.02775, "specific stage": 0.01238, "observation support": 0.00409, "multiple cytokine production deficiency": 0.00561, "integration": 0.0013, "cytokine-inducible neutrophil chemoattractant": 0.00331, "immediate-early": 0.00304, "il-4 gene": 0.04355, "proteasome inhibitor psi": 0.006, "cd3 receptor-mediated signalling": 0.00108, "cell-type-specific transactivation": 0.00515, "massive megakaryocyte accumulation": 0.00215, "hsv-2 vp-16-derived peptide": 0.00502, "leukemic cell contamination decrease": 0.0384, "alpha2 integrin enhancer": 0.00606, "dem abolish phorbol 12-myristate 13-acetate-induced activation": 0.01055, "proteasomal degradation": 0.00332, "re-expression": 0.00031, "subsequent transcriptional activity": 0.0195, "amino-terminal region": 0.01467, "b-cell-and monocyte/macrophage-differentiation lineage": 0.00244, "persistent viral replication": 0.00488, "pdgf": 0.00031, "stable attenuation": 0.00171, "tnf promoter": 0.02336, "u373 mg astrocytoma cell due": 0.03072, "gr-responsive element": 0.01672, "nfat-controlled luciferase gene system distinguishes cif": 0.01452, "tissue-specific induction": 0.01607, "fcr-dependent activation": 0.03164, "human promonocytic u-937 cell": 0.0384, "surrogate gamma'-chain": 0.00047, "sea": 0.00087, "signal trigger": 0.01635, "two-dimensional phosphopeptide map": 0.00136, "toremifene therapy": 0.00372, "plasma membrane receptor": 0.01714, "activity remain unknown": 0.0195, "xpg": 6e-05, "compete": 0.00155, "dna-binding affinity and/or specificity": 0.00281, "cellular immune response": 0.01294, "9-cis ra": 0.00596, "il-2 involves p38 mitogen-activated protein kinase": 0.0151, "lytic regulatory gene bzlf": 0.02177, "gram-negative bacteria": 0.00037, "clinical/histological parameter": 0.00127, "protein p60": 0.04529, "hematopoietic tissue": 0.00664, "library": 0.00186, "demonstrate regulation": 0.01597, "nk/t cell progenitor": 0.0512, "breast-conserving therapy": 0.00372, "equal concentration": 0.0067, "identical experiment": 0.00397, "selected protein": 0.04529, "increase mrna accumulation": 0.01464, "pharmacokinetic behavior": 0.00059, "activate nf-at complex": 0.01185, "ribosomal protein s6 kinase": 0.02264, "-binding site": 0.02168, "polypryrimidine-binding factor": 0.0286, "include up-regulation": 0.01439, "transcription factor ikaros": 0.01907, "relative insensitivity": 0.00276, "methylation interference analysis": 0.00786, "cytokine": 0.02246, "functional unit": 0.00816, "kr body": 0.00136, "m.bina": 6e-05, "pathway protect": 0.01278, "il-2 promoter link": 0.01557, "anti-cd28 mab increase induction": 0.01098, "re/ap construct expression": 0.02775, "htoll": 0.00019, "constitutive activation": 0.03164, "parallel signal transduction pathway": 0.00817, "enhancer tc-ii": 0.00909, "short-term incubation": 0.00208, "immune senescence": 0.00599, "patient enter disease remission": 0.00833, "polarized functional architecture": 0.00544, "transactivation ability": 0.00515, "death-promoting activity": 0.02925, "dicoumarol": 0.0, "t-cell-specific response element": 0.01294, "duplicated cysteine-rich region": 0.00978, "mechanism mycobacterium tuberculosis induces": 0.00529, "northern blot analysis reveal": 0.00589, "nfil-2a": 0.00019, "fk506 prior": 0.00155, "gas element": 0.01672, "p27kip1 gene": 0.04355, "mammalian transcription factor": 0.01907, "immunofluorescent staining": 0.00177, "leukocyte-specific component": 0.00456, "5-fold low": 0.00707, "k+": 0.00056, "il-10 effect dose-dependent inhibition": 0.01058, "12-o-tetradecanoyl phorbol 13-acetate": 0.00362, "protein interact": 0.04529, "detect e2a protein": 0.03019, "gene correspond": 0.04355, "jurkat cell clone": 0.0512, "homodimeric stat1 protein": 0.03019, "hybridization signal": 0.01635, "c-jun transactivating function": 0.00887, "corresponds": 0.00031, "critical ci element": 0.01115, "aiolos-binding site": 0.02168, "meta": 0.00068, "dg": 0.00025, "dna recombination": 0.01483, "gene result": 0.04355, "hiv-1-infected myeloid cell": 0.0512, "atf/cre motif overlap bind sequence": 0.0081, "dimethyl sulfoxide-induced mel cell": 0.0384, "induce 24-hydroxylase mrna": 0.01694, "gag p24": 0.00065, "244-bp deoxycytidine kinase core promoter": 0.00934, "fp treatment": 0.01014, "activated mapkk-1": 0.00589, "decreased vitamin": 0.00236, "tax protein induce": 0.03019, "cells-family protein": 0.04529, "cv3988": 0.00012, "activate interleukin-6 expression": 0.02775, "northern blot analysis show": 0.013, "intense mucocutaneous melanosis": 0.00039, "nfatx2": 0.00019, "ad5e1a-peptide": 6e-05, "biscoclaurine alkaloid": 0.00012, "transcriptional synergy mediate": 0.00821, "oct2 isoforms generate": 0.00302, "shuttle transcription factor nfat": 0.0143, "block htoll-induced activation": 0.02109, "hiv-1 protease": 0.00878, "hmg-box": 0.00012, "hormonal parameter": 0.00127, "normal volunteer": 0.0121, "cif fail": 0.00347, "utilizing sp1": 0.0036, "bp -90": 0.00267, "region upstream": 0.01467, "hiv promoter": 0.02336, "g-rich switch region": 0.00978, "lymphoid organ": 0.00409, "123+/-9": 0.00012, "rar": 0.0031, "mouse bear mc38 colon adenocarcinoma": 0.0039, "transcription factor regulate": 0.01907, "cell activation require": 0.0512, "inducible pkc activity": 0.0195, "selectively inhibit": 0.01904, "ec activation": 0.03164, "caccc site": 0.02168, "abnormal glucocorticoid receptor": 0.01714, "ap-1 site mediate": 0.01445, "tat mutant": 0.0081, "adult beta-like globin gene": 0.02177, "low level rag gene expression": 0.01742, "increase ikappab expression": 0.02775, "network": 0.00112, "pma-stimulated u1 cell": 0.0512, "bronchial patency disorder": 0.00149, "suggestion": 6e-05, "il-18-induced activation": 0.03164, "human serum-inducible element": 0.02508, "th2-selective expression": 0.04163, "marcks-related protein": 0.04529, "autosomal dominant neurocutaneous disorder": 0.00123, "freshly isolated cell": 0.0512, "purified defensins np-1": 0.00174, "potential antiviral effect": 0.0141, "cell protein kinase": 0.0512, "ifn-gammar conjugation": 0.00022, "grpl": 0.00037, "isolate pbmc": 0.00416, "antioxidant sensitive activate pathway distinct": 0.00711, "hormone receptor protein": 0.03019, "anti cd28 fail": 0.00232, "ccgccc": 0.00012, "nf-munr binding site": 0.01445, "complex interaction": 0.01684, "represent site": 0.02168, "negative factor": 0.0286, "simultaneous addition": 0.00673, "peak thrombin": 0.00143, "tnfalpha signalling": 0.00136, "tnf stimulate expression": 0.02775, "drosophila homeodomains": 0.00121, "octa site": 0.02168, "cytolytic action": 0.00499, "grs": 6e-05, "incidence": 0.00056, "salicylate affect cytokine gene transcription": 0.01742, "heb": 0.00012, "ap-1-related protein": 0.04529, "important immune-modulating effect": 0.0141, "affected tyrosyl phosphorylation": 0.00656, "corticosteroid-resistant": 0.00025, "increased production": 0.01042, "dnasei footprinting assay demonstrate": 0.00799, "dicysteine motif": 0.00875, "thp-1 mature monocytic cell line": 0.03072, "western blot analysis confirm": 0.00589, "clinical malaria": 0.00425, "molecular": 0.009, "j. physiol": 0.00056, "il-8": 0.00378, "hypoxia-evoked decrease": 0.00971, "anti-cd3-treated peripheral blood lymphocyte": 0.00741, "b-cell-restricted activity": 0.02925, "regulatory subunit": 0.00682, "weak reactivation": 0.00174, "zeta-luciferase construct": 0.00726, "recombinant human nucleolin": 0.02508, "probe": 0.00521, "increase activity": 0.02925, "induce nuclear translocation": 0.01694, "good characterized cytokine": 0.00749, "il-2-driven proliferation remain": 0.00536, "c/ebpdelta": 6e-05, "mutated octamer site": 0.01445, "ligand activate transcription factor": 0.0143, "ep4 receptor subtype": 0.01714, "enzyme activity": 0.02925, "microg/10": 0.0, "cancer therapy": 0.00372, "ubiquitinated": 6e-05, "avidity window": 0.00025, "mobility shift analysis": 0.00786, "gene rearrangement determine": 0.02903, "recognition sit play": 0.00474, "mature platelet function": 0.00887, "protease-treated extract": 0.00459, "m7": 0.00043, "calcium channel blocker": 0.00157, "t-cell immortalization": 0.00962, "increase c-fos mrna": 0.01464, "ish": 0.00012, "current literature": 0.00084, "proximal gamma-promoter": 0.00301, "partner": 0.00161, "om-10.1 promyelocytic model": 0.00281, "early g1 cell cycle regulatory function": 0.0256, "consideration": 0.00031, "signal transduction distinguishable": 0.0109, "homologous peptide 430-444,442a": 0.00502, "substrata": 0.0, "pre-monocytic cell": 0.0768, "increase intracellular free calcium level correlate": 0.00732, "hematopoietic progenitors/precursors": 0.00366, "parasite-induced constitutive nf-kappab activation": 0.01582, "putative transcriptional regulator": 0.00767, "phox": 6e-05, "thp-1": 0.00478, "putative il-3-regulated factor": 0.01907, "type-ii eb": 0.00031, "bsap recognition sequence demonstrate": 0.00813, "cd19-expressing b-cell line": 0.01102, "cell death specification protein": 0.0384, "defective hiv-1": 0.00878, "fm patient display": 0.0111, "mannose receptor-mediated endocytosis": 0.00048, "human chromosomal il-16 gene": 0.02177, "biphasic stimulation": 0.0112, "human b-cells": 0.03762, "adhesiveness": 0.00025, "pretranslational level cdna cloning": 0.0091, "calcium homeostasis": 0.00236, "severe combine immunodeficiency due": 0.00185, "biochemical change": 0.0063, "human chromosomal band 6q26-27": 0.01881, "b-cell lymphoma": 0.00459, "myeloid-": 6e-05, "activate human immunodeficiency virus type": 0.01505, "unstimulated hela cell": 0.0512, "erythrocyte ghost": 0.0013, "lymphoma cell transfected": 0.0512, "egr-1 expression correlate": 0.02775, "human monocyte monokine synthesis": 0.01881, "microm dexamethasone": 0.00394, "high prevalence": 0.00931, "stimulation reveal": 0.0112, "leukotriene b4 stimulate c-fos": 0.00551, "nur77 knock-out mouse": 0.00649, "p84": 6e-05, "tax stimulate transcription": 0.01873, "adaptation": 0.00012, "specific promoter sequence": 0.01557, "thiol-containing antioxidant": 0.00251, "peripheral blood mononuclear cell isolate": 0.03072, "dominant negative c-fos abolish": 0.00257, "drosophila melanogaster homeobox gene proboscipedia": 0.01742, "essential intermediate step": 0.00325, "type ii il-1r gene expression": 0.01742, "spi-1 mrna": 0.01526, "oncogenicity": 0.00012, "maximal binding capacity": 0.01237, "u-937 human promonocytic leukemia cell": 0.03072, "nfat docking site peptide": 0.01084, "minimal ebna-2-responsive lmp-1 promoter include": 0.00934, "match point mutation": 0.00395, "correspond bind factor": 0.01907, "pregnant woman": 0.00233, "oct-2 participates": 0.00226, "pha-mediated ifn-gamma production": 0.00695, "rna polymerase ii -and rna polymerase iii-transcribed mammalian small nuclear rna": 0.00306, "similar functional cooperation": 0.00544, "single ap-2-": 0.0036, "alpha gene enhancer": 0.02903, "comparable amount": 0.00285, "specific band": 0.01238, "complement receptor-1": 0.00099, "participation": 0.00062, "lmp-1 induces": 0.00803, "heterologous thymidine kinase promoter": 0.01168, "alanine-rich": 6e-05, "specific tissue": 0.01238, "beta 2-m increase": 0.01464, "nf-kappa b-dependent il-6 expression": 0.02081, "important immunoregulatory protein": 0.03019, "dissociation constant decrease": 0.00647, "tnfri death domain interact protein tradd": 0.0151, "non-cytotoxic lmp-1 signaling": 0.00372, "vitro responsiveness": 0.00785, "pre-existing": 0.00068, "normal lymphoid tissue structure": 0.00605, "loci occur": 0.00654, "transformants": 0.0, "potential signaling pathway": 0.00852, "cell adhesion": 0.0768, "oca-b bind dna": 0.0135, "murine lymphocyte": 0.01483, "sap kinase": 0.01188, "non-b lymphoma": 0.00226, "pg490 inhibits interleukin": 0.00354, "selective phosphorylation": 0.00983, "hcleo region": 0.01467, "host cell activation": 0.0512, "cytokine induce assembly": 0.01694, "leukotriene biosynthesis": 0.00034, "negative regulation require zta dna-binding activity": 0.00975, "mutant allele encode cell-surface ifngamma receptor": 0.00857, "c-myc oncoprotein": 0.00223, "exogenous stimulus": 0.0027, "phytohaemagglutinin": 0.00025, "induce qr": 0.0254, "il-2-independent event": 0.00552, "bmlf1 open reading frame": 0.00036, "costimulatory": 0.00205, "complex interplay": 0.01684, "induce t-cell lymphoma": 0.01694, "high rakfkqllq-specific ctl precursor frequency": 0.00372, "charcot-leyden crystal": 0.00019, "srf/nfkappab-like element": 0.01672, "calcium stimulation": 0.0112, "long-term persistence": 0.00171, "pkc depletion": 0.00332, "nf-kappa b1/p105": 0.01414, "/cd3 stimulation": 0.0112, "regulate dimerization": 0.01253, "ink4a": 0.00012, "glucose oxidase selectively inhibit p75": 0.00762, "wild-type phenotype": 0.00378, "bha": 0.00062, "gynecomastia": 0.00037, "share similar dna binding specificity mediate": 0.00618, "cle0 sequence interacts": 0.01084, "immuno-pathological condition": 0.0036, "affect glucocorticoid receptor function": 0.01286, "mediate transactivation": 0.01231, "interferon-gamma activation": 0.03164, "simultaneous stimulation": 0.0112, "kruppel-related zinc finger gene": 0.02177, "biphasic control": 0.01303, "acidic domain": 0.01207, "streptoavidin-biotin peroxidase method": 0.00157, "parent compound": 0.0022, "prdii regulatory element": 0.01115, "wild type motif": 0.00633, "xi": 0.00012, "coordinate suppression": 0.00416, "proenkephalin": 0.00068, "observed decrease": 0.00971, "close association": 0.00282, "chlamydia pneumoniae": 9e-05, "plaque rupture": 0.0004, "dna strand competition": 0.00988, "ra response": 0.01942, "situ rt-pcr detection": 0.00068, "cd4+ memory": 0.00288, "inconsistent": 6e-05, "candidate gene": 0.04355, "equal amount": 0.00285, "late endosomes": 0.00254, "intermediate phenotype": 0.00366, "nongenomic signaling pathway": 0.00852, "induce cellular differentiation": 0.01694, "kb 5'-flanking dna": 0.00988, "positive physiological role": 0.00885, "htlv-1": 0.00223, "single cell level": 0.0512, "768-bp upstream negative regulatory region": 0.00587, "c-terminal activate region": 0.01185, "cytokine production profile": 0.00749, "integrin-containing focal adhesion": 0.00387, "nk cell function": 0.0512, "e. holley-guthrie": 0.00102, "f.barre-sinoussi": 6e-05, "active nf-kappab heterodimer": 0.00666, "long lived physiological oxidant": 0.00138, "low apparent affinity": 0.00471, "cp1": 0.00019, "non-monocytic cell": 0.0768, "vdr expression": 0.04163, "activation-dependent hs1 phosphorylation": 0.00656, "il-2 dependent": 0.01117, "transcription site": 0.0281, "molecular machinery underlie": 0.003, "promyelocyte cell line om10.1": 0.0384, "endogenous protease": 0.00459, "substitution analysis": 0.01179, "vitro binding assay": 0.01237, "unstimulated nk cell": 0.0512, "augment human alpha-globin promoter activity": 0.01505, "basophil": 0.00093, "il-2 mrna production": 0.01017, "c5a induce kappab binding activity": 0.0117, "pan expression": 0.04163, "costimulation requirement": 0.00264, "ras/protein kinase": 0.01188, "eliminate pu.1 bind decrease m-csf receptor promoter activity": 0.00731, "shed form": 0.01055, "stable divergence": 0.00171, "induced extract": 0.0054, "strong inhibitory activity": 0.0195, "nf-kappa b. thiol modulation inhibit": 0.00762, "pharmacological basis": 0.00143, "p65 translocation": 0.00515, "stimulatory mab bw": 0.00178, "direct result": 0.0161, "activated human monocyte": 0.02508, "human gata-1": 0.03762, "1-beta-d-arabino-furanosylcytosine": 6e-05, "macrophage receptor": 0.02571, "enhancer": 0.01818, "galdbd-raralpha hybrid activity": 0.0195, "commonly observed transcript abnormality": 0.00299, "site alpha-binding activity": 0.0195, "yy1": 0.00118, "hybrid cd8-nef protein": 0.03019, "ciita expression serf": 0.02775, "adherence/contact": 0.0, "male patient present": 0.0111, "tcr contact": 0.00478, "effect require surface expression": 0.02081, "initial interleukin-1beta mrna transcription rate": 0.01124, "pzvb10": 0.00012, "translation initiation codon": 0.00141, "granulocyte/macrophage colony-stimulating factor": 0.01907, "induce icam-1": 0.0254, "functional correlate": 0.00816, "nuclear factor nf-kappab": 0.01907, "phorbol-12-myristate-13-acetate response": 0.01942, "activation-induced fasl promoter activity": 0.01462, "c-fos sre dna sequence motif": 0.0065, "endogenous il-2 gene": 0.02903, "tcr engagement stimulate": 0.00734, "panel": 0.00099, "il4": 0.00081, "enhance hiv replication": 0.00649, "renal cell carcinoma patient exhibit": 0.03072, "injury/activation": 6e-05, "c-myc proto-oncogene": 0.00223, "previous study show": 0.01733, "distinct enhancer element": 0.01115, "rat air pouch model": 0.00211, "cpo gene promoter": 0.02903, "prb molecular weight": 0.003, "encoded tax protein": 0.03019, "il-2 receptor component": 0.01714, "delay growth late": 0.00546, "hla-dra gene expression": 0.02903, "metallothionein enhancer": 0.00909, "insulin gene promoter activity": 0.02177, "spleen-cell culture": 0.0062, "molecular genetic characterization": 0.003, "th2 cell induce humoral": 0.0384, "wnt signal cascade": 0.0109, "ifn-gamma activation sequence": 0.02109, "nuclear factor stat-1": 0.01907, "mu": 0.00124, "c-terminal regulatory module": 0.00455, "ligand wy": 0.00592, "deleted sequence": 0.01625, "human tf gene": 0.02903, "respiratory burst activity induce": 0.01462, "p95vav activate": 0.01777, "u-937 cell induce": 0.0512, "cell il-5 synthesis": 0.0512, "allele loss": 0.00298, "elf-2": 6e-05, "gcr level estimate": 0.01214, "locus-activating region": 0.01467, "induce beta-globin expression": 0.02775, "recombinant nf-ya subunit": 0.00323, "1-": 0.0005, "mm6": 0.00012, "transcriptional hierarchy": 0.01151, "profound conformational change": 0.0042, "fms patient display low cbg": 0.00666, "cell signal transduction": 0.0512, "ets dna-binding domain common": 0.00603, "ligand bind": 0.02025, "bfgf": 6e-05, "c5a-induced reporter gene expression": 0.02177, "tcf/lef protein": 0.04529, "conserved element": 0.01672, "low risk": 0.00707, "distinct element": 0.01672, "constitutively express receptor": 0.01714, "cytokine-stimulated human saphenous vein endothelial cell": 0.0256, "c3heb/fej": 6e-05, "enhancer region": 0.01467, "alter normal immunoregulatory signal transduction": 0.00654, "sh2-dependent association": 0.00282, "intracellular glutathione": 0.00583, "purified hsp90": 0.00261, "cll": 0.00118, "i-kappabalpha": 0.00012, "interleukin-2 gene transcription": 0.02903, "viral transcription": 0.0281, "purified fl hpcs": 0.00174, "vitro erythroid differentiation": 0.00786, "cell increase": 0.0768, "succinate ester": 0.00202, "crossreactive recognition": 0.00257, "b-cell nuclear extract": 0.01123, "additional cis-acting element": 0.01115, "significant correlation": 0.00416, "gc-r parameter": 0.00127, "human homeobox gene": 0.02903, "faithful expression": 0.04163, "transcriptional level": 0.01821, "rothman": 6e-05, "event link": 0.00552, "age dependent": 0.00388, "igf2": 0.00012, "study intercellular communication": 0.00904, "render yeast cell resistant": 0.0384, "bsap-stimulated cd19 gene transcription": 0.02177, "differentiation-dependent transcription": 0.0281, "tat effect": 0.02115, "hiv-1 express ikappab-alphas32/36a down-regulates viral expression": 0.01388, "positive cell population": 0.0512, "transfected expression vector": 0.02775, "activate p21ras": 0.01777, "cem-c7 cell culture": 0.0512, "enhance hiv-1 ltr-mediated reporter gene activity": 0.01452, "white pulp": 0.00031, "epstein-barr viral latency": 0.00488, "base-pair sequence": 0.01625, "ag receptor": 0.02571, "nf-munr repressor": 0.00223, "supernatant": 0.00186, "human class ii mhc ag": 0.01505, "human mineralocorticoid receptor": 0.02508, "undergo long period": 0.00184, "gc border": 0.0031, "atherosclerotic plaque": 0.00056, "binary tf.viia complex induce": 0.0127, "hematopoietic precursers": 0.00366, "mhc antigen": 0.00819, "reaction": 0.0044, "bw": 0.00043, "gain insight": 0.00065, "inhibit hsv-1-mediated induction": 0.0127, "transcriptional status": 0.01151, "truncated promoter": 0.02336, "hiv-1-replicative cycle": 0.00307, "peripheral monocyte": 0.01197, "hyaluronan augmented vcam-1 expression": 0.02081, "human brain": 0.03762, "microm diacylglycerol": 0.0013, "original ddpcr protocol": 0.00033, "-643": 6e-05, "murine pu.1": 0.00623, "prolactin activate stat5": 0.01185, "enhance il-6 production": 0.00695, "primary inducer": 0.00738, "dna sequence isolate represent": 0.00813, "u1 cellular proliferation": 0.00596, "bv173": 6e-05, "murine e3 promoter harbor": 0.01168, "mol cell biol": 0.0512, "activated cell": 0.0768, "prevent cd4+ cell depletion associate": 0.03072, "charybdotoxin": 0.00012, "induce nf-": 0.0254, "epor": 0.00118, "activate viral gene expression associate": 0.01742, "unmodified asparagine": 0.00025, "rxr-rar": 0.00025, "brca1 function": 0.01331, "gre site": 0.02168, "phenol layer": 0.0004, "overlap cosmid encode human ciita": 0.01505, "hypoxia": 0.00124, "dr1": 6e-05, "protein tyrosine kinase": 0.03019, "mn-dependent superoxide dismutase": 0.00035, "cytosolic protein": 0.04529, "separable": 0.00043, "short period": 0.0013, "target": 0.0165, "oligopeptides": 0.00012, "jaks/stats": 6e-05, "surface tr75": 0.00515, "pi-3 kinase": 0.01188, "reduced amount": 0.00285, "similar array": 0.00673, "bisindolylmaleimide": 0.00019, "provirus establishment": 0.00062, "yang-deficiency": 0.00012, "iono stimulation": 0.0112, "implicate oxidative signalling": 0.00234, "hmrp8 promoter element": 0.01557, "cd19 gene expression": 0.02903, "regulate protein": 0.04529, "average expansion": 0.00099, "group iii ebv genome carry cell line": 0.02194, "r.c.gallo": 6e-05, "nonimmune hela cell": 0.0512, "hiv-1 ltr show": 0.01733, "-positive patient suggest": 0.01348, "peripheral eosinophil": 0.00524, "alpha-globin promoter": 0.02336, "antibody-encoding gene": 0.04355, "typical apoptotic feature": 0.00145, "total disappearance": 0.00161, "fascinating": 6e-05, "additional factor and/or post-translational modification": 0.01144, "octamer site": 0.02168, "p24 antigen release": 0.00546, "fgf-1": 0.00062, "fly": 0.00012, "atopic asthma": 0.00161, "p53 protein expression": 0.03019, "constitutively express high level": 0.00923, "il-4 inhibited lps-induced nf-kappa": 0.00707, ".0014": 0.0, "dominant negative creb": 0.00343, "simian epstein-barr virus oncogene lmp1": 0.00355, "nonpermissive": 0.00043, "2-me": 6e-05, "normal glucocorticoid response": 0.01294, "htlv-1 tax target ikappabalpha": 0.00413, "proximal cis-acting element": 0.01115, "mono mac-6 cell": 0.0512, "e2f function": 0.01331, "lt remission": 0.00071, "hiv-ltr suggest": 0.02022, "similar adhesive response": 0.01294, "htlv-i-mediated": 0.00012, "gm2 sequence": 0.01625, "suppress nuclear factor-kappa": 0.01123, "multimerized short bind motif": 0.01013, "tnf-alpha promoter": 0.02336, "estrogen receptor expression": 0.02775, "p53-conjugating ligase": 0.00019, "central component": 0.00456, "hinge region distinguish androgen-bound": 0.00734, "repression match": 0.00211, "critical proximal step": 0.00285, "neurologic dysfunction associate": 0.00728, "increase transcriptional rate correlate": 0.01098, "lung macrophage": 0.00589, "selectively inhibit nf-kappa": 0.0127, "actin cytoskeleton": 0.00074, "cytoplasmic fraction": 0.004, "cell surface antigenes cd33": 0.0384, "hygromycin resistant": 0.00211, "result define": 0.0161, "c-jun-specific antisense": 0.00161, "successive stage": 0.00248, "independent regulatory module": 0.00455, "c/ebp beta activate": 0.01185, "tradd differs": 0.00078, "oncogene amplification correlate": 0.00436, "low molecular weight stat5 isoforms": 0.00283, "acetyl salicylic acid-mediated inhibition": 0.0053, "diverged homeodomain": 0.00043, "phagocytic ability": 0.00431, "heterologous minimal promoter": 0.01557, "steroid binding": 0.01855, "mol/l phorbol myristate acetate": 0.00271, "igd-": 0.0, "lymphocyte glucocorticoid receptor number": 0.01286, "ebv-induced growth transformation": 0.00546, "dominant-negative suppressor": 0.00105, "cd4+ t-cell deletion": 0.00641, "hpa abnormality": 0.00239, "one-third": 6e-05, "asthma remain": 0.00521, "serine/threonine phosphatase": 0.00264, "human monocytic cell": 0.0512, "pmns": 0.00043, "k562 stem cell": 0.0512, "conservative surgery": 0.0005, "immortalized cell": 0.0768, "concomitant presence": 0.00524, "ifn-gamma increase": 0.02196, "bind assay": 0.02025, "mip-1alpha-r mrna": 0.01526, "cell cycle analysis show shift": 0.03072, "lacking": 0.00025, "acute myeloid leukemia blast cell": 0.03072, "e3-dependent ubiquitinylation": 0.00022, "cell number": 0.0768, "acute fulminant hepatitis": 0.00246, "sequence diversity": 0.01625, "zinc addition": 0.00673, "elderly donor stain": 0.00093, "hsf-1 activity": 0.02925, "cellular mechanism contribute": 0.00705, "th2-restricted il-4 expression": 0.02775, "htlv-i infected human t-cell line": 0.01505, "matrix metalloproteinases": 0.0013, "creb isoforms": 0.00307, "human platelet activate": 0.02508, "lymphocyte induces transcription": 0.01873, "w-x-y": 0.00012, "effective": 0.00329, "putative ap-1 recognition sequence": 0.00813, "rm": 0.00012, "il-2r regulation gene": 0.02903, "trophoblast invasion": 0.00022, "negative control": 0.01303, "cholesterol": 0.00074, "cell antigen-specific signaling response": 0.0384, "peripheral blood t-lymphocytes express cryptic epitope": 0.00615, "active oxygen specie serve": 0.00296, "b-cell-specific coregulator": 0.00121, "increase kcat": 0.02196, "previous data": 0.00254, "healthy control subject": 0.00868, "enhanced nuclear staining": 0.01123, "spi-1/pu.1 require signal": 0.0109, "nf-kappa b-like nuclear factor": 0.0143, "unidentified": 0.00155, "sre sequence": 0.01625, "epsilon-": 0.00019, "human gata-1 gene": 0.02903, "genuine hugata-3": 0.00022, "soccer player": 6e-05, "mutation": 0.01185, "steel factor suggest": 0.01907, "unspliced gag-pol mrna": 0.01017, "cd1a-": 0.00012, "amino terminus": 0.00273, "apocynin": 0.00012, "exogenous pge2": 0.00214, "mek1 expression": 0.04163, "mouse embryonic globin gene": 0.02177, "huvec surface vcam-1": 0.00343, "pebp2betamyh11": 0.00056, "end": 0.00118, "de novo macromolecule synthesis": 0.00292, "analogous effect": 0.02115, "vivo generate lak cell-mediated lysis": 0.00212, "sp family member": 0.0056, "calcium-dependent phosphatase": 0.00264, "neutrophil maturation": 0.00496, "regulate il-2 transcription": 0.01873, "transcription initiation direct": 0.01873, "myelomonocytic cell": 0.0768, "1.5-2.6 kd fraction": 0.00116, "retarded mobility": 0.00133, "inflammatory infiltrate": 0.00471, "unbalanced inactivation": 0.00174, "ah receptor deficient c12 cell line": 0.0256, "biological response": 0.01942, "nontranscribed region": 0.01467, "current knowledge": 0.00084, "adenylate cyclase": 0.00037, "percentage": 0.00143, "monocyte line": 0.01653, "cell-to-cell contact": 0.00093, "intact e1a": 0.00248, "acute hepatic injury": 0.00246, "latency": 0.00279, "-141 base pair": 0.00207, "constitutive viral enhancer": 0.00606, "obligatory heterodimerization": 0.00059, "t-cell tumour": 0.00962, "well-defined": 0.00068, "position -460": 0.00236, "mineralocorticoid receptors/cell": 0.0013, "0.2-1.2": 0.0, "hypophosphorylated form": 0.01055, "transcription factor ccaat enhancer bind protein alpha": 0.01294, "subnuclear dot-like structure": 0.00213, "overexpressed egfr": 0.00087, "oct-2 synthesis": 0.00583, "p55/c-rel complex": 0.01684, "gene encode protein": 0.03019, "leukemic cell carry": 0.0512, "chronic eosinophilic inflammation": 0.00265, "translation start site": 0.01445, "underwent rearrangement": 0.00199, "polymorphic trinucleotide repeat": 0.00252, "metabolic labeling combine": 0.00108, "ra oppose anti-apoptotic effect": 0.01058, "alter membrane phospholipid metabolism": 0.00225, "appearance": 0.00199, "major coping strategy": 0.00383, "rabbit antiserum": 0.00074, "assay confirm": 0.01002, "il-4r alpha cytoplasmic domain": 0.00603, "raf-1 protein": 0.04529, "tax expressing cell": 0.0512, "il-1beta-converting enzyme family protease inhibitor": 0.0036, "c-jun protein expression": 0.03019, "acute lymphoblastic leukemia cell line reh": 0.0256, "separable gene regulatory": 0.02903, "increase 3-10 fold": 0.01464, "tumor necrosis factor-alpha mrna level": 0.00728, "gata-1 activity": 0.02925, "thyroid hormone act": 0.00331, "nuclear factor-kappa b. inhibitory effect": 0.00846, "epinephrine": 0.00012, "ikappab proteolysis": 0.00136, "normal myeloid cell": 0.0512, "hiv-ltr/tat transgenic mouse": 0.00649, "regulate expression": 0.04163, "glucocorticoid receptor antagonist ru38486": 0.01286, "nf-kappab show": 0.02599, "cd4+ cd8int/- cell": 0.0512, "late phase": 0.00276, "e12": 6e-05, "cdna encode": 0.00853, "beta-catenin accumulates": 0.00047, "gr affinity": 0.004, "lymphoma receptor": 0.02571, "inhibit tnf-": 0.01904, "full-length bob.1/obf.1": 0.00124, "unlabeled nf-at binding site": 0.01084, "vitamin": 0.00471, "healthy human leukocyte antigen-b8": 0.01881, "lps-": 0.00043, "human thymocyte nucleus": 0.02508, "monocyte/macrophage cell": 0.0768, "function analysis": 0.01331, "leucocyte": 0.00136, "inherent resistance": 0.00326, "propagates signal": 0.01635, "mapped": 6e-05, "3q21-24": 6e-05, "peripheral human mononuclear cell": 0.0384, "-beta1": 0.00025, "rest t-lymphocytes": 0.00267, "intracellular na+": 0.00583, "chimeric type ii/type": 0.00633, "ig heavy chain mu e1 site": 0.00723, "protein phosphatase inhibitor": 0.03019, "breast cancer target susceptibility": 0.00413, "growth phase-dependent resistance": 0.00546, "clonality": 0.00087, "cytoplasmic tail": 0.004, "synthetic glucocorticoid bind": 0.0135, "human th2-type lymphocyte": 0.02508, "duplication": 0.00037, "beta gene promoter": 0.02903, "lrr": 0.00012, "cytokine receptor expression": 0.02775, "megakaryocyte-specific promoter": 0.02336, "acla-treated cell": 0.0768, "transient transfection assay demonstrate": 0.00799, "zap-70 autophosphorylation": 0.00155, "fmol/mg": 0.00031, "ino production": 0.01042, "c-myc probe": 0.00261, "precipitation": 0.00025, "interleukin-13": 0.00031, "increase ip-10 mrna induction": 0.01098, "target molecule": 0.00853, "pax5 gene": 0.04355, "valine substitution": 0.00112, "rescue cytokine": 0.01123, "exhibit": 0.01328, "express pou domain transcription factor oct-1": 0.00953, "recent study demonstrate": 0.01065, "endogenous c/ebp protein": 0.03019, "recent report demonstrate": 0.01065, "human myeloid cell nuclear differentiation antigen": 0.0256, "human autosomal recessive disease": 0.01881, "contraction": 0.00031, "serum-response element": 0.01672, "pma inhibit": 0.01904, "serum cortisol level": 0.01214, "lps-mediated nuclear binding": 0.01237, "htlv-i long terminal repeat": 0.00189, "pbmc stimulate": 0.01101, "lipopolysaccharide": 0.0049, "striking degree": 0.00146, "hiv-1 gene transcription": 0.02903, "icsat overexpression": 0.00382, "nm23 gene encode protein": 0.02264, "presurgical group": 0.00487, "tf mrna": 0.01526, "transcriptional repression": 0.01151, "bead-1 function": 0.01331, "e-selectin gene exhibit mark difference": 0.01742, "regulate e2f transcriptional activity": 0.01462, "tubulointerstitium": 0.0, "intracellular receptor belong": 0.01714, "activation dependent": 0.03164, "traf interaction domain": 0.00804, "transcription-independent": 0.00019, "embo j.16:332-342": 6e-05, "fluorescence chromosomal": 0.00102, "hla-dr synthesis": 0.00583, "cerulein-induced acute pancreatitis": 0.00246, "timp-1-negative bl line": 0.01102, "include tumor necrosis factor": 0.0143, "inhibitory pathway": 0.01278, "total enzyme": 0.0031, "somatic fusion": 0.00326, "reduced nf-at activity": 0.0195, "cd11b+ bone marrow cell reveal similar cd11b+ population": 0.0192, "transformed phenotype": 0.00366, "direct involvement": 0.0054, "nm23 gene product": 0.02903, "consensus sequence eliminate binding": 0.00927, "similarly prepared cfp extract devoid": 0.00184, "polyamine level": 0.01821, "result cytosol yield coimmunoadsorption": 0.00805, "airway": 0.0018, "similar age distribution": 0.00449, "cell show": 0.0768, "slide assay": 0.01002, "lymphoid cell": 0.0768, "increase lymphocyte binding": 0.01464, "forty-five": 0.0, "multiple ets": 0.00689, "transformed pre-b cell": 0.0512, "ig variable heavy chain sequence": 0.0065, "tgf-beta1 signaling": 0.00558, "neoplastic familial disorder": 0.00149, "interleukin-2 enhancer correlate": 0.00606, "aml1a": 0.00062, "c-jun-containing complex": 0.01684, "wp reporter construct": 0.00484, "co-transfecting bko": 0.00012, "nested pcr assay": 0.00668, "cell biological property": 0.0512, "sickle cell anemia": 0.0512, "fetal muscle": 0.00214, "c-terminal tax1 mutant m22": 0.00405, "tis-8": 6e-05, "mkp-1": 0.00031, "basal": 0.00701, "ig heavy chain enhancer component": 0.00364, "dominant-negative act stat-3 isoform": 0.00248, "early growth response gene c-fos": 0.01742, "beta-globin gene expression": 0.02903, "ikappabbeta provide": 0.00645, "vitd3 induce distinct monocytic differentiation pathway": 0.00847, "e1a induces susceptibility": 0.00536, "human tr beta": 0.02508, "cem-c7 cell": 0.0768, "aml1 antisense oligodeoxynucleotide": 0.00108, "igh locus": 0.00288, "significant il-2": 0.01117, "apoptosis-inducing ligand": 0.00592, "tissue differentiation": 0.01179, "cd45 expression": 0.04163, "immunosuppressant fk506": 0.00149, "gene activity": 0.04355, "free radical": 0.00127, "e1c3": 0.00025, "increased apoptosis": 0.0089, "adjacent activator site act-1": 0.01084, "g2/m": 0.00025, "1-2 minute": 0.00043, "myeloid differentiation primary response gene": 0.01742, "3-fold range": 0.00202, "curry spice": 9e-05, "15-hete": 0.00012, "human t-lymphocyte cell line": 0.0384, "fc gamma ri transcription": 0.01405, "t-pll": 0.00074, "strategy": 0.00242, "ms-2": 0.00031, "limit transcription": 0.0281, "time-frame": 6e-05, "protein lmp1": 0.04529, "beta-": 0.00118, "parath hormone": 0.00444, "significant apoptosis": 0.0089, "consecutive": 0.00062, "http": 0.00019, "neutral sphingomyelinase": 0.0004, "lps-responsive cell": 0.0768, "fast-migrating protein-dna complex": 0.01123, "positive-": 0.00012, "normal tissue histiocyte": 0.00806, "hbsag": 0.00019, "protein bind characteristic": 0.03019, "bad prognosis": 0.00028, "lymphokine activate killer cell": 0.0384, "cp activity result": 0.0195, "ra transformation": 0.00596, "acute leukemia cell": 0.0512, "nkl natural cytotoxicity": 0.00155, "-induced expression": 0.04163, "form platelet": 0.01055, "coreceptor": 0.00019, "receptor-vitamin": 0.00012, "nfatp-binding site": 0.02168, "tar mutant construct": 0.0054, "eicosanoid synthesis": 0.00583, "develop nephrotic syndrome": 0.00269, "quality": 0.00043, "au-dd": 6e-05, "relative inability": 0.00276, "peripheral blood monocyte serve": 0.00599, "tumoral": 0.00012, "gm-csf mrna": 0.01526, "subtotal colectomy": 0.00012, "detect": 0.01452, "human peripheral monocyte stimulate": 0.01881, "inducible retarded band": 0.00323, "il2rbeta promoter": 0.02336, "pkc alpha": 0.01169, "proviral induction": 0.01607, "subclone wurzburg cell oxidant challenge": 0.03072, "secrete p40": 0.00208, "-34": 0.00012, "total percentage": 0.00161, "ikappab-alpha level": 0.01821, "il-2-induced il-6 mrna expression": 0.02081, "g10-2/cd43 bore complex": 0.01123, "cemxl74 cell": 0.0768, "myeloid lineage": 0.00462, "regulate alpha2 integrin gene expression": 0.01742, "yeast express sr-bp": 0.0123, "venous blood": 0.00592, "transient short-term expression": 0.02775, "-76 nucleotide relative": 0.00184, "tritiated ligand": 0.00592, "drosophila segment polarity gene armadillo": 0.01742, "classical hla antigen": 0.00546, "regulatory factor": 0.0286, "neoplastic disorder": 0.00223, "definition": 0.00056, "minimal tissue-specific promoter region": 0.01168, "mutant probe": 0.0081, "immunoglobulin heavy-chain": 0.00276, "tyrosine kinase inhibition": 0.00792, "adenylyl cyclase signal transduction cascade": 0.00654, "side reaction": 0.0022, "downregulated pu.1 expression": 0.02775, "pma demonstrate considerable increase": 0.01098, "cd4-8-": 0.00031, "tumor-draining ln": 0.00028, "cell-specific transcriptional coactivator protein": 0.02264, "c/ebp proximal": 0.00301, "ig-expressing": 0.00012, "ha1004": 0.0, "carcinogenesis": 0.00019, "endothelial mcp-1 secretion": 0.00289, "functional context": 0.00816, "competence": 0.00043, "saturating amount": 0.00285, "thrombin-activated human platelet": 0.02508, "cd36-ox ldl interaction": 0.00658, "septic shock suggest": 0.01348, "ifn-alpha rna": 0.00456, "mcm6 gene": 0.04355, "fitc-dextran": 6e-05, "potent scavenger": 0.00357, "il-2 gene": 0.04355, "b-cell-specific transcription": 0.0281, "include thiol deprivation": 0.00959, "glucocorticoid affect": 0.0085, "hla-dmb function": 0.01331, "include human lymphoid cell": 0.0384, "arre": 6e-05, "mouse-repopulating stem cell": 0.0512, "leukocyte-type 12-lipoxygenase": 0.00025, "ig heavy chain": 0.00292, "irbp": 6e-05, "p38 mapk activation": 0.02109, "ebv carrier": 0.00565, "kinase inhibitor": 0.01188, "clonogenic capacity": 0.00329, "entire catalytic domain": 0.00804, "system suggest": 0.02022, "dimethyl sulfoxide": 0.00043, "u1 cellular clone": 0.00596, "boyden chamber method": 0.00157, "antigen-processing pathway": 0.01278, "differentiation suggest": 0.02022, "il-8 family": 0.00841, "initial event": 0.00552, "physiologic molecular switch": 0.003, "cd15 increase cat activity": 0.01462, "nf-kappa b/rel transcription factor": 0.0143, "dutpase react": 0.00074, "ebna1": 0.00012, "antisense hmg i/y": 0.00108, "lmp-1 e2re": 0.00118, "ca2+/calmodulin-dependent protein kinase iv": 0.02264, "related specie": 0.00236, "rev": 0.00093, "granulopoietic pathway": 0.01278, "stat1 activation": 0.03164, "antigen receptor-initiated signal": 0.0109, "regulate lps-triggered gene induction": 0.02177, "monoclonal reagent": 0.00279, "hiv gene": 0.04355, "stimulate hiv expression": 0.02775, "rxrs heterodimerize": 0.00031, "modulation subsequent": 0.00304, "brca2": 0.00025, "exogenous tnf": 0.00481, "strong transcription": 0.0281, "lymphocyte-specific mb-1 gene": 0.02903, "control line": 0.01653, "escherichia coli lp": 0.00236, "pkcalpha": 0.00025, "zif-268": 6e-05, "janus family": 0.00841, "m.a": 0.00012, "il-4": 0.01334, "comprise terminal differentiation": 0.00786, "u937 cell reveal": 0.0512, "numerous cytokine promoter": 0.01557, "normal vaginal flora": 0.00806, "high nf-kappa": 0.01414, "suppress il-12 production": 0.00695, "protein encode": 0.04529, "peripheral blood cell": 0.0512, "maggi": 0.00012, "shared component": 0.00456, "nfkappab/ikappab system": 0.00667, "target specific dna bind protein": 0.01811, "activate hiv-1 transcription": 0.01873, "rapid non-genomic action": 0.00333, "cis-acting sequence": 0.01625, "translocation partner": 0.00515, "result suggest": 0.02022, "anti-fas-mediated apoptosis": 0.0089, "enhance region": 0.01467, "ctla-4 ligation": 0.0018, "quiescent pbmc": 0.00236, "cd30-cd30l interaction mediate": 0.00821, "hmg box family": 0.0056, "human growth hormone": 0.02508, "nf-m-estrogen receptor express progenitor": 0.01286, "aetiology": 6e-05, "igh-enhancer": 6e-05, "reporter": 0.01104, "metabolic acidosis": 0.00065, "distal promoter sequence": 0.01557, "deprivation": 0.00087, "specific lymphocyte": 0.01483, "ingredient": 0.00019, "filarial antigen-specific t-cells": 0.00141, "active element": 0.01672, "vitro-translated pu.1": 0.00285, "dimeric form": 0.01055, "chloramphenicol acetyl transferase": 0.00062, "consensus sequence": 0.01625, "polyamines": 0.00031, "cellular differentiation program": 0.00786, "m-csf-induced blood monocyte": 0.00798, "scatchard analysis": 0.01179, "biochemical marker": 0.00382, "whole-cell assay": 0.01002, "western blot analysis demonstrate": 0.00799, "delta spi-b": 0.00211, "il-10 promoter": 0.02336, "analyze individual sequence element": 0.00836, "additional experiment show": 0.01733, "increase intracellular calcium": 0.01464, "previous finding": 0.00226, "adult-type profile": 0.00152, "cd20 promoter-cat construct": 0.00484, "il-10 effect occur": 0.0141, "hb-egf": 0.00031, "multiple nf-atc isoforms": 0.00459, "turn lead": 0.00996, "decreased km": 0.0022, "genetic characterization": 0.00288, "result vary": 0.0161, "multifocality": 0.00012, "vitro coexpress erythrocytic": 0.00523, "ss": 0.00056, "haptenation": 0.00019, "elderly healthy subject": 0.00236, "kbf1/p50": 0.00056, "heterozygous female": 0.00158, "hemopoietic-specific zinc finger protein": 0.02264, "expression status": 0.04163, "tnf-alpha-dose dependency": 0.00016, "derivative": 0.00385, "vimentin level": 0.01821, "arre-2": 0.00025, "kappab binding": 0.01855, "human tr2 orphan receptor response element": 0.01254, "trigger transactivation": 0.00515, "-557": 6e-05, "antisense rxr-alpha cdna suggest": 0.01011, "erythroid cell-specific gene": 0.02903, "untreated depressed": 0.00115, "stimulatory": 0.00099, "tartrate-resistant acid phosphatase": 0.00571, "exhibit change": 0.00664, "cell-specific co-activator": 0.00292, "genetic background": 0.00288, "pma/ca2+ ionophore stimulation": 0.00746, "accumulated form": 0.01055, "nf-kappab binding activity correlate": 0.01462, "g-csfr": 0.00068, "t-cell response": 0.01942, "gene open": 0.04355, "sivmac replication": 0.00471, "powerful enhancer": 0.00909, "cis-element": 0.00056, "mdhm-induced increase": 0.02196, "ligand-activated c-erba/tr induces differentiation": 0.00589, "inf-gamma": 0.00012, "k44m": 6e-05, "vitro binding site selection procedure": 0.00867, "ficoll density gradient": 0.00077, "general cofactor": 0.00155, "transcription unit span": 0.01873, "vivo occupancy": 0.0053, "lymphoid reservoir": 0.00409, "molecular regulation": 0.01008, "2-deoxyglucose uptake": 0.00167, "ms2-hbx fusion protein": 0.03019, "ggggactttccg": 6e-05, "affect b29 minimal promoter activity": 0.0117, "bacterially-produced mr construct": 0.00484, "nf-ats": 0.0, "growth-inhibited": 6e-05, "induced functional": 0.00816, "taci-induced activation": 0.03164, "rfx": 0.00093, "additional protein-protein interaction and/or post-translational modification": 0.00329, "vcam-inducer": 6e-05, "macrophage contrast": 0.00589, "hiv ltr": 0.00592, "nuclear subvolumes": 0.01684, "guinea pig": 0.00016, "nf-y-binding site": 0.02168, "cell cycle progression role": 0.0384, "ggggctgtccc": 0.00012, "variant peptide": 0.00754, "dna-binding conformation": 0.00561, "rex gene": 0.04355, "site term": 0.02168, "t-cell lymphoma share": 0.00641, "ab-associated change": 0.0063, "gca": 0.00012, "suppress transcriptional activator": 0.00767, "dnase": 0.00192, "normal nonpregnant": 0.0121, "t-cell function": 0.01331, "malignant human b-cell line": 0.01881, "substantial proportion": 0.00127, "il-13r alpha1 show": 0.01733, "prb": 0.00273, "direct ctl control": 0.00868, "independent complex": 0.01684, "critical factor": 0.0286, "intense tyrosine phosphorylation": 0.00656, "gm-csf receptor alpha promoter pu.1 site": 0.00857, "increased expression result": 0.02775, "paired box": 0.00304, "insufficient": 0.00074, "synthesize class ii molecule": 0.00426, "9-cis ra result": 0.01073, "proper microarchitecture": 0.00034, "bcl-6 gene rearrangement": 0.02903, "dihydrofolate reductase gene": 0.02903, "aldosterone-specific membrane receptor": 0.01714, "conditional immortalization": 0.00062, "par": 0.00019, "increase viral protein secretion": 0.02264, "isoform": 0.00341, "colony-forming unit-granulocyte-macrophage progenitor cell": 0.0384, "octa abolish enhancer activity": 0.01462, "staurosporine sensitive": 0.00273, "gene encode endothelial adhesion molecule": 0.01742, "cardiac infarction patient": 0.0111, "iggk phenotype": 0.00366, "ebv-b cell": 0.0768, "proenkephalin promoter": 0.02336, "tal-15": 6e-05, "htlv-i-infected leukemic t-cell line": 0.00827, "ra activates mechanism": 0.00705, "trolox": 0.00012, "promoter-bound multi-protein complex": 0.01123, "bcl-6/cd20": 0.00012, "preformed": 0.00056, "stress-induced down-regulation": 0.00195, "cd8+ cell": 0.0768, "enhance il-1 beta mrna expression": 0.01665, "il-4 receptor provide evidence": 0.01286, "hut102": 0.00019, "htlv-infected cell": 0.0768, "strong association": 0.00347, "microscopy": 0.00099, "caml gene": 0.04355, "soluble e-selectin": 0.00223, "peritoneum": 0.0, "vincristine": 0.00025, "e74 site": 0.02168, "300-fold high": 0.00931, "3-5-fold increased risk": 0.00242, "rate limit": 0.00279, "human zeta-globin gene": 0.02903, "fos expression": 0.04163, "responsive dna element": 0.01115, "transcriptional activator sequence": 0.01084, "murine kappa light chain enhancer motif": 0.00303, "utilizing oligonucleotides homologous": 0.00122, "major treatment modality": 0.00676, "growth factor deprivation apoptosis": 0.0143, "fibrosis score": 0.00031, "scaffold": 6e-05, "suggestive": 0.00031, "epithelial stat1": 0.00285, "xp-d cell": 0.0768, "blr2": 0.00037, "effector": 0.00552, "calcium-activated k+ channel": 0.00041, "cholesteryl ester": 0.00202, "concentration specific manner": 0.00825, "sp100": 0.00031, "inhibit": 0.03809, "bcl-2 expression": 0.04163, "aa565-647": 6e-05, "ccacc site": 0.02168, "distal ccaat box": 0.00203, "cellular substrate": 0.00893, "pre-leukemic phase": 0.00276, "anti-cd2 receptor antibody activate": 0.01286, "peptidylprolyl cis-trans isomerase distinct": 0.00349, "tnfr1 require": 0.01315, "cross-prime e1a-": 0.00025, "normal oestrogen target organ": 0.00605, "adult-onset form": 0.01055, "sex-matched control": 0.01303, "magnitude": 0.00099, "normal myelopoiesis": 0.0121, "c/ebp motif": 0.00875, "gata-1 nuclear body differ": 0.00842, "insulin receptor": 0.02571, "homologue": 0.00093, "biochemical study": 0.01355, "lymphoid tissue": 0.00664, "culture rcc explants inhibit nfkappab activity": 0.00975, "hemo-lymphoid system": 0.00667, "pma/ionomycin-induced activation": 0.03164, "cd40-": 6e-05, "stimulate htlv-i transcription": 0.01873, "ciprofloxacin induces": 0.00803, "synthetic oligonucleotides correspond": 0.00134, "protein associate": 0.04529, "gata family protein": 0.03019, "signal-induced degradation": 0.00332, "sequence comparison": 0.01625, "ligation-mediated polymerase chain reaction": 0.00219, "il4 expression": 0.04163, "human colon carcinoma cell line": 0.03072, "restricted hiv expression": 0.02775, "es cell": 0.0768, "pml-rar alpha fusion oncoprotein": 0.00585, "relationship remain controversial": 0.00347, "major histocompatibility complex class ii molecule": 0.00561, "leukemic sample": 0.00251, "transcriptional coactivator": 0.01151, "chromosome lack xist expression": 0.02081, "equal": 0.00062, "supernatant fluid": 0.00093, "undergone class switching": 0.00428, "molecular mechanism": 0.01058, "b-cell chronic lymphocytic leukemia": 0.0025, "single-copy gene": 0.04355, "mbob1 interacts": 0.00136, "5'-3": 6e-05, "suppress nf-kappa": 0.01414, "specific binding": 0.01855, "premature termination": 0.00037, "pkc-zeta display": 0.00499, "serine-threonine phosphatase pp2a": 0.00176, "ca2+-independent isoforms": 0.00307, "naive cd4": 0.00332, "33-kda protein": 0.04529, "mzf-1": 0.00205, "b29": 0.00167, "low activity": 0.02925, "bind pattern": 0.02025, "specific monoclonal antibody recognition": 0.00619, "q24": 6e-05, "exhibit distinct replicative": 0.00465, "src-family kinase lck": 0.00792, "unique dna-protein complex": 0.01123, "ebv early promoter": 0.01557, "characterize drosophila": 0.00425, "co-expression": 0.00019, "country": 0.0, "select adhesion mediate event": 0.00616, "increase intracellular ca2+": 0.01464, "ng/ml il-8": 0.00189, "cytokine gene expression": 0.02903, "negative autoregulation": 0.00515, "p65 component": 0.00456, "stat binding sequence": 0.01237, "p50/p65/c-rel": 0.00012, "hlh-2": 0.00043, "narrow window": 9e-05, "export factor": 0.0286, "proto-oncogene c-rel": 0.00245, "activate cd11c": 0.01777, "child age": 0.00226, "late stage cell": 0.0512, "macrophage-like phenotype": 0.00366, "octamer-dependent activation": 0.03164, "oppose transcription factor": 0.01907, "bronchial mucosa": 0.00093, "resistance": 0.00651, "intracranial inoculation": 9e-05, "immature haematopoietic population study": 0.00678, "antigen-specific t-cell receptor": 0.01714, "kt-3": 6e-05, "altered self-ags": 0.00161, "nonspecific inhibitor": 0.009, "e74": 0.00031, "footprinting analysis reveal": 0.00786, "litaf mrna": 0.01526, "soluble beta-": 0.00223, "low affinity class": 0.00471, "high resolution footprinting": 0.0062, "tata box": 0.00304, "cellular gene activation": 0.02903, "border": 0.0005, "virologic subtypes": 0.0004, "cycle-dependent initiation": 0.00211, "guanine residue": 0.00226, "36-41 kd": 0.00174, "ectopic id1 repress": 0.00147, "oncogenic potential": 0.00605, "human monocyte cell line thp-1 result": 0.0256, "putative function": 0.01331, "intracellular signal mediate tnf-alpha release": 0.00654, "keratoacanthoma": 6e-05, "roi-reactive fluorochrome dcfh-da": 6e-05, "autoinhibitory domain": 0.01207, "double-blind fashion": 0.00161, "pcd41 orf-a": 0.00025, "clonal immune response specific": 0.00971, "small cytoplasmic tail": 0.00267, "sodium acetate confirm": 0.00223, "me1a1 g3ag4ag3 motif": 0.00583, "skeletal myogenesis": 0.00025, "anti-stat3 antibody": 0.00893, "culture mcf-7 cell": 0.0512, "transcription factor selectively regulate cytokine production": 0.00953, "de novo translocation": 0.00343, "distinct group": 0.00698, "non-specific": 0.00025, "pu.1 transactivates": 0.00285, "primary": 0.01476, "rex-mediated trans-activation": 0.00078, "footprinted": 0.00031, "hog-1": 0.00012, "philadelphia chromosome": 0.00295, "encode zta": 0.00853, "tumor necrosis factor induce apoptosis": 0.01144, "important modulator": 0.00689, "induce transcriptional activity": 0.0195, "alpha display": 0.01169, "slb-i": 0.0, "random oligonucleotides": 0.00183, "promote fibrogenesis": 0.00465, "dna damage": 0.01483, "-atpase b2 subunit gene": 0.02177, "activation responsible": 0.03164, "c-fos oligonucleotides": 0.00471, "specific anti-hrbc antibody production": 0.00619, "antioxidant activity": 0.02925, "histochemical marker": 0.00382, "short life span": 0.00101, "kappa b-alpha gene": 0.02903, "protooncogene expression": 0.04163, "native promoter": 0.02336, "specific consequence": 0.01238, "-147/-130 nxs": 0.00012, "c81-66-45 cell": 0.0768, "cell-permeable peptide carry": 0.00502, "kappa b-specific dna binding protein": 0.01811, "inflammatory cytokine tnf-alpha": 0.00749, "transient pseudohypoaldosteronism due": 0.00246, "multiple functional element": 0.01115, "acute myelogenous leukemia 1-evi1 fusion": 0.002, "stem cell": 0.0768, "lymphocytic infiltrates": 0.00118, "pyrrolidine dithiocarbamate": 0.00047, "dyad symmetry region": 0.00978, "enzyme-linked immunosorbent assay": 0.00668, "mhc class ii mrna": 0.00763, "glucocorticoid receptor regulate expression": 0.02081, "increased c-fos synthesis": 0.00389, "discrete stage": 0.00248, "frequent polyomavirus reactivations": 0.00033, "lymphotropic virus": 0.00887, "ifn-inducible gene product regulate cell growth": 0.0256, "aml1-related transcription factor": 0.01907, "increased capacity": 0.00363, "lai": 0.00056, "p65/p50 heterodimer": 0.00205, "il-2 reverted anti-tnf-alpha inhibition": 0.00558, "p1 nfat-binding element": 0.01115, "heterologous replacement domain": 0.00804, "tnfrp55 function render mice resistant": 0.00532, "erythroleukemic cell line k562": 0.0384, "ifn inducible": 0.00484, "59-kda protein": 0.04529, "cyclosporin a-sensitive tumor necrosis factor-alpha gene transcription": 0.01244, "mature red blood cell": 0.0384, "inhibit tnf-alpha-induced vcam-1": 0.0127, "alpha fail": 0.01169, "tumorigenesis": 0.00112, "zap-70 regulate": 0.01253, "b-cell repertoire": 0.00459, "physiological relationship": 0.00183, "menstruating woman": 0.00233, "il-2": 0.02233, "macrophage cell line u937": 0.0384, "mouse mammary tumor virus long terminal repeat fuse": 0.00243, "pma inducible function": 0.00887, "vzv ie62 protein": 0.03019, "nf-at-like factor": 0.0286, "latent component": 0.00456, "reduced tissue concentration": 0.00447, "caii": 0.00056, "hematopoietic development": 0.00633, "metabolic stimulus": 0.0027, "non-genomic effect": 0.02115, "tpa addition": 0.00673, "distinct impaired deletion": 0.00465, "plc gamma": 0.0044, "tumor-eradicating ctl": 0.00115, "b-cell specific": 0.01238, "individual show": 0.02599, "human glial astrocyte": 0.02508, "noticeable adhesion": 0.0058, "3d-nmr study": 0.01355, "preeclampsia": 0.00037, "sugar": 0.00019, "oocyte development": 0.00633, "tk activity": 0.02925, "mnc lysates": 0.00102, "ebv transactivators": 0.00565, "facilitate viral transcription": 0.01873, "hindrance": 6e-05, "additional": 0.00682, "stimulation suggest": 0.02022, "induce mrna": 0.0254, "il-2 induces gene expression": 0.02177, "phosphocreatine": 0.00025, "maximal level": 0.01821, "reporter bear": 0.00552, "il-1 beta convertase mrna accumulation": 0.0061, "cd54": 0.00031, "abstract": 0.0, "independent cis-acting sequence": 0.01084, "structure-function analysis demonstrate": 0.01065, "il-1beta promoter": 0.02336, "demonstrate loss": 0.01597, "iso": 0.00025, "notch1 lack": 0.00633, "human monocytic thp": 0.02508, "activation-induced cell death": 0.0512, "mitogen-activated protein kinase kinase": 0.02264, "consensus octamer": 0.00288, "gr mrna expression": 0.02775, "crohn": 0.00019, "hhv-6": 0.00167, "igh pi site": 0.01445, "sivmac239": 0.00056, "rnaase protection assay demonstrate": 0.00799, "il-10 inhibited ifn-gamma-induced stat activation": 0.01266, "ige concentration": 0.0067, "bisdioxopiperazine icrf-193": 0.00012, "heterodimeric complex": 0.01684, "include adherence": 0.01439, "pharmacological modification": 0.00183, "multicopy basal enhancer motif": 0.00454, "ut-7 cell line exhibit": 0.0384, "r-276": 0.00012, "ap-1 binding activity": 0.0195, "tenen": 6e-05, "surface expression": 0.04163, "interesting therapeutic potential": 0.00403, "dominant negative regulator": 0.00343, "increase igm production": 0.01464, "lineage-positive cell": 0.0768, "include interferon": 0.01439, "mef2": 6e-05, "important": 0.01377, "non-inducible": 0.00037, "lambda phosphatase treatment": 0.00676, "dm gene": 0.04355, "apc-independent": 0.00012, "glycosylphosphatidylinositol-linked antigen": 0.00819, "stat induction": 0.01607, "mhc class": 0.00642, "full gene activity require additional enhancer element": 0.01244, "logarithmic growth phase": 0.00546, "sv40 probe": 0.00261, "pdgf-b": 0.00012, "human beta-globin gene expression": 0.02177, "cd28 up-regulation": 0.00323, "multispecific immune response": 0.01294, "murine gm-csf gene": 0.02903, "cdna fragment express": 0.0123, "hormone.2+o signal transduction abnormality": 0.00817, "select epitope": 0.00195, "functional parameter": 0.00816, "dual specificity phosphatase": 0.00223, "egr-1 promoter fragment link": 0.01168, "multiple tyrosine kinase": 0.00792, "m-csf regulates c-jun expression": 0.02081, "specific nuclear translocation mechanism exist": 0.00674, "collagen-coated plastic": 0.00028, "osm": 0.00025, "bipartite nuclear localization signal": 0.00842, "incompetent human g-csfr mutant": 0.01881, "clomiphene": 0.00012, "anti-csf-1r monoclonal antibody": 0.00596, "triamcinolone acetonide": 9e-05, "binding reaction": 0.01855, "human peripheral blood cell": 0.0384, "iron storage": 0.0004, "potential tfiid bind site": 0.01084, "epstein-barr early region": 0.00978, "increase hiv expression": 0.02775, "pt": 0.00043, "vkc": 0.00019, "cytokine-stimulated cell surface expression": 0.0384, "el4 cell": 0.0768, "cbp/p300 coactivator": 0.00149, "lt biologic activity": 0.0195, "low renin": 0.00707, "mycobacterial cell wall component mannose-capped lipoarabinomannan": 0.0256, "steroid hormone anti-sera": 0.00296, "develop breast cancer": 0.00269, "strong reduction": 0.00347, "lps-responsive member": 0.00413, "biochemical": 0.0036, "similar behaviour": 0.00673, "j.virol.63:3040-3050": 0.0, "uptake": 0.00335, "beclomethasone dipropionate": 6e-05, "activate jnk": 0.01777, "flavonoid": 0.00062, "lack cd45": 0.00633, "postreceptor level": 0.01821, "survival-promoting activity": 0.02925, "erythroid differentiation event": 0.00786, "chi": 0.00037, "auto": 0.00012, "implies": 0.00037, "induce early antigen": 0.01694, "mouse homolog": 0.00974, "premenopausal patient": 0.01666, "transcription factor active": 0.01907, "tr": 0.00081, "promoter selectivity": 0.02336, "developing": 0.00019, "tcc exhibit": 0.00664, "cleo element": 0.01672, "pkc play": 0.0071, "lcl": 0.00056, "human leukemia cell line": 0.0384, "psoriasis": 0.00025, "antithyroid drug treatment alter reactivity": 0.00406, "ability": 0.00862, "gssg deficiency": 0.00112, "alpha2beta1 integrin gene": 0.02903, "pmn stimulate": 0.01101, "simultaneous induction": 0.01607, "mutant ltrs": 0.0081, "gr isoforms": 0.004, "breast recurrence": 0.00257, "ra-resistant subclone": 0.0004, "il-10-inhibited lymphocyte": 0.01483, "bsap gene shift": 0.02903, "cyclic amp-responsive element modulator": 0.00836, "activate parallel": 0.01777, "epstein-barr virus": 0.00887, "mediate survival signal": 0.0109, "p105 undergoes degradation": 0.00221, "b-cell-specific transcription coactivator oca-b": 0.01405, "adhesive": 0.00099, "stromal cell rescue": 0.0512, "normal human cell": 0.0512, "innate immune system": 0.00445, "pax-5 allele": 0.0022, "genbank reveal": 0.01098, "transcription correlate": 0.0281, "il-4 substitute": 0.00667, "exosurf": 0.00019, "nlphd uniformly display": 0.00333, "hiv transcription": 0.0281, "human monoblastic cell": 0.0512, "65-kd subunit": 0.00484, "trans-activate": 0.00037, "-605 motif": 0.00875, "gene therapy": 0.04355, "signal transduction element": 0.01115, "sense oligomer": 0.00047, "hes-1 transcript": 0.00599, "microenvironment": 0.00068, "cd61 antigen": 0.00819, "nfatx": 0.00025, "promote mm cell growth": 0.0384, "transcriptional cofactor": 0.01151, "chimeric oncoprotein e2a-pbx1 result": 0.00805, "ebna-2-negative nuclear extract": 0.01123, "-3 gene product": 0.02903, "il-2+ cell": 0.0768, "monocyte gene": 0.04355, "il-2 gene require activation": 0.02177, "agreement": 0.00012, "hhv-6 variant": 0.00276, "oncogenic": 0.0018, "bona fide th2 cell": 0.0384, "anti-nf-atc": 6e-05, "kda protein factor": 0.03019, "understand good": 0.00155, "intranuclear icn": 0.00028, "transient expression experiment": 0.02775, "cd18": 0.00068, "basic helix loop helix": 0.00087, "ec lie upstream": 0.00246, "preservation": 6e-05, "thymus-derived lymphocyte": 0.01483, "alloantigenic stimulus": 0.0027, "nucleotide identity": 0.00202, "normal silent c-myc allele": 0.00605, "monocyte cultivation": 0.01197, "glucocorticoid receptor form": 0.01714, "intracytoplasmic": 0.00062, "kappab motif": 0.00875, "position -70": 0.00236, "lytic viral promoter": 0.01557, "antibody": 0.01787, "+/- sem": 0.00158, "gamma mrna": 0.01526, "chemically-exposed individual": 0.00409, "erbeta": 0.00012, "b-cell line represent": 0.01102, "tcr signal function": 0.0109, "pld activation": 0.03164, "drip coactivator complex": 0.01123, "immobilized anti-jun": 0.00025, "laz3/bcl6": 0.0005, "t-cell receptor stimulation": 0.01714, "standard serological technique": 0.00072, "ifn regulatory factor": 0.01907, "class ii-negative": 0.00642, "beta-catenin-lymphoid enhancer factor": 0.01907, "healthy donor": 0.00177, "negative control region upstream": 0.00734, "decrease p24 antigen synthesize": 0.00485, "specific uptake": 0.01238, "glucocorticoid receptor-dependent transcription": 0.01873, "tyr427": 0.00012, "enhance human immunodeficiency virus type": 0.01505, "immunogenetic basis": 0.00143, "tnf-alpha stimulation": 0.0112, "nf-kappa b. transient-transfection experiment": 0.00707, "month": 0.00136, "ifns inhibit il-4-induced activation": 0.01582, "specific isozyme activity": 0.0195, "m-tat cell": 0.0768, "stat1alpha-induced transcription": 0.0281, "pha": 0.00254, "stimulate il-2r alpha gene expression": 0.01742, "viral load": 0.00732, "acceleration": 6e-05, "6500+/-1001 sites/cell": 0.00043, "direct stimulation": 0.0112, "tf kappa b-like site": 0.01084, "high gssg level inhibit": 0.00952, "structural change": 0.0063, "proximal signal event dependent": 0.00817, "il-2-dependent proliferation": 0.00803, "evidence suggest disturbance": 0.01348, "good health": 0.00102, "recurrent tumor": 0.00934, "latent membrane protein 1-driven activation": 0.01811, "normal protein mds1/evi1": 0.03019, "neoplasia": 0.00056, "include adhesion": 0.01439, "redox homeostasis": 0.00121, "staphylococci": 6e-05, "proapoptotic member": 0.00413, "vitd3": 0.00186, "c. pneumoniae trigger": 0.00273, "mutation confirm": 0.00592, "cell morphology remain": 0.0512, "mature normal": 0.0121, "generate turn": 0.00453, "megakaryocyte progenitor proliferation": 0.00536, "unique deleterious mechanism": 0.00705, "mammalian homologues": 0.00174, "sex steroid regulation": 0.00672, "glrp share": 0.00288, "dominant negative n17rac": 0.00343, "parasite-mediated transformation": 0.00288, "biochemical purification": 0.0018, "cell subclones": 0.0768, "bcl-6/cd3": 6e-05, "beta-galactoside-binding lectin": 0.00071, "cold-shock-induced apoptosis": 0.0089, "v-rel oncogene product": 0.00356, "principle base": 0.0031, "c/ebp alpha": 0.01169, "iv-vii": 0.0, "molecular mass": 0.0045, "overlap bind site": 0.01445, "subtractive pcr method": 0.00157, "initial step": 0.00189, "human crh gene promoter": 0.02177, "janus kinase": 0.01188, "auzou": 0.0, "vitamin d-responsive cell line": 0.0384, "hiv long terminal repeat-cat construct": 0.0029, "-11": 0.00012, "continual proliferation": 0.00803, "intensive care unit": 0.0007, "selective function": 0.01331, "critical issue": 0.00428, "mild hypocortisolemia": 0.0004, "kappab molecule": 0.00853, "heterodimers varies": 0.00226, "pax-5-deficient pro-b cell demonstrate": 0.0384, "model": 0.00844, "detectable quantity": 0.00276, "double-stranded rna-dependent protein kinase": 0.02264, "present paper plasma membrane": 0.00368, "il-2 secretion": 0.01117, "yy-1": 0.0005, "orip": 0.00062, "tafii32": 0.00037, "molecule implicate": 0.00853, "ascorbic acid": 0.00856, "reverse": 0.00471, "c-abl": 0.00012, "mitogen assay procedure": 0.00668, "unde3r": 0.00012, "bioactive macrophage colony-stimulating factor protein": 0.01811, "oxidative stress induce catalase activity": 0.0117, "inhibit jnk activation": 0.02109, "protein tyrosine phosphatase": 0.03019, "tat gene": 0.04355, "complement receptor": 0.02571, "il-10 regulation": 0.01008, "promoter generates": 0.02336, "defensins": 0.00025, "lymphoid": 0.00819, "n-oct-3": 0.00012, "mef2c": 0.00037, "abundant cytosolic receptor": 0.01714, "inducible tnf-alpha expression": 0.02775, "regulate ap-1 dna binding": 0.00927, "important area": 0.00689, ":524": 6e-05, "human disorder": 0.03762, "globin promoter": 0.02336, "mouse": 0.01948, "department": 6e-05, "p50-": 0.00025, "soluble peptide": 0.00754, "severe restrictive anorexia nervosa": 0.00105, "define important regulatory domain": 0.00603, "anti-sense rna": 0.00456, "tcr-beta/tcr-delta double knockout mouse": 0.00487, "triflusal": 0.00056, "apparent dual function": 0.00887, "nonspecific reactive follicular hyperplasia": 0.00105, "nuclear transcription protein": 0.03019, "high ki-67 proliferation index": 0.00465, "mhc class ii gene": 0.02177, "mtiia mrna level increase": 0.01098, "slow": 0.00081, "pebp2/cbf family": 0.00841, "cd28 trigger molecule": 0.00569, "camp level": 0.01821, "provide clue": 0.00645, "oxidative stress stimulate transcriptional activation": 0.01266, "4.49+/-0.71 nm": 0.00093, "implantation": 0.00019, "term calcium-signal modulating cyclophilin ligand": 0.00237, "data report": 0.0049, "end-labelled reverse primer adjacent": 0.00118, "wild-type hiv": 0.00592, "fos-b": 0.00025, "signal transduce component": 0.0109, "tobacco smoke induces coordinate activation": 0.01266, "similar differentiation-inducing capacity": 0.00449, "divergent nf kappa": 0.00498, "macrophage-tropic strain": 0.00186, "cell-specific negative regulation": 0.00672, "drug remain": 0.00521, "cd3+ intrafollicular": 0.00028, "hamster": 0.00068, "subtelomeric position": 0.00236, "egr-1 binding": 0.01855, "genetic study": 0.01355, "hbmp-2-induced growth arrest": 0.00546, "p4": 0.00043, "pml expression": 0.04163, "erythroid precursor culture": 0.00414, "bjab": 0.00025, "social support": 0.00409, "csa-treated cell": 0.0768, "tcr-dependent signal transduction pathway": 0.00817, "tpa activate": 0.01777, "antigenic property indistinguishable": 0.00265, "promoter strength relative": 0.01557, "alpha-interferon": 0.00031, "gcii": 0.00056, "mig": 6e-05, "thromboxane receptor gene expression": 0.02177, "activate stat4": 0.01777, "protein kinase": 0.04529, "inflammatory cytokine il-1": 0.00749, "immunosuppressive effect": 0.02115, "polyclonal stimulus": 0.0027, "early branchpoints": 0.00828, "unique c-terminus": 0.00261, "tradd mutant consisting": 0.0054, "cd14 receptor": 0.02571, "dq alpha gene": 0.02903, "preterm baby": 0.00028, "e2f activity": 0.02925, "gene share": 0.04355, "c-jun inhibitory response": 0.01294, "progesterone status": 0.00217, "cell induce ige synthesis": 0.0384, "region encompass": 0.01467, "suggest utilization": 0.02022, "65-kd protein associate": 0.03019, "interferon regulatory factor family transcription factor": 0.00937, "interleukin-2 production": 0.01042, "pgg-glucan binding moiety": 0.01237, "oral cavity": 0.00074, "visible": 0.00025, "p-like element-binding complex": 0.01123, "u937 promonocytic cell": 0.0512, "high lymphocytic infiltration": 0.0062, "initiation binding repressor": 0.01237, "p38alpha mapk block lps-induced adhesion": 0.00429, "calcium-dependent apoptosis": 0.0089, "differentiation effect": 0.02115, "high-affinity site": 0.02168, "sbma": 0.00037, "affect cell survival": 0.0512, "fluoroquinolone antibiotic": 0.00016, "mzf-2": 0.00056, "spironolactone": 0.00031, "placental clone encode jun-b": 0.00426, "normal pbl express high level": 0.00738, "pcr study reveal": 0.00904, "nonstructured basal promoter": 0.01557, "human leukemia/lymphoma line": 0.02508, "high-throughput assay": 0.01002, "mrna-encoding member": 0.00413, "transgenic ikappabalpha": 0.00199, "tumor suppressor protein p53": 0.02264, "fas-ligand expression": 0.04163, "vivo footprint analysis": 0.00786, "erythroid factor": 0.0286, "pma-stimulated u937 cell": 0.0512, "sucrose density gradient": 0.00077, "mature double-positive": 0.00329, "instrumental": 6e-05, "il-1alpha kappab-like site": 0.01445, "promoter context-specific manner": 0.01557, "wnt signal transduction pathway": 0.00817, "t. parva-transformed": 0.00056, "il-2 receptor alpha chain promoter": 0.01029, "important molecular mediator": 0.00459, "nf-kappa b/rel": 0.01414, "p48": 0.00019, "cem c7": 0.00109, "il-13r alpha1": 0.00056, "tac": 0.00012, "tad-b remains unphosphorylated": 0.00025, "ibr/f": 0.0005, "pan anti gamma/delta antibody": 0.00447, "immobilized anti-cd3 monoclonal antibody": 0.00447, "class ii major histocompatibility complex gene transcription": 0.01244, "protein synthesis inhibitor cycloheximide": 0.02264, "suggest lack": 0.02022, "nfatc.beta": 0.00037, "rflps": 0.00019, "generate large colony": 0.00302, "ig gene extinction": 0.02903, "cdna library construct": 0.00484, "neomycin-resistance promoter": 0.02336, "po-b": 0.0005, "partial": 0.00285, "camp- stimulated il-5 promoter activation": 0.01266, "nf kappa b2 motif": 0.00437, "c-jun synthesis": 0.00583, "aspirin inhibits nuclear factor-kappa": 0.00842, "hemoglobin synthesis": 0.00583, "nb4 apl cell": 0.0512, "silent normal c-myc allele": 0.00605, "mutant thymocytes implicate ikaros": 0.00405, "freshly isolate": 0.00416, "great ape": 0.00205, "1-60 min": 0.00127, "increase mrna stability": 0.01464, "dithiothreitol": 0.00019, "recognizable increase": 0.02196, "nfat motif": 0.00875, "sc-i": 6e-05, "direct repeat space": 0.0036, "signal-induced activation": 0.03164, "erythroid cell growth": 0.0512, "jr-st cell": 0.0768, "spatial distribution": 0.00115, "g76": 0.00031, "subsequent transfection": 0.00304, "iga+": 0.00012, "protease pathway": 0.01278, "ap-1 transcription factor measure": 0.0143, "2-kb downstream": 0.00298, "stat3 exist": 0.00354, "core region": 0.01467, "major infectious disease": 0.00449, "receptor function": 0.02571, "cytokine-induced human immunodeficiency virus type": 0.01505, "-induced human monocyte tnf-alpha production": 0.01505, "rnase protection assay reveal": 0.00549, "deletion construct": 0.00726, "irf-1 gas-binding complex activate": 0.00889, "discovery": 0.00037, "hnf1": 0.00043, "coordinate inhibition": 0.01061, "stimulate il-6 release": 0.00734, "present experiment": 0.00735, "radiolabeled il-2r alpha kappa b-specific oligonucleotide probe": 0.00334, "constitutive manner": 0.00478, "human bcl6": 0.03762, "medication": 0.00031, "cd2-based signaling pathway": 0.00852, "low density lipoprotein-induced inflammatory response": 0.00777, "serine protease factor viia": 0.0143, "irf-1 5'-flanking dna link": 0.00741, "immunosuppressant binding protein": 0.03019, "electrolyte response": 0.01942, "e-stained section": 0.00031, "rnase protection assay": 0.00668, "il-2r jak/stat pathway": 0.00852, "prevents synergistic promoter activation": 0.01582, "h-cam": 0.0, "breast cancer correlate": 0.00436, "-ggactacag-": 6e-05, "tcdd mediates atrophy induction": 0.00803, "hla bind motif": 0.0135, "mouse cell line suggest": 0.0384, "ciita": 0.00589, "tumor-bearing mouse": 0.00974, "calcium-independent anti-cd28 ab": 0.00112, "important immunoregulatory gene": 0.02903, "lmp promoter-binding protein form": 0.02264, "er-eia": 6e-05, "ca2+/calmodulin-dependent serine-threonine phosphatase calcineurin": 0.00158, "co-cultured bronchial epithelial cell": 0.0384, "fc gamma ric gire": 0.0022, "elf-1 bind": 0.02025, "nodular sclerosis": 0.00025, "sequence homology": 0.01625, "htlv-ii tax": 0.00478, "bind egr family protein": 0.02264, "tpa": 0.00378, "multiple cytoplasmic inhibitor": 0.006, "ap-1-dependent transcriptional activity": 0.0195, "stuart schreiber": 6e-05, "differentiated cell provide": 0.0512, "infected thymocytes": 0.00257, "canonical element": 0.01672, "janus family tyrosine kinase jak2": 0.00475, "primary requirement": 0.00738, "cell provide": 0.0768, "fc gamma receptor activate hiv-1 long terminal repeat-driven transcription": 0.00624, "intracellular signal protein": 0.03019, "tyr-128": 6e-05, "position -42": 0.00236, "retinoid differentiation pathway": 0.00852, "transfected k562 cell": 0.0512, "biphasic activation": 0.03164, "promoter context": 0.02336, "synthesized product": 0.00533, "delay early cytokine": 0.00749, "basic-helix-loop-helix motif characteristic": 0.00583, "nf-at site provide": 0.01445, "regulate hiv-1 replication": 0.00835, "key gene": 0.04355, "dominant epitope": 0.00245, "tegument protein encode": 0.03019, "b-cell-specific b29 gene": 0.02903, "b29 promoter activity": 0.0195, "general biological principle": 0.00145, "negative modulator": 0.00515, "granulocyte-colony-stimulating factor receptor mrna": 0.0143, "ibuprofen": 0.00012, "t-cell receptor gene rearrangement": 0.02177, "monitor disease progression": 0.00449, "glucocorticoid receptor level": 0.01714, "c-rel complex play distinct role": 0.00674, "glutathione deficiency": 0.00112, "synovial biopsy specimen": 0.00056, "il-1beta promoter activity": 0.0195, "kappa b-related sequence element": 0.00836, "span extra c-terminal peptide": 0.00377, "-95": 0.0005, "prominent": 0.00155, "epstein-barr virus ebna3c repress cp": 0.00355, "include tumor cell": 0.0512, "large extent": 0.00205, "cyclic amp response element": 0.00971, "initiation": 0.00422, "cell antigen receptor signal": 0.0384, "fibronectin-vla-5 fibronectin receptor interaction": 0.01286, "neutral ph fail": 0.00232, "analyze modulation": 0.00456, "complete tolerance": 0.00171, "gm-csf induce": 0.0254, "sequela plaque rupture": 0.00027, "abnormal effector mechanism": 0.00705, "jnk-mediated phosphorylation": 0.00983, "high-level enhancer activity": 0.0195, "nf-kappab transcriptional factor": 0.01907, "freshly isolated": 0.00189, "elam": 0.00025, "gel shift mobility assay show stimulation": 0.00866, "h. rbpi21": 0.00118, "-207 bp": 0.00267, "ionomycin": 0.00167, "phosphate supplementation": 0.00065, "dqb x2-box": 0.00031, "notch1/tan-1 receptor": 0.02571, "il-2 response element": 0.01294, "igh": 0.00167, "conserved region": 0.01467, "activate pparalpha": 0.01777, "4978+/-391 versus": 0.00136, "icp0": 0.00019, "inhibit leukocyte accumulation": 0.0127, "y731eam": 6e-05, "activation-dependent transcriptional regulation": 0.00767, "-2-methylpiperazine dihydrochloride": 0.00012, "egr2 mrna": 0.01526, "kappab-binding protein": 0.04529, "continued production": 0.01042, "internal aug": 0.00087, "activity": 0.0585, "protect naive preactivated": 0.00093, "human bob.1/obf.1": 0.03762, "tissue factor expression": 0.02775, "chesney": 0.00012, "lack jak3 protein": 0.03019, "middle-aged": 0.00012, "normal donor": 0.0121, "bhlh factor": 0.0286, "active p50/p65": 0.00592, "a6h mab costimulus": 0.00178, "protein tyrosine kinase inhibitor genistein": 0.01811, "hsv-2 comprise": 0.00105, "prevent rejection": 0.00524, "genetic makeup": 0.00288, "familial ovarian cancer case": 0.00181, "sh2 domain": 0.01207, "immunosuppressant action": 0.00499, "kappa b-alpha level": 0.01214, "triglyceride": 0.00031, "human helper": 0.03762, "megakaryoblastic transformation": 0.00288, "suppress il-1ri": 0.00611, "serum cortisol decrease": 0.00647, "statistically-significant difference": 0.00425, "promote b-cll survival": 0.0031, "cytosolic-anchoring protein": 0.04529, "instability": 0.00031, "sea urchin binding site": 0.01084, "r-dependent enhancer activity": 0.0195, "proliferative block": 0.01073, "murine": 0.01247, "butyric acid": 0.00856, "hiv-1 ltr-based vector suggest": 0.01011, "exact role": 0.01328, "case test": 0.00487, "pim-1 gene expression": 0.02903, "antigen-induced allergic airway hyperresponsiveness": 0.00048, "location": 0.00056, "negative dominant molecule": 0.00569, "isomer": 0.00031, "reintroduction": 0.0, "preclinical rationale": 0.00028, "specific nf-kappa": 0.01414, "lps stimulation result": 0.01073, "progress": 0.00087, "extinction": 0.00087, "dominant-negative cdk2 construct prevent hla class i-mediated inactivation": 0.00181, "synergistic manner": 0.00282, "represent differentiate": 0.004, "stat1s1": 0.00012, "il-2-induced proliferation": 0.00803, "selective pkc inhibitor gf109203x abrogate": 0.0036, "u9-iiib": 0.00025, "inhibit calcineurin activation": 0.02109, "endolysosomial membrane": 0.0045, "rectifier k+ channel": 0.00041, "3-day exposure": 0.0035, "self-reactive cell": 0.0768, "mammalian 27-kda heat shock protein": 0.01811, "depressed peripheral white blood cell": 0.03072, "d20s57": 0.00012, "complexity": 0.00019, "share sequence similarity": 0.01084, "thrombin activate": 0.01777, "cytokine tnf": 0.01123, "memory ctls": 0.00133, "functional ets bind site": 0.01084, "continued": 0.00068, "parasite-induced nf-kappab activation play": 0.01582, "depletion": 0.00242, "il-12 target gene": 0.02903, "selective expression": 0.04163, "fast kinetics": 0.00167, "p. falciparum": 0.00065, "optimal transcription": 0.0281, "thrombin activation": 0.03164, "gene transcription activation": 0.02903, "mature erythrocyte compartment": 0.00219, "murine retrovirus": 0.00623, "cml patient lack": 0.0111, "modest inhibitor": 0.009, "rflat-1": 6e-05, "major regulator": 0.00574, "encode protein": 0.04529, "egr-1 gene": 0.04355, "putative triggering molecule": 0.00569, "g0s2 mrna increase": 0.01464, "activate rho": 0.01777, "include stat5a": 0.01439, "ikappabbeta": 0.00081, "14-fold": 0.00019, "ctll-r8 cell": 0.0768, "zimmerman": 0.00012, "arnhl": 0.00037, "nre-2a": 0.00012, "sos2": 0.00012, "cytolytic effector t-cells": 0.00184, "glucocorticoid receptor messenger ribonucleic acid": 0.01029, "il-2r alpha-chain": 0.00251, "gata-binding site": 0.02168, "undergo tyrosine phosphorylation": 0.00656, "cd3/cd28 ligation": 0.0018, "low-dose ionizing radiation": 0.00031, "decrease adhesion molecule expression": 0.02081, "sequence bind": 0.02025, "upstream signal molecule": 0.0109, "e2-treated": 6e-05, "repress chloramphenicol acetyltransferase": 0.00147, "rhabdomyosarcoma": 0.00019, "cepharanthine": 0.00037, "m/z": 6e-05, "cytokine signal pathway": 0.0109, "beta pool": 0.00673, "dna-binding/immunoprecipitation assay": 0.01002, "aldosterone-mbp-hbd reveal complex sedimenting": 0.00842, "functional nuclear factor kb": 0.0143, "data reveal slight trend": 0.00549, "cd4+ t-cell subset": 0.00641, "diverse clonotypes": 0.00155, "inhibit tcr signal induce": 0.0127, "hyaluronan": 0.00019, "se trigger": 0.00409, "article": 0.00019, "human cytomegalovirus": 0.03762, "10000-fold selectivity": 0.00028, "related alpha-herpesviruses": 0.00236, "heat shock protein": 0.03019, "-90": 0.00037, "important hematopoietic gene": 0.02903, "insulin-gene activity": 0.02925, "family member play": 0.0056, "vitro reconstitution assay": 0.00668, "tandem nf-kappa b/rel bind motif": 0.0081, "c/ebp alpha expression vector demonstrate": 0.01665, "ifn-alpha receptor": 0.02571, "precisely similarity": 0.00099, "transcriptional activator function af-1": 0.00665, "msr protein": 0.04529, "present observation": 0.00735, "organ": 0.00236, "lp stimulate vcam-1 expression": 0.02081, "basic domain-helix-loop-helix protein": 0.03019, "antigen-dependent": 0.00012, "rheumatoid synovium represent": 0.00267, "mitogen-inducible gene isolate": 0.02903, "nf45": 6e-05, "tcr-initiated signal transduction": 0.0109, "nfat1 contributes": 0.00109, "kit/il-4r alpha induces cellular proliferation": 0.00468, "signalsome component": 0.00456, "tat-mediated activation": 0.03164, "study include structural comparison": 0.0072, "pma induction": 0.01607, "initiation codon": 0.00211, "conjunction": 0.00074, "sense orientation": 0.00047, "hiv-1 proviral dna": 0.00988, "bglii restriction site": 0.01445, "persistent hiv infection result": 0.00805, "nuclear binding factor include": 0.0143, "non-irradiated ht29 cell": 0.0512, "single tumor cell": 0.0512, "tcf-2 alpha": 0.01169, "c/ebpbeta expression": 0.04163, "oxidative stress dependent nf-kappab activation": 0.01266, "endogenous nf-kappa b-dependent granulocyte-macrophage colony stimulate factor gene": 0.01089, "initial observation": 0.00189, "follicular lymphoma": 0.00226, "activate jak-1": 0.01777, "cellular extraction": 0.00893, "exogenous tnf-alpha": 0.00546, "healthy non-pregnant woman": 0.00155, "plcgamma1": 6e-05, "costimulatory molecule cd28": 0.00569, "zap-70 affect multiple t-cell receptor signal pathway": 0.00735, "proinflammatory": 0.00329, "rapid transcriptional activation": 0.02109, "150-200 kd fraction": 0.00116, "syndrome": 0.00546, "gata1 expression": 0.04163, "seven-transmembrane-domain": 0.00012, "lps-stimulated thp-1-hgh cell": 0.0512, "fra-1 mrna": 0.01526, "bound stats": 0.00292, "gel shift assay distinct": 0.00501, "mouse erythroleukemia cell": 0.0512, "ligand stimulation": 0.0112, "-85": 0.00031, "labile inhibitor": 0.009, "e. histolytica infection": 0.00414, "e-selectin promoter": 0.02336, "non-transformed": 0.00019, "sequential development": 0.00633, "principal dna-binding protein": 0.03019, "surfactant": 0.00112, "platelet extract": 0.00459, "antisense oligos": 0.00161, "natural endogenous gene regulate": 0.02177, "deoxycholate treatment": 0.01014, "prepared viral stock": 0.00488, "pollio": 0.00012, "cell": 0.1536, "anti-cd3/cd28": 6e-05, "tre1": 0.00019, "c-jun delta-domain function": 0.00887, "ng angiotensin i/l": 0.00017, "ptdins bind": 0.02025, "diverse pathway": 0.01278, "interferon-gamma potentiate": 0.0018, "monoclonal gammopathy": 0.00279, "host control": 0.01303, "etoposide-": 6e-05, "true": 0.00068, "oft-2": 6e-05, "constitutively active shp2-deltash2": 0.00395, "lineage cell": 0.0768, "il-2-mediated cell cycle progression": 0.0384, "cell test": 0.0768, "positive regulation": 0.01008, "promoter region span base pair -1": 0.00779, "b-cell transformation": 0.00459, "k-ras mutated peptide": 0.00502, "project": 0.00012, "anti-cd3 stimulation": 0.0112, "adolescent callithrix jacchus erythropoietin stimulate transcription": 0.00937, "cyclosporin a-sensitive nuclear factor": 0.0143, "bone marrow cell survival": 0.0384, "p47phox": 0.00025, "reversible cytokine-induced reduction": 0.00196, "ori1yt enhancer": 0.00909, "ferritin expression": 0.04163, "dp1 form": 0.01055, "cell cycle regulation": 0.0512, "interleukin-2 receptor alpha": 0.01714, "protease treatment": 0.01014, "element homologous": 0.01672, "cell survival mechanism": 0.0512, "cell reactivity": 0.0768, "menopause onset": 0.00071, "transcription factor nuclear factor-kappab": 0.0143, "vitd3 induction result": 0.01073, "promonocytic cell line u937": 0.0384, "embryo fibroblast": 0.00338, "vzv serve": 0.00155, "block cellular uptake": 0.00715, "calcium signalling": 0.00236, "region distinct": 0.01467, "wnt signal": 0.01635, "kd mobility": 0.00174, "nuclear receptor ppargamma": 0.01714, "natural": 0.00465, "n. komatsu": 9e-05, "brlf1 immediate-early transcript": 0.00399, "pervanadate-mediated": 0.00012, "gp91phox promoter construct": 0.01557, "main transcription-activation element": 0.01115, "dna-associated protein": 0.04529, "udg expression": 0.04163, "autoantibody": 0.0005, "atf bind site": 0.01445, "differential presentation": 0.00323, "cd3-dependent": 0.00025, "chemokines monocyte chemoattractant protein": 0.02264, "platelet transfusion": 0.00372, "human kruppel-related zinc finger": 0.01881, "low dose": 0.00707, "long-distance effect": 0.02115, "dominant-negative effect": 0.02115, "5'-gttaaggttcgtaggtcatgga-3": 6e-05, "jnk-mediated transcriptional activation": 0.02109, "cellular immunity": 0.00893, "genetic level show": 0.01733, "bsap-binding site": 0.02168, "low molecular isoforms": 0.00471, "duffy blood group system": 0.00333, "genomic mbob1 clone": 0.00492, "bone mineralization": 0.00214, "beta-globin minimal promoter": 0.01557, "sap": 0.00019, "index absorptive hypercalciuric patient": 0.00833, "cd8": 0.00161, "cox multivariate analysis": 0.00786, "late lytic cycle gene": 0.02177, "p50/p65 nf-kappa": 0.01414, "interleukin-6 kappa b-related motif": 0.00437, "resulting hybrid": 0.00171, "macrophage procoagulant activity": 0.0195, "rb function": 0.01331, "activation process": 0.03164, "j.margolick": 0.00012, "ifn alpha": 0.01169, "adipocyte fatty acid bind protein gene": 0.0151, "protein binding region": 0.03019, "native nf-gm2 complex": 0.01123, "composite motif bind": 0.0135, "functional versatility": 0.00816, "regulatory activity": 0.02925, "interfered": 0.00012, "c-terminal residue augment": 0.00157, "tcrzeta associate molecule": 0.00728, "western blot experiment show": 0.013, "hyperproliferative disorder include psoriasis": 0.0072, "tp1 promoter-reporter gene construct": 0.02177, "membrane protein gene similar": 0.02264, "aml1 play": 0.0071, "analyze cell population": 0.0512, "ige synthesis induce": 0.01694, "c-terminal peptide": 0.00754, "pax-5d": 0.00037, "ng": 0.00025, "nonproliferating hematopoietic cell": 0.0512, "increase capacity": 0.02196, "cyclooxygenase activity": 0.02925, "heterotrimeric": 0.00031, "turn": 0.00186, "hla class": 0.00642, "anti-p selectin antibody": 0.00596, "nh2-terminal amino acid sequence analysis": 0.0065, "-41": 6e-05, "death-inducing receptor": 0.02571, "multiple": 0.01377, "acinar epithelial cell": 0.0512, "activated rho": 0.00589, "long-term": 0.00341, "atl patient": 0.01666, "early stage": 0.00828, "decrease silencing": 0.00971, "maintain significant level": 0.01214, "mammalian nf-kappab": 0.00999, "common intermediate structure": 0.00234, "6gg-3": 6e-05, "ikappabalpha overexpression inhibit": 0.0127, "vzv ge-hsv": 0.00065, "bcl2": 0.00068, "ultraviolet absorbance maximum shift": 0.00092, "impair il-9-induced cell growth": 0.0384, "direct binding": 0.01855, "recombinant fusion protein": 0.03019, "hormone-dependent regulator": 0.00304, "interferon-induced transcription factor complex isgf3": 0.01144, "xscid": 0.00019, "normal pancreatic beta-cell function": 0.00665, "redox mechanism": 0.01058, "considerable significance": 0.00078, "increase transcription efficiency": 0.01873, "effector site": 0.02168, "mrd-/lt patient": 0.01666, "high affinity site bind cvz": 0.00867, "pyrolidine dithiocarbamate": 0.00034, "4,5-dihydro derivative": 0.00192, "c-fos expression": 0.04163, "ro13-7410": 6e-05, "tcr alpha control region": 0.00734, "activate nuclear nf-kappa": 0.01185, "gtpase rho": 0.00062, "active": 0.01185, "cd40/cd40l pathway": 0.01278, "ige germline promoter reporter gene construct carry point mutation": 0.00968, "similar capacity": 0.00673, "myf3 gene reveal": 0.02903, "astrocyte": 0.00149, "work review": 0.00081, "tissue pattern": 0.00664, "strong transactivator": 0.00347, "fvc": 6e-05, "il-2-induced tyrosine phosphorylation": 0.00656, "relative proportion": 0.00276, "rat utilized": 0.00285, "hiv-1 latency reactivation": 0.00585, "rest jurkat cell express fa": 0.03072, "low sp1 activity": 0.0195, "pit-1": 0.00056, "bash show": 0.02599, "beta-casein gene promoter": 0.02903, "key subdominant reactivity": 0.00101, "filaria-induced lymphatic pathology": 0.00023, "activate hiv-2 transcription": 0.01873, "ss rbc": 0.00034, "electrophoretic mobility shift assay analysis": 0.00471, "macrophagelike cell": 0.0768, "gp41": 0.00068, "erythroid proliferation": 0.00803, "remainder": 0.0, "3.93+/-0.89 nm": 0.00093, "nfatc": 0.00155, "sris": 0.00012, "ar": 0.00161, "receptor mediated system": 0.01714, "basophil suggest": 0.02022, "engineering": 0.00012, "anti-cd14 monoclonal antibody": 0.00596, "sequence specific": 0.01625, "cross-linking cd40": 0.00372, "gasd/ebsd": 0.00012, "western blotting yield": 0.00108, "mitogen-activated protein kinase signal cascade": 0.01811, "data point": 0.00254, "activated u1 cell": 0.0512, "atl": 0.00099, "express significant amount": 0.0123, "arsenic content": 0.00158, "human u2 small nuclear rna": 0.01505, "bind dopamine present": 0.0135, "assay system": 0.01002, "prb hyperphosphorylation": 0.00136, "dominant control region": 0.00978, "protein-binding site": 0.02168, "unique activation": 0.03164, "efficient rescue": 0.00189, "preleukemic state": 0.00267, "stat6 isoforms": 0.00307, "signal pathway molecule janus kinase": 0.00654, "normal hematopoiesis": 0.0121, "hormonocytes": 6e-05, "death domain-containing member": 0.00275, "endogenous cortisol": 0.00459, "nf-e1 messenger rna": 0.00304, "ikappab-alphas32/36a permit": 0.00081, "splice": 0.00186, "heterozygous germline brca1 mutation": 0.00296, "steel factor stimulation": 0.01907, "phorbol 12-myristate 13-acetate lead": 0.00498, "quiescent cd4": 0.00332, "human x-scid": 0.03762, "respective ltr": 0.0031, "mediate fasl expression": 0.02775, "radiation": 0.00093, "dna-binding eukaryotic transcription factor tata-binding protein": 0.0151, "glucocorticoid receptor density": 0.01714, "steroid/thyroid hormone response element": 0.00971, "influence": 0.00943, "activated neutrophil": 0.00589, "time-dependent": 0.00105, "intact usa": 0.00239, "il-1-induced response": 0.01942, "phytohemagglutin": 6e-05, "oca-b function": 0.01331, "well-defined phenotypic change": 0.0042, "deficient proliferative ability": 0.00287, "beta-globin cluster": 0.0013, "thyroid disease serve": 0.00449, "absent": 0.00217, "il-13 share signal event": 0.00817, "extreme susceptibility": 0.00146, "outgrowth": 0.00087, "alkylaryl polyether alcohol polymer detergent": 0.0001, "expression suggest": 0.04163, "vitro system consist": 0.00523, "analogous pattern": 0.00549, "potassium": 0.00031, "affect gene regulation": 0.02903, "induce high-level transcription": 0.01873, "peptidoglycan": 0.00031, "dicarba-closo-dodecaborane": 6e-05, "tcf-1 activity": 0.02925, "adult program occurs": 0.00281, "reversible loss": 0.00298, "nuclear factor kappa b/rel nuclear activity": 0.00975, "il-1ri-associated protein kinase": 0.03019, "iv": 0.00155, "inflammatory lung disease": 0.00449, "oxldl": 0.00043, "spontaneous expression": 0.04163, "gene expression": 0.04355, "tcr-directed t-cell activation": 0.02109, "grave": 0.00012, "distinct signal property": 0.0109, "bcr1/25": 0.00031, "young adult": 0.00422, "p40 gene promoter reveal": 0.02177, "induces strong": 0.00803, "activation domain": 0.03164, "gene technology": 0.04355, "il-9r": 0.00019, "intermediate mobility": 0.00133, "xcid": 0.00037, "insert": 0.00087, "nuclear factor-activated": 0.01684, "corticosteroid action": 0.00499, "multiprotein complex": 0.01684, "dr3 signal transduction": 0.0109, "myeloid cell line": 0.0512, "camp signal transduction pathway": 0.00817, "adherent pbmc culture": 0.00414, "raf-1": 0.0013, "biological variation": 0.00217, "rapid time": 0.00323, "potential cellular homologues": 0.00596, "murine th1": 0.00623, "cell il-2 production remain low": 0.03072, "palindromic sequence": 0.01625, "ribosome salt wash fraction": 0.00085, "b-cell extract": 0.00459, "rantes promoter region": 0.01557, "regulate ige synthesis": 0.00835, "superoxide formation": 0.00484, "antigen presentation": 0.00819, "length": 0.00143, "calyculin a-treated cell": 0.0512, "120-amino-acid n-terminal motif": 0.00583, "interleukin 2-directed gene expression": 0.02177, "neural cell adhesion molecule": 0.0384, "cell show viral capsid antigen": 0.03072, "competition study": 0.01355, "common haplotype": 0.0035, "result production": 0.0161, "glycation reaction": 0.0022, "clinical consequence": 0.00425, "efficient transport": 0.00189, "enhancer-blocking element": 0.01672, "/mac-1": 0.00012, "radioimmunoassay": 6e-05, "uterus": 0.00025, "band neutrophil": 0.00496, "supply": 0.00037, "allele t.": 0.0022, "isomerase": 0.00081, "dna-laddering": 6e-05, "regulate hiv activation": 0.02109, "il-1 beta transcript degradation": 0.00337, "csa-treated patient": 0.01666, "sp1 bind site adjacent": 0.01084, "slp-76-associated protein": 0.04529, "negative responding element": 0.01115, "nos": 0.00037, "crude extract": 0.00459, "lacz gene": 0.04355, "express sequence tag": 0.0123, "macrophage remain unknown": 0.00393, "detect variant er": 0.00484, "cdna correspond": 0.00456, "property": 0.00794, "antitumor immunity": 0.00112, "clone human gene encode cyclophilin b-binding-proteins": 0.01452, "amino terminal": 0.00332, "serine-phenylalanine": 6e-05, "apoptotic lymphocyte": 0.01483, "enhanced p75tnf-r production": 0.00695, "cadmium stimulation": 0.0112, "phosphorylation": 0.01967, "transcription factor stat6": 0.01907, "review focus": 0.00078, "intrafollicular cd57+ cell": 0.0512, "htlv-1-transformed cell line": 0.0512, "induce hyperphosphorylation": 0.0254, "cd30 lead": 0.00996, "pulse-field gel electrophoresis": 0.0011, "nf-kappab1": 0.00031, "srg3 protein": 0.04529, "assay": 0.02004, "impaired response": 0.01942, "normal component": 0.0121, "proapoptotic": 0.00031, "maz transcription factor": 0.01907, "numerous heinz body": 0.00091, "receptor mrna": 0.02571, "il-2r signaling": 0.00558, "mol/microgram rna": 0.00456, "alpha,25 dihydroxyvitamin d3 result": 0.00805, "include fc epsilonrii": 0.00959, "share gamma": 0.0044, "small apolar substitution": 0.00209, "il-10 release": 0.00484, "pbsc harvest": 0.00022, "spi-1/pu.1 proto-oncogene induces opposite effect": 0.00846, "collagenase expression": 0.04163, "synergistic effect": 0.02115, "primary sensitization": 0.00738, "bcl-2 oncogene": 0.00295, "introduction": 0.00037, "diabetes mellitus correlate": 0.00436, "n-ethylmaleimide": 6e-05, "cd21 activate": 0.01777, "creb protein": 0.04529, "constitutively aggregate pseudo-tumor necrosis factor receptor": 0.00953, "interferon gamma": 0.0044, "interferon inhibit activation": 0.02109, "hla-dr-restricted cd4": 0.00332, "cd69 expression": 0.04163, "medullary thymocytes remain": 0.00347, "thiol": 0.00118, "theileria infection": 0.0062, "il-1 beta protein": 0.03019, "fk506-sensitive": 0.00031, "calmodulin-dependent phosphatase calcineurin": 0.00211, "express ebna2": 0.01846, "intracellular phosphorylated stat-1": 0.00389, "fibroblast pilot gene expression require": 0.01742, "eosinophil granule major basic protein promoter": 0.0151, "nuclear location": 0.01684, "cell increase camp level": 0.0384, "purified adult-progenitor culture": 0.00414, "-prostaglandin": 0.0, "enzymatic": 0.00124, "complex require atp": 0.01123, "influence differential expression": 0.02775, "xanthomatosis": 0.00037, "stable clone": 0.00738, "lmp gene": 0.04355, "specific pattern": 0.01238, "secondary hyperaldosteronism": 0.00189, "iexl320g": 0.00019, "phoq": 0.0005, "stat6 signal molecule": 0.0109, "immune system cell play": 0.0384, "reporter luciferase gene vector": 0.02177, "allergen-specific cd4+": 0.00288, "autoimmune rheumatic disease characterize": 0.00337, "aa protein": 0.04529, "malignant progression": 0.00164, "mitogenic activation": 0.03164, "endogenous catalase": 0.00459, "nf-munr binding": 0.01855, "ouabain": 0.00019, "hiv1 infection": 0.0062, "-257": 0.00012, "c-myc translocation": 0.00515, "50-fold": 0.00037, "control subclone": 0.01303, "fetal/neonatal t-cell activation": 0.02109, "erythroblast cell line hd6": 0.0384, "study gene regulation": 0.02903, "turner mosaicism": 0.00022, "mutant p53": 0.0081, "permanent occupancy": 0.00071, "il-1 signaling pathway lead": 0.00639, "erythroid-specific gene": 0.04355, "high-proliferative potential colony-forming cell": 0.0384, "pbmc respond": 0.00251, "camp-dependent regulation": 0.01008, "vary degree": 0.00146, "e.g.": 0.0013, "drug inhibit isomerase activity": 0.01462, "alpha-tcp": 0.00043, "sodium supplementation": 0.00186, "endogenous b29 gene": 0.02903, "km": 0.00025, "facilitate rapid progress": 0.00215, "depolarization": 6e-05, "cytokine-specific mrna": 0.01526, "bzip transcriptional activator": 0.00767, "inhibit ca2+ mobilization dependent expression": 0.01665, "normal comparison subject": 0.00806, "interdomain": 0.00037, "increased il-2 secretion": 0.00744, "measure level": 0.01821, "basic helix-loop-helix protein": 0.03019, "thyroid hormone receptor alpha": 0.01286, "include macrophage": 0.01439, "cell-free supernatant": 0.00093, "p95vav-induced nfat activation": 0.02109, "high constitutive expression": 0.02775, "epithelium": 0.00105, "eicosanoid": 0.00056, "ro activity": 0.02925, "cryptic splice site": 0.01445, "region account": 0.01467, "physiological shear flow condition show": 0.0104, "viability great": 0.00205, "eosinophil-derived neurotoxin": 6e-05, "beta globin gene flank region lead": 0.01452, "sh-groups": 6e-05, "histological prognostic factor": 0.01907, "reverse transcription-pcr analysis show": 0.013, "base substitution mutation": 0.00395, "cell-like": 0.00019, "critical transcription factor": 0.01907, "t-leukemia cell line": 0.0512, "htlv-i tax mutant": 0.0054, "western immunoblots": 0.00084, "recombination": 0.00186, "cd28re bind": 0.02025, "transcription factor e2f activate": 0.0143, "eb1-responsive b-cell-specific element": 0.01115, "neoglucogenesis": 6e-05, "neonate": 0.00037, "m. tuberculosis": 0.00115, "independent site": 0.02168, "tnf-beta": 0.00012, "direct output": 0.0054, "rt-pcr assay": 0.01002, "costimulatory action": 0.00499, "p21ras small gtp bind protein participate": 0.0151, "single protein fraction require": 0.02264, "hematolymphopoietrope": 0.0, "45-nucleotide sequence": 0.01625, "gal4 dna-binding domain reveal": 0.00603, "cox-2 gene": 0.04355, "genetic alteration": 0.00288, "wurzburg": 0.00062, "drop": 0.00025, "small lymphocytic lymphoma": 0.00209, "benzene contaminating water": 0.00021, "zeta-globin promoter deletion construct": 0.01168, "viral strain": 0.00732, "urinary thf": 0.00056, "jak-stat": 0.00043, "maeda": 0.00012, "nuclear autoantigen la/ss-b alters": 0.00842, "de novo expression": 0.02775, "rxrs": 0.00062, "primary murine thymocytes": 0.00492, "mua": 0.00012, "hpc": 0.0013, "bcl-6 mrna level": 0.01214, "splenic t-lymphocytes culture": 0.00414, "pkc enzymatic activity": 0.0195, "zinc finger transcription factor": 0.0143, "il-4-activated transcription factor signal transducer": 0.01144, "serum influence steroid effect": 0.01058, "additional mapping study": 0.00904, "/p50 heterodimers": 0.00226, "concerted action": 0.00499, "mue3-binding protein tfe3": 0.03019, "unlabelled testosterone": 0.00071, "previous result": 0.0161, "medium": 0.00279, "activated primary human": 0.02508, "nfatx1 transactivation activity": 0.0195, "antioxidant n-acetyl-l-cysteine": 0.00251, "saf activity": 0.02925, "proliferative activity": 0.02925, "aberrant splicing": 0.0009, "multiple blood sample": 0.00459, "signal function similar": 0.0109, "dna fragmentation confirm apoptosis": 0.00741, "stat signaling pathway": 0.00852, "peroxisome proliferator-activated receptor": 0.01714, "high nk activity": 0.0195, "drive initial proliferation": 0.00536, "lipoprotein stimulate tlr-dependent transcription": 0.01405, "bipartite il-4r abolish": 0.00236, "abolish binding": 0.01855, "oligonucleotides map": 0.00205, "il-10 inhibited b-cll proliferation": 0.00402, "leukemic clone cem c1": 0.00369, "single mp dose": 0.0024, "surface igm": 0.00515, "differential induction": 0.01607, "0.1-0.5 microm dmdtc inhibit tnf-alpha-induced activation": 0.01055, "-10 inhibits lipopolysaccharide": 0.00354, "cd14-mediated signaling": 0.00558, "block nf-kappa": 0.01414, "synthetic dna-binding ligand": 0.00395, "human cd3epsilon transgenic mouse line": 0.01505, "4-5.13": 6e-05, "mutant element": 0.01672, "immediate-early factor": 0.0286, "smad6 show": 0.02599, "nwp": 0.0005, "human paf receptor transcript": 0.01881, "e2f site": 0.02168, "sialoadhesin": 0.00043, "steroid-sensitive group range": 0.00325, "reduced thioredoxin": 0.00208, "high promoter activity": 0.0195, "finding suggest": 0.02022, "aml blast": 0.00127, "etiological relationship": 0.00158, "differ": 0.00385, "trans result": 0.0161, "decreased bind affinity": 0.0135, "mhc class ii-negative human": 0.01881, "cemx174 cell": 0.0768, "thp-1 upregulation": 0.00239, "il-2-treated patient": 0.01666, "bcl-xl protein": 0.04529, "anti-igm-induced b-cell apoptosis": 0.00593, "footprinting assay reveal": 0.00732, "erk2 kinase": 0.01188, "5-day culture": 0.0062, "type iv/gr": 0.00949, "hcmv infection": 0.0062, "true variant": 0.00276, "hela s3 cell": 0.0512, "cis-acting element reveal specific complex": 0.00674, "human immunodeficiency virus 1-induced": 0.01881, "ap-1 transcription factor family demonstrate": 0.01144, "mortality": 0.00025, "fresh primary leukemic cell": 0.0384, "adolescent mdd": 0.00037, "receptor turnover": 0.02571, "phorbol ester-inducible element": 0.01115, "conserved": 0.00273, "cloned": 0.00037, "malignant tumor": 0.00934, "altered spacing": 0.00161, "cytotoxicity assay": 0.01002, "-131": 0.00012, "human interleukin-2 receptor alpha gene": 0.01742, "pi 3-kinase effector": 0.00184, "critical tool": 0.00428, "mutated pp repeat element demonstrate": 0.00669, "activate pkb/akt": 0.01777, "ribosomal protein s6 serine/threonine kinase": 0.01811, "relationship": 0.00316, "post-triggering stage": 0.00248, "cho/cd14 cell": 0.0768, "cd36": 0.00143, "il-3 promoter construct link": 0.01168, "t-cell development": 0.00962, "ac-devd-fmk": 0.00012, "b-cell-specific transcription factor tcf-1": 0.0143, "transcription factor nfkappab": 0.01907, "triple-labellings": 6e-05, "bcl-2-overexpressed u937 cell": 0.0512, "ap-2 mrna": 0.01526, "stimulatory activity": 0.02925, "promote atherosclerosis": 0.00465, "endogenous hsf2-alpha": 0.00459, "cellular gene include gm-csf": 0.02177, "functional gr": 0.00816, "dominant negative gsk-3beta": 0.00343, "cni-1493 block": 0.01073, "il-4 naf complex": 0.01123, "obligate carrier": 0.00053, "agonist activity": 0.02925, "hiv proviral dna": 0.00988, "oxidoreductive regulation": 0.01008, "lpmc exhibit increased il-2 production": 0.00447, "major mhc class ii gene": 0.01742, "biochemical event": 0.00552, "lymphoid architecture": 0.00409, "30-kd protein product": 0.03019, "v-src activate": 0.01777, "heat shock factor-1": 0.00126, "delayed cd13 loss": 0.00199, "bind usf protein": 0.03019, "alpha-hydroxymethyl": 0.0, "dnase footprinting analysis": 0.00786, "receptor-negative erythroblast": 0.00105, "1,25-dihydroxycholecalciferol": 0.00037, "ctla-4 ligation inhibit cd3/cd28-induced il-2 mrna accumulation": 0.00544, "mdmac": 0.00019, "er-alpha protein expression": 0.03019, "3h-pgg-glucan": 0.00012, "bursa": 6e-05, "characterize murine il-2-responsive element": 0.00836, "tachycardia crisis": 0.00012, "-mediated immune response": 0.01294, "erythroid burst-forming unit": 0.00414, "apparent potency": 0.00192, "genistein inhibit nk cytotoxicity": 0.00952, "rna extraction": 0.00456, "activate mitogen-activated protein": 0.03019, "viral gene expression": 0.02903, "histamine-induced": 0.00025, "105-kd protein": 0.04529, "pps": 0.00012, "region promoter": 0.02336, "nucleus interacts": 0.00319, "cell control": 0.0768, "serum-containing medium": 0.0014, "occur gre": 0.00654, "gssg/gsh ratio": 0.00096, "ppb": 0.00012, "granulocyte-macrophage": 0.00236, "distinctive gene expression pattern": 0.02177, "minimal activation": 0.03164, "functional t1/2": 0.00816, "detect nf kappa": 0.00498, "-nf-kappa": 0.00012, "c-fos mrna indicating": 0.01017, "htlv-i tax protein": 0.03019, "obligatory step": 0.00189, "chronic myelogenous leukemia evolves": 0.0025, "-326": 6e-05, "jun": 0.00335, "indirect evidence suggest": 0.01348, "antagonist": 0.00484, "ifn-gamma trigger": 0.00481, "activated human neutrophil": 0.02508, "challenge clinical problem associate": 0.00546, "b2 complex": 0.01684, "human immunodeficiency virus type 1-infected cell": 0.0256, "monocytic specific expression": 0.02775, "potent inhibitory sequence": 0.01084, "major histocompatibility complex class ii gene promoter dra": 0.01089, "tumor necrosis factor receptor-associated death domain protein": 0.01294, "receptor messenger ribonucleic acid": 0.01286, "immediate-early gene encode": 0.02903, "signal pathway induce": 0.01694, "prevent il-6-induced downregulation": 0.00349, "dramatic loss": 0.00298, "prominent defect": 0.00279, "lymphotropic virus-i infection": 0.00414, "prevent monocyte activation": 0.02109, "pkc dependent": 0.00388, "molecular study": 0.01355, "content": 0.00316, "er-positive human breast cancer cell line": 0.0256, "distal region": 0.01467, "mmp9 activity": 0.02925, "q13": 0.00012, "tumour progression": 0.00183, "il-6 protein secretion": 0.03019, "pu.1/spi-1": 0.00019, "essential gene": 0.04355, "provide protection": 0.00645, "cp activity require amino acid": 0.0117, "mouse genomic sequence show high conservation": 0.00866, "cell differentiation mediate": 0.0512, "sequence requirement": 0.01625, "mrd-negative": 0.00012, "p56lck": 0.00062, "healthy female volunteer": 0.00118, "increase 3.4-fold": 0.02196, "extracellular matrix": 0.00167, "colony-stimulating factor receptor": 0.01907, "3-o-methyl-d glucose": 0.00078, "nf kappab-dependent enzyme": 0.00207, "induce cell proliferation": 0.0512, "-7.0 kb": 0.0014, "increase plasma estradiol level": 0.01098, "e2a remain intact": 0.00347, "biological process": 0.00444, "postgerminal center": 0.00112, "specific enzyme": 0.01238, "human ig heavy chain": 0.01881, "2-acetoxy-4-trifluoromethyl-benzoic acid": 0.00856, "distal delta": 0.00211, "pro-opiomelanocortin": 6e-05, "deficiency-cold": 0.00031, "pybf": 0.00037, "glycerol density gradient": 0.00077, "th1/th0 response": 0.01942, "subclone": 0.00081, "amino-terminal portion": 0.00074, "molecular pathogenesis": 0.0045, "bacterium": 0.00025, "au motif": 0.00875, "erythroid-specific reporter expression": 0.02775, "prolonged exposure": 0.0035, "long-lasting stimulatory effect": 0.0141, "pparalpha activator": 0.00552, "single serine": 0.0036, "include tissue factor": 0.01907, "constitutively arrest": 0.00406, "ik protein play": 0.03019, "unliganded c-erba/tr": 0.00028, "pnu156804 block human": 0.02508, "defense": 0.00124, "blood": 0.01185, "simultaneous correction": 0.00074, "activated endothelial cell": 0.0512, "newborn hemolytic disease": 0.00449, "vcam-1-mediated cell adhesion": 0.0512, "purified dc": 0.00261, "bp region analyze": 0.00978, "promote cd4 cell proliferation": 0.0384, "-15 induce multiple stat protein": 0.01811, "thirty percent": 0.00037, "strong genetic component": 0.00304, "rex gene encodes": 0.02903, "gliadin peptide-hla class ii molecule-t cell interaction": 0.02194, "potential nfat composite element": 0.00836, "regular gc border": 0.00207, "fibroblast characterize": 0.00425, "crma block fas-mediated apoptosis": 0.00537, "ifn receptor family": 0.01714, "nf-kb2": 0.00012, "cd4 antigen": 0.00819, "period": 0.00254, "cotransfection experiment reveal": 0.00732, "eosinophil priming": 0.00295, "il-4 stimulation": 0.0112, "lps stimulate ap-1-mediated transcription": 0.01405, "maximal reaction velocity": 0.00147, "tnf-alpha- stimulated thp-1 cell": 0.0384, "liver cytosol": 0.00143, "mouse macrophage": 0.00974, "motif attta": 0.00875, "phytohemagglutinin": 0.00155, "host cell transcription": 0.0512, "enhance igm production": 0.00695, "sfs block": 0.01073, "insulin concentration change": 0.00447, "transcription factor suggest": 0.01907, "patient exhibit allele loss": 0.00833, "monocyte versus": 0.01197, "sf": 0.00012, "inhibit tumor progression": 0.0127, "modulating activity": 0.02925, "access epstein-barr virus-specific t-cell memory": 0.00385, "hiv long terminal repeat": 0.00296, "transcription-independent turnover": 0.00112, "level relevant": 0.01821, "c-rel-like protein": 0.04529, "squirrel monkey gr": 0.00267, "protein kinase inhibitor": 0.03019, "il-4 and/or il-13": 0.00445, "ifn-alpha5": 0.00019, "il-4-induced stat6 phosphorylation": 0.00656, "inhibition correlate": 0.01061, "include cbl": 0.01439, "constitutive expression": 0.04163, "cdna encode nuclear factor": 0.0143, "stat protein binding": 0.03019, "receptor 3'-untranslated region polymorphism": 0.01286, "myeloid-specific gene expression": 0.02903, "extrapituitary site": 0.02168, "birth": 6e-05, "ifn-gamma and/or tnf-alpha action": 0.00273, "j.t.bruder": 6e-05, "important functional region": 0.00978, "protected area include sp1": 0.0072, "dr enhancer": 0.00909, "specific substrate": 0.01238, "anti-e. chaffeensis antibody complexed": 0.00447, "genotypic marker": 0.00382, "persistent": 0.00248, "t-lineage precursor population": 0.00215, "chromosome inversion": 0.00295, "mutation analysis": 0.01179, "vascular inflammation inhibition": 0.00707, "molecular aspect": 0.0045, "bind gc": 0.02025, "cytokine transduce signal": 0.0109, "trans-factors": 0.00019, "general role": 0.01328, "unrelated": 0.00068, "contaminant lp": 0.00354, "estimate molecular weight": 0.003, "episomal maintenance": 0.00099, "express detectable": 0.01846, "epstein-barr virus membrane protein express": 0.01811, "protein synthesis-independent appearance": 0.03019, "ebv-encoded small non-polyadenylated rna show": 0.0104, "-0.2 kb link": 0.00232, "alternative apoptotic": 0.00205, "beta-actin mrna": 0.01526, "'normal": 6e-05, "higher-molecular-weight specie": 0.00183, "cytoplasmic anchor": 0.004, "viral promoter": 0.02336, "e29.1": 6e-05, "maximal response identical": 0.01294, "cd30+": 0.00037, "p40 production": 0.01042, "l.e": 6e-05, "induce b-cell apoptosis": 0.01694, "ng/ml display": 0.00499, "carboxy terminal tax deletion mutant": 0.00324, "cytokine synthesis": 0.01123, "monocyte chemotactic peptide-1": 0.00798, "tf-h5r alpha": 0.01169, "normal condition": 0.0121, "allergen-specific": 0.00074, "interferon gamma induces class ii expression": 0.01388, "human malignant melanoma": 0.02508, "inhibit il-2-induced activation": 0.02109, "antagonist binding": 0.01855, "platelet-like k562 cell": 0.0512, "direct assay": 0.01002, "palindromic site": 0.02168, "hiv-infected individual": 0.00409, "185+/-38": 6e-05, "position -585": 0.00236, "nonfunctional mutant": 0.0081, "ra inhibit ige synthesis": 0.00952, "f.": 0.00043, "18-bp dna segment": 0.00988, "double-labeled probe decrease": 0.00647, "du": 6e-05, "heterologous promoter": 0.02336, "sequester": 0.00087, "protein kinase cascade": 0.03019, "nf-kappab dna bind activity require": 0.0117, "microm mbp show": 0.01733, "promote il-12 responsiveness": 0.0031, "u.r.rapp": 6e-05, "dose-dependent manner": 0.00282, "donor express p62c-fos": 0.0123, "forty-eight hour": 0.00115, "p450ia1 gene": 0.04355, "unrelated case": 0.00363, "bind site similar": 0.01445, "mature cell": 0.0768, "phase entry": 0.00276, "-0.784": 0.0, "ap-1 factor participate": 0.01907, "c-fos promoter sis-inducible element ifn-gamma-activated sequence-binding complex": 0.00667, "unaffected": 0.00298, "alpha-granules": 0.00019, "differentiated progeny": 0.0009, "cell fail": 0.0768, "th2-associated cytokine il-4": 0.00749, "microenvironmental homing": 0.00016, "hocl promote": 0.00465, "ca2+": 0.00608, "th1/th2 balance": 0.00065, "physical stress-induced signaling pathway": 0.00639, "immunocompromised host": 0.00214, "cooh-terminal region": 0.01467, "fetal brain development": 0.00422, "steady state kappa": 0.00498, "agonist stimulation": 0.0112, "erythroid progenitor express": 0.0123, "dominant negative ikappabalpha construct resistant": 0.0029, "c-erba/tr-alpha": 0.00019, "stimulus-": 0.00025, "northern analysis suggest": 0.01348, "lcd motif require": 0.00877, "c/ebp epsilon mrna level": 0.0091, "surface plasmon resonance approach": 0.00257, "e2f dna-binding activity": 0.0195, "il-2r alpha": 0.01169, "ikk complex-associated protein inhibit stimulus-mediated transcription": 0.0151, "specific antibody": 0.01238, "important relative": 0.00689, "fc": 0.00329, "stimulus test": 0.00487, "faster assay": 0.01002, "strain transactivated": 0.00186, "adenoviral technique describe": 0.00265, "stat1-": 6e-05, "zii abolish": 0.00354, "hbd subfragments": 0.00034, "hepatic nuclear factor": 0.01907, "dopamine": 0.00112, "highlight": 0.00099, "autoregulatory feedback inhibitor": 0.006, "inhibitor protein i-kb": 0.03019, "dna induces change": 0.00988, "nf-kappab-dependent pathway": 0.01278, "qp function": 0.01331, "thymic": 0.00236, "full length e2a cdna lead": 0.00398, "neutrophil-specific gene expression": 0.02903, "physiological significance": 0.00183, "-2 receptor alpha chain/cd25": 0.01286, "prostaglandin e2 up-regulates hiv-1 long terminal repeat-driven gene activity": 0.00968, "-15": 0.00019, "immunoglobulin heavy-chain gene expression": 0.02177, "v-abl oncogene": 0.00261, "gene organization": 0.04355, "lcr activity": 0.02925, "rapid translocation": 0.00515, "t3-responsive pituitary": 0.00065, "polymerase chain reaction": 0.00292, "immunosuppressive drug": 0.00338, "inactive mutant": 0.0081, "chronic autoimmune inflammatory disease": 0.00337, "autoimmune reaction": 0.0022, "probucol": 0.00012, "cd8-positive thymocytes": 0.00257, "l132 fibroblast": 0.00338, "transduced copy": 0.00078, "class ii-positive nonlymphoid glioblastoma cell line": 0.0256, "op": 0.00019, "pma-induced cd14 expression": 0.02775, "specific proteasome inhibitor": 0.00825, "upregulate nf-kappa b1 transcription": 0.01405, "irf-1 5'-flanking": 0.0013, "fusion partner": 0.00326, "receive glucocorticoid treatment": 0.00676, "opportunistic infection": 0.0062, "e.": 0.00205, "t-cell-": 0.00012, "neoplastic cell": 0.0768, "leukocyte-derived oxidant": 0.00105, "block binding": 0.01855, "'constitutive": 0.00012, "pkc-specific inhibitor": 0.009, "wild-type dra promoter": 0.01557, "g1 cyclins d2": 0.00072, "co-stimulatory gene": 0.04355, "similar downstream signalling": 0.00449, "translocates pkc": 0.00332, "b29 minimal promoter": 0.01557, "composite pu.1": 0.00285, "stat6-deficient jurkat": 0.00555, "-poly": 0.0, "tcr delta enhancer": 0.00606, "whole-cell lysates": 0.00102, "adjacent long terminal repeat region": 0.00587, "binary fate decision": 0.00029, "concurrent addition": 0.00673, "p/i activation": 0.03164, "responder": 0.00074, "sle disease activity": 0.0195, "inhibitory protein": 0.04529, "activate specific ebv promoter": 0.01168, "important physiological trigger": 0.00459, "90-kilodalton heat shock protein": 0.02264, "il-3 promoter": 0.02336, "cell line namalwa": 0.0512, "b-cell expansion": 0.00459, "gst-ebna-2 fusion protein": 0.03019, "map kinase erk-2": 0.00792, "from-": 6e-05, "dna methylation": 0.01483, "nonendocrine cell lineage": 0.0512, "close homology": 0.00183, "de anti-bcr1/25": 0.00158, "southwestern screening": 0.00062, "human renal cell carcinoma": 0.0384, "m-tat/gm-csf cell": 0.0768, "transient tranfection": 0.00344, "yacs flank": 0.00081, "7-16": 6e-05, "direct molecular effect": 0.0141, "syndrome patient": 0.01666, "v14rho bind": 0.02025, "germinal center maturation": 0.00167, "gp160-induced nf-kappa": 0.01414, "key oxidative-stress sensor": 0.00101, "maximal expression": 0.04163, "constitutive degradation": 0.00478, "n9 murine microglial cell line": 0.03072, "human th2 cell": 0.0512, "cohen": 0.00012, "takayasu arteritis patient": 0.0111, "expression vector encode": 0.02775, "ikappab-alpha proteolysis": 0.00112, "fi": 0.0, "nf-kappab-like site": 0.02168, "hpp-47.10 cell": 0.0768, "early hypothesis": 0.00828, "cortex": 0.00043, "macrophage lineage": 0.00589, "multiple cytokine deficiency": 0.00749, "similar spectrum": 0.00673, "cis": 0.00068, "nac treatment": 0.01014, "natural killer cell activity": 0.0384, "stable phase": 0.00276, "absolute block": 0.01073, "mcp-1 secretion": 0.00428, "macrophage-like pma-differentiated u937 cell": 0.0384, "permanent overexpression": 0.00382, "nucleoprotein extract": 0.00459, "palindromic arrangement": 0.00034, "aug codon": 0.00071, "effector cell": 0.0768, "pharmacological manipulation": 0.00068, "isolate mouse notch-1": 0.00649, "fibrosis": 0.00056, "dnase footprinting": 0.00118, "il-2/ifn alpha-based therapy": 0.00248, "human erythroleukemia cell line k562": 0.03072, "tnf-alpha-stimulated nuclear factor-kappa": 0.01123, "6-15 month": 0.00068, "fertile adult male": 0.00281, "purified human hematopoietic cell": 0.0384, "experimental series": 0.00161, "interleukin-2 receptor-alpha": 0.00332, "luciferase gene drive": 0.02903, "inhibited ap-1 binding activity": 0.01462, "unrelated japanese child": 0.00045, "hiv long terminal repeat reporter gene construct": 0.01244, "bmt exhibit antiviral activity": 0.01462, "coactivation": 0.00012, "lysp100 cdna": 0.00456, "cd45ro+": 0.00025, "nuclear factor nf-gm2": 0.01907, "mek inhibitor": 0.009, "disulfide": 0.00087, "pharmacokinetics": 0.00025, "construct result": 0.0161, "neutrophil accumulation": 0.00496, "murine g-csfr": 0.00623, "ebv-positive malignancy": 0.00115, "rex production": 0.01042, "maximal lps induction": 0.01071, "basal transcription activity": 0.0195, "sendai virus induce hela extract": 0.01016, "cyclin e-cdk2-": 0.00093, "regulatory dna element reveal": 0.00836, "paf-induced up-regulation": 0.00276, "common step": 0.0035, "wild-type cbp": 0.00378, "jak-stat signaling": 0.00558, "nuclear nf-kb binding protein": 0.02264, "oxidative process": 0.00444, "fibronectin receptor mrna": 0.01714, "activated phenotype": 0.00589, "delta cam-ai": 0.00211, "slg+b-all": 0.00012, "human interleukin-6 gene": 0.02903, "differential activation": 0.03164, "potent inducer": 0.00357, "pb granulocyte": 0.00254, "defective apoptosis": 0.0089, "provide additional": 0.00645, "jy": 0.00012, "purine-rich part": 0.00152, "brain involution": 0.00084, "mouse tnf-alpha gene display weak activity": 0.01452, "bcr1/9": 6e-05, "bind rela": 0.02025, "human tumor necrosis factor alpha promoter region": 0.01075, "freshly isolated leukemic cell": 0.0384, "glucocorticoid pharmacokinetics": 0.0085, "il-10 act": 0.00496, "negative function": 0.01331, "f. j.": 0.00056, "il-10 receptor expression": 0.02775, "acute promyelocytic leukaemia": 0.00246, "actin stress fiber": 0.00207, "vitamin d-dependent gene regulation": 0.02177, "polymorphonuclear neutrophilic granulocyte": 0.0017, "immediate-early viral transactivators": 0.00488, "xp11be": 6e-05, "promoter element mediate proper hormone-dependent": 0.00934, "pouhd moiety": 0.0005, "putative role": 0.01328, "virus progeny": 0.00887, "irf-1 gamma-activated site": 0.01445, "interferon-induced": 0.0005, "dominant effect": 0.02115, "serum-activated cell line": 0.0512, "endothelium play": 0.0071, "transcriptional signal": 0.01635, "ro 13-7410": 0.0009, "-533 base": 0.0031, "normal phagocyte function": 0.00887, "clone icsbp": 0.00738, "lymphocyte cell line library": 0.0384, "human hiv-1": 0.03762, "tcr signal pathway": 0.0109, "25-fold": 0.00025, "zebrafish pax-b": 3e-05, "synovial lining": 0.00084, "cysteine-containing t-cell determinant": 0.00641, "pioglitazone show activity": 0.0195, "nfat-1-linked lac-z transfectants": 0.00066, "expression clone strategy": 0.02775, "pml/raralpha play": 0.0071, "fusion splice": 0.00326, "polyclonal antiserum": 0.00115, "death-inducing ligand": 0.00592, "methyl tertiary-butyl ether": 0.00014, "immunohistochemical study": 0.01355, "85-kda cytosolic phospholipase a2": 0.00076, "gcrbeta-positive": 6e-05, "related dna bind specificity": 0.01013, "burkitt lymphoma line raji": 0.00827, "full maturation": 0.00251, "hgata-4 selectively interacts": 0.00194, "sapk": 0.00012, "tzds": 6e-05, "digestion": 0.0005, "primary immunomodulator": 0.00738, "human basal brain": 0.02508, "ductal cell": 0.0768, "twelve in-vitro-stimulated normal cord blood": 0.00484, "peripheral lymphocyte receptor": 0.01714, "inhibit cellular proliferation": 0.0127, "posttranslational modification": 0.00183, "interleukin-2 control transcription": 0.01873, "cell growth regulation": 0.0512, "activate mouse epor": 0.01185, "heavy-chain promoter": 0.02336, "lymphoid-restricted gene": 0.04355, "normal thymic epithelial cell": 0.0384, "u-373 mg glioblastoma cell line": 0.03072, "undifferentiated spindle-shaped carcinoma": 0.0012, "dexamethasone bind": 0.02025, "t-lymphocyte lineage": 0.00366, "induce p50/p65": 0.0254, "qakwrlqtl": 6e-05, "slight flow": 0.00152, "beta-globin locus control region": 0.00734, "intranuclear delivery": 0.00059, "v-erba oncogene action": 0.00333, "oleic acid": 0.00856, "cell-specific transcription factor interact": 0.0143, "enriched preparation": 0.00074, "lmp1 amplifies": 0.0027, "pf treatment": 0.01014, "neutrophil surface": 0.00515, "v-fos protein": 0.04529, "apparent kd": 0.00192, "tax response": 0.01942, "nfs-60 cell constitutively express": 0.0384, "traf protein": 0.04529, "mrna assay": 0.01526, "il-1r interact": 0.00372, "delay progression": 0.00164, "ectopic endometrial fragment": 0.00232, "inhibit transcription": 0.0281, "herpes simplex virus vp16 protein": 0.01811, "impaired ligand-induced plasticity": 0.0012, "and/or schedule": 0.0045, "full-length pml/raralpha cdna drive": 0.00228, "p53 protein": 0.04529, "specific nuclear factor": 0.01907, "ng/ml": 0.00081, "vitamin d-dependent rickets type ii show functional defect": 0.0065, "drug concentration require": 0.00877, "insulin content": 0.00158, "bz1 reactivity suggest": 0.01348, "b-lymphocytes progress": 0.00043, "b-cell line carry": 0.01102, "eukaryotic transcription factor nf-kappa": 0.0143, "brdu": 0.00019, "shc": 0.00068, "cloned isolate": 0.00416, "athlete": 0.00025, "human cd34": 0.03762, "jurkat cd4+": 0.00555, "sds-gel electrophoresis": 0.00071, "selenium supplementation": 0.00028, "potent t-cell-specific enhancer": 0.00606, "c-kit": 0.00074, "rp1": 0.00043, "recombinase activity": 0.02925, "rakfkqll": 6e-05, "nfat-dna complex migrate": 0.01123, "unknown cdna sequence": 0.01084, "-independent activation": 0.03164, "primary human cd34+ hemopoietic progenitor cell": 0.0256, "myeloid lineage development": 0.00422, "pathogenic infection": 0.0062, "activates transcription": 0.0281, "eukaryotic origin": 0.00105, "rise": 0.00136, "cell type oct-2 protein": 0.0384, "host immunologic destruction": 0.00143, "kappab-responsive element": 0.01672, "phosphoprotein": 0.00105, "ectopic": 0.00161, "sv40 promoter respond": 0.01557, "p50-p65": 0.00068, "pous": 0.00012, "dominant": 0.0049, "fos gene family": 0.02903, "increase transcript level": 0.01464, "virus infectivity": 0.00887, "ip9": 6e-05, "percent inhibition +/- sem": 0.0053, "biologic marker": 0.00382, "sp1- mediated activation": 0.02109, "substantial sequence similarity": 0.01084, "nk-derived polya+ rna confirm": 0.00228, "v-abl-mediated signaling": 0.00558, "mds1/evi1 enhances tgf-beta1 signaling": 0.00279, "effort": 0.00019, "ra time-response": 0.00596, "molecular approach": 0.0045, "ebna transcription": 0.0281, "nuclear dual-specific map kinase phosphatase": 0.00674, "confers resistance": 0.00326, "undetected viral gene product": 0.02177, "favorable activity profile": 0.0195, "sk-n-be": 0.0, "exogenous growth stimulus": 0.00546, "constitutively high": 0.00931, "-specific": 0.00056, "molecular-biologic aspect": 0.00124, "term p0": 0.00413, "obligatory intracellular bacterium": 0.00389, "nf-kappab binding complex": 0.01237, "critical region": 0.01467, "erk2 function": 0.01331, "tyrosine-protein kinase-specific inhibitor": 0.006, "cox-2 expression": 0.04163, "sequence ggggacgtcccc": 0.01625, "warm hcl": 3e-05, "anti-v3 loop monoclonal antibody": 0.00447, "pel growth": 0.00819, "thp-1 monocyte/macrophage cell": 0.0512, "high thymidine kinase mrna expression": 0.01665, "requisite bacterial ligand": 0.00395, "class ii transactivator": 0.00484, "ets transcription factor/oncoprotein family": 0.01405, "affinity column fraction": 0.00261, "reactive nitrogen intermediate release": 0.00242, "human neutrophil elastase": 0.02508, "globin cis-elements demonstrate hmg-i binding": 0.00742, "caspase-3-like": 6e-05, "sv40 early promoter": 0.01557, "dimeric complex": 0.01684, "th2 cell": 0.0768, "subtractive hybridization": 0.00155, "ad2": 0.00062, "steroid/thyroid hormone receptor superfamily": 0.01286, "demonstrate membrane bind site": 0.01084, "human immunodeficiency virus long terminal repeat": 0.01254, "antigen responsiveness": 0.00819, "alpha-globin locus enhancer": 0.00606, "resistance develops": 0.00326, "baseline": 0.00081, "il2r alpha promoter": 0.01557, "scl": 0.00261, "soluble il-1rii": 0.00223, "functional responsiveness": 0.00816, "result complex target": 0.01123, "bzlf1 mrna": 0.01526, "ig isotype switching": 0.00143, "enhance ikappabalpha phosphorylation": 0.00656, "serum immunoglobulin level": 0.01214, "invertebrate transcription factor": 0.01907, "tar primary sequence result": 0.00813, "anti-cd2 mabs capable": 0.00174, "p53 transcript": 0.00599, "release p24 ag": 0.00323, "murine macrophage 12/15-lipoxygenase activity": 0.01462, "bloom": 0.00019, "bind octamer-binding protein": 0.03019, "tissue damage": 0.00664, "negative activity": 0.02925, "mechanistic consequence": 0.00115, "ang ii-induced nf-kappab activation": 0.01582, "gender difference": 0.00425, "granulocyte colony-stimulating factor": 0.01907, "vitro senescence": 0.00785, "c-fos protein synthesis": 0.03019, "interferon-regulated expression": 0.04163, "bridge": 0.00043, "rflp pair occur": 0.00436, "ile50 contributes": 0.00109, "rat macrophage": 0.00589, "mutant myc protein capable": 0.02264, "growth transformation": 0.00819, "rar-rxr": 0.0005, "positive autoregulation": 0.00468, "report dominant negative function": 0.00665, "human b-cell line": 0.02508, "mol/l": 0.00105, "receive anti-estrogen therapy show similar enhancement": 0.00866, "induce interleukin": 0.0254, "classical nf-kappa": 0.01414, "kappa b.": 0.00748, "janus tyrosine kinase": 0.00792, "important prognostic factor": 0.01907, "yy1 consensus sequence": 0.01084, "putative transcriptional activation domain": 0.01582, "nos activity": 0.02925, "bfu-e response": 0.01942, "acute myeloid leukaemia": 0.00308, "signal transduction mechanism": 0.0109, "eb1-like gene family": 0.02903, "crm1": 0.00037, "cd8 negative": 0.00515, "homodimers": 0.00155, "trigger activation signal lead": 0.01582, "negative clinical outcome": 0.00343, "phorbol ester phorbol 12-myristate 13-acetate": 0.00109, "ubiquitous repressor zeb": 0.00149, "s. aureus enterotoxin": 0.00043, "oct-2 mrna": 0.01526, "mitogen-mediated ltr transcription": 0.01873, "differentiation assay": 0.01179, "gel shift analysis reveal": 0.00589, "salient difference": 0.00425, "salicylate treatment": 0.01014, "heat shock induce hiv-1 production": 0.01016, "androgen-modulated rat ventral prostate tissue": 0.00266, "cis-acting regulatory site": 0.01445, "regulatory pathway": 0.01278, "eryf-1": 6e-05, "occur early": 0.00828, "variant cell": 0.0768, "small intragenic mutation": 0.00395, "vitro substrate": 0.00785, "epstein-barr virus oncoprotein latent membrane protein": 0.0151, "mbcl6 gene": 0.04355, "smmhc": 0.00025, "human platelet/endothelial cell adhesion molecule-1 promoter": 0.0256, "palmitic": 6e-05, "hnf3 beta": 0.00673, "lbf3": 6e-05, "transcription deficiency": 0.0281, "fundamental implication": 0.00158, "differentiation-promoting substance": 0.00047, "ppar-gamma mrna": 0.01526, "novelty stress": 0.0031, "grb2 form": 0.01055, "gc b-cell phenotype": 0.00306, "regulate systemic glucose": 0.00835, "sequence downstream": 0.01625, "protein capable": 0.04529, "property identical": 0.00397, "typical sedimentation coefficient": 0.00079, "l. pneumophila": 0.00047, "parent peptide": 0.00754, "multicomponent receptor model": 0.01714, "th2 subset": 0.00192, "serca": 0.00025, "inhibit effect": 0.02115, "isg15 mrna accumulation": 0.01017, "single-cell reverse transcriptase-polymerase chain reaction": 0.00175, "alternative": 0.00409, "1-2 microm": 0.0013, "primary murine": 0.00738, "mutant rj2.2.5": 0.0081, "high-dose estrogen administration induces anemia": 0.00321, "kappab": 0.00329, "nuclear signal step": 0.01123, "ebna2-dependent enhancer": 0.00909, "transient increase": 0.02196, "hugata-3 transcription factor": 0.01907, "cd40 signal determinant regulate nuclear factor-kappa": 0.00561, "il-2 mrna expression": 0.02775, "15d-pgj": 0.00012, "p65 increase endogenous": 0.01464, "major transcription factor": 0.01907, "single viral immediate-early protein": 0.02264, "hiv-1 ltr promoter activity": 0.01462, "bmt": 0.00074, "display normal proliferative response": 0.00971, "prime nb4 cell": 0.0512, "senescent": 0.00056, "dna staining": 0.01483, "sodium deoxycholate": 0.00186, "kidney fibroblast": 0.00338, "caspase 3-like protease": 0.00118, "ehrlichia chaffeensis": 0.0004, "burkitt": 0.0013, "up-regulated surface expression": 0.02775, "sedentary group": 0.00487, "multicolor flow cytometric assay confirm": 0.00401, "illness due": 0.00369, "human gm-csf receptor alpha": 0.01881, "partial sequence": 0.01625, "synthetic peptide arg-gly-asp": 0.00502, "site-specific": 0.00062, "tcf-1 bound": 0.00292, "p91/84": 6e-05, "critical il-2 dna enhancer element": 0.00669, "fas ligation": 0.0018, "defective retinoblastoma gene": 0.02903, "ifn-induced change": 0.0063, "virologic feature": 0.00217, "germline cepsilon gene": 0.02903, "observed cooperativities": 0.00062, "sse": 6e-05, "member": 0.00825, "transplantation": 0.00112, "p38delta": 0.00012, "c/ebp-epsilon mrna detect": 0.01017, "antigen-driven somatic hypermutation": 0.0006, "blood-derived monocyte": 0.01197, "adherent population": 0.00307, "hiv-infected": 0.00174, "astrocyte regulates nf kappab activity": 0.0117, "high interindividual variation": 0.0062, "cd40-regulated antiapoptotic molecule": 0.00569, "il-6 luciferase assay": 0.00668, "lipophilic ligand": 0.00592, "sequence-specific dna-binding small molecule": 0.00426, "transient stimulation": 0.0112, "temporal expression pattern": 0.02775, "recurrent aborters": 0.00084, "sp1 family": 0.00841, "dominant negative version": 0.00343, "chronic sodium depletion": 0.00265, "autoantigens": 0.00019, "viral transactivators": 0.00732, "msr ligand": 0.00592, "sequence affect": 0.01625, "modified vector": 0.00319, "major active component": 0.00395, "influence histamine-induced": 0.00471, "cellular treatment": 0.01014, "neutrophil granulocyte": 0.00496, "gp120 induces tyrosine phosphorylation": 0.00492, "-specific dutpase": 0.00031, "growth-": 6e-05, "cellular susceptibility": 0.00893, "bl cell line": 0.0512, "renal inflammation": 0.00316, "interferon beta prdii site": 0.01084, "pdn": 0.00012, "multiple criterion encode ebf": 0.00426, "camkiv/gr": 0.00025, "lipid mediator increase activity": 0.01462, "embryonic skeletal muscle": 0.00085, "resistant": 0.00422, "gamma delta cell": 0.0512, "tradd protein": 0.04529, "porcine endothelium": 0.00062, "dna clone": 0.01483, "informative female patient": 0.0111, "g.a.": 0.00012, "mnli-alui fragment": 0.00347, "inhibitory capacity": 0.00357, "specific anti-hla antibody": 0.00825, "cbp/p300-mediated increase": 0.02196, "cytochrome p4501a1 gene expression": 0.02177, "state associate": 0.01092, "ptdins": 0.00081, "data provide strong evidence": 0.00323, "consistence": 0.0, "fluorescence": 0.0013, "normal diurnal decline": 0.00806, "finding inconsistent": 0.00226, "respective immunophilins": 0.0009, "b- lymphocyte": 0.01483, "percent": 0.00074, "induce il-1beta promoter-driven cat activity": 0.0117, "include phagocytosis": 0.01439, "-induced": 0.00372, "paired daughter cell culture": 0.0384, "harbor subtle modification": 0.00122, "induced nuclear expression": 0.02775, "transactivation property": 0.00515, "receptor activator": 0.02571, "link cellular": 0.00893, "potent transactivator": 0.00357, "immune-endocrine function": 0.01331, "lectin-like": 0.00012, "nf-at protein": 0.04529, "immunocytes": 0.00012, "preincubation": 0.00105, "immunoglobulin light-chain enhancer": 0.00606, "recessive": 0.00037, "b-cell proliferation": 0.00803, "raghavan": 0.00012, "cd19 cross-linked blin-1 cell": 0.0384, "defective production": 0.01042, "monocyte-macrophage colony stimulate factor": 0.0143, "additional distinct transcription factor": 0.0143, "5.1-fold": 6e-05, "hcmv": 0.00143, "single c-myb bind site": 0.01084, "e-cm": 6e-05, "-selective antagonist inhibits differentiation": 0.00589, "cell expression": 0.0768, "concomitant removal": 0.00112, "histone deacetylase catalytic subunit": 0.00242, "cd4 molecule": 0.00853, "human cd40-activated": 0.03762, "parasitemia": 0.00012, "poorly": 0.00167, "dominant-negative mutant tnfri inhibit ec activation": 0.01055, "antiviral therapy": 0.00372, "cell-specific transcription factor tcf-1 alpha play": 0.00953, "sensitive western blot assay": 0.00501, "quiescent simian peripheral blood mononuclear cell": 0.0256, "cell surface induce": 0.0512, "zta interference": 0.0009, "fo protein": 0.04529, "incubation medium": 0.00208, "functional differentiation marker": 0.00786, "e1a -and e7-expressing human fibroblastic": 0.01505, "distal nuclear matrix associate promoter element": 0.00779, "organization": 0.00081, "high spi-1-dna binding activity": 0.01462, "polymorphic site": 0.02168, "cis-acting region": 0.01467, "bp -92": 0.00267, "mody": 0.00025, "pma-induced ap-1": 0.00695, "present work": 0.00735, "past decade": 6e-05, "dex inhibition": 0.01061, "reveal increase leukocyte-platelet adhesion": 0.01098, "retinoic acid-resistant acute promyelocytic leukemia cell line": 0.02194, "lmp1 usurps cellular signal pathway result": 0.00545, "analyze nuclear factor bind": 0.0143, "inhibitory mechanims": 0.00357, "-85 bp": 0.00267, "beta interferon promoter": 0.01557, "defined topographical region": 0.00978, "ribonuclease protection assay": 0.00668, "hela": 0.00465, "xic": 0.00012, "absorptive hypercalciuria": 0.00019, "include stat1": 0.01439, "small exon span": 0.00209, "env": 0.00031, "hiv-ltr-kappab site": 0.02168, "monocyte-macrophages": 0.00012, "heterologous acidic": 0.00127, "oct-1 dna binding activity": 0.01462, "inhibitory complex": 0.01684, "ribosomal scanning": 0.00043, "mouse perforin gene": 0.02903, "human beta-globin yeast artificial chromosome transgene": 0.01254, "caspase substrate poly": 0.00132, "nonphlogistic clearance": 0.00062, "nonresident vascular wall cell": 0.0384, "monoblast differentiation": 0.01179, "constellation": 6e-05, "mediate receptor-receptor dimerizations": 0.00821, "actin tail": 0.00074, "dests": 0.00031, "gp 160-induced nuclear extract": 0.00842, "respective pathogenetic role": 0.00885, "synergistic suppression": 0.00416, "tumor necrosis factor receptor-1": 0.0143, "lymphoid/myeloid somatic hybrid suggest": 0.01011, "deficit": 0.00019, "non-steroidal anti-inflammatory drug inhibit": 0.00952, "phorbol-12-myristate-13-acetate": 0.00031, "serial 5'-deletion mutation show": 0.013, "cytokine-encoding gene": 0.04355, "cell occur": 0.0768, "latency type ii pattern": 0.00475, "myogenin": 0.00012, "active dimer": 0.00592, "hypothalamic-pituitary-adrenal axis implicate": 0.00234, "jnks": 0.00019, "seborrheic keratoses": 3e-05, "alternate rcgcrygcgy consensus constitute high-affinity ibr/f bind site": 0.00542, "mediate": 0.02463, "nuclear cell extract": 0.0512, "activate zp": 0.01777, "human breast cancer cell line": 0.03072, "vivo close": 0.0053, "vitro mutagenesis experiment demonstrate": 0.00799, "gata-1 undergo coordinate modulation": 0.00206, "base pair upstream": 0.00246, "namalwa cell": 0.0768, "prb release": 0.00484, "similar pattern": 0.00673, "nickel": 6e-05, "multi-agent therapy": 0.00372, "c- fo": 0.00071, "regulate transcriptional activation": 0.02109, "il-2 superinduction": 0.01117, "map erk kinase kinase-1": 0.00594, "creb dna bind": 0.0135, "gc-insensitive asthma": 0.00161, "downstream beta-like globin gene 10-50 kilobases": 0.01452, "t-cell leukemia": 0.00962, "therapeutic measure carry": 0.00258, "placebo": 0.00043, "gdp/gtp exchange": 0.00074, "proximal il-5 promoter": 0.01557, "complement": 0.00199, "h. fragmentation": 0.00118, "p50/p65 heterodimer": 0.00205, "qp-cat reporter": 0.00552, "c-jun induction": 0.01607, "anti-tumor ctl response": 0.01294, "bhlf1/noti oligoprobes": 6e-05, "cell line skw6.4": 0.0512, "immunogenic human malignant melanoma augments": 0.01505, "hb24": 0.00087, "post-transcriptional event": 0.00552, "systemic bacterial infection": 0.00414, "trancriptional activity": 0.02925, "nre-ii": 6e-05, "regulatory switch contributes": 0.00455, "epor promoter": 0.02336, "transcription factor nf-kappa b. xenogeneic human serum promotes leukocyte adhesion": 0.00752, "27-amino acid regulatory motif": 0.00437, "regulate transcriptional event": 0.00835, "il-2 inhibition": 0.01117, "extracellular pool": 0.00167, "ssa": 0.00037, "increase blood urea nitrogen": 0.01098, "multipotential cytokine": 0.01123, "cdk6 construct": 0.00726, "developmental stage homogeneity": 0.00165, "estrogen receptor-related protein": 0.03019, "induced apoptosis": 0.0089, "human il-5 receptor": 0.02508, "elevated total ige": 0.00126, "taxi": 0.0005, "nls peptide-mediated disruption": 0.00058, "adenosine triphosphate": 0.00037, "kb-like proto-enhancer element": 0.01115, "stat5-containing dna-binding activity": 0.0195, "lt-293 cat activity": 0.0195, "constitutively express sp1 protein": 0.02264, "ra-mediated type ii tgase up-regulation": 0.0038, "gpix promoter": 0.02336, "sepsis initiate intravascular thrombosis": 0.00181, "specific methylation": 0.01238, "alpha-tcp act": 0.00496, "depressed capacity": 0.00329, "de novo transcription": 0.01873, "erythroid-specific chromatin structure": 0.00213, "leukocyte function": 0.01331, "icam-3": 6e-05, "cellular receptor": 0.02571, "adhesion response": 0.01942, "perforin locus": 0.00288, "pyrimidine": 0.00025, "tnf-induced activation": 0.03164, "stat3 tyrosine phosphorylation": 0.00656, "macrolide rapamycin": 0.00062, "ciita mrna transcription": 0.01873, "activates p21ras": 0.00164, "thrombin-induced": 0.00062, "specific expression": 0.04163, "anti-igm ab": 0.00167, "upstream c/ebp-beta site": 0.01445, "e2a-hlf protein": 0.04529, "ebna-2-positive cell line": 0.0512, "adult b-lymphopoiesis": 0.00422, "fk506": 0.00298, "related thiols": 0.00236, "c-erba bind": 0.02025, "relative molecular mass": 0.003, "mthc line": 0.01653, "traf1 coactivation": 0.0004, "otf1": 0.00019, "fva cell": 0.0768, "maximal inhibition": 0.01061, "manipulation": 0.00037, "repressed tpa-mediated activation": 0.02109, "cdc": 6e-05, "stat pathway": 0.01278, "rela protein": 0.04529, "putative target": 0.00825, "bind glucocorticoid": 0.02025, "basal cell epithelioma": 0.0512, "il-10 prevent ifn-gamma-induced binding activity": 0.0117, "cif block": 0.01073, "isgf3 gamma": 0.0044, "erk kinase": 0.01188, "86-nucleotide fragment": 0.00347, "mhc class ii immunodeficiency": 0.00363, "monochloramine inhibits phorbol ester-inducible neutrophil respiratory burst activation": 0.00791, "leukocyte adhesion": 0.0058, "oxanaphthalen-4-one": 0.00012, "auto-inhibitory": 0.00012, "calcemic activity": 0.02925, "ikappabalpha expression": 0.04163, "cd40l+ reactive": 0.00211, "trigger activation": 0.03164, "splice pax-5 isoforms suggest": 0.01011, "rapid response": 0.01942, "b104 cell": 0.0768, "barrier": 0.0005, "endometriosis": 0.00056, "p35 mrna": 0.01526, "poor binding peptide induce": 0.0127, "runt box polypeptide": 0.00203, "abnormal glucocorticoid clearance": 0.00567, "e1a oncogene expression increase mammalian cell susceptibility": 0.02194, "gm-csf show": 0.02599, "btk promoter": 0.02336, "optimized peptide sequence": 0.01084, "chronic hepatitis": 0.00397, "viral coreceptors": 0.00732, "dexamethasone binding": 0.01855, "tight complex": 0.01684, "surrogate thyroglobulin receptor": 0.01714, "dermal fibroblast": 0.00338, "sp1 site": 0.02168, "express multiple gata-binding protein": 0.02264, "regulate calcium signalling": 0.00835, "ca2+ ionophore ionomycin": 0.00203, "modified oligonucleotides": 0.00183, "active site": 0.02168, "gata-1 protein": 0.04529, "late effect": 0.02115, "respective role": 0.01328, "human aortic ec": 0.02508, "enhanced response": 0.01942, "human il-3 proximal promoter": 0.01881, "class ii major histocompatibility complex surface protein": 0.01294, "delayed-early": 0.00031, "5-lox inhibitor": 0.009, "specific bright focus": 0.00825, "tnf promoter activity": 0.0195, "cell leukemia jurkat cell": 0.0192, "pu.1 bound": 0.00292, "research": 0.00056, "myeloid developmental stage": 0.00308, "healthy age person": 0.00151, "growth hormone": 0.00819, "gradient-gel electrophoresis": 0.00071, "long-term effect": 0.02115, "glucocorticoid action": 0.0085, "carboxyterminal half": 0.0004, "c-jun expression": 0.04163, "safety parameter": 0.00127, "tcralpha enhancer function": 0.00887, "sustained nuclear nf-kappa": 0.01123, "therapeutic concentration result": 0.01073, "ab cross-linking": 0.00242, "overlap stat protein": 0.03019, "sp-a exerts": 0.00037, "common progenitor cell": 0.0512, "lbf7": 6e-05, "percent-age": 0.00012, "sensitivity": 0.00471, "protein show": 0.04529, "affect total cellular": 0.00596, "moderate abundance": 0.00059, "-termini decrease": 0.00971, "activate rar-rxr": 0.01777, "match normotensive volunteer": 0.00043, "sequence-specific dna-binding characteristic": 0.00374, "interferon regulatory factor-1": 0.00455, "independent sequence": 0.01625, "delay onset": 0.00096, "immortalised lymphoblastoid cell line": 0.0384, "cle0 element": 0.01672, "kinetics": 0.00335, "functional ra": 0.00816, "prototypic class ii promoter": 0.01168, "estimate": 0.00099, "trophic effect": 0.02115, "promyelocytic leukemia": 0.00499, "persistent nuclear accumulation": 0.01123, "cortisol metabolism": 0.00295, "significant role": 0.01328, "pharmacological dos": 0.00121, "inappropriate binding": 0.01855, "normal human igg": 0.02508, "consequent decrease": 0.00971, "fluorogenic peptide assay reveal": 0.00549, "murine pu.1 promoter": 0.01557, "non-hematopoietic cell": 0.0768, "nf-e1 result": 0.0161, "xist transcription": 0.0281, "decrease lps-induced nf-kappab dna binding": 0.00742, "specific transcription factor complex": 0.0143, "ap-2 site": 0.02168, "firm arrest": 0.00171, "lymphocyte monoclonicity": 0.01483, "accessory factor": 0.0286, "-2-": 0.00012, "kca channel": 0.00062, "human mcm5": 0.03762, "delta transcript express": 0.0123, "dna position tax": 0.00988, "common pathological finding": 0.00234, "distinct transcription factor family": 0.0143, "minor b-cell component": 0.00306, "proinflammatory molecule": 0.00853, "cerebral cortex": 0.00022, "unidentified pos-binding protein": 0.03019, "hiv expression": 0.04163, "lps-induced proinflammatory function": 0.00887, "main aim": 0.00087, "chemoattractant cytokine": 0.01123, "induce c-jun transcription": 0.01873, "lacked expression": 0.04163, "inhibits tnf translation": 0.00354, "lineage-specific transcription factor gata-1": 0.0143, "observed repertoire heterogeneity": 0.00041, "antagonistic effect": 0.02115, "astrocytomas": 0.00025, "c-terminal cytoplasmic domain": 0.00804, "ap-1 complex consists": 0.01123, "type-ii eb correlate": 0.00436, "transcription factor egr-1": 0.01907, "intracellular ca2+ store": 0.00389, "fetal bovine serum": 0.00252, "jun immunoreactivity": 0.00167, "cytotoxic drug doxorubicin": 0.00225, "protein product mediate monocyte binding": 0.01811, "natural thiol antioxidant": 0.00167, "repress ltr transcription": 0.01873, "cd38 antigen": 0.00819, "cortisol level correlate": 0.01214, "fp promoter": 0.02336, "require host cell transcription factor": 0.03072, "sh2": 0.00118, "nac block": 0.01073, "explanation": 0.00031, "form b-lymphoblastoid cell line": 0.0384, "result reveal": 0.0161, "jurkat mutant deficient": 0.0054, "-230 gata-1 site": 0.01445, "receptor oligomerization": 0.02571, "gene encode": 0.04355, "cdk2-dependent phosphorylation": 0.00983, "e6-ap": 6e-05, "recent gene target": 0.02903, "primary infection show": 0.01733, "c-fos content": 0.00471, "transactivation potential": 0.00605, "cell-cycle control": 0.01303, "extrathymic t-cell development": 0.00641, "elevated rate": 0.00279, "represses vcam-1 gene transcription": 0.02177, "vitamin d.": 0.00236, "differentiate neutrophil": 0.00496, "c/ebp-beta": 0.00037, "nontreated platelet": 0.00372, "strategy describe": 0.00397, "vivo footprinting agent reveals": 0.00265, "t-cell-derived chromosome encode": 0.00569, "amol gr mrna/microg rna": 0.00228, "nuclear factor-kappab-dependent induction": 0.01123, "circularization": 0.0, "targeted gene inactivation": 0.02903, "result define essential cis-acting element responsible": 0.00557, "tcf-1 express": 0.01846, "human mzf-2": 0.03762, "cd40 cell": 0.0768, "cell extract": 0.0768, "human t-lymphotropic virus type": 0.01881, "h-2b": 6e-05, "adjacent promoter proximal ap-1-binding site": 0.00934, "alternative type": 0.00949, "demonstrate increased level": 0.01214, "deoxycorticosterone": 6e-05, "transcriptional start site": 0.01445, "ga-binding protein": 0.04529, "nf-kappab/ikappab system regulate": 0.00835, "macrophage inflammatory protein-1alpha": 0.00393, "raf1/mek1/erk1/2 pathway": 0.01278, "intraperitoneal injection": 0.00043, "prolonged degradation": 0.00332, "t-cell receptor gene activation": 0.02177, "proteasomes": 6e-05, "phop-activated gene": 0.04355, "latent cytoplasmic form": 0.00703, "beta-globin gene": 0.04355, "calcium-calmodulin-dependent phosphatase": 0.00264, "p45 nf-e2": 0.00096, "lac+clones": 0.0, "clue": 0.00031, "generate enhance oxidant stress lead": 0.00398, "total number": 0.0053, "cell-specific background": 0.00292, "architectural protein": 0.04529, "informative probe specific": 0.00825, "yeast artificial chromosome contig reveal": 0.00439, "lipopolysaccharide-induced monocyte interleukin-1 receptor antagonist synthesis": 0.00857, "54-year-old woman": 0.00233, "acute myeloid leukemia enhance": 0.00487, "remission": 0.00143, "bursal": 0.00012, "fresh atl cell": 0.0512, "mzf-1 mrna occur": 0.01017, "nuclear protein bind": 0.03019, "hl-60 myeloid leukemia cell line": 0.03072, "-103 region": 0.01467, "transcription factor iid": 0.01907, "persistent relationship": 0.00158, "usual mechanism": 0.01058, "cell-type-independent lipopolysaccharide": 0.00245, "entry": 0.00186, "455-bp u3 region": 0.00978, "applicable": 6e-05, "related simian immunodeficiency virus": 0.00444, "allergic bronchial asthma": 0.00108, "alpha,25-dihydroxyvitamin d3 result": 0.01073, "dex-mediated ikappabalpha induction": 0.01071, "invariant chain": 0.00437, "cytoplasmic inhibitory molecule": 0.00569, "tnfalpha-induced phosphorylation": 0.00983, "emcv": 0.00025, "ngfi-b/nur77 bind": 0.02025, "anti-cd3 mab stimulation": 0.00746, "ige production": 0.01042, "k562 cell induce": 0.0512, "gm-csf promoter": 0.02336, "ten healthy control": 0.00868, "pma treatment induce cd3": 0.0127, "responder cell line": 0.0512, "sv40": 0.00093, "tumor necrosis factor alpha decrease": 0.01144, "low plasma cysteine level": 0.0091, "clear": 0.00093, "chronicity": 0.0, "teniposide": 6e-05, "gene kox": 0.04355, "mutant e6 motif": 0.00583, "adenovirus serotype": 0.00189, "bound peptide": 0.00754, "duffy gene promoter abolishes erythroid gene expression": 0.01189, "detailed analysis": 0.01179, "tnf mrna expression induce": 0.02081, "cis-acting element term": 0.01115, "adult alpha": 0.01169, "clone labile mrna": 0.01017, "stimulus mediate": 0.01231, "tax express": 0.01846, "kappa b-alpha pool": 0.00498, "transfected tissue culture cell": 0.0384, "lr1-dna complex": 0.01684, "positive c-fos expression remain unaffected": 0.01665, "trans-activating signal": 0.01635, "cross-linking cell surface cd3": 0.0384, "phorbol myristate acetate/ionomycin and/or anti-cd3 monoclonal antibody": 0.00255, "protect": 0.00279, "cd4+": 0.00577, "activate pr": 0.01777, "gcr-beta-immunoreactive cell": 0.0768, "immunoblot analysis": 0.01179, "silent dra reporter construct": 0.00363, "generate transgenic mouse express": 0.00923, "induction specific dna bind protein": 0.01811, "megakaryocytic characteristic": 0.00329, "bcl-6 mrna": 0.01526, "distinct promoter": 0.02336, "normal ter": 0.0121, "lbp-1 sequence": 0.01625, "interleukin-12 receptor component": 0.01714, "promoter-enhancer": 0.00043, "death-inducing protein share": 0.03019, "ang ii stimulate nf-kappab activation": 0.01266, "cd11b promoter show": 0.01733, "metastasis reveal": 0.01098, "observed phenomenon": 0.00093, "induce eosinophilic differentiation": 0.01694, "experimental system": 0.00667, "ebna2-dependent transcriptional induction": 0.01071, "elk-1 fusion protein occur": 0.02264, "kappa b/rel family protein": 0.02264, "autoantibody-producing": 6e-05, "bind calcineurin": 0.02025, "ankyrin repeat": 0.00378, "microbial pathogen": 0.0004, "nuclear nf-kappab protein bind": 0.02264, "present peptide bcr1/25": 0.00502, "centimorgan": 6e-05, "rho-family gtpases": 0.00012, "suppress hiv-1 replication": 0.00585, "gr mrna level": 0.01214, "kbf1/p50 factor bind": 0.01907, "inhibit hiv-1 long terminal repeat": 0.00762, "characterized signal pathway": 0.0109, "lbp group": 0.00487, "hemopoietic lineage restriction": 0.00244, "erk-activating stimulus": 0.0027, "non-cross-resisting agent": 0.00422, "connection": 0.00019, "serine/threonine protein": 0.04529, "ebs1": 0.00025, "gene remain unchanged": 0.02903, "erythroid cell": 0.0768, "high incidence": 0.00931, "intrahepatic lymphoid follicle": 0.00273, "multiple distinct allelic family": 0.0042, "monocyte induce": 0.0254, "occupied receptor": 0.02571, "microtubule": 0.00074, "ifn-gamma-stimulated monocyte": 0.01197, "r2": 0.00019, "th2 cell differentiation": 0.0512, "eber-1 locus": 0.00288, "cell receptor positive cell": 0.0192, "surface charge": 0.00515, "potent transactivators": 0.00357, "transcriptional factor nf-kappa": 0.01907, "autoreactive b-cells": 0.00093, "12-o-tetradecanoylphorbol 13-acetate/phytohemagglutinin-stimulated human jurkat": 0.01881, "female show": 0.02599, "gene demonstrate": 0.04355, "c-rich region": 0.01467, "functional interaction": 0.00986, "rapamycin-suppressed e2f response": 0.01294, "consensus motif": 0.00875, "anti-inflammatory cytokine inhibit lps": 0.00952, "similar reactivity": 0.00673, "uv-": 0.00012, "hsv-1-activated cellular factor": 0.01907, "chromatinized viral episome": 0.00488, "3-hydroxy-3-methylglutaryl coenzyme": 6e-05, "akt/pkb activation": 0.03164, "daudi cell increase lmp1 mrna": 0.03072, "part play": 0.0071, "k+ channel": 0.00062, "s.c. lymph node": 0.00052, "polyamine pattern": 0.00549, "hla class ii dependency": 0.00363, "agonist combination": 0.00288, "healthy untrained male volunteer": 0.00088, "young subject type ii receptor": 0.01029, "high local failure rate": 0.00465, "active stat3": 0.00592, "t-cell translocation": 0.00962, "th-dependent positive effect": 0.0141, "exogenous il-4": 0.00667, "mtetra-induced il-1 beta mrna accumulation": 0.0061, "distinguishable": 0.00043, "specific dna target sequence": 0.00813, "protein represent": 0.04529, "ig gene": 0.04355, "multiple initiation site": 0.01445, "cd45-dependent event": 0.00552, "anti-il-10 antibody": 0.00893, "m-csf responsiveness": 0.00323, "important costimulatory molecule": 0.00569, "nuclear autoantigen la/ss-b": 0.01123, "receptor occupancy": 0.02571, "select nf-kappa b-regulated gene": 0.02177, "lymphoproliferative disorder": 0.00223, "primed state": 0.00267, "solution hybridization assay": 0.00668, "fk506 inhibit": 0.01904, "early class": 0.00828, "1,25-dihydroxyvitamin d2": 0.00053, "nfat-1 activity resemble": 0.0195, "block differentiation": 0.01179, "significant specificity": 0.00416, "interferon alpha-": 0.00298, "repressive chromatin organization": 0.00079, "tf site bound": 0.01445, "in-vitro cleavage": 0.00093, "socs-3": 0.00074, "ribosomal entry": 0.00093, "htlv-i encode": 0.00853, "-172": 6e-05, "stress-induced susceptibility": 0.00146, "subsequent adherence": 0.00304, "active raf-1": 0.00592, "dm": 0.00155, "phospholipase c-gamma1": 0.00078, "anti-fos": 0.00037, "beta h1-globin": 0.00673, "positive element": 0.01672, "mzf-1 binding site": 0.01445, "complex mediate": 0.01684, "inhibit leukocyte-endothelial cell interaction": 0.0384, "truncated erythropoeitin receptor": 0.01714, "computerized tomography": 3e-05, "active heterodimers": 0.00592, "hs2 enhancer function": 0.00887, "allele specificity": 0.00335, "cofactor": 0.00155, "ebv-positive b-lymphoblastoid cell line": 0.0384, "ninety-seven percent": 0.00037, "mild oxidation": 0.0004, "rj": 6e-05, "prototypical vitamin d-resistant nwp": 0.00118, "dhs": 0.00037, "patient resemble": 0.01666, "primary lymphocyte model": 0.00988, "peptide carry": 0.00754, "bso enhance as2o3-induced atp depletion": 0.0039, "hiv-tf1": 0.00056, "cd16- counterpart cell": 0.0512, "chimera transduce il-4-specific signal": 0.00817, "peptide g76": 0.00754, "mediate nf-kappab activation": 0.02109, "heme-treated": 0.00037, "relative importance": 0.00276, "-181": 0.00012, "microgram": 0.00037, "21-bp element": 0.01672, "decrease kappab binding activity induce": 0.0117, "murine interleukin": 0.00623, "transfected cdna encode ebf": 0.00426, "anterior pituitary": 0.00065, "mpd": 0.00031, "kappa enhancer": 0.00909, "major sp1 bind site": 0.01084, "monocyte function": 0.01331, "constitutive ets1": 0.00478, "female subject": 0.00354, "pathological process": 0.00444, "switch gear": 0.00245, "complex process": 0.01684, "cell division control": 0.0512, "multipotent progenitor cell line": 0.0384, "steroid action include": 0.00959, "follicular dc": 0.00202, "relb": 0.00236, "calcineurin substrate": 0.00316, "igh-luciferase construct": 0.00726, "thioanhydride": 0.0, "helm": 0.0, "paf-receptor antagonist inhibit": 0.0127, "genomic sequence reveal": 0.01084, "scd8": 6e-05, "sexual difference": 0.00425, "change affect": 0.00797, "development factor": 0.0286, "convergent signal transduction pathway": 0.00817, "cellular kinase ikappab kinase alpha": 0.00468, "deltaspl234": 0.00025, "b-cell-specific promoter": 0.02336, "varicella-zoster virus glycoprotein": 0.00591, "ecto-5'-nt core promoter": 0.01557, "-inducible enhancer": 0.00909, "transient expression assay link zta expression": 0.00694, "human rbc": 0.03762, "full-length c-rel": 0.00245, "decrease proteasome-mediated degradation": 0.00647, "chimeric ebna2 protein": 0.03019, "proliferation rate": 0.00803, "bcl-6+ cell": 0.0768, "relevant role": 0.01328, "ebna gene transcription": 0.02903, "alpha chain gene": 0.02903, "ets1 transactivation": 0.00515, "progesterone-induced blocking factor": 0.01907, "sodium salicylate inhibit lps-induced nf-kappa b/c-rel nuclear translocation": 0.00476, "regulate cellular immunity": 0.00835, "rest raji cell": 0.0512, "diversification": 0.00025, "describe result demonstrate": 0.01073, "antagonism": 0.00074, "cell line express cell surface mu/kappa": 0.0128, "ataxia telangiectasia patient": 0.0111, "2-8 min": 0.00127, "gm-csf promoter cbf site tgtggtca": 0.00934, "include monocyte": 0.01439, "stable chromatin-integrated yeast cell": 0.0384, "th2 immune response determine": 0.00971, "antioxidant defence": 0.00251, "transfected hela cell": 0.0512, "red cell production": 0.0512, "ferritin h-chain gene": 0.02903, "multiple protein exhibit arre-2 binding activity": 0.0151, "woman young": 0.00233, "sodium phenylacetate induce erythroid differentiation": 0.01016, "soluble cd4 abrogate": 0.00221, "regulate adenoviral gene expression": 0.02177, "mammalian type-c retrovirus": 0.00116, "enhance dra gene transcription": 0.02177, "hiv long terminal repeat-driven transcription": 0.01124, "sry-related gene sox9": 0.02903, "nef-expressing t-cell line": 0.01102, "gr concentration": 0.0067, "cell antigen receptor-stimulated protein tyrosine kinase": 0.0256, "tnf-alpha receptor": 0.02571, "human endothelial cell": 0.0512, "proximal ccaat box": 0.00203, "intestinal permeability": 0.00078, "virus-infected": 0.00074, "tnf-alpha gene induce": 0.02903, "igh gene regulation": 0.02903, "adult peripheral blood": 0.00395, "mineralocorticoid aldosterone exert": 0.00194, "atl-16t cell express mrna": 0.0384, "fc gamma riia": 0.00294, "distinct activation": 0.03164, "ifn-gamma activation site-like sequence": 0.01582, "beta-globin locus lcr": 0.00192, "viral mechanism": 0.01058, "lymphoid-specific enhancer element": 0.01115, "global tcr/cd3-signaling defect": 0.00186, "human scl locus": 0.02508, "ab supershift assay reveal": 0.00549, "neutrophil stimulation": 0.0112, "cocl2": 0.00025, "ms.": 6e-05, "u937 monocytic cell line": 0.0384, "tcr-stimulated apoptosis require expression": 0.02081, "dse": 0.00074, "transcription-activating domain": 0.01207, "lps activation": 0.03164, "infectious progeny virion": 0.00064, "myeloid cell specific": 0.0512, "chimeric receptor express": 0.01714, "cell-specific negative regulatory element": 0.00836, "binding complex similar": 0.01237, "permanent": 0.0013, "lps-mediated saa gene induction": 0.02177, "activate region": 0.01777, "cryptococcal stimulation": 0.0112, "lymphotropic herpesvirus": 0.00074, "bal content": 0.00158, "fnf-e2 promoter": 0.02336, "herpes simplex virus immediate-early gene": 0.01742, "jurkat cell extract": 0.0512, "complete inhibition occur": 0.00707, "cd40 surface expression": 0.02775, "therapeutic modality": 0.00167, "night": 0.0, "takahashi": 0.00012, "p50 epitope": 0.00288, "4-bp mutation": 0.00592, "human disease syndrome": 0.02508, "antibody d07 reveal marked overexpression": 0.00439, "stat3 activation": 0.03164, "rel-related complementary dna": 0.00988, "visceral tsc2 expression": 0.02775, "phasing analysis demonstrate": 0.01065, "pkc-dependent": 0.00074, "hyperpolarization": 0.00019, "-reporter gene construct": 0.02903, "stringent cut-off": 0.00022, "nf-kappa b-binding activity": 0.0195, "confirm": 0.0067, "thymic dc": 0.00202, "restricted tissue distribution": 0.00443, "ccaac": 6e-05, "-induced degradation": 0.00332, "comparative mapping": 0.00099, "ifn-gamma production induce": 0.01694, "distinct agent": 0.00698, "hiv evolution": 0.00592, "persistent hypophosphatemia": 0.00124, "low shear": 0.00707, "specific block": 0.01238, "male": 0.00161, "unique mechanism": 0.01058, "fos kinase phosphorylates c-fos": 0.00594, "group term sit": 0.00325, "beta degradation occur downstream": 0.00337, "extrathymic t-cell precursor": 0.00641, "unusual heterologous syncytium": 0.00085, "heterozygote": 0.00019, "potentiate tnfr1-mediated death": 0.0017, "m1-cat": 0.00012, "collagenase transcription": 0.0281, "computer analysis": 0.01179, "-245": 0.00031, "il-1 receptor-associated protein kinase": 0.02264, "as2o3": 0.00068, "pml/raralpha impairs myelopoiesis": 0.00052, "cycloheximide display": 0.00499, "finding offer important insight": 0.00344, "pibf": 0.00025, "hiv pathogenesis": 0.00592, "virus-infected human": 0.03762, "n-terminal half": 0.00202, "mtbe": 0.0005, "mature monocytic leukemia cell line thp-1": 0.0256, "chemotactic": 0.00149, "site-specific antibody": 0.00893, "human mhc hla-dra class ii gene": 0.01452, "ethanol": 0.00056, "nfat-1 mutant ltr": 0.0054, "-1011": 0.0, "steroid-resistant bronchial asthmatic subject": 0.00177, "monoclonal anti-d reagent": 0.00186, "nhl": 0.00056, "mrna differential display reverse transcriptase pcr": 0.00509, "c-fes promoter result": 0.01557, "chronic rejection": 0.00397, "mutation affect": 0.00797, "tf promoter": 0.02336, "situ hybridization pattern": 0.00366, "initiate innate defense mechanism": 0.00529, "critical inflammatory mediator": 0.00314, "rt-pcr-based approach": 0.00164, "downstream regulatory region": 0.00978, "kruppel-like zinc finger": 0.00118, "show homology": 0.02599, "dhcc": 0.00025, "dr haplotype": 0.00059, "peripheral level": 0.01821, "finding provide insight": 0.0043, "hbmp-2-induced smad1/smad5 phosphorylation": 0.00656, "footprinting experiment": 0.00397, "trigger occupation": 0.00409, "il-3-dependent pro-b cell": 0.0512, "rare disorder characterize": 0.00283, "university": 6e-05, "mouse lung tissue": 0.00649, "tnf gene induction": 0.02903, "non-pregnant woman": 0.00233, "e2f": 0.00385, "vertebrate development": 0.00633, "hour": 0.0023, "cell-specific otf-2": 0.00292, "oligonucleotides carry base substitution": 0.00155, "activate hiv-1-ltr-driven transcription": 0.01873, "perforin": 0.00025, "spermatogenesis": 6e-05, "body fat": 0.00136, "neutrophil-like hl60 cell bind": 0.0384, "gasd/ebsd element": 0.01672, "p38 pathway": 0.01278, "physiological level": 0.01821, "thrombin responsiveness": 0.00323, "membrane viability": 0.0045, "social variable": 0.00155, "ligand-dependent recruitment": 0.00164, "cell decrease pkr expression": 0.0384, "gold compound": 0.0022, "initiate tcr gene rearrangement": 0.02177, "undetectable basal level": 0.01214, "phorbol ester stimulate": 0.00734, "type ii estrogenic receptor": 0.01286, "inhibitory protein mad3/i kappa": 0.02264, "cell line base": 0.0512, "oligomer peak": 0.00143, "reporter show": 0.02599, "pp-2a-opposing kinase": 0.01188, "murine macrophage inflammatory protein": 0.02264, "disease state include septic shock": 0.00576, "gc-dependent enhancement": 0.00233, "anti-allergic/hypereosinophilic agent": 0.00422, "leukemic cell proliferation": 0.0512, "plasmid express taxi": 0.0123, "palindromic binding site": 0.01445, "target cell hla-dr expression induce": 0.03072, "t-cell dysfunction": 0.00962, "ltr-driven cat expression vector confirm": 0.01665, "silastic membrane": 0.0045, "lie": 0.00093, "human myeloid differentiation": 0.02508, "protooncogene c-fos": 0.00471, "monocyte cell line": 0.0512, "physical property": 0.00397, "human ip-10 promoter region": 0.01881, "conformational change": 0.0063, "signal-dependent manner": 0.00282, "low saturation density": 0.00471, "augmentation": 0.00099, "stat1 bind": 0.02025, "antiinflammatory mechanism": 0.01058, "ap-1 family protein": 0.03019, "intronic dhs": 0.00028, "ets proto-oncogene family": 0.0056, "important negative role": 0.00885, "induced nfkappab": 0.0054, "sri responder differ": 0.00128, "human p65 subunit": 0.02508, "yield high activity": 0.0195, "lfa-3": 0.00081, "htlv-i-bearing cell line test": 0.0384, "ikk2": 0.0005, "diffuse": 0.00081, "distal element upstream": 0.01115, "predominance": 0.00056, "lymphocyte demonstrate": 0.01597, "sucrose gradient fraction": 0.00114, "mutational analysis show": 0.01733, "ciita function": 0.01331, "3.5-10 nm": 0.00093, "osteolytic bone lesion": 0.00143, "lp signal receptor": 0.01714, "cd28 -or cd3-activated": 0.00215, "mm edta": 0.00118, "e1a-negative cell": 0.0768, "controlled phase": 0.00276, "rb-transformed cell line": 0.0512, "cd14-mediated signal transduction": 0.0109, "cell migration": 0.0768, "type ii receptor decrease": 0.01286, "report expression profile": 0.02775, "celiac disease": 0.00673, "exercise protocol": 0.0005, "subsequent internalization": 0.00304, "selectively increased antiproliferative effect": 0.01058, "fgf receptor-1": 0.00047, "normal mammary gland": 0.00806, "specific mab": 0.01238, "progesterone-induced lymphocyte factor": 0.01907, "multiple intracellular protein": 0.03019, "383-bp": 0.00012, "cell interleukin-2 receptor expression": 0.0384, "predominant androgen secrete": 0.00139, "t3 -group show": 0.01733, "drastic effect": 0.02115, "diesel exhaust particle": 0.0005, "anti-inflammatory": 0.00261, "active ocim1 cell": 0.0512, "alpha-interferon therapy": 0.00372, "p98 precursor share functional property": 0.00326, "cinc": 6e-05, "pseudomonas aeruginosa": 0.00016, "ad5-induced inhibition": 0.01061, "histone h4 mark": 0.00089, "histamine activate": 0.01777, "cd8+ cell-derived supernatant": 0.00093, "increased pcdd/pcdf-body burden": 0.00242, "cd40 triggering": 0.00372, "poor prognosis": 0.0004, "decreased concentration": 0.0067, "menopause": 0.00019, "sh2 domain-binding phosphotyrosine-based motif": 0.00437, "unidentified ets-like factor present": 0.0143, "ra-responsive reporter gene": 0.02903, "hs-40 enhancer motif": 0.00606, "heterologous dc-t-cell syncytium": 0.00085, "induce il-2 secretion": 0.01694, "differential binding affinity": 0.01237, "weak agonist": 0.0022, "overt apl": 0.00124, "show impaired uv-induced tyrosine phosphorylation": 0.0104, "cross-competition electrophoretic mobility shift assay": 0.00401, "generate conditional ebv mutant": 0.00405, "u937 monocyte": 0.01197, "active functional state": 0.00544, "cell form 7-": 0.0512, "detectable basal phosphorylation": 0.00656, "elbow": 0.00012, "jun/fos early response gene expression": 0.01742, "runt domain-encoding pebp2 alpha gene": 0.01742, "nitroso": 6e-05, "pb precursor": 0.00323, "immunological parameter": 0.00127, "h-2kb promoter": 0.02336, "induce severe gut inflammation": 0.0127, "enhancer positive regulatory element": 0.00836, "promote high level": 0.01214, "il-4-dependent induction": 0.01607, "putative glycolipid": 0.00372, "c. neoformans": 0.00143, "transient overexpression": 0.00382, "internal methionine codon": 0.00058, "genomic sequence upstream": 0.01084, "cell line b104": 0.0512, "gm3 block recombinant": 0.00715, "plasma t4": 0.00375, "virus dna": 0.01483, "cd25 receptor": 0.02571, "viral promoter switch": 0.01557, "human herpesvirus-6": 0.03762, "activate tre-1": 0.01777, "dual-target fluorescence in-situ hybridization": 0.00078, "measure small difference": 0.00283, "hiv-1 entry": 0.00878, "ptt": 0.00025, "dra gene": 0.04355, "alpha-fluoromethyl": 0.0, "oct binding protein": 0.03019, "constitutive transcription factor sp1": 0.0143, "human il-10": 0.03762, "interleukin-1 alpha production": 0.0078, "gr-mediated transrepression": 0.00025, "eligible high risk woman": 0.00465, "clinical correlation": 0.00425, "plasma cell differentiation phosphorylation": 0.0384, "h-rs cell": 0.0768, "potential transcription factor bind site": 0.01144, "lymphotoxin alpha": 0.01169, "p65 subunit bind": 0.0135, "dna bind": 0.02025, "hyperplastic germinal center": 0.00074, "nf-atc/c": 6e-05, "eukaryotic rna polymerase ii": 0.00363, "morphologic feature": 0.00217, "polyclonal": 0.0023, "relative quantification": 0.00276, "result support": 0.0161, "clip": 0.00025, "additional factor require": 0.01907, "chronic rheumatic disease": 0.00449, "endothelial hypoxia provide": 0.0043, "activated tnfrii": 0.00589, "phorbol myristate acetate-": 0.00362, "appraisal": 6e-05, "3h-labelled": 6e-05, "vitro cd4 cross-linking": 0.00523, "human t-cell type": 0.02508, "apparent lack": 0.00633, "target ag": 0.00825, "pml-rar alpha enhance": 0.0078, "induced phosphorylation": 0.00983, "elderly": 0.00136, "asthmatic patient": 0.01666, "icam-i gene": 0.04355, "cd48 gene demonstrate": 0.02903, "leukocyte activation": 0.03164, "tolerant blood monocyte": 0.00798, "unwanted": 0.00019, "complex group": 0.01684, "diploid state": 0.00267, "human gamma-globin gene": 0.02903, "eosinophil-committed hl-60-c15 cell": 0.0512, "homotypic cell adhesion": 0.0512, "variant": 0.00552, "v3 region": 0.01467, "tartrate resistant acid phosphatase positive": 0.00342, "predominant factor bind": 0.01907, "succinimide intermediate": 0.00118, "octamerlike motif": 0.00875, "constitutive expression c-fos": 0.02775, "cell-specific tyrosine kinase": 0.00792, "disease expression": 0.04163, "regulate interferon": 0.01253, "obvious regulation": 0.01008, "cell phenotype": 0.0768, "transgenic versus control mouse reveal": 0.00521, "il-2-dependent": 0.00093, "mcp-1 rna level": 0.01214, "fcm": 0.00031, "apoplexy patient": 0.01666, "-en-20-one": 0.0, "gralpha-induced transactivation": 0.00515, "human gene": 0.04355, "aggarwal": 0.00012, "-200": 0.00012, "v-abl kinase inactivation": 0.00792, "equivalent increase": 0.02196, "t-cell subtypes": 0.00962, "cytokine receptor": 0.02571, "biophysical": 0.00019, "il-2-r alpha promoter": 0.01557, "late g1": 0.00254, "disordered memory": 0.00133, "macrophage provide": 0.00645, "il-2/il-15": 6e-05, "term gcr-beta": 0.00413, "hypersensitive element": 0.01672, "il-6 regulation": 0.01008, "normal regard t4": 0.00806, "megakaryocytopoiesis": 0.00025, "vitamin derivative": 0.00236, "lps stimulation selectively activate p38alpha": 0.00711, "protein bind": 0.04529, "alpha-chain receptor": 0.02571, "decreased estrogen receptor concentration": 0.01286, "cd34+ hpc": 0.00087, "plzf-rar alpha apls": 0.0078, "macrophage regard": 0.00589, "total human": 0.03762, "consensus ap-1 tre": 0.00463, "il-10 inhibited translocation": 0.00343, "form homo-": 0.01055, "human transcriptional activator": 0.02508, "complete lymphocyte suppression": 0.00988, "ikappabalpha degradation": 0.00332, "promiscuous transcriptional activity": 0.0195, "cultured endothelial cell induce cellular oxidant stress": 0.02194, "clinical evidence": 0.00425, "early step": 0.00828, "epo-induced erythroid colony growth": 0.00409, "suppressor function": 0.01331, "cellular repressor": 0.00893, "1,25-dihydroxy-vitamin d3": 0.00245, "bmlf1 transcript": 0.00599, "caspase-1-like": 0.00012, "-177 relative": 0.00276, "genotype tt": 0.0004, "mitogen-": 0.00031, "gal4 bind site": 0.01445, "flexible regulatory mechanism": 0.00705, "class ii major histocompatibility complex gene": 0.01452, "megakaryocytic cell surface marker": 0.0384, "ltr-directed gene expression increase": 0.02177, "afr": 0.00025, "precise mechanism lead": 0.00705, "intermediary factor": 0.0286, "sv40 core sequence compete": 0.00813, "hbd": 0.00068, "b-cell-specific factor": 0.0286, "costimulatory receptor cd28": 0.01714, "meeting dsm-iii-r criterion": 0.00031, "silent mutation": 0.00592, "phorbol ester-treated jurkat cell": 0.0384, "cr3 induces": 0.00803, "stat5 gene": 0.04355, "half-life": 0.00093, "host response": 0.01942, "ebv-negative b-lymphoma cell line bjab": 0.03072, "cd28 engagement occur": 0.00436, "detect bind": 0.02025, "weak rbp-jkappa-binding site": 0.01445, "macrophage form": 0.01055, "suppressive nfat1 activity": 0.0195, "network aspect": 0.00124, "developing brain": 0.00084, "primary hyperparathyroidism": 0.00738, "inhibit il-2 secretion": 0.0127, "activation-responsive element": 0.01672, "pma/a23187 stimulation": 0.0112, "microsomal p-nitrophenyl sulfatase activity": 0.01462, "pre-b-": 6e-05, "systematic dna footprinting": 0.00988, "metabolic cascade": 0.00214, "monocyte inhibit ifn alpha-stimulated tyrosine phosphorylation": 0.00635, "promising": 0.00019, "il-6 gene promoter": 0.02903, "receive continued adjuvant tamoxifen treatment": 0.00406, "atf/cre site": 0.02168, "baseline unstimulated state": 0.00178, "pp65-derived peptide": 0.00754, "drug protect": 0.00338, "tpa-dependent activation": 0.03164, "ldl-enhanced endothelial recruitment": 0.00289, "adjacent regulatory region": 0.00978, "ets-1-containing complex": 0.01684, "nf-kappab function": 0.01331, "include specific cell-surface receptor": 0.01286, "mutation present": 0.00735, "cholera toxin display": 0.00333, "t3 administration": 0.00118, "northern blot analysis": 0.00786, "subsequent addition": 0.00673, "water": 0.0005, "granulocyte lineage": 0.00366, "dtcs": 0.00031, "apparent m.w": 0.00192, "jurkat cell": 0.0768, "detailed structural analysis": 0.00786, "underlie etiology": 0.00217, "fc3": 0.00025, "taxol": 0.00012, "a-myb genome": 0.0014, "individual pkc isotypes": 0.00273, "recombinant gp41": 0.00391, "kinase isoform erk2": 0.00792, "serum stimulation": 0.0112, "increase glucocorticoid receptor beta": 0.01286, "altered differentiation status": 0.00786, "z/c-myb combination": 0.00288, "human immunoglobulin heavy-chain enhancer": 0.01881, "repressor region": 0.01467, "initiate early tcr-mediated signal event": 0.00654, "tt": 0.00012, "homo-": 0.00062, "segment -326": 0.00189, "erythroid gene expression": 0.02903, "mechanisms": 0.00031, "mineralocorticoid binding site grows": 0.01084, "n.ringertz": 0.00012, "vegeto": 6e-05, "positive feedback loop": 0.00312, "ht29": 0.00031, "undergo proteolytic processing": 0.00153, "hyporesponsiveness": 0.00037, "mitogen-induced": 0.00019, "present suggests": 0.00735, "il-2 gene expression show": 0.02177, "ifn-gamma treated u937 cell": 0.0384, "air-1 locus defect correlate": 0.00327, "transcription factor nuclear factor kappab": 0.01124, "il4r complex": 0.01684, "lymphocyte infiltrate": 0.01483, "suggest antigen specific": 0.01348, "immunoglobulin heavy-chain gene": 0.02903, "tryptophan": 0.00062, "pkc-dependent signal system": 0.0109, "brca1": 0.0013, "nk cell activity": 0.0512, "potent 15-mer": 0.00357, "gabp factor": 0.0286, "ras-dependent": 0.00031, "bcl-2 family": 0.00841, "non-pregnant endometrium": 0.00034, "enhance hiv-1 long terminal repeat": 0.0039, "favor expansion": 0.00099, "motif differ": 0.00875, "detect change": 0.00726, "low-level ifn production": 0.00695}